Citrus Sinensis ID: 001440

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------800-------810-------820-------830-------840-------850-------860-------870-------880-------890-------900-------910-------920-------930-------940-------950-------960-------970-------980-------990------1000------1010------1020------1030------1040------1050------1060------1070------108
Protein Sequence
MVLANLKNEFGIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI
Secondary Structure (PSIPRED)
ccccccHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHccccccccccccccccccccccccccEEEEEEccccccEEEEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEcccccccccccccEEEccccccEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccEEccccccccccccccEEEEccccccccccccccccccccEEcccccccccccHHHHccccccEEEcccccccccccHHHHcccccccEEccccccEEEccccccccccccEEEcccccccccccccccccccccEEEccccEEEEccccccccccccccccccccEEEEEcccccccccccEEEcccccccccccccccccccccEEEccccEEEEcccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccEEEcccccccccccHHHHccccccEEEcccccccccccHHccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccHHHHHHHHcccccccEEccccccEEEEEEEccccEEEEEEEcccccccccccHHHHHHHHHHccccccccccEEEEEEcccccEEEEcccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEcccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccccHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHccccccccccccccccccccccccccEEEEEEcccccEEEEEEccccccccccHHHHccccccEEEEccEccEEccccHHHHHcccccEEEEEEccEEccccHHHHHcccccEEEEEEEccEEEccccccccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEccccccccccHHHHcccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHHccccccEEEccccccEEEccHHHHcccccEEEEEccccccccccccccccccEEEEEccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHccccccEEEcccccccccccHHHcccccEEEEEcccccccccccHHHHHHHcccEEEcccccccccccHHHHHccccEEEEEcccccccccccccHHccccHHHHccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHHcccccccEEEccccEEEEEEEcccccEEEEEEccccccccccccHHHHHHHHHHHHHHHHHHHHHHEEccccccEEEEEEccccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEccccccEEEcccccHHHHHccHHEEEccccccccEEEccccccccHHcEEEEEcccccHHHHHHHHHHHHcccccccccEEcccccccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHcc
Coil and Loop (DISEMBL)
mvlanlknefGIFSLILLILfpaldfplivssnstEEAHALLKWKTSLqnhnnkgsflpswtlnnatkispcawfgihcnhagkvnsinltsagligtlhdfsfssfphlayldlrvnqifgiipsqiannsklkyldlssnsfsgtippqignlSMLKILYLStnqfsgrippqighLSYLKALHLFenglsgsippslgnltNLAIMYLYNnslsgsipseignlkslsglelgynklsgsmplslgnlpnlatldlhdnslsgsiplsfgnltnldilnlphnslsgsipsemgnlkSLYGLGlsfnklsgsipsslgnltKLTILYLsdnllfgsipceignLRYLFYLELgdnklsgsiphslgnltNLATLYLFTNLlsgsipseignlnslsdlglsenelsgsipysfgnltNMIVLSIYSNAlsgaipkeygNLVKLTLLVLSYnqlqgpipdlrnlTRLARVRLDrnhltgnisesfgihsnlsyinlshkkfygeisfdwgkfpnlgtldvsannitgilppeigdspqlkvldlssnhivgeipsELGKLRSLIKLTLnrnqfsgqlptELGSLIQLEhldlssnrlsnsipgslGNLVKLYYLNlsnnqfsgeipiklekfihlsdldlshnflgeeipsqvcsmqsLEKLNLAHNNLSGFIPRCFKEMHGLVYIdisynklhgpipnsaafkhapmealqgnkglcgdikgfpsckasksdkqasrKIWVVIVFPLLGSFALLISLIGLFFmfrrrsssqtqqssagnapgflsVLTFDRKIAYEEIVRAtndfdeehcigtggqgSVYRAELSSGEIVAVKKfhspllsemTCQQEFLNEVKSLTEIRHRNIVKFygfcsharhsFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYlhndcfppivyrdissknvlldleyeahvsdfgiskslkpdssnwteLAGTIGYVAPELAYTMkvteksdvySFGVLALEAikgkhprdfissicstssnldrtldeildprlpapscnirdKLISIMEVAIScldenpdsrptmQKVSQLLKI
Flexible Loop (DISEMBL)
MVLANLKNEFGIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLqgpipdlrnLTRLARVRLDRNhltgnisesfgihSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKasksdkqasrKIWVVIVFPLLGSFALLISLIGLFFMFRRRSSSqtqqssagnapgfLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSdfgiskslkpdssNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIkgkhprdfISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCldenpdsrptmqkvsqllki
Low Complexity Region (SEG)
MVLANLKNEfgifslillilfpaldfpliVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIgnlnslsdlglsenelsgsIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMFrrrsssqtqqssAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI
Disordered region (IsUnstruct)
***ANLKNEFGIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL*******MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFP************RKIWVVIVFPLLGSFALLISLIGLFFMF*****************GFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCL*******************
Disordered Region (DISOPRED)
**********GIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDI*********************VIVFPLLGSFALLISLIGLFFMF*********************VLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS******EFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI
Disordered Region (DISEMBL)
MVLANLKNEFGIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSC*********SRKIWVVIVFPLLGSFALLISLIGLFFMFRR************NAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDS*************
Disordered Region (DISPRO)
*VLANLKNEFGIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQN*****SFLPSW******KISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPS********QASRKIWVVIVFPLLGSFALLISLIGLFFMFRRRSS************GFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT*QKVS**LK*
Transmembrane Helix (TMHMM)
oooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVLANLKNEFGIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	1077	2.2.26 [Sep-21-2011]
Q9LP24	1120	Probable leucine-rich rep	yes	no	0.953	0.916	0.479	0.0
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.909	0.937	0.437	0.0
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.955	0.934	0.373	0.0
Q9LVP0	1102	Probable leucine-rich rep	no	no	0.930	0.909	0.378	1e-178
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.956	0.824	0.338	1e-167
O49318	1124	Probable leucine-rich rep	no	no	0.920	0.881	0.364	1e-165
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.886	0.762	0.367	1e-164
P93194	1109	Receptor-like protein kin	N/A	no	0.923	0.897	0.343	1e-161
Q9LHP4	1141	Receptor-like protein kin	no	no	0.904	0.853	0.356	1e-159
Q9SSL9	1123	Leucine-rich repeat recep	no	no	0.931	0.893	0.345	1e-156

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  935 bits (2416), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 524/1093 (47%), Positives = 699/1093 (63%), Gaps = 66/1093 (6%)

Query: 37   EAHALLKWKTSLQNHNNKGSFLPSWT--LNNATKISPCAWFGIHCNHAGKVNSINLTSAG 94
            EA+ALLKWK++  N     S L SW    N  T  S  +W+G+ CN  G +  +NLT+ G
Sbjct: 33   EANALLKWKSTFTN----SSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNTG 88

Query: 95   LIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGN 154
            + GT  DF F S  +LAY+DL +N + G IP Q  N SKL Y DLS+N  +G I P +GN
Sbjct: 89   IEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGN 148

Query: 155  LSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN 214
            L  L +LYL  N  +  IP ++G++  +  L L +N L+GSIP SLGNL NL ++YLY N
Sbjct: 149  LKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYEN 208

Query: 215  SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
             L+G IP E+GN++S++ L L  NKL+GS+P +LGNL NL  L L++N L+G IP   GN
Sbjct: 209  YLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGN 268

Query: 275  LTNLDILNLPHNSLSGSIPSEMGNLK------------------------SLYGLGLSFN 310
            + ++  L L  N L+GSIPS +GNLK                        S+  L LS N
Sbjct: 269  MESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNN 328

Query: 311  KLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
            KL+GSIPSSLGNL  LTILYL +N L G IP E+GN+  +  L+L +NKL+GSIP S GN
Sbjct: 329  KLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGN 388

Query: 371  LTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
            L NL  LYL+ N L+G IP E+GN+ S+ +L LS+N+L+GS+P SFGN T +  L +  N
Sbjct: 389  LKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVN 448

Query: 431  ALSGAIPKEYGNLVKLTLLV------------------------LSYNQLQGPIPD-LRN 465
             LSGAIP    N   LT L+                        L YN L+GPIP  LR+
Sbjct: 449  HLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRD 508

Query: 466  LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
               L R R   N  TG+I E+FGI+ +L++I+ SH KF+GEIS +W K P LG L +S N
Sbjct: 509  CKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNN 568

Query: 526  NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS 585
            NITG +P EI +  QL  LDLS+N++ GE+P  +G L +L +L LN NQ SG++P  L  
Sbjct: 569  NITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSF 628

Query: 586  LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            L  LE LDLSSN  S+ IP +  + +KL+ +NLS N+F G IP +L K   L+ LDLSHN
Sbjct: 629  LTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHN 687

Query: 646  FLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAF 705
             L  EIPSQ+ S+QSL+KL+L+HNNLSG IP  F+ M  L  +DIS NKL GP+P++  F
Sbjct: 688  QLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTF 747

Query: 706  KHAPMEALQGNKGLCGDI---KGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIG 762
            + A  +AL+ N GLC +I   +  P  +  K  K  +  +W+++  P+LG   +L     
Sbjct: 748  RKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVILSICAN 805

Query: 763  LFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSV 822
             F    R+   Q  +++       +S+ + D K  Y++I+ +TN+FD  H IGTGG   V
Sbjct: 806  TFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKV 865

Query: 823  YRAELSSGEIVAVKKFHSPLLSEMT---CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH 879
            YRA L    I+AVK+ H  +  E++    +QEFLNEVK+LTEIRHRN+VK +GFCSH RH
Sbjct: 866  YRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRH 924

Query: 880  SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS 939
            +F++YEY+E GSL  +L+N   A+ L WT+R+NV+KGVA ALSY+H+D   PIV+RDISS
Sbjct: 925  TFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISS 984

Query: 940  KNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
             N+LLD +Y A +SDFG +K LK DSSNW+ +AGT GYVAPE AYTMKVTEK DVYSFGV
Sbjct: 985  GNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGV 1044

Query: 1000 LALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLD 1059
            L LE I GKHP D +SS+ S+S     +L  I D R+  P    R+KL+ ++E+A+ CL 
Sbjct: 1045 LILELIIGKHPGDLVSSL-SSSPGEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQ 1103

Query: 1060 ENPDSRPTMQKVS 1072
             NP+SRPTM  +S
Sbjct: 1104 ANPESRPTMLSIS 1116

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  832 bits (2150), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 476/1089 (43%), Positives = 663/1089 (60%), Gaps = 109/1089 (10%)

Query: 16   ILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWF 75
            +LLI+   L     VS+ + EEA+ALLKWK++  N  +  S L SW   N +     +W+
Sbjct: 30   VLLIISIVLSCSFAVSA-TVEEANALLKWKSTFTNQTS-SSKLSSWVNPNTSSFC-TSWY 86

Query: 76   GIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLK 135
            G+ C+  G +  +NLT+ G+ GT  D     FP            F  +P+       L 
Sbjct: 87   GVACS-LGSIIRLNLTNTGIEGTFED-----FP------------FSSLPN-------LT 121

Query: 136  YLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGS 195
            ++DLS                         N+FSG I P  G  S L+   L  N L G 
Sbjct: 122  FVDLS------------------------MNRFSGTISPLWGRFSKLEYFDLSINQLVGE 157

Query: 196  IPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLA 255
            IPP                        E+G+L +L  L L  NKL+GS+P  +G L  + 
Sbjct: 158  IPP------------------------ELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVT 193

Query: 256  TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
             + ++DN L+G IP SFGNLT L  L L  NSLSGSIPSE+GNL +L  L L  N L+G 
Sbjct: 194  EIAIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGK 253

Query: 316  IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLA 375
            IPSS GNL  +T+L + +N L G IP EIGN+  L  L L  NKL+G IP +LGN+  LA
Sbjct: 254  IPSSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLA 313

Query: 376  TLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGA 435
             L+L+ N L+GSIP E+G + S+ DL +SEN+L+G +P SFG LT +  L +  N LSG 
Sbjct: 314  VLHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGP 373

Query: 436  IPKEYGNLVKLTLLVLSYNQLQGPIPD-------------------------LRNLTRLA 470
            IP    N  +LT+L L  N   G +PD                         LR+   L 
Sbjct: 374  IPPGIANSTELTVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLI 433

Query: 471  RVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGI 530
            RVR   N  +G+ISE+FG++  L++I+LS+  F+G++S +W +   L    +S N+ITG 
Sbjct: 434  RVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGA 493

Query: 531  LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLE 590
            +PPEI +  QL  LDLSSN I GE+P  +  +  + KL LN N+ SG++P+ +  L  LE
Sbjct: 494  IPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLE 553

Query: 591  HLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEE 650
            +LDLSSNR S+ IP +L NL +LYY+NLS N     IP  L K   L  LDLS+N L  E
Sbjct: 554  YLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGE 613

Query: 651  IPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPM 710
            I SQ  S+Q+LE+L+L+HNNLSG IP  FK+M  L ++D+S+N L GPIP++AAF++AP 
Sbjct: 614  ISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPP 673

Query: 711  EALQGNKGLCGDI---KGFPSCKASKSDK-QASRKIWVVIVFPLLGSFALLISLIGLFFM 766
            +A +GNK LCG +   +G   C  + S K    R + + I+ P++G+  +L    G+F  
Sbjct: 674  DAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFIC 733

Query: 767  FRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAE 826
            FR+R+    + + + +    LS+ +FD K+ Y+EI++AT +FD ++ IGTGG G VY+A+
Sbjct: 734  FRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAK 793

Query: 827  LSSGEIVAVKKFHSPL---LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV 883
            L +  I+AVKK +      +S  + +QEFLNE+++LTEIRHRN+VK +GFCSH R++F+V
Sbjct: 794  LPNA-IMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLV 852

Query: 884  YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL 943
            YEY+E GSL  +L N   A++L W +R+NV+KGVA ALSY+H+D  P IV+RDISS N+L
Sbjct: 853  YEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNIL 912

Query: 944  LDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
            L  +YEA +SDFG +K LKPDSSNW+ +AGT GYVAPELAY MKVTEK DVYSFGVL LE
Sbjct: 913  LGEDYEAKISDFGTAKLLKPDSSNWSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLE 972

Query: 1004 AIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPD 1063
             IKG+HP D +S++ S+  +   +L  I D RLP P+  I+++++ I++VA+ CL  +P 
Sbjct: 973  VIKGEHPGDLVSTLSSSPPDATLSLKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQ 1032

Query: 1064 SRPTMQKVS 1072
            +RPTM  +S
Sbjct: 1033 ARPTMLSIS 1041

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  643 bits (1658), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/1106 (37%), Positives = 587/1106 (53%), Gaps = 77/1106 (6%)

Query: 11   GIFSLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKIS 70
            G    + +++  +  F L+ S N  EE   LL++K  L   N+   +L SW   N    +
Sbjct: 3    GRICFLAIVILCSFSFILVRSLN--EEGRVLLEFKAFL---NDSNGYLASW---NQLDSN 54

Query: 71   PCAWFGIHCNHAGKVNSINLTSAGLIGTLHDF--------------SFSSFP-------- 108
            PC W GI C H   V S++L    L GTL                 +F S P        
Sbjct: 55   PCNWTGIACTHLRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLC 114

Query: 109  -HLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQ 167
              L  LDL  N+  G+IP Q+     LK L L  N   G+IP QIGNLS L+ L + +N 
Sbjct: 115  RSLEVLDLCTNRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNN 174

Query: 168  FSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNL 227
             +G IPP +  L  L+ +    NG SG IP  +    +L ++ L  N L GS+P ++  L
Sbjct: 175  LTGVIPPSMAKLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKL 234

Query: 228  KSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNS 287
            ++L+ L L  N+LSG +P S+GN+  L  L LH+N  +GSIP   G LT +  L L  N 
Sbjct: 235  QNLTDLILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQ 294

Query: 288  LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNL 347
            L+G IP E+GNL     +  S N+L+G IP   G++  L +L+L +N+L G IP E+G L
Sbjct: 295  LTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGEL 354

Query: 348  RYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENE 407
              L  L+L  N+L+G+IP  L  L  L  L LF N L G IP  IG  ++ S L +S N 
Sbjct: 355  TLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANS 414

Query: 408  LSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIP-DLRNL 466
            LSG IP  F     +I+LS+ SN LSG IP++      LT L+L  NQL G +P +L NL
Sbjct: 415  LSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNL 474

Query: 467  TRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANN 526
              L  + L +N L+GNIS   G                        K  NL  L ++ NN
Sbjct: 475  QNLTALELHQNWLSGNISADLG------------------------KLKNLERLRLANNN 510

Query: 527  ITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSL 586
             TG +PPEIG+  ++   ++SSN + G IP ELG   ++ +L L+ N+FSG +  ELG L
Sbjct: 511  FTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQL 570

Query: 587  IQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLS-DLDLSHN 645
            + LE L LS NRL+  IP S G+L +L  L L  N  S  IP++L K   L   L++SHN
Sbjct: 571  VYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHN 630

Query: 646  FLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAF 705
             L   IP  + ++Q LE L L  N LSG IP     +  L+  +IS N L G +P++A F
Sbjct: 631  NLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVF 690

Query: 706  KHAPMEALQGNKGLCGDIKGFPSCKASKSDKQ-------ASRKIWVVIVFPLLGSFALLI 758
            +        GN GLC   +         SD +       + R+  + I   ++GS   LI
Sbjct: 691  QRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGS-VFLI 749

Query: 759  SLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRK-IAYEEIVRATNDFDEEHCIGTG 817
            + +GL +  +RR  +          P  +    F +K   Y+ +V AT +F E+  +G G
Sbjct: 750  TFLGLCWTIKRREPAFVALEDQ-TKPDVMDSYYFPKKGFTYQGLVDATRNFSEDVVLGRG 808

Query: 818  GQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA 877
              G+VY+AE+S GE++AVKK +S      +    F  E+ +L +IRHRNIVK YGFC H 
Sbjct: 809  ACGTVYKAEMSGGEVIAVKKLNSR-GEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQ 867

Query: 878  RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDI 937
              + ++YEY+  GSL   L        L W  R  +  G A+ L YLH+DC P IV+RDI
Sbjct: 868  NSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDI 927

Query: 938  SSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIGYVAPELAYTMKVTEKSDVYS 996
             S N+LLD  ++AHV DFG++K +    S + + +AG+ GY+APE AYTMKVTEK D+YS
Sbjct: 928  KSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYS 987

Query: 997  FGVLALEAIKGKHPR-------DFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            FGV+ LE I GK P        D ++ +  +  N+  T+ E+ D RL         ++  
Sbjct: 988  FGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTI-EMFDARLDTNDKRTVHEMSL 1046

Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            ++++A+ C   +P SRPTM++V  ++
Sbjct: 1047 VLKIALFCTSNSPASRPTMREVVAMI 1072

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1

 Score =  627 bits (1616), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 411/1086 (37%), Positives = 584/1086 (53%), Gaps = 84/1086 (7%)

Query: 37   EAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLI 96
            E   LL+ K+   +       L +W  N++    PC W G+ C++               
Sbjct: 30   EGQYLLEIKSKFVDAKQN---LRNWNSNDSV---PCGWTGVMCSN--------------- 68

Query: 97   GTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLS 156
                   +SS P +  L+L    + G +   I     LK LDLS N  SG IP +IGN S
Sbjct: 69   -------YSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCS 121

Query: 157  MLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSL 216
             L+IL L+ NQF G IP +IG L  L+ L ++ N +SGS+P  +GNL +L+ +  Y+N++
Sbjct: 122  SLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNI 181

Query: 217  SGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLT 276
            SG +P  IGNLK L+    G N +SGS+P  +G   +L  L L  N LSG +P   G L 
Sbjct: 182  SGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLK 241

Query: 277  NLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL 336
             L  + L  N  SG IP E+ N  SL  L L  N+L G IP  LG+L  L  LYL  N L
Sbjct: 242  KLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGL 301

Query: 337  FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLN 396
             G+IP EIGNL Y   ++  +N L+G IP  LGN+  L  LYLF N L+G+IP E+  L 
Sbjct: 302  NGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLK 361

Query: 397  SLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
            +LS L LS N L+G IP  F  L  + +L ++ N+LSG IP + G    L +L +S N L
Sbjct: 362  NLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHL 421

Query: 457  QGPIPD-------------------------LRNLTRLARVRLDRNHLTGNISESFGIHS 491
             G IP                          +     L ++RL RN+L G    +     
Sbjct: 422  SGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQV 481

Query: 492  NLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI 551
            N++ I L   +F G I  + G    L  L ++ N  TG LP EIG   QL  L++SSN +
Sbjct: 482  NVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKL 541

Query: 552  VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLV 611
             GE+PSE+   + L +L +  N FSG LP+E+GSL QLE L LS+N LS +IP +LGNL 
Sbjct: 542  TGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLS 601

Query: 612  KLYYLNLSNNQFSGEIPIKLEKFIHLS-DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNN 670
            +L  L +  N F+G IP +L     L   L+LS+N L  EIP ++ ++  LE L L +NN
Sbjct: 602  RLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNN 661

Query: 671  LSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCG-------DI 723
            LSG IP  F  +  L+  + SYN L GPIP     ++  M +  GN+GLCG         
Sbjct: 662  LSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSSFIGNEGLCGPPLNQCIQT 718

Query: 724  KGF-PSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRRSSSQTQQSSAGN 782
            + F PS    K     S KI + I   ++G  +L+  LI L     RR       S+   
Sbjct: 719  QPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVSLM--LIALIVYLMRRPVRTVASSAQDG 775

Query: 783  APGFLSVLTF---DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFH 839
             P  +S+  +        ++++V AT++FDE   +G G  G+VY+A L +G  +AVKK  
Sbjct: 776  QPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLA 835

Query: 840  S--PLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
            S     +       F  E+ +L  IRHRNIVK +GFC+H   + ++YEY+  GSL  IL 
Sbjct: 836  SNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH 895

Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
            + +    L W++R  +  G A  L+YLH+DC P I +RDI S N+LLD ++EAHV DFG+
Sbjct: 896  DPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 953

Query: 958  SKSLK-PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP------ 1010
            +K +  P S + + +AG+ GY+APE AYTMKVTEKSD+YS+GV+ LE + GK P      
Sbjct: 954  AKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQ 1013

Query: 1011 -RDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069
              D ++ + S     D     +LD RL      I   +++++++A+ C   +P +RP+M+
Sbjct: 1014 GGDVVNWVRSYIRR-DALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMR 1072

Query: 1070 KVSQLL 1075
            +V  +L
Sbjct: 1073 QVVLML 1078

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  589 bits (1519), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 419/1239 (33%), Positives = 619/1239 (49%), Gaps = 209/1239 (16%)

Query: 21   FPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCN 80
            F  L  P I+++    +   LL+ K SL  +  +   L  W   N+  I+ C+W G+ C+
Sbjct: 14   FSGLGQPGIINN----DLQTLLEVKKSLVTNPQEDDPLRQW---NSDNINYCSWTGVTCD 66

Query: 81   HAG--KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLD 138
            + G  +V ++NLT  GL G++  + F  F +L +LDL  N + G IP+ ++N + L+ L 
Sbjct: 67   NTGLFRVIALNLTGLGLTGSISPW-FGRFDNLIHLDLSSNNLVGPIPTALSNLTSLESLF 125

Query: 139  LSSNSFSGTIPPQIG------------------------NLSMLKILYLSTNQFSGRIPP 174
            L SN  +G IP Q+G                        NL  L++L L++ + +G IP 
Sbjct: 126  LFSNQLTGEIPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPS 185

Query: 175  QIGHLSYLKALHL------------------------FENGLSGSIPPSLGNLTNLAIMY 210
            Q+G L  +++L L                         EN L+G+IP  LG L NL I+ 
Sbjct: 186  QLGRLVRVQSLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRLENLEILN 245

Query: 211  LYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL 270
            L NNSL+G IPS++G +  L  L L  N+L G +P SL +L NL TLDL  N+L+G IP 
Sbjct: 246  LANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPE 305

Query: 271  SFGNL-------------------------TNLDILNLPHNSLSGSIPSEMGNLKSLYGL 305
             F N+                         TNL+ L L    LSG IP E+   +SL  L
Sbjct: 306  EFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQL 365

Query: 306  GLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSI------------------------P 341
             LS N L+GSIP +L  L +LT LYL +N L G++                        P
Sbjct: 366  DLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLP 425

Query: 342  CEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIG-------- 393
             EI  LR L  L L +N+ SG IP  +GN T+L  + +F N   G IP  IG        
Sbjct: 426  KEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLL 485

Query: 394  ----------------NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
                            N + L+ L L++N+LSGSIP SFG L  +  L +Y+N+L G +P
Sbjct: 486  HLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLP 545

Query: 438  KEYGNLVKLTLLVLSYNQLQGPIP------------------------DLRNLTRLARVR 473
                +L  LT + LS+N+L G I                         +L N   L R+R
Sbjct: 546  DSLISLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLR 605

Query: 474  LDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
            L +N LTG I  + G    LS +++S     G I         L  +D++ N ++G +PP
Sbjct: 606  LGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPP 665

Query: 534  EIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLD 593
             +G   QL  L LSSN  V  +P+EL     L+ L+L+ N  +G +P E+G+L  L  L+
Sbjct: 666  WLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLN 725

Query: 594  LSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHL-SDLDLSHNFLGEEIP 652
            L  N+ S S+P ++G L KLY L LS N  +GEIP+++ +   L S LDLS+N    +IP
Sbjct: 726  LDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIP 785

Query: 653  SQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEA 712
            S + ++  LE L+L+HN L+G +P    +M  L Y+++S+N L G +     F   P ++
Sbjct: 786  STIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKL--KKQFSRWPADS 843

Query: 713  LQGNKGLCGDIKGFPSCKASKSDKQ----ASRKIWVVIVFPLLGSFALLISLIGLFF--- 765
              GN GLCG       C   +S+ +    ++R + ++     L +  L+I +I LFF   
Sbjct: 844  FLGNTGLCG--SPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALFFKQR 901

Query: 766  --MFRRRSSSQTQQS------SAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTG 817
               F++     T  +       A + P F +  +    I +E+I+ AT++  EE  IG+G
Sbjct: 902  HDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGAS-KSDIRWEDIMEATHNLSEEFMIGSG 960

Query: 818  GQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA 877
            G G VY+AEL +GE VAVKK       ++   + F  EVK+L  IRHR++VK  G+CS  
Sbjct: 961  GSGKVYKAELENGETVAVKKILWK--DDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSK 1018

Query: 878  RH--SFIVYEYLEMGSLAMILSNATSAEE-----LGWTQRMNVIKGVADALSYLHNDCFP 930
                + ++YEY++ GS+   L       E     L W  R+ +  G+A  + YLH+DC P
Sbjct: 1019 SEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVP 1078

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP------DSSNWTELAGTIGYVAPELAY 984
            PIV+RDI S NVLLD   EAH+ DFG++K L        DS+ W   A + GY+APE AY
Sbjct: 1079 PIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTW--FACSYGYIAPEYAY 1136

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFI------------SSICSTSSNLDRTLDEIL 1032
            ++K TEKSDVYS G++ +E + GK P D +            + +    S  D+ +D  L
Sbjct: 1137 SLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVRWVETHLEVAGSARDKLIDPKL 1196

Query: 1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             P LP       D    ++E+A+ C   +P  RP+ ++ 
Sbjct: 1197 KPLLPFE----EDAACQVLEIALQCTKTSPQERPSSRQA 1231

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1

 Score =  582 bits (1501), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 387/1061 (36%), Positives = 561/1061 (52%), Gaps = 70/1061 (6%)

Query: 65   NATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGII 124
            N    +PC W G++C+        + +S  L+ T              LDL    + GI+
Sbjct: 59   NGIDETPCNWIGVNCSSQ----GSSSSSNSLVVT-------------SLDLSSMNLSGIV 101

Query: 125  PSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKA 184
               I     L YL+L+ N+ +G IP +IGN S L++++L+ NQF G IP +I  LS L++
Sbjct: 102  SPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRS 161

Query: 185  LHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSM 244
             ++  N LSG +P  +G+L NL  +  Y N+L+G +P  +GNL  L+    G N  SG++
Sbjct: 162  FNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNI 221

Query: 245  PLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYG 304
            P  +G   NL  L L  N +SG +P   G L  L  + L  N  SG IP ++GNL SL  
Sbjct: 222  PTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLET 281

Query: 305  LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI 364
            L L  N L G IPS +GN+  L  LYL  N L G+IP E+G L  +  ++  +N LSG I
Sbjct: 282  LALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEI 341

Query: 365  PHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIV 424
            P  L  ++ L  LYLF N L+G IP+E+  L +L+ L LS N L+G IP  F NLT+M  
Sbjct: 342  PVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQ 401

Query: 425  LSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD---------LRNL--------- 466
            L ++ N+LSG IP+  G    L ++  S NQL G IP          L NL         
Sbjct: 402  LQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNI 461

Query: 467  -------TRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGT 519
                     L ++R+  N LTG          NLS I L   +F G +  + G    L  
Sbjct: 462  PPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQR 521

Query: 520  LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
            L ++AN  +  LP EI     L   ++SSN + G IPSE+   + L +L L+RN F G L
Sbjct: 522  LHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSL 581

Query: 580  PTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLS- 638
            P ELGSL QLE L LS NR S +IP ++GNL  L  L +  N FSG IP +L     L  
Sbjct: 582  PPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQI 641

Query: 639  DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGP 698
             ++LS+N    EIP ++ ++  L  L+L +N+LSG IP  F+ +  L+  + SYN L G 
Sbjct: 642  AMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQ 701

Query: 699  IPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSD-------KQASRKIWVVIVFPLL 751
            +P++  F++  + +  GNKGLCG      SC  S S        K  S +   +I+    
Sbjct: 702  LPHTQIFQNMTLTSFLGNKGLCGG--HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSS 759

Query: 752  GSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTF---DRKIAYEEIVRATNDF 808
                + + LI +   F R     T        P F     +     +   ++I+ AT  F
Sbjct: 760  VIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGF 819

Query: 809  DEEHCIGTGGQGSVYRAELSSGEIVAVKKFH----SPLLSEMTCQQEFLNEVKSLTEIRH 864
             + + +G G  G+VY+A + SG+ +AVKK          +       F  E+ +L +IRH
Sbjct: 820  HDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRH 879

Query: 865  RNIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RNIV+ Y FC H  +  + ++YEY+  GSL  +L    S   + W  R  +  G A+ L+
Sbjct: 880  RNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS-HSMDWPTRFAIALGAAEGLA 938

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-PDSSNWTELAGTIGYVAPE 981
            YLH+DC P I++RDI S N+L+D  +EAHV DFG++K +  P S + + +AG+ GY+APE
Sbjct: 939  YLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPE 998

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS---ICSTSSN--LDRTL-DEILDPR 1035
             AYTMKVTEK D+YSFGV+ LE + GK P   +     + + + N   D +L  EILDP 
Sbjct: 999  YAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWTRNHIRDHSLTSEILDPY 1058

Query: 1036 LPAPSCN-IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            L     + I + +I++ ++A+ C   +P  RPTM++V  +L
Sbjct: 1059 LTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  581 bits (1498), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 377/1026 (36%), Positives = 559/1026 (54%), Gaps = 71/1026 (6%)

Query: 110  LAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS 169
            LA      N++ G +P+++     L+ L+L  NSFSG IP Q+G+L  ++ L L  NQ  
Sbjct: 218  LALFAAAFNRLNGSLPAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNLIGNQLQ 277

Query: 170  GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLK 228
            G IP ++  L+ L+ L L  N L+G I      +  L  + L  N LSGS+P  I  N  
Sbjct: 278  GLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKTICSNNT 337

Query: 229  SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL 288
            SL  L L   +LSG +P  + N  +L  LDL +N+L+G IP S   L  L  L L +NSL
Sbjct: 338  SLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLYLNNNSL 397

Query: 289  SGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLR 348
             G++ S + NL +L    L  N L G +P  +G L KL I+YL +N   G +P EIGN  
Sbjct: 398  EGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCT 457

Query: 349  YLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENEL 408
             L  ++   N+LSG IP S+G L +L  L+L  N L G+IP+ +GN + ++ + L++N+L
Sbjct: 458  RLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQL 517

Query: 409  SGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ------------- 455
            SGSIP SFG LT + +  IY+N+L G +P    NL  LT +  S N+             
Sbjct: 518  SGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSS 577

Query: 456  ----------LQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
                       +G IP +L   T L R+RL +N  TG I  +FG  S LS +++S     
Sbjct: 578  YLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLS 637

Query: 505  GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRS 564
            G I  + G    L  +D++ N ++G++P  +G  P L  L LSSN  VG +P+E+  L +
Sbjct: 638  GIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTN 697

Query: 565  LIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
            ++ L L+ N  +G +P E+G+L  L  L+L  N+LS  +P ++G L KL+ L LS N  +
Sbjct: 698  ILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALT 757

Query: 625  GEIPIKLEKFIHL-SDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH 683
            GEIP+++ +   L S LDLS+N     IPS + ++  LE L+L+HN L G +P    +M 
Sbjct: 758  GEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMK 817

Query: 684  GLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIW 743
             L Y+++SYN L G +     F     +A  GN GLCG      +   SK+ +  S K  
Sbjct: 818  SLGYLNLSYNNLEGKL--KKQFSRWQADAFVGNAGLCGSPLSHCNRAGSKNQRSLSPKTV 875

Query: 744  VVI-VFPLLGSFALLISLIGLFF-----MFRRRSSS---QTQQSSAGNAPGFLSVLTFDR 794
            V+I     L + AL++ +I LFF     +F++        +  SS+  AP F S      
Sbjct: 876  VIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLF-SNGGAKS 934

Query: 795  KIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLN 854
             I +++I+ AT+  +EE  IG+GG G VY+AEL +GE +AVKK       ++   + F  
Sbjct: 935  DIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWK--DDLMSNKSFNR 992

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARH--SFIVYEYLEMGSLAMIL---SNATSAEELGWTQ 909
            EVK+L  IRHR++VK  G+CS      + ++YEY+  GS+   L    N    E LGW  
Sbjct: 993  EVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWET 1052

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
            R+ +  G+A  + YLH DC PPIV+RDI S NVLLD   EAH+ DFG++K L  +    T
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNT 1112

Query: 970  E----LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD 1025
            E     AG+ GY+APE AY++K TEKSDVYS G++ +E + GK P +   ++    +++ 
Sbjct: 1113 ESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE---AMFDEETDMV 1169

Query: 1026 RTLDEILDPRLPAPSCNIRDKLI----------------SIMEVAISCLDENPDSRPTMQ 1069
            R ++ +LD     P    R+KLI                 ++E+A+ C    P  RP+ +
Sbjct: 1170 RWVETVLD---TPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSR 1226

Query: 1070 KVSQLL 1075
            + S+ L
Sbjct: 1227 QASEYL 1232

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2

 Score =  568 bits (1464), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 366/1066 (34%), Positives = 567/1066 (53%), Gaps = 71/1066 (6%)

Query: 60   SWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQ 119
            SW   NA+  +PC+W G+ C+    V+++NL+S G+ G       S   HL  + L  N 
Sbjct: 48   SW---NASDSTPCSWLGVECDRRQFVDTLNLSSYGISGEFGP-EISHLKHLKKVVLSGNG 103

Query: 120  IFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHL 179
             FG IPSQ+ N S L+++DLSSNSF+G IP  +G L  L+ L L  N   G  P  +  +
Sbjct: 104  FFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSI 163

Query: 180  SYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNK 239
             +L+ ++   NGL+GSIP ++GN++ L  ++L +N  SG +PS +GN+ +L  L L  N 
Sbjct: 164  PHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNN 223

Query: 240  LSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNL 299
            L G++P++L NL NL  LD+ +NSL G+IPL F +   +D ++L +N  +G +P  +GN 
Sbjct: 224  LVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNC 283

Query: 300  KSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNK 359
             SL   G     LSG IPS  G LTKL  LYL+ N   G IP E+G  + +  L+L  N+
Sbjct: 284  TSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQ 343

Query: 360  LSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNL 419
            L G IP  LG L+ L  L+L+TN LSG +P  I  + SL  L L +N LSG +P     L
Sbjct: 344  LEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTEL 403

Query: 420  TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPI-PDLRNLTRLARVRLDRNH 478
              ++ L++Y N  +G IP++ G    L +L L+ N   G I P+L +  +L R+ L  N+
Sbjct: 404  KQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNY 463

Query: 479  LTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS 538
            L G++    G  S L  + L      G +  D+ +  NL   D+S NN TG +PP +G+ 
Sbjct: 464  LEGSVPSDLGGCSTLERLILEENNLRGGLP-DFVEKQNLLFFDLSGNNFTGPIPPSLGNL 522

Query: 539  PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
              +  + LSSN + G IP ELG L  L  L L+ N   G LP+EL +  +L  LD S N 
Sbjct: 523  KNVTAIYLSSNQLSGSIPPELGSLVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNL 582

Query: 599  LSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK-----------------------FI 635
            L+ SIP +LG+L +L  L+L  N FSG IP  L +                         
Sbjct: 583  LNGSIPSTLGSLTELTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPPVGALQ 642

Query: 636  HLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
             L  L+LS N L  ++P  +  ++ LE+L+++HNNLSG + R    +  L +I+IS+N  
Sbjct: 643  ALRSLNLSSNKLNGQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLF 701

Query: 696  HGPIPNS-AAFKHAPMEALQGNKGLCGDIKG-----------FPSCKASKSDKQASRKIW 743
             GP+P S   F ++   +  GN  LC +               P    S + K     + 
Sbjct: 702  SGPVPPSLTKFLNSSPTSFSGNSDLCINCPADGLACPESSILRPCNMQSNTGKGGLSTLG 761

Query: 744  VVIVFPLLGSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVR 803
            + ++  +LG+   +I L               Q+ +     G  S+L         +++ 
Sbjct: 762  IAMI--VLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLN--------KVLE 811

Query: 804  ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            AT + ++++ IG G  G++Y+A LS  ++ AVKK     +   +     + E++++ ++R
Sbjct: 812  ATENLNDKYVIGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVS--MVREIETIGKVR 869

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            HRN++K   F     +  I+Y Y+E GSL  IL      + L W+ R N+  G A  L+Y
Sbjct: 870  HRNLIKLEEFWLRKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAY 929

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--TELAGTIGYVAPE 981
            LH DC P IV+RDI   N+LLD + E H+SDFGI+K L   +++     + GTIGY+APE
Sbjct: 930  LHFDCDPAIVHRDIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPE 989

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRD-----------FISSICSTSSNLDRTLD- 1029
             A+T   + +SDVYS+GV+ LE I  K   D           ++ S+ + +  + + +D 
Sbjct: 990  NAFTTVKSRESDVYSYGVVLLELITRKKALDPSFNGETDIVGWVRSVWTQTGEIQKIVDP 1049

Query: 1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             +LD  + +   ++ +++   + +A+ C ++  D RPTM+ V + L
Sbjct: 1050 SLLDELIDS---SVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQL 1092

Possible role in short-day photoperiod floral induction.

Ipomoea nil (taxid: 35883)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1

 Score =  563 bits (1451), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 371/1041 (35%), Positives = 559/1041 (53%), Gaps = 67/1041 (6%)

Query: 65   NATKISPCA-WFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGI 123
            N+   +PC  W  I C+  G +  I++ S  L  +L                        
Sbjct: 62   NSIDNTPCNNWTFITCSSQGFITDIDIESVPLQLSL------------------------ 97

Query: 124  IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK 183
             P  +     L+ L +S  + +GT+P  +G+   LK+L LS+N   G IP  +  L  L+
Sbjct: 98   -PKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLE 156

Query: 184  ALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNK-LSG 242
             L L  N L+G IPP +   + L  + L++N L+GSIP+E+G L  L  + +G NK +SG
Sbjct: 157  TLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISG 216

Query: 243  SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSL 302
             +P  +G+  NL  L L + S+SG++P S G L  L+ L++    +SG IPS++GN   L
Sbjct: 217  QIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSEL 276

Query: 303  YGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG 362
              L L  N LSGSIP  +G LTKL  L+L  N L G IP EIGN   L  ++L  N LSG
Sbjct: 277  VDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSG 336

Query: 363  SIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNM 422
            SIP S+G L+ L    +  N  SGSIP+ I N +SL  L L +N++SG IP   G LT +
Sbjct: 337  SIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKL 396

Query: 423  IVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD----LRNLTRLARVRLDRNH 478
             +   +SN L G+IP    +   L  L LS N L G IP     LRNLT+L  +    N 
Sbjct: 397  TLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLI---SNS 453

Query: 479  LTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS 538
            L+G I +  G  S+L  + L   +  GEI    G    +  LD S+N + G +P EIG  
Sbjct: 454  LSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSC 513

Query: 539  PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
             +L+++DLS+N + G +P+ +  L  L  L ++ NQFSG++P  LG L+ L  L LS N 
Sbjct: 514  SELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNL 573

Query: 599  LSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLS-DLDLSHNFLGEEIPSQVCS 657
             S SIP SLG    L  L+L +N+ SGEIP +L    +L   L+LS N L  +IPS++ S
Sbjct: 574  FSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIAS 633

Query: 658  MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNK 717
            +  L  L+L+HN L G +      +  LV ++ISYN   G +P++  F+    + L+GNK
Sbjct: 634  LNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNK 692

Query: 718  GLCGDIKG-----FPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRRSS 772
             LC   +      +        D  ASR   + +   LL +  +++ ++G   + R R +
Sbjct: 693  KLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRN 752

Query: 773  SQTQQSSAGNAPGFLSVLTFDR-KIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGE 831
               ++ S            F +   + ++I+R      E + IG G  G VYRA++ +GE
Sbjct: 753  IDNERDSELGETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSGVVYRADVDNGE 809

Query: 832  IVAVKKFHSPLLS----EMT--CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE 885
            ++AVKK    +++    E T   +  F  EVK+L  IRH+NIV+F G C +     ++Y+
Sbjct: 810  VIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYD 869

Query: 886  YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD 945
            Y+  GSL  +L +      L W  R  ++ G A  L+YLH+DC PPIV+RDI + N+L+ 
Sbjct: 870  YMPNGSLGSLL-HERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIG 928

Query: 946  LEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
            L++E +++DFG++K +           +AG+ GY+APE  Y+MK+TEKSDVYS+GV+ LE
Sbjct: 929  LDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLE 988

Query: 1004 AIKGKHPRD--------FISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAI 1055
             + GK P D         +  +     +L+  LD  L  R  A +    D+++ ++  A+
Sbjct: 989  VLTGKQPIDPTVPEGIHLVDWVRQNRGSLE-VLDSTLRSRTEAEA----DEMMQVLGTAL 1043

Query: 1056 SCLDENPDSRPTMQKVSQLLK 1076
             C++ +PD RPTM+ V+ +LK
Sbjct: 1044 LCVNSSPDERPTMKDVAAMLK 1064

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1

 Score =  554 bits (1428), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 370/1070 (34%), Positives = 570/1070 (53%), Gaps = 67/1070 (6%)

Query: 60   SWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQ 119
            +W +N A++ +PC WFGI C+ +  V S+N T + + G L          L  LDL  N 
Sbjct: 53   TWKIN-ASEATPCNWFGITCDDSKNVASLNFTRSRVSGQLGP-EIGELKSLQILDLSTNN 110

Query: 120  IFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHL 179
              G IPS + N +KL  LDLS N FS  IP  + +L  L++LYL  N  +G +P  +  +
Sbjct: 111  FSGTIPSTLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYLYINFLTGELPESLFRI 170

Query: 180  SYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNK 239
              L+ L+L  N L+G IP S+G+   L  + +Y N  SG+IP  IGN  SL  L L  NK
Sbjct: 171  PKLQVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPESIGNSSSLQILYLHRNK 230

Query: 240  LSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNL 299
            L GS+P SL  L NL TL + +NSL G +     N  NL  L+L +N   G +P  +GN 
Sbjct: 231  LVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDLSYNEFEGGVPPALGNC 290

Query: 300  KSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNK 359
             SL  L +    LSG+IPSSLG L  LTIL LS+N L GSIP E+GN   L  L+L DN+
Sbjct: 291  SSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQ 350

Query: 360  LSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNL 419
            L G IP +LG L  L +L LF N  SG IP EI    SL+ L + +N L+G +P     +
Sbjct: 351  LVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEM 410

Query: 420  TNMIVLSIYSNALSGAIPKEYG---------------------NLV---KLTLLVLSYNQ 455
              + + ++++N+  GAIP   G                     NL    KL +L L  N 
Sbjct: 411  KKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNL 470

Query: 456  LQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF 514
            L G IP  + +   + R  L  N+L+G + E    HS LS+++ +   F G I    G  
Sbjct: 471  LHGTIPASIGHCKTIRRFILRENNLSGLLPEFSQDHS-LSFLDFNSNNFEGPIPGSLGSC 529

Query: 515  PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
             NL ++++S N  TG +PP++G+   L  ++LS N + G +P++L    SL +  +  N 
Sbjct: 530  KNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNS 589

Query: 575  FSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK---L 631
             +G +P+   +   L  L LS NR S  IP  L  L KL  L ++ N F GEIP     +
Sbjct: 590  LNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLI 649

Query: 632  EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
            E  I+  DLDLS N L  EIP+++  +  L +LN+++NNL+G +    K +  L+++D+S
Sbjct: 650  EDLIY--DLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVS 706

Query: 692  YNKLHGPIPNSAAFK-HAPMEALQGNKGLC---------GDIKGFPSCKASKSDKQASRK 741
             N+  GPIP++   +  +   +  GN  LC                 CK     +++   
Sbjct: 707  NNQFTGPIPDNLEGQLLSEPSSFSGNPNLCIPHSFSASNNSRSALKYCKDQSKSRKSGLS 766

Query: 742  IWVVIVFPLLGSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEI 801
             W +++  +L S  +L+ ++ L F+  RR   + ++ +      ++        +   ++
Sbjct: 767  TWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPEKDA------YVFTQEEGPSLLLNKV 820

Query: 802  VRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            + AT++ +E++ IG G  G VYRA L SG++ AVK+      S +   Q  + E+ ++ +
Sbjct: 821  LAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRL--VFASHIRANQSMMREIDTIGK 878

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-LGWTQRMNVIKGVADA 920
            +RHRN++K  GF        ++Y Y+  GSL  +L   +  E  L W+ R NV  GVA  
Sbjct: 879  VRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSARYNVALGVAHG 938

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            L+YLH DC PPIV+RDI  +N+L+D + E H+ DFG+++ L   + +   + GT GY+AP
Sbjct: 939  LAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDSTVSTATVTGTTGYIAP 998

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD------------FISSICSTSSNLDRTL 1028
            E A+      +SDVYS+GV+ LE +  K   D              S++ S+++N++  +
Sbjct: 999  ENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDMV 1058

Query: 1029 DEILDPRLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              I+DP L       ++R++++ + E+A+SC  ++P  RPTM+   +LL+
Sbjct: 1059 TTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLE 1108

Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	1077
297846638	1123	hypothetical protein ARALYDRAFT_473694 [	0.956	0.917	0.490	0.0
147772402	996	hypothetical protein VITISV_022117 [Viti	0.889	0.961	0.513	0.0
15219699	1120	putative leucine-rich repeat receptor-li	0.953	0.916	0.479	0.0
147767326	1032	hypothetical protein VITISV_008862 [Viti	0.820	0.856	0.549	0.0
357439013	1131	Receptor protein kinase-like protein [Me	0.965	0.919	0.472	0.0
359491509	1032	PREDICTED: probable LRR receptor-like se	0.820	0.856	0.545	0.0
225456159	1038	PREDICTED: probable LRR receptor-like se	0.818	0.849	0.536	0.0
359484864	1091	PREDICTED: probable LRR receptor-like se	0.932	0.920	0.494	0.0
225456161	1037	PREDICTED: probable LRR receptor-like se	0.818	0.849	0.530	0.0
356577797	1204	PREDICTED: probable LRR receptor-like se	0.962	0.861	0.450	0.0

>gi|297846638|ref|XP_002891200.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata] gi|297337042|gb|EFH67459.1| hypothetical protein ARALYDRAFT_473694 [Arabidopsis lyrata subsp. lyrata]

 Score =  978 bits (2529), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 536/1093 (49%), Positives = 704/1093 (64%), Gaps = 63/1093 (5%)

Query: 37   EAHALLKWKTSLQNHNNKGSFLPSWT--LNNATKISPCAWFGIHCNHAGKVNSINLTSAG 94
            EA+ALLKWK++  N ++  S L SW    N     S  +W+G+ CN  G +  +NLT   
Sbjct: 33   EANALLKWKSTFTNQSHS-SKLSSWVNDANTNPSFSCTSWYGVFCNSRGSIEKLNLTDNA 91

Query: 95   LIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGN 154
            + GT  DF FSS P+LA +DL +N+  G IP Q  N SKL Y DLS+N  +  IPP +GN
Sbjct: 92   IEGTFQDFPFSSLPNLASIDLSMNRFSGTIPPQFGNLSKLIYFDLSTNHLTREIPPSLGN 151

Query: 155  LSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN 214
            L  L +L L  N  +G IPP +G++  +  L L  N L+GSIP SLGNL NL ++YLY N
Sbjct: 152  LKNLTVLDLHHNYLTGVIPPDLGNMESMTYLELSHNKLTGSIPSSLGNLKNLTVLYLYQN 211

Query: 215  SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
             L+G IP E+GN++S+  LEL  NKL+GS+P SLGNL NL  L LH N L+G IP   GN
Sbjct: 212  YLTGVIPPELGNMESMIDLELSTNKLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGN 271

Query: 275  LTNLDILNLPHNSLSGSIPSEMGNLK------------------------SLYGLGLSFN 310
            + ++  L L  N L+GSIPS +GNLK                        S+  L LS N
Sbjct: 272  MESMIDLELSDNKLTGSIPSSLGNLKNLTVLYLYKNYLTGVIPPELGNMESMTYLDLSEN 331

Query: 311  KLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
            KL+GSIPSSLGNL  LT+LYL  N L G IP E+GNL  +  LEL DNKL+GSIP SLGN
Sbjct: 332  KLTGSIPSSLGNLKNLTVLYLHHNYLTGVIPPELGNLESMIDLELSDNKLTGSIPSSLGN 391

Query: 371  LTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
            L NL  LYL  N L+G IP E+GN+ S+ DL LS+N L+GSIP SFGN T +  L +  N
Sbjct: 392  LKNLTVLYLHHNYLTGVIPPELGNMESMIDLALSQNNLTGSIPSSFGNFTKLESLYLRDN 451

Query: 431  ALSGAIPKEYGNLVKLTLLV------------------------LSYNQLQGPIPD-LRN 465
             LSG IP+   N  +LT L+                        L YN L+G IP  LR+
Sbjct: 452  HLSGTIPRGVANSSELTELLLDINNFTGFLPENICKGGKLQNFSLDYNHLEGHIPKSLRD 511

Query: 466  LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
               L R +   N   GNISE+FG++ +L +I+LSH KF GEIS +W K P LG L +S N
Sbjct: 512  CKSLIRAKFVGNKFIGNISEAFGVYPDLDFIDLSHNKFNGEISSNWQKSPKLGALIMSNN 571

Query: 526  NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS 585
            NITG +PPEI +  QL  LDLS+N++ GE+P  +G L  L KL LN N+ SG++PT L  
Sbjct: 572  NITGAIPPEIWNMKQLGELDLSTNNLTGELPEAIGNLTGLSKLLLNGNKLSGRVPTGLSF 631

Query: 586  LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            L  LE LDLSSNR S+ IP +  + +KL+ +NLS N F G IP  L K   L+ LDLSHN
Sbjct: 632  LTNLESLDLSSNRFSSQIPQTFDSFLKLHEMNLSKNNFDGRIP-GLTKLTQLTHLDLSHN 690

Query: 646  FLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAF 705
             L  EIPSQ+ S+QSL+KLNL+HNNLSGFIP  F+ M  L +IDIS NKL GP+P++ AF
Sbjct: 691  QLDGEIPSQLSSLQSLDKLNLSHNNLSGFIPTTFESMKALTFIDISNNKLEGPLPDNPAF 750

Query: 706  KHAPMEALQGNKGLCGDI--KGFPSCKA-SKSDKQASRKIWVVIVFPLLGSFALLISLIG 762
            ++A  +AL+GN+GLC +I  +   SC+   K  K  +  +W+++  P+LG+  +L    G
Sbjct: 751  QNATSDALEGNRGLCSNIPKQRLKSCRGFQKPKKNGNLLVWILV--PILGALVILSICAG 808

Query: 763  LFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSV 822
             F  + R+      +++       +S+ + D K  Y++I+ +TN+FD+ + IG+GG   V
Sbjct: 809  AFTYYIRKRKPHNGRNTDSETGENMSIFSVDGKFKYQDIIESTNEFDQRYLIGSGGYSKV 868

Query: 823  YRAELSSGEIVAVKKFHSPLLSEMT---CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH 879
            Y+A L    IVAVK+ H  +  E++    +QEFLNEV++LTEIRHRN+VK +GFCSH RH
Sbjct: 869  YKANLPDA-IVAVKRLHDTIDEEISKPVVKQEFLNEVRALTEIRHRNVVKLFGFCSHRRH 927

Query: 880  SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS 939
            +F++YEY+E GSL  +L+N   A+ L WT+R+N++KGVA ALSY+H+D   PIV+RDISS
Sbjct: 928  TFLIYEYMEKGSLNKLLANEEEAKRLTWTKRINIVKGVAHALSYMHHDRSTPIVHRDISS 987

Query: 940  KNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
             N+LLD +Y A +SDFG +K LK DSSNW+ +AGT GYVAPE AYTMKVTEK DVYSFGV
Sbjct: 988  GNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGV 1047

Query: 1000 LALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLD 1059
            L LE I GKHP D ++S+ S+S     +L  I D R+  P    R+KLI ++EVA+SCL 
Sbjct: 1048 LILEVIMGKHPGDLVASL-SSSPGETLSLRSISDERILEPRGQNREKLIKMVEVALSCLQ 1106

Query: 1060 ENPDSRPTMQKVS 1072
             +P SRPTM  +S
Sbjct: 1107 ADPQSRPTMLSIS 1119

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772402|emb|CAN73988.1| hypothetical protein VITISV_022117 [Vitis vinifera]

 Score =  946 bits (2444), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 541/1054 (51%), Positives = 681/1054 (64%), Gaps = 96/1054 (9%)

Query: 30   VSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTL--NNATKISPCAWFGIHCNHAGKVNS 87
            VSS S EE  ALLKWK SLQNH++  S L SW L  NN+T  S          H G   S
Sbjct: 27   VSSYSNEETQALLKWKASLQNHDH--SSLLSWDLYPNNSTNSS---------THLGTATS 75

Query: 88   INLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGT 147
                                                 P +  NN             SG 
Sbjct: 76   -------------------------------------PCKCMNN------------LSGP 86

Query: 148  IPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLA 207
            IPPQIG LS LK L LS NQFSG IP +IG L+ L+ LHL +N L+GSIP  +G L +L 
Sbjct: 87   IPPQIGLLSELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIGQLASLY 146

Query: 208  IMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGS 267
             + LY N L GSIP+ +GNL +L+ L L  N+LS S+P  +GNL NL  +    N+L G 
Sbjct: 147  ELALYTNQLEGSIPASLGNLSNLAYLYLYENQLSDSIPPEMGNLTNLVEIYSDTNNLIGP 206

Query: 268  IPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLT 327
            IP +FGNL  L +L L +N LSG IP E+GNLKSL GL L  N LSG IP+SLG+L+ LT
Sbjct: 207  IPSTFGNLKRLTVLYLFNNRLSGHIPPEIGNLKSLQGLSLYENNLSGPIPASLGDLSGLT 266

Query: 328  ILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
            +L+L  N L G IP EIGNL+ L  LEL +N+L+GSIP SLGNLTNL TL+L  N LSG 
Sbjct: 267  LLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLETLFLRDNQLSGY 326

Query: 388  IPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLT 447
            IP EIG L+ L                        +VL I +N L G++P+       L 
Sbjct: 327  IPQEIGKLHKL------------------------VVLEIDTNQLFGSLPEGICQGGSLE 362

Query: 448  LLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGE 506
               +S N L GPIP  L+N   L R     N LTGNISE  G   NL YIN+S+  F+GE
Sbjct: 363  RFTVSDNHLSGPIPKSLKNCKNLTRALFGGNQLTGNISEVVGDCPNLEYINVSYNSFHGE 422

Query: 507  ISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLI 566
            +S +WG++P L  L+++ NNITG +P + G S  L +LDLSSNH+ GEIP ++G + SL 
Sbjct: 423  LSHNWGRYPRLQRLEMAWNNITGSIPEDFGISTDLTLLDLSSNHLFGEIPKKMGSVTSLW 482

Query: 567  KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
            KL LN NQ SG +P ELGSL  L +LDLS+NRL+ SIP  LG+ + L YLNLSNN+ S  
Sbjct: 483  KLILNDNQLSGNIPPELGSLADLGYLDLSANRLNGSIPEHLGDCLGLNYLNLSNNKLSHG 542

Query: 627  IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLV 686
            IP+++ K  HLS LDLSHN L  +IP Q+  +QSLE LNL+HNNLSGFIP+ F+EM GL 
Sbjct: 543  IPVQMGKLGHLSQLDLSHNLLTGDIPPQIEGLQSLENLNLSHNNLSGFIPKAFEEMLGLS 602

Query: 687  YIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCK-ASKSDKQ---ASRKI 742
             +DISYN+L GPIPNS AF+ A +EAL+GNKGLCG++K    CK  S  D+Q    S K+
Sbjct: 603  DVDISYNQLQGPIPNSKAFRDATIEALKGNKGLCGNVKRLRPCKYGSGVDQQPVKKSHKV 662

Query: 743  WVVIVFPLLGSFALLISLIGLFFM-FRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEI 801
              +I+FPLLG+  LL + IG+F +  RR  + + ++    N     S+ TFD +  YEEI
Sbjct: 663  VFIIIFPLLGALVLLFAFIGIFLIAARRERTPEIKEGEVQN--DLFSISTFDGRTMYEEI 720

Query: 802  VRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            ++AT DFD  +CIG GG GSVY+AEL S  IVAVKK H P  +EM  Q++FLNE+++LTE
Sbjct: 721  IKATKDFDPMYCIGKGGHGSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTE 779

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            I+HRNIVK  GFCSH RH F+VYEYLE GSLA ILS    A++LGW  R+N+IKGVA AL
Sbjct: 780  IKHRNIVKLLGFCSHPRHKFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHAL 838

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            +Y+H+DC PPIV+RDISS N+LLD +YEAH+SDFG +K LK DSSN + LAGT GY+APE
Sbjct: 839  AYMHHDCSPPIVHRDISSNNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPE 898

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
            LAYTMKVTEK+DV+SFGV+ALE IKG+HP D I S+  +    +  L+++LDPRLP  + 
Sbjct: 899  LAYTMKVTEKTDVFSFGVIALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTP 958

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                ++I+I++ A  CL  NP SRPTMQ VSQ+L
Sbjct: 959  QDEGEVIAIIKQATECLKANPQSRPTMQTVSQML 992

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15219699|ref|NP_174809.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana] gi|75175345|sp|Q9LP24.1|Y1571_ARATH RecName: Full=Probable leucine-rich repeat receptor-like protein kinase At1g35710; Flags: Precursor gi|8778966|gb|AAF79881.1|AC021198_1 Contains similarity to receptor protein kinase-like protein from Arabidopsis thaliana gb|AL161513. It contains a eukaryotic protein kinase domain PF|00069. EST gb|AI997574 comes from this gene [Arabidopsis thaliana] gi|332193703|gb|AEE31824.1| putative leucine-rich repeat receptor-like protein [Arabidopsis thaliana]

 Score =  935 bits (2416), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 524/1093 (47%), Positives = 699/1093 (63%), Gaps = 66/1093 (6%)

Query: 37   EAHALLKWKTSLQNHNNKGSFLPSWT--LNNATKISPCAWFGIHCNHAGKVNSINLTSAG 94
            EA+ALLKWK++  N     S L SW    N  T  S  +W+G+ CN  G +  +NLT+ G
Sbjct: 33   EANALLKWKSTFTN----SSKLSSWVHDANTNTSFSCTSWYGVSCNSRGSIEELNLTNTG 88

Query: 95   LIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGN 154
            + GT  DF F S  +LAY+DL +N + G IP Q  N SKL Y DLS+N  +G I P +GN
Sbjct: 89   IEGTFQDFPFISLSNLAYVDLSMNLLSGTIPPQFGNLSKLIYFDLSTNHLTGEISPSLGN 148

Query: 155  LSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN 214
            L  L +LYL  N  +  IP ++G++  +  L L +N L+GSIP SLGNL NL ++YLY N
Sbjct: 149  LKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIPSSLGNLKNLMVLYLYEN 208

Query: 215  SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
             L+G IP E+GN++S++ L L  NKL+GS+P +LGNL NL  L L++N L+G IP   GN
Sbjct: 209  YLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVLYLYENYLTGVIPPEIGN 268

Query: 275  LTNLDILNLPHNSLSGSIPSEMGNLK------------------------SLYGLGLSFN 310
            + ++  L L  N L+GSIPS +GNLK                        S+  L LS N
Sbjct: 269  MESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIPPKLGNIESMIDLELSNN 328

Query: 311  KLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
            KL+GSIPSSLGNL  LTILYL +N L G IP E+GN+  +  L+L +NKL+GSIP S GN
Sbjct: 329  KLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGN 388

Query: 371  LTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
            L NL  LYL+ N L+G IP E+GN+ S+ +L LS+N+L+GS+P SFGN T +  L +  N
Sbjct: 389  LKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVN 448

Query: 431  ALSGAIPKEYGNLVKLTLLV------------------------LSYNQLQGPIPD-LRN 465
             LSGAIP    N   LT L+                        L YN L+GPIP  LR+
Sbjct: 449  HLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRD 508

Query: 466  LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
               L R R   N  TG+I E+FGI+ +L++I+ SH KF+GEIS +W K P LG L +S N
Sbjct: 509  CKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEISSNWEKSPKLGALIMSNN 568

Query: 526  NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS 585
            NITG +P EI +  QL  LDLS+N++ GE+P  +G L +L +L LN NQ SG++P  L  
Sbjct: 569  NITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSF 628

Query: 586  LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            L  LE LDLSSN  S+ IP +  + +KL+ +NLS N+F G IP +L K   L+ LDLSHN
Sbjct: 629  LTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLSHN 687

Query: 646  FLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAF 705
             L  EIPSQ+ S+QSL+KL+L+HNNLSG IP  F+ M  L  +DIS NKL GP+P++  F
Sbjct: 688  QLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISNNKLEGPLPDTPTF 747

Query: 706  KHAPMEALQGNKGLCGDI---KGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIG 762
            + A  +AL+ N GLC +I   +  P  +  K  K  +  +W+++  P+LG   +L     
Sbjct: 748  RKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGNLVVWILV--PILGVLVILSICAN 805

Query: 763  LFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSV 822
             F    R+   Q  +++       +S+ + D K  Y++I+ +TN+FD  H IGTGG   V
Sbjct: 806  TFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDPTHLIGTGGYSKV 865

Query: 823  YRAELSSGEIVAVKKFHSPLLSEMT---CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH 879
            YRA L    I+AVK+ H  +  E++    +QEFLNEVK+LTEIRHRN+VK +GFCSH RH
Sbjct: 866  YRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVVKLFGFCSHRRH 924

Query: 880  SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS 939
            +F++YEY+E GSL  +L+N   A+ L WT+R+NV+KGVA ALSY+H+D   PIV+RDISS
Sbjct: 925  TFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDRITPIVHRDISS 984

Query: 940  KNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
             N+LLD +Y A +SDFG +K LK DSSNW+ +AGT GYVAPE AYTMKVTEK DVYSFGV
Sbjct: 985  GNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTYGYVAPEFAYTMKVTEKCDVYSFGV 1044

Query: 1000 LALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLD 1059
            L LE I GKHP D +SS+ S+S     +L  I D R+  P    R+KL+ ++E+A+ CL 
Sbjct: 1045 LILELIIGKHPGDLVSSL-SSSPGEALSLRSISDERVLEPRGQNREKLLKMVEMALLCLQ 1103

Query: 1060 ENPDSRPTMQKVS 1072
             NP+SRPTM  +S
Sbjct: 1104 ANPESRPTMLSIS 1116

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767326|emb|CAN68996.1| hypothetical protein VITISV_008862 [Vitis vinifera]

 Score =  925 bits (2390), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 501/911 (54%), Positives = 633/911 (69%), Gaps = 27/911 (2%)

Query: 190  NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
            N LSG IPP +G L+ L  + L  N  SG IPSEIG L +L  L L  N+L+GS+P  +G
Sbjct: 120  NKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIG 179

Query: 250  NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSF 309
             L +L  L L+ N L GSIP S GNL+NL  L L  N LSG IP EMGNL  L  L L+ 
Sbjct: 180  QLKSLCDLSLYTNKLEGSIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNA 239

Query: 310  NKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLG 369
            N L+G IPS+LGNL  LT+L L +N L G IP EIGNL++L  L L  N LSG IP SLG
Sbjct: 240  NNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLG 299

Query: 370  NLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
            +L+ L +L LF N LSG IP E+GNL SL DL +S+N+L+GSIP S GNL N+ +L +  
Sbjct: 300  DLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTSLGNLINLEILYLRD 359

Query: 430  NALSGAIPKEYGNLVKLTLLVLSYNQLQG------------------------PIPD-LR 464
            N LS +IP E G L KL  L +  NQL G                        PIP+ L+
Sbjct: 360  NKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLK 419

Query: 465  NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA 524
            N   LAR RL RN LTGNISE+FG+  NL +INLS+ KFYGE+S +WG+   L  LD++ 
Sbjct: 420  NCPSLARARLQRNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAG 479

Query: 525  NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
            NNITG +P + G S QL VL+LSSNH+VGEIP +LG + SL KL LN N+ SG +P ELG
Sbjct: 480  NNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELG 539

Query: 585  SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSH 644
            SL  L +LDLS NRL+ SIP  LGN + L YLNLSNN+ S  IP+++ K  HLS LDLSH
Sbjct: 540  SLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSH 599

Query: 645  NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAA 704
            N L  EIPSQ+  +QSLEKLNL+HNNLSG IP+ F++MHGL  +DISYN L G IPNS A
Sbjct: 600  NLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEA 659

Query: 705  FKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLF 764
            F++  +E LQGNKGLCG +KG   C+ ++S  + + K   +I+F LLG+  +L + IG+ 
Sbjct: 660  FQNVTIEVLQGNKGLCGSVKGLQPCE-NRSATKGTHKAVFIIIFSLLGALLILSAFIGIS 718

Query: 765  FMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYR 824
             + + R +++ +++         S+ TFD +  YE I+ AT DFD  +CIG GG GSVY+
Sbjct: 719  LISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYK 778

Query: 825  AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY 884
            AEL SG IVAVKK H     +M  Q++F+NE+++LTEI+HRNIVK  GFCSH+RHSF+VY
Sbjct: 779  AELPSGNIVAVKKLHR-FDIDMAHQKDFMNEIRALTEIKHRNIVKLLGFCSHSRHSFLVY 837

Query: 885  EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL 944
            EYLE GSL  ILS    A+E+GW  R+N+IKGVA ALSYLH+DC PPIV+RDISS NVLL
Sbjct: 838  EYLERGSLGTILSKELQAKEVGWGTRVNIIKGVAHALSYLHHDCVPPIVHRDISSNNVLL 897

Query: 945  DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEA 1004
            D +YEAHVSDFG +K LK DSSNW+ LAGT GYVAPELAYTMKVTEK DVYSFGVLALE 
Sbjct: 898  DSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 957

Query: 1005 IKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDS 1064
            ++G+HP D ISS+ ++    +  L ++LDPRLP P+     +++S++++A +CL+ +P S
Sbjct: 958  MRGRHPGDLISSLSASPGKDNVVLKDVLDPRLPPPTLRDEAEVMSVIQLATACLNGSPQS 1017

Query: 1065 RPTMQKVSQLL 1075
            RPTMQ VSQ+L
Sbjct: 1018 RPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357439013|ref|XP_003589783.1| Receptor protein kinase-like protein [Medicago truncatula] gi|355478831|gb|AES60034.1| Receptor protein kinase-like protein [Medicago truncatula]

 Score =  924 bits (2389), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 524/1108 (47%), Positives = 698/1108 (62%), Gaps = 68/1108 (6%)

Query: 27   PLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCA-WFGIHCNHAGK- 84
            P   +++   EA ALLKWK SL NH+N  + L SW  NN     PC+ W GI C++  K 
Sbjct: 26   PYAATNDQGSEADALLKWKASLDNHSN--ALLSSWIGNN-----PCSSWEGITCDYKSKS 78

Query: 85   VNSINLTSAGLIGTLHDFSFSSF-----------------PH-------LAYLDLRVNQI 120
            +N +NLT  GL GTL   +FSS                  PH       L  LDL VN +
Sbjct: 79   INKVNLTDIGLKGTLQSLNFSSLTKIHTLVLTNNFLYGVVPHHIGEMSSLKTLDLSVNNL 138

Query: 121  FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLS 180
             G IP+ I N SK+ YLDLS N  +G IP +I  L  L  L ++TNQ  G IP +IG+L 
Sbjct: 139  SGTIPNSIGNLSKISYLDLSFNYLTGIIPFEITQLVSLYFLSMATNQLIGHIPREIGNLV 198

Query: 181  YLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL 240
             L+ L +  N L+GS+P  +G LT LA + L  N LSG+IPS IGNL +L  L L  N L
Sbjct: 199  NLERLDIQLNNLTGSVPQEIGFLTKLAELDLSANYLSGTIPSTIGNLSNLHWLYLYQNHL 258

Query: 241  SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLK 300
             GS+P  +GNL +L T+ L  N LSG IP S GNL NL+ + L HN LSG IP  +G L 
Sbjct: 259  MGSIPSEVGNLYSLFTIQLLGNHLSGPIPSSIGNLVNLNSIRLDHNDLSGEIPISIGKLV 318

Query: 301  SLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKL 360
            +L  + LS NK+SG +PS++GNLTKLT+LYLS N L G IP  IGNL  L  ++L +NKL
Sbjct: 319  NLDTIDLSDNKISGPLPSTIGNLTKLTVLYLSSNALTGQIPPSIGNLVNLDTIDLSENKL 378

Query: 361  SGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLT 420
            S  IP ++GNLT ++ L L +N L+G +P  IGN+ +L  + LSEN+LSG IP + GNLT
Sbjct: 379  SRPIPSTVGNLTKVSILSLHSNALTGQLPPSIGNMVNLDTIYLSENKLSGPIPSTIGNLT 438

Query: 421  NMIVLSIYSNALSGAIPKEYGNLV------------------------KLTLLVLSYNQL 456
             +  LS++SN+L+G IPK   N+                         KLT    S NQ 
Sbjct: 439  KLNSLSLFSNSLTGNIPKVMNNIANLESLQLASNNFTGHLPLNICAGRKLTKFSASNNQF 498

Query: 457  QGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFP 515
             GPIP  L+  + L RVRL +N +T NI+++FG++ NL Y+ LS   FYG IS +WGK  
Sbjct: 499  TGPIPKSLKKCSSLIRVRLQQNQITDNITDAFGVYPNLDYMELSDNNFYGHISPNWGKCK 558

Query: 516  NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
            NL +L +S NN+TG +P E+G + QL+ L+LSSNH+ G+IP ELG L  LIKL+++ N  
Sbjct: 559  NLTSLQISNNNLTGSIPQELGGATQLQELNLSSNHLTGKIPEELGNLSLLIKLSISNNNL 618

Query: 576  SGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI 635
             G++P ++ SL  L  L+L  N LS  IP  LG L +L +LNLS N+F G IP++ ++  
Sbjct: 619  LGEVPVQIASLQALTALELEKNNLSGFIPRRLGRLSELIHLNLSQNKFEGNIPVEFDQLK 678

Query: 636  HLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
             + DLDLS N +   IPS +  +  L+ LNL+HNNLSG IP  + EM  L  +DISYN+L
Sbjct: 679  VIEDLDLSENVMSGTIPSMLGQLNHLQTLNLSHNNLSGTIPLSYGEMLSLTIVDISYNQL 738

Query: 696  HGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFA 755
             GPIP+  AF+ AP+EAL+ NKGLCG++ G   C  S  +  + +   ++++   L    
Sbjct: 739  EGPIPSITAFQKAPIEALRNNKGLCGNVSGLVCCSTSGGNFHSHKTSNILVLVLPLTLGT 798

Query: 756  LLISLI--GLFFMFRRRSSS-QTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEH 812
            LL++    G+ ++F + SS+ +   +         ++ +FD K+ YE I+ AT DFD +H
Sbjct: 799  LLLAFFAYGISYLFCQTSSTKEDNHAEEFQTENLFAIWSFDGKMVYETIIEATEDFDNKH 858

Query: 813  CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
             IG GG GSVY+AEL +G++VAVKK HS    EM+  + F NE+ +L EIRHRNIVK YG
Sbjct: 859  LIGVGGHGSVYKAELPTGQVVAVKKLHSLQNEEMSNLKAFTNEIHALKEIRHRNIVKLYG 918

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            FCSH  HSF+VYE+LE GS+  IL +   A E  W +R+NVIK +A+AL YLH+DC PPI
Sbjct: 919  FCSHRLHSFLVYEFLEKGSMDNILKDNEQAAEFDWNRRVNVIKDIANALCYLHHDCSPPI 978

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            V+RDISSKNV+LDLEY AHVSDFG SK L P+SSN T  AGT GY APELAYTM+V EK 
Sbjct: 979  VHRDISSKNVILDLEYVAHVSDFGTSKFLNPNSSNMTSFAGTFGYAAPELAYTMEVNEKC 1038

Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSN--LDRTLD-----EILDPRLPAPSCNIRD 1045
            DVYSFG+L LE + GKHP D ++S+    S   +D TLD     E LD RLP P+  I  
Sbjct: 1039 DVYSFGILTLEILFGKHPGDVVTSLWKQPSQSVIDVTLDTMPLIERLDQRLPHPTNTIVQ 1098

Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            ++ S++ +A++CL E+  SRPTM+ V +
Sbjct: 1099 EVASVVRIAVACLAESLRSRPTMEHVCK 1126

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359491509|ref|XP_002278522.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  915 bits (2364), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 497/911 (54%), Positives = 629/911 (69%), Gaps = 27/911 (2%)

Query: 190  NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
            N LSG IPP +G L+ L  + L  N  SG IPSEIG L +L  L L  N+L+GS+P  +G
Sbjct: 120  NKLSGPIPPQIGFLSKLKYLDLSTNQFSGRIPSEIGLLTNLEVLHLVENQLNGSIPHEIG 179

Query: 250  NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSF 309
             L +L  L L+ N L G+IP S GNL+NL  L L  N LSG IP EMGNL  L  L L+ 
Sbjct: 180  QLKSLCDLSLYTNKLEGTIPASLGNLSNLTNLYLDENKLSGLIPPEMGNLTKLVELCLNA 239

Query: 310  NKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLG 369
            N L+G IPS+LGNL  LT+L L +N L G IP EIGNL++L  L L  N LSG IP SLG
Sbjct: 240  NNLTGPIPSTLGNLKSLTLLRLYNNQLSGPIPTEIGNLKHLRNLSLSSNYLSGPIPMSLG 299

Query: 370  NLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
            +L+ L +L LF N LSG IP E+GNL SL DL +S+N+L+GSIP   GNL N+ +L +  
Sbjct: 300  DLSGLKSLQLFDNQLSGPIPQEMGNLRSLVDLEISQNQLNGSIPTLLGNLINLEILYLRD 359

Query: 430  NALSGAIPKEYGNLVKLTLLVLSYNQLQG------------------------PIPD-LR 464
            N LS +IP E G L KL  L +  NQL G                        PIP+ L+
Sbjct: 360  NKLSSSIPPEIGKLHKLVELEIDTNQLSGFLPEGICQGGSLENFTVFDNFLIGPIPESLK 419

Query: 465  NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA 524
            N   LAR RL  N LTGNISE+FG+  NL +INLS+ KFYGE+S +WG+   L  LD++ 
Sbjct: 420  NCPSLARARLQGNQLTGNISEAFGVCPNLYHINLSNNKFYGELSQNWGRCHKLQWLDIAG 479

Query: 525  NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
            NNITG +P + G S QL VL+LSSNH+VGEIP +LG + SL KL LN N+ SG +P ELG
Sbjct: 480  NNITGSIPADFGISTQLTVLNLSSNHLVGEIPKKLGSVSSLWKLILNDNRLSGNIPPELG 539

Query: 585  SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSH 644
            SL  L +LDLS NRL+ SIP  LGN + L YLNLSNN+ S  IP+++ K  HLS LDLSH
Sbjct: 540  SLADLGYLDLSGNRLNGSIPEHLGNCLDLNYLNLSNNKLSHGIPVQMGKLSHLSLLDLSH 599

Query: 645  NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAA 704
            N L  EIPSQ+  +QSLEKLNL+HNNLSG IP+ F++MHGL  +DISYN L G IPNS A
Sbjct: 600  NLLTGEIPSQIQGLQSLEKLNLSHNNLSGIIPKAFEDMHGLWQVDISYNDLQGSIPNSEA 659

Query: 705  FKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLF 764
            F++  +E LQGNKGLCG +KG   C+ ++S  + + K   +I+F LLG+  +L + IG+ 
Sbjct: 660  FQNVTIEVLQGNKGLCGSVKGLQPCE-NRSATKGTHKAVFIIIFSLLGALLILSAFIGIS 718

Query: 765  FMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYR 824
             + + R +++ +++         S+ TFD +  YE I+ AT DFD  +CIG GG GSVY+
Sbjct: 719  LISQGRRNAKMEKAGDVQTENLFSISTFDGRTTYEAIIEATKDFDPMYCIGEGGHGSVYK 778

Query: 825  AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY 884
            AEL SG IVAVKK H     +M  Q++F+NE+++LTEI+HRNIVK  GFCSH+RHSF+VY
Sbjct: 779  AELPSGNIVAVKKLHR-FDIDMAHQKDFVNEIRALTEIKHRNIVKLLGFCSHSRHSFLVY 837

Query: 885  EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL 944
            EYLE GSL  ILS    A+E+GW  R+N+IKGV+ ALSYLH+DC PPIV+RDISS NVLL
Sbjct: 838  EYLERGSLGTILSKELQAKEVGWGTRVNIIKGVSHALSYLHHDCVPPIVHRDISSNNVLL 897

Query: 945  DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEA 1004
            D +YEAHVSDFG +K LK DSSNW+ LAGT GYVAPELAYTMKVTEK DVYSFGVLALE 
Sbjct: 898  DSKYEAHVSDFGTAKFLKLDSSNWSTLAGTYGYVAPELAYTMKVTEKCDVYSFGVLALEV 957

Query: 1005 IKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDS 1064
            ++G+HP D ISS+  +    +  L ++LDPRLP P+     ++ S++++A +CL+ +P S
Sbjct: 958  MRGRHPGDLISSLSDSPGKDNVVLKDVLDPRLPPPTFRDEAEVTSVIQLATACLNGSPQS 1017

Query: 1065 RPTMQKVSQLL 1075
            RPTMQ VSQ+L
Sbjct: 1018 RPTMQMVSQML 1028

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456159|ref|XP_002278561.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  910 bits (2353), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 491/916 (53%), Positives = 627/916 (68%), Gaps = 34/916 (3%)

Query: 190  NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
            N LSG IPP +G L  L  + L  N  SG IPSEIG L +L  L L  N+L+GS+P  +G
Sbjct: 123  NNLSGPIPPQIGLLFELKYLDLSINQFSGGIPSEIGLLTNLEVLHLVQNQLNGSIPHEIG 182

Query: 250  NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSF 309
             L +L  L L+ N L GSIP S GNL+NL  L L  N LSGSIP EMGNL +L  +  + 
Sbjct: 183  QLASLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVEIYSNN 242

Query: 310  NKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLG 369
            N L+G IPS+ GNL +LT+LYL +N L G IP EIGNL+ L  L L +N LSG IP SL 
Sbjct: 243  NNLTGPIPSTFGNLKRLTVLYLFNNSLSGPIPPEIGNLKSLQELSLYENNLSGPIPVSLC 302

Query: 370  NLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
            +L+ L  L+L+ N LSG IP EIGNL SL DL LSEN+L+GSIP S GNLTN+ +L +  
Sbjct: 303  DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362

Query: 430  NALSGAIPKEYGNLVKLTLLVLSYNQL------------------------QGPIPD-LR 464
            N LSG IP+E G L KL +L +  NQL                         GPIP  L+
Sbjct: 363  NQLSGYIPQEIGKLHKLVVLEIDTNQLFGSLPEGICQAGSLVRFAVSDNHLSGPIPKSLK 422

Query: 465  NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA 524
            N   L R     N LTGNISE  G   NL +I+LS+ +F+GE+S +WG+ P L  L+++ 
Sbjct: 423  NCRNLTRALFQGNRLTGNISEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482

Query: 525  NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
            NNITG +P + G S  L +LDLSSNH+VGEIP ++G L SL+ L LN NQ SG +P ELG
Sbjct: 483  NNITGSIPEDFGISTNLTLLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542

Query: 585  SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSH 644
            SL  LE+LDLS+NRL+ SIP  LG+ + L+YLNLSNN+ S  IP+++ K  HLS LDLSH
Sbjct: 543  SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602

Query: 645  NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAA 704
            N L   IP Q+  +QSLE L+L+HNNL GFIP+ F++M  L Y+DISYN+L GPIP+S A
Sbjct: 603  NLLAGGIPPQIQGLQSLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662

Query: 705  FKHAPMEALQGNKGLCGDIKGFPSCK----ASKSDKQASRKIWVVIVFPLLGSFALLISL 760
            F++A +E L+GNK LCG++KG   CK      +   + S K+  +I+FPLLG+  LL + 
Sbjct: 663  FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLFAF 722

Query: 761  IGLFFMFRRRSSSQTQQSSAGNAPG-FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQ 819
            IG+F +  RR   +T +   G+      S+  FD +  YEEI++AT DFD  +CIG GG 
Sbjct: 723  IGIFLIAERR--ERTPEIEEGDVQNDLFSISNFDGRTMYEEIIKATKDFDPMYCIGKGGH 780

Query: 820  GSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH 879
            GSVY+AEL S  IVAVKK H P  +EM  Q++FLNE+++LTEI+HRNIVK  GFCSH RH
Sbjct: 781  GSVYKAELPSSNIVAVKKLH-PSDTEMANQKDFLNEIRALTEIKHRNIVKLLGFCSHPRH 839

Query: 880  SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS 939
             F+VYEYLE GSLA ILS    A++LGW  R+N+IKGVA AL+Y+H+DC PPIV+RD+SS
Sbjct: 840  KFLVYEYLERGSLATILSRE-EAKKLGWATRVNIIKGVAHALAYMHHDCSPPIVHRDVSS 898

Query: 940  KNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
             N+LLD +YEAH+SDFG +K LK DSSN + LAGT GY+APELAYTMKVTEK+DV+SFGV
Sbjct: 899  NNILLDSQYEAHISDFGTAKLLKLDSSNQSILAGTFGYLAPELAYTMKVTEKTDVFSFGV 958

Query: 1000 LALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLD 1059
            +ALE IKG+HP D I S+  +    +  L+++LDPRLP  +     ++I+I++ AI CL 
Sbjct: 959  IALEVIKGRHPGDQILSLSVSPEKDNIALEDMLDPRLPPLTPQDEGEVIAILKQAIECLK 1018

Query: 1060 ENPDSRPTMQKVSQLL 1075
             NP SRPTMQ VSQ+L
Sbjct: 1019 ANPQSRPTMQTVSQML 1034

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484864|ref|XP_002273966.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  908 bits (2347), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 519/1050 (49%), Positives = 675/1050 (64%), Gaps = 46/1050 (4%)

Query: 36   EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCA-WFGIHCNHAGKVNSINLTSAG 94
            +EA ALL WK+SL  H    SFL SW+      +SPC  WFG+ C+ +  V+S+NL S G
Sbjct: 56   KEALALLTWKSSL--HIRSQSFLSSWS-----GVSPCNNWFGVTCHKSKSVSSLNLESCG 108

Query: 95   LIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGN 154
            L GTL++ +F S P+L  LDL  N + G IP +I     L  L LS+N+ SG IPP IGN
Sbjct: 109  LRGTLYNLNFLSLPNLVTLDLYNNSLSGSIPQEIGLLRSLNNLKLSTNNLSGPIPPSIGN 168

Query: 155  LSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN 214
            L  L  LYL TN+ SG IP +IG L  L  L L  N LSG IPPS+GNL NL  +YL+ N
Sbjct: 169  LRNLTTLYLHTNKLSGSIPQEIGLLRSLNDLELSANNLSGPIPPSIGNLRNLTTLYLHTN 228

Query: 215  SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
             LSGSIP EIG L+SL+ LEL  N L+G +P S+GNL NL TL LH N LSGSIP   G 
Sbjct: 229  KLSGSIPQEIGLLRSLNDLELSTNNLNGPIPPSIGNLRNLTTLYLHTNKLSGSIPKEIGM 288

Query: 275  LTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
            L +L+ L L  N+L+G IP  +G L++L  L L  NKLSGSIP  +G L  L  L LS N
Sbjct: 289  LRSLNDLELSTNNLNGPIPPSIGKLRNLTTLYLHNNKLSGSIPLEIGLLRSLFNLSLSTN 348

Query: 335  LLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGN 394
             L G IP  IGNLR L  L L +N+ SGSIP  +G L +L  L L TN LSG IP EI N
Sbjct: 349  NLSGPIPPFIGNLRNLTKLYLDNNRFSGSIPREIGLLRSLHDLALATNKLSGPIPQEIDN 408

Query: 395  LNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYN 454
            L  L  L L EN  +G +P                  L GA+     N   +       N
Sbjct: 409  LIHLKSLHLEENNFTGHLPQQM--------------CLGGALE----NFTAMG------N 444

Query: 455  QLQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGK 513
               GPIP  LRN T L RVRL+RN L GNI+E FG++ NL++++LS    YGE+S  WG+
Sbjct: 445  HFTGPIPMSLRNCTSLFRVRLERNQLEGNITEVFGVYPNLNFMDLSSNNLYGELSHKWGQ 504

Query: 514  FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
              +L +L++S NN++GI+PP++G++ QL  LDLSSNH++G+IP ELGKL S+  L L+ N
Sbjct: 505  CGSLTSLNISHNNLSGIIPPQLGEAIQLHRLDLSSNHLLGKIPRELGKLTSMFHLVLSNN 564

Query: 574  QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
            Q SG +P E+G+L  LEHL L+SN LS SIP  LG L KL++LNLS N+F   IP ++  
Sbjct: 565  QLSGNIPLEVGNLFNLEHLSLTSNNLSGSIPKQLGMLSKLFFLNLSKNKFGESIPDEIGN 624

Query: 634  FIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYN 693
               L +LDLS N L  +IP Q+  +Q LE LNL+HN LSG IP  F++M  L  +DIS N
Sbjct: 625  MHSLQNLDLSQNMLNGKIPQQLGELQRLETLNLSHNELSGSIPSTFEDMLSLTSVDISSN 684

Query: 694  KLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGS 753
            +L GP+P+  AF+ AP EA   N GLCG+  G   C    + K+  R + ++I   +   
Sbjct: 685  QLEGPLPDIKAFQEAPFEAFMSNGGLCGNATGLKPC-IPFTQKKNKRSMILIISSTV--- 740

Query: 754  FALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHC 813
            F L IS+ G++F    R+ ++  +SS        ++   D  I Y++I+  T +F+ ++C
Sbjct: 741  FLLCISM-GIYFTLYWRARNRKGKSSETPCEDLFAIWDHDGGILYQDIIEVTEEFNSKYC 799

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+GGQG+VY+AEL +G +VAVKK H P   EM+  + F +E+++LTEIRHRNIVKFYG+
Sbjct: 800  IGSGGQGTVYKAELPTGRVVAVKKLHPPQDGEMSSLKAFTSEIRALTEIRHRNIVKFYGY 859

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            CSHARHSF+VY+ +E GSL  ILSN   A  L W +R+N++KGVA+ALSY+H+DC PPI+
Sbjct: 860  CSHARHSFLVYKLMEKGSLRNILSNEEEAIGLDWIRRLNIVKGVAEALSYMHHDCSPPII 919

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIGYVAPELAYTMKVTEKS 992
            +RDISS NVLLD EYEAHVSDFG ++ LKPD SSNWT  AGT GY APELAYT +V  K+
Sbjct: 920  HRDISSNNVLLDSEYEAHVSDFGTARLLKPDSSSNWTSFAGTFGYSAPELAYTTQVNNKT 979

Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRT-------LDEILDPRLPAPSCNIRD 1045
            DVYS+GV+ LE I GKHP D ISS+ S SS+   T       L + +D RL  P   I +
Sbjct: 980  DVYSYGVVTLEVIMGKHPGDLISSLSSASSSSSVTAVADSLLLKDAIDQRLSPPIHQISE 1039

Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            ++   +++A +C   NP  RPTM++VSQ L
Sbjct: 1040 EVAFAVKLAFACQHVNPHCRPTMRQVSQAL 1069

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225456161|ref|XP_002278590.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Vitis vinifera]

 Score =  897 bits (2317), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 486/916 (53%), Positives = 628/916 (68%), Gaps = 35/916 (3%)

Query: 190  NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
            N LSG IPP +G L+ L  + L  N  SG IP EIG L +L  L L  N+L+GS+P  +G
Sbjct: 123  NNLSGPIPPQIGLLSKLKYLDLSINQFSGGIPPEIGLLTNLEVLHLVQNQLNGSIPHEIG 182

Query: 250  NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSF 309
             L +L  L L+ N L GSIP S GNL+NL  L L  N LSGSIP EMGNL +L  L    
Sbjct: 183  QLTSLYELALYTNQLEGSIPASLGNLSNLASLYLYENQLSGSIPPEMGNLTNLVQLYSDT 242

Query: 310  NKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLG 369
            N L+G IPS+ GNL  LT+LYL +N L G IP EIGNL+ L  L L  N LSG IP SL 
Sbjct: 243  NNLTGPIPSTFGNLKHLTVLYLFNNSLSGPIPPEIGNLKSLQGLSLYGNNLSGPIPVSLC 302

Query: 370  NLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
            +L+ L  L+L+ N LSG IP EIGNL SL DL LSEN+L+GSIP S GNLTN+ +L +  
Sbjct: 303  DLSGLTLLHLYANQLSGPIPQEIGNLKSLVDLELSENQLNGSIPTSLGNLTNLEILFLRD 362

Query: 430  NALSGAIPKEYGNLVKLTLLVLSYNQL------------------------QGPIPD-LR 464
            N LSG  P+E G L KL +L +  NQL                         GPIP  L+
Sbjct: 363  NRLSGYFPQEIGKLHKLVVLEIDTNQLFGSLPEGICQGGSLERFTVSDNHLSGPIPKSLK 422

Query: 465  NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA 524
            N   L R     N LTGN+SE  G   NL +I+LS+ +F+GE+S +WG+ P L  L+++ 
Sbjct: 423  NCRNLTRALFQGNRLTGNVSEVVGDCPNLEFIDLSYNRFHGELSHNWGRCPQLQRLEIAG 482

Query: 525  NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
            NNITG +P + G S  L +LDLSSNH+VGEIP ++G L SL+ L LN NQ SG +P ELG
Sbjct: 483  NNITGSIPEDFGISTNLILLDLSSNHLVGEIPKKMGSLTSLLGLILNDNQLSGSIPPELG 542

Query: 585  SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSH 644
            SL  LE+LDLS+NRL+ SIP  LG+ + L+YLNLSNN+ S  IP+++ K  HLS LDLSH
Sbjct: 543  SLSHLEYLDLSANRLNGSIPEHLGDCLDLHYLNLSNNKLSHGIPVQMGKLSHLSQLDLSH 602

Query: 645  NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAA 704
            N L   IP+Q+  ++SLE L+L+HNNL GFIP+ F++M  L Y+DISYN+L GPIP+S A
Sbjct: 603  NLLTGGIPAQIQGLESLEMLDLSHNNLCGFIPKAFEDMPALSYVDISYNQLQGPIPHSNA 662

Query: 705  FKHAPMEALQGNKGLCGDIKGFPSCK----ASKSDKQASRKIWVVIVFPLLGSFALLISL 760
            F++A +E L+GNK LCG++KG   CK      +   + S K+  +I+FPLLG+  LL + 
Sbjct: 663  FRNATIEVLKGNKDLCGNVKGLQPCKYGFGVDQQPVKKSHKVVFIIIFPLLGALVLLSAF 722

Query: 761  IGLFFMFRRRSSS-QTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQ 819
            IG+F +  RR  + + ++    N    LS+ TFD +  YEEI++AT DFD  +CIG GG 
Sbjct: 723  IGIFLIAERRERTPEIEEGDVQN--NLLSISTFDGRAMYEEIIKATKDFDPMYCIGKGGH 780

Query: 820  GSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH 879
            GSVY+AEL SG IVAVKK H P   +M  Q++FLN+V+++TEI+HRNIV+  GFCS+ RH
Sbjct: 781  GSVYKAELPSGNIVAVKKLH-PSDMDMANQKDFLNKVRAMTEIKHRNIVRLLGFCSYPRH 839

Query: 880  SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS 939
            SF+VYEYLE GSLA ILS    A++LGW  R+ +IKGVA ALSY+H+DC PPIV+RDISS
Sbjct: 840  SFLVYEYLERGSLATILSRE-EAKKLGWATRVKIIKGVAHALSYMHHDCSPPIVHRDISS 898

Query: 940  KNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
             N+LLD +YEAH+S+ G +K LK DSSN ++LAGT+GYVAPE AYTMKVTEK+DVYSFGV
Sbjct: 899  NNILLDSQYEAHISNLGTAKLLKVDSSNQSKLAGTVGYVAPEHAYTMKVTEKTDVYSFGV 958

Query: 1000 LALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLD 1059
            +ALE IKG+HP D I SI S S   +  L ++LDPRLP  +     ++++I+++A +CL+
Sbjct: 959  IALEVIKGRHPGDQILSI-SVSPEKNIVLKDMLDPRLPPLTPQDEGEVVAIIKLATACLN 1017

Query: 1060 ENPDSRPTMQKVSQLL 1075
             NP SRPTM+ +SQ+L
Sbjct: 1018 ANPQSRPTMEIISQML 1033

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356577797|ref|XP_003557009.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At4g08850-like [Glycine max]

 Score =  896 bits (2315), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 530/1176 (45%), Positives = 696/1176 (59%), Gaps = 139/1176 (11%)

Query: 30   VSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSIN 89
             SS    EA+ALLKWK+SL N +     L SW+ NN     PC W GI C+    V++IN
Sbjct: 29   ASSEIASEANALLKWKSSLDNQSRAS--LSSWSGNN-----PCIWLGIACDEFNSVSNIN 81

Query: 90   LTSAGLIGTLHDFSFSSFPH------------------------LAYLDLRVNQIFGIIP 125
            LT+ GL GTL + +FS  P+                        LA LDL  N + G IP
Sbjct: 82   LTNVGLRGTLQNLNFSLLPNILTLNMSHNSLNGTIPPQIGSLSKLARLDLSDNFLSGEIP 141

Query: 126  SQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKAL 185
            S I N S L YL    NS SG IP  IGNL  L  + L  N+ SG IP  IG+LS L  L
Sbjct: 142  STIGNLSNLYYLSFYDNSLSGAIPSSIGNLVNLDSMILHKNKLSGSIPFIIGNLSKLSVL 201

Query: 186  HLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGL------------ 233
             ++ N L+G IP S+GNL N+  + LY N LSGSIP  IGNL  LSGL            
Sbjct: 202  SIYSNELTGPIPTSIGNLVNMDSLLLYENKLSGSIPFTIGNLSKLSGLYISLNELTGPIP 261

Query: 234  ------------ELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
                         L  NKLSGS+P ++GNL  L+ L +H N L+G IP S GNL NLD +
Sbjct: 262  ASIGNLVNLEAMRLFKNKLSGSIPFNIGNLSKLSKLSIHSNELTGPIPASIGNLVNLDSM 321

Query: 282  NLPHNSLSGSIPSEMGNLKSLYGLGLSFN------------------------KLSGSIP 317
             L  N LSGSIP  +GNL     L +SFN                        KLSGSIP
Sbjct: 322  ILHKNKLSGSIPFIIGNLSKFSVLSISFNELTGPIPASIGNLVHLDSLLLEENKLSGSIP 381

Query: 318  SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL 377
             ++GNL+KL+ LY+S N L G IP  IGNL  L  + L  NKLSGSIP ++GNL+ L+ L
Sbjct: 382  FTIGNLSKLSGLYISLNELTGPIPASIGNLVNLEAMRLFKNKLSGSIPFTIGNLSKLSKL 441

Query: 378  YLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
             + +N L+G IP+ IGNL  L  L L EN+LSGSIP++ GNL+ + VLSI  N L+G+IP
Sbjct: 442  SIHSNELTGPIPASIGNLVHLDSLLLEENKLSGSIPFTIGNLSKLSVLSISLNELTGSIP 501

Query: 438  KEYGNLVKLTLLVLSYNQLQGPIP------------------------------------ 461
               GNL  +  L    N+L G IP                                    
Sbjct: 502  STIGNLSNVRELFFIGNELGGKIPIEMSMLTALESLQLADNNFIGHLPQNICIGGTLKNF 561

Query: 462  -------------DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEIS 508
                          L+N + L RVRL RN LTG+I+++FG+  NL YI LS   FYG++S
Sbjct: 562  TAGDNNFIGPIPVSLKNCSSLIRVRLQRNQLTGDITDAFGVLPNLDYIELSDNNFYGQLS 621

Query: 509  FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL 568
             +WGKF +L +L +S NN++G++PPE+  + +L+ L LSSNH+ G IP +L  L  L  L
Sbjct: 622  PNWGKFRSLTSLRISNNNLSGVIPPELAGATKLQRLQLSSNHLTGNIPHDLCNL-PLFDL 680

Query: 569  TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIP 628
            +L+ N  +G +P E+ S+ +L+ L L SN+LS  IP  LGNL+ L+ ++LS N F G IP
Sbjct: 681  SLDNNNLTGNVPKEIASMQKLQILKLGSNKLSGLIPKQLGNLLNLWNMSLSQNNFQGNIP 740

Query: 629  IKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYI 688
             +L K   L+ LDL  N L   IPS    ++SLE LNL+HNNLSG +   F +M  L  I
Sbjct: 741  SELGKLKSLTSLDLGGNSLRGTIPSMFGELKSLETLNLSHNNLSGNL-SSFDDMTSLTSI 799

Query: 689  DISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKAS--KSDKQASRKIWVVI 746
            DISYN+  GP+PN  AF +A +EAL+ NKGLCG++ G   C  S  KS     +K+ +VI
Sbjct: 800  DISYNQFEGPLPNILAFHNAKIEALRNNKGLCGNVTGLEPCSTSSGKSHNHMRKKVMIVI 859

Query: 747  VFPLLGSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATN 806
            +   LG   L +   G+++   + S+++  Q+++   P   ++ +FD K+ +E I+ AT 
Sbjct: 860  LPLTLGILILALFAFGVWYHLCQTSTNKEDQATSIQTPNIFAIWSFDGKMVFENIIEATE 919

Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            DFD++H IG GGQG VY+A L +G++VAVKK HS    EM   + F  E+++LTEIRHRN
Sbjct: 920  DFDDKHLIGVGGQGCVYKAVLPTGQVVAVKKLHSVPNGEMLNLKAFTCEIQALTEIRHRN 979

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IVK YGFCSH++ SF+V E+LE GS+   L +   A    W +R+NV+K VA+AL Y+H+
Sbjct: 980  IVKLYGFCSHSQFSFLVCEFLENGSVEKTLKDDGQAMAFDWYKRVNVVKDVANALCYMHH 1039

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
            +C P IV+RDISSKNVLLD EY AHVSDFG +K L PDSSNWT   GT GY APELAYTM
Sbjct: 1040 ECSPRIVHRDISSKNVLLDSEYVAHVSDFGTAKFLNPDSSNWTSFVGTFGYAAPELAYTM 1099

Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSI--CSTSSNLDRTLDEI-----LDPRLPAP 1039
            +V EK DVYSFGVLA E + GKHP D ISS+   S S+ +  TLD +     LDPRLP P
Sbjct: 1100 EVNEKCDVYSFGVLAWEILVGKHPGDDISSLLGSSPSTLVASTLDHMALMDKLDPRLPHP 1159

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            +  I  ++ SI ++A++CL E+P SRPTM++V+  L
Sbjct: 1160 TKPIGKEVASIAKIAMACLTESPRSRPTMEQVANEL 1195

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	1077
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.911	0.876	0.462	6.5e-225
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.868	0.894	0.452	5.5e-212
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.954	0.933	0.384	1.7e-171
TAIR|locus:2160791	1102	AT5G63930 [Arabidopsis thalian	0.933	0.911	0.382	2e-166
TAIR|locus:2046525	1124	AT2G33170 [Arabidopsis thalian	0.915	0.877	0.374	4.8e-158
TAIR|locus:2007918	1088	PEPR2 "PEP1 receptor 2" [Arabi	0.921	0.911	0.346	7.2e-155
TAIR|locus:2156349	1252	GSO2 "GASSHO 2" [Arabidopsis t	0.909	0.782	0.363	1.5e-152
TAIR|locus:2182870	1192	EMS1 "EXCESS MICROSPOROCYTES1"	0.610	0.552	0.388	3.1e-151
TAIR|locus:2085949	1141	AT3G24240 [Arabidopsis thalian	0.934	0.881	0.348	3.8e-149
TAIR|locus:2154344	1135	AT5G48940 [Arabidopsis thalian	0.909	0.863	0.350	5.7e-146

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 2171 (769.3 bits), Expect = 6.5e-225, P = 6.5e-225
 Identities = 461/997 (46%), Positives = 630/997 (63%)

Query:    84 KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNS 143
             K+   +L++  L G +   S  +  +L  L L  N +  +IPS++ N   +  L LS N 
Sbjct:   127 KLIYFDLSTNHLTGEISP-SLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNK 185

Query:   144 FSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNL 203
              +G+IP  +GNL  L +LYL  N  +G IPP++G++  +  L L +N L+GSIP +LGNL
Sbjct:   186 LTGSIPSSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNL 245

Query:   204 TNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS 263
              NL ++YLY N L+G IP EIGN++S++ L L  NKL+GS+P SLGNL NL  L L  N 
Sbjct:   246 KNLMVLYLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNY 305

Query:   264 LSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL 323
             L+G IP   GN+ ++  L L +N L+GSIPS +GNLK+L  L L  N L+G IP  LGN+
Sbjct:   306 LTGGIPPKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNM 365

Query:   324 TKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNL 383
               +  L L++N L GSIP   GNL+ L YL L  N L+G IP  LGN+ ++  L L  N 
Sbjct:   366 ESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNK 425

Query:   384 LSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNL 443
             L+GS+P                      IP    N +++  L + +N  +G  P+     
Sbjct:   426 LTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKG 485

Query:   444 VKLTLLVLSYNQLQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKK 502
              KL  + L YN L+GPIP  LR+   L R R   N  TG+I E+FGI+ +L++I+ SH K
Sbjct:   486 RKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNK 545

Query:   503 FYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKL 562
             F+GEIS +W K P LG L +S NNITG +P EI +  QL  LDLS+N++ GE+P  +G L
Sbjct:   546 FHGEISSNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNL 605

Query:   563 RSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
              +L +L LN NQ SG++P  L  L  LE LDLSSN  S+ IP +  + +KL+ +NLS N+
Sbjct:   606 TNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNK 665

Query:   623 FSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEM 682
             F G IP +L K   L+ LDLSHN L  EIPSQ+ S+QSL+KL+L+HNNLSG IP  F+ M
Sbjct:   666 FDGSIP-RLSKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGM 724

Query:   683 HGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDI--KGFPSCKASKSDKQ-AS 739
               L  +DIS NKL GP+P++  F+ A  +AL+ N GLC +I  +    C+  K  K+  +
Sbjct:   725 IALTNVDISNNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCRELKKPKKNGN 784

Query:   740 RKIWVVIVFPLLGSFALLISLIGLFFMFXXXXXXXXXXXXAGNAPGF-LSVLTFDRKIAY 798
               +W+++  P+LG   +L S+    F +                 G  +S+ + D K  Y
Sbjct:   785 LVVWILV--PILGVLVIL-SICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKY 841

Query:   799 EEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPL---LSEMTCQQEFLNE 855
             ++I+ +TN+FD  H IGTGG   VYRA L    I+AVK+ H  +   +S+   +QEFLNE
Sbjct:   842 QDIIESTNEFDPTHLIGTGGYSKVYRANLQD-TIIAVKRLHDTIDEEISKPVVKQEFLNE 900

Query:   856 VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             VK+LTEIRHRN+VK +GFCSH RH+F++YEY+E GSL  +L+N   A+ L WT+R+NV+K
Sbjct:   901 VKALTEIRHRNVVKLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVK 960

Query:   916 GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             GVA ALSY+H+D   PIV+RDISS N+LLD +Y A +SDFG +K LK DSSNW+ +AGT 
Sbjct:   961 GVAHALSYMHHDRITPIVHRDISSGNILLDNDYTAKISDFGTAKLLKTDSSNWSAVAGTY 1020

Query:   976 GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
             GYVAPE AYTMKVTEK DVYSFGVL LE I GKHP D +SS+ S+S     +L  I D R
Sbjct:  1021 GYVAPEFAYTMKVTEKCDVYSFGVLILELIIGKHPGDLVSSL-SSSPGEALSLRSISDER 1079

Query:  1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
             +  P    R+KL+ ++E+A+ CL  NP+SRPTM  +S
Sbjct:  1080 VLEPRGQNREKLLKMVEMALLCLQANPESRPTMLSIS 1116

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 2049 (726.3 bits), Expect = 5.5e-212, P = 5.5e-212
 Identities = 428/945 (45%), Positives = 595/945 (62%)

Query:   137 LDLSSNSFSGTIPP-QIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGS 195
             L+L++    GT       +L  L  + LS N+FSG I P  G  S L+   L  N L G 
Sbjct:    98 LNLTNTGIEGTFEDFPFSSLPNLTFVDLSMNRFSGTISPLWGRFSKLEYFDLSINQLVGE 157

Query:   196 IPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLA 255
             IPP LG+L+NL  ++L  N L+GSIPSEIG L  ++ + +  N L+G +P S GNL  L 
Sbjct:   158 IPPELGDLSNLDTLHLVENKLNGSIPSEIGRLTKVTEIAIYDNLLTGPIPSSFGNLTKLV 217

Query:   256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
              L L  NSLSGSIP   GNL NL  L L  N+L+G IPS  GNLK++  L +  N+LSG 
Sbjct:   218 NLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIPSSFGNLKNVTLLNMFENQLSGE 277

Query:   316 IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLA 375
             IP  +GN+T L  L L  N L G IP  +GN++ L  L L  N+L+GSIP  LG + ++ 
Sbjct:   278 IPPEIGNMTALDTLSLHTNKLTGPIPSTLGNIKTLAVLHLYLNQLNGSIPPELGEMESMI 337

Query:   376 TLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGA 435
              L +  N L+G +P                      IP    N T + VL + +N  +G 
Sbjct:   338 DLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPIPPGIANSTELTVLQLDTNNFTGF 397

Query:   436 IPKEYGNLVKLTLLVLSYNQLQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLS 494
             +P       KL  L L  N  +GP+P  LR+   L RVR   N  +G+ISE+FG++  L+
Sbjct:   398 LPDTICRGGKLENLTLDDNHFEGPVPKSLRDCKSLIRVRFKGNSFSGDISEAFGVYPTLN 457

Query:   495 YINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGE 554
             +I+LS+  F+G++S +W +   L    +S N+ITG +PPEI +  QL  LDLSSN I GE
Sbjct:   458 FIDLSNNNFHGQLSANWEQSQKLVAFILSNNSITGAIPPEIWNMTQLSQLDLSSNRITGE 517

Query:   555 IPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLY 614
             +P  +  +  + KL LN N+ SG++P+ +  L  LE+LDLSSNR S+ IP +L NL +LY
Sbjct:   518 LPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLDLSSNRFSSEIPPTLNNLPRLY 577

Query:   615 YLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF 674
             Y+NLS N     IP  L K   L  LDLS+N L  EI SQ  S+Q+LE+L+L+HNNLSG 
Sbjct:   578 YMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISSQFRSLQNLERLDLSHNNLSGQ 637

Query:   675 IPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDI---KGFPSCKA 731
             IP  FK+M  L ++D+S+N L GPIP++AAF++AP +A +GNK LCG +   +G   C  
Sbjct:   638 IPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAFEGNKDLCGSVNTTQGLKPCSI 697

Query:   732 SKSDKQ-ASRKIWVVIVFPLLGSFALLISLIGLFFMFXXXXXXXXXXXXAGNAPGFLSVL 790
             + S K    R + + I+ P++G+  +L    G+F  F            + +    LS+ 
Sbjct:   698 TSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRKRTKQIEEHTDSESGGETLSIF 757

Query:   791 TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPL---LSEMT 847
             +FD K+ Y+EI++AT +FD ++ IGTGG G VY+A+L +  I+AVKK +      +S  +
Sbjct:   758 SFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPNA-IMAVKKLNETTDSSISNPS 816

Query:   848 CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
              +QEFLNE+++LTEIRHRN+VK +GFCSH R++F+VYEY+E GSL  +L N   A++L W
Sbjct:   817 TKQEFLNEIRALTEIRHRNVVKLFGFCSHRRNTFLVYEYMERGSLRKVLENDDEAKKLDW 876

Query:   908 TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
              +R+NV+KGVA ALSY+H+D  P IV+RDISS N+LL  +YEA +SDFG +K LKPDSSN
Sbjct:   877 GKRINVVKGVAHALSYMHHDRSPAIVHRDISSGNILLGEDYEAKISDFGTAKLLKPDSSN 936

Query:   968 WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRT 1027
             W+ +AGT GYVAPELAY MKVTEK DVYSFGVL LE IKG+HP D +S++ S+  +   +
Sbjct:   937 WSAVAGTYGYVAPELAYAMKVTEKCDVYSFGVLTLEVIKGEHPGDLVSTLSSSPPDATLS 996

Query:  1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
             L  I D RLP P+  I+++++ I++VA+ CL  +P +RPTM  +S
Sbjct:   997 LKSISDHRLPEPTPEIKEEVLEILKVALLCLHSDPQARPTMLSIS 1041

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 1667 (591.9 bits), Expect = 1.7e-171, P = 1.7e-171
 Identities = 407/1059 (38%), Positives = 563/1059 (53%)

Query:    36 EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGL 95
             EE   LL++K  L   N+   +L SW   N    +PC W GI C H   V S++L    L
Sbjct:    26 EEGRVLLEFKAFL---NDSNGYLASW---NQLDSNPCNWTGIACTHLRTVTSVDLNGMNL 79

Query:    96 IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
              GTL          L  L++  N I G IP  ++    L+ LDL +N F G IP Q+  +
Sbjct:    80 SGTLSPL-ICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMI 138

Query:   156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS 215
               LK LYL  N   G IP QIG+LS L+ L ++ N L+G IPPS+  L  L I+    N 
Sbjct:   139 ITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNG 198

Query:   216 LSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNL 275
              SG IPSEI   +SL  L L  N L GS+P  L  L NL  L L  N LSG IP S GN+
Sbjct:   199 FSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNI 258

Query:   276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
             + L++L L  N  +GSIP E+G L  +  L L  N+L+G IP  +GNL     +  S+N 
Sbjct:   259 SRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQ 318

Query:   336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXX 395
             L G IP E G++  L  L L +N L G IP  LG LT L  L L  N L+G+IP E+   
Sbjct:   319 LTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFL 378

Query:   396 XXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
                             IP   G  +N  VL + +N+LSG IP  +     L LL L  N+
Sbjct:   379 PYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNK 438

Query:   456 LQGPIP-DLRNLTRLARVRLDRNHLTGNIS-ESFGIHSNLSYINLSHKKFYGEISFDWGK 513
             L G IP DL+    L ++ L  N LTG++  E F +  NL+ + L      G IS D GK
Sbjct:   439 LSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQ-NLTALELHQNWLSGNISADLGK 497

Query:   514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
               NL  L ++ NN TG +PPEIG+  ++   ++SSN + G IP ELG   ++ +L L+ N
Sbjct:   498 LKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGN 557

Query:   574 QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
             +FSG +  ELG L+ LE L LS NRL+  IP S G+L +L  L L  N  S  IP++L K
Sbjct:   558 KFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGK 617

Query:   634 FIHLS-DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISY 692
                L   L++SHN L   IP  + ++Q LE L L  N LSG IP     +  L+  +IS 
Sbjct:   618 LTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISN 677

Query:   693 NKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQ-------ASRKIWVV 745
             N L G +P++A F+        GN GLC   +         SD +       + R+  + 
Sbjct:   678 NNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILT 737

Query:   746 IVFPLLGSFALLISLIGLFFMFXXXXXXXXXXXXAGNAPGFLSVLTFDRK-IAYEEIVRA 804
             I   ++GS   LI+ +GL +                  P  +    F +K   Y+ +V A
Sbjct:   738 ITCIVIGS-VFLITFLGLCWTIKRREPAFVALEDQ-TKPDVMDSYYFPKKGFTYQGLVDA 795

Query:   805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             T +F E+  +G G  G+VY+AE+S GE++AVKK +S      +    F  E+ +L +IRH
Sbjct:   796 TRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRG-EGASSDNSFRAEISTLGKIRH 854

Query:   865 RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             RNIVK YGFC H   + ++YEY+  GSL   L        L W  R  +  G A+ L YL
Sbjct:   855 RNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYL 914

Query:   925 HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIGYVAPELA 983
             H+DC P IV+RDI S N+LLD  ++AHV DFG++K +    S + + +AG+ GY+APE A
Sbjct:   915 HHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYA 974

Query:   984 YTMKVTEKSDVYSFGVLALEAIKGKHP-------RDFISSICSTSSNLDRTLDEILDPRL 1036
             YTMKVTEK D+YSFGV+ LE I GK P        D ++ +  +  N+  T+ E+ D RL
Sbjct:   975 YTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIPTI-EMFDARL 1033

Query:  1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                      ++  ++++A+ C   +P SRPTM++V  ++
Sbjct:  1034 DTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMI 1072

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)]

 Score = 1619 (575.0 bits), Expect = 2.0e-166, P = 2.0e-166
 Identities = 399/1044 (38%), Positives = 570/1044 (54%)

Query:    58 LPSWTLNNATKISPCAWFGIHC-NHAG--KVNSINLTSAGLIGTLHDFSFSSFPHLAYLD 114
             L +W  N++    PC W G+ C N++   +V S+NL+S  L G L   S     HL  LD
Sbjct:    48 LRNWNSNDSV---PCGWTGVMCSNYSSDPEVLSLNLSSMVLSGKLSP-SIGGLVHLKQLD 103

Query:   115 LRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPP 174
             L  N + G IP +I N S L+ L L++N F G IP +IG L  L+ L +  N+ SG +P 
Sbjct:   104 LSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPV 163

Query:   175 QIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLE 234
             +IG+L  L  L  + N +SG +P S+GNL  L       N +SGS+PSEIG  +SL  L 
Sbjct:   164 EIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLG 223

Query:   235 LGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPS 294
             L  N+LSG +P  +G L  L+ + L +N  SG IP    N T+L+ L L  N L G IP 
Sbjct:   224 LAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPK 283

Query:   295 EMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLE 354
             E+G+L+SL  L L  N L+G+IP  +GNL+    +  S+N L G IP E+GN+  L  L 
Sbjct:   284 ELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLY 343

Query:   355 LGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPY 414
             L +N+L+G+IP  L  L NL+ L L  N L+G IP                      IP 
Sbjct:   344 LFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPP 403

Query:   415 SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVR 473
               G  +++ VL +  N LSG IP        + +L L  N L G IP  +     L ++R
Sbjct:   404 KLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLR 463

Query:   474 LDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
             L RN+L G    +     N++ I L   +F G I  + G    L  L ++ N  TG LP 
Sbjct:   464 LARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPR 523

Query:   534 EIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLD 593
             EIG   QL  L++SSN + GE+PSE+   + L +L +  N FSG LP+E+GSL QLE L 
Sbjct:   524 EIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLK 583

Query:   594 LSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLS-DLDLSHNFLGEEIP 652
             LS+N LS +IP +LGNL +L  L +  N F+G IP +L     L   L+LS+N L  EIP
Sbjct:   584 LSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIP 643

Query:   653 SQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEA 712
              ++ ++  LE L L +NNLSG IP  F  +  L+  + SYN L GPIP     ++  M +
Sbjct:   644 PELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP---LLRNISMSS 700

Query:   713 LQGNKGLCG-------DIKGF-PSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLF 764
               GN+GLCG         + F PS    K     S KI + I   ++G  +L+  LI L 
Sbjct:   701 FIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI-IAITAAVIGGVSLM--LIALI 757

Query:   765 FMFXXXXXXXXXXXXAGNAPGFLSV-LTFDRK--IAYEEIVRATNDFDEEHCIGTGGQGS 821
                                P  +S+ + F  K    ++++V AT++FDE   +G G  G+
Sbjct:   758 VYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGT 817

Query:   822 VYRAELSSGEIVAVKKFHSPLL--SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH 879
             VY+A L +G  +AVKK  S     +       F  E+ +L  IRHRNIVK +GFC+H   
Sbjct:   818 VYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGS 877

Query:   880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS 939
             + ++YEY+  GSL  IL + +    L W++R  +  G A  L+YLH+DC P I +RDI S
Sbjct:   878 NLLLYEYMPKGSLGEILHDPSC--NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKS 935

Query:   940 KNVLLDLEYEAHVSDFGISKSLK-PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFG 998
              N+LLD ++EAHV DFG++K +  P S + + +AG+ GY+APE AYTMKVTEKSD+YS+G
Sbjct:   936 NNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYG 995

Query:   999 VLALEAIKGKHP-------RDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
             V+ LE + GK P        D ++ + S     D     +LD RL      I   +++++
Sbjct:   996 VVLLELLTGKAPVQPIDQGGDVVNWVRSYIRR-DALSSGVLDARLTLEDERIVSHMLTVL 1054

Query:  1052 EVAISCLDENPDSRPTMQKVSQLL 1075
             ++A+ C   +P +RP+M++V  +L
Sbjct:  1055 KIALLCTSVSPVARPSMRQVVLML 1078

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)]

 Score = 1540 (547.2 bits), Expect = 4.8e-158, P = 4.8e-158
 Identities = 381/1018 (37%), Positives = 547/1018 (53%)

Query:    85 VNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSF 144
             V S++L+S  L G +   S     +L YL+L  N + G IP +I N SKL+ + L++N F
Sbjct:    87 VTSLDLSSMNLSGIVSP-SIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQF 145

Query:   145 SGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLT 204
              G+IP +I  LS L+   +  N+ SG +P +IG L  L+ L  + N L+G +P SLGNL 
Sbjct:   146 GGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLN 205

Query:   205 NLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL 264
              L       N  SG+IP+EIG   +L  L L  N +SG +P  +G L  L  + L  N  
Sbjct:   206 KLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKF 265

Query:   265 SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLT 324
             SG IP   GNLT+L+ L L  NSL G IPSE+GN+KSL  L L  N+L+G+IP  LG L+
Sbjct:   266 SGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGTIPKELGKLS 325

Query:   325 KLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLL 384
             K+  +  S+NLL G IP E+  +  L  L L  NKL+G IP+ L  L NLA L L  N L
Sbjct:   326 KVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSL 385

Query:   385 SGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLV 444
             +G IP                      IP   G  + + V+    N LSG IP       
Sbjct:   386 TGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGKIPPFICQQS 445

Query:   445 KLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
              L LL L  N++ G IP  +     L ++R+  N LTG          NLS I L   +F
Sbjct:   446 NLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRF 505

Query:   504 YGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLR 563
              G +  + G    L  L ++AN  +  LP EI     L   ++SSN + G IPSE+   +
Sbjct:   506 SGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGPIPSEIANCK 565

Query:   564 SLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
              L +L L+RN F G LP ELGSL QLE L LS NR S +IP ++GNL  L  L +  N F
Sbjct:   566 MLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLF 625

Query:   624 SGEIPIKLEKFIHLS-DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEM 682
             SG IP +L     L   ++LS+N    EIP ++ ++  L  L+L +N+LSG IP  F+ +
Sbjct:   626 SGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENL 685

Query:   683 HGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCG--------DIKGFPSCKASKS 734
               L+  + SYN L G +P++  F++  + +  GNKGLCG            +P   + K+
Sbjct:   686 SSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSCDPSHSSWPHISSLKA 745

Query:   735 DKQASRKIWVVIVFPLLGSFALLISLIGLFFMFXXXXXXXXXXXXAGNAPGFL-SVLTF- 792
                   +I ++IV  ++G  +LL  LI +   F                P F  S + F 
Sbjct:   746 GSARRGRI-IIIVSSVIGGISLL--LIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFV 802

Query:   793 -DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLL----SEMT 847
                +   ++I+ AT  F + + +G G  G+VY+A + SG+ +AVKK  S       +   
Sbjct:   803 PKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNN 862

Query:   848 CQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNATSAEEL 905
                 F  E+ +L +IRHRNIV+ Y FC H  +  + ++YEY+  GSL  +L    S   +
Sbjct:   863 TDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKS-HSM 921

Query:   906 GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-PD 964
              W  R  +  G A+ L+YLH+DC P I++RDI S N+L+D  +EAHV DFG++K +  P 
Sbjct:   922 DWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPL 981

Query:   965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS---ICSTS 1021
             S + + +AG+ GY+APE AYTMKVTEK D+YSFGV+ LE + GK P   +     + + +
Sbjct:   982 SKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLATWT 1041

Query:  1022 SN--LDRTL-DEILDPRLPAPSCN-IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N   D +L  EILDP L     + I + +I++ ++A+ C   +P  RPTM++V  +L
Sbjct:  1042 RNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1510 (536.6 bits), Expect = 7.2e-155, P = 7.2e-155
 Identities = 360/1039 (34%), Positives = 553/1039 (53%)

Query:    60 SWTLNNATKISPCA--WFGIHCNHAGKV-NSINLTSAGLIGTLHDFSFSSFPHLAYLDLR 116
             +W   N ++ +PC   WFG+ C+ +G V  ++NL+++GL G L          L  LDL 
Sbjct:    51 TWK-ENTSETTPCNNNWFGVICDLSGNVVETLNLSASGLSGQLGS-EIGELKSLVTLDLS 108

Query:   117 VNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI 176
             +N   G++PS + N + L+YLDLS+N FSG +P   G+L  L  LYL  N  SG IP  +
Sbjct:   109 LNSFSGLLPSTLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASV 168

Query:   177 GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELG 236
             G L  L  L +  N LSG+IP  LGN + L  + L NN L+GS+P+ +  L++L  L + 
Sbjct:   169 GGLIELVDLRMSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGELFVS 228

Query:   237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM 296
              N L G +     N   L +LDL  N   G +P   GN ++L  L +   +L+G+IPS M
Sbjct:   229 NNSLGGRLHFGSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSM 288

Query:   297 GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELG 356
             G L+ +  + LS N+LSG+IP  LGN + L  L L+DN L G IP  +  L+ L  LEL 
Sbjct:   289 GMLRKVSVIDLSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELF 348

Query:   357 DNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSF 416
              NKLSG IP  +  + +L  + ++ N L+G +P E+                   IP S 
Sbjct:   349 FNKLSGEIPIGIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSL 408

Query:   417 GNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIP-DLRNLTRLARVRLD 475
             G   ++  + +  N  +G IP    +  KL L +L  NQL G IP  +R    L RVRL+
Sbjct:   409 GLNRSLEEVDLLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLE 468

Query:   476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEI 535
              N L+G + E F    +LSY+NL    F G I    G   NL T+D+S N +TG++PPE+
Sbjct:   469 DNKLSGVLPE-FPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPEL 527

Query:   536 GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLS 595
             G+   L +L+LS N++ G +PS+L     L+   +  N  +G +P+   S   L  L LS
Sbjct:   528 GNLQSLGLLNLSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLS 587

Query:   596 SNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIP--IKLEKFIHLSDLDLSHNFLGEEIPS 653
              N    +IP  L  L +L  L ++ N F G+IP  + L K +    LDLS N    EIP+
Sbjct:   588 DNNFLGAIPQFLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYG-LDLSANVFTGEIPT 646

Query:   654 QVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIP-----NSAAFKHA 708
              + ++ +LE+LN+++N L+G +    + +  L  +D+SYN+  GPIP     NS+ F   
Sbjct:   647 TLGALINLERLNISNNKLTGPLS-VLQSLKSLNQVDVSYNQFTGPIPVNLLSNSSKFSGN 705

Query:   709 PMEALQGNKGLCGDI-KGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMF 767
             P   +Q +  +   I K F SCK      Q     W + +     S ++L  L  LF + 
Sbjct:   706 PDLCIQASYSVSAIIRKEFKSCKG-----QVKLSTWKIALIAAGSSLSVLALLFALFLVL 760

Query:   768 XXXXXXXXXXXXAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL 827
                            A   LS+L         +++ AT++ D+++ IG G  G VYRA L
Sbjct:   761 CRCKRGTKTEDANILAEEGLSLLL-------NKVLAATDNLDDKYIIGRGAHGVVYRASL 813

Query:   828 SSGEIVAVKKFHSPLLSE-MTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY 886
              SGE  AVKK    + +E +   Q    E++++  +RHRN+++   F        ++Y+Y
Sbjct:   814 GSGEEYAVKKL---IFAEHIRANQNMKREIETIGLVRHRNLIRLERFWMRKEDGLMLYQY 870

Query:   887 LEMGSLAMILSNATSAEE-LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD 945
             +  GSL  +L      E  L W+ R N+  G++  L+YLH+DC PPI++RDI  +N+L+D
Sbjct:   871 MPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHGLAYLHHDCHPPIIHRDIKPENILMD 930

Query:   946 LEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI 1005
              + E H+ DFG+++ L   + +   + GT GY+APE AY    +++SDVYS+GV+ LE +
Sbjct:   931 SDMEPHIGDFGLARILDDSTVSTATVTGTTGYIAPENAYKTVRSKESDVYSYGVVLLELV 990

Query:  1006 KGKH------PRD-----FISSICSTSSNLDRTLDEILDPRLPAP--SCNIRDKLISIME 1052
              GK       P D     ++ S+ S+  + D T   I+DP+L        +R++ I + +
Sbjct:   991 TGKRALDRSFPEDINIVSWVRSVLSSYEDEDDTAGPIVDPKLVDELLDTKLREQAIQVTD 1050

Query:  1053 VAISCLDENPDSRPTMQKV 1071
             +A+ C D+ P++RP+M+ V
Sbjct:  1051 LALRCTDKRPENRPSMRDV 1069

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=IEP

GO:0009753 "response to jasmonic acid stimulus" evidence=IEP

GO:0042277 "peptide binding" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1488 (528.9 bits), Expect = 1.5e-152, P = 1.5e-152
 Identities = 375/1033 (36%), Positives = 554/1033 (53%)

Query:    83 GKVNSINLTSAG---LIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDL 139
             G   S+ L +A    L G+L     +   +L  L+L  N   G IPSQ+ +   ++YL+L
Sbjct:   213 GNCTSLALFAAAFNRLNGSL-PAELNRLKNLQTLNLGDNSFSGEIPSQLGDLVSIQYLNL 271

Query:   140 SSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPS 199
               N   G IP ++  L+ L+ L LS+N  +G I  +   ++ L+ L L +N LSGS+P +
Sbjct:   272 IGNQLQGLIPKRLTELANLQTLDLSSNNLTGVIHEEFWRMNQLEFLVLAKNRLSGSLPKT 331

Query:   200 L-GNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLD 258
             +  N T+L  ++L    LSG IP+EI N +SL  L+L  N L+G +P SL  L  L  L 
Sbjct:   332 ICSNNTSLKQLFLSETQLSGEIPAEISNCQSLKLLDLSNNTLTGQIPDSLFQLVELTNLY 391

Query:   259 LHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS 318
             L++NSL G++  S  NLTNL    L HN+L G +P E+G L  L  + L  N+ SG +P 
Sbjct:   392 LNNNSLEGTLSSSISNLTNLQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPV 451

Query:   319 SLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLY 378
              +GN T+L  +    N L G IP  IG L+ L  L L +N+L G+IP SLGN   +  + 
Sbjct:   452 EIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLRENELVGNIPASLGNCHQMTVID 511

Query:   379 LFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPK 438
             L  N LSGSIPS                     +P S  NL N+  ++  SN  +G+I  
Sbjct:   512 LADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISP 571

Query:   439 EYGNLVKLTLLVLSYNQLQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
               G+   L+  V   N  +G IP +L   T L R+RL +N  TG I  +FG  S LS ++
Sbjct:   572 LCGSSSYLSFDVTE-NGFEGDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLD 630

Query:   498 LSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPS 557
             +S     G I  + G    L  +D++ N ++G++P  +G  P L  L LSSN  VG +P+
Sbjct:   631 ISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPT 690

Query:   558 ELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLN 617
             E+  L +++ L L+ N  +G +P E+G+L  L  L+L  N+LS  +P ++G L KL+ L 
Sbjct:   691 EIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELR 750

Query:   618 LSNNQFSGEIPIKLEKFIHL-SDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP 676
             LS N  +GEIP+++ +   L S LDLS+N     IPS + ++  LE L+L+HN L G +P
Sbjct:   751 LSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVP 810

Query:   677 RCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDK 736
                 +M  L Y+++SYN L G +     F     +A  GN GLCG      +   SK+ +
Sbjct:   811 GQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCGSPLSHCNRAGSKNQR 868

Query:   737 QASRKIWVVI-VFPLLGSFALLISLIGLFF-----MFXXXX---XXXXXXXXAGNAPGFL 787
               S K  V+I     L + AL++ +I LFF     +F               +  AP F 
Sbjct:   869 SLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLF- 927

Query:   788 SVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMT 847
             S       I +++I+ AT+  +EE  IG+GG G VY+AEL +GE +AVKK       ++ 
Sbjct:   928 SNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWK--DDLM 985

Query:   848 CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH--SFIVYEYLEMGSLAMIL---SNATSA 902
               + F  EVK+L  IRHR++VK  G+CS      + ++YEY+  GS+   L    N    
Sbjct:   986 SNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKK 1045

Query:   903 EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK 962
             E LGW  R+ +  G+A  + YLH DC PPIV+RDI S NVLLD   EAH+ DFG++K L 
Sbjct:  1046 EVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILT 1105

Query:   963 PDSSNWTE----LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
              +    TE     AG+ GY+APE AY++K TEKSDVYS G++ +E + GK P +   ++ 
Sbjct:  1106 GNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTE---AMF 1162

Query:  1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLIS----------------IMEVAISCLDENP 1062
                +++ R ++ +LD   P P    R+KLI                 ++E+A+ C    P
Sbjct:  1163 DEETDMVRWVETVLDT--P-PGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYP 1219

Query:  1063 DSRPTMQKVSQLL 1075
               RP+ ++ S+ L
Sbjct:  1220 QERPSSRQASEYL 1232

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009553 "embryo sac development" evidence=IMP

GO:0008544 "epidermis development" evidence=IGI

GO:0009790 "embryo development" evidence=IGI

TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1024 (365.5 bits), Expect = 3.1e-151, Sum P(2) = 3.1e-151
 Identities = 265/682 (38%), Positives = 360/682 (52%)

Query:    35 TEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAG 94
             + E  +L+ +K SL+N     S L SW ++++   S C W G+ C   G+VNS++L S  
Sbjct:    24 SSETTSLISFKRSLENP----SLLSSWNVSSSA--SHCDWVGVTCL-LGRVNSLSLPSLS 76

Query:    95 LIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGN 154
             L G +     SS  +L  L L  NQ  G IP +I N   L+ LDLS NS +G +P  +  
Sbjct:    77 LRGQIPK-EISSLKNLRELCLAGNQFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPRLLSE 135

Query:   155 LSMLKILYLSTNQFSGRIPPQIG-HLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
             L  L  L LS N FSG +PP     L  L +L +  N LSG IPP +G L+NL+ +Y+  
Sbjct:   136 LPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNLYMGL 195

Query:   214 NSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFG 273
             NS SG IPSEIGN+  L          +G +P  +  L +LA LDL  N L  SIP SFG
Sbjct:   196 NSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKLKHLAKLDLSYNPLKCSIPKSFG 255

Query:   274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD 333
              L NL ILNL    L G IP E+GN KSL  L LSFN LSG +P  L  +  LT      
Sbjct:   256 ELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELSEIPLLTFS-AER 314

Query:   334 NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIX 393
             N L GS+P  +G  + L  L L +N+ SG IPH + +   L  L L +NLLSGSIP E+ 
Sbjct:   315 NQLSGSLPSWMGKWKVLDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNLLSGSIPRELC 374

Query:   394 XXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
                               I   F   +++  L + +N ++G+IP++   L  L  L L  
Sbjct:   375 GSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL-PLMALDLDS 433

Query:   454 NQLQGPIP-DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWG 512
             N   G IP  L   T L       N L G +    G  ++L  + LS  +  GEI  + G
Sbjct:   434 NNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLTGEIPREIG 493

Query:   513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
             K  +L  L+++AN   G +P E+GD   L  LDL SN++ G+IP ++  L  L  L L+ 
Sbjct:   494 KLTSLSVLNLNANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITALAQLQCLVLSY 553

Query:   573 NQFSGQLPT---------ELGSLIQLEH---LDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
             N  SG +P+         E+  L  L+H    DLS NRLS  IP  LG  + L  ++LSN
Sbjct:   554 NNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSGPIPEELGECLVLVEISLSN 613

Query:   621 NQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFK 680
             N  SGEIP  L +  +L+ LDLS N L   IP ++ +   L+ LNLA+N L+G IP  F 
Sbjct:   614 NHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFG 673

Query:   681 EMHGLVYIDISYNKLHGPIPNS 702
              +  LV ++++ NKL GP+P S
Sbjct:   674 LLGSLVKLNLTKNKLDGPVPAS 695

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009556 "microsporogenesis" evidence=IMP

GO:0010234 "tapetal cell fate specification" evidence=IMP

GO:0016020 "membrane" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)]

 Score = 1456 (517.6 bits), Expect = 3.8e-149, P = 3.8e-149
 Identities = 365/1048 (34%), Positives = 551/1048 (52%)

Query:    52 NNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLA 111
             N + S L SW  +++   S  + F  +       N+    +    G + D    S P   
Sbjct:    36 NPEASILYSWLHSSSPTPSSLSLFNWNSIDNTPCNNWTFITCSSQGFITDIDIESVP--- 92

Query:   112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGR 171
              L L        +P  +     L+ L +S  + +GT+P  +G+   LK+L LS+N   G 
Sbjct:    93 -LQLS-------LPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGD 144

Query:   172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLS 231
             IP  +  L  L+ L L  N L+G IPP +   + L  + L++N L+GSIP+E+G L  L 
Sbjct:   145 IPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLE 204

Query:   232 GLELGYNK-LSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSG 290
              + +G NK +SG +P  +G+  NL  L L + S+SG++P S G L  L+ L++    +SG
Sbjct:   205 VIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISG 264

Query:   291 SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYL 350
              IPS++GN   L  L L  N LSGSIP  +G LTKL  L+L  N L G IP EIGN   L
Sbjct:   265 EIPSDLGNCSELVDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNL 324

Query:   351 FYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXX 410
               ++L  N LSGSIP S+G L+ L    +  N  SGSIP+ I                  
Sbjct:   325 KMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISG 384

Query:   411 XIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD----LRNL 466
              IP   G LT + +   +SN L G+IP    +   L  L LS N L G IP     LRNL
Sbjct:   385 LIPSELGTLTKLTLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNL 444

Query:   467 TRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANN 526
             T+L  +    N L+G I +  G  S+L  + L   +  GEI    G    +  LD S+N 
Sbjct:   445 TKLLLIS---NSLSGFIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNR 501

Query:   527 ITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSL 586
             + G +P EIG   +L+++DLS+N + G +P+ +  L  L  L ++ NQFSG++P  LG L
Sbjct:   502 LHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRL 561

Query:   587 IQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLS-DLDLSHN 645
             + L  L LS N  S SIP SLG    L  L+L +N+ SGEIP +L    +L   L+LS N
Sbjct:   562 VSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSN 621

Query:   646 FLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAF 705
              L  +IPS++ S+  L  L+L+HN L G +      +  LV ++ISYN   G +P++  F
Sbjct:   622 RLTGKIPSKIASLNKLSILDLSHNMLEGDLAP-LANIENLVSLNISYNSFSGYLPDNKLF 680

Query:   706 KHAPMEALQGNKGLCGDIKG--FPSCKASKS---DKQASRKIWVVIVFPLLGSFALLISL 760
             +    + L+GNK LC   +   F + +       D  ASR   + +   LL +  +++ +
Sbjct:   681 RQLSPQDLEGNKKLCSSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMI 740

Query:   761 IGLFFMFXXXXXXXXXXXXAGNAPGFLSVLTFDR-KIAYEEIVRATNDFDEEHCIGTGGQ 819
             +G   +                         F +   + ++I+R      E + IG G  
Sbjct:   741 LGAVAVIRARRNIDNERDSELGETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCS 797

Query:   820 GSVYRAELSSGEIVAVKKFHSPLLS----EMT--CQQEFLNEVKSLTEIRHRNIVKFYGF 873
             G VYRA++ +GE++AVKK    +++    E T   +  F  EVK+L  IRH+NIV+F G 
Sbjct:   798 GVVYRADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGC 857

Query:   874 CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             C +     ++Y+Y+  GSL  +L     +  L W  R  ++ G A  L+YLH+DC PPIV
Sbjct:   858 CWNRNTRLLMYDYMPNGSLGSLLHERRGSS-LDWDLRYRILLGAAQGLAYLHHDCLPPIV 916

Query:   934 YRDISSKNVLLDLEYEAHVSDFGISKSL-KPDSSNWTE-LAGTIGYVAPELAYTMKVTEK 991
             +RDI + N+L+ L++E +++DFG++K + + D    +  +AG+ GY+APE  Y+MK+TEK
Sbjct:   917 HRDIKANNILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEK 976

Query:   992 SDVYSFGVLALEAIKGKHPRD--FISSICSTS-SNLDRTLDEILDPRLPAPSCNIRDKLI 1048
             SDVYS+GV+ LE + GK P D      I        +R   E+LD  L + +    D+++
Sbjct:   977 SDVYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVRQNRGSLEVLDSTLRSRTEAEADEMM 1036

Query:  1049 SIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              ++  A+ C++ +PD RPTM+ V+ +LK
Sbjct:  1037 QVLGTALLCVNSSPDERPTMKDVAAMLK 1064

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0010359 "regulation of anion channel activity" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)]

 Score = 1426 (507.0 bits), Expect = 5.7e-146, P = 5.7e-146
 Identities = 362/1033 (35%), Positives = 544/1033 (52%)

Query:    65 NATKISPCAWFGIHCNHAGK--VNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFG 122
             N +   PC W  I C+ +    V  IN+ S  L       + SSF  L  L +    + G
Sbjct:    62 NPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPP-NISSFTSLQKLVISNTNLTG 120

Query:   123 IIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYL 182
              I S+I + S+L  +DLSSNS  G IP  +G L  L+ L L++N  +G+IPP++G    L
Sbjct:   121 AISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSL 180

Query:   183 KALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS-LSGSIPSEIGNLKSLSGLELGYNKLS 241
             K L +F+N LS ++P  LG ++ L  +    NS LSG IP EIGN ++L  L L   K+S
Sbjct:   181 KNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKIS 240

Query:   242 GSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKS 301
             GS+P+SLG L  L +L ++   LSG IP   GN + L  L L  N LSG++P E+G L++
Sbjct:   241 GSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQN 300

Query:   302 LYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLS 361
             L  + L  N L G IP  +G +  L  + LS N   G+IP   GNL  L  L L  N ++
Sbjct:   301 LEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNIT 360

Query:   362 GSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTN 421
             GSIP  L N T L    +  N +SG IP EI                   IP       N
Sbjct:   361 GSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQN 420

Query:   422 MIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIP-DLRNLTRLARVRLDRNHLT 480
             +  L +  N L+G++P     L  LT L+L  N + G IP ++ N T L R+RL  N +T
Sbjct:   421 LQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRIT 480

Query:   481 GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQ 540
             G I +  G   NLS+++LS     G +  +      L  L++S N + G LP  +    +
Sbjct:   481 GEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK 540

Query:   541 LKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS 600
             L+VLD+SSN + G+IP  LG L SL +L L++N F+G++P+ LG    L+ LDLSSN +S
Sbjct:   541 LQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNIS 600

Query:   601 NSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQS 660
              +IP  L ++  L            +I            L+LS N L   IP ++ ++  
Sbjct:   601 GTIPEELFDIQDL------------DIA-----------LNLSWNSLDGFIPERISALNR 637

Query:   661 LEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLC 720
             L  L+++HN LSG +      +  LV ++IS+N+  G +P+S  F+      ++GN GLC
Sbjct:   638 LSVLDISHNMLSGDLS-ALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLC 696

Query:   721 GDIKGFPSCKASKSDKQASRK----IWVVIVFPLLGSFALLISLIGLFFMFXXXXXXXXX 776
                KGF SC  S S +  +++      + I   LL S   +++++G+  +          
Sbjct:   697 S--KGFRSCFVSNSSQLTTQRGVHSHRLRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDD 754

Query:   777 XXXAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVK 836
                      +    T  +K+ +  +        E + IG G  G VY+AE+ + E++AVK
Sbjct:   755 NDSETGENLWTWQFTPFQKLNFT-VEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVK 813

Query:   837 KFHS---PLLSEMT----CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM 889
             K      P L+E T     +  F  EVK+L  IRH+NIV+F G C +     ++Y+Y+  
Sbjct:   814 KLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSN 873

Query:   890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
             GSL  +L   +    LGW  R  +I G A  L+YLH+DC PPIV+RDI + N+L+  ++E
Sbjct:   874 GSLGSLLHERSGVCSLGWEVRYKIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFE 933

Query:   950 AHVSDFGISKSLKPD----SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI 1005
              ++ DFG++K +       SSN   +AG+ GY+APE  Y+MK+TEKSDVYS+GV+ LE +
Sbjct:   934 PYIGDFGLAKLVDDGDFARSSN--TIAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVL 991

Query:  1006 KGKHPRD-FISSICSTSSNLDRTLD-EILDPRLPA-PSCNIRDKLISIMEVAISCLDENP 1062
              GK P D  I         + +  D +++D  L A P   + ++++  + VA+ C++  P
Sbjct:   992 TGKQPIDPTIPDGLHIVDWVKKIRDIQVIDQGLQARPESEV-EEMMQTLGVALLCINPIP 1050

Query:  1063 DSRPTMQKVSQLL 1075
             + RPTM+ V+ +L
Sbjct:  1051 EDRPTMKDVAAML 1063

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9LP24	Y1571_ARATH	2, ., 7, ., 1, 1, ., 1	0.4794	0.9535	0.9169	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: fgenesh2_kg.1__3648__AT1G35710.1 annotation not avaliable (1123 aa) (Arabidopsis lyrata)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	1077
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-160
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-46
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-42
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-39
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-38
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-31
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-29
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-28
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-27
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	4e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-25
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-25
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-24
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	9e-23
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-22
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-22
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-21
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-21
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-20
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	5e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	6e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-20
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-20
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-19
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-19
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	6e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-18
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-18
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	6e-18
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-18
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-17
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-17
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-17
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	5e-17
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-17
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-16
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-16
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-15
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-15
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-15
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-15
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	9e-15
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-14
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-14
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-14
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-14
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	6e-14
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	8e-14
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-13
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-13
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	3e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-13
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	8e-13
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-12
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-12
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-12
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	6e-12
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-12
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-11
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-11
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	4e-11
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-11
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-11
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-11
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-11
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-10
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-10
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	8e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	8e-10
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-10
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-10
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-09
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-09
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-09
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-09
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-09
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-09
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	9e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-08
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	1e-08
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-08
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-08
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-08
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-08
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-08
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-07
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	5e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	7e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	8e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	9e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-06
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-06
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	3e-06
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-06
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-06
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-05
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-05
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-05
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	5e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-05
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	6e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
cd00116	319	cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-04
PLN03210	1153	PLN03210, PLN03210, Resistant to P	2e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	5e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	8e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	0.001
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.001
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	0.001
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.003
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.003
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  498 bits (1285), Expect = e-160
 Identities = 351/1080 (32%), Positives = 526/1080 (48%), Gaps = 160/1080 (14%)

Query: 15   LILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAW 74
            LI ++ F  L+F ++      EE   LL +K+S+   N+   +L +W  +       C W
Sbjct: 12   LIFMLFFLFLNFSML----HAEELELLLSFKSSI---NDPLKYLSNWNSSADV----CLW 60

Query: 75   FGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQI-ANNSK 133
             GI CN++ +V SI+L+   + G +    F   P++  ++L  NQ+ G IP  I   +S 
Sbjct: 61   QGITCNNSSRVVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSS 119

Query: 134  LKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLS 193
            L+YL+LS+N+F+G+IP   G++  L+ L LS N  SG IP  IG  S LK L L  N L 
Sbjct: 120  LRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Query: 194  GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPN 253
            G IP SL NLT+L  + L +N L G IP E+G +KSL  + LGYN LSG +P  +G L +
Sbjct: 178  GKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS 237

Query: 254  LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS 313
            L  LDL  N+L+G IP S GNL NL  L L  N                        KLS
Sbjct: 238  LNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQN------------------------KLS 273

Query: 314  GSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
            G IP S+ +L KL  L LSDN L G IP  +  L+ L  L L  N  +G IP +L +L  
Sbjct: 274  GPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333

Query: 374  LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
            L  L L++N  SG IP  +G  N+L+ L LS N L+G IP    +  N+  L ++SN+L 
Sbjct: 334  LQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLE 393

Query: 434  GAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
            G IP                         L     L RVRL  N  +G +   F      
Sbjct: 394  GEIP-----------------------KSLGACRSLRRVRLQDNSFSGELPSEFT----- 425

Query: 494  SYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG 553
                               K P +  LD+S NN+ G +     D P L++L L+      
Sbjct: 426  -------------------KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLA------ 460

Query: 554  EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKL 613
                              RN+F G LP   GS  +LE+LDLS N+ S ++P  LG+L +L
Sbjct: 461  ------------------RNKFFGGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSEL 501

Query: 614  YYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSG 673
              L LS N+ SGEIP +L     L  LDLSHN L  +IP+    M  L +L+L+ N LSG
Sbjct: 502  MQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSG 561

Query: 674  FIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIK--GFPSCKA 731
             IP+    +  LV ++IS+N LHG +P++ AF      A+ GN  LCG     G P CK 
Sbjct: 562  EIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR 621

Query: 732  SKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMF-RRRSSSQTQQSSAGNAPGFLSVL 790
             +         W   +   LG+F L+++L+   F+F R R++ + ++    N  G   + 
Sbjct: 622  VRKT-----PSWWFYITCTLGAF-LVLALVAFGFVFIRGRNNLELKRVE--NEDGTWELQ 673

Query: 791  TFDRK----IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI----VAVKKFHSPL 842
             FD K    I   +I+ +     EE+ I  G +G+ Y+ +     +      +   +S  
Sbjct: 674  FFDSKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-- 728

Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA 902
            +           E+  + +++H NIVK  G C   + +++++EY+E  +L+ +L N    
Sbjct: 729  IPSS--------EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---- 776

Query: 903  EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK 962
              L W +R  +  G+A AL +LH  C P +V  ++S + +++D + E H+    +   L 
Sbjct: 777  --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC 833

Query: 963  PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS 1022
             D+  +   A    YVAPE   T  +TEKSD+Y FG++ +E + GK P D    +  +  
Sbjct: 834  TDTKCFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIV 889

Query: 1023 NLDRT------LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               R       LD  +DP +       +++++ +M +A+ C   +P +RP    V + L+
Sbjct: 890  EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  165 bits (419), Expect = 9e-46
 Identities = 79/276 (28%), Positives = 128/276 (46%), Gaps = 27/276 (9%)

Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            ++    +G+G  G+VY+A    +G+IVAVK             Q    E++ L  + H N
Sbjct: 1    YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEK-SKKDQTARREIRILRRLSHPN 59

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+         H ++V EY E G L   LS       L   +   +   +   L YLH+
Sbjct: 60   IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHS 116

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYT 985
            +    I++RD+  +N+LLD      ++DFG++K L   SS+ T   GT  Y+APE L   
Sbjct: 117  N---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAP---S 1040
                 K DV+S GV+  E + GK P        S  + LD  + +  IL P L       
Sbjct: 174  NGYGPKVDVWSLGVILYELLTGKPP-------FSGENILDQLQLIRRILGPPLEFDEPKW 226

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +  ++   +++    CL+++P  RPT +   ++L+
Sbjct: 227  SSGSEEAKDLIK---KCLNKDPSKRPTAE---EILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (412), Expect = 8e-45
 Identities = 72/269 (26%), Positives = 124/269 (46%), Gaps = 22/269 (8%)

Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            ++    +G G  G VY A +  +G++VA+K      + +   ++  L E+K L +++H N
Sbjct: 1    YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPN 58

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+ Y         ++V EY E G L  +L       E    +    ++ +  AL YLH+
Sbjct: 59   IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHS 115

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 IV+RD+  +N+LLD +    ++DFG+++ L P     T   GT  Y+APE+    
Sbjct: 116  KG---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT-FVGTPEYMAPEVLLGK 171

Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL--DPRLPAPSCNIR 1044
               +  D++S GV+  E + GK P  F          L     +I    P  P P  +I 
Sbjct: 172  GYGKAVDIWSLGVILYELLTGKPP--F-----PGDDQLLELFKKIGKPKPPFPPPEWDIS 224

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
             +   ++      L ++P+ R T ++  Q
Sbjct: 225  PEAKDLIR---KLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  153 bits (389), Expect = 3e-42
 Identities = 67/193 (34%), Positives = 105/193 (54%), Gaps = 10/193 (5%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG G+VY A    +G+ VA+K       S +   +E L E++ L ++ H NIVK YG
Sbjct: 1    LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                  H ++V EY E GSL  +L       +L   + + ++  + + L YLH++    I
Sbjct: 59   VFEDENHLYLVMEYCEGGSLKDLLKENEG--KLSEDEILRILLQILEGLEYLHSN---GI 113

Query: 933  VYRDISSKNVLLD-LEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTE 990
            ++RD+  +N+LLD    +  ++DFG+SK L  D S    + GT  Y+APE L      +E
Sbjct: 114  IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 991  KSDVYSFGVLALE 1003
            KSD++S GV+  E
Sbjct: 174  KSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  146 bits (371), Expect = 3e-39
 Identities = 74/277 (26%), Positives = 127/277 (45%), Gaps = 31/277 (11%)

Query: 814  IGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G VY+ +L   +     VAVK        E   +++FL E + + ++ H N+V+
Sbjct: 3    LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE--RKDFLKEARVMKKLGHPNVVR 60

Query: 870  FYGFCSHARHSFIVYEYLEMGSL------AMILSNATSAEELGWTQRMNVIKGVADALSY 923
              G C+     ++V EY+E G L      +  +  +     L     ++    +A  + Y
Sbjct: 61   LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPE 981
            L +      V+RD++++N L+  +    +SDFG+S+ +  D     +  G   I ++APE
Sbjct: 121  LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 982  LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-RLPAP 1039
                   T KSDV+SFGVL  E    G  P   +S+        +  L+ +    RLP P
Sbjct: 178  SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLPKP 229

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 D+L  +M    SC   +P+ RPT  ++ + L+
Sbjct: 230  E-YCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  145 bits (367), Expect = 7e-39
 Identities = 85/284 (29%), Positives = 131/284 (46%), Gaps = 48/284 (16%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             F+    IG GG G VY+A    +G+ VA+K      L     +++ +NE++ L + +H 
Sbjct: 1    LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN------VIKGVAD 919
            NIVK+YG        +IV E+   GSL  +L +          Q +       V K +  
Sbjct: 58   NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKS--------TNQTLTESQIAYVCKELLK 109

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVA 979
             L YLH++    I++RDI + N+LL  + E  + DFG+S  L  D+     + GT  ++A
Sbjct: 110  GLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLS-DTKARNTMVGTPYWMA 165

Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD---PR 1035
            PE+        K+D++S G+ A+E  +GK P  +             + L +I     P 
Sbjct: 166  PEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---------MKALFKIATNGPPG 216

Query: 1036 LPAP---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            L  P   S   +D L         CL +NP+ RPT     QLLK
Sbjct: 217  LRNPEKWSDEFKDFL-------KKCLQKNPEKRPT---AEQLLK 250

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  144 bits (367), Expect = 1e-38
 Identities = 76/281 (27%), Positives = 118/281 (41%), Gaps = 48/281 (17%)

Query: 814  IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQ--EFLNEVKSLTEIRHRN 866
            +G G  G VY+  L      +   VAVK     L    + ++  EFL E   + ++ H N
Sbjct: 7    LGEGAFGEVYKGTLKGDGEGTETKVAVKT----LKEGASEEEREEFLEEASIMKKLSHPN 62

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+  G C+     +IV EY+  G L   L      E+L     + +   +A  + YL +
Sbjct: 63   IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV-----APE 981
              F   V+RD++++N L+       +SDFG+S+ +  D           G +     APE
Sbjct: 121  KNF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIKWMAPE 174

Query: 982  LAYTMKVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDP 1034
                 K T KSDV+SFGVL  E          G    + +  +                 
Sbjct: 175  SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED-------------GY 221

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            RLP P  N  D+L  +M   + C   +P+ RPT  ++ + L
Sbjct: 222  RLPRPE-NCPDELYELM---LQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  142 bits (360), Expect = 7e-38
 Identities = 77/274 (28%), Positives = 123/274 (44%), Gaps = 35/274 (12%)

Query: 814  IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            +G G  G VY+ +L          VAVK       +     +EFL E + + ++ H N+V
Sbjct: 7    LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVV 64

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G C+     +IV EY+E G L   L    +  +L  +  ++    +A  + YL +  
Sbjct: 65   KLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLESK- 121

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAPELAYTMK 987
                ++RD++++N L+       +SDFG+S+ L  D           I ++APE     K
Sbjct: 122  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEIL-----DPRLPAPSC 1041
             T KSDV+SFGVL  E    G+ P                + +E+L       RLP P  
Sbjct: 180  FTSKSDVWSFGVLLWEIFTLGEQPYP------------GMSNEEVLEYLKNGYRLPQPP- 226

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            N   +L  +M     C  E+P+ RPT  ++ ++L
Sbjct: 227  NCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (359), Expect = 1e-37
 Identities = 78/274 (28%), Positives = 121/274 (44%), Gaps = 34/274 (12%)

Query: 814  IGTGGQGSVYRAELS-----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            +G G  G VY+  L          VAVK       +     +EFL E + + ++ H NIV
Sbjct: 7    LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIV 64

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G C+      IV EY+  G L   L      +EL  +  ++    +A  + YL +  
Sbjct: 65   KLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLESK- 122

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAPELAYTMK 987
                ++RD++++N L+       +SDFG+S+ L  D     +     I ++APE     K
Sbjct: 123  --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGK 180

Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILD-----PRLPAPSC 1041
             T KSDV+SFGVL  E    G+ P                +  E+L+      RLP P  
Sbjct: 181  FTSKSDVWSFGVLLWEIFTLGEEPYP------------GMSNAEVLEYLKKGYRLPKPP- 227

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            N   +L  +M     C  E+P+ RPT  ++ ++L
Sbjct: 228  NCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 2e-35
 Identities = 72/278 (25%), Positives = 127/278 (45%), Gaps = 40/278 (14%)

Query: 812  HCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
              +G G  GSVY A +  +GE++AVK       SE    +    E++ L+ ++H NIV++
Sbjct: 6    ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSE-EELEALEREIRILSSLQHPNIVRY 64

Query: 871  YGFCSHARHSF--IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA----DALSYL 924
            YG       +   I  EY+  GSL+ +L       E        VI+       + L+YL
Sbjct: 65   YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPE-------PVIRKYTRQILEGLAYL 117

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPEL 982
            H++    IV+RDI   N+L+D +    ++DFG +K L    +      + GT  ++APE+
Sbjct: 118  HSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP----RDFISSICSTSSNLDRTLDEILDPRLPA 1038
                +    +D++S G   +E   GK P     + ++++    S+ +        P +P 
Sbjct: 175  IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP-------PEIP- 226

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               ++ ++    +     CL  +P  RPT     +LL+
Sbjct: 227  --EHLSEEAKDFLR---KCLRRDPKKRPT---ADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  123 bits (312), Expect = 2e-31
 Identities = 78/277 (28%), Positives = 129/277 (46%), Gaps = 30/277 (10%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D +    +G G  G VY+     +G+I A+KK H     E   +++ L E+K+L     
Sbjct: 1    SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEF--RKQLLRELKTLRSCES 58

Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADAL 921
              +VK YG F      S IV EY++ GSLA +L      +     + +   + + +   L
Sbjct: 59   PYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGL 112

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH      I++RDI   N+L++ + E  ++DFGISK L+          GT+ Y++PE
Sbjct: 113  DYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE 170

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPA 1038
                   +  +D++S G+  LE   GK P  F+     +   L   +  I D   P LPA
Sbjct: 171  RIQGESYSYAADIWSLGLTLLECALGKFP--FLPPGQPSFFEL---MQAICDGPPPSLPA 225

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               +   +    +    +CL ++P  RP+    ++LL
Sbjct: 226  EEFS--PEFRDFIS---ACLQKDPKKRPS---AAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  117 bits (297), Expect = 2e-29
 Identities = 81/284 (28%), Positives = 126/284 (44%), Gaps = 42/284 (14%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMT--CQQEFLNEVKSLTEIR 863
             ++    IG G  G VY     S G++  +K+     LS M+   +++ LNEVK L ++ 
Sbjct: 1    KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEID---LSNMSEKEREDALNEVKILKKLN 57

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA-----EE--LGW-TQRMNVIK 915
            H NI+K+Y          IV EY + G L+  +           EE  L W  Q      
Sbjct: 58   HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ------ 111

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +  AL YLH+     I++RDI  +N+ L       + DFGISK L         + GT 
Sbjct: 112  -LCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
             Y++PEL        KSD++S G +  E    KHP  F         NL     +IL  +
Sbjct: 168  YYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHP--F------EGENLLELALKIL--K 217

Query: 1036 LPAPSCNIR--DKLISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077
               P    +   +L +++    S L ++P+ RP+   ++Q+L+ 
Sbjct: 218  GQYPPIPSQYSSELRNLVS---SLLQKDPEERPS---IAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  116 bits (292), Expect = 8e-29
 Identities = 75/210 (35%), Positives = 116/210 (55%), Gaps = 19/210 (9%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQE------FLNEVKSLTEIRHRN 866
            IG+G  GSVY     SSGE++AVK+   P +S  +  ++         E+  L E++H N
Sbjct: 8    IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV++ G    A H  I  EY+  GS+A +L+N  + EE   T   N ++ +   L+YLHN
Sbjct: 68   IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE---TLVRNFVRQILKGLNYLHN 124

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTIGYVAP 980
                 I++RDI   N+L+D +    +SDFGISK L+ +S +         L G++ ++AP
Sbjct: 125  R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+      T K+D++S G L +E + GKHP
Sbjct: 182  EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 3e-28
 Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 32/269 (11%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G+G  G V+  +      VA+K      +SE     +F+ E K + ++ H N+V+ YG 
Sbjct: 12   LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGV 67

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FIV EY+  G L   L          W   +++   V +A+ YL ++ F   +
Sbjct: 68   CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLESNGF---I 122

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L+  +    VSDFG+++ +  D   +T   GT   + +  PE+    + + 
Sbjct: 123  HRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 991  KSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLI 1048
            KSDV+SFGVL  E   +GK P +         SN +  ++ +    RL  P      KL 
Sbjct: 181  KSDVWSFGVLMWEVFSEGKMPYE-------RFSNSE-VVESVSAGYRLYRP------KLA 226

Query: 1049 S--IMEVAISCLDENPDSRPTMQKVSQLL 1075
               +  +  SC  E P+ RP  +K+   L
Sbjct: 227  PTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  113 bits (284), Expect = 2e-27
 Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 60/283 (21%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQE--FLNEVKSLTEIRHRNIVKF 870
            IG G  G VY+A + ++G+ VA+KK        +  Q +   +NE+  + + +H NIV +
Sbjct: 27   IGEGASGEVYKATDRATGKEVAIKKMR------LRKQNKELIINEILIMKDCKHPNIVDY 80

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN------VIKGVADALSYL 924
            Y         ++V EY++ GSL  I++            RMN      V + V   L YL
Sbjct: 81   YDSYLVGDELWVVMEYMDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYL 132

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-- 982
            H+     +++RDI S N+LL  +    ++DFG +  L  + S    + GT  ++APE+  
Sbjct: 133  HSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 983  --AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD----RTLDEILD--- 1033
               Y  KV    D++S G++ +E  +G+ P             L     R L  I     
Sbjct: 190  RKDYGPKV----DIWSLGIMCIEMAEGEPPY------------LREPPLRALFLITTKGI 233

Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            P L  P      +    +     CL ++P+ RP+ +   +LL+
Sbjct: 234  PPLKNPE-KWSPEFKDFLN---KCLVKDPEKRPSAE---ELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  111 bits (280), Expect = 3e-27
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 39/279 (13%)

Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V R  L      EI VA+K   +    +     +FL E   + +  H N
Sbjct: 9    EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPN 66

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I++  G  + +R   I+ EY+E GSL   L    +  +    Q + +++G+A  + YL  
Sbjct: 67   IIRLEGVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYLSE 124

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG--YVAPE-LA 983
              +   V+RD++++N+L++      VSDFG+S+ L+   + +T   G I   + APE +A
Sbjct: 125  MNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDPRL 1036
            Y  K T  SDV+SFG++  E +  G+ P      +D I ++                 RL
Sbjct: 182  YR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-------------GYRL 227

Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            P P     D   ++ ++ + C  ++ + RPT  ++   L
Sbjct: 228  PPP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 4e-27
 Identities = 73/273 (26%), Positives = 122/273 (44%), Gaps = 38/273 (13%)

Query: 813  CIGTGGQGSVYRAE-LSSGEIVAVKKF--HSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
             IG G  G VY+   L +G+ VA+K+          +   +  + E+  L  ++H NIVK
Sbjct: 7    LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEAL---KSIMQEIDLLKNLKHPNIVK 63

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            + G    +   +I+ EY E GSL  I+       E   +     +  V   L+YLH    
Sbjct: 64   YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPE---SLVAVYVYQVLQGLAYLHEQ-- 118

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
              +++RDI + N+L   +    ++DFG++  L   S +   + GT  ++APE+      +
Sbjct: 119  -GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177

Query: 990  EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEIL-DPRLPAP---SCNI 1043
              SD++S G   +E + G  P            +L+    L  I+ D   P P   S  +
Sbjct: 178  TASDIWSLGCTVIELLTGNPP----------YYDLNPMAALFRIVQDDHPPLPEGISPEL 227

Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +D L       + C  ++P+ RPT +   QLLK
Sbjct: 228  KDFL-------MQCFQKDPNLRPTAK---QLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  110 bits (276), Expect = 6e-26
 Identities = 71/267 (26%), Positives = 122/267 (45%), Gaps = 17/267 (6%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNIVKFYG 872
            +G G  G VY A     ++VA+K     L S+    + FL E++ L  + H  NIVK Y 
Sbjct: 8    LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       ++V EY++ GSL  +L        L  ++ + ++  +  AL YLH+     I
Sbjct: 66   FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122

Query: 933  VYRDISSKNVLLDLEY-EAHVSDFGISKSLKPDSSN------WTELAGTIGYVAPELAYT 985
            ++RDI  +N+LLD +     + DFG++K L    S        +   GT GY+APE+   
Sbjct: 123  IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 986  M---KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
            +     +  SD++S G+   E + G  P +   +  +TS  L   L+          S +
Sbjct: 183  LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242

Query: 1043 IRDKLIS-IMEVAISCLDENPDSRPTM 1068
              + +     ++    L ++P +R + 
Sbjct: 243  NPELISKAASDLLKKLLAKDPKNRLSS 269

Length = 384

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (269), Expect = 1e-25
 Identities = 81/283 (28%), Positives = 130/283 (45%), Gaps = 35/283 (12%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D++    IG G  G+V +    S G+I+  K+     ++E   QQ  ++EV  L E++H 
Sbjct: 1    DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQ-LVSEVNILRELKHP 59

Query: 866  NIVKFYG-FCSHARHS-FIVYEYLEMGSLAMILSNATS-----AEELGWTQRMNVIKGVA 918
            NIV++Y      +  + +IV EY E G LA ++           EE  W     ++  + 
Sbjct: 60   NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW----RILTQLL 115

Query: 919  DALSYLHN--DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG 976
             AL   HN  D    +++RD+   N+ LD      + DFG++K L  DSS      GT  
Sbjct: 116  LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY 175

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--- 1033
            Y++PE    M   EKSD++S G L  E      P  F      T+ N  +   +I +   
Sbjct: 176  YMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP--F------TARNQLQLASKIKEGKF 227

Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             R+P    +  +++I       S L+ +PD RP+     +LL+
Sbjct: 228  RRIPYRYSSELNEVIK------SMLNVDPDKRPS---TEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  105 bits (264), Expect = 3e-25
 Identities = 75/279 (26%), Positives = 123/279 (44%), Gaps = 45/279 (16%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G VY+  L     VAVK   S L  ++  +++FL E + L +  H NIVK  G 
Sbjct: 3    IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C   +  +IV E +  GSL   L        L   + + +    A  + YL +      +
Sbjct: 61   CVQKQPIYIVMELVPGGSLLTFLR--KKKNRLTVKKLLQMSLDAAAGMEYLESKN---CI 115

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IGYVAPELAYTMKVT 989
            +RD++++N L+       +SDFG+S+  + +   +T   G     I + APE     + T
Sbjct: 116  HRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 990  EKSDVYSFGVLALEAI-KGKHP---------RDFISSICSTSSNLDRTLDEILDPRLPAP 1039
             +SDV+S+G+L  E    G  P         R+ I S                  R+PAP
Sbjct: 174  SESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES----------------GYRMPAP 217

Query: 1040 -SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077
              C   +++  +M     C   +P++RP+  ++   L+I
Sbjct: 218  QLCP--EEIYRLML---QCWAYDPENRPSFSEIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  105 bits (264), Expect = 4e-25
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 26/262 (9%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K + ++ H  +V+ YG 
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  +IV EY+  G L   L       +   +Q + + K V + ++YL +  F   +
Sbjct: 68   CTKQRPIYIVTEYMSNGCLLNYLREHGKRFQP--SQLLEMCKDVCEGMAYLESKQF---I 122

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L+D +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 123  HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSDV++FGVL  E    GK P +         +N +         RL  P     +K+ +
Sbjct: 181  KSDVWAFGVLMWEVYSLGKMPYERF-------NNSETVEKVSQGLRLYRPHL-ASEKVYA 232

Query: 1050 IMEVAISCLDENPDSRPTMQKV 1071
            IM    SC  E  + RPT Q++
Sbjct: 233  IM---YSCWHEKAEERPTFQQL 251

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 1e-24
 Identities = 82/283 (28%), Positives = 123/283 (43%), Gaps = 48/283 (16%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +      IG G  G V   +   G+ VAVK     L  + T  Q FL E   +T +RH 
Sbjct: 6    KELKLGATIGKGEFGDVMLGDYR-GQKVAVKC----LKDDSTAAQAFLAEASVMTTLRHP 60

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+V+  G        +IV EY+  GSL   L +   A  +   Q++     V + + YL 
Sbjct: 61   NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLE 119

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK--SLKPDSS----NWTELAGTIGYVA 979
               F   V+RD++++NVL+  +  A VSDFG++K  S   DS      WT         A
Sbjct: 120  EKNF---VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT---------A 167

Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP---- 1034
            PE     K + KSDV+SFG+L  E    G+ P   I             L +++      
Sbjct: 168  PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP------------LKDVVPHVEKG 215

Query: 1035 -RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             R+ AP  C        + +V   C + +P  RPT +++ + L
Sbjct: 216  YRMEAPEGCP-----PEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  102 bits (255), Expect = 6e-24
 Identities = 72/277 (25%), Positives = 126/277 (45%), Gaps = 41/277 (14%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            R   +F  E  +G+G  G V+     +   VA+K   S    ++  QQ+F  EV++L  +
Sbjct: 3    RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKS---DDLLKQQDFQKEVQALKRL 59

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH++++  +  CS     +I+ E +E GSL   L +    + L     +++   VA+ ++
Sbjct: 60   RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMA 118

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-----PDSSN----WTELAG 973
            YL        ++RD++++N+L+  +    V+DFG+++ +K              WT    
Sbjct: 119  YLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT---- 171

Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEIL 1032
                 APE A     + KSDV+SFG+L  E    G+ P            N     D+I 
Sbjct: 172  -----APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP--------GMNNHEVYDQIT 218

Query: 1033 DP-RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPT 1067
               R+P P+ C    ++  IM   + C    P+ RP+
Sbjct: 219  AGYRMPCPAKCP--QEIYKIM---LECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  101 bits (254), Expect = 1e-23
 Identities = 59/198 (29%), Positives = 109/198 (55%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+K+ +   L +   ++  +NE+  + E +H NIV +  
Sbjct: 27   IGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLD 83

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++  T  +E    Q   V +    AL +LH++    +
Sbjct: 84   SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDE---GQIAAVCRECLQALEFLHSN---QV 136

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 137  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E ++G+ P
Sbjct: 197  DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  101 bits (253), Expect = 1e-23
 Identities = 69/211 (32%), Positives = 102/211 (48%), Gaps = 27/211 (12%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK--KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG G  G VY A  L +GE++AVK  +        +   +E  +E+K L  ++H N+VK+
Sbjct: 8    IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI---KEIADEMKVLELLKHPNLVKY 64

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA----DALSYLHN 926
            YG   H    +I  EY   G+L  +L       E G     +VI+       + L+YLH+
Sbjct: 65   YGVEVHREKVYIFMEYCSGGTLEELL-------EHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE----LAGTIGYVAPEL 982
                 IV+RDI   N+ LD      + DFG +  LK +++   E    LAGT  Y+APE+
Sbjct: 118  H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 983  AYTMKVTEK---SDVYSFGVLALEAIKGKHP 1010
                K       +D++S G + LE   GK P
Sbjct: 175  ITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (250), Expect = 4e-23
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 29/219 (13%)

Query: 814  IGTGGQGSVYRAELSSG------EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+  E          E+VAVK       +    +++F  E + LT  +H NI
Sbjct: 13   LGEGAFGKVFLGECYHLEPENDKELVAVKTLKET--ASNDARKDFEREAELLTNFQHENI 70

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNATSAE-ELGWTQRMNVIKG 916
            VKFYG C+      +V+EY+E G L          A  L +  S   EL  +Q + +   
Sbjct: 71   VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT-- 974
            +A  + YL +  F   V+RD++++N L+  +    + DFG+S+ +   ++++  + G   
Sbjct: 131  IASGMVYLASQHF---VHRDLATRNCLVGYDLVVKIGDFGMSRDVY--TTDYYRVGGHTM 185

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
              I ++ PE     K T +SDV+SFGV+  E    GK P
Sbjct: 186  LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.9 bits (247), Expect = 8e-23
 Identities = 80/281 (28%), Positives = 134/281 (47%), Gaps = 41/281 (14%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
              FD    +G G  GSVY+A    +G++VA+K    P+  ++   QE + E+  L +   
Sbjct: 3    EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV--PVEEDL---QEIIKEISILKQCDS 57

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADALS 922
              IVK+YG        +IV EY   GS+   M ++N T  EE    +   ++      L 
Sbjct: 58   PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEE----EIAAILYQTLKGLE 113

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH++     ++RDI + N+LL+ E +A ++DFG+S  L    +    + GT  ++APE+
Sbjct: 114  YLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEV 170

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               +    K+D++S G+ A+E  +GK P   I  +        R +  I  P  P P+ +
Sbjct: 171  IQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFMI--PNKPPPTLS 220

Query: 1043 IRDK-------LISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              +K        +        CL ++P+ RP+     QLL+
Sbjct: 221  DPEKWSPEFNDFVK------KCLVKDPEERPS---AIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 98.9 bits (246), Expect = 9e-23
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 26/274 (9%)

Query: 810  EEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            ++  IG G  G V+R  L         VA+K    P  +E   +Q+FL+E   + +  H 
Sbjct: 9    KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL-KPGYTEKQ-RQDFLSEASIMGQFSHH 66

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI++  G  +  + + I+ EY+E G+L   L +     E    Q + +++G+A  + YL 
Sbjct: 67   NIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLS 124

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPEL 982
            +  +   V+RD++++N+L++   E  VSDFG+S+ L+ D    +T   G I   + APE 
Sbjct: 125  DMNY---VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181

Query: 983  AYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
                K T  SDV+SFG++  E +  G+ P   +S     +  + + +++    RLPAP  
Sbjct: 182  IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-----NHEVMKAINDGF--RLPAP-- 232

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               D   ++ ++ + C  ++   RP    +  LL
Sbjct: 233  --MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 98.4 bits (245), Expect = 1e-22
 Identities = 74/268 (27%), Positives = 130/268 (48%), Gaps = 30/268 (11%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G+G  G V+  +  +   VA+K  +   +SE    ++F+ E K + ++ H  +V+ YG 
Sbjct: 12   LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGV 67

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  +  +IV E++E G L   L       +L     +++ + V + + YL  + F   +
Sbjct: 68   CTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNSF---I 122

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L+       VSDFG+++ +  D   +T  +G    + +  PE+    K + 
Sbjct: 123  HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 991  KSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSDV+SFGVL  E   +GK P +         SN +         RL  P      KL S
Sbjct: 181  KSDVWSFGVLMWEVFTEGKMPFE-------KKSNYEVVEMISRGFRLYRP------KLAS 227

Query: 1050 --IMEVAISCLDENPDSRPTMQKVSQLL 1075
              + EV  SC  E P+ RPT  ++ + +
Sbjct: 228  MTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 4e-22
 Identities = 79/277 (28%), Positives = 125/277 (45%), Gaps = 33/277 (11%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIR 863
              F    CIG G  G VY+A +  + ++VA+K      L E   + E +  E++ L++ R
Sbjct: 1    ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID---LEEAEDEIEDIQQEIQFLSQCR 57

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
               I K+YG        +I+ EY   GS   +L      E         +++ V   L Y
Sbjct: 58   SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF----ILREVLLGLEY 113

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH +     ++RDI + N+LL  E +  ++DFG+S  L    S      GT  ++APE+ 
Sbjct: 114  LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAPSC 1041
                  EK+D++S G+ A+E  KG+ P           S+L   R L  I  P+   PS 
Sbjct: 171  KQSGYDEKADIWSLGITAIELAKGEPPL----------SDLHPMRVLFLI--PKNNPPS- 217

Query: 1042 NIRDKLIS--IMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +     S    +    CL+++P  RP+     +LLK
Sbjct: 218  -LEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLK 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 96.7 bits (241), Expect = 4e-22
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 31/263 (11%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    ++   VAVK      +      ++FL E + + ++RH  +++ Y  
Sbjct: 14   LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDP----KDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+     +IV E ++ GSL   L        L   Q +++   VA  ++YL    +   +
Sbjct: 70   CTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQNY---I 125

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD++++NVL+       V+DFG+++ +K D     E A   I + APE A   + + KS
Sbjct: 126  HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 993  DVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIRDK 1046
            DV+SFG+L  E +  G+ P           +N      E+L       R+P P      +
Sbjct: 186  DVWSFGILLTEIVTYGRMPY-------PGMTNA-----EVLQQVDQGYRMPCPP-GCPKE 232

Query: 1047 LISIMEVAISCLDENPDSRPTMQ 1069
            L  IM   + C  E+PD RPT +
Sbjct: 233  LYDIM---LDCWKEDPDDRPTFE 252

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 97.1 bits (241), Expect = 6e-22
 Identities = 59/198 (29%), Positives = 107/198 (54%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+V+ A ++++G+ VA+K+ +   L +   ++  +NE+  + E+++ NIV F  
Sbjct: 27   IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    F+V EYL  GSL  +++     E     Q   V +    AL +LH +    +
Sbjct: 84   SFLVGDELFVVMEYLAGGSLTDVVTETCMDE----AQIAAVCRECLQALEFLHAN---QV 136

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S NVLL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 137  IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E ++G+ P
Sbjct: 197  DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 96.6 bits (240), Expect = 8e-22
 Identities = 70/221 (31%), Positives = 114/221 (51%), Gaps = 32/221 (14%)

Query: 814  IGTGGQGSVYRAE---LSSGE---IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE   LS  +   +VAVK    P L+    +++F  E + LT ++H +I
Sbjct: 13   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHI 69

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNA---TSAEELGWTQRMNVI 914
            VKFYG C       +V+EY++ G L          AMIL +     +  ELG +Q +++ 
Sbjct: 70   VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG- 973
              +A  + YL +  F   V+RD++++N L+       + DFG+S+ +   S+++  + G 
Sbjct: 130  SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 184

Query: 974  ---TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
                I ++ PE     K T +SDV+SFGV+  E    GK P
Sbjct: 185  TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.4 bits (240), Expect = 9e-22
 Identities = 75/268 (27%), Positives = 121/268 (45%), Gaps = 27/268 (10%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH---RNIVK 869
            IG G  G+VYR   + +G +VA+K  +  L +      +   EV  L+++R     NI K
Sbjct: 9    IGRGAYGAVYRGKHVPTGRVVALKIIN--LDTPDDDVSDIQREVALLSQLRQSQPPNITK 66

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            +YG        +I+ EY E GS+   L  A    E   +    +I+ V  AL Y+H    
Sbjct: 67   YYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISV---IIREVLVALKYIHKV-- 120

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
              +++RDI + N+L+       + DFG++  L  +SS  +   GT  ++APE+    K  
Sbjct: 121  -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179

Query: 990  E-KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLI 1048
            + K+D++S G+   E   G  P           S++D     +L P+   P         
Sbjct: 180  DTKADIWSLGITIYEMATGNPPY----------SDVDAFRAMMLIPKSKPPRLEDNGYSK 229

Query: 1049 SIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             + E   +CLDE P  R +     +LLK
Sbjct: 230  LLREFVAACLDEEPKERLS---AEELLK 254

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 27/266 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTC--QQEFLNEVKSLTEIR 863
            DF+  + IG G  G V++    +   + A+K+     LS+M    ++E ++E + L ++ 
Sbjct: 1    DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQID---LSKMNRREREEAIDEARVLAKLD 57

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS---AEELGWTQRMNVIKGVADA 920
               I+++Y          IV EY E G L  +L         E+  W   + ++ G    
Sbjct: 58   SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG---- 113

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            L++LH+     I++RDI S N+ LD      + D G++K L  +++    + GT  Y++P
Sbjct: 114  LAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
            EL       EKSDV++ GV+  E   GKHP D        ++N    + +I+    P  S
Sbjct: 171  ELCEDKPYNEKSDVWALGVVLYECCTGKHPFD--------ANNQGALILKIIRGVFPPVS 222

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRP 1066
                 +L  +++    CL ++   RP
Sbjct: 223  QMYSQQLAQLID---QCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 75/274 (27%), Positives = 118/274 (43%), Gaps = 34/274 (12%)

Query: 814  IGTGGQGSV----YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  GSV    Y  +      VAVK            ++EFL E   + ++ H  IV+
Sbjct: 3    LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE--HIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMIL---SNATSAEELGWTQRMNVIKGVADALSYLHN 926
              G C       +V E   +G L   L        ++      +      VA  ++YL +
Sbjct: 61   LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGT--IGYVAPELA 983
              F   V+RD++++NVLL   ++A +SDFG+S++L   S  +    AG   + + APE  
Sbjct: 114  KHF---VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170

Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               K + KSDV+S+GV   EA   G  P   +       + +   L+     RLP P   
Sbjct: 171  NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-----KGAEVIAMLESGE--RLPRPE-E 222

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               ++ SIM    SC    P+ RPT  ++    +
Sbjct: 223  CPQEIYSIML---SCWKYRPEDRPTFSELESTFR 253

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 73/259 (28%), Positives = 131/259 (50%), Gaps = 27/259 (10%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQE-FLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V+    +    VAVK      L   T   E FL E + + ++RH  +V+ Y 
Sbjct: 14   LGAGQFGEVWMGTWNGTTKVAVKT-----LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYA 68

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
             CS     +IV EY+  GSL   L +    ++L   Q +++   +A+ ++YL +  +   
Sbjct: 69   VCSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRNY--- 124

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVT 989
            ++RD++++N+L+       ++DFG+++ ++ D   +T   G    I + APE A   + T
Sbjct: 125  IHRDLAARNILVGENLVCKIADFGLARLIEDDE--YTAREGAKFPIKWTAPEAANYGRFT 182

Query: 990  EKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLI 1048
             KSDV+SFG+L  E +  G+ P   +++       ++R        R+P P  N  ++L 
Sbjct: 183  IKSDVWSFGILLTEIVTYGRVPYPGMTN-REVLEQVERGY------RMPRPP-NCPEELY 234

Query: 1049 SIMEVAISCLDENPDSRPT 1067
             +M   + C D++P+ RPT
Sbjct: 235  DLM---LQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 28/273 (10%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D +    +G G  G V +     +G+I+AVK     +   +  Q++ L E+  L +   
Sbjct: 1    DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI--QKQILRELDILHKCNS 58

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA---EELGWTQRMNVIKGVADAL 921
              IV FYG   +     I  EY++ GSL  IL           LG      +   V   L
Sbjct: 59   PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGL 113

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            +YLH      I++RD+   N+L++   +  + DFG+S  L    +      GT  Y+APE
Sbjct: 114  TYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPE 169

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPA 1038
                   + KSD++S G+  +E   G+ P             +   L  I++   PRLP+
Sbjct: 170  RIQGNDYSVKSDIWSLGLSLIELATGRFP---YPPENDPPDGIFELLQYIVNEPPPRLPS 226

Query: 1039 PSCNIRDKLISIMEVAIS-CLDENPDSRPTMQK 1070
                   K     +  ++ CL ++P  RP+ ++
Sbjct: 227  ------GKFSPDFQDFVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 95.9 bits (238), Expect = 2e-21
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 85   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---QV 137

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 138  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E I+G+ P
Sbjct: 198  DIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 66/210 (31%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQ--EFL-NEVKSLTEI 862
              D    IG G  G V  A + S+G  VAVKK       ++  QQ  E L NEV  + + 
Sbjct: 20   YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDY 73

Query: 863  RHRNIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
            +H NIV+ Y   S+      ++V E+LE G+L  I+++    EE    Q   V   V  A
Sbjct: 74   QHPNIVEMYS--SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLAVLKA 127

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            LS+LH      +++RDI S ++LL  +    +SDFG    +  +      L GT  ++AP
Sbjct: 128  LSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAP 184

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+   +    + D++S G++ +E + G+ P
Sbjct: 185  EVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 77/279 (27%), Positives = 125/279 (44%), Gaps = 40/279 (14%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEF---LNEVKSLTEIRHRNIVK 869
            IG G    VY A  L + E VA+K+     +    CQ        EV+++++  H N+VK
Sbjct: 9    IGVGATAVVYAAICLPNNEKVAIKR-----IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            +Y         ++V  YL  GSL  I+ ++     L       V+K V   L YLH++  
Sbjct: 64   YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW----TELAGTIGYVAPELAYT 985
               ++RDI + N+LL  +    ++DFG+S SL               GT  ++APE+   
Sbjct: 122  -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180

Query: 986  MK-VTEKSDVYSFGVLALEAIKGKHP-------RDFISSICSTSSNLDRTLDEILDPRLP 1037
            +     K+D++SFG+ A+E   G  P       +  + ++ +   +L+   D        
Sbjct: 181  VHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGAD------YK 234

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              S + R K+IS       CL ++P  RPT     +LLK
Sbjct: 235  KYSKSFR-KMIS------LCLQKDPSKRPT---AEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.0 bits (234), Expect = 3e-21
 Identities = 73/263 (27%), Positives = 118/263 (44%), Gaps = 27/263 (10%)

Query: 814  IGTGGQGSVYRAEL--SSGEI--VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E   S G++  VAVK   S  LS+     +FL E   +  + H N+++
Sbjct: 3    LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD--IMDDFLKEAAIMHSLDHENLIR 60

Query: 870  FYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
             YG      H   +V E   +GSL   L        L  +   +    +A+ + YL +  
Sbjct: 61   LYGVV--LTHPLMMVTELAPLGSLLDRLRKDALGHFL-ISTLCDYAVQIANGMRYLESKR 117

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYT 985
            F   ++RD++++N+LL  + +  + DFG+ ++L  +  ++     L     + APE   T
Sbjct: 118  F---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 986  MKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
               +  SDV+ FGV   E    G+ P  +     S S  L + +D+  + RL  P    +
Sbjct: 175  RTFSHASDVWMFGVTLWEMFTYGEEP--WAG--LSGSQIL-KKIDKEGE-RLERPEACPQ 228

Query: 1045 DKLISIMEVAISCLDENPDSRPT 1067
            D    I  V + C   NP  RPT
Sbjct: 229  D----IYNVMLQCWAHNPADRPT 247

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 94.0 bits (233), Expect = 8e-21
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+K+ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 27   IGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 83

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 84   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALDFLHSN---QV 136

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 137  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 196

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E ++G+ P
Sbjct: 197  DIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 80/280 (28%), Positives = 127/280 (45%), Gaps = 37/280 (13%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF---LNEVKSLTEI 862
            D++    IG+G  G VY+A ++++GE+VA+K      + ++    +F     E+  L E 
Sbjct: 4    DYELIQRIGSGTYGDVYKARDIATGELVAIK------VIKLEPGDDFEIIQQEISMLKEC 57

Query: 863  RHRNIVKFYGFCSHARHS--FIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVAD 919
            RH NIV ++G  S+ R    +IV EY   GSL  I         EL   Q   V +    
Sbjct: 58   RHPNIVAYFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL---QIAYVCRETLK 112

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVA 979
             L+YLH       ++RDI   N+LL  + +  ++DFG+S  L    +      GT  ++A
Sbjct: 113  GLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMA 169

Query: 980  PELA---YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDP 1034
            PE+A          K D+++ G+ A+E  + + P            +L   R L  I   
Sbjct: 170  PEVAAVERKGGYDGKCDIWALGITAIELAELQPPM----------FDLHPMRALFLISKS 219

Query: 1035 RLPAPSCNIRDKLISIMEVAI-SCLDENPDSRPTMQKVSQ 1073
              P P    ++K   +    I  CL ++P  RPT  K+ Q
Sbjct: 220  NFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 92.2 bits (229), Expect = 1e-20
 Identities = 83/285 (29%), Positives = 135/285 (47%), Gaps = 34/285 (11%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQ-QEFLNEVK 857
            E+ R   D   +H +G G  G VY          VAVK      L E T + +EFL E  
Sbjct: 2    EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAA 54

Query: 858  SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
             + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +   +
Sbjct: 55   VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQI 113

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--- 974
            + A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG    
Sbjct: 114  SSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFP 168

Query: 975  IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEIL 1032
            I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++  
Sbjct: 169  IKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK-- 220

Query: 1033 DPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              R+  P  C        + E+  +C   NP  RP+  ++ Q  +
Sbjct: 221  GYRMERPEGCP-----PKVYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 93.2 bits (231), Expect = 1e-20
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A E  SG  VAVK      L +   ++   NEV  + + +H+N+V+ Y 
Sbjct: 29   IGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    +++ E+L+ G+L  I+S     EE    Q   V + V  AL YLH+     +
Sbjct: 86   SYLVGEELWVLMEFLQGGALTDIVSQTRLNEE----QIATVCESVLQALCYLHSQ---GV 138

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL L+    +SDFG    +  D      L GT  ++APE+        + 
Sbjct: 139  IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 199  DIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 91.9 bits (228), Expect = 2e-20
 Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 41/284 (14%)

Query: 811  EHCIGTGGQGSVYRAELS---SGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V R  L      EI VA+K   S    +   +++FL+E   + +  H N
Sbjct: 9    EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPN 66

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I+   G  + +R   I+ E++E G+L   L       +    Q + +++G+A  + YL  
Sbjct: 67   IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSE 124

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE---LAGTIG--YVAPE 981
              +   V+RD++++N+L++      VSDFG+S+ L+ D+S+ T    L G I   + APE
Sbjct: 125  MNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDP 1034
                 K T  SDV+S+G++  E +  G+ P      +D I++I               D 
Sbjct: 182  AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------DY 228

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTM-QKVSQLLKI 1077
            RLP P     D   ++ ++ + C  ++ ++RP   Q VS L K+
Sbjct: 229  RLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 91.2 bits (226), Expect = 3e-20
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 38/264 (14%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+         VA+K      +SE    ++F+ E + + ++ H  +V+ YG 
Sbjct: 12   IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGV 67

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C+      +V+E++E G L+  L       S E L     + +   V + ++YL +    
Sbjct: 68   CTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLESSNV- 121

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
              ++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    K
Sbjct: 122  --IHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--QYTSSTGTKFPVKWSSPEVFSFSK 177

Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLD---EILDPRLPAPSCNI 1043
             + KSDV+SFGVL  E   +GK P +       ++S +  T++    +  PRL A     
Sbjct: 178  YSSKSDVWSFGVLMWEVFSEGKTPYE-----NRSNSEVVETINAGFRLYKPRL-ASQ--- 228

Query: 1044 RDKLISIMEVAISCLDENPDSRPT 1067
                 S+ E+   C  E P+ RP+
Sbjct: 229  -----SVYELMQHCWKERPEDRPS 247

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 75/264 (28%), Positives = 111/264 (42%), Gaps = 41/264 (15%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK-FY 871
            +G G  G V    +  +G++ A+K      + +    +  L E   L+ I H  IVK  Y
Sbjct: 1    LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD---ALSYLHNDC 928
             F +     ++V EY   G L   LS      E    +        A+   AL YLH+  
Sbjct: 61   AFQTE-EKLYLVLEYAPGGELFSHLSKEGRFSE-ERARFY-----AAEIVLALEYLHSL- 112

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AY 984
               I+YRD+  +N+LLD +    ++DFG++K L  + S      GT  Y+APE+     Y
Sbjct: 113  --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC--- 1041
               V    D +S GVL  E + GK P  F       + +     ++IL   L  P     
Sbjct: 171  GKAV----DWWSLGVLLYEMLTGKPP--F------YAEDRKEIYEKILKDPLRFPEFLSP 218

Query: 1042 NIRDKLISIMEVAISCLDENPDSR 1065
              RD LIS        L ++P  R
Sbjct: 219  EARD-LIS------GLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 90.4 bits (224), Expect = 5e-20
 Identities = 72/268 (26%), Positives = 127/268 (47%), Gaps = 28/268 (10%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VAVK      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 14   LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L +      L     +++   VA  ++Y+    +   +
Sbjct: 70   VSE-EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNY---I 124

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ S N+L+       ++DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 125  HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 991  KSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEI-LDPRLPAPSCNIRDKLI 1048
            KSDV+SFG+L  E + KG+ P            N    L+++    R+P P    +D  I
Sbjct: 183  KSDVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCPI 230

Query: 1049 SIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            S+ E+ + C  ++P+ RPT + +   L+
Sbjct: 231  SLHELMLQCWKKDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 6e-20
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 36/272 (13%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 14   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 69

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 70   VSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMNY---V 124

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 125  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 183  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 226

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  + P+ RPT + +   L+
Sbjct: 227  ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 7e-20
 Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 40/288 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G VY+A +  +GEIVA+KK      SE   +   L E+K L E+ H NI+K   
Sbjct: 7    IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-LREIKLLKELNHPNIIKLLD 65

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
               H    ++V+E+++   L  ++        L  +   + +  +   L++ H+     I
Sbjct: 66   VFRHKGDLYLVFEFMDT-DLYKLIK--DRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV-TEK 991
            ++RD+  +N+L++ E    ++DFG+++S       +T    T  Y APEL    K  +  
Sbjct: 120  LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTP 179

Query: 992  SDVYSFGVLALEAIK------GKHPRDFISSICST-----------------SSNLDRTL 1028
             D++S G +  E +       GK   D +  I  T                 +       
Sbjct: 180  VDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPK 239

Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               +      P  N   + + ++      L  +P  R T     Q L 
Sbjct: 240  KAGMPLPKLFP--NASPQALDLLS---QMLHYDPHKRIT---AEQALA 279

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 90.6 bits (225), Expect = 8e-20
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 45/284 (15%)

Query: 814  IGTGGQGSVYRA-----ELSSGE-IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ A     E   GE +V VK        +   Q EF  E+    ++ H+N+
Sbjct: 13   LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--TKDENLQSEFRRELDMFRKLSHKNV 70

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE------LGWTQRMNVIKGVADAL 921
            V+  G C  A   +++ EY ++G L   L    S +E      L   Q++ +   +A  +
Sbjct: 71   VRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYV 978
             +L N  F   V+RD++++N L+  + E  VS   +SK     +S + +L      + ++
Sbjct: 131  DHLSNARF---VHRDLAARNCLVSSQREVKVSLLSLSKD--VYNSEYYKLRNALIPLRWL 185

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEIL----- 1032
            APE       + KSDV+SFGVL  E   +G+ P   +S             +E+L     
Sbjct: 186  APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD------------EEVLNRLQA 233

Query: 1033 -DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                LP P      +L  +M     C   NP  RP+  ++   L
Sbjct: 234  GKLELPVPE-GCPSRLYKLMT---RCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 90.6 bits (225), Expect = 9e-20
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 45/271 (16%)

Query: 814  IGTGGQGSVYRA----ELSSGEI-VAVKKFHSPLLSEMTCQQ---EFLNEVKSLTEIRHR 865
            +G+G  G+VY+     E    +I VA+K     +L E T  +   E L+E   +  + H 
Sbjct: 15   LGSGAFGTVYKGVWIPEGEKVKIPVAIK-----VLREETSPKANKEILDEAYVMASVDHP 69

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            ++V+  G C  ++   I  + + +G L   + N    + +G    +N    +A  +SYL 
Sbjct: 70   HVVRLLGICLSSQVQLIT-QLMPLGCLLDYVRN--HKDNIGSQYLLNWCVQIAKGMSYLE 126

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELA 983
                  +V+RD++++NVL+       ++DFG++K L  D   +    G   I ++A E  
Sbjct: 127  EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-----PRLP 1037
                 T KSDV+S+GV   E +  G  P + I ++            EI D      RLP
Sbjct: 184  LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------------EIPDLLEKGERLP 231

Query: 1038 APS-CNIRDKLISIMEVAISCLDENPDSRPT 1067
             P  C      I +  V + C   + +SRPT
Sbjct: 232  QPPICT-----IDVYMVLVKCWMIDAESRPT 257

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.8 bits (223), Expect = 9e-20
 Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 35/270 (12%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  GSVY+ + LS  +  A+K+     +S+   +++ +NE++ L  + H NI+ +  
Sbjct: 8    LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKE-REDAVNEIRILASVNHPNIISYKE 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSA-----EELGWTQRMNVIKGVADALSYLHND 927
                     IV EY   G L+  +S          E+  W   + +++G    L  LH  
Sbjct: 67   AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG----LQALHEQ 122

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMK 987
                I++RD+ S N+LL       + D GISK LK + +  T++ GT  Y+APE+     
Sbjct: 123  ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQI-GTPHYMAPEVWKGRP 177

Query: 988  VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE----ILDPRLPAPSCNI 1043
             + KSD++S G L  E      P +             R++ +    +   + P      
Sbjct: 178  YSYKSDIWSLGCLLYEMATFAPPFE------------ARSMQDLRYKVQRGKYPPIPPIY 225

Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
               L + +    S L   P  RP   K+  
Sbjct: 226  SQDLQNFIR---SMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 89.7 bits (222), Expect = 2e-19
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 31/220 (14%)

Query: 814  IGTGGQGSVYRAELSS------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE  +        +VAVK       SE   +Q+F  E + LT ++H++I
Sbjct: 13   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESA-RQDFQREAELLTVLQHQHI 69

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNATSAE--ELGWTQRMNVIK 915
            V+FYG C+  R   +V+EY+  G L          A IL+        +L   Q + +  
Sbjct: 70   VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-- 973
             +A  + YL +  F   V+RD++++N L+       + DFG+S+ +   S+++  + G  
Sbjct: 130  QIASGMVYLASLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 184

Query: 974  --TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               I ++ PE     K T +SD++SFGV+  E    GK P
Sbjct: 185  MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 35/277 (12%)

Query: 814  IGTGGQGSVYRAEL-----SSGEIVAVKKF-HSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V          ++GE VAVK   HS    E   + +F  E++ L  + H NI
Sbjct: 12   LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHENI 68

Query: 868  VKFYGFC--SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            VK+ G C     R   ++ EYL  GSL   L      +++   + +     +   + YL 
Sbjct: 69   VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR--HRDQINLKRLLLFSSQICKGMDYLG 126

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-----ELAGTIGYVAP 980
            +      ++RD++++N+L++ E    +SDFG++K L  D   +      E    I + AP
Sbjct: 127  SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESP--IFWYAP 181

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAI----KGKHP-RDFISSICSTSSNLDRT-LDEILDP 1034
            E   T K +  SDV+SFGV   E        + P  +F+  I      +  T L E+L  
Sbjct: 182  ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241

Query: 1035 --RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069
              RLP P  +  D++  +M+    C +  P  RP+  
Sbjct: 242  GERLPRPP-SCPDEVYDLMK---LCWEAEPQDRPSFA 274

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 67/274 (24%), Positives = 124/274 (45%), Gaps = 29/274 (10%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKF----HSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            +GTG   S Y+A ++ +G ++AVK+     ++    E   +     E++ +  + H +I+
Sbjct: 8    LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHPHII 66

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            +  G      H  +  E++  GS++ +LS   + +E      +N  + +   LSYLH + 
Sbjct: 67   RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE---AVIINYTEQLLRGLSYLHEN- 122

Query: 929  FPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTE----LAGTIGYVAPELA 983
               I++RD+   N+L+D       ++DFG +  L    +   E    L GTI ++APE+ 
Sbjct: 123  --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP-SCN 1042
               +     DV+S G + +E    K P +      +  + + +       P +P   S  
Sbjct: 181  RGEQYGRSCDVWSVGCVIIEMATAKPPWN-AEKHSNHLALIFKIASATTAPSIPEHLSPG 239

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +RD       V + CL+  P+ RP      +LLK
Sbjct: 240  LRD-------VTLRCLELQPEDRP---PSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 88.9 bits (220), Expect = 4e-19
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 28   IGEGSTGIVCIATVKSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 85   SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLKALSVLHAQ---GV 137

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 138  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 198  DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.9 bits (218), Expect = 5e-19
 Identities = 75/277 (27%), Positives = 128/277 (46%), Gaps = 46/277 (16%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLN-------EVKSLTEIRHR 865
            IG G  G VY A  +++GE++AVK+   P            +       E+++L ++ H 
Sbjct: 9    IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIV++ GF +   +  I  EY+  GS+   L      EE          + V + L+YLH
Sbjct: 69   NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE---QLVRFFTEQVLEGLAYLH 125

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP--DSSNWTELAGTIGYVAPEL- 982
            +     I++RD+ + N+L+D +    +SDFGISK      D+     + G++ ++APE+ 
Sbjct: 126  SK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 983  -----AYTMKVTEKSDVYSFGVLALEAIKGKHP---RDFISSICSTSSNLDRTLDEILDP 1034
                  Y+ KV    D++S G + LE   G+ P    + I+++    +            
Sbjct: 183  HSYSQGYSAKV----DIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN---------KRS 229

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDE----NPDSRPT 1067
              P P     D  +++  VA+  L+     NPD+RPT
Sbjct: 230  APPIPP----DVSMNLSPVALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 88.0 bits (218), Expect = 5e-19
 Identities = 76/279 (27%), Positives = 134/279 (48%), Gaps = 38/279 (13%)

Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V    L      EI VA+K   +    +   +++FL+E   + +  H N
Sbjct: 9    EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ--RRDFLSEASIMGQFDHPN 66

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I+   G  + ++   IV EY+E GSL   L       +    Q + +++G+A  + YL +
Sbjct: 67   IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSD 124

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPELA 983
              +   V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G I   + APE  
Sbjct: 125  MGY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDPRL 1036
               K T  SDV+S+G++  E +  G+ P      +D I +I           +E    RL
Sbjct: 182  AYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI-----------EE--GYRL 228

Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            PAP     D   ++ ++ + C  ++ + RP  +++  +L
Sbjct: 229  PAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.7 bits (218), Expect = 6e-19
 Identities = 66/202 (32%), Positives = 93/202 (46%), Gaps = 16/202 (7%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG G V   ++ S     A+K      + E   Q+   +E + L E  H  IVK Y 
Sbjct: 1    LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                 ++ +++ EY   G L  IL +    +E  +T R   I  V  A  YLHN     I
Sbjct: 61   TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE--YTARF-YIACVVLAFEYLHNR---GI 114

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AYTMKV 988
            +YRD+  +N+LLD      + DFG +K LK     WT   GT  YVAPE+     Y   V
Sbjct: 115  IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT-FCGTPEYVAPEIILNKGYDFSV 173

Query: 989  TEKSDVYSFGVLALEAIKGKHP 1010
                D +S G+L  E + G+ P
Sbjct: 174  ----DYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.4 bits (217), Expect = 6e-19
 Identities = 69/227 (30%), Positives = 102/227 (44%), Gaps = 13/227 (5%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-Y 871
            IG G  G V   +   + ++ A+K  +     E    +  LNE + L E+ H  +V   Y
Sbjct: 8    IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
             F     + ++V + L  G L   LS      E    Q    I  +  AL YLH+     
Sbjct: 68   SFQDE-ENMYLVVDLLLGGDLRYHLSQKVKFSE---EQVKFWICEIVLALEYLHSK---G 120

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            I++RDI   N+LLD +   H++DF I+  + PD+   T  +GT GY+APE+      +  
Sbjct: 121  IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT-TSTSGTPGYMAPEVLCRQGYSVA 179

Query: 992  SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             D +S GV A E ++GK P    S    T  +  R   E  D   PA
Sbjct: 180  VDWWSLGVTAYECLRGKRPYRGHS---RTIRDQIRAKQETADVLYPA 223

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 87.6 bits (217), Expect = 9e-19
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 35/281 (12%)

Query: 815  GTGGQGSVYR---AELSSGEIVAVKKFHSPLLSEMTCQQE--FLNEVKSLTEIRHRNIVK 869
            G  G+ S+Y    A   +GE+VAVK     L  E   Q    +  E+  L  + H NIVK
Sbjct: 15   GHFGKVSLYCYDPANDGTGEMVAVKT----LKRECGQQNTSGWKKEINILKTLYHENIVK 70

Query: 870  FYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            + G CS    +   ++ EY+ +GSL   L       +L   Q +   + + + ++YLH+ 
Sbjct: 71   YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQ 126

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA----GTIGYVAPELA 983
             +   ++RD++++NVLLD +    + DFG++K++ P+   +  +       + + A E  
Sbjct: 127  HY---IHRDLAARNVLLDNDRLVKIGDFGLAKAV-PEGHEYYRVREDGDSPVFWYAVECL 182

Query: 984  YTMKVTEKSDVYSFGVLALEAI-----KGKHPRDFISSICSTSSNLDRT-LDEILD--PR 1035
               K +  SDV+SFGV   E +     K   P+ F   I      +    L E+L+   R
Sbjct: 183  KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR 242

Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            LP P  N   ++  +M+   +C +     RPT + +  +LK
Sbjct: 243  LPCPK-NCPQEVYILMK---NCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 87.8 bits (217), Expect = 1e-18
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A E  +G+ VAVKK     L +   ++   NEV  + +  H N+V  Y 
Sbjct: 30   IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALSYLHN     +
Sbjct: 87   SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ---GV 139

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APE+   +    + 
Sbjct: 140  IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E I G+ P
Sbjct: 200  DIWSLGIMVIEMIDGEPP 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 76/301 (25%), Positives = 122/301 (40%), Gaps = 61/301 (20%)

Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
             T  F+    IG G  G VY+A    +G++VA+K        E   ++E  N ++  +  
Sbjct: 4    PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE-YNILRKYSN- 61

Query: 863  RHRNIVKFYGFCSHARHS------FIVYEYLEMGSLAMILSNATSAEELGWTQRMN---- 912
             H NI  FYG              ++V E    GS+  ++            +R+     
Sbjct: 62   -HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL-----RKKGKRLKEEWI 115

Query: 913  --VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
              +++     L+YLH +    +++RDI  +N+LL    E  + DFG+S  L         
Sbjct: 116  AYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT 172

Query: 971  LAGTIGYVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGK------HPRDFISSICS 1019
              GT  ++APE+    +  +     +SDV+S G+ A+E   GK      HP         
Sbjct: 173  FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--------- 223

Query: 1020 TSSNLDRTLDEILDPRLPAP----SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                  R L +I  PR P P      N   K    +     CL +N + RP M+   +LL
Sbjct: 224  -----MRALFKI--PRNPPPTLKSPENWSKKFNDFIS---ECLIKNYEQRPFME---ELL 270

Query: 1076 K 1076
            +
Sbjct: 271  E 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 4e-18
 Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 29/267 (10%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  GSV + + + +G ++A K  H    S +  +++ L E++ + E R   IV FYG
Sbjct: 13   LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSV--RKQILRELQIMHECRSPYIVSFYG 70

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNA--TSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
               +  +  +  E+++ GSL  I         E LG      +   V + L+YL+N    
Sbjct: 71   AFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLYNV--H 123

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             I++RDI   N+L++   +  + DFG+S  L    ++     GT  Y++PE     K T 
Sbjct: 124  RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD--TFVGTSTYMSPERIQGGKYTV 181

Query: 991  KSDVYSFGVLALEAIKGKHPRDF----ISSICSTSSNLDRTLDEILD---PRLPAPSCNI 1043
            KSDV+S G+  +E   GK P  F              LD  L +I+    PRLP+     
Sbjct: 182  KSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-LLQQIVQEPPPRLPS----- 235

Query: 1044 RDKLISIMEVAIS-CLDENPDSRPTMQ 1069
                   +   +  CL ++P  RPT Q
Sbjct: 236  -SDFPEDLRDFVDACLLKDPTERPTPQ 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 84.9 bits (210), Expect = 5e-18
 Identities = 73/282 (25%), Positives = 140/282 (49%), Gaps = 37/282 (13%)

Query: 811  EHCIGTGGQGSVY--RAELSSGEIVAVKK--FHSPLLSEMTCQQE-----FLNEVKSLTE 861
            EH +G+G  G VY  R + +   ++A+K+   H+P   +   +++      ++EV  + E
Sbjct: 6    EH-LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 862  -IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-----ATSAEELGWTQRMNVIK 915
             +RH NIV++Y         +IV + +E   L    ++         EE  W    N+  
Sbjct: 65   QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFV 120

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +  AL YLH +    IV+RD++  N++L  + +  ++DFG++K  +P+S   T + GTI
Sbjct: 121  QMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK-LTSVVGTI 177

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
             Y  PE+       EK+DV++FG +  +    + P  F S+  +  S   + ++ + +P 
Sbjct: 178  LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYST--NMLSLATKIVEAVYEP- 232

Query: 1036 LPAPSCNIRDKLIS--IMEVAISCLDENPDSRPTMQKVSQLL 1075
                   + + + S  + +V  SCL  + ++RP + +VS ++
Sbjct: 233  -------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 5e-18
 Identities = 78/277 (28%), Positives = 132/277 (47%), Gaps = 42/277 (15%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G VY+A+   +G   A K        E+   ++F+ E+  L+E +H NIV  Y 
Sbjct: 13   LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL---EDFMVEIDILSECKHPNIVGLYE 69

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKGVADALSYLHNDCFP 930
               +    +I+ E+ + G+L  I+       E G T  Q   V + + +AL++LH+    
Sbjct: 70   AYFYENKLWILIEFCDGGALDSIM----LELERGLTEPQIRYVCRQMLEALNFLHSH--- 122

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY--TMKV 988
             +++RD+ + N+LL L+ +  ++DFG+S   K          GT  ++APE+    T K 
Sbjct: 123  KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182

Query: 989  TE---KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP--- 1039
                 K+D++S G+  +E  + + P   ++ +        R L +IL    P L  P   
Sbjct: 183  NPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEPPTLDQPSKW 234

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            S +  D L        SCL ++PD RPT    ++LLK
Sbjct: 235  SSSFNDFL-------KSCLVKDPDDRPT---AAELLK 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 84.7 bits (209), Expect = 6e-18
 Identities = 68/269 (25%), Positives = 125/269 (46%), Gaps = 30/269 (11%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +      + FL E + + ++RH  +V  Y  
Sbjct: 14   LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPLYAV 69

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV E++  GSL   L      + L   Q +++   +AD ++Y+    +   +
Sbjct: 70   VSE-EPIYIVTEFMGKGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMNY---I 124

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       ++DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 125  HRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 991  KSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPSCNIRDKL 1047
            KSDV+SFG+L  E + KG+ P             ++R + E ++   R+P P        
Sbjct: 183  KSDVWSFGILLTELVTKGRVP---------YPGMVNREVLEQVERGYRMPCPQGCPE--- 230

Query: 1048 ISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             S+ E+   C  ++PD RPT + +   L+
Sbjct: 231  -SLHELMKLCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 65/199 (32%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +      IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N
Sbjct: 7    ELKLLQTIGKGEFGDVMLGDYR-GNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSN 60

Query: 867  IVKFYGFCSHARHS-FIVYEYLEMGSLAMIL-SNATSAEELGWTQRMNVIKGVADALSYL 924
            +V+  G     +   +IV EY+  GSL   L S   S   LG    +     V +A+ YL
Sbjct: 61   LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL 118

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
              + F   V+RD++++NVL+  +  A VSDFG++K     SS        + + APE   
Sbjct: 119  EANNF---VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 172

Query: 985  TMKVTEKSDVYSFGVLALE 1003
              K + KSDV+SFG+L  E
Sbjct: 173  EKKFSTKSDVWSFGILLWE 191

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 84.8 bits (210), Expect = 7e-18
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 44/288 (15%)

Query: 808  FDEEHCI-----GTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLN 854
            F+E H       G G  GSV   EL        ++GE+VAVKK        +   ++F  
Sbjct: 1    FEERHLKFIQQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHL---RDFER 54

Query: 855  EVKSLTEIRHRNIVKFYGFC-SHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            E++ L  ++H NIVK+ G C S  R +  +V EYL  GSL   L      E L   + + 
Sbjct: 55   EIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLL 112

Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL- 971
                +   + YL +  +   V+RD++++N+L++ E    + DFG++K L  D   +    
Sbjct: 113  YASQICKGMEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVRE 169

Query: 972  --AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKHP-RDFISSICSTSSN- 1023
                 I + APE     K +  SDV+SFGV+  E      K   P  +F+  + +     
Sbjct: 170  PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQ 229

Query: 1024 -LDRTLDEILDP--RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPT 1067
             +   L E+L    RLPAP  C    ++ +IM+    C + +P  RP+
Sbjct: 230  MIVYHLIELLKNNGRLPAPPGCP--AEIYAIMK---ECWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 84.7 bits (209), Expect = 7e-18
 Identities = 71/265 (26%), Positives = 124/265 (46%), Gaps = 26/265 (9%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRHRNIVKFY 871
            IG G  G V++  +  + ++VA+K      L E   + ++   E+  L++     + K+Y
Sbjct: 12   IGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
            G        +I+ EYL  GS A+ L  A   +E    Q   ++K +   L YLH++    
Sbjct: 69   GSYLKGTKLWIIMEYLGGGS-ALDLLRAGPFDEF---QIATMLKEILKGLDYLHSE---K 121

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
             ++RDI + NVLL  + +  ++DFG++  L           GT  ++APE+        K
Sbjct: 122  KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181

Query: 992  SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
            +D++S G+ A+E  KG+ P   +  +        R L  I  P+   P+    +      
Sbjct: 182  ADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI--PKNNPPTL-TGEFSKPFK 230

Query: 1052 EVAISCLDENPDSRPTMQKVSQLLK 1076
            E   +CL+++P  RPT +   +LLK
Sbjct: 231  EFIDACLNKDPSFRPTAK---ELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 84.0 bits (208), Expect = 1e-17
 Identities = 72/273 (26%), Positives = 121/273 (44%), Gaps = 36/273 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE----MTCQQEFLNEVKSLTEIRHRNIV 868
            +G+G  GSVY    L  G+  AVK+    L  +        ++   E+  L++++H NIV
Sbjct: 8    LGSGSFGSVYEGLNLDDGDFFAVKE--VSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            ++ G      + +I  E +  GSLA +L    S  E          + +   L YLH+  
Sbjct: 66   QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPE---PVIRLYTRQILLGLEYLHDR- 121

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMK 987
                V+RDI   N+L+D      ++DFG++K +  + S      G+  ++APE +A    
Sbjct: 122  --NTVHRDIKGANILVDTNGVVKLADFGMAKQVV-EFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 988  VTEKSDVYSFGVLALEAIKGKHP---RDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
                +D++S G   LE   GK P    + ++++      + R+        LP     I 
Sbjct: 179  YGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF----KIGRS------KELPP----IP 224

Query: 1045 DKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
            D L    +  I  CL  +P  RPT    ++LL+
Sbjct: 225  DHLSDEAKDFILKCLQRDPSLRPT---AAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 1e-17
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 29/218 (13%)

Query: 814  IGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE           +VAVK       +    +++F  E + LT ++H +I
Sbjct: 13   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 69

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNATSAEELGWTQRMNVIKGV 917
            VKFYG C       +V+EY++ G L          A++++      EL  +Q +++ + +
Sbjct: 70   VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG---- 973
            A  + YL +  F   V+RD++++N L+       + DFG+S+ +   S+++  + G    
Sbjct: 130  AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTML 184

Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
             I ++ PE     K T +SDV+S GV+  E    GK P
Sbjct: 185  PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 87.9 bits (218), Expect = 1e-17
 Identities = 42/87 (48%), Positives = 57/87 (65%)

Query: 211 LYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL 270
           L N  L G IP++I  L+ L  + L  N + G++P SLG++ +L  LDL  NS +GSIP 
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484

Query: 271 SFGNLTNLDILNLPHNSLSGSIPSEMG 297
           S G LT+L ILNL  NSLSG +P+ +G
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 70/268 (26%), Positives = 123/268 (45%), Gaps = 26/268 (9%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V+   L +    VAVK     L  ++  + +FL E + L +  H NIV+  G
Sbjct: 3    IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIG 60

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
             C+  +  +IV E ++ G     L        L   + + +++  A  + YL +      
Sbjct: 61   VCTQKQPIYIVMELVQGGDFLTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IGYVAPELAYTMKV 988
            ++RD++++N L+  +    +SDFG+S+  + +   +    G     + + APE     + 
Sbjct: 116  IHRDLAARNCLVTEKNVLKISDFGMSR--EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 989  TEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047
            + +SDV+SFG+L  EA   G  P   +S+   T   +++ +      RLP P     D +
Sbjct: 174  SSESDVWSFGILLWEAFSLGAVPYANLSNQ-QTREAIEQGV------RLPCPE-LCPDAV 225

Query: 1048 ISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              +ME    C + +P  RP+   V Q L
Sbjct: 226  YRLME---RCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 48/285 (16%)

Query: 818  GQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            G+G   + EL        ++GE VAVK              +   E++ L  + H NIVK
Sbjct: 13   GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI--ADLKKEIEILRNLYHENIVK 70

Query: 870  FYGFCSHARHSFI--VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            + G C+    + I  + E+L  GSL   L    +  ++   Q++     +   + YL + 
Sbjct: 71   YKGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGSR 128

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAY 984
             +   V+RD++++NVL++ E++  + DFG++K+++ D   +T   +L   + + APE   
Sbjct: 129  QY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS----------------TSSNLDRTL 1028
              K    SDV+SFGV   E +       +  S  S                T + L R L
Sbjct: 186  QSKFYIASDVWSFGVTLYELLT------YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239

Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +E    RLP P  N  +++  +M     C +  P  R T Q + +
Sbjct: 240  EE--GKRLPRPP-NCPEEVYQLMR---KCWEFQPSKRTTFQNLIE 278

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 31/274 (11%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLN---EVKSLTEIRHRNIVKF 870
            +G G  G+VY    + G+++AVK+      + +  ++E+     EV  L  ++H NIV++
Sbjct: 8    LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
             G C       I  E++  GS++ IL+      E  + +     K + D ++YLHN+C  
Sbjct: 68   LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK---YTKQILDGVAYLHNNC-- 122

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE------LAGTIGYVAPELAY 984
             +V+RDI   NV+L       + DFG ++ L     + T       + GT  ++APE+  
Sbjct: 123  -VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR--TLDEILDPRLPAPSCN 1042
                  KSD++S G    E   GK P           +++DR   +  I   R   P   
Sbjct: 182  ESGYGRKSDIWSIGCTVFEMATGKPPL----------ASMDRLAAMFYIGAHRGLMPRLP 231

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                  +I +   SCL  +   RP+     QLL+
Sbjct: 232  DSFSAAAI-DFVTSCLTRDQHERPS---ALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 82.4 bits (203), Expect = 3e-17
 Identities = 69/270 (25%), Positives = 120/270 (44%), Gaps = 28/270 (10%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V++  L     VAVK     L  E+  +  FL+E + L +  H NIVK  G 
Sbjct: 3    LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK--FLSEARILKQYDHPNIVKLIGV 60

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPI 932
            C+  +  +IV E +  G     L      +EL   Q +      A  ++YL + +C    
Sbjct: 61   CTQRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNC---- 114

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKP---DSSNWTELAGTIGYVAPELAYTMKVT 989
            ++RD++++N L+       +SDFG+S+        SS   ++   I + APE     + +
Sbjct: 115  IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP--IKWTAPEALNYGRYS 172

Query: 990  EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPSCNIRDKL 1047
             +SDV+S+G+L  E         F   +C      ++   E ++   R+  P     D +
Sbjct: 173  SESDVWSYGILLWET--------FSLGVCPYPGMTNQQAREQVEKGYRMSCPQ-KCPDDV 223

Query: 1048 ISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077
              +M+    C D  P++RP   ++ + L  
Sbjct: 224  YKVMQ---RCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 81.9 bits (202), Expect = 5e-17
 Identities = 71/264 (26%), Positives = 128/264 (48%), Gaps = 26/264 (9%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G+V + E + G+ VAVK     + +     Q FL E   +T++ H+N+V+  G 
Sbjct: 14   IGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA-----QAFLEETAVMTKLHHKNLVRLLGV 67

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
              H    +IV E +  G+L   L     A  +   Q +     VA+ + YL +     +V
Sbjct: 68   ILH-NGLYIVMELMSKGNLVNFLRTRGRAL-VSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSD 993
            +RD++++N+L+  +  A VSDFG+++ +     + ++L   + + APE     K + KSD
Sbjct: 123  HRDLAARNILVSEDGVAKVSDFGLAR-VGSMGVDNSKLP--VKWTAPEALKHKKFSSKSD 179

Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+S+GVL  E    G+ P   + S+      +++     ++P    P+      +  +M 
Sbjct: 180  VWSYGVLLWEVFSYGRAPYPKM-SLKEVKECVEKGYR--MEPPEGCPA-----DVYVLMT 231

Query: 1053 VAISCLDENPDSRPTMQKVSQLLK 1076
               SC +  P  RP+  K+ + L+
Sbjct: 232  ---SCWETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D +    +GTG  G V+   +  S    A+K    P +  +  +Q   NE + L E+ H 
Sbjct: 2    DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADALSY 923
             I++ +      R  +++ EY+  G L   L N+       ++    +     +  AL Y
Sbjct: 62   FIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR-----FSNSTGLFYASEIVCALEY 116

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH+     IVYRD+  +N+LLD E    ++DFG +K L+     WT L GT  Y+APE+ 
Sbjct: 117  LHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTWT-LCGTPEYLAPEVI 170

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             +    +  D ++ G+L  E + G  P
Sbjct: 171  QSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 85.3 bits (211), Expect = 7e-17
 Identities = 44/113 (38%), Positives = 67/113 (59%), Gaps = 1/113 (0%)

Query: 230 LSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS 289
           + GL L    L G +P  +  L +L +++L  NS+ G+IP S G++T+L++L+L +NS +
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 290 GSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGN-LTKLTILYLSDNLLFGSIP 341
           GSIP  +G L SL  L L+ N LSG +P++LG  L        +DN     IP
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 76/308 (24%), Positives = 135/308 (43%), Gaps = 58/308 (18%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL---------SSGEIVAVKKFHSPLLSEMTCQQ 850
            EI  +   F EE  +G G  G VY+ EL         +S  I  +K+   P +     QQ
Sbjct: 1    EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV-----QQ 53

Query: 851  EFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL------SNATSAEE 904
            EF  E + +++++H NIV   G C+  + + +++EYL  G L   L      S+  +   
Sbjct: 54   EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 905  LGWTQR-------MNVIKGVADALSYL--HNDCFPPIVYRDISSKNVLLDLEYEAHVSDF 955
                +        +++   +A  + YL  H+      V+RD++++N L+       +SDF
Sbjct: 114  DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168

Query: 956  GISKSLKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
            G+S+ +   S+++  +       + ++ PE     K T +SD++SFGV+  E    G  P
Sbjct: 169  GLSRDIY--SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Query: 1011 RDFISSICSTSSNLDRTLDEILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPTM 1068
                      S+     + E++  R  LP P     D    +  + I C +E P  RP  
Sbjct: 227  ------YYGFSNQ---EVIEMIRSRQLLPCPE----DCPARVYALMIECWNEIPARRPRF 273

Query: 1069 QKVSQLLK 1076
            + +   L+
Sbjct: 274  KDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 82.4 bits (204), Expect = 7e-17
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 27/167 (16%)

Query: 850 QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS------------ 897
           ++FL EVK L+ +   NI +  G C+      ++ EY+E G L   L             
Sbjct: 64  EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123

Query: 898 -NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG 956
             + S   L     + +   +A  + YL +  F   V+RD++++N L+   Y   ++DFG
Sbjct: 124 SKSLSFSTL-----LYMATQIASGMRYLESLNF---VHRDLATRNCLVGKNYTIKIADFG 175

Query: 957 ISKSLKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGV 999
           +S++L   SS++  + G     I ++A E     K T KSDV++FGV
Sbjct: 176 MSRNLY--SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 81.5 bits (202), Expect = 1e-16
 Identities = 73/300 (24%), Positives = 118/300 (39%), Gaps = 54/300 (18%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-R 863
            +DF     IG G   +V  A E  + +  A+K      L +    +    E + LT +  
Sbjct: 1    DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 864  HRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H  I+K Y +      + + V EY   G L   +    S +E   T+       +  AL 
Sbjct: 61   HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK-CTR--FYAAEILLALE 116

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA---------- 972
            YLH+     I++RD+  +N+LLD +    ++DFG +K L P+SS  +             
Sbjct: 117  YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 973  ----------GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS 1022
                      GT  YV+PEL       + SD+++ G +  + + GK P           S
Sbjct: 174  KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR--------GS 225

Query: 1023 NLDRTLDEILD------PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            N   T  +IL       P  P  + ++ +KL          L  +P  R  + +    LK
Sbjct: 226  NEYLTFQKILKLEYSFPPNFPPDAKDLIEKL----------LVLDPQDRLGVNEGYDELK 275

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 1e-16
 Identities = 69/264 (26%), Positives = 121/264 (45%), Gaps = 21/264 (7%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    ++   VAVK      +S     Q FL E   +  ++H  +V+ Y  
Sbjct: 14   LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +     +I+ EY+  GSL   L  +    ++   + ++    +A+ ++Y+    +   +
Sbjct: 70   VTKEEPIYIITEYMAKGSLLDFL-KSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY---I 125

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ + NVL+       ++DFG+++ ++ +     E A   I + APE       T KS
Sbjct: 126  HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 993  DVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
            DV+SFG+L  E +  GK P   +S+     S L R        R+P    N  D+L  IM
Sbjct: 186  DVWSFGILLYEIVTYGKIPYPGMSN-SDVMSALQRGY------RMPRME-NCPDELYDIM 237

Query: 1052 EVAISCLDENPDSRPTMQKVSQLL 1075
            +   +C  E  + RPT   +  +L
Sbjct: 238  K---TCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 80.0 bits (197), Expect = 2e-16
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 17/205 (8%)

Query: 814  IGTGGQGSVYRA---ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G+G  G+V +       S + VAVK   +   ++   + E L E   + ++ +  IV+ 
Sbjct: 3    LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRM 61

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
             G C  A    +V E  E+G L   L       E   T+   ++  V+  + YL    F 
Sbjct: 62   IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITE---LVHQVSMGMKYLEETNF- 116

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IGYVAPELAYTM 986
              V+RD++++NVLL  ++ A +SDFG+SK+L  D  N+ +        + + APE     
Sbjct: 117  --VHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 987  KVTEKSDVYSFGVLALEAIK-GKHP 1010
            K + KSDV+SFGVL  EA   G+ P
Sbjct: 174  KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 2e-16
 Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 26/214 (12%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF+    +GTG  G V       SG+  A+K      + ++   +  LNE + L  IRH
Sbjct: 1    DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK----GVADA 920
              +V  YG      + ++V EY+  G L   L  +    E        V +     V  A
Sbjct: 61   PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE-------PVARFYAAQVVLA 113

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            L YLH+     IVYRD+  +N+LLD +    ++DFG +K +K  +  +T L GT  Y+AP
Sbjct: 114  LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT-LCGTPEYLAP 167

Query: 981  EL----AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+     Y   V    D ++ G+L  E + G  P
Sbjct: 168  EIILSKGYGKAV----DWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.4 bits (199), Expect = 3e-16
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V++A +  +GE VA+KK     L       + L E+K+L   +H  +VK   
Sbjct: 8    IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGI-PNQALREIKALQACQHPYVVKLLD 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSYLHNDC 928
               H     +V EY+    L+ +L +       A+   +  RM ++KGVA    Y+H + 
Sbjct: 67   VFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYM-RM-LLKGVA----YMHAN- 118

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-WTELAGTIGYVAPELAY-TM 986
               I++RD+   N+L+  +    ++DFG+++    +    ++    T  Y APEL Y   
Sbjct: 119  --GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 987  KVTEKSDVYSFGVLALEAIKG 1007
            K     D+++ G +  E + G
Sbjct: 177  KYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 79.8 bits (198), Expect = 3e-16
 Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 31/209 (14%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIV 868
             +G G  G VY+A +  +GEIVA+KK       E    T     L E+  L E++H NIV
Sbjct: 6    KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA----LREISLLKELKHPNIV 61

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA----DALSYL 924
            K        R  ++V+EY +M  L   L               N+IK +       L+Y 
Sbjct: 62   KLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP------NLIKSIMYQLLRGLAYC 114

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-- 982
            H+     I++RD+  +N+L++ +    ++DFG++++       +T    T+ Y APE+  
Sbjct: 115  HSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILL 171

Query: 983  ---AYTMKVTEKSDVYSFGVLALEAIKGK 1008
                Y+  V    D++S G +  E I GK
Sbjct: 172  GSKHYSTAV----DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 82.2 bits (203), Expect = 6e-16
 Identities = 42/105 (40%), Positives = 59/105 (56%)

Query: 278 LDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
           +D L L +  L G IP+++  L+ L  + LS N + G+IP SLG++T L +L LS N   
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479

Query: 338 GSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTN 382
           GSIP  +G L  L  L L  N LSG +P +LG        + FT+
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD 524

Length = 623

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.5 bits (196), Expect = 7e-16
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 38/285 (13%)

Query: 800  EIVRATNDFDEE------HCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF 852
            EI    +  D E        IG G  G+VY A ++ + E+VA+KK            Q+ 
Sbjct: 3    EIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDI 62

Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            + EV+ L ++RH N +++ G C    H+ ++V EY  +GS + IL      + L   +  
Sbjct: 63   IKEVRFLQQLRHPNTIEYKG-CYLREHTAWLVMEYC-LGSASDILE--VHKKPLQEVEIA 118

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
             +  G    L+YLH+      ++RDI + N+LL       ++DFG +  + P +S     
Sbjct: 119  AICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANS----F 171

Query: 972  AGTIGYVAPELAYTM---KVTEKSDVYSFGVLALEAIKGKHP---RDFISSICSTSSNLD 1025
             GT  ++APE+   M   +   K DV+S G+  +E  + K P    + +S++   + N  
Sbjct: 172  VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS 231

Query: 1026 RTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQK 1070
             TL           S +  D   + ++   SCL + P  RP+ ++
Sbjct: 232  PTL----------SSNDWSDYFRNFVD---SCLQKIPQDRPSSEE 263

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 78.4 bits (194), Expect = 1e-15
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 49/287 (17%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEF----LNEVKSLTEIRHRNIV 868
            IG G  G VY+A    +GE+VA+KK     +        F    + E+K L ++RH NIV
Sbjct: 7    IGEGTYGQVYKARNKKTGELVALKKI---RMENEKE--GFPITAIREIKLLQKLRHPNIV 61

Query: 869  KFYGFC-SHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +      S  + S ++V+EY++   L  +L +     +   +Q    +K + + L YLH+
Sbjct: 62   RLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV--KFTESQIKCYMKQLLEGLQYLHS 118

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-NWTELAGTIGYVAPEL--- 982
            +    I++RDI   N+L++ +    ++DFG+++     +S ++T    T+ Y  PEL   
Sbjct: 119  N---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG 175

Query: 983  --AYTMKVTEKSDVYSFGVLALEAIKGK---------HPRDFISSICSTSSNLD----RT 1027
               Y  +V    D++S G +  E   GK            + I  +C + ++ +      
Sbjct: 176  ATRYGPEV----DMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231

Query: 1028 LD--EILDPRLPAPSCNIRDKLISIM-EVAISCLDE----NPDSRPT 1067
            L   E L P+ P     +R+    ++   A+  LD+    +P  R +
Sbjct: 232  LPWFENLKPKKPYKR-RLREFFKHLIDPSALDLLDKLLTLDPKKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 80/284 (28%), Positives = 125/284 (44%), Gaps = 38/284 (13%)

Query: 808  FDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F+    +G G  G VY+   + +G++ A+K        E   +QE +N +K  +   HRN
Sbjct: 8    FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYSH--HRN 64

Query: 867  IVKFYGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
            I  +YG              ++V E+   GS+  ++ N T    L       + + +   
Sbjct: 65   IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRG 123

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            LS+LH      +++RDI  +NVLL    E  + DFG+S  L           GT  ++AP
Sbjct: 124  LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180

Query: 981  ELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            E+    +  +     KSD++S G+ A+E  +G  P      +C       R L   L PR
Sbjct: 181  EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP------LCDMHPM--RAL--FLIPR 230

Query: 1036 LPAPSCNIR---DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             PAP    +    K  S +E   SCL +N   RPT +   QL+K
Sbjct: 231  NPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPTTE---QLMK 268

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 80.0 bits (197), Expect = 1e-15
 Identities = 81/188 (43%), Positives = 104/188 (55%), Gaps = 7/188 (3%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
             +L  LDL  N I  I P      S LK LDLS N    ++P  + NL  LK L LS N
Sbjct: 115 LTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173

Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGN 226
             S  +P  + +LS L  L L  N +S  +PP +  L+ L  + L NNS+   + S + N
Sbjct: 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSN 230

Query: 227 LKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHN 286
           LK+LSGLEL  NKL    P S+GNL NL TLDL +N +  S   S G+LTNL  L+L  N
Sbjct: 231 LKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGN 287

Query: 287 SLSGSIPS 294
           SLS ++P 
Sbjct: 288 SLSNALPL 295

Length = 394

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.6 bits (199), Expect = 2e-15
 Identities = 40/89 (44%), Positives = 53/89 (59%)

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSI 316
           L L +  L G IP     L +L  +NL  NS+ G+IP  +G++ SL  L LS+N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 317 PSSLGNLTKLTILYLSDNLLFGSIPCEIG 345
           P SLG LT L IL L+ N L G +P  +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 39/275 (14%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  GSV +  L +  ++   K  +   +    Q++ L E++     +   IVK+YG 
Sbjct: 9    LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDL-QKQILRELEINKSCKSPYIVKYYGA 67

Query: 874  CSHARHS--FIVYEYLEMGSLAMIL------SNATSAEELGWTQRMNVIKGVADALSYLH 925
                  S   I  EY E GSL  I             + LG      + + V   LSYLH
Sbjct: 68   FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-----KIAESVLKGLSYLH 122

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE---- 981
            +     I++RDI   N+LL  + +  + DFG+S  L   +S      GT  Y+APE    
Sbjct: 123  SR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQG 177

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLP- 1037
              Y++     SDV+S G+  LE  + + P  F          ++  L  I++   P L  
Sbjct: 178  KPYSI----TSDVWSLGLTLLEVAQNRFP--FPPEGEPPLGPIE-LLSYIVNMPNPELKD 230

Query: 1038 APSCNIR--DKLISIMEVAISCLDENPDSRPTMQK 1070
             P   I+  ++    ++    CL+++P  RPT   
Sbjct: 231  EPGNGIKWSEEFKDFIKQ---CLEKDPTRRPTPWD 262

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 33/284 (11%)

Query: 805  TNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
              +F  E  IG G    VY+A  L  G +VA+KK     + +   +Q+ L E+  L ++ 
Sbjct: 1    LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA-----EELGWTQRMNVIKGVA 918
            H N++K+           IV E  + G L+ ++ +         E   W   + +     
Sbjct: 61   HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQL----C 116

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             AL ++H+     I++RDI   NV +       + D G+ +     ++    L GT  Y+
Sbjct: 117  SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173

Query: 979  APELAYTMKVTEKSDVYSFGVLALE--AIKGKHPRDFIS--SICSTSSNLDRTLDEILDP 1034
            +PE  +      KSD++S G L  E  A++     D ++  S+C      D        P
Sbjct: 174  SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-------P 226

Query: 1035 RLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             LPA   S  +RD L+S       C++ +P+ RP +  V Q+ K
Sbjct: 227  PLPADHYSEELRD-LVSR------CINPDPEKRPDISYVLQVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 31/273 (11%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVK--KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            I  G  G V+ A+  S+G+I A+K  K    +        + L E   L++ +   +VK 
Sbjct: 1    ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQV--DQVLTERDILSQAQSPYVVKL 58

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            Y      ++ ++V EYL  G LA +L N  S +E         I  +  AL YLH++   
Sbjct: 59   YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE---DVARIYIAEIVLALEYLHSN--- 112

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISK--------SLKPDSSNWTELAGTIGYVAPEL 982
             I++RD+   N+L+D      ++DFG+SK        +L  D      + GT  Y+APE+
Sbjct: 113  GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC- 1041
                  ++  D +S G +  E + G  P  F           +     IL+ ++  P   
Sbjct: 173  ILGQGHSKTVDWWSLGCILYEFLVGIPP--F------HGETPEEIFQNILNGKIEWPEDV 224

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074
             + D+ I ++      L  +P+ R   + + ++
Sbjct: 225  EVSDEAIDLIS---KLLVPDPEKRLGAKSIEEI 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.1 bits (192), Expect = 2e-15
 Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)

Query: 812  HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            H IG G  G+VY A  S + E+VAVKK            Q+ + EVK L +++H N +++
Sbjct: 27   HEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 871  YGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             G C    H+ ++V EY  +GS + +L      + L   +   +  G    L+YLH+   
Sbjct: 87   KG-CYLKEHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN- 141

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
              +++RDI + N+LL    +  ++DFG +    P +S      GT  ++APE+   M   
Sbjct: 142  --MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS----FVGTPYWMAPEVILAMDEG 195

Query: 990  E---KSDVYSFGVLALEAIKGKHP 1010
            +   K DV+S G+  +E  + K P
Sbjct: 196  QYDGKVDVWSLGITCIELAERKPP 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 80.2 bits (198), Expect = 3e-15
 Identities = 39/93 (41%), Positives = 57/93 (61%)

Query: 181 YLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL 240
           ++  L L   GL G IP  +  L +L  + L  NS+ G+IP  +G++ SL  L+L YN  
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478

Query: 241 SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFG 273
           +GS+P SLG L +L  L+L+ NSLSG +P + G
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.0 bits (189), Expect = 3e-15
 Identities = 69/260 (26%), Positives = 119/260 (45%), Gaps = 23/260 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRHRNIVKFY 871
            IG G  G VY+  +  + E+VA+K      L E   + ++   E+  L++     I ++Y
Sbjct: 12   IGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
            G        +I+ EYL  GS   +L      E    T    ++KG    L YLH++    
Sbjct: 69   GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKG----LDYLHSE---R 121

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
             ++RDI + NVLL  + +  ++DFG++  L           GT  ++APE+        K
Sbjct: 122  KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181

Query: 992  SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
            +D++S G+ A+E  KG+ P          +S+L       L P+   P+   +       
Sbjct: 182  ADIWSLGITAIELAKGEPP----------NSDLHPMRVLFLIPKNSPPTLEGQYSK-PFK 230

Query: 1052 EVAISCLDENPDSRPTMQKV 1071
            E   +CL+++P  RPT +++
Sbjct: 231  EFVEACLNKDPRFRPTAKEL 250

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 25/218 (11%)

Query: 802  VRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHS-------PLLSEMTCQQEFL 853
             R+  +F++ + IG G  G VYRA + +SGEIVA+KK          P+ S        L
Sbjct: 3    CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--------L 54

Query: 854  NEVKSLTEIRHRNIVKFYGFC--SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
             E+  L  +RH NIV+        H    F+V EY E   LA +L N  +      +Q  
Sbjct: 55   REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP--FSESQVK 111

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
             ++  +   L YLH +    I++RD+   N+LL  +    ++DFG++++    +   T  
Sbjct: 112  CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPK 168

Query: 972  AGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGK 1008
              T+ Y APEL       T   D+++ G +  E +  K
Sbjct: 169  VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 76.7 bits (188), Expect = 4e-15
 Identities = 67/260 (25%), Positives = 117/260 (45%), Gaps = 23/260 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRHRNIVKFY 871
            IG G  G V++  +  + ++VA+K      L E   + ++   E+  L++     + K+Y
Sbjct: 12   IGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
            G        +I+ EYL  GS   +L      E    TQ   +++ +   L YLH++    
Sbjct: 69   GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHSE---K 121

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
             ++RDI + NVLL    E  ++DFG++  L           GT  ++APE+        K
Sbjct: 122  KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181

Query: 992  SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
            +D++S G+ A+E  KG+ P   +  +        + L  I     P    N    L   +
Sbjct: 182  ADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNPPTLEGNYSKPLKEFV 233

Query: 1052 EVAISCLDENPDSRPTMQKV 1071
            E   +CL++ P  RPT +++
Sbjct: 234  E---ACLNKEPSFRPTAKEL 250

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.0 bits (187), Expect = 5e-15
 Identities = 65/265 (24%), Positives = 125/265 (47%), Gaps = 22/265 (8%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E   + +++H  +V+ Y  
Sbjct: 14   LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAV 69

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +     +I+ EY+E GSL   L       +L   + +++   +A+ ++++    +   +
Sbjct: 70   VTQ-EPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---I 124

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ + N+L+       ++DFG+++ ++ +     E A   I + APE       T KS
Sbjct: 125  HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 993  DVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
            DV+SFG+L  E +  G+ P   +++      NL+R        R+P P  N  ++L  +M
Sbjct: 185  DVWSFGILLTEIVTYGRIPYPGMTNP-EVIQNLERGY------RMPRPD-NCPEELYELM 236

Query: 1052 EVAISCLDENPDSRPTMQKVSQLLK 1076
                 C  E P+ RPT + +  +L+
Sbjct: 237  ---RLCWKEKPEERPTFEYLRSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 77.7 bits (191), Expect = 6e-15
 Identities = 89/213 (41%), Positives = 116/213 (54%), Gaps = 9/213 (4%)

Query: 197 PPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS-LSGLELGYNKLSGSMPLSLGNLPNLA 255
              L  LTNL  + L NN+++  IP  IG LKS L  L+L  NK+  S+P  L NLPNL 
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK 166

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
            LDL  N LS  +P    NL+NL+ L+L  N +S  +P E+  L +L  L LS N +   
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-E 223

Query: 316 IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLA 375
           + SSL NL  L+ L LS+N L   +P  IGNL  L  L+L +N++S     SLG+LTNL 
Sbjct: 224 LLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLR 280

Query: 376 TLYLFTNLLSGSIPSEIGNLNSLSDLGLSENEL 408
            L L  N LS ++P     L  L  L      L
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313

Length = 394

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 6e-15
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 20/210 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N ++    +G G  G V +    ++GEIVA+KKF      E   ++  L EVK L ++RH
Sbjct: 1    NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDV-KKTALREVKVLRQLRH 59

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NIV            ++V+EY+E   L ++ ++          +    I  +  A++Y 
Sbjct: 60   ENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDA-VRS--YIWQLLQAIAYC 116

Query: 925  H-NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-PDSSNWTELAGTIGYVAPEL 982
            H ++    I++RDI  +N+L+       + DFG +++L+   +S  T+   T  Y APEL
Sbjct: 117  HSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPEL 172

Query: 983  -----AYTMKVTEKSDVYSFGVLALEAIKG 1007
                  Y   V    DV++ G +  E + G
Sbjct: 173  LVGDTNYGKPV----DVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 15/204 (7%)

Query: 814  IGTGGQGSVYRA--ELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G+G  G V +   ++   +I VA+K   +   +E + + E + E + + ++ +  IV+ 
Sbjct: 3    LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
             G C  A    +V E    G L   LS     +E+  +  + ++  V+  + YL    F 
Sbjct: 61   IGVC-EAEALMLVMEMASGGPLNKFLS--GKKDEITVSNVVELMHQVSMGMKYLEGKNF- 116

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG---TIGYVAPELAYTMK 987
              V+RD++++NVLL  ++ A +SDFG+SK+L  D S +   +     + + APE     K
Sbjct: 117  --VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 988  VTEKSDVYSFGVLALEAIK-GKHP 1010
             + +SDV+S+G+   EA   G+ P
Sbjct: 175  FSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 76.3 bits (187), Expect = 9e-15
 Identities = 72/271 (26%), Positives = 126/271 (46%), Gaps = 30/271 (11%)

Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G+VY A ++ + E+VA+KK            Q+ + EVK L  I+H N
Sbjct: 27   FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
             +++ G       +++V EY  +GS + +L      + L   +   +  G    L+YLH+
Sbjct: 87   SIEYKGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHS 143

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 +++RDI + N+LL    +  ++DFG +    P +S      GT  ++APE+   M
Sbjct: 144  H---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS----FVGTPYWMAPEVILAM 196

Query: 987  KVTE---KSDVYSFGVLALEAIKGKHP---RDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
               +   K DV+S G+  +E  + K P    + +S++   + N   TL           S
Sbjct: 197  DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ----------S 246

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                D   + ++   SCL + P  RPT +++
Sbjct: 247  NEWSDYFRNFVD---SCLQKIPQDRPTSEEL 274

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 75.2 bits (185), Expect = 9e-15
 Identities = 71/262 (27%), Positives = 120/262 (45%), Gaps = 27/262 (10%)

Query: 815  GTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFC 874
            G  G+ ++YR       +V  K+ +   LSE   +++ LNE+  L+ ++H NI+ +Y   
Sbjct: 11   GAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKE-RRDALNEIVILSLLQHPNIIAYYNHF 68

Query: 875  SHARHSFIVYEYLEMGSLAMILS----NATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
                   I  EY   G+L   +          E + W      +  +  A+SY+H     
Sbjct: 69   MDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYIHKA--- 120

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             I++RDI + N+ L       + DFGISK L  + S    + GT  Y++PEL   +K   
Sbjct: 121  GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180

Query: 991  KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-PRLPAPSCNIRDKLIS 1049
            KSD+++ G +  E +  K  R F       ++N    + +I+     P  S     +LIS
Sbjct: 181  KSDIWALGCVLYELLTLK--RTF------DATNPLNLVVKIVQGNYTPVVS-VYSSELIS 231

Query: 1050 IMEVAISCLDENPDSRPTMQKV 1071
            ++    S L ++P+ RPT  +V
Sbjct: 232  LVH---SLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 9e-15
 Identities = 69/292 (23%), Positives = 118/292 (40%), Gaps = 49/292 (16%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKF 870
             +G G  GSVY A    +GE+VA+KK      S   C    L EVKSL ++  H NIVK 
Sbjct: 6    QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNEHPNIVKL 63

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATS--AEELGWTQRMNVIKGVADALSYLHNDC 928
                      + V+EY+E     ++        +E        ++I  +   L+++H   
Sbjct: 64   KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSES----VIRSIIYQILQGLAHIHKHG 119

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-----A 983
            F    +RD+  +N+L+       ++DFG+++ ++     +T+   T  Y APE+     +
Sbjct: 120  F---FHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP-------RDFISSICST---------------S 1021
            Y+  V    D+++ G +  E    + P        D +  ICS                +
Sbjct: 176  YSSPV----DIWALGCIMAELYTLR-PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLA 230

Query: 1022 SNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            S L     +     L     N   + I +++     L  +P  RPT  +  Q
Sbjct: 231  SKLGFRFPQFAPTSLHQLIPNASPEAIDLIK---DMLRWDPKKRPTASQALQ 279

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 78.3 bits (193), Expect = 1e-14
 Identities = 42/101 (41%), Positives = 62/101 (61%), Gaps = 1/101 (0%)

Query: 170 GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS 229
           G IP  I  L +L++++L  N + G+IPPSLG++T+L ++ L  NS +GSIP  +G L S
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 230 LSGLELGYNKLSGSMPLSLGNLP-NLATLDLHDNSLSGSIP 269
           L  L L  N LSG +P +LG    + A+ +  DN+    IP
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.9 bits (192), Expect = 1e-14
 Identities = 37/91 (40%), Positives = 52/91 (57%)

Query: 496 INLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEI 555
           + L ++   G I  D  K  +L ++++S N+I G +PP +G    L+VLDLS N   G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 556 PSELGKLRSLIKLTLNRNQFSGQLPTELGSL 586
           P  LG+L SL  L LN N  SG++P  LG  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.5 bits (185), Expect = 1e-14
 Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 14/201 (6%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++ + E+VA+KK            Q+ + EV+ L ++RH N +++ G
Sbjct: 23   IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                   +++V EY  +GS + +L      + L   +   V  G    L+YLH+     +
Sbjct: 83   CYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE-- 990
            ++RD+ + N+LL       + DFG +  + P +       GT  ++APE+   M   +  
Sbjct: 137  IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAMDEGQYD 192

Query: 991  -KSDVYSFGVLALEAIKGKHP 1010
             K DV+S G+  +E  + K P
Sbjct: 193  GKVDVWSLGITCIELAERKPP 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 39/283 (13%)

Query: 814  IGTGGQGSVYRAEL------SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G+G  G VY           SG I VAVK        +   ++EFL E   ++   H N
Sbjct: 3    LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE--KKEFLKEAHLMSNFNHPN 60

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE----LGWTQRMNVIKGVADALS 922
            IVK  G C      +I+ E +E G L   L +A         L   + +++   VA    
Sbjct: 61   IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 923  YLHNDCFPPIVYRDISSKNVLL-----DLEYEAHVSDFGISKSLKPDSSNWTELAG---- 973
            YL    F   ++RD++++N L+     D +    + DFG+++ +    S++    G    
Sbjct: 121  YLEQMHF---IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY--KSDYYRKEGEGLL 175

Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL 1032
             + ++APE     K T +SDV+SFGVL  E +  G+ P           +N +       
Sbjct: 176  PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-------PALNNQEVLQHVTA 228

Query: 1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              RL  P  N  DK+  +M    +C  ++P  RPT  ++ ++L
Sbjct: 229  GGRLQKPE-NCPDKIYQLMT---NCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.2 bits (190), Expect = 2e-14
 Identities = 40/101 (39%), Positives = 61/101 (60%), Gaps = 1/101 (0%)

Query: 122 GIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSY 181
           G IP+ I+    L+ ++LS NS  G IPP +G+++ L++L LS N F+G IP  +G L+ 
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491

Query: 182 LKALHLFENGLSGSIPPSLGN-LTNLAIMYLYNNSLSGSIP 221
           L+ L+L  N LSG +P +LG  L + A     +N+    IP
Sbjct: 492 LRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP 532

Length = 623

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 68/279 (24%), Positives = 116/279 (41%), Gaps = 62/279 (22%)

Query: 833  VAVKKFHSPLLSEMTCQQEF---LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM 889
            VAVK     +L E     E    L+E   L ++ H +++K YG CS      ++ EY + 
Sbjct: 33   VAVK-----MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKY 87

Query: 890  GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI----------------- 932
            GSL   L  +             +        SYL N     +                 
Sbjct: 88   GSLRSFLRESRKVGPSY------LGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQ 141

Query: 933  -------VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI--GYVAPELA 983
                   V+RD++++NVL+    +  +SDFG+S+ +  + S      G I   ++A E  
Sbjct: 142  YLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201

Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFIS-----SICSTSSNLDRTLDEILDPRLP 1037
            +    T +SDV+SFGVL  E +  G +P   I+     ++  T   ++R           
Sbjct: 202  FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER----------- 250

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  +++ ++M   ++C  + PD RPT   +S+ L+
Sbjct: 251  -PE-NCSEEMYNLM---LTCWKQEPDKRPTFADISKELE 284

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.7 bits (183), Expect = 2e-14
 Identities = 77/284 (27%), Positives = 124/284 (43%), Gaps = 38/284 (13%)

Query: 808  FDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F+    +G G  G VY+   + +G++ A+K        E   + E +N +K  +   HRN
Sbjct: 18   FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLE-INMLKKYSH--HRN 74

Query: 867  IVKFYGF------CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
            I  +YG         H    ++V E+   GS+  ++ N T    L       + + +   
Sbjct: 75   IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKN-TKGNALKEDWIAYICREILRG 133

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            L++LH      +++RDI  +NVLL    E  + DFG+S  L           GT  ++AP
Sbjct: 134  LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190

Query: 981  ELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            E+    +  +     +SD++S G+ A+E  +G  P      +C       R L   L PR
Sbjct: 191  EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP------LCDMHPM--RAL--FLIPR 240

Query: 1036 LPAPSCNIR---DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P P    +    K I  +E    CL +N  SRP+ +   QLLK
Sbjct: 241  NPPPKLKSKKWSKKFIDFIE---GCLVKNYLSRPSTE---QLLK 278

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 38/265 (14%)

Query: 832  IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 891
            +VAVK   + +    T + +FL E+K ++ +++ NI++  G C       ++ EY+E G 
Sbjct: 46   LVAVKMLRADVTK--TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 892  LAMILSNA------TSAEELGWTQRMNVI---KGVADALSYLHNDCFPPIVYRDISSKNV 942
            L   LS        T A  +      N++     +A  + YL +  F   V+RD++++N 
Sbjct: 104  LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF---VHRDLATRNC 160

Query: 943  LLDLEYEAHVSDFGISKSLKPDSSNWTELAG----TIGYVAPELAYTMKVTEKSDVYSFG 998
            L+   Y   ++DFG+S++L   S ++  + G     I ++A E     K T  SDV++FG
Sbjct: 161  LVGNHYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 999  VLALE--AIKGKHPRDFISS---ICSTSS---NLDRTLDEILDPRLPAPSCNIRDKLISI 1050
            V   E   +  + P   +S    I +T     N  R +     P  P+P          +
Sbjct: 219  VTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSP----------V 268

Query: 1051 MEVAISCLDENPDSRPTMQKVSQLL 1075
             ++ + C   +   RPT  K+   L
Sbjct: 269  FKLMMRCWSRDIKDRPTFNKIHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 77.6 bits (191), Expect = 2e-14
 Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 25/195 (12%)

Query: 829  SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY--GFCSHARHSFIVYEY 886
            +G  VA+K   +    E   +  F  E      + H NIV     G        F V+EY
Sbjct: 2    TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60

Query: 887  LEMGSLAMILSN--ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL 944
            +   +L  +L+   A  A E G      ++  V DAL+  HN     IV+RD+  +N+++
Sbjct: 61   VPGRTLREVLAADGALPAGETG-----RLMLQVLDALACAHNQ---GIVHRDLKPQNIMV 112

Query: 945  ---DLEYEAHVSDFGISKSLKPDSSNW--------TELAGTIGYVAPELAYTMKVTEKSD 993
                +   A V DFGI  +L P   +         TE+ GT  Y APE      VT  SD
Sbjct: 113  SQTGVRPHAKVLDFGIG-TLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171

Query: 994  VYSFGVLALEAIKGK 1008
            +Y++G++ LE + G+
Sbjct: 172  LYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 73.9 bits (182), Expect = 4e-14
 Identities = 73/291 (25%), Positives = 119/291 (40%), Gaps = 56/291 (19%)

Query: 814  IGTGGQGSVYR---AELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY      +  GE    VA+K  +    + M  + EFLNE   + E    ++
Sbjct: 14   LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 72   VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG-------------ISKSLKPDSSN 967
            ++YL    F   V+RD++++N ++  +    + DFG               K L P    
Sbjct: 132  MAYLAAKKF---VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP---- 184

Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDR 1026
                   + ++APE       T KSDV+SFGV+  E A   + P   +S+        + 
Sbjct: 185  -------VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EE 229

Query: 1027 TLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L  ++D   L  P     DKL+ +M +   C   NP  RPT  ++   LK
Sbjct: 230  VLKFVIDGGHLDLPEN-CPDKLLELMRM---CWQYNPKMRPTFLEIVSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 76.0 bits (187), Expect = 6e-14
 Identities = 39/89 (43%), Positives = 52/89 (58%)

Query: 137 LDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSI 196
           L L +    G IP  I  L  L+ + LS N   G IPP +G ++ L+ L L  N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 197 PPSLGNLTNLAIMYLYNNSLSGSIPSEIG 225
           P SLG LT+L I+ L  NSLSG +P+ +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 36/268 (13%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRNIVK 869
             +G G  G VY   ++ +G  +AVK+      S  T +       E++ L  ++H  IV+
Sbjct: 9    LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 870  FYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            +YG         I  EY+  GS+   + +     E +       +++GV     YLH++ 
Sbjct: 69   YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVE----YLHSN- 123

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               IV+RDI   N+L D      + DFG SK L+   S+ T +    G   +++PE+   
Sbjct: 124  --MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG 181

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP-RDF-----ISSICSTSSNLDRTLDEILDPRLPAP 1039
                 K+DV+S G   +E +  K P  +F     I  I +  +N          P+LP+ 
Sbjct: 182  EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN----------PQLPSH 231

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPT 1067
                    +           EN   RP+
Sbjct: 232  VSPDARNFLRR------TFVENAKKRPS 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.6 bits (186), Expect = 7e-14
 Identities = 39/90 (43%), Positives = 53/90 (58%)

Query: 304 GLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGS 363
           GLGL    L G IP+ +  L  L  + LS N + G+IP  +G++  L  L+L  N  +GS
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 364 IPHSLGNLTNLATLYLFTNLLSGSIPSEIG 393
           IP SLG LT+L  L L  N LSG +P+ +G
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 75.6 bits (186), Expect = 7e-14
 Identities = 39/88 (44%), Positives = 51/88 (57%)

Query: 544 LDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI 603
           L L +  + G IP+++ KLR L  + L+ N   G +P  LGS+  LE LDLS N  + SI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 604 PGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
           P SLG L  L  LNL+ N  SG +P  L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 72.7 bits (178), Expect = 8e-14
 Identities = 67/278 (24%), Positives = 119/278 (42%), Gaps = 25/278 (8%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F  E  IG G    VYRA  L  G  VA+KK     L +   + + + E+  L ++ H 
Sbjct: 3    NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK---GVADALS 922
            N++K+Y          IV E  + G L+ ++ +    + L       V K    +  AL 
Sbjct: 63   NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL--IPEKTVWKYFVQLCSALE 120

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            ++H+     +++RDI   NV +       + D G+ +     ++    L GT  Y++PE 
Sbjct: 121  HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP----RDFISSICSTSSNLDRTLDEILDPRLPA 1038
             +      KSD++S G L  E    + P    +  + S+C      D           P 
Sbjct: 178  IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP---------PL 228

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            PS +  ++L  ++ +   C++ +P+ RP +  V  + K
Sbjct: 229  PSDHYSEELRQLVNM---CINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 33/221 (14%)

Query: 807  DFDEEH---CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            ++DE      +G G  G VY A +LS+   +A+K+       +    Q    E+   + +
Sbjct: 6    EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYL 62

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            +HRNIV++ G  S      I  E +  GSL+ +L +     +      +   K + + L 
Sbjct: 63   KHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLK 122

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEA--HVSDFGISKSL---KPDSSNWTELAGTIGY 977
            YLH++    IV+RDI   NVL++  Y     +SDFG SK L    P +  +T   GT+ Y
Sbjct: 123  YLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFT---GTLQY 175

Query: 978  VAPELAYTMKVTEK--------SDVYSFGVLALEAIKGKHP 1010
            +APE      V +K        +D++S G   +E   GK P
Sbjct: 176  MAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 72.0 bits (176), Expect = 1e-13
 Identities = 65/280 (23%), Positives = 131/280 (46%), Gaps = 26/280 (9%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            EI R +   +++  +G G  G V+ A  +    VAVK      +S     + FL E   +
Sbjct: 2    EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVM 55

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
              ++H  +VK +   +     +I+ E++  GSL   L  +    +    + ++    +A+
Sbjct: 56   KTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAE 113

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 114  GMAFIEQRNY---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L +E +  G+ P   +     ++  + R L+     R+P
Sbjct: 171  APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALER--GYRMP 223

Query: 1038 -APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               +C   ++L +IM   + C    P+ RPT + +  +L 
Sbjct: 224  RPENCP--EELYNIM---MRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 72.4 bits (177), Expect = 1e-13
 Identities = 76/279 (27%), Positives = 133/279 (47%), Gaps = 46/279 (16%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G VY+A+   +G + A K   +    E+   ++++ E++ L    H  IVK  G
Sbjct: 20   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPYIVKLLG 76

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    +I+ E+   G++  I+        L   Q   + + + +AL YLH+     I
Sbjct: 77   AFYWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHSM---KI 131

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGIS----KSLKPDSSNWTELAGTIGYVAPELAY--TM 986
            ++RD+ + NVLL L+ +  ++DFG+S    K+L+   S      GT  ++APE+    TM
Sbjct: 132  IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS----FIGTPYWMAPEVVMCETM 187

Query: 987  KVTE---KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP- 1039
            K T    K+D++S G+  +E  + + P   ++ +        R L +I     P L  P 
Sbjct: 188  KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTLSQPS 239

Query: 1040 --SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              S   RD L        + LD++P++RP+    +QLL+
Sbjct: 240  KWSMEFRDFL-------KTALDKHPETRPS---AAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 31/269 (11%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQ---EFLNEVKSLTEIRHRNIVK 869
            +G+G  G+VY+   +  GE V +      +L+E T  +   EF++E   +  + H ++V+
Sbjct: 15   LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
              G C       +V + +  G L   +      + +G    +N    +A  + YL     
Sbjct: 74   LLGVCLSPTIQ-LVTQLMPHGCLLDYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER-- 128

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTMK 987
              +V+RD++++NVL+       ++DFG+++ L+ D   +    G   I ++A E  +  K
Sbjct: 129  -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 187

Query: 988  VTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS-CNI 1043
             T +SDV+S+GV   E +  G  P D I +         R + ++L+   RLP P  C  
Sbjct: 188  FTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPICT- 237

Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVS 1072
                I +  V + C   + DSRP  ++++
Sbjct: 238  ----IDVYMVMVKCWMIDADSRPKFKELA 262

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 73.7 bits (181), Expect = 3e-13
 Identities = 60/205 (29%), Positives = 84/205 (40%), Gaps = 29/205 (14%)

Query: 592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEI 651
           L L +  L   IP  +  L  L  +NLS N   G IP  L     L  LDLS+N     I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 652 PSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPME 711
           P  +  + SL  LNL  N+LSG +P     + G +        LH    N          
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP---AALGGRL--------LHRASFN---------- 521

Query: 712 ALQGNKGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISLIGLFFMFRRRS 771
               N GLCG I G  +C    S      KI   I F +  +F L + +  + +  RR++
Sbjct: 522 -FTDNAGLCG-IPGLRACGPHLS---VGAKI--GIAFGVSVAF-LFLVICAMCWWKRRQN 573

Query: 772 SSQTQQSSAGNAPGFLSVLTFDRKI 796
             + Q+ +A  AP   +   F R +
Sbjct: 574 ILRAQRIAAREAPYAKARTHFSRDV 598

Length = 623

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 70.9 bits (174), Expect = 3e-13
 Identities = 77/272 (28%), Positives = 114/272 (41%), Gaps = 39/272 (14%)

Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G VY+    S E     VAVK   +     +   ++FL E   + +  H +IV
Sbjct: 13   CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQEAYIMRQFDHPHIV 70

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +IV E   +G L   L    +   L     +     ++ AL+YL +  
Sbjct: 71   KLIGVITE-NPVWIVMELAPLGELRSYLQ--VNKYSLDLASLILYSYQLSTALAYLESKR 127

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ L+ D S +    G   I ++APE     
Sbjct: 128  F---VHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183

Query: 987  KVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +  G  P       D I  I +               RLP P
Sbjct: 184  RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGE-------------RLPMP 230

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              N    L S+M     C   +P  RP   ++
Sbjct: 231  P-NCPPTLYSLMT---KCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.8 bits (176), Expect = 3e-13
 Identities = 71/246 (28%), Positives = 106/246 (43%), Gaps = 40/246 (16%)

Query: 807  DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF+    +GTG  G V  A+   +GE  A+K      + +M   Q    E   L E+ H 
Sbjct: 19   DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78

Query: 866  NIVKFY-GFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRMNVI 914
             IV     F    R  + + E++  G L   L  A            AE           
Sbjct: 79   FIVNMMCSFQDENR-VYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE----------- 126

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT 974
              +  A  YLH+     I+YRD+  +N+LLD +    V+DFG +K + PD + +T L GT
Sbjct: 127  --LVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRT-FT-LCGT 178

Query: 975  IGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
              Y+APE+  +    +  D ++ GVL  E I G +P  F  +         R  ++IL  
Sbjct: 179  PEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG-YPPFFDDTPF-------RIYEKILAG 230

Query: 1035 RLPAPS 1040
            RL  P+
Sbjct: 231  RLKFPN 236

Length = 329

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 71.5 bits (175), Expect = 6e-13
 Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 7/230 (3%)

Query: 442 NLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHK 501
           NL+ L  L L+ N+L+  I +L  LT L  + LD N++T        + SNL  ++LS  
Sbjct: 91  NLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDN 150

Query: 502 KFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGK 561
           K    +       PNL  LD+S N+++  LP  + +   L  LDLS N I  ++P E+  
Sbjct: 151 K-IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIEL 207

Query: 562 LRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
           L +L +L L+ N    +L + L +L  L  L+LS+N+L + +P S+GNL  L  L+LSNN
Sbjct: 208 LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNN 265

Query: 622 QFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNL 671
           Q        L    +L +LDLS N L   +P     +  LE L      L
Sbjct: 266 Q--ISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTL 313

Length = 394

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 41/284 (14%)

Query: 814  IGTGGQGSVYRAELSSGEIVA---VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG G  G V   E   G   A   VK+  +   +    Q  FL EV+   E+ H N+++ 
Sbjct: 3    IGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK---GVADALSYLHND 927
             G C  +    +V E+  +G L   L +          Q+  + +    VA  L +LH  
Sbjct: 61   LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVA-QMAQKDVLQRMACEVASGLLWLHQA 119

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELA-- 983
             F   ++ D++ +N  L  +    + D+G++    P+    T+   A  + ++APEL   
Sbjct: 120  DF---IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176

Query: 984  -----YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL---DP 1034
                      T+KS+++S GV   E       P           S+    L +++   D 
Sbjct: 177  RGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-------PDLSDEQ-VLKQVVREQDI 228

Query: 1035 RLPAPSCNIR--DKLISIMEVAISC-LDENPDSRPTMQKVSQLL 1075
            +LP P  +++  D+   +M+    C LD  P++RPT ++V +LL
Sbjct: 229  KLPKPQLDLKYSDRWYEVMQF---CWLD--PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.0 bits (174), Expect = 7e-13
 Identities = 77/317 (24%), Positives = 131/317 (41%), Gaps = 57/317 (17%)

Query: 771  SSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSS 829
            SSS +  S++G+AP            +  E+ R          IG+G  G+VY+     +
Sbjct: 54   SSSSSSSSASGSAPS--------AAKSLSELERVNR-------IGSGAGGTVYKVIHRPT 98

Query: 830  GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM 889
            G + A+K  +     E T +++   E++ L ++ H N+VK +    H     ++ E+++ 
Sbjct: 99   GRLYALKVIYGN--HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156

Query: 890  GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
            GSL         A+E       +V + +   ++YLH      IV+RDI   N+L++    
Sbjct: 157  GSL----EGTHIADEQ---FLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKN 206

Query: 950  AHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-----LAYTMKVTEKSDVYSFGVLALEA 1004
              ++DFG+S+ L           GTI Y++PE     L +        D++S GV  LE 
Sbjct: 207  VKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEF 266

Query: 1005 IKGKHP------RDFISSICSTSSNLDRTLDEILDPRLPAP--SCNIRDKLISIMEVAIS 1056
              G+ P       D+ S +C+   +          P       S   R   IS       
Sbjct: 267  YLGRFPFGVGRQGDWASLMCAICMS---------QPPEAPATASREFRH-FISC------ 310

Query: 1057 CLDENPDSRPTMQKVSQ 1073
            CL   P  R +  ++ Q
Sbjct: 311  CLQREPAKRWSAMQLLQ 327

Length = 353

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 69.7 bits (170), Expect = 8e-13
 Identities = 65/282 (23%), Positives = 126/282 (44%), Gaps = 38/282 (13%)

Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 14   LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 70

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-------VAD 919
            +V+  G  S  + + ++ E +  G L   L +     E    Q    +K        +AD
Sbjct: 71   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 131  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 186  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLRFVMEG 237

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 238  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 71.8 bits (176), Expect = 1e-12
 Identities = 39/89 (43%), Positives = 53/89 (59%)

Query: 329 LYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSI 388
           L L +  L G IP +I  LR+L  + L  N + G+IP SLG++T+L  L L  N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 389 PSEIGNLNSLSDLGLSENELSGSIPYSFG 417
           P  +G L SL  L L+ N LSG +P + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 70/301 (23%), Positives = 129/301 (42%), Gaps = 65/301 (21%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKF----HSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G V++     +G+IVA+KKF      P++ ++      L E++ L +++H N+V
Sbjct: 9    IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-----LREIRMLKQLKHPNLV 63

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH-ND 927
                     R   +V+EY +   L  +  N     E        +I     A+++ H ++
Sbjct: 64   NLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH---LIKKIIWQTLQAVNFCHKHN 120

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----- 982
            C    ++RD+  +N+L+  + +  + DFG ++ L     ++T+   T  Y APEL     
Sbjct: 121  C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD------RTLDEILDPR- 1035
             Y   V    DV++ G +  E + G+        +    S++D      +TL +++ PR 
Sbjct: 177  QYGPPV----DVWAIGCVFAELLTGQ-------PLWPGKSDVDQLYLIRKTLGDLI-PRH 224

Query: 1036 --------------LPAPSCN--IRDKLISIMEVAIS----CLDENPDSRPTMQKVSQLL 1075
                          +P P     +  K  +I   A+S    CL  +P  R +     +LL
Sbjct: 225  QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELL 281

Query: 1076 K 1076
            +
Sbjct: 282  E 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.5 bits (167), Expect = 2e-12
 Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 28/275 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFH-SPLLSEMTCQQEFLNEVKSLTEIRH 864
            DF+    IG+G  G VY+A  +++GE+ A+K     P       QQE +     + + +H
Sbjct: 10   DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEII----MMKDCKH 65

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NIV ++G        +I  E+   GSL  I        E    Q   V +     L YL
Sbjct: 66   SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSES---QIAYVSRETLQGLYYL 122

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+      ++RDI   N+LL       ++DFG+S  +    +      GT  ++APE+A 
Sbjct: 123  HSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAA 179

Query: 985  TMK---VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
              +     +  D+++ G+ A+E  + + P   +  +        R L  +       P  
Sbjct: 180  VERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--------RALFLMTKSNFQPP-- 229

Query: 1042 NIRDKLI---SIMEVAISCLDENPDSRPTMQKVSQ 1073
             ++DK+    S        L +NP  RPT +K+ Q
Sbjct: 230  KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 51/292 (17%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            ND   +  IG G  G V +A +    +    A+K+      +     ++F  E++ L ++
Sbjct: 7    NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKL 64

Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--------------AMILSNATSAEELGW 907
              H NI+   G C H  + ++  EY   G+L              A  ++N+T A  L  
Sbjct: 65   GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSS 123

Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q ++    VA  + YL    F   ++RD++++N+L+   Y A ++DFG+S+  +     
Sbjct: 124  QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE----- 175

Query: 968  WTELAGTIG-----YVAPE-LAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS- 1019
               +  T+G     ++A E L Y++  T  SDV+S+GVL  E +  G  P       C  
Sbjct: 176  -VYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP------YCGM 227

Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            T + L   L      RL  P  N  D++  +M     C  E P  RP+  ++
Sbjct: 228  TCAELYEKLP--QGYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.0 bits (169), Expect = 2e-12
 Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 16/208 (7%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF++   +G G  G V +     SG I+A K  H  L  +   + + + E+K L E    
Sbjct: 2    DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIH--LEIKPAIRNQIIRELKVLHECNSP 59

Query: 866  NIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATSAEE--LGWTQRMNVIKGVADALS 922
             IV FYG F S    S I  E+++ GSL  +L  A    E  LG      +   V   L+
Sbjct: 60   YIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLT 113

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 114  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 169

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  T +SD++S G+  +E   G++P
Sbjct: 170  LQGTHYTVQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 68.8 bits (169), Expect = 2e-12
 Identities = 55/207 (26%), Positives = 94/207 (45%), Gaps = 26/207 (12%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEF--LNEVKSLTEIRHRNIVKF 870
            +G G    VY+A    +G IVA+KK       E      F  L E+K L E++H NI+  
Sbjct: 8    LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSYLHN 926
                 H  +  +V+E++E   L  ++ +     T A+   +      ++G    L YLH+
Sbjct: 68   LDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT--LRG----LEYLHS 120

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
              +  I++RD+   N+L+  +    ++DFG+++S    +   T    T  Y APEL    
Sbjct: 121  -NW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGA 177

Query: 983  -AYTMKVTEKSDVYSFGVLALEAIKGK 1008
              Y + V    D++S G +  E +   
Sbjct: 178  RHYGVGV----DMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 67.9 bits (166), Expect = 3e-12
 Identities = 78/281 (27%), Positives = 129/281 (45%), Gaps = 42/281 (14%)

Query: 814  IGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            IG G  G VY   L   +      AVK  +   ++++   ++FL E   + +  H N++ 
Sbjct: 3    IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 870  FYGFCSHARHS-FIVYEYLEMGSLAMIL----SNATSAEELGWTQRMNVIKGVADALSYL 924
              G C  +  S  +V  Y++ G L   +     N T  + +G+  +      VA  + YL
Sbjct: 61   LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQ------VAKGMEYL 114

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSS--NWTELAGTIGYVAP 980
             +  F   V+RD++++N +LD  +   V+DFG+++ +  K   S  N T     + ++A 
Sbjct: 115  ASKKF---VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            E   T K T KSDV+SFGVL  E + +G  P   + S        D T+  +   RL  P
Sbjct: 172  ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRRLLQP 224

Query: 1040 S-CNIRDKLISIMEVAISCLDENPDSRPT----MQKVSQLL 1075
              C   D L  +M   +SC    P+ RPT    + ++ Q+ 
Sbjct: 225  EYCP--DPLYEVM---LSCWHPKPEMRPTFSELVSRIEQIF 260

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.8 bits (165), Expect = 3e-12
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 13/202 (6%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D++    +G+G  G VY+A  L +GE+ AVK        + +  Q+   E+  + E +H
Sbjct: 9    HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKH 65

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NIV ++G        +I  EY   GSL  I        EL   Q   V +     L+YL
Sbjct: 66   CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL---QIAYVCRETLQGLAYL 122

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+      ++RDI   N+LL    +  ++DFG++  +    +      GT  ++APE+A 
Sbjct: 123  HSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAA 179

Query: 985  TMK---VTEKSDVYSFGVLALE 1003
              K     +  D+++ G+ A+E
Sbjct: 180  VEKNGGYNQLCDIWAVGITAIE 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 70.2 bits (172), Expect = 4e-12
 Identities = 35/89 (39%), Positives = 54/89 (60%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI 412
           L L +  L G IP+ +  L +L ++ L  N + G+IP  +G++ SL  L LS N  +GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKEYG 441
           P S G LT++ +L++  N+LSG +P   G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 67.9 bits (166), Expect = 4e-12
 Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 36/227 (15%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE---LSSGE---IVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            N+ +    IG G  G V++A    L   E   +VAVK       ++M  Q +F  E   +
Sbjct: 5    NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 62

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL---------SNATSAEE------ 904
             E  H NIVK  G C+  +   +++EY+  G L   L         S + S         
Sbjct: 63   AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122

Query: 905  ----LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS 960
                L  T+++ + K VA  ++YL    F   V+RD++++N L+       ++DFG+S++
Sbjct: 123  NPLPLSCTEQLCIAKQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLSRN 179

Query: 961  LKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
            +   S+++ + +      I ++ PE  +  + T +SDV+++GV+  E
Sbjct: 180  IY--SADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.7 bits (165), Expect = 5e-12
 Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 28/215 (13%)

Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   +G GG G V   ++ ++G++ A KK     + +   +   LNE + L ++  R 
Sbjct: 2    FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE---------ELGWTQRMNVIKG- 916
            +V             + Y Y    +L ++L+     +         E G+ +   V    
Sbjct: 62   VVS------------LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109

Query: 917  -VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +   L  LH +    IVYRD+  +N+LLD      +SD G++  + P+        GT+
Sbjct: 110  EICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRVGTV 165

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            GY+APE+    + T   D ++ G L  E I G+ P
Sbjct: 166  GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.1 bits (166), Expect = 5e-12
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG I+A K  H  L  +   + + + E++ L E   
Sbjct: 5    DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62

Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 63   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 117

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 118  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 174  LQGTHYSVQSDIWSMGLSLVEMAIGRYP 201

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 6e-12
 Identities = 68/274 (24%), Positives = 120/274 (43%), Gaps = 36/274 (13%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G VY+A+     ++A  K       E    ++++ E+  L    H NIVK    
Sbjct: 13   LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHPNIVKLLDA 70

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
              +  + +I+ E+   G++  ++        L   Q   V K   +AL+YLH +    I+
Sbjct: 71   FYYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KII 125

Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE--- 990
            +RD+ + N+L  L+ +  ++DFG+S              GT  ++APE+       +   
Sbjct: 126  HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 991  --KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP---SCN 1042
              K+DV+S G+  +E  + + P   ++ +        R L +I     P L  P   S  
Sbjct: 186  DYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTLAQPSRWSSE 237

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +D L         CL++N D+R T    +QLL+
Sbjct: 238  FKDFL-------KKCLEKNVDARWT---TTQLLQ 261

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 67.1 bits (164), Expect = 6e-12
 Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 12/201 (5%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-Y 871
            +G GG G V   ++ ++G++ A KK     L +   +Q  LNE K L ++  R IV   Y
Sbjct: 1    LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ-RMNVIKG-VADALSYLHNDCF 929
             F +      ++   +  G L   + N     E G+ + R       +   L +LH    
Sbjct: 61   AFETKDDLCLVM-TLMNGGDLKYHIYNV---GEPGFPEARAIFYAAQIICGLEHLHQR-- 114

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
              IVYRD+  +NVLLD      +SD G++  L          AGT GY+APE+       
Sbjct: 115  -RIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRAGTPGYMAPEVLQGEVYD 172

Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
               D ++ G    E I G+ P
Sbjct: 173  FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 67.8 bits (165), Expect = 6e-12
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 14/208 (6%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF+    +G G  G V + +   SG I+A K  H  L  +   + + + E++ L E   
Sbjct: 5    DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 62

Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    EE+     + V++G    L+
Sbjct: 63   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG----LA 117

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 118  YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 173

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 174  LQGTHYSVQSDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 67.2 bits (164), Expect = 7e-12
 Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 49/275 (17%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  GSVY+     +G  +A+K+    L  E    Q  + E+  L +     IV FYG
Sbjct: 9    LGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQ-IIMELDILHKAVSPYIVDFYG 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL---HNDCF 929
                    ++  EY++ GSL  + +   + E +       +   V   L +L   HN   
Sbjct: 67   AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--- 123

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT-IG---YVAPE---- 981
              I++RD+   NVL++   +  + DFG+S +L         LA T IG   Y+APE    
Sbjct: 124  --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV------ASLAKTNIGCQSYMAPERIKS 175

Query: 982  ------LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-- 1033
                    YT+    +SDV+S G+  LE   G++P         T +N+   L  I+D  
Sbjct: 176  GGPNQNPTYTV----QSDVWSLGLSILEMALGRYPYP-----PETYANIFAQLSAIVDGD 226

Query: 1034 -PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067
             P LP+   +     ++       CL++ P+ RPT
Sbjct: 227  PPTLPSGYSDDAQDFVA------KCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 66.5 bits (162), Expect = 7e-12
 Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)

Query: 818  GQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            G+GS  RA L    +S +  A+K+   P  S     ++   E   L +++H NIV F   
Sbjct: 9    GEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAV--EDSRKEAVLLAKMKHPNIVAFKES 66

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNA-----TSAEELGWTQRMNVIKGVADALSYLHNDC 928
                 H +IV EY + G L   +             L W  +M +       + ++H   
Sbjct: 67   FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK- 119

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
               +++RDI SKN+ L    +  + DFG ++ L    +      GT  YV PE+   M  
Sbjct: 120  --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY 177

Query: 989  TEKSDVYSFGVLALEAIKGKHP------RDFISSICSTSSN 1023
              KSD++S G +  E    KHP      ++ I  +C  S  
Sbjct: 178  NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK 218

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 8e-12
 Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 20/208 (9%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFH----SPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            +G G  G VY   ++ +G  +A K+      SP  S+     E   E++ L  ++H  IV
Sbjct: 10   LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC--EIQLLKNLQHERIV 67

Query: 869  KFYGFC--SHARHSFIVY-EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            ++YG C    A  +  ++ EY+  GS+   L    +  E   +      + + + +SYLH
Sbjct: 68   QYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTE---SVTRKYTRQILEGMSYLH 123

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPEL 982
            ++    IV+RDI   N+L D      + DFG SK L+    + T    + GT  +++PE+
Sbjct: 124  SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                    K+DV+S G   +E +  K P
Sbjct: 181  ISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.9 bits (163), Expect = 8e-12
 Identities = 57/234 (24%), Positives = 103/234 (44%), Gaps = 36/234 (15%)

Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            QE  + + ++  + H  IV+  G C  A    +V +   +GSL   +     +  L   +
Sbjct: 54   QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDS--LDPQR 110

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-- 967
             +N    +A  + YL       +V+R+++++N+LL  +    ++DFG++  L PD     
Sbjct: 111  LLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
            ++E    I ++A E     + T +SDV+S+GV   E +  G  P   +            
Sbjct: 168  YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR----------- 216

Query: 1027 TLDEILD-----PRLPAPS-CNIRDKLISIMEVAISC--LDENPDSRPTMQKVS 1072
               E+ D      RL  P  C      I +  V + C  +DEN   RPT ++++
Sbjct: 217  -PHEVPDLLEKGERLAQPQICT-----IDVYMVMVKCWMIDEN--VRPTFKELA 262

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.6 bits (162), Expect = 1e-11
 Identities = 82/301 (27%), Positives = 130/301 (43%), Gaps = 46/301 (15%)

Query: 796  IAYEEIVRATNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLN 854
            +  E +   T+ ++    IG G  G VY+      G + AVK        +   + E+ N
Sbjct: 12   LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEY-N 70

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS--NATSAEEL-----GW 907
             ++SL    H N+VKFYG        F   + L  G L ++L   N  S  EL       
Sbjct: 71   ILQSLPN--HPNVVKFYGM-------FYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC 121

Query: 908  TQRMN------VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
             QR++      ++ G    L +LHN+    I++RD+   N+LL  E    + DFG+S  L
Sbjct: 122  GQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178

Query: 962  KPDSSNWTELAGTIGYVAPEL-----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016
                       GT  ++APE+      Y      + DV+S G+ A+E   G  P   +  
Sbjct: 179  TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238

Query: 1017 ICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAIS-CLDENPDSRPTMQKVSQLL 1075
            +        +TL +I  PR P P+    +K        IS CL ++ ++RP+   V+ LL
Sbjct: 239  V--------KTLFKI--PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLL 285

Query: 1076 K 1076
            +
Sbjct: 286  E 286

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 67/278 (24%), Positives = 117/278 (42%), Gaps = 25/278 (8%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F  E  IG G    VYRA  L   + VA+KK     + +   +Q+ + E+  L ++ H 
Sbjct: 3    NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK---GVADALS 922
            N++K+           IV E  + G L+ ++      + L       V K    +  A+ 
Sbjct: 63   NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL--IPERTVWKYFVQLCSAVE 120

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            ++H+     +++RDI   NV +       + D G+ +     ++    L GT  Y++PE 
Sbjct: 121  HMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP----RDFISSICSTSSNLDRTLDEILDPRLPA 1038
             +      KSD++S G L  E    + P    +  + S+C      D           P 
Sbjct: 178  IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYP---------PL 228

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            P+ +  +KL    E+   C+  +PD RP +  V Q+ K
Sbjct: 229  PTEHYSEKL---RELVSMCIYPDPDQRPDIGYVHQIAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 16/177 (9%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEV---KSLTEIRHRNIVK 869
           IG G  G+VY+A +L++G  VA+KK   PL SE       L E+   K L    H NIV+
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPL-SEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 870 FYGFC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
               C            +V+E+++   LA  LS       L      ++++ +   + +L
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFL 123

Query: 925 HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
           H+     IV+RD+  +N+L+  + +  ++DFG+++    + +  T +  T+ Y APE
Sbjct: 124 HSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA-LTSVVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 1e-11
 Identities = 52/161 (32%), Positives = 83/161 (51%), Gaps = 14/161 (8%)

Query: 854  NEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
             E   L E+ H  IVK  Y F +  +  +++ ++L  G L   LS     +E+ +T+  +
Sbjct: 47   MERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS-----KEVMFTEE-D 99

Query: 913  V---IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
            V   +  +A AL +LH+     I+YRD+  +N+LLD E    ++DFG+SK          
Sbjct: 100  VKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY 156

Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               GT+ Y+APE+      T+ +D +SFGVL  E + G  P
Sbjct: 157  SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.1 bits (161), Expect = 1e-11
 Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 17/199 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G+VY+A  L +  I+AVK    PL   +  Q++ ++E++ L +     I+ FYG
Sbjct: 9    LGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 873  -FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
             F    R S I  E+++ GSL +          LG   R+ V   V   L+YL +     
Sbjct: 67   AFFVENRIS-ICTEFMDGGSLDVYRK--IPEHVLG---RIAV--AVVKGLTYLWS---LK 115

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            I++RD+   N+L++   +  + DFG+S  L   +S      GT  Y+APE     +    
Sbjct: 116  ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIH 173

Query: 992  SDVYSFGVLALEAIKGKHP 1010
            SDV+S G+  +E   G+ P
Sbjct: 174  SDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 37/287 (12%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V + +   +G+IVA+KKF      +M  ++  + E++ L ++RH N+V    
Sbjct: 9    VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMV-KKIAMREIRMLKQLRHENLVNLIE 67

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADALSYLHNDCFP 930
                 +  ++V+E+++   L   L    +  +    ++    +++G+     + H+    
Sbjct: 68   VFRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESRVRKYLFQILRGIE----FCHSH--- 119

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVT 989
             I++RDI  +N+L+       + DFG +++L      +T+   T  Y APEL     K  
Sbjct: 120  NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYG 179

Query: 990  EKSDVYSFGVLALEAIKGKHPR-------DFISSICSTSSNLDRTLDEILDP-------R 1035
               D+++ G L  E + G+ P        D +  I     NL     EI          R
Sbjct: 180  RAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238

Query: 1036 LPAPS--CNIRDKLISIMEVAI----SCLDENPDSRPTMQKVSQLLK 1076
            LP       +  +   +  + +     CL  +PD RP+    SQLL 
Sbjct: 239  LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 67.9 bits (166), Expect = 2e-11
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 1/103 (0%)

Query: 520 LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
           L +    + G +P +I     L+ ++LS N I G IP  LG + SL  L L+ N F+G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGN-LVKLYYLNLSNN 621
           P  LG L  L  L+L+ N LS  +P +LG  L+     N ++N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 66.9 bits (163), Expect = 2e-11
 Identities = 97/338 (28%), Positives = 150/338 (44%), Gaps = 17/338 (5%)

Query: 265 SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLT 324
             ++     N   L++ +         +PS +  L SL  L  S    S     +L NL 
Sbjct: 39  DSNLESVAVNRLALNLSSNTLLL----LPSSLSRLLSLDLLSPSGIS-SLDGSENLLNLL 93

Query: 325 KLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLT-NLATLYLFTNL 383
            L  L L+ N L  +I  E+  L  L  L+L +N ++  IP  +G L  NL  L L  N 
Sbjct: 94  PLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK 151

Query: 384 LSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNL 443
           +  S+PS + NL +L +L LS N+LS  +P    NL+N+  L +  N +S  +P E   L
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208

Query: 444 VKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKK- 502
             L  L LS N +   +  L NL  L+ + L  N L  ++ ES G  SNL  ++LS+ + 
Sbjct: 209 SALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI 267

Query: 503 FYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKL 562
                    G   NL  LD+S N+++  LP        L  L L+    +  +  +L  +
Sbjct: 268 SSISSL---GSLTNLRELDLSGNSLSNALPLIALL-LLLLELLLNLLLTLKALELKLNSI 323

Query: 563 RSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS 600
                +  N    S +  + L SL  L  LD + +  +
Sbjct: 324 LLNNNILSNGETSSPEALSILESLNNLWTLDNALDESN 361

Length = 394

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.1 bits (161), Expect = 2e-11
 Identities = 60/258 (23%), Positives = 116/258 (44%), Gaps = 25/258 (9%)

Query: 832  IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 891
            +VAVK       +    + +FL E+K ++ ++  NI++    C  +    ++ EY+E G 
Sbjct: 48   LVAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 892  LAMILSN--------ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL 943
            L   LS               + ++  + +   +A  + YL +  F   V+RD++++N L
Sbjct: 106  LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF---VHRDLATRNCL 162

Query: 944  LDLEYEAHVSDFGISKSLKPDSSNWTELAG----TIGYVAPELAYTMKVTEKSDVYSFGV 999
            +   Y   ++DFG+S++L   S ++  + G     I +++ E     K T  SDV++FGV
Sbjct: 163  VGKNYTIKIADFGMSRNLY--SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 1000 LALEAIK--GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISC 1057
               E +    + P   +S      +  +   D+     LP P+        S+ ++ +SC
Sbjct: 221  TLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPD----SLYKLMLSC 276

Query: 1058 LDENPDSRPTMQKVSQLL 1075
               N   RP+ Q++   L
Sbjct: 277  WRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 69/283 (24%), Positives = 126/283 (44%), Gaps = 40/283 (14%)

Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFH-SPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY     ++  GE    VAVK  + S  L E   + EFLNE   +      +
Sbjct: 14   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE---RIEFLNEASVMKGFTCHH 70

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------SNATSAEELGWTQRMNVIKGVAD 919
            +V+  G  S  + + +V E +  G L   L        N          + + +   +AD
Sbjct: 71   VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+   F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 131  GMAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 185

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD- 1033
             ++APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D 
Sbjct: 186  RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDG 237

Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              L  P  N  +++  +M +   C   NP  RPT  ++  LLK
Sbjct: 238  GYLDQPD-NCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 65.8 bits (160), Expect = 2e-11
 Identities = 70/284 (24%), Positives = 128/284 (45%), Gaps = 36/284 (12%)

Query: 801  IVRATNDFDEEHCIGTGGQGSVYRA-ELSSGE----IVAVKKFHSPLLSEMT---CQQEF 852
            I++ T +F +   +G+G  G+VY+   +  GE     VA+K+     L E T     +E 
Sbjct: 3    ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE-----LREATSPKANKEI 56

Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            L+E   +  + + ++ +  G C  +    I  + +  G L   +      + +G    +N
Sbjct: 57   LDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLN 113

Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
                +A  ++YL       +V+RD++++NVL+       ++DFG++K L  D   +    
Sbjct: 114  WCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 973  GT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLD 1029
            G   I ++A E       T +SDV+S+GV   E +  G  P D I      +S +   L+
Sbjct: 171  GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP-----ASEISSILE 225

Query: 1030 EILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            +    RLP P  C      I +  + + C   + DSRP  +++ 
Sbjct: 226  K--GERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 17/204 (8%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFL--NEVKSLTEIRHRNIVKFY 871
            IG G  G +Y A+  S     V K     L++M  +++     EV  L +++H NIV F+
Sbjct: 8    IGEGSFGKIYLAKAKSDSEHCVIKEID--LTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                     FIV EY + G L M   N          Q ++    ++  L ++H+     
Sbjct: 66   ASFQENGRLFIVMEYCDGGDL-MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---K 121

Query: 932  IVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELA----GTIGYVAPELAYTM 986
            I++RDI S+N+ L      A + DFGI++ L    ++  ELA    GT  Y++PE+    
Sbjct: 122  ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPYYLSPEICQNR 177

Query: 987  KVTEKSDVYSFGVLALEAIKGKHP 1010
                K+D++S G +  E    KHP
Sbjct: 178  PYNNKTDIWSLGCVLYELCTLKHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 65.6 bits (160), Expect = 3e-11
 Identities = 63/253 (24%), Positives = 117/253 (46%), Gaps = 32/253 (12%)

Query: 833  VAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEMGS 891
            VAVK       +  + ++  ++E+K ++ +  H NIV   G C+      ++ EY   G 
Sbjct: 68   VAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 892  LAMIL-----SNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL 946
            L   L     S  T  + L ++ +      VA  +++L        ++RD++++NVLL  
Sbjct: 126  LLNFLRRKRESFLTLEDLLSFSYQ------VAKGMAFL---ASKNCIHRDLAARNVLLTH 176

Query: 947  EYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
                 + DFG+++ +  D SN+         + ++APE  +    T +SDV+S+G+L  E
Sbjct: 177  GKIVKICDFGLARDIMND-SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235

Query: 1004 AIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENP 1062
                G +P   +  + S    L +    +  P   AP      ++  IM+   +C D +P
Sbjct: 236  IFSLGSNPYPGM-PVDSKFYKLIKEGYRMAQPEH-AP-----AEIYDIMK---TCWDADP 285

Query: 1063 DSRPTMQKVSQLL 1075
              RPT +++ QL+
Sbjct: 286  LKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 66.8 bits (163), Expect = 4e-11
 Identities = 31/78 (39%), Positives = 48/78 (61%)

Query: 384 LSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNL 443
           L G IP++I  L  L  + LS N + G+IP S G++T++ VL +  N+ +G+IP+  G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489

Query: 444 VKLTLLVLSYNQLQGPIP 461
             L +L L+ N L G +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507

Length = 623

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.7 bits (157), Expect = 4e-11
 Identities = 71/285 (24%), Positives = 124/285 (43%), Gaps = 44/285 (15%)

Query: 814  IGTGGQGSVYRAELSSGEI---VAVKKFHSPLL--SEMTCQQEFLNEVKSLTEIRHRNIV 868
            +G G  GSV   +L+  +    VAVK     +   SEM   ++FL+E   + E  H N++
Sbjct: 7    LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM---EDFLSEAVCMKEFDHPNVM 63

Query: 869  KFYGFC--SHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD--- 919
            +  G C  +     +    ++  +++ G L   L  +   +   +     ++K + D   
Sbjct: 64   RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL-KPDSSNWTELAGT-IGY 977
             + YL +  F   ++RD++++N +L+      V+DFG+SK +   D      +A   + +
Sbjct: 124  GMEYLSSKSF---IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKW 180

Query: 978  VAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILD--- 1033
            +A E       T KSDV+SFGV   E A +G+ P   + +             EI D   
Sbjct: 181  IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------------SEIYDYLR 228

Query: 1034 --PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               RL  P     D L  +  +  SC   NP  RP+ + +   L+
Sbjct: 229  QGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 65.4 bits (159), Expect = 4e-11
 Identities = 54/208 (25%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLL---SEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V+ AEL  + +  A+K     ++    ++ C         ++ E R  ++  
Sbjct: 3    LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVEC---------TMVEKRVLSLAW 53

Query: 870  FYGFCSH-------ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             + F +H         + F V EYL  G L   + +  S  +    +       +   L 
Sbjct: 54   EHPFLTHLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQ 110

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            +LH+     IVYRD+   N+LLD +    ++DFG+ K      +      GT  Y+APE+
Sbjct: 111  FLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEI 167

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                K     D +SFGVL  E + G+ P
Sbjct: 168  LLGQKYNTSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 51/192 (26%), Positives = 91/192 (47%), Gaps = 8/192 (4%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V+     +  ++V +K+     +++   +    NE + L  + H NI+++Y 
Sbjct: 8    VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE-RLAAQNECQVLKLLSHPNIIEYYE 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                 +   IV EY   G+LA  +        L     ++    +  AL ++H      I
Sbjct: 67   NFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDTILHFFVQILLALHHVHTKL---I 122

Query: 933  VYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            ++RD+ ++N+LLD       + DFGISK L   S  +T + GT  Y++PEL       +K
Sbjct: 123  LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVGTPCYISPELCEGKPYNQK 181

Query: 992  SDVYSFGVLALE 1003
            SD+++ G +  E
Sbjct: 182  SDIWALGCVLYE 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 64.7 bits (158), Expect = 4e-11
 Identities = 64/222 (28%), Positives = 95/222 (42%), Gaps = 33/222 (14%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             D  +   IG G  G+V +     SG I+AVK+  S    +   Q+  L ++  +  +R 
Sbjct: 4    EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRS--TVDEKEQKRLLMDLDVV--MRS 59

Query: 865  RN---IVKFYGFCSHARHSFIVYEYLE--MGSLAMILSNATSA---EE-LGWTQRMNVIK 915
             +   IVKFYG        +I  E ++  +      +     +   EE LG      +  
Sbjct: 60   SDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILG-----KIAV 114

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
                AL+YL  +    I++RD+   N+LLD      + DFGIS  L  DS   T  AG  
Sbjct: 115  ATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV-DSIAKTRDAGCR 171

Query: 976  GYVAPEL-------AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE         Y +    +SDV+S G+   E   GK P
Sbjct: 172  PYMAPERIDPSARDGYDV----RSDVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.5 bits (157), Expect = 4e-11
 Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 41/283 (14%)

Query: 814  IGTGGQGSVYRAELSSGEI----VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  GSV   +LS  +     VAVK     + +  +  +EFL+E   + +  H N++K
Sbjct: 7    LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSEAACMKDFDHPNVMK 65

Query: 870  FYGFC--SHARHSF----IVYEYLEMGSL-AMILSNATSAEELGWTQRMNV--IKGVADA 920
              G C  + +        ++  +++ G L + +L +           +  +  +  +A  
Sbjct: 66   LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL-KPDSSNWTELAGT-IGYV 978
            + YL N  F   ++RD++++N +L  +    V+DFG+SK +   D      +A   + ++
Sbjct: 126  MEYLSNRNF---IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 979  APELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILD---- 1033
            A E       T KSDV++FGV   E A +G+ P   + +             EI D    
Sbjct: 183  AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN------------HEIYDYLRH 230

Query: 1034 -PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              RL  P  +  D+L  +M    SC   +P  RPT  K+ ++L
Sbjct: 231  GNRLKQPE-DCLDELYDLM---YSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 64.8 bits (158), Expect = 4e-11
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 24/207 (11%)

Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY               VAVK    P       + +FL E   +++  H+NI
Sbjct: 14   LGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMIL----SNATSAEELGWTQRMNVIKGVADALSY 923
            V+  G        FI+ E +  G L   L            L     +   + VA    Y
Sbjct: 72   VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGT----IG 976
            L  + F   ++RDI+++N LL  +     A ++DFG+++ +    +++    G     I 
Sbjct: 132  LEENHF---IHRDIAARNCLLTCKGPGRVAKIADFGMARDIY--RASYYRKGGRAMLPIK 186

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALE 1003
            ++ PE       T K+DV+SFGVL  E
Sbjct: 187  WMPPEAFLDGIFTSKTDVWSFGVLLWE 213

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 64.9 bits (159), Expect = 4e-11
 Identities = 53/196 (27%), Positives = 95/196 (48%), Gaps = 25/196 (12%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVK--KFHS-----PLLSEMTCQQEFLNEVKSLTEIRHR 865
           I  G  G VYRA +  +GEIVA+K  K        P+ S        L E+  L +++H 
Sbjct: 13  IEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--------LREINILLKLQHP 64

Query: 866 NIV--KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
           NIV  K     S+    ++V EY+E   L  ++   T  +    ++   ++  +   +++
Sbjct: 65  NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLME--TMKQPFLQSEVKCLMLQLLSGVAH 121

Query: 924 LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
           LH++    I++RD+ + N+LL+      + DFG+++        +T+L  T+ Y APEL 
Sbjct: 122 LHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178

Query: 984 Y-TMKVTEKSDVYSFG 998
               + +   D++S G
Sbjct: 179 LGAKEYSTAIDMWSVG 194

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 30/233 (12%)

Query: 848  CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
              + F      ++++ H+++V  YG C     S +V EY++ GSL   L    +   + W
Sbjct: 42   YSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW 101

Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH--------VSDFGISK 959
              ++ V K +A AL +L +     + + ++ +KNVLL  E +          +SD GIS 
Sbjct: 102  --KLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156

Query: 960  SLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
            ++ P       L   I +V PE +     ++  +D +SFG    E   G    D   S  
Sbjct: 157  TVLPKEI----LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGG---DKPLSAL 209

Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             +   L    D     +LPAP      K   +  +   C+D  PD RP+ + +
Sbjct: 210  DSQKKLQFYEDRH---QLPAP------KWTELANLINQCMDYEPDFRPSFRAI 253

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.3 bits (154), Expect = 8e-11
 Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 818  GQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRNIVKFY 871
            G+GS  +A L      G+   +K+ +   +S+M+ +  +E   EV  L+ ++H NIV++ 
Sbjct: 9    GEGSFGKAILVKSKEDGKQYVIKEIN---ISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                   + +IV +Y E G L   + NA         Q ++    +  AL ++H+     
Sbjct: 66   ESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQILDWFVQICLALKHVHDR---K 121

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA----GTIGYVAPELAYTMK 987
            I++RDI S+N+ L  +    + DFGI++ L    ++  ELA    GT  Y++PE+     
Sbjct: 122  ILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPYYLSPEICENRP 177

Query: 988  VTEKSDVYSFGVLALEAIKGKH 1009
               KSD+++ G +  E    KH
Sbjct: 178  YNNKSDIWALGCVLYEMCTLKH 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 63.9 bits (155), Expect = 9e-11
 Identities = 77/294 (26%), Positives = 126/294 (42%), Gaps = 55/294 (18%)

Query: 807  DFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
            D   E  IG G  G V RA +       +  I  +K+F S         ++F  E++ L 
Sbjct: 3    DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE-----NDHRDFAGELEVLC 57

Query: 861  EI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT-------------SAEELG 906
            ++  H NI+   G C +  + +I  EY   G+L   L  +              +A  L 
Sbjct: 58   KLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLT 117

Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
              Q +     VA  + YL    F   ++RD++++NVL+     + ++DFG+S+  +    
Sbjct: 118  SQQLLQFASDVATGMQYLSEKQF---IHRDLAARNVLVGENLASKIADFGLSRGEE---- 170

Query: 967  NWTELAGTIG-----YVAPE-LAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
                +  T+G     ++A E L Y++  T KSDV+SFGVL  E +  G  P       C 
Sbjct: 171  --VYVKKTMGRLPVRWMAIESLNYSVYTT-KSDVWSFGVLLWEIVSLGGTP------YCG 221

Query: 1020 -TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
             T + L   L +    R+  P  N  D++  +M     C  + P  RP   ++S
Sbjct: 222  MTCAELYEKLPQGY--RMEKPR-NCDDEVYELMR---QCWRDRPYERPPFAQIS 269

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 64.6 bits (157), Expect = 1e-10
 Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 29/203 (14%)

Query: 525 NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIK-LTLNRNQFSGQLPTEL 583
            N       E+ +   L  LDL +N+I  +IP  +G L+S +K L L+ N+    LP+ L
Sbjct: 102 LNRLRSNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPL 159

Query: 584 GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG------------------ 625
            +L  L++LDLS N LS  +P  L NL  L  L+LS N+ S                   
Sbjct: 160 RNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSN 218

Query: 626 ----EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKE 681
               E+   L    +LS L+LS+N L E++P  + ++ +LE L+L++N +S         
Sbjct: 219 NSIIELLSSLSNLKNLSGLELSNNKL-EDLPESIGNLSNLETLDLSNNQIS--SISSLGS 275

Query: 682 MHGLVYIDISYNKLHGPIPNSAA 704
           +  L  +D+S N L   +P  A 
Sbjct: 276 LTNLRELDLSGNSLSNALPLIAL 298

Length = 394

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 40/213 (18%)

Query: 814  IGTGGQGSV-YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV---- 868
            +G+G  G+V    +  +G  VA+KK + P  SE+  ++ +  E++ L  ++H N++    
Sbjct: 23   VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGLLD 81

Query: 869  ---------KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
                     +F+ F            YL M  +   L      E+L   +   ++  +  
Sbjct: 82   VFTPDLSLDRFHDF------------YLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG---TIG 976
             L Y+H      I++RD+   N+ ++ + E  + DFG+++  + DS    E+ G   T  
Sbjct: 130  GLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDS----EMTGYVVTRW 180

Query: 977  YVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            Y APE+    M  T+  D++S G +  E + GK
Sbjct: 181  YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 46/151 (30%), Positives = 73/151 (48%), Gaps = 10/151 (6%)

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTI 975
            ++ AL+YLH      I+YRD+   NVLLD E    ++D+G+ K  L+P  +  +   GT 
Sbjct: 105  ISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-STFCGTP 160

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL-DRTLDEILDP 1034
             Y+APE+          D ++ GVL  E + G+ P D + S  +   N  D     IL+ 
Sbjct: 161  NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 220

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            ++  P    R   +    V  S L+++P  R
Sbjct: 221  QIRIP----RSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 34/276 (12%)

Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  +GTG  G + R  L   S  E+ VA+    +    +   ++ FL E  +L +  H N
Sbjct: 10   ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ--RRGFLAEALTLGQFDHSN 67

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+  G  +      IV EY+  G+L   L       +L   Q M ++ G+A  + YL  
Sbjct: 68   IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSE 125

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAG--TIGYVAPEL 982
              +   V++ +++  VL++ +    +S F     L+ D S   +T ++G   + + APE 
Sbjct: 126  MGY---VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSPVLWAAPEA 179

Query: 983  AYTMKVTEKSDVYSFGVLALEAIK-GKHPR-DFISSICSTSSNLDRTLDEILDP-RLPAP 1039
                  +  SDV+SFG++  E +  G+ P  D         S  D  +  + D  RLPAP
Sbjct: 180  IQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM--------SGQD-VIKAVEDGFRLPAP 230

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N  + L  +M   + C  +    RP   ++  +L
Sbjct: 231  R-NCPNLLHQLM---LDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 63.1 bits (153), Expect = 2e-10
 Identities = 49/207 (23%), Positives = 94/207 (45%), Gaps = 12/207 (5%)

Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   +G GG G V   ++ ++G++ A K+     + +   +   LNE + L ++  + 
Sbjct: 2    FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 867  IVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADALSY 923
            +V    +    + +  +V   +  G L   + N  +    G+ +   +     +   L  
Sbjct: 62   VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLED 117

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH +     VYRD+  +N+LLD      +SD G++  + P+  +     GT+GY+APE+ 
Sbjct: 118  LHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-PEGESIRGRVGTVGYMAPEVL 173

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               + T   D +  G L  E I+G+ P
Sbjct: 174  NNQRYTLSPDYWGLGCLIYEMIEGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 64.8 bits (158), Expect = 2e-10
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 28/213 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG GG G VY A +      VA+KK    L      ++ FL E K   ++ H  IV  Y 
Sbjct: 10   IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP-- 930
             CS     +    Y+E  +L  +L +    E L  ++ +     V   LS  H  C    
Sbjct: 70   ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESL--SKELAEKTSVGAFLSIFHKICATIE 127

Query: 931  -----PIVYRDISSKNVLLDLEYEAHVSDFG--ISKSLKPD-------------SSNWT- 969
                  +++RD+   N+LL L  E  + D+G  I K L+ +              S+ T 
Sbjct: 128  YVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTI 187

Query: 970  --ELAGTIGYVAPELAYTMKVTEKSDVYSFGVL 1000
              ++ GT  Y+APE    +  +E +D+Y+ GV+
Sbjct: 188  PGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220

Length = 932

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 63.4 bits (154), Expect = 2e-10
 Identities = 50/205 (24%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 812  HCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
              +G+G  GSV  A +  +GE VA+KK   P  SE+  ++ +  E+  L  ++H N++  
Sbjct: 21   KQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAY-RELTLLKHMQHENVIGL 79

Query: 871  YG-FCS----HARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
               F S         F +V  Y++   L  I+ +  S +++ +     ++  +   L Y+
Sbjct: 80   LDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQY-----LVYQMLCGLKYI 133

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+  
Sbjct: 134  HS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVIL 187

Query: 985  T-MKVTEKSDVYSFGVLALEAIKGK 1008
              M   +  D++S G +  E + GK
Sbjct: 188  NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 62.9 bits (153), Expect = 2e-10
 Identities = 48/141 (34%), Positives = 64/141 (45%), Gaps = 10/141 (7%)

Query: 873  FCSHA--RHSFIVYEYLEMGSLAM-ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            FC+     H F V EYL  G L   I S+    E         +I G    L +LH    
Sbjct: 62   FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICG----LQFLHKK-- 115

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
              I+YRD+   NVLLD +    ++DFG+ K         +   GT  Y+APE+    K  
Sbjct: 116  -GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYN 174

Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
            E  D +SFGVL  E + G+ P
Sbjct: 175  ESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 63.3 bits (154), Expect = 2e-10
 Identities = 60/242 (24%), Positives = 108/242 (44%), Gaps = 36/242 (14%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            TN + +   +G G  G V  A +  +G+ VA+KK   P  + +  ++ +  E+K L  +R
Sbjct: 9    TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67

Query: 864  HRNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H NI+     F S     + V E L    L  +L++    ++        +++G    L 
Sbjct: 68   HENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRG----LK 122

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y+H+     +V+RD+   N+L++   +  + DFG++   +      T    T  Y APE+
Sbjct: 123  YVHS---AGVVHRDLKPSNILINENCDLKICDFGLA---RIQDPQMTGYVSTRYYRAPEI 176

Query: 983  AYT-MKVTEKSDVYSFGVLALEAIKGK-------H--------------PRDFISSICST 1020
              T  K   + D++S G +  E ++GK       H              P D I++ICS 
Sbjct: 177  MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236

Query: 1021 SS 1022
            ++
Sbjct: 237  NT 238

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.8 bits (152), Expect = 3e-10
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 815  GTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGF 873
            GT G+  + R E +SG+  A+K     ++         L E + L   RH  +    Y F
Sbjct: 6    GTFGKVILVR-EKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF 64

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADALSYLHNDCFPP 931
             +  R  F++ EY+  G L   LS      E  +++      G  +  AL YLH+     
Sbjct: 65   QTKDRLCFVM-EYVNGGELFFHLS-----RERVFSEDRTRFYGAEIVSALDYLHSG---K 115

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            IVYRD+  +N++LD +    ++DFG+ K    D++      GT  Y+APE+         
Sbjct: 116  IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 992  SDVYSFGVLALEAIKGKHP 1010
             D +  GV+  E + G+ P
Sbjct: 176  VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 12/207 (5%)

Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F     +G GG G V   ++ ++G++ A KK     + +   +   LNE + L ++  R 
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 867  IVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADALSY 923
            +V    +    + +  +V   +  G L   + N  +    G+ ++  +     +   L  
Sbjct: 62   VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLED 117

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            L  +    IVYRD+  +N+LLD      +SD G++  + P+        GT+GY+APE+ 
Sbjct: 118  LQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRVGTVGYMAPEVI 173

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               K T   D +  G L  E I+G+ P
Sbjct: 174  NNEKYTFSPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 62.4 bits (152), Expect = 3e-10
 Identities = 54/212 (25%), Positives = 83/212 (39%), Gaps = 34/212 (16%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLL---SEMTCQQEFLNEVKSL-TEIRHRNIV 868
            +G G  G V  AEL  + E+ AVK     ++    ++ C      E + L    +H  + 
Sbjct: 3    LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTM---TEKRVLALAGKHPFLT 59

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMIL--------SNAT--SAEELGWTQRMNVIKGVA 918
            + +         F V EY+  G L   +          A   +AE             + 
Sbjct: 60   QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE-------------IV 106

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
              L +LH      I+YRD+   NVLLD E    ++DFG+ K         +   GT  Y+
Sbjct: 107  LGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYI 163

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            APE+          D ++ GVL  E + G+ P
Sbjct: 164  APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 62.4 bits (152), Expect = 4e-10
 Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 26/265 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             DF     +G GG G V+ A+   +GEIVA+K+    LL ++   +  L E   LT  + 
Sbjct: 1    KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60

Query: 865  RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
              +VK  Y F     + ++  EY+  G    +L+N     E     R  + +    A+  
Sbjct: 61   EWLVKLLYAF-QDDEYLYLAMEYVPGGDFRTLLNNLGVLSED--HARFYMAEMFE-AVDA 116

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA----GTIGYVA 979
            LH       ++RD+  +N L+D      ++DFG+SK            A    G+  Y+A
Sbjct: 117  LHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMA 166

Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-PRLPA 1038
            PE+          D +S G +  E + G  P    S+   T  NL +   E L  P    
Sbjct: 167  PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWENL-KYWKETLQRPVYDD 224

Query: 1039 PSCNIRDKLISIMEVAISCLDENPD 1063
            P  N+ D+   ++      +++   
Sbjct: 225  PRFNLSDEAWDLIT---KLINDPSR 246

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 61.6 bits (150), Expect = 5e-10
 Identities = 78/289 (26%), Positives = 116/289 (40%), Gaps = 49/289 (16%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR- 863
            ND +    IG+G  G VY+     +G ++AVK+         T  +E    +  L ++  
Sbjct: 15   NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR------RTGNKEENKRI--LMDLDV 66

Query: 864  ----HR--NIVKFYGFCSHARHSFIVYEYLEM--GSLAMILSNATSAEELGWTQRMNVIK 915
                H    IVK YG+       FI  E +      L   +      + LG   +M V  
Sbjct: 67   VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILG---KMTV-- 121

Query: 916  GVADALSYL---HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
             +  AL YL   H      +++RD+   N+LLD      + DFGIS  L  DS   T  A
Sbjct: 122  AIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV-DSKAKTRSA 175

Query: 973  GTIGYVAPELAYTMKVTEK----SDVYSFGVLALEAIKGKHPRDFISSICSTS-SNLDRT 1027
            G   Y+APE         K    +DV+S G+  +E   G+ P       C T    L + 
Sbjct: 176  GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK----NCKTEFEVLTKI 231

Query: 1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            L E  +P    P+        S ++    CL ++   RP   K  +LL+
Sbjct: 232  LQE--EPPSLPPNEGFSPDFCSFVD---LCLTKDHRKRP---KYRELLQ 272

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFH-SPLLSEMTCQQEFLN-EVKSLTEIRHRNIVKF 870
            +G G  G VY   +  +G  +AVK+    P   E + +   L  E++ L  + H  IV++
Sbjct: 10   LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 871  YGFC--SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            YG       R   I  E++  GS+   L +  +  E   T++    + + + +SYLH++ 
Sbjct: 70   YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTE-NVTRKYT--RQILEGVSYLHSNM 126

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP---DSSNWTELAGTIGYVAPELAYT 985
               IV+RDI   N+L D      + DFG SK L+      +    + GT  +++PE+   
Sbjct: 127  ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
                 K+D++S G   +E +  K P
Sbjct: 184  EGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 30/225 (13%)

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHS--------FIVYEYLEMGSLAMILSNATSAEELG 906
            E + L++++H NIV +       R S        +IV  + E G L   L      + L 
Sbjct: 49   EAQLLSQLKHPNIVAY-------RESWEGEDGLLYIVMGFCEGGDLYHKLKE-QKGKLLP 100

Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
              Q +     +A AL YLH      I++RD+ ++NV L       V D GI++ L+    
Sbjct: 101  ENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157

Query: 967  NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
              + L GT  Y++PEL        KSDV++ G    E    KH  +        + +++ 
Sbjct: 158  MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN--------AKDMNS 209

Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             +  I++ +LP      +D    + E+  + L + P+ RP+++ +
Sbjct: 210  LVYRIIEGKLPPMP---KDYSPELGELIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 60.8 bits (147), Expect = 7e-10
 Identities = 65/271 (23%), Positives = 122/271 (45%), Gaps = 37/271 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGE----IVAVKKFHSPLLSEMT---CQQEFLNEVKSLTEIRHR 865
            +G+G  G+VY+   +  GE     VA+K     +L E T     +E L+E   +  +   
Sbjct: 15   LGSGAFGTVYKGIWIPDGENVKIPVAIK-----VLRENTSPKANKEILDEAYVMAGVGSP 69

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
             + +  G C  +    +V + +  G L   +    + + +G    +N    +A  +SYL 
Sbjct: 70   YVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRE--NKDRIGSQDLLNWCVQIAKGMSYLE 126

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELA 983
                  +V+RD++++NVL+       ++DFG+++ L  D + +    G   I ++A E  
Sbjct: 127  E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS 1040
               + T +SDV+S+GV   E +  G  P D I +         R + ++L+   RLP P 
Sbjct: 184  LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGERLPQP- 233

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                  +  IM   + C   + + RP  +++
Sbjct: 234  PICTIDVYMIM---VKCWMIDSECRPRFREL 261

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 48/194 (24%), Positives = 92/194 (47%), Gaps = 8/194 (4%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H NIVK   
Sbjct: 8    IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V+E+L    L   + +A+    +      + +  +   L++ H+     +
Sbjct: 67   VIHTENKLYLVFEFLHQ-DLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RV 121

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV-TEK 991
            ++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+    K  +  
Sbjct: 122  LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 181

Query: 992  SDVYSFGVLALEAI 1005
             D++S G +  E +
Sbjct: 182  VDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 9/205 (4%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N F+    +G G  G V +     + EIVA+KKF     +E   ++  L E+K L  ++ 
Sbjct: 1    NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENE-EVKETTLRELKMLRTLKQ 59

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NIV+           ++V+EY+E   L ++             +  + I  +  A+ + 
Sbjct: 60   ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWC 116

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS-SNWTELAGTIGYVAPELA 983
            H +    IV+RDI  +N+L+       + DFG +++L   S +N+TE   T  Y +PEL 
Sbjct: 117  HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGK 1008
                  +  D++S G +  E   G+
Sbjct: 174  LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.6 bits (147), Expect = 8e-10
 Identities = 57/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-Y 871
            +G GG G V   ++ ++G++ A KK +   L +    +  + E + L ++  R IV   Y
Sbjct: 1    LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI--KGVADALSYLHNDCF 929
             F +      +V   +  G L   + N    E  G+ +         +   L +LH    
Sbjct: 61   AFQTKTDLC-LVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AYT 985
              I+YRD+  +NVLLD +    +SD G++  LK   S     AGT G++APEL     Y 
Sbjct: 117  -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V    D ++ GV   E I  + P
Sbjct: 176  FSV----DYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 60.2 bits (146), Expect = 9e-10
 Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 24/205 (11%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR-----NI 867
            I  G  GSVY A+  S+G+  A+K       S+M  + +  N VK+   I         +
Sbjct: 4    ISKGAFGSVYLAKKRSTGDYFAIKVLKK---SDMIAKNQVTN-VKAERAIMMIQGESPYV 59

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             K Y       + ++V EYL  G  A ++       E  W +    I  V   +  LH  
Sbjct: 60   AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPE-DWAK--QYIAEVVLGVEDLHQR 116

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS--LKPDSSNWTELAGTIGYVAPELAYT 985
                I++RDI  +N+L+D      ++DFG+S++              GT  Y+APE    
Sbjct: 117  ---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK------FVGTPDYLAPETILG 167

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
            +   + SD +S G +  E + G  P
Sbjct: 168  VGDDKMSDWWSLGCVIFEFLFGYPP 192

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 60.9 bits (148), Expect = 9e-10
 Identities = 54/196 (27%), Positives = 94/196 (47%), Gaps = 27/196 (13%)

Query: 803 RATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF----LNEVK 857
           R  + FD    IG G  G VY+A +  +GE+VA+KK    L +E   ++ F    + E+K
Sbjct: 4   RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVR--LDNE---KEGFPITAIREIK 58

Query: 858 SLTEIRHRNIVKFY----------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
            L ++ HRNIV              F       ++V+EY++   + ++ S      E   
Sbjct: 59  ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE--- 115

Query: 908 TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
               + +K + + L+Y H   F   ++RDI   N+LL+ + +  ++DFG+++    + S 
Sbjct: 116 DHIKSFMKQLLEGLNYCHKKNF---LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 968 -WTELAGTIGYVAPEL 982
            +T    T+ Y  PEL
Sbjct: 173 PYTNKVITLWYRPPEL 188

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.1 bits (148), Expect = 9e-10
 Identities = 74/298 (24%), Positives = 125/298 (41%), Gaps = 59/298 (19%)

Query: 814  IGTGGQGSVYRAELSSGE--------IVAVK--------KFHSPLLSEMTCQQEFLNEVK 857
            +G G  G V RAE    +         VAVK        K  + L+SEM        E+ 
Sbjct: 20   LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM--------ELM 71

Query: 858  SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-------------NATSAEE 904
             L   +H+NI+   G C+     +++ EY   G+L   L                   E+
Sbjct: 72   KLIG-KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130

Query: 905  LGWTQRMNVIKGVADALSYLHND-CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
            L +   ++    VA  + YL +  C    ++RD++++NVL+  +    ++DFG+++ +  
Sbjct: 131  LSFKDLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVH- 185

Query: 964  DSSNWTELAG---TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
            D   + + +     + ++APE  +    T +SDV+SFG+L  E    G  P   I     
Sbjct: 186  DIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---- 241

Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077
                L + L E    R+  PS N   +L  +M     C    P  RPT +++ + L  
Sbjct: 242  -VEELFKLLRE--GHRMDKPS-NCTHELYMLMR---ECWHAVPTQRPTFKQLVEALDK 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.5 bits (147), Expect = 1e-09
 Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 55/287 (19%)

Query: 812  HCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI 862
              +G G  G V +AE    +       VAVK      L +   +++    ++E++ +  I
Sbjct: 18   KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKM-----LKDDATEKDLSDLVSEMEMMKMI 72

Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------------SNATSAEELGWT 908
             +H+NI+   G C+     ++V EY   G+L   L                   E L   
Sbjct: 73   GKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK 132

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              ++    VA  + +L +      ++RD++++NVL+  ++   ++DFG+++ +       
Sbjct: 133  DLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYR 189

Query: 969  TELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLD 1025
                G   + ++APE  +    T +SDV+SFGVL  E    G  P   I           
Sbjct: 190  KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP---------- 239

Query: 1026 RTLDEILD-----PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067
              ++E+        R+  P  N   +L  +M     C  E P  RPT
Sbjct: 240  --VEELFKLLKEGYRMEKPQ-NCTQELYHLM---RDCWHEVPSQRPT 280

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 61.1 bits (148), Expect = 1e-09
 Identities = 58/209 (27%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLL---SEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V  AEL   GE  AVK     ++    ++ C         ++ E R   +  
Sbjct: 3    LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVEC---------TMVEKRVLALAW 53

Query: 870  FYGFCSH-------ARHSFIVYEYLEMGSLAMILSNATSAEELGWT-QRMNVIKGVADAL 921
               F +H         H F V E+L  G L   + +    +    T     ++ G    L
Sbjct: 54   ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCG----L 109

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             +LH+     I+YRD+   NV+LD +    ++DFG+ K      +  +   GT  Y+APE
Sbjct: 110  QFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPE 166

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +   +K T   D +SFGVL  E + G+ P
Sbjct: 167  ILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 20/208 (9%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKF-HSPLLSEMTCQQEFLN-EVKSLTEIRHRNIVKF 870
            +G G  G VY   +  +G  +AVK+    P   E + +   L  E++ L  +RH  IV++
Sbjct: 10   LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 871  YGFC---SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADALSYLH 925
            YG C      +   I  EY+  GS+   L  A  A     T+R    +++GV    SYLH
Sbjct: 70   YG-CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGV----SYLH 123

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPEL 982
            ++    IV+RDI   N+L D      + DFG SK ++    + T    + GT  +++PE+
Sbjct: 124  SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                    K+DV+S     +E +  K P
Sbjct: 181  ISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 1e-09
 Identities = 61/246 (24%), Positives = 107/246 (43%), Gaps = 32/246 (13%)

Query: 768  RRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL 827
            +++ S  T++    N            K+ YE       DF+    +GTG  G V  A  
Sbjct: 11   KKKDSDSTKEPKRKN------------KMKYE-------DFNFIRTLGTGSFGRVILATY 51

Query: 828  SSGEI--VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE 885
             + +   VA+K+F    + +        +E K L  I H   V  YG      + ++V E
Sbjct: 52   KNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111

Query: 886  YLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL 944
            ++  G     L  N     ++G      ++  + + L  L+      IVYRD+  +N+LL
Sbjct: 112  FVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IFEYLQSLN------IVYRDLKPENLLL 164

Query: 945  DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEA 1004
            D +    ++DFG +K +  D+  +T L GT  Y+APE+   +   + +D ++ G+   E 
Sbjct: 165  DKDGFIKMTDFGFAKVV--DTRTYT-LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEI 221

Query: 1005 IKGKHP 1010
            + G  P
Sbjct: 222  LVGCPP 227

Length = 340

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 60.8 bits (147), Expect = 1e-09
 Identities = 57/199 (28%), Positives = 87/199 (43%), Gaps = 13/199 (6%)

Query: 815  GTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGF 873
            GT G+  + R E ++G   A+K     ++         + E + L   RH  +    Y F
Sbjct: 6    GTFGKVILVR-EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64

Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADALSYLHNDCFPP 931
             +H R  F V EY   G L   LS      E  +T+      G  +  AL YLH+     
Sbjct: 65   QTHDRLCF-VMEYANGGELFFHLS-----RERVFTEERARFYGAEIVSALEYLHSR---D 115

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE+         
Sbjct: 116  VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 175

Query: 992  SDVYSFGVLALEAIKGKHP 1010
             D +  GV+  E + G+ P
Sbjct: 176  VDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 60.1 bits (146), Expect = 1e-09
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 53/284 (18%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIRHRNIVKFY 871
            +G G  G V +   + +G I+AVK+  + + S    Q+  L ++  S+  +     V FY
Sbjct: 9    LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 872  GFCSHARHSFIVYEYLEMGSL-----AMILSNATSAEE-LGWTQRMNVIKGVADALSYLH 925
            G        +I  E ++  SL      +     T  E+ LG   ++ V   +  AL YLH
Sbjct: 67   GALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILG---KIAV--SIVKALEYLH 120

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL--- 982
            +     +++RD+   NVL++   +  + DFGIS  L  DS   T  AG   Y+APE    
Sbjct: 121  SKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV-DSVAKTIDAGCKPYMAPERINP 177

Query: 983  -----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---P 1034
                  Y +    KSDV+S G+  +E   G+ P D       +     + L ++++   P
Sbjct: 178  ELNQKGYDV----KSDVWSLGITMIELATGRFPYD-------SWKTPFQQLKQVVEEPSP 226

Query: 1035 RLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +LPA   S   +D  ++       CL +N   RP      +LL+
Sbjct: 227  QLPAEKFSPEFQD-FVN------KCLKKNYKERP---NYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 52/215 (24%), Positives = 101/215 (46%), Gaps = 43/215 (20%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQE-------FLNEVKSLTEIRHR 865
            IG G  G VY+A +  + E +A+KK        +  +QE        + E+  L E++H 
Sbjct: 10   IGEGTYGVVYKARDRVTNETIALKK--------IRLEQEDEGVPSTAIREISLLKEMQHG 61

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM------NVIKGVAD 919
            NIV+        +  ++V+EYL++     +  +  S+ +     R+       +++G+A 
Sbjct: 62   NIVRLQDVVHSEKRLYLVFEYLDLD----LKKHMDSSPDFAKNPRLIKTYLYQILRGIA- 116

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
               Y H+     +++RD+  +N+L+D    A  ++DFG++++       +T    T+ Y 
Sbjct: 117  ---YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYR 170

Query: 979  APEL-----AYTMKVTEKSDVYSFGVLALEAIKGK 1008
            APE+      Y+  V    D++S G +  E +  K
Sbjct: 171  APEILLGSRHYSTPV----DIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 59.6 bits (144), Expect = 2e-09
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 11/222 (4%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-Y 871
            +G GG G V   ++ ++G++ A KK     L + + ++  L E + L ++    IV   Y
Sbjct: 1    LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
             F S   H  +V   +  G L   + N      L   + ++    +   + +LH+     
Sbjct: 61   AFESKT-HLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MD 115

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            IVYRD+  +NVLLD +    +SD G++  L  D    T+ AGT GY+APE+      +  
Sbjct: 116  IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 992  SDVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTL-DEI 1031
             D ++ G    E + G+ P +D    + +      RTL DE+
Sbjct: 175  VDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTLEDEV 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 60.0 bits (145), Expect = 2e-09
 Identities = 55/200 (27%), Positives = 85/200 (42%), Gaps = 10/200 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-Y 871
            +G G  G V    E ++G   A+K     ++         L E + L   RH  +    Y
Sbjct: 3    LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALSYLHNDCFP 930
             F +H R  F++ EY   G L   LS      E     R       +  AL YLH++   
Sbjct: 63   SFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALDYLHSE--K 115

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             +VYRD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+        
Sbjct: 116  NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGR 175

Query: 991  KSDVYSFGVLALEAIKGKHP 1010
              D +  GV+  E + G+ P
Sbjct: 176  AVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 56/219 (25%), Positives = 92/219 (42%), Gaps = 36/219 (16%)

Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F     +G GG G V   ++ ++G++ A KK     + +   +   LNE + L ++  R 
Sbjct: 2    FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILS---------------NATSAEELGWTQRM 911
            +V             + Y Y    +L ++L+               N    EE       
Sbjct: 62   VVS------------LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
             +  G+ D    LH +    IVYRD+  +N+LLD      +SD G++  + P+       
Sbjct: 110  EITCGLED----LHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGR 161

Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             GT+GY+APE+    + T   D +  G L  E I+GK P
Sbjct: 162  VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 2e-09
 Identities = 66/247 (26%), Positives = 110/247 (44%), Gaps = 51/247 (20%)

Query: 814  IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH----R 865
            +G GG G V++        +G+I A+K     +L + T        V++  +  H    R
Sbjct: 4    LGKGGYGKVFQVRKVTGADTGKIFAMK-----VLKKATI-------VRNQKDTAHTKAER 51

Query: 866  NIVKFYGFCSHARHSFIV---YEYLEMGSLAMILSNATSAEELGWTQRMNV--------- 913
            NI++        +H FIV   Y +   G L +IL   +  E     +R  +         
Sbjct: 52   NILE------AVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY 105

Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK-SLKPDSSNWTELA 972
            +  ++ AL +LH      I+YRD+  +N+LLD +    ++DFG+ K S+   +   T   
Sbjct: 106  LSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FC 161

Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032
            GTI Y+APE+       +  D +S G L  + + G  P         T+ N  +T+D+IL
Sbjct: 162  GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP--------FTAENRKKTIDKIL 213

Query: 1033 DPRLPAP 1039
              +L  P
Sbjct: 214  KGKLNLP 220

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 63/287 (21%), Positives = 120/287 (41%), Gaps = 41/287 (14%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E   G   +G +Y   +   ++VA+K      ++      EF  E   + E+ H NIV  
Sbjct: 15   ECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMIL--------------SNATSAEELGWTQRMNVIKG 916
             G  +  +   +++EYL  G L   L               + T    L     +++   
Sbjct: 73   LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT-- 974
            +A  + YL +  F   V++D++++N+L+  +    +SD G+S+ +   S+++  +     
Sbjct: 133  IAAGMEYLSSHFF---VHKDLAARNILIGEQLHVKISDLGLSREIY--SADYYRVQPKSL 187

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031
              I ++ PE     K +  SD++SFGV+  E    G  P    S         ++ + E+
Sbjct: 188  LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS---------NQEVIEM 238

Query: 1032 LDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +  R  LP    +   ++ S+M     C  E P  RP  + +   L+
Sbjct: 239  VRKRQLLPCSE-DCPPRMYSLM---TECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 68/303 (22%), Positives = 134/303 (44%), Gaps = 48/303 (15%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL---SSGE---IVAVKKFHSPLLSEMTCQQEFL 853
            EI  +T  F EE  +G    G VY+  L   + GE    VA+K       +E   ++EF 
Sbjct: 1    EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFK 56

Query: 854  NEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--- 910
            +E    + ++H NIV   G  +  +   +++ Y     L   L   +   ++G T     
Sbjct: 57   HEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 911  ----------MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS 960
                      ++++  +A  + +L +     +V++D++++NVL+  +    +SD G+ + 
Sbjct: 117  VKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFRE 173

Query: 961  LKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFIS 1015
            +   ++++ +L G     I +++PE     K +  SD++S+GV+  E    G  P     
Sbjct: 174  VY--AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----- 226

Query: 1016 SICSTSSNLDRTLDEILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              C  S   ++ + E++  R  LP P     D    +  + + C +E P  RP  + +  
Sbjct: 227  -YCGYS---NQDVIEMIRNRQVLPCPD----DCPAWVYTLMLECWNEFPSRRPRFKDIHS 278

Query: 1074 LLK 1076
             L+
Sbjct: 279  RLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 58.8 bits (142), Expect = 3e-09
 Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 41/284 (14%)

Query: 814  IGTGGQGSVYRAELSSG---EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG G  G V   E++SG     V VK+      + +  Q +FL E +    ++H N+++ 
Sbjct: 3    IGNGWFGKVILGEVNSGYTPAQVVVKELRVS--ASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
             G C+      +V E+  +G L   L +   AE    +    QRM     +A  L +LH 
Sbjct: 61   LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMAC--EIALGLLHLHK 118

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-------LKPDSSNWTELAGTIGYVA 979
            + F   ++ D++ +N LL  +    + D+G+S +       + PD     +L   + ++A
Sbjct: 119  NNF---IHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPD-----QLWVPLRWIA 170

Query: 980  PELA-------YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031
            PEL          +  T++S+V+S GV   E  + G  P   +S     +  +     ++
Sbjct: 171  PELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230

Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              PRL  P   + D+   +M+    C  + P+ RP+ ++V  LL
Sbjct: 231  PKPRLKLP---LSDRWYEVMQ---FCWLQ-PEQRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 59.6 bits (145), Expect = 3e-09
 Identities = 74/304 (24%), Positives = 128/304 (42%), Gaps = 65/304 (21%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKK----FHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
             IG+G  G V  A +  SG+ VA+KK    F  P L++ T     L E+K L   +H NI
Sbjct: 12   NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRT-----LRELKILRHFKHDNI 66

Query: 868  VK----FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            +          +  +  ++V + +E     +I S+    EE        +++G    L Y
Sbjct: 67   IAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG----LKY 122

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPD--SSNWTELAGTIGYVA 979
            +H+     +++RD+   N+L++ + E  + DFG+++ L   P       TE   T  Y A
Sbjct: 123  IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 980  PELAYTM-KVTEKSDVYSFGVLALEAI------KGKH---------------PRDFISSI 1017
            PEL  ++ + T   D++S G +  E +       GK+                 + ++ I
Sbjct: 180  PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI 239

Query: 1018 CSTSSNLDRTLDEILDPRLPAP--------SCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069
                S+  R   + L  + P P        S    D L+S M      L  +P+ R T++
Sbjct: 240  ---GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALD-LLSQM------LQFDPEERITVE 289

Query: 1070 KVSQ 1073
            +  Q
Sbjct: 290  QALQ 293

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 73/283 (25%), Positives = 123/283 (43%), Gaps = 47/283 (16%)

Query: 814  IGTGGQGSVYRAELSSG--EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKF 870
            IG G  G V +A +      + A  K      S+    ++F  E++ L ++  H NI+  
Sbjct: 3    IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD-HRDFAGELEVLCKLGHHPNIINL 61

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNAT-------------SAEELGWTQRMNVIKGV 917
             G C H  + ++  EY   G+L   L  +              +A  L   Q ++    V
Sbjct: 62   LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG- 976
            A  + YL    F   ++RD++++N+L+   Y A ++DFG+S+  +        +  T+G 
Sbjct: 122  ARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE------VYVKKTMGR 172

Query: 977  ----YVAPE-LAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS-TSSNLDRTLD 1029
                ++A E L Y++  T  SDV+S+GVL  E +  G  P       C  T + L   L 
Sbjct: 173  LPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP------YCGMTCAELYEKLP 225

Query: 1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            +    RL  P  N  D++  +M     C  E P  RP+  ++ 
Sbjct: 226  Q--GYRLEKPL-NCDDEVYDLMR---QCWREKPYERPSFAQIL 262

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 59/253 (23%), Positives = 108/253 (42%), Gaps = 43/253 (16%)

Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 64   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 118

Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                         E++ +   ++    VA  + YL +      ++RD++++NVL+     
Sbjct: 119  GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNV 175

Query: 950  AHVSDFGISKSLKPDSSNWTELAGT------IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
              ++DFG+++    D +N      T      + ++APE  +    T +SDV+SFGVL  E
Sbjct: 176  MKIADFGLAR----DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 231

Query: 1004 AIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENP 1062
                G  P   I         L + L E    R+  P+ N  ++L  +M     C    P
Sbjct: 232  IFTLGGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAIP 280

Query: 1063 DSRPTMQKVSQLL 1075
              RPT +++ + L
Sbjct: 281  SHRPTFKQLVEDL 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 3e-09
 Identities = 66/255 (25%), Positives = 105/255 (41%), Gaps = 45/255 (17%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +     IG G  G V  A    +G  VA+KK  SP   +  CQ+  L E+K L   +H 
Sbjct: 6    RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI-SPFEHQTFCQRT-LREIKILRRFKHE 63

Query: 866  NIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN------V 913
            NI+          F S     +IV E +E           T   +L  TQ ++       
Sbjct: 64   NIIGILDIIRPPSFESF-NDVYIVQELME-----------TDLYKLIKTQHLSNDHIQYF 111

Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTE 970
            +  +   L Y+H+     +++RD+   N+LL+   +  + DFG+++   P+  +    TE
Sbjct: 112  LYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTE 168

Query: 971  LAGTIGYVAPELAYTMKVTEKS-DVYSFGVLALEAIK------GKHPRD---FISSICST 1020
               T  Y APE+    K   K+ D++S G +  E +       GK        I  +  T
Sbjct: 169  YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228

Query: 1021 SSNLDRTLDEILDPR 1035
             S  D  L+ I+  R
Sbjct: 229  PSQED--LNCIISLR 241

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 59.5 bits (145), Expect = 3e-09
 Identities = 59/234 (25%), Positives = 99/234 (42%), Gaps = 46/234 (19%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  G V  A    +G  VA+KK  +     +  ++  L E+K L  +RH NI+    
Sbjct: 8    IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKR-ILREIKLLRHLRHENIIGLLD 66

Query: 873  -FCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRM-----NVIKGVADALS 922
                 +   F    IV E +E   L  ++    S + L     +      +++G    L 
Sbjct: 67   ILRPPSPEDFNDVYIVTELMET-DLHKVIK---SPQPLT-DDHIQYFLYQILRG----LK 117

Query: 923  YLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS---NWTELAGTIGY 977
            YLH  N     +++RD+   N+L++   +  + DFG+++ + PD       TE   T  Y
Sbjct: 118  YLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWY 172

Query: 978  VAPEL-----AYTMKVTEKSDVYSFGVLALEAI------KGKHPRDFISSICST 1020
             APEL      YT  +    D++S G +  E +       G+   D ++ I   
Sbjct: 173  RAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.8 bits (142), Expect = 4e-09
 Identities = 49/194 (25%), Positives = 91/194 (46%), Gaps = 27/194 (13%)

Query: 832  IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS 891
            +VAVK       +    + +FL EVK L+ ++  NI++  G C       ++ EY+E G 
Sbjct: 48   LVAVKILRPD--ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 892  LAMILSN-------ATSAEELG---------WTQRMNVIKGVADALSYLHNDCFPPIVYR 935
            L   LS+           + +          ++  ++V   +A  + YL +  F   V+R
Sbjct: 106  LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF---VHR 162

Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG----TIGYVAPELAYTMKVTEK 991
            D++++N L+       ++DFG+S++L   + ++  + G     I ++A E     K T  
Sbjct: 163  DLATRNCLVGENLTIKIADFGMSRNLY--AGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220

Query: 992  SDVYSFGVLALEAI 1005
            SDV++FGV   E +
Sbjct: 221  SDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.4 bits (141), Expect = 5e-09
 Identities = 71/279 (25%), Positives = 119/279 (42%), Gaps = 31/279 (11%)

Query: 814  IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  GSV  A+L     S + VAVK   + + S  +  +EFL E   + E  H N++K
Sbjct: 7    LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSS-SDIEEFLREAACMKEFDHPNVIK 65

Query: 870  FYGFCSHARHS------FIVYEYLEMGSLAMILSNATSAEE---LGWTQRMNVIKGVADA 920
              G    +R         ++  +++ G L   L  +   EE   L     +  +  +A  
Sbjct: 66   LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYV 978
            + YL +  F   ++RD++++N +L+      V+DFG+SK +          A    + ++
Sbjct: 126  MEYLSSKNF---IHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 979  APELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            A E       T  SDV++FGV   E   +G+ P   +      +S +   L  I   RL 
Sbjct: 183  ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSEIYNYL--IKGNRLK 235

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P     D L  + E+   C    P  RP+ Q +   L+
Sbjct: 236  QPP----DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 5e-09
 Identities = 38/130 (29%), Positives = 60/130 (46%), Gaps = 6/130 (4%)

Query: 881  FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSK 940
            F V EY+  G L   +  +   +E    +       V  AL +LH      ++YRD+   
Sbjct: 72   FFVMEYVNGGDLMFQIQRSRKFDE---PRSRFYAAEVTLALMFLHRH---GVIYRDLKLD 125

Query: 941  NVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVL 1000
            N+LLD E    ++DFG+ K    +    T   GT  Y+APE+   ++     D ++ GVL
Sbjct: 126  NILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVL 185

Query: 1001 ALEAIKGKHP 1010
              E + G+ P
Sbjct: 186  MYEMMAGQPP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 58.5 bits (142), Expect = 6e-09
 Identities = 51/187 (27%), Positives = 91/187 (48%), Gaps = 30/187 (16%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQE-F----LNEVKSLTEIRHRNI 867
           IG G  G V++A    + +IVA+KK        M  ++E F    L E+K L  ++H N+
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKV------LMENEKEGFPITALREIKILQLLKHENV 73

Query: 868 VKFYGFC-------SHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
           V     C       +  + SF +V+E+ E   LA +LSN      L   +++  +K + +
Sbjct: 74  VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV--MKMLLN 130

Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL----KPDSSNWTELAGTI 975
            L Y+H      I++RD+ + N+L+  +    ++DFG++++         + +T    T+
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187

Query: 976 GYVAPEL 982
            Y  PEL
Sbjct: 188 WYRPPEL 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.3 bits (138), Expect = 9e-09
 Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 41/229 (17%)

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            F      + ++ H++IV  YG C     + +V E++E G L + +   +      W  + 
Sbjct: 51   FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KF 108

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLL-----DLEYEAHV--SDFGISKSLKPD 964
             V K +A ALSYL +     +V+ ++ +KN+LL     D E    +  SD GI  ++   
Sbjct: 109  KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR 165

Query: 965  SSNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSS 1022
                 E    I ++APE     K  +  +D +SFG    E    G+ P            
Sbjct: 166  Q----ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK---------- 211

Query: 1023 NLDRTLDE-----ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
              D+TL E          L  PSC    +L  +M     C++ +P+ RP
Sbjct: 212  --DKTLAEKERFYEGQCMLVTPSC---KELADLMT---HCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 57.7 bits (140), Expect = 9e-09
 Identities = 62/307 (20%), Positives = 113/307 (36%), Gaps = 66/307 (21%)

Query: 813  CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            C        + + +  +  +VAVKK +    S     +    E+ +  +++H NI+ +  
Sbjct: 9    CFEDLMIVHLAKHK-PTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V   +  GS   +L      E L       ++K V +AL Y+H+  F   
Sbjct: 67   SFIVDSELYVVSPLMAYGSCEDLLKT-HFPEGLPELAIAFILKDVLNALDYIHSKGF--- 122

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL------------KPDSS----NWTELAGTIG 976
            ++R + + ++LL  + +  +S    S S+             P SS     W        
Sbjct: 123  IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL------- 175

Query: 977  YVAPELAYT--MKVTEKSDVYSFGVLA-------------------LEAIKG--KHPRDF 1013
              +PE+         EKSD+YS G+ A                   LE ++G      D 
Sbjct: 176  --SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLD- 232

Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS-----IMEVAISCLDENPDSRPTM 1068
             S+      ++ ++      P       +   +  S      +E+   CL  +P+SRP+ 
Sbjct: 233  KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL---CLQRDPESRPS- 288

Query: 1069 QKVSQLL 1075
               SQLL
Sbjct: 289  --ASQLL 293

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.5 bits (139), Expect = 1e-08
 Identities = 33/97 (34%), Positives = 52/97 (53%), Gaps = 5/97 (5%)

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK-SLKPDSSNWTELAGTI 975
            +A  L +LH+     I+YRD+   NV+LD E    ++DFG+ K ++    +  T   GT 
Sbjct: 110  IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-FCGTP 165

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
             Y+APE+       +  D ++FGVL  E + G+ P D
Sbjct: 166  DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 57.9 bits (140), Expect = 1e-08
 Identities = 57/206 (27%), Positives = 99/206 (48%), Gaps = 19/206 (9%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-Y 871
            IG G  G V  A +  +GE VA+KK +  +   ++     L E+K L  +RH +IV+  +
Sbjct: 8    IGKGSYGVVCSAIDTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLRHPDIVEIKH 66

Query: 872  GFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                 +R  F    +V+E +E     +I +N    ++L        +  +  AL Y+H  
Sbjct: 67   IMLPPSRREFKDIYVVFELMESDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHT- 121

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPEL-- 982
                + +RD+  KN+L + + +  + DFG+++    D+     WT+   T  Y APEL  
Sbjct: 122  --ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGK 1008
            ++  K T   D++S G +  E + GK
Sbjct: 180  SFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 10/200 (5%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +G G  G V  A L  SG + AVK     ++ +    +  + E + L+  R H  + + Y
Sbjct: 3    LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALSYLHNDCFP 930
                     F V E++  G L   +  +   +E     R       +  AL +LH+    
Sbjct: 63   CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE----ARARFYAAEITSALMFLHDK--- 115

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             I+YRD+   NVLLD E    ++DFG+ K    +    +   GT  Y+APE+   M    
Sbjct: 116  GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGP 175

Query: 991  KSDVYSFGVLALEAIKGKHP 1010
              D ++ GVL  E + G  P
Sbjct: 176  SVDWWAMGVLLYEMLCGHAP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 40/270 (14%)

Query: 814  IGTGGQGSVYRAEL---SSGEIVAVKKFHSPLL----SEMTCQQEFLNEVKSLTEIRHRN 866
            +G G   ++Y+  L   S  +IV   +  S +L    S+      F      ++++ H++
Sbjct: 3    LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +VK YG C    +  +V EY++ G L + L    +   L W  +++V K +A AL YL +
Sbjct: 63   LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119

Query: 927  DCFPPIVYRDISSKNVLL---DLEYE----AHVSDFGISKSLKPDSSNWTELAGTIGYVA 979
                 +V+ ++  KN+L+    L         +SD GI  ++        E    I ++A
Sbjct: 120  K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE----ERVERIPWIA 172

Query: 980  PELAY--TMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            PE        +T  +D +SFG   LE    G+ P   +SS    S       D+    RL
Sbjct: 173  PECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS----SEKERFYQDQ---HRL 225

Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            P P C     LI+       C   +P  RP
Sbjct: 226  PMPDCAELANLIN------QCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 56.9 bits (137), Expect = 2e-08
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 18/205 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G+VY+A +  SG  VA+K          L   T ++  L  +K L    H NIV
Sbjct: 8    IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL--LKRLEAFDHPNIV 65

Query: 869  KFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            +    C+ +R        +V+E+++   L   L        L      ++++     L +
Sbjct: 66   RLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDF 123

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH +C   IV+RD+  +N+L+    +  ++DFG+++      +  T +  T+ Y APE+ 
Sbjct: 124  LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-LTPVVVTLWYRAPEVL 179

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGK 1008
                     D++S G +  E  + K
Sbjct: 180  LQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 56.7 bits (137), Expect = 2e-08
 Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 53/248 (21%)

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGW--- 907
             L E   L  + H+NI+     C       F++Y Y+  G+L + L      E       
Sbjct: 55   LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114

Query: 908  TQRMNVIKG--VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP-- 963
            + +  V     +A  +SYLH      ++++DI+++N ++D E +  ++D  +S+ L P  
Sbjct: 115  STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Query: 964  -----DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
                 D+ N       + ++A E     + +  SDV+SFGVL  E +             
Sbjct: 172  YHCLGDNEN-----RPVKWMALESLVNKEYSSASDVWSFGVLLWELM------------- 213

Query: 1019 STSSNLDRTLDEILDP-----------RLPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067
                 L +T    +DP           RL  P  N  D+L ++M     C   +P+ RP+
Sbjct: 214  ----TLGQTPYVEIDPFEMAAYLKDGYRLAQPI-NCPDELFAVMAC---CWALDPEERPS 265

Query: 1068 MQKVSQLL 1075
              ++ Q L
Sbjct: 266  FSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 34/94 (36%), Positives = 46/94 (48%), Gaps = 6/94 (6%)

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGTIGYV 978
            AL +LH      I+YRDI  +N+LLD E    ++DFG+SK    +         GTI Y+
Sbjct: 117  ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173

Query: 979  APELAYTMKVTEKS--DVYSFGVLALEAIKGKHP 1010
            APE+            D +S GVL  E + G  P
Sbjct: 174  APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 41/136 (30%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 881  FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSK 940
            F+V EY+  G L   +       E            +  AL++LH      I+YRD+   
Sbjct: 72   FLVIEYVNGGDLMFHMQRQRKLPE---EHARFYAAEICIALNFLHER---GIIYRDLKLD 125

Query: 941  NVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
            NVLLD +    ++D+G+ K  L P  +  T   GT  Y+APE+    +     D ++ GV
Sbjct: 126  NVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPEILRGEEYGFSVDWWALGV 184

Query: 1000 LALEAIKGKHPRDFIS 1015
            L  E + G+ P D I+
Sbjct: 185  LMFEMMAGRSPFDIIT 200

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 56.5 bits (136), Expect = 3e-08
 Identities = 38/132 (28%), Positives = 60/132 (45%), Gaps = 6/132 (4%)

Query: 881  FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSK 940
            + V EY+  G L   +      +E    Q +     ++  L +LH      I+YRD+   
Sbjct: 77   YFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISVGLFFLHRR---GIIYRDLKLD 130

Query: 941  NVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVL 1000
            NV+LD E    ++DFG+ K    D        GT  Y+APE+       +  D +++GVL
Sbjct: 131  NVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 190

Query: 1001 ALEAIKGKHPRD 1012
              E + G+ P D
Sbjct: 191  LYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG 976
            +A  L +LH+     I+YRD+   NV+LD E    ++DFG+ K    D        GT  
Sbjct: 110  IAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPD 166

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
            Y+APE+       +  D ++FGVL  E + G+ P +
Sbjct: 167  YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 56.2 bits (135), Expect = 4e-08
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 25   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 83

Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 84   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 139

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 140  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 196

Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 197  QTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 55.8 bits (135), Expect = 5e-08
 Identities = 72/274 (26%), Positives = 105/274 (38%), Gaps = 59/274 (21%)

Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFL---NEVKSL---------- 859
            +G G  G V  AE   +GE+ A+K            ++  +   +EV+SL          
Sbjct: 7    LGRGHFGKVLLAEYKKTGELYAIKAL----------KKGDIIARDEVESLMCEKRIFETA 56

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
               RH  +V  +       H   V EY   G L M +      +     + +     V  
Sbjct: 57   NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVL 112

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYV 978
             L YLH +    IVYRD+   N+LLD E    ++DFG+ K  +       T   GT  ++
Sbjct: 113  GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFL 168

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHP------RDFISSICSTSSNLDRTLDEIL 1032
            APE+      T   D +  GVL  E + G+ P       +   SI +         DE+ 
Sbjct: 169  APEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN---------DEVR 219

Query: 1033 DPR-LPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             PR L   +       ISIM      L  NP+ R
Sbjct: 220  YPRFLSREA-------ISIMR---RLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 6e-08
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 5/98 (5%)

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK-SLKPDSSNWTELAGTIGYV 978
            AL++LH      I+YRD+   NVLLD E    ++D+G+ K  ++P  +  T   GT  Y+
Sbjct: 108  ALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYI 163

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016
            APE+          D ++ GVL  E + G+ P D +  
Sbjct: 164  APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGM 201

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.0 bits (132), Expect = 7e-08
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)

Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 53   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 107

Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L                   E+L +   ++    VA  + YL +      ++R
Sbjct: 108  KGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHR 164

Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 165  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224

Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 225  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 276

Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 277  ---DCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.0 bits (132), Expect = 8e-08
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 18/214 (8%)

Query: 807  DFDEEHCIGTGGQGSVYRAELSSG----EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +F+    +GTG  G V+     +G    ++ A+K      L +     E     +++ E 
Sbjct: 1    NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 863  RHRN---IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VA 918
              ++   +   Y F + A+   I+ +Y+  G +   L    +  E      +    G + 
Sbjct: 61   VRQSPFLVTLHYAFQTEAKLHLIL-DYVSGGEMFTHLYQRDNFSE----DEVRFYSGEII 115

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGTIGY 977
             AL +LH      IVYRDI  +N+LLD E    ++DFG+SK    +    T    GTI Y
Sbjct: 116  LALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 978  VAPELAYTMKVTEKS-DVYSFGVLALEAIKGKHP 1010
            +APE+        K+ D +S G+L  E + G  P
Sbjct: 173  MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 20/232 (8%)

Query: 814  IGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVKFY 871
            IG G  G V  A+  S G   AVK      + +   Q   + E   L + ++H  +V  +
Sbjct: 3    IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALSYLHNDCFP 930
                 A   + V +Y+  G L   L       E     R       VA A+ YLH+    
Sbjct: 63   YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE----PRARFYAAEVASAIGYLHS---L 115

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYVAPELAYTMKVT 989
             I+YRD+  +N+LLD +    ++DFG+ K  ++P+ +  T   GT  Y+APE+       
Sbjct: 116  NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYD 174

Query: 990  EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
               D +  G +  E + G  P          S ++ +  D IL   L  P  
Sbjct: 175  RTVDWWCLGAVLYEMLYGLPP--------FYSRDVSQMYDNILHKPLQLPGG 218

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 54.8 bits (132), Expect = 1e-07
 Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 40/225 (17%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFH-SPLLSEMTCQQEF----------LNEVKSLTE 861
            +G G  G V +A    +G+IVA+KK     + +++T  ++           L E+K + E
Sbjct: 17   LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 862  IRHRNIVKFYG-FCSHARHSFI--VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            I+H NI+     +       FI  V + +    L  ++       E   +Q   ++  + 
Sbjct: 77   IKHENIMGLVDVYVEG---DFINLVMDIMA-SDLKKVVDRKIRLTE---SQVKCILLQIL 129

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-----LKPDSS------- 966
            + L+ LH   +   ++RD+S  N+ ++ +    ++DFG+++           S       
Sbjct: 130  NGLNVLHK-WY--FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186

Query: 967  --NWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
                T    T+ Y APEL     K     D++S G +  E + GK
Sbjct: 187  REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 55.1 bits (132), Expect = 1e-07
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 10/198 (5%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +    + VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 23   VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY-RELRLLKHMKHENVIGLLD 81

Query: 873  FCSHARHSFIVYE-YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
              + A       E YL    +   L+N    ++L       +I  +   L Y+H+     
Sbjct: 82   VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AG 138

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTE 990
            I++RD+   NV ++ + E  + DFG+++    + + +     T  Y APE+    M   +
Sbjct: 139  IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYV---ATRWYRAPEIMLNWMHYNQ 195

Query: 991  KSDVYSFGVLALEAIKGK 1008
              D++S G +  E +KGK
Sbjct: 196  TVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 60/251 (23%), Positives = 107/251 (42%), Gaps = 43/251 (17%)

Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL------ 896
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 61   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPP 115

Query: 897  -------SNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                   +     E+L +   ++    VA  + YL +      ++RD++++NVL+  +  
Sbjct: 116  GMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNV 172

Query: 950  AHVSDFGISKSLKPDSSNWTELAGT------IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
              ++DFG+++    D  N      T      + ++APE  +    T +SDV+SFGVL  E
Sbjct: 173  MKIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWE 228

Query: 1004 AIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENP 1062
                G  P   I         L + L E    R+  P+ N   +L  IM     C    P
Sbjct: 229  IFTLGGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTHELYMIMR---ECWHAVP 277

Query: 1063 DSRPTMQKVSQ 1073
              RPT +++ +
Sbjct: 278  SQRPTFKQLVE 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.2 bits (130), Expect = 1e-07
 Identities = 58/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)

Query: 807  DFDEEHCIGTGGQGSVYRAELSSG----EIVAVKKFH-SPLLSEMTCQQEFLNEVKSLTE 861
            +F+    +GTG  G V+     SG    ++ A+K    + ++ +    +    E + L  
Sbjct: 1    NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 862  IRHRN--IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VA 918
            IR     +   Y F +  +   I+ +Y+  G L   LS     +E    Q + +  G + 
Sbjct: 61   IRQSPFLVTLHYAFQTDTKLHLIL-DYINGGELFTHLSQRERFKE----QEVQIYSGEIV 115

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGTIGY 977
             AL +LH      I+YRDI  +N+LLD      ++DFG+SK    D         GTI Y
Sbjct: 116  LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 978  VAPELAYTMKVTEKS--DVYSFGVLALEAIKGKHP 1010
            +AP++            D +S GVL  E + G  P
Sbjct: 173  MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 54.6 bits (132), Expect = 1e-07
 Identities = 53/196 (27%), Positives = 87/196 (44%), Gaps = 32/196 (16%)

Query: 808 FDEEHCIGTGGQGSVYRA---ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
           ++ E CIG G  G VY+A       G+  A+KKF           Q    E+  L E++H
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61

Query: 865 RNIVKFYG-FCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADA 920
            N+V     F  HA  S +++++Y E   L  I+     A+ +     M  +++  + + 
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 921 LSYLHNDCFPPIVYRDISSKNVLLDLEYEAH----VSDFGIS----KSLKPDSSNWTELA 972
           + YLH++    +++RD+   N+L+  E        + D G++      LKP       LA
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-------LA 170

Query: 973 G------TIGYVAPEL 982
                  TI Y APEL
Sbjct: 171 DLDPVVVTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 1e-07
 Identities = 35/92 (38%), Positives = 47/92 (51%), Gaps = 4/92 (4%)

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVA 979
            AL +LH      IVYRD+  +N+LLD      + DFG+SK+   D+       GT  Y+A
Sbjct: 108  ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLA 164

Query: 980  PELAYTMK-VTEKSDVYSFGVLALEAIKGKHP 1010
            PE+    K  T+  D +S GVL  E   G  P
Sbjct: 165  PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 31/229 (13%)

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            F      ++++ H ++   +G C     + +V E++E G L + L        + W  ++
Sbjct: 63   FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KI 120

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLL---DLEYEA----HVSDFGISKSLKPD 964
             V + +A ALSYL +     +V+ ++ +KN+LL    L         +SD G+S +    
Sbjct: 121  TVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT---- 173

Query: 965  SSNWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSS 1022
            + +  E    I ++APE +     ++  +D +SFG   LE    G+ P         T S
Sbjct: 174  ALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLK-----ERTPS 228

Query: 1023 NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +R  ++    RLP PSC     LIS       CL   P  RP+ + +
Sbjct: 229  EKERFYEKKH--RLPEPSCKELATLIS------QCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.4 bits (131), Expect = 2e-07
 Identities = 29/89 (32%), Positives = 43/89 (48%)

Query: 472 VRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGIL 531
           + LD   L G I        +L  INLS     G I    G   +L  LD+S N+  G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSELG 560
           P  +G    L++L+L+ N + G +P+ LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 63/224 (28%), Positives = 97/224 (43%), Gaps = 28/224 (12%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSP-LLSEMTCQQEFLNEVKSLTEIR 863
             DF+    I  G  G+VY      + +  A+KK +   L+     QQ F+ E   LT   
Sbjct: 1    EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFV-ERDILTFAE 59

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN--ATSAEELGWTQRMNVIKGVADAL 921
            +  +V  +      RH  +V EY+E G  A +L N  A   +      RM   + V  AL
Sbjct: 60   NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD----MARMYFAETVL-AL 114

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK-SLKPDSSNWTE---------- 970
             YLHN     IV+RD+   N+L+       ++DFG+SK  L   ++N  E          
Sbjct: 115  EYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171

Query: 971  ----LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                + GT  Y+APE+       +  D ++ G++  E + G  P
Sbjct: 172  LDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.9 bits (129), Expect = 2e-07
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 8/199 (4%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVKFY 871
            IG G  G V  A+    G+  AVK     ++     Q+  + E   L + ++H  +V  +
Sbjct: 3    IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                     + V +++  G L   L    S  E    +       +A AL YLH+     
Sbjct: 63   YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPE---PRARFYAAEIASALGYLHS---IN 116

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            IVYRD+  +N+LLD +    ++DFG+ K     S   T   GT  Y+APE+         
Sbjct: 117  IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 992  SDVYSFGVLALEAIKGKHP 1010
             D +  G +  E + G  P
Sbjct: 177  VDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 54/264 (20%), Positives = 106/264 (40%), Gaps = 25/264 (9%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            I    Q S+Y+   +  + V ++ F               NE+K+L  I   NI+K YGF
Sbjct: 28   IKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF 86

Query: 874  ----CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                        ++ EY   G L  +L      ++L +  ++++       L  L+    
Sbjct: 87   IIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN 143

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM--K 987
             P  Y++++S + L+   Y+  +   G+ K L             + Y + ++   +  +
Sbjct: 144  KP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK---NVNFMVYFSYKMLNDIFSE 198

Query: 988  VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047
             T K D+YS GV+  E   GK P + +    +T    D  +++    +LP       D  
Sbjct: 199  YTIKDDIYSLGVVLWEIFTGKIPFENL----TTKEIYDLIINKNNSLKLPL------DCP 248

Query: 1048 ISIMEVAISCLDENPDSRPTMQKV 1071
            + I  +  +C   +   RP ++++
Sbjct: 249  LEIKCIVEACTSHDSIKRPNIKEI 272

Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 34/210 (16%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE-----MTCQQEFLNEVKSLTEIRHRNI 867
            IG G  G VY+A +  +GEIVA+KK    L +E      T     + E+  L E+ H NI
Sbjct: 7    IGEGTYGVVYKARDKLTGEIVALKKIR--LETEDEGVPSTA----IREISLLKELNHPNI 60

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG----VADALSY 923
            V+           ++V+E+L++  L   +    S+   G    +  IK     +   ++Y
Sbjct: 61   VRLLDVVHSENKLYLVFEFLDL-DLKKYMD---SSPLTGLDPPL--IKSYLYQLLQGIAY 114

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL- 982
             H+     +++RD+  +N+L+D E    ++DFG++++       +T    T+ Y APE+ 
Sbjct: 115  CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 983  ----AYTMKVTEKSDVYSFGVLALEAIKGK 1008
                 Y+  V    D++S G +  E +  +
Sbjct: 172  LGSRQYSTPV----DIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.7 bits (129), Expect = 2e-07
 Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 12/161 (7%)

Query: 853  LNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            L E + L   RH  +    Y F +H R  F V EY   G L   LS      E  +++  
Sbjct: 43   LTESRVLQNTRHPFLTALKYSFQTHDRLCF-VMEYANGGELFFHLS-----RERVFSEDR 96

Query: 912  NVIKG--VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
                G  +  AL YLH+     +VYRD+  +N++LD +    ++DFG+ K    D +   
Sbjct: 97   ARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK 153

Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               GT  Y+APE+          D +  GV+  E + G+ P
Sbjct: 154  TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 52.6 bits (126), Expect = 4e-07
 Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 30/278 (10%)

Query: 814  IGTGGQGSVYRAELSSGEIVA---VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG G  G V  +E+ +   VA   VK+  +   S+   Q EFL +      ++H NI++ 
Sbjct: 3    IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKE--QNEFLQQGDPYRILQHPNILQC 60

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHND 927
             G C  A    +V+EY E+G L   LS         +L   QRM     +A  ++++H  
Sbjct: 61   LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMAC--EIAAGVTHMHKH 118

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELA-- 983
             F   ++ D++ +N  L  +    V D+GI  S   +    TE      + ++APEL   
Sbjct: 119  NF---LHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 984  -----YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
                  T + T+ S+V++ GV   E  +    P   +S     +  +     ++  P+L 
Sbjct: 176  FHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLE 235

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             P            EV   C   +P+ R T ++V +LL
Sbjct: 236  LPYSE------RWYEVLQFCW-LSPEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 5e-07
 Identities = 33/93 (35%), Positives = 47/93 (50%), Gaps = 7/93 (7%)

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS--DFGISKSLKPDSSNWTELAGTIGY 977
            AL  LH      ++YRD+  +N+LLD  Y+ H++  DFG+ K    D        GT  Y
Sbjct: 105  ALENLHK---FNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 978  VAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +APEL      T+  D ++ GVL  E + G  P
Sbjct: 160  LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.2 bits (125), Expect = 7e-07
 Identities = 47/166 (28%), Positives = 84/166 (50%), Gaps = 22/166 (13%)

Query: 917  VADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
            VA  + +L   +C    ++RD++++NVLL     A + DFG+++ +  D SN+  + G  
Sbjct: 221  VAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMND-SNYV-VKGNA 274

Query: 975  ---IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDE 1030
               + ++APE  +    T +SDV+S+G+L  E    GK P   I  + S    + +   +
Sbjct: 275  RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI-LVNSKFYKMVKRGYQ 333

Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +  P    P      ++ SIM+    C +  P  RPT  ++SQL++
Sbjct: 334  MSRPDFAPP------EIYSIMK---MCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 42/281 (14%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V++     +G   AVK        +   + E+ N +K+L++  H N+VKFYG
Sbjct: 26   IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEY-NILKALSD--HPNVVKFYG 82

Query: 873  F-----CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN------VIKGVADAL 921
                    +    ++V E    GS+  ++        L   +RM       ++      L
Sbjct: 83   MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF-----LKRGERMEEPIIAYILHEALMGL 137

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             +LH +     ++RD+   N+LL  E    + DFG+S  L           GT  ++APE
Sbjct: 138  QHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 982  L-----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            +             + DV+S G+ A+E   G  P   +  +        R L +I  PR 
Sbjct: 195  VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--------RALFKI--PRN 244

Query: 1037 PAPSCNIRDKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
            P P+ +  +   +     I  CL ++ + RPT   VS LL+
Sbjct: 245  PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQ 282

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.6 bits (126), Expect = 9e-07
 Identities = 42/142 (29%), Positives = 66/142 (46%), Gaps = 13/142 (9%)

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVT 989
            +++RDI S N+LL       + DFG SK      S+       GT  YVAPE+      +
Sbjct: 164  MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 990  EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +K+D++S GVL  E +  K P D      +    + +TL    DP  P+ S  ++     
Sbjct: 224  KKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTLAGRYDPLPPSISPEMQ----- 274

Query: 1050 IMEVAISCLDENPDSRPTMQKV 1071
              E+  + L  +P  RP+  K+
Sbjct: 275  --EIVTALLSSDPKRRPSSSKL 294

Length = 496

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 1e-06
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 12/201 (5%)

Query: 814  IGTGGQGSVYRAELSSGEIV-AVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVKFY 871
            IG G  G V  A   + E   AVK      + +   ++  ++E   L + ++H  +V  +
Sbjct: 3    IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALSYLHNDCFP 930
                 A   + V +Y+  G L   L      E      R       +A AL YLH+    
Sbjct: 63   FSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHS---L 115

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISK-SLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
             IVYRD+  +N+LLD +    ++DFG+ K +++ + +  T   GT  Y+APE+ +     
Sbjct: 116  NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174

Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
               D +  G +  E + G  P
Sbjct: 175  RTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 51.7 bits (124), Expect = 1e-06
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            +G G  G V+ A +    + VAVKK    +L++    +  L E+K +  + H NIVK Y 
Sbjct: 13   LGCGSNGLVFSAVDSDCDKRVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69

Query: 872  -------------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
                         G  +     +IV EY+E   LA +L     +EE        +++G  
Sbjct: 70   VLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRG-- 126

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSN---WTELAGT 974
              L Y+H+     +++RD+   NV ++ E     + DFG+++ + P  S+    +E   T
Sbjct: 127  --LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 975  IGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
              Y +P L  +    T+  D+++ G +  E + GK
Sbjct: 182  KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 51.3 bits (123), Expect = 1e-06
 Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMT-CQQEFLNEVKSLTEIRH 864
            D+ +   IG G  G VY+     +G+IVA+KK    L SE        + E+  L E++H
Sbjct: 1    DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR--LESEEEGVPSTAIREISLLKELQH 58

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NIV            ++++E+L M  L   L +    + +      + +  +   + + 
Sbjct: 59   PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-- 982
            H+     +++RD+  +N+L+D +    ++DFG++++       +T    T+ Y APE+  
Sbjct: 118  HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLL 174

Query: 983  ---AYTMKVTEKSDVYSFGVLALEAIKGK 1008
                Y+  V    D++S G +  E    K
Sbjct: 175  GSPRYSTPV----DIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.4 bits (123), Expect = 1e-06
 Identities = 62/216 (28%), Positives = 99/216 (45%), Gaps = 19/216 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKF-HSPLLSEMTCQQEFLNEVKSLTEIR 863
             DFD +  +G G  G V    E ++G+I A+K    S LL++ T    F  E + +  I 
Sbjct: 1    KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVS--FFEEERDILSIS 58

Query: 864  HRN-IVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +   I +  Y F     + ++V EY   G L  +L+      +    Q    +  +  A+
Sbjct: 59   NSPWIPQLQYAF-QDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY--LAELVLAI 115

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL-AGTIGYVAP 980
              +H   +   V+RDI  +NVL+D      ++DFG +  L  +    ++L  GT  Y+AP
Sbjct: 116  HSVHQMGY---VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172

Query: 981  ELAYTMKVTEKS------DVYSFGVLALEAIKGKHP 1010
            E+  TM    K       D +S GV+A E I G+ P
Sbjct: 173  EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 44/197 (22%), Positives = 95/197 (48%), Gaps = 8/197 (4%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G   +VY+    ++GEIVA+K+ H  L +E       + E+  + E++H NIV+ + 
Sbjct: 8    LGEGTYATVYKGRNRTTGEIVALKEIH--LDAEEGTPSTAIREISLMKELKHENIVRLHD 65

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                     +V+EY++   L   +        L      +    +   +++ H +    +
Sbjct: 66   VIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+  +N+L++   E  ++DFG++++     + ++    T+ Y AP++    +    S
Sbjct: 122  LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTS 181

Query: 993  -DVYSFGVLALEAIKGK 1008
             D++S G +  E I G+
Sbjct: 182  IDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 46.0 bits (110), Expect = 1e-06
 Identities = 22/61 (36%), Positives = 33/61 (54%), Gaps = 2/61 (3%)

Query: 636 HLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
           +L  LDLS+N L   IP      + +L+ L+L+ NNL+   P  F  +  L  +D+S N 
Sbjct: 1   NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59

Query: 695 L 695
           L
Sbjct: 60  L 60

Length = 60

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 30/236 (12%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN----IV 868
            IG GG G VY   +  +G++ A+K      +     +   LNE   L+ +   +    + 
Sbjct: 2    IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSN--ATSAEELGWTQRMNVIKGVADALSYLHN 926
              Y F +  + SFI+ + +  G L   LS     S  E+ +     +I G    L ++HN
Sbjct: 62   MSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEAEMRFYA-AEIILG----LEHMHN 115

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGI----SKSLKPDSSNWTELAGTIGYVAPE- 981
                 +VYRD+   N+LLD      +SD G+    SK  KP +S      GT GY+APE 
Sbjct: 116  RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS-----VGTHGYMAPEV 166

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            L   +     +D +S G +  + ++G  P  F          +DR +   +   LP
Sbjct: 167  LQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDR-MTLTMAVELP 219

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 51.2 bits (122), Expect = 2e-06
 Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 18/201 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G QG V  A +   G  VAVKK   P  ++   ++ +  E+  L  + H+NI+    
Sbjct: 29   IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 87

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHNDC 928
              +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+  
Sbjct: 88   VFTPQK----SLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS-- 141

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--TELAGTIGYVAPELAYTM 986
               I++RD+   N+++  +    + DFG++++     +N+  T    T  Y APE+   M
Sbjct: 142  -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGM 197

Query: 987  KVTEKSDVYSFGVLALEAIKG 1007
               E  D++S G +  E +KG
Sbjct: 198  GYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.8 bits (122), Expect = 2e-06
 Identities = 58/242 (23%), Positives = 86/242 (35%), Gaps = 59/242 (24%)

Query: 513 KFPNLGTLDVSANNITGI----LPPEIGDSPQLKVLDLSSNH------IVGEIPSELGKL 562
           K   L  L +  N +       L   +   P LK L LS N        +  +   L K 
Sbjct: 21  KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80

Query: 563 RSLIKLTLNRNQFSGQLPTELGSLIQ---LEHLDLSSNRLSNSI-----------PGSLG 608
             L +L L+ N         L SL++   L+ L L++N L +             P +L 
Sbjct: 81  CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALE 140

Query: 609 NLV----------------------KLYYLNLSNNQFSGEIPIKLEK----FIHLSDLDL 642
            LV                       L  LNL+NN         L +      +L  LDL
Sbjct: 141 KLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL 200

Query: 643 SHNFLGEEIPSQVC----SMQSLEKLNLAHNNLSGFIPRCFKE-----MHGLVYIDISYN 693
           ++N L +E  S +     S++SLE LNL  NNL+                 L+ + +S N
Sbjct: 201 NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260

Query: 694 KL 695
            +
Sbjct: 261 DI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 45/165 (27%), Positives = 85/165 (51%), Gaps = 20/165 (12%)

Query: 917  VADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
            VA  +S+L + +C    ++RD++++N+LL       + DFG+++ ++ D SN+       
Sbjct: 223  VAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND-SNYVVKGNAR 277

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031
              + ++APE  +    T +SDV+S+G+L  E    G  P   +       S   + + E 
Sbjct: 278  LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM----PVDSKFYKMIKEG 333

Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               R+ +P C    ++  IM+   SC D +P  RPT +++ QL++
Sbjct: 334  Y--RMLSPECA-PSEMYDIMK---SCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 50.9 bits (122), Expect = 2e-06
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)

Query: 814  IGTGGQG---SVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVK 869
            +G G  G   S   AE S  E VA+KK  +    ++  ++  L E+K L   R H+NI  
Sbjct: 8    LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNITC 66

Query: 870  FYG----FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
             Y     F  +    ++ YE L    L  I+    S + L      + I  +   L Y+H
Sbjct: 67   LYDMDIVFPGNFNELYL-YEELMEADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIH 122

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD----SSNWTELAGTIGYVAPE 981
            +     +++RD+   N+L++ + E  + DFG+++    +    +   TE   T  Y APE
Sbjct: 123  S---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 982  LAYTMKVTEKS-DVYSFGVLALEAIKGK 1008
            +  + +   K+ DV+S G +  E +  K
Sbjct: 180  IMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.8 bits (121), Expect = 2e-06
 Identities = 61/236 (25%), Positives = 96/236 (40%), Gaps = 40/236 (16%)

Query: 798  YEEIVR-------ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQ 850
            YE+IVR          D+D    IG G  G V      S + V   K    LLS+     
Sbjct: 28   YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMK----LLSKF---- 79

Query: 851  EFLNEVKSLTEIRHRNIVKFYG-------FCSHA--RHSFIVYEYLEMGSLAMILSNATS 901
            E +    S      R+I+ F         FC+    ++ ++V EY+  G L  ++SN   
Sbjct: 80   EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV 139

Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
             E+  W +       V  AL  +H+     +++RD+   N+LLD      ++DFG    +
Sbjct: 140  PEK--WAKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG--TCM 190

Query: 962  KPDSSNWTEL---AGTIGYVAPELAYTMK----VTEKSDVYSFGVLALEAIKGKHP 1010
            K D +         GT  Y++PE+  +         + D +S GV   E + G  P
Sbjct: 191  KMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 50.0 bits (120), Expect = 3e-06
 Identities = 54/244 (22%), Positives = 89/244 (36%), Gaps = 46/244 (18%)

Query: 440 YGNLVKLTLLVLSYNQLQ----GPIPDLRNLTRLARVRLDRNHLTGN----ISESFGIHS 491
                 L  L LS N L     G +  L   + L  ++L+ N L       +++      
Sbjct: 77  LTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLP 136

Query: 492 -NLSYINLSHKKFYGEISFDWGK----FPNLGTLDVSANNIT--GI--LPPEIGDSPQLK 542
             L  + L   +  G       K      +L  L+++ N I   GI  L   +  +  L+
Sbjct: 137 PALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLE 196

Query: 543 VLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNS 602
           VLDL++N +                     ++ +  L   L SL  LE L+L  N L+++
Sbjct: 197 VLDLNNNGL--------------------TDEGASALAETLASLKSLEVLNLGDNNLTDA 236

Query: 603 I-----PGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIH----LSDLDLSHNFLGEEIPS 653
                    L   + L  L+LS N  + +    L + +     L +LDL  N  GEE   
Sbjct: 237 GAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQ 296

Query: 654 QVCS 657
            +  
Sbjct: 297 LLAE 300

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 49.6 bits (118), Expect = 6e-06
 Identities = 46/171 (26%), Positives = 78/171 (45%), Gaps = 38/171 (22%)

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK------SLKPDSSNWTELAG 973
            AL  +H+     +++RD+ S N+ L       + DFG SK      SL   SS      G
Sbjct: 181  ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS----FCG 233

Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAI------KGKHPRDFISSICSTSSNLDRT 1027
            T  Y+APEL    + ++K+D++S GV+  E +      KG   R+ +  +       D  
Sbjct: 234  TPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV--LYGKYD-- 289

Query: 1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV--SQLLK 1076
                     P P C +   + ++++  +S   +NP  RPT Q++  ++ LK
Sbjct: 290  ---------PFP-CPVSSGMKALLDPLLS---KNPALRPTTQQLLHTEFLK 327

Length = 478

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN----IV 868
            IG GG G VY   +  +G++ A+K      +     +   LNE   L+ +   +    + 
Sbjct: 2    IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSN--ATSAEELGWTQRMNVIKGVADALSYLHN 926
              Y F +  +  FI+ + +  G L   LS     S +E+ +     +I G    L ++HN
Sbjct: 62   MTYAFHTPDKLCFIL-DLMNGGDLHYHLSQHGVFSEKEMRFYA-TEIILG----LEHMHN 115

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS---KSLKPDSSNWTELAGTIGYVAPELA 983
                 +VYRD+   N+LLD      +SD G++      KP +S      GT GY+APE+ 
Sbjct: 116  RF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHGYMAPEVL 167

Query: 984  YTMKVTEKS-DVYSFGVLALEAIKGKHP 1010
                  + S D +S G +  + ++G  P
Sbjct: 168  QKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 48.8 bits (116), Expect = 6e-06
 Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 18/215 (8%)

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-LGWTQRMNV 913
            E + L+++ H  IVKF+          I+ EY E   L   L       + L   Q    
Sbjct: 52   EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
               +   + Y+H      I++RD+ +KN+ L       + DFG+S+ L       T   G
Sbjct: 112  FIQLLLGVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTG 167

Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033
            T  Y++PE         KSD++S G +  E     H   F         N    +  I++
Sbjct: 168  TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA--FE------GQNFLSVVLRIVE 219

Query: 1034 PRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPT 1067
               P+ P    R +L SIM+   S L+++P  RP+
Sbjct: 220  GPTPSLPETYSR-QLNSIMQ---SMLNKDPSLRPS 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 49.3 bits (118), Expect = 7e-06
 Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 42/275 (15%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
             IG G  G V  A    + E VA+KK  +   + +  ++  L E+K L  + H N++   
Sbjct: 12   PIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT-LREIKLLRHLDHENVIAIK 70

Query: 872  GFCS-HARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                   R +F    IVYE ++     +I S+ T +++        +++G    L Y+H+
Sbjct: 71   DIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG----LKYIHS 126

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
                 +++RD+   N+LL+   +  + DFG++++        TE   T  Y APEL    
Sbjct: 127  ---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNC 183

Query: 983  -AYTMKVTEKSDVYSFGVLALEAIKGK---------HPRDFISSICSTSSNLDRTLDEIL 1032
              YT  +    DV+S G +  E +  K         H    I+ +  + S  D  L  I 
Sbjct: 184  SEYTTAI----DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEED--LGFIR 237

Query: 1033 DPR-------LP-APSCNIRDKLISIMEVAISCLD 1059
            + +       LP  P  +          +AI  L+
Sbjct: 238  NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLE 272

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 49.3 bits (117), Expect = 9e-06
 Identities = 43/215 (20%), Positives = 85/215 (39%), Gaps = 42/215 (19%)

Query: 854  NEVKSLTEIRHRNIVKF--------YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL 905
            NE+ +L  + H NI+K           +    ++ F +Y ++   +             L
Sbjct: 212  NEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDW------KDRPL 265

Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG----ISKSL 961
                R  ++K +  A+ Y+H+     +++RDI  +N+ L+ + +  + DFG      K  
Sbjct: 266  LKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER 321

Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK---------GKHPRD 1012
            +     W    GT+   +PE+       E +D++S G++ L+ +          G  P  
Sbjct: 322  EAFDYGWV---GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378

Query: 1013 FISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047
             +  I  + S        + D   P P C + D +
Sbjct: 379  QLLKIIDSLS--------VCDEEFPDPPCKLFDYI 405

Length = 501

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.8 bits (117), Expect = 9e-06
 Identities = 46/198 (23%), Positives = 87/198 (43%), Gaps = 10/198 (5%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  G V  A  + +G  VA+KK   P  S +  ++ +  E++ L  + H N++    
Sbjct: 23   VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY-RELRLLKHMDHENVIGLLD 81

Query: 873  -FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
             F   +        YL    +   L+N    ++L       ++  +   L Y+H+     
Sbjct: 82   VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AG 138

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTE 990
            I++RD+   N+ ++ + E  + DFG+++         T    T  Y APE+    M   +
Sbjct: 139  IIHRDLKPSNIAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQ 195

Query: 991  KSDVYSFGVLALEAIKGK 1008
              D++S G +  E + GK
Sbjct: 196  TVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 49.0 bits (117), Expect = 1e-05
 Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLS--EMTCQQE--FLNEVKSLTE 861
            DFD    IG G  G V      SS ++ A+K     LLS  EM  + +  F  E + +  
Sbjct: 44   DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK-----LLSKFEMIKRSDSAFFWEERDI-- 96

Query: 862  IRHRN---IVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
            + H N   IV+  Y F    ++ ++V EY+  G L  ++SN    E+  W +       V
Sbjct: 97   MAHANSEWIVQLHYAF-QDDKYLYMVMEYMPGGDLVNLMSNYDIPEK--WARFY--TAEV 151

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIG 976
              AL  +H+  F   ++RD+   N+LLD      ++DFG    +  +     + A GT  
Sbjct: 152  VLALDAIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208

Query: 977  YVAPELAYTMKVT----EKSDVYSFGVLALEAIKGKHP 1010
            Y++PE+  +         + D +S GV   E + G  P
Sbjct: 209  YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 48.7 bits (116), Expect = 1e-05
 Identities = 38/158 (24%), Positives = 70/158 (44%), Gaps = 20/158 (12%)

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
            Q + + K + + L YLH      I++RD+ ++N+ ++   +  + D G ++     +  +
Sbjct: 158  QALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAF 213

Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
              LAGT+   APE+    K   K+D++S G++  E +   +P        ST        
Sbjct: 214  LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML--AYPSTIFEDPPST-------- 263

Query: 1029 DEILDPRLPAPSCNIR-DKLISIMEVAISCLDENPDSR 1065
                 P     SC+    K+IS ++V       +P SR
Sbjct: 264  -----PEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296

Length = 357

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 49.0 bits (116), Expect = 2e-05
 Identities = 52/217 (23%), Positives = 95/217 (43%), Gaps = 37/217 (17%)

Query: 849  QQEFLNEVKSLTEIRHRNIVKFYG-FCSHARHS-FIVYEYLEMGSLAMILSNATSAEELG 906
            + + + EV  + E++H+NIV++   F + A    +I+ E+ + G L+  +         G
Sbjct: 56   KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM--FG 113

Query: 907  WTQR---MNVIKGVADALSYLHNDCFPP----IVYRDISSKNVLLDLEYE---------- 949
              +    +++ + +  AL+Y HN    P    +++RD+  +N+ L               
Sbjct: 114  KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQAN 173

Query: 950  -------AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY--TMKVTEKSDVYSFGVL 1000
                   A + DFG+SK++  +S   +   GT  Y +PEL    T    +KSD+++ G +
Sbjct: 174  NLNGRPIAKIGDFGLSKNIGIESMAHS-CVGTPYYWSPELLLHETKSYDDKSDMWALGCI 232

Query: 1001 ALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
              E   GK P    ++     S L R       P LP
Sbjct: 233  IYELCSGKTPFHKANNFSQLISELKR------GPDLP 263

Length = 1021

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 30/94 (31%), Positives = 46/94 (48%), Gaps = 3/94 (3%)

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG 976
            +A AL YLH+     I+YRD+  +N+LLD +    ++DFG+ K     S   +   GT  
Sbjct: 105  IASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPE 161

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            Y+APE+          D +  G +  E + G  P
Sbjct: 162  YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 48.0 bits (115), Expect = 2e-05
 Identities = 57/209 (27%), Positives = 98/209 (46%), Gaps = 27/209 (12%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +G G  G V++A +  + E+VA+KK      +    Q+ F  E+  L E+  H NIVK  
Sbjct: 15   LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTF-REIMFLQELGDHPNIVKLL 73

Query: 872  GF--CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                  + +  ++V+EY+E       L     A  L    +  ++  +  AL Y+H+   
Sbjct: 74   NVIKAENDKDIYLVFEYMETD-----LHAVIRANILEDVHKRYIMYQLLKALKYIHSG-- 126

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW-----TELAGTIGYVAPEL-- 982
              +++RD+   N+LL+ +    ++DFG+++SL     N      T+   T  Y APE+  
Sbjct: 127  -NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL 185

Query: 983  ---AYTMKVTEKSDVYSFGVLALEAIKGK 1008
                YT  V    D++S G +  E + GK
Sbjct: 186  GSTRYTKGV----DMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 27/153 (17%)

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL       + DFG+++ +   PD     +    + ++APE  +    T 
Sbjct: 195  IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 991  KSDVYSFGVLALEAIK-GKHP-------RDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
            +SDV+SFGVL  E    G  P        +F    C       R L E    R+ AP   
Sbjct: 255  QSDVWSFGVLLWEIFSLGASPYPGVQIDEEF----C-------RRLKE--GTRMRAPE-Y 300

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               ++ SIM   + C   NP+ RPT  ++ ++L
Sbjct: 301  ATPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 47.7 bits (113), Expect = 2e-05
 Identities = 62/243 (25%), Positives = 94/243 (38%), Gaps = 46/243 (18%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF+    IG G  G V   +   +G I A+K      + E         E   L E   
Sbjct: 1    DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 865  RNIVK-FYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALS 922
              +VK FY F    R+ +++ E+L  G +  +++   T +EE         I     A+ 
Sbjct: 61   AWVVKMFYSF-QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE----ATQFYIAETVLAID 115

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK--------------PDS--- 965
             +H   F   ++RDI   N+LLD +    +SDFG+   LK              P S   
Sbjct: 116  AIHQLGF---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172

Query: 966  --------------SNWTELA----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKG 1007
                           N  +LA    GT  Y+APE+       +  D +S GV+  E + G
Sbjct: 173  FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Query: 1008 KHP 1010
              P
Sbjct: 233  YPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 18/215 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGE-IVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
            +DF+    IG G  G V   ++   E I A+K   K+     +E  C   F  E   L  
Sbjct: 1    DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETAC---FREERNVLVN 57

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
               + I   +       + ++V +Y   G L  +LS     + L        I  +  A+
Sbjct: 58   GDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAI 115

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAP 980
              +H   +   V+RDI   NVLLD+     ++DFG    +  D +  + +A GT  Y++P
Sbjct: 116  HSIHQLHY---VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172

Query: 981  ELAYTM-----KVTEKSDVYSFGVLALEAIKGKHP 1010
            E+   M     K   + D +S GV   E + G+ P
Sbjct: 173  EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.9 bits (112), Expect = 3e-05
 Identities = 66/315 (20%), Positives = 126/315 (40%), Gaps = 70/315 (22%)

Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKF--HS-----PLLSEMTCQQEFLNE 855
               D++    +G G  G VY+A ++ +G +VA+KK   H+     P+ +        L E
Sbjct: 6    KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--------LRE 57

Query: 856  VKSLTEIRHRNIVK----FYGFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGW 907
            +K L +++H N+V            ++      ++V  Y++   L+ +L N +   +L  
Sbjct: 58   IKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSV--KLTE 114

Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
            +Q    +  + + ++YLH +    I++RDI + N+L+D +    ++DFG+++       N
Sbjct: 115  SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171

Query: 968  W-----------TELAGTIGYVAPELA-----YTMKVTEKSDVYSFGVLALEAIKGK--- 1008
                        T L  T  Y  PEL      YT  V    D++  G +  E    +   
Sbjct: 172  PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRRPIL 227

Query: 1009 ------HPRDFISSICSTSSNLD----RTLD--EILDPRLPAPSCNIRDKLISIMEVAIS 1056
                       I  +C T +       R+L   E +      P   + ++   +    + 
Sbjct: 228  QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR-TLEERFGKLGPEGLD 286

Query: 1057 CLDE----NPDSRPT 1067
             L +    +P  R T
Sbjct: 287  LLSKLLSLDPYKRLT 301

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.8 bits (112), Expect = 3e-05
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 21/153 (13%)

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            + N +K Y   +  +   ++ +Y++ G L  +L       E    +   +I+ + +AL+ 
Sbjct: 68   NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSE---AEVKKIIRQLVEALND 124

Query: 924  LHNDCFPPIVYRDISSKNVLLD-LEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            LH      I++ DI  +NVL D  +   ++ D+G+ K +   S       GT+ Y +PE 
Sbjct: 125  LHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC----YDGTLDYFSPE- 176

Query: 983  AYTMKVTEKSDVYSF-----GVLALEAIKGKHP 1010
                K+   +   SF     GVL  E + GKHP
Sbjct: 177  ----KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.0 bits (111), Expect = 3e-05
 Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 22/216 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRAELSSGE-IVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEI 862
            DF+    IG G  G V   +L + + + A+K   K+     +E  C   F  E   L   
Sbjct: 2    DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVNG 58

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS--AEELGWTQRMNVIKGVADA 920
             ++ I   +       + ++V +Y   G L  +LS       E++       ++  + D+
Sbjct: 59   DNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI-DS 117

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVA 979
            +  LH       V+RDI   N+L+D+     ++DFG    L  D +  + +A GT  Y++
Sbjct: 118  VHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 171

Query: 980  PELAYTM-----KVTEKSDVYSFGVLALEAIKGKHP 1010
            PE+   M     K   + D +S GV   E + G+ P
Sbjct: 172  PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 46.9 bits (112), Expect = 3e-05
 Identities = 59/244 (24%), Positives = 93/244 (38%), Gaps = 44/244 (18%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF+    IG G  G V+   +  +G++ A+K      + +         E   L +   
Sbjct: 1    DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 865  RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
              IVK +Y F     H ++V EY+  G L  +L       E   T R  + + V  AL  
Sbjct: 61   PWIVKLYYSF-QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEE--TARFYIAELVL-ALDS 116

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTEL---------- 971
            +H   F   ++RDI   N+L+D   + H+  +DFG+ K +         L          
Sbjct: 117  VHKLGF---IHRDIKPDNILIDA--DGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 972  -------------------AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
                                GT  Y+APE+        + D +S GV+  E + G  P  
Sbjct: 172  NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP-- 229

Query: 1013 FISS 1016
            F S 
Sbjct: 230  FYSD 233

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 41.2 bits (97), Expect = 5e-05
 Identities = 14/45 (31%), Positives = 24/45 (53%), Gaps = 5/45 (11%)

Query: 36 EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCN 80
          ++  ALL +K+SL    +    L SW  ++     PC+W G+ C+
Sbjct: 3  DDRDALLAFKSSLNGDPS--GALSSWNPSS---SDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 46.1 bits (109), Expect = 5e-05
 Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 34/225 (15%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIV---AVKKFHSPLLSEMTCQQEFL-----------NEV 856
            +  IG GG G VY  + +S   +   AV K  +  L   T   E L              
Sbjct: 17   DKLIGCGGFGCVYETQCASDHCINNQAVAKIEN--LENETIVMETLVYNNIYDIDKIALW 74

Query: 857  KSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVI 914
            K++  I H  I K+YG C   +   + Y ++ +  L +  +           +++  N++
Sbjct: 75   KNIHNIDHLGIPKYYG-CGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIM 132

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS-------KSLK--PDS 965
            K +   L Y+H      I + DI  +N+++D     ++ D+GI+       K ++   + 
Sbjct: 133  KDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQ 189

Query: 966  SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             +     GT+ Y   +      VT + D+ S G   L+    K P
Sbjct: 190  KDLHR--GTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232

Length = 294

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 46.6 bits (110), Expect = 5e-05
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)

Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 25   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 82   LNVFTPQK----SLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 138  ---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 194  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (110), Expect = 6e-05
 Identities = 70/298 (23%), Positives = 103/298 (34%), Gaps = 76/298 (25%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V+   L  +G++ A+K      + +    +  L E + L  + H  +   Y 
Sbjct: 9    LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYA 68

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG---------VADALSY 923
                  +  +V +Y   G L  +L            Q    +           V  AL Y
Sbjct: 69   SFQTETYLCLVMDYCPGGELFRLLQ----------RQPGKCLSEEVARFYAAEVLLALEY 118

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLK--------------PDSSN 967
            LH      IVYRD+  +N+L  L    H+  SDF +SK                   SS 
Sbjct: 119  LHLL---GIVYRDLKPENIL--LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 968  WTEL---------------AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
             +                  GT  Y+APE+          D ++ G+L  E + G  P  
Sbjct: 174  NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP-- 231

Query: 1013 FISSICSTSSNLDRTLDEILD-----PRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            F        SN D T   IL      P  P  S + RD LI  +      L ++P  R
Sbjct: 232  F------KGSNRDETFSNILKKEVTFPGSPPVSSSARD-LIRKL------LVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 13/146 (8%)

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            FY F    R+ ++V EY+  G L  ++SN    E+  W +       V  AL  +H+  F
Sbjct: 109  FYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALDAIHSMGF 163

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAPELAYTMK- 987
               ++RD+   N+LLD      ++DFG    +  +     + A GT  Y++PE+  +   
Sbjct: 164  ---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 988  ---VTEKSDVYSFGVLALEAIKGKHP 1010
                  + D +S GV   E + G  P
Sbjct: 221  DGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.2 bits (109), Expect = 6e-05
 Identities = 37/146 (25%), Positives = 65/146 (44%), Gaps = 13/146 (8%)

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL       + DFG+++ +   PD     +    + ++APE  +    T 
Sbjct: 201  IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +SDV+SFGVL  E    G  P   +           R L E    R+ AP     +    
Sbjct: 261  QSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLKE--GTRMRAPDYTTPE---- 310

Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            + +  + C    P  RPT  ++ + L
Sbjct: 311  MYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.5 bits (108), Expect = 8e-05
 Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 24/218 (11%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTE 861
            +DF+    IG G  G V   ++ ++G++ A+K  +     EM  + E   F  E   L  
Sbjct: 1    DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNK---WEMLKRAETACFREERDVLVN 57

Query: 862  IRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATS--AEELGWTQRMNVIKGVA 918
               R I    Y F     + ++V +Y   G L  +LS       E++       ++  + 
Sbjct: 58   GDRRWITNLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAI- 115

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGY 977
            D++  L        V+RDI   NVLLD      ++DFG    L  D +  + +A GT  Y
Sbjct: 116  DSVHQLG------YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDY 169

Query: 978  VAPELAYTM-----KVTEKSDVYSFGVLALEAIKGKHP 1010
            ++PE+   M     +   + D +S GV   E + G+ P
Sbjct: 170  ISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 19/60 (31%), Positives = 28/60 (46%)

Query: 564 SLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           +L  L L+ N+ +         L  L+ LDLS N L++  P +   L  L  L+LS N  
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

 Score = 44.7 bits (106), Expect = 1e-04
 Identities = 52/233 (22%), Positives = 84/233 (36%), Gaps = 49/233 (21%)

Query: 108 PHLAYLDLRVNQ------IFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           P L  L L +N+          +   +     L+ LDLS N+        + +L      
Sbjct: 51  PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLL----- 105

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLG-----NLTNLAIMYLYNNSL 216
                             S L+ L L  NGL       L          L  + L  N L
Sbjct: 106 ----------------RSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRL 149

Query: 217 SG----SIPSEIGNLKSLSGLELGYNKLSG----SMPLSLGNLPNLATLDLHDNSLS--G 266
            G    ++   +   + L  L L  N +      ++   L    NL  LDL++N L+  G
Sbjct: 150 EGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEG 209

Query: 267 SIPLS--FGNLTNLDILNLPHNSLSGSIPSEM-----GNLKSLYGLGLSFNKL 312
           +  L+    +L +L++LNL  N+L+ +  + +         SL  L LS N +
Sbjct: 210 ASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDI 262

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 36/149 (24%), Positives = 64/149 (42%), Gaps = 19/149 (12%)

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL       + DFG+++ +   PD          + ++APE  +    T 
Sbjct: 196  IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 991  KSDVYSFGVLALEAIK-GKHPRDFIS---SICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
            +SDV+SFGVL  E    G  P   +      C    +  R    +  P    P       
Sbjct: 256  QSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR----MRAPENATP------- 304

Query: 1047 LISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               I  + ++C   +P  RPT   + ++L
Sbjct: 305  --EIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 48/204 (23%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88

Query: 871  YGFCSHARH------SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 198

Query: 985  TMKVTEKSDVYSFGVLALEAIKGK 1008
             M   E  D++S G +  E IKG 
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.4 bits (107), Expect = 1e-04
 Identities = 44/199 (22%), Positives = 89/199 (44%), Gaps = 23/199 (11%)

Query: 884  YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNV 942
            Y+      +  +LS+  S E L     ++    VA  + +L + +C    V+RD++++NV
Sbjct: 214  YKGSNDSEVKNLLSDDGS-EGLTTLDLLSFTYQVARGMEFLASKNC----VHRDLAARNV 268

Query: 943  LLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTEKSDVYSFGV 999
            LL       + DFG+++ +  D SN+     T   + ++APE  +    T  SDV+S+G+
Sbjct: 269  LLAQGKIVKICDFGLARDIMHD-SNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327

Query: 1000 LALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPSCNIRDKLISIMEVAISC 1057
            L  E          +         +D T    +    R+  P    ++    + ++ + C
Sbjct: 328  LLWEIFS-------LGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQE----VYDIMVKC 376

Query: 1058 LDENPDSRPTMQKVSQLLK 1076
             +  P+ RP+   +S +++
Sbjct: 377  WNSEPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.2 bits (95), Expect = 2e-04
 Identities = 24/60 (40%), Positives = 32/60 (53%)

Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL 312
           NL +LDL +N L+     +F  L NL +L+L  N+L+   P     L SL  L LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.8 bits (94), Expect = 2e-04
 Identities = 21/60 (35%), Positives = 26/60 (43%)

Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
            LK LDLS+N +          L +L  L L+ N  +   P     L  L  LDLS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.3 bits (105), Expect = 2e-04
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 17/203 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+V++A    + EIVA+K+       E       L E+  L E++H+NIV+ Y 
Sbjct: 8    IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLYD 66

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG----VADALSYLHNDC 928
                 +   +V+EY +   L     +              ++K     +   L++ H+  
Sbjct: 67   VLHSDKKLTLVFEYCDQ-DLKKYFDS------CNGDIDPEIVKSFMFQLLKGLAFCHSH- 118

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
               +++RD+  +N+L++   E  ++DFG++++       ++    T+ Y  P++ +  K+
Sbjct: 119  --NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 176

Query: 989  TEKS-DVYSFGVLALEAIKGKHP 1010
               S D++S G +  E      P
Sbjct: 177  YSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 42/160 (26%), Positives = 63/160 (39%), Gaps = 34/160 (21%)

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEEL--GWTQRMNVIKGVADALS 922
            N+V  + +       F+V ++ E G L + I       EE    W   M V      AL 
Sbjct: 46   NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVV------ALD 99

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG------ 976
             LH +    IV RD++  N+LLD      ++ F            W+E+  +        
Sbjct: 100  ALHRE---GIVCRDLNPNNILLDDRGHIQLTYFS----------RWSEVEDSCDGEAVEN 146

Query: 977  -YVAPELAYTMKVTEKSDVYSFGVLALEAIKGK-----HP 1010
             Y APE+    + TE  D +S G +  E + GK     HP
Sbjct: 147  MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 44.4 bits (105), Expect = 2e-04
 Identities = 39/164 (23%), Positives = 70/164 (42%), Gaps = 35/164 (21%)

Query: 855  EVKSLTEIRHRNIVKF-YGF------CSHARH-SFIVYEYLE-MGSLAMILSNATSAEEL 905
            E+  L  I HR I+   + +      C         ++ Y++  G L +           
Sbjct: 136  EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPL----------- 184

Query: 906  GWTQRMNVI-KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL--- 961
               ++   I + + +AL+YLH      I++RD+ ++N+ LD    A + DFG +  L   
Sbjct: 185  ---EQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238

Query: 962  --KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
               P    W   +GT+   +PEL        K+D++S G++  E
Sbjct: 239  PDTPQCYGW---SGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279

Length = 392

>gnl|CDD|215633 PLN03210, PLN03210, Resistant to P

 Score = 44.9 bits (106), Expect = 2e-04
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 22/270 (8%)

Query: 106 SFPHLAYLDLRVNQIFGIIPS-QIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS 164
           S   L  +DLR ++    IP   +A N  L+ L LS  S    +P  I  L+ L+ L +S
Sbjct: 632 SLTGLRNIDLRGSKNLKEIPDLSMATN--LETLKLSDCSSLVELPSSIQYLNKLEDLDMS 689

Query: 165 TNQFSGRIPPQIGHLSYLKALHLFENGLSG-SIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
             +    +P  I +L  L  L+L  +G S     P +   TN++ + L   ++    PS 
Sbjct: 690 RCENLEILPTGI-NLKSLYRLNL--SGCSRLKSFPDIS--TNISWLDLDETAIE-EFPSN 743

Query: 224 I--GNLKSLSGLELGYNKLSGSM----PLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTN 277
           +   NL  L   E+   KL   +    PL     P+L  L L D      +P S  NL  
Sbjct: 744 LRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHK 803

Query: 278 LDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
           L+ L + +     ++P+ + NL+SL  L LS      + P    N++ L +         
Sbjct: 804 LEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDISTNISDLNLSRTG----I 858

Query: 338 GSIPCEIGNLRYLFYLEL-GDNKLSGSIPH 366
             +P  I     L +L++ G N L     +
Sbjct: 859 EEVPWWIEKFSNLSFLDMNGCNNLQRVSLN 888

syringae 6; Provisional. Length = 1153

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 24/204 (11%)

Query: 814  IGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G   +V+  R++L+   +VA+K+    L  E       + EV  L  ++H NIV  +
Sbjct: 13   LGEGTYATVFKGRSKLT-ENLVALKEIR--LEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK----GVADALSYLHND 927
                  R   +V+EYL+   L   L N       G    M+ +K     +   LSY H  
Sbjct: 70   DIIHTERCLTLVFEYLD-SDLKQYLDNC------GNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMK 987
                I++RD+  +N+L++ + E  ++DFG++++    +  ++    T+ Y  P++   + 
Sbjct: 123  ---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV--LLG 177

Query: 988  VTEKS---DVYSFGVLALEAIKGK 1008
             TE S   D++  G +  E   G+
Sbjct: 178  STEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.4 bits (93), Expect = 3e-04
 Identities = 22/60 (36%), Positives = 33/60 (55%)

Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL 288
           +L  L+L  N+L+     +   LPNL  LDL  N+L+   P +F  L +L  L+L  N+L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 39.1 bits (92), Expect = 5e-04
 Identities = 22/58 (37%), Positives = 28/58 (48%)

Query: 588 QLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            L+ LDLS+NRL+    G+   L  L  L+LS N  +   P        L  LDLS N
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 43.6 bits (103), Expect = 5e-04
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            IG G  G V+   +   G+ VA+KK  +   + ++C++ F  E+K L   +H N++    
Sbjct: 8    IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLSALD 66

Query: 872  ----GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                         ++V E ++     +I+S    + +        +++G    L YLH+ 
Sbjct: 67   ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----LKYLHS- 121

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-NWTELAGTIGYVAPELA--- 983
                I++RDI   N+L++      + DFG+++  +PD S + T+   T  Y APE+    
Sbjct: 122  --AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGS 179

Query: 984  --YTMKVTEKSDVYSFGVLALEAIKGK 1008
              YT  V    D++S G +  E +  +
Sbjct: 180  RHYTSAV----DIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 43.2 bits (102), Expect = 5e-04
 Identities = 49/204 (24%), Positives = 93/204 (45%), Gaps = 22/204 (10%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G QG V  A +  +G+ VA+KK   P  +    ++ +  E+  +  + H+NI+    
Sbjct: 24   IGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY-RELVLMKLVNHKNIIGLLN 82

Query: 873  -FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKGVADALSYL 924
             F         +  ++V E ++  +L  ++      E + +   Q +  IK       +L
Sbjct: 83   VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMDLDHERMSYLLYQMLCGIK-------HL 134

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 135  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVIL 190

Query: 985  TMKVTEKSDVYSFGVLALEAIKGK 1008
             M   E  D++S G +  E I+G 
Sbjct: 191  GMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 42.3 bits (99), Expect = 8e-04
 Identities = 46/205 (22%), Positives = 90/205 (43%), Gaps = 17/205 (8%)

Query: 814  IGTGGQGSVYRAE--LSSGEIVAVKKFHSPLLSEMTCQQEFLNEV---KSLTEIRHRNIV 868
            IG G  G V++A    + G  VA+K+       E       + EV   + L    H N+V
Sbjct: 9    IGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 869  KFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            + +  C+ +R        +V+E+++   L   L           T + +++  +   L +
Sbjct: 68   RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIK-DMMFQLLRGLDF 125

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH+     +V+RD+  +N+L+    +  ++DFG+++      +  T +  T+ Y APE+ 
Sbjct: 126  LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVVTLWYRAPEVL 181

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGK 1008
                     D++S G +  E  + K
Sbjct: 182  LQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 46/203 (22%), Positives = 95/203 (46%), Gaps = 22/203 (10%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G   +VY+     +G++VA+K     + +E       + E   L  ++H NIV  + 
Sbjct: 13   LGEGSYATVYKGISRINGQLVALKVIS--MKTEEGVPFTAIREASLLKGLKHANIVLLHD 70

Query: 873  FCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNV---IKGVADALSYLHNDC 928
               H + +   V+EY+    LA  +      +  G     NV   +  +   L+Y+H   
Sbjct: 71   II-HTKETLTFVFEYMHT-DLAQYM-----IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ- 122

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
               I++RD+  +N+L+    E  ++DFG++++    S  ++    T+ Y  P++   +  
Sbjct: 123  --HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV--LLGA 178

Query: 989  TEKS---DVYSFGVLALEAIKGK 1008
            T+ S   D++  G + +E ++G+
Sbjct: 179  TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 42.3 bits (99), Expect = 0.001
 Identities = 46/202 (22%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 814  IGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G   +VY  R++L+   +VA+K+    L  E       + EV  L +++H NIV  +
Sbjct: 14   LGEGTYATVYKGRSKLTD-NLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK----GVADALSYLHND 927
                  +   +V+EYL+   L   L      ++ G +  M+ +K     +   L+Y H  
Sbjct: 71   DIIHTEKSLTLVFEYLDK-DLKQYL------DDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTM 986
                +++RD+  +N+L++   E  ++DFG++++    +  ++    T+ Y  P+ L  + 
Sbjct: 124  ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
              + + D++  G +  E   G+
Sbjct: 181  DYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 42.7 bits (100), Expect = 0.001
 Identities = 38/175 (21%), Positives = 74/175 (42%), Gaps = 22/175 (12%)

Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS-KSLKPDSSNWT 969
            + + + V  A+ YLH +    I++RDI ++N+ ++   +  + DFG +   +  +++ + 
Sbjct: 185  LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241

Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP---RDFISSICSTSSNLDR 1026
              AGTI   APEL          D++S G++  E          +D +   C +    DR
Sbjct: 242  GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDS----DR 297

Query: 1027 TLDEIL------DPRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074
             +  I+          P     N+ +  I + + +       P SRP    + +L
Sbjct: 298  QIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKS----SRKPGSRPLWTNLYEL 348

Length = 391

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 43/202 (21%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 814  IGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G   +V+  R++L+   +VA+K+    L  E       + EV  L +++H NIV  +
Sbjct: 14   LGEGTYATVFKGRSKLTE-NLVALKEIR--LEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK----GVADALSYLHND 927
                  +   +V+EYL+      +       ++ G    M+ +K     +   L+Y H  
Sbjct: 71   DIVHTDKSLTLVFEYLDKDLKQYM-------DDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTM 986
                +++RD+  +N+L++   E  ++DFG++++    +  ++    T+ Y  P+ L  + 
Sbjct: 124  ---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180

Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
            + + + D++  G +  E   G+
Sbjct: 181  EYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.9 bits (98), Expect = 0.001
 Identities = 29/91 (31%), Positives = 52/91 (57%), Gaps = 9/91 (9%)

Query: 917  VADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
            VA+ + +L + +C    V+RD++++NVL+       + DFG+++ +  DS N+     T 
Sbjct: 248  VANGMEFLASKNC----VHRDLAARNVLICEGKLVKICDFGLARDIMRDS-NYISKGSTF 302

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
              + ++APE  +    T  SDV+SFG+L  E
Sbjct: 303  LPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.6 bits (97), Expect = 0.002
 Identities = 58/242 (23%), Positives = 91/242 (37%), Gaps = 46/242 (19%)

Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF+    IG G  G V   +   +G + A+K      + E         E   L E    
Sbjct: 2    DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 866  NIVK-FYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSY 923
             +VK FY F     + +++ E+L  G +  +++   T  EE    +    I     A+  
Sbjct: 62   WVVKMFYSF-QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE----ETQFYIAETVLAIDS 116

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP-------------------- 963
            +H   F   ++RDI   N+LLD +    +SDFG+   LK                     
Sbjct: 117  IHQLGF---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173

Query: 964  -------DSSNWT----ELA----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK 1008
                    +  W     +LA    GT  Y+APE+       +  D +S GV+  E + G 
Sbjct: 174  QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233

Query: 1009 HP 1010
             P
Sbjct: 234  PP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.003
 Identities = 21/60 (35%), Positives = 29/60 (48%)

Query: 397 SLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           +L  L LS N L+     +F  L N+ VL +  N L+   P+ +  L  L  L LS N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.003
 Identities = 21/61 (34%), Positives = 29/61 (47%), Gaps = 2/61 (3%)

Query: 109 HLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQ-IGNLSMLKILYLSTNQ 167
           +L  LDL  N++  I          LK LDLS N+ + +I P+    L  L+ L LS N 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59

Query: 168 F 168
            
Sbjct: 60  L 60

Length = 60

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 40.9 bits (96), Expect = 0.003
 Identities = 50/217 (23%), Positives = 94/217 (43%), Gaps = 40/217 (18%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN-IVKFY 871
            IG G  G VY+A + ++G++VA+KK    +  E       L E+  L  +     IV+  
Sbjct: 9    IGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 872  GFCSHARHS------FIVYEYLEMGSLAMILSN---------ATSAEELGWTQRMNVIKG 916
                H          ++V+EYL+      + SN         A + +   +     ++KG
Sbjct: 68   D-VEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMY----QLLKG 122

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTI 975
            VA    + H      +++RD+  +N+L+D +     ++D G+ ++      ++T    T+
Sbjct: 123  VA----HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTL 175

Query: 976  GYVAPEL-----AYTMKVTEKSDVYSFGVLALEAIKG 1007
             Y APE+      Y+  V    D++S G +  E  + 
Sbjct: 176  WYRAPEVLLGSTHYSTPV----DIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 40.4 bits (94), Expect = 0.004
 Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 20/209 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + +++   +G G   +VY+ +   +G++VA+K     L  E       + E   L  ++H
Sbjct: 5    DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR--LQEEEGTPFTAIREASLLKGLKH 62

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNV---IKGVADAL 921
             NIV  +          +V+EY+    L   +      +  G     NV   +  +   L
Sbjct: 63   ANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMD-----KHPGGLHPENVKLFLFQLLRGL 116

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            SY+H      I++RD+  +N+L+    E  ++DFG++++    S  ++    T+ Y  P+
Sbjct: 117  SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPD 173

Query: 982  LAYTMKVTEKS---DVYSFGVLALEAIKG 1007
            +   +  TE S   D++  G + +E I+G
Sbjct: 174  V--LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	1077
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.98
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.98
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.98
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.98
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.98
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.98
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.98
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.98
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.98
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.98
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.98
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.98
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.98
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.98
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.98
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.98
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.98
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.98
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.98
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.98
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.98
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.97
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.97
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.97
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.93
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.93
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.92
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PLN00181	793	protein SPA1-RELATED; Provisional	99.9
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.9
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.89
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.89
PRK09188	365	serine/threonine protein kinase; Provisional	99.87
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.85
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.79
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
PRK12274	218	serine/threonine protein kinase; Provisional	99.77
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.77
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
PRK10345	210	hypothetical protein; Provisional	99.69
smart00090	237	RIO RIO-like kinase.	99.66
PRK14879	211	serine/threonine protein kinase; Provisional	99.65
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.64
PLN03150	623	hypothetical protein; Provisional	99.64
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.62
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.62
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.55
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.53
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.47
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.46
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.41
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
PLN03150	623	hypothetical protein; Provisional	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.24
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.22
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.21
KOG1243	690	consensus Protein kinase [General function predict	99.19
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.14
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.11
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.11
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.11
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.11
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.11
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.1
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.08
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.04
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.03
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.99
COG4248	637	Uncharacterized protein with protein kinase and he	98.99
KOG3087	229	consensus Serine/threonine protein kinase [General	98.96
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.93
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.92
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.91
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.84
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.69
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.68
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.65
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.64
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.6
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.57
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.52
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.48
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.47
COG5238	388	RNA1 Ran GTPase-activating protein (RanGAP) involv	98.43
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.34
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.34
PRK09902	216	hypothetical protein; Provisional	98.33

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.7e-115  Score=1129.23  Aligned_cols=911  Identities=37%  Similarity=0.605  Sum_probs=591.7

Q ss_pred             CHHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCccCceeecCCCCccccccCCCCcccccCCcccCCCCCCcEE
Q 001440           34 STEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYL  113 (1077)
Q Consensus        34 ~~~~~~all~~k~~~~~~~~~~~~l~~W~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~~~l~~~~~~~l~~L~~L  113 (1077)
                      .++|++||++||+++.++   .+.+.+|+.    +.+||.|.||+|+..++|+.|+|+++++.|.+++. |..+++|++|
T Consensus        27 ~~~~~~~l~~~~~~~~~~---~~~~~~w~~----~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~-~~~l~~L~~L   98 (968)
T PLN00113         27 HAEELELLLSFKSSINDP---LKYLSNWNS----SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA-IFRLPYIQTI   98 (968)
T ss_pred             CHHHHHHHHHHHHhCCCC---cccCCCCCC----CCCCCcCcceecCCCCcEEEEEecCCCccccCChH-HhCCCCCCEE
Confidence            578999999999999754   346789975    57899999999987788888888877777766543 6677777777


Q ss_pred             EccCCcccccCCcccC-CCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccC
Q 001440          114 DLRVNQIFGIIPSQIA-NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGL  192 (1077)
Q Consensus       114 ~L~~n~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l  192 (1077)
                      +|++|++.|.+|..+. ++++|++|+|++|.++|.+|.  +.+++|++|+|++|.+.+.+|..++.+++|++|+|++|.+
T Consensus        99 ~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l  176 (968)
T PLN00113         99 NLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVL  176 (968)
T ss_pred             ECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcc
Confidence            7777777766666544 677777777777777666664  3466666666666666666666666666666666666666


Q ss_pred             CCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCC
Q 001440          193 SGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF  272 (1077)
Q Consensus       193 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  272 (1077)
                      .+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..|
T Consensus       177 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l  256 (968)
T PLN00113        177 VGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL  256 (968)
T ss_pred             cccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhH
Confidence            65556556666666666666665555555555555555555555555555555555555555555555555555555555


Q ss_pred             CCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccccccccE
Q 001440          273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFY  352 (1077)
Q Consensus       273 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  352 (1077)
                      +++++|+.|+|++|++++.+|..+.++++|+.|++++|++.+.+|..+.++++|+.|++++                   
T Consensus       257 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~-------------------  317 (968)
T PLN00113        257 GNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFS-------------------  317 (968)
T ss_pred             hCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCC-------------------
Confidence            5555555555555555444444444444444444444444444444444444444444444                   


Q ss_pred             EeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccC
Q 001440          353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNAL  432 (1077)
Q Consensus       353 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  432 (1077)
                           |.+++.+|..++.+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++++|.+
T Consensus       318 -----n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l  392 (968)
T PLN00113        318 -----NNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSL  392 (968)
T ss_pred             -----CccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEe
Confidence                 444444444444444444444444444444444455555555555555555544444444444444444444444


Q ss_pred             cCCCCCccCCcccCcEEecccCcCCCCccccccccccceEeecCCccCCCCCcccccccccceeccccccccCCCCcCCC
Q 001440          433 SGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWG  512 (1077)
Q Consensus       433 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~  512 (1077)
                      .+.+|..+..+++|+.|++++|+++                                                       
T Consensus       393 ~~~~p~~~~~~~~L~~L~L~~n~l~-------------------------------------------------------  417 (968)
T PLN00113        393 EGEIPKSLGACRSLRRVRLQDNSFS-------------------------------------------------------  417 (968)
T ss_pred             cccCCHHHhCCCCCCEEECcCCEee-------------------------------------------------------
Confidence            4444444444444444444444333                                                       


Q ss_pred             CCCCCcEEEcccccccCCCCCCCCCCCCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhccccccee
Q 001440          513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL  592 (1077)
Q Consensus       513 ~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L  592 (1077)
                                      +..|..+..++.|+.|++++|.+++.++..+..+++|+.|++++|++.+.+|..+ ..++|+.|
T Consensus       418 ----------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L  480 (968)
T PLN00113        418 ----------------GELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENL  480 (968)
T ss_pred             ----------------eECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEE
Confidence                            2233333333444444444444444444444444455555555555544444433 23567777


Q ss_pred             eccCCcccCCCCCcccccccceeeeeccccccCCcchhccccccccceecccccCCCCCccccccccccchhcccccccc
Q 001440          593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS  672 (1077)
Q Consensus       593 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~  672 (1077)
                      ++++|++++..|..|..+++|++|+|++|++.+..|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|+++
T Consensus       481 ~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  560 (968)
T PLN00113        481 DLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLS  560 (968)
T ss_pred             ECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCccc
Confidence            77777777777777777777777888888777777777888888888888888888888888888888889999999998


Q ss_pred             cccchhhhccccccEEeccCCcccCCCCCCcccccCCcccccCCCcccCCCC--CCCcccCCCCcccccceeEEEEehhh
Q 001440          673 GFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIK--GFPSCKASKSDKQASRKIWVVIVFPL  750 (1077)
Q Consensus       673 ~~~~~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~~~~~~n~~~c~~~~--~~~~~~~~~~~~~~~~~~~~~ii~~~  750 (1077)
                      +.+|..+..+++|+.+++++|++.|.+|...+|.++....+.||+.+|+...  +.++|...    .. ...|.++++++
T Consensus       561 ~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~----~~-~~~~~~~~~~~  635 (968)
T PLN00113        561 GEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRV----RK-TPSWWFYITCT  635 (968)
T ss_pred             ccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccc----cc-cceeeeehhHH
Confidence            8889999999999999999999999999988898888889999999998643  35667421    11 22233333344


Q ss_pred             hhHHHHHHHHHhhhhhhccccccccccCCCCCCCCccc--cccccccCCHHHHHHHhcCCCccceecccCCceEEEEEe-
Q 001440          751 LGSFALLISLIGLFFMFRRRSSSQTQQSSAGNAPGFLS--VLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL-  827 (1077)
Q Consensus       751 ~~~~~~li~~~~~~~~~~r~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-  827 (1077)
                      +++++++++++++++++|||+..+.+............  .......+.++++   ...|...+.||+|+||.||+|+. 
T Consensus       636 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~  712 (968)
T PLN00113        636 LGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---LSSLKEENVISRGKKGASYKGKSI  712 (968)
T ss_pred             HHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---HhhCCcccEEccCCCeeEEEEEEC
Confidence            44443333333333333333221111111100000000  0011122334443   34577788999999999999976 


Q ss_pred             cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCH
Q 001440          828 SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW  907 (1077)
Q Consensus       828 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~  907 (1077)
                      .+++.||||++......       ...|++.+++++|||||+++|++.+++..++||||+++|+|.++++      .++|
T Consensus       713 ~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~------~l~~  779 (968)
T PLN00113        713 KNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR------NLSW  779 (968)
T ss_pred             CCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh------cCCH
Confidence            47899999998653211       1245788899999999999999999999999999999999999994      2789


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcccccccccccCccccccCC
Q 001440          908 TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMK  987 (1077)
Q Consensus       908 ~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  987 (1077)
                      .++.+++.|||+|++|||..+.++|+||||||+||+++.++.+++. ||.+.....+    ....+++.|+|||++.+..
T Consensus       780 ~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~  854 (968)
T PLN00113        780 ERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD----TKCFISSAYVAPETRETKD  854 (968)
T ss_pred             HHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----CCccccccccCcccccCCC
Confidence            9999999999999999997666699999999999999999988876 6655433222    2236789999999999999


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCccccccccCc------ccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCC
Q 001440          988 VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS------NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDEN 1061 (1077)
Q Consensus       988 ~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 1061 (1077)
                      ++.++|||||||++|||+||+.||+..........      ........++++..........+....+.+++.+||+.|
T Consensus       855 ~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~  934 (968)
T PLN00113        855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATD  934 (968)
T ss_pred             CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCC
Confidence            99999999999999999999999853221100000      001122334444443332333456667889999999999


Q ss_pred             CCCCCCHHHHHhhhc
Q 001440         1062 PDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1062 P~~RPs~~evl~~L~ 1076 (1077)
                      |++||+|+||++.|+
T Consensus       935 P~~RPt~~evl~~L~  949 (968)
T PLN00113        935 PTARPCANDVLKTLE  949 (968)
T ss_pred             chhCcCHHHHHHHHH
Confidence            999999999999886

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-63  Score=642.80  Aligned_cols=497  Identities=42%  Similarity=0.623  Sum_probs=424.3

Q ss_pred             CCccccccCCCCcccccCCcccCCCCCCcEEEccCCcccccCCcccCCCCCCCEEeCCCCCCCCCCCCCCCCcCccceec
Q 001440           83 GKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILY  162 (1077)
Q Consensus        83 ~~v~~l~l~~~~l~~~l~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~  162 (1077)
                      ..+..|+|+++.+.|.+|+..+..+++|++|+|++|++.+.+|.  +.+++|++|+|++|.+++.+|..++++++|++|+
T Consensus        93 ~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~  170 (968)
T PLN00113         93 PYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLD  170 (968)
T ss_pred             CCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEE
Confidence            36778899999999999988778999999999999999998886  5689999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccC
Q 001440          163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSG  242 (1077)
Q Consensus       163 L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~  242 (1077)
                      |++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..|+++++|++|++++|.+++
T Consensus       171 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~  250 (968)
T PLN00113        171 LGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTG  250 (968)
T ss_pred             CccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceecc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCC
Q 001440          243 SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGN  322 (1077)
Q Consensus       243 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  322 (1077)
                      .+|..|+++++|++|+|++|++++.+|..+.++++|+.|+|++|++++.+|..+.++++|+.|++++|.+++.+|..+.+
T Consensus       251 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~  330 (968)
T PLN00113        251 PIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS  330 (968)
T ss_pred             ccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeee
Q 001440          323 LTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLG  402 (1077)
Q Consensus       323 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~  402 (1077)
                      +++|+.|++++|.+.+.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++.+|.+.+.+|..++.+++|+.|+
T Consensus       331 l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~  410 (968)
T PLN00113        331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR  410 (968)
T ss_pred             CCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEE
Confidence            99999999999999999999999999999999999999888888888888888888888888888888888888888888


Q ss_pred             cCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCCccccccccccceEeecCCccCCC
Q 001440          403 LSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGN  482 (1077)
Q Consensus       403 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~  482 (1077)
                      +++|++++.+|..|.++++|+.|++++|.+++.+|..+..+++|+.|+|++|++                          
T Consensus       411 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~--------------------------  464 (968)
T PLN00113        411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF--------------------------  464 (968)
T ss_pred             CcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCcee--------------------------
Confidence            888877777777666666666666666666665555554444454444444444                          


Q ss_pred             CCcccccccccceeccccccccCCCCcCCCCCCCCcEEEcccccccCCCCCCCCCCCCCCEEEccCCccCCCCchhhcCC
Q 001440          483 ISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKL  562 (1077)
Q Consensus       483 ~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l  562 (1077)
                                                                   .+..|..+ ..++|+.|++++|++.+..|..+..+
T Consensus       465 ---------------------------------------------~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l  498 (968)
T PLN00113        465 ---------------------------------------------FGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSL  498 (968)
T ss_pred             ---------------------------------------------eeecCccc-ccccceEEECcCCccCCccChhhhhh
Confidence                                                         33333322 23567888888888887778778778


Q ss_pred             CCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCCCCcccccccceeeeeccccccCCcchhccccccccceec
Q 001440          563 RSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDL  642 (1077)
Q Consensus       563 ~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L  642 (1077)
                      ++|+.|+|++|++++.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|+|++|++++.+|..+..+.+|+.|++
T Consensus       499 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~l  578 (968)
T PLN00113        499 SELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI  578 (968)
T ss_pred             hccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEec
Confidence            88888888888887777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             ccccCCCCCcc
Q 001440          643 SHNFLGEEIPS  653 (1077)
Q Consensus       643 s~N~i~~~~~~  653 (1077)
                      ++|++.+.+|.
T Consensus       579 s~N~l~~~~p~  589 (968)
T PLN00113        579 SHNHLHGSLPS  589 (968)
T ss_pred             cCCcceeeCCC
Confidence            77777665553

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=423.05  Aligned_cols=281  Identities=42%  Similarity=0.692  Sum_probs=236.2

Q ss_pred             ccccCCHHHHHHHhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEE
Q 001440          792 FDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY  871 (1077)
Q Consensus       792 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~  871 (1077)
                      ..+.++++++..|+++|...++||+|+||.||+|...+|+.||||++.......   .++|.+|+.++.+++|||+|+++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll  137 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL  137 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence            456789999999999999999999999999999999999999999887643221   45699999999999999999999


Q ss_pred             EEEeeCC-eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCce
Q 001440          872 GFCSHAR-HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA  950 (1077)
Q Consensus       872 ~~~~~~~-~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  950 (1077)
                      |||.+.+ +.++|||||++|+|.++++..... .++|.+|++||.++|+||+|||+.+.|+|+|||||++|||+|+++++
T Consensus       138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            9999988 599999999999999999876544 78999999999999999999999988899999999999999999999


Q ss_pred             EEecccccccCCCCCCCcccc-cccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccc------cC-c
Q 001440          951 HVSDFGISKSLKPDSSNWTEL-AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS------TS-S 1022 (1077)
Q Consensus       951 kl~Dfgla~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~------~~-~ 1022 (1077)
                      ||+|||+|+............ .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+.......      .. .
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             EccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            999999997654412222222 899999999999999999999999999999999999988764321100      00 1


Q ss_pred             ccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1023 NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .....+.+++|+++........+....+..++.+|++.+|++||+|.||+++|+
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~  350 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE  350 (361)
T ss_pred             HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence            112367788898876322222256777999999999999999999999999884

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=406.60  Aligned_cols=250  Identities=27%  Similarity=0.469  Sum_probs=227.8

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|...+.||+|||+.||+++. .+|+.||+|++.+.........+++.+|+++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5699999999999999999977 789999999998877777777889999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |+|+.|+|.+++++.   ..+++.+++.+++||+.|+.|||+.   +|+|||||..|++++++.++||+|||+|..+..+
T Consensus        98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc
Confidence            999999999999744   3589999999999999999999999   9999999999999999999999999999999988


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      .+...+.+|||.|.|||++....++..+||||+||+||-|+.|++||+        ...+.+....+....+..|.    
T Consensus       172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFe--------tk~vkety~~Ik~~~Y~~P~----  239 (592)
T KOG0575|consen  172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFE--------TKTVKETYNKIKLNEYSMPS----  239 (592)
T ss_pred             ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcc--------cchHHHHHHHHHhcCccccc----
Confidence            788888999999999999999999999999999999999999999997        34456677777766666654    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .......++|.++|+.||.+|||+++|+.
T Consensus       240 ~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            33446778999999999999999999985

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=403.44  Aligned_cols=252  Identities=31%  Similarity=0.544  Sum_probs=210.3

Q ss_pred             CCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-eeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-HSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~  886 (1077)
                      ....+.+|+|+||+||+|.|+....||||++......... .++|.+|+.++.+++|||||+++|+|.++. ..++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            3445569999999999999984444999999876555444 789999999999999999999999999887 79999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEeccCCCCCeeeCCCC-ceEEecccccccCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP-IVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPD  964 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  964 (1077)
                      +++|+|.++++.. ....+++..+++||.|||+||.|||++   + ||||||||+|||++.++ .+||+|||+++.....
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999875 345699999999999999999999999   7 99999999999999997 9999999999876654


Q ss_pred             CCCcccccccccccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhc-CC-CCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAY--TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL-DP-RLPAPS 1040 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~ 1040 (1077)
                      ....+...||++|||||++.  ...|+.|+||||||+++|||+||+.||.....        .+....+. .. +.+.+.
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v~~~~~Rp~~p~  269 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAVVVGGLRPPIPK  269 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCCCc
Confidence            34445578999999999999  66999999999999999999999999974432        11222222 11 222222


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .    ....+..++..||+.||++||++.|++..|+
T Consensus       270 ~----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~  301 (362)
T KOG0192|consen  270 E----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLE  301 (362)
T ss_pred             c----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence            1    3346888899999999999999999999886

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-45  Score=379.83  Aligned_cols=253  Identities=27%  Similarity=0.400  Sum_probs=213.7

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-eeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-HSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~  884 (1077)
                      +.+....||+|..|+||+++++ +++.+|+|.+...  .+...++++.+|++++++.+||+||.++|+|...+ ...|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            3455678999999999999876 7889999999543  34445788999999999999999999999999998 599999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |||++|+|++++...   +.+++...-+|+.+|++||.|||+..  +||||||||+|||++..|+|||||||.++.+...
T Consensus       158 EYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999999765   34788999999999999999999742  9999999999999999999999999999877554


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||...   ........+.+..+++...|..+..  
T Consensus       233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~ppP~lP~~--  305 (364)
T KOG0581|consen  233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPPPRLPEG--  305 (364)
T ss_pred             --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCCCCCCcc--
Confidence              456789999999999999999999999999999999999999998643   1122344556666766433322211  


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....++..++..||++||.+||+++|+++
T Consensus       306 ~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  306 EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            34567999999999999999999999976

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-44  Score=380.29  Aligned_cols=256  Identities=25%  Similarity=0.351  Sum_probs=219.0

Q ss_pred             HhcCCCccceecccCCceEEEE-EecCCCEEEEEEccCCccchhh----HHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMT----CQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      ..+.|.+.+.+|+|+||.|-+| ..++|+.||||++++.......    ....+.+|+++|++++|||||++++++..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            3456788899999999999999 4568999999999876544322    2334679999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC---CceEEecc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDF  955 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Df  955 (1077)
                      ..||||||++||+|.+++-....   +.+.....+++|++.|+.|||+.   ||+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999999876553   55577788999999999999999   99999999999999876   77999999


Q ss_pred             cccccCCCCCCCcccccccccccCccccccCCC---CCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhc
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYTMKV---TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1032 (1077)
                      |+|+... ....+.+.+||+.|.|||++.++.+   ..++|+||+||++|-+++|.+||.....       .....+++.
T Consensus       324 GlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-------~~sl~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-------DPSLKEQIL  395 (475)
T ss_pred             chhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-------CccHHHHHh
Confidence            9999876 5567789999999999999987653   3478999999999999999999973322       122456777


Q ss_pred             CCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+++...+..+.....+..++|.+||..||++|||++|+++
T Consensus       396 ~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  396 KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            78888777777888889999999999999999999999986

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-44  Score=392.59  Aligned_cols=251  Identities=29%  Similarity=0.500  Sum_probs=210.2

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ..+...+.||+|-||+||.|+++...+||+|.++.....    .+.|.+|+.+|++++|++||+++|+|..++..+||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE  281 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE  281 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence            344567889999999999999987779999999875332    5778899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      ||+.|+|.+|++.. ....+...+.+.++.|||+||+||+++   ++|||||.++||||+++..+||+|||+|+...++.
T Consensus       282 ~m~~GsLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~  357 (468)
T KOG0197|consen  282 YMPKGSLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDE  357 (468)
T ss_pred             ecccCcHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence            99999999999873 345588899999999999999999999   99999999999999999999999999999554443


Q ss_pred             CCcc-cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC-CCCCCCCCC
Q 001440          966 SNWT-ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-PRLPAPSCN 1042 (1077)
Q Consensus       966 ~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1042 (1077)
                      ...+ ...-+..|+|||.+....++.|||||||||+|||++| |+.||...        ...+.++.+.. .+++.|.. 
T Consensus       358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m--------sn~ev~~~le~GyRlp~P~~-  428 (468)
T KOG0197|consen  358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM--------SNEEVLELLERGYRLPRPEG-  428 (468)
T ss_pred             eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC--------CHHHHHHHHhccCcCCCCCC-
Confidence            3222 2234789999999999999999999999999999999 88887522        23344444433 34555543 


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         ++..++++|..||+.+|++|||++.+...|+
T Consensus       429 ---CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~  459 (468)
T KOG0197|consen  429 ---CPDEVYELMKSCWHEDPEDRPTFETLREVLE  459 (468)
T ss_pred             ---CCHHHHHHHHHHhhCCcccCCCHHHHHHHHH
Confidence               3346889999999999999999998887764

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.6e-48  Score=404.14  Aligned_cols=492  Identities=32%  Similarity=0.436  Sum_probs=379.8

Q ss_pred             CCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCe
Q 001440          177 GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLAT  256 (1077)
Q Consensus       177 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~  256 (1077)
                      +.-.-|+.|.+++|.++. +-+.+.+|..|.+|++++|+++ ..|.+++.+..++.|+.++|+++ .+|..++++.+|..
T Consensus        42 W~qv~l~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~  118 (565)
T KOG0472|consen   42 WEQVDLQKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVK  118 (565)
T ss_pred             hhhcchhhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhh
Confidence            334556777777777763 3444777888888888888888 67888888888888999999888 78888888889999


Q ss_pred             EEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCccc
Q 001440          257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL  336 (1077)
Q Consensus       257 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l  336 (1077)
                      |+.++|.+. .+|++++.+..|+.|+..+|+++ ..|+.++++.+|..|++.+|++....|..+ +++.|++||..+|.+
T Consensus       119 l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ld~~~N~L  195 (565)
T KOG0472|consen  119 LDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKHLDCNSNLL  195 (565)
T ss_pred             hhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHhcccchhhh
Confidence            999999988 67788888888999999999988 577888888899999999999885544444 488899999988888


Q ss_pred             ccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCccccc-CCCCCCeeecCCCCcCCCcccc
Q 001440          337 FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIG-NLNSLSDLGLSENELSGSIPYS  415 (1077)
Q Consensus       337 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~  415 (1077)
                      + .+|..++.+.+|..|+|..|+|. .+| .|.+++.|.++++..|+|+ .+|.+.+ ++.++..|||..|+++ ..|..
T Consensus       196 ~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde  270 (565)
T KOG0472|consen  196 E-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDE  270 (565)
T ss_pred             h-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchH
Confidence            6 78888999999999999999887 566 7888999999999999998 5666655 7899999999999997 78888


Q ss_pred             cccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCCccccccccc---cceEeecCCccCCCCCcccccccc
Q 001440          416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTR---LARVRLDRNHLTGNISESFGIHSN  492 (1077)
Q Consensus       416 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~---L~~L~L~~n~l~~~~~~~~~~~~~  492 (1077)
                      ++-+.+|.+||+++|.|+ .+|..++++ .|+.|-+.+|.+...-.++-+...   |+.|+   ..++......-. -..
T Consensus       271 ~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLr---s~~~~dglS~se-~~~  344 (565)
T KOG0472|consen  271 ICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLR---SKIKDDGLSQSE-GGT  344 (565)
T ss_pred             HHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHH---HhhccCCCCCCc-ccc
Confidence            888888999999999887 467788888 888888888887543222111111   11111   011110000000 000


Q ss_pred             cceeccccccccCCCCcCCCCCCCCcEEEcccccccCCCCCCCCCCCC---CCEEEccCCccCCCCchhhcCCCCCcE-E
Q 001440          493 LSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQ---LKVLDLSSNHIVGEIPSELGKLRSLIK-L  568 (1077)
Q Consensus       493 L~~L~Ls~n~i~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~---L~~L~Ls~N~l~~~~~~~l~~l~~L~~-L  568 (1077)
                      -..-+     ...........+.+.+.|++++-+++.+ |+......+   ....+++.|++. ++|..+..+..+.+ +
T Consensus       345 e~~~t-----~~~~~~~~~~~~i~tkiL~~s~~qlt~V-PdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l  417 (565)
T KOG0472|consen  345 ETAMT-----LPSESFPDIYAIITTKILDVSDKQLTLV-PDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDL  417 (565)
T ss_pred             cccCC-----CCCCcccchhhhhhhhhhcccccccccC-CHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHH
Confidence            00000     0001111222446788899999888854 444433333   789999999997 78888887776554 5


Q ss_pred             EccCccccCCcchhhhcccccceeeccCCcccCCCCCcccccccceeeeeccccccCCcchhccccccccceecccccCC
Q 001440          569 TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLG  648 (1077)
Q Consensus       569 ~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~  648 (1077)
                      .+++|.++ .+|..+..+++|..|+|++|.+. .+|..++.+..|+.|++++|++. ..|..+..+..|+.+-.++|++.
T Consensus       418 ~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~  494 (565)
T KOG0472|consen  418 VLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIG  494 (565)
T ss_pred             HhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhcccccc
Confidence            56666665 88999999999999999999997 78999999999999999999998 88998888888888888889998


Q ss_pred             CCCccccccccccchhcccccccccccchhhhccccccEEeccCCccc
Q 001440          649 EEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH  696 (1077)
Q Consensus       649 ~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~N~l~  696 (1077)
                      .+.++.+.+|.+|.+|||.+|.+. .+|..+++|.+|++|+++||+++
T Consensus       495 ~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  495 SVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            888888999999999999999998 78999999999999999999998

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=359.67  Aligned_cols=256  Identities=25%  Similarity=0.349  Sum_probs=214.0

Q ss_pred             cCCCccceecccCCceEEEE-EecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEE-EEeeCC-eeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG-FCSHAR-HSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~-~~~l  882 (1077)
                      .+|.+.++||+|.||+||++ +..+|..||.|.+.-.. .+....+....|+.++++++|||||++++ .+.++. ..+|
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~-md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni   97 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGM-MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI   97 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhh-ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence            35778899999999999999 55689999999998543 34455778999999999999999999998 344444 4899


Q ss_pred             EEeecCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeccCCCCCeeeCCCCceEEecccccc
Q 001440          883 VYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPP--IVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      |||||+.|+|..+++..+. ...+++..++++..|++.||.++|.. .|.  |+||||||.||+++.+|.+|++|||+++
T Consensus        98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            9999999999999876543 44588999999999999999999994 235  8999999999999999999999999999


Q ss_pred             cCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      .+........+.+|||.||+||.+.+.+|+.||||||+||++|||+.-++||..        .+.......+....+++ 
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g--------~n~~~L~~KI~qgd~~~-  247 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG--------DNLLSLCKKIEQGDYPP-  247 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc--------ccHHHHHHHHHcCCCCC-
Confidence            998887777889999999999999999999999999999999999999999862        23344444555554442 


Q ss_pred             CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       .+..-++..+.++|..|+..||+.||+.-.+++
T Consensus       248 -~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~  280 (375)
T KOG0591|consen  248 -LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ  280 (375)
T ss_pred             -CcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence             222445668999999999999999998544444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=368.62  Aligned_cols=201  Identities=29%  Similarity=0.484  Sum_probs=180.8

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+.+.... ...++-+..|+.+++.++|||||++++++..++..|+|
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            467888889999999999999775 6899999999876543 33366788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC------CceEEecccc
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE------YEAHVSDFGI  957 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~kl~Dfgl  957 (1077)
                      ||||.+|+|.+|++...   .+++..+..++.|+|.|+++||++   +||||||||.|||++..      -.+||+|||+
T Consensus        88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999998764   478899999999999999999999   99999999999999875      4589999999


Q ss_pred             cccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCc
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDF 1013 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 1013 (1077)
                      |+.+.+. ....+.+|++-|||||+++...|+.|+|+||+|+++||+++|+.||+.
T Consensus       162 AR~L~~~-~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  162 ARFLQPG-SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             hhhCCch-hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence            9988744 334677899999999999999999999999999999999999999983

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-43  Score=366.69  Aligned_cols=245  Identities=27%  Similarity=0.427  Sum_probs=216.5

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.++||+|+||.||.++.+ +++.+|+|++.+....+..+.+...+|..++.+++||.||+++..|.+....|+|
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            468999999999999999999654 7899999999988777777788999999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +||+.||.|+.++++..   .+++..+.-++..|+.||.|||++   +|||||+||+|||+|.+|.++|+|||+++....
T Consensus       104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999997654   377788888999999999999999   999999999999999999999999999997766


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      ++....+++||+.|||||++.+.+|+.++|+||+|+++|||++|.+||.        .++.....+.+...+.+.+....
T Consensus       178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~--------~~~~~~~~~~I~~~k~~~~p~~l  249 (357)
T KOG0598|consen  178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY--------AEDVKKMYDKILKGKLPLPPGYL  249 (357)
T ss_pred             CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc--------CccHHHHHHHHhcCcCCCCCccC
Confidence            6666778899999999999999999999999999999999999999987        34455667777766644443322


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 001440         1044 RDKLISIMEVAISCLDENPDSRP 1066 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RP 1066 (1077)
                      .   ....+++.+.++.||++|.
T Consensus       250 s---~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  250 S---EEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             C---HHHHHHHHHHhccCHHHhc
Confidence            2   3577899999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-44  Score=399.43  Aligned_cols=268  Identities=28%  Similarity=0.508  Sum_probs=224.8

Q ss_pred             ccccccCCHHHHHHHhcCC---------CccceecccCCceEEEEEec----CCCEEEEEEccCCccchhhHHHHHHHHH
Q 001440          790 LTFDRKIAYEEIVRATNDF---------DEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEV  856 (1077)
Q Consensus       790 ~~~~~~~~~~~~~~~~~~~---------~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~  856 (1077)
                      .+..++.+||+.-.+..+|         .+.++||.|.||.||+|+++    ....||||.++...  .+.++++|..|+
T Consensus       604 k~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EA  681 (996)
T KOG0196|consen  604 KTYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEA  681 (996)
T ss_pred             eeecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhh
Confidence            3445566666655554443         45789999999999999875    23569999998764  334588999999


Q ss_pred             HHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEecc
Q 001440          857 KSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRD  936 (1077)
Q Consensus       857 ~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D  936 (1077)
                      .+|.+++||||+++.|+....+..+||+|||++|+|+.||+.+.  .++++.|...|.++||.||.||.+.   ++||||
T Consensus       682 sIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm---~YVHRD  756 (996)
T KOG0196|consen  682 SIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRD  756 (996)
T ss_pred             hhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhc---Cchhhh
Confidence            99999999999999999999999999999999999999998765  5689999999999999999999998   999999


Q ss_pred             CCCCCeeeCCCCceEEecccccccCCCCCCC-cccccc--cccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q 001440          937 ISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-WTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRD 1012 (1077)
Q Consensus       937 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~ 1012 (1077)
                      |.++|||++.+..+|++|||++|.+.++... +++..|  +.+|.|||.+..+.++.++||||||++|||.++ |..||.
T Consensus       757 LAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  757 LAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             hhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence            9999999999999999999999988776533 333333  689999999999999999999999999999998 999987


Q ss_pred             ccccccccCcccccchhhhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1013 FISSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.        .++.+..+.+. ++|+|.    +.+..+.++|..||++|-.+||+++||+..|+
T Consensus       837 dmS--------NQdVIkaIe~gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lD  889 (996)
T KOG0196|consen  837 DMS--------NQDVIKAIEQGYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLD  889 (996)
T ss_pred             ccc--------hHHHHHHHHhccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHH
Confidence            443        23445555443 466554    44567999999999999999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=9.4e-43  Score=400.41  Aligned_cols=255  Identities=28%  Similarity=0.471  Sum_probs=213.0

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      .+....+.||+|.||+||+|+..      +...||||.++..  .+...+++|.+|+++++.++|||||+++|+|..++.
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            34456678999999999999653      3457999999876  334458899999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          880 SFIVYEYLEMGSLAMILSNAT-------S----AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      .+||+|||..|+|.+||.-..       .    ..+++..+.+.||.|||.||+||.++   .+|||||..+|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence            999999999999999996432       1    23488999999999999999999999   899999999999999999


Q ss_pred             ceEEecccccccCCC-CCCCcc-cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccc
Q 001440          949 EAHVSDFGISKSLKP-DSSNWT-ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLD 1025 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~-~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1025 (1077)
                      .|||+|||+++.+-. +..+.. ...-+.+|||||.+..++|+.+||||||||++||+++ |+.||...        ..+
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl--------Sn~  712 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL--------SNQ  712 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc--------chH
Confidence            999999999997533 333222 3345789999999999999999999999999999998 88897632        335


Q ss_pred             cchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1026 RTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +.++.+.+++.-.-   +...+.+++++|..||+.+|++||++.||-..|+
T Consensus       713 EVIe~i~~g~lL~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~  760 (774)
T KOG1026|consen  713 EVIECIRAGQLLSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQ  760 (774)
T ss_pred             HHHHHHHcCCcccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHH
Confidence            66666666665322   2344557999999999999999999999998875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.2e-42  Score=348.27  Aligned_cols=261  Identities=22%  Similarity=0.375  Sum_probs=208.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|+...++|+|+||+||+|+.+ +|+.||||+|.... .+....+-..+|++++++++|+|+|.++++|...+..++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            35777888999999999999776 79999999997653 33444566899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |||+.--|.+ +.+..  .-++.+.+.+++.|++.|++|+|++   +++||||||+||+++.+|.+|+||||+|+.+...
T Consensus        81 E~~dhTvL~e-Le~~p--~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   81 EYCDHTVLHE-LERYP--NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             eecchHHHHH-HHhcc--CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9998855554 43333  2267788999999999999999999   9999999999999999999999999999999878


Q ss_pred             CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccccchhhh-----
Q 001440          965 SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRTLDEI----- 1031 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~----- 1031 (1077)
                      +..++..+.|..|.|||.+.+ ..|+..+||||+||++.||++|.+-|...++....       +....+...-+     
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            888899999999999998887 78999999999999999999999887644432211       00111111100     


Q ss_pred             -cCCCCCCCCCC------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1032 -LDPRLPAPSCN------IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1032 -~~~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       ..-++|.+...      .......+.+++++|++.||++|++.+|++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence             01122322211      1223346789999999999999999999874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=2.5e-46  Score=389.38  Aligned_cols=491  Identities=32%  Similarity=0.437  Sum_probs=303.0

Q ss_pred             CCCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcE
Q 001440          129 ANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAI  208 (1077)
Q Consensus       129 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  208 (1077)
                      ..-..|+.|++++|.+. .+-+.+.+|..|.+|++.+|++. ..|++++.+.+++.|+.++|+++ .+|+.++.+.+|..
T Consensus        42 W~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~  118 (565)
T KOG0472|consen   42 WEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVK  118 (565)
T ss_pred             hhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhh
Confidence            34456777777777776 44455667777777777777766 56666666666666666666665 44555555555555


Q ss_pred             EEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCC
Q 001440          209 MYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL  288 (1077)
Q Consensus       209 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  288 (1077)
                      |+.++|.+. .+|+.++.+..|..                        |+..+|+++ ..|+.++.+.+|..|++.+|++
T Consensus       119 l~~s~n~~~-el~~~i~~~~~l~d------------------------l~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l  172 (565)
T KOG0472|consen  119 LDCSSNELK-ELPDSIGRLLDLED------------------------LDATNNQIS-SLPEDMVNLSKLSKLDLEGNKL  172 (565)
T ss_pred             hhcccccee-ecCchHHHHhhhhh------------------------hhccccccc-cCchHHHHHHHHHHhhccccch
Confidence            555555555 34444444444444                        444444444 3444444555555555555555


Q ss_pred             CCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCC-
Q 001440          289 SGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS-  367 (1077)
Q Consensus       289 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-  367 (1077)
                      ....|..+. ++.|++||...|-++ .+|..++.+.+|+.|||.+|+|. .+| +|.+++.|.+|+++.|+|+ .+|.. 
T Consensus       173 ~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~  247 (565)
T KOG0472|consen  173 KALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEH  247 (565)
T ss_pred             hhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHH
Confidence            533333332 555555555555444 44555555555555555555554 333 4555555555555555554 33333 


Q ss_pred             CCCCcccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcc---
Q 001440          368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLV---  444 (1077)
Q Consensus       368 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~---  444 (1077)
                      ..++.++..|+|..|+++ ..|.++.-+++|++||+|+|.|+ ..|.+++++ .|+.|-+.+|.+..+ ...+-+..   
T Consensus       248 ~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTi-Rr~ii~~gT~~  323 (565)
T KOG0472|consen  248 LKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTI-RREIISKGTQE  323 (565)
T ss_pred             hcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHH-HHHHHcccHHH
Confidence            225555556666666665 55666666666666666666666 455566666 666666666666421 11111110   


Q ss_pred             cCcEEe--cccCcCCCCccccccccccceEeecCCccCCCCCcccccccccceeccccccccCCCCcCCCCC--CCCcEE
Q 001440          445 KLTLLV--LSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF--PNLGTL  520 (1077)
Q Consensus       445 ~L~~L~--Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~--~~L~~L  520 (1077)
                      -|++|.  +-.-.++..-..     +-....     .............+.+.|+++.-+++.++.+.|..-  .-++.+
T Consensus       324 vLKyLrs~~~~dglS~se~~-----~e~~~t-----~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~V  393 (565)
T KOG0472|consen  324 VLKYLRSKIKDDGLSQSEGG-----TETAMT-----LPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSV  393 (565)
T ss_pred             HHHHHHHhhccCCCCCCccc-----ccccCC-----CCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEE
Confidence            011111  000000000000     000000     000001111223456666777777766666555433  237788


Q ss_pred             EcccccccCCCCCCCCCCCCCC-EEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcc
Q 001440          521 DVSANNITGILPPEIGDSPQLK-VLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL  599 (1077)
Q Consensus       521 ~Ls~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l  599 (1077)
                      +++.|++. .+|+.+..+..+. .+++++|.+. .+|..++.+++|+.|+|++|-+. .+|.+++.+..|+.||+|.|++
T Consensus       394 nfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrF  470 (565)
T KOG0472|consen  394 NFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRF  470 (565)
T ss_pred             ecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccccc
Confidence            99999997 4677777776654 4566666665 88899999999999999999998 7899999999999999999999


Q ss_pred             cCCCCCcccccccceeeeeccccccCCcchhccccccccceecccccCCCCCccccccccccchhcccccccc
Q 001440          600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS  672 (1077)
Q Consensus       600 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~  672 (1077)
                      . .+|+.+..+..|+.+-.++|++....+..+..+.+|..|||.+|.|. .+|..+++|.+|++|++.+|++.
T Consensus       471 r-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  471 R-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             c-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            7 78888888888888888889999888888999999999999999995 78889999999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-41  Score=362.65  Aligned_cols=255  Identities=25%  Similarity=0.354  Sum_probs=219.4

Q ss_pred             HHHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCe
Q 001440          802 VRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       802 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  879 (1077)
                      ....++|...+.||+|+|++||+|+. .+++.||||++.+.....+...+-+..|-..|.+| .||.|++++..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34457899999999999999999965 47899999999887766655566788899999999 89999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .|+|+||+++|+|.+++++..   .+++...+.+|.+|+.|++|||++   |||||||||+|||+|.||++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999998765   477788999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCC-----------C--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCccccc
Q 001440          960 SLKPDSS-----------N--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026 (1077)
Q Consensus       960 ~~~~~~~-----------~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~ 1026 (1077)
                      .+.+...           .  ...++||..|.+||++.+...++.+|+|+|||++|+|+.|.+||...        +..-
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~--------Neyl  294 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA--------NEYL  294 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc--------cHHH
Confidence            7754321           1  14589999999999999999999999999999999999999998733        3345


Q ss_pred             chhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .++.+++-.+..+....    ..+.+++++.|..||.+|+|++||.+.
T Consensus       295 iFqkI~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 IFQKIQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence            66666665555554433    357889999999999999999998763

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=351.68  Aligned_cols=256  Identities=26%  Similarity=0.384  Sum_probs=212.1

Q ss_pred             HhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..++|++.+.||.|..++||+|+. +.++.||||++.-+.....  .+.+.+|+..++.++||||++++..|..+...|+
T Consensus        24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWv  101 (516)
T KOG0582|consen   24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWV  101 (516)
T ss_pred             CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEE
Confidence            456899999999999999999954 5789999999987654432  6789999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||.||.+|++.+.++.....+ +.+..+..|.+++++||.|||.+   |.||||||+.|||++.+|.|||+|||.+..+.
T Consensus       102 VmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  102 VMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             eehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            999999999999998776544 78889999999999999999999   99999999999999999999999999887765


Q ss_pred             CCCCCc----ccccccccccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCC
Q 001440          963 PDSSNW----TELAGTIGYVAPELAY--TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036 (1077)
Q Consensus       963 ~~~~~~----~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1077)
                      ..+.+.    ...+||+.|||||+++  -.+|+.|+||||||++..|+.+|..||..+.+...        +-..+....
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--------Ll~tLqn~p  249 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--------LLLTLQNDP  249 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--------HHHHhcCCC
Confidence            544332    4568999999999954  35799999999999999999999999986654322        111111111


Q ss_pred             CC------CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1037 PA------PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1037 ~~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      |.      +..........+.+++..||++||.+|||++++++
T Consensus       250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            10      11112233458899999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=365.87  Aligned_cols=261  Identities=25%  Similarity=0.384  Sum_probs=210.3

Q ss_pred             HHHHHHhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      +++....+++.+...||+|+||+||+|+|- | .||||++........ ..+.|+.|+..+++-+|.||+-+.|||..+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            444445556678889999999999999985 3 599999988766655 5889999999999999999999999999888


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      . .||+.+|+|.+|+.+++..+  .++...+.+.||+|||+||.|||.+   +|||||+|..||++.++++|||+|||++
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccce
Confidence            7 89999999999999998765  4577889999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCC--CCCCcccccccccccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC
Q 001440          959 KSLKP--DSSNWTELAGTIGYVAPELAYT---MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033 (1077)
Q Consensus       959 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1077)
                      ..-..  .........|...|||||+++.   .+|++.+||||||+|+|||+||..||.. ..       .++.+-.+=.
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~-------~dqIifmVGr  607 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QN-------RDQIIFMVGR  607 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CC-------hhheEEEecc
Confidence            75332  2233455678899999999864   5789999999999999999999999872 11       1111101101


Q ss_pred             CC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1034 PR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1034 ~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +. .+...........++.+++..||..+|++||.+.+|+..|+
T Consensus       608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~  651 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLE  651 (678)
T ss_pred             cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHH
Confidence            11 11111222334457889999999999999999999999664

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=363.15  Aligned_cols=249  Identities=25%  Similarity=0.413  Sum_probs=213.0

Q ss_pred             cCCCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ..|+...+||+|+.|.||.|+ ..+++.||||++.....   ...+-+.+|+.+|+..+|+|||++++.|...+..|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            457777889999999999995 45788999999976432   23567899999999999999999999998889999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |||++|+|.|.+....    +++.++..|+.++++||+|||.+   ||+|||||.+|||++.+|.+||+|||++..+...
T Consensus       350 Eym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             eecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999986654    78899999999999999999999   9999999999999999999999999999999888


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      .....+.+||+.|||||++....|++|+||||+|++++||+-|.+||-...+        -+.+..+.+..-+. -....
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--------lrAlyLIa~ng~P~-lk~~~  493 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNGTPK-LKNPE  493 (550)
T ss_pred             cCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--------HHHHHHHhhcCCCC-cCCcc
Confidence            8888899999999999999999999999999999999999999999863222        22232232211111 11223


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ..+..+.+|+.+||+.||++||+|.|+++
T Consensus       494 klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  494 KLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            44568999999999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.2e-40  Score=325.29  Aligned_cols=262  Identities=21%  Similarity=0.294  Sum_probs=209.1

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|...+++|+|.||.||+|++ .+|+.||||+++.....+.. .....+|+..++.++|+||+.++++|.+.+...+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi-~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGI-NRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCc-cHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            4677888999999999999954 58999999999876544332 456789999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |||+. +|+..++...  ..++..++..++.++.+|++|||++   .|+|||+||.|+|++++|.+||+|||+|+.+.+.
T Consensus        81 Efm~t-dLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             Eeccc-cHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            99975 8998886654  4588899999999999999999999   9999999999999999999999999999999887


Q ss_pred             CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc--------------cCcccccchh
Q 001440          965 SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS--------------TSSNLDRTLD 1029 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--------------~~~~~~~~~~ 1029 (1077)
                      .......+-|..|.|||.+.+ +.|+..+||||+||++.||+-|.+-|....+...              ...+....-+
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd  234 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD  234 (318)
T ss_pred             CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence            777677789999999998876 4699999999999999999998876654333211              0111111111


Q ss_pred             hhcCCCCCCCCC--CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1030 EILDPRLPAPSC--NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1030 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...-...|.+..  ..........+++.++|.+||.+|.++.|++++
T Consensus       235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            110011222211  122334466899999999999999999999864

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=328.90  Aligned_cols=239  Identities=26%  Similarity=0.369  Sum_probs=212.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.+|.|+||.|..++.+ +|..+|+|++.+...-+..+.+...+|..+++.+.||.++++++.+.+.+..+|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            46888899999999999999776 68899999999887777788889999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++||.|+.++++.+   +++...++.+|.||+.|++|||+.   +|++||+||+|||+|++|.+||+|||+|+.+...
T Consensus       124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999997754   477789999999999999999999   9999999999999999999999999999976533


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                         ..+.+||+.|+|||++..++|..++|.|||||++|||+.|.+||....        ..+..+.++..+...|+... 
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--------~~~iY~KI~~~~v~fP~~fs-  265 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--------PIQIYEKILEGKVKFPSYFS-  265 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--------hHHHHHHHHhCcccCCcccC-
Confidence               467899999999999999999999999999999999999999987432        24566777777777665332 


Q ss_pred             HHHHHHHHHHHhccCCCCCCC
Q 001440         1045 DKLISIMEVAISCLDENPDSR 1065 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~R 1065 (1077)
                         ..+.+++.+.++.|-.+|
T Consensus       266 ---~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  266 ---SDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---HHHHHHHHHHHhhhhHhh
Confidence               357788899999998888

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=386.61  Aligned_cols=255  Identities=27%  Similarity=0.442  Sum_probs=209.1

Q ss_pred             cCCCccceecccCCceEEEEEec--CCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS--SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      ...+..+.||+|.||.||+|...  .|.    .||||.+.+.  .+..+..+|.+|+.+|+.++|||||+++|++-+...
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            34456788999999999999765  333    4899988764  455668899999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          880 SFIVYEYLEMGSLAMILSNATS----AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                      .+|++|||++|+|..|+++.+.    ...++..+.+.++.|||+|+.||+++   ++|||||.++|+|++....|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999987732    33588999999999999999999999   8999999999999999999999999


Q ss_pred             cccccCCCCCCC-cccc-cccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhc
Q 001440          956 GISKSLKPDSSN-WTEL-AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL 1032 (1077)
Q Consensus       956 gla~~~~~~~~~-~~~~-~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1032 (1077)
                      |+|+.+...... .... .-+.+|||||.+.++.++.|+|||||||++||++| |..||.....       .+-...-..
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n-------~~v~~~~~~  919 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN-------FEVLLDVLE  919 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch-------HHHHHHHHh
Confidence            999955433222 2222 34689999999999999999999999999999999 8888763322       122222333


Q ss_pred             CCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .++++.|+..+    ..++++|.+||+.+|++||++..+++.++
T Consensus       920 ggRL~~P~~CP----~~ly~lM~~CW~~~pe~RP~F~~i~~q~~  959 (1025)
T KOG1095|consen  920 GGRLDPPSYCP----EKLYQLMLQCWKHDPEDRPSFRTIVEQDP  959 (1025)
T ss_pred             CCccCCCCCCC----hHHHHHHHHHccCChhhCccHHHHHhhhh
Confidence            45666654332    25789999999999999999999998653

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-40  Score=357.86  Aligned_cols=248  Identities=25%  Similarity=0.373  Sum_probs=212.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.... ..+.+.+.+|++++++++|||||.++++|+...+.|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            46788889999999999999655 7889999999876433 334778999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+.| +|+.++....   .++++++..++.+++.|+.|||+.   +|+|||+||+||+++..+.+|+||||+|+.+...
T Consensus        81 e~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            99977 9999997654   488899999999999999999999   9999999999999999999999999999998877


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ....+...||+-|||||...+.+|+..+|+||+||++||+++|++||...        .+.+.++.+.......|    .
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~v~~p----~  221 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDPVKPP----S  221 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCCCCCc----c
Confidence            66667788999999999999999999999999999999999999998632        22333444433222222    2


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +....+..+++..+.+||.+|.+-.+++.
T Consensus       222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            55567899999999999999999887764

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-40  Score=368.55  Aligned_cols=266  Identities=27%  Similarity=0.411  Sum_probs=214.3

Q ss_pred             ccCCHHHHHHHhcCCCccceecccCCceEEEEEecC--C---CEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCcee
Q 001440          794 RKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSS--G---EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV  868 (1077)
Q Consensus       794 ~~~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  868 (1077)
                      .++....|+-..++....++||+|.||.||+|+++.  +   ..||||..+...........+|.+|+++|+.++|||||
T Consensus       145 ~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVV  224 (474)
T KOG0194|consen  145 RPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVV  224 (474)
T ss_pred             ccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence            344445566666777778999999999999997652  2   22899998864434456689999999999999999999


Q ss_pred             eEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       869 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      +++|++..+.+.++|||+|+||+|.+++++...  .++..+++.++.++|.||+|||++   +++||||.++|+|++.++
T Consensus       225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~  299 (474)
T KOG0194|consen  225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKG  299 (474)
T ss_pred             EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCC
Confidence            999999999999999999999999999987653  589999999999999999999999   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccc
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 1027 (1077)
                      .+||+|||+++.-...........-+.+|+|||.+....|++++|||||||++||+++ |..||.....        .+.
T Consensus       300 ~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v  371 (474)
T KOG0194|consen  300 VVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEV  371 (474)
T ss_pred             eEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHH
Confidence            9999999998764311111112235789999999999999999999999999999999 7888763322        122


Q ss_pred             hhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1028 LDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1028 ~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...+..  .+.+.+.    ..+..+..++.+||..||++||+|.++.+.++
T Consensus       372 ~~kI~~~~~r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~  418 (474)
T KOG0194|consen  372 KAKIVKNGYRMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE  418 (474)
T ss_pred             HHHHHhcCccCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence            223312  2233322    23446778888999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-40  Score=353.53  Aligned_cols=261  Identities=23%  Similarity=0.350  Sum_probs=208.8

Q ss_pred             hcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCC-eeE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHAR-HSF  881 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~  881 (1077)
                      .++|.+.++||.|.||+||+|+. .+|+.||||++++.... ++ ...-.+|+..++++. |||||++.+++.+.+ ..+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            46789999999999999999954 57899999999876444 22 345578999999998 999999999998887 999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +|||||+. +|++.+++.  ...++..+++.|+.||++||+|+|++   |++|||+||+|||+.....+||+|||+||.+
T Consensus        87 fVfE~Md~-NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev  160 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREV  160 (538)
T ss_pred             eeHHhhhh-hHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccc
Confidence            99999965 999999776  46699999999999999999999999   9999999999999999999999999999987


Q ss_pred             CCCCCCcccccccccccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccc------cCc--ccc-----cc
Q 001440          962 KPDSSNWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS------TSS--NLD-----RT 1027 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~------~~~--~~~-----~~ 1027 (1077)
                      ... ..++..+.|..|.|||++. .+.|+.++||||+||+++|+.+-++-|....+...      .-.  ..+     ..
T Consensus       161 ~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  161 RSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             ccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            654 4467788999999999765 66789999999999999999999888764433211      100  111     11


Q ss_pred             hhhhcCCCCCCCCCC-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1028 LDEILDPRLPAPSCN-----IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1028 ~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      +...+.-++|.....     ......+..+++.+|+++||++||||+|+++.
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            112222222221111     11234578899999999999999999999874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=348.87  Aligned_cols=252  Identities=27%  Similarity=0.412  Sum_probs=200.6

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC--eeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR--HSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~l  882 (1077)
                      .+|...+.||+|+||+||++... +|+..|||.+.....  . ..+.+.+|+.++++++|||||+++|......  .+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~--~-~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS--P-TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccc--h-hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence            45777889999999999999665 589999999876521  1 1567899999999999999999999854433  6899


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CCceEEecccccccC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EYEAHVSDFGISKSL  961 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~  961 (1077)
                      .|||+++|+|.+++.+...  .+++..+..+++||++|++|||++   ||+||||||+|||++. ++.+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccc
Confidence            9999999999999987653  589999999999999999999999   9999999999999999 799999999999877


Q ss_pred             CCC---CCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          962 KPD---SSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       962 ~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      ...   ........||+.|||||++..+ ....++||||+||++.||+||+.||...      .......+........|
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P  242 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLP  242 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCC
Confidence            631   1223457899999999999963 3345999999999999999999998742      01111122222222222


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .-   +...+....+++.+|+++||++||||+|+++.
T Consensus       243 ~i---p~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  243 EI---PDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             CC---CcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence            11   12233467889999999999999999999864

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-40  Score=355.15  Aligned_cols=239  Identities=30%  Similarity=0.496  Sum_probs=201.4

Q ss_pred             cceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          811 EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      .+-+|.|+.|.||+|+.. ++.||||+++.-          -..+|+-+++|+||||+.+.|+|.....++||||||+.|
T Consensus       129 LeWlGSGaQGAVF~Grl~-netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH-NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhccCcccceeeeecc-CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence            456999999999999996 788999997542          125788899999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE  970 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  970 (1077)
                      -|+..++..+   .++......|..+||.||.|||.+   .|||||||.-||||..+..|||+|||-++..... ...-.
T Consensus       198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMS  270 (904)
T KOG4721|consen  198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMS  270 (904)
T ss_pred             cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh-hhhhh
Confidence            9999997654   477889999999999999999999   9999999999999999999999999999876655 44456


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1050 (1077)
                      ++||..|||||++...+.++|+||||||||+|||+||..||.........    ...-..  .-.++.|+..    +..+
T Consensus       271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII----wGVGsN--sL~LpvPstc----P~Gf  340 (904)
T KOG4721|consen  271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII----WGVGSN--SLHLPVPSTC----PDGF  340 (904)
T ss_pred             hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE----EeccCC--cccccCcccC----chHH
Confidence            89999999999999999999999999999999999999998754432111    011000  1134555433    3467


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHhhhcC
Q 001440         1051 MEVAISCLDENPDSRPTMQKVSQLLKI 1077 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RPs~~evl~~L~~ 1077 (1077)
                      .-++++||+.+|..||++.+++..|+|
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            788999999999999999999999987

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-39  Score=358.54  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=214.8

Q ss_pred             HHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchh--hHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCC
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEM--TCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHAR  878 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~  878 (1077)
                      ...+.|.+.+.||+|+||.|+.|+. .+|+.||+|.+.+......  ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999965 4789999997765422211  23456678999999998 999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEecccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGI  957 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgl  957 (1077)
                      ..++||||+.+|+|++++.+.   ..+.+.++..+++|++.|++|+|+.   ||+||||||+||+++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence            999999999999999999773   3477799999999999999999999   99999999999999999 9999999999


Q ss_pred             cccCCCCCCCcccccccccccCccccccCC-CC-CcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYTMK-VT-EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1077)
                      +...........+..|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||+.        .+.......+....
T Consensus       168 s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--------~~~~~l~~ki~~~~  239 (370)
T KOG0583|consen  168 SAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--------SNVPNLYRKIRKGE  239 (370)
T ss_pred             ccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--------ccHHHHHHHHhcCC
Confidence            998754445667889999999999999987 85 689999999999999999999984        23344455566666


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +..|....   ..++..++.+|+..||.+|+++.|+++
T Consensus       240 ~~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  240 FKIPSYLL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ccCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence            66554332   557889999999999999999999983

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=349.56  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=206.2

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ....++++||+|-||+|..|....+.+||||+++....  ...+.+|.+|+++|.+++|||||+++|+|..++..++|+|
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            34566789999999999999998789999999987643  3447899999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      ||++|+|.+|+....... +......+|+.|||.||+||.+.   ++||||+.++|+|++.++++||+|||+++.+-...
T Consensus       616 YmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999997764322 45567788999999999999998   99999999999999999999999999999654433


Q ss_pred             CC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCccccccccCcccccchhhhc-CCCCCCCC
Q 001440          966 SN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK--GKHPRDFISSICSTSSNLDRTLDEIL-DPRLPAPS 1040 (1077)
Q Consensus       966 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1040 (1077)
                      ..  ....+-+.+|||||.+.-++++.++|||+||+++||+++  ...||........ .++....+..-- ...++.| 
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven~~~~~~~~~~~~~l~~P-  769 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VENAGEFFRDQGRQVVLSRP-  769 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHhhhhhcCCCCcceeccCC-
Confidence            22  234456899999999999999999999999999999876  6778764322111 111111111000 0011111 


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         .-....+++++..||++|-++||+++++...|+
T Consensus       770 ---~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq  802 (807)
T KOG1094|consen  770 ---PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQ  802 (807)
T ss_pred             ---CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHH
Confidence               223346889999999999999999999987764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-39  Score=342.99  Aligned_cols=257  Identities=27%  Similarity=0.442  Sum_probs=197.1

Q ss_pred             CCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcC--CCCCceeeEEEEEeeCC----ee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE--IRHRNIVKFYGFCSHAR----HS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~  880 (1077)
                      ..+..+.||+|+||.||+|.+. ++.||||++...      ..+.|..|-++++.  ++|+||++++++....+    .+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             chhhHHHhhcCccceeehhhcc-CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            4455678999999999999986 589999998653      24556666665554  48999999999986655    89


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeEeccCCCCCeeeCCCCceEEec
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF------PPIVYRDISSKNVLLDLEYEAHVSD  954 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~------~~ivH~Dlk~~NIll~~~~~~kl~D  954 (1077)
                      ++|+||++.|+|.+|++.+.    ++|.+..+|+..+++||+|||+...      |+|+|||||.+|||+..|+++.|+|
T Consensus       284 wLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             eEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999999999998765    8999999999999999999997643      7899999999999999999999999


Q ss_pred             ccccccCCCCCCC--cccccccccccCccccccCC-C-----CCcchHHHHHHHHHHHHhCCCCCC------cccc---c
Q 001440          955 FGISKSLKPDSSN--WTELAGTIGYVAPELAYTMK-V-----TEKSDVYSFGVLALEAIKGKHPRD------FISS---I 1017 (1077)
Q Consensus       955 fgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~-~-----~~~~Dv~s~G~~l~elltg~~p~~------~~~~---~ 1017 (1077)
                      ||+|..+.+....  .-..+||.+|||||++.+.. +     -.+.||||+|.|+|||+++-.-++      +.-+   .
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e  439 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE  439 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence            9999988765432  33478999999999987642 1     236899999999999998543321      0011   1


Q ss_pred             cccCcccccchhhh----cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1018 CSTSSNLDRTLDEI----LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1018 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      .+.....+++.+-+    .+|.++...... .....+.+.+..||+.||+.|.|+.-|.+++
T Consensus       440 vG~hPt~e~mq~~VV~kK~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~  500 (534)
T KOG3653|consen  440 VGNHPTLEEMQELVVRKKQRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERM  500 (534)
T ss_pred             hcCCCCHHHHHHHHHhhccCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHH
Confidence            12223333333333    334444332222 3456788899999999999999998887764

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-39  Score=347.38  Aligned_cols=261  Identities=26%  Similarity=0.377  Sum_probs=203.6

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  882 (1077)
                      +.|+..++||+|.||.||+|+. .+|+.||+|++..+...+. ....+.+||.++++++||||+++.+...+.  +..||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~-~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEG-FPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCc-chHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4566778899999999999954 5899999999987653332 356788999999999999999999998776  68999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |+|||+. +|.-++...  .-.++..++..+++|++.||+|+|++   ||+|||||.+|||||.+|.+||+|||+|+++.
T Consensus       196 VFeYMdh-DL~GLl~~p--~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP--GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhcCC--CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999987 676666443  23588999999999999999999999   99999999999999999999999999999887


Q ss_pred             CCCCC-cccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc------cCccc-ccchh----
Q 001440          963 PDSSN-WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS------TSSNL-DRTLD---- 1029 (1077)
Q Consensus       963 ~~~~~-~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~------~~~~~-~~~~~---- 1029 (1077)
                      ..... ++..+-|..|.|||.+.+ ..|+.++|+||.|||+.||++|++.|..-.+...      ..... +..+.    
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            76543 788899999999998876 4699999999999999999999999863222111      00000 00000    


Q ss_pred             ---hhcCCCCCCCCC---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1030 ---EILDPRLPAPSC---NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1030 ---~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ..+.+..+....   ..........+++..+|..||.+|.||.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence               111111111100   01122346778999999999999999999875

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=359.62  Aligned_cols=365  Identities=26%  Similarity=0.243  Sum_probs=268.6

Q ss_pred             ceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCC
Q 001440          303 YGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTN  382 (1077)
Q Consensus       303 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N  382 (1077)
                      +.||+|+|+++..-+..|.++++|+++++.+|.++ .+|...+...+|+.|+|.+|.|+..-.+.+..++.|+.|+|+.|
T Consensus        81 ~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN  159 (873)
T KOG4194|consen   81 QTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRN  159 (873)
T ss_pred             eeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhc
Confidence            34666666666555555666666666666666665 45554444555666666666666555555666666666666666


Q ss_pred             CCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCC-cc
Q 001440          383 LLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGP-IP  461 (1077)
Q Consensus       383 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~  461 (1077)
                      .|+...-..|..-.++++|+|++|.|+......|.++.+|..|.|+.|+|+...+..|.++++|+.|+|..|+|... .-
T Consensus       160 ~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l  239 (873)
T KOG4194|consen  160 LISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL  239 (873)
T ss_pred             hhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhh
Confidence            66655445666666777777777777777777777777777777777777766667777788888888888887643 33


Q ss_pred             ccccccccceEeecCCccCCCCCcccccccccceeccccccccCCCCcCCCCCCCCcEEEcccccccCCCCCCCCCCCCC
Q 001440          462 DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQL  541 (1077)
Q Consensus       462 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L  541 (1077)
                      .|.++++|+.|.|.+|.+......+|-.+.++++|+|+.|++.......+.++..|+.|++|.|.|..+.++.+...++|
T Consensus       240 tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL  319 (873)
T KOG4194|consen  240 TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKL  319 (873)
T ss_pred             hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccc
Confidence            57777778888888888877777788888888888888888887777777788888888888888888888888888888


Q ss_pred             CEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCC---CCcccccccceeeee
Q 001440          542 KVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI---PGSLGNLVKLYYLNL  618 (1077)
Q Consensus       542 ~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~L  618 (1077)
                      ++|+|++|+|+...+..|..+..|++|+|++|+++..--..|..+++|+.|||++|.|+..+   ...|.+++.|+.|+|
T Consensus       320 ~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l  399 (873)
T KOG4194|consen  320 KELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRL  399 (873)
T ss_pred             eeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheee
Confidence            88888888888777888888888888888888887554556777888888888888876543   445777888888888


Q ss_pred             ccccccCCcchhccccccccceecccccCCCCCccccccccccchhccccc
Q 001440          619 SNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHN  669 (1077)
Q Consensus       619 s~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N  669 (1077)
                      .+|+|..+.-..|..++.|++|||.+|.|..+-+.+|..| .|++|-++.-
T Consensus       400 ~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs  449 (873)
T KOG4194|consen  400 TGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS  449 (873)
T ss_pred             cCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence            8888886666677888888888888888877778888888 7877776543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=360.03  Aligned_cols=391  Identities=24%  Similarity=0.199  Sum_probs=210.9

Q ss_pred             cEEEccCCcccccCCcccCCC--CCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecc
Q 001440          111 AYLDLRVNQIFGIIPSQIANN--SKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLF  188 (1077)
Q Consensus       111 ~~L~L~~n~~~~~~p~~~~~l--~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~  188 (1077)
                      ..||.+++.+..+--..+.++  +.-+.||+++|.++..-+..|.++++|+.+++..|.++ .||...+...+|+.|+|.
T Consensus        55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~  133 (873)
T KOG4194|consen   55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR  133 (873)
T ss_pred             eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence            345666666554322222221  22345666666666555666666666666666666665 455544444445555555


Q ss_pred             cccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCC
Q 001440          189 ENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSI  268 (1077)
Q Consensus       189 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~  268 (1077)
                      +|.|+..-.+.+.-++.|+.||||.|.++...-..|..-.++++|+|++|+|+..--                       
T Consensus       134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~-----------------------  190 (873)
T KOG4194|consen  134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLET-----------------------  190 (873)
T ss_pred             ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccc-----------------------
Confidence            555555444445555555555555555553322334433444444444444444444                       


Q ss_pred             CCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccccc
Q 001440          269 PLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLR  348 (1077)
Q Consensus       269 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~  348 (1077)
                       ..|.++.+|..|.|++|+++...+..|.++++|+.|+|..|+|.-.--..|.+|++|+.|.|..|.+...-...|..+.
T Consensus       191 -~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~  269 (873)
T KOG4194|consen  191 -GHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLE  269 (873)
T ss_pred             -ccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeec
Confidence             4444444444444444444443334444444444444444444421122344455555555555555444444455555


Q ss_pred             cccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecc
Q 001440          349 YLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIY  428 (1077)
Q Consensus       349 ~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~  428 (1077)
                      ++++|+|+.|+++..-.+++.+++.|+.|+|+.|.|...-++++...++|++|+|++|+|+...+..|..+..|++|+|+
T Consensus       270 kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs  349 (873)
T KOG4194|consen  270 KMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLS  349 (873)
T ss_pred             ccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhccc
Confidence            55555555555554444555555555555555555555555555556666666666666666666666666666666666


Q ss_pred             cccCcCCCCCccCCcccCcEEecccCcCCCCccccccccccceEeecCCccCCCCCcccccccccceeccccccccCCCC
Q 001440          429 SNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEIS  508 (1077)
Q Consensus       429 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~  508 (1077)
                      +|.+......+|..+++|+.|||+.|.++..+.+                    ....|..++.|+.|++.+|++..+..
T Consensus       350 ~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED--------------------aa~~f~gl~~LrkL~l~gNqlk~I~k  409 (873)
T KOG4194|consen  350 HNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED--------------------AAVAFNGLPSLRKLRLTGNQLKSIPK  409 (873)
T ss_pred             ccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec--------------------chhhhccchhhhheeecCceeeecch
Confidence            6666655556666666666777766666543332                    12344445555555555555555555


Q ss_pred             cCCCCCCCCcEEEcccccccCCCCCCCCCCCCCCEEEcc
Q 001440          509 FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS  547 (1077)
Q Consensus       509 ~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  547 (1077)
                      .+|.+++.|+.|||.+|.|..+-|.+|..| .|++|.+.
T Consensus       410 rAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n  447 (873)
T KOG4194|consen  410 RAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN  447 (873)
T ss_pred             hhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence            556666666666666666666666666666 66666554

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-39  Score=315.92  Aligned_cols=252  Identities=27%  Similarity=0.396  Sum_probs=217.4

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|.||.||.|+.+ ++-.||+|++.+..........++.+|+++...++||||.++++++.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            468999999999999999999765 6788999999877665555567899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +||.+.|.++..+..... .+++......++.|+|.|+.|+|.+   +|+||||||+|+|++.++..|++|||-+..-. 
T Consensus       101 lEya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            999999999999985543 3467788889999999999999998   99999999999999999999999999987543 


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                       .....+.+||..|.|||+..+..++.++|+|++|++.||++.|.+||...        ...+...++..-++..|+   
T Consensus       176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~--------~~~etYkrI~k~~~~~p~---  243 (281)
T KOG0580|consen  176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ--------SHSETYKRIRKVDLKFPS---  243 (281)
T ss_pred             -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh--------hhHHHHHHHHHccccCCc---
Confidence             45567789999999999999999999999999999999999999998732        234556666555555543   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                       .......++|.+|+.++|.+|.+..|+++.
T Consensus       244 -~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  244 -TISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             -ccChhHHHHHHHHhccCccccccHHHHhhh
Confidence             233467889999999999999999999863

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=346.95  Aligned_cols=250  Identities=26%  Similarity=0.433  Sum_probs=211.1

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ..|+..++||+|.||.||+|.+ .+++.||+|++.-+..  ..+.+++++|+.++..++++||.++|+.+..+...|++|
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM   90 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM   90 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence            4577778999999999999955 5789999999987643  344788999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |||.+|++.+.++....   +.+.++.-|++++..|+.|+|++   +.+|||||+.||++..+|.+|++|||.+..+...
T Consensus        91 ey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   91 EYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999999865542   35567777899999999999999   9999999999999999999999999999988877


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      .....+++||+.|||||++....|+.|+||||+|++++||.+|.+|+....+.        +.+- .+ ++-.+|... .
T Consensus       165 ~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------rvlf-lI-pk~~PP~L~-~  233 (467)
T KOG0201|consen  165 VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------RVLF-LI-PKSAPPRLD-G  233 (467)
T ss_pred             hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------eEEE-ec-cCCCCCccc-c
Confidence            77778899999999999999989999999999999999999999998755442        1111 11 111111111 1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++..||++||+.||+|.++++.
T Consensus       234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  234 DFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            445678999999999999999999999863

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-39  Score=333.51  Aligned_cols=249  Identities=22%  Similarity=0.350  Sum_probs=218.9

Q ss_pred             hcCCCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..+|++.+.+|+|.||.|-+|. ...|+.||||.+++....++.+.-.+.+|+++|..++||||+.++++|+..+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            4678888999999999999995 478999999999999888888788899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||..+|.|+||+.+..   .++..++..++.||..|+.|+|++   +++|||+|.+|||+|+++.+||+|||++..+..
T Consensus       132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999997765   488899999999999999999999   999999999999999999999999999986653


Q ss_pred             CCCCcccccccccccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                       ....++++|++-|.+||++.+.+| ++.+|-||+||++|-++.|.+||+..        +....+.++-.+.+..|...
T Consensus       206 -~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~--------Dhk~lvrQIs~GaYrEP~~P  276 (668)
T KOG0611|consen  206 -KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR--------DHKRLVRQISRGAYREPETP  276 (668)
T ss_pred             -ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc--------hHHHHHHHhhcccccCCCCC
Confidence             455678899999999999999988 57899999999999999999999833        33455666666655544322


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                           -...-+|++||..+|++|.|+++|..
T Consensus       277 -----SdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  277 -----SDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             -----chHHHHHHHHHhcCcccchhHHHHhh
Confidence                 13456899999999999999999865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=346.19  Aligned_cols=253  Identities=25%  Similarity=0.316  Sum_probs=211.1

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..++|+....||+|+||+||.|+.+ +|+.+|+|++.+..+....+.+.+..|-.++...++|.||+++..|.+....|+
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999654 799999999999888777888999999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||++||++..+|.+..   .++...+..++.+++.|++.+|+.   |+|||||||+|+|||..|.+||+|||++.-+.
T Consensus       219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999996654   488899999999999999999999   99999999999999999999999999985321


Q ss_pred             C-----------------------CCC-----C-------------------cccccccccccCccccccCCCCCcchHH
Q 001440          963 P-----------------------DSS-----N-------------------WTELAGTIGYVAPELAYTMKVTEKSDVY  995 (1077)
Q Consensus       963 ~-----------------------~~~-----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~  995 (1077)
                      .                       +..     .                   ....+|||.|||||++.+.+|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                       000     0                   0125799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC--CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHH
Q 001440          996 SFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPT---MQK 1070 (1077)
Q Consensus       996 s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~e 1070 (1077)
                      |+|||||||+.|-+||..        +...+++..++..+  +..|...  ....+..++|.+|+. ||+.|.-   ++|
T Consensus       373 SLG~ImyEmLvGyPPF~s--------~tp~~T~rkI~nwr~~l~fP~~~--~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCS--------ETPQETYRKIVNWRETLKFPEEV--DLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHHHhhhccCCCcC--cccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            999999999999999873        23344455554433  3333221  223568899999999 9999984   566


Q ss_pred             HHh
Q 001440         1071 VSQ 1073 (1077)
Q Consensus      1071 vl~ 1073 (1077)
                      |.+
T Consensus       442 IK~  444 (550)
T KOG0605|consen  442 IKK  444 (550)
T ss_pred             Hhc
Confidence            543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.2e-38  Score=358.32  Aligned_cols=257  Identities=24%  Similarity=0.415  Sum_probs=202.0

Q ss_pred             HhcCCCccceecccCCceEEEEEe------cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ..++|++.++||+|+||.||+|.+      .+++.||||++....  .....+.+.+|+.+++.+ +||||+++++++..
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~   82 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTK   82 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence            346799999999999999999964      235679999987542  222356789999999999 89999999998876


Q ss_pred             C-CeeEEEEeecCCCCHHHHHhcCCC------------------------------------------------------
Q 001440          877 A-RHSFIVYEYLEMGSLAMILSNATS------------------------------------------------------  901 (1077)
Q Consensus       877 ~-~~~~lV~E~~~~g~L~~~l~~~~~------------------------------------------------------  901 (1077)
                      . ...++||||+++|+|.+++.....                                                      
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (338)
T cd05102          83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE  162 (338)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence            4 468999999999999999865321                                                      


Q ss_pred             -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC--ccccccc
Q 001440          902 -----AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGT  974 (1077)
Q Consensus       902 -----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~  974 (1077)
                           ...+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........  .....++
T Consensus       163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence                 12477889999999999999999998   9999999999999999999999999999865433221  1233456


Q ss_pred             ccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CCCCCCCcHHHHHHHHH
Q 001440          975 IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCNIRDKLISIME 1052 (1077)
Q Consensus       975 ~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~ 1052 (1077)
                      +.|+|||++.+..++.++|||||||++|||++ |..||......       +.......+.. ...+    ......+.+
T Consensus       240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~----~~~~~~l~~  308 (338)
T cd05102         240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFCQRLKDGTRMRAP----ENATPEIYR  308 (338)
T ss_pred             ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHHHHHhcCCCCCCC----CCCCHHHHH
Confidence            88999999999999999999999999999997 99998642211       11111111111 1111    122346889


Q ss_pred             HHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1053 VAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1053 li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ++.+||+.||++|||++|+++.|+
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~  332 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILG  332 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHH
Confidence            999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-38  Score=351.35  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=216.6

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .-|...+-||.|+-|.|-.|++ .+|+.+|||.+.+...........+.+|+.+|+-+.||||+++++++++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            4577888999999999999966 489999999998764333334567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|-|++++.+..   .++..++.+++.||..|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|..-. +
T Consensus        92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~  164 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV-P  164 (786)
T ss_pred             EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc-C
Confidence            9999999999996644   478899999999999999999998   99999999999999999999999999997544 3


Q ss_pred             CCCcccccccccccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      +.-..+.+|++.|.|||++.+.+| +.++||||.||++|.|+||+.||+        ..+....+..+..+.+..|..  
T Consensus       165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd--------DdNir~LLlKV~~G~f~MPs~--  234 (786)
T KOG0588|consen  165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD--------DDNIRVLLLKVQRGVFEMPSN--  234 (786)
T ss_pred             CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC--------CccHHHHHHHHHcCcccCCCc--
Confidence            445567899999999999999998 468999999999999999999998        345566666666777766543  


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                        ...+.++++++|+..||+.|-|++||.+.
T Consensus       235 --Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  235 --ISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             --CCHHHHHHHHHHhccCccccccHHHHhhC
Confidence              33468899999999999999999999863

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-38  Score=332.03  Aligned_cols=257  Identities=26%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             HhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC--CCCceeeEEEEEeeCC---
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI--RHRNIVKFYGFCSHAR---  878 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~---  878 (1077)
                      ...+..+.+.||+|+||.||+|+|+ |+.||||+|....      ++.+.+|.++++.+  +|+||..+++....++   
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc-CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            3456778899999999999999997 8999999997642      34556666666655  9999999999875443   


Q ss_pred             -eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEeccCCCCCeeeCCCCceEE
Q 001440          879 -HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC-----FPPIVYRDISSKNVLLDLEYEAHV  952 (1077)
Q Consensus       879 -~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~kl  952 (1077)
                       ..|+|++|++.|+|+||+.+..    ++....++++..+|.||+|||.+.     .|.|+|||||..|||+++++.+.|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             6799999999999999997754    788999999999999999999654     489999999999999999999999


Q ss_pred             ecccccccCCCCCC----CcccccccccccCccccccCC----C--CCcchHHHHHHHHHHHHh----C------CCCCC
Q 001440          953 SDFGISKSLKPDSS----NWTELAGTIGYVAPELAYTMK----V--TEKSDVYSFGVLALEAIK----G------KHPRD 1012 (1077)
Q Consensus       953 ~Dfgla~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~----~--~~~~Dv~s~G~~l~ellt----g------~~p~~ 1012 (1077)
                      +|+|+|.....+..    .....+||.+|||||++...-    +  -..+||||||.|+||+.-    |      +.||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            99999987765532    234578999999999986531    1  236899999999999974    2      24544


Q ss_pred             ccccccccCcccccchh----hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1013 FISSICSTSSNLDRTLD----EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1013 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      ..-+   ..+..+++.+    +...|..|... ...+....+.++|+.||..+|..|.|+-.+.+.|
T Consensus       438 d~Vp---~DPs~eeMrkVVCv~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl  500 (513)
T KOG2052|consen  438 DVVP---SDPSFEEMRKVVCVQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTALRIKKTL  500 (513)
T ss_pred             cCCC---CCCCHHHHhcceeecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHH
Confidence            3222   1222222222    23344444332 3355677899999999999999999998777654

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=347.58  Aligned_cols=253  Identities=23%  Similarity=0.351  Sum_probs=220.2

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe-eEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH-SFIV  883 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV  883 (1077)
                      ++|...+.+|+|+||.++.++++ +++.||+|++......+.. ++...+|+.++++++|||||.+.+.|..++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57888999999999999999765 6789999999877655544 4578899999999999999999999988887 9999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |+|++||++.+.+.+.+ ...++.+++..|+.|++.|+.|||++   .|+|||||+.||+++.+..||++|||+|+.+.+
T Consensus        83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~  158 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP  158 (426)
T ss_pred             EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence            99999999999998766 45688899999999999999999988   999999999999999999999999999999988


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      +.....+.+||+.||.||.+.+.+|..|+||||+||++|||++-+++|..        .+....+..+......+.+   
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a--------~~m~~Li~ki~~~~~~Plp---  227 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKA--------SNMSELILKINRGLYSPLP---  227 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCc--------cchHHHHHHHhhccCCCCC---
Confidence            87677788999999999999999999999999999999999999999873        2334455555555533222   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ..+..++..++..|++.+|+.||++.+++.+
T Consensus       228 ~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  228 SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2344578899999999999999999999875

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-37  Score=352.03  Aligned_cols=244  Identities=22%  Similarity=0.307  Sum_probs=201.2

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      +.||+|+||.||+|+.. +|+.||+|++.............+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999664 78999999987643333344567888999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE  970 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  970 (1077)
                      +|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  154 (323)
T cd05571          81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccc
Confidence            9999986543   478899999999999999999999   9999999999999999999999999999865444444455


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1050 (1077)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||....        .......+.......+.    .....+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~~~~~~~~~p~----~~~~~~  222 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFPR----TLSPEA  222 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC----CCCHHH
Confidence            679999999999999999999999999999999999999986321        12222223222222222    223468


Q ss_pred             HHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1051 MEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      .+++.+||++||++||     ++.|+++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         223 KSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            8999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=351.28  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=212.5

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  881 (1077)
                      ..++|...++||+|.||.|++|..+ +++.+|||.+++...-..++.+..+.|.+++... +||.++.++.+|.+.++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            3468999999999999999999776 6789999999998877777788888888888777 5999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      .||||+.||++..+.+    ...++...+..+|..|+.||.|||++   +|||||||.+|||+|.+|.+||+|||+++.-
T Consensus       446 fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccccc
Confidence            9999999999544432    24488899999999999999999999   9999999999999999999999999999976


Q ss_pred             CCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ...+....++.||+.|||||++.+..|+.++|+|||||+||||+.|..||.        .++.++.++.++......|. 
T Consensus       519 m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~--------gddEee~FdsI~~d~~~yP~-  589 (694)
T KOG0694|consen  519 MGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP--------GDDEEEVFDSIVNDEVRYPR-  589 (694)
T ss_pred             CCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC--------CCCHHHHHHHHhcCCCCCCC-
Confidence            655566788999999999999999999999999999999999999999986        33445667776654444332 


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCH
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 1068 (1077)
                         ..+.+...++++++.++|++|.-+
T Consensus       590 ---~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  590 ---FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---cccHHHHHHHHHHhccCcccccCC
Confidence               334567889999999999999965

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-37  Score=344.60  Aligned_cols=253  Identities=22%  Similarity=0.305  Sum_probs=202.2

Q ss_pred             CCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+.............+.+|+.+++.++|++|+++++++.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            67788999999999999966 47899999998765433333345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++|+|.+++.... ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..... .
T Consensus        82 ~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~  156 (285)
T cd05631          82 MNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-E  156 (285)
T ss_pred             cCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-C
Confidence            99999998875433 23478899999999999999999999   9999999999999999999999999999875432 2


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ......|+..|+|||++.+..++.++||||+||++|||++|+.||.......    ..+.............    ....
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~----~~~~  228 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVDRRVKEDQEEY----SEKF  228 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHHHHhhcccccC----CccC
Confidence            2344578999999999999999999999999999999999999986322110    0011111111111111    1123


Q ss_pred             HHHHHHHHHhccCCCCCCCCC-----HHHHHh
Q 001440         1047 LISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1073 (1077)
                      ...+.+++++||+.||++||+     ++|+++
T Consensus       229 s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         229 SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            346889999999999999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=317.08  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=216.1

Q ss_pred             hcCCCccceecccCCceEEEE-EecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .+.|++.+.||+|.|+.||++ ...+|+.+|+|.+........ ..+++.+|+++-+.++|||||++.+.....+..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            457888889999999999999 455899999998876554443 478899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC---CCceEEeccccccc
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL---EYEAHVSDFGISKS  960 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~Dfgla~~  960 (1077)
                      +|+|.||+|..-+-..   ...++..+-..++||++|+.|+|.+   +|||||+||+|+++.+   ...+|++|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999997544322   2356677788999999999999999   9999999999999954   35699999999998


Q ss_pred             CCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCC
Q 001440          961 LKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040 (1077)
Q Consensus       961 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1077)
                      +. ++..+..++|||+|||||++...+|+..+|||+.||++|-++.|..||..        +...+.+++++...+..++
T Consensus       163 l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~--------~~~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  163 VN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD--------EDQHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             eC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC--------ccHHHHHHHHhccccCCCC
Confidence            88 66777888999999999999999999999999999999999999999873        2334566777777666655


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .......++..+++++||..||++|-|+.|.+.
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            555566677889999999999999999999875

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3.1e-37  Score=341.13  Aligned_cols=244  Identities=22%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee----CCeeEEEEeec
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH----ARHSFIVYEYL  887 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~  887 (1077)
                      ..||+|++|.||+|.+ +|+.||||++...........+.+.+|+.++++++||||++++|++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            5799999999999988 588999999976544333335778899999999999999999999876    34789999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN  967 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  967 (1077)
                      ++|+|.+++....   .+++.....++.|++.|++|||+..  +++||||||+||+++.++.+|++|||+++......  
T Consensus       105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            9999999997543   4788999999999999999999842  78899999999999999999999999998654321  


Q ss_pred             cccccccccccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC--CCCCCCCCCc
Q 001440          968 WTELAGTIGYVAPELAYT--MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNI 1043 (1077)
Q Consensus       968 ~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 1043 (1077)
                       ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.....        .+....+..  .+.+.+    
T Consensus       178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~~----  244 (283)
T PHA02988        178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINKNNSLKLP----  244 (283)
T ss_pred             -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcCCCCCCC----
Confidence             23467899999999876  6789999999999999999999999873321        122222221  122221    


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ......+.+++.+||+.||++|||++|+++.|+
T Consensus       245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~  277 (283)
T PHA02988        245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS  277 (283)
T ss_pred             CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHH
Confidence            122346889999999999999999999999886

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=345.95  Aligned_cols=247  Identities=26%  Similarity=0.351  Sum_probs=204.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... +|+.||+|++......+....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999765 68999999986543333344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            9999999999996543   478899999999999999999999   9999999999999999999999999999865432


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                         .....|++.|+|||++.+..++.++||||+||++|||++|+.||....        .......+.......+..   
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~~---  220 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--------PFGIYEKILAGKLEFPRH---  220 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcCCCcc---
Confidence               234568999999999999999999999999999999999999986322        122233333333332221   


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCC-----HHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1073 (1077)
                       ....+.+++++||+.||++||+     ++|+++
T Consensus       221 -~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         221 -LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -CCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence             1346789999999999999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-38  Score=341.63  Aligned_cols=255  Identities=28%  Similarity=0.467  Sum_probs=212.3

Q ss_pred             HHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA  877 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  877 (1077)
                      .+|+-...+..+..+||-|.||.||.|.|+ -.-.||||.++.+.+    ..++|..|+.+|+.++|||+|+++|+|..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            344444556778899999999999999886 356799999986533    488999999999999999999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      ...|||+|||.+|+|.+|+++... .+++.--.++||.||+.||+||..+   ++||||+.++|+|+.++..|||+|||+
T Consensus       336 pPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  336 PPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             CCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccch
Confidence            999999999999999999988764 4477778899999999999999999   899999999999999999999999999


Q ss_pred             cccCCCCCCCcccccc---cccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC
Q 001440          958 SKSLKPDSSNWTELAG---TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD 1033 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g---~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1077)
                      ++.+..+..  +..+|   ++.|.|||-+....++.|+|||+|||++||+.| |..||...+        ..+. ..++.
T Consensus       412 sRlMtgDTY--TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--------lSqV-Y~LLE  480 (1157)
T KOG4278|consen  412 SRLMTGDTY--TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQV-YGLLE  480 (1157)
T ss_pred             hhhhcCCce--ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--------HHHH-HHHHh
Confidence            999876543  44444   678999999999999999999999999999998 778875322        1111 12221


Q ss_pred             --CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1034 --PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1034 --~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        -++..|.    .++..++++|+.||++.|.+||+++|+-+.+|
T Consensus       481 kgyRM~~Pe----GCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  481 KGYRMDGPE----GCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ccccccCCC----CCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence              2233333    33446899999999999999999999998876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-37  Score=347.33  Aligned_cols=242  Identities=24%  Similarity=0.320  Sum_probs=198.1

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|+||.||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999999765 6889999998754333334456788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccccc
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA  972 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  972 (1077)
                      .+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.............
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  154 (312)
T cd05585          81 FHHLQREG---RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC  154 (312)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccccc
Confidence            99986543   478899999999999999999998   999999999999999999999999999986544434444567


Q ss_pred             ccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHH
Q 001440          973 GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052 (1077)
Q Consensus       973 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1052 (1077)
                      ||+.|+|||++.+..++.++||||+||++|||++|+.||....        ..+....+.......+.    .....+.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~~~~~~----~~~~~~~~  222 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEPLRFPD----GFDRDAKD  222 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCCCCCCC----cCCHHHHH
Confidence            9999999999999999999999999999999999999986321        12223333333332222    22346789


Q ss_pred             HHHhccCCCCCCCCC---HHHHHh
Q 001440         1053 VAISCLDENPDSRPT---MQKVSQ 1073 (1077)
Q Consensus      1053 li~~cl~~dP~~RPs---~~evl~ 1073 (1077)
                      ++.+||+.||++||+   ++|+++
T Consensus       223 li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         223 LLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHcCCCHHHcCCCCCHHHHHc
Confidence            999999999999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.7e-37  Score=349.49  Aligned_cols=247  Identities=27%  Similarity=0.339  Sum_probs=204.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|+++ +++.||+|.+...........+.+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57889999999999999999775 68899999987643333344567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            9999999999987543   477888999999999999999999   9999999999999999999999999999876432


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      .   ....|++.|+|||++.+..++.++|||||||++|||++|+.||.....        .+....+.....+.+...  
T Consensus       172 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~p~~~--  238 (329)
T PTZ00263        172 T---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKILAGRLKFPNWF--  238 (329)
T ss_pred             c---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHhcCCcCCCCCC--
Confidence            2   235789999999999999999999999999999999999999863221        222333333333333221  


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCC-----HHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1073 (1077)
                        ...+.+++.+||+.||++||+     ++|+++
T Consensus       239 --~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        239 --DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             --CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence              235789999999999999997     677764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=6.7e-37  Score=343.03  Aligned_cols=261  Identities=23%  Similarity=0.370  Sum_probs=199.7

Q ss_pred             cCCCccceecccCCceEEEEEecC-----------------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCcee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSS-----------------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV  868 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  868 (1077)
                      ++|.+.+.||+|+||.||+|.+++                 +..||+|.+....  ......++.+|+.++++++||||+
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCee
Confidence            578889999999999999997532                 3369999987542  223356789999999999999999


Q ss_pred             eEEEEEeeCCeeEEEEeecCCCCHHHHHhcCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001440          869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPI  932 (1077)
Q Consensus       869 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  932 (1077)
                      ++++++.+.+..++||||+++|+|.+++....                ....+++.++..++.||+.|++|||+.   +|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            99999999999999999999999999985432                112467889999999999999999998   99


Q ss_pred             EeccCCCCCeeeCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh--CC
Q 001440          933 VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK--GK 1008 (1077)
Q Consensus       933 vH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~ 1008 (1077)
                      +||||||+||+++.++.+||+|||+++........  .....++..|+|||++....++.++||||||+++|||++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            99999999999999999999999999865433221  123345788999999988899999999999999999987  55


Q ss_pred             CCCCccccccccCcccccchhhhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1009 HPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1009 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .||......... ............. ....+    ...+..+.+++.+||+.||++|||++||.+.|+
T Consensus       240 ~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDEQVI-ENAGEFFRDQGRQVYLFRP----PPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHHHHH-HHHHHHhhhccccccccCC----CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            666532211000 0000000000000 00011    112346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.9e-37  Score=346.43  Aligned_cols=244  Identities=23%  Similarity=0.310  Sum_probs=200.2

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      +.||+|+||.||+|+.. +|+.||+|++.............+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            36999999999999764 78999999987643333344567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE  970 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  970 (1077)
                      +|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  154 (323)
T cd05595          81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT  154 (323)
T ss_pred             cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcccc
Confidence            9999886543   478899999999999999999999   9999999999999999999999999998865444344445


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1050 (1077)
                      ..|++.|+|||++.+..++.++|||||||++|||++|+.||....        .......+.......+.    .....+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--------~~~~~~~~~~~~~~~p~----~~~~~~  222 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEEIRFPR----TLSPEA  222 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCCCCCC----CCCHHH
Confidence            679999999999999999999999999999999999999986321        12222233222222222    223467


Q ss_pred             HHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1051 MEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      .+++.+||++||++||     ++.|+++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         223 KSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            8999999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.7e-37  Score=345.95  Aligned_cols=244  Identities=23%  Similarity=0.320  Sum_probs=200.6

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      +.||+|+||.||+|+.. +|+.||+|++.............+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            36899999999999764 68999999987654334444667889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE  970 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  970 (1077)
                      +|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~  154 (328)
T cd05593          81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT  154 (328)
T ss_pred             CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCccccccc
Confidence            9999886543   478899999999999999999999   9999999999999999999999999999865443334445


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1050 (1077)
                      ..|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+.    .....+
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~~~~~~~p~----~~~~~~  222 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEDIKFPR----TLSADA  222 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhccCCccCCC----CCCHHH
Confidence            6799999999999999999999999999999999999999863211        1222222222222222    223467


Q ss_pred             HHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1051 MEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      .+++.+||++||++||     +++|+++
T Consensus       223 ~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         223 KSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            8999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-37  Score=316.56  Aligned_cols=256  Identities=24%  Similarity=0.279  Sum_probs=201.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CCeeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  882 (1077)
                      ++|+..++|++|.||.||+|+++ +++.||+|+++.....+.- .-...+|+.++.+.+|||||.+..+...  -+..||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GF-PItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGF-PITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCC-cchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            46778889999999999999665 7899999999865422211 2245889999999999999999998754  457999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |||||+. +|...+..-.  +++...++..++.|+++|++|||+.   .|+|||+|++|+|+...|.+||+|||+|+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            9999987 8888886544  4688899999999999999999999   99999999999999999999999999999999


Q ss_pred             CCCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccc-------
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRT------- 1027 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~------- 1027 (1077)
                      .....++..+-|..|.|||.+.+. .|+.++||||+||++.|++++++-|...+.......       ..+..       
T Consensus       229 sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~l  308 (419)
T KOG0663|consen  229 SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSEL  308 (419)
T ss_pred             CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcccc
Confidence            888888999999999999988764 689999999999999999999988764332211000       00000       


Q ss_pred             -----------hhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 -----------LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 -----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                                 ....+.++++...     ....-.+++...+.+||++|-||+|.++
T Consensus       309 p~~k~~~f~~~pyn~lr~kF~~~~-----lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  309 PAVKKMTFSEHPYNNLRKKFGALS-----LSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             chhhccccCCCCchhhhhhccccc-----cchhHHHHHHHHhccCccccccHHHhhc
Confidence                       0000111111100     1234567888999999999999999875

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.7e-37  Score=321.70  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=215.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|+..+.||.|.-|+||.++.+ ++..+|+|++.+..........+...|.++++.++||.++.+|+.++.++..++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            35677889999999999999876 45889999999887776666778889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC-
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP-  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~-  963 (1077)
                      |||+||+|+...+++. ...++...++.+|..++.||+|||..   |||+|||||+||||.++|.+.++||.++..... 
T Consensus       157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            9999999999887665 45689999999999999999999999   999999999999999999999999998754311 


Q ss_pred             --------------------------------C-C----------------------CCcccccccccccCccccccCCC
Q 001440          964 --------------------------------D-S----------------------SNWTELAGTIGYVAPELAYTMKV  988 (1077)
Q Consensus       964 --------------------------------~-~----------------------~~~~~~~g~~~y~aPE~~~~~~~  988 (1077)
                                                      . .                      .....++||-+|.|||++.+.+.
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                      01123578999999999999999


Q ss_pred             CCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC-
Q 001440          989 TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT- 1067 (1077)
Q Consensus       989 ~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs- 1067 (1077)
                      +.++|+|+|||++|||+.|..||.        ..+.++++..++......+...  .......++|++.|.+||.+|.- 
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFK--------G~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~  382 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFK--------GSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGS  382 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcC--------CCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhcc
Confidence            999999999999999999999986        3345566777766555544332  44567889999999999999997 


Q ss_pred             ---HHHHHh
Q 001440         1068 ---MQKVSQ 1073 (1077)
Q Consensus      1068 ---~~evl~ 1073 (1077)
                         |+||.+
T Consensus       383 ~rGA~eIK~  391 (459)
T KOG0610|consen  383 KRGAAEIKR  391 (459)
T ss_pred             ccchHHhhc
Confidence               777754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-37  Score=348.52  Aligned_cols=256  Identities=21%  Similarity=0.293  Sum_probs=204.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|++. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36889999999999999999775 68999999987654333344667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.... 
T Consensus        81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            9999999999996543   478899999999999999999999   999999999999999999999999999986543 


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ......|++.|+|||++.+..++.++||||+||++|||++|+.||......... ............+....   ...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~~---~~~  227 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW-ENLKYWKETLQRPVYDD---PRF  227 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH-HHHHhccccccCCCCCc---ccc
Confidence              234457899999999999999999999999999999999999998632211000 00000000000111110   011


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++||+++|+++.
T Consensus       228 ~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         228 NLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            224468899999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-40  Score=374.90  Aligned_cols=507  Identities=31%  Similarity=0.367  Sum_probs=275.9

Q ss_pred             EEccCCcccccCCcccCCCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccC
Q 001440          113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGL  192 (1077)
Q Consensus       113 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l  192 (1077)
                      +|.+..++. .||..+..-..++.|+++.|.+-...-+.+.+.-+|+.|||++|+++ ..|..+..+++|+.|.++.|-+
T Consensus         3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i   80 (1081)
T KOG0618|consen    3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI   80 (1081)
T ss_pred             cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence            344444443 23333333333555666555544211122233334555555555544 4455555555555555555555


Q ss_pred             CCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCC
Q 001440          193 SGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF  272 (1077)
Q Consensus       193 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  272 (1077)
                      .                         ..|.+..++.+|++|.|..|++. ..|.++..+.+|+.||++.|.+. .+|..+
T Consensus        81 ~-------------------------~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i  133 (1081)
T KOG0618|consen   81 R-------------------------SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVI  133 (1081)
T ss_pred             h-------------------------hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhH
Confidence            4                         33444444445555555544444 44555555555555555555554 455555


Q ss_pred             CCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccccccccE
Q 001440          273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFY  352 (1077)
Q Consensus       273 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~  352 (1077)
                      ..++.++.+..++|....    .++... ++.+++..|.+.+.++..+..++.  .|+|++|.+.   -..+.++.+|+.
T Consensus       134 ~~lt~~~~~~~s~N~~~~----~lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~  203 (1081)
T KOG0618|consen  134 EVLTAEEELAASNNEKIQ----RLGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEV  203 (1081)
T ss_pred             HhhhHHHHHhhhcchhhh----hhcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhh
Confidence            555555555555551111    111111 455555555555555555544444  4555555554   123444555555


Q ss_pred             EeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccC
Q 001440          353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNAL  432 (1077)
Q Consensus       353 L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  432 (1077)
                      +....|+++...    -.-++|+.|+.+.|.++...+..  --.+|+++++++|+++ .+|.+++.+.+|+.++..+|++
T Consensus       204 l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l  276 (1081)
T KOG0618|consen  204 LHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRL  276 (1081)
T ss_pred             hhhhhcccceEE----ecCcchheeeeccCcceeecccc--ccccceeeecchhhhh-cchHHHHhcccceEecccchhH
Confidence            555555554211    12245666666666665222211  1245666666666666 3446666666666666666666


Q ss_pred             cCCCCCccCCcccCcEEecccCcCCCCccccccccccceEeecCCccCCCCCcccccccc-cceeccccccccCCCCcCC
Q 001440          433 SGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSN-LSYINLSHKKFYGEISFDW  511 (1077)
Q Consensus       433 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~-L~~L~Ls~n~i~~~~~~~~  511 (1077)
                      + .+|..+...++|+.|.+.+|.++..++...+++.|+.|+|..|.+...+...+..... +..++.+.|++....... 
T Consensus       277 ~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~-  354 (1081)
T KOG0618|consen  277 V-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYE-  354 (1081)
T ss_pred             H-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccccc-
Confidence            3 5666666666777777777777666666666666666666666666555544433322 444444444443322111 


Q ss_pred             CCCCCCcEEEcccccccCCCCCCCCCCCCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccce
Q 001440          512 GKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEH  591 (1077)
Q Consensus       512 ~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~  591 (1077)
                                             =..++.|+.|++.+|++++..-..+.+.++|+.|+|++|++.......+.++..|++
T Consensus       355 -----------------------e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~Lee  411 (1081)
T KOG0618|consen  355 -----------------------ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEE  411 (1081)
T ss_pred             -----------------------chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHH
Confidence                                   123344666666666666655556666666777777777666333345566677777


Q ss_pred             eeccCCcccCCCCCcccccccceeeeeccccccCCcchhccccccccceecccccCCCCCccccccccccchhccccccc
Q 001440          592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNL  671 (1077)
Q Consensus       592 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l  671 (1077)
                      |+||+|+++ .+|+.+..++.|++|...+|+|. ..| .+..++.|+.+|+|.|+++...-.+-..-++|++||+++|.-
T Consensus       412 L~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~  488 (1081)
T KOG0618|consen  412 LNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTR  488 (1081)
T ss_pred             Hhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcc
Confidence            777777776 56666666777777777777766 455 666677777777777776653222222226777777777764


Q ss_pred             ccccchhhhccccccEEeccCC
Q 001440          672 SGFIPRCFKEMHGLVYIDISYN  693 (1077)
Q Consensus       672 ~~~~~~~l~~l~~L~~l~l~~N  693 (1077)
                      ..+.-+.|..+..+...++.-|
T Consensus       489 l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  489 LVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             cccchhhhHHhhhhhheecccC
Confidence            4455566666666666666666

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.3e-37  Score=346.04  Aligned_cols=248  Identities=23%  Similarity=0.301  Sum_probs=203.5

Q ss_pred             hcCCCccceecccCCceEEEEEecC--CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSS--GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      .++|++.+.||+|+||.||+|.++.  +..||+|++...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3578999999999999999997543  36899999865433333445678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            999999999999997543   478899999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      ..   .....||+.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+.. 
T Consensus       183 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~p~~-  250 (340)
T PTZ00426        183 TR---TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKILEGIIYFPKF-  250 (340)
T ss_pred             CC---cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCCC-
Confidence            32   2345789999999999998899999999999999999999999863321        12222333333222221 


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                         ....+.+++.+|++.||++|+     +++|+++
T Consensus       251 ---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        251 ---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence               123577899999999999995     8988875

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.5e-36  Score=335.72  Aligned_cols=249  Identities=23%  Similarity=0.314  Sum_probs=199.4

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|+||+||+|... +|+.||+|++...........+.+..|+.+++.++||||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999664 7889999998765433333446678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcccc
Q 001440          893 AMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL  971 (1077)
Q Consensus       893 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  971 (1077)
                      .+++.... ....+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||++..+..........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  157 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY  157 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcccccc
Confidence            98875432 234588999999999999999999999   99999999999999999999999999998765544444456


Q ss_pred             cccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHH
Q 001440          972 AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051 (1077)
Q Consensus       972 ~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1051 (1077)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||.......    ................+    ......+.
T Consensus       158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~----~~~~~~~~  229 (280)
T cd05608         158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILNDSVTYP----DKFSPASK  229 (280)
T ss_pred             CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcccCCCCc----ccCCHHHH
Confidence            78999999999999999999999999999999999999986322110    01111112222211111    22345688


Q ss_pred             HHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1052 EVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1052 ~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      +++.+||+.||++||     +++|+++
T Consensus       230 ~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         230 SFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            999999999999999     6777764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.9e-36  Score=342.23  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=197.8

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHH---hcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS---LTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      |++.+.||+|+||.||+|.+. +++.||||++...........+.+.+|+.+   ++.++||||+++++++.+.+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999765 689999999875432333334556666554   4677899999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|..++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999988854    2488999999999999999999998   999999999999999999999999999876544


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........|++.|+|||++.+..++.++|||||||++|||++|+.||.....        .+....+.......+.   
T Consensus       154 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~p~---  222 (324)
T cd05589         154 FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDEVRYPR---  222 (324)
T ss_pred             CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC---
Confidence            44444556799999999999999999999999999999999999999863221        1222233332222222   


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                       .....+.+++.+||+.||++||     +++++++
T Consensus       223 -~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         223 -FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             -CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence             1234578899999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.3e-36  Score=330.45  Aligned_cols=252  Identities=24%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             cCCCccceecccCCceEEEEEec----CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|++.+.||+|+||.||+|.++    .+..||+|.+.....  ....+.+.+|+..++.++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            56888999999999999999653    356899999876532  233567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||.+...
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999997543  3588999999999999999999998   9999999999999999999999999987653


Q ss_pred             CCCCCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCC
Q 001440          962 KPDSSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPA 1038 (1077)
Q Consensus       962 ~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1038 (1077)
                      ...... .....++..|+|||++.+..++.++|||||||++||+++ |+.||.....        .+....+.+. ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  229 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAVEDGFRLPA  229 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCC
Confidence            222111 112234678999999999999999999999999999875 9999864321        1112222221 1122


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +.    .....+.+++.+||+.+|++||+++|+.+.|+
T Consensus       230 ~~----~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~  263 (266)
T cd05064         230 PR----NCPNLLHQLMLDCWQKERGERPRFSQIHSILS  263 (266)
T ss_pred             CC----CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHH
Confidence            21    23346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.8e-36  Score=331.42  Aligned_cols=260  Identities=23%  Similarity=0.308  Sum_probs=209.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|+.. +++.||||.+......+......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57889999999999999999764 78999999886543344444667899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||+++|+|.+++..... ...++..++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998854322 23478889999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........++..|+|||++.+..++.++||||+|+++|||++|+.||.....      ........+.....+.  ...
T Consensus       159 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~  230 (267)
T cd08228         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKIEQCDYPP--LPT  230 (267)
T ss_pred             hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHHhcCCCCC--CCh
Confidence            43333445688999999999988899999999999999999999999752211      1111112211111111  111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ......+.+++.+||+.+|++||+++||++.++
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~  263 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK  263 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHH
Confidence            233456889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=339.12  Aligned_cols=253  Identities=25%  Similarity=0.309  Sum_probs=223.3

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  882 (1077)
                      ...|++.+.||+|.||.||+|+.+ +|+.+|+|.+.+...........+.+|+.+|+++. |||||.+.+++++....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            457888899999999999999776 59999999998876655555678999999999998 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC----CceEEeccccc
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE----YEAHVSDFGIS  958 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfgla  958 (1077)
                      |||++.||.|++.+...    ..++.++..++.||+.|+.|||+.   ||+|||+||+|+|+...    +.+|++|||+|
T Consensus       114 vmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla  186 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLA  186 (382)
T ss_pred             EEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence            99999999999999765    278899999999999999999998   99999999999999654    47999999999


Q ss_pred             ccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      ..... .......+||+.|+|||++...+|+.++||||.||++|.|++|..||....        .......+....+..
T Consensus       187 ~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~--------~~~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  187 KFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET--------EFEIFLAILRGDFDF  257 (382)
T ss_pred             eEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC--------hhHHHHHHHcCCCCC
Confidence            98877 566778899999999999999999999999999999999999999987432        233444666666666


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+......+.+++++|+..||.+|+|++++++
T Consensus       258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            66666777788999999999999999999999986

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.7e-36  Score=328.16  Aligned_cols=250  Identities=26%  Similarity=0.451  Sum_probs=203.4

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ++|++.+.||+|+||.||+|+++++..+|+|.+.....    ..+.+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e   79 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE   79 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence            46888899999999999999988888999998764322    24578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          80 FMENGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999999986543  3478999999999999999999998   99999999999999999999999999998654322


Q ss_pred             CC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CCCCCCC
Q 001440          966 SN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCN 1042 (1077)
Q Consensus       966 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1042 (1077)
                      .. .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....        .+....+.... ...+.  
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~~~~~~~--  224 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGFRLYRPK--  224 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCCCCCCC--
Confidence            21 122345678999999988889999999999999999999 8999863221        12222222211 11111  


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        .....+.+++.+||+.+|++||+++|+++.|.
T Consensus       225 --~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         225 --LASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              12346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-37  Score=326.24  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccch-----------hhHHHHHHHHHHHhcCCCCCceeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSE-----------MTCQQEFLNEVKSLTEIRHRNIVKFY  871 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~l~  871 (1077)
                      ..++|++.+.||+|.||.|-+|+.. +++.||||++.+.....           ....+++.+|+.++++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3578999999999999999999665 78999999987543211           11235789999999999999999999


Q ss_pred             EEEeeC--CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCc
Q 001440          872 GFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE  949 (1077)
Q Consensus       872 ~~~~~~--~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  949 (1077)
                      ++..++  +..|||+|||..|.+...=   ....+++..++++++.+++.||+|||.+   |||||||||.|+|++.+|+
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence            998664  5899999999999875321   2223389999999999999999999999   9999999999999999999


Q ss_pred             eEEecccccccCCCC-----CCCcccccccccccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCcccccccc
Q 001440          950 AHVSDFGISKSLKPD-----SSNWTELAGTIGYVAPELAYTMK----VTEKSDVYSFGVLALEAIKGKHPRDFISSICST 1020 (1077)
Q Consensus       950 ~kl~Dfgla~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~ 1020 (1077)
                      +||+|||.+......     .......+||+.|+|||...++.    .+.+.||||+||++|.++.|+.||-.       
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-------  321 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-------  321 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-------
Confidence            999999999765222     11233478999999999887632    35688999999999999999999852       


Q ss_pred             CcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1021 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       ....+.++.++...+..|...  +....+.++|.++|.+||++|.+..+|..
T Consensus       322 -~~~~~l~~KIvn~pL~fP~~p--e~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  322 -DFELELFDKIVNDPLEFPENP--EINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             -chHHHHHHHHhcCcccCCCcc--cccHHHHHHHHHHhhcChhheeehhhhee
Confidence             233456667776666555433  33456889999999999999999998864

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-36  Score=349.89  Aligned_cols=256  Identities=25%  Similarity=0.414  Sum_probs=201.5

Q ss_pred             hcCCCccceecccCCceEEEEEe------cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHA  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  877 (1077)
                      .++|++.+.||+|+||.||+|++      .++..||||++.....  ....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~  111 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG  111 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence            35788999999999999999963      2456899999875432  22356788999999999 899999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCC--------------------------------------------------------
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATS--------------------------------------------------------  901 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~--------------------------------------------------------  901 (1077)
                      +..++||||+++|+|.+++.....                                                        
T Consensus       112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (375)
T cd05104         112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS  191 (375)
T ss_pred             CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence            999999999999999999865321                                                        


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          902 ----------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       902 ----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                                      ...+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  268 (375)
T cd05104         192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDS  268 (375)
T ss_pred             ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence                            12478889999999999999999998   99999999999999999999999999998664432


Q ss_pred             CC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CCCCCC
Q 001440          966 SN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041 (1077)
Q Consensus       966 ~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1041 (1077)
                      ..  .....++..|+|||++.+..++.++|||||||++|||++ |..||......       ......+.... ...+. 
T Consensus       269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~-  340 (375)
T cd05104         269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-------SKFYKMIKEGYRMLSPE-  340 (375)
T ss_pred             cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-------HHHHHHHHhCccCCCCC-
Confidence            21  112334678999999999999999999999999999998 88887532110       01111111111 11111 


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         .....+.+++.+||+.||++||+++||++.|+
T Consensus       341 ---~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~  372 (375)
T cd05104         341 ---CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIE  372 (375)
T ss_pred             ---CCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence               11246889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-36  Score=349.81  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=202.1

Q ss_pred             HhcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++......  .....+.+|+.+++.+ +|+||+++++++..
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            3457889999999999999999642      3457999999764322  2356788999999999 89999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS-------------------------------------------------------  901 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------------------------------------------------  901 (1077)
                      .+..++||||+++|+|.+++.....                                                       
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            9999999999999999999854211                                                       


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC--
Q 001440          902 ------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--  967 (1077)
Q Consensus       902 ------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--  967 (1077)
                                  ...+++.++++++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++........  
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                        12477889999999999999999998   9999999999999999999999999999865433221  


Q ss_pred             cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          968 WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       968 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||.....        ................  ....
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~--------~~~~~~~~~~~~~~~~--~~~~  340 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV--------NSKFYKMVKRGYQMSR--PDFA  340 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc--------cHHHHHHHHcccCccC--CCCC
Confidence            122335678999999998899999999999999999997 9999863221        0111111111111100  0011


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1047 LISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...+.+++.+||+.||++||+++|++++|+
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~  370 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQ  370 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.2e-37  Score=344.89  Aligned_cols=244  Identities=23%  Similarity=0.308  Sum_probs=199.6

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      +.||+|+||.||+|+.. +|+.||+|.+............++..|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            36999999999999754 78999999987654333344567788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      +|.+++....   .+++.++..++.||+.||+|||+ .   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (325)
T cd05594          81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK  154 (325)
T ss_pred             cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccc
Confidence            9999886543   47889999999999999999997 6   999999999999999999999999999976544444444


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||....        .+.....+.......+..    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--------~~~~~~~i~~~~~~~p~~----~~~~  222 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEEIRFPRT----LSPE  222 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--------HHHHHHHHhcCCCCCCCC----CCHH
Confidence            5679999999999999999999999999999999999999985321        112222222222222221    2346


Q ss_pred             HHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1050 IMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      +.+++.+||++||++|+     +++|+++
T Consensus       223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            78999999999999997     8988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.2e-36  Score=342.13  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=200.5

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.. +++.||+|++......+....+.+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999765 6889999999765444444456788899999888 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++...   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccc
Confidence            9999988654   3488999999999999999999999   999999999999999999999999999975433333445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccc-cchhhhcCCCCCCCCCCcHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD-RTLDEILDPRLPAPSCNIRDKLI 1048 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1077)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||+............. .....+.......+..    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~----~~~  230 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS----LSV  230 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC----CCH
Confidence            56799999999999999999999999999999999999999964322111111111 1122223333332222    234


Q ss_pred             HHHHHHHhccCCCCCCCCC------HHHHHh
Q 001440         1049 SIMEVAISCLDENPDSRPT------MQKVSQ 1073 (1077)
Q Consensus      1049 ~l~~li~~cl~~dP~~RPs------~~evl~ 1073 (1077)
                      .+.+++.+||++||++||+      ++|+++
T Consensus       231 ~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            5788999999999999997      567654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.2e-36  Score=341.32  Aligned_cols=244  Identities=25%  Similarity=0.388  Sum_probs=199.0

Q ss_pred             ceecccCCceEEEEEe----cCCCEEEEEEccCCccc-hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          812 HCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      +.||+|+||.||+++.    .+++.||+|.+...... .......+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999999999965    35789999998753221 222345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++|+|.+++....   .+.+.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (323)
T cd05584          82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT  155 (323)
T ss_pred             CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence            99999999986543   367788889999999999999999   999999999999999999999999999976544434


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||....        .......+.......+..    .
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--------~~~~~~~~~~~~~~~~~~----~  223 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--------RKKTIDKILKGKLNLPPY----L  223 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCCC----C
Confidence            3445679999999999999889999999999999999999999986322        122333444444333322    2


Q ss_pred             HHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1047 LISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      ...+.+++.+||++||++||     +++++++
T Consensus       224 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         224 TPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            34678999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-37  Score=303.42  Aligned_cols=261  Identities=23%  Similarity=0.349  Sum_probs=208.7

Q ss_pred             HhcCCCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  877 (1077)
                      ..++|.+.+.+|+|||+-||.++ ..+++.||+|++....   .++.+...+|++..++++|||+++++++...+     
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            45789999999999999999996 4578899999997653   34477889999999999999999999887433     


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                      ...|++++|...|+|.+.+..... ...+++.+++.|+.+|++|+++||+. .|+++||||||.||++..++.+++.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence            358999999999999999876553 33789999999999999999999998 3469999999999999999999999999


Q ss_pred             ccccCCCCCCC---------cccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCccc
Q 001440          957 ISKSLKPDSSN---------WTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024 (1077)
Q Consensus       957 la~~~~~~~~~---------~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 1024 (1077)
                      .++...-.-..         +..-..|..|.|||.+.   +...++++||||+||++|+||.|..||+....   .+..+
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---~GgSl  251 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---QGGSL  251 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---cCCeE
Confidence            99865322111         12234688999999886   34578999999999999999999999974432   12222


Q ss_pred             ccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         .-.+..+.+..|....  .+..+.+++++|++.||.+||++.|++..++
T Consensus       252 ---aLAv~n~q~s~P~~~~--yse~l~~lik~mlqvdP~qRP~i~~ll~~~d  298 (302)
T KOG2345|consen  252 ---ALAVQNAQISIPNSSR--YSEALHQLIKSMLQVDPNQRPTIPELLSKLD  298 (302)
T ss_pred             ---EEeeeccccccCCCCC--ccHHHHHHHHHHhcCCcccCCCHHHHHHHHH
Confidence               1122333444333322  4557999999999999999999999998764

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.1e-36  Score=340.77  Aligned_cols=239  Identities=25%  Similarity=0.383  Sum_probs=195.2

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||+||+|+.+ +++.||+|++...........+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 6889999998754333333456677888888776 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTS  154 (320)
T ss_pred             chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCccc
Confidence            99999886543   478899999999999999999998   999999999999999999999999999886544434444


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        .......+.......+..    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~~~i~~~~~~~~~~----~~~~  222 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDEVVYPTW----LSQD  222 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHhcCCCCCCCC----CCHH
Confidence            5679999999999999999999999999999999999999986322        122233333333322221    2346


Q ss_pred             HHHHHHhccCCCCCCCCCH
Q 001440         1050 IMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      +.+++.+||+.||++||++
T Consensus       223 ~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         223 AVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHcccCHHHCCCC
Confidence            7899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=352.12  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=208.3

Q ss_pred             hcCCCccceecccCCceEEEEEecCC-CEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEE-Eee-----
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSG-EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGF-CSH-----  876 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~-----  876 (1077)
                      ..++++.+.|.+|||+.||.|+...+ .+||+|++...   ++...+.+.+|+++|+.|+ |||||.+++. ...     
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            45678889999999999999987655 99999998764   5556888999999999996 9999999993 211     


Q ss_pred             -CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          877 -ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       877 -~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                       ..+.+|.||||++|.|-|++....... +++.++++|+.++++|+++||.. .|+|||||||.+|||++.++..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence             136789999999999999997665544 99999999999999999999986 678999999999999999999999999


Q ss_pred             cccccCCCCCCCc---------ccccccccccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcc
Q 001440          956 GISKSLKPDSSNW---------TELAGTIGYVAPELA---YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       956 gla~~~~~~~~~~---------~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 1023 (1077)
                      |.|..........         -....|+.|+|||++   .+.++++|+||||+||++|-|+....||+...        
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg--------  262 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG--------  262 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence            9997543322111         123468999999986   47789999999999999999999999997322        


Q ss_pred             cccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                          .-.+++.++..|..  ..+...+..||+.||+.||++||++.||+..+
T Consensus       263 ----~laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  263 ----KLAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             ----ceeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence                23456666665542  35666899999999999999999999998865

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.8e-36  Score=338.53  Aligned_cols=259  Identities=25%  Similarity=0.327  Sum_probs=203.4

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||.||+|+.. +|..||+|.+....  .....+.+.+|+++++.++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            368999999999999999999765 68889999887542  222356789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++....   .+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++.....
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          82 MEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             eecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            99999999999996543   3788899999999999999999862  699999999999999999999999999986543


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc---Cc-c------c---------
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST---SS-N------L--------- 1024 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~---~~-~------~--------- 1024 (1077)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........   .. .      .         
T Consensus       157 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         157 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             c--ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence            2  223456899999999999999999999999999999999999998632211000   00 0      0         


Q ss_pred             -------------------ccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1025 -------------------DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1025 -------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                                         ....+.+.....+.  .........+.+++.+||++||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPK--LPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcC--CCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                               00000011100010  0011234568899999999999999999999864

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3e-36  Score=340.82  Aligned_cols=247  Identities=25%  Similarity=0.359  Sum_probs=196.2

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.. +++.||+|++.............+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999765 6789999998765444444456678888888776 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~  154 (329)
T cd05618          81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS  154 (329)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccc
Confidence            99998886543   478899999999999999999999   999999999999999999999999999986543333444


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCccccc-chhhhcCCCCCCCCCCcHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR-TLDEILDPRLPAPSCNIRDKLI 1048 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1048 (1077)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||............... ....+.......+.    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~~~  230 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----SLSV  230 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----CCCH
Confidence            567999999999999999999999999999999999999998643221111111111 12222233332222    2234


Q ss_pred             HHHHHHHhccCCCCCCCCCH
Q 001440         1049 SIMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1049 ~l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      .+.+++.+||++||++||++
T Consensus       231 ~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         231 KAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHHHHHhcCCHHHcCCC
Confidence            57789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.9e-36  Score=339.59  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=198.1

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCC-CceeeEEEEEeeCCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +|++.+.||+|+||.||+|+.. +++.||+|++...........+.+..|+.+++.++| ++|+++++++.+.+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788899999999999999765 578999999876433333445677889999999966 56888999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            9999999999986543   478899999999999999999998   9999999999999999999999999998754333


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+.    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~~~----  222 (324)
T cd05587         155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPK----  222 (324)
T ss_pred             CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----
Confidence            3334456789999999999999999999999999999999999999863221        2222333333322222    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      .....+.+++.+||++||++||++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         223 SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCHHHHHHHHHHhhcCHHHcCCC
Confidence            123467889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9e-37  Score=333.17  Aligned_cols=249  Identities=35%  Similarity=0.538  Sum_probs=193.4

Q ss_pred             ccceecccCCceEEEEEec-----CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          810 EEHCIGTGGQGSVYRAELS-----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       810 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ..+.||.|.||.||+|.+.     .+..|+||.+...  ......+++.+|++.+++++||||++++|++...+..++|+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            4578999999999999776     3567999999553  22334788999999999999999999999999888899999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.... ...+++.++.+|+.||+.||+|||+.   +++|+||+++||+++.++.+||+|||++......
T Consensus        81 e~~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             E--TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccccc-cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999998762 24589999999999999999999999   9999999999999999999999999999876322


Q ss_pred             CCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          965 SSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       965 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ...  .........|+|||.+.+..++.++||||||+++||+++ |+.||....        .......+.+....... 
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--------~~~~~~~~~~~~~~~~~-  227 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--------NEEIIEKLKQGQRLPIP-  227 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--------HHHHHHHHHTTEETTSB-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc--------cccccccccccccceec-
Confidence            221  223456789999999999889999999999999999999 678875331        11222222222221111 


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                        ......+.+++.+||+.||++||+++|+++.|
T Consensus       228 --~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  228 --DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              11234588999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3e-36  Score=334.70  Aligned_cols=260  Identities=19%  Similarity=0.270  Sum_probs=198.8

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.++||+|+||+||+|+.+ +++.||+|++......  .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            57899999999999999999765 6889999998654222  22456778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++ +|.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          83 EYLDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             eCCCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            99975 8998886443  3467889999999999999999998   9999999999999999999999999999865444


Q ss_pred             CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccccc---------
Q 001440          965 SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRT--------- 1027 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~--------- 1027 (1077)
                      ........+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........       .......         
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            334445678999999998865 56899999999999999999999998632211000       0000000         


Q ss_pred             hhhhcCCCCCCCC--CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 LDEILDPRLPAPS--CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +.....+......  ...........+++.+|+++||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0000111110000  000112346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=331.80  Aligned_cols=251  Identities=27%  Similarity=0.427  Sum_probs=202.9

Q ss_pred             cCCCccceecccCCceEEEEEec---CCC--EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS---SGE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      +.....++||.|-||.||+|.+.   .|+  .||||.-+.+..  ....+.|.+|+.+|+.++|||||+++|+|.+. ..
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~  465 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PM  465 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ce
Confidence            34456688999999999999653   233  488888776533  33478899999999999999999999999764 68


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      |||||.++.|.|..|++.+.  ..++......++.||+.||+|||+.   ..|||||.++|||+.+...||++|||+++.
T Consensus       466 WivmEL~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eEEEecccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence            99999999999999997764  4578889999999999999999999   899999999999999999999999999998


Q ss_pred             CCCCCCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC-CCCC
Q 001440          961 LKPDSSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-PRLP 1037 (1077)
Q Consensus       961 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1037 (1077)
                      +..+... .+...-+..|||||.+.-..++.++|||.|||+|||+++ |..||.....        .+.+..+.. .++|
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--------sDVI~~iEnGeRlP  612 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--------SDVIGHIENGERLP  612 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--------cceEEEecCCCCCC
Confidence            7655332 222234678999999999999999999999999999987 9999874321        112222222 3455


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .|..    +++.++.++.+||++||.+||++.|+...|.
T Consensus       613 ~P~n----CPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  613 CPPN----CPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCCC----CChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            4432    2346889999999999999999999988763

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.8e-36  Score=338.04  Aligned_cols=243  Identities=26%  Similarity=0.384  Sum_probs=193.0

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcC-CCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.. +++.||+|.+...........+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999765 678999999876433333334455566666654 4899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .++..++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAS  154 (316)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccc
Confidence            99999986543   478889999999999999999998   999999999999999999999999999986544434445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.....        .+....+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~  222 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSILNDRPHFPR----WISKE  222 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----CCCHH
Confidence            56799999999999999999999999999999999999999863221        1222222222222221    12335


Q ss_pred             HHHHHHhccCCCCCCCCCHH-HHH
Q 001440         1050 IMEVAISCLDENPDSRPTMQ-KVS 1072 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~-evl 1072 (1077)
                      +.+++.+||+.||++||++. ++.
T Consensus       223 ~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         223 AKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHH
Confidence            77899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=370.41  Aligned_cols=492  Identities=31%  Similarity=0.350  Sum_probs=354.6

Q ss_pred             cCCCCCCcEEEccCCcccccCCcccCCCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccc
Q 001440          104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK  183 (1077)
Q Consensus       104 ~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~  183 (1077)
                      +..-.+++.|+++.|-+..-.-+.+.+.-+|+.|||++|.++ ..|..+..+..|+.|.++.|.+. ..|.+..++.+|+
T Consensus        17 i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~   94 (1081)
T KOG0618|consen   17 ILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQ   94 (1081)
T ss_pred             hccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcch
Confidence            334455999999999776433344555666999999999987 89999999999999999999988 7889999999999


Q ss_pred             eeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCC
Q 001440          184 ALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS  263 (1077)
Q Consensus       184 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  263 (1077)
                      +|.|.+|.+. ..|.++..+.+|++|+++.|.+. .+|..+..++.+..+..++|.....    ++... .+.++|..|.
T Consensus        95 ~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~  167 (1081)
T KOG0618|consen   95 YLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNV  167 (1081)
T ss_pred             hheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhh
Confidence            9999999987 78999999999999999999998 8899999999999999999933222    22222 7888899999


Q ss_pred             CCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCcc
Q 001440          264 LSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCE  343 (1077)
Q Consensus       264 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  343 (1077)
                      +.+.++..+..++.  .|+|+.|.+.   -..+.++.+|+.|....|+++...    -..++|+.|+.++|.++...+. 
T Consensus       168 l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~-  237 (1081)
T KOG0618|consen  168 LGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH-  237 (1081)
T ss_pred             cccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc-
Confidence            98888888887776  7999999887   235677888888888888887421    1346788888888888733322 


Q ss_pred             ccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccc
Q 001440          344 IGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMI  423 (1077)
Q Consensus       344 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~  423 (1077)
                       ..-.+|+++++++|+++ .+|.+++.+.+|+.+...+|.++ .+|..+....+|+.|.+.+|+++ .+|.....++.|+
T Consensus       238 -p~p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~  313 (1081)
T KOG0618|consen  238 -PVPLNLQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLR  313 (1081)
T ss_pred             -cccccceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceee
Confidence             22356778888888887 45577777777777777777775 66777777777777777777776 5666666677777


Q ss_pred             eeecccccCcCCCCCccCCccc-CcEEecccCcCCCCccccccccccceEeecCCccCCCCCcccccccccceecccccc
Q 001440          424 VLSIYSNALSGAIPKEYGNLVK-LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKK  502 (1077)
Q Consensus       424 ~L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~  502 (1077)
                      +|+|..|+|....+..+.-+.. |..|+.+.|++...+                       ...-..++.|+.|.+.+|.
T Consensus       314 tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp-----------------------~~~e~~~~~Lq~LylanN~  370 (1081)
T KOG0618|consen  314 TLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLP-----------------------SYEENNHAALQELYLANNH  370 (1081)
T ss_pred             eeeehhccccccchHHHhhhhHHHHHHhhhhccccccc-----------------------cccchhhHHHHHHHHhcCc
Confidence            7777777775333322222222 555555555554322                       1111223445555555555


Q ss_pred             ccCCCCcCCCCCCCCcEEEcccccccCCCCCCCCCCCCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchh
Q 001440          503 FYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTE  582 (1077)
Q Consensus       503 i~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~  582 (1077)
                      +++.....+.++++|+.|+|++|+++......+.++..|+.|+||+|+++ .+|..+..++.|++|...+|++. .+| +
T Consensus       371 Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e  447 (1081)
T KOG0618|consen  371 LTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-E  447 (1081)
T ss_pred             ccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-h
Confidence            55555555566777777777777777666666777777888888888887 67777778888888888888887 666 7


Q ss_pred             hhcccccceeeccCCcccCC-CCCcccccccceeeeeccccccCCcchhccccccccceecccc
Q 001440          583 LGSLIQLEHLDLSSNRLSNS-IPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN  645 (1077)
Q Consensus       583 l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N  645 (1077)
                      +..+++|+.+|+|.|+++.. +|..... ++|++|||++|.-....-..|..+.++...++.-|
T Consensus       448 ~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~l~~d~~~l~~l~~l~~~~i~~~  510 (1081)
T KOG0618|consen  448 LAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTRLVFDHKTLKVLKSLSQMDITLN  510 (1081)
T ss_pred             hhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcccccchhhhHHhhhhhheecccC
Confidence            77788888888888887653 3333332 77777777777643344455555555655555555

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=2.7e-36  Score=340.41  Aligned_cols=244  Identities=24%  Similarity=0.363  Sum_probs=198.6

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.. +++.||+|++...........+.+..|.++++.+ +||||+++++++.+++..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36899999999999765 5789999998764333333455677788888766 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  154 (321)
T cd05591          81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT  154 (321)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCcccc
Confidence            99999886543   478899999999999999999999   999999999999999999999999999986544444445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        .......+.......+..    ....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--------~~~~~~~i~~~~~~~p~~----~~~~  222 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--------EDDLFESILHDDVLYPVW----LSKE  222 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--------HHHHHHHHHcCCCCCCCC----CCHH
Confidence            5678999999999999999999999999999999999999986322        122333333333322221    1245


Q ss_pred             HHHHHHhccCCCCCCCC-------CHHHHHh
Q 001440         1050 IMEVAISCLDENPDSRP-------TMQKVSQ 1073 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RP-------s~~evl~ 1073 (1077)
                      +.+++.+||+.||++||       +++++++
T Consensus       223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            78899999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=7.5e-36  Score=331.02  Aligned_cols=255  Identities=26%  Similarity=0.450  Sum_probs=204.9

Q ss_pred             cCCCccceecccCCceEEEEEecC------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSS------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      ++|++.+.||+|+||.||+|....      ...||+|.+....  ......++.+|+..++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP   82 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence            468888999999999999997642      2579999987542  22335678999999999999999999999999899


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC
Q 001440          880 SFIVYEYLEMGSLAMILSNATSA-------------EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL  946 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~-------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  946 (1077)
                      .+++|||+++|+|.+++......             ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.
T Consensus        83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~  159 (283)
T cd05048          83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGE  159 (283)
T ss_pred             eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcC
Confidence            99999999999999999654221             3478889999999999999999999   9999999999999999


Q ss_pred             CCceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcc
Q 001440          947 EYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       947 ~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 1023 (1077)
                      ++.+||+|||+++.......  ......+++.|+|||++.+..++.++|||||||++|||++ |..||.....       
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------  232 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999986543321  1233456789999999998899999999999999999998 9999763221       


Q ss_pred             cccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       .+....+.....+..   ....+..+.+++.+||+.||++||+++||++.|+
T Consensus       233 -~~~~~~i~~~~~~~~---~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05048         233 -QEVIEMIRSRQLLPC---PEDCPARVYALMIECWNEIPARRPRFKDIHTRLR  281 (283)
T ss_pred             -HHHHHHHHcCCcCCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHh
Confidence             122222222222111   1233457899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.3e-36  Score=348.99  Aligned_cols=253  Identities=22%  Similarity=0.275  Sum_probs=203.1

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+++..++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            3467899999999999999999765 688999999865333333334567889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||+++|+|.+++...    .++...+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            99999999999998653    367788889999999999999998   99999999999999999999999999998765


Q ss_pred             CCCC-CcccccccccccCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC--
Q 001440          963 PDSS-NWTELAGTIGYVAPELAYTM----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR-- 1035 (1077)
Q Consensus       963 ~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 1035 (1077)
                      .... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.....        ......+....  
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~~  265 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKNS  265 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCCc
Confidence            4322 22345799999999988653    478899999999999999999999863221        12223333221  


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHh
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDS--RPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1073 (1077)
                      +..+.  ....+..+.+++.+|++.+|++  ||+++|+++
T Consensus       266 ~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         266 LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            11111  1123456789999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.3e-36  Score=328.72  Aligned_cols=254  Identities=27%  Similarity=0.478  Sum_probs=209.5

Q ss_pred             HhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ...+|++.+.||.|+||.||+|...+++.||+|.+....   .....++..|+.+++.++||||+++++++.+....++|
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII   80 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence            446788999999999999999998889999999987643   22355788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.+|++|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          81 TELMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             EeecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            99999999999997654 34578999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1041 (1077)
                      +........++..|+|||+.....++.++||||||+++|+|++ |+.||....        ....+..+... ..+.+  
T Consensus       157 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~--  226 (261)
T cd05148         157 DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--------NHEVYDQITAGYRMPCP--  226 (261)
T ss_pred             ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--------HHHHHHHHHhCCcCCCC--
Confidence            4333334456778999999988899999999999999999998 899985322        11222222221 11211  


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        ......+.+++.+||+.||++|||++++.+.|+
T Consensus       227 --~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~  259 (261)
T cd05148         227 --AKCPQEIYKIMLECWAAEPEDRPSFKALREELD  259 (261)
T ss_pred             --CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.7e-36  Score=315.05  Aligned_cols=264  Identities=20%  Similarity=0.302  Sum_probs=203.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCc-eeeEEEEEeeCC-----
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN-IVKFYGFCSHAR-----  878 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~-----  878 (1077)
                      ..|+..++||+|.||+||+|+.+ +|+.||+|++.-.... +.......+|+.++++++|+| ||++++++...+     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            45667778999999999999654 7899999999765332 112456789999999999999 999999998877     


Q ss_pred             -eeEEEEeecCCCCHHHHHhcCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          879 -HSFIVYEYLEMGSLAMILSNATSA-EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       879 -~~~lV~E~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                       ..++|+||++. +|.+++...... ..++...+..++.||+.|++|||++   +|+||||||.||+++.+|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             78999999965 999999766532 3366678999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCcccccch
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDRTL 1028 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~ 1028 (1077)
                      +|+...-+...++.-++|..|.|||++.+. .|+..+||||+||+++||++++.-|....+...       .....++.+
T Consensus       166 lAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  166 LARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             hHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            999877666667778899999999998876 799999999999999999999888764332211       000001111


Q ss_pred             hhh---cCCCCCCCCC-----CcH---HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1029 DEI---LDPRLPAPSC-----NIR---DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1029 ~~~---~~~~~~~~~~-----~~~---~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...   .+.+.+.+..     ...   .......+++.+|++++|++|.|++.+++.
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111   0111111110     001   111367899999999999999999998874

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=4.8e-36  Score=338.69  Aligned_cols=244  Identities=23%  Similarity=0.338  Sum_probs=198.9

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999999765 6789999998765433333345567777777777 6899999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            9999999999886543   478899999999999999999998   9999999999999999999999999999865444


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+.    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~~~~~~p~----  222 (323)
T cd05616         155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIMEHNVAYPK----  222 (323)
T ss_pred             CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC----
Confidence            4444556799999999999999999999999999999999999999863321        2223333333333222    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      .....+.+++.+|+++||++|+++
T Consensus       223 ~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         223 SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             cCCHHHHHHHHHHcccCHHhcCCC
Confidence            223467889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=348.89  Aligned_cols=252  Identities=23%  Similarity=0.320  Sum_probs=206.3

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||+||+|+.. +|+.||+|++.............+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999765 78999999987644333344667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++...   ..+++.++..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999999765   3478899999999999999999998   9999999999999999999999999999876543


Q ss_pred             C-----------------------------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccc
Q 001440          965 S-----------------------------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFIS 1015 (1077)
Q Consensus       965 ~-----------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 1015 (1077)
                      .                             .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            3                             12234578999999999999999999999999999999999999986332


Q ss_pred             cccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHHhh
Q 001440         1016 SICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT-MQKVSQL 1074 (1077)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1074 (1077)
                      .        ......+..  .....+...  .....+.+++.+|++ ||++||+ ++|+++.
T Consensus       235 ~--------~~~~~~i~~~~~~~~~p~~~--~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         235 L--------QETYNKIINWKESLRFPPDP--PVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             H--------HHHHHHHhccCCcccCCCCC--CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            1        111222222  111111111  123468899999997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.4e-36  Score=337.06  Aligned_cols=261  Identities=20%  Similarity=0.292  Sum_probs=198.2

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||.||+|+.. +++.||+|++......  .....+.+|+.+++.++||||+++++++.++...++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            468999999999999999999775 6889999998654322  1234567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||++ +++.+++....  ..++..++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          82 FEYVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             EECCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            99996 67887775432  3478889999999999999999999   999999999999999999999999999976544


Q ss_pred             CCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc--------ccccchhhh---
Q 001440          964 DSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS--------NLDRTLDEI--- 1031 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~--------~~~~~~~~~--- 1031 (1077)
                      .........+++.|+|||++.+ ..++.++||||+||++|||++|+.||...........        .....+...   
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         156 PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence            4344455678999999998865 4578899999999999999999999974322110000        000000000   


Q ss_pred             --cC-CCCCCCC-CCcH------HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1032 --LD-PRLPAPS-CNIR------DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1032 --~~-~~~~~~~-~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        .. ....... ....      .....+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              00 0000000 0000      01235778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-36  Score=344.93  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=194.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|+..+.||+|+||.||+|++. +++.||||++....  .......+.+|+++++.++|+||+++++++.+.+..++||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  151 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL  151 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence            34567788999999999999765 68999999986542  2233567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+..       ...+..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus       152 e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        152 EFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             ecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999999986432       245677889999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAYT-----MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      ........|+..|+|||++..     ...+.++|||||||++|||++|+.||.....     .........+.....+. 
T Consensus       222 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~-  295 (353)
T PLN00034        222 MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICMSQPPE-  295 (353)
T ss_pred             cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhccCCCC-
Confidence            333445679999999998743     2345689999999999999999999862111     01111111111111111 


Q ss_pred             CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                        ........+.+++.+||+.||++||+++|+++.
T Consensus       296 --~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 --APATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             --CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              111233468899999999999999999999863

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=6.7e-36  Score=330.25  Aligned_cols=257  Identities=22%  Similarity=0.376  Sum_probs=203.3

Q ss_pred             HhcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  877 (1077)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|++....  ......++.+|+.+++.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4567999999999999999999653      34679999986432  223356788999999999999999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCce
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATS-------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA  950 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  950 (1077)
                      ...++||||+++|+|.+++.....       ....++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCE
Confidence            999999999999999999865332       12357888999999999999999998   99999999999999999999


Q ss_pred             EEecccccccCCCCCCCc--ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccc
Q 001440          951 HVSDFGISKSLKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       951 kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 1027 (1077)
                      |++|||+++.........  ....++..|+|||++.+..++.++|||||||++|||++ |..||....        .+..
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--------~~~~  230 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--------NEQV  230 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHH
Confidence            999999997654332211  12345778999999998889999999999999999999 688875321        1122


Q ss_pred             hhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .........+....   .....+.+++.+||+.||++|||+.|+++.|+
T Consensus       231 ~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         231 LRFVMEGGLLDKPD---NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHHHcCCcCCCCC---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            22222222221111   22346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.4e-37  Score=303.75  Aligned_cols=256  Identities=22%  Similarity=0.350  Sum_probs=217.1

Q ss_pred             HHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccc-----hhhHHHHHHHHHHHhcCC-CCCceeeEEEEEe
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLS-----EMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCS  875 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  875 (1077)
                      ..-..|...+.+|+|..++|.++.. .+|+.+|+|++......     ...-.++..+|+.+++++ .||+|+.+.++++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3445678888999999999999955 47888999988643221     112245677899999999 6999999999999


Q ss_pred             eCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          876 HARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       876 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                      .+...++|+|.|+.|.|+|++...-   .+++.+..+|++|+.+|++|||.+   .|||||+||+|||++++.++||+||
T Consensus        94 s~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEecc
Confidence            9999999999999999999996543   478899999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCcccccc------CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYT------MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      |+|..+.+. ......+|||+|.|||.+.-      .+|+..+|+||.||+||-++.|.+||..-.+.        -++.
T Consensus       168 GFa~~l~~G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm--------lMLR  238 (411)
T KOG0599|consen  168 GFACQLEPG-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM--------LMLR  238 (411)
T ss_pred             ceeeccCCc-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH--------HHHH
Confidence            999987754 45577899999999998752      35888999999999999999999998743322        2455


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .++.+++...+..+.+......++|.+||+.||.+|-|++|+++
T Consensus       239 ~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  239 MIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            66777777777777888888999999999999999999999875

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.5e-36  Score=344.46  Aligned_cols=252  Identities=22%  Similarity=0.289  Sum_probs=196.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.............+.+|+.+++.++|++|+++++++.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999999665 68999999987643333344567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.+.   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            999999999999654   3478899999999999999999999   9999999999999999999999999999764321


Q ss_pred             CC-----------------------------------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 001440          965 SS-----------------------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKH 1009 (1077)
Q Consensus       965 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~ 1009 (1077)
                      ..                                   ......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                   0123479999999999999999999999999999999999999


Q ss_pred             CCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccC--CCCCCCCCHHHHHh
Q 001440         1010 PRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLD--ENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1010 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~ 1073 (1077)
                      ||.....        ......+..  .....+...  .....+.+++.+++.  .++..||+++|+++
T Consensus       235 Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~  292 (363)
T cd05628         235 PFCSETP--------QETYKKVMNWKETLIFPPEV--PISEKAKDLILRFCCEWEHRIGAPGVEEIKT  292 (363)
T ss_pred             CCCCCCH--------HHHHHHHHcCcCcccCCCcC--CCCHHHHHHHHHHcCChhhcCCCCCHHHHhC
Confidence            9863221        112222221  111111111  112245556665333  34445799999976

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=5.2e-36  Score=337.49  Aligned_cols=244  Identities=25%  Similarity=0.351  Sum_probs=198.4

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||+||+|+.. +++.||+|++.............+..|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999765 5789999998764333333456677888888877 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++.+..   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (318)
T cd05570          81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS  154 (318)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCccc
Confidence            99999886543   488999999999999999999999   999999999999999999999999999976443333344


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+.    .....
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~  222 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE--------DELFQSILEDEVRYPR----WLSKE  222 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCCCCC----cCCHH
Confidence            55789999999999999999999999999999999999999863221        1222222222222221    12346


Q ss_pred             HHHHHHhccCCCCCCCCCH-----HHHHh
Q 001440         1050 IMEVAISCLDENPDSRPTM-----QKVSQ 1073 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~-----~evl~ 1073 (1077)
                      +.+++.+||+.||++||++     .++++
T Consensus       223 ~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         223 AKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            7899999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-35  Score=324.00  Aligned_cols=251  Identities=26%  Similarity=0.428  Sum_probs=203.4

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ++|++.+.||+|+||+||+|++.++..||+|.+.....    ...++.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE   79 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence            46788899999999999999887777799999875432    24578899999999999999999999998889999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++.....  .+++.+++.++.||+.|++|||+.   +++|+||||+||+++.++.+|++|||.++......
T Consensus        80 ~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          80 YMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             cCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999965432  578999999999999999999998   99999999999999999999999999988654332


Q ss_pred             CC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          966 SN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       966 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .. .....++..|+|||+..+..++.++||||||+++|||++ |+.||.....        ......+.....+....  
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  224 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVSQGLRLYRPH--  224 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHhcCCCCCCCC--
Confidence            21 112345678999999998889999999999999999999 9999763221        11122222221111111  


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       .....+.+++.+||+.||++||++.++++.|+
T Consensus       225 -~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 -LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             12356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.9e-36  Score=346.34  Aligned_cols=251  Identities=21%  Similarity=0.274  Sum_probs=197.6

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|...+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788899999999999999654 688999999876544444446778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++....   .+++..+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            999999999986543   377888899999999999999998   99999999999999999999999999976431100


Q ss_pred             C-----------------------------------------------CcccccccccccCccccccCCCCCcchHHHHH
Q 001440          966 S-----------------------------------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFG  998 (1077)
Q Consensus       966 ~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G  998 (1077)
                      .                                               ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                               01234699999999999998999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHh--ccCCCCCCCCCHHHHHh
Q 001440          999 VLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAIS--CLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus       999 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~evl~ 1073 (1077)
                      |++|||++|+.||......        .....+..  .....+.  .......+.+++.+  |+..+|..||+++|+++
T Consensus       236 ~il~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPT--------ETQLKVINWENTLHIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHH--------HHHHHHHccccccCCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            9999999999998633211        11111111  1111111  01123456777877  56667777999999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-36  Score=347.35  Aligned_cols=251  Identities=23%  Similarity=0.297  Sum_probs=200.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++.............+.+|+.+++.++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999765 68999999987543333344567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+...
T Consensus        81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            9999999999986543   478899999999999999999999   9999999999999999999999999998754321


Q ss_pred             CC--------------------------------------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh
Q 001440          965 SS--------------------------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK 1006 (1077)
Q Consensus       965 ~~--------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 1006 (1077)
                      ..                                      ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            10                                      0012368999999999999999999999999999999999


Q ss_pred             CCCCCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHHh
Q 001440         1007 GKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT---MQKVSQ 1073 (1077)
Q Consensus      1007 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1073 (1077)
                      |+.||......        .....+..  .....+..  ......+.+++.+|+. +|.+|++   ++|+++
T Consensus       235 G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQ--------ETYRKIINWKETLQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHH--------HHHHHHHcCCCccCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99998643221        11112211  11121111  1123457788999997 9999998   888865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.1e-35  Score=325.37  Aligned_cols=252  Identities=23%  Similarity=0.420  Sum_probs=204.7

Q ss_pred             hcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.++||+|+||+||+|...+++.||+|.+.....    ..+.+.+|+.++++++|+||+++++++.+....++||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT   80 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence            357889999999999999999888888999998765321    2567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.... ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++.....
T Consensus        81 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          81 EYMAKGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             ecCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            9999999999986543 23578899999999999999999998   9999999999999999999999999999876433


Q ss_pred             CCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCC
Q 001440          965 SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1041 (1077)
                      ... .....++..|+|||+.....++.++|||||||++|||++ |+.||.....        ......+... ..+... 
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  227 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSALQRGYRMPRME-  227 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCCCCC-
Confidence            211 122345678999999988889999999999999999998 9999853211        1111111111 111111 


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         .....+.+++.+||+.+|++||+++++.+.|+
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  259 (261)
T cd05072         228 ---NCPDELYDIMKTCWKEKAEERPTFDYLQSVLD  259 (261)
T ss_pred             ---CCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence               12346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.8e-36  Score=345.60  Aligned_cols=254  Identities=22%  Similarity=0.284  Sum_probs=201.7

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..++|++.+.||+|+||.||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.++...++
T Consensus        41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (370)
T cd05621          41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM  120 (370)
T ss_pred             CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence            4568999999999999999999775 678999999865333333335568889999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||+++|+|.+++...    .++..++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|....
T Consensus       121 v~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         121 VMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999643    367889999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCC-CcccccccccccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC--
Q 001440          963 PDSS-NWTELAGTIGYVAPELAYTMK----VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR-- 1035 (1077)
Q Consensus       963 ~~~~-~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 1035 (1077)
                      .... ......||+.|+|||++.+..    ++.++||||+||++|||++|+.||....        .......+.+..  
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--------~~~~~~~i~~~~~~  265 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--------LVGTYSKIMDHKNS  265 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCcc
Confidence            3322 224567999999999987543    7889999999999999999999986322        122233333322  


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHhh
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDS--RPTMQKVSQL 1074 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1074 (1077)
                      +..+..  ......+.+++.+|++.+|.+  ||+++|+++.
T Consensus       266 ~~~p~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         266 LNFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cCCCCc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            221111  122345778888999866544  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=6.3e-36  Score=336.29  Aligned_cols=243  Identities=24%  Similarity=0.345  Sum_probs=193.7

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.+ +|+.||+|.+...........+....|..++... +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999765 6889999998754322222345566777777654 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05620          81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAS  154 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCcee
Confidence            9999988653   3478889999999999999999999   999999999999999999999999999875433333445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ....+.+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~~~~~~~~~~----~~~~~  222 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESIRVDTPHYPR----WITKE  222 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCC----CCCHH
Confidence            56799999999999999999999999999999999999999863221        1222222222221111    12345


Q ss_pred             HHHHHHhccCCCCCCCCCHH-HHH
Q 001440         1050 IMEVAISCLDENPDSRPTMQ-KVS 1072 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~-evl 1072 (1077)
                      +.+++.+||+.||++||++. ++.
T Consensus       223 ~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         223 SKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHccCCHHHcCCChHHHH
Confidence            78899999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-36  Score=332.33  Aligned_cols=254  Identities=22%  Similarity=0.301  Sum_probs=202.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|++.+.||+|+||+||++... +++.||+|++.............+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            3778899999999999999764 689999999875443333334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++.... ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++|+|||+++..... 
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  155 (285)
T cd05605          81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-  155 (285)
T ss_pred             ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-
Confidence            999999998886533 23588999999999999999999998   9999999999999999999999999999865432 


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......|+..|+|||++.+..++.++||||+||++||+++|+.||......     .....+...+.....   .....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~---~~~~~  227 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKEDQE---EYSEK  227 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhccc---ccCcc
Confidence            2223457899999999999888999999999999999999999998632110     000111111111111   11122


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      ....+.+++.+||+.||++||     +++++++
T Consensus       228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         228 FSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            345688999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-35  Score=329.13  Aligned_cols=255  Identities=27%  Similarity=0.482  Sum_probs=205.9

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      .+|.+.+.||+|+||.||+|...      +++.||||.+.....  ....+.+.+|+++++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            46888899999999999999763      347899999876432  2235788999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          880 SFIVYEYLEMGSLAMILSNAT-----------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      .++||||+++|+|.+++....           ....+++.++..++.|++.|+.|||+.   +++||||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCC
Confidence            999999999999999996542           123478899999999999999999999   999999999999999999


Q ss_pred             ceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccc
Q 001440          949 EAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLD 1025 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~ 1025 (1077)
                      .+|++|||+++.......  ......+++.|+|||++.+..++.++||||+||++|||++ |+.||.....        .
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~  231 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------E  231 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------H
Confidence            999999999976533221  1123345788999999999999999999999999999998 9999753221        2


Q ss_pred             cchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1026 RTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1026 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +..+.+.....+.+.   ......+.+++.+||+.||++||+++||++.|+
T Consensus       232 ~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         232 EVIECITQGRLLQRP---RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHHHHcCCcCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            222233333322211   123346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.8e-36  Score=338.05  Aligned_cols=240  Identities=24%  Similarity=0.334  Sum_probs=192.9

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHH-HhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||+||+|+.. +|+.||+|++............++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            36999999999999765 78999999987543333333344555544 56889999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (323)
T cd05575          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTS  154 (323)
T ss_pred             CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccc
Confidence            99999986543   478889999999999999999999   999999999999999999999999999976544434445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++|||||||++|||++|+.||....        ..+..+.+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~~~~~~----~~~~~  222 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKPLRLKP----NISVS  222 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCCCCCCC----CCCHH
Confidence            5679999999999999999999999999999999999999986321        12223333333222221    12346


Q ss_pred             HHHHHHhccCCCCCCCCCHH
Q 001440         1050 IMEVAISCLDENPDSRPTMQ 1069 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~ 1069 (1077)
                      +.+++.+||+.||++||++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         223 ARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHhhcCHHhCCCCC
Confidence            88999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.2e-36  Score=335.17  Aligned_cols=244  Identities=23%  Similarity=0.359  Sum_probs=193.0

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcC-CCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.. +++.||+|++...........+.+..|..+++. .+||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999765 578999999875432222234456667777765 4999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (316)
T cd05619          81 GDLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC  154 (316)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCcee
Confidence            9999998653   2478899999999999999999999   999999999999999999999999999976433333344


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...||+.|+|||++.+..++.++||||+||++|||++|+.||.....        .+....+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~  222 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSIRMDNPCYPR----WLTRE  222 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----cCCHH
Confidence            56789999999999998999999999999999999999999863221        1122222111111111    12235


Q ss_pred             HHHHHHhccCCCCCCCCCHH-HHHh
Q 001440         1050 IMEVAISCLDENPDSRPTMQ-KVSQ 1073 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~-evl~ 1073 (1077)
                      +.+++.+||+.||++||++. ++.+
T Consensus       223 ~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         223 AKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             HHHHHHHHhccCHhhcCCChHHHHc
Confidence            78899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1e-35  Score=326.97  Aligned_cols=260  Identities=23%  Similarity=0.321  Sum_probs=209.7

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|.. .+++.||||.+......+.....++.+|+.+++.++||||+++++++.+++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688889999999999999975 478999999886544444445678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||+++++|.+++.... ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            9999999999986432 234588999999999999999999999   999999999999999999999999999887654


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........++..|+|||++.+..++.++||||||+++|||++|..||.....      ........+.....+.  ...
T Consensus       159 ~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~--~~~  230 (267)
T cd08229         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQCDYPP--LPS  230 (267)
T ss_pred             CCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhhcCCCCC--CCc
Confidence            43333445688999999999988899999999999999999999999752211      1111111111111111  111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ......+.+++.+||+.||++|||+++|+++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~  263 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAK  263 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHh
Confidence            223456889999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=7.2e-36  Score=344.00  Aligned_cols=257  Identities=24%  Similarity=0.400  Sum_probs=202.8

Q ss_pred             HhcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEee
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  876 (1077)
                      ..++|.+.++||+|+||.||+|++.      .+..||||++....  .....+.+.+|+.++++++ ||||+++++++.+
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            3568889999999999999999753      23479999986542  2233567899999999996 9999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS-------------------------------------------------------  901 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------------------------------------------------  901 (1077)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            9999999999999999999865321                                                       


Q ss_pred             --------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCee
Q 001440          902 --------------------------------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL  943 (1077)
Q Consensus       902 --------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIl  943 (1077)
                                                            ...+++.++..++.|++.|++|||+.   +|+||||||+||+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence                                                  12377888899999999999999998   9999999999999


Q ss_pred             eCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 001440          944 LDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICST 1020 (1077)
Q Consensus       944 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 1020 (1077)
                      ++.++.+|++|||+++........  .....++..|+|||++.+..++.++|||||||++|||++ |+.||......   
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~---  346 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD---  346 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence            999999999999999865433221  223456788999999999899999999999999999997 88997632110   


Q ss_pred             CcccccchhhhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1021 SSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1021 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                          ......+... ..+.+    ......+.+++.+||+.||++||++.+|.++|+
T Consensus       347 ----~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~  395 (400)
T cd05105         347 ----STFYNKIKSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE  395 (400)
T ss_pred             ----HHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence                0011111111 11111    122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6.3e-36  Score=332.37  Aligned_cols=261  Identities=24%  Similarity=0.335  Sum_probs=200.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|+++ +++.||+|++...... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            36889999999999999999775 6788999998754322 223567788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++++.+..+...   ...+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        80 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          80 EYVEKNMLELLEEM---PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             ecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            99999877665432   23478899999999999999999998   9999999999999999999999999999876433


Q ss_pred             CC-CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccccchhhh-cCC-
Q 001440          965 SS-NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRTLDEI-LDP- 1034 (1077)
Q Consensus       965 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~-~~~- 1034 (1077)
                      .. ......|++.|+|||++.+..++.++||||+||++|||++|+.||.........       ........... .++ 
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            22 233457899999999999889999999999999999999999998643211000       00000000000 000 


Q ss_pred             ----CCCCCCC-------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1035 ----RLPAPSC-------NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1035 ----~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                          ..+....       ........+.+++.+||++||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                0010000       00112346889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-36  Score=340.73  Aligned_cols=240  Identities=26%  Similarity=0.359  Sum_probs=196.3

Q ss_pred             ceecccCCceEEEEEe----cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          812 HCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      +.||+|+||.||+++.    .+|+.||+|++...... ......+..|+.++++++||||+++++++.+++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999999999964    36789999998754322 222456778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN  967 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  967 (1077)
                      ++|+|.+++.+.   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~  154 (318)
T cd05582          81 RGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  154 (318)
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCc
Confidence            999999998653   3478899999999999999999999   9999999999999999999999999999876544344


Q ss_pred             cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHH
Q 001440          968 WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047 (1077)
Q Consensus       968 ~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1077)
                      .....|++.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.......+..    ..
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~~~~~~p~~----~~  222 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILKAKLGMPQF----LS  222 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHcCCCCCCCC----CC
Confidence            4456789999999999988899999999999999999999999863221        22223333333332221    23


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHH
Q 001440         1048 ISIMEVAISCLDENPDSRPTMQK 1070 (1077)
Q Consensus      1048 ~~l~~li~~cl~~dP~~RPs~~e 1070 (1077)
                      ..+.+++.+||+.||++||++.+
T Consensus       223 ~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         223 PEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             HHHHHHHHHHhhcCHhHcCCCCC
Confidence            46788999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-35  Score=351.09  Aligned_cols=250  Identities=21%  Similarity=0.242  Sum_probs=202.1

Q ss_pred             CCCccceecccCCceEEEEEec-C-CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-S-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .|.+.+.||+|+||.||+|... + ++.||+|.+...   +......+.+|+.+++.++|||||++++++..++..++||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            4889999999999999999654 4 678888876543   2233456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNA-TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||+++|+|.+++... .....+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.+..
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~  221 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD  221 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence            999999999988643 2233578889999999999999999998   999999999999999999999999999987654


Q ss_pred             CCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          964 DSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       964 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....        ......+.....+....
T Consensus       222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~~~~  293 (478)
T PTZ00267        222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLYGKYDPFPC  293 (478)
T ss_pred             ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCCc
Confidence            322  23345689999999999999999999999999999999999999863221        12223332222221111


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         .....+.+++.+||+.||++||+++|+++
T Consensus       294 ---~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        294 ---PVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---cCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               12346889999999999999999999875

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2e-35  Score=322.44  Aligned_cols=252  Identities=26%  Similarity=0.374  Sum_probs=207.6

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|++|.||+|..+ +++.||+|.+...... ....+++.+|+++++.++|||++++++++.+.+..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            4778889999999999999765 6899999998654323 2346778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++.... ...+++.+++.++.|++.|+.|||+.   +++|+||||+||+++.++.+|++|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          80 YAENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             eCCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            999999999997653 34588899999999999999999998   99999999999999999999999999998766554


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......|++.|+|||+..+..++.++||||||+++|||++|+.||.....        ............+...   ..
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---~~  224 (256)
T cd08529         156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILKIIRGVFPPVS---QM  224 (256)
T ss_pred             chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHcCCCCCCc---cc
Confidence            444455688999999999999999999999999999999999999863321        1112222222222111   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ....+.+++.+||+.+|++||++.|+++.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            34568899999999999999999999864

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-35  Score=322.56  Aligned_cols=252  Identities=27%  Similarity=0.484  Sum_probs=204.8

Q ss_pred             hcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.+.||+|++|.||+|.+.+++.||+|.+.....    ..+++.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT   80 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence            457889999999999999999887788899999875432    2467889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++.... ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          81 ELMKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ecccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            9999999999996644 34588999999999999999999998   9999999999999999999999999999876533


Q ss_pred             CCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCC
Q 001440          965 SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1041 (1077)
                      ... ......+..|+|||+..+..++.++||||||+++||+++ |+.||.....        ......+... ..+.+  
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--  226 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQQVDQGYRMPCP--  226 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence            211 111223468999999999899999999999999999999 9999853211        1111111111 11111  


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        ......+.+++.+||+.+|++||+++++.+.||
T Consensus       227 --~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~  259 (261)
T cd05068         227 --PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE  259 (261)
T ss_pred             --CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence              122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=316.34  Aligned_cols=263  Identities=22%  Similarity=0.332  Sum_probs=203.7

Q ss_pred             HHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee-----
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-----  876 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----  876 (1077)
                      .....|...+.||+|+||.|+.|.. .+|+.||||++..+. ......++..+|+.+++.++|+||+.+.+++..     
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~   97 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK   97 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence            3445666678899999999999965 479999999998653 444457788999999999999999999999855     


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                      -+..|+|+|+| +.+|...++...   .++...+..++.|+++|+.|+|+.   +|+|||+||.|++++.+...||+|||
T Consensus        98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence            34789999999 558999986543   388899999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCC--CCCCcccccccccccCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCccccc
Q 001440          957 ISKSLKP--DSSNWTELAGTIGYVAPELA-YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDR 1026 (1077)
Q Consensus       957 la~~~~~--~~~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~ 1026 (1077)
                      +|+....  ....++..+.|..|.|||.. ....|+.+.||||+||++.||++|++-|........       .+...++
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            9998764  23446778889999999975 467899999999999999999999998864332211       0000111


Q ss_pred             chhh--------hcCCCCCCCCC----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1027 TLDE--------ILDPRLPAPSC----NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1027 ~~~~--------~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+..        .+......+.-    ..........+++.+||..||.+|+|++|.++
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            1111        11111111110    11122346788999999999999999999876

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2.6e-36  Score=342.22  Aligned_cols=252  Identities=23%  Similarity=0.280  Sum_probs=202.6

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|+.. +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999765 78999999987654333344667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            9999999999997642  3478899999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCC-cccccccccccCccccc------cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC--
Q 001440          965 SSN-WTELAGTIGYVAPELAY------TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR-- 1035 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~------~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 1035 (1077)
                      ... .....||+.|+|||++.      ...++.++|||||||++|||++|+.||.....        ......+....  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~  227 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQRF  227 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCCc
Confidence            332 23356899999999986      45678899999999999999999999863221        11122222111  


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ...+.  .......+.+++.+|++ +|++||+++++++
T Consensus       228 ~~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         228 LKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             cCCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            11111  11123457889999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-36  Score=346.17  Aligned_cols=252  Identities=21%  Similarity=0.286  Sum_probs=198.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|+.. +++.||||++...........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46889999999999999999664 78999999986543333334567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            9999999999986543   477888999999999999999999   9999999999999999999999999999643211


Q ss_pred             CC-----------------------------------------------CcccccccccccCccccccCCCCCcchHHHH
Q 001440          965 SS-----------------------------------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSF  997 (1077)
Q Consensus       965 ~~-----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~  997 (1077)
                      ..                                               ......||+.|+|||++.+..++.++||||+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            00                                               0012468999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCC---CCHHHHH
Q 001440          998 GVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSR---PTMQKVS 1072 (1077)
Q Consensus       998 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl 1072 (1077)
                      ||++|||++|+.||.....        ......+..  ..+..+..  ......+.+++.+|+. +|.+|   ++++|++
T Consensus       235 Gvil~elltG~~Pf~~~~~--------~~~~~~i~~~~~~~~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l  303 (377)
T cd05629         235 GAIMFECLIGWPPFCSENS--------HETYRKIINWRETLYFPDD--IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK  303 (377)
T ss_pred             chhhhhhhcCCCCCCCCCH--------HHHHHHHHccCCccCCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence            9999999999999863221        111112211  11111111  1123457789999998 66665   5999987


Q ss_pred             hh
Q 001440         1073 QL 1074 (1077)
Q Consensus      1073 ~~ 1074 (1077)
                      +.
T Consensus       304 ~h  305 (377)
T cd05629         304 SH  305 (377)
T ss_pred             cC
Confidence            63

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-35  Score=322.92  Aligned_cols=252  Identities=28%  Similarity=0.472  Sum_probs=204.2

Q ss_pred             cCCCccceecccCCceEEEEEecC----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|++.+.||+|+||+||+|.+..    ...||||.+....  ......++.+|+..++.++||||+++++++...+..+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            578899999999999999997742    4579999987543  2333567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++++|.+++....  ..+++.+++.++.|++.|++|||+.   +|+|+||||+||+++.++.+|++|||+++..
T Consensus        82 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          82 IITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999996543  3588999999999999999999998   9999999999999999999999999999877


Q ss_pred             CCCCCCcc--cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CC
Q 001440          962 KPDSSNWT--ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LP 1037 (1077)
Q Consensus       962 ~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1037 (1077)
                      ........  ...++..|+|||.+.+..++.++||||||+++||+++ |..||.....        .+....+.... .+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  228 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKAVEDGYRLP  228 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            53222211  2334678999999998899999999999999999998 9999753221        11122222211 11


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+    ......+.+++.+||+.+|++||+++|+++.|+
T Consensus       229 ~~----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~  263 (266)
T cd05033         229 PP----MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD  263 (266)
T ss_pred             CC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11    122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.4e-35  Score=322.81  Aligned_cols=260  Identities=23%  Similarity=0.328  Sum_probs=210.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... +|+.||+|.++.....+....+.+.+|++++++++|++++++++++.+.+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999776 78999999887544444444678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||+++|+|.+++.... ....+++.++..++.+++.|++|||+.   +|+|+||+|+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            9999999999986532 234578899999999999999999998   999999999999999999999999999886654


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........++..|+|||++.+..++.++|||||||++|||++|+.||.....      ...+..+.......+..  ..
T Consensus       159 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~--~~  230 (267)
T cd08224         159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPPL--PA  230 (267)
T ss_pred             CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCCC--Ch
Confidence            43333445688899999999988899999999999999999999999753211      11111222211111111  11


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ......+.+++.+||+.+|++||++.+|+++|+
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~  263 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAK  263 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence            133446889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=312.52  Aligned_cols=247  Identities=27%  Similarity=0.425  Sum_probs=210.8

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |++..++|+|+||+||+|.++ +|+.||+|++..+     .+.+++..|+.++++.+.|++|++||.+......|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            567788999999999999554 7999999998654     2378899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      |..|+..|.++-.+  ..++..++..+.+..+.||+|||..   .-+|||||+.|||++.+|.+|++|||.|..+.+.-.
T Consensus       110 CGAGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  110 CGAGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             cCCCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            99999999986543  4588999999999999999999998   779999999999999999999999999987766555


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC-CCCCCcHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP-APSCNIRD 1045 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1045 (1077)
                      ...+..||+.|||||++..-.|+.++||||+|++..||..|++||.+..+...          .++-|.-| +....+..
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA----------IFMIPT~PPPTF~KPE~  254 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA----------IFMIPTKPPPTFKKPEE  254 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce----------eEeccCCCCCCCCChHh
Confidence            55678999999999999999999999999999999999999999986554311          11222222 22233455


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .+..+-+++++||-++|++|-|+.++++.
T Consensus       255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  255 WSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            56789999999999999999999998763

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.3e-36  Score=340.22  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=195.0

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----Cee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----RHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~  880 (1077)
                      +|++.+.||+|+||.||+|... +|+.||||++..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            5788899999999999999764 789999999864322 222345688999999999999999999988543     257


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||++ ++|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          80 YVVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            99999995 68998886543   488999999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCC---CcccccccccccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCccccc--
Q 001440          961 LKPDSS---NWTELAGTIGYVAPELAYT--MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDR-- 1026 (1077)
Q Consensus       961 ~~~~~~---~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~-- 1026 (1077)
                      ......   ......|++.|+|||++.+  ..++.++|||||||++|||++|+.||........       .......  
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            533221   2234578999999999865  6789999999999999999999999864321100       0000000  


Q ss_pred             ----------chhhhcCCCCCCC-CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1027 ----------TLDEILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1027 ----------~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                                ..... .+..+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus       233 ~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         233 SRVRNEKARRYLSSM-RKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHhhhhhHHHHHHhh-cccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                      00011 1111110 0000112345789999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.4e-35  Score=357.67  Aligned_cols=258  Identities=26%  Similarity=0.372  Sum_probs=201.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.++||+|+||.||+|... +|+.||+|++...........+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57899999999999999999765 68999999987654333444667999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          885 EYLEMGSLAMILSNATS--------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                      ||+++|+|.+++.....        ....++.++++++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211        12356778899999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCC------------------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccc
Q 001440          957 ISKSLKPDS------------------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018 (1077)
Q Consensus       957 la~~~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~ 1018 (1077)
                      +++......                  .......||+.|+|||++.+..++.++||||+||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            998652111                  01123468999999999999999999999999999999999999986321100


Q ss_pred             ccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHHhhh
Q 001440         1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT-MQKVSQLL 1075 (1077)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~L 1075 (1077)
                      .    .  .......+...   ....+.+..+.+++.+||+.||++||+ ++++.+.|
T Consensus       239 i----~--~~~~i~~P~~~---~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        239 I----S--YRDVILSPIEV---APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             h----h--hhhhccChhhc---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            0    0  00011111100   011233456889999999999999974 55555544

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=320.27  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=215.6

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .-|+..+.||+|.|++|-.|++- +|++||||++.+....+.. ...+.+|++.|+-++|||||++|++...+...|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~s-t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLS-TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhh-hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            45788889999999999999654 8999999999887655443 677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeC-CCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD-LEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~  963 (1077)
                      |.-++|+|+||+-+...  -+.+.-..+++.||+.|+.|+|+.   .+||||+||+||.+- .-|-||++|||++..+.+
T Consensus        97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            99999999999976553  377788899999999999999998   899999999998775 458999999999998876


Q ss_pred             CCCCcccccccccccCccccccCCCCC-cchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTE-KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      .. ...+.+|+..|-|||++.+..|+. ++||||+||++|.+++|+.||+.        .+..+.+..++|=++..|.  
T Consensus       172 G~-kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe--------ANDSETLTmImDCKYtvPs--  240 (864)
T KOG4717|consen  172 GK-KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE--------ANDSETLTMIMDCKYTVPS--  240 (864)
T ss_pred             cc-hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc--------ccchhhhhhhhcccccCch--
Confidence            54 456789999999999999999864 78999999999999999999973        3445667777887777664  


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        -...+..++|..||..||++|.+.+||+.
T Consensus       241 --hvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  241 --HVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             --hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence              34456789999999999999999999874

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-35  Score=335.61  Aligned_cols=240  Identities=24%  Similarity=0.350  Sum_probs=192.4

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHH-HhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|+.. +++.||+|++............++.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            36999999999999775 68899999987543333333445555554 67889999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++...   ..++..++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (321)
T cd05603          81 GELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTS  154 (321)
T ss_pred             CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccc
Confidence            9999888653   2467788999999999999999998   999999999999999999999999999876433333344


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        .....+.+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~~~~~~----~~~~~  222 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKPLQLPG----GKTVA  222 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCCCCCCC----CCCHH
Confidence            5678999999999999899999999999999999999999986321        22233333333333222    22346


Q ss_pred             HHHHHHhccCCCCCCCCCHH
Q 001440         1050 IMEVAISCLDENPDSRPTMQ 1069 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~ 1069 (1077)
                      +.+++.+||+.||.+||++.
T Consensus       223 ~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         223 ACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHccCCHhhcCCCC
Confidence            78999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.9e-36  Score=344.71  Aligned_cols=250  Identities=20%  Similarity=0.271  Sum_probs=195.7

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|+..+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999764 688999999876433334446678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++.+..   .++...+..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            999999999986543   367788899999999999999999   99999999999999999999999999975321100


Q ss_pred             -----------------------------------------------CCcccccccccccCccccccCCCCCcchHHHHH
Q 001440          966 -----------------------------------------------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFG  998 (1077)
Q Consensus       966 -----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G  998 (1077)
                                                                     .......||+.|+|||++.+..++.++||||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                           001124689999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHHh
Q 001440          999 VLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT---MQKVSQ 1073 (1077)
Q Consensus       999 ~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1073 (1077)
                      |++|||++|+.||......        .....+..  .....+..  ........+++.+|+ .+|++|++   ++|+++
T Consensus       236 vil~elltG~~Pf~~~~~~--------~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPL--------ETQMKVINWQTSLHIPPQ--AKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHH--------HHHHHHHccCCCcCCCCc--ccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            9999999999998633211        11111111  11111111  112235667777765 59999997   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-35  Score=333.77  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=197.7

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +|+..+.||+|+||+||+|... +|+.||+|++...........+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999765 68999999987543333334556778888888885 578888999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            9999999999986543   488899999999999999999998   9999999999999999999999999999865444


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........|++.|+|||++.+..++.++||||+||++|||++|+.||.....        ......+.......+.    
T Consensus       155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~~~~p~----  222 (323)
T cd05615         155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHNVSYPK----  222 (323)
T ss_pred             CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCCCCCc----
Confidence            3334456789999999999999999999999999999999999999863321        2223333333332222    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCH
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      .....+.+++.+||+++|++|++.
T Consensus       223 ~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             cCCHHHHHHHHHHcccCHhhCCCC
Confidence            123457889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.6e-35  Score=329.62  Aligned_cols=261  Identities=20%  Similarity=0.296  Sum_probs=193.0

Q ss_pred             cCCCccceecccCCceEEEEEec--CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC---CCCceeeEEEEEe-----
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS--SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---RHRNIVKFYGFCS-----  875 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----  875 (1077)
                      ++|++.+.||+|+||+||+|+..  +++.||+|++......+. ....+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            36889999999999999999763  467899998865432221 133455666666555   7999999999985     


Q ss_pred             eCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          876 HARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       876 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                      .....++||||++ ++|.+++..... ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            2456899999996 689998865432 3478899999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcc--------cccc
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN--------LDRT 1027 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~--------~~~~ 1027 (1077)
                      |+++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||............        ....
T Consensus       155 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         155 GLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             cceEeccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            999865433 2334557899999999999889999999999999999999999998643221100000        0000


Q ss_pred             h------hhhcCCCCCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 L------DEILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~------~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .      .....+....+. ....+....+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            0      000000000000 000112345779999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=5.4e-36  Score=345.95  Aligned_cols=250  Identities=20%  Similarity=0.256  Sum_probs=196.7

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|+||.||+|+.. +++.||+|++.............+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6889999999999999999764 689999999865433333345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++....   .++...+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|..+....
T Consensus        82 ~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999996543   467788899999999999999999   99999999999999999999999999985321000


Q ss_pred             -------------------------------------------CCcccccccccccCccccccCCCCCcchHHHHHHHHH
Q 001440          966 -------------------------------------------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLAL 1002 (1077)
Q Consensus       966 -------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ 1002 (1077)
                                                                 .......||+.|+|||++.+..++.++||||+||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                       0011346899999999999999999999999999999


Q ss_pred             HHHhCCCCCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCC---CHHHHHh
Q 001440         1003 EAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRP---TMQKVSQ 1073 (1077)
Q Consensus      1003 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl~ 1073 (1077)
                      ||++|+.||......        .....+..  .....+.  .......+.+++.+|+ .+|++|+   +++|+++
T Consensus       236 ell~G~~Pf~~~~~~--------~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPA--------ETQLKVINWETTLHIPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHH--------HHHHHHhccCccccCCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999998643221        11111111  1111111  1112335667777876 5999999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.1e-36  Score=337.60  Aligned_cols=257  Identities=24%  Similarity=0.388  Sum_probs=200.4

Q ss_pred             hcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHA  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  877 (1077)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.....  ....+.+..|+.+++++ +|+||+++++++...
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~   83 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP   83 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence            457899999999999999999532      357899999875432  22356678899999999 899999999988644


Q ss_pred             -CeeEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 001440          878 -RHSFIVYEYLEMGSLAMILSNATS-------------------------------------------------------  901 (1077)
Q Consensus       878 -~~~~lV~E~~~~g~L~~~l~~~~~-------------------------------------------------------  901 (1077)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (337)
T cd05054          84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD  163 (337)
T ss_pred             CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence             578899999999999999864321                                                       


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC--ccccccccc
Q 001440          902 ---AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIG  976 (1077)
Q Consensus       902 ---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~  976 (1077)
                         ...+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++.+......  .....++..
T Consensus       164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence               12578999999999999999999998   9999999999999999999999999999876443221  223445778


Q ss_pred             ccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHH
Q 001440          977 YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAI 1055 (1077)
Q Consensus       977 y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1055 (1077)
                      |+|||++.+..++.++|||||||++|||++ |..||......        +.+...+.......  ........+.+++.
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  310 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------EEFCRRLKEGTRMR--APEYATPEIYSIML  310 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--------HHHHHHHhccCCCC--CCccCCHHHHHHHH
Confidence            999999999999999999999999999998 99998632111        11111111110000  00122346889999


Q ss_pred             hccCCCCCCCCCHHHHHhhhc
Q 001440         1056 SCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1056 ~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +||+.+|++||+++|+++.|+
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~  331 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILG  331 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHH
Confidence            999999999999999999885

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.9e-35  Score=333.27  Aligned_cols=200  Identities=28%  Similarity=0.409  Sum_probs=174.0

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+....  .......+.+|+++++.++||||+++++++.+++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            368999999999999999999776 68889999876542  222356789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++....   .+++..+..++.|++.|+.|||+..  +|+||||||+||+++.++.+||+|||++..+..
T Consensus        82 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          82 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            99999999999996543   3778889999999999999999752  799999999999999999999999999976533


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDF 1013 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~ 1013 (1077)
                      ..  .....|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         157 SM--ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hc--cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            21  2335689999999999988899999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.1e-35  Score=336.12  Aligned_cols=241  Identities=23%  Similarity=0.305  Sum_probs=191.6

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHH-HHhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEV-KSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||+||+|+.. +++.||+|++............++..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            36999999999999765 6788999998754322222233444444 456888999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+...++..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~  154 (325)
T cd05602          81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS  154 (325)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcc
Confidence            99999986543   366788888999999999999999   999999999999999999999999999986544444445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||.....        .+....+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~~~----~~~~~  222 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNKPLQLKP----NITNS  222 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhCCcCCCC----CCCHH
Confidence            56799999999999999999999999999999999999999863221        1222223222222211    22346


Q ss_pred             HHHHHHhccCCCCCCCCCHHH
Q 001440         1050 IMEVAISCLDENPDSRPTMQK 1070 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~e 1070 (1077)
                      +.+++.+|+++||.+||++.+
T Consensus       223 ~~~li~~~l~~~p~~R~~~~~  243 (325)
T cd05602         223 ARHLLEGLLQKDRTKRLGAKD  243 (325)
T ss_pred             HHHHHHHHcccCHHHCCCCCC
Confidence            789999999999999998874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.3e-35  Score=325.64  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=195.8

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|+||.||+++.+ +|+.||+|++.............+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999764 6899999998654333333344566799999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccccc
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA  972 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  972 (1077)
                      .+++..... ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~  155 (277)
T cd05607          81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRA  155 (277)
T ss_pred             HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccC
Confidence            988865432 3478899999999999999999998   99999999999999999999999999998764332 223456


Q ss_pred             ccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHH
Q 001440          973 GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052 (1077)
Q Consensus       973 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1052 (1077)
                      |+..|+|||++.+..++.++||||+||++|||++|+.||......    ...............+...   ......+.+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  228 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK----VAKEELKRRTLEDEVKFEH---QNFTEESKD  228 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcch----hhHHHHHHHhhcccccccc---ccCCHHHHH
Confidence            899999999999888999999999999999999999998632211    0111112222222222111   122346789


Q ss_pred             HHHhccCCCCCCCCCHHHHHh
Q 001440         1053 VAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1053 li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ++.+||++||++||+++|+++
T Consensus       229 li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         229 ICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             HHHHHhccCHhhCCCCccchh
Confidence            999999999999999976553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.6e-35  Score=324.64  Aligned_cols=254  Identities=22%  Similarity=0.403  Sum_probs=201.6

Q ss_pred             cCCCccceecccCCceEEEEEe-----cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      ++|++.+.||+|+||.||+|..     .+++.||+|.+....  ......++.+|+.++++++||||+++++++..+...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            4678889999999999999974     246789999987532  223356788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC
Q 001440          881 FIVYEYLEMGSLAMILSNATS--------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL  946 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  946 (1077)
                      ++||||+++|+|.+++.....              ...+++.+++.++.|++.|++|||++   +|+||||||+||+++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~  159 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE  159 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence            999999999999999853221              22478889999999999999999999   9999999999999999


Q ss_pred             CCceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcc
Q 001440          947 EYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       947 ~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 1023 (1077)
                      ++.+|++|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |..||.....       
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------  232 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------  232 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999987543321  1223345678999999988889999999999999999998 8888753211       


Q ss_pred             cccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1024 LDRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1024 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ....+...... .+.+.    .....+.+++.+||+.||++||+++++.+.|+
T Consensus       233 -~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  281 (283)
T cd05090         233 -QEVIEMVRKRQLLPCSE----DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR  281 (283)
T ss_pred             -HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence             11111111111 12111    12346888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.1e-35  Score=341.14  Aligned_cols=259  Identities=20%  Similarity=0.269  Sum_probs=203.4

Q ss_pred             HHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA  877 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  877 (1077)
                      .++....++|++.+.||+|+||.||+|+.+ +++.||+|.+...........+.+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344455689999999999999999999775 6889999998653333333355678899999999999999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      +..++||||+++|+|.+++...    .++...+..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            9999999999999999998653    367788899999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCC-CcccccccccccCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhc
Q 001440          958 SKSLKPDSS-NWTELAGTIGYVAPELAYTM----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032 (1077)
Q Consensus       958 a~~~~~~~~-~~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1032 (1077)
                      ++....... ......||+.|+|||++...    .++.++||||+||++|||++|+.||.....        ......+.
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~  260 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIM  260 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHH
Confidence            987654322 22356799999999998754    378899999999999999999999863221        12223332


Q ss_pred             CCC--CCCCCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHhh
Q 001440         1033 DPR--LPAPSCNIRDKLISIMEVAISCLDENPDS--RPTMQKVSQL 1074 (1077)
Q Consensus      1033 ~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1074 (1077)
                      ...  ...+.  .......+.+++.+|++.+|.+  ||+++|+++.
T Consensus       261 ~~~~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         261 NHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cCCCcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            211  11111  1123346778999999844433  7799998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-35  Score=339.53  Aligned_cols=253  Identities=20%  Similarity=0.279  Sum_probs=196.1

Q ss_pred             hcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|...         ...+.+|+.++++++||||+++++++......++|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            35799999999999999999966 478899999743         23467899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +|++. ++|.+++....   .+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+|+....
T Consensus       162 ~e~~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EecCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            99995 68888885543   478899999999999999999999   999999999999999999999999999975432


Q ss_pred             C-CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc--------------------
Q 001440          964 D-SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------------------- 1022 (1077)
Q Consensus       964 ~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------------------- 1022 (1077)
                      . ........||+.|+|||++.+..++.++||||+||++|||++|+.||...........                    
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            2 2233456799999999999999999999999999999999999988642211100000                    


Q ss_pred             -ccccchhhhc----C--CCCCCC---CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1023 -NLDRTLDEIL----D--PRLPAP---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1023 -~~~~~~~~~~----~--~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       ..........    .  ...+..   ..........+.+++.+||+.||++|||++|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence             0000000000    0  000000   0011123457889999999999999999999985

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4.5e-35  Score=320.96  Aligned_cols=251  Identities=27%  Similarity=0.446  Sum_probs=202.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|++.+.||+|+||.||+|.++ +++.||+|.+....    ....++.+|++.+++++||||+++++++..+...++||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   81 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence            45788899999999999999664 58889999986432    22567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++.... ...+++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||++......
T Consensus        82 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          82 EFMTYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EeCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            9999999999986543 23478899999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCc-ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCC
Q 001440          965 SSNW-TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041 (1077)
Q Consensus       965 ~~~~-~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1041 (1077)
                      .... ....++..|+|||++.+..++.++|||||||++|||++ |..||....        .++....+... ....+  
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~--  227 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--------LSQVYELLEKGYRMERP--  227 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--------HHHHHHHHHCCCCCCCC--
Confidence            2211 12234668999999999999999999999999999998 888875321        11111111111 11111  


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        ...+..+.+++.+||+.||++||++.|++++|+
T Consensus       228 --~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~  260 (263)
T cd05052         228 --EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE  260 (263)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence              122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-35  Score=349.64  Aligned_cols=258  Identities=24%  Similarity=0.288  Sum_probs=205.3

Q ss_pred             HHHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC--
Q 001440          802 VRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR--  878 (1077)
Q Consensus       802 ~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--  878 (1077)
                      ....++|.+.+.||+|+||+||+|+. .+|+.||||++...... ......+.+|+..+..++|+|++++.+.+....  
T Consensus        28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~  106 (496)
T PTZ00283         28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR  106 (496)
T ss_pred             cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence            34457999999999999999999965 47899999998765433 233567889999999999999999988764332  


Q ss_pred             ------eeEEEEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceE
Q 001440          879 ------HSFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH  951 (1077)
Q Consensus       879 ------~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  951 (1077)
                            ..++||||+++|+|.+++.... ....+++.++..++.|++.||+|+|+.   +|+||||||+||+++.++.+|
T Consensus       107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vk  183 (496)
T PTZ00283        107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVK  183 (496)
T ss_pred             CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEE
Confidence                  3689999999999999986532 234588899999999999999999999   999999999999999999999


Q ss_pred             EecccccccCCCCC--CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh
Q 001440          952 VSDFGISKSLKPDS--SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       952 l~Dfgla~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      |+|||+++.+....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....        ....+.
T Consensus       184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~  255 (496)
T PTZ00283        184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMH  255 (496)
T ss_pred             EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHH
Confidence            99999998764321  22334679999999999999999999999999999999999999986321        122222


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...........   ......+.+++.+||+.||++||+++|+++.
T Consensus       256 ~~~~~~~~~~~---~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLAGRYDPLP---PSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhcCCCCCCC---CCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            22222222111   1223468899999999999999999999763

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.6e-36  Score=336.54  Aligned_cols=240  Identities=24%  Similarity=0.341  Sum_probs=192.5

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHH-HhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||+||+|+.. +|+.||+|++............++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            36899999999999764 78999999986543333333445555554 56788999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  154 (325)
T cd05604          81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT  154 (325)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcc
Confidence            99998886543   478899999999999999999998   999999999999999999999999999976443333445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...|++.|+|||++.+..++.++||||+||++|||++|+.||....        ..+....+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--------~~~~~~~~~~~~~~~~~----~~~~~  222 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--------VAEMYDNILHKPLVLRP----GASLT  222 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--------HHHHHHHHHcCCccCCC----CCCHH
Confidence            5679999999999999999999999999999999999999986321        12223333332222221    12345


Q ss_pred             HHHHHHhccCCCCCCCCCHH
Q 001440         1050 IMEVAISCLDENPDSRPTMQ 1069 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~ 1069 (1077)
                      +.+++.+|++.+|++||++.
T Consensus       223 ~~~ll~~ll~~~p~~R~~~~  242 (325)
T cd05604         223 AWSILEELLEKDRQRRLGAK  242 (325)
T ss_pred             HHHHHHHHhccCHHhcCCCC
Confidence            77899999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=9.1e-36  Score=338.10  Aligned_cols=253  Identities=23%  Similarity=0.319  Sum_probs=198.4

Q ss_pred             CCCccceecccCCceEEEEEe----cCCCEEEEEEccCCccc-hhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCee
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  880 (1077)
                      +|++.+.||+|+||.||+++.    .+++.||+|++...... .....+.+..|+.+++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999965    36789999998653221 222345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++|+|.+++....   .+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            99999999999999986543   478899999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCC-CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          961 LKPDSS-NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       961 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      +..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......    .........+.....+.
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~  230 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGER----NTQSEVSRRILKCDPPF  230 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCC----CCHHHHHHHHhcCCCCC
Confidence            543322 23345789999999998765 4788999999999999999999998632211    01111112222222222


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      +.    .....+.+++.+||+.||++||     +++|+++
T Consensus       231 ~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         231 PS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            11    2234678999999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.7e-35  Score=332.90  Aligned_cols=246  Identities=23%  Similarity=0.332  Sum_probs=196.6

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||+||+|+.. +++.||+|++......+....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999765 6789999999865444444566788899998888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTS  154 (327)
T ss_pred             CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCcee
Confidence            99998886543   488999999999999999999999   999999999999999999999999999976443333445


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||+....... ..........+.......+.    .....
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~p~----~~~~~  229 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD-MNTEDYLFQVILEKPIRIPR----FLSVK  229 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcc-cccHHHHHHHHHhCCCCCCC----CCCHH
Confidence            56799999999999999999999999999999999999999863221110 00111122222222222222    12245


Q ss_pred             HHHHHHhccCCCCCCCCCH
Q 001440         1050 IMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      +.+++.+||++||++||++
T Consensus       230 ~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         230 ASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             HHHHHHHHhccCHHHcCCC
Confidence            7889999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4e-35  Score=330.40  Aligned_cols=250  Identities=25%  Similarity=0.470  Sum_probs=199.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .+|+..+.||+|+||.||+|.+. +++    .||+|.+...  ......+++.+|+.+++.++||||++++|++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            46889999999999999999764 333    4899998643  2223356788999999999999999999999765 56


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+++|+|.+++....  ..+++..++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            79999999999999997643  3478889999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCCCCc--ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC--CC
Q 001440          961 LKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD--PR 1035 (1077)
Q Consensus       961 ~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 1035 (1077)
                      +.......  ....++..|+|||++.+..++.++|||||||++||+++ |+.||+.....        + +..+..  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--------~-~~~~~~~~~~  229 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--------E-ISSILEKGER  229 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--------H-HHHHHhCCCC
Confidence            65443322  22234678999999999999999999999999999998 99998632211        1 111111  12


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+..    ....+.+++.+||+.+|++||++.|+++.+.
T Consensus       230 ~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~  266 (316)
T cd05108         230 LPQPPI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFS  266 (316)
T ss_pred             CCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            222211    2245789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4e-35  Score=319.81  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=204.8

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|+||.||+++.. +++.||+|.+.....  ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            4788899999999999999765 688999998865422  2335678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|++.+++.... ...++...+..++.|++.|+.|||+.   +|+|+||||+||+++.++.++++|||.++......
T Consensus        79 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          79 YCDGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             eCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            999999999886533 23478889999999999999999998   99999999999999999999999999998765544


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......|+..|+|||++.+..++.++||||||+++|+|++|+.||.....        ................   ..
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---~~  223 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW--------KNLILKVCQGSYKPLP---SH  223 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH--------HHHHHHHhcCCCCCCC---cc
Confidence            444456789999999999988899999999999999999999999863211        1111222222221111   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ....+.+++.+||+.||++||++.|++..
T Consensus       224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         224 YSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            23457899999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-35  Score=320.40  Aligned_cols=251  Identities=23%  Similarity=0.440  Sum_probs=203.1

Q ss_pred             hcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.++||+|+||.||+|..++++.||+|.+......    .+++.+|+.++++++||||+++++++. .+..++||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~   79 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT   79 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence            4578899999999999999999888999999998754322    457889999999999999999999874 45689999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.++++|||++......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          80 EYMENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EcCCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999986543 24578999999999999999999998   9999999999999999999999999999866532


Q ss_pred             CC-CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCC
Q 001440          965 SS-NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041 (1077)
Q Consensus       965 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1041 (1077)
                      .. ......++..|+|||++....++.++||||||+++||+++ |+.||.....        .+........ ..+.+. 
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~-  226 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLERGYRMPRPD-  226 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHHcCCCCCCCC-
Confidence            21 1223345678999999998889999999999999999999 9999863221        1111111111 111111 


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         .....+.+++.+||+.+|++||+++++.+.|+
T Consensus       227 ---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  258 (260)
T cd05067         227 ---NCPEELYELMRLCWKEKPEERPTFEYLRSVLE  258 (260)
T ss_pred             ---CCCHHHHHHHHHHccCChhhCCCHHHHHHHhh
Confidence               12346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.7e-35  Score=324.63  Aligned_cols=254  Identities=26%  Similarity=0.463  Sum_probs=202.7

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      ++|.+.+.||+|+||.||++...      ++..||+|.+....   ......+.+|+.++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            57888999999999999999642      34568999886532   2235678999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCc
Q 001440          880 SFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE  949 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~  949 (1077)
                      .++||||+++++|.+++....          ....+++.+++.++.|++.|++|||++   +++||||||+||+++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence            999999999999999986432          123489999999999999999999998   9999999999999999999


Q ss_pred             eEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCccccc
Q 001440          950 AHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026 (1077)
Q Consensus       950 ~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~ 1026 (1077)
                      +|++|||+++........  .....++..|+|||++.+..++.++|||||||++|||++ |..||.....        .+
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~  230 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NE  230 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH
Confidence            999999999865433211  122345778999999998899999999999999999999 8888753221        11


Q ss_pred             chhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1027 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ....+.........   ......+.+++.+||+.||.+|||++|+.+.|+
T Consensus       231 ~~~~i~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~  277 (288)
T cd05093         231 VIECITQGRVLQRP---RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ  277 (288)
T ss_pred             HHHHHHcCCcCCCC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            22222222211111   112346899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-35  Score=324.65  Aligned_cols=254  Identities=28%  Similarity=0.499  Sum_probs=203.5

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      .+|.+.+.||+|+||.||+|...      ++..|++|.+....   ....+.+.+|+..+++++||||+++++++...+.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            46788899999999999999642      34568999886532   2234678899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC
Q 001440          880 SFIVYEYLEMGSLAMILSNAT-------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL  946 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  946 (1077)
                      .++||||+++++|.+++....             ....+++.+++.++.||+.|++|||++   +|+||||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence            999999999999999996532             123488999999999999999999999   9999999999999999


Q ss_pred             CCceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcc
Q 001440          947 EYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       947 ~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 1023 (1077)
                      ++.+|++|||++........  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....       
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------  231 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------  231 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------
Confidence            99999999999976543321  1223456788999999999999999999999999999999 9999753221       


Q ss_pred             cccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ....+.+.....+...   ...+..+.+++.+||+.||++||++++|+++|+
T Consensus       232 -~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~  280 (291)
T cd05094         232 -TEVIECITQGRVLERP---RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH  280 (291)
T ss_pred             -HHHHHHHhCCCCCCCC---ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence             1122222222222111   112346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-35  Score=318.69  Aligned_cols=250  Identities=28%  Similarity=0.475  Sum_probs=201.2

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .+|++.+.||+|+||.||+|+++++..+|+|.+......    ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE   79 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence            357888999999999999998887788999998654322    4567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++....  ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++......
T Consensus        80 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          80 YMANGCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             cCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            999999999986543  2578999999999999999999999   99999999999999999999999999998654322


Q ss_pred             CC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCC
Q 001440          966 SN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCN 1042 (1077)
Q Consensus       966 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1042 (1077)
                      .. .....++..|+|||++.+..++.++||||||+++||+++ |+.||......        +........ ..+.+.  
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--  224 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--------EVVESVSAGYRLYRPK--  224 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--------HHHHHHHcCCcCCCCC--
Confidence            11 112223568999999998899999999999999999999 88888633211        111111111 111111  


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        ..+..+.+++.+||+.+|++|||++|+++.|.
T Consensus       225 --~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         225 --LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             --CCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence              12346889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-35  Score=323.66  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             hcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+....  ......++.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQ   82 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCC
Confidence            457889999999999999999664      23679999986542  2233567889999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceE
Q 001440          879 HSFIVYEYLEMGSLAMILSNATS-------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH  951 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  951 (1077)
                      ..++||||+++|+|.+++.....       ...+++.+++.++.|++.|+.|||+.   +|+||||||+||+++.++.+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~k  159 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEE
Confidence            99999999999999999865432       12368889999999999999999998   999999999999999999999


Q ss_pred             EecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccch
Q 001440          952 VSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTL 1028 (1077)
Q Consensus       952 l~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1028 (1077)
                      |+|||+++.......  ......++..|+|||++.+..++.++|||||||++||+++ |..||.....        .+..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~  231 (277)
T cd05032         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVL  231 (277)
T ss_pred             ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHH
Confidence            999999986544321  1223456789999999988889999999999999999998 8888753221        1122


Q ss_pred             hhhcCCCC-CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1029 DEILDPRL-PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1029 ~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ........ ..+..    ....+.+++.+||+.+|++|||+.|+++.|+
T Consensus       232 ~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         232 KFVIDGGHLDLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HHHhcCCCCCCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            22222221 11211    2456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-35  Score=324.51  Aligned_cols=254  Identities=20%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             CCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      +|.+.+.||+|+||.||+|...      +++.||+|++....  .....+.+.+|+.+++.++||||+++++++.+....
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            4667788999999999999753      24789999987543  222356788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC
Q 001440          881 FIVYEYLEMGSLAMILSNAT-------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE  947 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  947 (1077)
                      ++++||+++++|.+++....             ....+++..+..++.|++.|++|+|+.   +|+||||||+||+++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCC
Confidence            99999999999999985321             123478888999999999999999998   99999999999999999


Q ss_pred             CceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCccc
Q 001440          948 YEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNL 1024 (1077)
Q Consensus       948 ~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 1024 (1077)
                      +.+||+|||+++.......  ......+++.|+|||++.+..++.++||||+|+++|||++ |..||....        .
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~  232 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------N  232 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------H
Confidence            9999999999886543322  1223445789999999988889999999999999999998 777875321        1


Q ss_pred             ccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+..+.+.++......   .+....+.+++.+||+.+|++||+++||++.|+
T Consensus       233 ~~~~~~i~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         233 QDVIEMIRNRQVLPCP---DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHHHHHHcCCcCCCC---CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            2233333333322111   123345889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.8e-35  Score=320.95  Aligned_cols=255  Identities=24%  Similarity=0.336  Sum_probs=201.3

Q ss_pred             hcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||.||+|+. .+++.||+|++.....   .....+.+|+.++++++||||+++++++..+...++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence            35789999999999999999976 4688999999864321   2245678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++++|.+++...   ..+++.++..++.|++.|+.|||+.   +|+|||++|+||+++.++.+|++|||++.....
T Consensus        85 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          85 MEYCGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999999999998643   3478899999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1077)
                      .........++..|+|||.+.   ...++.++||||+||++|||++|+.||............   .......+....  
T Consensus       159 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~--  233 (267)
T cd06646         159 TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM---SKSNFQPPKLKD--  233 (267)
T ss_pred             cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee---ecCCCCCCCCcc--
Confidence            333334456889999999874   445788999999999999999999997533211100000   000001111111  


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                        .......+.+++.+||+.+|++||+++++++.+
T Consensus       234 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         234 --KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              112235688999999999999999999998754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-34  Score=317.30  Aligned_cols=251  Identities=27%  Similarity=0.490  Sum_probs=202.6

Q ss_pred             hcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.+.||+|+||.||+|...++..||+|.+......    .+.+.+|+.++++++|++++++++++. ....++||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~   79 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVT   79 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEE
Confidence            3578889999999999999998888888999998754322    456889999999999999999999885 45678999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++.... ...+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+..+...
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          80 EYMSKGSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            9999999999997543 23478999999999999999999998   9999999999999999999999999999865443


Q ss_pred             CCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCC
Q 001440          965 SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1041 (1077)
                      ... .....++..|+|||+..+..++.++||||||+++||+++ |+.||.....        .+..+.+... ..+.+  
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~--  225 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVERGYRMPCP--  225 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCCCC--
Confidence            221 122345678999999988889999999999999999999 8888863211        1122222211 11111  


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        ......+.+++.+||+++|++|||++++.+.|+
T Consensus       226 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  258 (260)
T cd05070         226 --QDCPISLHELMLQCWKKDPEERPTFEYLQSFLE  258 (260)
T ss_pred             --CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence              223456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=8.5e-35  Score=318.45  Aligned_cols=250  Identities=26%  Similarity=0.438  Sum_probs=201.2

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ++|++.++||+|+||+||+|++.++..||+|++.....    ..+++.+|+.++++++||||+++++++.. ...++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            56899999999999999999887777899999875332    14568899999999999999999998754 56799999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++.... ...+++.++..++.|++.|++|+|+.   +++||||||+||+++.++.+||+|||.++.+....
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          81 YMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             cCCCCcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            999999999997543 23478899999999999999999998   99999999999999999999999999998664432


Q ss_pred             CC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CCCCCCC
Q 001440          966 SN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCN 1042 (1077)
Q Consensus       966 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1042 (1077)
                      .. .....++..|+|||+..+..++.++||||||+++||+++ |+.||.....        .+......... .+.    
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~~~~~~~~~~----  224 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQVERGYRMPC----  224 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHHHhcCCCCCC----
Confidence            22 123346778999999988899999999999999999999 7878753211        11112221111 111    


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+....+.+++.+||+.||++||+++++.+.|+
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~  258 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE  258 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            1233456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-36  Score=315.36  Aligned_cols=255  Identities=24%  Similarity=0.309  Sum_probs=192.6

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----ee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----HS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  880 (1077)
                      .|...+++|.|+||.||+|... +++.||||++-.+..       .-.+|+.+|+.++|||||++..+|....     ..
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l   97 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL   97 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence            4667889999999999999665 578999999865321       1246899999999999999999885432     34


Q ss_pred             EEEEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEeccccc
Q 001440          881 FIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGIS  958 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla  958 (1077)
                      .+|||||+. +|+++++... ....++...+.-++.||++|++|||+.   +|+||||||.|+|+|.+ |.+||||||.|
T Consensus        98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcc
Confidence            589999986 8999887532 233477778888999999999999998   99999999999999987 99999999999


Q ss_pred             ccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccchh-
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRTLD- 1029 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~~- 1029 (1077)
                      +.+...... .....|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|...+......+       ...+.+. 
T Consensus       174 K~L~~~epn-iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  174 KVLVKGEPN-ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeeccCCCc-eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            988766555 55577999999998775 5799999999999999999999998864332211000       0000000 


Q ss_pred             ------hhcCCCCCCCCC---CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1030 ------EILDPRLPAPSC---NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1030 ------~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                            +...+.+.....   ......++..+++.++++++|.+|.++.|+++
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                  111111111110   11233457889999999999999999999875

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-36  Score=335.14  Aligned_cols=247  Identities=28%  Similarity=0.494  Sum_probs=203.4

Q ss_pred             CccceecccCCceEEEEEe-cCCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          809 DEEHCIGTGGQGSVYRAEL-SSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       809 ~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ...++||.|+||+||+|.| ..|+    +||+|++...  ...+...++.+|+..|.+++|||+++++|+|.... ..||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            4567899999999999955 4443    6899988654  33344688999999999999999999999998766 7899


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ++|++.|+|.||++..+  ..+..+..+.|..|||+||.|||++   ++|||||.++|||+++-..+|++|||+|+...+
T Consensus       776 tq~mP~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHhcccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999998754  4578899999999999999999998   999999999999999999999999999998888


Q ss_pred             CCCCcccccc--cccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC-CCCCCC
Q 001440          964 DSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-PRLPAP 1039 (1077)
Q Consensus       964 ~~~~~~~~~g--~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1039 (1077)
                      +...+....|  .+.|||=|.+....|+.++|||||||++||++| |..|++....        ++.-+-+.+ .+++.|
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------~eI~dlle~geRLsqP  922 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------EEIPDLLEKGERLSQP  922 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------HHhhHHHhccccCCCC
Confidence            7766555444  678999999999999999999999999999999 8889763321        111111111 234443


Q ss_pred             CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      +.    ...+++.++.+||..|++.||+++++.+.+
T Consensus       923 pi----CtiDVy~~mvkCwmid~~~rp~fkel~~~f  954 (1177)
T KOG1025|consen  923 PI----CTIDVYMVMVKCWMIDADSRPTFKELAEEF  954 (1177)
T ss_pred             CC----ccHHHHHHHHHHhccCcccCccHHHHHHHH
Confidence            32    234688899999999999999999988765

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=8.1e-35  Score=323.41  Aligned_cols=257  Identities=22%  Similarity=0.377  Sum_probs=202.2

Q ss_pred             HhcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  877 (1077)
                      ..++|++.++||+|+||.||+|..+      .+..||+|.+....  ......++.+|+..++.++||||+++++++.+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4578999999999999999999643      24579999886542  222345678899999999999999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCce
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATS-------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA  950 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~  950 (1077)
                      ...++||||+++|+|.+++.....       ....++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcE
Confidence            999999999999999999965321       23456778899999999999999998   99999999999999999999


Q ss_pred             EEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccc
Q 001440          951 HVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       951 kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 1027 (1077)
                      |++|||+++........  .....++..|+|||++.+..++.++|||||||++|||++ |..||....        .++.
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~  230 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQV  230 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHH
Confidence            99999999865433221  122345678999999998899999999999999999999 788875321        1122


Q ss_pred             hhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...+.+.......   ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       231 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~  276 (288)
T cd05061         231 LKFVMDGGYLDQP---DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK  276 (288)
T ss_pred             HHHHHcCCCCCCC---CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            2222222221111   112346889999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.1e-34  Score=323.32  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=203.2

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|+..+.||+|+||.||+|.. .+++.||+|.+......   ..+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence            5788899999999999999975 46889999988754322   2466888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++...    .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        97 e~~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cccCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            999999999998543    378899999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........+++.|+|||++.+..++.++|||||||++|||++|+.||......       .........+..+.  ....
T Consensus       170 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~--~~~~  240 (296)
T cd06654         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYLIATNGTPEL--QNPE  240 (296)
T ss_pred             ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHHHhcCCCCCC--CCcc
Confidence            43334457889999999999888999999999999999999999998633221       01111111111110  1112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||++||++||+++|+++.
T Consensus       241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            234568899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7e-35  Score=324.98  Aligned_cols=256  Identities=24%  Similarity=0.401  Sum_probs=203.4

Q ss_pred             HhcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ..++|++.+.||+|+||.||+|.+.      ....||+|.+.....  .....++.+|+.+++++ +|+||+++++++..
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            4467888999999999999999764      235799999875422  22356788999999999 89999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCee
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNA-------------TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL  943 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIl  943 (1077)
                      ++..++||||+++|+|.+++...             .....+++.+++.++.|++.|++|||+.   +|+||||||+||+
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence            99999999999999999998653             2234688999999999999999999998   9999999999999


Q ss_pred             eCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 001440          944 LDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICST 1020 (1077)
Q Consensus       944 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 1020 (1077)
                      ++.++.+|++|||+++.+......  .....++..|+|||+..+..++.++|||||||++||+++ |..||.....    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            999999999999999876543221  122334678999999988899999999999999999998 8888753211    


Q ss_pred             CcccccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1021 SSNLDRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1021 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                          .+......... ...+.    .....+.+++.+||+.||++|||++|+++.|+
T Consensus       241 ----~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~  289 (293)
T cd05053         241 ----EELFKLLKEGYRMEKPQ----NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLD  289 (293)
T ss_pred             ----HHHHHHHHcCCcCCCCC----CCCHHHHHHHHHHcccCcccCcCHHHHHHHHH
Confidence                11122221111 11111    22346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.7e-34  Score=319.15  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=196.8

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      ++|++.+.||+|+||+||+|.+. +++    +|++|.+...  .......++..|+..+++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Ccc
Confidence            46788899999999999999764 444    4788887543  222334678888889999999999999998854 457


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+++|+|.+++....  ..+++..+..++.||+.|++|||+.   +++||||||+||+++.++.+|++|||+++.
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            88999999999999996543  3478999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-C
Q 001440          961 LKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-L 1036 (1077)
Q Consensus       961 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1036 (1077)
                      ..+...  ......++..|+|||++.+..++.++||||||+++||+++ |+.||......        ...+.+.... .
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~  230 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH--------EVPDLLEKGERL  230 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHCCCcC
Confidence            644322  2234456788999999998899999999999999999998 99998632211        1111111111 1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +.+..    ....+.+++.+||..||++|||++|+++.|+
T Consensus       231 ~~~~~----~~~~~~~li~~c~~~~p~~Rps~~el~~~l~  266 (279)
T cd05111         231 AQPQI----CTIDVYMVMVKCWMIDENVRPTFKELANEFT  266 (279)
T ss_pred             CCCCC----CCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            11111    1235778899999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=329.00  Aligned_cols=246  Identities=26%  Similarity=0.433  Sum_probs=202.3

Q ss_pred             ccceecccCCceEEEEEec--CCC--EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          810 EEHCIGTGGQGSVYRAELS--SGE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       810 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ..++||+|.||+|++|.|.  +|+  .||||.+.......  ...+|.+|+..|-+|+|+|++++||+.-+ ....||+|
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            4567999999999999875  344  58999998765443  46789999999999999999999999987 67889999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      .++.|+|.+.+++ .....+-......++.|||.||.||.++   +.||||+.++|+++.....|||+|||+.+.+....
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999988 4455678888999999999999999999   99999999999999999999999999999887665


Q ss_pred             CCccc---ccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhc-CCCCCCCC
Q 001440          966 SNWTE---LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL-DPRLPAPS 1040 (1077)
Q Consensus       966 ~~~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1040 (1077)
                      ..|..   ..-+..|+|||.+....++.++|||+|||++|||+| |..||......        +.++.+- ..+++.+.
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--------qIL~~iD~~erLpRPk  338 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--------QILKNIDAGERLPRPK  338 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--------HHHHhccccccCCCCC
Confidence            54421   223678999999999999999999999999999999 67786533221        1122221 22344433


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                          .+..+++++++.||..+|++|||+..+.+.
T Consensus       339 ----~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  339 ----YCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             ----CChHHHHHHHHHhccCCccccccHHHHHHh
Confidence                334579999999999999999999999743

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-34  Score=314.59  Aligned_cols=246  Identities=27%  Similarity=0.445  Sum_probs=195.7

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      +.||+|+||.||+|... +++.||+|.+....  .......+.+|+++++.++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            36899999999999764 78899999876542  2233567899999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc--
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--  968 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--  968 (1077)
                      +|.+++....  ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++..........  
T Consensus        79 ~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          79 DFLTFLRTEG--PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             cHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999986532  3478899999999999999999998   99999999999999999999999999987654321111  


Q ss_pred             ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC-CCCCCCCCCcHHH
Q 001440          969 TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-PRLPAPSCNIRDK 1046 (1077)
Q Consensus       969 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 1046 (1077)
                      ....++..|+|||.+.+..++.++||||+|+++||+++ |..||......        ........ ...+.+    ...
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~--------~~~~~~~~~~~~~~~----~~~  221 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ--------QTREAIEQGVRLPCP----ELC  221 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH--------HHHHHHHcCCCCCCc----ccC
Confidence            11123567999999998889999999999999999998 88887532211        11111111 111111    122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1047 LISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...+.+++.+||+.+|++|||+.|+.++|+
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.2e-34  Score=323.40  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=198.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC--EEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|++.+.||+|+||.||+|..+ ++.  .+|+|.+....  .....+.+.+|+.+++++ +||||+++++++...+..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence            47889999999999999999765 333  47888876422  222356788999999999 7999999999999989999


Q ss_pred             EEEeecCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          882 IVYEYLEMGSLAMILSNAT-------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      +|+||+++|+|.+++....             ....+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~  156 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL  156 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence            9999999999999996532             112478899999999999999999998   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccc
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 1027 (1077)
                      .+||+|||++........ ......+..|+|||+..+..++.++|||||||++|||++ |+.||.....        ...
T Consensus       157 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~  227 (297)
T cd05089         157 ASKIADFGLSRGEEVYVK-KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AEL  227 (297)
T ss_pred             eEEECCcCCCccccceec-cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHH
Confidence            999999999864322111 111223567999999998889999999999999999998 9999863221        111


Q ss_pred             hhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .............   ......+.+++.+||+.+|.+||+++++++.|+
T Consensus       228 ~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  273 (297)
T cd05089         228 YEKLPQGYRMEKP---RNCDDEVYELMRQCWRDRPYERPPFAQISVQLS  273 (297)
T ss_pred             HHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            2222211111111   112346889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-34  Score=321.16  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=200.0

Q ss_pred             CCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      +|++.+.||+|+||.||+|...      ....||+|.+.....  ....+.+.+|+.+++.++||||+++++++...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            4678889999999999999653      235688888865432  23356788999999999999999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 001440          881 FIVYEYLEMGSLAMILSNAT---------------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS  939 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~  939 (1077)
                      ++|+||+++|+|.+++....                     ....+++.+++.++.|++.|++|||+.   +|+||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence            99999999999999986432                     123478899999999999999999998   999999999


Q ss_pred             CCeeeCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccc
Q 001440          940 KNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISS 1016 (1077)
Q Consensus       940 ~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 1016 (1077)
                      +||+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999999865433221  122345678999999988889999999999999999998 9988753211


Q ss_pred             ccccCcccccchhhhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1017 ICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                              ++........ ..+.+    ......+.+++.+||+.+|++||+++|+++.|+
T Consensus       236 --------~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         236 --------ERLFNLLKTGYRMERP----ENCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             --------HHHHHHHhCCCCCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence                    1111111111 11111    122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=8.8e-35  Score=322.41  Aligned_cols=253  Identities=21%  Similarity=0.300  Sum_probs=200.3

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |+..+.||+|+||+||+|.+. +++.||+|.+.............+.+|+.+++.++|++|+++.+++.+++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667788999999999999664 7889999998765444333345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++++|.+++.... ...+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+||+|||++...... .
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~  156 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-E  156 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC-C
Confidence            99999998886543 23488999999999999999999998   9999999999999999999999999999765432 2


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ......|+..|+|||++.+..++.++|+||+|+++||+++|+.||........    .+.............    ....
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~----~~~~~~~~~~~~~~~----~~~~  228 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRVLETEEVY----SAKF  228 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhhhcccccc----CccC
Confidence            22345789999999999988999999999999999999999999863221100    011111111111111    1122


Q ss_pred             HHHHHHHHHhccCCCCCCCCC-----HHHHHh
Q 001440         1047 LISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1073 (1077)
                      ...+.+++.+||+.||++||+     ++|+++
T Consensus       229 ~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         229 SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            345788999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.1e-35  Score=338.69  Aligned_cols=251  Identities=22%  Similarity=0.306  Sum_probs=196.8

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||+|+||+||+|+.. +++.||+|++.............+.+|+.++..++||+|+++++++.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999765 68999999987543333344567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.+..   .+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            9999999999986543   478899999999999999999999   9999999999999999999999999998754321


Q ss_pred             CC-----------------------------------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 001440          965 SS-----------------------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKH 1009 (1077)
Q Consensus       965 ~~-----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~ 1009 (1077)
                      ..                                   ......||+.|+|||++.+..++.++||||+||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                   0123468999999999999999999999999999999999999


Q ss_pred             CCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHHh
Q 001440         1010 PRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT---MQKVSQ 1073 (1077)
Q Consensus      1010 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1073 (1077)
                      ||.....        ......+..  .....+...  .....+.+++.+|+ .||++|++   ++|+++
T Consensus       235 Pf~~~~~--------~~~~~~i~~~~~~~~~p~~~--~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         235 PFCSETP--------QETYRKVMNWKETLVFPPEV--PISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCCH--------HHHHHHHHcCCCceecCCCC--CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9863321        112222221  111111111  11234667777766 49999995   566654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-34  Score=320.86  Aligned_cols=256  Identities=24%  Similarity=0.386  Sum_probs=204.7

Q ss_pred             HhcCCCccceecccCCceEEEEEecC-----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee-C
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSS-----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-A  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~  877 (1077)
                      ..++|++.+.||+|+||.||+|.+..     +..||+|++...  ......+.+.+|+.++++++||||+++++++.. +
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            34678899999999999999997765     678999988643  233346778899999999999999999998866 4


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEE
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSA-----EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV  952 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  952 (1077)
                      ...++++||+++|+|.+++......     ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+|+
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl  158 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI  158 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence            6789999999999999998765432     4588999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchh
Q 001440          953 SDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       953 ~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      +|||+++.+.+....  .....++..|+|||++.+..++.++||||||+++||+++ |+.||......        +...
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--------~~~~  230 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--------EMAA  230 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--------HHHH
Confidence            999999876543321  122345678999999998889999999999999999999 99998633211        1111


Q ss_pred             hhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1030 EILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1030 ~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+. ..+.+    ......+.+++.+||+.||++|||+.|+++.|+
T Consensus       231 ~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  274 (280)
T cd05043         231 YLKDGYRLAQP----INCPDELFAVMACCWALDPEERPSFSQLVQCLT  274 (280)
T ss_pred             HHHcCCCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            11111 11111    112346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.6e-35  Score=336.30  Aligned_cols=256  Identities=25%  Similarity=0.417  Sum_probs=202.5

Q ss_pred             HhcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEee
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  876 (1077)
                      ..++|.+.+.||+|+||.||+|++.      .++.||+|++......  ...+.+.+|+.++.++. ||||+++++++..
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            3456788899999999999999753      3467999999764322  22457889999999997 9999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS-------------------------------------------------------  901 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------------------------------------------------  901 (1077)
                      .+..++||||+++|+|.++++....                                                       
T Consensus       113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (401)
T cd05107         113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM  192 (401)
T ss_pred             CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence            9999999999999999999965421                                                       


Q ss_pred             ----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 001440          902 ----------------------------------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKN  941 (1077)
Q Consensus       902 ----------------------------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  941 (1077)
                                                              ...+++.++..++.|++.|++|||+.   +|+||||||+|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N  269 (401)
T cd05107         193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN  269 (401)
T ss_pred             hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence                                                    12367788899999999999999998   99999999999


Q ss_pred             eeeCCCCceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccccc
Q 001440          942 VLLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSIC 1018 (1077)
Q Consensus       942 Ill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~ 1018 (1077)
                      |+++.++.+|++|||+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....  
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~--  347 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM--  347 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc--
Confidence            9999999999999999986543221  1123456789999999998889999999999999999998 8889763221  


Q ss_pred             ccCcccccchhhhcCC--CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1019 STSSNLDRTLDEILDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1019 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                            .+.....+..  +.+.+.    .....+.+++.+||+.+|++||+++||++.|+
T Consensus       348 ------~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~  397 (401)
T cd05107         348 ------NEQFYNAIKRGYRMAKPA----HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG  397 (401)
T ss_pred             ------hHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                  1111111111  111111    12346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=325.55  Aligned_cols=243  Identities=28%  Similarity=0.410  Sum_probs=198.1

Q ss_pred             CCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |.-.+.||+|+||.||.|++ .+.+.||||++.-..-.....-.++..|+..+++++|||++.+.|+|-.+.+.|+||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            44456799999999999965 47889999998755444444457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      |- |+-.|.+.-.+  .++...++..|+.+.+.||+|||+.   +.||||||+.|||+++.|.||++|||.|..+.+.  
T Consensus       108 Cl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--  179 (948)
T ss_pred             Hh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence            95 46667665443  3467788999999999999999999   9999999999999999999999999999876654  


Q ss_pred             CcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhc---CCCCCCCC
Q 001440          967 NWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL---DPRLPAPS 1040 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 1040 (1077)
                        ..++|||.|||||++.   .+.|+-|+||||+|++..|+.-.++|+..+.        .-..+.-+.   .|.++   
T Consensus       180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--------AMSALYHIAQNesPtLq---  246 (948)
T KOG0577|consen  180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNESPTLQ---  246 (948)
T ss_pred             --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--------HHHHHHHHHhcCCCCCC---
Confidence              4579999999999875   5679999999999999999999999954221        111122222   22232   


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        ..+....+..++..||++-|.+|||.+++++
T Consensus       247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence              2344557899999999999999999999875

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.1e-34  Score=314.57  Aligned_cols=244  Identities=27%  Similarity=0.421  Sum_probs=194.0

Q ss_pred             eecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          813 CIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      .||+|+||.||+|.++   +++.||+|++.... .+....+++.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            5899999999999653   57889999986543 233346788999999999999999999998854 467899999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc-
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW-  968 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  968 (1077)
                      |+|.+++....   .+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+|++|||+++.+....... 
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          80 GPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999996543   478899999999999999999998   99999999999999999999999999998765433221 


Q ss_pred             --ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CCCCCCCcH
Q 001440          969 --TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCNIR 1044 (1077)
Q Consensus       969 --~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 1044 (1077)
                        ....++..|+|||.+....++.++||||||+++|||++ |+.||......        .....+.... .+.+.    
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~i~~~~~~~~~~----  221 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--------EVTQMIESGERMECPQ----  221 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHCCCCCCCCC----
Confidence              12234578999999988889999999999999999998 99998633211        1111111111 11111    


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .....+.+++.+||+.||++||++++|++.|+
T Consensus       222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~  253 (257)
T cd05116         222 RCPPEMYDLMKLCWTYGVDERPGFAVVELRLR  253 (257)
T ss_pred             CCCHHHHHHHHHHhccCchhCcCHHHHHHHHh
Confidence            12346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-34  Score=314.55  Aligned_cols=250  Identities=26%  Similarity=0.461  Sum_probs=200.9

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ++|.+.+.||+|++|.||+|.+..+..||+|.+.....    ..+.+.+|+.++++++|||++++++++. .+..++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE   80 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence            46888899999999999999887777899998765322    2456888999999999999999999875 456789999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++|+|||.++......
T Consensus        81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          81 FMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCCCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999997543 23478999999999999999999998   99999999999999999999999999997654332


Q ss_pred             CC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCC
Q 001440          966 SN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCN 1042 (1077)
Q Consensus       966 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1042 (1077)
                      .. .....++..|+|||+..+..++.++||||||+++|||++ |+.||.....        .+....+... ..+.+   
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---  225 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQVERGYRMPCP---  225 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHcCCCCCCC---
Confidence            21 123345778999999988889999999999999999999 8888763211        1111112111 11111   


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ......+.+++.+||++||++||+++++.+.|+
T Consensus       226 -~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  258 (260)
T cd05069         226 -QGCPESLHELMKLCWKKDPDERPTFEYIQSFLE  258 (260)
T ss_pred             -cccCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence             223457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.8e-34  Score=318.76  Aligned_cols=255  Identities=24%  Similarity=0.378  Sum_probs=200.8

Q ss_pred             hcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+....  .......+.+|+.+++.++|+||+++++++.+..
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            457889999999999999999765      35678999876432  2223567889999999999999999999999888


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC---ceE
Q 001440          879 HSFIVYEYLEMGSLAMILSNATS----AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY---EAH  951 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~k  951 (1077)
                      ..++||||+++++|.+++.....    ...+++.++++++.||+.|++|||+.   +++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence            99999999999999999976532    12588999999999999999999999   999999999999998764   599


Q ss_pred             EecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccch
Q 001440          952 VSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTL 1028 (1077)
Q Consensus       952 l~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1028 (1077)
                      ++|||+++........  ......+..|+|||++.+..++.++|||||||++|||++ |+.||.....        ++..
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~  231 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVM  231 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence            9999999876332111  112234568999999998999999999999999999997 9999863211        1111


Q ss_pred             hhhcC-CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1029 DEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1029 ~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+.. .+...+.    .....+.+++.+||+.+|++||+++||++.|+
T Consensus       232 ~~~~~~~~~~~~~----~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 EFVTGGGRLDPPK----GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHHcCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11111 1111111    22346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6.7e-35  Score=321.39  Aligned_cols=252  Identities=25%  Similarity=0.385  Sum_probs=198.6

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeC----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHA----  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----  877 (1077)
                      +.+.|+..+.||+|+||.||+|... +++.||+|++....    ....++.+|+.+++++ +||||+++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            4567888899999999999999764 68899999986432    1245678899999998 799999999998653    


Q ss_pred             --CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          878 --RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       878 --~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                        ...++||||+++|+|.+++.... ...+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccC
Confidence              46899999999999999987543 23478899999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhh
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE 1030 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1030 (1077)
                      |+++.............|+..|+|||++.     ...++.++||||+||++|||++|+.||.........       ...
T Consensus       156 g~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-------~~~  228 (272)
T cd06637         156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FLI  228 (272)
T ss_pred             CCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HHH
Confidence            99987654434445567899999999886     345788999999999999999999998633221100       000


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ...+....   ........+.+++.+||+.||.+|||++|+++
T Consensus       229 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcCCCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            00110000   11122346889999999999999999999976

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-35  Score=322.59  Aligned_cols=253  Identities=21%  Similarity=0.309  Sum_probs=200.6

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |+..+.||+|+||.||+|... +++.||+|.+...........+.+.+|+.++++++|++++++++++.+.+..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667788999999999999665 7889999998764433333345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++|+|.+++..... ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.++++|||++....... 
T Consensus        82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            999999998865332 3478899999999999999999998   99999999999999999999999999987654332 


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ......|+..|+|||++.+..++.++||||+|+++|||++|+.||.......     ..+............   .....
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~~~~---~~~~~  228 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEVQEE---YSEKF  228 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhhhhh---cCccC
Confidence            2234578999999999999899999999999999999999999986321100     001111111100000   11122


Q ss_pred             HHHHHHHHHhccCCCCCCCCC-----HHHHHh
Q 001440         1047 LISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1073 (1077)
                      ...+.+++.+||+.||++|||     ++|+++
T Consensus       229 ~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         229 SPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            346789999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-35  Score=324.31  Aligned_cols=254  Identities=32%  Similarity=0.502  Sum_probs=202.0

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |++.++||+|+||+||+|+.. +++.||+|.+......... .....+|+..+++++||||+++++++.+....++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence            567899999999999999776 5668999999876433332 33445699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++++|.+++..   ...+++.++..++.|+++|++|||+.   +|+|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~  153 (260)
T PF00069_consen   80 CPGGSLQDYLQK---NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE  153 (260)
T ss_dssp             ETTEBHHHHHHH---HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS
T ss_pred             cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            999999999972   23478899999999999999999999   999999999999999999999999999986533344


Q ss_pred             CcccccccccccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          967 NWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      ......++..|+|||++. +..++.++||||+|+++|+|++|+.||......     .......................
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~  228 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-----DQLEIIEKILKRPLPSSSQQSRE  228 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-----HHHHHHHHHHHTHHHHHTTSHTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccch-----hhhhhhhhcccccccccccccch
Confidence            445667899999999998 888999999999999999999999998743100     01111111111111100000011


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+.+++.+||+.||++||++.|+++
T Consensus       229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  229 KSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             hHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1257999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=2.6e-34  Score=316.71  Aligned_cols=253  Identities=24%  Similarity=0.399  Sum_probs=196.3

Q ss_pred             CCccceecccCCceEEEEEecC-CC--EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC------C
Q 001440          808 FDEEHCIGTGGQGSVYRAELSS-GE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA------R  878 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~  878 (1077)
                      |.+.+.||+|+||.||+|.+.+ +.  .||+|.+..... .....+.+.+|+..++.++||||+++++++...      .
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3467889999999999997754 32  689998875432 233367788999999999999999999987432      2


Q ss_pred             eeEEEEeecCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          879 HSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                      ..++||||+++|+|.+++....   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df  156 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADF  156 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCC
Confidence            5689999999999999874322   223478999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhc
Q 001440          956 GISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL 1032 (1077)
Q Consensus       956 gla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1032 (1077)
                      |+++.+......  .....+++.|+|||+..+..++.++||||||+++||+++ |+.||.....        .+..+.+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~  228 (272)
T cd05075         157 GLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYDYLR  228 (272)
T ss_pred             CcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHH
Confidence            999876443221  122345778999999999999999999999999999999 7888763211        11122222


Q ss_pred             CCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1033 DPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1033 ~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ... .+.+.    .....+.+++.+||+.||++|||++|+++.|+
T Consensus       229 ~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  269 (272)
T cd05075         229 QGNRLKQPP----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELE  269 (272)
T ss_pred             cCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            211 11111    22345889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.4e-34  Score=313.88  Aligned_cols=253  Identities=24%  Similarity=0.319  Sum_probs=208.5

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|+||.||.++.. +++.||+|.+....... ...+++.+|+.++++++|+||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            4788899999999999999654 68899999986543332 335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|+|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          80 YANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             ecCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            999999999997653 34578899999999999999999998   99999999999999999999999999998765544


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......+++.|+|||+..+..++.++||||||+++|||++|+.||....        ..+....+..+..+...   ..
T Consensus       156 ~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~  224 (256)
T cd08221         156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--------PLNLVVKIVQGNYTPVV---SV  224 (256)
T ss_pred             ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHcCCCCCCc---cc
Confidence            34445678999999999988889999999999999999999999986321        12223333333332211   22


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      ....+.+++.+||+.+|++||+++|+++.+
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         225 YSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            334688999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.9e-34  Score=313.19  Aligned_cols=243  Identities=26%  Similarity=0.420  Sum_probs=192.3

Q ss_pred             ecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          814 IGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      ||+|+||.||+|.+.   ++..||+|.+....  .....+++.+|+.++++++||||+++++++.. ...++||||+++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~   79 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG   79 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence            899999999999664   35569999986542  23335678999999999999999999998854 5679999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc-
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-  969 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-  969 (1077)
                      +|.+++....  ..+++.++++++.|++.|++|||++   +++||||||+||+++.++.+|++|||+++....+..... 
T Consensus        80 ~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          80 PLNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            9999986433  3578899999999999999999998   999999999999999999999999999986544432211 


Q ss_pred             --cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-CCCCCCCcHH
Q 001440          970 --ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCNIRD 1045 (1077)
Q Consensus       970 --~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 1045 (1077)
                        ...++..|+|||++....++.++||||||+++||+++ |+.||.....        ......+.... .+.+.    .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~----~  222 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSFIEQGKRLDCPA----E  222 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHHCCCCCCCCC----C
Confidence              1223578999999988889999999999999999996 9999863321        11111111111 11111    2


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...++.+++.+||+.||++||++.+|.+.|+
T Consensus       223 ~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~  253 (257)
T cd05115         223 CPPEMYALMKDCWIYKWEDRPNFAKVEERMR  253 (257)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=316.21  Aligned_cols=253  Identities=26%  Similarity=0.512  Sum_probs=206.2

Q ss_pred             HhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..++|.+.+.||+|+||.||+|..++++.||||.+.....    ..+++.+|+..+++++|+||+++++++......++|
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIV   79 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEE
Confidence            3468899999999999999999888888999999875432    246788999999999999999999999988899999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.++....
T Consensus        80 ~e~~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          80 TEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EeccCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            99999999999997643 23588999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCC
Q 001440          964 DSSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPS 1040 (1077)
Q Consensus       964 ~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1040 (1077)
                      .... .....++..|+|||.+.+..++.++||||+|+++||+++ |+.||....        .......+... ..+.+.
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~  227 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--------NREVLEQVERGYRMPRPP  227 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHcCCCCCCCC
Confidence            2111 122334678999999998889999999999999999999 999975321        11222222211 112111


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                          .....+.+++.+||+.+|++||+++|+.+.|+
T Consensus       228 ----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~  259 (261)
T cd05034         228 ----NCPEELYDLMLQCWDKDPEERPTFEYLQSFLE  259 (261)
T ss_pred             ----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHh
Confidence                12346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=333.63  Aligned_cols=243  Identities=24%  Similarity=0.289  Sum_probs=190.0

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC---CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      ||+|+||+||+|+.. +++.||||++.............+..|..++...   +||+|+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999765 6899999998654332222334455566666555   799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.+++...   ..+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+++..........
T Consensus        81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~  154 (330)
T cd05586          81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN  154 (330)
T ss_pred             ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCcc
Confidence            9999988653   3478899999999999999999999   999999999999999999999999999976544434445


Q ss_pred             cccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHH
Q 001440          970 ELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLI 1048 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1077)
                      ...||+.|+|||++.+. .++.++||||+||++|||++|+.||....        ..+....+.......+...   ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~---~~~  223 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--------TQQMYRNIAFGKVRFPKNV---LSD  223 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--------HHHHHHHHHcCCCCCCCcc---CCH
Confidence            56799999999998754 48899999999999999999999986321        1222223322222222111   233


Q ss_pred             HHHHHHHhccCCCCCCCC----CHHHHHh
Q 001440         1049 SIMEVAISCLDENPDSRP----TMQKVSQ 1073 (1077)
Q Consensus      1049 ~l~~li~~cl~~dP~~RP----s~~evl~ 1073 (1077)
                      .+.+++.+||++||++||    +++|+++
T Consensus       224 ~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         224 EGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            577899999999999998    5666654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.6e-34  Score=322.74  Aligned_cols=262  Identities=24%  Similarity=0.392  Sum_probs=201.8

Q ss_pred             hcCCCccceecccCCceEEEEEecC-----------------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCce
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSS-----------------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI  867 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  867 (1077)
                      ..+|++.+.||+|+||.||+|....                 +..||+|.+......  ...+++.+|++++++++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence            3578899999999999999996542                 245899998754322  346788999999999999999


Q ss_pred             eeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 001440          868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS--------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS  939 (1077)
Q Consensus       868 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~  939 (1077)
                      +++++++..++..++||||+++++|.+++.....        ...+++..++.++.|++.|++|||+.   +|+||||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence            9999999999999999999999999999876431        12578999999999999999999998   999999999


Q ss_pred             CCeeeCCCCceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCccc
Q 001440          940 KNVLLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK--GKHPRDFIS 1015 (1077)
Q Consensus       940 ~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~ 1015 (1077)
                      +||+++.++.++++|||+++.......  ......++..|+|||++.+..++.++|||||||++|||++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            999999999999999999986543321  1223456788999999988889999999999999999998  666765321


Q ss_pred             cccccCcccccchhhhc-CCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1016 SICSTSSNLDRTLDEIL-DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...     ......... ..............+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       239 ~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQ-----VIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHH-----HHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            110     000000000 00000000001112246899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-34  Score=322.59  Aligned_cols=261  Identities=23%  Similarity=0.379  Sum_probs=199.1

Q ss_pred             cCCCccceecccCCceEEEEEecC---------------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSS---------------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF  870 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l  870 (1077)
                      .+|++.+.||+|+||.||+|+...               ...||+|++.....  ......+.+|++++++++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            578899999999999999986532               23589999875422  2335678999999999999999999


Q ss_pred             EEEEeeCCeeEEEEeecCCCCHHHHHhcCCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 001440          871 YGFCSHARHSFIVYEYLEMGSLAMILSNATS---------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKN  941 (1077)
Q Consensus       871 ~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  941 (1077)
                      ++++......++||||+++++|.+++.....         ...+++.+++.++.|++.|++|||+.   +++||||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            9999999999999999999999999864321         12367889999999999999999998   99999999999


Q ss_pred             eeeCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCccccc
Q 001440          942 VLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK--GKHPRDFISSI 1017 (1077)
Q Consensus       942 Ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~~ 1017 (1077)
                      |+++.++.+|++|||++.........  .....++..|+|||+...+.++.++|||||||++|||++  |..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            99999999999999999765433211  122345678999999998889999999999999999998  55666532211


Q ss_pred             cccCcccccchhhhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1018 CSTSSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .... ............ ....+    ...+..+.+++.+||++||++||++++|++.|+
T Consensus       240 ~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIE-NTGEFFRNQGRQIYLSQT----PLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHH-HHHHhhhhccccccCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            0000 000000000000 01111    112346899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.2e-34  Score=321.67  Aligned_cols=262  Identities=19%  Similarity=0.290  Sum_probs=199.3

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|++|.||+|+.. +++.||+|++...... ......+.+|+.++++++||||+++++++.+++..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            4788899999999999999765 6899999998654322 2224667889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |++ +++.+++........+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            997 68988887655445688999999999999999999998   99999999999999999999999999998655443


Q ss_pred             CCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccccc---hhhh--c
Q 001440          966 SNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLDRT---LDEI--L 1032 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~~~---~~~~--~ 1032 (1077)
                      .......+++.|+|||++.+. .++.++||||+|+++|||+||+.||..........       ......   ....  .
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            333444678899999988654 47889999999999999999999986322110000       000000   0000  0


Q ss_pred             CCCCC---CC--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 DPRLP---AP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 ~~~~~---~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+   ..  .........++.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000   00  0000112346778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-34  Score=318.83  Aligned_cols=253  Identities=27%  Similarity=0.466  Sum_probs=201.4

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      .+|...++||+|+||.||+|...      ++..||+|.+....   ......+.+|++.++.++|+||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            46778899999999999999542      35678999876532   2335678999999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC
Q 001440          880 SFIVYEYLEMGSLAMILSNATS------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE  947 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  947 (1077)
                      .++||||+++|+|.+++.....            ...+++.+++.++.|++.|++|||+.   +++||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCC
Confidence            9999999999999999875432            12478899999999999999999998   99999999999999999


Q ss_pred             CceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCccc
Q 001440          948 YEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNL 1024 (1077)
Q Consensus       948 ~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~ 1024 (1077)
                      +.+||+|||+++.+.....  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....        
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------  230 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------  230 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------
Confidence            9999999999976543221  1122345788999999999999999999999999999998 8888753221        


Q ss_pred             ccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1025 DRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1025 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+......... ...+.    ..+..+.+++.+||+.||++||+++||.+.|+
T Consensus       231 ~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         231 TEAIECITQGRELERPR----TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHHHHcCccCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11122222211 11111    12345889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-34  Score=316.47  Aligned_cols=254  Identities=25%  Similarity=0.410  Sum_probs=199.4

Q ss_pred             CCccceecccCCceEEEEEecC----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe----
Q 001440          808 FDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH----  879 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----  879 (1077)
                      |++.+.||+|+||.||+|....    +..||+|++...... ......+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            5677889999999999997642    367999998754322 2335678999999999999999999998865543    


Q ss_pred             --eEEEEeecCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEec
Q 001440          880 --SFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSD  954 (1077)
Q Consensus       880 --~~lV~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  954 (1077)
                        .++|+||+++|+|.+++....   ....+++.++..++.|++.|++|||+.   +|+||||||+||++++++.+||+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECC
Confidence              799999999999999985432   223588999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCCCc--ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhh
Q 001440          955 FGISKSLKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031 (1077)
Q Consensus       955 fgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1031 (1077)
                      ||+++.+.......  ....++..|+|||++.+..++.++||||||+++|||++ |..||.....        .+..+..
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~  228 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYL  228 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH
Confidence            99998765432211  12234678999999988899999999999999999999 8888753221        1222222


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+......   ......+.+++.+||+.||++||++.|+++.|+
T Consensus       229 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~  270 (273)
T cd05035         229 RHGNRLKQP---EDCLDELYDLMYSCWRADPKDRPTFTKLREVLE  270 (273)
T ss_pred             HcCCCCCCC---cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            222211111   122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.9e-34  Score=321.83  Aligned_cols=261  Identities=24%  Similarity=0.388  Sum_probs=200.2

Q ss_pred             cCCCccceecccCCceEEEEEec-----------------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCcee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-----------------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV  868 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv  868 (1077)
                      ++|++.+.||+|+||.||+++..                 ++..||+|++....  ......++.+|+.+++.++|+||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            56899999999999999998542                 23468999987542  223356789999999999999999


Q ss_pred             eEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCC
Q 001440          869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNATS--------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSK  940 (1077)
Q Consensus       869 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~  940 (1077)
                      ++++++...+..++||||+++|+|.+++.....        ...+++.++..++.|++.|++|||+.   +++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence            999999999999999999999999999876431        12367889999999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh--CCCCCCcccc
Q 001440          941 NVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK--GKHPRDFISS 1016 (1077)
Q Consensus       941 NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt--g~~p~~~~~~ 1016 (1077)
                      ||+++.++.++++|||+++.+......  .....++..|+|||+...+.++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999999865433211  122344678999999888889999999999999999998  6777753221


Q ss_pred             ccccCcccccchhhh-cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1017 ICSTSSNLDRTLDEI-LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1017 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .... .......... .....+.+.    .....+.+++.+||+.||++||+++||.+.|+
T Consensus       240 ~~~~-~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQVI-ENTGEFFRDQGRQVYLPKPA----LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHH-HHHHHHHhhccccccCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1100 0000000000 011112111    12246889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-34  Score=320.35  Aligned_cols=256  Identities=24%  Similarity=0.439  Sum_probs=203.5

Q ss_pred             hcCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      .++|++.+.||+|+||.||+|...      ++..||+|++.....  ....+++.+|+.++++++||||+++++++.++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            457889999999999999999753      467899999875432  233567889999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhcCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCC
Q 001440          879 HSFIVYEYLEMGSLAMILSNAT-------------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISS  939 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~  939 (1077)
                      ..++||||+++|+|.+++....                   ....+++.+++.++.|++.|++|||+.   +++||||||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p  158 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLAT  158 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccH
Confidence            9999999999999999996432                   112477889999999999999999998   999999999


Q ss_pred             CCeeeCCCCceEEecccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccc
Q 001440          940 KNVLLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISS 1016 (1077)
Q Consensus       940 ~NIll~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~ 1016 (1077)
                      +||+++.++.+|++|||+++.+.....  .......+..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999876543321  1122334678999999998899999999999999999998 8788752211


Q ss_pred             ccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1017 ICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1017 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                              .+....+.+.......   ......+.+++.+||+.||++|||++|+++.|+
T Consensus       239 --------~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 --------EEVIYYVRDGNVLSCP---DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             --------HHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                    1222222222221111   122346889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.8e-34  Score=315.48  Aligned_cols=252  Identities=28%  Similarity=0.477  Sum_probs=202.3

Q ss_pred             cCCCccceecccCCceEEEEEec-C---CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-S---GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      .+|++.+.||+|+||.||+|.+. +   +..||+|.+.....  ....+.+..|+.++++++||||+++++++.+++..+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            56888999999999999999763 2   33799999875432  223568899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++++|.+++....  ..+++.+++.++.|++.|++|||+.   +++||||||+||+++.++.++++|||++..+
T Consensus        82 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999996543  3578899999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCCCcc---cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CC
Q 001440          962 KPDSSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RL 1036 (1077)
Q Consensus       962 ~~~~~~~~---~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1036 (1077)
                      ........   ...++..|+|||++.+..++.++||||||+++||+++ |+.||.....        .+....+.+. ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~~~~~~~  228 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN--------QDVIKAIEEGYRL  228 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH--------HHHHHHHhCCCcC
Confidence            54332211   1223568999999998899999999999999999887 9999863321        1112222221 11


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +.+.    ..+..+.+++.+||+++|++||+++++++.|+
T Consensus       229 ~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  264 (267)
T cd05066         229 PAPM----DCPAALHQLMLDCWQKDRNERPKFEQIVSILD  264 (267)
T ss_pred             CCCC----CCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence            1111    22346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-36  Score=302.14  Aligned_cols=244  Identities=24%  Similarity=0.315  Sum_probs=210.2

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      -++|+..+++|+|.||.|..++-+ +|+.||+|++++...-...+......|-++++..+||.+..+...+...+..++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            367889999999999999999655 7999999999998888777888899999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+.||.|+-++.+.+   .++....+.+-..|+.||.|||++   +||+||+|.+|.++|.||.+||+|||+++.--.
T Consensus       247 MeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999998886644   366677778889999999999999   999999999999999999999999999987666


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .+...++++||+.|.|||++....|+.++|+|.+||+||||++|+.||..        .+.+..++-++-..+..|... 
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn--------~dh~kLFeLIl~ed~kFPr~l-  391 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN--------KDHEKLFELILMEDLKFPRTL-  391 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc--------cchhHHHHHHHhhhccCCccC-
Confidence            66778889999999999999999999999999999999999999999862        223444554444444443322 


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCC
Q 001440         1044 RDKLISIMEVAISCLDENPDSRP 1066 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RP 1066 (1077)
                         ..+...++...|.+||.+|.
T Consensus       392 ---s~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  392 ---SPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ---CHHHHHHHHHHhhcChHhhc
Confidence               23456778889999999997

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=315.30  Aligned_cols=253  Identities=24%  Similarity=0.308  Sum_probs=202.1

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccc--hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLS--EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      +.|+..+.||+|++|.||+|.. .++++||+|.+......  .....+.+.+|+.++++++||||+++++++.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999965 46899999988654322  12234678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |+||+++++|.+++....   .++...+..++.|++.|++|||+.   +|+|+||+|+||+++.++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            999999999999986543   477889999999999999999999   99999999999999999999999999997654


Q ss_pred             CCCCC---cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC
Q 001440          963 PDSSN---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       963 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      .....   .....++..|+|||++.+..++.++||||+|+++||+++|+.||......        ............. 
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~-  226 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM--------AAIFKIATQPTNP-  226 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH--------HHHHHHhccCCCC-
Confidence            32211   12345788999999999999999999999999999999999998633211        0111111110000 


Q ss_pred             CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                       .........+.+++.+||+.+|++|||+.|+++.
T Consensus       227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         227 -QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             -CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence             0111233468899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-35  Score=320.51  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             HHHhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCee
Q 001440          802 VRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       802 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  880 (1077)
                      ......|++.+.||.||.+.||++...+.+.||+|++.... .+.....-|.+|+.++.++ .|.+||++++|...++..
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            34456799999999999999999988888889999876543 3444577899999999999 599999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      |||||| ..-+|..++....... ..| .++.++.|++.|+.++|.+   ||||.||||.|+++= .|.+||+|||+|..
T Consensus       436 YmvmE~-Gd~DL~kiL~k~~~~~-~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  436 YMVMEC-GDIDLNKILKKKKSID-PDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             EEEeec-ccccHHHHHHhccCCC-chH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            999996 4569999997665322 334 7888999999999999999   999999999999984 68999999999998


Q ss_pred             CCCCCCC--cccccccccccCccccccCC-----------CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccc
Q 001440          961 LKPDSSN--WTELAGTIGYVAPELAYTMK-----------VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       961 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~-----------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~ 1027 (1077)
                      +.++...  ....+||+.|||||.+....           .+.++||||+||++|+|+.|+.||..+.       +....
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-------n~~aK  581 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-------NQIAK  581 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-------HHHHH
Confidence            8776443  34678999999999987543           4578999999999999999999987432       22344


Q ss_pred             hhhhcCCCC--CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 LDEILDPRL--PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +..+.+|.-  +.+......   .++++++.||++||++||+..|+++
T Consensus       582 l~aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  582 LHAITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHhhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence            556666633  332222122   2889999999999999999999986

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.5e-34  Score=316.23  Aligned_cols=252  Identities=24%  Similarity=0.356  Sum_probs=189.8

Q ss_pred             eecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          813 CIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      .||+|+||.||+|.+.   ++..+|+|++.....  ......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            5899999999999764   345799998865432  22345788899999999999999999999998999999999999


Q ss_pred             CCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC-
Q 001440          890 GSLAMILSNATS--AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-  966 (1077)
Q Consensus       890 g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-  966 (1077)
                      |+|.+++.....  ....++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            999999965432  22356778889999999999999999   999999999999999999999999999975433221 


Q ss_pred             -CcccccccccccCccccccC-------CCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          967 -NWTELAGTIGYVAPELAYTM-------KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       967 -~~~~~~g~~~y~aPE~~~~~-------~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                       ......++..|+|||++.+.       .++.++||||||+++|||++ |+.||............    .. ....+.+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~  231 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT----VR-EQQLKLP  231 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----hh-cccCCCC
Confidence             11234567889999988642       35789999999999999996 99998643221100000    00 0011111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+. ........+.+++..|| .+|++|||++||++.|+
T Consensus       232 ~~~-~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPR-LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCc-cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            111 01112235778899999 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.2e-34  Score=321.81  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCC
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~  878 (1077)
                      ++|.+.+.||+|+||.||+|...      ++..||+|++.....  ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            56889999999999999999641      345799999875422  22356789999999999 7999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++||||+++|+|.++++.... ..+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.+|++|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999975432 3378999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC
Q 001440          959 KSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR 1035 (1077)
Q Consensus       959 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1077)
                      +........  .....++..|+|||++.+..++.++||||+||++||+++ |+.||.....        ...+.......
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--------~~~~~~~~~~~  260 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--------DSKFYKLIKEG  260 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--------hHHHHHHHHcC
Confidence            866443221  122345778999999999999999999999999999998 9999753221        11111111111


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .....  .......+.+++.+||+++|++||++.|+++.|+
T Consensus       261 ~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~  299 (302)
T cd05055         261 YRMAQ--PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIG  299 (302)
T ss_pred             CcCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            11110  0112346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=325.55  Aligned_cols=260  Identities=16%  Similarity=0.268  Sum_probs=198.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||.||+|+.+ +++.||+|++......  .....+.+|+.++++++||||+++++++..++..++||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            57889999999999999999765 6788999998654322  22345778999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++ ++.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          84 EYLDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             eCCCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            99975 8888875543  3478889999999999999999998   9999999999999999999999999999765444


Q ss_pred             CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccccchhhh-----
Q 001440          965 SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRTLDEI----- 1031 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~----- 1031 (1077)
                      ........+++.|+|||++.+ ..++.++||||+||++|||++|+.||.........       .......+..+     
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         158 TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            333445568899999998865 45889999999999999999999998643211000       00000000000     


Q ss_pred             -cCCCCCCCC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1032 -LDPRLPAPS-----CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1032 -~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       .+...+...     .........+.+++.+|++.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence             000000000     000112346789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.8e-34  Score=310.33  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=197.3

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCC
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS  891 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~  891 (1077)
                      +.||+|+||.||+|...+++.||+|.+.....  ......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            36899999999999888889999999876432  2224568899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc-cc
Q 001440          892 LAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW-TE  970 (1077)
Q Consensus       892 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~  970 (1077)
                      |.+++....  ..+++.+++.++.|++.|+.|+|+.   +++||||||+||+++.++.+|++|||++.......... ..
T Consensus        79 L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          79 FLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            999986543  3478999999999999999999998   99999999999999999999999999987543322111 12


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCCcHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLI 1048 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 1048 (1077)
                      ..++..|+|||+..+..++.++||||||+++||+++ |..||......        .....+... ....+.    ....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~----~~~~  221 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ--------QAREQVEKGYRMSCPQ----KCPD  221 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH--------HHHHHHHcCCCCCCCC----CCCH
Confidence            234678999999998889999999999999999998 89898632211        111111111 111111    1234


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1049 SIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1049 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+++.+||+.+|++||++.|+++.|+
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            6889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4e-34  Score=314.46  Aligned_cols=252  Identities=30%  Similarity=0.525  Sum_probs=201.6

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC---EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE---IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      .+|+..+.||+|+||.||+|..+ +++   .||+|++....  .....+++..|+++++.++|||++++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            46788899999999999999765 333   69999886542  2233567899999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||++...
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          83 IITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999999986533  3578999999999999999999998   9999999999999999999999999999866


Q ss_pred             CCCCCCc-c--cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CC
Q 001440          962 KPDSSNW-T--ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RL 1036 (1077)
Q Consensus       962 ~~~~~~~-~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1036 (1077)
                      ....... .  ....+..|+|||++....++.++|||||||++||+++ |+.||.....        .+....+... ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~~~~~~  229 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAINDGFRL  229 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhcCCCC
Confidence            4332211 1  1223467999999998889999999999999999998 9999853221        1222222221 11


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +.+    .+....+.+++.+||+.+|++||++++|++.|+
T Consensus       230 ~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~  265 (268)
T cd05063         230 PAP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLD  265 (268)
T ss_pred             CCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            111    122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-34  Score=313.70  Aligned_cols=248  Identities=29%  Similarity=0.502  Sum_probs=203.0

Q ss_pred             ceecccCCceEEEEEecC----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          812 HCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      +.||+|+||.||+|....    +..||+|.+.......  ..+.+.+|++.++.++|+|++++++++......++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            468999999999997653    7889999987654332  4678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          888 EMGSLAMILSNATS------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      ++++|.+++.....      ...+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.+|++|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999976521      25589999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCC--CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCC
Q 001440          962 KPDS--SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLP 1037 (1077)
Q Consensus       962 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1037 (1077)
                      ....  .......++..|+|||++....++.++||||+|+++|||++ |..||.....        .+..+..... ...
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~  227 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN--------EEVLEYLRKGYRLP  227 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCCCCC
Confidence            5443  22234457889999999988889999999999999999999 6888864321        1122222221 111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+    ......+.+++.+||+.+|++|||++|+++.|+
T Consensus       228 ~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         228 KP----EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC----ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11    122456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.1e-34  Score=317.96  Aligned_cols=258  Identities=25%  Similarity=0.397  Sum_probs=198.7

Q ss_pred             cCC-CccceecccCCceEEEEEe-----cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--
Q 001440          806 NDF-DEEHCIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--  877 (1077)
Q Consensus       806 ~~~-~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--  877 (1077)
                      ++| +..+.||+|+||+||++..     .+++.||+|.+.....  ......+.+|+++++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            344 7889999999999988643     3578899999875422  12356788999999999999999999988653  


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      ...++||||+++|+|.+++...    .+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccc
Confidence            4688999999999999999653    388999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCC---cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-cC-----cccccch
Q 001440          958 SKSLKPDSSN---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-TS-----SNLDRTL 1028 (1077)
Q Consensus       958 a~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-~~-----~~~~~~~ 1028 (1077)
                      ++........   .....++..|+|||+..+..++.++||||||+++|||++|+.||........ ..     .......
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRL  233 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhh
Confidence            9876543221   1123456779999999888899999999999999999999999754321100 00     0000011


Q ss_pred             hhhcCCC--CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1029 DEILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1029 ~~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ....+..  .+.+    ......+.+++.+||+.||++|||+++++++|+
T Consensus       234 ~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~  279 (283)
T cd05080         234 IELLERGMRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLIPILK  279 (283)
T ss_pred             hhhhhcCCCCCCC----CCCCHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence            1111111  1111    122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.8e-34  Score=321.76  Aligned_cols=255  Identities=23%  Similarity=0.395  Sum_probs=202.4

Q ss_pred             hcCCCccceecccCCceEEEEEec--------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEe
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS--------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCS  875 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  875 (1077)
                      .++|++.+.||+|+||.||+|++.        ++..||+|.+....  .....+++.+|+..++.+ +||||+++++++.
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            467888999999999999999641        24579999886542  223356789999999999 8999999999999


Q ss_pred             eCCeeEEEEeecCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 001440          876 HARHSFIVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV  942 (1077)
Q Consensus       876 ~~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NI  942 (1077)
                      .....++||||+++|+|.+++.....             ...+++.+++.++.||+.|++|||+.   +|+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999976422             23578889999999999999999999   999999999999


Q ss_pred             eeCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccc
Q 001440          943 LLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019 (1077)
Q Consensus       943 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~ 1019 (1077)
                      +++.++.+|++|||.++........  .....++..|+|||++.+..++.++||||||+++||+++ |..||....    
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----  244 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----  244 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----
Confidence            9999999999999999876543222  122345678999999998889999999999999999998 777765221    


Q ss_pred             cCcccccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1020 TSSNLDRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1020 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                          ..+....+.... ...+    ......+.+++.+||+.+|++||++.|+++.|+
T Consensus       245 ----~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~  294 (304)
T cd05101         245 ----VEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLD  294 (304)
T ss_pred             ----HHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence                112222222111 1111    122346888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-34  Score=322.93  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=197.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC--EEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|++.+.||+|+||.||+|.++ ++.  .+|+|.+...  ......+.+.+|+.++.++ +||||+++++++.+++..+
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~   84 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   84 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence            46888899999999999999764 454  4577776542  2223356788999999999 8999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          882 IVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      +||||+++|+|.+++.....             ...+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~  161 (303)
T cd05088          85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  161 (303)
T ss_pred             EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCC
Confidence            99999999999999975431             22478899999999999999999998   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccc
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~ 1027 (1077)
                      .+||+|||++........ .....++..|+|||++.+..++.++|||||||++|||+| |..||.....        .+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~  232 (303)
T cd05088         162 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL  232 (303)
T ss_pred             cEEeCccccCcccchhhh-cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHH
Confidence            999999999864321111 112234678999999988889999999999999999998 9999752211        111


Q ss_pred             hhhhcCC-CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1028 LDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1028 ~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ....... ....+.    .....+.+++.+||+.+|++||+++++++.++
T Consensus       233 ~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~  278 (303)
T cd05088         233 YEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  278 (303)
T ss_pred             HHHHhcCCcCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111111 111111    12346789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.3e-34  Score=311.90  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=202.3

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .+|++.+.||+|+||.||+|.+.+++.+|+|.+......    ..++.+|++++++++||+++++++++......++|||
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE   79 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence            467888999999999999998877889999998754332    4568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++....  ..++++.+..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.++......
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          80 FMEHGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             cCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999999986543  3478899999999999999999998   99999999999999999999999999987654332


Q ss_pred             CC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCC
Q 001440          966 SN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCN 1042 (1077)
Q Consensus       966 ~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1042 (1077)
                      .. .....++.+|+|||+..+..++.++||||+|+++||+++ |+.||.....        ....+.+... +...+.  
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~--  224 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETINAGFRLYKPR--  224 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHhCCCCCCCCC--
Confidence            11 122335678999999998889999999999999999998 8999863221        1112221111 111111  


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        .....+.+++.+||+.+|++||+++|++++|.
T Consensus       225 --~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 --LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence              12346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.6e-34  Score=312.71  Aligned_cols=252  Identities=25%  Similarity=0.341  Sum_probs=203.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee-CCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-ARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~  884 (1077)
                      +|++.+.||+|++|.||++..+ +++.||+|++...... ....+.+.+|+.++++++|+|++++++.+.. ....++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            4788999999999999999765 5788999998654322 2235668889999999999999999998764 45689999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++.... ...+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.++|+|||++......
T Consensus        80 e~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          80 GFCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             cccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            9999999999997643 23478999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........+++.|+|||+..+..++.++||||+|+++||+++|+.||....        .............+..   ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~---~~  224 (257)
T cd08223         156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEGKLPPM---PK  224 (257)
T ss_pred             CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCCCC---cc
Confidence            444445678899999999999999999999999999999999999986321        1112222222222211   12


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.||++||++.|+++.
T Consensus       225 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         225 DYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            234568899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.9e-34  Score=322.03  Aligned_cols=254  Identities=24%  Similarity=0.397  Sum_probs=200.5

Q ss_pred             cCCCccceecccCCceEEEEEec--------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS--------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ++|.+.+.||+|+||.||+|++.        ++..||+|.+....  ......++.+|+.+++.+ +||||+++++++..
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            57899999999999999999652        23569999987542  222356788899999999 79999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCee
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL  943 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIl  943 (1077)
                      .+..++||||+++|+|.+++.....             ...+++.+++.++.|++.|++|||+.   +++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence            9999999999999999999975432             13488999999999999999999998   9999999999999


Q ss_pred             eCCCCceEEecccccccCCCCCCCc--ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 001440          944 LDLEYEAHVSDFGISKSLKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICST 1020 (1077)
Q Consensus       944 l~~~~~~kl~Dfgla~~~~~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 1020 (1077)
                      ++.++.+|++|||.++.........  ....++..|+|||++.+..++.++||||+||++|||++ |+.||....     
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~-----  247 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----  247 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC-----
Confidence            9999999999999997654322111  11224568999999998889999999999999999998 888875221     


Q ss_pred             CcccccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1021 SSNLDRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1021 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         ..+......... ...+    ......+.+++.+||+.+|++||++.|+++.|+
T Consensus       248 ---~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~  297 (307)
T cd05098         248 ---VEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  297 (307)
T ss_pred             ---HHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence               111111111111 1111    122346888999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5e-34  Score=315.50  Aligned_cols=252  Identities=24%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|.. .+++.||+|.+....  .....+++.+|+.++++++||||+++++++..++..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            3678889999999999999965 478899999986542  2233567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++++++..+.       .+++..+..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||++......
T Consensus        79 e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          79 EFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             ecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999997652       367788899999999999999998   9999999999999999999999999999765432


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ......|+..|+|||++.+..++.++||||||+++|||++|+.||.......... ........+.+...+..  ...
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~~  223 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVL--PVG  223 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHhccCCCCC--CCC
Confidence              2234578999999999999999999999999999999999999986432111100 11111222222111111  011


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++||+++|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         224 QFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            223468899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3e-34  Score=313.31  Aligned_cols=246  Identities=28%  Similarity=0.460  Sum_probs=198.9

Q ss_pred             ceecccCCceEEEEEecC--C--CEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          812 HCIGTGGQGSVYRAELSS--G--EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      +.||+|++|.||+|.+.+  +  ..||+|.+......  ...+.+.+|+..+++++||||+++++++.. ...++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            368999999999997643  3  36999998776443  446789999999999999999999999988 8899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN  967 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  967 (1077)
                      ++|+|.+++..... ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||+++.+......
T Consensus        78 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          78 PLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999999976543 4588999999999999999999999   9999999999999999999999999999876543222


Q ss_pred             c---ccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhc--CCCCCCCCC
Q 001440          968 W---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL--DPRLPAPSC 1041 (1077)
Q Consensus       968 ~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 1041 (1077)
                      +   ....++..|+|||++.+..++.++||||||+++|||++ |+.||......        +....+.  ....+.+  
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--------~~~~~~~~~~~~~~~~--  223 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS--------QILKKIDKEGERLERP--  223 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHhcCCcCCCC--
Confidence            1   12356788999999998899999999999999999999 99998532211        1111111  1111111  


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                        ...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus       224 --~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 --EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             --ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence              122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-35  Score=328.34  Aligned_cols=247  Identities=22%  Similarity=0.336  Sum_probs=199.1

Q ss_pred             ccceecccCCceEEEEEe-cCCCEEEEEEccCCc-cchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC--eeEEEEe
Q 001440          810 EEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPL-LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR--HSFIVYE  885 (1077)
Q Consensus       810 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E  885 (1077)
                      ....||+|+|-+||+|.+ .+|..||.-.++... .......++|..|+.+++.|+||||++++++|.+..  ...+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            345799999999999955 467788764333221 233344688999999999999999999999997765  4788999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEecccccccCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla~~~~~~  964 (1077)
                      .+..|+|..|.++.+   .+....+..|++||++||.|||++ .|+|+|||||.+||+|+.+ |.|||+|.|+|+.....
T Consensus       124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            999999999998765   377789999999999999999997 7899999999999999865 99999999999876543


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        +....+|||.|||||+.. ..|++.+||||||++|+||+|+.+||...       .+..+....+..+.-|..-..  
T Consensus       200 --~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC-------~n~AQIYKKV~SGiKP~sl~k--  267 (632)
T KOG0584|consen  200 --HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC-------TNPAQIYKKVTSGIKPAALSK--  267 (632)
T ss_pred             --ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh-------CCHHHHHHHHHcCCCHHHhhc--
Confidence              334579999999999987 67999999999999999999999998632       333444444444444332111  


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      -..+.+.+||.+|+.. .++|||+.|+++
T Consensus       268 V~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 VKDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            1134789999999999 889999999975

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.6e-34  Score=320.24  Aligned_cols=249  Identities=26%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|++.+.||.|++|.||+|.. .+++.||+|.+.....   ...+.+.+|+..++.++|||++++++++......++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence            4689999999999999999965 4789999998865322   23567888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++...    .+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          96 EYLAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             EecCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            999999999998643    378899999999999999999999   9999999999999999999999999999876555


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........++..|+|||.+.+..++.++|||||||++||+++|+.||.........     ........+....+    .
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~----~  239 (296)
T cd06655         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGTPELQNP----E  239 (296)
T ss_pred             cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHHhcCCcccCCc----c
Confidence            44334456889999999999888999999999999999999999998643221100     00000001111111    1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .....+.+++.+||..||++||++.++++
T Consensus       240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            23346888999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.5e-35  Score=351.98  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             HHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CCe
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARH  879 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~  879 (1077)
                      ....+|.+.+.||+|+||+||+|+.. +++.||+|.+...... ......+..|+.+++.++|||||++++++.+  ...
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            44578999999999999999999765 5778999988754333 2335678999999999999999999998854  357


Q ss_pred             eEEEEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeccCCCCCeeeCCC-------
Q 001440          880 SFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCF----PPIVYRDISSKNVLLDLE-------  947 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~Dlk~~NIll~~~-------  947 (1077)
                      .|+||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+...    .+||||||||+|||++.+       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            899999999999999986532 23458999999999999999999998521    259999999999999642       


Q ss_pred             ----------CceEEecccccccCCCCCCCcccccccccccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCccc
Q 001440          948 ----------YEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT--MKVTEKSDVYSFGVLALEAIKGKHPRDFIS 1015 (1077)
Q Consensus       948 ----------~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 1015 (1077)
                                +.+||+|||++..+.... ......||+.|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      348999999998764332 2234578999999999854  458899999999999999999999986322


Q ss_pred             cccccCcccccchhhhcC-CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1016 SICSTSSNLDRTLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .       ....+..+.. +.++.     ......+.++|..||+.+|++||++.|+++
T Consensus       248 ~-------~~qli~~lk~~p~lpi-----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        248 N-------FSQLISELKRGPDLPI-----KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             c-------HHHHHHHHhcCCCCCc-----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            1       1111222111 11221     122346889999999999999999999984

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.1e-34  Score=314.35  Aligned_cols=256  Identities=25%  Similarity=0.309  Sum_probs=198.9

Q ss_pred             HHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      .+++.+.....||+|+||.||+|.+. ++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34555666678999999999999754 67889999886542   223567889999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CCceEEeccccccc
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EYEAHVSDFGISKS  960 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~  960 (1077)
                      +|+||+++++|.+++.........++.++..++.||+.|++|||+.   +|+||||||+||+++. ++.+||+|||.+..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            9999999999999997543221226788889999999999999998   9999999999999986 67999999999986


Q ss_pred             CCCCCCCcccccccccccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          961 LKPDSSNWTELAGTIGYVAPELAYTMK--VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       961 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      ............++..|+|||++....  ++.++||||||+++||+++|+.||.......      ............+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~  232 (268)
T cd06624         159 LAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ------AAMFKVGMFKIHPE  232 (268)
T ss_pred             cccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh------hhHhhhhhhccCCC
Confidence            654433334456889999999986543  7889999999999999999999986322100      00000000011110


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ........+.+++.+||+.+|++|||++|+++
T Consensus       233 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         233 ---IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             ---CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence               11123346889999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=325.13  Aligned_cols=243  Identities=26%  Similarity=0.374  Sum_probs=199.5

Q ss_pred             eecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCC
Q 001440          813 CIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS  891 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~  891 (1077)
                      ++|+|.||+||.|++. +...+|||.+....   ....+-+..|+.+.++++|+|||+++|.+.+.++.-|.||-++||+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence            6999999999999776 45678999987643   2235668899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeC-CCCceEEecccccccCCCCCCCc
Q 001440          892 LAMILSNATSAEEL--GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD-LEYEAHVSDFGISKSLKPDSSNW  968 (1077)
Q Consensus       892 L~~~l~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~  968 (1077)
                      |.+.++..=  +++  .+..+-.+.+||++|+.|||+.   .|||||||-+||+++ ..|.+||+|||-++++..-..-.
T Consensus       659 LSsLLrskW--GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  659 LSSLLRSKW--GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             HHHHHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            999996532  233  5567778899999999999999   999999999999996 57999999999999887666666


Q ss_pred             ccccccccccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh-hhcCCCCCCCCCCcHH
Q 001440          969 TELAGTIGYVAPELAYTM--KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD-EILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       969 ~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 1045 (1077)
                      .++.||..|||||++..+  +|+.++|||||||++.||.||++||.......      ..++. .+.+...+.    +.+
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkVGmyKvHP~i----Pee  803 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKVGMYKVHPPI----PEE  803 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------HhhhhhcceecCCCC----cHH
Confidence            788999999999999865  58999999999999999999999987433211      11111 112222222    245


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ..++...+|.+|+.+||.+||+|.++++
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            6678889999999999999999999875

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.3e-34  Score=325.75  Aligned_cols=259  Identities=20%  Similarity=0.281  Sum_probs=193.4

Q ss_pred             ccceeccc--CCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          810 EEHCIGTG--GQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       810 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      +.++||+|  +||+||+++. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccH-HHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            45679999  6889999966 478999999987643322 2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++|++.+++..... ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.++++||+.+........
T Consensus        81 ~~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          81 MAYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             cCCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            999999999865432 3478999999999999999999998   999999999999999999999999986654322111


Q ss_pred             C-------cccccccccccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhc-----
Q 001440          967 N-------WTELAGTIGYVAPELAYT--MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL----- 1032 (1077)
Q Consensus       967 ~-------~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----- 1032 (1077)
                      .       .....++..|+|||++.+  ..++.++|||||||++|||++|+.||.....................     
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccch
Confidence            1       122356778999999876  45889999999999999999999998643211100000000000000     


Q ss_pred             --------------C-------------CCCCC--CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 --------------D-------------PRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 --------------~-------------~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                                    +             +....  ...........+.+++.+||++||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                          0             00000  00011223457889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-34  Score=310.90  Aligned_cols=244  Identities=28%  Similarity=0.463  Sum_probs=194.4

Q ss_pred             ceecccCCceEEEEEec-C---CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          812 HCIGTGGQGSVYRAELS-S---GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      ++||+|+||.||+|.+. .   +..||+|.+......  ...+++.+|+.+++.++||||+++++++. ....++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            46999999999999653 2   268999998765433  33567899999999999999999999876 45679999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN  967 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  967 (1077)
                      ++|+|.+++....   .+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||+++........
T Consensus        78 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          78 PLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999997644   478899999999999999999998   9999999999999999999999999999876544332


Q ss_pred             ccc---ccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCC
Q 001440          968 WTE---LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCN 1042 (1077)
Q Consensus       968 ~~~---~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1042 (1077)
                      ...   ..++..|+|||...+..++.++||||||+++||+++ |+.||......        +....+... ..+.+   
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--------~~~~~~~~~~~~~~~---  220 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--------EVIAMLESGERLPRP---  220 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--------HHHHHHHcCCcCCCC---
Confidence            221   123467999999998899999999999999999998 99998633211        111111111 11111   


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ......+.+++.+||+.+|++||++.++.+.|+
T Consensus       221 -~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~  253 (257)
T cd05060         221 -EECPQEIYSIMLSCWKYRPEDRPTFSELESTFR  253 (257)
T ss_pred             -CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence             122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=339.59  Aligned_cols=256  Identities=22%  Similarity=0.261  Sum_probs=189.7

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC------
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA------  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  877 (1077)
                      ..+|++.+.||+|+||.||+|... +++.||||++....       ....+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            457999999999999999999764 68899999885431       2234699999999999999999886432      


Q ss_pred             --CeeEEEEeecCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-ceEEe
Q 001440          878 --RHSFIVYEYLEMGSLAMILSNA-TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVS  953 (1077)
Q Consensus       878 --~~~~lV~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~  953 (1077)
                        ...++||||+++ ++.+++... .....+++..+..++.||+.||+|||+.   +|+||||||+||+++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence              246799999985 677766432 2234588899999999999999999999   999999999999999764 79999


Q ss_pred             cccccccCCCCCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccc
Q 001440          954 DFGISKSLKPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLD 1025 (1077)
Q Consensus       954 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~ 1025 (1077)
                      |||+|+.+..... .....|++.|+|||++.+. .++.++||||+||++|||++|.+||..........       ....
T Consensus       214 DFGla~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        214 DFGSAKNLLAGQR-SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccccchhccCCCC-cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9999987654332 2345789999999988754 68999999999999999999999986432110000       0000


Q ss_pred             cchhhhcCC-----CCCCCCC-C-----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1026 RTLDEILDP-----RLPAPSC-N-----IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1026 ~~~~~~~~~-----~~~~~~~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +.+.. ..+     .++.... .     ....+..+.+++.+||++||++|||+.|+++
T Consensus       293 ~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKE-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHH-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            00000 000     0110000 0     0012346889999999999999999999875

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.3e-34  Score=319.76  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=203.2

Q ss_pred             hcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..+|++.+.||+|+||.||+|.. .+++.||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            36789999999999999999975 4789999999865322   2346688899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++++|.+++.+.    .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.++++|||++.....
T Consensus        95 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          95 MEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ecccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999998643    378889999999999999999998   999999999999999999999999999987655


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........+++.|+|||+..+..++.++|||||||++|++++|+.||........       ..........+  ....
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~-------~~~~~~~~~~~--~~~~  238 (297)
T cd06656         168 EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-------LYLIATNGTPE--LQNP  238 (297)
T ss_pred             CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh-------eeeeccCCCCC--CCCc
Confidence            44433455788999999999988899999999999999999999999863222110       00000011100  0111


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ......+.+++.+||+.+|++||+++++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            223345788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.1e-34  Score=315.59  Aligned_cols=252  Identities=23%  Similarity=0.411  Sum_probs=198.4

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      ..+|+..+.||+|+||+||+|++. +|+    +||+|.+....  .....+++.+|+..++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~   82 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T   82 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence            357888999999999999999753 444    48999986542  223356788999999999999999999999754 4


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .++++||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            679999999999999986543  3588899999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCC-
Q 001440          960 SLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR- 1035 (1077)
Q Consensus       960 ~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 1035 (1077)
                      ........  .....++..|+|||+..+..++.++|||||||++||+++ |..||+....        ......+.... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~~  229 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA--------REIPDLLEKGER  229 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCCc
Confidence            76543222  122335678999999998899999999999999999998 8888763211        01111111111 


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+.    .....+.+++.+||+.||++||++.|+++.|+
T Consensus       230 ~~~~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~  266 (279)
T cd05109         230 LPQPP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFS  266 (279)
T ss_pred             CCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            11111    22346789999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-34  Score=321.77  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=200.1

Q ss_pred             cCCCccceecccCCceEEEEEec--------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS--------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ++|.+.+.||+|+||.||+|+..        ++..||+|.+.....  .....++..|+.+++++ +||||+++++++.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            57888999999999999999642        245689998875422  23356788999999999 69999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCee
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL  943 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIl  943 (1077)
                      .+..++||||+++|+|.+++.....             ...+++.++..++.|++.|+.|||+.   ||+||||||+||+
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEE
Confidence            9999999999999999999965421             23488999999999999999999998   9999999999999


Q ss_pred             eCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCcccccccc
Q 001440          944 LDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICST 1020 (1077)
Q Consensus       944 l~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~ 1020 (1077)
                      ++.++.+|++|||.++........  .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....    
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----  242 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----  242 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----
Confidence            999999999999999876432221  112234467999999998899999999999999999999 8888753211    


Q ss_pred             CcccccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1021 SSNLDRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1021 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                          .+......... ...+.    .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       243 ----~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~  291 (314)
T cd05099         243 ----EELFKLLREGHRMDKPS----NCTHELYMLMRECWHAVPTQRPTFKQLVEALD  291 (314)
T ss_pred             ----HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence                11222222211 11111    12235778999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-34  Score=316.14  Aligned_cols=251  Identities=25%  Similarity=0.344  Sum_probs=199.2

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||.||+|+.. +++.||+|.+....   ......+.+|+.+++.++||||+++++++..++..++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            46778889999999999999664 68899999886532   222456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++....   .+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        86 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          86 EFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             eccCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999999986543   478899999999999999999999   9999999999999999999999999999766544


Q ss_pred             CCCcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC-C
Q 001440          965 SSNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP-S 1040 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1040 (1077)
                      ........|+..|+|||++.   ...++.++||||+||++|||++|+.||........        ...........+ .
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~--------~~~~~~~~~~~~~~  231 (267)
T cd06645         160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLMTKSNFQPPKL  231 (267)
T ss_pred             ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh--------HHhhhccCCCCCcc
Confidence            33334567899999999874   45688999999999999999999999753221100        000000111100 0


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .........+.+++.+||+.+|++||+++++++
T Consensus       232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            001112345789999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.9e-34  Score=312.21  Aligned_cols=252  Identities=22%  Similarity=0.327  Sum_probs=206.1

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|+||.||++... +|+.||+|++...... ....+++.+|+.++++++||||+++++++...+..++|+|
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            4788899999999999999654 6889999998654322 2235678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++..... ..+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          80 YCEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999999865432 3478899999999999999999998   99999999999999999999999999998765543


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......|++.|+|||+..+..++.++|||||||++||+++|+.||....        .......+.....+...   ..
T Consensus       156 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~~~---~~  224 (256)
T cd08218         156 ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSYPPVS---SH  224 (256)
T ss_pred             hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCCCCCc---cc
Confidence            33344568889999999998889999999999999999999999986321        12223333333322111   12


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ....+.+++.+||+.+|++||++.||++.
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         225 YSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            34468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=315.75  Aligned_cols=249  Identities=28%  Similarity=0.423  Sum_probs=204.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||.|++|.||+|... +++.||+|.+....  .......+.+|+.+++.++|+||+++++++.++...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            36788899999999999999765 68899999986542  2233567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++...    .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||+++.....
T Consensus        79 e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          79 EYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             EeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999998653    578899999999999999999998   9999999999999999999999999999877655


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........++..|+|||++.+..++.++||||||+++|||++|+.||......        .....+.....+....  .
T Consensus       152 ~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~--------~~~~~~~~~~~~~~~~--~  221 (274)
T cd06609         152 MSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM--------RVLFLIPKNNPPSLEG--N  221 (274)
T ss_pred             ccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH--------HHHHHhhhcCCCCCcc--c
Confidence            34444567888999999999888999999999999999999999998633211        1111111111111000  1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .....+.+++.+||..+|++||+++++++
T Consensus       222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            13346889999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=326.14  Aligned_cols=255  Identities=22%  Similarity=0.269  Sum_probs=197.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999999765 68899999986533233334566888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.+..  ..+++.++..++.||+.||+|||++   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            9999999999996532  3478889999999999999999999   9999999999999999999999999999766543


Q ss_pred             CCC-cccccccccccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC--CCC
Q 001440          965 SSN-WTELAGTIGYVAPELAYT-----MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRL 1036 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~ 1036 (1077)
                      ... .....||+.|+|||++..     ..++.++||||+||++|||++|+.||.....        .+....+..  ...
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~  227 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKEHF  227 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCcc
Confidence            322 223468999999999863     4578899999999999999999999863221        111112211  111


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCC--CCCCHHHHHhh
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPD--SRPTMQKVSQL 1074 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 1074 (1077)
                      +.+.. .......+.+++++|+..+++  .||+++++++.
T Consensus       228 ~~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 QFPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            11111 111234577888887755443  38899988753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.5e-34  Score=311.75  Aligned_cols=249  Identities=28%  Similarity=0.434  Sum_probs=203.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||+|+||.||+|... +++.||+|.+....     ..+++.+|+++++.++||||+++++++.++...++|+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            57888999999999999999876 47899999986431     1578899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++....  ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.+|++|||++......
T Consensus        78 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence            9999999999986533  3578999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........++..|+|||++.+..++.++||||||+++|||++|+.||.......        ....... ..........
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--------~~~~~~~-~~~~~~~~~~  223 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--------AIFMIPN-KPPPTLSDPE  223 (256)
T ss_pred             ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--------hhhhhcc-CCCCCCCchh
Confidence            433344568899999999998899999999999999999999999986432211        0000000 1111011112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .....+.+++.+||+.||++|||+.|+++
T Consensus       224 ~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         224 KWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            23346889999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-34  Score=310.29  Aligned_cols=248  Identities=29%  Similarity=0.463  Sum_probs=203.0

Q ss_pred             hcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.+.||.|+||.||+|... |+.||+|.+.....    ..+++.+|+.+++.++|+||+++++++.+....++||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   79 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT   79 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence            357888999999999999999875 78999999876432    3567899999999999999999999999889999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++..... ..+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.+||+|||.++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          80 EYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999976542 3588999999999999999999999   9999999999999999999999999999876322


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCN 1042 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1042 (1077)
                      ..   ....+..|+|||++....++.++||||||+++||+++ |+.||.....        .......... ....+   
T Consensus       156 ~~---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---  221 (256)
T cd05039         156 QD---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPHVEKGYRMEAP---  221 (256)
T ss_pred             cc---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHhcCCCCCCc---
Confidence            21   2334678999999988889999999999999999997 9999753211        1111111111 11111   


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ......+.+++.+||+.+|++||+++|++++|+
T Consensus       222 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  254 (256)
T cd05039         222 -EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLA  254 (256)
T ss_pred             -cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHh
Confidence             122356889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.3e-34  Score=315.22  Aligned_cols=259  Identities=28%  Similarity=0.446  Sum_probs=198.7

Q ss_pred             cCCCccceecccCCceEEEEEe-----cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CC
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--AR  878 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  878 (1077)
                      .+|++.+.||+|+||+||+|..     .+++.||+|++....   ....+.+.+|+.+++.++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4688889999999999999964     257899999986542   2335678899999999999999999998754  34


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++||||+++|+|.+++....  ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccc
Confidence            6889999999999999996543  3478999999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCc---ccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccc--cCcc-----cccch
Q 001440          959 KSLKPDSSNW---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS--TSSN-----LDRTL 1028 (1077)
Q Consensus       959 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~--~~~~-----~~~~~ 1028 (1077)
                      +.........   ....++..|+|||+..+..++.++|||||||++|||++|..|+........  ....     .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL  235 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence            8765433221   112234569999999988899999999999999999998776532211100  0000     00011


Q ss_pred             hhhcCC--CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1029 DEILDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1029 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+..  ..+.+    ......+.+++.+||+++|++|||++|+++.|+
T Consensus       236 ~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05081         236 IELLKNNGRLPAP----PGCPAEIYAIMKECWNNDPSQRPSFSELALQVE  281 (284)
T ss_pred             HHHHhcCCcCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence            111111  11111    122346889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-34  Score=328.35  Aligned_cols=260  Identities=23%  Similarity=0.324  Sum_probs=196.1

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR----  878 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----  878 (1077)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++..... ......++.+|+.+++.++||||+++++++...+    
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3578999999999999999999764 689999999876532 2233567789999999999999999999986443    


Q ss_pred             --eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          879 --HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       879 --~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                        ..++||||+++ ++.+.+..     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg  168 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  168 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCC
Confidence              57999999976 56555532     367788999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Cccc-----
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNL----- 1024 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~----- 1024 (1077)
                      +++..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.........       ....     
T Consensus       169 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  247 (359)
T cd07876         169 LARTACTN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMN  247 (359)
T ss_pred             CccccccC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHH
Confidence            99765432 2223457899999999999999999999999999999999999998643211000       0000     


Q ss_pred             --ccchhhhcC--CCCCC------------C--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1025 --DRTLDEILD--PRLPA------------P--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1025 --~~~~~~~~~--~~~~~------------~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                        .........  +..+.            +  ..........+.+++.+||+.||++|||++|+++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         248 RLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence              000000000  01100            0  00001113457899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-34  Score=332.60  Aligned_cols=259  Identities=23%  Similarity=0.319  Sum_probs=196.4

Q ss_pred             CCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----ee
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----HS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  880 (1077)
                      +|+..+.||+|+||+||+|.. .+|+.||+|++.... .+....+++.+|+.+++.++||||+++++++..+.     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            478889999999999999976 478999999986542 22233567889999999999999999999998776     78


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+. ++|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        80 ~lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            99999997 5788877543   3488899999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCCC-CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC--------cccc-----
Q 001440          961 LKPDSS-NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS--------SNLD----- 1025 (1077)
Q Consensus       961 ~~~~~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~--------~~~~----- 1025 (1077)
                      ...... ......+++.|+|||++.+. .++.++||||+||++|||++|+.||..........        ....     
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            543322 22344678999999998764 47899999999999999999999986432211000        0000     


Q ss_pred             --cchhhhcCCCCCCCC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1026 --RTLDEILDPRLPAPS-----CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1026 --~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        .....+.......+.     .........+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence              000000000000000     000112346789999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5.3e-34  Score=315.93  Aligned_cols=250  Identities=24%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |++.+.||+|+||.||+|... ++..+|+|.+....   ....+.+.+|+.+++.++|||++++++++..+...++|+||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            567788999999999999765 57788999886532   23356788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++|++.+++....  ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++++|++|||++........
T Consensus        84 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          84 CAGGAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             cCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            99999998876432  3588999999999999999999998   999999999999999999999999999976544433


Q ss_pred             CcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          967 NWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ......++..|+|||++.     +..++.++|||||||++|||++|+.||......        +..........+.. .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~-~  229 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPPTL-A  229 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH--------HHHHHHhhcCCCCC-C
Confidence            334457899999999874     445778999999999999999999998633211        11111111111100 0


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ........+.+++.+||+.||++||+++++++.
T Consensus       230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111223468899999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.3e-34  Score=325.05  Aligned_cols=194  Identities=25%  Similarity=0.339  Sum_probs=169.0

Q ss_pred             CCCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-C-----CceeeEEEEEeeCCe
Q 001440          807 DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-H-----RNIVKFYGFCSHARH  879 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~  879 (1077)
                      +|.+.+.||+|+||.|.+|. .++++.||||+++...    ....+-..|+.++..++ |     -|+|++++||...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            78999999999999999995 4579999999997642    23456677899999886 3     389999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC--CceEEecccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE--YEAHVSDFGI  957 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~kl~Dfgl  957 (1077)
                      .|||+|.+.. +|+++++.+...+ ++...++.|+.||+.||.+||+.   +|||+||||+|||+...  ..+||+|||.
T Consensus       263 lciVfELL~~-NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccc
Confidence            9999999854 9999998877544 89999999999999999999998   99999999999999754  4799999999


Q ss_pred             cccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      |....+..  + ..+.+..|.|||++.+.+|+.+.||||||||++||++|.+-|.
T Consensus       338 Sc~~~q~v--y-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  338 SCFESQRV--Y-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             ccccCCcc--e-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            98754332  2 5678899999999999999999999999999999999976654

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.6e-34  Score=309.94  Aligned_cols=247  Identities=28%  Similarity=0.407  Sum_probs=197.8

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEe-eCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCS-HARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... |..||+|.+....     ..+.+.+|+.++++++|++++++++++. .....++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence            47888999999999999999775 7889999886432     2457889999999999999999999764 456789999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++..... ..+++..++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++.....
T Consensus        80 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999876442 3478899999999999999999998   9999999999999999999999999998765432


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .   ....++..|+|||++.+..++.++||||||+++|||++ |+.||.....        .+....+.....+.   ..
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~--------~~~~~~~~~~~~~~---~~  221 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRVEKGYKMD---AP  221 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHhcCCCCC---CC
Confidence            2   22344678999999998889999999999999999998 9998753211        11111111111110   11


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ......+.+++.+||+.+|++|||++++++.|+
T Consensus       222 ~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  254 (256)
T cd05082         222 DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE  254 (256)
T ss_pred             CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence            122346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7.7e-34  Score=311.94  Aligned_cols=255  Identities=27%  Similarity=0.430  Sum_probs=205.6

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||.|+||+||+|... ++..||+|++.......  ..+.+.+|+..++.++|+|++++++.+..+...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            46889999999999999999754 67899999987543332  4678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++........+++..+..++.|++.|++|||+.   +++|+||+|+||++++++.++++|||++..+...
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            9999999999997654334588999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCCc----ccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC
Q 001440          965 SSNW----TELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       965 ~~~~----~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      ....    ....|+..|+|||++... .++.++||||||+++|||++|+.||......        +..........+..
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  227 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQNDPPSL  227 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCCCCCc
Confidence            3321    334688999999998776 7899999999999999999999998633221        11111111111110


Q ss_pred             CC--CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1040 SC--NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ..  ........+.+++.+||++||++||+++|+++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00  01233456889999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.9e-34  Score=316.23  Aligned_cols=251  Identities=24%  Similarity=0.376  Sum_probs=200.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|++.+.||+|+||.||+|+.. +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            56888999999999999999775 5889999998653   2333667888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++++++..++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++......
T Consensus        89 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  163 (292)
T cd06644          89 EFCPGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT  163 (292)
T ss_pred             ecCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence            9999999998875433  3478899999999999999999998   9999999999999999999999999998765444


Q ss_pred             CCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      ........++..|+|||++.     ...++.++|||||||++|||++|+.||.....        ............+..
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~  235 (292)
T cd06644         164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEPPTL  235 (292)
T ss_pred             ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCCCccC
Confidence            33344566889999999884     34568899999999999999999999863221        111111111111110


Q ss_pred             CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       .........+.+++.+||+.||++||+++|+++
T Consensus       236 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 -SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence             011223346889999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.8e-34  Score=326.79  Aligned_cols=254  Identities=23%  Similarity=0.274  Sum_probs=199.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||+||+|+.. +++.||+|.+.............+.+|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999999765 67889999986533233333556888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....  ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.....
T Consensus        81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            9999999999997532  3478889999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCC-cccccccccccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCC--CC
Q 001440          965 SSN-WTELAGTIGYVAPELAYT-----MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP--RL 1036 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 1036 (1077)
                      ... .....|++.|+|||++.+     ..++.++|||||||++|||++|+.||.....        .+....+...  +.
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEERF  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCcc
Confidence            322 223568999999999875     4678899999999999999999999863221        1122222221  12


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHh
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDS--RPTMQKVSQ 1073 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~ 1073 (1077)
                      +.+. ...+....+.+++.+|+..++++  |++++++++
T Consensus       228 ~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 QFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             cCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            2111 11223446788899999876544  467888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.4e-34  Score=326.03  Aligned_cols=255  Identities=21%  Similarity=0.269  Sum_probs=198.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.++||+|+||+||+++.+ +++.||+|.+.+...........+.+|+.++..++|++|+++++++.+++..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999999775 57889999986533333333456888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.+..  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            9999999999997532  3478889999999999999999998   9999999999999999999999999999765433


Q ss_pred             CCC-cccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC--C
Q 001440          965 SSN-WTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR--L 1036 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~ 1036 (1077)
                      ... .....||+.|+|||++.     ...++.++|||||||++|||++|+.||.....        .+....+....  .
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~~  227 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKERF  227 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH--------HHHHHHHhCCCccc
Confidence            322 23357899999999986     34578899999999999999999999863321        12222222211  1


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCC--CCCHHHHHhh
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDS--RPTMQKVSQL 1074 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1074 (1077)
                      +.+. ........+.+++.+|+..+|++  |++++|+++.
T Consensus       228 ~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         228 QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            1111 11223346778888988655444  7899988753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=8.4e-34  Score=313.43  Aligned_cols=249  Identities=25%  Similarity=0.397  Sum_probs=203.3

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ..|+..+.||.|+||.||+|.+. +++.||+|.+.....  ......+.+|+.++++++||||+++++++.+....++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            35777788999999999999765 688999998865422  233567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++...    .+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          82 EYLGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999998643    378889999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........++..|+|||++.+..++.++|||||||++|||++|+.||......        ...... ....+  .....
T Consensus       155 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~-~~~~~--~~~~~  223 (277)
T cd06640         155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFLI-PKNNP--PTLTG  223 (277)
T ss_pred             ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhhh-hcCCC--CCCch
Confidence            43334456788999999999888999999999999999999999998633211        111111 11111  11223


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++||+++|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         224 EFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            445678899999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.4e-34  Score=315.16  Aligned_cols=249  Identities=26%  Similarity=0.380  Sum_probs=188.3

Q ss_pred             eecccCCceEEEEEecC---CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          813 CIGTGGQGSVYRAELSS---GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      .||+|+||+||+|...+   ...+|+|.+....  .......+.+|+..++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            58999999999996543   3568888876432  233356788999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC-
Q 001440          890 GSLAMILSNATS--AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-  966 (1077)
Q Consensus       890 g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-  966 (1077)
                      |+|.+++.....  ....++.....++.||+.|++|||+.   +|+||||||+||+++.++.+|++|||+++....... 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            999999976542  12345778889999999999999999   999999999999999999999999999876433321 


Q ss_pred             -CcccccccccccCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhc---CC
Q 001440          967 -NWTELAGTIGYVAPELAYT-------MKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL---DP 1034 (1077)
Q Consensus       967 -~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 1034 (1077)
                       ......++..|+|||+...       ..++.++|||||||++|||++ |..||......        +......   ..
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~~  228 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--------QVLKQVVREQDI  228 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccCc
Confidence             1123345778999998643       356789999999999999999 77887533211        1111111   11


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+.+. ........+.+++..|| .||++|||++||++.|.
T Consensus       229 ~~~~~~-~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         229 KLPKPQ-LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             cCCCCc-ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111111 11123345677888999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-34  Score=333.37  Aligned_cols=255  Identities=20%  Similarity=0.241  Sum_probs=193.8

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ...|.+.+.||+|+||.||+|.+. .++.||||...         ...+.+|+.++++++|+|||++++++..++..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            346899999999999999999775 57889999642         22356799999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||++. ++|.+++....  ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++....
T Consensus       239 ~e~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        239 LPKYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            99995 68888886432  3589999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccc---cchhhh-------
Q 001440          964 DSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD---RTLDEI------- 1031 (1077)
Q Consensus       964 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~---~~~~~~------- 1031 (1077)
                      ....  .....||..|+|||++.+..++.++|||||||++|||++|..|+..............   +.+...       
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            3221  2245699999999999999999999999999999999998876432111000000000   000000       


Q ss_pred             -------------------cCCCCCCC-CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1032 -------------------LDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1032 -------------------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                                         ..+....+ ..........+.+++.+||+.||++|||++|+++.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                               00000000 00000122367889999999999999999999874

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.8e-34  Score=312.79  Aligned_cols=252  Identities=29%  Similarity=0.516  Sum_probs=200.8

Q ss_pred             cCCCccceecccCCceEEEEEec-CC---CEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SG---EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      .+|++.+.||+|+||.||+|... ++   ..||+|.+....  ......++..|+..++.++||||+++++++.++...+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            35788899999999999999765 33   369999987542  2334678999999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          82 IITEFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EEEecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccc
Confidence            9999999999999986543  3578999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCC--ccc-cc--ccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC-C
Q 001440          962 KPDSSN--WTE-LA--GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-P 1034 (1077)
Q Consensus       962 ~~~~~~--~~~-~~--g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~ 1034 (1077)
                      ......  ... ..  .+..|+|||++.+..++.++||||+||++||+++ |..||.....        .+....+.. .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~--------~~~~~~i~~~~  228 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN--------QDVINAIEQDY  228 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH--------HHHHHHHHcCC
Confidence            433221  111 11  2457999999999999999999999999999987 9999863221        111111111 1


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+.+.    +.+..+.+++.+||+.+|++||+++++++.|+
T Consensus       229 ~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  266 (269)
T cd05065         229 RLPPPM----DCPTALHQLMLDCWQKDRNARPKFGQIVSTLD  266 (269)
T ss_pred             cCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            122221    22346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.6e-34  Score=327.20  Aligned_cols=256  Identities=23%  Similarity=0.402  Sum_probs=198.7

Q ss_pred             hcCCCccceecccCCceEEEEEe------cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHA  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~  877 (1077)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++.....  ......+.+|+.++.++ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            35789999999999999999963      3567899999875432  22356788999999999 689999999988654


Q ss_pred             -CeeEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 001440          878 -RHSFIVYEYLEMGSLAMILSNATS-------------------------------------------------------  901 (1077)
Q Consensus       878 -~~~~lV~E~~~~g~L~~~l~~~~~-------------------------------------------------------  901 (1077)
                       ...++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence             467899999999999999864321                                                       


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC--ccc
Q 001440          902 ---------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTE  970 (1077)
Q Consensus       902 ---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--~~~  970 (1077)
                               ...+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+|++|||++.........  ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                     12367888999999999999999998   9999999999999999999999999999865433221  122


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCCcHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLI 1048 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 1048 (1077)
                      ..++..|+|||++.+..++.++||||||+++||+++ |..||......       .......... ..+.+..    ...
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~  309 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-------EEFCRRLKEGTRMRAPDY----TTP  309 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc-------HHHHHHHhccCCCCCCCC----CCH
Confidence            345678999999988899999999999999999997 88887632211       0111111111 1111111    123


Q ss_pred             HHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1049 SIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1049 ~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+++.+||+.||++||++.|+++.|+
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~  337 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLG  337 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            5789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6.8e-34  Score=311.07  Aligned_cols=252  Identities=21%  Similarity=0.405  Sum_probs=202.2

Q ss_pred             hcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.+.||+|+||.||+|...++..||+|.+....    ...+.+.+|+.+++.++|+||+++++++.+ ...++||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            46789999999999999999988778889999886532    225678899999999999999999999887 7789999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.... ...+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||.+......
T Consensus        80 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          80 EFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EeCCCCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            9999999999997643 34578899999999999999999998   9999999999999999999999999999765432


Q ss_pred             CCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          965 SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      ... .....++..|+|||++....++.++|||||||++||+++ |+.||.....        ......+. .....+.  
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~-~~~~~~~--  224 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--------PEVIRALE-RGYRMPR--  224 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHh-CCCCCCC--
Confidence            211 122345678999999998889999999999999999999 8988863211        11111111 1111110  


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .......+.+++.+||+++|++||++.++.++|+
T Consensus       225 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~  258 (260)
T cd05073         225 PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD  258 (260)
T ss_pred             cccCCHHHHHHHHHHcccCcccCcCHHHHHHHHh
Confidence            1122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-34  Score=310.60  Aligned_cols=252  Identities=29%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||.|+||.||+|... +++.+|+|.+......   ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            57889999999999999999764 6788999998754222   3678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++....  ..++..++..++.|++.|++|||+.   +|+|+||+|+||+++.++.+|++|||.+......
T Consensus        80 e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  154 (262)
T cd06613          80 EYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT  154 (262)
T ss_pred             eCCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence            9999999999986542  3478899999999999999999998   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCC-C
Q 001440          965 SSNWTELAGTIGYVAPELAYTM---KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP-S 1040 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1040 (1077)
                      ........++..|+|||.+...   .++.++||||||+++|||++|+.||.......        .........+..+ .
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--------~~~~~~~~~~~~~~~  226 (262)
T cd06613         155 IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--------ALFLISKSNFPPPKL  226 (262)
T ss_pred             hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhccCCCccc
Confidence            3333455788899999998776   78999999999999999999999986432211        1111111101110 1


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .........+.+++.+||+.+|++|||++|++.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            112234567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-34  Score=317.48  Aligned_cols=254  Identities=25%  Similarity=0.373  Sum_probs=201.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... +++.||+|.+....  .......+.+|+.++++++||||+++++++...+..++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            36788899999999999999776 78999999886532  2223567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++........+++..+..++.|++.|+.|||+.+  +|+|+||||+||+++.++.+|++|||++......
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999999876533345889999999999999999999742  8999999999999999999999999999765332


Q ss_pred             CCCcccccccccccCccccccCC------CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAYTMK------VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                        ......++..|+|||++.+..      ++.++||||+||++|||++|+.||.....     .........+.....+.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~  229 (286)
T cd06622         157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIVDGDPPT  229 (286)
T ss_pred             --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHhhcCCCC
Confidence              223346788999999885543      47899999999999999999999863211     01111122222222111


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ........+.+++.+||+.+|++||+++|+++
T Consensus       230 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         230 ---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ---CCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence               11224456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9e-34  Score=314.43  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=200.6

Q ss_pred             CCCccceecccCCceEEEEEe-----cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--Ce
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RH  879 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~  879 (1077)
                      -|++.+.||+|+||.||+|++     .+++.||+|.+....  .....+.+.+|+.+++.++|||++++++++...  ..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   82 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence            467889999999999999964     357889999986542  233356789999999999999999999998765  56


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .++||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++
T Consensus        83 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          83 IKLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             eEEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            899999999999999986543  3478999999999999999999999   99999999999999999999999999998


Q ss_pred             cCCCCCCC---cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccc-c------cCcccccchh
Q 001440          960 SLKPDSSN---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC-S------TSSNLDRTLD 1029 (1077)
Q Consensus       960 ~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~-~------~~~~~~~~~~ 1029 (1077)
                      ........   .....++..|+|||++.+..++.++||||||+++||+++++.|+....... .      ..........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76543221   123456778999999988889999999999999999999877643211100 0      0000111111


Q ss_pred             hhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1030 EILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1030 ~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...... .+.+    ......+.+++.+||+.||++||+++|+++.|+
T Consensus       238 ~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  281 (284)
T cd05079         238 VLEEGKRLPRP----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFE  281 (284)
T ss_pred             HHHcCccCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHH
Confidence            111111 1111    123457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.7e-34  Score=318.00  Aligned_cols=264  Identities=23%  Similarity=0.345  Sum_probs=203.2

Q ss_pred             CCHHHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEE
Q 001440          796 IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGF  873 (1077)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~  873 (1077)
                      +.++.+..+.++|++.+.||+|+||.||+|... +++.||+|++.....    ...++.+|+.+++.+ +||||++++++
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~   83 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD----IDEEIEAEYNILKALSDHPNVVKFYGM   83 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc----hHHHHHHHHHHHHHHhcCCCeeeeeee
Confidence            334555667789999999999999999999664 678999998754211    135677899999999 79999999998


Q ss_pred             Ee-----eCCeeEEEEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC
Q 001440          874 CS-----HARHSFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE  947 (1077)
Q Consensus       874 ~~-----~~~~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  947 (1077)
                      +.     .+...++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.   +|+||||||+||+++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~  160 (286)
T cd06638          84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCC
Confidence            74     3457899999999999999875422 234578889999999999999999998   99999999999999999


Q ss_pred             CceEEecccccccCCCCCCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc
Q 001440          948 YEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS 1022 (1077)
Q Consensus       948 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~ 1022 (1077)
                      +.+|++|||+++.............|+..|+|||++.     ...++.++||||+||++|||++|+.||.......... 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-  239 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-  239 (286)
T ss_pred             CCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-
Confidence            9999999999987654433334457899999999875     3457889999999999999999999986432211000 


Q ss_pred             ccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1023 NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                          .......+....+.    .....+.+++.+||+.||++|||+.|+++..
T Consensus       240 ----~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 ----KIPRNPPPTLHQPE----LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             ----hccccCCCcccCCC----CcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                00000011111111    1223588999999999999999999998753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-33  Score=317.20  Aligned_cols=258  Identities=25%  Similarity=0.341  Sum_probs=200.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... ++..||+|.+....  ......++.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            36889999999999999999765 67889999886532  2223567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++...   ..+++..+..++.|++.|++|||+.+  +++|+||||+||+++.++.+|++|||++......
T Consensus        79 ey~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          79 EHMDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             eccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            999999999999654   34788899999999999999999742  8999999999999999999999999998765332


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-----Ccc-c--------------
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-----SSN-L-------------- 1024 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-----~~~-~-------------- 1024 (1077)
                      .  .....++..|+|||+..+..++.++||||||+++|||++|+.||.........     ... .              
T Consensus       154 ~--~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         154 M--ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             c--cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence            1  23457889999999998888999999999999999999999998532210000     000 0              


Q ss_pred             --------ccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1025 --------DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1025 --------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                              .+..+.......+  ..........+.+++.+||+.||++||+++|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPP--KLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCc--cCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0000001100000  00011133468899999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-34  Score=319.95  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=206.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||+|++|+||+|... +++.||+|.+...........+.+..|+..++.++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888899999999999999765 58999999998765444345677899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+.+++|.+++.... ...+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||++......
T Consensus        81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            9999999999987543 34588899999999999999999998   9999999999999999999999999998765322


Q ss_pred             CC-----------------------------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccc
Q 001440          965 SS-----------------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFIS 1015 (1077)
Q Consensus       965 ~~-----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~ 1015 (1077)
                      ..                             ......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            11                             1113467889999999999889999999999999999999999986322


Q ss_pred             cccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC----HHHHHh
Q 001440         1016 SICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT----MQKVSQ 1073 (1077)
Q Consensus      1016 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~ 1073 (1077)
                      .        ...+..+.......+..  ......+.+++.+||+.||++||+    ++|+++
T Consensus       237 ~--------~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 R--------DETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             h--------HHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            1        12222223222222211  113457899999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=9.2e-34  Score=311.03  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=200.4

Q ss_pred             CCCccceecccCCceEEEEEecCCCEEEEEEccCCccc---hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS---EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      +|++.+.||+|+||+||+|...+++.||+|.+......   .....+.+.+|++.+++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            47888999999999999998888999999988643221   222345688999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +||+++++|.+++.+..   .+++.++..++.|++.|++|||+.   +|+|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999996543   367889999999999999999998   999999999999999999999999999876432


Q ss_pred             CC------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCC--C
Q 001440          964 DS------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP--R 1035 (1077)
Q Consensus       964 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~ 1035 (1077)
                      ..      .......++..|+|||++.+..++.++||||+|+++||+++|+.||.......        ........  .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~  226 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--------AMFYIGAHRGL  226 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--------HHHHhhhccCC
Confidence            11      11223468899999999999889999999999999999999999986322110        00011110  1


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+..   .......+.+++++||+.+|++||+++|+++
T Consensus       227 ~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            1111   1123346789999999999999999999975

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=6.7e-34  Score=318.81  Aligned_cols=255  Identities=24%  Similarity=0.268  Sum_probs=200.3

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.............+.+|+.+++.++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999765 67899999987654333344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++....   .+++..+..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++.....
T Consensus        81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            9999999999996543   478899999999999999999998   9999999999999999999999999998642110


Q ss_pred             C---------------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh
Q 001440          965 S---------------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       965 ~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      .               .......++..|+|||++....++.++||||||+++||+++|..||....        ..+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--------~~~~~~  226 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--------PEELFG  226 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHH
Confidence            0               00112357889999999988889999999999999999999999985221        122222


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      .........+... ......+.+++.+||+.||++||+++++.+.+
T Consensus       227 ~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll  271 (305)
T cd05609         227 QVISDDIEWPEGD-EALPADAQDLISRLLRQNPLERLGTGGAFEVK  271 (305)
T ss_pred             HHHhcccCCCCcc-ccCCHHHHHHHHHHhccChhhccCccCHHHHH
Confidence            2222222111111 12234688999999999999999965555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=5.3e-34  Score=317.09  Aligned_cols=260  Identities=23%  Similarity=0.319  Sum_probs=191.0

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC---CCCceeeEEEEEee-----C
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---RHRNIVKFYGFCSH-----A  877 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~  877 (1077)
                      +|++.+.||+|+||+||+|+.+ +++.||+|.+......+. ....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            4788899999999999999765 688999998865422211 123345566666555   79999999998854     3


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      ...++||||+++ ++.+++..... ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          80 TKVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             ceEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            457999999984 88888865432 3488999999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccchhh
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRTLDE 1030 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~~~ 1030 (1077)
                      ++...... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...........       .....+..
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         155 ARIYSCQM-ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccccCcc-cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            98664332 22345688999999999998999999999999999999999999853221100000       00000000


Q ss_pred             -------hcCCCCCCC-CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1031 -------ILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1031 -------~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                             ...+..+.+ ..........+.+++.+|+++||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   000000000 0000122345789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.2e-33  Score=309.54  Aligned_cols=247  Identities=26%  Similarity=0.400  Sum_probs=190.2

Q ss_pred             ceecccCCceEEEEEec----CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEe-eCCeeEEEEee
Q 001440          812 HCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCS-HARHSFIVYEY  886 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~  886 (1077)
                      +.||+|+||.||+|.+.    ++..||+|++...  ......+.+.+|+.+++.++||||+++++++. .++..++|+||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            35899999999999753    2357999987542  22333567889999999999999999999875 45568999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +.+|+|.+++....  ...++..++.++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++.+.....
T Consensus        79 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          79 MKHGDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999996543  2357788899999999999999998   999999999999999999999999999986543211


Q ss_pred             ----CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCC-CCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          967 ----NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK-HPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       967 ----~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                          ......++..|+|||+.....++.++||||||+++|||++|+ .||.....        ............+....
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~  225 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--------FDITVYLLQGRRLLQPE  225 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHhcCCCCCCCC
Confidence                112334577899999998888999999999999999999964 55542211        11122222221111111


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                         ..+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       226 ---~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~  257 (262)
T cd05058         226 ---YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE  257 (262)
T ss_pred             ---cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence               12346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-33  Score=308.80  Aligned_cols=240  Identities=22%  Similarity=0.392  Sum_probs=187.5

Q ss_pred             ceecccCCceEEEEEecC-------------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          812 HCIGTGGQGSVYRAELSS-------------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      +.||+|+||.||+|.+..             ...||+|.+....   ......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            358999999999997532             2358888876532   233557888999999999999999999999988


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCc-------eE
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE-------AH  951 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~k  951 (1077)
                      ..++||||+++|+|..++....  ..+++.++.+++.||+.|++|||+.   +|+||||||+||+++.++.       +|
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeE
Confidence            9999999999999999886433  3478899999999999999999998   9999999999999987664       89


Q ss_pred             EecccccccCCCCCCCcccccccccccCccccc-cCCCCCcchHHHHHHHHHHHH-hCCCCCCccccccccCcccccchh
Q 001440          952 VSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       952 l~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      ++|||++......    ....++..|+|||++. +..++.++|||||||++|||+ +|+.||......         ...
T Consensus       153 l~d~g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---------~~~  219 (262)
T cd05077         153 LSDPGIPITVLSR----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA---------EKE  219 (262)
T ss_pred             eCCCCCCccccCc----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh---------HHH
Confidence            9999998755332    2345788999999886 566899999999999999998 588886532110         011


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...........    .....+.+++.+||+.||++||++.|+++.+.
T Consensus       220 ~~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         220 RFYEGQCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HHHhcCccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11111111111    11246789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-33  Score=310.57  Aligned_cols=246  Identities=26%  Similarity=0.420  Sum_probs=191.7

Q ss_pred             eecccCCceEEEEEec-CCC--EEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecC
Q 001440          813 CIGTGGQGSVYRAELS-SGE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~  888 (1077)
                      .||+|+||.||+|..+ ++.  .+|+|.+....  .....+.+.+|+.+++++ +||||+++++++...+..++||||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            5899999999999775 343  46888876432  223356788999999999 89999999999999999999999999


Q ss_pred             CCCHHHHHhcCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          889 MGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       889 ~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                      +|+|.+++.....             ...+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCC
Confidence            9999999975431             12478899999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP 1034 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1077)
                      |++........ ......+..|+|||++....++.++||||||+++|||++ |..||.....        ......+...
T Consensus       157 gl~~~~~~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~~~  227 (270)
T cd05047         157 GLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLPQG  227 (270)
T ss_pred             CCccccchhhh-ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHhCC
Confidence            99863221111 111233567999999988889999999999999999997 9999853211        1111111111


Q ss_pred             -CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1035 -RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1035 -~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ....+.    .....+.+++.+||+.||.+|||++|+++.|+
T Consensus       228 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  266 (270)
T cd05047         228 YRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLN  266 (270)
T ss_pred             CCCCCCC----cCCHHHHHHHHHHcccChhhCCCHHHHHHHHH
Confidence             111111    12246789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=8.8e-34  Score=315.46  Aligned_cols=247  Identities=27%  Similarity=0.374  Sum_probs=204.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999999765 68999999987544333444667889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++...   ..++..++..++.|++.|++|||+.   +|+|+||+|+||+++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999998664   3478899999999999999999998   9999999999999999999999999999876543


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                         .....+++.|+|||.+.+..++.++||||||+++|||++|+.||.....        ............+.+..   
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~---  220 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKILEGKVRFPSF---  220 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCccCCcc---
Confidence               2344688999999999888889999999999999999999999863321        12222233333332222   


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1045 DKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                       ....+.+++.+||+.||++||     +++|+++
T Consensus       221 -~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         221 -FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -CCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence             134688999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-34  Score=315.39  Aligned_cols=248  Identities=27%  Similarity=0.439  Sum_probs=201.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|.+. +++.||+|.+...   .....+.+.+|+.++++++||||+++++++..+...++||
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI   81 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence            46888899999999999999765 6889999998643   2333567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++....  ..+++.++..++.|++.|+.|||+.   +|+|+||+|+||+++.++.++++|||++......
T Consensus        82 e~~~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          82 EFCDGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            9999999999986543  3488899999999999999999999   9999999999999999999999999998766544


Q ss_pred             CCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC---CCC
Q 001440          965 SSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRL 1036 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 1036 (1077)
                      ........++..|+|||++.     ...++.++||||||+++|||++|+.||......        +....+..   +..
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~  228 (280)
T cd06611         157 LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM--------RVLLKILKSEPPTL  228 (280)
T ss_pred             ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH--------HHHHHHhcCCCCCc
Confidence            44444567899999999874     345778999999999999999999998643211        11111111   111


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ..+    ......+.+++.+||+.+|++||+++++++
T Consensus       229 ~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         229 DQP----SKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCc----ccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            111    122346789999999999999999999976

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=8.7e-34  Score=322.05  Aligned_cols=255  Identities=24%  Similarity=0.389  Sum_probs=201.3

Q ss_pred             hcCCCccceecccCCceEEEEEec--------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEe
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS--------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCS  875 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  875 (1077)
                      ..+|++.+.||+|+||.||+|++.        .+..||+|.+....  .....+++.+|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGACT   88 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence            356889999999999999999642        12368999887532  223356889999999999 8999999999999


Q ss_pred             eCCeeEEEEeecCCCCHHHHHhcCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCe
Q 001440          876 HARHSFIVYEYLEMGSLAMILSNAT-------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV  942 (1077)
Q Consensus       876 ~~~~~~lV~E~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NI  942 (1077)
                      .++..++|+||+++|+|.+++....             ....+++.+++.++.|++.|++|||+.   +|+||||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  165 (334)
T cd05100          89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNV  165 (334)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceE
Confidence            9999999999999999999987532             123578899999999999999999998   999999999999


Q ss_pred             eeCCCCceEEecccccccCCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccc
Q 001440          943 LLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019 (1077)
Q Consensus       943 ll~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~ 1019 (1077)
                      +++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|||++ |..||....    
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----  241 (334)
T cd05100         166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----  241 (334)
T ss_pred             EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----
Confidence            9999999999999999866433221  112234567999999999999999999999999999998 888875321    


Q ss_pred             cCcccccchhhhcCCCC-CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1020 TSSNLDRTLDEILDPRL-PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1020 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                          .++....+..... +.+.    .....+.+++.+||+.+|++||++.|+++.|+
T Consensus       242 ----~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~  291 (334)
T cd05100         242 ----VEELFKLLKEGHRMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLD  291 (334)
T ss_pred             ----HHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence                1122222222111 1111    22346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.5e-34  Score=311.29  Aligned_cols=251  Identities=31%  Similarity=0.463  Sum_probs=200.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchh------hHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEM------TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      +|.+...||+|++|.||+|... +++.||+|.+........      ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            4677889999999999999664 678999998865433211      223568899999999999999999999999999


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .++||||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||.++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence            999999999999999996543   477889999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCC------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC
Q 001440          960 SLKPDSS------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033 (1077)
Q Consensus       960 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1077)
                      .......      ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||......        ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~  226 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--------QAIFKIGE  226 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--------HHHHHHhc
Confidence            7653211      112345788999999999888999999999999999999999998643211        11111111


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1034 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...+.   ........+.+++.+||+.||++||+++|+++.
T Consensus       227 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 NASPE---IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             cCCCc---CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            11111   111233468899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.8e-34  Score=328.98  Aligned_cols=260  Identities=21%  Similarity=0.289  Sum_probs=196.7

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  877 (1077)
                      ..++|++.+.||+|+||.||+|... .++.||||++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4578999999999999999999654 688999999876532 223356778899999999999999999988543     


Q ss_pred             -CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          878 -RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       878 -~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                       ...++||||+++ ++.+++..     .+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg  164 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence             357999999975 56666632     377889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC--------------c
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS--------------S 1022 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~--------------~ 1022 (1077)
                      +++..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..........              .
T Consensus       165 ~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         165 LARTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccccCCCc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            99865432 22234578999999999999999999999999999999999999986322110000              0


Q ss_pred             ccccchhhhcCC----------------CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1023 NLDRTLDEILDP----------------RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1023 ~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ............                ..+............+.+++.+||+.||++|||++|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            000000000000                0000000111123467899999999999999999999873

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=4.2e-34  Score=315.85  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=200.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.....  ....+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            4566778999999999999654 678899998864422  2235678999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++..    ..+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          83 YLGGGSALDLLKP----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             ccCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            9999999998854    3478899999999999999999998   99999999999999999999999999998765443


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......++..|+|||++.+..++.++||||||+++|||++|+.||......        .....+.....+.   ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~~---~~~~  224 (277)
T cd06642         156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM--------RVLFLIPKNSPPT---LEGQ  224 (277)
T ss_pred             hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh--------hHHhhhhcCCCCC---CCcc
Confidence            3333456788999999999989999999999999999999999997532211        0111111111111   1112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ....+.+++.+||+.+|++||++.|+++.
T Consensus       225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         225 YSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            34568899999999999999999999873

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.1e-34  Score=319.75  Aligned_cols=194  Identities=20%  Similarity=0.335  Sum_probs=159.5

Q ss_pred             cceecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CCeeEEEEe
Q 001440          811 EHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHSFIVYE  885 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E  885 (1077)
                      .++||+|+||+||+|+..   +++.||+|.+.....     ...+.+|+.++++++||||+++++++..  +...++|||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            457999999999999764   467899999865422     3456789999999999999999998854  457899999


Q ss_pred             ecCCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeee----CCCCceEEecc
Q 001440          886 YLEMGSLAMILSNAT------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL----DLEYEAHVSDF  955 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Df  955 (1077)
                      |++ +++.+++....      ....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            986 48888775322      122478889999999999999999999   99999999999999    45678999999


Q ss_pred             cccccCCCCCC---CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCc
Q 001440          956 GISKSLKPDSS---NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDF 1013 (1077)
Q Consensus       956 gla~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 1013 (1077)
                      |+++.......   ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            99987643322   2234578999999999876 4588999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=6.1e-34  Score=315.51  Aligned_cols=259  Identities=24%  Similarity=0.382  Sum_probs=202.5

Q ss_pred             CHHHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEE
Q 001440          797 AYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFC  874 (1077)
Q Consensus       797 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  874 (1077)
                      +..++....+.|++.+.||+|+||.||+|... +++.||+|.+....    ....++..|+.+++++ +|+||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            44555556678999999999999999999764 68899999875431    2245678899999888 799999999998


Q ss_pred             ee------CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          875 SH------ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       875 ~~------~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      ..      ....++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+.   +|+|+||+|+||+++.++
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~  158 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCC
Confidence            53      4578999999999999999865432 3477888899999999999999998   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcc
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 1023 (1077)
                      .++|+|||++..............|+..|+|||++.     ...++.++|||||||++|||++|+.||........    
T Consensus       159 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~----  234 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA----  234 (282)
T ss_pred             CEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh----
Confidence            999999999886544333344567899999999875     34678899999999999999999999863322110    


Q ss_pred             cccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                          ........  .+..........+.+++.+||+.||.+||++.|+++
T Consensus       235 ----~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         235 ----LFLIPRNP--PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ----hhhHhhCC--CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                00111111  111111223457889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-33  Score=305.25  Aligned_cols=247  Identities=29%  Similarity=0.457  Sum_probs=198.3

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCC
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS  891 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~  891 (1077)
                      ++||+|+||.||+|...+++.||+|++......  ....++.+|+.++++++|+||+++++++.+....++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            368999999999998777999999998765332  345688999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc--c
Q 001440          892 LAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--T  969 (1077)
Q Consensus       892 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--~  969 (1077)
                      |.+++....  ..+++..++.++.+++.|++|||+.   +++||||||+||+++.++.+|++|||.+..........  .
T Consensus        79 l~~~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          79 LLTFLRKKK--NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            999986543  2478899999999999999999999   99999999999999999999999999997654221111  1


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CCCCCCCCcHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKL 1047 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 1047 (1077)
                      ...++..|+|||++.+..++.++||||||+++|||+| |..||.....        ......+... ..+.+    ...+
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~~~~~~~~~~~----~~~~  221 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRERIESGYRMPAP----QLCP  221 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHHHhcCCCCCCC----ccCC
Confidence            1233567999999998899999999999999999999 7888753221        1111111111 11111    1234


Q ss_pred             HHHHHHHHhccCCCCCCCCCHHHHHhhhcC
Q 001440         1048 ISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077 (1077)
Q Consensus      1048 ~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1077 (1077)
                      ..+.+++.+||+.+|++||+++|+++.|+.
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            478899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=3.6e-37  Score=335.49  Aligned_cols=362  Identities=26%  Similarity=0.394  Sum_probs=206.9

Q ss_pred             ccccccCCCCcccccCCcccCCCCCCcEEEccCCcccccCCcccCCCCCCCEEeCCCCCCCCCCCCCCCCcCccceeccc
Q 001440           85 VNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS  164 (1077)
Q Consensus        85 v~~l~l~~~~l~~~l~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~  164 (1077)
                      |..++++++.+.|.--|.+...+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-+.++.|+.|+.+++.
T Consensus         9 VrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R   86 (1255)
T KOG0444|consen    9 VRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVR   86 (1255)
T ss_pred             eecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhh
Confidence            4455566666554333333555566666666555553 45666666666666666666655 344555566666666666


Q ss_pred             ccccCC-CCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCC-cccCccccceEEeecccccC
Q 001440          165 TNQFSG-RIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS-EIGNLKSLSGLELGYNKLSG  242 (1077)
Q Consensus       165 ~N~~~~-~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~  242 (1077)
                      .|++.. -+|+.+.+|..|..|||++|+++ ..|..+..-+++-.|+||+|++. .||. -|.+|+.|-.||||+|++. 
T Consensus        87 ~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-  163 (1255)
T KOG0444|consen   87 DNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-  163 (1255)
T ss_pred             ccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-
Confidence            665532 35555566666666666666665 45555555566666666666665 3333 3556666666666666665 


Q ss_pred             CCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCC-CCCccccCCCCCcceEEcCCCCCCCCcCCCcC
Q 001440          243 SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS-GSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG  321 (1077)
Q Consensus       243 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  321 (1077)
                      .+|..+..|..|++|+|++|.+.-.--..+-.+++|++|.+++.+=+ .-+|.++..+.+|..+|+|.|.+. .+|+.+.
T Consensus       164 ~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly  242 (1255)
T KOG0444|consen  164 MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLY  242 (1255)
T ss_pred             hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHh
Confidence            45555555666666666666544211122334455555555554422 235556666666666666666665 5566666


Q ss_pred             CCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCC-CCcccccCCCCCCe
Q 001440          322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG-SIPSEIGNLNSLSD  400 (1077)
Q Consensus       322 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~  400 (1077)
                      ++.+|+.|+||+|+|+ .+....+...+|+.|+||.|+++ .+|.+++.++.|+.|++.+|+++- -+|+.+++|.+|+.
T Consensus       243 ~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Lev  320 (1255)
T KOG0444|consen  243 KLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEV  320 (1255)
T ss_pred             hhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHH
Confidence            6666666666666665 33344455555666666666665 556666666666666666666542 35566666666666


Q ss_pred             eecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcC
Q 001440          401 LGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL  456 (1077)
Q Consensus       401 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  456 (1077)
                      +..++|.+. ..|+.++.+..|+.|.|+.|++. .+|+++.-++.|..|||..|.-
T Consensus       321 f~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpn  374 (1255)
T KOG0444|consen  321 FHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPN  374 (1255)
T ss_pred             HHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcC
Confidence            666666664 55666666666666666666664 4566666666666666665543

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=320.94  Aligned_cols=249  Identities=25%  Similarity=0.370  Sum_probs=203.2

Q ss_pred             CCccceecccCCceEEEEEecC-CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |.++..||.|+||.||+|..++ +-..|.|.+..   ......++|.-|+++++..+||+||++++.|..++..||..||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            4556679999999999996654 44456676654   3334578899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      |+||-.+..+-+..  ..++..++..+++|++.||.|||+.   .|||||+|+.|||++.+|.++++|||.+........
T Consensus       111 C~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q  185 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ  185 (1187)
T ss_pred             cCCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh
Confidence            99999998876543  4588999999999999999999999   999999999999999999999999999887666656


Q ss_pred             CcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          967 NWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ....++||+.|||||+..     ..+|+.++||||||+++.||..+.+|.....+.        +.+-.+.....| .-.
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM--------RVllKiaKSePP-TLl  256 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSEPP-TLL  256 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH--------HHHHHHhhcCCC-ccc
Confidence            667899999999999864     568999999999999999999999995433221        222222222211 112


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+......+.+++.+||.+||..||+++++++
T Consensus       257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            23344567999999999999999999999986

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-33  Score=310.71  Aligned_cols=239  Identities=22%  Similarity=0.360  Sum_probs=185.9

Q ss_pred             eecccCCceEEEEEecC-------------------------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCce
Q 001440          813 CIGTGGQGSVYRAELSS-------------------------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI  867 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  867 (1077)
                      .||+|+||.||+|....                         ...||+|.+...   ......++.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            58999999999996421                         135888887643   22234678889999999999999


Q ss_pred             eeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC
Q 001440          868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE  947 (1077)
Q Consensus       868 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~  947 (1077)
                      +++++++.+....++||||+++|+|.+++....  ..+++..++.++.||+.||+|||++   +|+||||||+||+++..
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999999999999999999999999999986533  3578899999999999999999998   99999999999999764


Q ss_pred             C-------ceEEecccccccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHH-hCCCCCCcccccc
Q 001440          948 Y-------EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAI-KGKHPRDFISSIC 1018 (1077)
Q Consensus       948 ~-------~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~ell-tg~~p~~~~~~~~ 1018 (1077)
                      +       .+|++|||.+......    ....++..|+|||++.+ ..++.++||||||+++||++ +|+.||...... 
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-  228 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS-  228 (274)
T ss_pred             CcccCccceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH-
Confidence            3       4899999988654322    22357788999998865 56899999999999999995 688887632211 


Q ss_pred             ccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1019 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                              ............+...    ...+.+++.+||+.+|++||+++|+++.|.
T Consensus       229 --------~~~~~~~~~~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         229 --------EKERFYEKKHRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --------HHHHHHHhccCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                    0011111111111111    235789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-34  Score=316.39  Aligned_cols=258  Identities=27%  Similarity=0.393  Sum_probs=203.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....  .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            56788899999999999999765 68889999876532  2223567899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++...   ..+++..+..++.+++.|+.|||+..  +++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          83 EFMDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             ecCCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999999998653   34788999999999999999999742  8999999999999999999999999998754322


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc---ccccchhhhcCCCCCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS---NLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      .  .....|+..|+|||++.+..++.++|||||||++||+++|+.||+..........   ..............+..  
T Consensus       158 ~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  233 (284)
T cd06620         158 I--ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--  233 (284)
T ss_pred             c--cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--
Confidence            1  1235689999999999888899999999999999999999999874332110000   01112222222111111  


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ........+.+++.+||++||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111234568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.6e-34  Score=317.36  Aligned_cols=261  Identities=17%  Similarity=0.260  Sum_probs=198.2

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|.+.+.||+|+||.||+|+.+ +++.||+|.+......  .....+.+|+..++.++||||+++++++..++..++|
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv   82 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   82 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence            357899999999999999999765 6889999998644222  2234577899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||++ ++|.+++....  ..+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||++.....
T Consensus        83 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  156 (301)
T cd07873          83 FEYLD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSI  156 (301)
T ss_pred             Eeccc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence            99997 58988886543  3478889999999999999999998   999999999999999999999999999976544


Q ss_pred             CCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCcccccchhhhc---
Q 001440          964 DSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDRTLDEIL--- 1032 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~--- 1032 (1077)
                      .........+++.|+|||++.+. .++.++||||+||++|||++|+.||........       ........+..+.   
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         157 PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence            33333445678999999987654 578899999999999999999999864321000       0000000000000   


Q ss_pred             ---CCCCCCCCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 ---DPRLPAPSC-----NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 ---~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ....+....     ........+.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence               000110000     00112335788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.3e-33  Score=310.44  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=202.4

Q ss_pred             CCCccceecccCCceEEEEEecC--CCEEEEEEccCCcc-------chhhHHHHHHHHHHHhcC-CCCCceeeEEEEEee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELSS--GEIVAVKKFHSPLL-------SEMTCQQEFLNEVKSLTE-IRHRNIVKFYGFCSH  876 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~  876 (1077)
                      .|++.+.||+|+||.||+|....  ++.+|+|.+.....       .......++.+|+.++.+ ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999997764  68899998754221       122234567788887765 799999999999999


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNA-TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                      .+..++||||+++++|.+++... .....+++.+++.++.|++.|+.|||+..  +++|+||+|+||+++.++.+|++||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999987542 22345888999999999999999999632  8999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCC
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1077)
                      |.+....... ......|+..|+|||+..+..++.++||||||+++||+++|+.||.....        ...........
T Consensus       159 g~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~~~~  229 (269)
T cd08528         159 GLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKIVEAV  229 (269)
T ss_pred             cceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHHhhcc
Confidence            9998755443 33455688999999999988899999999999999999999999863221        11122222222


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .....  .......+.+++.+||+.||++||++.|+.++++
T Consensus       230 ~~~~~--~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YEPLP--EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CCcCC--cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            21111  1122346889999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-33  Score=309.96  Aligned_cols=251  Identities=26%  Similarity=0.453  Sum_probs=200.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .+|++.+.||+|+||.||+|.++ +|+    .||+|.......  .....++.+|+..+++++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            56888899999999999999764 333    589998765532  3345678899999999999999999999987 788


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++|+|.+++....  ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||.++.
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999999997643  2478999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCCcc--cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCC-CC
Q 001440          961 LKPDSSNWT--ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RL 1036 (1077)
Q Consensus       961 ~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1036 (1077)
                      .........  ...++..|+|||.+....++.++||||||+++||+++ |+.||.....        .+....+... ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~  230 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLEKGERL  230 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHhCCCCC
Confidence            654332221  1223568999999988889999999999999999999 9999863221        1112222221 12


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      +.+..    ....+.+++.+||..||++||++.++++.|+
T Consensus       231 ~~~~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~  266 (279)
T cd05057         231 PQPPI----CTIDVYMVLVKCWMIDAESRPTFKELINEFS  266 (279)
T ss_pred             CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence            22211    2235788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-33  Score=311.58  Aligned_cols=256  Identities=25%  Similarity=0.432  Sum_probs=202.7

Q ss_pred             cCCCccceecccCCceEEEEEec------CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  879 (1077)
                      ++|+..+.||+|+||.||+|+.+      +.+.||+|.+....  .....+++.+|+.++++++|+||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            56888899999999999999764      24679999876532  22235678999999999999999999999999899


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEe
Q 001440          880 SFIVYEYLEMGSLAMILSNATSA------EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS  953 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  953 (1077)
                      .++||||+++|+|.+++......      ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEc
Confidence            99999999999999999765422      1588999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCC-CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhh
Q 001440          954 DFGISKSLKPD-SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031 (1077)
Q Consensus       954 Dfgla~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1031 (1077)
                      |||++...... ........++..|+|||.+.+..++.++||||||+++||+++ |..||.....        .......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~~  231 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNRL  231 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHHH
Confidence            99998754322 122334456788999999988889999999999999999999 7788753211        1111122


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .......+.  .......+.+++.+||+.+|++||++.|+++.|+
T Consensus       232 ~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         232 QAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            111111110  1122346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=7.1e-34  Score=326.70  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  877 (1077)
                      ..++|.+.+.||+|+||.||+|... .++.||||++..... .......+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3578999999999999999999664 688999999876432 223356778899999999999999999987543     


Q ss_pred             -CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          878 -RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       878 -~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                       ...++||||+++ ++.+++..     .+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG  171 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  171 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence             357999999975 67776632     367889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc--------------
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------------- 1022 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------------- 1022 (1077)
                      +++...... ......++..|+|||++.+..++.++|||||||++|||++|+.||...........              
T Consensus       172 ~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (364)
T cd07875         172 LARTAGTSF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  250 (364)
T ss_pred             CccccCCCC-cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            998654322 22345789999999999999999999999999999999999999864321110000              


Q ss_pred             ccccchhhhcC--CC--------------CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1023 NLDRTLDEILD--PR--------------LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1023 ~~~~~~~~~~~--~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...........  +.              .+............+.+++.+|++.||++|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         251 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00000000000  00              000000001122467899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.1e-33  Score=308.02  Aligned_cols=253  Identities=28%  Similarity=0.390  Sum_probs=204.0

Q ss_pred             CCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CCeeEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHSFIV  883 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV  883 (1077)
                      +|++.+.||.|+||.||+|.. .+++.||+|.+...... ....+++..|+.+++.++||||+++++++..  +...++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            478889999999999999965 46889999988654332 2335678899999999999999999998754  4568999


Q ss_pred             EeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          884 YEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLH-----NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      |||+++++|.+++.... ....+++.+++.++.|++.|++|||     +.   +++|+||+|+||+++.++.+|++|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEecccc
Confidence            99999999999986542 2346889999999999999999999     66   999999999999999999999999999


Q ss_pred             cccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      +..............++..|+|||++.+..++.++||||||+++|+|++|+.||....        .....+.+.....+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~  228 (265)
T cd08217         157 AKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASKIKEGKFR  228 (265)
T ss_pred             cccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHHHhcCCCC
Confidence            9877655443445678999999999999889999999999999999999999986332        11122222222222


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ..   .......+.+++.+||+.+|++||+++||++.
T Consensus       229 ~~---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         229 RI---PYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CC---ccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            11   12234568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.3e-34  Score=328.63  Aligned_cols=255  Identities=20%  Similarity=0.270  Sum_probs=195.9

Q ss_pred             hcCCCccceecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      ..+|.+.+.||+|+||.||+|...   .+++||+|.+...        ....+|+.+++.++||||+++++++......+
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            457999999999999999999653   4578999987643        23457999999999999999999999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +|||++. +++.+++...   ..+++.+++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++..
T Consensus       163 lv~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             EEehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            9999986 6888888432   4588999999999999999999999   9999999999999999999999999999866


Q ss_pred             CCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-----------------cCc
Q 001440          962 KPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-----------------TSS 1022 (1077)
Q Consensus       962 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-----------------~~~ 1022 (1077)
                      .....  ......||+.|+|||++.+..++.++||||+||++|||++|+.||........                 ...
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            54322  22346799999999999999999999999999999999999999853221100                 000


Q ss_pred             c----cccchhhhc---CCCCCCCCC-CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1023 N----LDRTLDEIL---DPRLPAPSC-NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1023 ~----~~~~~~~~~---~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .    ....+....   .+....+.. ........+.+++.+||..||++|||++|+++.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0    000000000   111111100 001123467789999999999999999999863

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.4e-33  Score=309.87  Aligned_cols=252  Identities=24%  Similarity=0.352  Sum_probs=185.9

Q ss_pred             eecccCCceEEEEEecCC---CEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          813 CIGTGGQGSVYRAELSSG---EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      .||+|+||.||+|+..++   ..+++|.+....  .....+.+.+|+..++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999999999965433   345667665432  123357899999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC--C
Q 001440          890 GSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--S  966 (1077)
Q Consensus       890 g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~--~  966 (1077)
                      |+|.+++.+... ....++..+..++.||+.|++|||+.   +++||||||+||+++.++.+|++|||++.......  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999976432 23456677889999999999999998   99999999999999999999999999986432211  1


Q ss_pred             CcccccccccccCcccccc-------CCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          967 NWTELAGTIGYVAPELAYT-------MKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      ......++..|+|||+...       ..++.++||||||+++|||++ |..||..............+......++..+.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            1234567889999998753       245789999999999999997 46676532211000000000001111122211


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                            .....+.+++..|| .+|++||+++||++.|.
T Consensus       237 ------~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         237 ------PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ------CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                  12346778899999 67999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.6e-33  Score=312.97  Aligned_cols=262  Identities=21%  Similarity=0.357  Sum_probs=200.8

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++...... ....+.+.+|+.++++++|||++++++++......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            46888899999999999999776 6899999988643221 122456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++++++..+....   ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          80 EYCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             eccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            999999888877543   2478999999999999999999998   9999999999999999999999999999877654


Q ss_pred             CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC------cccccchhhhcC----
Q 001440          965 SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS------SNLDRTLDEILD---- 1033 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~------~~~~~~~~~~~~---- 1033 (1077)
                      ........++..|+|||++.+ ..++.++||||||+++|||++|+.||..........      ...........+    
T Consensus       154 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         154 GDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             cccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            433445567889999999876 457889999999999999999999986332210000      000000000000    


Q ss_pred             ---CCCCCCCCC------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1034 ---PRLPAPSCN------IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1034 ---~~~~~~~~~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                         ...+.+...      .......+.+++.+||+.||++||++.|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence               000110000      01123568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.6e-33  Score=313.69  Aligned_cols=261  Identities=26%  Similarity=0.375  Sum_probs=202.6

Q ss_pred             CHHHHHHHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEE
Q 001440          797 AYEEIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFC  874 (1077)
Q Consensus       797 ~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  874 (1077)
                      ..+++..+.++|++.+.||+|+||.||+|.. .+++.||+|.+....    .....+.+|+.+++++ +|||++++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            3445556678999999999999999999976 468899999886432    1245677888899988 899999999998


Q ss_pred             eeC-----CeeEEEEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          875 SHA-----RHSFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       875 ~~~-----~~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      ...     +..++||||+++|+|.++++... ....+++..++.++.|++.|++|||+.   +++|+||||+||+++.++
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~  165 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCC
Confidence            653     36899999999999999886432 234578999999999999999999998   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCCcccccccccccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcc
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM-----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 1023 (1077)
                      .+||+|||.++.............|+..|+|||++...     .++.++|||||||++|||++|+.||......      
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------  239 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------  239 (291)
T ss_pred             CEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence            99999999998765443333445688999999987543     3688999999999999999999998633211      


Q ss_pred             cccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        .....+.....+. ..........+.+++.+||+.+|++||+++|+++
T Consensus       240 --~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         240 --KTLFKIPRNPPPT-LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             --HHHHHHhcCCCCC-CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              1111111111100 0011223346889999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=2e-36  Score=329.68  Aligned_cols=372  Identities=31%  Similarity=0.428  Sum_probs=293.7

Q ss_pred             CCCcceEEcCCCCCCC-CcCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceE
Q 001440          299 LKSLYGLGLSFNKLSG-SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL  377 (1077)
Q Consensus       299 l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L  377 (1077)
                      ++-.+..|+|+|.++| ..|.....+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-+.+..++.|+.+
T Consensus         6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv   83 (1255)
T KOG0444|consen    6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV   83 (1255)
T ss_pred             cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence            3445556667777663 56677777777777777777776 56777777777777777777776 455567777777777


Q ss_pred             EccCCCCCC-CCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcC
Q 001440          378 YLFTNLLSG-SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL  456 (1077)
Q Consensus       378 ~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  456 (1077)
                      .+..|++.. -+|..+-.+..|+.||||+|++. ..|..+..-+++.+|+|++|+|..+....|.+++.|-+||||+|++
T Consensus        84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL  162 (1255)
T KOG0444|consen   84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL  162 (1255)
T ss_pred             hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence            777777653 35667777788888888888887 6777777778888888888888765556677888888888888888


Q ss_pred             CCCccccccccccceEeecCCccCCCCCcccccccccceeccccccccCCCCcCCCCCCCCcEEEccccccc-CCCCCCC
Q 001440          457 QGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT-GILPPEI  535 (1077)
Q Consensus       457 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~~~~~  535 (1077)
                      ...+|....+..|+.|.|++|.+.-.....                        +-.+..|+.|.+++.+-+ .-+|..+
T Consensus       163 e~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQ------------------------LPsmtsL~vLhms~TqRTl~N~Ptsl  218 (1255)
T KOG0444|consen  163 EMLPPQIRRLSMLQTLKLSNNPLNHFQLRQ------------------------LPSMTSLSVLHMSNTQRTLDNIPTSL  218 (1255)
T ss_pred             hhcCHHHHHHhhhhhhhcCCChhhHHHHhc------------------------CccchhhhhhhcccccchhhcCCCch
Confidence            877777777777777777777654221111                        123455666666665533 3578889


Q ss_pred             CCCCCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCCCCccccccccee
Q 001440          536 GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYY  615 (1077)
Q Consensus       536 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  615 (1077)
                      ..+.+|..+|+|.|.+. .+|.++.++++|+.|+|++|+|+ .+....+...+|+.|+||+|+++ .+|.++.++++|+.
T Consensus       219 d~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~k  295 (1255)
T KOG0444|consen  219 DDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTK  295 (1255)
T ss_pred             hhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHH
Confidence            99999999999999998 88999999999999999999998 67777788899999999999998 89999999999999


Q ss_pred             eeeccccccCC-cchhccccccccceecccccCCCCCccccccccccchhcccccccccccchhhhccccccEEeccCCc
Q 001440          616 LNLSNNQFSGE-IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK  694 (1077)
Q Consensus       616 L~Ls~N~l~~~-~~~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~N~  694 (1077)
                      |++.+|++.-. +|..++++.+|+.+..++|.+ +..|+.++.+.+|+.|.|++|++- .+|+++.-++.|+.||+..|+
T Consensus       296 Ly~n~NkL~FeGiPSGIGKL~~Levf~aanN~L-ElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp  373 (1255)
T KOG0444|consen  296 LYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL-ELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP  373 (1255)
T ss_pred             HHhccCcccccCCccchhhhhhhHHHHhhcccc-ccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence            99999998743 788999999999999999999 589999999999999999999997 679999999999999999998


Q ss_pred             ccCCCCCC
Q 001440          695 LHGPIPNS  702 (1077)
Q Consensus       695 l~~~~p~~  702 (1077)
                      =-.++|.+
T Consensus       374 nLVMPPKP  381 (1255)
T KOG0444|consen  374 NLVMPPKP  381 (1255)
T ss_pred             CccCCCCc
Confidence            77666653

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.2e-34  Score=316.06  Aligned_cols=248  Identities=28%  Similarity=0.398  Sum_probs=198.7

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |.....||+|+||.||++... ++..||+|++....   ....+.+.+|+..++.++|+||+++++++..++..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            334466999999999999764 68899999886432   23356688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++++|.+++...    .+++.++..++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||++........
T Consensus       101 ~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         101 LEGGALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999999988542    378899999999999999999999   999999999999999999999999999976544433


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ......|+..|+|||+..+..++.++||||||+++||+++|+.||........     .........+..+.    ....
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~  244 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----MRRIRDNLPPRVKD----SHKV  244 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhcCCCcccc----cccc
Confidence            33445789999999999888899999999999999999999999863221100     00111111122111    1122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1047 LISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...+.+++.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         245 SSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            3467889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.7e-33  Score=311.03  Aligned_cols=258  Identities=28%  Similarity=0.358  Sum_probs=200.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~l  882 (1077)
                      ++|...+.||.|++|.||+|... +++.||+|.+.....  .....++.+|++++++++||||+++++++.+.  +..++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            36788899999999999999774 688899998875422  23356789999999999999999999988543  47899


Q ss_pred             EEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          883 VYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      ||||+++++|.+++.... ....++...+..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++...
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~  155 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL  155 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence            999999999998875422 234578889999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC---CCCCC
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPA 1038 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 1038 (1077)
                      .....  ....++..|+|||.+.+..++.++||||+|+++|||++|+.||......   .....+.......   +.++.
T Consensus       156 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd06621         156 VNSLA--GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP---PLGPIELLSYIVNMPNPELKD  230 (287)
T ss_pred             ccccc--ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC---CCChHHHHHHHhcCCchhhcc
Confidence            43222  2345788999999999989999999999999999999999998743220   0011111122221   11111


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ...........+.+++.+||+++|++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11111223457889999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-33  Score=309.25  Aligned_cols=240  Identities=25%  Similarity=0.415  Sum_probs=187.9

Q ss_pred             ceecccCCceEEEEEecC--------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          812 HCIGTGGQGSVYRAELSS--------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      +.||+|+||+||+|..+.        ..+||+|.+...   .....+++.+|+.+++.++||||+++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            358999999999996532        234888887542   223356788899999999999999999999998999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCc--------eEEecc
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE--------AHVSDF  955 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~kl~Df  955 (1077)
                      |||+++|+|.+++....  ..+++..++.++.||+.|++|||+.   +|+||||||+||+++.++.        ++++||
T Consensus        78 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          78 QEYVKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             EecCCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccc
Confidence            99999999999997644  2578899999999999999999998   9999999999999987765        699999


Q ss_pred             cccccCCCCCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCC-CCCCccccccccCcccccchhhhcC
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGK-HPRDFISSICSTSSNLDRTLDEILD 1033 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1077)
                      |.+......    ....++..|+|||++.+. .++.++||||||+++||+++|. .|+......         .......
T Consensus       153 g~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---------~~~~~~~  219 (258)
T cd05078         153 GISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---------KKLQFYE  219 (258)
T ss_pred             ccccccCCc----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---------HHHHHHH
Confidence            988755432    234578899999998864 5789999999999999999985 554422111         0011111


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1034 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+...+.    .....+.+++.+||+.||++|||++|+++.|+
T Consensus       220 ~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 DRHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ccccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            1111111    11245889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-33  Score=310.66  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=204.3

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||+|++|.||+|..+ +++.||+|.+.....  ....+++.+|+..+++++||||+++++++..++..++|+
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            35778889999999999999775 688999999876532  234677889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||+++++|.+++....  ..++...+.+++.|++.|++|+|+ .   +++|+||||+||+++.++.+||+|||.+.....
T Consensus        79 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          79 EYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             EecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            9999999999997643  457888999999999999999999 7   999999999999999999999999999876543


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      ....  ...++..|+|||++.+..++.++||||||+++|++++|+.||......   ................+..  ..
T Consensus       154 ~~~~--~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~  226 (265)
T cd06605         154 SLAK--TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPPPRL--PS  226 (265)
T ss_pred             HHhh--cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCCCCC--Ch
Confidence            3221  256888999999999999999999999999999999999998633210   1111122222222221111  11


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ......+.+++.+||..||++|||+.|+++
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         227 GKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            113456889999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.6e-33  Score=305.36  Aligned_cols=246  Identities=27%  Similarity=0.438  Sum_probs=197.3

Q ss_pred             cCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ++|++.+.||+|+||.||+|.. +++.||+|.+....     ..+.+.+|+.++++++|||++++++++... ..++|||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e   78 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME   78 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence            4688899999999999999975 57889999986532     245788999999999999999999998765 4689999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++.... ...+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++...... 
T Consensus        79 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          79 LMSKGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             CCCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            999999999997543 23478899999999999999999998   9999999999999999999999999998764322 


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ......+..|+|||++.+..++.++||||||+++|||++ |+.||.....        .+....+.......+   ..
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~~~~---~~  220 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECVEKGYRMEP---PE  220 (254)
T ss_pred             --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHHhCCCCCCC---CC
Confidence              122334678999999988899999999999999999998 8998763221        111111111111111   11


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+..+.+++.+||+.+|++||+++++++.|+
T Consensus       221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            23346889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=308.28  Aligned_cols=250  Identities=23%  Similarity=0.300  Sum_probs=206.7

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .+.|..-++||+||||.||-++.+ +|+.||.|++.+.+............|-.++..++.+.||.+-.+|++.+..++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            456788899999999999999654 7999999999877666666667788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +..|.||+|.-++.+... +-++++.++.+|.+|+.||++||.+   +||+||+||+|||+|+.|.++|+|.|+|..+..
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999988866554 3488899999999999999999999   999999999999999999999999999998876


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .... ...+||.+|||||++....|+...|+||+||++|||+.|+.||.....-..    . +.+++..   ...+..+.
T Consensus       340 g~~~-~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----~-eEvdrr~---~~~~~ey~  410 (591)
T KOG0986|consen  340 GKPI-RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----R-EEVDRRT---LEDPEEYS  410 (591)
T ss_pred             CCcc-ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----H-HHHHHHH---hcchhhcc
Confidence            6554 445999999999999999999999999999999999999999863322110    0 1111111   12222233


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCC
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPT 1067 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs 1067 (1077)
                      ...+.+..++.+..|++||++|.-
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhcc
Confidence            344556778888999999999973

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.3e-34  Score=323.60  Aligned_cols=259  Identities=22%  Similarity=0.325  Sum_probs=195.3

Q ss_pred             HHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC----
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA----  877 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----  877 (1077)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|+.+++.++||||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence            4567899999999999999999965 4788999999875432 222345677899999999999999999987533    


Q ss_pred             --CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          878 --RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       878 --~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                        ...++++|++ +++|.+++..    ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+||+||
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence              3568999987 7799888753    2488899999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccccc
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRT 1027 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~ 1027 (1077)
                      |+++.....   .....|++.|+|||++.+ ..++.++||||+||++|||++|+.||.........       .......
T Consensus       163 g~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         163 GLARQADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ccceecCCC---cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999865432   234578999999999876 56889999999999999999999998632211000       0000000


Q ss_pred             h--------hhhcC--CCCCCCC--CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 L--------DEILD--PRLPAPS--CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~--------~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .        .....  +..+...  .........+.+++.+|++.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0        00000  0001000  000011234678999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.9e-33  Score=305.86  Aligned_cols=238  Identities=26%  Similarity=0.445  Sum_probs=188.1

Q ss_pred             ceecccCCceEEEEEecCCC-----------EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          812 HCIGTGGQGSVYRAELSSGE-----------IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      +.||+|+||.||+|.+.+..           .|++|.+....   .. ...+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            36899999999999775332           47777765432   11 5778899999999999999999999988 778


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-------ceEEe
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-------EAHVS  953 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~kl~  953 (1077)
                      ++||||+++|+|.+++.....  .+++..++.++.||+.|++|||+.   +|+||||||+||+++.++       .+|++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeC
Confidence            999999999999999976442  578899999999999999999998   999999999999999887       79999


Q ss_pred             cccccccCCCCCCCcccccccccccCccccccC--CCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhh
Q 001440          954 DFGISKSLKPDSSNWTELAGTIGYVAPELAYTM--KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDE 1030 (1077)
Q Consensus       954 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1030 (1077)
                      |||++.....    .....++..|+|||++.+.  .++.++||||||+++||+++ |..||......     ....... 
T Consensus       151 Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~~~~~-  220 (259)
T cd05037         151 DPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKERFYQ-  220 (259)
T ss_pred             CCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHHHHHh-
Confidence            9999986543    1234567789999998876  78999999999999999999 56666532110     0000000 


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       .....+.+.      ...+.+++.+||+.+|++|||+.|+++.|+
T Consensus       221 -~~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 -DQHRLPMPD------CAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             -cCCCCCCCC------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             111122211      156889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9.7e-34  Score=315.85  Aligned_cols=247  Identities=27%  Similarity=0.409  Sum_probs=198.0

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |+....||+|+||.||+|... +++.||+|.+....   ....+.+.+|+..++.++|||++++++++..++..++|+||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc---cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            344457999999999999764 68999999986432   22356688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++++|.+++..    ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||++........
T Consensus       100 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         100 LQGGALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            999999998754    2378899999999999999999998   999999999999999999999999999976654444


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||......        .....+.. ............
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~-~~~~~~~~~~~~  243 (297)
T cd06659         173 KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--------QAMKRLRD-SPPPKLKNAHKI  243 (297)
T ss_pred             cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHhc-cCCCCccccCCC
Confidence            344567899999999999888999999999999999999999998632211        11111111 100000011122


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1047 LISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ...+.+++.+||+.+|++||+++|+++
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            345789999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.6e-33  Score=306.10  Aligned_cols=251  Identities=29%  Similarity=0.426  Sum_probs=201.7

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|+||.||+|... +++.||+|.+...... ....+.+.+|+.++++++|+||+++++++......++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            5788899999999999999764 7889999998765433 3357789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++....   .+++..+..++.|++.|+.|||+.   +|+|+||+|+||+++.++.+||+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          80 YCSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             cCCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            999999999986542   367889999999999999999998   99999999999999999999999999998765443


Q ss_pred             CCcc----cccccccccCccccccCC---CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhc-CCCCC
Q 001440          966 SNWT----ELAGTIGYVAPELAYTMK---VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL-DPRLP 1037 (1077)
Q Consensus       966 ~~~~----~~~g~~~y~aPE~~~~~~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1037 (1077)
                      ....    ...++..|+|||++.+..   ++.++||||||+++||+++|+.||......       ........ .....
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~  226 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE-------FQIMFHVGAGHKPP  226 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch-------HHHHHHHhcCCCCC
Confidence            3222    356788999999988766   889999999999999999999998633210       00000111 11111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+.  .......+.+++.+||+.+|++||+++|++.
T Consensus       227 ~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         227 IPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111  1122446789999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.3e-33  Score=315.46  Aligned_cols=262  Identities=21%  Similarity=0.283  Sum_probs=200.2

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccc--hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLS--EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      +|+..+.||+|+||.||+|... +|+.||+|++......  .......+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999999765 6899999998765433  122245677899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+ +|+|.+++....  ..+++.++..++.||++||+|||+.   +|+|+||+|+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999996543  3588999999999999999999999   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccccchh------
Q 001440          964 DSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLDRTLD------ 1029 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~~------ 1029 (1077)
                      .........+++.|+|||++.+ ..++.++|||||||++|||++|..||..........       ........      
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         155 PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            5444444567889999998854 457889999999999999999987765322210000       00000000      


Q ss_pred             hhcCCCC-CCC--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1030 EILDPRL-PAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1030 ~~~~~~~-~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ....... +..  ..........+.+++.+||++||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000 000  00011224578899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-33  Score=305.92  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=208.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|++|.||+|... +++.||+|++......  ...+.+.+|+..+++++|+|++++++++..+...++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            36788899999999999999776 5899999998765332  34678899999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||+++++|.+++...   ..++...+..++.|+++|++|||+ .   +++|+||+|+||+++.++.++++|||.+.....
T Consensus        79 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          79 EYMDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999999754   347889999999999999999999 8   999999999999999999999999999987765


Q ss_pred             CCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........++..|+|||.+.+..++.++||||||+++|||++|+.||.....     ....+....+.....+..... 
T Consensus       153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~-  226 (264)
T cd06623         153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPPPSLPAE-  226 (264)
T ss_pred             CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCCCCCCcc-
Confidence            54444456788999999999988899999999999999999999999864431     011122222222222111111 


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                       .....+.+++.+||+.+|++||+++|+++.
T Consensus       227 -~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 -EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             -cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             134578899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.7e-33  Score=307.14  Aligned_cols=252  Identities=27%  Similarity=0.411  Sum_probs=198.7

Q ss_pred             hcCCCccceecccCCceEEEEEecC----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .++|++.+.||+|+||.||+|.+.+    ...||+|......  .....+.+.+|+.++++++||||+++++++.+ ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            3568888999999999999997643    2468999886542  23345688999999999999999999999875 456


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++|+|.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++.+|++|||+++.
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            89999999999999996543  2478999999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCCCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC-CCCC
Q 001440          961 LKPDSSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD-PRLP 1037 (1077)
Q Consensus       961 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1037 (1077)
                      ....... .....++..|+|||++....++.++||||||+++||+++ |..||......        +....+.. .+.+
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~~~~  228 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN--------DVIGRIENGERLP  228 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH--------HHHHHHHcCCcCC
Confidence            5443221 112234568999999988889999999999999999986 99998633211        11111111 1122


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.    ..+..+.+++.+||..+|++|||+.|+++.|+
T Consensus       229 ~~~----~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~  263 (270)
T cd05056         229 MPP----NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS  263 (270)
T ss_pred             CCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            211    22346889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-33  Score=312.04  Aligned_cols=260  Identities=26%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             cCCCccceecccCCceEEEEEec-----CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CC
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--AR  878 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~  878 (1077)
                      +.|+..+.||+|+||.||+|++.     +++.||||.+......  ...+.+.+|+..++.++||||+++++++..  +.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            45777899999999999999753     3678999998765332  346789999999999999999999999877  55


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++||||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||.+
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            7899999999999999997544  2488999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCCc---ccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc------Ccccccchh
Q 001440          959 KSLKPDSSNW---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST------SSNLDRTLD 1029 (1077)
Q Consensus       959 ~~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~------~~~~~~~~~ 1029 (1077)
                      ..........   ....++..|+|||+..+..++.++||||||+++|||++|+.|+.........      .........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            8765332221   1224456799999998889999999999999999999999997532211100      000011111


Q ss_pred             hhcCC--CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1030 EILDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1030 ~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+..  +.+.+    ......+.+++.+||+.+|++||++.||+++|+
T Consensus       237 ~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~  281 (284)
T cd05038         237 ELLKEGERLPRP----PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD  281 (284)
T ss_pred             HHHHcCCcCCCC----ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHh
Confidence            11111  11211    122356889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=4.4e-33  Score=305.79  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=195.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccc--hhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLS--EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~  880 (1077)
                      .+|+..+.||+|+||.||+|... +++.||+|++......  .......+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999664 6889999988654321  22234578889999999999999999998865  3578


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+++++|.+++....   .+++.+...++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            89999999999999986543   378889999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCC---CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          961 LKPDS---SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       961 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      .....   .......++..|+|||++.+..++.++||||+||++||+++|+.||......       .........+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~  228 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTNP  228 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCCC
Confidence            54321   1123345788999999999888999999999999999999999998633211       1111111111111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .   ........+..++ .||..+|++||+++||++
T Consensus       229 ~---~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         229 Q---LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             C---CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            1   1112223455666 688899999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-33  Score=314.18  Aligned_cols=260  Identities=19%  Similarity=0.292  Sum_probs=196.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|+||.||+|+.. +|+.||+|++...... ......+.+|+.++++++||||+++++++.+.+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            4778899999999999999765 6899999998654222 1223567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |++ +++.+++....  ..+++.+++.++.||++|+.|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        80 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          80 YCD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             cCC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            997 57888775432  3488999999999999999999999   99999999999999999999999999998765444


Q ss_pred             CCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc--------cccc---chhhhcC
Q 001440          966 SNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS--------NLDR---TLDEILD 1033 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~--------~~~~---~~~~~~~ 1033 (1077)
                      .......++..|+|||++.+. .++.++||||+||++|||++|+.|+...........        ....   ......+
T Consensus       154 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         154 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            434445678999999988764 468999999999999999999998642211100000        0000   0000000


Q ss_pred             C-CCCCCCC------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1034 P-RLPAPSC------NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1034 ~-~~~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      . ..+....      ........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0 0000000      00112346789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.5e-33  Score=304.15  Aligned_cols=251  Identities=29%  Similarity=0.457  Sum_probs=200.1

Q ss_pred             CCccceecccCCceEEEEEecC-----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          808 FDEEHCIGTGGQGSVYRAELSS-----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      +++.+.||+|+||.||+|.+.+     +..||+|++......  ...+.+..|+..++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3567889999999999997753     378999998654322  246788999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||+++++|.+++..... ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.++++|||+++...
T Consensus        79 i~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             EEeccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecc
Confidence            9999999999999875432 1278999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcc-cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcCCCCCCCC
Q 001440          963 PDSSNWT-ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040 (1077)
Q Consensus       963 ~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1077)
                      ....... ...++..|+|||.+.+..++.++||||+|+++|||++ |+.||....        .................
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~  226 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--------NEEVLEYLKKGYRLPKP  226 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHhcCCCCCCC
Confidence            4422111 2236789999999988889999999999999999998 778875311        11112222221111111


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                         ......+.+++.+||+.||++|||+.|+++.|
T Consensus       227 ---~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      227 ---ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               11334688899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.2e-33  Score=312.87  Aligned_cols=250  Identities=26%  Similarity=0.454  Sum_probs=196.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCC----EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .+|+..+.||+|+||.||+|.+. +|+    .||+|.+.....  .....++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            56788889999999999999764 444    578888765422  22345788999999999999999999998754 46


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+++|++.+++....  ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            79999999999999986543  3478889999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCCCC--cccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhcC--CC
Q 001440          961 LKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD--PR 1035 (1077)
Q Consensus       961 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 1035 (1077)
                      .......  .....++..|+|||++.+..++.++||||||+++||+++ |+.||.....         ......+.  ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~---------~~~~~~~~~~~~  229 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGER  229 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH---------HHHHHHHHCCCC
Confidence            6543221  222345678999999998899999999999999999998 8889753211         00111111  11


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.+.    .....+.+++.+||..+|++||+++|+++.|+
T Consensus       230 ~~~~~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~  266 (303)
T cd05110         230 LPQPP----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFS  266 (303)
T ss_pred             CCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            22111    12246789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-33  Score=321.38  Aligned_cols=192  Identities=21%  Similarity=0.302  Sum_probs=164.8

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ...+|.+.+.||+|+||.||+|+.. +++.||+|.....         ....|+.++++++||||+++++++......++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  134 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM  134 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence            3457999999999999999999775 5678999975432         22458889999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |+||+. +++.+++....  ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++...
T Consensus       135 v~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        135 VLPHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            999995 68888886533  3588999999999999999999999   99999999999999999999999999997533


Q ss_pred             CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPR 1011 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~ 1011 (1077)
                      .. .......||..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       209 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        209 VA-PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cC-cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            22 2234457899999999999999999999999999999999966554

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.7e-33  Score=303.66  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=202.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|+||.||+|... +++.||+|.+....... .....+.+|+.++++++|||++++++++..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            4788899999999999999664 68899999987654332 336778999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEecccccccCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla~~~~~~  964 (1077)
                      |+++++|.+++.... ...+++.++.+++.|++.|++|||+.   +++|+||+|+||+++.+ +.+|++|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          80 YAPGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             cCCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            999999999996543 23478899999999999999999998   99999999999999865 46899999999876543


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||....        .................   .
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~---~  223 (256)
T cd08220         156 SK-AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--------LPALVLKIMSGTFAPIS---D  223 (256)
T ss_pred             cc-ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--------hHHHHHHHHhcCCCCCC---C
Confidence            22 233568899999999998889999999999999999999999986321        11222222222211111   1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++|||++|+++.
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            123468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.6e-33  Score=315.01  Aligned_cols=194  Identities=20%  Similarity=0.341  Sum_probs=158.7

Q ss_pred             cceecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--CCeeEEEEe
Q 001440          811 EHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHSFIVYE  885 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E  885 (1077)
                      ..+||+|+||+||+|+..   ++..||+|.+.....     ...+.+|+.+++.++||||+++++++..  +...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            357999999999999765   457899998865321     3456789999999999999999998853  467899999


Q ss_pred             ecCCCCHHHHHhcCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeee----CCCCceEEecc
Q 001440          886 YLEMGSLAMILSNAT------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL----DLEYEAHVSDF  955 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~kl~Df  955 (1077)
                      |+++ ++.+++....      ....+++..+..++.|++.||+|||+.   +|+||||||+||++    +.++.+||+||
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            9875 7777764321      123478889999999999999999998   99999999999999    56689999999


Q ss_pred             cccccCCCCCC---CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCc
Q 001440          956 GISKSLKPDSS---NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDF 1013 (1077)
Q Consensus       956 gla~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~ 1013 (1077)
                      |+++.......   ......||+.|+|||++.+ ..++.++||||+||++|||+||+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            99987644322   2234568999999999876 4578999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=308.50  Aligned_cols=248  Identities=26%  Similarity=0.420  Sum_probs=199.5

Q ss_pred             CCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC---CCceeeEEEEEeeCCeeEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR---HRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~l  882 (1077)
                      .|+..+.||+|+||.||+|.+ .+++.||+|.+.....  .....++.+|+.+++.++   |||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            467788899999999999976 4789999998865422  223567888999988886   9999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||+++++|.+++...    .+++..+..++.|++.|+.|||+.   +|+|+||+|+||+++.++.++++|||.+..+.
T Consensus        80 v~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          80 IMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             EEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999999998543    488999999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ..........|+..|+|||++.+ ..++.++||||||+++|+|++|+.||......        ...........+  ..
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~~~~~~~~--~~  222 (277)
T cd06917         153 QNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMMLIPKSKPP--RL  222 (277)
T ss_pred             CCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhccccCCCC--CC
Confidence            55444455678999999998865 45688999999999999999999998633211        111111111111  11


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ........+.+++.+||+.||++||+++|+++
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            11113456889999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4e-34  Score=336.48  Aligned_cols=252  Identities=27%  Similarity=0.430  Sum_probs=201.1

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee-------
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-------  876 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  876 (1077)
                      ..+|+..+.||+||||.||+++-+ ||+.||||++.-..  .......+.+|+..+++++|||||+++..|.+       
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            457778889999999999999776 89999999998764  33446788999999999999999999843210       


Q ss_pred             --------------------------------------------------------------------------------
Q 001440          877 --------------------------------------------------------------------------------  876 (1077)
Q Consensus       877 --------------------------------------------------------------------------------  876 (1077)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 001440          877 ------------------------A--------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL  924 (1077)
Q Consensus       877 ------------------------~--------~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L  924 (1077)
                                              +        ...||-||||+..++.++++++....  .....++++++|++|++|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence                                    0        23478999999988888887665321  3467889999999999999


Q ss_pred             HhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC------------------CCCCCcccccccccccCccccccC
Q 001440          925 HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK------------------PDSSNWTELAGTIGYVAPELAYTM  986 (1077)
Q Consensus       925 H~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~------------------~~~~~~~~~~g~~~y~aPE~~~~~  986 (1077)
                      |+.   |||||||||.||+++++..|||+|||+|+...                  ....+.+..+||.-|+|||++.+.
T Consensus       714 H~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            999   99999999999999999999999999998721                  011234567899999999998765


Q ss_pred             C---CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCC
Q 001440          987 K---VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPD 1063 (1077)
Q Consensus       987 ~---~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1063 (1077)
                      .   |+.|+||||+|||++||+.   ||..       .......+..+.++.+|.+..........-..+|+++++.||.
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~  860 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGT-------SMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPS  860 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCc-------hHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCc
Confidence            4   9999999999999999984   4431       1122334555667777776444455555667899999999999


Q ss_pred             CCCCHHHHHh
Q 001440         1064 SRPTMQKVSQ 1073 (1077)
Q Consensus      1064 ~RPs~~evl~ 1073 (1077)
                      +||||.|++.
T Consensus       861 kRPtA~eLL~  870 (1351)
T KOG1035|consen  861 KRPTATELLN  870 (1351)
T ss_pred             cCCCHHHHhh
Confidence            9999999985

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-33  Score=311.15  Aligned_cols=250  Identities=24%  Similarity=0.393  Sum_probs=202.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||.||+|... +++.||+|.+...   .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence            57888999999999999999654 6889999998543   2223567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++++|.+++.+.    .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++......
T Consensus        96 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~  168 (293)
T cd06647          96 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (293)
T ss_pred             ecCCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence            999999999998643    367889999999999999999999   9999999999999999999999999998866555


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........+++.|+|||++....++.++||||||+++||+++|+.||.........       ......+....  ....
T Consensus       169 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-------~~~~~~~~~~~--~~~~  239 (293)
T cd06647         169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------YLIATNGTPEL--QNPE  239 (293)
T ss_pred             ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-------eehhcCCCCCC--CCcc
Confidence            44444557889999999998888999999999999999999999998643221110       00000111111  1112


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++||+++|++..
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            233468899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=3.2e-33  Score=305.31  Aligned_cols=251  Identities=24%  Similarity=0.346  Sum_probs=201.0

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccc--hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLS--EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      +|+..+.||+|++|+||+|... +++.||+|.+......  .....+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677889999999999999765 7899999987653221  223456789999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +||+++++|.+++.+..   .+++.++..++.|++.|++|||+.   +|+|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            99999999999996543   478899999999999999999998   999999999999999999999999999886544


Q ss_pred             CCCCcccccccccccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      .. ......++..|+|||.+.... ++.++|+||||+++||+++|+.||......       ............+..   
T Consensus       155 ~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~---  223 (258)
T cd06632         155 FS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-------AAVFKIGRSKELPPI---  223 (258)
T ss_pred             cc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-------HHHHHHHhcccCCCc---
Confidence            33 234456889999999987766 899999999999999999999998643211       001110000111111   


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .......+.+++.+||+.+|++||+++|+++.
T Consensus       224 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         224 PDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence            11223467889999999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.7e-33  Score=304.70  Aligned_cols=252  Identities=22%  Similarity=0.296  Sum_probs=197.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCcc--chhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--Cee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLL--SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  880 (1077)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....  ......+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999764 689999998753221  1223356788999999999999999999998663  467


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++++|.+++....   .+++....+++.|++.|++|||+.   +|+|+||||+||+++.++.+||+|||.++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccc
Confidence            89999999999999986543   367888999999999999999999   999999999999999999999999999986


Q ss_pred             CCCCC---CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          961 LKPDS---SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       961 ~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      .....   .......++..|+|||++.+..++.++|||||||++||+++|+.||......       .........+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~  228 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNP  228 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-------HHHHHHhcCCCCC
Confidence            54321   1223346888999999998888999999999999999999999998632211       1111111111111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .   ........+.+++.+||. +|++||+++|+++.
T Consensus       229 ~---~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         229 V---LPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             C---CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            1   122334567788999995 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=293.25  Aligned_cols=260  Identities=22%  Similarity=0.324  Sum_probs=209.7

Q ss_pred             HHHHHHhcCCCccceecccCCceEEEEEecC------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEE
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELSS------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG  872 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  872 (1077)
                      +++.....+++....+.+|.||.||+|.|++      .+.|-||.++..  ....+...+..|..++....|||+..+.+
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            3455556677778889999999999996643      345777877654  23334678999999999999999999999


Q ss_pred             EEeeC-CeeEEEEeecCCCCHHHHHh-----cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC
Q 001440          873 FCSHA-RHSFIVYEYLEMGSLAMILS-----NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL  946 (1077)
Q Consensus       873 ~~~~~-~~~~lV~E~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  946 (1077)
                      ++.++ ..+++.+.++.-|+|..|+.     +....+.++..+...++.|++.|++|||+.   +|||.||.++|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence            98654 57899999999999999998     333344577889999999999999999999   9999999999999999


Q ss_pred             CCceEEecccccccCCCCCCCcc--cccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcc
Q 001440          947 EYEAHVSDFGISKSLKPDSSNWT--ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       947 ~~~~kl~Dfgla~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~ 1023 (1077)
                      ..++|++|-.++|.+.+.+.+.-  .--.+..||+||.+....|+.++|||||||++|||+| |+.||...+++      
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------  505 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------  505 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------
Confidence            99999999999999887765532  2235789999999999999999999999999999999 99998755543      


Q ss_pred             cccchhhhcCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1024 LDRTLDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1024 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                        ++...+.|++ +..|. .++   .++..++.-||+.+|++||+++|++..|
T Consensus       506 --Em~~ylkdGyRlaQP~-NCP---DeLf~vMacCWallpeeRPsf~Qlv~cL  552 (563)
T KOG1024|consen  506 --EMEHYLKDGYRLAQPF-NCP---DELFTVMACCWALLPEERPSFSQLVICL  552 (563)
T ss_pred             --HHHHHHhccceecCCC-CCc---HHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence              2333334443 33332 223   3578888999999999999999999876

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.8e-33  Score=307.89  Aligned_cols=248  Identities=27%  Similarity=0.464  Sum_probs=195.2

Q ss_pred             ceecccCCceEEEEEecC-------CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          812 HCIGTGGQGSVYRAELSS-------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.||+|+||.||+|+..+       ++.||+|.+....  ......++.+|+..++.++||||+++++++...+..++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            358999999999997642       2578999876532  1223567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-----ceEEecc
Q 001440          885 EYLEMGSLAMILSNAT----SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-----EAHVSDF  955 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~Df  955 (1077)
                      ||+++|+|.+++....    ....+++.+++.++.|++.|++|||+.   +++|+||||+||+++.++     .+|++||
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df  155 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF  155 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence            9999999999996532    123478899999999999999999998   999999999999999887     8999999


Q ss_pred             cccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhhc
Q 001440          956 GISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEIL 1032 (1077)
Q Consensus       956 gla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1032 (1077)
                      |+++.......  ......++..|+|||++.+..++.++||||||+++|||++ |+.||......        +....+.
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~  227 (269)
T cd05044         156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--------EVLQHVT  227 (269)
T ss_pred             ccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--------HHHHHHh
Confidence            99976543221  1123345788999999999999999999999999999998 99998632211        1111111


Q ss_pred             C-CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1033 D-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1033 ~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      . .....+    ...+..+.+++.+||+.+|++||+++++.+.|+
T Consensus       228 ~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         228 AGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             cCCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1 111111    122356889999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-34  Score=286.12  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=196.0

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.+....||.|..|.||+++.+ +|...|||.+.+.  ...++.+++...++++..- ++|+||+.+|||......++-|
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM  170 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM  170 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence            3445567999999999999776 6889999999765  3344466777777766555 5899999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |.|.. ..+..+++-.  .++++.-+-++...+..||.||.+++  +|+|||+||+|||+|..|.+|+||||++.++.+.
T Consensus       171 elMs~-C~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  171 ELMST-CAEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHH-HHHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            98853 5555555433  34677777789999999999999986  9999999999999999999999999999887654


Q ss_pred             CCCcccccccccccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC---CCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAYT---MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPA 1038 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 1038 (1077)
                      .. .+..+|.+.|||||.+.-   ..|+.++||||||++++|+.||..||......       -+.+..+++   |.++.
T Consensus       246 kA-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~ePP~L~~  317 (391)
T KOG0983|consen  246 KA-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEEPPLLPG  317 (391)
T ss_pred             cc-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcCCCCCCc
Confidence            33 355689999999999864   46889999999999999999999998743221       122333333   33332


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .    ...+..+.+++..||++|+.+||...++++.
T Consensus       318 ~----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  318 H----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             c----cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            2    2245679999999999999999999998863

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-33  Score=312.17  Aligned_cols=261  Identities=22%  Similarity=0.369  Sum_probs=200.8

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|+..+.||+|+||.||+|.++ +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..++|+
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            46888999999999999999875 58999999986543322 23556888999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++++++.++....   ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          80 EFVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             ecCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            999999998877543   2378999999999999999999998   9999999999999999999999999999876554


Q ss_pred             CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc------Ccccccchhh-------
Q 001440          965 SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST------SSNLDRTLDE------- 1030 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~------~~~~~~~~~~------- 1030 (1077)
                      ........++..|+|||++.+ ..++.++||||||+++|||++|+.||.........      ..........       
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07846         154 GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL  233 (286)
T ss_pred             ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence            444445668899999998875 34788999999999999999999988532211000      0000000000       


Q ss_pred             ---hcCCCCCCCC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1031 ---ILDPRLPAPS---CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1031 ---~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ...+......   .........+.+++.+||+.+|++||+++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence               0000000000   000122356889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-33  Score=309.82  Aligned_cols=255  Identities=27%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCC---
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHAR---  878 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~---  878 (1077)
                      ..++|++.+.||+|++|.||+|..+ +++.||+|.+.....    ..+.+.+|+.+++++ +|+||+++++++.+..   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            4578999999999999999999775 678999998865422    246788999999999 7999999999996644   


Q ss_pred             ---eeEEEEeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEec
Q 001440          879 ---HSFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSD  954 (1077)
Q Consensus       879 ---~~~lV~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  954 (1077)
                         ..++||||+++++|.+++.... ....+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.+|++|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence               4899999999999999986533 234588999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCCCcccccccccccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh
Q 001440          955 FGISKSLKPDSSNWTELAGTIGYVAPELAYT-----MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       955 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      ||++..............|+..|+|||++..     ..++.++||||+|+++||+++|+.||......        ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--------~~~~  228 (275)
T cd06608         157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--------RALF  228 (275)
T ss_pred             CccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--------HHHH
Confidence            9999876544444445678999999998753     34678999999999999999999998632211        1111


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .+.....+ ...........+.+++.+||+.||++|||++|+++.
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         229 KIPRNPPP-TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             HhhccCCC-CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            11111111 111112234578899999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-33  Score=311.72  Aligned_cols=261  Identities=18%  Similarity=0.300  Sum_probs=196.5

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|++|.||+|..+ +++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence            367889999999999999999765 68999999986543221  134567899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++ +|.+++....  ..+++.++..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++|||+++....
T Consensus        82 ~e~~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  155 (291)
T cd07844          82 FEYLDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSV  155 (291)
T ss_pred             EecCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence            999985 9999886543  2578899999999999999999999   999999999999999999999999999876533


Q ss_pred             CCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc--------Ccccccchhhh---
Q 001440          964 DSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST--------SSNLDRTLDEI--- 1031 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~--- 1031 (1077)
                      .........++..|+|||++.+ ..++.++||||+|+++|||++|+.||.........        ...........   
T Consensus       156 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07844         156 PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN  235 (291)
T ss_pred             CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence            3222333456889999998875 45789999999999999999999998633210000        00000000000   


Q ss_pred             ---cCCCCCCCC-C------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1032 ---LDPRLPAPS-C------NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1032 ---~~~~~~~~~-~------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         .....+... .      ........+.+++.+||+.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               000000000 0      00011146778999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=7.9e-33  Score=305.64  Aligned_cols=248  Identities=26%  Similarity=0.405  Sum_probs=201.2

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      -|+..+.||+|+||.||+|... +++.||+|.+.....  ....+.+.+|+..+++++||||+++++++..++..++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            4677889999999999999654 688999998764322  2335678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++...    .+++.++..++.|++.|+.|||+.   +++|+||+|+||+++.++.++++|||++.......
T Consensus        83 ~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          83 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            99999999998643    478899999999999999999998   99999999999999999999999999987765443


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......++..|+|||++.+..++.++|||||||++||+++|..||......        .....+.....+.   ....
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~---~~~~  224 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM--------KVLFLIPKNNPPT---LEGN  224 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH--------HHHHHHhcCCCCC---CCcc
Confidence            3334456788999999998888899999999999999999999998632211        1111111111111   1112


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ....+.+++.+||+.+|++||+++|+++.
T Consensus       225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         225 YSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            33568899999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.4e-33  Score=311.01  Aligned_cols=262  Identities=19%  Similarity=0.271  Sum_probs=197.0

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      +.++|.+.+.||+|+||.||+|... +|+.||+|.+......  .....+.+|+.+++.++|+||+++++++.+++..++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   80 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTF   80 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEE
Confidence            4578999999999999999999654 6889999998654222  223456789999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |+||++ +++.+++....  ..+++.++..++.|++.||+|||+.   +|+|+||||+||+++.++.+||+|||+++...
T Consensus        81 v~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          81 VFEYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             EEeccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            999996 67777765432  3467888999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCcccccccc----------Cc--------c
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICST----------SS--------N 1023 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~----------~~--------~ 1023 (1077)
                      ..........++..|+|||++.+. .++.++|||||||++|||++|+.||+........          ..        .
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            443333445678999999998754 5788999999999999999999998643221000          00        0


Q ss_pred             cccchhhhcCCCCCCCC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1024 LDRTLDEILDPRLPAPS---CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .............+...   .........+.+++.+|++.||++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            00000000000000000   000011346789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.8e-33  Score=308.49  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=199.1

Q ss_pred             CCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|...+.||+|++|.||+|.. .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            345557899999999999975 47889999987543   22235568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++..    ..+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.+.......
T Consensus        97 ~~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          97 FLEGGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             ccCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            9999999999865    2378899999999999999999998   99999999999999999999999999887655443


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......|+..|+|||+..+..++.++||||||+++|||++|+.||......        ...........+. ......
T Consensus       170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--------~~~~~~~~~~~~~-~~~~~~  240 (285)
T cd06648         170 PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--------QAMKRIRDNLPPK-LKNLHK  240 (285)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--------HHHHHHHhcCCCC-Cccccc
Confidence            3334456899999999998888999999999999999999999998532211        1111111111110 001111


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+.+++.+||+++|++||++.|+++
T Consensus       241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         241 VSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            3346889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.8e-33  Score=333.57  Aligned_cols=260  Identities=17%  Similarity=0.199  Sum_probs=187.4

Q ss_pred             HHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC------CCCceeeEEEE
Q 001440          801 IVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI------RHRNIVKFYGF  873 (1077)
Q Consensus       801 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~  873 (1077)
                      +....++|++.+.||+|+||+||+|... +++.||||++.....    ..++...|+.+++.+      +|.++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            3345678999999999999999999764 678899999864211    123344455555544      45668999998


Q ss_pred             EeeC-CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC----
Q 001440          874 CSHA-RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY----  948 (1077)
Q Consensus       874 ~~~~-~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----  948 (1077)
                      +..+ ++.++|||++ +++|.+++.+.   ..+++.++..++.||+.||+|||++.  +|+||||||+|||++.++    
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCcccc
Confidence            8765 5789999988 67888888654   34888999999999999999999732  899999999999998765    


Q ss_pred             ------------ceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccc
Q 001440          949 ------------EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016 (1077)
Q Consensus       949 ------------~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~ 1016 (1077)
                                  .+||+|||.+....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||+....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                        49999999886432   223456799999999999999999999999999999999999999964322


Q ss_pred             cccc------Ccccccch---------hhhcC------CCCCC---------CCCCcHHHHHHHHHHHHhccCCCCCCCC
Q 001440         1017 ICST------SSNLDRTL---------DEILD------PRLPA---------PSCNIRDKLISIMEVAISCLDENPDSRP 1066 (1077)
Q Consensus      1017 ~~~~------~~~~~~~~---------~~~~~------~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RP 1066 (1077)
                      ....      .......+         ..+.+      +....         ...........+.+++.+||++||++||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            1000      00000000         00000      00000         0000001124577999999999999999


Q ss_pred             CHHHHHh
Q 001440         1067 TMQKVSQ 1073 (1077)
Q Consensus      1067 s~~evl~ 1073 (1077)
                      |++|+++
T Consensus       431 ta~e~L~  437 (467)
T PTZ00284        431 NARQMTT  437 (467)
T ss_pred             CHHHHhc
Confidence            9999986

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.6e-33  Score=304.75  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=202.9

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|+||.||+|... +|..||+|.+....... ...+.+.+|+.+++.++|+||+++++++......++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            4778899999999999999765 58889999986543222 235677899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-ceEEecccccccCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPD  964 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~  964 (1077)
                      |+++++|.+++.+... ..+++..+..++.|++.|++|||+.   +++|+||||+||+++.++ .+|++|||.+......
T Consensus        80 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          80 YCDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             cCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999999865432 3478999999999999999999998   999999999999999886 4699999999876554


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........|++.|+|||+..+..++.++||||||+++||+++|+.||.....        .+..........+...   .
T Consensus       156 ~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---~  224 (257)
T cd08225         156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL--------HQLVLKICQGYFAPIS---P  224 (257)
T ss_pred             cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHhcccCCCCC---C
Confidence            4333445688999999999888899999999999999999999999863211        1122222222221111   1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++|||++|+++.
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 NFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            122468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.9e-33  Score=310.40  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=197.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|+..+.||+|+||+||+|... +++.||+|++...........+++.+|+.+++.++||||+++++++.+++..++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999765 68999999886543333344567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++ |++.+++....  ..+++.++..++.|++.|+.|||+.   +|+|+||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 57777765332  3488999999999999999999998   9999999999999999999999999998765433


Q ss_pred             CCCcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          965 SSNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                          ....++..|+|||++.   ...++.++||||||+++|||++|+.||......        ...........+  ..
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~--------~~~~~~~~~~~~--~~  234 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNDSP--TL  234 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH--------HHHHHHhcCCCC--CC
Confidence                2346788999999874   456888999999999999999999997532211        111111111111  11


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ........+.+++.+||+.||++||++.++++.
T Consensus       235 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            112234568899999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.3e-33  Score=311.26  Aligned_cols=261  Identities=21%  Similarity=0.322  Sum_probs=197.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||.|++|.||+|+.. +|+.||||++....... .....+.+|++++++++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccccc-ccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            4788899999999999999765 68999999886543222 224578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |++ +++.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++.......
T Consensus        80 ~~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          80 FLH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             ccc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            996 68988886543 24588999999999999999999998   99999999999999999999999999998665443


Q ss_pred             CCcccccccccccCccccccCC-CCCcchHHHHHHHHHHHHhCCCCCCccccccccCc------cccc----chhhhc--
Q 001440          966 SNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS------NLDR----TLDEIL-- 1032 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~------~~~~----~~~~~~-- 1032 (1077)
                      .......++..|+|||++.+.. ++.++||||||+++|||+||+.||...........      ....    ......  
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            3334445788999999887644 58899999999999999999999853221100000      0000    000000  


Q ss_pred             ---CCCCCCC--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 ---DPRLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 ---~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         .+.....  ..........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence               0000000  0000112245778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.3e-33  Score=307.72  Aligned_cols=247  Identities=24%  Similarity=0.316  Sum_probs=194.9

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|+||+||+|... +|+.||+|.+.............+..|+.+++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999654 6899999998754333333355667899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccccc
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA  972 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  972 (1077)
                      .+++..... ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||.+...... .......
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA  155 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccC-Ccccccc
Confidence            999876543 3578899999999999999999999   9999999999999999999999999998765432 2223456


Q ss_pred             ccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHH
Q 001440          973 GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052 (1077)
Q Consensus       973 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1052 (1077)
                      ++..|+|||+..+..++.++||||+|+++|+|++|+.||.......    ...............    ........+.+
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~~  227 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEELKRRTLEMAVE----YPDKFSPEAKD  227 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHHHhcccccccc----CCccCCHHHHH
Confidence            7889999999988889999999999999999999999986432210    000111111111111    11122456889


Q ss_pred             HHHhccCCCCCCCC-----CHHHHHh
Q 001440         1053 VAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1053 li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      ++.+||+.||++||     ++.++++
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         228 LCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHccCChhHccCCCcccHHHHHh
Confidence            99999999999999     6666764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1e-32  Score=304.14  Aligned_cols=253  Identities=25%  Similarity=0.423  Sum_probs=196.4

Q ss_pred             CCccceecccCCceEEEEEec----CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----
Q 001440          808 FDEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----  878 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  878 (1077)
                      |.+.+.||+|+||+||+|.+.    +++.||||++...... ....+++.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            566788999999999999653    4688999998764333 233567889999999999999999999886532     


Q ss_pred             -eeEEEEeecCCCCHHHHHhcCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEec
Q 001440          879 -HSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSD  954 (1077)
Q Consensus       879 -~~~lV~E~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  954 (1077)
                       ..++++||+.+|++.+++....   ....+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECc
Confidence             3478999999999998875322   122478889999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhh
Q 001440          955 FGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031 (1077)
Q Consensus       955 fgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1031 (1077)
                      ||.++.......  ......++..|++||......++.++||||||+++|||++ |+.||.....        ......+
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--------~~~~~~~  228 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--------SEIYNYL  228 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--------HHHHHHH
Confidence            999986643321  1123345678999999998889999999999999999999 8888753211        1111111


Q ss_pred             cCCC-CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1032 LDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1032 ~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .... ...+    ......+.+++.+||+.+|++||++.|+++.|+
T Consensus       229 ~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~  270 (273)
T cd05074         229 IKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE  270 (273)
T ss_pred             HcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            1111 1111    122346889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-33  Score=306.37  Aligned_cols=255  Identities=27%  Similarity=0.402  Sum_probs=198.2

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccc-------hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLS-------EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR  878 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  878 (1077)
                      +|...+.||+|+||.||+|... +|+.||+|.+......       .....+.+.+|+.+++.++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999999654 6899999987543211       1112356788999999999999999999999999


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++||||+++|+|.+++.+.   ..+++..+..++.|++.|+.|||+.   +++||||+|+||+++.++.++++|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999998664   3478889999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCC--CcccccccccccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC-
Q 001440          959 KSLKPDSS--NWTELAGTIGYVAPELAYTMK--VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD- 1033 (1077)
Q Consensus       959 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 1033 (1077)
                      +.......  ......++..|+|||++....  ++.++||||+|+++||+++|+.||.......       ...+.... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~  228 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-------AMFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-------HHHHhhccc
Confidence            76543211  122345788999999987654  7899999999999999999999985322110       00000000 


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1034 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+..........+.+++.+||+++|++||+++||++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            01111111112234578899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-33  Score=307.96  Aligned_cols=262  Identities=26%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++..... .......+.+|++++++++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            36888999999999999999775 688999998865322 2233567889999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||++++.+..+....   ..+++.++..++.|++.|++|||+.   +++|+|++|+||+++.++.+||+|||++......
T Consensus        80 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          80 EYVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             ecCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            999987777666432   3378899999999999999999998   9999999999999999999999999999876554


Q ss_pred             CC-CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC------cccccchh------h
Q 001440          965 SS-NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS------SNLDRTLD------E 1030 (1077)
Q Consensus       965 ~~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~------~~~~~~~~------~ 1030 (1077)
                      .. ......++..|+|||++.+. .++.++||||||+++|||++|+.||..........      ........      .
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            33 33456678899999999888 88999999999999999999999986322110000      00000000      0


Q ss_pred             hcCC-CCCCCCC-------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1031 ILDP-RLPAPSC-------NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1031 ~~~~-~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .... ..+....       ........+.+++++||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            0000 0000000       001124578899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=9.2e-33  Score=302.51  Aligned_cols=243  Identities=27%  Similarity=0.375  Sum_probs=199.0

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||.|++|.||+|+.. +++.||+|.+...........+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999775 5889999998765444444567899999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccccc
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA  972 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  972 (1077)
                      .+++.+..   .+++.++..++.|++.|++|+|+.   +++|+||+|+||+++.++.++++|||.+....... ......
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~  153 (262)
T cd05572          81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC  153 (262)
T ss_pred             HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-cccccc
Confidence            99996543   378899999999999999999998   99999999999999999999999999998765432 223346


Q ss_pred             ccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC--CCCCCCCCCcHHHHHHH
Q 001440          973 GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       973 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 1050 (1077)
                      ++..|+|||++.+..++.++|+||+|+++||+++|+.||.....      ...+....+.+  .....+.    .....+
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~----~~~~~~  223 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDILKGNGKLEFPN----YIDKAA  223 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHhccCCCCCCCc----ccCHHH
Confidence            78899999999888899999999999999999999999863321      11222223331  1122211    114578


Q ss_pred             HHHHHhccCCCCCCCCC-----HHHHHh
Q 001440         1051 MEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RPs-----~~evl~ 1073 (1077)
                      .+++.+||+.+|++||+     ++|+++
T Consensus       224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         224 KDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            99999999999999999     788765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-33  Score=302.97  Aligned_cols=246  Identities=23%  Similarity=0.276  Sum_probs=189.4

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHH-hcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+||.||+|... +|+.||+|.+.............+..|... ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46899999999999764 688999999865433222223344455443 4455899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      ++|.+++....   .+++.++..++.|++.||.|||+.   +++|+||+|+||+++.++.+|++|||+++....    ..
T Consensus        82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  151 (260)
T cd05611          82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NK  151 (260)
T ss_pred             CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----cc
Confidence            99999996543   478899999999999999999998   999999999999999999999999999875433    22


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHH
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1077)
                      ...++..|+|||+..+..++.++||||+|+++||+++|..||.....        ..............+..........
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~  223 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNILSRRINWPEEVKEFCSPE  223 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcccCCCCcccccCCHH
Confidence            34678899999999888899999999999999999999999863211        1122222211111111111123456


Q ss_pred             HHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1050 l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      +.+++.+||+.+|++||++.++.+.+
T Consensus       224 ~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         224 AVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHHHccCCHHHccCCCcHHHHH
Confidence            88999999999999999776554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-32  Score=303.02  Aligned_cols=254  Identities=23%  Similarity=0.379  Sum_probs=200.6

Q ss_pred             CCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccch---hhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+.......   ....+.+.+|+..+++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477888999999999999965 578999999986543211   2235678999999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-ceEEecccccccC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSL  961 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~  961 (1077)
                      |+||+++++|.+++.+..   .+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++ .+||+|||.+..+
T Consensus        81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            999999999999996543   478899999999999999999999   999999999999998776 5999999999876


Q ss_pred             CCCCCC----cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          962 KPDSSN----WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       962 ~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      ......    .....++..|+|||++.+..++.++||||+|+++|++++|+.||......     ...............
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~  229 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASATTA  229 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhccCCC
Confidence            543211    12346788999999998888999999999999999999999998532110     001111111111111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        ..........+.+++.+||+.+|++||++.|+++
T Consensus       230 --~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         230 --PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              1111233457889999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.9e-33  Score=307.46  Aligned_cols=261  Identities=20%  Similarity=0.315  Sum_probs=199.2

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..++||.|++|.||+|+.. +|+.||+|++......  .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            4788899999999999999875 6889999998754321  224567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++ ++.+++........+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+|++|||+++......
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            9985 8888886655445689999999999999999999998   99999999999999999999999999998654433


Q ss_pred             CCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccccchhhhc-----
Q 001440          966 SNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLDRTLDEIL----- 1032 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~~~~~----- 1032 (1077)
                      .......++..|+|||++.+. .++.++||||+|+++||+++|+.||..........       ......+..+.     
T Consensus       155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            333445678899999988654 56889999999999999999999986332110000       00000000000     


Q ss_pred             CCCCCCCCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 DPRLPAPSC-----NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 ~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+....     ........+.+++.+||+.||++||+++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            001110000     00112346789999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-33  Score=309.41  Aligned_cols=260  Identities=21%  Similarity=0.272  Sum_probs=197.6

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |++.+.||.|++|.||+|... +|+.||+|++...... ....+.+.+|+..++.++|||++++++++.+++..++||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            567889999999999999764 7899999998654322 22245678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      ++ ++|.+++..... ..+++.+++.++.|++.|++|||+.   +++||||+|+||+++.++.++++|||.++.......
T Consensus        80 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          80 LD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             cC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            95 689999865442 3588999999999999999999998   999999999999999999999999999976544333


Q ss_pred             CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------cc----------ccch
Q 001440          967 NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NL----------DRTL 1028 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~----------~~~~ 1028 (1077)
                      ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........       ..          .+..
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            33344668899999987654 578899999999999999999999864322110000       00          0000


Q ss_pred             hhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1029 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ........+............+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            000000000000011122346889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.8e-33  Score=310.93  Aligned_cols=257  Identities=23%  Similarity=0.309  Sum_probs=198.6

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSF  881 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  881 (1077)
                      .++|++.+.||+|+||.||+|.+. +++.||+|.+...... ......+.+|+.++++++||||+++++++...  ...+
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            357888999999999999999776 6889999998654322 12234567899999999999999999998877  8899


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||++ ++|.+++....  ..+++.++..++.|++.||+|||+.   +++|+||||+||+++.++.+|++|||+++..
T Consensus        83 lv~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          83 MVMEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            9999997 49998886543  2588999999999999999999998   9999999999999999999999999999877


Q ss_pred             CCCCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccchh----
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRTLD---- 1029 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~~---- 1029 (1077)
                      ...........++..|+|||++.+. .++.++||||+|+++|||++|+.||...........       .....+.    
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            6544444455678899999988754 468899999999999999999999864322110000       0000000    


Q ss_pred             --------------hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1030 --------------EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1030 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                                    ......++.     ......+.+++++||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPA-----LSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccc-----cCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                          000011110     002346789999999999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-32  Score=305.88  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=205.0

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..+.|+..+.||+|++|.||+|.++ +++.||+|++.....    ..+.+.+|++.++.++|+|++++++++......++
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   92 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV   92 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence            3456788889999999999999776 688999999865422    35678899999999999999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |+||+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+....
T Consensus        93 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999999997653  3588999999999999999999998   99999999999999999999999999987655


Q ss_pred             CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      ..........++..|+|||++.+..++.++||||||+++|||++|+.||......        .....+.....+. ...
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~-~~~  238 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTKGIPP-LKN  238 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcCCCC-Ccc
Confidence            4433334456788999999998888999999999999999999999998633221        1111111111111 011


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .......+.+++.+||+.+|.+||+++|+++.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11123468899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-33  Score=305.65  Aligned_cols=251  Identities=26%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||.|+||.||+|... +++.||+|.+...........+.+.+|+..+++++||||+++++++.++...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999775 689999999876544443456789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++...   ..+++.++..++.|+++|+.|||+.   +++|+||+|+||+++.++.++++|||.+.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999999654   3478899999999999999999998   99999999999999999999999999998765432


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                       ......|+..|+|||++.+..++.++|+||+|+++|++++|+.||......     ................+.    .
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~----~  224 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIRAKQETADVLYPA----T  224 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHHHHhccccccCcc----c
Confidence             223456888999999999888999999999999999999999998743221     011111111111222221    2


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCH--HHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTM--QKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~--~evl~ 1073 (1077)
                      ....+.+++.+||+.||.+||++  +|+++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            23578899999999999999999  77654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=9.9e-33  Score=306.01  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=193.4

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHH-hcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.......  ...++..|+.. ++..+||||+++++++..++..++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            46888999999999999999765 68999999987543222  13344555554 6667999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          884 YEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |||++ |+|.+++.... ....+++.++..++.|++.|++|||+++  +++||||||+||+++.++.+||+|||+++...
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            99996 68888875432 2345889999999999999999999853  89999999999999999999999999998654


Q ss_pred             CCCCCcccccccccccCcccccc----CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYT----MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      ... ......++..|+|||++.+    ..++.++||||||+++|||++|+.||......       .+..........+.
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~  227 (283)
T cd06617         156 DSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-------FQQLKQVVEEPSPQ  227 (283)
T ss_pred             ccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-------HHHHHHHHhcCCCC
Confidence            322 1233467889999998864    45688999999999999999999998632110       01111111111110


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        ......+..+.+++.+||+.+|++||+++|+++
T Consensus       228 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         228 --LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              001122346889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-33  Score=310.17  Aligned_cols=249  Identities=24%  Similarity=0.337  Sum_probs=210.2

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ...|.+...||+|.|+.|..|++. ++..||+|.+++...... ..+.+.+|+++|+.++|||||+++.+.+.+...|+|
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            457888999999999999999765 789999999988754443 355699999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+.+|.+++|+.+...   +...++..+..|+..|++|||++   .|||||||++||+++.+..+||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999977654   34478888999999999999999   999999999999999999999999999998873


Q ss_pred             CCCCcccccccccccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                       .....++.|++.|.|||++.+..| ++++|+||+|+++|.+++|..||+.        ......-...+..++..+...
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG--------~~lk~Lr~rvl~gk~rIp~~m  278 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDG--------QNLKELRPRVLRGKYRIPFYM  278 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCC--------cccccccchheeeeeccccee
Confidence             344577899999999999998877 5789999999999999999999972        223333334444444443322


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .    .+..+++++++-.+|.+|++++++++
T Consensus       279 s----~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  279 S----CDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             e----chhHHHHHHhhccCccccCCHHHhhh
Confidence            2    24567899999999999999999875

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-32  Score=305.95  Aligned_cols=261  Identities=22%  Similarity=0.332  Sum_probs=199.8

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|+||.||+|++. +|+.||+|++....... .....+.+|+.++++++||||+++++++..+...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            4788899999999999999764 68999999987653222 235678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+ +++|.+++....  ..+++.+++.++.||+.|++|||+.   +++|+||||+||+++.++.++++|||++.......
T Consensus        80 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          80 YM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             cc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            99 999999986543  4488999999999999999999998   99999999999999999999999999998765433


Q ss_pred             C-CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccc---------cc
Q 001440          966 S-NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLD---------RT 1027 (1077)
Q Consensus       966 ~-~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~---------~~ 1027 (1077)
                      . ......++..|+|||++.+. .++.++||||+|+++|||++|..||.........       .....         ..
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            2 23445689999999988654 4688999999999999999998777532210000       00000         00


Q ss_pred             hhhhcCCCCCC-C-CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1028 LDEILDPRLPA-P-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1028 ~~~~~~~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...+..+.... + .....+....+.+++.+||++||++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00000000000 0 00001223578899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-32  Score=296.77  Aligned_cols=249  Identities=30%  Similarity=0.468  Sum_probs=203.2

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..+.||+|++|.||+|... +++.|++|++.....   ...+.+.+|+..++.++|++++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            4778899999999999999775 688999999876533   336788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++....  ..+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        78 ~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          78 FCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             cCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            999999999986643  3588999999999999999999998   99999999999999999999999999998766543


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      . .....++..|+|||++.+..++.++||||||+++|+|++|+.||.........     ........+..+..    ..
T Consensus       153 ~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~~----~~  222 (253)
T cd05122         153 A-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL-----FKIATNGPPGLRNP----EK  222 (253)
T ss_pred             c-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHHhcCCCCcCcc----cc
Confidence            2 34557889999999998888999999999999999999999998643211000     00000001111111    11


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+.+++.+||+.||++|||++|+++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1346889999999999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.9e-33  Score=308.07  Aligned_cols=254  Identities=26%  Similarity=0.360  Sum_probs=193.6

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +|...+.||+|+||.||++... +++.||+|++......  .....+.+|+..+.++. |+||+++++++..++..+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            4556678999999999999765 6899999998754322  34567889999999996 999999999999999999999


Q ss_pred             eecCCCCHHHHHhc--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          885 EYLEMGSLAMILSN--ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       885 E~~~~g~L~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||++. ++.++...  ......+++..+..++.|++.|++|||+..  +++||||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            99864 55443321  111245888999999999999999999743  89999999999999999999999999997654


Q ss_pred             CCCCCcccccccccccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC-
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTM---KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA- 1038 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1038 (1077)
                      .... .....|+..|+|||++.+.   .++.++||||+||++|||++|+.||.....       ......+......+. 
T Consensus       160 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~  231 (288)
T cd06616         160 DSIA-KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-------VFDQLTQVVKGDPPIL  231 (288)
T ss_pred             cCCc-cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-------HHHHHhhhcCCCCCcC
Confidence            3322 2334678899999998766   689999999999999999999999864321       111111111111110 


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +..........+.+++.+||++||++|||++||++
T Consensus       232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111223457889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-33  Score=333.55  Aligned_cols=257  Identities=26%  Similarity=0.443  Sum_probs=206.2

Q ss_pred             HhcCCCccceecccCCceEEEEEec----C----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS----S----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFC  874 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  874 (1077)
                      ..++..+.+.+|+|.||.||+|...    .    ...||||..+.....  .+.+.+..|+.+++.+ +|+||+.++|+|
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~  371 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGAC  371 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence            3344456669999999999999642    1    356999999876443  5578899999999999 699999999999


Q ss_pred             eeCCeeEEEEeecCCCCHHHHHhcCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCC
Q 001440          875 SHARHSFIVYEYLEMGSLAMILSNAT-----------SA--EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKN  941 (1077)
Q Consensus       875 ~~~~~~~lV~E~~~~g~L~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  941 (1077)
                      ..++..++|+||+..|+|.+|++..+           ..  ..++..+.+.++.|||.|++||++.   ++||||+.++|
T Consensus       372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN  448 (609)
T KOG0200|consen  372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN  448 (609)
T ss_pred             ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence            99999999999999999999998765           01  1388899999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEecccccccCCCCCCCc-cccc--ccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccc
Q 001440          942 VLLDLEYEAHVSDFGISKSLKPDSSNW-TELA--GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSI 1017 (1077)
Q Consensus       942 Ill~~~~~~kl~Dfgla~~~~~~~~~~-~~~~--g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~ 1017 (1077)
                      |+++.+..+||+|||+|+......... +...  -+..|||||.+....|+.|+|||||||++||++| |..||..... 
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-  527 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-  527 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence            999999999999999999765543322 2222  3567999999999999999999999999999999 7888753110 


Q ss_pred             cccCcccccchhhhcCCCC-CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1018 CSTSSNLDRTLDEILDPRL-PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1018 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                            ..+.++.+.+++. ..|. ..   ..+++++|+.||+.+|++||++.|+++.++
T Consensus       528 ------~~~l~~~l~~G~r~~~P~-~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~  577 (609)
T KOG0200|consen  528 ------TEELLEFLKEGNRMEQPE-HC---SDEIYDLMKSCWNADPEDRPTFSECVEFFE  577 (609)
T ss_pred             ------HHHHHHHHhcCCCCCCCC-CC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHH
Confidence                  1222333333332 3322 22   336889999999999999999999999875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.1e-33  Score=303.37  Aligned_cols=246  Identities=24%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|+||.||+|.+. +|+.||+|.+...........+.+.+|+.++++++||||+++++.+..++..++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999876 5899999998765444444567889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC------
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS------  966 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------  966 (1077)
                      .+++.+..   .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++........      
T Consensus        81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            99997643   478899999999999999999998   999999999999999999999999999876543321      


Q ss_pred             --CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          967 --NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       967 --~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ......++..|+|||+.....++.++||||||+++||+++|+.||....        .............+.+...  
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~~--  224 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--------PEEIFQNILNGKIEWPEDV--  224 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHhcCCcCCCccc--
Confidence              2234567889999999988889999999999999999999999986322        1122222222222222111  


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      .....+.+++.+||+.+|++|||+.++.+.|
T Consensus       225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            1235688999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.5e-32  Score=303.44  Aligned_cols=242  Identities=21%  Similarity=0.290  Sum_probs=186.4

Q ss_pred             eecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHH---HhcCCCCCceeeEEEEEeeCCeeEEEEeecC
Q 001440          813 CIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVK---SLTEIRHRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  888 (1077)
                      .||+|+||.||+|... +++.||+|.+.............+.+|..   .+...+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            3899999999999764 68899999886543332222233334433   3344579999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc
Q 001440          889 MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW  968 (1077)
Q Consensus       889 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  968 (1077)
                      +|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||++.......  .
T Consensus        81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--~  152 (279)
T cd05633          81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (279)
T ss_pred             CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--c
Confidence            99999998654   3488999999999999999999999   99999999999999999999999999987554322  2


Q ss_pred             ccccccccccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhh---cCCCCCCCCCCcH
Q 001440          969 TELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI---LDPRLPAPSCNIR 1044 (1077)
Q Consensus       969 ~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 1044 (1077)
                      ....|+..|+|||+.. +..++.++||||+||++|||++|+.||......     .. ......   .....+      .
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~~~~~~~------~  220 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DK-HEIDRMTLTVNVELP------D  220 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCc-----CH-HHHHHHhhcCCcCCc------c
Confidence            3346899999999886 456889999999999999999999998632210     00 011111   111111      1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCC-----CHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRP-----TMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1074 (1077)
                      .....+.+++.+||+.||++||     +++|+++.
T Consensus       221 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2345688999999999999999     59998763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.8e-32  Score=305.59  Aligned_cols=262  Identities=21%  Similarity=0.305  Sum_probs=196.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|++|+||+|... +|+.||+|++....... ...+.+.+|+.++++++||||+++++++.++...++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            47889999999999999999765 68899999986543221 22456788999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CCceEEecccccccCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~  963 (1077)
                      ||++ +++.+++..... ...++..+..++.||+.|++|||++   +++|+||+|+||+++. ++.+|++|||++.....
T Consensus        81 e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             eccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            9996 578887755432 2357788889999999999999998   9999999999999985 56799999999976544


Q ss_pred             CCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccccchh------
Q 001440          964 DSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLDRTLD------ 1029 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~~------ 1029 (1077)
                      .........+++.|+|||++.+ ..++.++||||+|+++|||+||+.||..........       ......+.      
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        156 PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence            4333344567899999998865 457899999999999999999999986332110000       00000000      


Q ss_pred             --hhcCCCCCCCC--CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1030 --EILDPRLPAPS--CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1030 --~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        ....+..+...  .........+.+++.+|++.+|++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              00000111000  001112345789999999999999999999986

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.4e-32  Score=306.77  Aligned_cols=263  Identities=18%  Similarity=0.252  Sum_probs=196.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCe----
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARH----  879 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----  879 (1077)
                      ++|+..+.||+|+||.||+|.+. +++.||+|++...... ......+.+|+.+++.++ ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            46888999999999999999765 6899999987654322 222456788999999995 6999999999876655    


Q ss_pred             -eEEEEeecCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CCceEEecc
Q 001440          880 -SFIVYEYLEMGSLAMILSNATS--AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EYEAHVSDF  955 (1077)
Q Consensus       880 -~~lV~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Df  955 (1077)
                       .|+||||+++ ++.+++.....  ...+++.+++.++.||+.||+|||+.   +|+||||||+||+++. ++.+|++||
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~df  155 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADL  155 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeec
Confidence             8999999985 78888765432  24578999999999999999999999   9999999999999998 899999999


Q ss_pred             cccccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccc
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRT 1027 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~ 1027 (1077)
                      |+++.+...........+++.|+|||++.+ ..++.++||||||+++|||++|..||...........       .....
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         156 GLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             ccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            999876544333344467889999998765 4578999999999999999999999864322110000       00000


Q ss_pred             hhhh-------cCCCCCC--CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 LDEI-------LDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~~~~-------~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....       ..+....  ...........+.+++.+||++||++||+++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000       0000000  00000123356889999999999999999999975

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.1e-32  Score=304.56  Aligned_cols=260  Identities=19%  Similarity=0.229  Sum_probs=186.7

Q ss_pred             hcCCCccceecccCCceEEEEEecC----CCEEEEEEccCCccchhhH--------HHHHHHHHHHhcCCCCCceeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTC--------QQEFLNEVKSLTEIRHRNIVKFYG  872 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~  872 (1077)
                      .++|.+.+.||+|+||+||+|.+.+    +..+|+|...........+        ......+...+..++|++++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3689999999999999999997654    3456666543221110000        111233445566779999999999


Q ss_pred             EEeeCC----eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          873 FCSHAR----HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       873 ~~~~~~----~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      ++....    ..++++|++.. ++.+.+....   ..++..+..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            875543    44788887744 6666664432   246778899999999999999998   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCC-------cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC
Q 001440          949 EAHVSDFGISKSLKPDSSN-------WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS 1021 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~ 1021 (1077)
                      .++|+|||+|+.+......       .....||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999876432211       123468999999999999999999999999999999999999997442111100


Q ss_pred             -cccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1022 -SNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1022 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       ....+....+..+....+.     ....+.+++..||+.+|++||+++++.+.|+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKN-----ANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCC-----CCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             0011112222223222221     1346889999999999999999999999874

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.5e-32  Score=296.10  Aligned_cols=253  Identities=28%  Similarity=0.399  Sum_probs=207.0

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|+||.||++... +++.||+|++...... ....+++.+|++.++.++|||++++.+.+......++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            4788899999999999999765 6889999998765432 2346678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          886 YLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |+++++|.+++.... ....+++.++..++.+++.|++|||+.   +++|+||+|+||+++.++.++++|||.+......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987643 134588999999999999999999999   9999999999999999999999999999876554


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ........|++.|+|||...+..++.++||||+|+++|+|++|+.||....        ..+..........+....   
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~~~~---  225 (258)
T cd08215         157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQYPPIPS---  225 (258)
T ss_pred             cceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCCCCCCCC---
Confidence            433344578899999999988889999999999999999999999986332        112222222222221111   


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++||++.|+++.
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            223468899999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.6e-32  Score=305.51  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=196.8

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|+..+.||+|+||.||+|+.. +++.||+|++.............+.+|+.+++.++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677888999999999999764 688999999875433333445678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |++ |++.+++....  ..+++.++..++.|++.|+.|||+.   +|+||||+|+||+++.++.+|++|||++...... 
T Consensus       106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-  178 (317)
T cd06635         106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA-  178 (317)
T ss_pred             CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence            997 47777765432  3488999999999999999999998   9999999999999999999999999998754432 


Q ss_pred             CCcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          966 SNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                         ....++..|+|||++.   ...++.++|||||||++|||++|+.||.....        ......+.....+..  .
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~~~~--~  245 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPTL--Q  245 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhccCCCC--C
Confidence               2346788999999874   45688999999999999999999999763211        111111211111111  1


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .......+.+++.+||+.+|++||+++|+++.
T Consensus       246 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  277 (317)
T cd06635         246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH  277 (317)
T ss_pred             CccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence            11233468899999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-32  Score=304.52  Aligned_cols=243  Identities=27%  Similarity=0.408  Sum_probs=195.8

Q ss_pred             ceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      ..||+|+||.||+|..+ +++.||+|++....   ......+.+|+.+++.++|+|++++++++...+..++||||++++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            56999999999999764 78999999875432   223567889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE  970 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  970 (1077)
                      +|.+++...    .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++............
T Consensus       103 ~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~  175 (292)
T cd06657         103 ALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  175 (292)
T ss_pred             cHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccc
Confidence            999987543    378899999999999999999998   9999999999999999999999999998766544333344


Q ss_pred             ccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHH
Q 001440          971 LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       971 ~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1050 (1077)
                      ..++..|+|||++.+..++.++||||+|+++|||++|..||........     .........+....    .......+
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~l  246 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-----MKMIRDNLPPKLKN----LHKVSPSL  246 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhhCCcccCC----cccCCHHH
Confidence            5688999999999888889999999999999999999999863221100     00111111111111    11223467


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHh
Q 001440         1051 MEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+++.+||+.||.+||+++|+++
T Consensus       247 ~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         247 KGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHhCCcccCcCHHHHhc
Confidence            88999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=283.06  Aligned_cols=253  Identities=19%  Similarity=0.333  Sum_probs=208.7

Q ss_pred             ceecccCCceEEEE-EecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          812 HCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      +.||+|+|++|--+ ...+|..||||++.+.   ....+.++.+|++++.+. .|+||+.++++|++++..|+|||-|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence            46999999999988 5678999999999875   334477889999999999 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC---CceEEecccccccCCCC--
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPD--  964 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfgla~~~~~~--  964 (1077)
                      |.|..++.+..   .+++.++.++.++||.||.|||.+   ||.|||+||+|||....   ..+|||||.+..-+...  
T Consensus       161 GplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  161 GPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             chHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            99999997654   477899999999999999999999   99999999999999765   45899999887643221  


Q ss_pred             -----CCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhCCCCCCcccc-cccc--Cc----ccccc
Q 001440          965 -----SSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISS-ICST--SS----NLDRT 1027 (1077)
Q Consensus       965 -----~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~~~--~~----~~~~~ 1027 (1077)
                           .....+.+|+..|||||+..     ...|+.+.|.||+||++|-|++|.+||...-. .++.  .+    .....
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L  314 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL  314 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence                 12234678999999999763     34688999999999999999999999974321 1111  11    22455


Q ss_pred             hhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ++.+-++++..|...+...+....+++...+..||.+|.++.++++
T Consensus       315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            6777788888887777777778888999999999999999998875

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-32  Score=298.86  Aligned_cols=251  Identities=25%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|+||.||+++.. +++.+|+|.+....... ....++.+|+.+++.++|+||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            4778899999999999999654 78899999987543332 335677889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          886 YLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |+++++|.+++.+... ...+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999999866322 24578899999999999999999999   9999999999999999999999999999876544


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ......++..|+|||+..+..++.++|+||+|+++||+++|+.||.....        ......+.....+...   .
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~---~  223 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLRYKVQRGKYPPIP---P  223 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCCCCCc---h
Confidence              22334678899999999998999999999999999999999999863221        1111222222222211   1


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+.+++.+||+.+|++||++.|+++.
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         224 IYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            334568999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-33  Score=281.12  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=208.8

Q ss_pred             HhcCCCcc-ceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee----
Q 001440          804 ATNDFDEE-HCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH----  876 (1077)
Q Consensus       804 ~~~~~~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----  876 (1077)
                      .+++|++. ++||-|-.|.|-.+.. .+|+++|+|++..        ..+..+|++..=.. .|||||.++++++.    
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            45667653 5799999999999955 4899999998854        23445677765544 69999999999853    


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC---CCceEEe
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL---EYEAHVS  953 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~kl~  953 (1077)
                      .....+|||.|+||.|+..+..... ..+++.++-+|++||+.|+.|||+.   .|+||||||+|+|.+.   +..+|++
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEec
Confidence            3567899999999999999977654 4589999999999999999999999   9999999999999975   4679999


Q ss_pred             cccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC
Q 001440          954 DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033 (1077)
Q Consensus       954 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1077)
                      |||+|+.-.. .....+..-|+.|.|||++....|+...|+||+||+||-|++|.+||.....    .....++...+..
T Consensus       207 DfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg----~aispgMk~rI~~  281 (400)
T KOG0604|consen  207 DFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG----LAISPGMKRRIRT  281 (400)
T ss_pred             ccccccccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC----ccCChhHHhHhhc
Confidence            9999986543 3445667789999999999988999999999999999999999999874332    1223455666777


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1034 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +.+..|...+...+....++|+++|+.+|.+|.|++|+++
T Consensus       282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            7777777777888888999999999999999999999875

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.4e-32  Score=306.92  Aligned_cols=262  Identities=27%  Similarity=0.314  Sum_probs=196.2

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSF  881 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  881 (1077)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....... .....+.+|+.++++++|+||+++++++...  +..+
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            467999999999999999999764 68999999986443221 1123456799999999999999999998655  5689


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++ +|.+++....  ..+++.++..++.|++.|++|||+.   +++||||||+||+++.++.+||+|||.+...
T Consensus        85 lv~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~  158 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY  158 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence            99999974 8888886543  4588999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccchhhhc-
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRTLDEIL- 1032 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~~~~~- 1032 (1077)
                      ...........++..|+|||++.+ ..++.++||||+|+++|||++|+.||...........       .......... 
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07845         159 GLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSD  238 (309)
T ss_pred             CCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhc
Confidence            554333344456788999998865 4578999999999999999999999864322110000       0000000000 


Q ss_pred             ---CCC--CCC-CCCCc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1033 ---DPR--LPA-PSCNI----RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1033 ---~~~--~~~-~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ...  .+. +....    ......+.+++.+|++.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               000  000 00000    012346778999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-32  Score=306.07  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=195.3

Q ss_pred             CCCccceecccCCceEEEEEec---CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSF  881 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~  881 (1077)
                      +|++.+.||+|+||.||+|...   +++.||+|.+...........+.+.+|+.+++.++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999999765   4789999998764322222345678899999999999999999999888  7899


Q ss_pred             EEEeecCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC----CCceEEecc
Q 001440          882 IVYEYLEMGSLAMILSNATS--AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL----EYEAHVSDF  955 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~kl~Df  955 (1077)
                      +||||+++ ++.+++.....  ...++...+..++.|++.|++|||+.   +|+||||||+||+++.    ++.+|++||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 67666643322  23578889999999999999999999   9999999999999999    899999999


Q ss_pred             cccccCCCCCC---CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-----cccc
Q 001440          956 GISKSLKPDSS---NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-----NLDR 1026 (1077)
Q Consensus       956 gla~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-----~~~~ 1026 (1077)
                      |+++.......   ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........     ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987644322   12334678899999987664 578999999999999999999999864322110000     0000


Q ss_pred             chh--------------------hh--cCCCCCCCCCCcH-------HHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1027 TLD--------------------EI--LDPRLPAPSCNIR-------DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1027 ~~~--------------------~~--~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+.                    ..  .......+.....       .....+.+++.+||++||++|||++|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            000                    00  0000000000000       22346889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-32  Score=295.59  Aligned_cols=249  Identities=24%  Similarity=0.437  Sum_probs=204.4

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|++.+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++|+|++++++++.++...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            4778899999999999999665 6789999999765433 2345788999999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++++|.+++...   ..+++..+..++.|++.|+.|||+.   +|+||||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          80 YAENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             cCCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            99999999998654   3588999999999999999999998   99999999999999999999999999998776554


Q ss_pred             CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHH
Q 001440          966 SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1045 (1077)
                      .......++..|+|||+..+..++.++||||+|+++|++++|+.||......       ............+.+.    .
T Consensus       154 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~----~  222 (254)
T cd06627         154 KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQDDHPPLPE----G  222 (254)
T ss_pred             ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhccCCCCCCC----C
Confidence            4444567889999999998888899999999999999999999998633211       0011111111111111    1


Q ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1046 KLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1046 ~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+.+++.+||+.+|++||+++|++.
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         223 ISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            2346889999999999999999999975

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.3e-32  Score=294.17  Aligned_cols=250  Identities=27%  Similarity=0.387  Sum_probs=204.7

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIV  883 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV  883 (1077)
                      +|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|+..+++++||||+++++++...  ...++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            4777889999999999999776 7899999998765432 33467889999999999999999999999888  899999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      +||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          80 LEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            99999999999987653   588999999999999999999998   999999999999999999999999999987665


Q ss_pred             CCC--CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC-CCCCCCC
Q 001440          964 DSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-PRLPAPS 1040 (1077)
Q Consensus       964 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1040 (1077)
                      ...  ......++..|+|||...+..++.++||||||+++|++++|+.||.....       .......... ...+.  
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~--  224 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKIGSSGEPPE--  224 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhccccCCCcC--
Confidence            433  13445688999999999888899999999999999999999999864331       0011111111 11111  


Q ss_pred             CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       ........+.+++.+|++.||++||++.|+++
T Consensus       225 -~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         225 -IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence             11122457889999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7e-32  Score=308.79  Aligned_cols=259  Identities=22%  Similarity=0.332  Sum_probs=196.3

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----  877 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----  877 (1077)
                      ..++|+..+.||+|+||.||+|+.. +|+.||+|++..... +.....++.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4578999999999999999999764 789999999865432 223345677899999999999999999988543     


Q ss_pred             -CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          878 -RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       878 -~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                       ...++||||++ +++.+.+...     ++..++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg  163 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  163 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence             35799999996 4888877432     67889999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccc------
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSN------ 1023 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~------ 1023 (1077)
                      +++....... .....++..|+|||++.+..++.++||||+||++|+|++|+.||.........       ...      
T Consensus       164 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (353)
T cd07850         164 LARTAGTSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS  242 (353)
T ss_pred             cceeCCCCCC-CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            9987543322 23346788999999999999999999999999999999999998633211000       000      


Q ss_pred             -cccchhhhcCCC----------------CCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1024 -LDRTLDEILDPR----------------LPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1024 -~~~~~~~~~~~~----------------~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       .........+.+                .+... .........+.+++.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         243 RLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             000000000000                00000 001122446789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.6e-32  Score=302.15  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=205.0

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ++|.+.+.||+|+||.||+|... +|+.||+|.+...........+.+.+|+.++++++ ||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999765 78999999987644333344577889999999998 99999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++++|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            99999999999997643   488999999999999999999998   999999999999999999999999999986644


Q ss_pred             CCC--------------------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcc
Q 001440          964 DSS--------------------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023 (1077)
Q Consensus       964 ~~~--------------------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~ 1023 (1077)
                      ...                    ......++..|+|||+.....++.++||||+|+++||+++|+.||.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------  227 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------  227 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------
Confidence            321                    12234578899999999888899999999999999999999999874321       


Q ss_pred             cccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCH----HHHHh
Q 001440         1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTM----QKVSQ 1073 (1077)
Q Consensus      1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~ 1073 (1077)
                       ...+..........+..    ....+.+++.+||+.+|++||++    +|+++
T Consensus       228 -~~~~~~~~~~~~~~~~~----~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         228 -YLTFQKILKLEYSFPPN----FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHHHHHhcCCCCCCc----cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             11122222222222221    13468899999999999999999    88775

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-32  Score=322.58  Aligned_cols=267  Identities=16%  Similarity=0.215  Sum_probs=187.3

Q ss_pred             HhcCCCccceecccCCceEEEEEec--CCCEEEEEEc--------------cCCccchhhHHHHHHHHHHHhcCCCCCce
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS--SGEIVAVKKF--------------HSPLLSEMTCQQEFLNEVKSLTEIRHRNI  867 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~--------------~~~~~~~~~~~~~~~~e~~~l~~l~h~ni  867 (1077)
                      ..++|++.+.||+|+||+||+|..+  .+..+++|.+              .+...........+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            3578999999999999999998654  2222222211              11101112234568899999999999999


Q ss_pred             eeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeC
Q 001440          868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS--AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD  945 (1077)
Q Consensus       868 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~  945 (1077)
                      +++++++.+++..|+|+|++. +++.+++.....  .......++..++.|++.||+|||+.   +|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence            999999999999999999985 577777644321  12234567788999999999999998   999999999999999


Q ss_pred             CCCceEEecccccccCCCCCCC-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccc-cc--c--
Q 001440          946 LEYEAHVSDFGISKSLKPDSSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS-IC--S-- 1019 (1077)
Q Consensus       946 ~~~~~kl~Dfgla~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~-~~--~-- 1019 (1077)
                      .++.+||+|||+++.+...... .....|+..|+|||++.+..++.++|||||||++|||++|+.++..... ..  .  
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            9999999999999876544322 2346799999999999999999999999999999999998865321110 00  0  


Q ss_pred             -----cC---cccc----cchhhhcCCCCCCCCCCcH------HHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1020 -----TS---SNLD----RTLDEILDPRLPAPSCNIR------DKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1020 -----~~---~~~~----~~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                           ..   ....    ..++.+....+........      .....+.+++.+|+++||++|||++|+++.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                 00   0000    0000000000000000000      012356678999999999999999999863

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-34  Score=336.96  Aligned_cols=251  Identities=28%  Similarity=0.410  Sum_probs=200.8

Q ss_pred             hcCCCccceecccCCceEEEE-EecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      +-+|+....||.|.||.||-| ...+|+..|||.+.-.... ......+.+|..++..++|||+|+++|+-.+....+|.
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            446777788999999999999 5568999999987654322 33466788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||||++|+|.+.+...+.   .++.-...+..|++.|++|||+.   |||||||||.||+++.+|-+|++|||.|+.+..
T Consensus      1313 MEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999976653   23344455788999999999999   999999999999999999999999999998766


Q ss_pred             CCCC----cccccccccccCccccccC---CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC-CC
Q 001440          964 DSSN----WTELAGTIGYVAPELAYTM---KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-PR 1035 (1077)
Q Consensus       964 ~~~~----~~~~~g~~~y~aPE~~~~~---~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 1035 (1077)
                      ..+.    ....+||+.|||||++.+.   +...++||||+|||+.||+||+.||...+..       ......+.. ..
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~gh~ 1459 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAAGHK 1459 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhccCC
Confidence            5432    3457899999999999754   4677999999999999999999998743321       111111111 22


Q ss_pred             CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .+.|.    .....-.+++.+|+..||++|.++.|+++
T Consensus      1460 Pq~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 PQIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             CCCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            22222    24456678999999999999999988876

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-31  Score=294.15  Aligned_cols=252  Identities=23%  Similarity=0.293  Sum_probs=197.9

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCcc--chhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--Cee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLL--SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHS  880 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~  880 (1077)
                      .+|++.+.||+|+||.||+|... +++.||+|.+.....  ........+.+|+.++++++|+||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46888999999999999999764 689999998753211  1223456788999999999999999999998654  468


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+++++|.+++....   .+++.++..++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccc
Confidence            89999999999999986543   367889999999999999999998   999999999999999999999999999986


Q ss_pred             CCCC---CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          961 LKPD---SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       961 ~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      ....   ........++..|+|||++.+..++.++|||||||++||+++|+.||......       .........+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~  228 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTKP  228 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-------HHHHHHHcCCCCC
Confidence            5432   11223456889999999999888999999999999999999999998632111       1111111111111


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                         ..+......+.+++.+||+ +|..||++.+++..
T Consensus       229 ---~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         229 ---MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             ---CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence               1112334568899999999 57999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.7e-32  Score=301.26  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=194.5

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  882 (1077)
                      .++|++.+.||+|+||.||+|.+. +++.||||++......  ....++..|+..+... +||||+++++++.++...++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~   91 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI   91 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence            467888999999999999999876 4899999998754322  2245566677666666 59999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||++ +++.++.....  ..+++.++..++.|++.|++|||+..  +|+||||+|+||+++.++.+||+|||++..+.
T Consensus        92 v~e~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~  166 (296)
T cd06618          92 CMELMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV  166 (296)
T ss_pred             EeeccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence            999985 47777765432  35888999999999999999999732  89999999999999999999999999997654


Q ss_pred             CCCCCcccccccccccCccccccCC----CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMK----VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      .... .....++..|+|||++.+..    ++.++||||||+++|||++|+.||......       .+..........+.
T Consensus       167 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~  238 (296)
T cd06618         167 DSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-------FEVLTKILQEEPPS  238 (296)
T ss_pred             CCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-------HHHHHHHhcCCCCC
Confidence            3322 23345788999999987554    788999999999999999999998632111       11122222222111


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .. ........+.+++.+||+.||++||+++++++.
T Consensus       239 ~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         239 LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11 011223468899999999999999999999764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.98  E-value=1e-31  Score=304.15  Aligned_cols=255  Identities=21%  Similarity=0.277  Sum_probs=190.6

Q ss_pred             ceeccc--CCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecC
Q 001440          812 HCIGTG--GQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       812 ~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  888 (1077)
                      ..||+|  +||+||+|++. +|+.||+|.+....... ...+.+.+|+.+++.++||||+++++++..++..++|+||++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            346666  89999999764 78999999987543332 335778899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc
Q 001440          889 MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW  968 (1077)
Q Consensus       889 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  968 (1077)
                      +|++.+++..... ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+|++||+.+..........
T Consensus        83 ~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~  158 (328)
T cd08226          83 YGSANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA  158 (328)
T ss_pred             CCCHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence            9999999876542 3478889999999999999999998   99999999999999999999999998654332211110


Q ss_pred             -------ccccccccccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc----cc---------cc
Q 001440          969 -------TELAGTIGYVAPELAYTM--KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS----NL---------DR 1026 (1077)
Q Consensus       969 -------~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~----~~---------~~ 1026 (1077)
                             ....++..|+|||++.+.  .++.++||||+||++|||++|+.||...........    ..         ..
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence                   112345679999998764  478899999999999999999999864321100000    00         00


Q ss_pred             c---------------hhhh---------cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1027 T---------------LDEI---------LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1027 ~---------------~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .               .+..         .......  .........+.+++++||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRT--PSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccc--hhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            0               0000         0000000  011234567889999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.98  E-value=1.2e-31  Score=301.48  Aligned_cols=246  Identities=28%  Similarity=0.408  Sum_probs=193.5

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |...+.||+|+||+||+|+.. +++.||+|++...........+.+.+|+..++.++|||++++++++.+....|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556677999999999999764 6889999998754433334456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +. |++.+++....  ..+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++.++.+||+|||++......  
T Consensus       103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 57777775432  3478999999999999999999998   9999999999999999999999999998653322  


Q ss_pred             CcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCc
Q 001440          967 NWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                        ....|+..|+|||++.   ...++.++|||||||++|||++|..||.......        ..........+..  ..
T Consensus       175 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~--------~~~~~~~~~~~~~--~~  242 (313)
T cd06633         175 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNDSPTL--QS  242 (313)
T ss_pred             --CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH--------HHHHHHhcCCCCC--Cc
Confidence              3456888999999974   4568889999999999999999999976332111        1111111111110  01


Q ss_pred             HHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ......+.+++.+||+++|++||+++++++
T Consensus       243 ~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         243 NEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            112235788999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.98  E-value=5.5e-32  Score=303.57  Aligned_cols=248  Identities=27%  Similarity=0.394  Sum_probs=194.8

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      .|+..+.||+|+||.||+|+.. +++.||+|.+...........+++.+|+.+++.++|+|++++.+++......++|||
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            4667788999999999999765 678899998864332333335678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+. |++.+++....  ..+++.++..++.|++.|+.|||+.   +++||||+|+||+++.++.+|++|||++...... 
T Consensus        96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            996 68877765432  3478899999999999999999998   9999999999999999999999999998765433 


Q ss_pred             CCcccccccccccCccccc---cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          966 SNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~---~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                         ....++..|+|||++.   ...++.++|||||||++|||++|+.||......        ...........+..  .
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--------~~~~~~~~~~~~~~--~  235 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--------SALYHIAQNESPAL--Q  235 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--------HHHHHHhhcCCCCc--C
Confidence               2346788999999874   356788999999999999999999997532211        11111111111110  1


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .......+.+++.+||+.+|++||+++++++.
T Consensus       236 ~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            11233568899999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.98  E-value=3.5e-32  Score=309.36  Aligned_cols=262  Identities=23%  Similarity=0.339  Sum_probs=196.8

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeC--Ce
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHA--RH  879 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~  879 (1077)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++.... ........+.+|+.+++++ +||||+++++++...  ..
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            3467888999999999999999765 68899999886532 2223345677899999999 999999999998643  46


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .++||||++ ++|.+++...    .+.+.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||+++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            899999997 5999888653    477889999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCCC-----CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccc-
Q 001440          960 SLKPDSS-----NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLD- 1025 (1077)
Q Consensus       960 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~- 1025 (1077)
                      .......     ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||..........       .... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6644321     2234568899999998765 457889999999999999999999986332111000       0000 


Q ss_pred             -----------cchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1026 -----------RTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1026 -----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                                 ..+.....................+.+++.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                       0000000011110001111124568899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.3e-33  Score=289.51  Aligned_cols=245  Identities=24%  Similarity=0.353  Sum_probs=208.6

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..+|....+||+|+||.|-.|..+ +.+.+|||+++++......+.+-...|-++++-. +-|.++++..++...+..|.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            457889999999999999999555 5678999999887765555555556677777766 67899999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||||+.||+|.-.++....   +.+..+..+|..||-||-+||++   ||++||+|..|||+|.+|.+||+|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc
Confidence            9999999999888866543   45578889999999999999999   99999999999999999999999999998765


Q ss_pred             CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      -+.....+..||+.|+|||++...+|+..+|+|||||++|||+.|.+||+        .++.++.+..+++.....|.  
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd--------GeDE~elF~aI~ehnvsyPK--  571 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD--------GEDEDELFQAIMEHNVSYPK--  571 (683)
T ss_pred             cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC--------CCCHHHHHHHHHHccCcCcc--
Confidence            56667788999999999999999999999999999999999999999998        34455677777777766543  


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCC
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPT 1067 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs 1067 (1077)
                        ..+.+.+.+.+..+.+.|.+|.-
T Consensus       572 --slSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  572 --SLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             --cccHHHHHHHHHHhhcCCccccC
Confidence              33445778888999999999963

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.98  E-value=7.1e-32  Score=299.78  Aligned_cols=260  Identities=25%  Similarity=0.368  Sum_probs=196.8

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC--CeeEEEE
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVY  884 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~  884 (1077)
                      |++.+.||+|+||.||+|... +++.||+|++.... ........+.+|+.+++.++|||++++++++...  +..++|+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            567889999999999999776 58899999997653 2233356788999999999999999999999887  8999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++ ++.+++....  ..+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||++......
T Consensus        80 e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          80 EYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             ccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            99975 8888886542  3588999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CC-CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccch-------
Q 001440          965 SS-NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRTL------- 1028 (1077)
Q Consensus       965 ~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~~------- 1028 (1077)
                      .. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........       .....+       
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            32 2233456888999997764 4578999999999999999999999864321100000       000000       


Q ss_pred             -hhhcCCCCCCCC---CCcHH-HHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1029 -DEILDPRLPAPS---CNIRD-KLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1029 -~~~~~~~~~~~~---~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                       .....+....+.   ..... ....+.+++++||+.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             000000000000   00001 14568899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.98  E-value=1.5e-31  Score=293.51  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=191.6

Q ss_pred             HHHHHHhcCCCcccee--cccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEE
Q 001440          799 EEIVRATNDFDEEHCI--GTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFC  874 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~l--G~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~  874 (1077)
                      .+.....++|++.+.+  |+|+||.||++..+ +++.+|+|.+........        |+.....+ +||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--------e~~~~~~~~~h~~iv~~~~~~   78 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--------EPMVHQLMKDNPNFIKLYYSV   78 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--------hHHHHHHhhcCCCEEEEEEEE
Confidence            4445556677777766  99999999999654 688899998865322211        11111112 799999999999


Q ss_pred             eeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-ceEEe
Q 001440          875 SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVS  953 (1077)
Q Consensus       875 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~  953 (1077)
                      ..++..++||||+++|+|.+++....   .+++.++..++.|++.|+.|||+.   +++||||||+||+++.++ .++++
T Consensus        79 ~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         79 TTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             ecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEe
Confidence            99999999999999999999996543   588999999999999999999999   999999999999999998 99999


Q ss_pred             cccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcC
Q 001440          954 DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033 (1077)
Q Consensus       954 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1033 (1077)
                      |||+++.....    ....++..|+|||++.+..++.++||||+|+++|||++|+.||.......   ....... ....
T Consensus       153 dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~---~~~~~~~-~~~~  224 (267)
T PHA03390        153 DYGLCKIIGTP----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLL-KRQQ  224 (267)
T ss_pred             cCccceecCCC----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch---hhHHHHH-Hhhc
Confidence            99998765432    22457899999999999899999999999999999999999986322110   0011111 1111


Q ss_pred             CCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC-HHHHHh
Q 001440         1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT-MQKVSQ 1073 (1077)
Q Consensus      1034 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1073 (1077)
                      ...+    ........+.+++.+||+.+|.+||+ ++|+++
T Consensus       225 ~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 KKLP----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             ccCC----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            1111    11234457889999999999999996 598875

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.98  E-value=1e-31  Score=296.75  Aligned_cols=245  Identities=21%  Similarity=0.253  Sum_probs=187.4

Q ss_pred             eecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHH---HHHhcCCCCCceeeEEEEEeeCCeeEEEEeecC
Q 001440          813 CIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNE---VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e---~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  888 (1077)
                      .||+|+||.||+|... +++.||+|.+.............+..|   ...++..+||+|+++++++.+.+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999664 688999999876433322212223333   334555689999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc
Q 001440          889 MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW  968 (1077)
Q Consensus       889 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  968 (1077)
                      +|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||++.......  .
T Consensus        81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~  152 (278)
T cd05606          81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--P  152 (278)
T ss_pred             CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--C
Confidence            99999988643   3589999999999999999999998   99999999999999999999999999987654322  2


Q ss_pred             ccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHH
Q 001440          969 TELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047 (1077)
Q Consensus       969 ~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1077)
                      ....|+..|+|||++.++ .++.++||||+|+++|||++|+.||.......     ...............+.    ...
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~----~~s  223 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLTMAVELPD----SFS  223 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHHHHHhhccCCCCCC----cCC
Confidence            345689999999998754 68999999999999999999999986432110     01111111111111111    123


Q ss_pred             HHHHHHHHhccCCCCCCCC-----CHHHHHhh
Q 001440         1048 ISIMEVAISCLDENPDSRP-----TMQKVSQL 1074 (1077)
Q Consensus      1048 ~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1074 (1077)
                      ..+.+++.+|+..+|++||     +++|+++.
T Consensus       224 ~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         224 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            4688999999999999999     99998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.98  E-value=3.4e-32  Score=309.26  Aligned_cols=260  Identities=23%  Similarity=0.339  Sum_probs=194.1

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----C
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----R  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  878 (1077)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...  ........+.+|+.++++++||||+++++++...     .
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            468999999999999999999654 7899999998642  2222356678899999999999999999987544     3


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++|+||+++ ++.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        82 ~~~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          82 DVYIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             eEEEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            57999999974 88877743    2488899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCC---cccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCcccccc
Q 001440          959 KSLKPDSSN---WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDRT 1027 (1077)
Q Consensus       959 ~~~~~~~~~---~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~~ 1027 (1077)
                      +........   .....|+..|+|||++.+ ..++.++||||+||++|||++|+.||........       ......+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~  233 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED  233 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            865433221   223467899999998654 5688999999999999999999999853211000       00000011


Q ss_pred             hhhhcCCC-------CCCCCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1028 LDEILDPR-------LPAPSC-----NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1028 ~~~~~~~~-------~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      ...+....       .+....     ........+.+++.+||+.||++|||++|+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111000       000000     001123468899999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.98  E-value=3.9e-32  Score=308.77  Aligned_cols=262  Identities=23%  Similarity=0.307  Sum_probs=197.1

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-----C
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----R  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  878 (1077)
                      ..+|.+.+.||+|+||+||+|+.. +++.||||++...... ......+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            457899999999999999999654 7899999998754322 22345677899999999999999999987544     3


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++|+||+. ++|.+++...   ..+++.++..++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~  155 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA  155 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence            5799999996 6898888653   3488899999999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCcccccch--
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDRTL-- 1028 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~-- 1028 (1077)
                      +.............++..|+|||++.. ..++.++|||||||++|||++|+.||........       .........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07858         156 RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF  235 (337)
T ss_pred             cccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence            876544333344567889999998764 4688999999999999999999999863211000       000000000  


Q ss_pred             ------hhhcC--CCCCCC--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1029 ------DEILD--PRLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1029 ------~~~~~--~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                            .....  +..+.+  ..........+.+++++||+.+|++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                  00000  000000  00011234567899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.98  E-value=1.4e-31  Score=296.55  Aligned_cols=256  Identities=20%  Similarity=0.235  Sum_probs=191.3

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeC--CeeEEE
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHA--RHSFIV  883 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV  883 (1077)
                      |++.+.||+|+||.||+|... +++.||+|++.......  ......+|+..++++. |+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            567788999999999999754 68899999986542221  1234457888888885 99999999999887  889999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||++ |++.+++....  ..+++.++..++.|++.|++|||+.   +++||||+|+||+++. +.+||+|||+++....
T Consensus        79 ~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          79 FELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            99997 58888876533  3578999999999999999999999   9999999999999999 9999999999987644


Q ss_pred             CCCCcccccccccccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc------CcccccchhhhcCC--
Q 001440          964 DSSNWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST------SSNLDRTLDEILDP-- 1034 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~------~~~~~~~~~~~~~~-- 1034 (1077)
                      ... .....++..|+|||++. +..++.++||||+||++|||++|..||.........      .......+......  
T Consensus       152 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         152 KPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            322 23346788999999765 455788999999999999999999998643211100      00000000000000  


Q ss_pred             --CCCCCCC-------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1035 --RLPAPSC-------NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1035 --~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        ....+..       .....+..+.+++.+||+++|++||+++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence              0000000       01123467899999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.98  E-value=6.3e-32  Score=304.38  Aligned_cols=257  Identities=19%  Similarity=0.241  Sum_probs=189.8

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCC
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGS  891 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~  891 (1077)
                      +.+|.|+++.||++.. +++.||||++...... ....+.+.+|+..++.++||||+++++++.+....+++|||+++|+
T Consensus         8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             HhhcCCceEEEEEecC-CCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            3344445555555544 6899999998764322 2346789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC-----
Q 001440          892 LAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-----  966 (1077)
Q Consensus       892 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----  966 (1077)
                      +.+++..... ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||.+..+.....     
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          86 CEDLLKTHFP-EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             HHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            9999976432 3478889999999999999999999   999999999999999999999999998876543221     


Q ss_pred             --CcccccccccccCcccccc--CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccc----cc-----------
Q 001440          967 --NWTELAGTIGYVAPELAYT--MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD----RT----------- 1027 (1077)
Q Consensus       967 --~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~----~~----------- 1027 (1077)
                        ......++..|+|||++..  ..++.++|||||||++|||++|+.||..........+...    ..           
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence              1223456788999999875  3588999999999999999999999874322110000000    00           


Q ss_pred             -hh----hhcCCC--CCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1028 -LD----EILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1028 -~~----~~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                       ..    ...++.  ..............+.+++.+||++||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence             00    000000  001111122334568889999999999999999999863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=308.55  Aligned_cols=253  Identities=28%  Similarity=0.419  Sum_probs=197.1

Q ss_pred             CCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC------ee
Q 001440          808 FDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR------HS  880 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~  880 (1077)
                      |...+.||+|+||.||+|+ ..+|+.||||.+....  ....++...+|++++++++|||||+++++-++..      ..
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            4456789999999999998 4589999999997643  2334677889999999999999999999875543      56


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeC--CCCc--eEEeccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD--LEYE--AHVSDFG  956 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~--~~~~--~kl~Dfg  956 (1077)
                      .+|||||.+|+|+..+.+.....-++..+.+.+..+++.||.|||++   +|+||||||.||++-  .+|+  -||+|||
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            89999999999999998877666799999999999999999999998   999999999999994  3343  7999999


Q ss_pred             ccccCCCCCCCcccccccccccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCccc-----------
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL----------- 1024 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~----------- 1024 (1077)
                      .|+.+.++. .....+||..|.+||.+. .+.|+..+|.|||||++|+++||..||..........+..           
T Consensus       170 ~Arel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  170 AARELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             ccccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            999887654 678899999999999998 4889999999999999999999999987443221100000           


Q ss_pred             ccchhhh------cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCC
Q 001440         1025 DRTLDEI------LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066 (1077)
Q Consensus      1025 ~~~~~~~------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1066 (1077)
                      .-...+.      ....+|.+..........+...+..++..+|++|-
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            0000000      11234443333344445566667778888888887

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.98  E-value=9.3e-32  Score=299.30  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=196.7

Q ss_pred             CCCccceecccCCceEEEEEe----cCCCEEEEEEccCCccc-hhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCee
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  880 (1077)
                      +|++.+.||+|+||.||+|+.    .+|+.||+|++...... .....+++.+|+.+++++ +|++|+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999975    36889999998654322 122346678899999999 699999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++++|.+++....   .+++.++..++.|++.|++|||+.   +++||||+|+||+++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            99999999999999986543   477888999999999999999998   999999999999999999999999999986


Q ss_pred             CCCCC-CCcccccccccccCccccccC--CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          961 LKPDS-SNWTELAGTIGYVAPELAYTM--KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       961 ~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      ..... .......|+..|+|||++...  .++.++||||||+++|||++|+.||.....    ................+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~~~  230 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSEPP  230 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccCCC
Confidence            54432 122345688999999998753  467899999999999999999999863211    11111122222222222


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCC-----CHHHHHh
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1073 (1077)
                      .+    ......+.+++.+||+.||++||     +++++++
T Consensus       231 ~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         231 YP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             CC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            11    12334678999999999999997     6677654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.98  E-value=2.2e-31  Score=295.92  Aligned_cols=255  Identities=25%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC---CCCceeeEEEEEeeCCe----
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---RHRNIVKFYGFCSHARH----  879 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----  879 (1077)
                      |++.+.||+|+||.||+|+++ +++.||+|++......+ .....+.+|+.+++++   +|+|++++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            567889999999999999876 58999999987543322 2234566677766555   69999999999987766    


Q ss_pred             -eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          880 -SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       880 -~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                       .+++|||+++ ++.+++..... ..+++.+++.++.|++.|++|||+.   +++|+||+|+||+++.++.+|++|||.+
T Consensus        80 ~~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          80 KLTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eeEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence             8999999974 89888866432 3488999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh---------
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD--------- 1029 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 1029 (1077)
                      ..+..... .....++..|+|||++.+..++.++||||||+++|||++|+.||........    .....+         
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~  229 (287)
T cd07838         155 RIYSFEMA-LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ----LDKIFDVIGLPSEEE  229 (287)
T ss_pred             eeccCCcc-cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH----HHHHHHHcCCCChHh
Confidence            87654322 2334578899999999999999999999999999999999999864321100    000000         


Q ss_pred             ---------hhcCCCCCC-CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1030 ---------EILDPRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1030 ---------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                               .......+. ...........+.+++.+||+.||++||+++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                     000000000 01111233456789999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.98  E-value=9.9e-32  Score=301.03  Aligned_cols=265  Identities=23%  Similarity=0.341  Sum_probs=196.7

Q ss_pred             HHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC---
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR---  878 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  878 (1077)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|++......+ .....+.+|+.++++++||||+++++++.+..   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            34578999999999999999999775 68899999986543222 22456778999999999999999999986654   


Q ss_pred             -------eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceE
Q 001440          879 -------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH  951 (1077)
Q Consensus       879 -------~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k  951 (1077)
                             ..++|+||+++ ++.+++...  ...+++.++..++.|++.|++|||+.   +|+|+||||+||+++.++.+|
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                   78999999986 677776543  23588999999999999999999999   999999999999999999999


Q ss_pred             EecccccccCCCCCC-CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Cc
Q 001440          952 VSDFGISKSLKPDSS-NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SS 1022 (1077)
Q Consensus       952 l~Dfgla~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~ 1022 (1077)
                      |+|||.+........ ......++..|+|||++.+ ..++.++||||+||++|||++|+.||.........       ..
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999999987654432 2233456788999998765 35788999999999999999999998643221100       00


Q ss_pred             ccccchhhhc--------CCCCCC--C-CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1023 NLDRTLDEIL--------DPRLPA--P-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1023 ~~~~~~~~~~--------~~~~~~--~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+..+.        ++....  . .......+..+.+++.+||+.||++||+++|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            0000000000        000000  0 00000123468899999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.98  E-value=1.7e-31  Score=300.30  Aligned_cols=262  Identities=22%  Similarity=0.304  Sum_probs=191.8

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  878 (1077)
                      .++|++.+.||+|+||.||+|... +++.||||++....... .....+.+|+.++++++||||+++++++....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            457999999999999999999765 68999999886543221 12345568999999999999999999986543     


Q ss_pred             ---eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          879 ---HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       879 ---~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                         ..++||||+++ ++.+++....  ..+++.++..++.|++.|++|||+.   +++|+||||+||+++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence               45999999975 7888775432  3478999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCC----CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCcccccccc------C-cc
Q 001440          956 GISKSLKPDSS----NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICST------S-SN 1023 (1077)
Q Consensus       956 gla~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~------~-~~ 1023 (1077)
                      |++..+.....    ......++..|+|||++.+. .++.++||||||+++|||++|+.||.........      . ..
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99986643322    12234578899999987664 4688999999999999999999998643211000      0 00


Q ss_pred             cccc------hhhhcCCCCCCCCC-C------cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1024 LDRT------LDEILDPRLPAPSC-N------IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1024 ~~~~------~~~~~~~~~~~~~~-~------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....      .+....-..+.... .      .......+.+++.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            0000      00000000000000 0      0001235678999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.98  E-value=1e-31  Score=297.78  Aligned_cols=259  Identities=23%  Similarity=0.332  Sum_probs=199.9

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |++.+.||+|++|.||+|... +++.+|+|++....... .....+.+|+.++++++|+||+++++++.++...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            567788999999999999765 78899999987653322 2356788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      +++ ++.+++....  ..+++.+++.++.|++.|++|||+.   +|+|+||+|+||+++.++.+|++|||.+........
T Consensus        80 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~  153 (283)
T cd05118          80 MDT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR  153 (283)
T ss_pred             cCC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence            975 8888876532  3588999999999999999999998   999999999999999999999999999987765543


Q ss_pred             CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------CcccccchhhhcC-----
Q 001440          967 NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRTLDEILD----- 1033 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~----- 1033 (1077)
                      ......++..|+|||.+.+. .++.++||||+|+++|++++|+.||.........       .......+.....     
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY  233 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence            33445678899999998776 7899999999999999999999998543221100       0000000000000     


Q ss_pred             ----CCC--CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1034 ----PRL--PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1034 ----~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                          +..  .............+.+++.+||++||.+||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                000  0000011223457889999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.98  E-value=6.8e-32  Score=300.08  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             CCCccceecccCCceEEEEEe----cCCCEEEEEEccCCccc-hhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCee
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  880 (1077)
                      +|++.+.||+|++|.||+|+.    .+++.||||.+...... .....+.+.+|+.+++++ +||+|+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999964    35788999988653222 222345688899999999 699999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++|+|.+++...   ..+++.++..++.|+++|++|||+.   +++||||+|+||+++.++.++++|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccc
Confidence            9999999999999998643   3478889999999999999999998   999999999999999999999999999886


Q ss_pred             CCCCCCC-cccccccccccCccccccCC--CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCC
Q 001440          961 LKPDSSN-WTELAGTIGYVAPELAYTMK--VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       961 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~--~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      ....... .....|+..|+|||+..+..  ++.++||||||+++|||++|+.||......    ...............+
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~  230 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKSKPP  230 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHccCCC
Confidence            5443222 22345789999999987655  788999999999999999999998532111    0011111122222222


Q ss_pred             CCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .+.    .....+.+++.+||+.||++|||+.++.+.|+
T Consensus       231 ~~~----~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         231 FPK----TMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             CCc----ccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence            221    12346789999999999999999888876653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.8e-31  Score=290.08  Aligned_cols=242  Identities=26%  Similarity=0.366  Sum_probs=199.8

Q ss_pred             ecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|+||.||++... +++.||+|.+.............+..|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999765 5899999998776544444567889999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccccc
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA  972 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  972 (1077)
                      .+++....   .+++.++..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++..............
T Consensus        81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC  154 (250)
T ss_pred             HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCc
Confidence            99996543   478899999999999999999998   999999999999999999999999999987655433344567


Q ss_pred             ccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHH
Q 001440          973 GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052 (1077)
Q Consensus       973 g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1052 (1077)
                      ++..|+|||...+..++.++|+||||+++||+++|+.||.....        ......+.....+.+...    ...+.+
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~~~~~~~~~~----~~~l~~  222 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILKDPLRFPEFL----SPEARD  222 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhcCCCCCCCCC----CHHHHH
Confidence            88999999999888889999999999999999999999863221        122222332333332221    346789


Q ss_pred             HHHhccCCCCCCCCCH---HHHHh
Q 001440         1053 VAISCLDENPDSRPTM---QKVSQ 1073 (1077)
Q Consensus      1053 li~~cl~~dP~~RPs~---~evl~ 1073 (1077)
                      ++++||..||++||++   +++.+
T Consensus       223 ~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         223 LISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             HHHHHhcCCHhhCCCcccHHHHHh
Confidence            9999999999999999   56543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.98  E-value=7.7e-33  Score=296.74  Aligned_cols=246  Identities=25%  Similarity=0.336  Sum_probs=204.8

Q ss_pred             cceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCC
Q 001440          811 EHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~  889 (1077)
                      .+.+|.|-||+||-|+++ +|+.||||.+.+-++.... ...+.+|+.+++.++||+||.+.-.|+..+..++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence            478999999999999654 8999999999887665544 57889999999999999999999999999999999999976


Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC---CceEEecccccccCCCCCC
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfgla~~~~~~~~  966 (1077)
                      .-|.-.+.. . ..+++......++.||+.||.|||.+   +|+|+|+||+|||+.+.   -.+|+||||+|+.+.+. .
T Consensus       648 DMLEMILSs-E-kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-s  721 (888)
T KOG4236|consen  648 DMLEMILSS-E-KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-S  721 (888)
T ss_pred             hHHHHHHHh-h-cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchh-h
Confidence            555444433 2 35588888888999999999999999   99999999999999765   47999999999987654 4


Q ss_pred             CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHH
Q 001440          967 NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1077)
                      ..+..+||+.|.|||++..+.|...-||||+||++|.-++|-.||...+          +.-+++-+..+-.|..++.+.
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE----------dIndQIQNAaFMyPp~PW~ei  791 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE----------DINDQIQNAAFMYPPNPWSEI  791 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc----------chhHHhhccccccCCCchhhc
Confidence            4567899999999999999999999999999999999999999986322          222333344444445566777


Q ss_pred             HHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1047 LISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1047 ~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .....++|...|+.+=.+|.|.++.+.
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            788899999999999999998876543

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.98  E-value=1.4e-32  Score=278.04  Aligned_cols=205  Identities=21%  Similarity=0.328  Sum_probs=168.4

Q ss_pred             HHhcCCCccceecccCCceEEEEEec-C----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee-
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAELS-S----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-  876 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-  876 (1077)
                      +....|+....||+|.||.||+|..+ +    .+.+|+|+++....... ......+|+.+++.++|||++.+..++-. 
T Consensus        21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tG-iS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTG-ISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCC-cCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34567899999999999999999432 2    23689999976532221 13456789999999999999999998865 


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC----Cce
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNAT--SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE----YEA  950 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~  950 (1077)
                      +...++++||.+. +|.+.++..+  ....++...+..|+.||+.|++|||++   .|+|||+||.||++..+    |.|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            7899999999987 7878775432  234688889999999999999999999   89999999999999888    899


Q ss_pred             EEecccccccCCCCCCC---cccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q 001440          951 HVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       951 kl~Dfgla~~~~~~~~~---~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      ||+|+|+|+.+...-..   ....+.|..|.|||.+.+. .|+.+.||||+||++.||+|-++-|.
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~  241 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK  241 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence            99999999987654332   2345679999999988765 58999999999999999999876664

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.98  E-value=1e-31  Score=293.91  Aligned_cols=252  Identities=21%  Similarity=0.257  Sum_probs=196.8

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccc--hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLS--EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      +|.+.+.||+|+||.||++.+. .+..+++|.++.....  ......++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788899999999999999765 3445556555432211  112234567789999999999999999999988899999


Q ss_pred             EeecCCCCHHHHHhcCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          884 YEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |||+++++|.+++.... ....+++.+++.++.|++.|+.|||+.   +++|+||+|+||+++. +.+|++|||.+....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            99999999999886532 234689999999999999999999998   9999999999999975 679999999998765


Q ss_pred             CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      ..........|+..|+|||+..+..++.++|+||||+++|++++|..||.....        ............+.   .
T Consensus       157 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~---~  225 (260)
T cd08222         157 GSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--------LSVVLRIVEGPTPS---L  225 (260)
T ss_pred             CCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCCCCC---C
Confidence            544434455688899999999888899999999999999999999999853211        11112222222221   1


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .......+.+++.+||+.+|++||+++|+++
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         226 PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1233457889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=6.2e-32  Score=306.84  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=196.9

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee----CCe
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH----ARH  879 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~  879 (1077)
                      ..+|++.+.||+|+||.||+|... +|+.||+|++...... ......+.+|+.++++++||||+++++++..    ...
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccccc-ccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            368899999999999999999654 6899999998754322 2234567789999999999999999988753    356


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .++||||+. |+|.+++...   ..+++.++..++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence            899999996 6898888543   3388999999999999999999998   99999999999999999999999999997


Q ss_pred             cCCCCCCC----cccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCccc---
Q 001440          960 SLKPDSSN----WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNL--- 1024 (1077)
Q Consensus       960 ~~~~~~~~----~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~--- 1024 (1077)
                      ........    .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........       .....   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~  235 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV  235 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence            65433221    234568899999998765 4588999999999999999999999864321100       00000   


Q ss_pred             -----ccchhhhcC---CCCCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1025 -----DRTLDEILD---PRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1025 -----~~~~~~~~~---~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                           ........+   ...+.+. .........+.+++++||+.+|++||+++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                 000111110   0111000 0011234578999999999999999999998863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2.3e-31  Score=325.83  Aligned_cols=149  Identities=27%  Similarity=0.347  Sum_probs=133.7

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|.+.++||+|+||.||+|.+. +++.||+|++.............+.+|+.+++.++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            367899999999999999999776 6899999998765444444457788999999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      |||+.+++|.+++....   .+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999996543   477889999999999999999998   99999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=9e-32  Score=305.37  Aligned_cols=260  Identities=23%  Similarity=0.332  Sum_probs=199.5

Q ss_pred             CCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----ee
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----HS  880 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~  880 (1077)
                      +|++.+.||+|++|.||+|+.. +++.||+|++.... ......+.+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            4788899999999999999765 58999999987643 22334567889999999999999999999987765     78


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||++ ++|.+++....   .+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.++++|||.+..
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            99999998 58988886543   588999999999999999999999   999999999999999999999999999987


Q ss_pred             CCCCC---CCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Cccccc---
Q 001440          961 LKPDS---SNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDR--- 1026 (1077)
Q Consensus       961 ~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~--- 1026 (1077)
                      .....   .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||.........       ......   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence            65543   223445678899999999887 7899999999999999999999998633211000       000000   


Q ss_pred             -----chhhhcC---CCCCCC-CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1027 -----TLDEILD---PRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1027 -----~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                           .......   .....+ ..........+.+++.+||+++|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 0000000   000000 00001123468899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.7e-33  Score=322.57  Aligned_cols=258  Identities=23%  Similarity=0.271  Sum_probs=213.6

Q ss_pred             HHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA  877 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  877 (1077)
                      .+++-..++|.+.++||+|+||.|..++++ +++.||+|++.+..+.......-|..|-.+|..-+.+=|+.+..+|.++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            344445678999999999999999999876 6888999999875555455567789999999988999999999999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      .+.|+||||++||+|-..+.+..   +++..-+..++..|+-||+-+|+.   |+|||||||+|||+|..|.+|++|||.
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGs  221 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGS  221 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchh
Confidence            99999999999999999997654   477788889999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCC-cccccccccccCccccc----c-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhh
Q 001440          958 SKSLKPDSSN-WTELAGTIGYVAPELAY----T-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031 (1077)
Q Consensus       958 a~~~~~~~~~-~~~~~g~~~y~aPE~~~----~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1031 (1077)
                      +..+..++.. ....+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||..        +.+-++...+
T Consensus       222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa--------dslveTY~KI  293 (1317)
T KOG0612|consen  222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA--------DSLVETYGKI  293 (1317)
T ss_pred             HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH--------HHHHHHHHHH
Confidence            9988866554 45678999999999885    3 5689999999999999999999999862        3344566666


Q ss_pred             cCC--CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC---HHHHHh
Q 001440         1032 LDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPT---MQKVSQ 1073 (1077)
Q Consensus      1032 ~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1073 (1077)
                      ++.  .+..|  ...+.+....++|++.+. +|+.|..   ++++..
T Consensus       294 m~hk~~l~FP--~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNHKESLSFP--DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hchhhhcCCC--cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            665  44444  223355567777877776 6778876   777653

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=2.9e-31  Score=294.21  Aligned_cols=259  Identities=24%  Similarity=0.348  Sum_probs=195.3

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEEEEe
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      |++.+.||+|++|+||+|... +++.||+|++......  .......+|+..+++++ |||++++++++.+++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            567789999999999999875 5788999998654322  12334457889999998 9999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+ +|++.+++.... ...+++.++..++.|++.|++|||+.   +++|+||+|+||+++.++.++|+|||.+.......
T Consensus        79 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          79 YM-EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             cC-CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence            99 789999886654 23578999999999999999999998   99999999999999999999999999998664332


Q ss_pred             CCcccccccccccCccccc-cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC------cc-cc------cchhhh
Q 001440          966 SNWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS------SN-LD------RTLDEI 1031 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~-~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~------~~-~~------~~~~~~ 1031 (1077)
                       ......++..|+|||++. ...++.++||||||+++|||++|+.||..........      .. ..      ......
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             223456788999999875 4557899999999999999999999985332110000      00 00      000000


Q ss_pred             cCCCCCCCCC-----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1032 LDPRLPAPSC-----NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1032 ~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .....+....     ........+.+++++||+.||++|||++|++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0101110000     001113568899999999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.97  E-value=2.3e-31  Score=300.75  Aligned_cols=261  Identities=23%  Similarity=0.332  Sum_probs=196.8

Q ss_pred             HHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee-CCe
Q 001440          802 VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-ARH  879 (1077)
Q Consensus       802 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~  879 (1077)
                      ...+++|++.+.||+|+||.||+|... +++.||+|++...... ....+.+.+|+.+++.++||||+++.+++.. ...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            446788999999999999999999655 7899999988654322 2235667889999999999999999999865 557


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      .++|+||+ +++|.+++...    .+++..+..++.|++.|++|||+.   +|+||||+|+||+++.++.+|++|||.+.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            89999998 56898888543    367788889999999999999999   99999999999999999999999999987


Q ss_pred             cCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCcccccchhhh
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDRTLDEI 1031 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~ 1031 (1077)
                      .....   .....++..|+|||++.+ ..++.++||||+|+++||+++|+.||........       .....++.....
T Consensus       157 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         157 IQDPQ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             ccCCC---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            54322   233467889999998765 5689999999999999999999999864321000       000000000000


Q ss_pred             cC-----------CCCCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1032 LD-----------PRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1032 ~~-----------~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .+           ...+.+. .........+.+++++||+.+|++||+++|++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00           0000000 0011123578899999999999999999999763

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=3.8e-31  Score=300.74  Aligned_cols=261  Identities=21%  Similarity=0.262  Sum_probs=192.5

Q ss_pred             cCCC-ccceecccCCceEEEEEec-CCCEEEEEEccCCccchhh-----------HHHHHHHHHHHhcCCCCCceeeEEE
Q 001440          806 NDFD-EEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMT-----------CQQEFLNEVKSLTEIRHRNIVKFYG  872 (1077)
Q Consensus       806 ~~~~-~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~  872 (1077)
                      ++|. +.+.||+|+||+||+|... +++.||||++.........           ....+.+|+.+++.++||||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4555 4567999999999999765 6899999988654322100           0124678999999999999999999


Q ss_pred             EEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEE
Q 001440          873 FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV  952 (1077)
Q Consensus       873 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  952 (1077)
                      ++..+...++||||++ |++.+++...   ..+++.....++.|++.|++|||+.   +|+|+||+|+||+++.++.+|+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEE
Confidence            9999999999999997 6899988643   3478899999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCC--------------CCCCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccc
Q 001440          953 SDFGISKSLKP--------------DSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSI 1017 (1077)
Q Consensus       953 ~Dfgla~~~~~--------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 1017 (1077)
                      +|||+++....              .........++..|+|||++.+. .++.++||||+|+++|||++|+.||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999976541              11122233467889999998764 4688999999999999999999998643221


Q ss_pred             cccC-------cccccchhhhc-----CCCCCC-CC---CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1018 CSTS-------SNLDRTLDEIL-----DPRLPA-PS---CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1018 ~~~~-------~~~~~~~~~~~-----~~~~~~-~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....       ......+....     .+.... +.   .........+.+++.+||+.+|++||+++|++.
T Consensus       241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            1000       00000000000     000000 00   000112346789999999999999999999986

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.6e-31  Score=301.63  Aligned_cols=266  Identities=21%  Similarity=0.293  Sum_probs=198.8

Q ss_pred             CCHHHHHHHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEE
Q 001440          796 IAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFC  874 (1077)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  874 (1077)
                      ...+++....++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            34456677889999999999999999999965 47899999998764322 22345678899999999999999999988


Q ss_pred             eeC------CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC
Q 001440          875 SHA------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       875 ~~~------~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~  948 (1077)
                      ...      ...++|+|++ +++|.+++...    .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~  157 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  157 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCC
Confidence            543      3467888876 77998887542    378899999999999999999999   999999999999999999


Q ss_pred             ceEEecccccccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC------
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS------ 1021 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~------ 1021 (1077)
                      .+|++|||+++....   ......++..|+|||++.+ ..++.++||||+||++|||++|+.||..........      
T Consensus       158 ~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         158 ELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             CEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999999876432   2234567889999998766 567889999999999999999999985322110000      


Q ss_pred             -cccccch--------hhhcC--CCCCCCC--CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1022 -SNLDRTL--------DEILD--PRLPAPS--CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1022 -~~~~~~~--------~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       .......        .....  +..+...  .........+.+++.+|++.||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence             0000000        00000  0010000  000012346789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-31  Score=293.76  Aligned_cols=259  Identities=24%  Similarity=0.350  Sum_probs=198.6

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |+..+.||+|++|.||+|... +++.||+|.+.... ......+.+..|+.+++.++|+|++++++++.+.+..++|+||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            556788999999999999765 58999999987653 2222346678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      ++ ++|.+++....  ..+++.++..++.|++.|++|||+.   +|+||||+|+||+++.++.+||+|||.++.......
T Consensus        80 ~~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          80 CD-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             cC-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            98 58999997653  3488999999999999999999999   999999999999999999999999999987655443


Q ss_pred             CcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-------Ccccccchhhh-----cC
Q 001440          967 NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRTLDEI-----LD 1033 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~-----~~ 1033 (1077)
                      ......++..|+|||++.+. .++.++||||||+++||+++|+.||.........       .......+...     .+
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYK  233 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccc
Confidence            33444567889999998766 7899999999999999999999998532211000       00000000000     00


Q ss_pred             CCCCCCC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1034 PRLPAPS-----CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1034 ~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ...+...     .........+.+++.+||+.||++||+++|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         234 PTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0000000     000112356899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=3.8e-31  Score=301.16  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=191.3

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC------
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA------  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  877 (1077)
                      ..+|...+.||+|+||.||+|... +|+.||+|++......+ .....+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSE-IFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccc-cchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            368999999999999999999764 68999999987643222 2245678899999999999999999998654      


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      ...++|+||+.. ++.++..     ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+
T Consensus        93 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~  163 (342)
T cd07879          93 QDFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL  163 (342)
T ss_pred             ceEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence            246899999964 7776652     2378899999999999999999999   999999999999999999999999999


Q ss_pred             cccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc-------ccccc--
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------NLDRT-- 1027 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-------~~~~~-- 1027 (1077)
                      ++.....   .....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........       .....  
T Consensus       164 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         164 ARHADAE---MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CcCCCCC---CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            8765322   234467889999999876 4688899999999999999999999864321100000       00000  


Q ss_pred             ------hhhhcC--CCCCCCC--CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 ------LDEILD--PRLPAPS--CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ------~~~~~~--~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                            ......  +..+...  .........+.+++.+||+.||++||+++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  000000  0000000  000012345789999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-33  Score=277.53  Aligned_cols=251  Identities=26%  Similarity=0.351  Sum_probs=193.2

Q ss_pred             cceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHH-hcCCCCCceeeEEEEEeeCCeeEEEEeecC
Q 001440          811 EHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTEIRHRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E~~~  888 (1077)
                      ...||.|.||+|++-.++ +|+..|||++.....  ..+++++..|.+. ++.-++||||+++|++..++..||-||.|+
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            456999999999999665 799999999987644  3346677777765 444589999999999999999999999996


Q ss_pred             CCCHHHHHhcCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC
Q 001440          889 MGSLAMILSNAT--SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       889 ~g~L~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      - +++.+.+...  ...++++.-.-.|+...+.||.||.+..  .|+|||+||+|||++..|.+|+||||++..+...- 
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-  222 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-  222 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH-
Confidence            4 6654432211  2335777777788888999999999885  89999999999999999999999999987654332 


Q ss_pred             CcccccccccccCccccc--cCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCC--CCCC
Q 001440          967 NWTELAGTIGYVAPELAY--TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA--PSCN 1042 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~--~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 1042 (1077)
                      ..+.-+|...|||||.+.  +.+|+.+|||||+|+++||+.||+.||..+..       +-+.+..++.+..|.  ....
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-------vfeql~~Vv~gdpp~l~~~~~  295 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-------VFEQLCQVVIGDPPILLFDKE  295 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-------HHHHHHHHHcCCCCeecCccc
Confidence            223447889999999886  34689999999999999999999999874332       223333344333222  1222


Q ss_pred             cHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .......+..++..|+.+|-..||.+.++.++
T Consensus       296 ~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  296 CVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            23456789999999999999999999988753

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.97  E-value=5.6e-31  Score=299.73  Aligned_cols=259  Identities=20%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             HHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC---
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR---  878 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---  878 (1077)
                      ...++|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.++||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            3567899999999999999999965 4789999999865432 2223456789999999999999999999986543   


Q ss_pred             ---eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          879 ---HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       879 ---~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                         ..++||||+ ++++.+++..    ..+++..+..++.|++.|++|||+.   +|+||||||+||+++.++.+|++||
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df  162 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  162 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence               458999998 6799888753    2478899999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccccc
Q 001440          956 GISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLDRT 1027 (1077)
Q Consensus       956 gla~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~~~ 1027 (1077)
                      |++......   .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||..........       ......
T Consensus       163 g~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         163 GLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            999865432   233467889999998875 457889999999999999999999986332110000       000000


Q ss_pred             hhhhcC-------CCCCCCC-----CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1028 LDEILD-------PRLPAPS-----CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1028 ~~~~~~-------~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ...+..       ...+...     .........+.+++.+|++.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000       0000000     000112335789999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=4.2e-31  Score=301.99  Aligned_cols=256  Identities=25%  Similarity=0.405  Sum_probs=212.8

Q ss_pred             HHHHhcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEee--
Q 001440          801 IVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH--  876 (1077)
Q Consensus       801 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~--  876 (1077)
                      ....++.|.+.+.||.|.+|.||+++. ++|+.+|+|+.......    .++...|.++++.. +|||++.++|++..  
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~   89 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKD   89 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence            334456788899999999999999965 47899999998765332    45677788888888 79999999999853  


Q ss_pred             ---CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEe
Q 001440          877 ---ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS  953 (1077)
Q Consensus       877 ---~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  953 (1077)
                         ++..|+|||||.+|+..|.++... ...+.|+.+..|++.++.|+.+||..   .++|||||-.||+++.++.||++
T Consensus        90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence               468999999999999999998766 67799999999999999999999999   89999999999999999999999


Q ss_pred             cccccccCCCCCCCcccccccccccCcccccc-----CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccch
Q 001440          954 DFGISKSLKPDSSNWTELAGTIGYVAPELAYT-----MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028 (1077)
Q Consensus       954 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~ 1028 (1077)
                      |||.+..+........+.+||+.|||||++..     ..|+.++|+||+|++..||.-|.+|+.++.+..          
T Consensus       166 DFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr----------  235 (953)
T KOG0587|consen  166 DFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR----------  235 (953)
T ss_pred             eeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh----------
Confidence            99999988877777788899999999999863     347789999999999999999999987554321          


Q ss_pred             hhhcCCCCCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1029 DEILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1029 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      .-+.-++-|+|. ..+......+.++|..|+.+|-++||++.++++.
T Consensus       236 aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            111123333332 2355667789999999999999999999988763

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=3.6e-31  Score=297.87  Aligned_cols=262  Identities=23%  Similarity=0.300  Sum_probs=191.8

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  878 (1077)
                      .++|++.++||+|+||.||+|... +++.||+|++......+. ....+.+|+++++.++||||+++++++.+..     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            468999999999999999999765 689999998865432221 1345678999999999999999999875433     


Q ss_pred             ---eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecc
Q 001440          879 ---HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       879 ---~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Df  955 (1077)
                         ..++|+||+.+ ++...+...  ...+++.++..++.|+++|++|||+.   +|+|+||||+||+++.++.+|++||
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENP--SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence               46999999875 677666543  23588999999999999999999999   9999999999999999999999999


Q ss_pred             cccccCCCCCCC-----------cccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC--
Q 001440          956 GISKSLKPDSSN-----------WTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-- 1021 (1077)
Q Consensus       956 gla~~~~~~~~~-----------~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-- 1021 (1077)
                      |+++........           .....+++.|+|||++.+. .++.++||||||+++|||++|+.||..........  
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999865433221           1233567889999987654 57899999999999999999999986322210000  


Q ss_pred             -----c----------ccccchhhhcCCCCCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1022 -----S----------NLDRTLDEILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1022 -----~----------~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                           .          ..............+... .........+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                 0          000000000000010000 000112246889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-32  Score=284.73  Aligned_cols=258  Identities=27%  Similarity=0.361  Sum_probs=195.7

Q ss_pred             hcCCCccceecccCCceEEEE-EecCCCEEEEEEccCCccchh----hHHHHHHHHHHHhcCCCCCceeeEEEEEeeC-C
Q 001440          805 TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEM----TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-R  878 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~  878 (1077)
                      .++|-....||+|||+.||+| +....+.||||+-........    ...+...+|.++.+.++||.||++|+|+.-+ +
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            456888899999999999999 455678899997654322211    1235578899999999999999999999655 5


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeC---CCCceEEecc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD---LEYEAHVSDF  955 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~kl~Df  955 (1077)
                      ..+-|+|||+|.+|+-|++..+   -+++.++..|+.||+.||.||.+. .|+|||-|+||.|||+-   ..|.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeec
Confidence            6788999999999999997665   378899999999999999999987 67999999999999994   4589999999


Q ss_pred             cccccCCCCCCC-------cccccccccccCccccccC----CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCccc
Q 001440          956 GISKSLKPDSSN-------WTELAGTIGYVAPELAYTM----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024 (1077)
Q Consensus       956 gla~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 1024 (1077)
                      |+++.+..+...       ....+||..|.+||.+.-+    .++.|+||||+||++|+++.|+.||.....-...  ..
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI--Lq  695 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI--LQ  695 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH--Hh
Confidence            999988766443       2356799999999987533    4678999999999999999999999743321100  00


Q ss_pred             ccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001440         1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072 (1077)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1072 (1077)
                      +..+-....-.+|..+    ....+...+|++||++--++|....|+.
T Consensus       696 eNTIlkAtEVqFP~KP----vVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 ENTILKATEVQFPPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hhchhcceeccCCCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            0111111111222211    1223567889999999888887766653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=272.93  Aligned_cols=252  Identities=24%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..+|+..++||+|+|+.|..++++ +.+.||+|++++....+.+...=+..|-.+..+- +||.+|.+..++..+...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            468999999999999999999765 6788999999876655544444455555555555 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |.||+++|+|.-++++.+   .++++.+..+...|..|+.|||++   ||++||+|..||++|..|.+|++|+|+++.--
T Consensus       329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999987776544   488899999999999999999999   99999999999999999999999999998766


Q ss_pred             CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccc-cchhhhcCCCCCCCCC
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD-RTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 1041 (1077)
                      .++....++.||+.|.|||.+.+..|+..+|+|++||+|+||+.|+.||+-.... ....+.+ -.+.-++...+..|..
T Consensus       403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~-n~d~ntedylfqvilekqiriprs  481 (593)
T KOG0695|consen  403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMD-NPDMNTEDYLFQVILEKQIRIPRS  481 (593)
T ss_pred             CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCC-CcccchhHHHHHHHhhhcccccce
Confidence            6667778899999999999999999999999999999999999999999854421 1122222 2333444444444432


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCC
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPT 1067 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs 1067 (1077)
                          .+.....+++.-+++||.+|.-
T Consensus       482 ----lsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  482 ----LSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ----eehhhHHHHHHhhcCCcHHhcC
Confidence                2334567788899999999863

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=297.70  Aligned_cols=239  Identities=22%  Similarity=0.278  Sum_probs=192.0

Q ss_pred             hcCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ++.|.....+|.|+|++|-.+.. .+++..+||++.+..       .+..+|+.++... +||||+++.+.+.++.+.|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence            45677788899999999999955 478889999997652       2233566554444 79999999999999999999


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeee-CCCCceEEecccccccC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL-DLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~kl~Dfgla~~~  961 (1077)
                      |||++.+|-+.+.+...+.   .. .++.+|+.+|+.|++|||++   ||||||+||+|||+ +..+.++|+|||.++..
T Consensus       394 v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             eehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            9999999988887755432   22 67888999999999999998   99999999999999 58899999999999877


Q ss_pred             CCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCC
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ..+   ....+-|..|.|||+....+|++++||||+|+++|+|++|+.||......       .+....+..+...    
T Consensus       467 ~~~---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~~~~~s----  532 (612)
T KOG0603|consen  467 ERS---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQMPKFS----  532 (612)
T ss_pred             chh---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhcCCccc----
Confidence            655   33456688999999999999999999999999999999999998733221       1222222222222    


Q ss_pred             CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                        ...+....+++.+||+.||.+||+|+|+..
T Consensus       533 --~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 --ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              233456778999999999999999999864

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4.4e-31  Score=300.81  Aligned_cols=258  Identities=21%  Similarity=0.314  Sum_probs=195.1

Q ss_pred             HhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCe---
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARH---  879 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---  879 (1077)
                      ..++|++.+.||+|++|.||+|+.. +++.||+|++...... ....+.+.+|+.+++.++|||++++.+++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4578999999999999999999775 6789999998754322 2234567789999999999999999988765544   


Q ss_pred             ---eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          880 ---SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       880 ---~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                         .++|+||+ +++|.+++..    ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 5699998864    3488999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccC-------cccccch
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS-------SNLDRTL 1028 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~-------~~~~~~~ 1028 (1077)
                      ++......   .....++..|+|||...+ ..++.++||||+|+++||+++|+.||..........       ...+...
T Consensus       164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         164 LARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            99865433   233467889999998765 467889999999999999999999986322110000       0000000


Q ss_pred             h--------hhcCCCCCCCCC----CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1029 D--------EILDPRLPAPSC----NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1029 ~--------~~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .        ..+.........    ........+.+++.+||+.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0        000000000000    00012456889999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.97  E-value=4.3e-31  Score=300.75  Aligned_cols=258  Identities=22%  Similarity=0.294  Sum_probs=190.5

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC------
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA------  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------  877 (1077)
                      ..+|.+.+.||.|+||.||+|... +|+.||+|++.....   ...+.+.+|+++++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            368899999999999999999664 689999998865432   3356788899999999999999999776543      


Q ss_pred             --------CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CC
Q 001440          878 --------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EY  948 (1077)
Q Consensus       878 --------~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~  948 (1077)
                              ...++||||++ ++|.+++...    .+++.++..++.||+.|+.|||+.   +|+||||||+||+++. ++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~  152 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCc
Confidence                    35789999997 5898888542    378899999999999999999998   9999999999999975 56


Q ss_pred             ceEEecccccccCCCCCC---CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCc--
Q 001440          949 EAHVSDFGISKSLKPDSS---NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-- 1022 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~-- 1022 (1077)
                      .+|++|||.++.......   ......++..|+|||++.. ..++.++|||||||++|||++|+.||...........  
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~  232 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL  232 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            789999999976543211   1123457889999997654 5678899999999999999999999863321110000  


Q ss_pred             -----ccccchh-------hhcCCCCCCCCCC----cHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1023 -----NLDRTLD-------EILDPRLPAPSCN----IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1023 -----~~~~~~~-------~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                           .......       .........+...    .......+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                 0000000       0000000000000    0112346789999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.97  E-value=1.6e-30  Score=294.91  Aligned_cols=259  Identities=22%  Similarity=0.323  Sum_probs=190.2

Q ss_pred             CCCccceecccCCceEEEEEec-C--CCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeC----C
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-S--GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHA----R  878 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~  878 (1077)
                      +|++.+.||+|+||.||+|+.. +  +..||+|++.... ......+.+.+|+.+++++ +||||+++++++...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            4778899999999999999765 3  7789999986432 2222245678899999999 599999999875432    4


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..++++||++ ++|.+++...   ..+++.+++.++.||+.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            5788999886 6899888543   3478899999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCCC----CcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCccccccc-------cCccccc
Q 001440          959 KSLKPDSS----NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSNLDR 1026 (1077)
Q Consensus       959 ~~~~~~~~----~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~-------~~~~~~~ 1026 (1077)
                      +.......    ......|+..|+|||+..+ ..++.++||||+||++|++++|+.||........       .......
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            86543321    1223468899999998765 4688999999999999999999999864321100       0000000


Q ss_pred             chhhhcCC----------CCCCC--CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1027 TLDEILDP----------RLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1027 ~~~~~~~~----------~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ....+..+          ..+..  ..........+.+++.+|++.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00000000          00000  0000111346889999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=3e-31  Score=247.55  Aligned_cols=197  Identities=22%  Similarity=0.389  Sum_probs=169.7

Q ss_pred             CCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          807 DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      +|+..++||+|.||+||+|+. .+++.||+|++.-+...+ .......+|+.+++.++|+|||+++++...++..-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde-gvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC-CCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            466678899999999999965 478999999987653222 224567899999999999999999999999999999999


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      ||.. +|..|.....  +.++.+.+..++.|+.+|+.++|++   ++.|||+||.|.+++.+|+.|++|||+|+.+.-..
T Consensus        82 ~cdq-dlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             HhhH-HHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            9965 7888775543  5688899999999999999999999   99999999999999999999999999999887665


Q ss_pred             CCcccccccccccCccccccCC-CCCcchHHHHHHHHHHHHhCCCC
Q 001440          966 SNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIKGKHP 1010 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~s~G~~l~elltg~~p 1010 (1077)
                      .-+..-+.|..|.+|.++.+.. |+...|+||-||++.|+.....|
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            5566667899999999988754 78899999999999999985555

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=7.8e-30  Score=274.52  Aligned_cols=219  Identities=21%  Similarity=0.183  Sum_probs=174.2

Q ss_pred             cCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCHHHH
Q 001440          817 GGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMI  895 (1077)
Q Consensus       817 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~  895 (1077)
                      |.+|.||+++.. +++.||+|++....        .+.+|...+....||||+++++++.+....++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            889999999664 78999999986532        223344445556799999999999999999999999999999999


Q ss_pred             HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcccccccc
Q 001440          896 LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI  975 (1077)
Q Consensus       896 l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~  975 (1077)
                      +.+..   .+++.++..++.|++.|++|+|+.   +|+||||||+||+++.++.++++|||.+......   .....++.
T Consensus        76 l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~  146 (237)
T cd05576          76 ISKFL---NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVEN  146 (237)
T ss_pred             HHHhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCc
Confidence            86543   388999999999999999999998   9999999999999999999999999988765432   12334567


Q ss_pred             cccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHH
Q 001440          976 GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAI 1055 (1077)
Q Consensus       976 ~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1055 (1077)
                      .|+|||+..+..++.++||||+|+++|||++|+.|+......          .........+  .    .....+.+++.
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~~~~~~~--~----~~~~~~~~li~  210 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTHTTLNIP--E----WVSEEARSLLQ  210 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccccccCCc--c----cCCHHHHHHHH
Confidence            899999998888999999999999999999999886522110          0000000111  1    12245788999


Q ss_pred             hccCCCCCCCCCH
Q 001440         1056 SCLDENPDSRPTM 1068 (1077)
Q Consensus      1056 ~cl~~dP~~RPs~ 1068 (1077)
                      +|++.||++||++
T Consensus       211 ~~l~~dp~~R~~~  223 (237)
T cd05576         211 QLLQFNPTERLGA  223 (237)
T ss_pred             HHccCCHHHhcCC
Confidence            9999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-30  Score=272.67  Aligned_cols=257  Identities=19%  Similarity=0.237  Sum_probs=196.1

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-C-C----ceeeEEEEEeeC
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-H-R----NIVKFYGFCSHA  877 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----niv~l~~~~~~~  877 (1077)
                      +++|.+...+|+|.||.|-.+.+. .+..||||+++..    ....+...-|+++++++. + |    -+|.+.+++...
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            678999999999999999999554 5789999998642    223556677899999993 2 2    378888999999


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-----------
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-----------  946 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-----------  946 (1077)
                      ++.+||+|.+ |-++++++..+.. .+++..++..|+.|++++++|||+.   +++|-|+||+||++-+           
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~  238 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKK  238 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCC
Confidence            9999999987 5599999987653 4578899999999999999999999   9999999999999932           


Q ss_pred             ---------CCceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccc
Q 001440          947 ---------EYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSI 1017 (1077)
Q Consensus       947 ---------~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~ 1017 (1077)
                               +..+|++|||.|+.-.++   ....+.|..|.|||++.+-+++.++||||+||+++|+.||..-|+..+..
T Consensus       239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  239 KVCFIRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccceeccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                     235899999999864433   35678899999999999999999999999999999999999988754421


Q ss_pred             c---cc----Ccccccchhhh------cCCCCCCC-------------C--------CCcHHHHHHHHHHHHhccCCCCC
Q 001440         1018 C---ST----SSNLDRTLDEI------LDPRLPAP-------------S--------CNIRDKLISIMEVAISCLDENPD 1063 (1077)
Q Consensus      1018 ~---~~----~~~~~~~~~~~------~~~~~~~~-------------~--------~~~~~~~~~l~~li~~cl~~dP~ 1063 (1077)
                      +   ..    +.....++...      ...++.-+             .        .....+...+.+++++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            1   00    00000000000      00011100             0        01123345789999999999999


Q ss_pred             CCCCHHHHHh
Q 001440         1064 SRPTMQKVSQ 1073 (1077)
Q Consensus      1064 ~RPs~~evl~ 1073 (1077)
                      +|+|+.|+++
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999975

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=1.2e-29  Score=302.63  Aligned_cols=259  Identities=19%  Similarity=0.186  Sum_probs=168.5

Q ss_pred             HhcCCCccceecccCCceEEEEEec-C----CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEE-----
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-S----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF-----  873 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~-----  873 (1077)
                      ..++|.+.+.||+|+||.||+|++. +    +..||+|++......     +....|  .++...+.+++.++..     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            4678999999999999999999775 4    689999987643211     111111  1111122222222111     


Q ss_pred             -EeeCCeeEEEEeecCCCCHHHHHhcCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001440          874 -CSHARHSFIVYEYLEMGSLAMILSNATSA-----------------EELGWTQRMNVIKGVADALSYLHNDCFPPIVYR  935 (1077)
Q Consensus       874 -~~~~~~~~lV~E~~~~g~L~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  935 (1077)
                       ...+...++||||+++++|.+++......                 .......+..++.|++.||+|||+.   +|+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeC
Confidence             24556889999999999999998654211                 0112234567999999999999998   99999


Q ss_pred             cCCCCCeeeCC-CCceEEecccccccCCCCC-CCcccccccccccCccccccC----------------------CCCCc
Q 001440          936 DISSKNVLLDL-EYEAHVSDFGISKSLKPDS-SNWTELAGTIGYVAPELAYTM----------------------KVTEK  991 (1077)
Q Consensus       936 Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~-~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~  991 (1077)
                      ||||+|||++. ++.+||+|||+|+.+.... .......+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999986 5899999999998664332 223456789999999965322                      23456


Q ss_pred             chHHHHHHHHHHHHhCCCCCCcccc-----ccccCcccccchhhhcCCCCCCC----CCCcHHHHHHHHHHHHhccCCCC
Q 001440          992 SDVYSFGVLALEAIKGKHPRDFISS-----ICSTSSNLDRTLDEILDPRLPAP----SCNIRDKLISIMEVAISCLDENP 1062 (1077)
Q Consensus       992 ~Dv~s~G~~l~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP 1062 (1077)
                      +||||+||++|||+++..|++....     ........ ..+.....+.....    ............+++.+|+++||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDL-VAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcH-HHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            7999999999999998776542110     00000000 01111111111100    00000011234589999999999


Q ss_pred             CCCCCHHHHHh
Q 001440         1063 DSRPTMQKVSQ 1073 (1077)
Q Consensus      1063 ~~RPs~~evl~ 1073 (1077)
                      ++|||++|+++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999986

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4e-31  Score=283.28  Aligned_cols=245  Identities=24%  Similarity=0.358  Sum_probs=203.1

Q ss_pred             cCCCccceecccCCceEEEEEecCCC-EEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGE-IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++..+..||-|+||.|=..+..+.. .+|+|.+++...-+..+.+.+..|-.+|...+.|.||++|..|.+.+..|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566677999999999998776433 48999998877777777889999999999999999999999999999999999


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |-|-||.+...+++...   +.......++..+.+|++|||++   +||+||+||+|.+++.+|.+|+.|||+|+.+...
T Consensus       500 EaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999977654   55577788999999999999999   9999999999999999999999999999998866


Q ss_pred             CCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                      ... .+++||+.|.|||++..+.++.++|.||+|+++||+++|.+||....++.-... +-.-++.+.-|         .
T Consensus       574 ~KT-wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-ILkGid~i~~P---------r  642 (732)
T KOG0614|consen  574 RKT-WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-ILKGIDKIEFP---------R  642 (732)
T ss_pred             Cce-eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-HHhhhhhhhcc---------c
Confidence            554 567999999999999999999999999999999999999999985544321110 01111111111         2


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCC
Q 001440         1045 DKLISIMEVAISCLDENPDSRPT 1067 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs 1067 (1077)
                      .......+++++....+|.+|.-
T Consensus       643 ~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  643 RITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ccchhHHHHHHHHHhcCcHhhhc
Confidence            22345678899999999999975

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.96  E-value=7.3e-29  Score=267.83  Aligned_cols=239  Identities=28%  Similarity=0.442  Sum_probs=193.7

Q ss_pred             CCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCHHHHH
Q 001440          818 GQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL  896 (1077)
Q Consensus       818 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l  896 (1077)
                      +||.||+|... +|+.||+|++........  .+.+.+|++.+++++|+|++++++++......++|+||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            58999999876 589999999876533221  578899999999999999999999999999999999999999999998


Q ss_pred             hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCccccccccc
Q 001440          897 SNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG  976 (1077)
Q Consensus       897 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~  976 (1077)
                      .....   +++.++..++.+++.+++|||+.   +++|+||+|+||+++.++.++++|||.+....... ......++..
T Consensus        79 ~~~~~---~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~  151 (244)
T smart00220       79 KKRGR---LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPE  151 (244)
T ss_pred             HhccC---CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcC
Confidence            65432   78899999999999999999998   99999999999999999999999999998765442 3344567889


Q ss_pred             ccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHh
Q 001440          977 YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAIS 1056 (1077)
Q Consensus       977 y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 1056 (1077)
                      |+|||......++.++||||+|+++|++++|..||....       ......+........... ........+.+++.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~  223 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-------QLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRK  223 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHH
Confidence            999999988889999999999999999999999986321       111222222222222111 100033468899999


Q ss_pred             ccCCCCCCCCCHHHHHh
Q 001440         1057 CLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1057 cl~~dP~~RPs~~evl~ 1073 (1077)
                      ||..+|++||++.++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.7e-31  Score=257.86  Aligned_cols=200  Identities=26%  Similarity=0.426  Sum_probs=163.5

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee--------
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--------  876 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------  876 (1077)
                      ..|....+||+|.||.||+|+.+ +|++||+|++..+...+. .-....+|+.++..++|+|++.+++.|..        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG-fpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC-CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            45666678999999999999665 678899987644221111 13456789999999999999999988732        


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                      ....|+|+++|+. +|.-.+.+..  ..++..++.++++++..|+.|+|..   .|+|||+||.|++|+.++.+|++|||
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccc
Confidence            3358999999987 7777775432  4578899999999999999999999   99999999999999999999999999


Q ss_pred             ccccCCCC----CCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q 001440          957 ISKSLKPD----SSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       957 la~~~~~~----~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      +|+.+...    ...++..+.|..|.+||.+.+ ..|+++.|||+-||++.||+||.+-++
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq  230 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ  230 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence            99765322    234667788999999998765 579999999999999999999987765

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=242.17  Aligned_cols=203  Identities=25%  Similarity=0.351  Sum_probs=164.7

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ++......||+|++|.|-+-++. +|+..|||++.....  ....++..+|+.+..+- .+|.+|+++|...+++..|+-
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            34455677999999999888664 799999999976533  23356677788765554 799999999999999999999


Q ss_pred             EeecCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          884 YEYLEMGSLAMILSNA-TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ||.|+. ++..+.++. .....+++.-.-+||..+..||.|||++.  .++|||+||+|||++.+|++|+||||++..+.
T Consensus       124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            999965 777665432 23445777788899999999999999986  89999999999999999999999999987654


Q ss_pred             CCCCCcccccccccccCccccc----cCCCCCcchHHHHHHHHHHHHhCCCCCCcc
Q 001440          963 PDSSNWTELAGTIGYVAPELAY----TMKVTEKSDVYSFGVLALEAIKGKHPRDFI 1014 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 1014 (1077)
                      ..- ..+--.|...|||||.+.    ...|+-|+||||+|+++.||.+++.||+.+
T Consensus       201 dSi-Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  201 DSI-AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             hhh-HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            322 222246888999999875    347999999999999999999999998743

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=288.35  Aligned_cols=243  Identities=26%  Similarity=0.410  Sum_probs=187.2

Q ss_pred             CCccceecccCCce-EEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEEEe
Q 001440          808 FDEEHCIGTGGQGS-VYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      |...+.+|.|+.|+ ||+|... |+.||||++-...      .....+|+..++.- +|||||++++...++...||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence            34456789999885 6999985 8899999986432      34567899988877 69999999999999999999999


Q ss_pred             ecCCCCHHHHHhcC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC---C--CceEEecccccc
Q 001440          886 YLEMGSLAMILSNA-TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL---E--YEAHVSDFGISK  959 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~kl~Dfgla~  959 (1077)
                      .|.. +|.+++... ...........+.+..|++.|+++||+.   +|||||+||.||||+.   +  .+++|+|||+++
T Consensus       584 LC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK  659 (903)
T KOG1027|consen  584 LCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK  659 (903)
T ss_pred             Hhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence            9964 999999764 1111122245678899999999999998   9999999999999976   3  579999999999


Q ss_pred             cCCCCCCCc---ccccccccccCccccccCCCCCcchHHHHHHHHHHHHhC-CCCCCccccccccCcccccchhhhcCCC
Q 001440          960 SLKPDSSNW---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKG-KHPRDFISSICSTSSNLDRTLDEILDPR 1035 (1077)
Q Consensus       960 ~~~~~~~~~---~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1077)
                      ++..+....   ....||-+|+|||++....-+.++||||+||++|..++| .+||......   .       ..++...
T Consensus       660 kl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R---~-------~NIl~~~  729 (903)
T KOG1027|consen  660 KLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER---Q-------ANILTGN  729 (903)
T ss_pred             ccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh---h-------hhhhcCc
Confidence            987765443   346789999999999988888899999999999999996 8998632211   0       1111111


Q ss_pred             CCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1036 LPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      ..... ....+.  ...++|.+|+++||..||+|.+|+.
T Consensus       730 ~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  730 YTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            11000 000111  5778999999999999999999974

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=6.2e-29  Score=272.27  Aligned_cols=212  Identities=22%  Similarity=0.309  Sum_probs=178.0

Q ss_pred             CHHHHHHHh---cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEE
Q 001440          797 AYEEIVRAT---NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG  872 (1077)
Q Consensus       797 ~~~~~~~~~---~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~  872 (1077)
                      .|-.+.++.   .-|..++.||-|+||+|.+++. ++...||.|.+.+...-...+...+..|-.+++.-+.+=||++|.
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            455555554   3477788999999999999954 456779999998766555666788999999999999999999999


Q ss_pred             EEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEE
Q 001440          873 FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV  952 (1077)
Q Consensus       873 ~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl  952 (1077)
                      .|.+.+..|+||||++||++...|-+-.   .+.+.-++.++..++.|+++.|+.   |+|||||||+|||||.||.+||
T Consensus       697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKL  770 (1034)
T KOG0608|consen  697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKL  770 (1034)
T ss_pred             EeccCCceEEEEeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceee
Confidence            9999999999999999999999886543   355677778899999999999999   9999999999999999999999


Q ss_pred             ecccccccCC--C------CCCC----------------------------------cccccccccccCccccccCCCCC
Q 001440          953 SDFGISKSLK--P------DSSN----------------------------------WTELAGTIGYVAPELAYTMKVTE  990 (1077)
Q Consensus       953 ~Dfgla~~~~--~------~~~~----------------------------------~~~~~g~~~y~aPE~~~~~~~~~  990 (1077)
                      +|||++.-+.  .      .+.+                                  ....+||+.|+|||++...+|+.
T Consensus       771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q  850 (1034)
T KOG0608|consen  771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ  850 (1034)
T ss_pred             eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence            9999986321  0      0000                                  01257999999999999999999


Q ss_pred             cchHHHHHHHHHHHHhCCCCCCcc
Q 001440          991 KSDVYSFGVLALEAIKGKHPRDFI 1014 (1077)
Q Consensus       991 ~~Dv~s~G~~l~elltg~~p~~~~ 1014 (1077)
                      -+|+||.||++|||+.|+.||-..
T Consensus       851 ~cdwws~gvil~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  851 LCDWWSVGVILYEMLVGQPPFLAD  874 (1034)
T ss_pred             cchhhHhhHHHHHHhhCCCCccCC
Confidence            999999999999999999998643

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=3.2e-28  Score=282.16  Aligned_cols=265  Identities=16%  Similarity=0.184  Sum_probs=181.0

Q ss_pred             HhcCCCccceecccCCceEEEEEe-----------------cCCCEEEEEEccCCccchhh-----------HHHHHHHH
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAEL-----------------SSGEIVAVKKFHSPLLSEMT-----------CQQEFLNE  855 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~e  855 (1077)
                      ..++|++.++||+|+||+||+|.+                 ..++.||||++.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999953                 23567999998653211100           11223456


Q ss_pred             HHHhcCCCCCce-----eeEEEEEee--------CCeeEEEEeecCCCCHHHHHhcCCC---------------------
Q 001440          856 VKSLTEIRHRNI-----VKFYGFCSH--------ARHSFIVYEYLEMGSLAMILSNATS---------------------  901 (1077)
Q Consensus       856 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~g~L~~~l~~~~~---------------------  901 (1077)
                      +.++.+++|.++     ++++++|..        .+..|+||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777766544     677777643        3568999999999999999864211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC-cccccccccccCc
Q 001440          902 AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-WTELAGTIGYVAP  980 (1077)
Q Consensus       902 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~g~~~y~aP  980 (1077)
                      ...+++..+..++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+++.+...... .....+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            11346778889999999999999998   9999999999999999999999999999765433221 1122347899999


Q ss_pred             cccccCC--------------------C--CCcchHHHHHHHHHHHHhCCC-CCCccccccccC---cccccchhhhcCC
Q 001440          981 ELAYTMK--------------------V--TEKSDVYSFGVLALEAIKGKH-PRDFISSICSTS---SNLDRTLDEILDP 1034 (1077)
Q Consensus       981 E~~~~~~--------------------~--~~~~Dv~s~G~~l~elltg~~-p~~~~~~~~~~~---~~~~~~~~~~~~~ 1034 (1077)
                      |++....                    +  ..+.||||+||++|||++|.. ||..........   ......+......
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            9875432                    1  134799999999999999885 654221111100   0111111111111


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhccCCCC---CCCCCHHHHHh
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENP---DSRPTMQKVSQ 1073 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~ 1073 (1077)
                      ....+  ..........+++.+++.++|   .+|+|++|+++
T Consensus       460 ~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111  112234467789999999866   68999999986

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.3e-28  Score=262.16  Aligned_cols=131  Identities=25%  Similarity=0.411  Sum_probs=111.1

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-----C---CceeeEEEEEee
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-----H---RNIVKFYGFCSH  876 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~  876 (1077)
                      .+|.+.++||.|.|++||+|.+ .+.+.||+|+.+..    ....+....||.++++++     |   ..||++++.|..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkh  153 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKH  153 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecccee
Confidence            6889999999999999999955 46788999998753    334566788999999883     3   479999999964


Q ss_pred             ----CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeee
Q 001440          877 ----ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL  944 (1077)
Q Consensus       877 ----~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll  944 (1077)
                          +.+.+||+|++ |.+|..++......+ ++...+.+|++||+.||.|||.+|  ||||-||||+|||+
T Consensus       154 sGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  154 SGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             cCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence                45899999998 558888887665433 889999999999999999999998  99999999999999

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-29  Score=249.70  Aligned_cols=258  Identities=24%  Similarity=0.345  Sum_probs=193.1

Q ss_pred             CccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC-----eeEE
Q 001440          809 DEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----HSFI  882 (1077)
Q Consensus       809 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~l  882 (1077)
                      +..+.||.|+||.||..++. +|+.||.|++... ......-+.+.+|+.++..++|.|+...++......     ..|+
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV  134 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV  134 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence            44577999999999999764 8999999998653 234444678899999999999999999988775443     4578


Q ss_pred             EEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |+|.|. .+|...+-.   ...++...+.-+..||++|+.|||+.   +|.||||||.|.+++++...||||||+|+.-+
T Consensus       135 ~TELmQ-SDLHKIIVS---PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  135 LTELMQ-SDLHKIIVS---PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-hhhhheecc---CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence            889885 477777643   34578788888999999999999999   99999999999999999999999999999766


Q ss_pred             CCC-CCcccccccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccC---------------cccc
Q 001440          963 PDS-SNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS---------------SNLD 1025 (1077)
Q Consensus       963 ~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~---------------~~~~ 1025 (1077)
                      .+. .+++.-+.|..|.|||.+++. .|+.+.||||+||++.|++..+.-|+...+.....               ..-+
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            553 345556778999999999875 58999999999999999998888876544332110               0011


Q ss_pred             cchhhhcCCCCCCCCC-------CcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1026 RTLDEILDPRLPAPSC-------NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1026 ~~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      +...-++......|+.       ...+.......+..+++..||++|.+.++.+..
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            1111122211111110       011223355677889999999999998887654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.95  E-value=4.4e-28  Score=235.35  Aligned_cols=254  Identities=20%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             HhcCCCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeC--Ce
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHA--RH  879 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~  879 (1077)
                      ..++|++.+++|+|.+++||.|. ..+.++++||.++..      ..+.+.+|+.++..++ ||||++++++..++  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            35689999999999999999994 557889999998753      2577899999999996 99999999998765  46


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEeccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGIS  958 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla  958 (1077)
                      +.+|+||+.+.+.....      +.++..++...+.+++.||.|+|+.   ||.|||+||.|+++|.. ...+++|+|+|
T Consensus       110 paLiFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             chhHhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchH
Confidence            78999999998776654      2366678899999999999999999   99999999999999965 67999999999


Q ss_pred             ccCCCCCCCcccccccccccCcccccc-CCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc-----------------
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST----------------- 1020 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~----------------- 1020 (1077)
                      .++.+... +.-.+.+..|--||.+.. ..|+..-|+|||||++.+|+-.+.||-...+....                 
T Consensus       181 EFYHp~~e-YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  181 EFYHPGKE-YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL  259 (338)
T ss_pred             hhcCCCce-eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence            99877644 344566778889998764 45788999999999999999999998543221110                 


Q ss_pred             ---CcccccchhhhcCCCCCCC------CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1021 ---SSNLDRTLDEILDPRLPAP------SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1021 ---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                         ...+...++.++......+      +....-..++..+++.+.|.+|-.+||||.|.++
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence               0011111112111111000      0111111356788999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=272.21  Aligned_cols=252  Identities=27%  Similarity=0.368  Sum_probs=204.2

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|+...++|.|.||.||||++. +++..|||.++-....   ...-..+|+-+++..+|||||.++|.+-.....|+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence            468899999999999999999664 7899999998764322   356678899999999999999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCC
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      ||||.+|+|++.-+-   ...+++.++..+++...+|++|||+.   +=+|||||-.||+++..|.+|++|||.+..+..
T Consensus        91 MEycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            999999999987643   34588889999999999999999999   889999999999999999999999999988877


Q ss_pred             CCCCcccccccccccCcccc---ccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCC
Q 001440          964 DSSNWTELAGTIGYVAPELA---YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1077)
                      .-...+.+.||+.|||||+.   +.+.|...+|||+.|++..|+---+.|.....+.        +...-.-...+..+.
T Consensus       165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--------r~l~LmTkS~~qpp~  236 (829)
T KOG0576|consen  165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--------RALFLMTKSGFQPPT  236 (829)
T ss_pred             hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--------HHHHHhhccCCCCCc
Confidence            76777889999999999975   4677999999999999999998777773211111        111111111122111


Q ss_pred             -CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1041 -CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 -~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                       .........+.++++.|+.++|++||+++.+++
T Consensus       237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence             122233457889999999999999999987764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-28  Score=263.25  Aligned_cols=209  Identities=22%  Similarity=0.307  Sum_probs=175.8

Q ss_pred             CCHHHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHH-----HHHHHHHHhcCCC---CCc
Q 001440          796 IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQ-----EFLNEVKSLTEIR---HRN  866 (1077)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~-----~~~~e~~~l~~l~---h~n  866 (1077)
                      +.++.......+|+..+.+|.|+||.|+.|.++ +...|+||.+.+.+.-...+.+     .+-.|+.+|..++   |+|
T Consensus       551 ~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~N  630 (772)
T KOG1152|consen  551 IGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHEN  630 (772)
T ss_pred             ccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccc
Confidence            344444444567999999999999999999776 4567999998776543322222     3667999999997   999


Q ss_pred             eeeEEEEEeeCCeeEEEEeecCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeC
Q 001440          867 IVKFYGFCSHARHSFIVYEYLEM-GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD  945 (1077)
Q Consensus       867 iv~l~~~~~~~~~~~lV~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~  945 (1077)
                      |++++++|++++.+|++||-+.. -+|++++....   .+++.++..|.+||+-|+++||+.   +|||||||-+||.++
T Consensus       631 IlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd  704 (772)
T KOG1152|consen  631 ILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVD  704 (772)
T ss_pred             hhhhhheeecCCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEe
Confidence            99999999999999999998754 48999996543   488899999999999999999999   999999999999999


Q ss_pred             CCCceEEecccccccCCCCCCCcccccccccccCccccccCCC-CCcchHHHHHHHHHHHHhCCCCCC
Q 001440          946 LEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       946 ~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      .+|-+|++|||.|.....  .....++||..|.|||++.+..| +..-||||+|+++|-++....||.
T Consensus       705 ~~g~~klidfgsaa~~ks--gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  705 SNGFVKLIDFGSAAYTKS--GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cCCeEEEeeccchhhhcC--CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999999876543  34567899999999999999887 556899999999999999888875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=4.4e-26  Score=240.12  Aligned_cols=212  Identities=33%  Similarity=0.569  Sum_probs=184.9

Q ss_pred             ecccCCceEEEEEecC-CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCH
Q 001440          814 IGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL  892 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L  892 (1077)
                      ||+|++|.||++.... ++.+++|++.......  ..+.+.+|+..++.++|++++++++++......++|+||+++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            6899999999998764 8999999987653322  356789999999999999999999999998999999999999999


Q ss_pred             HHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CCceEEecccccccCCCCCCCcccc
Q 001440          893 AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EYEAHVSDFGISKSLKPDSSNWTEL  971 (1077)
Q Consensus       893 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~  971 (1077)
                      .+++....  ..+++.++..++.+++.+++|||+.   +++|+||+|.||+++. ++.++++|||.+.............
T Consensus        79 ~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          79 KDLLKENE--GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            99986542  3478899999999999999999999   9999999999999999 8999999999998765443223445


Q ss_pred             cccccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHH
Q 001440          972 AGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050 (1077)
Q Consensus       972 ~g~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1050 (1077)
                      .+...|++||..... .++.++|+|++|++++++                                           ..+
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------~~~  190 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------PEL  190 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------HHH
Confidence            678899999998877 788999999999999998                                           358


Q ss_pred             HHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1051 MEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1051 ~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      .+++.+|++.+|++||+++++++.+
T Consensus       191 ~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         191 KDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHhhCCcccCcCHHHHhhCC
Confidence            8999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-27  Score=244.06  Aligned_cols=256  Identities=21%  Similarity=0.291  Sum_probs=193.9

Q ss_pred             cCCCccceecccCCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCC------
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR------  878 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------  878 (1077)
                      .+|.-.+.+|.|.- .|..|.+ -.++.||+|+...+. ......+...+|...+..+.|+||++++.++....      
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf-~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPF-QNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCcc-ccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            45666677888887 6666643 368999999998873 44555677889999999999999999999996543      


Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      ..|+|||||.. ++...+.     .+++-..+..+..|++.|+.|||+.   ||+|||+||+||++..++.+||.|||+|
T Consensus        95 e~y~v~e~m~~-nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELMDA-NLCQVIL-----MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhhhh-HHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhh
Confidence            56999999964 8877775     2366678889999999999999999   9999999999999999999999999999


Q ss_pred             ccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcccccccc------Cc----------
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST------SS---------- 1022 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~------~~---------- 1022 (1077)
                      +.-..+ -..+..+.+..|.|||++.+..+.+.+||||+||++.||++|+.-|.........      .+          
T Consensus       166 r~e~~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  166 RTEDTD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             cccCcc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            875544 3456678899999999999999999999999999999999999876522111000      00          


Q ss_pred             ---------ccc----cchhhhc-CCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1023 ---------NLD----RTLDEIL-DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1023 ---------~~~----~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                               +.+    ..+.+.+ |..++.......-......+++.+||-.||++|-+++++++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                     000    0011111 11122111112223346778899999999999999999986

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=231.14  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=183.9

Q ss_pred             hcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEE-EeeCCeeE
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGF-CSHARHSF  881 (1077)
Q Consensus       805 ~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~  881 (1077)
                      .+.|++.+.+|+|.||.+-.|+++ +.+.+|+|.++.+...    .++|.+|...--.+ .|.||+.-+++ |...+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            457899999999999999999876 5678999999876443    67899998776666 58999987764 57778889


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC--CCceEEecccccc
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL--EYEAHVSDFGISK  959 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~  959 (1077)
                      +++||++.|+|..-+....    +.+....+++.|++.|+.|||++   .+||||||.+||||-.  ..++|+||||..+
T Consensus        99 F~qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EeeccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999988775433    56677889999999999999999   9999999999999943  3589999999987


Q ss_pred             cCCCCCCCcccccccccccCccccccC-----CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCC
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYTM-----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1077)
                      ..+..   ....--+..|.|||.....     ...+.+|||.||+++|.++||+.||+.....+...... ..+.....+
T Consensus       172 k~g~t---V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~-~~w~~rk~~  247 (378)
T KOG1345|consen  172 KVGTT---VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEW-EQWLKRKNP  247 (378)
T ss_pred             ccCce---ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHH-HHHhcccCc
Confidence            65432   2223345679999976532     24668999999999999999999987332221111111 111122222


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1071 (1077)
                      +.|.   ........++++.++-+..+|++|=...++
T Consensus       248 ~~P~---~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  248 ALPK---KFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             cCch---hhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            3332   222334467788899999999998443333

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=2.6e-26  Score=247.12  Aligned_cols=207  Identities=20%  Similarity=0.209  Sum_probs=173.0

Q ss_pred             CCHHHHHHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC------CCcee
Q 001440          796 IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR------HRNIV  868 (1077)
Q Consensus       796 ~~~~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~------h~niv  868 (1077)
                      +.+.-.+....+|.+....|+|-|++|.+|.+. .|..||||++......    .+.=..|++++++|.      --+++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHH
Confidence            334444455678999899999999999999664 5789999999764322    455578999999994      34789


Q ss_pred             eEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-
Q 001440          869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-  947 (1077)
Q Consensus       869 ~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-  947 (1077)
                      +++..|.+.++.|||+|-+. .+|.+.++......-+....+..++.|+.-||..|...   +|+|.||||.||||++. 
T Consensus       498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            99999999999999999874 59999998887666688889999999999999999998   99999999999999986 


Q ss_pred             CceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 001440          948 YEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       948 ~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      ..+||||||.|.......-  +....+..|.|||++.+.+|+...|+||+||++||+.||+.-|.
T Consensus       574 ~iLKLCDfGSA~~~~enei--tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp  636 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEI--TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP  636 (752)
T ss_pred             ceeeeccCccccccccccc--cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence            5689999999987654322  22344678999999999999999999999999999999997764

>PLN03210 Resistant to P

Probab=99.93  E-value=1.9e-24  Score=279.96  Aligned_cols=340  Identities=24%  Similarity=0.286  Sum_probs=177.3

Q ss_pred             cCCcccCCCCCCcEEEccCCc------ccccCCcccCCCC-CCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCC
Q 001440           99 LHDFSFSSFPHLAYLDLRVNQ------IFGIIPSQIANNS-KLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGR  171 (1077)
Q Consensus        99 l~~~~~~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~  171 (1077)
                      +++..|.++++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .
T Consensus       549 i~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~  625 (1153)
T PLN03210        549 IHENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-K  625 (1153)
T ss_pred             ecHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-c
Confidence            344456677777777775543      2234555565553 4777777766665 556555 4566777777777665 4


Q ss_pred             CCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCC
Q 001440          172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNL  251 (1077)
Q Consensus       172 ~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  251 (1077)
                      +|..+..+++|++|+|++|...+.+|. ++.+++|+.|+|++|.....+|..++++++|+.|++++|...+.+|..+ ++
T Consensus       626 L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l  703 (1153)
T PLN03210        626 LWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NL  703 (1153)
T ss_pred             cccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CC
Confidence            566666667777777766654445553 6666667777776665555666666666666666666655444555544 56


Q ss_pred             CCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCC-------CcCCCcCCCC
Q 001440          252 PNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG-------SIPSSLGNLT  324 (1077)
Q Consensus       252 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-------~~p~~~~~l~  324 (1077)
                      ++|+.|++++|...+.+|..   .++|+.|+|++|.++ .+|..+ .+++|+.|+++++....       ..+......+
T Consensus       704 ~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~  778 (1153)
T PLN03210        704 KSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSP  778 (1153)
T ss_pred             CCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccc
Confidence            66666666666544444432   245666666666665 344433 35556666555532210       0111111223


Q ss_pred             CccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeeecC
Q 001440          325 KLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLS  404 (1077)
Q Consensus       325 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls  404 (1077)
                      +|+.|+|++|...+.+|..++++++|+.|++++|..-+.+|..+ ++++|+.|++++|..-..+|..   ..+|+.|+|+
T Consensus       779 sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls  854 (1153)
T PLN03210        779 SLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLS  854 (1153)
T ss_pred             cchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECC
Confidence            45555555554444455555555555555555443323344333 3444555555444322222221   1334444444


Q ss_pred             CCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEeccc
Q 001440          405 ENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY  453 (1077)
Q Consensus       405 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~  453 (1077)
                      +|.|+ .+|.++..+++|+.|++++|+--..+|..+..+++|+.+++++
T Consensus       855 ~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~  902 (1153)
T PLN03210        855 RTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSD  902 (1153)
T ss_pred             CCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCC
Confidence            44444 3344444444444444444222122333344444444444433

syringae 6; Provisional

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.93  E-value=1.2e-24  Score=232.10  Aligned_cols=198  Identities=31%  Similarity=0.500  Sum_probs=171.6

Q ss_pred             CCccceecccCCceEEEEEecC-CCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |+..+.||.|++|.||+|.... ++.+|+|.+......  ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            5667889999999999997764 889999998765433  2367888999999999999999999999988999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC-
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS-  965 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  965 (1077)
                      +++++|.+++.....  .+++.++..++.+++.+++|||+.   +++|+|++|.||+++.++.++++|||.+....... 
T Consensus        79 ~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       79 CEGGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             cCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999999976432  167899999999999999999998   99999999999999999999999999998765442 


Q ss_pred             CCcccccccccccCcccc-ccCCCCCcchHHHHHHHHHHHHhCCCCCC
Q 001440          966 SNWTELAGTIGYVAPELA-YTMKVTEKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      .......++..|++||.. ....++.++|||+||+++||+++|+.||+
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS  201 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence            122345678889999998 66778889999999999999999999986

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN03210 Resistant to P

Probab=99.92  E-value=3.5e-24  Score=277.39  Aligned_cols=315  Identities=23%  Similarity=0.231  Sum_probs=201.7

Q ss_pred             CCcccCCCCCCCEEeCCCCC------CCCCCCCCCCCcC-ccceecccccccCCCCCCCCCCcCccceeecccccCCCCC
Q 001440          124 IPSQIANNSKLKYLDLSSNS------FSGTIPPQIGNLS-MLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSI  196 (1077)
Q Consensus       124 ~p~~~~~l~~L~~L~L~~n~------l~~~~p~~~~~l~-~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~  196 (1077)
                      .+.+|.++.+|++|.+..+.      +...+|+.|..++ +|+.|++.+|.+. .+|..| ...+|+.|+|.+|++. .+
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L  626 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KL  626 (1153)
T ss_pred             cHHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cc
Confidence            34567788888888886553      3345677776664 5888888887765 667666 4578888888888876 46


Q ss_pred             CCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCC
Q 001440          197 PPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLT  276 (1077)
Q Consensus       197 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~  276 (1077)
                      |..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|.+++++++|+.|++++|..-+.+|..+ +++
T Consensus       627 ~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~  704 (1153)
T PLN03210        627 WDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLK  704 (1153)
T ss_pred             ccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCC
Confidence            67777788888888877665556664 7777888888888877666777778888888888888765444666655 677


Q ss_pred             ccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccc-------cccCcccccccc
Q 001440          277 NLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF-------GSIPCEIGNLRY  349 (1077)
Q Consensus       277 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~  349 (1077)
                      +|+.|+|++|...+.+|..   ..+|+.|+|++|.+. .+|..+ .+++|+.|++.++...       ...|..+...++
T Consensus       705 sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~s  779 (1153)
T PLN03210        705 SLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPS  779 (1153)
T ss_pred             CCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhcccc
Confidence            7888888877655555543   356777777777776 456554 4667777777653321       111112223355


Q ss_pred             ccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeeccc
Q 001440          350 LFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS  429 (1077)
Q Consensus       350 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  429 (1077)
                      |+.|++++|...+.+|.+++++++|+.|++.+|..-+.+|..+ ++++|+.|++++|..-..+|..   .++|+.|+|++
T Consensus       780 L~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~  855 (1153)
T PLN03210        780 LTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSR  855 (1153)
T ss_pred             chheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCC
Confidence            6666666666555666666666666666666654333455444 5566666666665443333332   24555666666


Q ss_pred             ccCcCCCCCccCCcccCcEEeccc
Q 001440          430 NALSGAIPKEYGNLVKLTLLVLSY  453 (1077)
Q Consensus       430 N~l~~~~p~~~~~l~~L~~L~Ls~  453 (1077)
                      |.++ .+|.++..+++|++|+|++
T Consensus       856 n~i~-~iP~si~~l~~L~~L~L~~  878 (1153)
T PLN03210        856 TGIE-EVPWWIEKFSNLSFLDMNG  878 (1153)
T ss_pred             CCCc-cChHHHhcCCCCCEEECCC
Confidence            6664 3455556666666666655

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.92  E-value=2e-27  Score=248.66  Aligned_cols=433  Identities=24%  Similarity=0.245  Sum_probs=276.0

Q ss_pred             CCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccC-CcCCCCCCCccc
Q 001440          147 TIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN-NSLSGSIPSEIG  225 (1077)
Q Consensus       147 ~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~  225 (1077)
                      .+|..+.  ..-..++|..|+|+...|.+|+.+++|++|||++|+|+.+-|++|.+|.+|..|.+.+ |+|+...-+.|+
T Consensus        60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~  137 (498)
T KOG4237|consen   60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFG  137 (498)
T ss_pred             cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhh
Confidence            5665542  2346789999999988889999999999999999999999999999999998887766 899966666899


Q ss_pred             CccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceE
Q 001440          226 NLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGL  305 (1077)
Q Consensus       226 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  305 (1077)
                      +|.+|+.|.+.-|++.-.....|..|++|..|.|.+|.+...--.+|..+..++.+.+..|.+-.     ..+++.+.. 
T Consensus       138 gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic-----dCnL~wla~-  211 (498)
T KOG4237|consen  138 GLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC-----DCNLPWLAD-  211 (498)
T ss_pred             hHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----ccccchhhh-
Confidence            99999999999999998888899999999999999999984444489999999999999987431     122222221 


Q ss_pred             EcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCcccccc-ccccEEeCCCCcCcccCCC-CCCCCcccceEEccCCC
Q 001440          306 GLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNL-RYLFYLELGDNKLSGSIPH-SLGNLTNLATLYLFTNL  383 (1077)
Q Consensus       306 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~  383 (1077)
                      ++.      ..|..+++..-..-..+.++++..+-+..|... ..+..--.+.+...+..|. .|..+++|+.|+|++|+
T Consensus       212 ~~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~  285 (498)
T KOG4237|consen  212 DLA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNK  285 (498)
T ss_pred             HHh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCc
Confidence            111      112233344444444455555544433333221 1221111222223333343 47778888888888888


Q ss_pred             CCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCC--cc
Q 001440          384 LSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGP--IP  461 (1077)
Q Consensus       384 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~~  461 (1077)
                      |+++-+.+|.++..+++|.|..|+|...-...|.++..|+.|+|++|+|+...|.+|..+.+|.+|+|-.|.+.-.  +.
T Consensus       286 i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~  365 (498)
T KOG4237|consen  286 ITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLA  365 (498)
T ss_pred             cchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchH
Confidence            8877777888888888888888888766667778888888888888888888888888888888888888876421  11


Q ss_pred             ccccccccceEeecCCccCCCCCcccccccccceeccccccccCCCCcCCCCCCCCcEEEcccccccCCCCCCCCCCCCC
Q 001440          462 DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQL  541 (1077)
Q Consensus       462 ~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L  541 (1077)
                      .+..       .+..+.-.+.+  ..+....++.+.+++..+.+.....      =+++..   .-....|   ..++-+
T Consensus       366 wl~~-------Wlr~~~~~~~~--~Cq~p~~~~~~~~~dv~~~~~~c~~------~ee~~~---~~s~~cP---~~c~c~  424 (498)
T KOG4237|consen  366 WLGE-------WLRKKSVVGNP--RCQSPGFVRQIPISDVAFGDFRCGG------PEELGC---LTSSPCP---PPCTCL  424 (498)
T ss_pred             HHHH-------HHhhCCCCCCC--CCCCCchhccccchhccccccccCC------ccccCC---CCCCCCC---CCcchh
Confidence            1111       11122211111  1122233455555555443322210      001000   0001111   122233


Q ss_pred             C-EEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCCCCcccccccceeeeecc
Q 001440          542 K-VLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN  620 (1077)
Q Consensus       542 ~-~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  620 (1077)
                      . +...|+..+. .+|..+.  ..-++|++.+|.++ .+|.+  .+..| .+|+|+|+|...---.|.++++|.+|-|+.
T Consensus       425 ~tVvRcSnk~lk-~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsy  497 (498)
T KOG4237|consen  425 DTVVRCSNKLLK-LLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSY  497 (498)
T ss_pred             hhhHhhcccchh-hcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEec
Confidence            2 2334444444 4554443  35567778888887 56665  55666 778888877755555677777777777766


Q ss_pred             c
Q 001440          621 N  621 (1077)
Q Consensus       621 N  621 (1077)
                      |
T Consensus       498 n  498 (498)
T KOG4237|consen  498 N  498 (498)
T ss_pred             C
Confidence            5

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.91  E-value=1.2e-26  Score=242.95  Aligned_cols=277  Identities=26%  Similarity=0.272  Sum_probs=203.5

Q ss_pred             CCCcEEEccCCcccccCCcccCCCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccc-cccCCCCCCCCCCcCccceee
Q 001440          108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLST-NQFSGRIPPQIGHLSYLKALH  186 (1077)
Q Consensus       108 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~~~~~~p~~~~~l~~L~~L~  186 (1077)
                      +..+.++|..|+|+.+.|.+|+.+++||.||||+|.|+.+-|++|.+|.+|-.|-+-+ |+|+...-+.|++|.+|+.|.
T Consensus        67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl  146 (498)
T KOG4237|consen   67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL  146 (498)
T ss_pred             CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence            3467889999999988889999999999999999999988899999999888876655 888866667889999999999


Q ss_pred             cccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCC-cccCccccceEEeecccc------------cCCCCccCCCCCC
Q 001440          187 LFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS-EIGNLKSLSGLELGYNKL------------SGSMPLSLGNLPN  253 (1077)
Q Consensus       187 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l------------~~~~p~~l~~l~~  253 (1077)
                      +.-|++.-...+.|..|++|..|.|.+|.+. .++. +|..+.+++.+.+..|.+            -...|..++...-
T Consensus       147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc  225 (498)
T KOG4237|consen  147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARC  225 (498)
T ss_pred             cChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhccccee
Confidence            9999998888888999999999999999888 4554 888889999998888873            2334455555555


Q ss_pred             CCeEEcccCCCCCCCCCCCCC-CCccceecCCCCCCCCCCc-cccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEc
Q 001440          254 LATLDLHDNSLSGSIPLSFGN-LTNLDILNLPHNSLSGSIP-SEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYL  331 (1077)
Q Consensus       254 L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  331 (1077)
                      ..-..+.++++....+..|.- +..+..=-.+.+...+..| ..|..+++|+.|+|++|++++.-+.+|.++..+++|+|
T Consensus       226 ~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L  305 (498)
T KOG4237|consen  226 VSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYL  305 (498)
T ss_pred             cchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhc
Confidence            555556666665444443332 1122211222232333444 35777777777777777777777777777777777777


Q ss_pred             cCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCC
Q 001440          332 SDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS  385 (1077)
Q Consensus       332 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~  385 (1077)
                      ..|+|...-...|.++..|+.|+|.+|+|+-..|.+|..+.+|.+|+|-.|.+.
T Consensus       306 ~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~  359 (498)
T KOG4237|consen  306 TRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN  359 (498)
T ss_pred             CcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence            777777665666777777777777777777777777777777777777776654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=1.4e-24  Score=231.12  Aligned_cols=198  Identities=27%  Similarity=0.377  Sum_probs=164.6

Q ss_pred             HHHHhcCCCccceecccCCceEEEEEec----CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEe
Q 001440          801 IVRATNDFDEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCS  875 (1077)
Q Consensus       801 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  875 (1077)
                      +....+.|..+++||+|.|++||+|.+.    .++.||+|.+.....     ...+..|++++..+ .+.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            3444567889999999999999999543    467899999865422     45688999999999 5899999999999


Q ss_pred             eCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-CCceEEec
Q 001440          876 HARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-EYEAHVSD  954 (1077)
Q Consensus       876 ~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~kl~D  954 (1077)
                      ..+...+|+||++.....++...      ++..++..+++.+..||+++|+.   |||||||||.|++.+. .++-.|.|
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvD  176 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVD  176 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEe
Confidence            99999999999999999998743      56788999999999999999999   9999999999999985 47889999


Q ss_pred             ccccccCCCCC------------------C--------------------------CcccccccccccCccccccC-CCC
Q 001440          955 FGISKSLKPDS------------------S--------------------------NWTELAGTIGYVAPELAYTM-KVT  989 (1077)
Q Consensus       955 fgla~~~~~~~------------------~--------------------------~~~~~~g~~~y~aPE~~~~~-~~~  989 (1077)
                      ||+|..+....                  .                          .....+||++|.|||++..- .-+
T Consensus       177 FgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qt  256 (418)
T KOG1167|consen  177 FGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQT  256 (418)
T ss_pred             chhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcC
Confidence            99997321100                  0                          00125799999999998754 457


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCC
Q 001440          990 EKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       990 ~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      .++||||.||++.-++++++||-
T Consensus       257 taiDiws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  257 TAIDIWSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             Cccceeeccceeehhhccccccc
Confidence            89999999999999999999974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=1.9e-24  Score=214.91  Aligned_cols=250  Identities=21%  Similarity=0.315  Sum_probs=188.5

Q ss_pred             CCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          808 FDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      .....+|.+...|+.|+|+|+ |..+++|++....... ...++|..|.-.++-+.||||.+++|.|..+....++..||
T Consensus       192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m  269 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM  269 (448)
T ss_pred             hhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence            344567889999999999997 5556667776543332 23578999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCC
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN  967 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  967 (1077)
                      +.|+|+..+++... ...+..|+.+++.+||+|++|||+. .|-|----+..+.+++|++.+++|. .+-+++..+.   
T Consensus       270 p~gslynvlhe~t~-vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfqe---  343 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQE---  343 (448)
T ss_pred             cchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeeec---
Confidence            99999999988764 3467789999999999999999997 3333345789999999999888774 1111211111   


Q ss_pred             cccccccccccCccccccCCCC---CcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcH
Q 001440          968 WTELAGTIGYVAPELAYTMKVT---EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       968 ~~~~~g~~~y~aPE~~~~~~~~---~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                       ....-.+.||+||.++.++-+   .++|+|||++++||+.|...||...++.+-....    .-+-+...+|+      
T Consensus       344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleglrv~ipp------  412 (448)
T KOG0195|consen  344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEGLRVHIPP------  412 (448)
T ss_pred             -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhccccccCCC------
Confidence             122346889999999877654   4789999999999999999999877654322111    11122333332      


Q ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ..+..+.+++.-|.+.||.+||.++.|+-.||
T Consensus       413 gis~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  413 GISRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             CccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence            22345778888899999999999999998876

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.90  E-value=4.1e-24  Score=269.04  Aligned_cols=195  Identities=19%  Similarity=0.202  Sum_probs=138.8

Q ss_pred             CCCC-CceeeEEEEE-------eeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 001440          861 EIRH-RNIVKFYGFC-------SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI  932 (1077)
Q Consensus       861 ~l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  932 (1077)
                      .++| +||+++++++       .+....+.++||+ +++|++++...  ...+++.+++.++.||++||+|||++   +|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---gI  101 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQ---GI  101 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            3455 5777788876       2234567788887 56999999643  23488899999999999999999998   99


Q ss_pred             EeccCCCCCeeeCC-------------------CCceEEecccccccCCCCC----------------CCcccccccccc
Q 001440          933 VYRDISSKNVLLDL-------------------EYEAHVSDFGISKSLKPDS----------------SNWTELAGTIGY  977 (1077)
Q Consensus       933 vH~Dlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~----------------~~~~~~~g~~~y  977 (1077)
                      +||||||+|||++.                   ++.+|++|||+++......                .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999954                   4556677777765421100                001123578889


Q ss_pred             cCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhc
Q 001440          978 VAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISC 1057 (1077)
Q Consensus       978 ~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1057 (1077)
                      ||||++.+..++.++|||||||++|||++|..|+.....          ..........+..   ..........++.+|
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~  248 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----------TMSSLRHRVLPPQ---ILLNWPKEASFCLWL  248 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----------HHHHHHHhhcChh---hhhcCHHHHHHHHHh
Confidence            999999999999999999999999999999888642111          1111111111110   011123456788899


Q ss_pred             cCCCCCCCCCHHHHHhh
Q 001440         1058 LDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1058 l~~dP~~RPs~~evl~~ 1074 (1077)
                      |+++|.+||+|+|+++.
T Consensus       249 L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        249 LHPEPSCRPSMSELLQS  265 (793)
T ss_pred             CCCChhhCcChHHHhhc
Confidence            99999999999999863

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.90  E-value=2.6e-23  Score=212.62  Aligned_cols=165  Identities=23%  Similarity=0.238  Sum_probs=124.3

Q ss_pred             CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcc
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT  969 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  969 (1077)
                      |+|.++++...  ..+++.++..++.||+.||+|||+.   +      ||+||+++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc----
Confidence            78999997532  3589999999999999999999998   5      999999999999999  99998654432    


Q ss_pred             cccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHH-
Q 001440          970 ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLI- 1048 (1077)
Q Consensus       970 ~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1048 (1077)
                       ..|++.|||||++.+..++.++|||||||++|||++|+.||.......   .......... .+..+........... 
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~~~~~  138 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGM-PADDPRDRSNLESVSAA  138 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHh-ccCCccccccHHHHHhh
Confidence             258899999999999999999999999999999999999986332210   0011111111 1111111111122222 


Q ss_pred             -HHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1049 -SIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1049 -~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                       .+.+++.+||+.||++||++.|+++.+.
T Consensus       139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      139 RSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             hhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence             5899999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=5e-23  Score=246.52  Aligned_cols=267  Identities=24%  Similarity=0.344  Sum_probs=185.0

Q ss_pred             CCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEc
Q 001440          132 SKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYL  211 (1077)
Q Consensus       132 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  211 (1077)
                      ..-..|||++|.++ .+|+.+.  ++|+.|++++|+++. +|..   +++|++|+|++|+|+. +|..   .++|+.|+|
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            34566777777776 5666664  367777777777763 5542   4677777777777774 3432   356777788


Q ss_pred             cCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCC
Q 001440          212 YNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGS  291 (1077)
Q Consensus       212 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~  291 (1077)
                      ++|.++ .+|..+   ++|+.|++++|+++. +|..   +++|++|+|++|+|++ +|...   .+|+.|++++|+|++ 
T Consensus       270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-  336 (788)
T PRK15387        270 FSNPLT-HLPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-  336 (788)
T ss_pred             cCCchh-hhhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-
Confidence            888777 445432   457778888888874 4432   4678888888888874 44432   357778888888874 


Q ss_pred             CccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCC
Q 001440          292 IPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNL  371 (1077)
Q Consensus       292 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l  371 (1077)
                      +|..   ..+|+.|+|++|+|++ +|...   .+|+.|++++|+|.+ +|..   ..+|+.|++++|+|++ +|..   .
T Consensus       337 LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~  401 (788)
T PRK15387        337 LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---P  401 (788)
T ss_pred             cccc---ccccceEecCCCccCC-CCCCC---cccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---c
Confidence            4532   2468888888888884 55432   467778888888874 5543   3567888888888884 5543   3


Q ss_pred             cccceEEccCCCCCCCCcccccCCCCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCC
Q 001440          372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGN  442 (1077)
Q Consensus       372 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~  442 (1077)
                      ++|+.|++++|++++ +|...   .+|+.|++++|+|+ .+|..++++++|+.|+|++|.+++..+..+..
T Consensus       402 s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~  467 (788)
T PRK15387        402 SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALRE  467 (788)
T ss_pred             cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHH
Confidence            578888888888884 56433   46778899999987 67888888999999999999998877665533

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.89  E-value=5.1e-23  Score=248.51  Aligned_cols=371  Identities=22%  Similarity=0.281  Sum_probs=235.8

Q ss_pred             CCCCHHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCccCc----------------eeecCCCCccccccCCCC
Q 001440           31 SSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFG----------------IHCNHAGKVNSINLTSAG   94 (1077)
Q Consensus        31 ~~~~~~~~~all~~k~~~~~~~~~~~~l~~W~~~~~~~~~~c~w~g----------------v~C~~~~~v~~l~l~~~~   94 (1077)
                      ....++|.+.++++.+.+.-|.-..+.-+.|++    .+++|.=..                |.|.. +.|+.+...+..
T Consensus        58 ~~~~~~~~~~~~~~~~~l~~p~~~~~~~~~~~~----~~~fc~~~~~~~~~l~~~~~~~~~tv~~~~-~~vt~l~~~g~~  132 (754)
T PRK15370         58 ETASPEEIKSKFECLRMLAFPAYADNIQYSRGG----ADQYCILSENSQEILSIVFNTEGYTVEGGG-KSVTYTRVTESE  132 (754)
T ss_pred             CCCCHHHHHHHHHHHHHhcCCchhhccccccCC----CCcccccCCcchhhheeeecCCceEEecCC-Cccccccccccc
Confidence            345678999999999999766422223344987    568884333                66743 455655544322


Q ss_pred             cccccCCcccCCCCCCcEEEcc-----CCcccccCC---ccc-----CCCCCCCEEeCCCCCCCCCCCCCCCCcCcccee
Q 001440           95 LIGTLHDFSFSSFPHLAYLDLR-----VNQIFGIIP---SQI-----ANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL  161 (1077)
Q Consensus        95 l~~~l~~~~~~~l~~L~~L~L~-----~n~~~~~~p---~~~-----~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  161 (1077)
                      ...+....     ..-..-+..     .+.-.+.-+   ..+     +-..+.+.|+|+++.++ .+|..+.  +.|+.|
T Consensus       133 ~~~~~~~~-----~~~~~~~~~w~~w~~~~~~~~~~~r~~a~~r~~~Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L  204 (754)
T PRK15370        133 QASSASGS-----KDAVNYELIWSEWVKEAPAKEAANREEAVQRMRDCLKNNKTELRLKILGLT-TIPACIP--EQITTL  204 (754)
T ss_pred             ccccCCCC-----CChhhHHHHHHHHHhcCCCCccccHHHHHHHHHhhcccCceEEEeCCCCcC-cCCcccc--cCCcEE
Confidence            11111100     000000000     000000000   001     11245678888888887 5666553  468888


Q ss_pred             cccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeeccccc
Q 001440          162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS  241 (1077)
Q Consensus       162 ~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  241 (1077)
                      +|++|+++ .+|..+.  ++|+.|++++|+++ .+|..+.  .+|+.|+|++|+++ .+|..+.  ++|+.|++++|+|+
T Consensus       205 ~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~  275 (754)
T PRK15370        205 ILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS  275 (754)
T ss_pred             EecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC
Confidence            88888887 4565554  47888888888887 4565543  46888888888887 6676654  47888888888888


Q ss_pred             CCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcC
Q 001440          242 GSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG  321 (1077)
Q Consensus       242 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  321 (1077)
                       .+|..+.  ++|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. +|..+.  ++|+.|++++|++++ +|..+.
T Consensus       276 -~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~  345 (754)
T PRK15370        276 -CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP  345 (754)
T ss_pred             -ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc
Confidence             4666553  578888888888884 565443  478888888888885 454432  578888888888884 666554


Q ss_pred             CCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccc----cCCCC
Q 001440          322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI----GNLNS  397 (1077)
Q Consensus       322 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l----~~l~~  397 (1077)
                        ++|+.|++++|+|+ .+|..+.  +.|++|++++|+|+ .+|..+.  ..|+.|++++|+++ .+|..+    +.++.
T Consensus       346 --~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~  416 (754)
T PRK15370        346 --PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQ  416 (754)
T ss_pred             --CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCC
Confidence              68888999988887 4666553  57888999999888 4565543  36888889999888 445443    44578


Q ss_pred             CCeeecCCCCcCCCcccccccccccceeecccccCcC-CCCCccCCcccCcEE
Q 001440          398 LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSG-AIPKEYGNLVKLTLL  449 (1077)
Q Consensus       398 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L  449 (1077)
                      +..|++.+|.++.      ..+.+|+.| ++.+.+.| .++...+.+.+++..
T Consensus       417 l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~~~  462 (754)
T PRK15370        417 PTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVRVT  462 (754)
T ss_pred             ccEEEeeCCCccH------HHHHHHHHh-hhcccccCCccccccccccccccc
Confidence            8899999999872      345555555 44455543 334444444555443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.89  E-value=8.8e-23  Score=244.41  Aligned_cols=263  Identities=25%  Similarity=0.340  Sum_probs=204.6

Q ss_pred             CccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEe
Q 001440          156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLEL  235 (1077)
Q Consensus       156 ~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  235 (1077)
                      ..-..|+|+.|.++ .+|+.+.  ++|+.|++.+|+++. +|..   +++|++|+|++|+|+ .+|..   .++|+.|++
T Consensus       201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L  269 (788)
T PRK15387        201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI  269 (788)
T ss_pred             CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence            44667899999998 6788776  479999999999985 5543   578999999999999 45653   467889999


Q ss_pred             ecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCC
Q 001440          236 GYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS  315 (1077)
Q Consensus       236 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  315 (1077)
                      ++|.++. +|..   +++|+.|++++|+++ .+|..   +++|+.|+|++|+|++ +|...   .+|+.|++++|++++ 
T Consensus       270 s~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-  336 (788)
T PRK15387        270 FSNPLTH-LPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-  336 (788)
T ss_pred             cCCchhh-hhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-
Confidence            9999984 4543   357889999999998 45643   4679999999999986 45432   457788999999984 


Q ss_pred             cCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCC
Q 001440          316 IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNL  395 (1077)
Q Consensus       316 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  395 (1077)
                      +|..   ..+|+.|+|++|+|++ +|..   ..+|+.|++++|+|+. +|..   ..+|+.|++++|.|++ +|..   .
T Consensus       337 LP~l---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~  401 (788)
T PRK15387        337 LPTL---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---P  401 (788)
T ss_pred             cccc---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---c
Confidence            5642   2578999999999984 5543   3567888999999984 6653   3578999999999985 5543   3


Q ss_pred             CCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCCccc
Q 001440          396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD  462 (1077)
Q Consensus       396 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~  462 (1077)
                      ++|+.|++++|+|+. +|..+   .+|+.|++++|+|+ .+|..+.++++|+.|+|++|++++..+.
T Consensus       402 s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~  463 (788)
T PRK15387        402 SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ  463 (788)
T ss_pred             cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence            578999999999985 56543   46788999999997 6788899999999999999999876554

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=7e-22  Score=219.81  Aligned_cols=170  Identities=19%  Similarity=0.169  Sum_probs=131.0

Q ss_pred             HHHHhcCCCccceecccCCceEEEEEec--CCCEEEEEEccCCcc--chhhHHHHHHHHHHHhcCCCCCceeeEEEEEee
Q 001440          801 IVRATNDFDEEHCIGTGGQGSVYRAELS--SGEIVAVKKFHSPLL--SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH  876 (1077)
Q Consensus       801 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~  876 (1077)
                      .....++|++.+.||+|+||+||+|.++  +++.||||+......  ......+.+.+|++++++++|+|+++.+..+  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3445678999999999999999999764  577789998753311  1222356799999999999999998533322  


Q ss_pred             CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCeeeCCCCceEEecc
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDI-SSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       877 ~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Df  955 (1077)
                       +..++||||+++++|... .  .    .   ....++.|+++|++|||+.   ||+|||| ||+||+++.++.+||+||
T Consensus        91 -~~~~LVmE~~~G~~L~~~-~--~----~---~~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLA-R--P----H---GDPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             -CCcEEEEEccCCCCHHHh-C--c----c---chHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence             457999999999999732 1  1    0   1146788999999999998   9999999 999999999999999999


Q ss_pred             cccccCCCCCCC--------cccccccccccCccccccC
Q 001440          956 GISKSLKPDSSN--------WTELAGTIGYVAPELAYTM  986 (1077)
Q Consensus       956 gla~~~~~~~~~--------~~~~~g~~~y~aPE~~~~~  986 (1077)
                      |+|+.+......        .....++..|+|||++...
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            999976544311        1245678889999988643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=9.4e-21  Score=212.60  Aligned_cols=253  Identities=20%  Similarity=0.229  Sum_probs=184.8

Q ss_pred             CCCccceecccCCceEEEEEecCC--CEEEEEEccCCccchhhHHHHHHHHHHHhcCCC----CCceeeEEEEE-eeCCe
Q 001440          807 DFDEEHCIGTGGQGSVYRAELSSG--EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR----HRNIVKFYGFC-SHARH  879 (1077)
Q Consensus       807 ~~~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~----h~niv~l~~~~-~~~~~  879 (1077)
                      +|.+.+.||+|+||.||.|.....  ..+|+|.........   ...+..|..++..+.    .+++..+++.. ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999999976543  478888765432111   114566777777775    36889999998 57888


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-----CceEEec
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-----YEAHVSD  954 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~kl~D  954 (1077)
                      .|+||+.+ |.+|.++..... ...++...+.+++.|++.+|+++|+.   |++||||||.|+++...     ..+.+.|
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            99999977 679999876555 56789999999999999999999999   99999999999999865     4699999


Q ss_pred             ccccc--cCCCCCC-------C-cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCccc
Q 001440          955 FGISK--SLKPDSS-------N-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024 (1077)
Q Consensus       955 fgla~--~~~~~~~-------~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~ 1024 (1077)
                      ||+|+  .+.....       . .....||.+|+++++..+.+.+.+.|+||++.++.|+..|..||........     
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-----  245 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-----  245 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-----
Confidence            99999  4322211       0 1235599999999999999999999999999999999999999864332111     


Q ss_pred             ccchhhhcCCCCCC-CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhh
Q 001440         1025 DRTLDEILDPRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1025 ~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1075 (1077)
                      ...+.......... ......   ..+.++...+-..+..++|..+.+...+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l  294 (322)
T KOG1164|consen  246 KSKFEKDPRKLLTDRFGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELL  294 (322)
T ss_pred             HHHHHHHhhhhccccccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHH
Confidence            11111111111110 011111   2344555555558888999998887664

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.85  E-value=2.6e-21  Score=233.80  Aligned_cols=267  Identities=26%  Similarity=0.418  Sum_probs=204.6

Q ss_pred             CccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEe
Q 001440          156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLEL  235 (1077)
Q Consensus       156 ~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L  235 (1077)
                      .+...|+++++.++ .+|..+.  ++|+.|+|++|+++. +|..+.  ++|+.|++++|+++ .+|..+.  .+|+.|+|
T Consensus       178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L  248 (754)
T PRK15370        178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL  248 (754)
T ss_pred             cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence            35678999999888 5676664  579999999999984 565554  58999999999998 5676553  47999999


Q ss_pred             ecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCC
Q 001440          236 GYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS  315 (1077)
Q Consensus       236 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  315 (1077)
                      ++|++. .+|..+.  ++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|+|++ +|..+.  ++|+.|++++|+++. 
T Consensus       249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-  318 (754)
T PRK15370        249 SINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-  318 (754)
T ss_pred             cCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-
Confidence            999998 5676664  58999999999998 5777664  589999999999985 555443  478999999999984 


Q ss_pred             cCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCCCCcccccCC
Q 001440          316 IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNL  395 (1077)
Q Consensus       316 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l  395 (1077)
                      +|..+.  ++|+.|++++|.+++ +|..+.  ++|+.|++++|+|+ .+|..+.  ++|+.|++++|.++ .+|..+.  
T Consensus       319 LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--  387 (754)
T PRK15370        319 LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--  387 (754)
T ss_pred             CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--
Confidence            565443  689999999999985 666553  68999999999998 4676553  68999999999998 4565554  


Q ss_pred             CCCCeeecCCCCcCCCccccc----ccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCCc
Q 001440          396 NSLSDLGLSENELSGSIPYSF----GNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPI  460 (1077)
Q Consensus       396 ~~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  460 (1077)
                      .+|+.|++++|+|+ .+|..+    +.++++..|++.+|.++.      ..+.+|+.| ++.+.+.|..
T Consensus       388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~  448 (754)
T PRK15370        388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPR  448 (754)
T ss_pred             HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCc
Confidence            36899999999998 455544    445788899999999862      345555555 4556666543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.84  E-value=9.5e-20  Score=206.96  Aligned_cols=257  Identities=28%  Similarity=0.400  Sum_probs=197.6

Q ss_pred             CCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCC-ceeeEEEEEeeCCeeEEEEee
Q 001440          808 FDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR-NIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      |...+.+|.|+||.||++...  ..+|+|.+.............+.+|+..++.+.|+ +++++.+++......++++||
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            667788999999999999876  78999998776544433467899999999999988 799999999887788999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-ceEEecccccccCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  965 (1077)
                      +.++++.+++........++......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||.++......
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            99999997775543112477889999999999999999999   999999999999999998 79999999998655443


Q ss_pred             C------CcccccccccccCcccccc---CCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCC
Q 001440          966 S------NWTELAGTIGYVAPELAYT---MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036 (1077)
Q Consensus       966 ~------~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1077)
                      .      ......|+..|+|||...+   ..+....|+||+|++++++++|..||......    .........+.....
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~  232 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILELPT  232 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhcCC
Confidence            2      2356789999999999987   57888999999999999999999996533210    000111111111111


Q ss_pred             C-CCCCCc----HHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1037 P-APSCNI----RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1037 ~-~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      + ......    ......+.+++..|+..+|..|.++.+...
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~  274 (384)
T COG0515         233 PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS  274 (384)
T ss_pred             cccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence            1 000000    111246788999999999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2e-21  Score=230.65  Aligned_cols=253  Identities=19%  Similarity=0.240  Sum_probs=186.8

Q ss_pred             ccceecccCCceEEEEEec-CCCEEEEEEccC---CccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEe
Q 001440          810 EEHCIGTGGQGSVYRAELS-SGEIVAVKKFHS---PLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       810 ~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E  885 (1077)
                      ..+.+|.|.+|.|+.+... ..+..+.|.+..   ...........+..|..+-..++|+|++..+....+.....-+||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            4567999999988877443 344445554431   222222223337778888899999999888777766666666699


Q ss_pred             ecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCC
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      ||++ +|+.++...   ..++..++..+++|+..|+.|+|+.   ||.|||+|++|++++.+|.+||+|||.+....-+.
T Consensus       402 ~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             cccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            9999 999998665   2477789999999999999999999   99999999999999999999999999997654333


Q ss_pred             C----CcccccccccccCccccccCCCCCc-chHHHHHHHHHHHHhCCCCCCcccccccc-CcccccchhhhcCCCCCCC
Q 001440          966 S----NWTELAGTIGYVAPELAYTMKVTEK-SDVYSFGVLALEAIKGKHPRDFISSICST-SSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       966 ~----~~~~~~g~~~y~aPE~~~~~~~~~~-~Dv~s~G~~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      +    .....+|+-.|+|||++.+..|+++ .||||.|+++..|.+|+.||......... ..........    ....+
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~----~~~~~  550 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRN----IFEGP  550 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccc----cccCh
Confidence            2    2456789999999999999999875 79999999999999999998644322111 0010000000    11111


Q ss_pred             CCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .......+.....++.++++.||.+|-|+++|++
T Consensus       551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            1223444556778999999999999999999986

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=3e-21  Score=225.69  Aligned_cols=254  Identities=21%  Similarity=0.240  Sum_probs=186.4

Q ss_pred             CHHHHHHHhc-CCCccceecccCCceEEEEEecCCCEEEEEEccCCccc-hhhHHHHHHHHHHHhcCCCCCceeeEEEEE
Q 001440          797 AYEEIVRATN-DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEIRHRNIVKFYGFC  874 (1077)
Q Consensus       797 ~~~~~~~~~~-~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  874 (1077)
                      +.+.+..... +|...+.+|.++|=.|.+|++++|. |+||++.+.... .-....+-..|++ .+.++|||++++.-+-
T Consensus        13 ~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~   90 (1431)
T KOG1240|consen   13 PVEVYFSDLSVECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL   90 (1431)
T ss_pred             hHHHHhhcCccceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH
Confidence            3444443333 6788899999999999999998887 889988664311 1112223333444 5556899999999888


Q ss_pred             eeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEec
Q 001440          875 SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSD  954 (1077)
Q Consensus       875 ~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~D  954 (1077)
                      ..++..|||-+|+.+ +|+|.+...   +-+...+..-||.|++.|+..+|+.   ||+|||||.+|||++.-..+.|+|
T Consensus        91 ~t~kAAylvRqyvkh-nLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtD  163 (1431)
T KOG1240|consen   91 VTDKAAYLVRQYVKH-NLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTD  163 (1431)
T ss_pred             HhhHHHHHHHHHHhh-hhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhc
Confidence            888889999999966 899988543   3366778888999999999999999   999999999999999999999999


Q ss_pred             ccccccC--CCCC-CCcc----cccccccccCccccccC----------C-CCCcchHHHHHHHHHHHHh-CCCCCCccc
Q 001440          955 FGISKSL--KPDS-SNWT----ELAGTIGYVAPELAYTM----------K-VTEKSDVYSFGVLALEAIK-GKHPRDFIS 1015 (1077)
Q Consensus       955 fgla~~~--~~~~-~~~~----~~~g~~~y~aPE~~~~~----------~-~~~~~Dv~s~G~~l~ellt-g~~p~~~~~ 1015 (1077)
                      |..-+..  .++. ..+.    +......|.|||.+...          . .+++.||||.||+++|+++ |++||...+
T Consensus       164 FAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ  243 (1431)
T KOG1240|consen  164 FASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ  243 (1431)
T ss_pred             ccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH
Confidence            9866532  2222 1222    23345679999987542          1 5678999999999999998 677776332


Q ss_pred             ccccc----CcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1016 SICST----SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1016 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                       ....    ....+..++++-++              .++.++..|++.||++|.+|++.++.
T Consensus       244 -L~aYr~~~~~~~e~~Le~Ied~--------------~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 -LLAYRSGNADDPEQLLEKIEDV--------------SLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             -HHhHhccCccCHHHHHHhCcCc--------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence             2221    12223333333222              46788999999999999999999874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=5.2e-20  Score=181.01  Aligned_cols=257  Identities=18%  Similarity=0.280  Sum_probs=188.0

Q ss_pred             HhcCCCccceecccCCceEEEE-EecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCC-CceeeEEEEEeeCCeeE
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       804 ~~~~~~~~~~lG~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~  881 (1077)
                      ....|.++++||.|+||.+|.| ...+|+.||+|.-....     ....+..|..+.+.+++ ..|..+..|..+..+-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            3568999999999999999999 45689999999865432     13467788899999965 78888888999999999


Q ss_pred             EEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC---CceEEeccccc
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGIS  958 (1077)
Q Consensus       882 lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~kl~Dfgla  958 (1077)
                      +|||.. |-+|.+...-..  ..++..+++-.|-|++.-++|+|.+   +++||||||+|+++.-+   ..+.++|||+|
T Consensus        88 lVMdLL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeecc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccch
Confidence            999988 568888775443  3478889999999999999999999   89999999999999754   46889999999


Q ss_pred             ccCCCCCC-------CcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhh
Q 001440          959 KSLKPDSS-------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031 (1077)
Q Consensus       959 ~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1031 (1077)
                      +.+.+...       ..+...||.+|.+=....+.+-+.+.|+=|+|.++...--|..||+.....     ...+..+.+
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-----tk~QKyEkI  236 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-----TKKQKYEKI  236 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-----hHHHHHHHH
Confidence            98754322       234578999999988888888888999999999999999999998743221     112223333


Q ss_pred             cCCCCCCCC-CCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1032 LDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1032 ~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      ...+...+. ..+...+.++.-.+.-|=..-=++-|...-+.+.++
T Consensus       237 ~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  237 SEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             HHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            333332221 011112233444444555555556666555544443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=5.6e-20  Score=189.65  Aligned_cols=184  Identities=13%  Similarity=0.149  Sum_probs=140.2

Q ss_pred             ccCCHHHHHH--HhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHH------HHHHHHHhcCCCCC
Q 001440          794 RKIAYEEIVR--ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQE------FLNEVKSLTEIRHR  865 (1077)
Q Consensus       794 ~~~~~~~~~~--~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~e~~~l~~l~h~  865 (1077)
                      ....|.++..  ...+|...+++|.|+||.||.+.. ++..+|+|.+.......+.....      +.+|+..+.++.|+
T Consensus        17 ~~~~~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~   95 (232)
T PRK10359         17 NDNKYKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE   95 (232)
T ss_pred             CcccHHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC
Confidence            3434444443  357899999999999999999866 57789999997654443333233      68999999999999


Q ss_pred             ceeeEEEEEeeC--------CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC
Q 001440          866 NIVKFYGFCSHA--------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDI  937 (1077)
Q Consensus       866 niv~l~~~~~~~--------~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl  937 (1077)
                      +|..+.+++...        +..++||||++|.+|.++..       ++.    ....+++.++..+|+.   |++|||+
T Consensus        96 GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Di  161 (232)
T PRK10359         96 GLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQH---GMVSGDP  161 (232)
T ss_pred             CCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCC
Confidence            999999886533        35789999999999988731       222    2456899999999999   9999999


Q ss_pred             CCCCeeeCCCCceEEecccccccCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHH
Q 001440          938 SSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI 1005 (1077)
Q Consensus       938 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ell 1005 (1077)
                      +|.||+++.++ ++++|||..+....+... .           .+.....|..++|+|++|+++....
T Consensus       162 kp~Nili~~~g-i~liDfg~~~~~~e~~a~-d-----------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        162 HKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-D-----------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ChHHEEEeCCC-EEEEECCCcccccchhhH-H-----------HHHHHhHhcccccccceeEeehHHH
Confidence            99999999988 999999988755322111 1           1344455778999999999977654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.80  E-value=3.9e-19  Score=182.82  Aligned_cols=198  Identities=20%  Similarity=0.338  Sum_probs=168.3

Q ss_pred             cCCCccceecccCCceEEEEE-ecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCeeEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      -.|.+.++||.|.||+++.|+ .-+++.||||.-...     .+..++..|.+..+.| ..++|..++.|..++.+-.+|
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            468999999999999999994 458999999975432     1245677888888888 579999999999999999999


Q ss_pred             EeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC-----ceEEeccccc
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-----EAHVSDFGIS  958 (1077)
Q Consensus       884 ~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~kl~Dfgla  958 (1077)
                      +|.+ |-+|+|...-+.  ..++...+..+|.|+..-++|+|++   ..|.|||||+|+||...+     .+.++|||+|
T Consensus       103 idLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA  176 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA  176 (449)
T ss_pred             hhhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccch
Confidence            9988 558888776554  4588899999999999999999999   899999999999997643     5899999999


Q ss_pred             ccCCCCCCC-------cccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCcc
Q 001440          959 KSLKPDSSN-------WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFI 1014 (1077)
Q Consensus       959 ~~~~~~~~~-------~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~ 1014 (1077)
                      +.+.+....       .+...||.+||+=....+.+-+.+.|+=|+|-++...+-|..||+..
T Consensus       177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            988654322       34578999999999999999999999999999999999999998743

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.79  E-value=1.9e-19  Score=184.52  Aligned_cols=143  Identities=20%  Similarity=0.222  Sum_probs=109.3

Q ss_pred             cceecccCCceEEEEEecCCCEEEEEEccCCccchhh-----------------------HHHHHHHHHHHhcCCCCCce
Q 001440          811 EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMT-----------------------CQQEFLNEVKSLTEIRHRNI  867 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~e~~~l~~l~h~ni  867 (1077)
                      ...||+|+||.||+|...+|+.||||+++........                       .......|+..++++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998878999999998754321111                       01223458999999988776


Q ss_pred             eeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCeeeCC
Q 001440          868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL-HNDCFPPIVYRDISSKNVLLDL  946 (1077)
Q Consensus       868 v~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlk~~NIll~~  946 (1077)
                      .....+...  ..++||||++++++.......   ..++..++..++.|++.+++|+ |+.   ||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEec--CCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-
Confidence            544433322  238999999998776543222   2477889999999999999999 687   999999999999998 


Q ss_pred             CCceEEecccccccCC
Q 001440          947 EYEAHVSDFGISKSLK  962 (1077)
Q Consensus       947 ~~~~kl~Dfgla~~~~  962 (1077)
                      ++.++++|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            5789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=8.8e-19  Score=186.27  Aligned_cols=235  Identities=19%  Similarity=0.259  Sum_probs=151.8

Q ss_pred             CCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCC----------CceeeEEEEEe-
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH----------RNIVKFYGFCS-  875 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~-  875 (1077)
                      +...+.||.|+++.||.+++. +|+.+|||.+..+........+++.+|.-....+.+          -.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            445678999999999999776 689999999876654555556777777766555422          12222222221 


Q ss_pred             --------eC---C-----eeEEEEeecCCCCHHHHHhc---CCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEec
Q 001440          876 --------HA---R-----HSFIVYEYLEMGSLAMILSN---ATS-AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR  935 (1077)
Q Consensus       876 --------~~---~-----~~~lV~E~~~~g~L~~~l~~---~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~  935 (1077)
                              ..   .     ..+++|+-+ .++|.+++..   ... ...+....++.+..|+++.+++||+.   |++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence                    11   1     225677766 5688877532   211 12244456677789999999999999   99999


Q ss_pred             cCCCCCeeeCCCCceEEecccccccCCCCCCCcccccccccccCcccccc--------CCCCCcchHHHHHHHHHHHHhC
Q 001440          936 DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT--------MKVTEKSDVYSFGVLALEAIKG 1007 (1077)
Q Consensus       936 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~Dv~s~G~~l~elltg 1007 (1077)
                      ||+|+|++++.+|.++++||+........   ......+..|.+||....        ..++.+.|.|++|+++|.|++|
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999999987754322   121345678999997644        2478899999999999999999


Q ss_pred             CCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCC
Q 001440         1008 KHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065 (1077)
Q Consensus      1008 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1065 (1077)
                      +.||...........              ....|.  +.+..+..+|..+|+++|++|
T Consensus       247 ~lPf~~~~~~~~~~~--------------~f~~C~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW--------------DFSRCR--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG--------------GGTTSS-----HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc--------------cchhcC--CcCHHHHHHHHHHccCCcccC
Confidence            999874332111100              111122  556678999999999999988

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=4.2e-18  Score=171.46  Aligned_cols=186  Identities=9%  Similarity=0.041  Sum_probs=139.2

Q ss_pred             CccceecccCCceEEEEEecCCCEEEEEEccCCccch-hhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEEEEee
Q 001440          809 DEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSE-MTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       809 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      .+...|++|+||+||.+.. .+.+++.+.+....... ......+.+|++++++++ |+++++++++    ...++||||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4567899999999998866 57788877765432111 111235789999999995 5889999886    346899999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccC-CCCCeeeCCCCceEEecccccccCCCCC
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDI-SSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      +.|.+|.+....          ....++.|++.+++++|+.   ||+|||| ||.||+++.++.++|+|||+|....+..
T Consensus        80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            999998754311          1235778999999999999   9999999 7999999999999999999998654433


Q ss_pred             CC-----cc--------cccccccccCccccccC-CCC-CcchHHHHHHHHHHHHhCCCCCC
Q 001440          966 SN-----WT--------ELAGTIGYVAPELAYTM-KVT-EKSDVYSFGVLALEAIKGKHPRD 1012 (1077)
Q Consensus       966 ~~-----~~--------~~~g~~~y~aPE~~~~~-~~~-~~~Dv~s~G~~l~elltg~~p~~ 1012 (1077)
                      ..     ..        ....++.|++|+...-- ..+ .+.+.++-|.-+|.++|++.|..
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~  208 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW  208 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence            21     00        12257778888754322 233 56799999999999999999853

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=3.2e-18  Score=176.51  Aligned_cols=143  Identities=20%  Similarity=0.241  Sum_probs=111.6

Q ss_pred             cceecccCCceEEEEEecCCCEEEEEEccCCccchh-----------------------hHHHHHHHHHHHhcCCCCCce
Q 001440          811 EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEM-----------------------TCQQEFLNEVKSLTEIRHRNI  867 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----------------------~~~~~~~~e~~~l~~l~h~ni  867 (1077)
                      ...||+|++|.||+|...+|+.||||++........                       .....+..|.+.+.+++|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999999877899999999876421100                       001224678999999999987


Q ss_pred             eeEEEEEeeCCeeEEEEeecCCCCHHHH-HhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeeeC
Q 001440          868 VKFYGFCSHARHSFIVYEYLEMGSLAMI-LSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLD  945 (1077)
Q Consensus       868 v~l~~~~~~~~~~~lV~E~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~  945 (1077)
                      .....+....  .++||||++++++... +..    ..++..+..+++.|++.++.++|+ .   ||+||||||+||+++
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~  152 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH  152 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence            6555544333  4899999998865433 322    236678899999999999999999 7   999999999999999


Q ss_pred             CCCceEEecccccccCCC
Q 001440          946 LEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       946 ~~~~~kl~Dfgla~~~~~  963 (1077)
                       ++.++++|||+|+....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             89999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.77  E-value=9e-19  Score=197.71  Aligned_cols=209  Identities=27%  Similarity=0.483  Sum_probs=159.3

Q ss_pred             hcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe-EeccC
Q 001440          859 LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI-VYRDI  937 (1077)
Q Consensus       859 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~Dl  937 (1077)
                      ++.+.|.|+.+++|.+.++...++|.+||..|+|.|.+...  ...++|--...++++|+.|++|+|..   +| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            46789999999999999999999999999999999999763  34588888999999999999999988   55 89999


Q ss_pred             CCCCeeeCCCCceEEecccccccCCC--CCCCcccccccccccCccccccCC-------CCCcchHHHHHHHHHHHHhCC
Q 001440          938 SSKNVLLDLEYEAHVSDFGISKSLKP--DSSNWTELAGTIGYVAPELAYTMK-------VTEKSDVYSFGVLALEAIKGK 1008 (1077)
Q Consensus       938 k~~NIll~~~~~~kl~Dfgla~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~~Dv~s~G~~l~elltg~ 1008 (1077)
                      +.+|.+++..+.+|++|||+......  +...........-|.|||.+....       .+.+.||||||++++|+++.+
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            99999999999999999999876642  112222233456799999987642       356799999999999999999


Q ss_pred             CCCCccccccccCcccccchhhhcC-CCCCC-CCCCcH-HHHHHHHHHHHhccCCCCCCCCCHHHHHhhhc
Q 001440         1009 HPRDFISSICSTSSNLDRTLDEILD-PRLPA-PSCNIR-DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1009 ~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1076 (1077)
                      .||+........    .+.+..+.+ +.-+. |.-... +....+..++.+||..+|++||++++|...++
T Consensus       156 ~~~~~~~~~~~~----~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~  222 (484)
T KOG1023|consen  156 GPFDLRNLVEDP----DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLL  222 (484)
T ss_pred             CccccccccCCh----HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhh
Confidence            998743322111    222222222 11111 111111 33336888999999999999999999987765

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=2.1e-20  Score=174.17  Aligned_cols=153  Identities=36%  Similarity=0.584  Sum_probs=90.9

Q ss_pred             CccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEc
Q 001440          180 SYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDL  259 (1077)
Q Consensus       180 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L  259 (1077)
                      ++.+.|.|++|+++ .+|+.+..|.+|+.|++++|+++ .+|..++.+++|+.|.++-|++. ..|..||.++.|+.|||
T Consensus        33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl  109 (264)
T KOG0617|consen   33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL  109 (264)
T ss_pred             hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence            44444555555554 34455666666666666666666 55666666666666666666665 56666666666666666


Q ss_pred             ccCCCCC-CCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccc
Q 001440          260 HDNSLSG-SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF  337 (1077)
Q Consensus       260 ~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  337 (1077)
                      .+|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.+++|++|.+.+|+++
T Consensus       110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~  186 (264)
T KOG0617|consen  110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT  186 (264)
T ss_pred             cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee
Confidence            6666653 45666666666666666666665 45555555555555555555554 34555555555555555555554

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=1.5e-19  Score=202.83  Aligned_cols=226  Identities=27%  Similarity=0.353  Sum_probs=181.3

Q ss_pred             ecccCCceEEEEEe----cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEEEEeecC
Q 001440          814 IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~  888 (1077)
                      +|+|.||.|+.++.    +.|.-+|.|...+......... ....|..++...+ ||.+|++...+..++..+++++|..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            68999999997732    3567788888766544333222 5566777888886 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCc
Q 001440          889 MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW  968 (1077)
Q Consensus       889 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  968 (1077)
                      +|.+...+....   ..+..........++-|++++|+.   +|+|||+|++||+++.+|.+|+.|||+++..-..... 
T Consensus        81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999988775543   345566677788999999999999   9999999999999999999999999999876544332 


Q ss_pred             ccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHH
Q 001440          969 TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLI 1048 (1077)
Q Consensus       969 ~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1077)
                         +||..|||||++.  .+..++|.||||++++||+||-.||..            +....+....+..|    .....
T Consensus       154 ---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~~~~~p----~~l~~  212 (612)
T KOG0603|consen  154 ---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKAELEMP----RELSA  212 (612)
T ss_pred             ---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhhccCCc----hhhhH
Confidence               7899999999988  678899999999999999999999862            33444444444433    45566


Q ss_pred             HHHHHHHhccCCCCCCCCCH
Q 001440         1049 SIMEVAISCLDENPDSRPTM 1068 (1077)
Q Consensus      1049 ~l~~li~~cl~~dP~~RPs~ 1068 (1077)
                      ...+++..+...+|..|.-.
T Consensus       213 ~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  213 EARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHHhhCHHHHhcc
Confidence            77888889999999998754

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=3.1e-18  Score=179.90  Aligned_cols=195  Identities=23%  Similarity=0.337  Sum_probs=136.9

Q ss_pred             CCCceeeEEEEEee---------------------------CCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHH
Q 001440          863 RHRNIVKFYGFCSH---------------------------ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK  915 (1077)
Q Consensus       863 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~  915 (1077)
                      +|||||++.++|.+                           +...|+||...+. +|.+|+....    .+.....-|+.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~----~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH----RSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC----CchHHHHHHHH
Confidence            59999999987633                           3466899987754 8999885443    45566777899


Q ss_pred             HHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC----CceEEecccccccCCCC------CCCcccccccccccCcccccc
Q 001440          916 GVADALSYLHNDCFPPIVYRDISSKNVLLDLE----YEAHVSDFGISKSLKPD------SSNWTELAGTIGYVAPELAYT  985 (1077)
Q Consensus       916 ~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl~Dfgla~~~~~~------~~~~~~~~g~~~y~aPE~~~~  985 (1077)
                      |+++|+.|||++   ||.|||+|.+||++.-+    -...|+|||.+-.-+..      ....-...|.-.-||||+...
T Consensus       349 QlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            999999999999   99999999999999533    35789999977432221      122234567788999998865


Q ss_pred             CC------CCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccC
Q 001440          986 MK------VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLD 1059 (1077)
Q Consensus       986 ~~------~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 1059 (1077)
                      .+      -..|+|.|+.|.+.||+++...||..-....-.    .....   ...+|..+   ......+.+++...++
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~----~r~Yq---e~qLPalp---~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD----TRTYQ---ESQLPALP---SRVPPVARQLVFDLLK  495 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec----hhhhh---hhhCCCCc---ccCChHHHHHHHHHhc
Confidence            42      135899999999999999999998632111100    01111   11222211   2334468899999999


Q ss_pred             CCCCCCCCHHHHHhhh
Q 001440         1060 ENPDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1060 ~dP~~RPs~~evl~~L 1075 (1077)
                      .||.+|+++.-....|
T Consensus       496 r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANVL  511 (598)
T ss_pred             CCccccCCccHHHhHH
Confidence            9999999876544443

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.76  E-value=1.5e-20  Score=175.18  Aligned_cols=163  Identities=36%  Similarity=0.600  Sum_probs=98.1

Q ss_pred             CccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceE
Q 001440          226 NLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGL  305 (1077)
Q Consensus       226 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  305 (1077)
                      +++..+.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++.|++. .+|..|+.++.|+.|
T Consensus        31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            3445555555555555 44555556666666666666665 45556666666666666666665 456666666666666


Q ss_pred             EcCCCCCCC-CcCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCC
Q 001440          306 GLSFNKLSG-SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLL  384 (1077)
Q Consensus       306 ~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l  384 (1077)
                      ||++|++.. .+|..|..++.|+-|+|+.|.+. .+|..++++++|+.|.+.+|.+- .+|..++.+++|++|++.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            666666643 45666666666666666666665 55666666666666666666655 4566666666666666666666


Q ss_pred             CCCCcccccC
Q 001440          385 SGSIPSEIGN  394 (1077)
Q Consensus       385 ~~~~p~~l~~  394 (1077)
                      + .+|.++++
T Consensus       186 ~-vlppel~~  194 (264)
T KOG0617|consen  186 T-VLPPELAN  194 (264)
T ss_pred             e-ecChhhhh
Confidence            5 44444443

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=1.8e-20  Score=211.69  Aligned_cols=283  Identities=23%  Similarity=0.275  Sum_probs=131.6

Q ss_pred             EEEccCCccc-ccCCcccCCCCCCCEEeCCCCCCCCC----CCCCCCCcCccceecccccccCCCCCCCCCCcCccceee
Q 001440          112 YLDLRVNQIF-GIIPSQIANNSKLKYLDLSSNSFSGT----IPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALH  186 (1077)
Q Consensus       112 ~L~L~~n~~~-~~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~  186 (1077)
                      .|+|..+.+. ...+..+..+..|++|+++++.++..    ++..+...++|++|+++++.+.+ .+..+          
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~----------   70 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL----------   70 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence            3566666665 33444555566677777776666422    34445555556666666665542 11100          


Q ss_pred             cccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccc---cceEEeecccccC----CCCccCCCC-CCCCeEE
Q 001440          187 LFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS---LSGLELGYNKLSG----SMPLSLGNL-PNLATLD  258 (1077)
Q Consensus       187 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~  258 (1077)
                             ..++..+..+++|++|++++|.+.+..+..+..+.+   |++|++++|++++    .+...+..+ ++|++|+
T Consensus        71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~  143 (319)
T cd00116          71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV  143 (319)
T ss_pred             -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence                   112233444455555555555555444444443333   5555555555542    122233344 5556666


Q ss_pred             cccCCCCCC----CCCCCCCCCccceecCCCCCCCCC----CccccCCCCCcceEEcCCCCCCCC----cCCCcCCCCCc
Q 001440          259 LHDNSLSGS----IPLSFGNLTNLDILNLPHNSLSGS----IPSEMGNLKSLYGLGLSFNKLSGS----IPSSLGNLTKL  326 (1077)
Q Consensus       259 L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L  326 (1077)
                      +++|.+++.    ++..+..+.+|++|++++|.+++.    ++..+..+++|+.|++++|.+++.    ++..+..+++|
T Consensus       144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L  223 (319)
T cd00116         144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL  223 (319)
T ss_pred             cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence            666655531    122334444555555555555431    122233334555555555554421    12223334444


Q ss_pred             cEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcccceEEccCCCCCC----CCcccccCCCCCCeee
Q 001440          327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG----SIPSEIGNLNSLSDLG  402 (1077)
Q Consensus       327 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~----~~p~~l~~l~~L~~L~  402 (1077)
                      ++|++++|.+++.....+...                .   ....+.|++|++++|.++.    .+...+..+++|++++
T Consensus       224 ~~L~ls~n~l~~~~~~~l~~~----------------~---~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~  284 (319)
T cd00116         224 EVLNLGDNNLTDAGAAALASA----------------L---LSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELD  284 (319)
T ss_pred             CEEecCCCcCchHHHHHHHHH----------------H---hccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEE
Confidence            444444444432111111110                0   0012455555555555541    1223344456667777


Q ss_pred             cCCCCcCCC----cccccccc-cccceeeccccc
Q 001440          403 LSENELSGS----IPYSFGNL-TNMIVLSIYSNA  431 (1077)
Q Consensus       403 Ls~N~l~~~----~~~~~~~l-~~L~~L~L~~N~  431 (1077)
                      +++|.++..    ....+... +.|+.+++.+|.
T Consensus       285 l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         285 LRGNKFGEEGAQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             CCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCC
Confidence            777776643    22223333 466666666654

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.74  E-value=2.5e-20  Score=210.46  Aligned_cols=259  Identities=22%  Similarity=0.232  Sum_probs=141.5

Q ss_pred             CcCccceeecccccCCC----CCCCCCCCCCcCcEEEccCCcCCC------CCCCcccCccccceEEeecccccCCCCcc
Q 001440          178 HLSYLKALHLFENGLSG----SIPPSLGNLTNLAIMYLYNNSLSG------SIPSEIGNLKSLSGLELGYNKLSGSMPLS  247 (1077)
Q Consensus       178 ~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~------~~p~~~~~l~~L~~L~L~~N~l~~~~p~~  247 (1077)
                      .+.+|++|++++|.++.    .++..+...++|++|+++++.+.+      .++..+..+++|+.|++++|.+.+..+..
T Consensus        21 ~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~  100 (319)
T cd00116          21 KLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGV  100 (319)
T ss_pred             HHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHH
Confidence            33344444444444421    133334444555555555555542      22334555556666666666665444444


Q ss_pred             CCCCCC---CCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCC-CCcceEEcCCCCCCCC----cCCC
Q 001440          248 LGNLPN---LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNL-KSLYGLGLSFNKLSGS----IPSS  319 (1077)
Q Consensus       248 l~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~----~p~~  319 (1077)
                      +..+.+   |++|++++|++++...                    ..+...+..+ ++|+.|++++|.+++.    ++..
T Consensus       101 ~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~  160 (319)
T cd00116         101 LESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA  160 (319)
T ss_pred             HHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence            433333   5555555555542100                    0111222333 4445555555544421    2223


Q ss_pred             cCCCCCccEEEccCcccccc----cCccccccccccEEeCCCCcCccc----CCCCCCCCcccceEEccCCCCCCCCccc
Q 001440          320 LGNLTKLTILYLSDNLLFGS----IPCEIGNLRYLFYLELGDNKLSGS----IPHSLGNLTNLATLYLFTNLLSGSIPSE  391 (1077)
Q Consensus       320 ~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p~~  391 (1077)
                      +..+++|++|++++|.+.+.    ++..+..+++|++|++++|.+++.    ++..+..+++|++|++++|.+++.....
T Consensus       161 ~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~  240 (319)
T cd00116         161 LRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAA  240 (319)
T ss_pred             HHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHH
Confidence            34445555555555555421    222333445666666666665432    2234556677777777777776533333


Q ss_pred             cc-----CCCCCCeeecCCCCcCC----CcccccccccccceeecccccCcCC----CCCccCCc-ccCcEEecccCcC
Q 001440          392 IG-----NLNSLSDLGLSENELSG----SIPYSFGNLTNMIVLSIYSNALSGA----IPKEYGNL-VKLTLLVLSYNQL  456 (1077)
Q Consensus       392 l~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l-~~L~~L~Ls~N~l  456 (1077)
                      +.     ..+.|+.|++++|.++.    .+...+..+++|+.+++++|.+...    ....+... +.|+++++.+|.+
T Consensus       241 l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         241 LASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence            32     24799999999999973    2344566678999999999999854    44444445 7899999998864

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1.9e-17  Score=199.58  Aligned_cols=198  Identities=23%  Similarity=0.230  Sum_probs=161.9

Q ss_pred             HHHHhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC---CCceeeEEEEEeeC
Q 001440          801 IVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR---HRNIVKFYGFCSHA  877 (1077)
Q Consensus       801 ~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~  877 (1077)
                      .+.-.+.|.+.+.||+|+||+||+|...+|+.||+|+-+.+...+..--.      +++.+|+   -+.|.++..++.-.
T Consensus       693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~------q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEFYICL------QVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceeeeehH------HHHHhhchhhhcchHHHHHHHccC
Confidence            34445678899999999999999998888999999998776554332222      2333333   34556666666667


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-------CCce
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-------EYEA  950 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~  950 (1077)
                      +..++|+||.+.|+|.+++.   ....++|.-++.++.|+++.+++||..   +|||+||||+|+++..       ..-+
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence            78899999999999999996   334588999999999999999999999   9999999999999953       2458


Q ss_pred             EEecccccccCC--CCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCC
Q 001440          951 HVSDFGISKSLK--PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010 (1077)
Q Consensus       951 kl~Dfgla~~~~--~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p 1010 (1077)
                      +|+|||-+..+.  +++......++|-.+-.+|+..++.+++.+|-|.++.+++-|+-|++-
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999999998763  455567778899999999999999999999999999999999999854

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=4.1e-18  Score=187.86  Aligned_cols=173  Identities=24%  Similarity=0.370  Sum_probs=138.9

Q ss_pred             eeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccc
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla  958 (1077)
                      +.||.|++|..++|.+|+.+.+...+.++.....++.|++.|++|   +   +.+|+|+||.||++..+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            578999999999999999877777778899999999999999999   5   8899999999999999999999999999


Q ss_pred             ccCCCCC------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh-CCCCCCccccccccCcccccchhhh
Q 001440          959 KSLKPDS------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031 (1077)
Q Consensus       959 ~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1031 (1077)
                      ..+....      ...+...||..||+||++.+..|+.|+||||+|++++|+++ -..+++           ....+..+
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------r~~t~~d~  472 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------RIATLTDI  472 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------HHHhhhhh
Confidence            8776554      23456789999999999999999999999999999999997 333332           22344455


Q ss_pred             cCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHH
Q 001440         1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071 (1077)
Q Consensus      1032 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1071 (1077)
                      .+..+|+...  .+. +.-+.++.+++.+.|.+||++.++
T Consensus       473 r~g~ip~~~~--~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  473 RDGIIPPEFL--QDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             hcCCCChHHh--hcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence            5555552211  111 123467889999999999966554

>PRK10345 hypothetical protein; Provisional

Probab=99.69  E-value=2.3e-16  Score=162.99  Aligned_cols=136  Identities=16%  Similarity=0.176  Sum_probs=104.2

Q ss_pred             CccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-----CCCceeeEEEEEeeCC---e-
Q 001440          809 DEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-----RHRNIVKFYGFCSHAR---H-  879 (1077)
Q Consensus       809 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-  879 (1077)
                      +..+.||+|+||.||.  +++....+||++.....   ...+.+.+|+.+++.+     +||||++++|++.++.   . 
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCeEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            4457899999999996  43333347898765322   2356789999999999     5799999999998763   3 


Q ss_pred             eEEEEee--cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeccCCCCCeeeCCC----CceEE
Q 001440          880 SFIVYEY--LEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL-SYLHNDCFPPIVYRDISSKNVLLDLE----YEAHV  952 (1077)
Q Consensus       880 ~~lV~E~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~kl  952 (1077)
                      ..+|+||  +.+|+|.+++.+..    ++..  ..++.+++.++ +|||+.   +|+||||||+||+++..    +.++|
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEE
Confidence            3478999  55899999996532    3333  35677888777 999999   99999999999999743    47999


Q ss_pred             eccccc
Q 001440          953 SDFGIS  958 (1077)
Q Consensus       953 ~Dfgla  958 (1077)
                      +||+-+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995434

>smart00090 RIO RIO-like kinase

Probab=99.66  E-value=4.2e-16  Score=165.46  Aligned_cols=149  Identities=20%  Similarity=0.219  Sum_probs=113.2

Q ss_pred             HHhcCCCccceecccCCceEEEEE--ecCCCEEEEEEccCCccch-------------------h--hHHHHHHHHHHHh
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAE--LSSGEIVAVKKFHSPLLSE-------------------M--TCQQEFLNEVKSL  859 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~-------------------~--~~~~~~~~e~~~l  859 (1077)
                      ....-|.+.+.||+|+||.||+|.  ..+|+.||+|++.......                   .  .....+..|+..+
T Consensus        25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L  104 (237)
T smart00090       25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL  104 (237)
T ss_pred             hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence            333458888999999999999997  5689999999987542110                   0  0113457899999


Q ss_pred             cCCCCC--ceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEecc
Q 001440          860 TEIRHR--NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP-IVYRD  936 (1077)
Q Consensus       860 ~~l~h~--niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~-ivH~D  936 (1077)
                      +++.+.  .+.+++++    ...++||||++++++..+....   ......+...++.|++.++++||+.   + |+|||
T Consensus       105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D  174 (237)
T smart00090      105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKE---GELVHGD  174 (237)
T ss_pred             HHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence            999753  34445543    2358999999998887654222   2244566789999999999999999   8 99999


Q ss_pred             CCCCCeeeCCCCceEEecccccccCC
Q 001440          937 ISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       937 lk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      |||+||+++ +++++++|||.|....
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhccC
Confidence            999999999 8899999999987544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.65  E-value=1e-15  Score=161.41  Aligned_cols=137  Identities=17%  Similarity=0.276  Sum_probs=115.0

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccc-----hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEee
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS-----EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~  886 (1077)
                      +.||+|++|.||+|.+ .|..|++|+.......     .......+.+|+..+..++|++++....++.+....++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5689999999999987 5788999986543221     112235678899999999999988888787777888999999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|++|.+++....      + ++..++.+++.++.++|+.   +++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999985422      2 7889999999999999999   999999999999999 88999999998864

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.64  E-value=8.7e-16  Score=159.88  Aligned_cols=148  Identities=19%  Similarity=0.182  Sum_probs=113.2

Q ss_pred             HHHHHhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCccc--hh-----------------hHHHHHHHHHHHhc
Q 001440          800 EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS--EM-----------------TCQQEFLNEVKSLT  860 (1077)
Q Consensus       800 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~-----------------~~~~~~~~e~~~l~  860 (1077)
                      ++.....-|.+.+.||+|+||.||+|..++|+.||||++......  ..                 .....+..|...+.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            344444457888999999999999998888999999987543210  00                 01123677888888


Q ss_pred             CCCCC--ceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCC
Q 001440          861 EIRHR--NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDIS  938 (1077)
Q Consensus       861 ~l~h~--niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk  938 (1077)
                      .+.|+  .+++.++.    ...++||||++++++.+....         ....+++.+++.++.++|+.   +|+|||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCC
Confidence            88777  44444442    345899999999998765321         34567889999999999998   99999999


Q ss_pred             CCCeeeCCCCceEEecccccccCCC
Q 001440          939 SKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       939 ~~NIll~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |+||+++.++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PLN03150 hypothetical protein; Provisional

Probab=99.64  E-value=4.1e-16  Score=188.80  Aligned_cols=164  Identities=32%  Similarity=0.488  Sum_probs=112.5

Q ss_pred             CCCHHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCccCceeecCCCCccccccCCCCcccccCCcccCCCCCCc
Q 001440           32 SNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLA  111 (1077)
Q Consensus        32 ~~~~~~~~all~~k~~~~~~~~~~~~l~~W~~~~~~~~~~c~w~gv~C~~~~~v~~l~l~~~~l~~~l~~~~~~~l~~L~  111 (1077)
                      .+.++|..||+++|+++.++.     ..+|+++.| ...+|.|.||.|+....                    .....++
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~-----~~~W~g~~C-~p~~~~w~Gv~C~~~~~--------------------~~~~~v~  421 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPL-----RFGWNGDPC-VPQQHPWSGADCQFDST--------------------KGKWFID  421 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCcc-----cCCCCCCCC-CCcccccccceeeccCC--------------------CCceEEE
Confidence            567789999999999986542     248975211 00112799999963110                    0011245


Q ss_pred             EEEccCCcccccCCcccCCCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeeccccc
Q 001440          112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENG  191 (1077)
Q Consensus       112 ~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~  191 (1077)
                      .|+|++|.+.|.+|..++.+++|++|+|++|.++|.+|..++.+++|++|+|++|+++|.+|+.+++|++|++|+|++|+
T Consensus       422 ~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~  501 (623)
T PLN03150        422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNS  501 (623)
T ss_pred             EEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCc
Confidence            66777777777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CCCCCCCCCCCC-CcCcEEEccCCcCCCCCC
Q 001440          192 LSGSIPPSLGNL-TNLAIMYLYNNSLSGSIP  221 (1077)
Q Consensus       192 l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p  221 (1077)
                      ++|.+|..++.+ .++..+++.+|......|
T Consensus       502 l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        502 LSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             ccccCChHHhhccccCceEEecCCccccCCC
Confidence            777777776653 456677777776554333

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.62  E-value=3.5e-16  Score=184.04  Aligned_cols=207  Identities=24%  Similarity=0.296  Sum_probs=141.1

Q ss_pred             cCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .+|+.++.|..|+||.||..+++ +.+.+|. ++.+...        +.+-  ++..-..|.+|                
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l--------ilRn--ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL--------ILRN--ILTFAGNPFVV----------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhh-cccccch--------hhhc--cccccCCccee----------------
Confidence            57888999999999999999887 4567787 4433211        1110  12222333332                


Q ss_pred             eecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                           |+-...++.-   +.++..        .+.+++|+|+.   ||+|||+||+|.+|+.-|.+|++|||+++.....
T Consensus       136 -----gDc~tllk~~---g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKNI---GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhcccC---CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence                 4444444332   223222        27899999998   9999999999999999999999999998753110


Q ss_pred             C---------------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchh
Q 001440          965 S---------------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029 (1077)
Q Consensus       965 ~---------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~ 1029 (1077)
                      .               -..+..+||+.|.|||++....|+..+|+|++|+++||.+-|.+||...        -.++.+.
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd--------tpeelfg  268 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD--------TPEELFG  268 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC--------CHHHHHh
Confidence            0               0123457999999999999999999999999999999999999998622        1223333


Q ss_pred             hhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCC
Q 001440         1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067 (1077)
Q Consensus      1030 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1067 (1077)
                      .++......+.. ......+.++++.+.|+.+|..|--
T Consensus       269 ~visd~i~wpE~-dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  269 QVISDDIEWPEE-DEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             hhhhhhcccccc-CcCCCHHHHHHHHHHHHhChHhhcc
Confidence            333222222211 1222346788899999999999973

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=3.3e-15  Score=179.35  Aligned_cols=143  Identities=20%  Similarity=0.256  Sum_probs=114.7

Q ss_pred             HHhcCCCccceecccCCceEEEEEecCCCEEEEEEccCCcc-----chhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeC
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLL-----SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA  877 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~  877 (1077)
                      .....|...+.||+|+||+||+|.+... .+++|+......     ......+.+.+|+++++.++|++++....++.++
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3344556788999999999999987644 344443222111     1112345688999999999999999888888777


Q ss_pred             CeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccc
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       878 ~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgl  957 (1077)
                      ...++||||+++++|.+++.           +...++.+++.++.|||+.   +++|||+||+||++ .++.++++|||+
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence            78899999999999999874           3567899999999999998   99999999999999 678999999999


Q ss_pred             cccC
Q 001440          958 SKSL  961 (1077)
Q Consensus       958 a~~~  961 (1077)
                      ++..
T Consensus       474 a~~~  477 (535)
T PRK09605        474 GKYS  477 (535)
T ss_pred             cccC
Confidence            9753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.62  E-value=2e-15  Score=157.58  Aligned_cols=134  Identities=19%  Similarity=0.315  Sum_probs=108.5

Q ss_pred             eecccCCceEEEEEecCCCEEEEEEccCCccc-----hhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          813 CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS-----EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      .||+|+||.||+|.+ +|..|++|........     ......++.+|+++++.++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            379999999999986 4788999986543211     1222466788999999999887666665666667779999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccC
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~  961 (1077)
                      +++++.+++....         . .++.+++.++.++|+.   +++|+|++|+||+++ ++.+++.|||.+...
T Consensus        80 ~g~~l~~~~~~~~---------~-~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN---------D-ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH---------H-HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998874321         0 7899999999999999   999999999999999 899999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.55  E-value=1.8e-14  Score=148.70  Aligned_cols=140  Identities=21%  Similarity=0.241  Sum_probs=98.8

Q ss_pred             cceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHH---------------------HHHHHHHhcCCCCC--ce
Q 001440          811 EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQE---------------------FLNEVKSLTEIRHR--NI  867 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~---------------------~~~e~~~l~~l~h~--ni  867 (1077)
                      .+.||+|+||+||+|...+|+.||||++.............                     ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            46799999999999988889999999876532211111111                     13455555555433  24


Q ss_pred             eeEEEEEeeCCeeEEEEeecCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeccCCCCCeeeC
Q 001440          868 VKFYGFCSHARHSFIVYEYLEMGSLAM-ILSNATSAEELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLD  945 (1077)
Q Consensus       868 v~l~~~~~~~~~~~lV~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dlk~~NIll~  945 (1077)
                      .+.+++    ...++||||++++.+.. .+....    .. .+...++.+++.++.++|. .   +|+|+||||+||+++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE
Confidence            444443    23589999999954321 111110    01 5678899999999999999 6   999999999999999


Q ss_pred             CCCceEEecccccccCCC
Q 001440          946 LEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       946 ~~~~~kl~Dfgla~~~~~  963 (1077)
                       ++.++++|||.+.....
T Consensus       150 -~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 -DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             -CCcEEEEECcccccccC
Confidence             99999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.53  E-value=3.6e-14  Score=140.89  Aligned_cols=135  Identities=17%  Similarity=0.146  Sum_probs=113.2

Q ss_pred             ccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCC--CceeeEEEEEeeCCeeEEEEeec
Q 001440          810 EEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH--RNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       810 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      +.+.||+|.++.||++...+ ..+++|.......     ...+.+|+..++.++|  ..+++++++...++..+++|||+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            35679999999999998864 7899999865422     4567889999999976  58999999988888899999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      +++.+..+          +......++.+++.+++++|....++++|+|++|+||+++..+.+++.|||.++.
T Consensus        76 ~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            98777543          4466778899999999999986444799999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3.7e-15  Score=177.47  Aligned_cols=254  Identities=21%  Similarity=0.275  Sum_probs=188.3

Q ss_pred             cCCCccceecccCCceEEEEEec--CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCC-CCceeeEEEEEeeCCeeEE
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS--SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..|...+.||+|+|+.|-.+...  ....+|+|.+.... ...........|..+-+.+. |+|++++++...+....++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            45667777999999999888543  34567777776553 22333455666888888886 9999999999999999999


Q ss_pred             EEeecCCCCHHHHHh-cCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeccCCCCCeeeCCCC-ceEEecccccc
Q 001440          883 VYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLH-NDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISK  959 (1077)
Q Consensus       883 V~E~~~~g~L~~~l~-~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~kl~Dfgla~  959 (1077)
                      ++||..+|++.+.+. ...  ...+....-.+..|+..++.|+| ..   ++.|+|+||+|.+++..+ ..+++|||+|.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhc
Confidence            999999999998873 222  12445667788999999999999 76   999999999999999999 99999999999


Q ss_pred             cCCC-CCCC--cccccc-cccccCccccccC-CCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCC
Q 001440          960 SLKP-DSSN--WTELAG-TIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034 (1077)
Q Consensus       960 ~~~~-~~~~--~~~~~g-~~~y~aPE~~~~~-~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1077)
                      .+.. .+..  .....| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.......       ....+...
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-------~~~~~~~~  246 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-------RYSSWKSN  246 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-------cceeeccc
Confidence            8766 3222  334567 9999999998885 446789999999999999999999875443221       11111111


Q ss_pred             CCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHH
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1072 (1077)
                      +-...............++..+++..+|..|.+.+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             ccccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            10000111122233566788899999999999988764

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=1.3e-15  Score=167.65  Aligned_cols=195  Identities=35%  Similarity=0.503  Sum_probs=113.0

Q ss_pred             CCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEE
Q 001440          130 NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIM  209 (1077)
Q Consensus       130 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  209 (1077)
                      .+..-...||+.|++. .+|..+..+..|+.|.|..|.+. .+|..+++|..|.+|+|+.|+++ .+|..++.|+     
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-----  144 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-----  144 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-----
Confidence            3444555666666665 56666666666666666666665 45555555555555555555554 3344444433     


Q ss_pred             EccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCC
Q 001440          210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS  289 (1077)
Q Consensus       210 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  289 (1077)
                                          |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.+|+.|.+..|++.
T Consensus       145 --------------------Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~  202 (722)
T KOG0532|consen  145 --------------------LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE  202 (722)
T ss_pred             --------------------ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence                                444455555554 44555555556666666666665 45556666666666666666666


Q ss_pred             CCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccccccCccccc---cccccEEeCCCC
Q 001440          290 GSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGN---LRYLFYLELGDN  358 (1077)
Q Consensus       290 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~~L~~L~L~~N  358 (1077)
                       .+|+.+.. -.|..||+|.|+++ .+|-.|.+|+.|++|-|.+|.+. ..|..+..   ..=.+||+..-+
T Consensus       203 -~lp~El~~-LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  203 -DLPEELCS-LPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             -hCCHHHhC-CceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence             34444543 34666777777776 56777777777777777777776 44544432   222345555544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.47  E-value=2.8e-13  Score=144.24  Aligned_cols=139  Identities=16%  Similarity=0.227  Sum_probs=107.2

Q ss_pred             ceec-ccCCceEEEEEecCCCEEEEEEccCCcc-----c-----hhhHHHHHHHHHHHhcCCCCCce--eeEEEEEeeC-
Q 001440          812 HCIG-TGGQGSVYRAELSSGEIVAVKKFHSPLL-----S-----EMTCQQEFLNEVKSLTEIRHRNI--VKFYGFCSHA-  877 (1077)
Q Consensus       812 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~-----~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~-  877 (1077)
                      ..|| .||.|+||.+... +..+|||.+.....     .     .......+.+|+.++..++|+++  ++.+++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            4688 8999999999875 77899998854321     0     11234567889999999998875  6777765332 


Q ss_pred             C---eeEEEEeecCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEe
Q 001440          878 R---HSFIVYEYLEM-GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS  953 (1077)
Q Consensus       878 ~---~~~lV~E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~  953 (1077)
                      .   ..++||||+++ .+|.+++...    .++..    .+.+++.++.+||+.   ||+||||||+|||++.++.++++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence            2   23599999997 6999888542    23332    357899999999999   99999999999999999999999


Q ss_pred             cccccccCC
Q 001440          954 DFGISKSLK  962 (1077)
Q Consensus       954 Dfgla~~~~  962 (1077)
                      |||.++...
T Consensus       185 Dfg~~~~~~  193 (239)
T PRK01723        185 DFDRGELRT  193 (239)
T ss_pred             ECCCcccCC
Confidence            999887643

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.46  E-value=4.1e-15  Score=163.78  Aligned_cols=195  Identities=33%  Similarity=0.484  Sum_probs=151.4

Q ss_pred             CcCccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceE
Q 001440          154 NLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGL  233 (1077)
Q Consensus       154 ~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L  233 (1077)
                      .|+--...||+.|++. .+|..+..+                        ..|+.+.|+.|.+- .+|..++++..|++|
T Consensus        73 ~ltdt~~aDlsrNR~~-elp~~~~~f------------------------~~Le~liLy~n~~r-~ip~~i~~L~~lt~l  126 (722)
T KOG0532|consen   73 DLTDTVFADLSRNRFS-ELPEEACAF------------------------VSLESLILYHNCIR-TIPEAICNLEALTFL  126 (722)
T ss_pred             cccchhhhhccccccc-cCchHHHHH------------------------HHHHHHHHHhccce-ecchhhhhhhHHHHh
Confidence            4444556677777766 455554444                        44455555555554 677777777777778


Q ss_pred             EeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCC
Q 001440          234 ELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS  313 (1077)
Q Consensus       234 ~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  313 (1077)
                      +|+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++.
T Consensus       127 ~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~  202 (722)
T KOG0532|consen  127 DLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE  202 (722)
T ss_pred             hhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh
Confidence            88888877 6677776665 899999999999 88999999999999999999998 68899999999999999999998


Q ss_pred             CCcCCCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCCCCCCCcc---cceEEccCC
Q 001440          314 GSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTN---LATLYLFTN  382 (1077)
Q Consensus       314 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~---L~~L~L~~N  382 (1077)
                       .+|+.+..| .|..||+|.|++. .+|..|.+|+.|++|-|.+|.+. ..|..++..-.   .++|+..-+
T Consensus       203 -~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~  270 (722)
T KOG0532|consen  203 -DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQAC  270 (722)
T ss_pred             -hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhc
Confidence             577777755 5999999999998 78999999999999999999998 56665543332   344444444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.41  E-value=3e-13  Score=157.16  Aligned_cols=193  Identities=41%  Similarity=0.558  Sum_probs=84.6

Q ss_pred             EEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcC-ccceeecccccCCCCCCCCCCCCCcCcEEEccCC
Q 001440          136 YLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLS-YLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN  214 (1077)
Q Consensus       136 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N  214 (1077)
                      .|+++.|.+... +..+..++.++.|++.+|.+. .+|+..+.+. +|+.|++++|++. .+|..++.+++|+.|++++|
T Consensus        97 ~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N  173 (394)
T COG4886          97 SLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN  173 (394)
T ss_pred             eeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence            455555554322 222333455555555555555 3444444442 5555555555554 23333444555555555555


Q ss_pred             cCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCcc
Q 001440          215 SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPS  294 (1077)
Q Consensus       215 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  294 (1077)
                      +++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.+. .++..+.++.++..|.+.+|++.. ++.
T Consensus       174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~  249 (394)
T COG4886         174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE  249 (394)
T ss_pred             hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence            554 33333334444444444444444 33333333333444444444322 233344444444444444444432 133


Q ss_pred             ccCCCCCcceEEcCCCCCCCCcCCCcCCCCCccEEEccCcccc
Q 001440          295 EMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF  337 (1077)
Q Consensus       295 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~  337 (1077)
                      .++.+++++.|++++|+++ .++. ++.+.+++.|++++|.+.
T Consensus       250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~  290 (394)
T COG4886         250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLS  290 (394)
T ss_pred             hhccccccceecccccccc-cccc-ccccCccCEEeccCcccc
Confidence            3444444444444444444 1222 444444444444444444

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=3.5e-13  Score=156.59  Aligned_cols=199  Identities=39%  Similarity=0.581  Sum_probs=125.4

Q ss_pred             ceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCC-cCcEEEccCCcCCCCCCCcccCccccceEEeec
Q 001440          159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLT-NLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGY  237 (1077)
Q Consensus       159 ~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~  237 (1077)
                      ..|+++.|.+... +..+..++.++.|++.+|.++ .+|+..+.++ +|+.|++++|++. .+|..++.+++|+.|++++
T Consensus        96 ~~l~~~~~~~~~~-~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          96 PSLDLNLNRLRSN-ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             ceeeccccccccC-chhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence            4577777776432 233444567777777777777 4555555564 7777777777777 5556667777777777777


Q ss_pred             ccccCCCCccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcC
Q 001440          238 NKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIP  317 (1077)
Q Consensus       238 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  317 (1077)
                      |+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|.+. ..+..+.+++.+..|.+++|++. .++
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~  248 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLP  248 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-ecc
Confidence            7776 45555546677777777777776 55655555556777777777433 34555666666666666666665 235


Q ss_pred             CCcCCCCCccEEEccCcccccccCccccccccccEEeCCCCcCcccCCC
Q 001440          318 SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH  366 (1077)
Q Consensus       318 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~  366 (1077)
                      ..++.+++++.|++++|+++.. +. ++.+.++++|++++|.+....|.
T Consensus       249 ~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~  295 (394)
T COG4886         249 ESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPL  295 (394)
T ss_pred             chhccccccceecccccccccc-cc-ccccCccCEEeccCccccccchh
Confidence            5566666666666666666533 22 66666666666666666544443

>PLN03150 hypothetical protein; Provisional

Probab=99.40  E-value=5.8e-13  Score=161.50  Aligned_cols=117  Identities=32%  Similarity=0.549  Sum_probs=64.4

Q ss_pred             ceeeeeccccccCCcchhccccccccceecccccCCCCCccccccccccchhcccccccccccchhhhccccccEEeccC
Q 001440          613 LYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISY  692 (1077)
Q Consensus       613 L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~l~~l~~L~~l~l~~  692 (1077)
                      ++.|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+..+++|+.|+|++|++++.+|..+..+++|+.|+|++
T Consensus       420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~  499 (623)
T PLN03150        420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG  499 (623)
T ss_pred             EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence            44555555555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             CcccCCCCCCc--ccccCCcccccCCCcccCCCCCCCccc
Q 001440          693 NKLHGPIPNSA--AFKHAPMEALQGNKGLCGDIKGFPSCK  730 (1077)
Q Consensus       693 N~l~~~~p~~~--~~~~~~~~~~~~n~~~c~~~~~~~~~~  730 (1077)
                      |+++|.+|..-  .+.......+.+|+.+|+. ++.+.|.
T Consensus       500 N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~-p~l~~C~  538 (623)
T PLN03150        500 NSLSGRVPAALGGRLLHRASFNFTDNAGLCGI-PGLRACG  538 (623)
T ss_pred             CcccccCChHHhhccccCceEEecCCccccCC-CCCCCCc
Confidence            55555555421  1122233457788888874 3456674

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=3.2e-13  Score=139.56  Aligned_cols=200  Identities=23%  Similarity=0.334  Sum_probs=137.9

Q ss_pred             HhcCCCCCceeeEEEEEeeCC-----eeEEEEeecCCCCHHHHHhcCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 001440          858 SLTEIRHRNIVKFYGFCSHAR-----HSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPP  931 (1077)
Q Consensus       858 ~l~~l~h~niv~l~~~~~~~~-----~~~lV~E~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~  931 (1077)
                      -+-.+.|.|+|++..|+.+.+     ...++.|||..|++..++++-+. ...+......+|+-||..||.|||+. .|+
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence            344457999999999986543     46789999999999999976543 22356667788999999999999985 789


Q ss_pred             eEeccCCCCCeeeCCCCceEEecccccccCCCCC-----CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHh
Q 001440          932 IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS-----SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK 1006 (1077)
Q Consensus       932 ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~ellt 1006 (1077)
                      |+|+++..+-|++..++-+|+.--.-. ...+..     .......+-++|.|||+-.....+.++|||+||+...||.-
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~-s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPD-STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCcc-ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999998887532111 111100     00112345689999999887788889999999999999987


Q ss_pred             CCCCCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1007 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      +..--..........++....+-..-++.              =..++.+|++..|..||+|.+++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~i~~len~l--------------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANVIIGLENGL--------------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeehhhhhhhheeeccCcc--------------ccCcCcccccCCCCCCcchhhhhc
Confidence            76442111111111111111111111111              124678999999999999998764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=5.1e-12  Score=146.42  Aligned_cols=144  Identities=19%  Similarity=0.239  Sum_probs=101.3

Q ss_pred             cceecccCCceEEEEEecCCCEEEEEEccCCccchhh-------------------------------------HHHHHH
Q 001440          811 EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMT-------------------------------------CQQEFL  853 (1077)
Q Consensus       811 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------------~~~~~~  853 (1077)
                      .+.||.|++|.||+|+.++|+.||||+.+........                                     .+-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998654211100                                     001255


Q ss_pred             HHHHHhcCCC-----CCceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 001440          854 NEVKSLTEIR-----HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD-ALSYLHND  927 (1077)
Q Consensus       854 ~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~~  927 (1077)
                      +|+..+.+++     ++++.-..-|....+..++||||++|+++.++......  ..   ++.+++.+++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            5666555552     34433222222334457999999999999887643211  11   24456666666 46888988


Q ss_pred             CCCCeEeccCCCCCeeeCCCCceEEecccccccCC
Q 001440          928 CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       928 ~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                         |++|+|++|.||+++.+++++++|||++..+.
T Consensus       277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               99999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=2.5e-12  Score=145.71  Aligned_cols=248  Identities=26%  Similarity=0.287  Sum_probs=177.9

Q ss_pred             CCCccceecc--cCCceEEEEEe---cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCee
Q 001440          807 DFDEEHCIGT--GGQGSVYRAEL---SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       807 ~~~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  880 (1077)
                      .|.....+|.  |.+|.||.++.   .++..+|+|+-+.+...... ...=.+|+...+.+ .|++.++.+..+...+..
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~-~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLD-SKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccc-cccccchhhcccccCccccccccCcccccCCcc
Confidence            4566778999  99999999965   36888999985544321111 22234567777777 499999999999999999


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEecc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD----ALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDF  955 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Df  955 (1077)
                      ++-+|++. .++.++.+...  ..++......+..+...    |++++|+.   +++|-|+||.||+...+ ..++++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence            99999986 67777765432  22445566667777777    99999999   99999999999999999 88999999


Q ss_pred             cccccCCCCCCCc-----ccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhh
Q 001440          956 GISKSLKPDSSNW-----TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE 1030 (1077)
Q Consensus       956 gla~~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1030 (1077)
                      |+...+....-..     ....|...|++||...+ -++.+.|+|++|.+..|..++..+.....         ...+.+
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~---------~~~W~~  337 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGK---------NSSWSQ  337 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCC---------CCCccc
Confidence            9998876654221     22367889999998655 47889999999999999999876643110         011111


Q ss_pred             hcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHh
Q 001440         1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1073 (1077)
                      .....++.  ..+.....++...+..+++.+|..|++++.+..
T Consensus       338 ~r~~~ip~--e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGYIPL--EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccCch--hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11111221  112222234555788999999999999887764

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.24  E-value=3.1e-13  Score=141.49  Aligned_cols=160  Identities=20%  Similarity=0.199  Sum_probs=75.9

Q ss_pred             cccccceeccccccccCCCCcCC----CCCCCCcEEEcccccccCCC-------------CCCCCCCCCCCEEEccCCcc
Q 001440          489 IHSNLSYINLSHKKFYGEISFDW----GKFPNLGTLDVSANNITGIL-------------PPEIGDSPQLKVLDLSSNHI  551 (1077)
Q Consensus       489 ~~~~L~~L~Ls~n~i~~~~~~~~----~~~~~L~~L~Ls~N~l~~~~-------------~~~~~~l~~L~~L~Ls~N~l  551 (1077)
                      .++.|++|+||+|.+.......|    ..+..|++|.|.+|.+....             .+....-++|+++..++|++
T Consensus        90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl  169 (382)
T KOG1909|consen   90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL  169 (382)
T ss_pred             cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence            34456666666665543332222    23455666666666554221             11122334566666666655


Q ss_pred             CCCC----chhhcCCCCCcEEEccCccccCC----cchhhhcccccceeeccCCcccCC----CCCcccccccceeeeec
Q 001440          552 VGEI----PSELGKLRSLIKLTLNRNQFSGQ----LPTELGSLIQLEHLDLSSNRLSNS----IPGSLGNLVKLYYLNLS  619 (1077)
Q Consensus       552 ~~~~----~~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls  619 (1077)
                      ....    ...|...+.|+.+.++.|.|...    ....+..++.|+.|||.+|-++..    +...++.+++|++|+++
T Consensus       170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~  249 (382)
T KOG1909|consen  170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG  249 (382)
T ss_pred             ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence            5322    22333445555556655555411    122344555555555555555431    23344445555555555


Q ss_pred             cccccCCcchhcc-----ccccccceecccccCC
Q 001440          620 NNQFSGEIPIKLE-----KFIHLSDLDLSHNFLG  648 (1077)
Q Consensus       620 ~N~l~~~~~~~l~-----~l~~L~~L~Ls~N~i~  648 (1077)
                      +|.++......+.     ..++|+.|.+.+|.|+
T Consensus       250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt  283 (382)
T KOG1909|consen  250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEIT  283 (382)
T ss_pred             ccccccccHHHHHHHHhccCCCCceeccCcchhH
Confidence            5555544443331     1344555555555444

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.22  E-value=1.4e-10  Score=135.46  Aligned_cols=147  Identities=18%  Similarity=0.217  Sum_probs=94.4

Q ss_pred             cCCCccceecccCCceEEEEEecC-CCEEEEEEccCCccch---------------------------h----hHH----
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSE---------------------------M----TCQ----  849 (1077)
Q Consensus       806 ~~~~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~---------------------------~----~~~----  849 (1077)
                      .+|+. +.||.|++|.||+|+.++ |+.||||+.+......                           .    +..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45666 789999999999999887 9999999987542110                           0    001    


Q ss_pred             --HHHHHHHHHhcCCC----CCceeeEEEEEe-eCCeeEEEEeecCCCCHHHHH--hcCCC-CCCCCHHHHHHHHHHHHH
Q 001440          850 --QEFLNEVKSLTEIR----HRNIVKFYGFCS-HARHSFIVYEYLEMGSLAMIL--SNATS-AEELGWTQRMNVIKGVAD  919 (1077)
Q Consensus       850 --~~~~~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~E~~~~g~L~~~l--~~~~~-~~~l~~~~~~~i~~~ia~  919 (1077)
                        -++.+|+..+.+++    +...+.+=.++. ..+..++||||++|+.+.++-  ..... ...+....+..++.    
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----  274 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----  274 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH----
Confidence              12455555555542    333333333332 245678999999999998752  21110 01122222222333    


Q ss_pred             HHHHHHhCCCCCeEeccCCCCCeeeCCCC----ceEEecccccccCCC
Q 001440          920 ALSYLHNDCFPPIVYRDISSKNVLLDLEY----EAHVSDFGISKSLKP  963 (1077)
Q Consensus       920 ~l~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~kl~Dfgla~~~~~  963 (1077)
                         .+...   |++|+|++|.||+++.++    ++++.|||++..+.+
T Consensus       275 ---Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 ---QVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ---HHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence               33445   999999999999999988    999999999976643

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.21  E-value=2.5e-12  Score=138.23  Aligned_cols=160  Identities=27%  Similarity=0.244  Sum_probs=73.2

Q ss_pred             cccccceEeecCCccCCCCC-cccccccccceeccccccccCC--CCcCCCCCCCCcEEEcccccccCCCCCC-CCCCCC
Q 001440          465 NLTRLARVRLDRNHLTGNIS-ESFGIHSNLSYINLSHKKFYGE--ISFDWGKFPNLGTLDVSANNITGILPPE-IGDSPQ  540 (1077)
Q Consensus       465 ~l~~L~~L~L~~n~l~~~~~-~~~~~~~~L~~L~Ls~n~i~~~--~~~~~~~~~~L~~L~Ls~N~l~~~~~~~-~~~l~~  540 (1077)
                      ++.+|+...|++..+..... +....+++++.|||+.|-++..  .......+|+|+.|+|+.|++....... -..++.
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            45555666666555543322 2334456666666666655432  2223345566666666666654221111 123344


Q ss_pred             CCEEEccCCccCC-CCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCC-CCcccccccceeeee
Q 001440          541 LKVLDLSSNHIVG-EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI-PGSLGNLVKLYYLNL  618 (1077)
Q Consensus       541 L~~L~Ls~N~l~~-~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L  618 (1077)
                      |+.|.|+.|.++. .+...+..+|+|+.|+|..|............+..|++|||++|++.+.. -...+.++.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            5555555555541 12223334455555555555322122233334445555555555543211 122344445555555


Q ss_pred             cccccc
Q 001440          619 SNNQFS  624 (1077)
Q Consensus       619 s~N~l~  624 (1077)
                      +.+.|.
T Consensus       279 s~tgi~  284 (505)
T KOG3207|consen  279 SSTGIA  284 (505)
T ss_pred             cccCcc
Confidence            555444

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=1.5e-10  Score=132.12  Aligned_cols=168  Identities=20%  Similarity=0.251  Sum_probs=128.6

Q ss_pred             EecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCC
Q 001440          826 ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL  905 (1077)
Q Consensus       826 ~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l  905 (1077)
                      +..++.+|.|+..+....   .......+.+..++.+|||+|+++++.++.++..|+|+|-+.  .|..++++      +
T Consensus        33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l  101 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------L  101 (690)
T ss_pred             eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------h
Confidence            455788888888765432   234556778889999999999999999999999999999885  56666644      3


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCCCcccccccccccCcccccc
Q 001440          906 GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT  985 (1077)
Q Consensus       906 ~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~  985 (1077)
                      +...+...+.||+.||.|||..+  +++|++|...-|+|+..|+.||++|-.+.....-........--..|..|+.+..
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCc
Confidence            34566778999999999999776  8999999999999999999999999988655433321122222334666765443


Q ss_pred             CCCCCcchHHHHHHHHHHHHhCC
Q 001440          986 MKVTEKSDVYSFGVLALEAIKGK 1008 (1077)
Q Consensus       986 ~~~~~~~Dv~s~G~~l~elltg~ 1008 (1077)
                      ..  -..|.|.||+++||++.|.
T Consensus       180 s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCcc
Confidence            22  2469999999999999983

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.14  E-value=4.7e-12  Score=147.24  Aligned_cols=151  Identities=30%  Similarity=0.323  Sum_probs=71.5

Q ss_pred             CCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCcEE
Q 001440          130 NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIM  209 (1077)
Q Consensus       130 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  209 (1077)
                      .+..++.+++..|.+.. +-..+..+++|+.|++.+|++... ...+..+++|++|+|++|.|+...+  +..++.|+.|
T Consensus        70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL  145 (414)
T ss_pred             HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence            34444555555555542 223345555555555555555422 2224445555555555555553322  3444445555


Q ss_pred             EccCCcCCCCCCCcccCccccceEEeecccccCCCC-ccCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCC
Q 001440          210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMP-LSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL  288 (1077)
Q Consensus       210 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  288 (1077)
                      ++++|.++..  +.+..+++|+.+++++|+++...+ . ...+.+|+.+++.+|.+..  ...+..+..+..+++..|.+
T Consensus       146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i  220 (414)
T KOG0531|consen  146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKI  220 (414)
T ss_pred             eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccc
Confidence            6666655522  233445555555555555553332 1 3444555555555555541  12233333444445555554


Q ss_pred             C
Q 001440          289 S  289 (1077)
Q Consensus       289 ~  289 (1077)
                      +
T Consensus       221 ~  221 (414)
T KOG0531|consen  221 S  221 (414)
T ss_pred             e
Confidence            4

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.14  E-value=1.4e-11  Score=125.62  Aligned_cols=132  Identities=33%  Similarity=0.382  Sum_probs=95.0

Q ss_pred             CCCCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCCCCcccccccceee
Q 001440          537 DSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYL  616 (1077)
Q Consensus       537 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  616 (1077)
                      ....|+++|||+|.|+ .+.....-.+.++.|++++|.|...  ..++.+++|+.||||+|.++ .+.+.=.++-+.+.|
T Consensus       282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL  357 (490)
T KOG1259|consen  282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTL  357 (490)
T ss_pred             hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeee
Confidence            3455777888888776 5556666677888888888888732  33777888888888888887 344444556778888


Q ss_pred             eeccccccCCcchhccccccccceecccccCCC-CCccccccccccchhcccccccccc
Q 001440          617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE-EIPSQVCSMQSLEKLNLAHNNLSGF  674 (1077)
Q Consensus       617 ~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~-~~~~~~~~l~~L~~L~l~~N~l~~~  674 (1077)
                      .|++|.|.  ....+.++.+|..||+++|+|.. .-...++++|.|+.+.|.+|++.+.
T Consensus       358 ~La~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~  414 (490)
T KOG1259|consen  358 KLAQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS  414 (490)
T ss_pred             ehhhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence            88888885  34567778888888888888854 2235677888888888888888743

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.11  E-value=1.3e-11  Score=125.82  Aligned_cols=133  Identities=28%  Similarity=0.260  Sum_probs=91.8

Q ss_pred             cCCCCCCCCeEEcccCCCCCCCCCCCCCCCccceecCCCCCCCCCCccccCCCCCcceEEcCCCCCCCCcCCCcCCCCCc
Q 001440          247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL  326 (1077)
Q Consensus       247 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  326 (1077)
                      .+.....|++||||+|.|+ .+.++..-+++++.|++|+|.|...  ..+..+++|+.||||+|.++ .+..+-..+-+.
T Consensus       279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI  354 (490)
T KOG1259|consen  279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNI  354 (490)
T ss_pred             ecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence            3444567888888888887 5667777778888888888888743  34778888888888888887 566676778888


Q ss_pred             cEEEccCcccccccCccccccccccEEeCCCCcCcccC-CCCCCCCcccceEEccCCCCC
Q 001440          327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI-PHSLGNLTNLATLYLFTNLLS  385 (1077)
Q Consensus       327 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~  385 (1077)
                      +.|.|+.|.|...  ..++.+-+|.+||+++|+|.... -..+++++.|+++.|.+|.+.
T Consensus       355 KtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~  412 (490)
T KOG1259|consen  355 KTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA  412 (490)
T ss_pred             eeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence            8888888888632  45666777777777777775311 123444444444444444444

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.11  E-value=2.3e-12  Score=135.04  Aligned_cols=186  Identities=25%  Similarity=0.270  Sum_probs=142.2

Q ss_pred             CCCCCCCcEEEcccccccCCCCCC----CCCCCCCCEEEccCCccCCCCch-------------hhcCCCCCcEEEccCc
Q 001440          511 WGKFPNLGTLDVSANNITGILPPE----IGDSPQLKVLDLSSNHIVGEIPS-------------ELGKLRSLIKLTLNRN  573 (1077)
Q Consensus       511 ~~~~~~L~~L~Ls~N~l~~~~~~~----~~~l~~L~~L~Ls~N~l~~~~~~-------------~l~~l~~L~~L~L~~N  573 (1077)
                      +...|+|++||||+|.+....+..    +..+..|+.|.|.+|.+...-..             ..+.-+.|+++..++|
T Consensus        88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rN  167 (382)
T KOG1909|consen   88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRN  167 (382)
T ss_pred             HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecc
Confidence            345679999999999987554443    34668899999999988732222             2334578999999999


Q ss_pred             cccCCc----chhhhcccccceeeccCCcccCC----CCCcccccccceeeeeccccccCCc----chhcccccccccee
Q 001440          574 QFSGQL----PTELGSLIQLEHLDLSSNRLSNS----IPGSLGNLVKLYYLNLSNNQFSGEI----PIKLEKFIHLSDLD  641 (1077)
Q Consensus       574 ~l~~~~----~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~l~~l~~L~~L~  641 (1077)
                      ++....    ...|...+.|+.+.++.|.|...    +..+|..+++|+.|||.+|-++...    ...+..+++|+.|+
T Consensus       168 rlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~  247 (382)
T KOG1909|consen  168 RLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELN  247 (382)
T ss_pred             ccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeec
Confidence            997433    34566788999999999998632    3356788999999999999998653    44567788999999


Q ss_pred             cccccCCCCCccccc-----cccccchhcccccccccc----cchhhhccccccEEeccCCccc
Q 001440          642 LSHNFLGEEIPSQVC-----SMQSLEKLNLAHNNLSGF----IPRCFKEMHGLVYIDISYNKLH  696 (1077)
Q Consensus       642 Ls~N~i~~~~~~~~~-----~l~~L~~L~l~~N~l~~~----~~~~l~~l~~L~~l~l~~N~l~  696 (1077)
                      +++|.+......++.     ..|+|+.|.+.+|.|+..    +..+....|.|..|+|++|++.
T Consensus       248 l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~  311 (382)
T KOG1909|consen  248 LGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG  311 (382)
T ss_pred             ccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence            999999865443332     468999999999999743    4556667899999999999984

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.11  E-value=2.1e-10  Score=116.32  Aligned_cols=130  Identities=18%  Similarity=0.162  Sum_probs=94.4

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCcee-eEEEEEeeCCeeEEEEeecCCC
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV-KFYGFCSHARHSFIVYEYLEMG  890 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~g  890 (1077)
                      +.++.|.++.||+++.. ++.|++|........    ...+..|+..++.+.+.+++ +++++..  ...++||||+++.
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~   76 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS   76 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence            56889999999999875 778999987654211    22356788888877554443 4555433  3457999999998


Q ss_pred             CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          891 SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF--PPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       891 ~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~--~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++.+.    .       .....++.+++++++.||+...  .+++|+|++|.||+++ ++.++++|||.+..
T Consensus        77 ~l~~~----~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTE----D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc----c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            77542    0       1112456789999999999821  1359999999999999 67899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.11  E-value=8.1e-12  Score=134.35  Aligned_cols=184  Identities=27%  Similarity=0.213  Sum_probs=94.8

Q ss_pred             cccccceeccccccccCCCC-cCCCCCCCCcEEEcccccccCC--CCCCCCCCCCCCEEEccCCccCCCCchh-hcCCCC
Q 001440          489 IHSNLSYINLSHKKFYGEIS-FDWGKFPNLGTLDVSANNITGI--LPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRS  564 (1077)
Q Consensus       489 ~~~~L~~L~Ls~n~i~~~~~-~~~~~~~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~-l~~l~~  564 (1077)
                      .+..|+.+.|.+..+..... .....+++++.||||.|-+...  +......+++|+.|+++.|++....... -..+++
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~  198 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH  198 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence            34556666666666544332 2334566666666666666532  1223345666666666666665222111 123556


Q ss_pred             CcEEEccCccccC-CcchhhhcccccceeeccCCcccCCCCCcccccccceeeeeccccccCCc-chhccccccccceec
Q 001440          565 LIKLTLNRNQFSG-QLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEI-PIKLEKFIHLSDLDL  642 (1077)
Q Consensus       565 L~~L~L~~N~l~~-~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~l~~l~~L~~L~L  642 (1077)
                      |+.|.|+.|.++- .+-..+..+|+|+.|+|+.|.....-.....-+..|++|||++|++-+.. -...+.++.|+.|++
T Consensus       199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl  278 (505)
T KOG3207|consen  199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL  278 (505)
T ss_pred             hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence            6666666666651 11222345566666666666422222333344556666666666654322 123445566666666


Q ss_pred             ccccCCCC-Cccc-----cccccccchhcccccccc
Q 001440          643 SHNFLGEE-IPSQ-----VCSMQSLEKLNLAHNNLS  672 (1077)
Q Consensus       643 s~N~i~~~-~~~~-----~~~l~~L~~L~l~~N~l~  672 (1077)
                      +.+.|... .|+.     ...+++|+.|++..|++.
T Consensus       279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             cccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            66666542 1221     234455666666666654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=5.3e-11  Score=135.03  Aligned_cols=247  Identities=21%  Similarity=0.204  Sum_probs=175.4

Q ss_pred             HHhcCCCccceecccCCceEEEEEe--cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEEEeeCCe
Q 001440          803 RATNDFDEEHCIGTGGQGSVYRAEL--SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARH  879 (1077)
Q Consensus       803 ~~~~~~~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~  879 (1077)
                      ....+|..+..||.|.|+.|++...  .++..|++|...........+. .-..|+.+...+ .|.++++++..+..-..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            3456888999999999999999854  3678899998876654433322 223455555555 58888888888887778


Q ss_pred             eEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCC-CceEEeccccc
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGIS  958 (1077)
Q Consensus       880 ~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~kl~Dfgla  958 (1077)
                      .|+--||+++++.......   ...+....++++..|++.++.++|+.   .++|+|+||+||++..+ +..++.|||.+
T Consensus       341 ~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~  414 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW  414 (524)
T ss_pred             ccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence            8899999999998876622   22356678889999999999999988   89999999999999886 88999999988


Q ss_pred             ccCCCCCCCccccccccccc--CccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccchhhhcCCCC
Q 001440          959 KSLKPDSSNWTELAGTIGYV--APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1077)
                      ..+.....  . ....-+++  +|+......+..+.|+||||..+.|.+++..--..           ......+.....
T Consensus       415 t~~~~~~~--~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-----------~~~~~~i~~~~~  480 (524)
T KOG0601|consen  415 TRLAFSSG--V-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-----------GVQSLTIRSGDT  480 (524)
T ss_pred             cccceecc--c-ccccccccccchhhccccccccccccccccccccccccCcccCcc-----------cccceeeecccc
Confidence            75321111  1 12233344  55566677788999999999999999988643110           011112222222


Q ss_pred             CCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                      +....    ....+..+.+.+...++..||.+.+....
T Consensus       481 p~~~~----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~  514 (524)
T KOG0601|consen  481 PNLPG----LKLQLQVLLKVMINPDRKRRPSAVELSLH  514 (524)
T ss_pred             cCCCc----hHHhhhhhhhhhcCCccccchhhhhhccc
Confidence            22221    11456677788999999999998877654

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.10  E-value=4.9e-11  Score=118.40  Aligned_cols=125  Identities=30%  Similarity=0.351  Sum_probs=46.8

Q ss_pred             CCCCCcEEEccCccccCCcchhhh-cccccceeeccCCcccCCCCCcccccccceeeeeccccccCCcchhc-ccccccc
Q 001440          561 KLRSLIKLTLNRNQFSGQLPTELG-SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLS  638 (1077)
Q Consensus       561 ~l~~L~~L~L~~N~l~~~~~~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l-~~l~~L~  638 (1077)
                      +..++++|+|++|+|+. + +.++ .+.+|+.|||++|.|+. + +.+..+++|++|++++|+|+...+ .+ ..+++|+
T Consensus        17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l-~~l~~L~~L~~L~L~~N~I~~i~~-~l~~~lp~L~   91 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-L-EGLPGLPRLKTLDLSNNRISSISE-GLDKNLPNLQ   91 (175)
T ss_dssp             ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CH-HHHHH-TT--
T ss_pred             ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-c-cCccChhhhhhcccCCCCCCcccc-chHHhCCcCC
Confidence            34466777777777762 2 3454 46777788888888773 3 356777888888888888875433 33 3577888


Q ss_pred             ceecccccCCCC-Cccccccccccchhcccccccccc---cchhhhccccccEEec
Q 001440          639 DLDLSHNFLGEE-IPSQVCSMQSLEKLNLAHNNLSGF---IPRCFKEMHGLVYIDI  690 (1077)
Q Consensus       639 ~L~Ls~N~i~~~-~~~~~~~l~~L~~L~l~~N~l~~~---~~~~l~~l~~L~~l~l  690 (1077)
                      .|+|++|+|.+. .-..+..+++|+.|+|.+|+++..   -...+..+|+|+.||-
T Consensus        92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD~  147 (175)
T PF14580_consen   92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEKKNYRLFVIYKLPSLKVLDG  147 (175)
T ss_dssp             EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGSTTHHHHHHHH-TT-SEETT
T ss_pred             EEECcCCcCCChHHhHHHHcCCCcceeeccCCcccchhhHHHHHHHHcChhheeCC
Confidence            888888888652 235567788888888888888743   1234567888888873

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.08  E-value=9.9e-10  Score=111.40  Aligned_cols=139  Identities=19%  Similarity=0.236  Sum_probs=99.0

Q ss_pred             ceecccCCceEEEEEecC-------CCEEEEEEccCCccc----------h---------hhHHHHH----HHHHHHhcC
Q 001440          812 HCIGTGGQGSVYRAELSS-------GEIVAVKKFHSPLLS----------E---------MTCQQEF----LNEVKSLTE  861 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~---------~~~~~~~----~~e~~~l~~  861 (1077)
                      .+||.|..+.||.|...+       +..+|||..+.....          +         ....+.+    .+|+..+++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999996543       478999976532110          0         0112233    379999998


Q ss_pred             CCC--CceeeEEEEEeeCCeeEEEEeecCCCCHHH-HHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccC
Q 001440          862 IRH--RNIVKFYGFCSHARHSFIVYEYLEMGSLAM-ILSNATSAEELGWTQRMNVIKGVADALSYL-HNDCFPPIVYRDI  937 (1077)
Q Consensus       862 l~h--~niv~l~~~~~~~~~~~lV~E~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dl  937 (1077)
                      +..  -.+.+++++    ...++||||++++.+.. .+++.    .++..+...+..+++.++.++ |+.   +++|+|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL  151 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL  151 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence            843  456666664    45689999998754421 22221    234456677889999999999 777   9999999


Q ss_pred             CCCCeeeCCCCceEEecccccccCC
Q 001440          938 SSKNVLLDLEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       938 k~~NIll~~~~~~kl~Dfgla~~~~  962 (1077)
                      ++.||+++ ++.+.++|||.|....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999997 5789999999887654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.04  E-value=3.7e-11  Score=139.74  Aligned_cols=267  Identities=28%  Similarity=0.268  Sum_probs=146.1

Q ss_pred             CCCCeeecCCCCcCCCcccccccccccceeecccccCcCCCCCccCCcccCcEEecccCcCCCCccccccccccceEeec
Q 001440          396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD  475 (1077)
Q Consensus       396 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~  475 (1077)
                      +.++.++..++.+.+.--. ...+..++.+++..|.+.. +-..+..+++|+.|++.+|+|......+            
T Consensus        49 ~~~~~~~~~~~~~~~~~~~-~~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~l------------  114 (414)
T KOG0531|consen   49 SDLEEIDLIFNLDGSDEDL-VESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENLL------------  114 (414)
T ss_pred             chhhhhcchhccccchhhh-HHHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccch------------
Confidence            3455566666554322111 1445666666677777753 2334556666666777766665433222            


Q ss_pred             CCccCCCCCcccccccccceeccccccccCCCCcCCCCCCCCcEEEcccccccCCCCCCCCCCCCCCEEEccCCccCCCC
Q 001440          476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEI  555 (1077)
Q Consensus       476 ~n~l~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  555 (1077)
                                  ..+++|++|++++|.|..+..  +..++.|+.|++++|.|..+  ..+..+..|+.+++++|++....
T Consensus       115 ------------~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie  178 (414)
T KOG0531|consen  115 ------------SSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIE  178 (414)
T ss_pred             ------------hhhhcchheeccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhh
Confidence                        334444444455554444332  22444566677777766643  34455666777777777776333


Q ss_pred             c-hhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCCCCccccccc--ceeeeeccccccCCcchhcc
Q 001440          556 P-SELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK--LYYLNLSNNQFSGEIPIKLE  632 (1077)
Q Consensus       556 ~-~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~~l~  632 (1077)
                      + . ...+.+++.+++.+|.+..  ...+..+..+..+++..|+++...  .+..+..  |+.+++++|++. ..+..+.
T Consensus       179 ~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~i~~~~--~l~~~~~~~L~~l~l~~n~i~-~~~~~~~  252 (414)
T KOG0531|consen  179 NDE-LSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNKISKLE--GLNELVMLHLRELYLSGNRIS-RSPEGLE  252 (414)
T ss_pred             hhh-hhhccchHHHhccCCchhc--ccchHHHHHHHHhhcccccceecc--CcccchhHHHHHHhcccCccc-ccccccc
Confidence            2 1 4556677777777777752  234444555555577777776322  1222232  677777777776 3334566


Q ss_pred             ccccccceecccccCCCCCccccccccccchhcccccccccc---cchh-hhccccccEEeccCCcccCCCC
Q 001440          633 KFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF---IPRC-FKEMHGLVYIDISYNKLHGPIP  700 (1077)
Q Consensus       633 ~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~l~~N~l~~~---~~~~-l~~l~~L~~l~l~~N~l~~~~p  700 (1077)
                      .+..+..|++.+|++..  ...+...+.+..+....|++...   .... ....+.++.+.+.+|+.....+
T Consensus       253 ~~~~l~~l~~~~n~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (414)
T KOG0531|consen  253 NLKNLPVLDLSSNRISN--LEGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS  322 (414)
T ss_pred             ccccccccchhhccccc--cccccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence            66677777777777642  23344555666666777766521   1111 3445566666666666554433

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.03  E-value=1.9e-09  Score=104.74  Aligned_cols=133  Identities=23%  Similarity=0.305  Sum_probs=102.8

Q ss_pred             eecccCCceEEEEEecCCCEEEEEEccCC-----ccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEEeec
Q 001440          813 CIGTGGQGSVYRAELSSGEIVAVKKFHSP-----LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL  887 (1077)
Q Consensus       813 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~  887 (1077)
                      .+++|+-+.+|.+.+. |.++++|.-.+.     .....-......+|+.++...+--.|....=+..++....|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999775 445666643222     2223334456788999999987666666666677778888999999


Q ss_pred             CCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          888 EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       888 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      +|..|.+++...          ...++..+-.-+.-||..   ||+|+|+.++||++..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999999888543          234667777888899999   999999999999997655 99999999874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=2.2e-10  Score=113.77  Aligned_cols=105  Identities=34%  Similarity=0.441  Sum_probs=31.4

Q ss_pred             CCCcEEEcccccccCCCCCCCC-CCCCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhh-hccccccee
Q 001440          515 PNLGTLDVSANNITGILPPEIG-DSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTEL-GSLIQLEHL  592 (1077)
Q Consensus       515 ~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l-~~l~~L~~L  592 (1077)
                      .++++|+|++|+|+.+  +.+. .+.+|+.|++++|.|+..  ..+..++.|++|++++|+|+ .+...+ ..+++|++|
T Consensus        19 ~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   19 VKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--EE
T ss_pred             cccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCEE
Confidence            4566677777777643  2343 456677777777777632  24566677777777777776 333333 356777777


Q ss_pred             eccCCcccCC-CCCcccccccceeeeecccccc
Q 001440          593 DLSSNRLSNS-IPGSLGNLVKLYYLNLSNNQFS  624 (1077)
Q Consensus       593 ~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~l~  624 (1077)
                      +|++|+|.+. .-..+..+++|+.|+|.+|++.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            7777777542 1234455666666666666665

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.99  E-value=1.4e-10  Score=137.71  Aligned_cols=253  Identities=19%  Similarity=0.233  Sum_probs=174.1

Q ss_pred             HHHhcCCCccceecccCCceEEEEEec-CCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCee
Q 001440          802 VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       802 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      ....+.+.+.+-+..|.++.++.++-. .|...+.|...........+.+....+-.+.-..++|-+++...-+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            345567777788899999999988543 3433344433221111111122222333333334567776665555566788


Q ss_pred             EEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccccccc
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~  960 (1077)
                      ++|++|..++++...++....   .+.+-....+..+..+.+|||..   .+.|+|++|.|++...++..+++|||....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence            999999999999998876552   33344455667788999999998   789999999999999999999999984432


Q ss_pred             CCC------C---------------C----------CCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCC
Q 001440          961 LKP------D---------------S----------SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKH 1009 (1077)
Q Consensus       961 ~~~------~---------------~----------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~ 1009 (1077)
                      ..-      .               .          .......||+.|.|||...+......+|+|++|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            210      0               0          00123568999999999999999999999999999999999999


Q ss_pred             CCCccccccccCcccccchhhhcCCCCCCCCCCcHHHHHHHHHHHHhccCCCCCCCCCHH
Q 001440         1010 PRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069 (1077)
Q Consensus      1010 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1069 (1077)
                      ||....        .++.++.+.....+.+. ..........+++...+..+|.+|-.|.
T Consensus      1034 p~na~t--------pq~~f~ni~~~~~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAET--------PQQIFENILNRDIPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcc--------hhhhhhccccCCCCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence            987332        24445555555544432 2334455677888889999999998765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.99  E-value=1.9e-08  Score=108.31  Aligned_cols=255  Identities=17%  Similarity=0.242  Sum_probs=161.3

Q ss_pred             CccceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCC-CCCceeeEEEE------EeeC-Cee
Q 001440          809 DEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGF------CSHA-RHS  880 (1077)
Q Consensus       809 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~~-~~~  880 (1077)
                      ...+.+|+|+.+.+|-.--- +.. +-|+++.+-.....      +.+..+... .||-+-.=+.+      ..++ ...
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCCccccCCccceeeecchh-hch-hheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            34567999999999965221 222 34777765432211      122223333 56643321111      1112 235


Q ss_pred             EEEEeecCCC-CHHHHH---hcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEeccc
Q 001440          881 FIVYEYLEMG-SLAMIL---SNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       881 ~lV~E~~~~g-~L~~~l---~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfg  956 (1077)
                      .+.|..+++. -+.++.   ++.++..+..|.-.++++..+|.+.+-||..   |.+-+|+.++|+|+.+++.+.+.|-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccc
Confidence            6777777654 222332   3344556788999999999999999999999   89999999999999999999999865


Q ss_pred             ccccCCCCCCCcccccccccccCccccc-----cCCCCCcchHHHHHHHHHHHHhC-CCCCCccccccccCcccccchh-
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKG-KHPRDFISSICSTSSNLDRTLD- 1029 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~s~G~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~- 1029 (1077)
                      .-.. ...+..+...+|...|.+||...     +.+-+...|-|.+||++++++.| ++||.............+..+. 
T Consensus       163 sfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         163 SFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             ceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            4332 23344456778999999999654     34556789999999999999886 9998754432221111111110 


Q ss_pred             -------hhcCCCCCCCCC-CcHHHHHHHHHHHHhccCCC--CCCCCCHHHHHhhh
Q 001440         1030 -------EILDPRLPAPSC-NIRDKLISIMEVAISCLDEN--PDSRPTMQKVSQLL 1075 (1077)
Q Consensus      1030 -------~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L 1075 (1077)
                             +.-.+..+.|.. ...-...++..+..+|+..-  |.-|||++-.+..|
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence                   011122233222 22233456777888888764  56799999887665

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.96  E-value=5.4e-09  Score=100.70  Aligned_cols=146  Identities=19%  Similarity=0.268  Sum_probs=108.3

Q ss_pred             ccceecccCCceEEEEEecCCCEEEEEEcc-----CCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEeeCCeeEEEE
Q 001440          810 EEHCIGTGGQGSVYRAELSSGEIVAVKKFH-----SPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       810 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-----~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ....+-+|+.+.|+++.++ |+...||.-.     .+.....-..++..+|++.+.+++--.|....=++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            4567889999999999986 7776776432     232333334567888999999887556655555666666678999


Q ss_pred             eecCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCC---ceEEeccccccc
Q 001440          885 EYLEM-GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY---EAHVSDFGISKS  960 (1077)
Q Consensus       885 E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~kl~Dfgla~~  960 (1077)
                      ||+++ .++.+++...-.... ..+.....+.+|-+.+.-||..   +|+|+|+..+||++..++   .+.+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 478888765443322 2233367899999999999999   999999999999997764   458999999853

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.93  E-value=4.9e-10  Score=138.64  Aligned_cols=132  Identities=32%  Similarity=0.399  Sum_probs=96.1

Q ss_pred             CCCCCCcEEEccCCcccccCCcccCCCCCCCEEeCCCCC--CCCCCCCCCCCcCccceecccccccCCCCCCCCCCcCcc
Q 001440          105 SSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNS--FSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYL  182 (1077)
Q Consensus       105 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~L~~N~~~~~~p~~~~~l~~L  182 (1077)
                      .+....++..+-+|.+... +... ..++|++|-+.+|.  +....++.|..++.|++|||++|.-.+.+|..++.|-+|
T Consensus       520 ~~~~~~rr~s~~~~~~~~~-~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  520 KSWNSVRRMSLMNNKIEHI-AGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             cchhheeEEEEeccchhhc-cCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            3446667777777776532 2222 23368888888886  443333446778888888888887777888888888888


Q ss_pred             ceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeeccc
Q 001440          183 KALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNK  239 (1077)
Q Consensus       183 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~  239 (1077)
                      |+|+|++..++ .+|.++++|..|.+|++..+.-...+|.....|++|++|.+..-.
T Consensus       598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            88888888887 778888888888888888777666667777778888888876654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.92  E-value=6.2e-10  Score=137.71  Aligned_cols=131  Identities=27%  Similarity=0.335  Sum_probs=99.0

Q ss_pred             CCCCCCEEeCCCCCCCCCCCCCCCCcCccceecccccc--cCCCCCCCCCCcCccceeecccccCCCCCCCCCCCCCcCc
Q 001440          130 NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQ--FSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLA  207 (1077)
Q Consensus       130 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~--~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  207 (1077)
                      +....+...+-+|.+. .++... ..+.|++|-+..|.  +....++.|..++.|++|||++|.--+.+|.++++|-+|+
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr  598 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR  598 (889)
T ss_pred             chhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence            3467788888888776 444443 33478888888886  4433344577788888888888877778888888888888


Q ss_pred             EEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCC
Q 001440          208 IMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS  263 (1077)
Q Consensus       208 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  263 (1077)
                      +|+|++..++ .+|..+++|+.|.+|++.++.-...+|.....|++|++|.+..-.
T Consensus       599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             cccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence            8888888888 788888888888888888877666666666678888888876654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.91  E-value=7.1e-09  Score=110.22  Aligned_cols=143  Identities=20%  Similarity=0.254  Sum_probs=108.8

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCC--ceeeEEEEEeeC---CeeEEEEee
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR--NIVKFYGFCSHA---RHSFIVYEY  886 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lV~E~  886 (1077)
                      +.++.|.++.||++...+|+.+++|........  ....++..|+.+++.+++.  .+.+++.+....   +..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            568999999999998877789999997654321  1245678899999998653  457778777654   256899999


Q ss_pred             cCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC--------------------------------------  928 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------  928 (1077)
                      ++++++.+.+..    ..++..+...++.++++++.+||+..                                      
T Consensus        82 i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          82 VDGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             eCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            999888765421    23566777888888888888888531                                      


Q ss_pred             ---------------CCCeEeccCCCCCeeeCC--CCceEEeccccccc
Q 001440          929 ---------------FPPIVYRDISSKNVLLDL--EYEAHVSDFGISKS  960 (1077)
Q Consensus       929 ---------------~~~ivH~Dlk~~NIll~~--~~~~kl~Dfgla~~  960 (1077)
                                     ...++|+|+.+.||+++.  ++.+.++||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           136799999999999998  56789999997753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.84  E-value=3e-09  Score=79.36  Aligned_cols=42  Identities=36%  Similarity=0.858  Sum_probs=30.0

Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCCCCCCCCCCCCCCCCccCceeec
Q 001440           35 TEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCN   80 (1077)
Q Consensus        35 ~~~~~all~~k~~~~~~~~~~~~l~~W~~~~~~~~~~c~w~gv~C~   80 (1077)
                      ++|++||++||+++.+++  .+.+.+|+...  .++||+|.||+|+
T Consensus         2 ~~d~~aLl~~k~~l~~~~--~~~l~~W~~~~--~~~~C~W~GV~Cd   43 (43)
T PF08263_consen    2 NQDRQALLAFKKSLNNDP--SGVLSSWNPSS--DSDPCSWSGVTCD   43 (43)
T ss_dssp             HHHHHHHHHHHHCTT-SC---CCCTT--TT----S-CCCSTTEEE-
T ss_pred             cHHHHHHHHHHHhccccc--CcccccCCCcC--CCCCeeeccEEeC
Confidence            679999999999998643  46899998721  3799999999996

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.69  E-value=1.4e-08  Score=82.93  Aligned_cols=58  Identities=40%  Similarity=0.555  Sum_probs=23.8

Q ss_pred             CcEEEccCCcCCCCCCCcccCccccceEEeecccccCCCCccCCCCCCCCeEEcccCC
Q 001440          206 LAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS  263 (1077)
Q Consensus       206 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~  263 (1077)
                      |++|++++|+++...+++|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus         3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            3344444444443333334444444444444444443333344444444444444443

...

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.68  E-value=1.3e-08  Score=83.06  Aligned_cols=60  Identities=38%  Similarity=0.494  Sum_probs=37.5

Q ss_pred             ccceeecccccCCCCCCCCCCCCCcCcEEEccCCcCCCCCCCcccCccccceEEeecccc
Q 001440          181 YLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL  240 (1077)
Q Consensus       181 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l  240 (1077)
                      +|++|++++|+++...+.+|.++++|++|++++|+++...|++|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455566666666555555666666666666666666655556666666666666666654

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.65  E-value=3.3e-07  Score=98.68  Aligned_cols=142  Identities=20%  Similarity=0.149  Sum_probs=98.8

Q ss_pred             ecccCCceEEEEEecCCCEEEEEEccCCccchh--------hHHHHHHHHHHHhcCCCCCc--eeeEEEEEee-----CC
Q 001440          814 IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEM--------TCQQEFLNEVKSLTEIRHRN--IVKFYGFCSH-----AR  878 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~-----~~  878 (1077)
                      +-......|++..+ +|+.|.||+.........        .....+.+|...+.++...+  +++++++.+.     ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333345667766 478899997744321110        00124778888888874333  3344555543     23


Q ss_pred             eeEEEEeecCCC-CHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC-------CCce
Q 001440          879 HSFIVYEYLEMG-SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-------EYEA  950 (1077)
Q Consensus       879 ~~~lV~E~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~  950 (1077)
                      ..++|||++++. +|.+++..... ...+......++.+++..+.-||..   ||+|+|++++|||++.       ++.+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceE
Confidence            578999999986 89998853221 2244567788999999999999999   9999999999999985       4689


Q ss_pred             EEeccccccc
Q 001440          951 HVSDFGISKS  960 (1077)
Q Consensus       951 kl~Dfgla~~  960 (1077)
                      .++||+.++.
T Consensus       185 ~LIDl~r~~~  194 (268)
T PRK15123        185 SVIDLHRAQI  194 (268)
T ss_pred             EEEECCcccc
Confidence            9999998753

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.64  E-value=1.8e-07  Score=94.69  Aligned_cols=129  Identities=23%  Similarity=0.297  Sum_probs=84.1

Q ss_pred             eEEEEEecCCCEEEEEEccCCcc-----------------------chhhHHHHHHHHHHHhcCCCCC--ceeeEEEEEe
Q 001440          821 SVYRAELSSGEIVAVKKFHSPLL-----------------------SEMTCQQEFLNEVKSLTEIRHR--NIVKFYGFCS  875 (1077)
Q Consensus       821 ~Vy~~~~~~~~~vavK~~~~~~~-----------------------~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~  875 (1077)
                      -||.|...+|..+|||.......                       ..........+|.+.|.++...  ++.+++++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            38999888899999997653211                       0111234578899999999765  466666553 


Q ss_pred             eCCeeEEEEeecC--CCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeccCCCCCeeeCCCCceEE
Q 001440          876 HARHSFIVYEYLE--MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHV  952 (1077)
Q Consensus       876 ~~~~~~lV~E~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dlk~~NIll~~~~~~kl  952 (1077)
                         ...+||||++  +..+.......     ++..+...++.+++..+..+ |..   ||+|+|+.+.||+++.+ .+.+
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEE
Confidence               3469999998  54454433211     11345667788888866664 676   99999999999999887 9999


Q ss_pred             ecccccccCC
Q 001440          953 SDFGISKSLK  962 (1077)
Q Consensus       953 ~Dfgla~~~~  962 (1077)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.60  E-value=9.8e-07  Score=98.10  Aligned_cols=215  Identities=16%  Similarity=0.209  Sum_probs=147.3

Q ss_pred             CCceEEEEEe-cCCCEEEEEEccCCccchhhHHHHHHHHHHHhcCCCCCceeeEEEEEee----CCeeEEEEeecCC-CC
Q 001440          818 GQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH----ARHSFIVYEYLEM-GS  891 (1077)
Q Consensus       818 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~~-g~  891 (1077)
                      ...+.|++.. .+|..|+.|+++..+....   .....-++.++++.|+|||++.+++..    +...++||+|.++ ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            3467899955 4899999999965433221   122344678899999999999998863    3467899999986 57


Q ss_pred             HHHHHhcCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccc
Q 001440          892 LAMILSNAT------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       892 L~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~  959 (1077)
                      |.+.-....            .....+++..+.++.|++.||.++|+.   |..-+-+.+++|+++.+.+++|+..|...
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~D  441 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMD  441 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEeccccee
Confidence            877654322            122466788999999999999999999   99999999999999999999999999887


Q ss_pred             cCCCCCCCcccccccccccCccccccCCCCCcchHHHHHHHHHHHHhCCCCCCccccccccCcccccc-hhhhcCCCCCC
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRT-LDEILDPRLPA 1038 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~s~G~~l~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 1038 (1077)
                      .+.++...              -+.+   -.+-|.=.||.++..+.||..--.       ........ .+.+       
T Consensus       442 vl~~d~~~--------------~le~---~Qq~D~~~lG~ll~aLAt~~~ns~-------~~d~~~~s~~~~I-------  490 (655)
T KOG3741|consen  442 VLQEDPTE--------------PLES---QQQNDLRDLGLLLLALATGTENSN-------RTDSTQSSHLTRI-------  490 (655)
T ss_pred             eecCCCCc--------------chhH---HhhhhHHHHHHHHHHHhhcccccc-------cccchHHHHHHHh-------
Confidence            66554310              0111   136688899999999999964311       00000011 1111       


Q ss_pred             CCCCcHHHHHHHHHHHHhccCCCCCCCCCHHHHHhh
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1074 (1077)
                          ...+..++++++.-.....+++ -+.++++.+
T Consensus       491 ----~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  491 ----TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ----hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                1223345666666666667765 467777655

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.57  E-value=3e-07  Score=94.98  Aligned_cols=139  Identities=21%  Similarity=0.197  Sum_probs=98.1

Q ss_pred             CCccceecccCCceEEEEEecCCCEEEEEEccCCccc-----------------hh--hHHHHHHHHHHHhcCCCCC--c
Q 001440          808 FDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS-----------------EM--TCQQEFLNEVKSLTEIRHR--N  866 (1077)
Q Consensus       808 ~~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~--~~~~~~~~e~~~l~~l~h~--n  866 (1077)
                      +.+...||.|.-+.||.|..+.|.++|||.=.....+                 .+  ..+....+|.+.|.++...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            3456789999999999999999999999953221110                 11  1234467889999999654  6


Q ss_pred             eeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCC
Q 001440          867 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL  946 (1077)
Q Consensus       867 iv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~  946 (1077)
                      |.+.+++    +...+||||+++-.|...-        ++.+..-.++..|.+-+...-..   ||||+|+.+-||+++.
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEec
Confidence            6667665    3457999999986664321        12233444555555555555555   9999999999999999


Q ss_pred             CCceEEecccccccC
Q 001440          947 EYEAHVSDFGISKSL  961 (1077)
Q Consensus       947 ~~~~kl~Dfgla~~~  961 (1077)
                      ||.+.++||--+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999766543

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.52  E-value=3.5e-09  Score=120.42  Aligned_cols=127  Identities=35%  Similarity=0.411  Sum_probs=97.2

Q ss_pred             CCCCEEEccCCccCCCCchhhcCCCCCcEEEccCccccCCcchhhhcccccceeeccCCcccCCCCCc-ccccccceeee
Q 001440          539 PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS-LGNLVKLYYLN  617 (1077)
Q Consensus       539 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~~L~  617 (1077)
                      ..|.+.+.+.|.+. .+...+.-++.|+.|+|++|+++..  ..+..++.|++|||+.|.++ .+|.. ...+ +|..|.
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~  238 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLN  238 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhh-hheeee
Confidence            34778888888887 5666777788899999999999843  37888999999999999998 44432 2233 489999


Q ss_pred             eccccccCCcchhccccccccceecccccCCCCC-ccccccccccchhcccccccc
Q 001440          618 LSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEI-PSQVCSMQSLEKLNLAHNNLS  672 (1077)
Q Consensus       618 Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~~~~-~~~~~~l~~L~~L~l~~N~l~  672 (1077)
                      |+||.++.  -..+.++.+|+.||+++|-|.+-. -..++.+..|+.|+|.+|++-
T Consensus       239 lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~  292 (1096)
T KOG1859|consen  239 LRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC  292 (1096)
T ss_pred             ecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence            99998873  345778888999999999886521 234567788999999999885

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.48  E-value=5.1e-08  Score=112.29  Aligned_cols=149  Identities=19%  Similarity=0.291  Sum_probs=102.2

Q ss_pred             HHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCceEEecccccccCCCCCC----Ccc-----cccccccccCccccc
Q 001440          914 IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS----NWT-----ELAGTIGYVAPELAY  984 (1077)
Q Consensus       914 ~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----~~~-----~~~g~~~y~aPE~~~  984 (1077)
                      +.+++.|+.|+|...  ++||++|.|++|.++..+.+|++.|+.+....+...    .+.     -......|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            345569999999884  999999999999999999999999998876554211    111     112457899999999


Q ss_pred             cCCCCCcchHHHHHHHHHHHHhCCCC-CCccccccccCcccccchhhhcC-CCCCCCCCCcHHHHHHHHHHHHhccCCCC
Q 001440          985 TMKVTEKSDVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDENP 1062 (1077)
Q Consensus       985 ~~~~~~~~Dv~s~G~~l~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1062 (1077)
                      ....+.++|+||+||++|-+..|+.+ ++.....      .....+...+ ....   ++....+.++.+=+.+++..++
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~------~~~~~~~~~~~~~~~---~~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL------LSYSFSRNLLNAGAF---GYSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCc------chhhhhhcccccccc---cccccCcHHHHHHHHHHhcCCc
Confidence            98889999999999999999855544 3321111      1111111111 0000   0112223457777889999999


Q ss_pred             CCCCCHHHHHh
Q 001440         1063 DSRPTMQKVSQ 1073 (1077)
Q Consensus      1063 ~~RPs~~evl~ 1073 (1077)
                      ..||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998877654

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.47  E-value=3.4e-09  Score=120.51  Aligned_cols=177  Identities=24%  Similarity=0.261  Sum_probs=128.2

Q ss_pred             CCCCCCCcEEEcccccccCCCCCCCCCC-CCCCEEEccCCccC----------CCCchhhcCCCCCcEEEccCccccCCc
Q 001440          511 WGKFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIV----------GEIPSELGKLRSLIKLTLNRNQFSGQL  579 (1077)
Q Consensus       511 ~~~~~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~----------~~~~~~l~~l~~L~~L~L~~N~l~~~~  579 (1077)
                      +..+..|+.|.+.++.|..  ...+..+ .+|+.|... |.+.          +.+...+. ...|...+.+.|++. ..
T Consensus       105 ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~-~m  179 (1096)
T KOG1859|consen  105 IFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV-LM  179 (1096)
T ss_pred             eccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH-hH
Confidence            3456677888888877763  2223333 235555433 3222          11211211 246888999999998 67


Q ss_pred             chhhhcccccceeeccCCcccCCCCCcccccccceeeeeccccccCCcch-hccccccccceecccccCCCCCccccccc
Q 001440          580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPI-KLEKFIHLSDLDLSHNFLGEEIPSQVCSM  658 (1077)
Q Consensus       580 ~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~l~~l~~L~~L~Ls~N~i~~~~~~~~~~l  658 (1077)
                      -..+.-++.|+.|||++|+++...  .+..+++|++|||+.|.+.. +|. .-..+ +|+.|.|++|.++.  -..+.++
T Consensus       180 D~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~-vp~l~~~gc-~L~~L~lrnN~l~t--L~gie~L  253 (1096)
T KOG1859|consen  180 DESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRH-VPQLSMVGC-KLQLLNLRNNALTT--LRGIENL  253 (1096)
T ss_pred             HHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcc-ccccchhhh-hheeeeecccHHHh--hhhHHhh
Confidence            788889999999999999998543  78899999999999999984 332 22233 49999999999963  2467899


Q ss_pred             cccchhcccccccccc-cchhhhccccccEEeccCCcccCC
Q 001440          659 QSLEKLNLAHNNLSGF-IPRCFKEMHGLVYIDISYNKLHGP  698 (1077)
Q Consensus       659 ~~L~~L~l~~N~l~~~-~~~~l~~l~~L~~l~l~~N~l~~~  698 (1077)
                      ++|+.||++.|-|.+. .-..++.+..|+.|+|.||++-+.
T Consensus       254 ksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  254 KSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             hhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            9999999999999864 234567788999999999999764

>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification]

Probab=98.43  E-value=2.4e-08  Score=101.24  Aligned_cols=185  Identities=21%  Similarity=0.144  Sum_probs=117.0

Q ss_pred             cccccccceeccccccccCCCCcC----CCCCCCCcEEEcccccccCCCCCC-------------CCCCCCCCEEEccCC
Q 001440          487 FGIHSNLSYINLSHKKFYGEISFD----WGKFPNLGTLDVSANNITGILPPE-------------IGDSPQLKVLDLSSN  549 (1077)
Q Consensus       487 ~~~~~~L~~L~Ls~n~i~~~~~~~----~~~~~~L~~L~Ls~N~l~~~~~~~-------------~~~l~~L~~L~Ls~N  549 (1077)
                      +..++.|+.++||+|.+.......    ++.-..|++|.+++|.+..+.-..             ..+-|.|++..+..|
T Consensus        88 Llkcp~l~~v~LSDNAfg~~~~e~L~d~is~~t~l~HL~l~NnGlGp~aG~rigkal~~la~nKKaa~kp~Le~vicgrN  167 (388)
T COG5238          88 LLKCPRLQKVDLSDNAFGSEFPEELGDLISSSTDLVHLKLNNNGLGPIAGGRIGKALFHLAYNKKAADKPKLEVVICGRN  167 (388)
T ss_pred             HhcCCcceeeeccccccCcccchHHHHHHhcCCCceeEEeecCCCCccchhHHHHHHHHHHHHhhhccCCCceEEEeccc
Confidence            345566666666666654333222    234466777777777765332111             234477888889988


Q ss_pred             ccCCCCch-----hhcCCCCCcEEEccCccccCCcch-----hhhcccccceeeccCCcccCC----CCCccccccccee
Q 001440          550 HIVGEIPS-----ELGKLRSLIKLTLNRNQFSGQLPT-----ELGSLIQLEHLDLSSNRLSNS----IPGSLGNLVKLYY  615 (1077)
Q Consensus       550 ~l~~~~~~-----~l~~l~~L~~L~L~~N~l~~~~~~-----~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~  615 (1077)
                      ++. ..+.     .+..-..|+++.+..|.|......     .+..+.+|+.|||.+|-++..    +..+++.++.|++
T Consensus       168 Rle-ngs~~~~a~~l~sh~~lk~vki~qNgIrpegv~~L~~~gl~y~~~LevLDlqDNtft~~gS~~La~al~~W~~lrE  246 (388)
T COG5238         168 RLE-NGSKELSAALLESHENLKEVKIQQNGIRPEGVTMLAFLGLFYSHSLEVLDLQDNTFTLEGSRYLADALCEWNLLRE  246 (388)
T ss_pred             hhc-cCcHHHHHHHHHhhcCceeEEeeecCcCcchhHHHHHHHHHHhCcceeeeccccchhhhhHHHHHHHhcccchhhh
Confidence            886 2222     233345788899998888633222     335678899999999988743    3455677788899


Q ss_pred             eeeccccccCCcchhcc------ccccccceecccccCCCCCccc-----c--ccccccchhcccccccc
Q 001440          616 LNLSNNQFSGEIPIKLE------KFIHLSDLDLSHNFLGEEIPSQ-----V--CSMQSLEKLNLAHNNLS  672 (1077)
Q Consensus       616 L~Ls~N~l~~~~~~~l~------~l~~L~~L~Ls~N~i~~~~~~~-----~--~~l~~L~~L~l~~N~l~  672 (1077)
                      |.+.+|-++......+-      ..++|..|...+|.+.+.....     +  ..+|-|..|.+.+|++.
T Consensus       247 L~lnDClls~~G~~~v~~~f~e~~~p~l~~L~~~Yne~~~~~i~~~~l~~~e~~~~p~L~~le~ngNr~~  316 (388)
T COG5238         247 LRLNDCLLSNEGVKSVLRRFNEKFVPNLMPLPGDYNERRGGIILDISLNEFEQDAVPLLVDLERNGNRIK  316 (388)
T ss_pred             ccccchhhccccHHHHHHHhhhhcCCCccccccchhhhcCceeeeechhhhhhcccHHHHHHHHccCcch
Confidence            99988888876655432      2577888888888775422211     1  24667777777777776

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.34  E-value=2.9e-06  Score=98.89  Aligned_cols=145  Identities=19%  Similarity=0.237  Sum_probs=96.2

Q ss_pred             ceecccCCceEEEEEecCCCEEEEEEccCCccchh-------------------------------------hHHHHHHH
Q 001440          812 HCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEM-------------------------------------TCQQEFLN  854 (1077)
Q Consensus       812 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~~~~  854 (1077)
                      +.|+.++-|.||+|++++|+.||||+.+.......                                     ..+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            57999999999999999999999998765322100                                     01112455


Q ss_pred             HHHHhcCC-----CCCceeeEEEEEeeCCeeEEEEeecCCCCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 001440          855 EVKSLTEI-----RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL-SYLHNDC  928 (1077)
Q Consensus       855 e~~~l~~l-----~h~niv~l~~~~~~~~~~~lV~E~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~  928 (1077)
                      |+..+.++     +.+.+.-..=|++..+...++|||++|-.+.+...-....  .+   +..++..++++. ..+=.. 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d---~k~ia~~~~~~f~~q~~~d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--ID---RKELAELLVRAFLRQLLRD-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhc-
Confidence            65555555     2455443333444456678999999998888774222211  22   223333333332 222223 


Q ss_pred             CCCeEeccCCCCCeeeCCCCceEEecccccccCCCC
Q 001440          929 FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       929 ~~~ivH~Dlk~~NIll~~~~~~kl~Dfgla~~~~~~  964 (1077)
                        |++|.|..|.||+++.+|++.+.|||+...+.+.
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              8999999999999999999999999999877653

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.34  E-value=5.7e-08  Score=88.64  Aligned_cols=104  Identities=30%  Similarity=0.411  Sum_probs=51.7

Q ss_pred             CCEEEccCCccCCCCchhhc---CCCCCcEEEccCccccCCcchhhhc-ccccceeeccCCcccCCCCCcccccccceee
Q 001440          541 LKVLDLSSNHIVGEIPSELG---KLRSLIKLTLNRNQFSGQLPTELGS-LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYL  616 (1077)
Q Consensus       541 L~~L~Ls~N~l~~~~~~~l~---~l~~L~~L~L~~N~l~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  616 (1077)
                      +..++|+++.+. .+++...   ....|+..+|++|.+. .+|+.|.. .+.++.|+|++|+|+ .+|+.+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            344555555543 2333322   2334445555555555 34444432 335555555555555 344445555555555


Q ss_pred             eeccccccCCcchhccccccccceecccccCC
Q 001440          617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLG  648 (1077)
Q Consensus       617 ~Ls~N~l~~~~~~~l~~l~~L~~L~Ls~N~i~  648 (1077)
                      ++++|.+. ..|..+..+.++..||..+|.+.
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            55555555 44444444555555555555553

>PRK09902 hypothetical protein; Provisional

Probab=98.33  E-value=7.8e-06  Score=83.13  Aligned_cols=141  Identities=18%  Similarity=0.119  Sum_probs=102.1

Q ss_pred             ecccCCceEEEEEecCCCEEEEEEccCCccch---hhHHHHHHHHHHHhcCCCCC--ceeeEEEEEeeC----CeeEEEE
Q 001440          814 IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHR--NIVKFYGFCSHA----RHSFIVY  884 (1077)
Q Consensus       814 lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~----~~~~lV~  884 (1077)
                      -|+||-+.|++-... |+.+-+|+-.......   ......|.+|...+.++...  .+.++..+....    -..+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            467899999998775 5578888754211111   22367899999999988432  244555222221    2468999


Q ss_pred             eecCC-CCHHHHHhcCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeccCCCCCeeeCCCCc--eEEecccccc
Q 001440          885 EYLEM-GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE--AHVSDFGISK  959 (1077)
Q Consensus       885 E~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~kl~Dfgla~  959 (1077)
                      |-+++ -+|.+++..... .+.+..+...++.+++..+.-||+.   |+.|+|+.+.||+++.++.  ++++||--++
T Consensus       105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97764 589888855432 2356677889999999999999999   9999999999999986666  9999997554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	1077
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		1e-58
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		1e-58
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-39
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		7e-39
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-30
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-30
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-30
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-30
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-30
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-29
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-27
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		5e-27
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-26
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		4e-22
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		1e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-21
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-21
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-21
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-21
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-20
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-20
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-20
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-20
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-20
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-20
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-20
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-20
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-20
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-20
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-20
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-20
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-20
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-20
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-20
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		5e-20
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-20
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-20
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-20
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-20
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-20
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-20
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-20
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		9e-20
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-19
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-19
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-19
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-19
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-19
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-19
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		6e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		4e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-17
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-17
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		6e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		8e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		8e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-16
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-16
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-16
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-16
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-16
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-16
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		7e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		7e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-16
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		9e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-15
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-15
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-15
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-15
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-14
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-14
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-14
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-14
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-14
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-14
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-14
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-14
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-14
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-14
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-14
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-14
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-14
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-13
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-13
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		1e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-13
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-13
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-13
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-13
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-13
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-12
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-12
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-12
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-12
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-12
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-12
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-12
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-12
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-12
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		5e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-12
2omx_A	462	Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX		5e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		6e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-12
2omt_A	462	Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt		6e-12
2omu_A	462	Crystal Structure Of Inla G194s+s Y369s/hec1 Comple		6e-12
2omv_A	461	Crystal Structure Of Inla S192n Y369s/hec1 Complex		6e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		7e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		7e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		8e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-12
2omy_A	461	Crystal Structure Of Inla S192n/hec1 Complex Length		8e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
2omz_A	466	Crystal Structure Of Inla Y369a/hec1 Complex Length		9e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-12
1o6s_A	466	Internalin (Listeria Monocytogenes) E-Cadherin (Hum		9e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		9e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		9e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		9e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		9e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		9e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-11
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-11
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-11
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-11
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-11
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-11
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-11
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-11
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-11
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-11
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-11
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-11
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-11
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-11
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-11
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-11
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		6e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		8e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		9e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		9e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		9e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		1e-10
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-10
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		5e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-10
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		6e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-10
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		6e-10
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		7e-10
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		8e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		9e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-10
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-09
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-09
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-09
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-09
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-09
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-09
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-09
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-09
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-09
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-09
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-09
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-09
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		4e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-09
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-09
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		5e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		6e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		6e-09
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		6e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		6e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		6e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		7e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		7e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		7e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		7e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		7e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		8e-09
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-09
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-09
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		9e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		9e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-09
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		9e-09
3ulu_A	694	Structure Of Quaternary Complex Of Human Tlr3ecd Wi		7e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		9e-09
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		9e-09
2a0z_A	705	The Molecular Structure Of Toll-like Receptor 3 Lig		7e-07
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		9e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		9e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		1e-08
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		6e-07
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		4e-05
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		6e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		1e-08
4fho_A	231	Crystal Structure Of An Internalin C2 (Inlc2) From		1e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-08
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		1e-08
1ziw_A	680	Human Toll-Like Receptor 3 Extracellular Domain Str		1e-06
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-08
4fmz_A	347	Crystal Structure Of An Internalin (Inlf) From List		2e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-08
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-08
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-08
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-08
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-08
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-08
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-08
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-08
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-08
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-08
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-08
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-08
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-08
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-08
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-08
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-08
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		3e-08
2id5_A	477	Crystal Structure Of The Lingo-1 Ectodomain Length		6e-05
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		5e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		5e-08
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-08
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		5e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-08
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		7e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		8e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		8e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		8e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		9e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		9e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		9e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		9e-08
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-07
3kj4_A	286	Structure Of Rat Nogo Receptor Bound To 1d9 Antagon		2e-07
3j0a_A	844	Homology Model Of Human Toll-Like Receptor 5 Fitted		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-07
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-07
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-07
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-07
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-07
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-07
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-07
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-07
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-07
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-07
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-07
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-07
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-07
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-07
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-07
1ozn_A	285	1.5a Crystal Structure Of The Nogo Receptor Ligand		4e-07
1p8t_A	285	Crystal Structure Of Nogo-66 Receptor Length = 285		4e-07
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		4e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-07
3b2d_A	603	Crystal Structure Of Human Rp105MD-1 Complex Length		4e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-07
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		5e-07
1xku_A	330	Crystal Structure Of The Dimeric Protein Core Of De		8e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-07
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		5e-07
1xcd_A	329	Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo		8e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		5e-07
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		7e-07
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-07
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		7e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-07
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		9e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-06
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-06
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		2e-06
3cig_A	697	Crystal Structure Of Mouse Tlr3 Ectodomain Length =		3e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-06
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		4e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-06
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		4e-06
3m19_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		2e-04
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		4e-06
3m18_A	251	Crystal Structure Of Variable Lymphocyte Receptor V		2e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		4e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		4e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-06
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-06
3soa_A	444	Full-Length Human Camkii Length = 444		5e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-06
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-06
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		6e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-06
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		6e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		8e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		9e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-06
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-05
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		1e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		8e-05
4b8c_D	727	Nuclease Module Of The Yeast Ccr4-Not Complex Lengt		5e-04
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		1e-05
3e6j_A	229	Crystal Structure Of Variable Lymphocyte Receptor (		2e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-05
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-05
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-05
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-05
3t6q_A	606	Crystal Structure Of Mouse Rp105MD-1 Complex Length		1e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-05
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-05
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-05
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-05
3zyo_A	411	Crystal Structure Of The N-Terminal Leucine Rich Re		3e-05
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		3e-05
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		7e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-05
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-05
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-05
3zyn_A	321	Crystal Structure Of The N-Terminal Leucine Rich Re		4e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		5e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		5e-05
2ft3_A	332	Crystal Structure Of The Biglycan Dimer Core Protei		5e-05
3rfs_A	272	Design Of A Binding Scaffold Based On Variable Lymp		5e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-05
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		8e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-05
3p72_A	269	Structure Of Platelet Glycoprotein 1b Alpha With A		8e-05
2z7x_B	520	Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu		9e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-04
3rg1_A	612	Crystal Structure Of The Rp105MD-1 Complex Length =		1e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-04
1u0n_D	265	The Ternary Von Willebrand Factor A1-Glycoprotein I		1e-04
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-04
1gwb_B	281	Structure Of Glycoprotein 1b Length = 281		1e-04
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-04
3pmh_G	290	Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib		1e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-04
1p9a_G	290	Crystal Structure Of N-terminal Domain Of Human Pla		1e-04
1ook_G	290	Crystal Structure Of The Complex Of Platelet Recept		1e-04
1m10_B	290	Crystal Structure Of The Complex Of Glycoprotein Ib		1e-04
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-04
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-04
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-04
1m0z_A	290	Crystal Structure Of The Von Willebrand Factor Bind		2e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-04
3fxi_A	605	Crystal Structure Of The Human Tlr4-Human Md-2-E.Co		2e-04
1p8v_A	279	Crystal Structure Of The Complex Of Platelet Recept		2e-04
3zyj_A	440	Netring1 In Complex With Ngl1 Length = 440		3e-04

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  225 bits (573), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 238/772 (30%), Positives = 348/772 (45%), Gaps = 95/772 (12%)
Query: 36  EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGL 95
            E H L+ +K  L + N     LP W+ N     +PC + G+ C    KV SI+L+S  L
Sbjct: 12  REIHQLISFKDVLPDKN----LLPDWSSNK----NPCTFDGVTC-RDDKVTSIDLSSKPL 62
Query: 96  IGTLHDFSFSSFPHLAYLD-------LRVNQIFGIIPSQIANNSKLKYLDLSSNSFSG-- 146
                +  FS+               L  + I G + S    ++ L  LDLS NS SG  
Sbjct: 63  -----NVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPV 116
Query: 147 TIPPQIGNLSMLKILYLSTN--QFSGRIPPQIGHLSYLKALHLFENGLSGS------IPP 198
           T    +G+ S LK L +S+N   F G++   +  L+ L+ L L  N +SG+      +  
Sbjct: 117 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL-KLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 199 SLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLD 258
             G L +LAI     N +SG +  ++    +L  L++  N  S  +P  LG+   L  LD
Sbjct: 176 GCGELKHLAI---SGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 229
Query: 259 LHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS 318
           +  N LSG    +    T L +LN+  N   G IP     LKSL  L L+ NK +G IP 
Sbjct: 230 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPD 287
Query: 319 SL-GNLTKLTILYLSDNLLFGSIPCEIG-------------------------NLRYLFY 352
            L G    LT L LS N  +G++P   G                          +R L  
Sbjct: 288 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKV 347
Query: 353 LELGDNKLSGSIPHSLGNLT-NLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXX--X 409
           L+L  N+ SG +P SL NL+ +L TL L +N  SG I   +                   
Sbjct: 348 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 407
Query: 410 XXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIP-DLRNLTR 468
             IP +  N + ++ L +  N LSG IP   G+L KL  L L  N L+G IP +L  +  
Sbjct: 408 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 467
Query: 469 LARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
           L  + LD N LTG I       +NL++I+LS+ +  GEI    G+  NL  L +S N+ +
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 527
Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLI--------KLTLNRNQFSGQLP 580
           G +P E+GD   L  LDL++N   G IP+ + K    I        +    +N    +  
Sbjct: 528 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 581 TELGSLIQLEHLDLSS-NRLSNSIPGSLGNLV-------------KLYYLNLSNNQFSGE 626
              G+L++ + +     NRLS   P ++ + V              + +L++S N  SG 
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 627 IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLV 686
           IP ++    +L  L+L HN +   IP +V  ++ L  L+L+ N L G IP+    +  L 
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 707
Query: 687 YIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQA 738
            ID+S N L GPIP    F+  P      N GLCG     P C  S +D  A
Sbjct: 708 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRCDPSNADGYA 757

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  225 bits (573), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 238/775 (30%), Positives = 349/775 (45%), Gaps = 95/775 (12%)
Query: 36  EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGL 95
            E H L+ +K  L + N     LP W+ N     +PC + G+ C    KV SI+L+S  L
Sbjct: 9   REIHQLISFKDVLPDKN----LLPDWSSNK----NPCTFDGVTC-RDDKVTSIDLSSKPL 59
Query: 96  IGTLHDFSFSSFPHLAYLD-------LRVNQIFGIIPSQIANNSKLKYLDLSSNSFSG-- 146
                +  FS+               L  + I G + S    ++ L  LDLS NS SG  
Sbjct: 60  -----NVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLSRNSLSGPV 113
Query: 147 TIPPQIGNLSMLKILYLSTN--QFSGRIPPQIGHLSYLKALHLFENGLSGS------IPP 198
           T    +G+ S LK L +S+N   F G++   +  L+ L+ L L  N +SG+      +  
Sbjct: 114 TTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL-KLNSLEVLDLSANSISGANVVGWVLSD 172
Query: 199 SLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLD 258
             G L +LAI     N +SG +  ++    +L  L++  N  S  +P  LG+   L  LD
Sbjct: 173 GCGELKHLAI---SGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLD 226
Query: 259 LHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS 318
           +  N LSG    +    T L +LN+  N   G IP     LKSL  L L+ NK +G IP 
Sbjct: 227 ISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPD 284
Query: 319 SL-GNLTKLTILYLSDNLLFGSIPCEIG-------------------------NLRYLFY 352
            L G    LT L LS N  +G++P   G                          +R L  
Sbjct: 285 FLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKV 344
Query: 353 LELGDNKLSGSIPHSLGNLT-NLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXX--X 409
           L+L  N+ SG +P SL NL+ +L TL L +N  SG I   +                   
Sbjct: 345 LDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFT 404
Query: 410 XXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIP-DLRNLTR 468
             IP +  N + ++ L +  N LSG IP   G+L KL  L L  N L+G IP +L  +  
Sbjct: 405 GKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKT 464
Query: 469 LARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
           L  + LD N LTG I       +NL++I+LS+ +  GEI    G+  NL  L +S N+ +
Sbjct: 465 LETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFS 524
Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLI--------KLTLNRNQFSGQLP 580
           G +P E+GD   L  LDL++N   G IP+ + K    I        +    +N    +  
Sbjct: 525 GNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKEC 584
Query: 581 TELGSLIQLEHLDLSS-NRLSNSIPGSLGNLV-------------KLYYLNLSNNQFSGE 626
              G+L++ + +     NRLS   P ++ + V              + +L++S N  SG 
Sbjct: 585 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 644
Query: 627 IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLV 686
           IP ++    +L  L+L HN +   IP +V  ++ L  L+L+ N L G IP+    +  L 
Sbjct: 645 IPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLT 704
Query: 687 YIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRK 741
            ID+S N L GPIP    F+  P      N GLCG     P C  S +D  A  +
Sbjct: 705 EIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRCDPSNADGYAHHQ 757

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  161 bits (408), Expect = 1e-39,   Method: Composition-based stats.
 Identities = 94/295 (31%), Positives = 158/295 (53%), Gaps = 17/295 (5%)
Query: 794  RKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFL 853
            ++ +  E+  A+++F  ++ +G GG G VY+  L+ G +VAVK+           + +F 
Sbjct: 26   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEE--RXQGGELQFQ 83
Query: 854  NEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAEELGWTQRMN 912
             EV+ ++   HRN+++  GFC       +VY Y+  GS+A  L     S   L W +R  
Sbjct: 84   TEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 143
Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-PDSSNWTEL 971
            +  G A  L+YLH+ C P I++RD+ + N+LLD E+EA V DFG++K +   D      +
Sbjct: 144  IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAV 203
Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL------- 1024
             GTIG++APE   T K +EK+DV+ +GV+ LE I G+   D           L       
Sbjct: 204  RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 263
Query: 1025 --DRTLDEILDPRLPAPSCNIRDKLI-SIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              ++ L+ ++D  L     N +D+ +  +++VA+ C   +P  RP M +V ++L+
Sbjct: 264  LKEKKLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  159 bits (402), Expect = 7e-39,   Method: Composition-based stats.
 Identities = 96/297 (32%), Positives = 160/297 (53%), Gaps = 21/297 (7%)
Query: 794  RKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMT--CQQE 851
            ++ +  E+  A+++F  ++ +G GG G VY+  L+ G +VAVK+    L  E T   + +
Sbjct: 18   KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKR----LKEERTQGGELQ 73
Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAEELGWTQR 910
            F  EV+ ++   HRN+++  GFC       +VY Y+  GS+A  L     S   L W +R
Sbjct: 74   FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-PDSSNWT 969
              +  G A  L+YLH+ C P I++RD+ + N+LLD E+EA V DFG++K +   D     
Sbjct: 134  QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX 193
Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL----- 1024
             + G IG++APE   T K +EK+DV+ +GV+ LE I G+   D           L     
Sbjct: 194  AVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 1025 ----DRTLDEILDPRLPAPSCNIRDKLI-SIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                ++ L+ ++D  L     N +D+ +  +++VA+ C   +P  RP M +V ++L+
Sbjct: 254  GLLKEKKLEALVDVDLQG---NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (330), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 152/296 (51%), Gaps = 25/296 (8%)
Query: 797  AYEEIVRATNDFDEE------HCIGTGGQGSVYRAELSSGEIVAVKKFHSPL-LSEMTCQ 849
            ++ E+   TN+FDE       + +G GG G VY+  +++   VAVKK  + + ++    +
Sbjct: 16   SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELK 74
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            Q+F  E+K + + +H N+V+  GF S      +VY Y+  GSL   LS       L W  
Sbjct: 75   QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-- 967
            R  + +G A+ +++LH +     ++RDI S N+LLD  + A +SDFG++++ +  +    
Sbjct: 135  RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKG-------KHPRDFISSICST 1020
             + + GT  Y+APE A   ++T KSD+YSFGV+ LE I G       + P+  +      
Sbjct: 192  XSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    D I      A S ++     ++  VA  CL E  + RP ++KV QLL+
Sbjct: 251  EDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  131 bits (329), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 151/296 (51%), Gaps = 25/296 (8%)
Query: 797  AYEEIVRATNDFDEE------HCIGTGGQGSVYRAELSSGEIVAVKKFHSPL-LSEMTCQ 849
            ++ E+   TN+FDE       + +G GG G VY+  +++   VAVKK  + + ++    +
Sbjct: 16   SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT-TVAVKKLAAMVDITTEELK 74
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            Q+F  E+K + + +H N+V+  GF S      +VY Y+  GSL   LS       L W  
Sbjct: 75   QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-- 967
            R  + +G A+ +++LH +     ++RDI S N+LLD  + A +SDFG++++ +  +    
Sbjct: 135  RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKG-------KHPRDFISSICST 1020
               + GT  Y+APE A   ++T KSD+YSFGV+ LE I G       + P+  +      
Sbjct: 192  XXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250
Query: 1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    D I      A S ++     ++  VA  CL E  + RP ++KV QLL+
Sbjct: 251  EDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  130 bits (327), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 151/296 (51%), Gaps = 25/296 (8%)
Query: 797  AYEEIVRATNDFDEE------HCIGTGGQGSVYRAELSSGEIVAVKKFHSPL-LSEMTCQ 849
            ++ E+   TN+FDE       + +G GG G VY+  +++   VAVKK  + + ++    +
Sbjct: 10   SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELK 68
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            Q+F  E+K + + +H N+V+  GF S      +VY Y+  GSL   LS       L W  
Sbjct: 69   QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 128
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-- 967
            R  + +G A+ +++LH +     ++RDI S N+LLD  + A +SDFG++++ +  +    
Sbjct: 129  RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKG-------KHPRDFISSICST 1020
               + GT  Y+APE A   ++T KSD+YSFGV+ LE I G       + P+  +      
Sbjct: 186  XXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 244
Query: 1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    D I      A S ++     ++  VA  CL E  + RP ++KV QLL+
Sbjct: 245  EDEEKTIEDYIDKKMNDADSTSVE----AMYSVASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  130 bits (327), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 94/288 (32%), Positives = 154/288 (53%), Gaps = 20/288 (6%)
Query: 795  KIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLN 854
            ++   ++  ATN+FD +  IG G  G VY+  L  G  VA+K+  +P  S+   +     
Sbjct: 28   RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEF--ET 84
Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNV 913
            E+++L+  RH ++V   GFC       ++Y+Y+E G+L   L  +      + W QR+ +
Sbjct: 85   EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELA 972
              G A  L YLH      I++RD+ S N+LLD  +   ++DFGISK   + D ++   + 
Sbjct: 145  CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 973  -GTIGYVAPELAYTMKVTEKSDVYSFGVLALE------AIKGKHPRDFIS-SICSTSSNL 1024
             GT+GY+ PE     ++TEKSDVYSFGV+  E      AI    PR+ ++ +  +  S+ 
Sbjct: 202  KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 1025 DRTLDEILDPRLPAPSCNIR-DKLISIMEVAISCLDENPDSRPTMQKV 1071
            +  L++I+DP L   +  IR + L    + A+ CL  + + RP+M  V
Sbjct: 262  NGQLEQIVDPNL---ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  129 bits (325), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 96/290 (33%), Positives = 152/290 (52%), Gaps = 24/290 (8%)
Query: 795  KIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLN 854
            ++   ++  ATN+FD +  IG G  G VY+  L  G  VA+K+  +P  S+   +     
Sbjct: 28   RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR-RTPESSQGIEEF--ET 84
Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT-SAEELGWTQRMNV 913
            E+++L+  RH ++V   GFC       ++Y+Y+E G+L   L  +      + W QR+ +
Sbjct: 85   EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL-- 971
              G A  L YLH      I++RD+ S N+LLD  +   ++DFGISK  K      T L  
Sbjct: 145  CIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXX 199
Query: 972  --AGTIGYVAPELAYTMKVTEKSDVYSFGVLALE------AIKGKHPRDFIS-SICSTSS 1022
               GT+GY+ PE     ++TEKSDVYSFGV+  E      AI    PR+ ++ +  +  S
Sbjct: 200  VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 1023 NLDRTLDEILDPRLPAPSCNIR-DKLISIMEVAISCLDENPDSRPTMQKV 1071
            + +  L++I+DP L   +  IR + L    + A+ CL  + + RP+M  V
Sbjct: 260  HNNGQLEQIVDPNL---ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  126 bits (316), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 92/296 (31%), Positives = 146/296 (49%), Gaps = 25/296 (8%)
Query: 797  AYEEIVRATNDFDEE------HCIGTGGQGSVYRAELSSGEIVAVKKFHSPL-LSEMTCQ 849
            ++ E+   TN+FDE       +  G GG G VY+  +++   VAVKK  + + ++    +
Sbjct: 7    SFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEELK 65
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            Q+F  E+K   + +H N+V+  GF S      +VY Y   GSL   LS       L W  
Sbjct: 66   QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHX 125
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK--PDSSN 967
            R  + +G A+ +++LH +     ++RDI S N+LLD  + A +SDFG++++ +       
Sbjct: 126  RCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKG-------KHPRDFISSICST 1020
             + + GT  Y APE A   ++T KSD+YSFGV+ LE I G       + P+  +      
Sbjct: 183  XSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 241
Query: 1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    D I      A S ++     +   VA  CL E  + RP ++KV QLL+
Sbjct: 242  EDEEKTIEDYIDKKXNDADSTSVE----AXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  121 bits (304), Expect = 2e-27,   Method: Composition-based stats.
 Identities = 92/275 (33%), Positives = 138/275 (50%), Gaps = 23/275 (8%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTE 861
            D + +  IG G  G+V+RAE   G  VAVK      FH+  ++E      FL EV  +  
Sbjct: 38   DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNE------FLREVAIMKR 90
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +RH NIV F G  +   +  IV EYL  GSL  +L  + + E+L   +R+++   VA  +
Sbjct: 91   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            +YLHN   PPIV+RD+ S N+L+D +Y   V DFG+S+            AGT  ++APE
Sbjct: 151  NYLHNRN-PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE 209
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
            +       EKSDVYSFGV+  E    + P   ++     ++   +        RL  P  
Sbjct: 210  VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------KRLEIPR- 262
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            N+  ++ +I+E    C    P  RP+   +  LL+
Sbjct: 263  NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  120 bits (300), Expect = 5e-27,   Method: Composition-based stats.
 Identities = 91/275 (33%), Positives = 139/275 (50%), Gaps = 23/275 (8%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTE 861
            D + +  IG G  G+V+RAE   G  VAVK      FH+  ++E      FL EV  +  
Sbjct: 38   DLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNE------FLREVAIMKR 90
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +RH NIV F G  +   +  IV EYL  GSL  +L  + + E+L   +R+++   VA  +
Sbjct: 91   LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            +YLHN   PPIV+R++ S N+L+D +Y   V DFG+S+       +    AGT  ++APE
Sbjct: 151  NYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
            +       EKSDVYSFGV+  E    + P   ++     ++   +        RL  P  
Sbjct: 210  VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC------KRLEIPR- 262
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            N+  ++ +I+E    C    P  RP+   +  LL+
Sbjct: 263  NLNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  118 bits (296), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 107/334 (32%), Positives = 162/334 (48%), Gaps = 38/334 (11%)
Query: 36  EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCN---HAGKVNSINLTS 92
           ++  ALL+ K  L N     S+LP+    N T      W G+ C+      +VN+++L+ 
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRT------WLGVLCDTDTQTYRVNNLDLSG 59
Query: 93  AGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSS-NSFSGTIPPQ 151
             L           +P               IPS +AN   L +L +   N+  G IPP 
Sbjct: 60  LNLP--------KPYP---------------IPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 152 IGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYL 211
           I  L+ L  LY++    SG IP  +  +  L  L    N LSG++PPS+ +L NL  +  
Sbjct: 97  IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 212 YNNSLSGSIPSEIGNLKSL-SGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL 270
             N +SG+IP   G+   L + + +  N+L+G +P +  NL NLA +DL  N L G   +
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASV 215
Query: 271 SFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILY 330
            FG+  N   ++L  NSL+  +  ++G  K+L GL L  N++ G++P  L  L  L  L 
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274
Query: 331 LSDNLLFGSIPCEIGNLRYLFYLELGDNK-LSGS 363
           +S N L G IP + GNL+        +NK L GS
Sbjct: 275 VSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 88/246 (35%), Positives = 116/246 (47%), Gaps = 33/246 (13%)
Query: 316 IPSSLGNLTKLTILYLSD-NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNL 374
           IPSSL NL  L  LY+   N L G IP  I  L  L YL +    +SG+IP  L  +  L
Sbjct: 68  IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTL 127
Query: 375 ATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSG 434
            TL    N LSG++P  I                         +L N++ ++   N +SG
Sbjct: 128 VTLDFSYNALSGTLPPSI------------------------SSLPNLVGITFDGNRISG 163
Query: 435 AIPKEYGNLVKL-TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
           AIP  YG+  KL T + +S N+L G IP       LA V L RN L G+ S  FG   N 
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT 223
Query: 494 SYINLSHKKFYGEISFDWGKF---PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
             I+L+       ++FD GK     NL  LD+  N I G LP  +     L  L++S N+
Sbjct: 224 QKIHLAKN----SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNN 279
Query: 551 IVGEIP 556
           + GEIP
Sbjct: 280 LCGEIP 285

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 27/229 (11%)
Query: 525 NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
           NN+ G +PP I    QL  L ++  ++ G IP  L ++++L+ L  + N  SG LP  + 
Sbjct: 87  NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 585 SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYY-LNLSNNQFSGEIPIKLEKFIHLSDLDLS 643
           SL  L  +    NR+S +IP S G+  KL+  + +S N+ +G+IP      ++L+ +DLS
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LNLAFVDLS 205
Query: 644 HNFLGEEIPSQVCSMQSLEKLNLAHNNLS-----------------------GFIPRCFK 680
            N L  +      S ++ +K++LA N+L+                       G +P+   
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 681 EMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSC 729
           ++  L  +++S+N L G IP     +   + A   NK LCG     P+C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  101 bits (251), Expect = 3e-21,   Method: Composition-based stats.
 Identities = 83/269 (30%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  TEL GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 5e-21,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  T+L GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 5e-21,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  T+L GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 67   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  T+L GT+ Y+ PE+
Sbjct: 124  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 178
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 179  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 234
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 235  -RD-LISRL------LKHNPSQRPMLREV 255

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 99.8 bits (247), Expect = 7e-21,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 126  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 181  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 236
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 237  -RD-LISRL------LKHNPSQRPMLREV 257

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-21,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 131/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  T+L GT+ Y+ PE+
Sbjct: 128  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEM 182
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 183  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 238
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 239  -RD-LISRL------LKHNPSQRPMLREV 259

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 99.8 bits (247), Expect = 8e-21,   Method: Composition-based stats.
 Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 26/262 (9%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G+G  G V   +      VAVK      +SE     EF  E +++ ++ H  +VKFYG 
Sbjct: 16   LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            CS     +IV EY+  G L   L   +  + L  +Q + +   V + +++L +  F   +
Sbjct: 72   CSKEYPIYIVTEYISNGCLLNYLR--SHGKGLEPSQLLEMCYDVCEGMAFLESHQF---I 126
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L+D +    VSDFG+++ +  D   +    GT   + + APE+ +  K + 
Sbjct: 127  HRDLAARNCLVDRDLCVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSDV++FG+L  E    GK P D         +N +  L      RL  P     D +  
Sbjct: 185  KSDVWAFGILMWEVFSLGKMPYDLY-------TNSEVVLKVSQGHRLYRPHL-ASDTIYQ 236
Query: 1050 IMEVAISCLDENPDSRPTMQKV 1071
            IM    SC  E P+ RPT Q++
Sbjct: 237  IM---YSCWHELPEKRPTFQQL 255

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-21,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTXLCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 5    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 65   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 121
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 122  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 176
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 177  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 232
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 233  -RD-LISRL------LKHNPSQRPMLREV 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 10   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 70   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 126
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 127  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 181
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 182  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 237
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 238  -RD-LISRL------LKHNPSQRPMLREV 258

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 128  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 182
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 183  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 238
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 239  -RD-LISRL------LKHNPSQRPMLREV 259

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 126  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 181  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 236
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 237  -RD-LISRL------LKHNPSQRPMLREV 257

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 23   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 82
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 83   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 139
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 140  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 194
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 195  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 250
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 251  -RD-LISRL------LKHNPSQRPMLREV 271

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 68/263 (25%), Positives = 123/263 (46%), Gaps = 33/263 (12%)
Query: 829  SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            +GE++ +K+    +  +   Q+ FL EVK +  + H N++KF G     +    + EY++
Sbjct: 34   TGEVMVMKEL---IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90
Query: 889  MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY 948
             G+L  I+ +  S  +  W+QR++  K +A  ++YLH+     I++RD++S N L+    
Sbjct: 91   GGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENK 145
Query: 949  EAHVSDFGISKSL--------------KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDV 994
               V+DFG+++ +              KPD      + G   ++APE+       EK DV
Sbjct: 146  NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDV 205
Query: 995  YSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEV 1053
            +SFG++  E I +     D++        N+   LD    P  P           S   +
Sbjct: 206  FSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP----------SFFPI 255
Query: 1054 AISCLDENPDSRPTMQKVSQLLK 1076
             + C D +P+ RP+  K+   L+
Sbjct: 256  TVRCCDLDPEKRPSFVKLEHWLE 278

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 67   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S    SS  T L+GT+ Y+ PE+
Sbjct: 124  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SCHAPSSRRTTLSGTLDYLPPEM 178
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 179  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 234
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 235  -RD-LISRL------LKHNPSQRPMLREV 255

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 32   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 92   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 148
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+
Sbjct: 149  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEM 203
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 204  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 259
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 260  -RD-LISRL------LKHNPSQRPMLREV 280

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 127
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE 
Sbjct: 128  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEX 182
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 183  IEGRXHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 238
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 239  -RD-LISRL------LKHNPSQRPXLREV 259

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 97.8 bits (242), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E     I+A+K      L +   + +   EV+  + +
Sbjct: 3    ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 63   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 119
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  T L GT+ Y+ PE+
Sbjct: 120  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 174
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 175  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 230
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 231  -RD-LISRL------LKHNPSQRPMLREV 251

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 126  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 181  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 236
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 237  -RD-LISRL------LKHNPSQRPMLREV 257

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS   +L GT+ Y+ PE+
Sbjct: 126  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEM 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 181  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 236
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 237  -RD-LISRL------LKHNPSQRPMLREV 257

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 97.4 bits (241), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 123  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 82/269 (30%), Positives = 128/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY   G +   L   +  +E    +    I  +A+ALS
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANALS 127
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG S  +   SS  T L GT+ Y+ PE+
Sbjct: 128  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 182
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 183  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 238
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 239  -RD-LISRL------LKHNPSQRPMLREV 259

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 97.1 bits (240), Expect = 5e-20,   Method: Composition-based stats.
 Identities = 83/290 (28%), Positives = 140/290 (48%), Gaps = 51/290 (17%)
Query: 814  IGTGGQGSVYRAE---LSSGE---IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE   LS  +   +VAVK    P L+    +++F  E + LT ++H +I
Sbjct: 23   LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHI 79
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNATSAE---ELGWTQRMNVI 914
            VKFYG C       +V+EY++ G L          AMIL +    +   ELG +Q +++ 
Sbjct: 80   VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG- 973
              +A  + YL +  F   V+RD++++N L+       + DFG+S+ +   S+++  + G 
Sbjct: 140  SQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMSRDVY--STDYYRVGGH 194
Query: 974  ---TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSI----CSTSSNLD 1025
                I ++ PE     K T +SDV+SFGV+  E    GK P   +S+     C T     
Sbjct: 195  TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG--- 251
Query: 1026 RTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            R L+    PR+  P          + +V + C    P  R  ++++ ++L
Sbjct: 252  RVLER---PRV-CPK--------EVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 126  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEM 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 181  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 236
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 237  -RD-LISRL------LKHNPSQRPMLREV 257

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 9    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 69   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 125
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  +++FG   S+   SS  T L GT+ Y+ PE+
Sbjct: 126  YCHSK---RVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEM 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 181  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 236
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 237  -RD-LISRL------LKHNPSQRPMLREV 257

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 8    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 68   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 124
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 125  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLCGTLDYLPPEM 179
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 180  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 235
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 236  -RD-LISRL------LKHNPSQRPMLREV 256

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 8    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 68   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 124
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  +++FG   S+   SS  T L GT+ Y+ PE+
Sbjct: 125  YCHSK---RVIHRDIKPENLLLGSAGELKIANFGW--SVHAPSSRRTTLCGTLDYLPPEM 179
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 180  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 235
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 236  -RD-LISRL------LKHNPSQRPMLREV 256

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 32   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 92   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 148
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS   +L GT+ Y+ PE+
Sbjct: 149  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDDLCGTLDYLPPEM 203
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 204  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 259
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 260  -RD-LISRL------LKHNPSQRPMLREV 280

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-20,   Method: Composition-based stats.
 Identities = 66/205 (32%), Positives = 105/205 (51%), Gaps = 9/205 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DFD    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +RH 
Sbjct: 13   DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALSY H
Sbjct: 73   NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYCH 129
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RDI  +N+LL    E  ++DFG   S+   SS  T L GT+ Y+ PE+   
Sbjct: 130  SK---RVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRTTLCGTLDYLPPEMIEG 184
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
                EK D++S GVL  E + G  P
Sbjct: 185  RMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 7e-20,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 129/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 7    ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 67   RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 123
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 124  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEM 178
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 179  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 234
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 235  -RD-LISRL------LKHNPSQRPMLREV 255

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-20,   Method: Composition-based stats.
 Identities = 80/269 (29%), Positives = 130/269 (48%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E +S  I+A+K      L +   + +   EV+  + +
Sbjct: 6    ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   +   +++ EY  +G++   L   +  +E    +    I  +A+ALS
Sbjct: 66   RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALS 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 123  YCHSK---KVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRAALCGTLDYLPPEM 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 178  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQDTYKRISRV--EFTFPDFVTEGA- 233
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 234  -RD-LISRL------LKHNPSQRPMLREV 254

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 96.3 bits (238), Expect = 9e-20,   Method: Composition-based stats.
 Identities = 58/198 (29%), Positives = 108/198 (54%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 85   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---QV 137
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  +E+ GT  ++APE+        K 
Sbjct: 138  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKV 197
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E I+G+ P
Sbjct: 198  DIWSLGIMAIEMIEGEPP 215

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 94.7 bits (234), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 21/269 (7%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A  DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +
Sbjct: 11   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            RH NI++ YG+   A   +++ EY   G +   L   +  +E    +    I  +A+ALS
Sbjct: 71   RHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDE---QRTATYITELANALS 127
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y H+     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+
Sbjct: 128  YCHSK---RVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRXXLXGTLDYLPPEM 182
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                   EK D++S GVL  E + GK P +  ++   T   + R   E   P        
Sbjct: 183  IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV--EFTFPDFVTEGA- 238
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             RD LIS +      L  NP  RP +++V
Sbjct: 239  -RD-LISRL------LKHNPSQRPMLREV 259

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 23   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 79   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 133
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 134  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 192  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 243
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 244  IM---YSCWHEKADERPTFK 260

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 16   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 72   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 126
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 127  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 185  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 236
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 237  IM---YSCWHEKADERPTFK 253

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 73   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 127
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 128  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 186  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 237
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 238  IM---YSCWHEKADERPTFK 254

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 88   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 142
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 143  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 201  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 252
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 253  IM---YSCWHEKADERPTFK 269

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 12   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 68   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 122
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 123  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 181  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 232
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 233  IM---YSCWHEKADERPTFK 249

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 65/205 (31%), Positives = 104/205 (50%), Gaps = 9/205 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DFD    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +RH 
Sbjct: 13   DFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHP 72
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALSY H
Sbjct: 73   NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDE---QRTATYITELANALSYCH 129
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RDI  +N+LL    E  ++DFG   S+   SS    L GT+ Y+ PE+   
Sbjct: 130  SK---RVIHRDIKPENLLLGSNGELKIADFGW--SVHAPSSRRDTLCGTLDYLPPEMIEG 184
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
                EK D++S GVL  E + G  P
Sbjct: 185  RMHDEKVDLWSLGVLCYEFLVGMPP 209

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Composition-based stats.
 Identities = 79/271 (29%), Positives = 134/271 (49%), Gaps = 28/271 (10%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            FD    +G G  GSVY+A    +G+IVA+K+   P+ S++   QE + E+  + +    +
Sbjct: 31   FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMI--LSNATSAEELGWTQRMNVIKGVADALSYL 924
            +VK+YG        +IV EY   GS++ I  L N T  E+   T   + +KG    L YL
Sbjct: 86   VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKG----LEYL 141
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H   F   ++RDI + N+LL+ E  A ++DFG++  L    +    + GT  ++APE+  
Sbjct: 142  H---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
             +     +D++S G+ A+E  +GK P   I  + +            + P  P P+   +
Sbjct: 199  EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI----------FMIPTNPPPTFR-K 247
Query: 1045 DKLIS--IMEVAISCLDENPDSRPTMQKVSQ 1073
             +L S    +    CL ++P+ R T  ++ Q
Sbjct: 248  PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 17   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 73   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 127
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + +  PE+    K + 
Sbjct: 128  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 186  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 237
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 238  IM---YSCWHEKADERPTFK 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Composition-based stats.
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 29   IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 86   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---QV 138
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 139  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 198
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E I+G+ P
Sbjct: 199  DIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-19,   Method: Composition-based stats.
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 85   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---QV 137
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 138  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKV 197
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E I+G+ P
Sbjct: 198  DIWSLGIMAIEMIEGEPP 215

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-19,   Method: Composition-based stats.
 Identities = 57/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 28   IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 85   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---QV 137
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 138  IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 197
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E I+G+ P
Sbjct: 198  DIWSLGIMAIEMIEGEPP 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 6e-19,   Method: Composition-based stats.
 Identities = 75/260 (28%), Positives = 125/260 (48%), Gaps = 26/260 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GTG  G V   +      VA+K      +SE     EF+ E K +  + H  +V+ YG 
Sbjct: 32   LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGV 87
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
            C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL +  F   +
Sbjct: 88   CTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQF---L 142
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD++++N L++ +    VSDFG+S+ +  D    T   G+   + +  PE+    K + 
Sbjct: 143  HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE--TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSD+++FGVL  E    GK P +  ++   T+ ++ + L  +  P L +      +K+ +
Sbjct: 201  KSDIWAFGVLMWEIYSLGKMPYERFTN-SETAEHIAQGL-RLYRPHLAS------EKVYT 252
Query: 1050 IMEVAISCLDENPDSRPTMQ 1069
            IM    SC  E  D RPT +
Sbjct: 253  IM---YSCWHEKADERPTFK 269

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-19,   Method: Composition-based stats.
 Identities = 86/302 (28%), Positives = 137/302 (45%), Gaps = 49/302 (16%)
Query: 798  YEEIVRATNDFDEE---------HCIGTGGQGSVYRAELS-SGE---IVAVKKFHSPLLS 844
            YEE  RA   F  E           IG+G  G V    L   G+    VA+K   +    
Sbjct: 32   YEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 845  EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE 904
                +++FL+E   + +  H NI++  G  +  R + IV EY+E GSL   L   T   +
Sbjct: 92   RQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQ 147
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
                Q + +++GV   + YL +  +   V+RD++++NVL+D      VSDFG+S+ L+ D
Sbjct: 148  FTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 965  -SSNWTELAGTIG--YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFI 1014
              + +T   G I   + APE       +  SDV+SFGV+  E +  G+ P      RD I
Sbjct: 205  PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 1015 SSICSTSSNLDRTLDEILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            SS+                 RLPAP  C       ++ ++ + C  ++   RP   ++  
Sbjct: 265  SSVEEGY-------------RLPAPMGCP-----HALHQLMLDCWHKDRAQRPRFSQIVS 306
Query: 1074 LL 1075
            +L
Sbjct: 307  VL 308

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-18,   Method: Composition-based stats.
 Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 29/275 (10%)
Query: 811  EHCIGTGGQGSVYRAEL--SSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +  IG G  G VY+  L  SSG+    VA+K   +    +   + +FL E   + +  H 
Sbjct: 49   QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQFSHH 106
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI++  G  S  +   I+ EY+E G+L   L       E    Q + +++G+A  + YL 
Sbjct: 107  NIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLA 164
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPEL 982
            N  +   V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G I   + APE 
Sbjct: 165  NMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 983  AYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPS 1040
                K T  SDV+SFG++  E +  G+ P   +S+           +  I D  RLP P 
Sbjct: 222  ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAINDGFRLPTP- 272
Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                D   +I ++ + C  +    RP    +  +L
Sbjct: 273  ---MDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.0 bits (227), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 49/302 (16%)
Query: 798  YEEIVRATNDFDEE---------HCIGTGGQGSVYRAELS-SGE---IVAVKKFHSPLLS 844
            YEE  RA   F  E           IG+G  G V    L   G+    VA+K   +    
Sbjct: 32   YEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91
Query: 845  EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE 904
                +++FL+E   + +  H NI++  G  +  R + IV EY+E GSL   L   T   +
Sbjct: 92   RQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR--THDGQ 147
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
                Q + +++GV   + YL +  +   V+RD++++NVL+D      VSDFG+S+ L+ D
Sbjct: 148  FTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204
Query: 965  SSNWTELAG---TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFI 1014
                    G    I + APE       +  SDV+SFGV+  E +  G+ P      RD I
Sbjct: 205  PDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264
Query: 1015 SSICSTSSNLDRTLDEILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            SS+                 RLPAP  C       ++ ++ + C  ++   RP   ++  
Sbjct: 265  SSVEEGY-------------RLPAPMGCP-----HALHQLMLDCWHKDRAQRPRFSQIVS 306
Query: 1074 LL 1075
            +L
Sbjct: 307  VL 308

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Composition-based stats.
 Identities = 56/198 (28%), Positives = 107/198 (54%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E ++ NIV +  
Sbjct: 29   IGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLD 85
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EYL  GSL  +++     E     Q   V +    AL +LH++    +
Sbjct: 86   SYLVGDELWVVMEYLAGGSLTDVVTETCMDE----GQIAAVCRECLQALEFLHSN---QV 138
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++R+I S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+        K 
Sbjct: 139  IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKV 198
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++A+E I+G+ P
Sbjct: 199  DIWSLGIMAIEMIEGEPP 216

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 147/302 (48%), Gaps = 35/302 (11%)
Query: 791  TFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKK 837
            TF     YE+  +  ++F +E           +G G  G V    L   S  EI VA+K 
Sbjct: 21   TFVDPHTYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 838  FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
                   +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L 
Sbjct: 81   LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
               +  +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+
Sbjct: 139  KHDA--QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 958  SKSLKPD-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013
            S+ L+ D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   
Sbjct: 194  SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +S     + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  
Sbjct: 254  MS-----NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 1074 LL 1075
            +L
Sbjct: 303  IL 304

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 147/302 (48%), Gaps = 35/302 (11%)
Query: 791  TFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKK 837
            TF     +E+  +  ++F +E           +G G  G V    L   S  EI VA+K 
Sbjct: 21   TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 838  FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
                   +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L 
Sbjct: 81   LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
               +  +    Q + +++G+A  + YL +  F   V+RD++++N+L++      VSDFG+
Sbjct: 139  KHDA--QFTVIQLVGMLRGIASGMKYLSDMGF---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 958  SKSLKPD-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013
            S+ L+ D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   
Sbjct: 194  SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +S     + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  
Sbjct: 254  MS-----NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 1074 LL 1075
            +L
Sbjct: 303  IL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 145/296 (48%), Gaps = 35/296 (11%)
Query: 797  AYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLL 843
             YE+  +  ++F +E           +G G  G V    L   S  EI VA+K       
Sbjct: 27   TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 844  SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE 903
             +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L    +  
Sbjct: 87   EKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-- 142
Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
            +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+S+ L+ 
Sbjct: 143  QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 964  D-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
            D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   +S    
Sbjct: 200  DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---- 255
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 256  -NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 91.3 bits (225), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/296 (25%), Positives = 145/296 (48%), Gaps = 35/296 (11%)
Query: 797  AYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLL 843
             YE+  +  ++F +E           +G G  G V    L   S  EI VA+K       
Sbjct: 25   TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 844  SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE 903
             +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L    +  
Sbjct: 85   EKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-- 140
Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
            +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+S+ L+ 
Sbjct: 141  QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLED 197
Query: 964  D-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
            D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   +S    
Sbjct: 198  DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---- 253
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 254  -NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-18,   Method: Composition-based stats.
 Identities = 79/284 (27%), Positives = 136/284 (47%), Gaps = 41/284 (14%)
Query: 811  EHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V R  L +       VA+K            ++EFL+E   + +  H N
Sbjct: 21   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ--RREFLSEASIMGQFEHPN 78
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I++  G  +++    I+ E++E G+L   L    +  +    Q + +++G+A  + YL  
Sbjct: 79   IIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAE 136
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE---LAGTIG--YVAPE 981
              +   V+RD++++N+L++      VSDFG+S+ L+ +SS+ TE   L G I   + APE
Sbjct: 137  MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPE 193
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDP 1034
                 K T  SD +S+G++  E +  G+ P      +D I++I               D 
Sbjct: 194  AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-------------DY 240
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTM-QKVSQLLKI 1077
            RLP P     D   S+ ++ + C  ++ ++RP   Q VS L K+
Sbjct: 241  RLPPPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 85/291 (29%), Positives = 139/291 (47%), Gaps = 30/291 (10%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTC 848
            L F     Y++      D   +H +G G  G VY        + VAVK      L E T 
Sbjct: 10   LYFQGSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTM 64
Query: 849  Q-QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
            + +EFL E   + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+  
Sbjct: 65   EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNA 123
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
               + +   ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  
Sbjct: 124  VVLLYMATQISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-- 178
Query: 968  WTELAGT---IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSS 1022
            +T  AG    I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S
Sbjct: 179  YTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LS 232
Query: 1023 NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
             +   L++  D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  QVYELLEK--DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 277

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Composition-based stats.
 Identities = 73/267 (27%), Positives = 130/267 (48%), Gaps = 28/267 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 32   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 88
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S A    IV ++ E  SL   L  + +  E+   + +++ +  A  + YLH      I+
Sbjct: 89   -STAPQLAIVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAK---SII 142
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPE---LAYTMKV 988
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE   +  +   
Sbjct: 143  HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 989  TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSCNIR 1044
            + +SDVY+FG++  E + G+ P        S  +N D+ ++ +    L P L     N  
Sbjct: 203  SFQSDVYAFGIVLYELMTGQLPY-------SNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKV 1071
             ++  +M     CL +  D RP+  ++
Sbjct: 256  KRMKRLMA---ECLKKKRDERPSFPRI 279

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 90.5 bits (223), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 134/275 (48%), Gaps = 28/275 (10%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELSSGE-IVAVKKF---HSPLLSEMTCQ-QEFLNEVKS 858
            A N+ + E  IG GG G V++  L   + +VA+K      S   +EM  + QEF  EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            ++ + H NIVK YG   +     +V E++  G L   L +   A  + W+ ++ ++  +A
Sbjct: 77   MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYE-----AHVSDFGISKSLKPDSSNWTELAG 973
              + Y+ N   PPIV+RD+ S N+ L    E     A V+DFG+S+       + + L G
Sbjct: 133  LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---SVHSVSGLLG 188
Query: 974  TIGYVAPEL--AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               ++APE   A     TEK+D YSF ++    + G+ P D  S       N+ R  +E 
Sbjct: 189  NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--EEG 246
Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            L P +P   C  R  L +++E+   C   +P  RP
Sbjct: 247  LRPTIPE-DCPPR--LRNVIEL---CWSGDPKKRP 275

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 137/273 (50%), Gaps = 26/273 (9%)
Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +  +G G  G V    L   S  EI VA+K        +   +++FL E   + +  H N
Sbjct: 38   DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLGEASIMGQFDHPN 95
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I++  G  + ++   IV EY+E GSL   L    +  +    Q + +++G+A  + YL +
Sbjct: 96   IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 153
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGT--IGYVAPELA 983
              +   V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G   I + +PE  
Sbjct: 154  MGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               K T  SDV+S+G++  E +  G+ P   +S     + ++ + +DE    RLP P   
Sbjct: 211  AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIKAVDEGY--RLPPPM-- 261
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              D   ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 262  --DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 59
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 60   AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 118
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 119  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 174  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 227
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 228  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 59
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 60   AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 118
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 119  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 174  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 227
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 228  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 10   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 64
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 65   AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 123
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 124  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 179  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 232
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 59
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 60   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 118
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 119  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 174  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 227
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 228  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 59
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 60   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 118
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 119  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 174  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 227
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 228  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 10   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 64
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 65   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 123
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 124  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 179  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 232
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 82/274 (29%), Positives = 134/274 (48%), Gaps = 30/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRH 864
            D   +H +G G  G VY        + VAVK      L E T + +EFL E   + EI+H
Sbjct: 12   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIKH 66
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             N+V+  G C+     +I+ E++  G+L   L    + +E+     + +   ++ A+ YL
Sbjct: 67   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 125
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPE 981
                F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG    I + APE
Sbjct: 126  EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--FTAHAGAKFPIKWTAPE 180
Query: 982  -LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
             LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++  D R+  P
Sbjct: 181  SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----PSQVYELLEK--DYRMERP 232
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                 +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  E-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 10   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 64
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 65   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 123
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 124  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 179  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 232
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 10   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 64
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 65   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 123
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 124  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 178
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 179  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 232
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 59
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 60   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 118
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 119  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 174  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 227
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 228  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 9    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 63
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 64   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 122
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 123  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 177
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 178  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 231
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 232  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 268

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 5    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 59
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 60   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 118
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 119  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 173
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 174  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 227
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 228  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 7    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 61
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 62   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 120
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 121  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 175
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 176  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 229
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 230  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 7    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 61
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 62   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 120
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 121  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 175
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 176  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 229
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 230  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 6    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 60
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 61   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 119
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 120  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAK 174
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 175  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 228
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 229  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 265

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-18,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 7    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 61
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 62   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 120
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 121  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAPAGAK 175
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 176  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 229
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 230  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 266

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/302 (25%), Positives = 147/302 (48%), Gaps = 35/302 (11%)
Query: 791  TFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKK 837
            TF     +E+  +  ++F +E           +G G  G V    L   S  EI VA+K 
Sbjct: 21   TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 838  FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
                   +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L 
Sbjct: 81   LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
               +  +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+
Sbjct: 139  KHDA--QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 958  SKSLKPD-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013
            S+ L+ D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   
Sbjct: 194  SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +S     + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  
Sbjct: 254  MS-----NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 1074 LL 1075
            +L
Sbjct: 303  IL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 137/273 (50%), Gaps = 26/273 (9%)
Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +  +G G  G V    L   S  EI VA+K        +   +++FL E   + +  H N
Sbjct: 50   DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLGEASIMGQFDHPN 107
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I++  G  + ++   IV EY+E GSL   L    +  +    Q + +++G+A  + YL +
Sbjct: 108  IIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSD 165
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGT--IGYVAPELA 983
              +   V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G   I + +PE  
Sbjct: 166  MGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               K T  SDV+S+G++  E +  G+ P   +S     + ++ + +DE    RLP P   
Sbjct: 223  AYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIKAVDEGY--RLPPPM-- 273
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              D   ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 274  --DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 118/276 (42%), Gaps = 27/276 (9%)
Query: 807  DFDE---EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            DF E   E  IG GG G VYRA     E+      H P        +    E K    ++
Sbjct: 5    DFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NI+   G C    +  +V E+   G L  +LS      ++     +N    +A  ++Y
Sbjct: 65   HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDI----LVNWAVQIARGMNY 120
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYE--------AHVSDFGISKSLKPDSSNWTELAGTI 975
            LH++   PI++RD+ S N+L+  + E          ++DFG+++     +      AG  
Sbjct: 121  LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAY 178
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
             ++APE+      ++ SDV+S+GVL  E + G+ P   I  +          L       
Sbjct: 179  AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------A 232
Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            LP PS    +    +ME    C + +P SRP+   +
Sbjct: 233  LPIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNI 264

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 72/270 (26%), Positives = 136/270 (50%), Gaps = 26/270 (9%)
Query: 814  IGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V    L   S  EI VA+K        +   +++FL E   + +  H NI++
Sbjct: 24   VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLGEASIMGQFDHPNIIR 81
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
              G  + ++   IV EY+E GSL   L    +  +    Q + +++G+A  + YL +  +
Sbjct: 82   LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPELAYTM 986
               V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G I   + +PE     
Sbjct: 140  ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
            K T  SDV+S+G++  E +  G+ P   +S     + ++ + +DE    RLP P     D
Sbjct: 197  KFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIKAVDE--GYRLPPP----MD 245
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 246  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-18,   Method: Composition-based stats.
 Identities = 82/274 (29%), Positives = 133/274 (48%), Gaps = 30/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRH 864
            D   +H +G G  G VY        + VAVK      L E T + +EFL E   + EI+H
Sbjct: 12   DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIKH 66
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             N+V+  G C+     +I+ E++  G+L   L    + +E+     + +   ++ A+ YL
Sbjct: 67   PNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 125
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPE 981
                F   ++RD++++N L+   +   V+DFG+S+ +  D+   T  AG    I + APE
Sbjct: 126  EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 180
Query: 982  -LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
             LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++  D R+  P
Sbjct: 181  SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----PSQVYELLEK--DYRMERP 232
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                 +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  E-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 133/275 (48%), Gaps = 28/275 (10%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELSSGE-IVAVKKF---HSPLLSEMTCQ-QEFLNEVKS 858
            A N+ + E  IG GG G V++  L   + +VA+K      S   +EM  + QEF  EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            ++ + H NIVK YG   +     +V E++  G L   L +   A  + W+ ++ ++  +A
Sbjct: 77   MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYE-----AHVSDFGISKSLKPDSSNWTELAG 973
              + Y+ N   PPIV+RD+ S N+ L    E     A V+DFG S+       + + L G
Sbjct: 133  LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ---SVHSVSGLLG 188
Query: 974  TIGYVAPEL--AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               ++APE   A     TEK+D YSF ++    + G+ P D  S       N+ R  +E 
Sbjct: 189  NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--EEG 246
Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            L P +P   C  R  L +++E+   C   +P  RP
Sbjct: 247  LRPTIPE-DCPPR--LRNVIEL---CWSGDPKKRP 275

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 147/302 (48%), Gaps = 35/302 (11%)
Query: 791  TFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKK 837
            TF     +E+  +  ++F +E           +G G  G V    L   S  EI VA+K 
Sbjct: 21   TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 838  FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
                   +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L 
Sbjct: 81   LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
               +  +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+
Sbjct: 139  KHDA--QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 958  SKSLKPD-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013
            ++ L+ D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   
Sbjct: 194  ARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +S     + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  
Sbjct: 254  MS-----NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 1074 LL 1075
            +L
Sbjct: 303  IL 304

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 78/284 (27%), Positives = 135/284 (47%), Gaps = 41/284 (14%)
Query: 811  EHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V R  L +       VA+K            ++EFL+E   + +  H N
Sbjct: 19   EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ--RREFLSEASIMGQFEHPN 76
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I++  G  +++    I+ E++E G+L   L    +  +    Q + +++G+A  + YL  
Sbjct: 77   IIRLEGVVTNSMPVMILTEFMENGALDSFLR--LNDGQFTVIQLVGMLRGIASGMRYLAE 134
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIG--YVAPE 981
              +   V+RD++++N+L++      VSDFG+S+ L+ +SS+ T    L G I   + APE
Sbjct: 135  MSY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDP 1034
                 K T  SD +S+G++  E +  G+ P      +D I++I               D 
Sbjct: 192  AIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ-------------DY 238
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTM-QKVSQLLKI 1077
            RLP P     D   S+ ++ + C  ++ ++RP   Q VS L K+
Sbjct: 239  RLPPPP----DCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 159  IGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 215
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 216  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQG---V 268
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 269  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 329  DIWSLGIMVIEMVDGEPP 346

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 89.4 bits (220), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 6    YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 60
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 61   AAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 119
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+   T  AG  
Sbjct: 120  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAK 174
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 175  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 228
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 229  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 265

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 83/283 (29%), Positives = 136/283 (48%), Gaps = 30/283 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 10   YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKE 64
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 65   AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVNAVVLLYMAT 123
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D+   T  AG  
Sbjct: 124  QISSAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAK 178
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 179  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 232
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 269

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Composition-based stats.
 Identities = 82/274 (29%), Positives = 133/274 (48%), Gaps = 30/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRH 864
            D   +H +G G  G VY        + VAVK      L E T + +EFL E   + EI+H
Sbjct: 12   DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIKH 66
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             N+V+  G C+     +I+ E++  G+L   L    + +E+     + +   ++ A+ YL
Sbjct: 67   PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL 125
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPE 981
                F   ++RD++++N L+   +   V+DFG+S+ +  D+   T  AG    I + APE
Sbjct: 126  EKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTX--TAHAGAKFPIKWTAPE 180
Query: 982  -LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
             LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++  D R+  P
Sbjct: 181  SLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----PSQVYELLEK--DYRMERP 232
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                 +K+  +M    +C   NP  RP+  ++ Q
Sbjct: 233  E-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQ 262

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 89.0 bits (219), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 146/302 (48%), Gaps = 35/302 (11%)
Query: 791  TFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKK 837
            TF     +E+  +  ++F +E           +G G  G V    L   S  EI VA+K 
Sbjct: 21   TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 838  FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
                   +   +++FL E   + +  H NI++  G  + ++   IV EY+E GSL   L 
Sbjct: 81   LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
               +  +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+
Sbjct: 139  KHDA--QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGL 193
Query: 958  SKSLKPD-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013
             + L+ D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   
Sbjct: 194  GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +S     + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  
Sbjct: 254  MS-----NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 1074 LL 1075
            +L
Sbjct: 303  IL 304

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 136/286 (47%), Gaps = 30/286 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 251  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-----TLKEDTMEVEEFLKE 305
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L      +E+     + +  
Sbjct: 306  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMAT 364
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++R+++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 365  QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 419
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I  +      L++    
Sbjct: 420  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEK---- 473
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q  +
Sbjct: 474  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 513

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 30/286 (10%)
Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNE 855
            Y++      D   +H +G G  G VY        + VAVK      L E T + +EFL E
Sbjct: 212  YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK-----TLKEDTMEVEEFLKE 266
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +  
Sbjct: 267  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMAT 325
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             ++ A+ YL    F   ++R+++++N L+   +   V+DFG+S+ +  D+  +T  AG  
Sbjct: 326  QISSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAK 380
Query: 975  --IGYVAPE-LAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDE 1030
              I + APE LAY  K + KSDV++FGVL  E A  G  P   I       S +   L++
Sbjct: 381  FPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEK 434
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              D R+  P     +K+  +M    +C   NP  RP+  ++ Q  +
Sbjct: 435  --DYRMERPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 474

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 130/267 (48%), Gaps = 28/267 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 20   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 76
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L  + +  E+   + +++ +  A  + YLH      I+
Sbjct: 77   STKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 130
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMK---V 988
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+         
Sbjct: 131  HRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 190
Query: 989  TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSCNIR 1044
            + +SDVY+FG++  E + G+ P        S  +N D+ ++ +    L P L     N  
Sbjct: 191  SFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 243
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKV 1071
             ++  +M     CL +  D RP+  ++
Sbjct: 244  KRMKRLM---AECLKKKRDERPSFPRI 267

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/296 (25%), Positives = 144/296 (48%), Gaps = 35/296 (11%)
Query: 797  AYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLL 843
             YE+  +  ++F +E           +G G  G V    L   S  EI VA+K       
Sbjct: 27   TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 844  SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE 903
             +   +++FL E   + +  H NI++  G  + ++   IV E +E GSL   L    +  
Sbjct: 87   EKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA-- 142
Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
            +    Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+S+ L+ 
Sbjct: 143  QFTVIQLVGMLRGIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLED 199
Query: 964  D-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
            D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   +S    
Sbjct: 200  DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS---- 255
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 256  -NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 133/275 (48%), Gaps = 28/275 (10%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELSSGE-IVAVKKF---HSPLLSEMTCQ-QEFLNEVKS 858
            A N+ + E  IG GG G V++  L   + +VA+K      S   +EM  + QEF  EV  
Sbjct: 17   ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            ++ + H NIVK YG   +     +V E++  G L   L +   A  + W+ ++ ++  +A
Sbjct: 77   MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIA 132
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYE-----AHVSDFGISKSLKPDSSNWTELAG 973
              + Y+ N   PPIV+RD+ S N+ L    E     A V+DF +S+       + + L G
Sbjct: 133  LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ---SVHSVSGLLG 188
Query: 974  TIGYVAPEL--AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               ++APE   A     TEK+D YSF ++    + G+ P D  S       N+ R  +E 
Sbjct: 189  NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR--EEG 246
Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            L P +P   C  R  L +++E+   C   +P  RP
Sbjct: 247  LRPTIPE-DCPPR--LRNVIEL---CWSGDPKKRP 275

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 130/267 (48%), Gaps = 28/267 (10%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 32   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 88
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L  + +  E+   + +++ +  A  + YLH      I+
Sbjct: 89   STKPQLA-IVTQWCEGSSLYHHLHASETKFEM--KKLIDIARQTARGMDYLHAKS---II 142
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMK---V 988
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+         
Sbjct: 143  HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 989  TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSCNIR 1044
            + +SDVY+FG++  E + G+ P        S  +N D+ ++ +    L P L     N  
Sbjct: 203  SFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKV 1071
             ++  +M     CL +  D RP+  ++
Sbjct: 256  KRMKRLM---AECLKKKRDERPSFPRI 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-17,   Method: Composition-based stats.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 37   IGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 94   SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ---GV 146
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 147  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 207  DIWSLGIMVIEMVDGEPP 224

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 76/295 (25%), Positives = 142/295 (48%), Gaps = 35/295 (11%)
Query: 798  YEEIVRATNDFDEE---------HCIGTGGQGSVYRAELS---SGEI-VAVKKFHSPLLS 844
            YE+  +A ++F +E           IG G  G V    L      E+ VA+K        
Sbjct: 5    YEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTE 64
Query: 845  EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE 904
            +   +++FL E   + +  H NI+   G  + ++   IV EY+E GSL   L       +
Sbjct: 65   KQ--RRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDG--Q 120
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
                Q + +++G++  + YL +  +   V+RD++++N+L++      VSDFG+S+ L+ D
Sbjct: 121  FTVIQLVGMLRGISAGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 965  -SSNWTELAGTIG--YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICST 1020
              + +T   G I   + APE     K T  SDV+S+G++  E +  G+ P   +     T
Sbjct: 178  PEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM-----T 232
Query: 1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            + ++ + ++E    RLP+P     D   ++ ++ + C  +  +SRP   ++  +L
Sbjct: 233  NQDVIKAVEE--GYRLPSP----MDCPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A E  +G+ VAVKK     L +   ++   NEV  + +  H N+V  Y 
Sbjct: 53   IGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALSYLHN     +
Sbjct: 110  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIATVCLSVLRALSYLHNQ---GV 162
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APE+   +    + 
Sbjct: 163  IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E I G+ P
Sbjct: 223  DIWSLGIMVIEMIDGEPP 240

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 82   IGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 139  SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ---GV 191
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 192  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 252  DIWSLGIMVIEMVDGEPP 269

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 28   IGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 85   SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ---GV 137
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 138  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 198  DIWSLGIMVIEMVDGEPP 215

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 32   IGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 89   SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ---GV 141
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 142  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 202  DIWSLGIMVIEMVDGEPP 219

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-17,   Method: Composition-based stats.
 Identities = 62/198 (31%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A + SSG++VAVKK     L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 39   IGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V E+LE G+L  I+++    EE    Q   V   V  ALS LH      +
Sbjct: 96   SYLVGDELWVVMEFLEGGALTDIVTHTRMNEE----QIAAVCLAVLQALSVLHAQ---GV 148
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL  +    +SDFG    +  +      L GT  ++APEL   +    + 
Sbjct: 149  IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 209  DIWSLGIMVIEMVDGEPP 226

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 79/287 (27%), Positives = 139/287 (48%), Gaps = 40/287 (13%)
Query: 796  IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNE 855
            I Y+EI       + E  +G G  G V +A+  + + VA+K+  S   SE   ++ F+ E
Sbjct: 6    IDYKEI-------EVEEVVGRGAFGVVCKAKWRAKD-VAIKQIESE--SE---RKAFIVE 52
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA------TSAEELGWTQ 909
            ++ L+ + H NIVK YG C +     +V EY E GSL  +L  A      T+A  + W  
Sbjct: 53   LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC- 109
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNW 968
             +   +GVA    YLH+     +++RD+   N+LL        + DFG +  ++   ++ 
Sbjct: 110  -LQCSQGVA----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THM 161
Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
            T   G+  ++APE+      +EK DV+S+G++  E I  + P D I           R +
Sbjct: 162  TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIM 215
Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              + +   P    N+   + S+M     C  ++P  RP+M+++ +++
Sbjct: 216  WAVHNGTRPPLIKNLPKPIESLM---TRCWSKDPSQRPSMEEIVKIM 259

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 70/266 (26%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + +++H  +V+ Y  
Sbjct: 17   LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP----ESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L +      L     +++   VA  ++Y+    +   +
Sbjct: 73   VSE-EPIYIVTEYMNKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMNY---I 127
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ S N+L+       ++DFG+++ ++ +     + A   I + APE A   + T KS
Sbjct: 128  HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 993  DVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEI-LDPRLPAPSCNIRDKLISI 1050
            DV+SFG+L  E + KG+ P            N    L+++    R+P P    +D  IS+
Sbjct: 188  DVWSFGILLTELVTKGRVP--------YPGMNNREVLEQVERGYRMPCP----QDCPISL 235
Query: 1051 MEVAISCLDENPDSRPTMQKVSQLLK 1076
             E+ I C  ++P+ RPT + +   L+
Sbjct: 236  HELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 79/287 (27%), Positives = 139/287 (48%), Gaps = 40/287 (13%)
Query: 796  IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNE 855
            I Y+EI       + E  +G G  G V +A+  + + VA+K+  S   SE   ++ F+ E
Sbjct: 5    IDYKEI-------EVEEVVGRGAFGVVCKAKWRAKD-VAIKQIESE--SE---RKAFIVE 51
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA------TSAEELGWTQ 909
            ++ L+ + H NIVK YG C +     +V EY E GSL  +L  A      T+A  + W  
Sbjct: 52   LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC- 108
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNW 968
             +   +GVA    YLH+     +++RD+   N+LL        + DFG +  ++   ++ 
Sbjct: 109  -LQCSQGVA----YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THM 160
Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
            T   G+  ++APE+      +EK DV+S+G++  E I  + P D I           R +
Sbjct: 161  TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF------RIM 214
Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              + +   P    N+   + S+M     C  ++P  RP+M+++ +++
Sbjct: 215  WAVHNGTRPPLIKNLPKPIESLM---TRCWSKDPSQRPSMEEIVKIM 258

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 86.7 bits (213), Expect = 6e-17,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 102/203 (50%), Gaps = 7/203 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D++  + IGTG  G   +    S G+I+  K+     ++E   +Q  ++EV  L E++H 
Sbjct: 7    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 866  NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEE-LGWTQRMNVIKGVADALS 922
            NIV++Y       ++  +IV EY E G LA +++  T   + L     + V+  +  AL 
Sbjct: 66   NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 923  YLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
              H  +D    +++RD+   NV LD +    + DFG+++ L  D     E  GT  Y++P
Sbjct: 126  ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSP 185
Query: 981  ELAYTMKVTEKSDVYSFGVLALE 1003
            E    M   EKSD++S G L  E
Sbjct: 186  EQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 86.7 bits (213), Expect = 7e-17,   Method: Composition-based stats.
 Identities = 71/270 (26%), Positives = 135/270 (50%), Gaps = 26/270 (9%)
Query: 814  IGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V    L   S  EI VA+K        +   +++FL E   + +  H NI++
Sbjct: 24   VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLGEASIMGQFDHPNIIR 81
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
              G  + ++   IV E +E GSL   L    +  +    Q + +++G+A  + YL +  +
Sbjct: 82   LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPELAYTM 986
               V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G I   + +PE     
Sbjct: 140  ---VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
            K T  SDV+S+G++  E +  G+ P   +S     + ++ + +DE    RLP P     D
Sbjct: 197  KFTSASDVWSYGIVLWEVMSYGERPYWEMS-----NQDVIKAVDE--GYRLPPP----MD 245
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               ++ ++ + C  ++ ++RP  +++  +L
Sbjct: 246  CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D++  + IGTG  G   +    S G+I+  K+     ++E   +Q  ++EV  L E++H 
Sbjct: 7    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 866  NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEE-LGWTQRMNVIKGVADALS 922
            NIV++Y       ++  +IV EY E G LA +++  T   + L     + V+  +  AL 
Sbjct: 66   NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 923  YLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
              H  +D    +++RD+   NV LD +    + DFG+++ L  D+S      GT  Y++P
Sbjct: 126  ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 185
Query: 981  ELAYTMKVTEKSDVYSFGVLALE 1003
            E    M   EKSD++S G L  E
Sbjct: 186  EQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 7/203 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D++  + IGTG  G   +    S G+I+  K+     ++E   +Q  ++EV  L E++H 
Sbjct: 7    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHP 65
Query: 866  NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEE-LGWTQRMNVIKGVADALS 922
            NIV++Y       ++  +IV EY E G LA +++  T   + L     + V+  +  AL 
Sbjct: 66   NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 923  YLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
              H  +D    +++RD+   NV LD +    + DFG+++ L  D+S      GT  Y++P
Sbjct: 126  ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP 185
Query: 981  ELAYTMKVTEKSDVYSFGVLALE 1003
            E    M   EKSD++S G L  E
Sbjct: 186  EQMNRMSYNEKSDIWSLGCLLYE 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-17,   Method: Composition-based stats.
 Identities = 84/300 (28%), Positives = 138/300 (46%), Gaps = 38/300 (12%)
Query: 797  AYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEM 846
            A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        +
Sbjct: 1    AFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 58
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEE 904
               ++F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L     AE 
Sbjct: 59   ---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ--AHAER 113
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
            +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D
Sbjct: 114  IDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 170
Query: 965  SSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISS 1016
                         I + APE     K +  SDV+SFGV+  E      K K  P +F+  
Sbjct: 171  KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 230
Query: 1017 ICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 231  IGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 286

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+     + + VA+K      +SE    ++F+ E + + ++ H  +V+ YG 
Sbjct: 13   IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C       +V+E++E G L+  L       +AE L     + +   V + ++YL   C  
Sbjct: 69   CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 121
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
             +++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    +
Sbjct: 122  -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 178
Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
             + KSDV+SFGVL  E   +GK P +         SN +   D     RL  P    R  
Sbjct: 179  YSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP----RLA 227
Query: 1047 LISIMEVAISCLDENPDSRPTMQK-VSQLLKI 1077
               + ++   C  E P+ RP   + + QL +I
Sbjct: 228  STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+     + + VA+K      +SE    ++F+ E + + ++ H  +V+ YG 
Sbjct: 15   IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C       +V+E++E G L+  L       +AE L     + +   V + ++YL   C  
Sbjct: 71   CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 123
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
             +++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    +
Sbjct: 124  -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 180
Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
             + KSDV+SFGVL  E   +GK P +         SN +   D     RL  P    R  
Sbjct: 181  YSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP----RLA 229
Query: 1047 LISIMEVAISCLDENPDSRPTMQK-VSQLLKI 1077
               + ++   C  E P+ RP   + + QL +I
Sbjct: 230  STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/302 (25%), Positives = 145/302 (48%), Gaps = 35/302 (11%)
Query: 791  TFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL---SSGEI-VAVKK 837
            TF     +E+  +  ++F +E           +G G  G V    L   S  EI VA+K 
Sbjct: 21   TFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT 80
Query: 838  FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS 897
                   +   +++FL E   + +  H NI++  G  + ++   IV E +E GSL   L 
Sbjct: 81   LKVGYTEKQ--RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLR 138
Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
               +  +    Q + +++G+A  + YL +      V+RD++++N+L++      VSDFG+
Sbjct: 139  KHDA--QFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 958  SKSLKPD-SSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013
            S+ L+ D  + +T   G   I + +PE     K T  SDV+S+G++  E +  G+ P   
Sbjct: 194  SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +S     + ++ + +DE    RLP P     D   ++ ++ + C  ++ ++RP  +++  
Sbjct: 254  MS-----NQDVIKAVDEGY--RLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302
Query: 1074 LL 1075
            +L
Sbjct: 303  IL 304

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A E  SG  VAVK      L +   ++   NEV  + + +H N+V+ Y 
Sbjct: 53   IGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    +++ E+L+ G+L  I+S     EE    Q   V + V  AL+YLH      +
Sbjct: 110  SYLVGEELWVLMEFLQGGALTDIVSQVRLNEE----QIATVCEAVLQALAYLHAQ---GV 162
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI S ++LL L+    +SDFG    +  D      L GT  ++APE+        + 
Sbjct: 163  IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 993  DVYSFGVLALEAIKGKHP 1010
            D++S G++ +E + G+ P
Sbjct: 223  DIWSLGIMVIEMVDGEPP 240

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Composition-based stats.
 Identities = 73/272 (26%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+     + + VA+K      +SE    ++F+ E + + ++ H  +V+ YG 
Sbjct: 18   IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C       +V+E++E G L+  L       +AE L     + +   V + ++YL   C  
Sbjct: 74   CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 126
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
             +++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    +
Sbjct: 127  -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 183
Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
             + KSDV+SFGVL  E   +GK P +         SN +   D     RL  P    R  
Sbjct: 184  YSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP----RLA 232
Query: 1047 LISIMEVAISCLDENPDSRPTMQK-VSQLLKI 1077
               + ++   C  E P+ RP   + + QL +I
Sbjct: 233  STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 26/273 (9%)
Query: 811  EHCIGTGGQGSVYRAELS---SGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V    L      EI VA+K   +    +   +++FL+E   + +  H N
Sbjct: 13   EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASIMGQFDHPN 70
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I+   G  +  +   I+ EY+E GSL   L            Q + +++G+   + YL +
Sbjct: 71   IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG--RFTVIQLVGMLRGIGSGMKYLSD 128
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPELA 983
              +   V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G I   + APE  
Sbjct: 129  MSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 185
Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               K T  SDV+S+G++  E +  G+ P   +S     + ++ + ++E    RLP P   
Sbjct: 186  AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVIKAIEE--GYRLPPP--- 235
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              D  I++ ++ + C  +    RP   ++  +L
Sbjct: 236  -MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 72/273 (26%), Positives = 130/273 (47%), Gaps = 26/273 (9%)
Query: 811  EHCIGTGGQGSVYRAELS---SGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V    L      EI VA+K   +    +   +++FL+E   + +  H N
Sbjct: 19   EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ--RRDFLSEASIMGQFDHPN 76
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            I+   G  +  +   I+ EY+E GSL   L            Q + +++G+   + YL +
Sbjct: 77   IIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDG--RFTVIQLVGMLRGIGSGMKYLSD 134
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIG--YVAPELA 983
              +   V+RD++++N+L++      VSDFG+S+ L+ D  + +T   G I   + APE  
Sbjct: 135  MSY---VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAI 191
Query: 984  YTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               K T  SDV+S+G++  E +  G+ P   +S     + ++ + ++E    RLP P   
Sbjct: 192  AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQDVIKAIEE--GYRLPPP--- 241
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              D  I++ ++ + C  +    RP   ++  +L
Sbjct: 242  -MDCPIALHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 78/304 (25%), Positives = 140/304 (46%), Gaps = 35/304 (11%)
Query: 789  VLTFDRKIAYEEIVRATNDFDEE---------HCIGTGGQGSVYRAELS---SGEI-VAV 835
            V TF     +E+  +A  +F +E           IG G  G V    L      EI VA+
Sbjct: 3    VRTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAI 62
Query: 836  KKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMI 895
            K   +    +   +++FL+E   + +  H NI+   G  +  +   I+ EY+E GSL   
Sbjct: 63   KTLKAGYTDKQ--RRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 120
Query: 896  LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF 955
            L            Q + +++G+   + YL +      V+RD++++N+L++      VSDF
Sbjct: 121  LRKNDG--RFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVSDF 175
Query: 956  GISKSLKPD-SSNWTELAGTIG--YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPR 1011
            G+S+ L+ D  + +T   G I   + APE     K T  SDV+S+G++  E +  G+ P 
Sbjct: 176  GMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 235
Query: 1012 DFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +S     + ++ + ++E    RLP P     D  I++ ++ + C  +    RP   ++
Sbjct: 236  WDMS-----NQDVIKAIEE--GYRLPPP----MDCPIALHQLMLDCWQKERSDRPKFGQI 284
Query: 1072 SQLL 1075
              +L
Sbjct: 285  VNML 288

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 75/281 (26%), Positives = 132/281 (46%), Gaps = 40/281 (14%)
Query: 811  EHCIGTGGQGSVYRAELS---SGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V    L      EI VA+K   S    +   +++FL+E   + +  H N
Sbjct: 38   EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPN 95
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            ++   G  + +    I+ E++E GSL   L       +    Q + +++G+A  + YL +
Sbjct: 96   VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLAD 153
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIG--YVAPE 981
              +   V+RD++++N+L++      VSDFG+S+ L+ D+S+ T    L G I   + APE
Sbjct: 154  MNY---VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDP 1034
                 K T  SDV+S+G++  E +  G+ P      +D I++I               D 
Sbjct: 211  AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------------DY 257
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            RLP P     D   ++ ++ + C  ++ + RP   ++   L
Sbjct: 258  RLPPP----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Composition-based stats.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 38/301 (12%)
Query: 796  IAYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSE 845
            +A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        
Sbjct: 3    MAFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 60
Query: 846  MTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAE 903
            +   ++F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E
Sbjct: 61   L---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKE 115
Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
             +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  
Sbjct: 116  RIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQ 172
Query: 964  DSSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFIS 1015
            D             I + APE     K +  SDV+SFGV+  E      K K  P +F+ 
Sbjct: 173  DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 232
Query: 1016 SICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + +
Sbjct: 233  MIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDL 288
Query: 1072 S 1072
            +
Sbjct: 289  A 289

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 83/301 (27%), Positives = 138/301 (45%), Gaps = 38/301 (12%)
Query: 796  IAYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSE 845
            +A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        
Sbjct: 1    MAFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH 58
Query: 846  MTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAE 903
            +   ++F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E
Sbjct: 59   L---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKE 113
Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
             +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  
Sbjct: 114  RIDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQ 170
Query: 964  DSSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFIS 1015
            D             I + APE     K +  SDV+SFGV+  E      K K  P +F+ 
Sbjct: 171  DKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMR 230
Query: 1016 SICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + +
Sbjct: 231  MIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDL 286
Query: 1072 S 1072
            +
Sbjct: 287  A 287

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 73/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 79   VSE-EPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + WT   G    I + APE A   + T 
Sbjct: 134  HRDLRAANILVGENLVCKVADFGLARLI--EDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 192  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 235
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  + P+ RPT + +   L+
Sbjct: 236  ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+     + + VA+K      +SE     +F+ E + + ++ H  +V+ YG 
Sbjct: 35   IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE----DDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C       +V+E++E G L+  L       +AE L     + +   V + ++YL   C  
Sbjct: 91   CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 143
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
             +++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    +
Sbjct: 144  -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 200
Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
             + KSDV+SFGVL  E   +GK P +         SN +   D     RL  P    R  
Sbjct: 201  YSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP----RLA 249
Query: 1047 LISIMEVAISCLDENPDSRPTMQK-VSQLLKI 1077
               + ++   C  E P+ RP   + + QL +I
Sbjct: 250  STHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 34/270 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 16   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S A    IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 73   -STAPQLAIVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 126
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 127  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 183
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 184  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            N    +  +M     CL +  D RP   ++
Sbjct: 237  NCPKAMKRLMA---ECLKKKRDERPLFPQI 263

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-16,   Method: Composition-based stats.
 Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 38/300 (12%)
Query: 797  AYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEM 846
            A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        +
Sbjct: 3    AFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 60
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEE 904
               ++F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E 
Sbjct: 61   ---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKER 115
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
            +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D
Sbjct: 116  IDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 172
Query: 965  SSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISS 1016
                         I + APE     K +  SDV+SFGV+  E      K K  P +F+  
Sbjct: 173  KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 232
Query: 1017 ICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 233  IGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 288

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 38/300 (12%)
Query: 797  AYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEM 846
            A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        +
Sbjct: 29   AFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 86
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEE 904
               ++F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E 
Sbjct: 87   ---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKER 141
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
            +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D
Sbjct: 142  IDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 198
Query: 965  SSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISS 1016
                         I + APE     K +  SDV+SFGV+  E      K K  P +F+  
Sbjct: 199  KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258
Query: 1017 ICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 259  IGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 314

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 50/290 (17%)
Query: 814  IGTGGQGSVYRAELSS------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE  +        +VAVK       +  + +Q+F  E + LT ++H++I
Sbjct: 26   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 82
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAE-----------ELGWTQRMNVIK 915
            V+F+G C+  R   +V+EY+  G L   L S+   A+            LG  Q + V  
Sbjct: 83   VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-- 973
             VA  + YL    F   V+RD++++N L+       + DFG+S+ +   S+++  + G  
Sbjct: 143  QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 197
Query: 974  --TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSI----CSTSSNLDR 1026
               I ++ PE     K T +SDV+SFGV+  E    GK P   +S+     C T      
Sbjct: 198  MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR--- 254
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               E+  PR   P      ++ +IM     C    P  R +++ V   L+
Sbjct: 255  ---ELERPRACPP------EVYAIMR---GCWQREPQQRHSIKDVHARLQ 292

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 50/290 (17%)
Query: 814  IGTGGQGSVYRAELSS------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE  +        +VAVK       +  + +Q+F  E + LT ++H++I
Sbjct: 20   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 76
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAE-----------ELGWTQRMNVIK 915
            V+F+G C+  R   +V+EY+  G L   L S+   A+            LG  Q + V  
Sbjct: 77   VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-- 973
             VA  + YL    F   V+RD++++N L+       + DFG+S+ +   S+++  + G  
Sbjct: 137  QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 191
Query: 974  --TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSI----CSTSSNLDR 1026
               I ++ PE     K T +SDV+SFGV+  E    GK P   +S+     C T      
Sbjct: 192  MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR--- 248
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               E+  PR   P      ++ +IM     C    P  R +++ V   L+
Sbjct: 249  ---ELERPRACPP------EVYAIMR---GCWQREPQQRHSIKDVHARLQ 286

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 80/290 (27%), Positives = 132/290 (45%), Gaps = 50/290 (17%)
Query: 814  IGTGGQGSVYRAELSS------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE  +        +VAVK       +  + +Q+F  E + LT ++H++I
Sbjct: 49   LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE---ASESARQDFQREAELLTMLQHQHI 105
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAE-----------ELGWTQRMNVIK 915
            V+F+G C+  R   +V+EY+  G L   L S+   A+            LG  Q + V  
Sbjct: 106  VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-- 973
             VA  + YL    F   V+RD++++N L+       + DFG+S+ +   S+++  + G  
Sbjct: 166  QVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSRDIY--STDYYRVGGRT 220
Query: 974  --TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSI----CSTSSNLDR 1026
               I ++ PE     K T +SDV+SFGV+  E    GK P   +S+     C T      
Sbjct: 221  MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR--- 277
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               E+  PR   P      ++ +IM     C    P  R +++ V   L+
Sbjct: 278  ---ELERPRACPP------EVYAIMR---GCWQREPQQRHSIKDVHARLQ 315

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 83/300 (27%), Positives = 137/300 (45%), Gaps = 38/300 (12%)
Query: 797  AYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEM 846
            A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        +
Sbjct: 5    AFED--RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 62
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEE 904
               ++F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E 
Sbjct: 63   ---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKER 117
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
            +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D
Sbjct: 118  IDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 174
Query: 965  SSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISS 1016
                         I + APE     K +  SDV+SFGV+  E      K K  P +F+  
Sbjct: 175  KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 234
Query: 1017 ICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 235  IGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 290

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 36/295 (12%)
Query: 802  VRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQE 851
            +R    F+E H      +G G  GSV          ++GE+VAVKK        +   ++
Sbjct: 1    MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RD 57
Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            F  E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   +
Sbjct: 58   FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIK 115
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
             +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D     
Sbjct: 116  LLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXK 172
Query: 970  ---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTS 1021
                    I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +  
Sbjct: 173  VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 1022 SN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
                +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 233  QGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 283

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 16   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 73   STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 126
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 127  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 183
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 184  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            N    +  +M     CL +  D RP   ++
Sbjct: 237  NCPKAMKRLMA---ECLKKKRDERPLFPQI 263

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-16,   Method: Composition-based stats.
 Identities = 61/218 (27%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 814  IGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G V+ AE           +VAVK       +    +++F  E + LT ++H +I
Sbjct: 21   LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHI 77
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL----------AMILSNATSAEELGWTQRMNVIKGV 917
            VKFYG C       +V+EY++ G L          A++++      EL  +Q +++ + +
Sbjct: 78   VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG---- 973
            A  + YL +  F   V+RD++++N L+       + DFG+S+ +   S+++  + G    
Sbjct: 138  AAGMVYLASQHF---VHRDLATRNCLVGENLLVKIGDFGMSRDVY--STDYYRVGGHTML 192
Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
             I ++ PE     K T +SDV+S GV+  E    GK P
Sbjct: 193  PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 16   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 73   STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 126
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 127  HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 183
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 184  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 236
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            N    +  +M     CL +  D RP   ++
Sbjct: 237  NCPKAMKRLMA---ECLKKKRDERPLFPQI 263

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 18   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 74
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 75   STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 128
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 129  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 185
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 186  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 238
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            N    +  +M     CL +  D RP   ++
Sbjct: 239  NCPKAMKRLMA---ECLKKKRDERPLFPQI 265

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 21   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 77
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 78   STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 131
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 132  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 188
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 189  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            N    +  +M     CL +  D RP   ++
Sbjct: 242  NCPKAMKRLMA---ECLKKKRDERPLFPQI 268

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.0 bits (206), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 21   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 77
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 78   STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 131
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 132  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 188
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 189  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 241
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            N    +  +M     CL +  D RP   ++
Sbjct: 242  NCPKAMKRLMA---ECLKKKRDERPLFPQI 268

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 36/294 (12%)
Query: 803  RATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEF 852
            R    F+E H      +G G  GSV          ++GE+VAVKK        +   ++F
Sbjct: 5    RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 61
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQR 910
              E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + 
Sbjct: 62   EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 119
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT- 969
            +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D      
Sbjct: 120  LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 970  --ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSS 1022
                   I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +   
Sbjct: 177  KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 236
Query: 1023 N--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
               +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 237  GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 286

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 81/294 (27%), Positives = 133/294 (45%), Gaps = 36/294 (12%)
Query: 803  RATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEF 852
            R    F+E H      +G G  GSV          ++GE+VAVKK        +   ++F
Sbjct: 1    RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 57
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQR 910
              E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + 
Sbjct: 58   EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 115
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT- 969
            +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D      
Sbjct: 116  LQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 970  --ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSS 1022
                   I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +   
Sbjct: 173  KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 232
Query: 1023 N--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
               +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 233  GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 282

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-16,   Method: Composition-based stats.
 Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+     + + VA+K      +SE    ++F+ E + + ++ H  +V+ YG 
Sbjct: 16   IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C       +V E++E G L+  L       +AE L     + +   V + ++YL   C  
Sbjct: 72   CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEEAC-- 124
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
             +++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    +
Sbjct: 125  -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 181
Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
             + KSDV+SFGVL  E   +GK P +         SN +   D     RL  P    R  
Sbjct: 182  YSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP----RLA 230
Query: 1047 LISIMEVAISCLDENPDSRPTMQK-VSQLLKI 1077
               + ++   C  E P+ RP   + + QL +I
Sbjct: 231  STHVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 70/211 (33%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQ-QEFLNEVKSLTEIRH 864
            D   +H +G G  G VY        + VAVK      L E T + +EFL E   + EI+H
Sbjct: 33   DITMKHKLGGGQYGEVYVGVWKKYSLTVAVKT-----LKEDTMEVEEFLKEAAVMKEIKH 87
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             N+V+  G C+     +IV EY+  G+L   L    + EE+     + +   ++ A+ YL
Sbjct: 88   PNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLREC-NREEVTAVVLLYMATQISSAMEYL 146
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPE 981
                F   ++RD++++N L+   +   V+DFG+S+ +  D+  +T  AG    I + APE
Sbjct: 147  EKKNF---IHRDLAARNCLVGENHVVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPE 201
Query: 982  -LAYTMKVTEKSDVYSFGVLALE-AIKGKHP 1010
             LAY    + KSDV++FGVL  E A  G  P
Sbjct: 202  SLAYN-TFSIKSDVWAFGVLLWEIATYGMSP 231

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 34/265 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 36   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 92
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 93   STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 146
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 147  HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 203
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 204  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 256
Query: 1042 NIRDKLISIMEVAISCLDENPDSRP 1066
            N    +  +M     CL +  D RP
Sbjct: 257  NCPKAMKRLMA---ECLKKKRDERP 278

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-16,   Method: Composition-based stats.
 Identities = 82/300 (27%), Positives = 137/300 (45%), Gaps = 38/300 (12%)
Query: 797  AYEEIVRATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEM 846
            A+E+  R    F+E H      +G G  GSV          ++GE+VAVKK        +
Sbjct: 1    AFED--RDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL 58
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEE 904
               ++F  E++ L  ++H NIVK+ G C  A  R+  ++ E+L  GSL   L      E 
Sbjct: 59   ---RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQK--HKER 113
Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
            +   + +     +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D
Sbjct: 114  IDHIKLLQYTSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQD 170
Query: 965  SSNWT---ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISS 1016
                         I + APE     K +  SDV+SFGV+  E      K K  P +F+  
Sbjct: 171  KEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 230
Query: 1017 ICSTSSN--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
            I +      +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 231  IGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 286

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 80/289 (27%), Positives = 133/289 (46%), Gaps = 36/289 (12%)
Query: 808  FDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK        +   ++F  E++
Sbjct: 7    FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 63
Query: 858  SLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + +    
Sbjct: 64   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 121
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELA 972
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D   +       
Sbjct: 122  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSSN--LD 1025
              I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +      + 
Sbjct: 179  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 1026 RTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
              L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 239  FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 283

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 34/265 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 43   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 99
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 100  STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 153
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 154  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 210
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 211  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 263
Query: 1042 NIRDKLISIMEVAISCLDENPDSRP 1066
            N    +  +M     CL +  D RP
Sbjct: 264  NCPKAMKRLMA---ECLKKKRDERP 285

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 34/265 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 100
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 101  STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 154
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 155  HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 211
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 212  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 264
Query: 1042 NIRDKLISIMEVAISCLDENPDSRP 1066
            N    +  +M     CL +  D RP
Sbjct: 265  NCPKAMKRLMA---ECLKKKRDERP 286

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.8 bits (203), Expect = 9e-16,   Method: Composition-based stats.
 Identities = 80/294 (27%), Positives = 134/294 (45%), Gaps = 36/294 (12%)
Query: 803  RATNDFDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEF 852
            R    F+E H      +G G  GSV          ++GE+VAVKK        +   ++F
Sbjct: 3    RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDF 59
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQR 910
              E++ L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + 
Sbjct: 60   EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKL 117
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT- 969
            +     +   + YL    +   ++R+++++N+L++ E    + DFG++K L  D   +  
Sbjct: 118  LQYTSQICKGMEYLGTKRY---IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 970  --ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSS 1022
                   I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +   
Sbjct: 175  KEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ 234
Query: 1023 N--LDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
               +   L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 235  GQMIVFHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 284

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 808  FDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK        +   ++F  E++
Sbjct: 5    FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 61
Query: 858  SLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + +    
Sbjct: 62   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 119
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELA 972
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D           
Sbjct: 120  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSSN--LD 1025
              I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +      + 
Sbjct: 177  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 236
Query: 1026 RTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
              L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 237  FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 281

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.8 bits (203), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 127/265 (47%), Gaps = 34/265 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V +    +P   ++   Q F NEV  L + RH NI+ F G+
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQL---QAFKNEVGVLRKTRHVNILLFMGY 100
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +  + + IV ++ E  SL   L    +  E+   + +++ +  A  + YLH      I+
Sbjct: 101  STKPQLA-IVTQWCEGSSLYHHLHIIETKFEM--IKLIDIARQTAQGMDYLHAKS---II 154
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+   +++ +K
Sbjct: 155  HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEV---IRMQDK 211
Query: 992  ------SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI----LDPRLPAPSC 1041
                  SDVY+FG++  E + G+ P        S  +N D+ +  +    L P L     
Sbjct: 212  NPYSFQSDVYAFGIVLYELMTGQLP-------YSNINNRDQIIFMVGRGYLSPDLSKVRS 264
Query: 1042 NIRDKLISIMEVAISCLDENPDSRP 1066
            N    +  +M     CL +  D RP
Sbjct: 265  NCPKAMKRLMA---ECLKKKRDERP 286

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 275  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 331  VSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 385
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 386  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P   +         ++R   E+LD      R+P P     
Sbjct: 444  KSDVWSFGILLTELTTKGRVPYPGM---------VNR---EVLDQVERGYRMPCPP---- 487
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  + P+ RPT + +   L+
Sbjct: 488  ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 808  FDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK        +   ++F  E++
Sbjct: 7    FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 63
Query: 858  SLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + +    
Sbjct: 64   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 121
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELA 972
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D           
Sbjct: 122  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSSN--LD 1025
              I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +      + 
Sbjct: 179  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238
Query: 1026 RTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
              L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 239  FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 283

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 70/269 (26%), Positives = 126/269 (46%), Gaps = 32/269 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G V+     + + VA+K      +SE    ++F+ E + + ++ H  +V+ YG 
Sbjct: 15   IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            C       +V+E++E G L+  L       +AE L     + +   V + ++YL      
Sbjct: 71   CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDVCEGMAYLEE---A 122
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
             +++RD++++N L+       VSDFG+++ +  D   +T   GT   + + +PE+    +
Sbjct: 123  SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD--QYTSSTGTKFPVKWASPEVFSFSR 180
Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
             + KSDV+SFGVL  E   +GK P +         SN +   D     RL  P    R  
Sbjct: 181  YSSKSDVWSFGVLMWEVFSEGKIPYE-------NRSNSEVVEDISTGFRLYKP----RLA 229
Query: 1047 LISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               + ++   C  E P+ RP   ++ + L
Sbjct: 230  STHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Composition-based stats.
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 808  FDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK        +   ++F  E++
Sbjct: 25   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 81
Query: 858  SLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + +    
Sbjct: 82   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELA 972
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D           
Sbjct: 140  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSSN--LD 1025
              I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +      + 
Sbjct: 197  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 256
Query: 1026 RTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
              L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 257  FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 301

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 80/289 (27%), Positives = 132/289 (45%), Gaps = 36/289 (12%)
Query: 808  FDEEHC-----IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK        +   ++F  E++
Sbjct: 25   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL---RDFEREIE 81
Query: 858  SLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A  R+  ++ EYL  GSL   L      E +   + +    
Sbjct: 82   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 139
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELA 972
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D           
Sbjct: 140  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI----KGKH-PRDFISSICSTSSN--LD 1025
              I + APE     K +  SDV+SFGV+  E      K K  P +F+  I +      + 
Sbjct: 197  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 256
Query: 1026 RTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
              L E+L  + RLP P     D++  IM     C + N + RP+ + ++
Sbjct: 257  FHLIELLKNNGRLPRPD-GCPDEIYMIM---TECWNNNVNQRPSFRDLA 301

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 248  VSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPA-PSCNI 1043
            KSDV+SFG+L  E   KG+ P   + +             E+LD      R+P  P C  
Sbjct: 361  KSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMPCPPECP- 407
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 S+ ++   C  + P+ RPT + +   L+
Sbjct: 408  ----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 126/273 (46%), Gaps = 38/273 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 248  VSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPA-PSCNI 1043
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P  P C  
Sbjct: 361  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPPECP- 407
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 S+ ++   C  + P+ RPT + +   L+
Sbjct: 408  ----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 38/273 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 192  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 248  VSE-EPIYIVGEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 302
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 303  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPA-PSCNI 1043
            KSDV+SFG+L  E   KG+ P   + +             E+LD      R+P  P C  
Sbjct: 361  KSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMPCPPECP- 407
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 S+ ++   C  + P+ RPT + +   L+
Sbjct: 408  ----ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 19   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 74
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 75   VSE-EPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 129
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 130  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 188  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 231
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  + P+ RPT + +   L+
Sbjct: 232  ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 263

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 40/281 (14%)
Query: 811  EHCIGTGGQGSVYRAELS---SGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E  IG G  G V    L      EI VA+K   S    +   +++FL+E   + +  H N
Sbjct: 12   EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQ--RRDFLSEASIMGQFDHPN 69
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            ++   G  + +    I+ E++E GSL   L       +    Q + +++G+A  + YL +
Sbjct: 70   VIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLAD 127
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIG--YVAPE 981
              +   V+R ++++N+L++      VSDFG+S+ L+ D+S+ T    L G I   + APE
Sbjct: 128  MNY---VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIK-GKHP------RDFISSICSTSSNLDRTLDEILDP 1034
                 K T  SDV+S+G++  E +  G+ P      +D I++I               D 
Sbjct: 185  AIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-------------DY 231
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            RLP P     D   ++ ++ + C  ++ + RP   ++   L
Sbjct: 232  RLPPP----MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 59/199 (29%), Positives = 97/199 (48%), Gaps = 8/199 (4%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG  +VY AE +   I VA+K    P   +    + F  EV + +++ H+NIV    
Sbjct: 19   LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EY+E  +L+  +    S   L     +N    + D + + H+     I
Sbjct: 79   VDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD---MRI 132
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGTIGYVAPELAYTMKVTEK 991
            V+RDI  +N+L+D      + DFGI+K+L   S   T  + GT+ Y +PE A      E 
Sbjct: 133  VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 992  SDVYSFGVLALEAIKGKHP 1010
            +D+YS G++  E + G+ P
Sbjct: 193  TDIYSIGIVLYEMLVGEPP 211

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 75/293 (25%), Positives = 137/293 (46%), Gaps = 31/293 (10%)
Query: 798  YEEIVRATNDFDEE---------HCIGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEM 846
            YE+  RA + F +E           IG G  G V   R +L     VAV      +    
Sbjct: 26   YEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTE 85
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG 906
              +++FL E   + +  H N+V   G  +  +   IV E++E G+L   L       +  
Sbjct: 86   KQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG--QFT 143
Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-S 965
              Q + +++G+A  + YL +  +   V+RD++++N+L++      VSDFG+S+ ++ D  
Sbjct: 144  VIQLVGMLRGIAAGMRYLADMGY---VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPE 200
Query: 966  SNWTELAGTIG--YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSS 1022
            + +T   G I   + APE     K T  SDV+S+G++  E +  G+ P   +S     + 
Sbjct: 201  AVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----NQ 255
Query: 1023 NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            ++ + ++E    RLPAP     D    + ++ + C  +    RP  +++  +L
Sbjct: 256  DVIKAIEE--GYRLPAP----MDCPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 23   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 78
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 79   VSE-EPIYIVTEYMNKGSLLDFLKGET-GKYLRLPQLVDMSAQIASGMAYVERMNY---V 133
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 134  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 192  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 235
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  + P+ RPT + +   L+
Sbjct: 236  ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 267

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-15,   Method: Composition-based stats.
 Identities = 72/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + +IRH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKIRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V+   L +   +VAVK     L  ++  +  FL E + L +  H NIV+  G
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLIG 179
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
             C+  +  +IV E ++ G     L   T    L     + ++   A  + YL + C    
Sbjct: 180  VCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-----TIGYVAPELAYTMK 987
            ++RD++++N L+  +    +SDFG+S+    ++      +G      + + APE     +
Sbjct: 235  IHRDLAARNCLVTEKNVLKISDFGMSRE---EADGVXAASGGLRQVPVKWTAPEALNYGR 291
Query: 988  VTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS-CNI 1043
             + +SDV+SFG+L  E    G  P   +S         ++   E ++   RLP P  C  
Sbjct: 292  YSSESDVWSFGILLWETFSLGASPYPNLS---------NQQTREFVEKGGRLPCPELCP- 341
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D +  +ME    C    P  RP+   + Q L+
Sbjct: 342  -DAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 124/265 (46%), Gaps = 21/265 (7%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G V++  +  + ++VA+K     L       ++   E+  L++     
Sbjct: 25   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            + K+YG        +I+ EYL  GS A+ L  A   +E    Q   ++K +   L YLH+
Sbjct: 83   VTKYYGSYLKGSKLWIIMEYLGGGS-ALDLLRAGPFDEF---QIATMLKEILKGLDYLHS 138
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
            +     ++RDI + NVLL  + +  ++DFG++  L           GT  ++APE+    
Sbjct: 139  E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
                K+D++S G+ A+E  KG+ P   +  +        R L   L P+   P+  + D 
Sbjct: 196  AYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVL--FLIPKNNPPTL-VGDF 244
Query: 1047 LISIMEVAISCLDENPDSRPTMQKV 1071
              S  E   +CL+++P  RPT +++
Sbjct: 245  TKSFKEFIDACLNKDPSFRPTAKEL 269

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 4e-15,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 127/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+++ N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLAAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 102/208 (49%), Gaps = 8/208 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF   + +G G    VYRAE + +G  VA+K      + +    Q   NEVK   +++H 
Sbjct: 12   DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            +I++ Y +   + + ++V E    G +   L N    +     +  + +  +   + YLH
Sbjct: 72   SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLH 129
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK-PDSSNWTELAGTIGYVAPELAY 984
            +     I++RD++  N+LL       ++DFG++  LK P   ++T L GT  Y++PE+A 
Sbjct: 130  SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIAT 185
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
                  +SDV+S G +    + G+ P D
Sbjct: 186  RSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 5e-15,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 25/270 (9%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF+    +G G  G+VY A E  S  IVA+K      + +   + +   E++    + H
Sbjct: 23   DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHH 82
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NI++ Y +    R  +++ EY   G L   L  + + +E    +   +++ +ADAL Y 
Sbjct: 83   PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDE---QRTATIMEELADALMYC 139
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H      +++RDI  +N+LL L+ E  ++DFG   S+   S     + GT+ Y+ PE+  
Sbjct: 140  HGK---KVIHRDIKPENLLLGLKGELKIADFGW--SVHAPSLRRKTMCGTLDYLPPEMIE 194
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI--LDPRLPAPSCN 1042
                 EK D++  GVL  E + G  P +        S++ + T   I  +D + PA    
Sbjct: 195  GRMHNEKVDLWCIGVLCYELLVGNPPFE--------SASHNETYRRIVKVDLKFPASVPT 246
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
                LIS +      L  NP  R  + +VS
Sbjct: 247  GAQDLISKL------LRHNPSERLPLAQVS 270

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 121/273 (44%), Gaps = 34/273 (12%)
Query: 814  IGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V+   L +   +VAVK     L  ++  +  FL E + L +  H NIV+  G
Sbjct: 122  IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLIG 179
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
             C+  +  +IV E ++ G     L   T    L     + ++   A  + YL + C    
Sbjct: 180  VCTQKQPIYIVMELVQGGDFLTFLR--TEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-----TIGYVAPELAYTMK 987
            ++RD++++N L+  +    +SDFG+S+    ++      +G      + + APE     +
Sbjct: 235  IHRDLAARNCLVTEKNVLKISDFGMSRE---EADGVYAASGGLRQVPVKWTAPEALNYGR 291
Query: 988  VTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS-CNI 1043
             + +SDV+SFG+L  E    G  P   +S         ++   E ++   RLP P  C  
Sbjct: 292  YSSESDVWSFGILLWETFSLGASPYPNLS---------NQQTREFVEKGGRLPCPELCP- 341
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D +  +ME    C    P  RP+   + Q L+
Sbjct: 342  -DAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 6e-15,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 15   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 70
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 71   VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 125
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 126  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 184  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 227
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 228  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 259

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 17   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 72
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 73   VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 127
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 128  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 186  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 229
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 230  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 7e-15,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 8e-15,   Method: Composition-based stats.
 Identities = 70/270 (25%), Positives = 125/270 (46%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVIEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ + N+L+       V+DFG+++ ++ +     + A   I + APE A   + T KS
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 993  DVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIRDK 1046
            DV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     + 
Sbjct: 197  DVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP----EC 240
Query: 1047 LISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              S+ ++   C  ++P+ RPT + +   L+
Sbjct: 241  PESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 9e-15,   Method: Composition-based stats.
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVCEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 9/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DFD    +G G  G+VY A E  +  I+A+K      L +   + +   E++  + +RH
Sbjct: 15   DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NI++ Y +    +  +++ E+   G L   L      +E    +    ++ +ADAL Y 
Sbjct: 75   PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 131
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H      +++RDI  +N+L+  + E  ++DFG   S+   S     + GT+ Y+ PE+  
Sbjct: 132  HER---KVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIE 186
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
                 EK D++  GVL  E + G  P D
Sbjct: 187  GKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 16   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 71
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S      IV EY+  GSL   L   T  + L   Q +++   +A  ++Y+    +   V
Sbjct: 72   VSE-EPIXIVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 126
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ + N+L+       V+DFG+++ ++ +     + A   I + APE A   + T KS
Sbjct: 127  HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 993  DVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIRDK 1046
            DV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     + 
Sbjct: 187  DVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP----EC 230
Query: 1047 LISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              S+ ++   C  + P+ RPT + +   L+
Sbjct: 231  PESLHDLMCQCWRKEPEERPTFEYLQAFLE 260

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 1e-14,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 9/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DFD    +G G  G+VY A E  +  I+A+K      L +   + +   E++  + +RH
Sbjct: 14   DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NI++ Y +    +  +++ E+   G L   L      +E    +    ++ +ADAL Y 
Sbjct: 74   PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE---QRSATFMEELADALHYC 130
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H      +++RDI  +N+L+  + E  ++DFG   S+   S     + GT+ Y+ PE+  
Sbjct: 131  HER---KVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRXMCGTLDYLPPEMIE 185
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRD 1012
                 EK D++  GVL  E + G  P D
Sbjct: 186  GKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 124/273 (45%), Gaps = 38/273 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 193  LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSP----EAFLQEAQVMKKLRHEKLVQLYAV 248
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  GSL   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 249  VSE-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 303
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+ + +  + + +T   G    I + APE A   + T 
Sbjct: 304  HRDLRAANILVGENLVCKVADFGLGRLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 361
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPA-PSCNI 1043
            KSDV+SFG+L  E   KG+ P   + +             E+LD      R+P  P C  
Sbjct: 362  KSDVWSFGILLTELTTKGRVPYPGMVN------------REVLDQVERGYRMPCPPECP- 408
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 S+ ++   C  ++P+ RPT + +   L+
Sbjct: 409  ----ESLHDLMCQCWRKDPEERPTFEYLQAFLE 437

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  G L   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVMEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 69/241 (28%), Positives = 112/241 (46%), Gaps = 32/241 (13%)
Query: 807  DFDEEHCIGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            DF     +GTG  G V+  R+   +G   A+K     ++  +   +   +E   L+ + H
Sbjct: 7    DFQILRTLGTGSFGRVHLIRSR-HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM-NVIKG-----VA 918
              I++ +G    A+  F++ +Y+E G L  +L           +QR  N +       V 
Sbjct: 66   PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK---------SQRFPNPVAKFYAAEVC 116
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             AL YLH+     I+YRD+  +N+LLD      ++DFG +K + PD +    L GT  Y+
Sbjct: 117  LALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVT--YXLCGTPDYI 170
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
            APE+  T    +  D +SFG+L  E + G  P           SN  +T ++IL+  L  
Sbjct: 171  APEVVSTKPYNKSIDWWSFGILIYEMLAGYTP--------FYDSNTMKTYEKILNAELRF 222
Query: 1039 P 1039
            P
Sbjct: 223  P 223

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 70/272 (25%), Positives = 125/272 (45%), Gaps = 36/272 (13%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    +    VA+K      +S     + FL E + + ++RH  +V+ Y  
Sbjct: 26   LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAV 81
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     +IV EY+  G L   L      + L   Q +++   +A  ++Y+    +   V
Sbjct: 82   VSE-EPIYIVTEYMSKGCLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMNY---V 136
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMKVTE 990
            +RD+ + N+L+       V+DFG+++ +  + + +T   G    I + APE A   + T 
Sbjct: 137  HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 991  KSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIR 1044
            KSDV+SFG+L  E   KG+ P             ++R   E+LD      R+P P     
Sbjct: 195  KSDVWSFGILLTELTTKGRVP---------YPGMVNR---EVLDQVERGYRMPCPP---- 238
Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   S+ ++   C  ++P+ RPT + +   L+
Sbjct: 239  ECPESLHDLMCQCWRKDPEERPTFEYLQAFLE 270

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 63/191 (32%), Positives = 92/191 (48%), Gaps = 14/191 (7%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N+V+  G 
Sbjct: 14   IGKGEFGDVMLGDYR-GNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 874  CSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                +   +IV EY+  GSL   L  +     LG    +     V +A+ YL  + F   
Sbjct: 68   IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 123
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            V+RD++++NVL+  +  A VSDFG++K     SS        + + APE     K + KS
Sbjct: 124  VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKS 180
Query: 993  DVYSFGVLALE 1003
            DV+SFG+L  E
Sbjct: 181  DVWSFGILLWE 191

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Composition-based stats.
 Identities = 63/191 (32%), Positives = 92/191 (48%), Gaps = 14/191 (7%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N+V+  G 
Sbjct: 29   IGKGEFGDVMLGDYR-GNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 874  CSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                +   +IV EY+  GSL   L  +     LG    +     V +A+ YL  + F   
Sbjct: 83   IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 138
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            V+RD++++NVL+  +  A VSDFG++K     SS        + + APE     K + KS
Sbjct: 139  VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKS 195
Query: 993  DVYSFGVLALE 1003
            DV+SFG+L  E
Sbjct: 196  DVWSFGILLWE 206

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 133/272 (48%), Gaps = 30/272 (11%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 9    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 66
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 67   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 121
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L  + +N  E  GT  Y++PE 
Sbjct: 122  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMAN--EFVGTRSYMSPER 177
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP 1039
                  + +SD++S G+  +E   G++PR  ++        +   LD I++   P+LP+ 
Sbjct: 178  LQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMA--------IFELLDYIVNEPPPKLPSA 229
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +     +   +    CL +NP  R  ++++
Sbjct: 230  VFS-----LEFQDFVNKCLIKNPAERADLKQL 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 17   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 70
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 71   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 128
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 129  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 185
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 186  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 238
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 239  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 273

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 9    EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 62
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 63   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 120
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 121  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 177
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 178  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 230
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 231  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 265

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 9    EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 62
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 63   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 120
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 121  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 177
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 178  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 230
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 231  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 265

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 15   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 68
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 69   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 126
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 127  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 183
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 184  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 236
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 237  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 271

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 10   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 63
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 64   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 121
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 122  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 178
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 179  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 231
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 232  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 266

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 11   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 64
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 65   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 122
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 123  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 179
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 180  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 232
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 233  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 267

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 18   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 71
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 72   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 129
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 130  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT 186
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 187  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 239
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 240  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 274

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 4e-14,   Method: Composition-based stats.
 Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 38/284 (13%)
Query: 808  FDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F+    +G G  G VY+   + +G++ A+K        E   +QE +N +K  +   HRN
Sbjct: 26   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE-INMLKKYSH--HRN 82
Query: 867  IVKFYGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
            I  +YG              ++V E+   GS+  ++ N T    L       + + +   
Sbjct: 83   IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRG 141
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            LS+LH      +++RDI  +NVLL    E  + DFG+S  L           GT  ++AP
Sbjct: 142  LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 198
Query: 981  ELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            E+    +  +     KSD++S G+ A+E  +G  P      +C       R L   L PR
Sbjct: 199  EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP------LCDMHPM--RAL--FLIPR 248
Query: 1036 LPAPSCNIR---DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             PAP    +    K  S +E   SCL +N   RP  +   QL+K
Sbjct: 249  NPAPRLKSKKWSKKFQSFIE---SCLVKNHSQRPATE---QLMK 286

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 129/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 9    EVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 62
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 63   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 120
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++       E A   I + 
Sbjct: 121  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWT 177
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 178  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 230
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 231  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 265

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 15   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 68
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 69   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 126
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 127  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 183
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 184  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 236
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 237  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 271

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 19   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 72
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 73   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 130
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 131  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 187
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 188  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 240
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 241  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 275

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 9    EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 62
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 63   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 120
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 121  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 177
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 178  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 230
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 231  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 265

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 4    EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 57
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 58   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 115
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 116  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 172
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 173  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 225
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 226  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 260

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-14,   Method: Composition-based stats.
 Identities = 70/279 (25%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 14   EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 67
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 68   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 125
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 126  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 182
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 183  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 235
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 236  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 270

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 71/280 (25%), Positives = 131/280 (46%), Gaps = 31/280 (11%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D++ +  IG+G    V  A  +   E VA+K+ +  L    T   E L E++++++  H
Sbjct: 10   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHH 67
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-----LGWTQRMNVIKGVAD 919
             NIV +Y         ++V + L  GS+  I+ +  +  E     L  +    +++ V +
Sbjct: 68   PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-----SSNWTELAGT 974
             L YLH +     ++RD+ + N+LL  +    ++DFG+S  L        +       GT
Sbjct: 128  GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 184
Query: 975  IGYVAPELAYTMKVTE-KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033
              ++APE+   ++  + K+D++SFG+ A+E   G  P      +      L  TL    D
Sbjct: 185  PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQN--D 238
Query: 1034 PRLPAPSCNIRDKLI------SIMEVAISCLDENPDSRPT 1067
            P  P+    ++DK +      S  ++   CL ++P+ RPT
Sbjct: 239  P--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 276

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-14,   Method: Composition-based stats.
 Identities = 71/280 (25%), Positives = 131/280 (46%), Gaps = 31/280 (11%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D++ +  IG+G    V  A  +   E VA+K+ +  L    T   E L E++++++  H
Sbjct: 15   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN--LEKCQTSMDELLKEIQAMSQCHH 72
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-----LGWTQRMNVIKGVAD 919
             NIV +Y         ++V + L  GS+  I+ +  +  E     L  +    +++ V +
Sbjct: 73   PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-----SSNWTELAGT 974
             L YLH +     ++RD+ + N+LL  +    ++DFG+S  L        +       GT
Sbjct: 133  GLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
Query: 975  IGYVAPELAYTMKVTE-KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD 1033
              ++APE+   ++  + K+D++SFG+ A+E   G  P      +      L  TL    D
Sbjct: 190  PCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM----KVLMLTLQN--D 243
Query: 1034 PRLPAPSCNIRDKLI------SIMEVAISCLDENPDSRPT 1067
            P  P+    ++DK +      S  ++   CL ++P+ RPT
Sbjct: 244  P--PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 7e-14,   Method: Composition-based stats.
 Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 21/264 (7%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    ++   VAVK      +S     Q FL E   +  ++H  +V+ Y  
Sbjct: 21   LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +     +I+ EY+  GSL   L +    + L   + ++    +A+ ++Y+    +   +
Sbjct: 77   VTREEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---I 132
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ + NVL+       ++DFG+++ ++ +     E A   I + APE       T KS
Sbjct: 133  HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 192
Query: 993  DVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIM 1051
            DV+SFG+L  E +  GK P           +N D         R+P    N  D+L  IM
Sbjct: 193  DVWSFGILLYEIVTYGKIPY-------PGRTNADVMTALSQGYRMPRVE-NCPDELYDIM 244
Query: 1052 EVAISCLDENPDSRPTMQKVSQLL 1075
            ++   C  E  + RPT   +  +L
Sbjct: 245  KM---CWKEKAEERPTFDYLQSVL 265

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-14,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 56   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 112  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 169  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 50   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 105
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 106  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 163  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 62   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 118  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 175  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 72   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 128  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 185  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 72   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 127
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 128  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 185  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 52   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 107
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 108  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 165  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 56   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 111
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 112  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 169  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 70   KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD---K 125
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 126  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 183  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 40/293 (13%)
Query: 813  CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            C+G G  G V+R     GE VAVK F S        + E  N V     +RH NI+ F  
Sbjct: 15   CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENILGFIA 69
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                +RHS    +++  Y EMGSL   L   T    L     + ++  +A  L++LH + 
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 929  F-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-----GTIGYV 978
            F     P I +RD+ SKN+L+    +  ++D G++  +   S+N  ++      GT  Y+
Sbjct: 126  FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 979  APE-LAYTMKVT-----EKSDVYSFGVLALE--------AIKGKHPRDFISSICSTSSNL 1024
            APE L  T++V      ++ D+++FG++  E         I   +   F   + +  S  
Sbjct: 185  APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 1025 DRTLDEILDPRLP-APSCNIRD-KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            D      +D + P  P+    D  L S+ ++   C  +NP +R T  ++ + L
Sbjct: 245  DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 40/293 (13%)
Query: 813  CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            C+G G  G V+R     GE VAVK F S        + E  N V     +RH NI+ F  
Sbjct: 15   CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENILGFIA 69
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                +RHS    +++  Y EMGSL   L   T    L     + ++  +A  L++LH + 
Sbjct: 70   SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 929  F-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-----GTIGYV 978
            F     P I +RD+ SKN+L+    +  ++D G++  +   S+N  ++      GT  Y+
Sbjct: 126  FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 979  APE-LAYTMKVT-----EKSDVYSFGVLALE--------AIKGKHPRDFISSICSTSSNL 1024
            APE L  T++V      ++ D+++FG++  E         I   +   F   + +  S  
Sbjct: 185  APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 1025 DRTLDEILDPRLP-APSCNIRD-KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            D      +D + P  P+    D  L S+ ++   C  +NP +R T  ++ + L
Sbjct: 245  DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 80   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  ++           + APE   T 
Sbjct: 137  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 194  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 247
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 248  ----IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 20   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 80   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 136
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  ++           + APE   T 
Sbjct: 137  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 194  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 247
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 248  ----IYNVMVQCWAHKPEDRPTFVALRDFL 273

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  ++           + APE   T 
Sbjct: 133  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 243
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 244  ----IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  ++           + APE   T 
Sbjct: 143  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 200  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 253
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 254  ----IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  ++           + APE   T 
Sbjct: 133  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 243
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 244  ----IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 62/191 (32%), Positives = 91/191 (47%), Gaps = 14/191 (7%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N+V+  G 
Sbjct: 20   IGKGEFGDVMLGDYR-GNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 73
Query: 874  CSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                +   +IV EY+  GSL   L  +     LG    +     V +A+ YL  + F   
Sbjct: 74   IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 129
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            V+RD++++NVL+  +  A VSDFG++K     SS        + + APE       + KS
Sbjct: 130  VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREAAFSTKS 186
Query: 993  DVYSFGVLALE 1003
            DV+SFG+L  E
Sbjct: 187  DVWSFGILLWE 197

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/191 (32%), Positives = 92/191 (48%), Gaps = 14/191 (7%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N+V+  G 
Sbjct: 201  IGKGEFGDVMLGDYR-GNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 874  CSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                +   +IV EY+  GSL   L  +     LG    +     V +A+ YL  + F   
Sbjct: 255  IVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF--- 310
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            V+RD++++NVL+  +  A VSDFG++K     SS        + + APE     K + KS
Sbjct: 311  VHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKS 367
Query: 993  DVYSFGVLALE 1003
            DV+SFG+L  E
Sbjct: 368  DVWSFGILLWE 378

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Composition-based stats.
 Identities = 80/293 (27%), Positives = 133/293 (45%), Gaps = 40/293 (13%)
Query: 813  CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            C+G G  G V+R     GE VAVK F S        + E  N V     +RH NI+ F  
Sbjct: 44   CVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTVM----LRHENILGFIA 98
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                +RHS    +++  Y EMGSL   L   T    L     + ++  +A  L++LH + 
Sbjct: 99   SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 154
Query: 929  F-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-----GTIGYV 978
            F     P I +RD+ SKN+L+    +  ++D G++  +   S+N  ++      GT  Y+
Sbjct: 155  FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA-VMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 979  APE-LAYTMKVT-----EKSDVYSFGVLALE--------AIKGKHPRDFISSICSTSSNL 1024
            APE L  T++V      ++ D+++FG++  E         I   +   F   + +  S  
Sbjct: 214  APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 273
Query: 1025 DRTLDEILDPRLP-APSCNIRD-KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            D      +D + P  P+    D  L S+ ++   C  +NP +R T  ++ + L
Sbjct: 274  DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 326

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G V++  +  + ++VA+K     L       ++   E+  L++     
Sbjct: 29   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 86
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            + K+YG        +I+ EYL  GS   +L      E    TQ   +++ +   L YLH+
Sbjct: 87   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHS 142
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
            +     ++RDI + NVLL    E  ++DFG++  L           GT  ++APE+    
Sbjct: 143  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
                K+D++S G+ A+E  +G+ P   +  +        + L  I     P    N    
Sbjct: 200  AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTLEGNYSKP 251
Query: 1047 LISIMEVAISCLDENPDSRPTMQKV 1071
            L   +E   +CL++ P  RPT +++
Sbjct: 252  LKEFVE---ACLNKEPSFRPTAKEL 273

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 21/259 (8%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G VY+  +  + E+VA+K     L       ++   E+  L++     I +++G
Sbjct: 27   IGKGSFGEVYKGIDNHTKEVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPYITRYFG 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                +   +I+ EYL  GS A+ L      EE   T    +++ +   L YLH++     
Sbjct: 85   SYLKSTKLWIIMEYLGGGS-ALDLLKPGPLEE---TYIATILREILKGLDYLHSE---RK 137
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RDI + NVLL  + +  ++DFG++  L           GT  ++APE+        K+
Sbjct: 138  IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKA 197
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            D++S G+ A+E  KG+ P          +S+L       L P+   P+   +       E
Sbjct: 198  DIWSLGITAIELAKGEPP----------NSDLHPMRVLFLIPKNSPPTLEGQHSK-PFKE 246
Query: 1053 VAISCLDENPDSRPTMQKV 1071
               +CL+++P  RPT +++
Sbjct: 247  FVEACLNKDPRFRPTAKEL 265

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 69/279 (24%), Positives = 130/279 (46%), Gaps = 24/279 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R T    E   +G G  G V+    +    VAVK      +S       FL E   +
Sbjct: 5    EVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLM 58
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 59   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAE 116
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYV 978
             ++++    +   ++R++ + N+L+       ++DFG+++ ++ +     E A   I + 
Sbjct: 117  GMAFIEERNY---IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT 173
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T KSDV+SFG+L  E +  G+ P   +++      NL+R        R+ 
Sbjct: 174  APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-EVIQNLERGY------RMV 226
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  N  ++L  +M +   C  E P+ RPT   +  +L+
Sbjct: 227  RPD-NCPEELYQLMRL---CWKERPEDRPTFDYLRSVLE 261

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 39/301 (12%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGS---VYRAELSSGEIVAVKKFHSPLLSEM 846
            L F     YE + R  N  D    IG  G G+   VY+A+     ++A  K       E 
Sbjct: 18   LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG 906
               ++++ E+  L    H NIVK      +  + +I+ E+   G++  ++        L 
Sbjct: 78   L--EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLT 133
Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
             +Q   V K   DAL+YLH++    I++RD+ + N+L  L+ +  ++DFG+S        
Sbjct: 134  ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 967  NWTELAGTIGYVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTS 1021
                  GT  ++APE+       +     K+DV+S G+  +E  + + P   ++ +    
Sbjct: 191  RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---- 246
Query: 1022 SNLDRTLDEILD---PRLPAP---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                R L +I     P L  P   S N +D L         CL++N D+R T    SQLL
Sbjct: 247  ----RVLLKIAKSEPPTLAQPSRWSSNFKDFL-------KKCLEKNVDARWT---TSQLL 292
Query: 1076 K 1076
            +
Sbjct: 293  Q 293

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 39/301 (12%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGS---VYRAELSSGEIVAVKKFHSPLLSEM 846
            L F     YE + R  N  D    IG  G G+   VY+A+     ++A  K       E 
Sbjct: 18   LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG 906
               ++++ E+  L    H NIVK      +  + +I+ E+   G++  ++        L 
Sbjct: 78   L--EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLT 133
Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
             +Q   V K   DAL+YLH++    I++RD+ + N+L  L+ +  ++DFG+S        
Sbjct: 134  ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 190
Query: 967  NWTELAGTIGYVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTS 1021
                  GT  ++APE+       +     K+DV+S G+  +E  + + P   ++ +    
Sbjct: 191  RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---- 246
Query: 1022 SNLDRTLDEILD---PRLPAP---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                R L +I     P L  P   S N +D L         CL++N D+R T    SQLL
Sbjct: 247  ----RVLLKIAKSEPPTLAQPSRWSSNFKDFL-------KKCLEKNVDARWT---TSQLL 292
Query: 1076 K 1076
            +
Sbjct: 293  Q 293

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 414  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 469
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 470  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 527  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            + E L E   + ++ +  IV+  G C  A    +V E  E+G L   L      ++    
Sbjct: 415  KDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKD---K 470
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + ++  V+  + YL    F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +
Sbjct: 471  NIIELVHQVSMGMKYLEESNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 969  ---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
               T     + + APE     K + KSDV+SFGVL  EA   G+ P
Sbjct: 528  KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 68/268 (25%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E  +G G  G V+ A  +    VAVK      +S     + FL E   +  ++H  +VK 
Sbjct: 20   EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKL 75
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            +   +     +I+ E++  GSL   L S+  S + L   + ++    +A+ ++++    +
Sbjct: 76   HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY 132
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKV 988
               ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + APE       
Sbjct: 133  ---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 989  TEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047
            T KSDV+SFG+L +E +  G+ P   +S     +  + R L+     R+P P  N  ++L
Sbjct: 190  TIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALER--GYRMPRPE-NCPEEL 241
Query: 1048 ISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             +IM   + C    P+ RPT + +  +L
Sbjct: 242  YNIM---MRCWKNRPEERPTFEYIQSVL 266

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Composition-based stats.
 Identities = 79/301 (26%), Positives = 132/301 (43%), Gaps = 39/301 (12%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGS---VYRAELSSGEIVAVKKFHSPLLSEM 846
            L F     YE + R  N  D    IG  G G+   VY+A+     ++A  K       E 
Sbjct: 18   LYFQSMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE 77
Query: 847  TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG 906
               ++++ E+  L    H NIVK      +  + +I+ E+   G++  ++        L 
Sbjct: 78   L--EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLT 133
Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
             +Q   V K   DAL+YLH++    I++RD+ + N+L  L+ +  ++DFG+S        
Sbjct: 134  ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQ 190
Query: 967  NWTELAGTIGYVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTS 1021
                  GT  ++APE+       +     K+DV+S G+  +E  + + P   ++ +    
Sbjct: 191  RRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---- 246
Query: 1022 SNLDRTLDEILD---PRLPAP---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                R L +I     P L  P   S N +D L         CL++N D+R T    SQLL
Sbjct: 247  ----RVLLKIAKSEPPTLAQPSRWSSNFKDFL-------KKCLEKNVDARWT---TSQLL 292
Query: 1076 K 1076
            +
Sbjct: 293  Q 293

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G V++  +  + ++VA+K     L       ++   E+  L++     
Sbjct: 24   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 81
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            + K+YG        +I+ EYL  GS   +L      E    TQ   +++ +   L YLH+
Sbjct: 82   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHS 137
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
            +     ++RDI + NVLL    E  ++DFG++  L           GT  ++APE+    
Sbjct: 138  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
                K+D++S G+ A+E  +G+ P   +  +        + L  I     P    N    
Sbjct: 195  AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTLEGNYSKP 246
Query: 1047 LISIMEVAISCLDENPDSRPTMQKV 1071
            L   +E   +CL++ P  RPT +++
Sbjct: 247  LKEFVE---ACLNKEPSFRPTAKEL 268

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 78/276 (28%), Positives = 136/276 (49%), Gaps = 40/276 (14%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G VY+A+   +G + A K   +    E+   ++++ E++ L    H  IVK  G
Sbjct: 19   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 75
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
               H    +I+ E+   G++  I+        L   Q   V + + +AL++LH+     I
Sbjct: 76   AYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RI 130
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGIS-KSLKPDSSNWTELAGTIGYVAPELAY--TMKVT 989
            ++RD+ + NVL+ LE +  ++DFG+S K+LK          GT  ++APE+    TMK T
Sbjct: 131  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDT 189
Query: 990  E---KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP---S 1040
                K+D++S G+  +E  + + P   ++ +        R L +I     P L  P   S
Sbjct: 190  PYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSDPPTLLTPSKWS 241
Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               RD     +++A   LD+NP++RP+    +QLL+
Sbjct: 242  VEFRD----FLKIA---LDKNPETRPS---AAQLLE 267

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 3e-13,   Method: Composition-based stats.
 Identities = 78/276 (28%), Positives = 136/276 (49%), Gaps = 40/276 (14%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G VY+A+   +G + A K   +    E+   ++++ E++ L    H  IVK  G
Sbjct: 27   LGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYIVEIEILATCDHPYIVKLLG 83
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
               H    +I+ E+   G++  I+        L   Q   V + + +AL++LH+     I
Sbjct: 84   AYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGIS-KSLKPDSSNWTELAGTIGYVAPELAY--TMKVT 989
            ++RD+ + NVL+ LE +  ++DFG+S K+LK          GT  ++APE+    TMK T
Sbjct: 139  IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR-DSFIGTPYWMAPEVVMCETMKDT 197
Query: 990  E---KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP---S 1040
                K+D++S G+  +E  + + P   ++ +        R L +I     P L  P   S
Sbjct: 198  PYDYKADIWSLGITLIEMAQIEPPHHELNPM--------RVLLKIAKSDPPTLLTPSKWS 249
Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               RD     +++A   LD+NP++RP+    +QLL+
Sbjct: 250  VEFRD----FLKIA---LDKNPETRPS---AAQLLE 275

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G V++  +  + ++VA+K     L       ++   E+  L++     
Sbjct: 9    FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            + K+YG        +I+ EYL  GS   +L      E    TQ   +++ +   L YLH+
Sbjct: 67   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHS 122
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
            +     ++RDI + NVLL    E  ++DFG++  L           GT  ++APE+    
Sbjct: 123  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
                K+D++S G+ A+E  +G+ P   +  +        + L  I     P    N    
Sbjct: 180  AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTLEGNYSKP 231
Query: 1047 LISIMEVAISCLDENPDSRPTMQKV 1071
            L   +E   +CL++ P  RPT +++
Sbjct: 232  LKEFVE---ACLNKEPSFRPTAKEL 253

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 117/265 (44%), Gaps = 21/265 (7%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G V++  +  + ++VA+K     L       ++   E+  L++     
Sbjct: 9    FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID--LEEAEDEIEDIQQEITVLSQCDSPY 66
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            + K+YG        +I+ EYL  GS   +L      E    TQ   +++ +   L YLH+
Sbjct: 67   VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDE----TQIATILREILKGLDYLHS 122
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
            +     ++RDI + NVLL    E  ++DFG++  L           GT  ++APE+    
Sbjct: 123  E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDK 1046
                K+D++S G+ A+E  +G+ P   +  +        + L  I     P    N    
Sbjct: 180  AYDSKADIWSLGITAIELARGEPPHSELHPM--------KVLFLIPKNNPPTLEGNYSKP 231
Query: 1047 LISIMEVAISCLDENPDSRPTMQKV 1071
            L   +E   +CL++ P  RPT +++
Sbjct: 232  LKEFVE---ACLNKEPSFRPTAKEL 253

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 14/208 (6%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG+G  G+VY+ +      V + K   P   +    Q F NEV  L + RH NI+ F G+
Sbjct: 44   IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQF---QAFRNEVAVLRKTRHVNILLFMGY 100
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +    + IV ++ E  SL   L    +  ++   Q +++ +  A  + YLH      I+
Sbjct: 101  MTKDNLA-IVTQWCEGSSLYKHLHVQETKFQM--FQLIDIARQTAQGMDYLHAK---NII 154
Query: 934  YRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPELAYTMK---V 988
            +RD+ S N+ L       + DFG++  KS    S    +  G++ ++APE+         
Sbjct: 155  HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 989  TEKSDVYSFGVLALEAIKGKHPRDFISS 1016
            + +SDVYS+G++  E + G+ P   I++
Sbjct: 215  SFQSDVYSYGIVLYELMTGELPYSHINN 242

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 115/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 86   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 142
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  +            + APE   T 
Sbjct: 143  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 200  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 253
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 254  ----IYNVMVQCWAHKPEDRPTFVALRDFL 279

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Composition-based stats.
 Identities = 74/270 (27%), Positives = 115/270 (42%), Gaps = 24/270 (8%)
Query: 814  IGTGGQGSVYRAELS--SGEIV--AVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E    SG+ V  AVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 16   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L        LG   R  V   VA+ + YL +  F
Sbjct: 76   LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYLESKRF 132
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  +            + APE   T 
Sbjct: 133  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              +  SD + FGV   E    G+ P      I    S +   +D+    RLP P    +D
Sbjct: 190  TFSHASDTWMFGVTLWEMFTYGQEPW-----IGLNGSQILHKIDK-EGERLPRPEDCPQD 243
Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                I  V + C    P+ RPT   +   L
Sbjct: 244  ----IYNVMVQCWAHKPEDRPTFVALRDFL 269

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/269 (27%), Positives = 129/269 (47%), Gaps = 20/269 (7%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 25   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 82
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 83   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 137
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 138  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 193
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                  + +SD++S G+  +E   G++P    S   +    LD  ++E   P+LP+   +
Sbjct: 194  LQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNE-PPPKLPSGVFS 252
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                 +   +    CL +NP  R  ++++
Sbjct: 253  -----LEFQDFVNKCLIKNPAERADLKQL 276

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-13,   Method: Composition-based stats.
 Identities = 66/266 (24%), Positives = 120/266 (45%), Gaps = 25/266 (9%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+    ++   VAVK      +S     Q FL E   +  ++H  +V+ Y  
Sbjct: 20   LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             +     +I+ E++  GSL   L +    + L   + ++    +A+ ++Y+    +   +
Sbjct: 76   VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIERKNY---I 131
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKVTEKS 992
            +RD+ + NVL+       ++DFG+++ ++ +     E A   I + APE       T KS
Sbjct: 132  HRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKS 191
Query: 993  DVYSFGVLALEAI---KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +V+SFG+L  E +   K  +P    + + S  S   R       PR+     N  D+L  
Sbjct: 192  NVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRM------PRME----NCPDELYD 241
Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            IM++   C  E  + RPT   +  +L
Sbjct: 242  IMKM---CWKEKAEERPTFDYLQSVL 264

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 818  GQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            G+G   + EL        ++GE VAVK       S      +   E++ L  + H NIVK
Sbjct: 18   GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVK 75
Query: 870  FYGFCSHARHSFI--VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            + G C+    + I  + E+L  GSL   L    +  ++   Q++     +   + YL + 
Sbjct: 76   YKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAY 984
             +   V+RD++++NVL++ E++  + DFG++K+++ D    T   +    + + APE   
Sbjct: 134  QY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 985  TMKVTEKSDVYSFGVLALEAI----KGKHPRD-FISSICSTS-----SNLDRTLDEILDP 1034
              K    SDV+SFGV   E +        P   F+  I  T      + L  TL E    
Sbjct: 191  QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE--GK 248
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            RLP P  N  D++  +M     C +  P +R + Q +
Sbjct: 249  RLPCPP-NCPDEVYQLMR---KCWEFQPSNRTSFQNL 281

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-13,   Method: Composition-based stats.
 Identities = 74/277 (26%), Positives = 125/277 (45%), Gaps = 36/277 (12%)
Query: 818  GQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            G+G   + EL        ++GE VAVK       S      +   E++ L  + H NIVK
Sbjct: 30   GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVK 87
Query: 870  FYGFCSHARHSFI--VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            + G C+    + I  + E+L  GSL   L    +  ++   Q++     +   + YL + 
Sbjct: 88   YKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT---ELAGTIGYVAPELAY 984
             +   V+RD++++NVL++ E++  + DFG++K+++ D    T   +    + + APE   
Sbjct: 146  QY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 985  TMKVTEKSDVYSFGVLALEAI----KGKHPRD-FISSICSTS-----SNLDRTLDEILDP 1034
              K    SDV+SFGV   E +        P   F+  I  T      + L  TL E    
Sbjct: 203  QSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE--GK 260
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            RLP P  N  D++  +M     C +  P +R + Q +
Sbjct: 261  RLPCPP-NCPDEVYQLMR---KCWEFQPSNRTSFQNL 293

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 69/238 (28%), Positives = 116/238 (48%), Gaps = 44/238 (18%)
Query: 817  GGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH 876
            G  G V++A+L + E VAVK F  P+  + + Q E+  EV SL  ++H NI++F G  + 
Sbjct: 35   GRFGCVWKAQLLN-EYVAVKIF--PIQDKQSWQNEY--EVYSLPGMKHENILQFIG--AE 87
Query: 877  ARHS------FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC-- 928
             R +      +++  + E GSL    S+   A  + W +  ++ + +A  L+YLH D   
Sbjct: 88   KRGTSVDVDLWLITAFHEKGSL----SDFLKANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 929  -----FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPE 981
                  P I +RDI SKNVLL     A ++DFG++   +   S  +     GT  Y+APE
Sbjct: 144  LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 982  -----LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
                 + +      + D+Y+ G++  E          ++S C+ +   D  +DE + P
Sbjct: 204  VLEGAINFQRDAFLRIDMYAMGLVLWE----------LASRCTAA---DGPVDEYMLP 248

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 54/200 (27%), Positives = 96/200 (48%), Gaps = 9/200 (4%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GT G+  +   +L+ G  VAVK  +   +  +    +   E+++L   RH +I+K Y  
Sbjct: 21   VGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     F+V EY+  G L   +      EE+   +   + + +  A+ Y H      +V
Sbjct: 80   ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSAVDYCHRHM---VV 133
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEKS 992
            +RD+  +NVLLD    A ++DFG+S ++  D     +  G+  Y APE ++  +    + 
Sbjct: 134  HRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEV 192
Query: 993  DVYSFGVLALEAIKGKHPRD 1012
            D++S GV+    + G  P D
Sbjct: 193  DIWSCGVILYALLCGTLPFD 212

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 128/268 (47%), Gaps = 24/268 (8%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E  +G G  G V+ A  +    VAVK      +S     + FL E   +  ++H  +VK 
Sbjct: 193  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKL 248
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            +   +     +I+ E++  GSL   L S+  S + L   + ++    +A+ ++++    +
Sbjct: 249  HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY 305
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG-TIGYVAPELAYTMKV 988
               ++RD+ + N+L+       ++DFG+++ ++ +     E A   I + APE       
Sbjct: 306  ---IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 989  TEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047
            T KSDV+SFG+L +E +  G+ P   +S     +  + R L+     R+P P  N  ++L
Sbjct: 363  TIKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALERGY--RMPRPE-NCPEEL 414
Query: 1048 ISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             +IM   + C    P+ RPT + +  +L
Sbjct: 415  YNIM---MRCWKNRPEERPTFEYIQSVL 439

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 74/301 (24%), Positives = 136/301 (45%), Gaps = 35/301 (11%)
Query: 793  DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQ 849
            D  + ++  ++   D  E H     G+ S+Y  + +   +GE+VAVK   +    +   +
Sbjct: 24   DPTVFHKRYLKKIRDLGEGHF----GKVSLYCYDPTNDGTGEMVAVKALKADAGPQH--R 77
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI--VYEYLEMGSLAMILSNATSAEELGW 907
              +  E+  L  + H +I+K+ G C  A  + +  V EY+ +GSL   L   +    +G 
Sbjct: 78   SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGL 133
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q +   + + + ++YLH   +   ++RD++++NVLLD +    + DFG++K++      
Sbjct: 134  AQLLLFAQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEX 190
Query: 968  W---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-----KGKHPRDFISSICS 1019
            +    +    + + APE     K    SDV+SFGV   E +         P  F+  I  
Sbjct: 191  YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
Query: 1020 TSSNLD-RTLDEILD--PRLPAPSCNIRDKL-ISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                +    L E+L+   RLP P     DK    +  +  +C +     RPT + +  +L
Sbjct: 251  AQGQMTVLRLTELLERGERLPRP-----DKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 1076 K 1076
            K
Sbjct: 306  K 306

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-12,   Method: Composition-based stats.
 Identities = 64/208 (30%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 808  FDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F+ +  +GTG    V  AE  ++G++ AVK      L       E  NE+  L +I+H N
Sbjct: 24   FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE--NEIAVLRKIKHEN 81
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            IV          H ++V + +  G L   I+      E+   T    +I+ V DA+ YLH
Sbjct: 82   IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST----LIRQVLDAVYYLH 137
Query: 926  NDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
                  IV+RD+  +N+L    D E +  +SDFG+SK ++      +   GT GYVAPE+
Sbjct: 138  R---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPEV 193
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  ++  D +S GV+A   + G  P
Sbjct: 194  LAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G+VY A ++ + E+VA+KK            Q+ + EV+ L ++RH N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
             +++ G       +++V EY  +GS + +L      + L   +   V  G    L+YLH+
Sbjct: 77   TIQYRGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 +++RD+ + N+LL       + DFG +  + P +       GT  ++APE+   M
Sbjct: 134  H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 186
Query: 987  KVTE---KSDVYSFGVLALEAIKGKHP 1010
               +   K DV+S G+  +E  + K P
Sbjct: 187  DEGQYDGKVDVWSLGITCIELAERKPP 213

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 127/271 (46%), Gaps = 18/271 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 64   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 119  YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
                  + +SD++S G+  +E   G++P           S     + E+LD  +  P   
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYP--IPPPDAKEDSRPPMAIFELLDYIVNEPPPK 232
Query: 1043 IRDKLISI--MEVAISCLDENPDSRPTMQKV 1071
            +   + S+   +    CL +NP  R  ++++
Sbjct: 233  LPSGVFSLEFQDFVNKCLIKNPAERADLKQL 263

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G+VY A ++ + E+VA+KK            Q+ + EV+ L ++RH N
Sbjct: 56   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
             +++ G       +++V EY  +GS + +L      + L   +   V  G    L+YLH+
Sbjct: 116  TIQYRGCYLREHTAWLVMEYC-LGSASDLLE--VHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 +++RD+ + N+LL       + DFG +  + P +       GT  ++APE+   M
Sbjct: 173  H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX----FVGTPYWMAPEVILAM 225
Query: 987  KVTE---KSDVYSFGVLALEAIKGKHP 1010
               +   K DV+S G+  +E  + K P
Sbjct: 226  DEGQYDGKVDVWSLGITCIELAERKPP 252

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 74/302 (24%), Positives = 138/302 (45%), Gaps = 37/302 (12%)
Query: 793  DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQ 849
            D  + ++  ++   D  E H     G+ S+Y  + +   +GE+VAVK   +    +   +
Sbjct: 7    DPTVFHKRYLKKIRDLGEGHF----GKVSLYCYDPTNDGTGEMVAVKALKADCGPQH--R 60
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCS-HARHSF-IVYEYLEMGSLAMILSNATSAEELGW 907
              +  E+  L  + H +I+K+ G C      S  +V EY+ +GSL   L   +    +G 
Sbjct: 61   SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGL 116
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q +   + + + ++YLH+  +   ++R+++++NVLLD +    + DFG++K++ P+   
Sbjct: 117  AQLLLFAQQICEGMAYLHSQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHE 172
Query: 968  WTELA----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-----KGKHPRDFISSIC 1018
            +  +       + + APE     K    SDV+SFGV   E +         P  F+  I 
Sbjct: 173  YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 232
Query: 1019 STSSNLD-RTLDEILD--PRLPAPSCNIRDKL-ISIMEVAISCLDENPDSRPTMQKVSQL 1074
                 +    L E+L+   RLP P     DK    +  +  +C +     RPT + +  +
Sbjct: 233  IAQGQMTVLRLTELLERGERLPRP-----DKCPCEVYHLMKNCWETEASFRPTFENLIPI 287
Query: 1075 LK 1076
            LK
Sbjct: 288  LK 289

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-12,   Method: Composition-based stats.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GT G+  +   +L+ G  VAVK  +   +  +    +   E+++L   RH +I+K Y  
Sbjct: 21   VGTFGKVKIGEHQLT-GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
             S     F+V EY+  G L   +      EE+   +   + + +  A+ Y H      +V
Sbjct: 80   ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM---EARRLFQQILSAVDYCHRHM---VV 133
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEKS 992
            +RD+  +NVLLD    A ++DFG+S ++  D        G+  Y APE ++  +    + 
Sbjct: 134  HRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEV 192
Query: 993  DVYSFGVLALEAIKGKHPRD 1012
            D++S GV+    + G  P D
Sbjct: 193  DIWSCGVILYALLCGTLPFD 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 31/269 (11%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQ---EFLNEVKSLTEIRHRNIVK 869
            +G+G  G+VY+   +  GE V +      +L+E T  +   EF++E   +  + H ++V+
Sbjct: 46   LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
              G C       +V + +  G L   +      + +G    +N    +A  + YL     
Sbjct: 105  LLGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER-- 159
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTMK 987
              +V+RD++++NVL+       ++DFG+++ L+ D   +    G   I ++A E  +  K
Sbjct: 160  -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 218
Query: 988  VTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS-CNI 1043
             T +SDV+S+GV   E +  G  P D I +         R + ++L+   RLP P  C  
Sbjct: 219  FTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPICT- 268
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVS 1072
                I +  V + C   + DSRP  ++++
Sbjct: 269  ----IDVYMVMVKCWMIDADSRPKFKELA 293

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-12,   Method: Composition-based stats.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 31/269 (11%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQ---EFLNEVKSLTEIRHRNIVK 869
            +G+G  G+VY+   +  GE V +      +L+E T  +   EF++E   +  + H ++V+
Sbjct: 23   LGSGAFGTVYKGIWVPEGETVKIP-VAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 81
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
              G C       +V + +  G L   +      + +G    +N    +A  + YL     
Sbjct: 82   LLGVCLSPTIQ-LVTQLMPHGCLLEYVHE--HKDNIGSQLLLNWCVQIAKGMMYLEER-- 136
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTMK 987
              +V+RD++++NVL+       ++DFG+++ L+ D   +    G   I ++A E  +  K
Sbjct: 137  -RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK 195
Query: 988  VTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS-CNI 1043
             T +SDV+S+GV   E +  G  P D I +         R + ++L+   RLP P  C  
Sbjct: 196  FTHQSDVWSYGVTIWELMTFGGKPYDGIPT---------REIPDLLEKGERLPQPPICT- 245
Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVS 1072
                I +  V + C   + DSRP  ++++
Sbjct: 246  ----IDVYMVMVKCWMIDADSRPKFKELA 270

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E +R   DF +   +GTG    V  AE   + ++VA+K      L       E  NE+  
Sbjct: 14   EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAV 69
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIKG 916
            L +I+H NIV          H +++ + +  G L   +      E+  +T+R    +I  
Sbjct: 70   LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQ 124
Query: 917  VADALSYLHNDCFPPIVYRDISSKNVL---LDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
            V DA+ YLH+     IV+RD+  +N+L   LD + +  +SDFG+SK   P S   T   G
Sbjct: 125  VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            T GYVAPE+      ++  D +S GV+A   + G  P
Sbjct: 181  TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E +R   DF +   +GTG    V  AE   + ++VA+K      L       E  NE+  
Sbjct: 14   EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAV 69
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIKG 916
            L +I+H NIV          H +++ + +  G L   +      E+  +T+R    +I  
Sbjct: 70   LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQ 124
Query: 917  VADALSYLHNDCFPPIVYRDISSKNVL---LDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
            V DA+ YLH+     IV+RD+  +N+L   LD + +  +SDFG+SK   P S   T   G
Sbjct: 125  VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            T GYVAPE+      ++  D +S GV+A   + G  P
Sbjct: 181  TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E +R   DF +   +GTG    V  AE   + ++VA+K      L       E  NE+  
Sbjct: 14   EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAV 69
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIKG 916
            L +I+H NIV          H +++ + +  G L   +      E+  +T+R    +I  
Sbjct: 70   LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQ 124
Query: 917  VADALSYLHNDCFPPIVYRDISSKNVL---LDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
            V DA+ YLH+     IV+RD+  +N+L   LD + +  +SDFG+SK   P S   T   G
Sbjct: 125  VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            T GYVAPE+      ++  D +S GV+A   + G  P
Sbjct: 181  TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 68/217 (31%), Positives = 104/217 (47%), Gaps = 19/217 (8%)
Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E +R   DF +   +GTG    V  AE   + ++VA+K      L       E  NE+  
Sbjct: 14   EDIRDIYDFRD--VLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSME--NEIAV 69
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIKG 916
            L +I+H NIV          H +++ + +  G L   +      E+  +T+R    +I  
Sbjct: 70   LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQ 124
Query: 917  VADALSYLHNDCFPPIVYRDISSKNVL---LDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
            V DA+ YLH+     IV+RD+  +N+L   LD + +  +SDFG+SK   P S   T   G
Sbjct: 125  VLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA-CG 180
Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            T GYVAPE+      ++  D +S GV+A   + G  P
Sbjct: 181  TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 217

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-12,   Method: Composition-based stats.
 Identities = 74/302 (24%), Positives = 137/302 (45%), Gaps = 37/302 (12%)
Query: 793  DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQ 849
            D  + ++  ++   D  E H     G+ S+Y  + +   +GE+VAVK   +    +   +
Sbjct: 7    DPTVFHKRYLKKIRDLGEGHF----GKVSLYCYDPTNDGTGEMVAVKALKADCGPQH--R 60
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCS-HARHSF-IVYEYLEMGSLAMILSNATSAEELGW 907
              +  E+  L  + H +I+K+ G C      S  +V EY+ +GSL   L   +    +G 
Sbjct: 61   SGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS----IGL 116
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q +   + + + ++YLH   +   ++R+++++NVLLD +    + DFG++K++ P+   
Sbjct: 117  AQLLLFAQQICEGMAYLHAQHY---IHRNLAARNVLLDNDRLVKIGDFGLAKAV-PEGHE 172
Query: 968  WTELA----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-----KGKHPRDFISSIC 1018
            +  +       + + APE     K    SDV+SFGV   E +         P  F+  I 
Sbjct: 173  YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 232
Query: 1019 STSSNLD-RTLDEILD--PRLPAPSCNIRDKL-ISIMEVAISCLDENPDSRPTMQKVSQL 1074
                 +    L E+L+   RLP P     DK    +  +  +C +     RPT + +  +
Sbjct: 233  IAQGQMTVLRLTELLERGERLPRP-----DKCPCEVYHLMKNCWETEASFRPTFENLIPI 287
Query: 1075 LK 1076
            LK
Sbjct: 288  LK 289

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 65/276 (23%), Positives = 119/276 (43%), Gaps = 21/276 (7%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F  E  IG G    VYRA  L  G  VA+KK     L +   + + + E+  L ++ H 
Sbjct: 33   NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM-NVIKGVADALSYL 924
            N++K+Y          IV E  + G L+ ++ +    + L   + +      +  AL ++
Sbjct: 93   NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     +++RDI   NV +       + D G+ +     ++    L GT  Y++PE  +
Sbjct: 153  HSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP----RDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
                  KSD++S G L  E    + P    +  + S+C      D           P PS
Sbjct: 210  ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP---------PLPS 260
Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +  ++L  ++ +   C++ +P+ RP +  V  + K
Sbjct: 261  DHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAK 293

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G VY+A+ + GE  A+KK       E       + E+  L E++H NIVK Y  
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68
Query: 874  CSHARHSFIVYEYLEMGSLAMI------LSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                +   +V+E+L+     ++      L + T+   L     + ++ G+A    Y H+ 
Sbjct: 69   IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA----YCHDR 119
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTM 986
                +++RD+  +N+L++ E E  ++DFG++++       +T    T+ Y AP+ L  + 
Sbjct: 120  ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 987  KVTEKSDVYSFGVLALEAIKG 1007
            K +   D++S G +  E + G
Sbjct: 177  KYSTTIDIWSVGCIFAEMVNG 197

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Composition-based stats.
 Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF+    +G G  G V + +   SG I+A K  H  L  +   + + + E++ L E   
Sbjct: 16   DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIH--LEIKPAIRNQIIRELQVLHECNS 73
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    EE+     + V++G    L+
Sbjct: 74   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG----LA 128
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y+APE 
Sbjct: 129  YLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMAPER 184
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 185  LQGTHYSVQSDIWSMGLSLVELAVGRYP 212

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G VY+A+ + GE  A+KK       E       + E+  L E++H NIVK Y  
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68
Query: 874  CSHARHSFIVYEYLEMGSLAMI------LSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                +   +V+E+L+     ++      L + T+   L     + ++ G+A    Y H+ 
Sbjct: 69   IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA----YCHDR 119
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTM 986
                +++RD+  +N+L++ E E  ++DFG++++       +T    T+ Y AP+ L  + 
Sbjct: 120  ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 987  KVTEKSDVYSFGVLALEAIKG 1007
            K +   D++S G +  E + G
Sbjct: 177  KYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 64   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 119  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 64   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 119  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 89/264 (33%), Positives = 131/264 (49%), Gaps = 25/264 (9%)
Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
             NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L 
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELS 137
Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILP 532
            N ++ +IS   G+ S L  +N S  +       D     NL TL   D+S+N ++ I  
Sbjct: 138 SNTIS-DISALSGLTS-LQQLNFSSNQVT-----DLKPLANLTTLERLDISSNKVSDI-- 188
Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
             +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  L
Sbjct: 189 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 244
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIP 652
           DL++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I 
Sbjct: 245 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI- 298
Query: 653 SQVCSMQSLEKLNLAHNNLSGFIP 676
           S + ++++L  L L  NN+S   P
Sbjct: 299 SPISNLKNLTYLTLYFNNISDISP 322

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 68   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 125
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 126  PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 180
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 181  YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 236
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 237  LQGTHYSVQSDIWSMGLSLVEMAVGRYP 264

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 64   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 119  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 6    DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 63
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 64   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 119  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 174
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYP 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 10   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 70   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 123
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 124  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 181  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 56   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 113  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 170
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 171  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 228  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 283
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 284  --------LYEVMLKCWHPKAEMRPSFSEL 305

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 65   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 118
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 176  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 65   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 118
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 176  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 65   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 118
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 176  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 35/221 (15%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +G G  G V+++ +  +GE+VAVKK      +    Q+ F  E+  LTE+  H NIV   
Sbjct: 17   LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 872  GF--CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                  + R  ++V++Y+E    A+I +N      L    +  V+  +   + YLH+   
Sbjct: 76   NVLRADNDRDVYLVFDYMETDLHAVIRANI-----LEPVHKQYVVYQLIKVIKYLHSGG- 129
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKS---------------------LKPDSSNW 968
              +++RD+   N+LL+ E    V+DFG+S+S                        D    
Sbjct: 130  --LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 969  TELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            T+   T  Y APE+   + K T+  D++S G +  E + GK
Sbjct: 188  TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 8    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 68   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 121
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 122  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 179  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 207

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 65   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 118
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 176  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Composition-based stats.
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 13/209 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V    E ++G   A+K     ++         + E + L   RH
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG--VADAL 921
              +    Y F +H R  F++ EY   G L   LS      E  +T+      G  +  AL
Sbjct: 65   PFLTALKYAFQTHDRLCFVM-EYANGGELFFHLS-----RERVFTEERARFYGAEIVSAL 118
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             YLH+     +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE
Sbjct: 119  EYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +          D +  GV+  E + G+ P
Sbjct: 176  VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 128/264 (48%), Gaps = 25/264 (9%)
Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
             NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L 
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELS 137
Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILP 532
            N ++ +IS   G+ S      L    F      D     NL TL   D+S+N ++ I  
Sbjct: 138 SNTIS-DISALSGLTS------LQQLSFSSNQVTDLKPLANLTTLERLDISSNKVSDI-- 188
Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
             +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  L
Sbjct: 189 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 244
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIP 652
           DL++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I 
Sbjct: 245 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI- 298
Query: 653 SQVCSMQSLEKLNLAHNNLSGFIP 676
           S + ++++L  L L  NN+S   P
Sbjct: 299 SPISNLKNLTYLTLYFNNISDISP 322

>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 128/264 (48%), Gaps = 25/264 (9%)
Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
             NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L 
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELS 137
Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILP 532
            N ++ +IS   G+ S      L    F      D     NL TL   D+S+N ++ I  
Sbjct: 138 SNTIS-DISALSGLTS------LQQLSFSSNQVTDLKPLANLTTLERLDISSNKVSDI-- 188
Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
             +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  L
Sbjct: 189 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 244
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIP 652
           DL++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I 
Sbjct: 245 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI- 298
Query: 653 SQVCSMQSLEKLNLAHNNLSGFIP 676
           S + ++++L  L L  NN+S   P
Sbjct: 299 SPISNLKNLTYLTLYFNNISDISP 322

>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 131/264 (49%), Gaps = 26/264 (9%)
Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
             NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L 
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELS 137
Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILP 532
            N ++ +IS   G+ S      L    F  +++ D     NL TL   D+S+N ++ I  
Sbjct: 138 SNTIS-DISALSGLTS------LQQLNFGNQVT-DLKPLANLTTLERLDISSNKVSDI-- 187
Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
             +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  L
Sbjct: 188 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 243
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIP 652
           DL++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I 
Sbjct: 244 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI- 297
Query: 653 SQVCSMQSLEKLNLAHNNLSGFIP 676
           S + ++++L  L L  NN+S   P
Sbjct: 298 SPISNLKNLTYLTLYFNNISDISP 321

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 30/287 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTE 861
            N+      +G G  G V  A     G+  AV K    +L       E    ++E+K ++ 
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 862  I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE-------ELGWTQRMNV 913
            + +H NIV   G C+H     ++ EY   G L   L     A+        L     ++ 
Sbjct: 106  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 165
Query: 914  IKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
               VA  +++L + +C    ++RD++++NVLL   + A + DFG+++ +  DS+   +  
Sbjct: 166  SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 221
Query: 973  G--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLD 1029
                + ++APE  +    T +SDV+S+G+L  E    G +P   I  + S    L +   
Sbjct: 222  ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGY 280
Query: 1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            ++  P   AP       + SIM+   +C    P  RPT Q++   L+
Sbjct: 281  QMAQPAF-APK-----NIYSIMQ---ACWALEPTHRPTFQQICSFLQ 318

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 57   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 114  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 171
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 172  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 229  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 284
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 285  --------LYEVMLKCWHPKAEMRPSFSEL 306

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 20/201 (9%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G VY+A+ + GE  A+KK       E       + E+  L E++H NIVK Y  
Sbjct: 10   IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDV 68
Query: 874  CSHARHSFIVYEYLEMGSLAMI------LSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                +   +V+E+L+     ++      L + T+   L     + ++ G+A    Y H+ 
Sbjct: 69   IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-----LQLLNGIA----YCHDR 119
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTM 986
                +++RD+  +N+L++ E E  ++DFG++++       +T    T+ Y AP+ L  + 
Sbjct: 120  ---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 987  KVTEKSDVYSFGVLALEAIKG 1007
            K +   D++S G +  E + G
Sbjct: 177  KYSTTIDIWSVGCIFAEMVNG 197

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Composition-based stats.
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 859  LTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIK 915
            L E+ H  IVK  Y F +  +  +++ ++L  G L   LS     +E+ +T+      + 
Sbjct: 80   LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLA 133
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +A AL +LH+     I+YRD+  +N+LLD E    ++DFG+SK             GT+
Sbjct: 134  ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE+      T+ +D +SFGVL  E + G  P
Sbjct: 191  EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 30   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 87   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 144
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 145  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 202  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 257
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 258  --------LYEVMLKCWHPKAEMRPSFSEL 279

>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 88/264 (33%), Positives = 131/264 (49%), Gaps = 26/264 (9%)
Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
             NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L 
Sbjct: 81  LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELS 137
Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILP 532
            N ++ +IS   G+ S      L    F  +++ D     NL TL   D+S+N ++ I  
Sbjct: 138 SNTIS-DISALSGLTS------LQQLNFGNQVT-DLKPLANLTTLERLDISSNKVSDI-- 187
Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
             +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  L
Sbjct: 188 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDL 243
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIP 652
           DL++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I 
Sbjct: 244 DLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI- 297
Query: 653 SQVCSMQSLEKLNLAHNNLSGFIP 676
           S + ++++L  L L  NN+S   P
Sbjct: 298 SPISNLKNLTYLTLYFNNISDISP 321

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 37   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 94   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS----NWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 152  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 209  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 264
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 265  --------LYEVMLKCWHPKAEMRPSFSEL 286

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
           NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L  N
Sbjct: 87  NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSN 143
Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILPPE 534
            ++ +IS   G+ S      L    F  +++ D     NL TL   D+S+N ++ I    
Sbjct: 144 TIS-DISALSGLTS------LQQLSFGNQVT-DLKPLANLTTLERLDISSNKVSDI--SV 193
Query: 535 IGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDL 594
           +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  LDL
Sbjct: 194 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 249
Query: 595 SSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQ 654
           ++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I S 
Sbjct: 250 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI-SP 303
Query: 655 VCSMQSLEKLNLAHNNLSGFIP 676
           + ++++L  L L  NN+S   P
Sbjct: 304 ISNLKNLTYLTLYFNNISDISP 325

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 73/287 (25%), Positives = 128/287 (44%), Gaps = 30/287 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTE 861
            N+      +G G  G V  A     G+  AV K    +L       E    ++E+K ++ 
Sbjct: 38   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 97
Query: 862  I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE-------ELGWTQRMNV 913
            + +H NIV   G C+H     ++ EY   G L   L     A+        L     ++ 
Sbjct: 98   LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHF 157
Query: 914  IKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
               VA  +++L + +C    ++RD++++NVLL   + A + DFG+++ +  DS+   +  
Sbjct: 158  SSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 213
Query: 973  G--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLD 1029
                + ++APE  +    T +SDV+S+G+L  E    G +P   I  + S    L +   
Sbjct: 214  ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGY 272
Query: 1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            ++  P   AP       + SIM+   +C    P  RPT Q++   L+
Sbjct: 273  QMAQPAF-APK-----NIYSIMQ---ACWALEPTHRPTFQQICSFLQ 310

>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 88/262 (33%), Positives = 131/262 (50%), Gaps = 26/262 (9%)
Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
           NLT ++ + + +N ++   P    NL  LT L L  NQ+    P L+NLT L R+ L  N
Sbjct: 88  NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-LKNLTNLNRLELSSN 144
Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL---DVSANNITGILPPE 534
            ++ +IS   G+ S      L    F  +++ D     NL TL   D+S+N ++ I    
Sbjct: 145 TIS-DISALSGLTS------LQQLSFGNQVT-DLKPLANLTTLERLDISSNKVSDI--SV 194
Query: 535 IGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDL 594
           +     L+ L  ++N I    P  LG L +L +L+LN NQ        L SL  L  LDL
Sbjct: 195 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 250
Query: 595 SSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQ 654
           ++N++SN  P  L  L KL  L L  NQ S   P  L     L++L+L+ N L E+I S 
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQL-EDI-SP 304
Query: 655 VCSMQSLEKLNLAHNNLSGFIP 676
           + ++++L  L L  NN+S   P
Sbjct: 305 ISNLKNLTYLTLYFNNISDISP 326

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 859  LTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIK 915
            L E+ H  IVK  Y F +  +  +++ ++L  G L   LS     +E+ +T+      + 
Sbjct: 81   LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLA 134
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +A AL +LH+     I+YRD+  +N+LLD E    ++DFG+SK             GT+
Sbjct: 135  ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 191
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE+      T+ +D +SFGVL  E + G  P
Sbjct: 192  EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 226

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 50/155 (32%), Positives = 80/155 (51%), Gaps = 12/155 (7%)
Query: 859  LTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIK 915
            L E+ H  IVK  Y F +  +  +++ ++L  G L   LS     +E+ +T+      + 
Sbjct: 80   LVEVNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLA 133
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +A AL +LH+     I+YRD+  +N+LLD E    ++DFG+SK             GT+
Sbjct: 134  ELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 190
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE+      T+ +D +SFGVL  E + G  P
Sbjct: 191  EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 35   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 92   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 149
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 150  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 207  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 262
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 263  --------LYEVMLKCWHPKAEMRPSFSEL 284

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 75/303 (24%), Positives = 138/303 (45%), Gaps = 39/303 (12%)
Query: 793  DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQ 849
            D  + ++  ++   D  E H     G+ S+Y  + +   +GE+VAVK        ++  +
Sbjct: 1    DPTVFHKRYLKKIRDLGEGHF----GKVSLYCYDPTNDGTGEMVAVKALKEGCGPQL--R 54
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGW 907
              +  E++ L  + H +IVK+ G C     +   +V EY+ +GSL   L        +G 
Sbjct: 55   SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 110
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q +   + + + ++YLH   +   ++R ++++NVLLD +    + DFG++K++ P+   
Sbjct: 111  AQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHE 166
Query: 968  WTELA----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI------KGKHPRDFISSI 1017
            +  +       + + APE     K    SDV+SFGV   E +      +  H + F   I
Sbjct: 167  YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTK-FTELI 225
Query: 1018 CSTSSNLD-RTLDEILD--PRLPAPSCNIRDKL-ISIMEVAISCLDENPDSRPTMQKVSQ 1073
              T   +    L E+L+   RLP P     D+    I  +  +C +     RPT Q +  
Sbjct: 226  GHTQGQMTVLRLTELLERGERLPRP-----DRCPCEIYHLMKNCWETEASFRPTFQNLVP 280
Query: 1074 LLK 1076
            +L+
Sbjct: 281  ILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 75/303 (24%), Positives = 138/303 (45%), Gaps = 39/303 (12%)
Query: 793  DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQ 849
            D  + ++  ++   D  E H     G+ S+Y  + +   +GE+VAVK        ++  +
Sbjct: 2    DPTVFHKRYLKKIRDLGEGHF----GKVSLYCYDPTNDGTGEMVAVKALKEGCGPQL--R 55
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGW 907
              +  E++ L  + H +IVK+ G C     +   +V EY+ +GSL   L        +G 
Sbjct: 56   SGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC----VGL 111
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q +   + + + ++YLH   +   ++R ++++NVLLD +    + DFG++K++ P+   
Sbjct: 112  AQLLLFAQQICEGMAYLHAQHY---IHRALAARNVLLDNDRLVKIGDFGLAKAV-PEGHE 167
Query: 968  WTELA----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI------KGKHPRDFISSI 1017
            +  +       + + APE     K    SDV+SFGV   E +      +  H + F   I
Sbjct: 168  YYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTK-FTELI 226
Query: 1018 CSTSSNLD-RTLDEILD--PRLPAPSCNIRDKL-ISIMEVAISCLDENPDSRPTMQKVSQ 1073
              T   +    L E+L+   RLP P     D+    I  +  +C +     RPT Q +  
Sbjct: 227  GHTQGQMTVLRLTELLERGERLPRP-----DRCPCEIYHLMKNCWETEASFRPTFQNLVP 281
Query: 1074 LLK 1076
            +L+
Sbjct: 282  ILQ 284

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 14/208 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++ +   SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 33   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90
Query: 865  RNIVKFYG-FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALS 922
              IV FYG F S    S I  E+++ GSL  +L  A    E++     + VIKG    L+
Sbjct: 91   PYIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKG----LT 145
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +N     GT  Y++PE 
Sbjct: 146  YLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFVGTRSYMSPER 201
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +SD++S G+  +E   G++P
Sbjct: 202  LQGTHYSVQSDIWSMGLSLVEMAVGRYP 229

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 814  IGTGGQGSVYRA--ELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G G  GSV +    +   +I VA+K       +E    +E + E + + ++ +  IV+ 
Sbjct: 18   LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
             G C  A    +V E    G L   L      EE+  +    ++  V+  + YL    F 
Sbjct: 76   IGVC-QAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEKNF- 131
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG---TIGYVAPELAYTMK 987
              V+RD++++NVLL   + A +SDFG+SK+L  D S +T  +     + + APE     K
Sbjct: 132  --VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 988  VTEKSDVYSFGVLALEAIK-GKHP 1010
             + +SDV+S+GV   EA+  G+ P
Sbjct: 190  FSSRSDVWSYGVTMWEALSYGQKP 213

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEIXINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 33   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 90   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 147
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 148  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 205  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 260
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 261  --------LYEVMLKCWHPKAEMRPSFSEL 282

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 38   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 153  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 210  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 265
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 266  --------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 122/300 (40%), Gaps = 60/300 (20%)
Query: 802  VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
            +R  +DF+E   +G G  G V +A  +      A+KK         T     L+EV  L 
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLA 57
Query: 861  EIRHRNIVKFYGFCSHARHS-------------FIVYEYLEMGSLAMIL--SNATSAEEL 905
             + H+ +V++Y      R+              FI  EY E G+L  ++   N     + 
Sbjct: 58   SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE 117
Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS----- 960
             W     + + + +ALSY+H+     I++RD+   N+ +D      + DFG++K+     
Sbjct: 118  YW----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 961  --LKPDSS-------NWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI----K 1006
              LK DS        N T   GT  YVA E L  T    EK D+YS G++  E I     
Sbjct: 171  DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G    + +  + S S            P        +  K+I ++      +D +P+ RP
Sbjct: 231  GMERVNILKKLRSVSIE--------FPPDFDDNKMKVEKKIIRLL------IDHDPNKRP 276

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 36   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 93   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 150
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 151  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 208  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 263
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 264  --------LYEVMLKCWHPKAEMRPSFSEL 285

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 37   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 94   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 151
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 152  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 209  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 264
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 265  --------LYEVMLKCWHPKAEMRPSFSEL 286

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 69/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 38   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + YL + 
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK 152
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 153  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 210  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 265
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 266  --------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            +GTGG G V R     +GE VA+K+    L  +   ++ +  E++ + ++ H N+V    
Sbjct: 22   LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79
Query: 872  ---GFCSHARHSF--IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
               G    A +    +  EY E G L   L+   +   L       ++  ++ AL YLH 
Sbjct: 80   VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 927  DCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +N++L    +     + D G +K L       TE  GT+ Y+APEL 
Sbjct: 140  N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPELL 195
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               K T   D +SFG LA E I G  P
Sbjct: 196  EQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            +GTGG G V R     +GE VA+K+    L  +   ++ +  E++ + ++ H N+V    
Sbjct: 23   LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 80
Query: 872  ---GFCSHARHSF--IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
               G    A +    +  EY E G L   L+   +   L       ++  ++ AL YLH 
Sbjct: 81   VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 927  DCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +N++L    +     + D G +K L       TE  GT+ Y+APEL 
Sbjct: 141  N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFVGTLQYLAPELL 196
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               K T   D +SFG LA E I G  P
Sbjct: 197  EQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 76/292 (26%), Positives = 130/292 (44%), Gaps = 51/292 (17%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            ND   +  IG G  G V +A +    +    A+K+      +     ++F  E++ L ++
Sbjct: 15   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKL 72
Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--------------AMILSNATSAEELGW 907
              H NI+   G C H  + ++  EY   G+L              A  ++N+T A  L  
Sbjct: 73   GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSS 131
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q ++    VA  + YL    F   ++RD++++N+L+   Y A ++DFG+S+  +     
Sbjct: 132  QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE----- 183
Query: 968  WTELAGTIG-----YVAPE-LAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS- 1019
               +  T+G     ++A E L Y++  T  SDV+S+GVL  E +  G  P       C  
Sbjct: 184  -VYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP------YCGM 235
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            T + L   L +    RL  P  N  D++  +M     C  E P  RP+  ++
Sbjct: 236  TCAELYEKLPQ--GYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQI 281

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 76/292 (26%), Positives = 130/292 (44%), Gaps = 51/292 (17%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            ND   +  IG G  G V +A +    +    A+K+      +     ++F  E++ L ++
Sbjct: 25   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKL 82
Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--------------AMILSNATSAEELGW 907
              H NI+   G C H  + ++  EY   G+L              A  ++N+T A  L  
Sbjct: 83   GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSS 141
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q ++    VA  + YL    F   ++RD++++N+L+   Y A ++DFG+S+  +     
Sbjct: 142  QQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGLSRGQE----- 193
Query: 968  WTELAGTIG-----YVAPE-LAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS- 1019
               +  T+G     ++A E L Y++  T  SDV+S+GVL  E +  G  P       C  
Sbjct: 194  -VYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP------YCGM 245
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            T + L   L +    RL  P  N  D++  +M     C  E P  RP+  ++
Sbjct: 246  TCAELYEKLPQ--GYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQI 291

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINAMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 21/238 (8%)
Query: 808  FDEEHCIGTGGQGSVYRAE----LSSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEI 862
            F+    +G GG G V++       ++G+I A+K     ++            E   L E+
Sbjct: 19   FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 863  RHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +H  IV   Y F +  +  +++ EYL  G L M L       E         +  ++ AL
Sbjct: 79   KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMAL 134
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             +LH      I+YRD+  +N++L+ +    ++DFG+ K    D +      GTI Y+APE
Sbjct: 135  GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPE 191
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            +          D +S G L  + + G  P         T  N  +T+D+IL  +L  P
Sbjct: 192  ILMRSGHNRAVDWWSLGALMYDMLTGAPP--------FTGENRKKTIDKILKCKLNLP 241

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 21/238 (8%)
Query: 808  FDEEHCIGTGGQGSVYRAE----LSSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEI 862
            F+    +G GG G V++       ++G+I A+K     ++            E   L E+
Sbjct: 19   FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 863  RHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +H  IV   Y F +  +  +++ EYL  G L M L       E         +  ++ AL
Sbjct: 79   KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFME---DTACFYLAEISMAL 134
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             +LH      I+YRD+  +N++L+ +    ++DFG+ K    D +      GTI Y+APE
Sbjct: 135  GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPE 191
Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            +          D +S G L  + + G  P         T  N  +T+D+IL  +L  P
Sbjct: 192  ILMRSGHNRAVDWWSLGALMYDMLTGAPP--------FTGENRKKTIDKILKCKLNLP 241

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 6    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 63
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 64   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 121  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 178  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 218

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG   V+ A +L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 20   LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                   +    +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 80   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               I++RD+   N+++       V DFGI++++    ++ T+ A  IG   Y++PE A  
Sbjct: 136  --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V  +SDVYS G +  E + G+ P
Sbjct: 194  DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG   V+ A +L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 20   LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                   +    +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 80   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               I++RD+   N+++       V DFGI++++    ++ T+ A  IG   Y++PE A  
Sbjct: 136  --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V  +SDVYS G +  E + G+ P
Sbjct: 194  DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 43   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 100  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 157
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 158  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 215  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 270
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 271  --------LYEVMLKCWHPKAEMRPSFSEL 292

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/270 (25%), Positives = 121/270 (44%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 39   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 96   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 153
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL---KPDS-SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +   + DS  N T     + ++A E  
Sbjct: 154  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 211  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 266
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 267  --------LYEVMLKCWHPKAEMRPSFSEL 288

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 8    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 65
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 66   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 123  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 180  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 220

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 62/221 (28%), Positives = 95/221 (42%), Gaps = 12/221 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
               +   E  DV+S G++    + G+ P D  S  C   S+
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD 219

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 97   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 154  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 211
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 212  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 269  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 324
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 325  --------LYEVMLKCWHPKAEMRPSFSEL 346

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 38   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 153  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 210  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 265
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 266  --------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 39   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 96   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 153
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 154  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 211  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 266
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 267  --------LYEVMLKCWHPKAEMRPSFSEL 288

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 123/267 (46%), Gaps = 32/267 (11%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E  +G G  G V+ A  +    VAVK      +S     + FL E   +  ++H  +VK 
Sbjct: 187  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKL 242
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMIL-SNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
            +   +     +I+ E++  GSL   L S+  S + L   + ++    +A+ ++++    +
Sbjct: 243  HAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQRNY 299
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
               ++RD+ + N+L+       ++DFG+++        WT         APE       T
Sbjct: 300  ---IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT---------APEAINFGSFT 347
Query: 990  EKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLI 1048
             KSDV+SFG+L +E +  G+ P   +S     +  + R L+     R+P P  N  ++L 
Sbjct: 348  IKSDVWSFGILLMEIVTYGRIPYPGMS-----NPEVIRALERGY--RMPRPE-NCPEELY 399
Query: 1049 SIMEVAISCLDENPDSRPTMQKVSQLL 1075
            +IM   + C    P+ RPT + +  +L
Sbjct: 400  NIM---MRCWKNRPEERPTFEYIQSVL 423

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 38   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 95   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 152
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 153  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 210  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 265
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 266  --------LYEVMLKCWHPKAEMRPSFSEL 287

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG   V+ A +L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 20   LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                   +    +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 80   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               I++RD+   N+++       V DFGI++++    ++ T+ A  IG   Y++PE A  
Sbjct: 136  --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V  +SDVYS G +  E + G+ P
Sbjct: 194  DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 73/295 (24%), Positives = 132/295 (44%), Gaps = 42/295 (14%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTE 861
            N+      +G G  G V  A     G+  AV K    +L       E    ++E+K ++ 
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 862  I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSL---------------AMILSNATSAEEL 905
            + +H NIV   G C+H     ++ EY   G L               A  ++N+T++   
Sbjct: 106  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTR- 164
Query: 906  GWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
                 ++    VA  +++L + +C    ++RD++++NVLL   + A + DFG+++ +  D
Sbjct: 165  ---DLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 965  SSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTS 1021
            S+   +      + ++APE  +    T +SDV+S+G+L  E    G +P   I  + S  
Sbjct: 218  SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-LVNSKF 276
Query: 1022 SNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              L +   ++  P   AP       + SIM+   +C    P  RPT Q++   L+
Sbjct: 277  YKLVKDGYQMAQPAF-APK-----NIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 94/201 (46%), Gaps = 11/201 (5%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +GT G+  V + EL+ G  VAVK  +   +  +    +   E+++L   RH +I+K Y  
Sbjct: 26   VGTFGKVKVGKHELT-GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84
Query: 874  CSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
             S     F+V EY+  G L   I  N    E+        ++ GV     Y H      +
Sbjct: 85   ISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV----DYCHRHM---V 137
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEK 991
            V+RD+  +NVLLD    A ++DFG+S ++  D        G+  Y APE ++  +    +
Sbjct: 138  VHRDLKPENVLLDAHMNAKIADFGLS-NMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPE 196
Query: 992  SDVYSFGVLALEAIKGKHPRD 1012
             D++S GV+    + G  P D
Sbjct: 197  VDIWSSGVILYALLCGTLPFD 217

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 118/270 (43%), Gaps = 32/270 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPL-----LSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G VY   L   +    KK H  +     ++++    +FL E   + +  H N++
Sbjct: 36   IGRGHFGCVYHGTLLDND---GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N T    +     +     VA  + +L + 
Sbjct: 93   SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK 150
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYVAPELA 983
             F   V+RD++++N +LD ++   V+DFG+++ +         N T     + ++A E  
Sbjct: 151  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041
             T K T KSDV+SFGVL  E + +G  P   +++   T   L      +L P   P P  
Sbjct: 208  QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--RLLQPEYCPDP-- 263
Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    + EV + C     + RP+  ++
Sbjct: 264  --------LYEVMLKCWHPKAEMRPSFSEL 285

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 66/260 (25%), Positives = 116/260 (44%), Gaps = 22/260 (8%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG   V+ A +L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 37   LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                   +    +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 97   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 152
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               I++RD+   N+++       V DFGI++++    ++ T+ A  IG   Y++PE A  
Sbjct: 153  --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 210
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
              V  +SDVYS G +  E + G+ P    S +     ++        DP +P PS     
Sbjct: 211  DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE------DP-IP-PSARHEG 262
Query: 1046 KLISIMEVAISCLDENPDSR 1065
                +  V +  L +NP++R
Sbjct: 263  LSADLDAVVLKALAKNPENR 282

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 26/215 (12%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLL---SEMTCQQEFLNEVKSLTEI 862
            DF+    +G G  G V+ AE   + +  A+K     ++    ++ C         ++ E 
Sbjct: 19   DFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---------TMVEK 69
Query: 863  RHRNIVKFYGFCSH-------ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
            R  ++   + F +H         + F V EYL  G L   + +  S  +   ++      
Sbjct: 70   RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA 126
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +   L +LH+     IVYRD+   N+LLD +    ++DFG+ K      +   E  GT 
Sbjct: 127  EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTP 183
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE+    K     D +SFGVL  E + G+ P
Sbjct: 184  DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 73/291 (25%), Positives = 128/291 (43%), Gaps = 34/291 (11%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTE 861
            N+      +G G  G V  A     G+  AV K    +L       E    ++E+K ++ 
Sbjct: 46   NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 862  I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-----------ATSAEELGWTQ 909
            + +H NIV   G C+H     ++ EY   G L   L             A +   L    
Sbjct: 106  LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRD 165
Query: 910  RMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
             ++    VA  +++L + +C    ++RD++++NVLL   + A + DFG+++ +  DS+  
Sbjct: 166  LLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 969  TELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLD 1025
             +      + ++APE  +    T +SDV+S+G+L  E    G +P   I  + S    L 
Sbjct: 222  VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-LVNSKFYKLV 280
Query: 1026 RTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +   ++  P   AP       + SIM+   +C    P  RPT Q++   L+
Sbjct: 281  KDGYQMAQPAF-APK-----NIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G VY+A+ S G IVA+K+       E       + E+  L E+ H NIV     
Sbjct: 29   VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM-NVIKGVADALSYLHNDCFPPI 932
                R   +V+E++E     ++  N T  ++      +  +++GVA    +        I
Sbjct: 88   IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-------I 140
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEK 991
            ++RD+  +N+L++ +    ++DFG++++      ++T    T+ Y AP+ L  + K +  
Sbjct: 141  LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 992  SDVYSFGVLALEAIKGK 1008
             D++S G +  E I GK
Sbjct: 201  VDIWSIGCIFAEMITGK 217

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G VY+A+ S G IVA+K+       E       + E+  L E+ H NIV     
Sbjct: 29   VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDE-GIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM-NVIKGVADALSYLHNDCFPPI 932
                R   +V+E++E     ++  N T  ++      +  +++GVA    +        I
Sbjct: 88   IHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-------I 140
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEK 991
            ++RD+  +N+L++ +    ++DFG++++      ++T    T+ Y AP+ L  + K +  
Sbjct: 141  LHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTS 200
Query: 992  SDVYSFGVLALEAIKGK 1008
             D++S G +  E I GK
Sbjct: 201  VDIWSIGCIFAEMITGK 217

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG   V+ A +L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 20   LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                   +    +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 80   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               I++RD+   N+++       V DFGI++++    ++ T+ A  IG   Y++PE A  
Sbjct: 136  --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V  +SDVYS G +  E + G+ P
Sbjct: 194  DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 41/219 (18%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNE--VKSLTEIRHRNIVKFY 871
            IG G  G+VY+  L     VAVK F          +Q F+NE  +  +  + H NI +F 
Sbjct: 21   IGRGRYGAVYKGSLDE-RPVAVKVF------SFANRQNFINEKNIYRVPLMEHDNIARFI 73
Query: 872  ----GFCSHARHSFI-VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                   +  R  ++ V EY   GSL   LS  TS     W     +   V   L+YLH 
Sbjct: 74   VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHT 129
Query: 927  DC------FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL---------KPDSSNWTEL 971
            +        P I +RD++S+NVL+  +    +SDFG+S  L         + D++  +E+
Sbjct: 130  ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189
Query: 972  AGTIGYVAPEL---AYTMKVTEKS----DVYSFGVLALE 1003
             GTI Y+APE+   A  ++  E +    D+Y+ G++  E
Sbjct: 190  -GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWE 227

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-11,   Method: Composition-based stats.
 Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 12/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++ +  +  +G G  G V   +   +G+  AVK      + + T ++  L EV+ L ++ 
Sbjct: 31   SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NI+K Y F     + ++V E    G L        S +         +I+ V   ++Y
Sbjct: 91   HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 147
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            +H +    IV+RD+  +N+LL+ + +     + DFG+S   +  S    +  GT  Y+AP
Sbjct: 148  MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 203
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+ +     EK DV+S GV+    + G  P
Sbjct: 204  EVLHG-TYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG   V+ A +L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 20   LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                   +    +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 80   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT 985
               I++RD+   N+L+       V DFGI++++    ++  + A  IG   Y++PE A  
Sbjct: 136  --GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V  +SDVYS G +  E + G+ P
Sbjct: 194  DSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 75/292 (25%), Positives = 130/292 (44%), Gaps = 51/292 (17%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            ND   +  IG G  G V +A +    +    A+K+      +     ++F  E++ L ++
Sbjct: 22   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKL 79
Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--------------AMILSNATSAEELGW 907
              H NI+   G C H  + ++  EY   G+L              A  ++N+T A  L  
Sbjct: 80   GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST-ASTLSS 138
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
             Q ++    VA  + YL    F   ++R+++++N+L+   Y A ++DFG+S+  +     
Sbjct: 139  QQLLHFAADVARGMDYLSQKQF---IHRNLAARNILVGENYVAKIADFGLSRGQE----- 190
Query: 968  WTELAGTIG-----YVAPE-LAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS- 1019
               +  T+G     ++A E L Y++  T  SDV+S+GVL  E +  G  P       C  
Sbjct: 191  -VYVKKTMGRLPVRWMAIESLNYSVYTT-NSDVWSYGVLLWEIVSLGGTP------YCGM 242
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            T + L   L +    RL  P  N  D++  +M     C  E P  RP+  ++
Sbjct: 243  TCAELYEKLPQ--GYRLEKP-LNCDDEVYDLMR---QCWREKPYERPSFAQI 288

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-11,   Method: Composition-based stats.
 Identities = 63/280 (22%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 18   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 74
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 75   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGY 977
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +           G   + +
Sbjct: 135  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 191
Query: 978  VAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            ++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++  L
Sbjct: 192  MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEGGL 243
Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 N  D L+ +M +   C   NP  RP+  ++   +K
Sbjct: 244  LDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIK 280

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 128/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 33   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 89
Query: 867  IVKFYGFCSHARHSFIVYEYLEMG-------SLAMILSNATSAEELGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G       SL   ++N         ++ + +   +AD
Sbjct: 90   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 150  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 204
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 205  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 256
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 257  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 295

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 6e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 128/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 23   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 79
Query: 867  IVKFYGFCSHARHSFIVYEYLEMG-------SLAMILSNATSAEELGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G       SL   ++N         ++ + +   +AD
Sbjct: 80   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 140  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 194
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 195  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 246
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 247  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 285

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 121/300 (40%), Gaps = 60/300 (20%)
Query: 802  VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
            +R  +DF+E   +G G  G V +A  +      A+KK         T     L+EV  L 
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVMLLA 57
Query: 861  EIRHRNIVKFYGFCSHARHS-------------FIVYEYLEMGSLAMIL--SNATSAEEL 905
             + H+ +V++Y      R+              FI  EY E  +L  ++   N     + 
Sbjct: 58   SLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE 117
Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS----- 960
             W     + + + +ALSY+H+     I++RD+   N+ +D      + DFG++K+     
Sbjct: 118  YW----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 961  --LKPDSS-------NWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI----K 1006
              LK DS        N T   GT  YVA E L  T    EK D+YS G++  E I     
Sbjct: 171  DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST 230
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G    + +  + S S            P        +  K+I ++      +D +P+ RP
Sbjct: 231  GMERVNILKKLRSVSIE--------FPPDFDDNKMKVEKKIIRLL------IDHDPNKRP 276

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    +  ++  + E+ A K     LL +   +++   E+     + H+++V F+G
Sbjct: 25   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       F+V E     SL   L      + L   +    ++ +     YLH +    +
Sbjct: 85   FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+      + + 
Sbjct: 139  IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            DV+S G +    + GK P     + C   + L    +E   P+   P   +   LI  M 
Sbjct: 199  DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQKM- 251
Query: 1053 VAISCLDENPDSRPTMQKV 1071
                 L  +P +RPT+ ++
Sbjct: 252  -----LQTDPTARPTINEL 265

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 59/260 (22%), Positives = 116/260 (44%), Gaps = 40/260 (15%)
Query: 803  RATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            R   DF+   C+G GG G V+ A+    +   A+K+   P  +    +++ + EVK+L +
Sbjct: 2    RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAK 59
Query: 862  IRHRNIVKFYGFCSHAR-------HSFIVYEYLEMG-----SLAMILSNATSAEELGWTQ 909
            + H  IV+++               S  VY Y++M      +L   ++   + EE   + 
Sbjct: 60   LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
             +++   +A+A+ +LH+     +++RD+   N+   ++    V DFG+  ++  D    T
Sbjct: 120  CLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 970  ELA------------GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSI 1017
             L             GT  Y++PE  +    + K D++S G++  E +   +P       
Sbjct: 177  VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP------- 226
Query: 1018 CSTSSNLDRTLDEILDPRLP 1037
             ST     RTL ++ + + P
Sbjct: 227  FSTQMERVRTLTDVRNLKFP 246

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 55   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 111
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 112  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 172  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 226
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 227  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 278
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 279  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 317

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 24   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 80
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 81   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 141  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 195
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 196  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 247
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 248  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 286

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 20   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 76
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 77   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 137  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 191
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 192  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 243
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 244  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 282

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 26   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 82
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 83   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 143  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 197
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 198  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 249
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 250  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 288

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/280 (22%), Positives = 124/280 (44%), Gaps = 34/280 (12%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 27   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 83
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 84   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGY 977
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +           G   + +
Sbjct: 144  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRW 200
Query: 978  VAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            ++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++  L
Sbjct: 201  MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEGGL 252
Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 253  LDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 289

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 26   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 82
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 83   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 143  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 197
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 198  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 249
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 250  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 288

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 33   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 89
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 90   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 150  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 204
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 205  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 256
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 257  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 295

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 27   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 83
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 84   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +    +++    G     +
Sbjct: 144  GMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 198
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 199  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 250
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L  +M +   C   NP  RP+  ++   +K
Sbjct: 251  GLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIK 289

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 824  RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV 883
            RA  ++  +  +K+  SP  SE+   ++ L+E   L ++ H +++K YG CS      ++
Sbjct: 50   RAGYTTVAVKMLKENASP--SEL---RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104
Query: 884  YEYLEMGSLAMILSNATSA---------------------EELGWTQRMNVIKGVADALS 922
             EY + GSL   L  +                          L     ++    ++  + 
Sbjct: 105  VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI--GYVAP 980
            YL       +V+RD++++N+L+    +  +SDFG+S+ +  + S      G I   ++A 
Sbjct: 165  YLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAI 221
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            E  +    T +SDV+SFGVL  E +  G +P   I        NL +T       R+  P
Sbjct: 222  ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKT-----GHRMERP 274
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              N  +++  +M   + C  + PD RP    +S+ L+
Sbjct: 275  D-NCSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    +  ++  + E+ A K     LL +   +++   E+     + H+++V F+G
Sbjct: 25   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       F+V E     SL   L      + L   +    ++ +     YLH +    +
Sbjct: 85   FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 138
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+      + + 
Sbjct: 139  IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            DV+S G +    + GK P     + C   + L    +E   P+   P   +   LI  M 
Sbjct: 199  DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQKM- 251
Query: 1053 VAISCLDENPDSRPTMQKV 1071
                 L  +P +RPT+ ++
Sbjct: 252  -----LQTDPTARPTINEL 265

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 32/222 (14%)
Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQ---EFLNEVKSLTEIR 863
            +D +  IG G    V R    ++G   AVK      + E+T ++   E L EV+  T   
Sbjct: 96   YDPKDVIGRGVSSVVRRCVHRATGHEFAVK------IMEVTAERLSPEQLEEVREATRRE 149
Query: 864  ---------HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI 914
                     H +I+        +   F+V++ +  G L   L+   +  E    +  +++
Sbjct: 150  THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIM 206
Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT 974
            + + +A+S+LH +    IV+RD+  +N+LLD   +  +SDFG S  L+P      EL GT
Sbjct: 207  RSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP-GEKLRELCGT 262
Query: 975  IGYVAPE-LAYTMKVT-----EKSDVYSFGVLALEAIKGKHP 1010
             GY+APE L  +M  T     ++ D+++ GV+    + G  P
Sbjct: 263  PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    +  ++  + E+ A K     LL +   +++   E+     + H+++V F+G
Sbjct: 29   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       F+V E     SL   L      + L   +    ++ +     YLH +    +
Sbjct: 89   FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 142
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+      + + 
Sbjct: 143  IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEV 202
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            DV+S G +    + GK P     + C   + L    +E   P+   P   +   LI  M 
Sbjct: 203  DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQKM- 255
Query: 1053 VAISCLDENPDSRPTMQKV 1071
                 L  +P +RPT+ ++
Sbjct: 256  -----LQTDPTARPTINEL 269

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 66.2 bits (160), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 805  TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++ +  +  +G G  G V   +   +G+  AVK      + + T ++  L EV+ L ++ 
Sbjct: 49   SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NI+K Y F     + ++V E    G L        S +         +I+ V   ++Y
Sbjct: 109  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 165
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            +H +    IV+RD+  +N+LL+ + +     + DFG+S   +  S    +  GT  Y+AP
Sbjct: 166  MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 221
Query: 981  ELAYTMKVTEKSDVYSFGVL 1000
            E+ +     EK DV+S GV+
Sbjct: 222  EVLHGT-YDEKCDVWSTGVI 240

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 12/200 (6%)
Query: 805  TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++ +  +  +G G  G V   +   +G+  AVK      + + T ++  L EV+ L ++ 
Sbjct: 48   SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NI+K Y F     + ++V E    G L        S +         +I+ V   ++Y
Sbjct: 108  HPNIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITY 164
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            +H +    IV+RD+  +N+LL+ + +     + DFG+S   +  S    +  GT  Y+AP
Sbjct: 165  MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAP 220
Query: 981  ELAYTMKVTEKSDVYSFGVL 1000
            E+ +     EK DV+S GV+
Sbjct: 221  EVLHGT-YDEKCDVWSTGVI 239

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 92/194 (47%), Gaps = 12/194 (6%)
Query: 811  EHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +  +G G  G V   +   +G+  AVK      + + T ++  L EV+ L ++ H NI+K
Sbjct: 31   QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y F     + ++V E    G L        S +         +I+ V   ++Y+H +  
Sbjct: 91   LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYMHKN-- 145
Query: 930  PPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
              IV+RD+  +N+LL+ + +     + DFG+S   +  S    +  GT  Y+APE+ +  
Sbjct: 146  -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKMKDKIGTAYYIAPEVLHGT 203
Query: 987  KVTEKSDVYSFGVL 1000
               EK DV+S GV+
Sbjct: 204  -YDEKCDVWSTGVI 216

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/285 (25%), Positives = 125/285 (43%), Gaps = 36/285 (12%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-RHRNIV 868
            +G G  G V  A     G+  AV K    +L       E    ++E+K ++ + +H NIV
Sbjct: 54   LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIK 915
               G C+H     ++ EY   G L   L                   E+L     ++   
Sbjct: 114  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 916  GVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT 974
             VA  +++L   +C    ++RD++++NVLL   + A + DFG+++ +  DS+   +    
Sbjct: 174  QVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 229
Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEI 1031
              + ++APE  +    T +SDV+S+G+L  E    G +P   I  + S    L +   ++
Sbjct: 230  LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI-LVNSKFYKLVKDGYQM 288
Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              P   AP       + SIM+   +C    P  RPT Q++   L+
Sbjct: 289  AQPAF-APK-----NIYSIMQ---ACWALEPTHRPTFQQICSFLQ 324

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 824  RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV 883
            RA  ++  +  +K+  SP  SE+   ++ L+E   L ++ H +++K YG CS      ++
Sbjct: 50   RAGYTTVAVKMLKENASP--SEL---RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104
Query: 884  YEYLEMGSLAMILSNATSA---------------------EELGWTQRMNVIKGVADALS 922
             EY + GSL   L  +                          L     ++    ++  + 
Sbjct: 105  VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI--GYVAP 980
            YL       +V+RD++++N+L+    +  +SDFG+S+ +  + S      G I   ++A 
Sbjct: 165  YLAE---MSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAI 221
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            E  +    T +SDV+SFGVL  E +  G +P   I        NL +T       R+  P
Sbjct: 222  ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKT-----GHRMERP 274
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              N  +++  +M   + C  + PD RP    +S+ L+
Sbjct: 275  D-NCSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 47/278 (16%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +FD    +   G+GS        G++  V+K  +  +  M    +++N+ K +     RN
Sbjct: 13   NFDHFEILRAIGKGSF-------GKVCIVQKNDTKKMYAM----KYMNKQKCVERNEVRN 61
Query: 867  IVKFYGFCSHARHSFIV---YEYLEMGSLAMIL-------------SNATSAEELGWTQR 910
            + K         H F+V   Y + +   + M++              N    EE   T +
Sbjct: 62   VFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE---TVK 118
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            + + + V  AL YL N     I++RD+   N+LLD     H++DF I+  L P  +  T 
Sbjct: 119  LFICELVM-ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT 173
Query: 971  LAGTIGYVAPELAYTMKVTEKS---DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRT 1027
            +AGT  Y+APE+  + K    S   D +S GV A E ++G+ P    SS  ++S  +  T
Sbjct: 174  MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS--TSSKEIVHT 231
Query: 1028 LDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             +  +   +  PS     +++S+++     L+ NPD R
Sbjct: 232  FETTV---VTYPSA-WSQEMVSLLK---KLLEPNPDQR 262

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 814  IGTGGQGSVYRA--ELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G G  GSV +    +   +I VA+K       +E    +E + E + + ++ +  IV+ 
Sbjct: 344  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
             G C  A    +V E    G L   L      EE+  +    ++  V+  + YL    F 
Sbjct: 402  IGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKNF- 457
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG---TIGYVAPELAYTMK 987
              V+R+++++NVLL   + A +SDFG+SK+L  D S +T  +     + + APE     K
Sbjct: 458  --VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 988  VTEKSDVYSFGVLALEAIK-GKHP 1010
             + +SDV+S+GV   EA+  G+ P
Sbjct: 516  FSSRSDVWSYGVTMWEALSYGQKP 539

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 67/277 (24%), Positives = 122/277 (44%), Gaps = 43/277 (15%)
Query: 824  RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV 883
            RA  ++  +  +K+  SP  SE+   ++ L+E   L ++ H +++K YG CS      ++
Sbjct: 50   RAGYTTVAVKMLKENASP--SEL---RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLI 104
Query: 884  YEYLEMGSLAMILSNATSA---------------------EELGWTQRMNVIKGVADALS 922
             EY + GSL   L  +                          L     ++    ++  + 
Sbjct: 105  VEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQ 164
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI--GYVAP 980
            YL       +V+RD++++N+L+    +  +SDFG+S+ +  + S      G I   ++A 
Sbjct: 165  YLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAI 221
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            E  +    T +SDV+SFGVL  E +  G +P   I        NL +T       R+  P
Sbjct: 222  ESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKT-----GHRMERP 274
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              N  +++  +M   + C  + PD RP    +S+ L+
Sbjct: 275  D-NCSEEMYRLM---LQCWKQEPDKRPVFADISKDLE 307

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 59/210 (28%), Positives = 91/210 (43%), Gaps = 12/210 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H 
Sbjct: 7    DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNHE 64
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+VKFYG   H R   I Y +LE  S   +         +           +   + YLH
Sbjct: 65   NVVKFYG---HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL 
Sbjct: 122  G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELL 178
Query: 984  YTMKV-TEKSDVYSFGVLALEAIKGKHPRD 1012
               +   E  DV+S G++    + G+ P D
Sbjct: 179  KRREFHAEPVDVWSCGIVLTAMLAGELPWD 208

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 83   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYV 978
            ++YL+   F   V+RD++++N ++  ++   + DFG+++ +           G   + ++
Sbjct: 143  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D    
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGGYL 251
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                N  +++  +M +   C   NP+ RPT  ++  LLK
Sbjct: 252  DQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLK 287

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G+ VAV+      L+  + Q+ F  EV+ 
Sbjct: 8    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRI 66
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  ++V EY   G +   L      +E    +     + + 
Sbjct: 67   MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIV 123
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +   E  G+  Y 
Sbjct: 124  SAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDEFCGSPPYA 179
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 180  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 1e-10,   Method: Composition-based stats.
 Identities = 63/282 (22%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 814  IGTGGQGSVYRAELSSGEI-------VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +G G  G VY   ++ G +       VA+K  +    + M  + EFLNE   + E    +
Sbjct: 20   LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHH 76
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-------LGWTQRMNVIKGVAD 919
            +V+  G  S  + + ++ E +  G L   L +     E          ++ + +   +AD
Sbjct: 77   VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----I 975
             ++YL+ + F   V+RD++++N  +  ++   + DFG+++ +    +++    G     +
Sbjct: 137  GMAYLNANKF---VHRDLAARNCXVAEDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPV 191
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             +++PE       T  SDV+SFGV+  E A   + P   +S+        ++ L  +++ 
Sbjct: 192  RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN--------EQVLRFVMEG 243
Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             L     N  D L+ +M +   C   NP  RP+  ++   +K
Sbjct: 244  GLLDKPDNCPDMLLELMRM---CWQYNPKMRPSFLEIISSIK 282

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    +  ++  + E+ A K     LL +   +++   E+     + H+++V F+G
Sbjct: 47   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       F+V E     SL   L      + L   +    ++ +     YLH +    +
Sbjct: 107  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 160
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+      + + 
Sbjct: 161  IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            DV+S G +    + GK P     + C   + L    +E   P+   P   +   LI  M 
Sbjct: 221  DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQKM- 273
Query: 1053 VAISCLDENPDSRPTMQKV 1071
                 L  +P +RPT+ ++
Sbjct: 274  -----LQTDPTARPTINEL 287

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 68/285 (23%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 796  IAYEEIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQ 850
            +A   I++ T +F +   +G+G  G+VY+   +  GE V    A+K+      +     +
Sbjct: 3    MALLRILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANK 59
Query: 851  EFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR 910
            E L+E   +  + + ++ +  G C  +    I  + +  G L   +      + +G    
Sbjct: 60   EILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYL 116
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            +N    +A+ ++YL +     +V+RD++++NVL+       ++DFG++K L  +   +  
Sbjct: 117  LNWCVQIAEGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 173
Query: 971  LAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027
              G   I ++A E       T +SDV+S+GV   E +  G  P D I +    SS L++ 
Sbjct: 174  EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK- 231
Query: 1028 LDEILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                   RLP P  C      I +  + + C   + DSRP  +++
Sbjct: 232  -----GERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFREL 266

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/259 (23%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    +  ++  + E+ A K     LL +   +++   E+     + H+++V F+G
Sbjct: 49   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       F+V E     SL   L      + L   +    ++ +     YLH +    +
Sbjct: 109  FFEDNDFVFVVLELCRRRSL---LELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RV 162
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+      + + 
Sbjct: 163  IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            DV+S G +    + GK P     + C   + L    +E   P+   P   +   LI  M 
Sbjct: 223  DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQKM- 275
Query: 1053 VAISCLDENPDSRPTMQKV 1071
                 L  +P +RPT+ ++
Sbjct: 276  -----LQTDPTARPTINEL 289

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/245 (26%), Positives = 119/245 (48%), Gaps = 30/245 (12%)
Query: 795  KIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFL 853
            K A+E  VRA   + +   +G+G  G+V  A +  +G  VA+KK + P  SE+  ++ + 
Sbjct: 18   KTAWE--VRAV--YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY- 72
Query: 854  NEVKSLTEIRHRNIVKFYGFCS--HARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
             E++ L  +RH N++      +       F  + YL M  +   L      E+LG  +  
Sbjct: 73   RELRLLKHMRHENVIGLLDVFTPDETLDDFTDF-YLVMPFMGTDLGKLMKHEKLGEDRIQ 131
Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
             ++  +   L Y+H      I++RD+   N+ ++ + E  + DFG+++  + DS    E+
Sbjct: 132  FLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QADS----EM 182
Query: 972  AGTI---GYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRT 1027
             G +    Y APE+    M+ T+  D++S G +  E I GK       ++   S +LD+ 
Sbjct: 183  XGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-------TLFKGSDHLDQ- 234
Query: 1028 LDEIL 1032
            L EI+
Sbjct: 235  LKEIM 239

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.5 bits (158), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 53/292 (18%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVK 869
            E  +G G  G+V       G  VAVK+    +L +  C    + E+K LTE   H N+++
Sbjct: 38   EKILGYGSSGTVVFQGSFQGRPVAVKR----MLIDF-CDIALM-EIKLLTESDDHPNVIR 91
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN---VIKGVADALSYLHN 926
            +Y   +  R  +I  E   +    ++ S   S E L   +  N   +++ +A  +++LH+
Sbjct: 92   YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 927  DCFPPIVYRDISSKNVLL--------DLEYEAH-----VSDFGISKSLKPDS----SNWT 969
                 I++RD+  +N+L+        D +  A      +SDFG+ K L         N  
Sbjct: 152  ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 970  ELAGTIGYVAPEL---AYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLD 1025
              +GT G+ APEL   +   ++T   D++S G +    + KGKHP        S  SN+ 
Sbjct: 209  NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYSRESNII 265
Query: 1026 R---TLDEIL---DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            R   +LDE+    D  L A + +    LIS M      +D +P  RPT  KV
Sbjct: 266  RGIFSLDEMKCLHDRSLIAEATD----LISQM------IDHDPLKRPTAMKV 307

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G+G  G V+  E  S  +  V K  +   S++  +Q    E++ L  + H NI+K +  
Sbjct: 30   LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ-IEAEIEVLKSLDHPNIIKIFEV 88
Query: 874  CSHARHSFIVYEYLEMGS-LAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                 + +IV E  E G  L  I+S     + L       ++K + +AL+Y H+     +
Sbjct: 89   FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 933  VYRDISSKNVLLDLEYEAH----VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
            V++D+  +N+L   +   H    + DFG+++  K D  + T  AGT  Y+APE+ +   V
Sbjct: 146  VHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKSDEHS-TNAAGTALYMAPEV-FKRDV 202
Query: 989  TEKSDVYSFGVLALEAIKGKHP 1010
            T K D++S GV+    + G  P
Sbjct: 203  TFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 53/292 (18%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVK 869
            E  +G G  G+V       G  VAVK+    +L +  C    + E+K LTE   H N+++
Sbjct: 38   EKILGYGSSGTVVFQGSFQGRPVAVKR----MLIDF-CDIALM-EIKLLTESDDHPNVIR 91
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN---VIKGVADALSYLHN 926
            +Y   +  R  +I  E   +    ++ S   S E L   +  N   +++ +A  +++LH+
Sbjct: 92   YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 927  DCFPPIVYRDISSKNVLL--------DLEYEAH-----VSDFGISKSLKPDS----SNWT 969
                 I++RD+  +N+L+        D +  A      +SDFG+ K L         N  
Sbjct: 152  ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 208
Query: 970  ELAGTIGYVAPEL---AYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLD 1025
              +GT G+ APEL   +   ++T   D++S G +    + KGKHP        S  SN+ 
Sbjct: 209  NPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYSRESNII 265
Query: 1026 R---TLDEIL---DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            R   +LDE+    D  L A + +    LIS M      +D +P  RPT  KV
Sbjct: 266  RGIFSLDEMKCLHDRSLIAEATD----LISQM------IDHDPLKRPTAMKV 307

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 22   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 79
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 80   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYV 978
            ++YL+   F   V+RD++++N ++  ++   + DFG+++ +           G   + ++
Sbjct: 140  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D    
Sbjct: 197  APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGGYL 248
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                N  +++  +M +   C   NP  RPT  ++  LLK
Sbjct: 249  DQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 284

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 83/296 (28%), Positives = 132/296 (44%), Gaps = 57/296 (19%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVK 869
            E  +G G  G+V       G  VAVK+    +L +  C    + E+K LTE   H N+++
Sbjct: 20   EKILGYGSSGTVVFQGSFQGRPVAVKR----MLIDF-CDIALM-EIKLLTESDDHPNVIR 73
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN---VIKGVADALSYLHN 926
            +Y   +  R  +I  E   +    ++ S   S E L   +  N   +++ +A  +++LH+
Sbjct: 74   YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 927  DCFPPIVYRDISSKNVLL--------DLEYEAH-----VSDFGISKSLKPDSS----NWT 969
                 I++RD+  +N+L+        D +  A      +SDFG+ K L    S    N  
Sbjct: 134  ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 970  ELAGTIGYVAPE-------LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTS 1021
              +GT G+ APE       L    ++T   D++S G +    + KGKHP        S  
Sbjct: 191  NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYSRE 247
Query: 1022 SNLDR---TLDEIL---DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            SN+ R   +LDE+    D  L A + +    LIS M      +D +P  RPT  KV
Sbjct: 248  SNIIRGIFSLDEMKCLHDRSLIAEATD----LISQM------IDHDPLKRPTAMKV 293

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 80/169 (47%), Gaps = 21/169 (12%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            ++KFH          +E  NE+  L  + H NI+K +      ++ ++V E+ E G L  
Sbjct: 86   IEKFH----------EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFE 135
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE---YEAH 951
             + N    +E       N++K +   + YLH      IV+RDI  +N+LL+ +       
Sbjct: 136  QIINRHKFDE---CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189
Query: 952  VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVL 1000
            + DFG+S     D      L GT  Y+APE+    K  EK DV+S GV+
Sbjct: 190  IVDFGLSSFFSKDYKLRDRL-GTAYYIAPEVL-KKKYNEKCDVWSCGVI 236

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/281 (22%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 24   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 81
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 82   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            ++YL+   F   V+RD++++N ++  ++   + DFG+++ +    +++    G     + 
Sbjct: 142  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 196
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            ++APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D  
Sbjct: 197  WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGG 248
Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                  N  +++  +M +   C   NP  RPT  ++  LLK
Sbjct: 249  YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 286

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/281 (22%), Positives = 124/281 (44%), Gaps = 36/281 (12%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 83   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            ++YL+   F   V+RD++++N ++  ++   + DFG+++ +    +++    G     + 
Sbjct: 143  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 197
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            ++APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D  
Sbjct: 198  WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGG 249
Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                  N  +++  +M +   C   NP  RPT  ++  LLK
Sbjct: 250  YLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 287

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 64/279 (22%), Positives = 121/279 (43%), Gaps = 32/279 (11%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 83   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYV 978
            ++YL+   F   V+RD++++N ++  ++   + DFG+++ +           G   + ++
Sbjct: 143  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D    
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGGYL 251
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                N  +++  +M +   C   NP  RPT  ++  LLK
Sbjct: 252  DQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 287

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 32/276 (11%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V +     +G IVA+KKF      +M  ++  + E+K L ++RH N+V    
Sbjct: 33   VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV-KKIAMREIKLLKQLRHENLVNLLE 91
Query: 873  FCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
             C   +  ++V+E+++   L    +  N    + +       +I G+     + HN    
Sbjct: 92   VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ-KYLFQIINGIG--FCHSHN---- 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVT 989
             I++RDI  +N+L+       + DFG +++L      + +   T  Y APEL    +K  
Sbjct: 145  -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 990  EKSDVYSFGVLALEAIKGK------HPRDFISSICSTSSNLDRTLDEILDP-------RL 1036
            +  DV++ G L  E   G+         D +  I     NL     E+ +        RL
Sbjct: 204  KAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263
Query: 1037 P-----APSCNIRDKLIS-IMEVAISCLDENPDSRP 1066
            P      P      KL   ++++A  CL  +PD RP
Sbjct: 264  PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 816  TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            T G+G+  + +L+    +G+ VAVK      L+  + Q+ F  EV+ +  + H NIVK +
Sbjct: 14   TIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRIMKVLNHPNIVKLF 72
Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNV---IKGVADALSYLHNDC 928
                  +  ++V EY   G +   L         GW +        + +  A+ Y H   
Sbjct: 73   EVIETEKTLYLVMEYASGGEVFDYLVAH------GWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
               IV+RD+ ++N+LLD +    ++DFG S       +      G+  Y APEL    K 
Sbjct: 127  ---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYAAPELFQGKKY 182
Query: 989  T-EKSDVYSFGVLALEAIKGKHPRD 1012
               + DV+S GV+    + G  P D
Sbjct: 183  DGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 59/259 (22%), Positives = 112/259 (43%), Gaps = 19/259 (7%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    +  ++  + E+ A K     LL +   +++   E+     + H+++V F+G
Sbjct: 23   LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       F+V E     SL  +     +  E    +    ++ +     YLH +    +
Sbjct: 83   FFEDNDFVFVVLELCRRRSLLELHKRRKALTE---PEARYYLRQIVLGCQYLHRN---RV 136
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS 992
            ++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+      + + 
Sbjct: 137  IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            DV+S G +    + GK P     + C   + L    +E   P+   P   +   LI  M 
Sbjct: 197  DVWSIGCIMYTLLVGKPP---FETSCLKETYLRIKKNEYSIPKHINP---VAASLIQKM- 249
Query: 1053 VAISCLDENPDSRPTMQKV 1071
                 L  +P +RPT+ ++
Sbjct: 250  -----LQTDPTARPTINEL 263

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 121/299 (40%), Gaps = 58/299 (19%)
Query: 802  VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
            +R  +DF+E   +G G  G V +A  +      A+KK         T     L+EV  L 
Sbjct: 2    LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTI----LSEVXLLA 57
Query: 861  EIRHRNIVKFYGFCSHARHS-------------FIVYEYLEMGSLAMIL--SNATSAEEL 905
             + H+ +V++Y      R+              FI  EY E  +L  ++   N     + 
Sbjct: 58   SLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE 117
Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS----- 960
             W     + + + +ALSY+H+     I++R++   N+ +D      + DFG++K+     
Sbjct: 118  YW----RLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSL 170
Query: 961  --LKPDSS-------NWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              LK DS        N T   GT  YVA E L  T    EK D YS G++  E I     
Sbjct: 171  DILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI----- 225
Query: 1011 RDFISSICSTSSNLDRTLDEI---LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
              +  S      N+ + L  +     P        +  K+I ++      +D +P+ RP
Sbjct: 226  --YPFSTGXERVNILKKLRSVSIEFPPDFDDNKXKVEKKIIRLL------IDHDPNKRP 276

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N+F+    +G G  G V    E ++G   A+K     ++         L E + L   RH
Sbjct: 8    NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALS 922
              +    Y F +H R  F++ EY   G L   LS      E     R       +  AL 
Sbjct: 68   PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 122
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH++    +VYRD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+
Sbjct: 123  YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 180
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                      D +  GV+  E + G+ P
Sbjct: 181  LEDNDYGRAVDWWGLGVVMYEMMCGRLP 208

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N+F+    +G G  G V    E ++G   A+K     ++         L E + L   RH
Sbjct: 9    NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALS 922
              +    Y F +H R  F++ EY   G L   LS      E     R       +  AL 
Sbjct: 69   PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 123
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH++    +VYRD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+
Sbjct: 124  YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 181
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                      D +  GV+  E + G+ P
Sbjct: 182  LEDNDYGRAVDWWGLGVVMYEMMCGRLP 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N+F+    +G G  G V    E ++G   A+K     ++         L E + L   RH
Sbjct: 10   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALS 922
              +    Y F +H R  F++ EY   G L   LS      E     R       +  AL 
Sbjct: 70   PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 124
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH++    +VYRD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+
Sbjct: 125  YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEV 182
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                      D +  GV+  E + G+ P
Sbjct: 183  LEDNDYGRAVDWWGLGVVMYEMMCGRLP 210

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 17   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 74
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 75   VDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 131
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 132  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 189  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 241
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 242  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 270

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 31   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 88
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 89   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 143  --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 201  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 18   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 75
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 76   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 132
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 133  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 190  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 242
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 243  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 19   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 76
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 77   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 133
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 134  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 191  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 243
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 244  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 20   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 77
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 78   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 134
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 135  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 192  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 244
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 245  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 273

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 17   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 74
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 75   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 131
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 132  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 188
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 189  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 241
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 242  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 270

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 124/274 (45%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 16   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 73
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 74   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 130
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 131  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 188  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 240
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 241  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 51   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 108
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 109  IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 162
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 163  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 221  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 106/229 (46%), Gaps = 38/229 (16%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            N+ +    IG G  G V++A            +VAVK       ++M  Q +F  E   +
Sbjct: 47   NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQREAALM 104
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN--------------ATSAE-- 903
             E  + NIVK  G C+  +   +++EY+  G L   L +              +T A   
Sbjct: 105  AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 904  -----ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS 958
                  L   +++ + + VA  ++YL    F   V+RD++++N L+       ++DFG+S
Sbjct: 165  SPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMVVKIADFGLS 221
Query: 959  KSLKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
            +++   S+++ +  G     I ++ PE  +  + T +SDV+++GV+  E
Sbjct: 222  RNIY--SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 31   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 88
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 89   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 143  --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 201  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 39   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 96
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 97   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 150
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 151  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 209  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 248

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 31   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 88
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 89   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 143  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 201  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 31   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 88
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 89   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 143  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 201  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G+ VAVK      L+  + Q+ F  EV+ 
Sbjct: 8    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRI 66
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  ++V EY   G +   L      +E    +     + + 
Sbjct: 67   MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIV 123
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +      G+  Y 
Sbjct: 124  SAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYA 179
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 180  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G+ VAVK      L+  + Q+ F  EV+ 
Sbjct: 8    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRI 66
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  ++V EY   G +   L      +E    +     + + 
Sbjct: 67   MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIV 123
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +      G+  Y 
Sbjct: 124  SAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYA 179
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 180  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 64/279 (22%), Positives = 122/279 (43%), Gaps = 32/279 (11%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 83   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYV 978
            ++YL+   F   V+RD++++N ++  ++   + DFG+++ +   +       G   + ++
Sbjct: 143  MAYLNAKKF---VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D    
Sbjct: 200  APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGGYL 251
Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                N  +++  +M +   C   NP  RPT  ++  LLK
Sbjct: 252  DQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLK 287

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 16   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 73
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 74   VDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 130
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 131  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 188  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 240
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 241  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 19/219 (8%)
Query: 805  TNDFDEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLN 854
            T+  DE+  IG      T G+G+  + +L+    +G  VAVK      L+  + Q+ F  
Sbjct: 5    TSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLF-R 63
Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI 914
            EV+ +  + H NIVK +      +  ++V EY   G +   L      +E    +     
Sbjct: 64   EVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKF 120
Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT 974
            + +  A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +      G+
Sbjct: 121  RQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTV-GNKLDTFCGS 176
Query: 975  IGYVAPELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
              Y APEL    K    + DV+S GV+    + G  P D
Sbjct: 177  PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 31   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 88
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 89   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 142
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 143  --ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 201  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 240

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 67/266 (25%), Positives = 109/266 (40%), Gaps = 21/266 (7%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---- 862
            DFD    IG G    V    L   + +   K    +  E+    E ++ V++   +    
Sbjct: 10   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV---VKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
              H  +V  +         F V EY+  G L   +       E            ++ AL
Sbjct: 67   SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLAL 123
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYVAP 980
            +YLH      I+YRD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+AP
Sbjct: 124  NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAP 179
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE-ILDPRLPAP 1039
            E+          D ++ GVL  E + G+ P D + S  +   N +  L + IL+ ++  P
Sbjct: 180  EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSR 1065
                R   +    V  S L+++P  R
Sbjct: 240  ----RSLSVKAASVLKSFLNKDPKER 261

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 35   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 92
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 93   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 147  --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 205  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 18   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 75
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 76   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 132
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 133  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 190  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 242
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 243  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 41   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 98
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 99   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 155
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 156  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 212
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 213  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 265
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 266  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 294

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 22   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 79
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 80   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 136
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 137  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 194  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 246
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 247  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 275

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 19   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 76
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 77   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 133
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 134  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 191  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 243
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 244  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 23   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 80
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 81   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 137
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 138  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 195  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 247
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 248  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 10   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 68   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 124
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 125  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 182  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 234
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 235  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 263

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 16   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 73
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 74   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 130
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 131  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 188  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 240
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 241  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 19   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 76
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 77   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 133
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 134  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 191  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 243
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 244  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 272

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.3 bits (155), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 33   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 90
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 91   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 144
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 145  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 203  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G  VA+K      L+  + Q+ F  EV+ 
Sbjct: 6    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRI 64
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  +++ EY   G +   L      +E    +  +  + + 
Sbjct: 65   MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIV 121
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S              G+  Y 
Sbjct: 122  SAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTFCGSPPYA 177
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 178  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Composition-based stats.
 Identities = 67/266 (25%), Positives = 107/266 (40%), Gaps = 21/266 (7%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---- 862
            DFD    IG G    V    L   + +   K    +  E+    E ++ V++   +    
Sbjct: 6    DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV---VKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
              H  +V  +         F V EY+  G L   +       E            ++ AL
Sbjct: 63   SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLAL 119
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYVAP 980
            +YLH      I+YRD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+AP
Sbjct: 120  NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIAP 175
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL-DRTLDEILDPRLPAP 1039
            E+          D ++ GVL  E + G+ P D + S  +   N  D     IL+ ++  P
Sbjct: 176  EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 235
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSR 1065
                R   +    V  S L+++P  R
Sbjct: 236  ----RSLSVKAASVLKSFLNKDPKER 257

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 36   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 93
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 94   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 147
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 148  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 206  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 37   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 94
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 95   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 148
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 149  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 207  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 246

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 28   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 85
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 86   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 139
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 140  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 198  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 237

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 35   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 92
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 93   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 147  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 205  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 63/289 (21%), Positives = 122/289 (42%), Gaps = 47/289 (16%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF E   IG+GG G V++A+    G+   +K+            ++   EVK+L ++ H 
Sbjct: 12   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVKALAKLDHV 64
Query: 866  NIVKFYGFC-----------------SHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            NIV + G C                 S  +  FI  E+ + G+L   +      E+L   
Sbjct: 65   NIVHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK-RRGEKLDKV 122
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              + + + +   + Y+H+     ++ RD+   N+ L    +  + DFG+  SLK D    
Sbjct: 123  LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR- 178
Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
                GT+ Y++PE   +    ++ D+Y+ G++  E +           +C T+    +  
Sbjct: 179  XRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH----------VCDTAFETSKFF 228
Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077
             ++ D  +     +I DK    +   +  L + P+ RP   ++ + L +
Sbjct: 229  TDLRDGIIS----DIFDKKEKTLLQKL--LSKKPEDRPNTSEILRTLTV 271

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHS-PLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G   +V+R     +G++ A+K F++   L  +  Q   + E + L ++ H+NIVK +
Sbjct: 17   LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKLF 73
Query: 872  GFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                    RH  ++ E+   GSL  +L   ++A  L  ++ + V++ V   +++L  +  
Sbjct: 74   AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 930  PPIVYRDISSKNVLL----DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
              IV+R+I   N++     D +    ++DFG ++ L+ D   +  L GT  Y+ P++ Y 
Sbjct: 133  --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVXLYGTEEYLHPDM-YE 188
Query: 986  MKVTEKS---------DVYSFGVLALEAIKGKHP 1010
              V  K          D++S GV    A  G  P
Sbjct: 189  RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G+ VAVK      L+  + Q+ F  EV+ 
Sbjct: 8    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRI 66
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  ++V EY   G +   L      +E    +     + + 
Sbjct: 67   MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIV 123
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +      G   Y 
Sbjct: 124  SAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDAFCGAPPYA 179
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 180  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 33   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLAFRHENIIGIND 90
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 91   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 144
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 145  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 203  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 63/281 (22%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 25   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 82
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 83   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            ++YL+   F   V+R+++++N ++  ++   + DFG+++ +    +++    G     + 
Sbjct: 143  MAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 197
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            ++APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D  
Sbjct: 198  WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGG 249
Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                  N  +++  +M +   C   NP+ RPT  ++  LLK
Sbjct: 250  YLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLK 287

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 29   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 86
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 87   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 140
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 141  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 199  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 63/281 (22%), Positives = 125/281 (44%), Gaps = 36/281 (12%)
Query: 814  IGTGGQGSVYRA---ELSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY     ++  GE    VAVK  +    + +  + EFLNE   +      ++
Sbjct: 26   LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES--ASLRERIEFLNEASVMKGFTCHHV 83
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELG-------WTQRMNVIKGVADA 920
            V+  G  S  + + +V E +  G L   L +     E           + + +   +AD 
Sbjct: 84   VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            ++YL+   F   V+R+++++N ++  ++   + DFG+++ +    +++    G     + 
Sbjct: 144  MAYLNAKKF---VHRNLAARNCMVAHDFTVKIGDFGMTRDIY--ETDYYRKGGKGLLPVR 198
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR 1035
            ++APE       T  SD++SFGV+  E     + P   +S+        ++ L  ++D  
Sbjct: 199  WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--------EQVLKFVMDGG 250
Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                  N  +++  +M +   C   NP+ RPT  ++  LLK
Sbjct: 251  YLDQPDNCPERVTDLMRM---CWQFNPNMRPTFLEIVNLLK 288

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 29   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 86
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 87   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 140
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 141  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 199  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 238

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Composition-based stats.
 Identities = 75/294 (25%), Positives = 131/294 (44%), Gaps = 40/294 (13%)
Query: 813  CIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            C+G G  G V+R  L  GE VAVK F S    E +  +E   E+ +   +RH NI+ F  
Sbjct: 15   CVGKGRYGEVWRG-LWHGESVAVKIFSSR--DEQSWFRE--TEIYNTVLLRHDNILGFIA 69
Query: 873  FCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
                +R+S    +++  Y E GSL   L   T    L     + +    A  L++LH + 
Sbjct: 70   SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA----LRLAVSAACGLAHLHVEI 125
Query: 929  F-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-----GTIGYV 978
            F     P I +RD  S+NVL+    +  ++D G++  +    S++ ++      GT  Y+
Sbjct: 126  FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA-VMHSQGSDYLDIGNNPRVGTKRYM 184
Query: 979  APELAYTMKVTE------KSDVYSFGVLALE--------AIKGKHPRDFISSICSTSSNL 1024
            APE+      T+       +D+++FG++  E         I   +   F   + +  S  
Sbjct: 185  APEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFE 244
Query: 1025 DRTLDEILDPRLPA-PSCNIRDKLIS-IMEVAISCLDENPDSRPTMQKVSQLLK 1076
            D      +D + P  P+    D ++S + ++   C   NP +R T  ++ + L+
Sbjct: 245  DMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQ 298

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/305 (23%), Positives = 133/305 (43%), Gaps = 56/305 (18%)
Query: 797  AYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEV 856
            A+ ++V AT         G G + +V +        VAVK   S   ++   ++  ++E+
Sbjct: 43   AFGKVVEAT-------AFGLGKEDAVLK--------VAVKMLKSTAHADE--KEALMSEL 85
Query: 857  KSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA------------- 902
            K ++ + +H NIV   G C+H     ++ EY   G L   L     A             
Sbjct: 86   KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPE 145
Query: 903  -------EELGWTQRMNVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSD 954
                     L     ++    VA  +++L + +C    ++RD++++NVLL   + A + D
Sbjct: 146  GLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNC----IHRDVAARNVLLTNGHVAKIGD 201
Query: 955  FGISKSLKPDSSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPR 1011
            FG+++ +  DS+   +      + ++APE  +    T +SDV+S+G+L  E    G +P 
Sbjct: 202  FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 261
Query: 1012 DFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              I  + S    L +   ++  P   AP       + SIM+   +C    P  RPT Q++
Sbjct: 262  PGI-LVNSKFYKLVKDGYQMAQPAF-APK-----NIYSIMQ---ACWALEPTHRPTFQQI 311
Query: 1072 SQLLK 1076
               L+
Sbjct: 312  CSFLQ 316

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G  VA+K      L+  + Q+ F  EV+ 
Sbjct: 9    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRI 67
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  +++ EY   G +   L      +E    +  +  + + 
Sbjct: 68   MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE---KEARSKFRQIV 124
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S              G   Y 
Sbjct: 125  SAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAFCGAPPYA 180
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 181  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHS-PLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G   +V+R     +G++ A+K F++   L  +  Q   + E + L ++ H+NIVK +
Sbjct: 17   LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ---MREFEVLKKLNHKNIVKLF 73
Query: 872  GFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                    RH  ++ E+   GSL  +L   ++A  L  ++ + V++ V   +++L  +  
Sbjct: 74   AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG- 132
Query: 930  PPIVYRDISSKNVLL----DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
              IV+R+I   N++     D +    ++DFG ++ L+ D   +  L GT  Y+ P++ Y 
Sbjct: 133  --IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDM-YE 188
Query: 986  MKVTEKS---------DVYSFGVLALEAIKGKHP 1010
              V  K          D++S GV    A  G  P
Sbjct: 189  RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 859  LTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIK 915
            L ++ H  +VK  Y F +  +  +++ ++L  G L   LS     +E+ +T+      + 
Sbjct: 84   LADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLS-----KEVMFTEEDVKFYLA 137
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +A  L +LH+     I+YRD+  +N+LLD E    ++DFG+SK             GT+
Sbjct: 138  ELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTV 194
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE+      +  +D +S+GVL  E + G  P
Sbjct: 195  EYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/278 (23%), Positives = 124/278 (44%), Gaps = 35/278 (12%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGE-------IVAVKKFHSPLLSEMTCQQEFLNEVK 857
             +F +   +G+G  G+VY+   +  GE       I+ +++  SP        +E L+E  
Sbjct: 49   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSP-----KANKEILDEAY 103
Query: 858  SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
             +  + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +
Sbjct: 104  VMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQI 160
Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--I 975
            A  ++YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I
Sbjct: 161  AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP 1034
             ++A E       T +SDV+S+GV   E +  G  P D I +    SS L++        
Sbjct: 218  KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GE 270
Query: 1035 RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            RLP P  C      I +  + + C   + DSRP  +++
Sbjct: 271  RLPQPPICT-----IDVYMIMVKCWMIDADSRPKFREL 303

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 131/296 (44%), Gaps = 57/296 (19%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVK 869
            E  +G G  G+V       G  VAVK+    +L +  C    + E+K LTE   H N+++
Sbjct: 20   EKILGYGSSGTVVFQGSFQGRPVAVKR----MLIDF-CDIALM-EIKLLTESDDHPNVIR 73
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN---VIKGVADALSYLHN 926
            +Y   +  R  +I  E   +    ++ S   S E L   +  N   +++ +A  +++LH+
Sbjct: 74   YYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 927  DCFPPIVYRDISSKNVLL--------DLEYEAH-----VSDFGISKSLKPDS----SNWT 969
                 I++RD+  +N+L+        D +  A      +SDFG+ K L         N  
Sbjct: 134  ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLN 190
Query: 970  ELAGTIGYVAPE-------LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTS 1021
              +GT G+ APE       L    ++T   D++S G +    + KGKHP        S  
Sbjct: 191  NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP---FGDKYSRE 247
Query: 1022 SNLDR---TLDEIL---DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            SN+ R   +LDE+    D  L A + +    LIS M      +D +P  RPT  KV
Sbjct: 248  SNIIRGIFSLDEMKCLHDRSLIAEATD----LISQM------IDHDPLKRPTAMKV 293

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 33   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLAFRHENIIGIND 90
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 91   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 144
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 145  --ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 203  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 242

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Composition-based stats.
 Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 26/215 (12%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLL---SEMTCQQEFLNEVKSLTEI 862
            DF     +G G  G V+ AE   + +  A+K     ++    ++ C         ++ E 
Sbjct: 18   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC---------TMVEK 68
Query: 863  RHRNIVKFYGFCSH-------ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
            R  ++   + F +H         + F V EYL  G L   + +  S  +   ++      
Sbjct: 69   RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAA 125
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +   L +LH+     IVYRD+   N+LLD +    ++DFG+ K      +      GT 
Sbjct: 126  EIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTP 182
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             Y+APE+    K     D +SFGVL  E + G+ P
Sbjct: 183  DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 63.5 bits (153), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 12/194 (6%)
Query: 811  EHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +  +G G  G V   +   +G+  AVK      + + T ++  L EV+ L ++ H NI K
Sbjct: 31   QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXK 90
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y F     + ++V E    G L        S +         +I+ V   ++Y H +  
Sbjct: 91   LYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSEVDAARIIRQVLSGITYXHKN-- 145
Query: 930  PPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
              IV+RD+  +N+LL+ + +     + DFG+S   +  S    +  GT  Y+APE+ +  
Sbjct: 146  -KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA-SKKXKDKIGTAYYIAPEVLHGT 203
Query: 987  KVTEKSDVYSFGVL 1000
               EK DV+S GV+
Sbjct: 204  -YDEKCDVWSTGVI 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G+ VAV+      L+  + Q+ F  EV+ 
Sbjct: 8    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLF-REVRI 66
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +  + H NIVK +      +  ++V EY   G +   L      +E    +     + + 
Sbjct: 67   MKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKE---KEARAKFRQIV 123
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +      G+  Y 
Sbjct: 124  SAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT-FGNKLDTFCGSPPYA 179
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 180  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 21/267 (7%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI--- 862
             DFD    IG G    V    L   + +   K    +  E+    E ++ V++   +   
Sbjct: 20   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKV---VKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 863  --RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
               H  +V  +         F V EY+  G L   +       E            ++ A
Sbjct: 77   ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLA 133
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYVA 979
            L+YLH      I+YRD+   NVLLD E    ++D+G+ K  L+P  +  +   GT  Y+A
Sbjct: 134  LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT-SXFCGTPNYIA 189
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE-ILDPRLPA 1038
            PE+          D ++ GVL  E + G+ P D + S  +   N +  L + IL+ ++  
Sbjct: 190  PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 249
Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSR 1065
            P    R   +    V  S L+++P  R
Sbjct: 250  P----RSMSVKAASVLKSFLNKDPKER 272

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 35   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 92
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++     S + + +      +  +   L Y+H+ 
Sbjct: 93   IIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 147  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 205  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 26/265 (9%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    Y   ++ + E+ A K     +L +   +++   E+     + + ++V F+G
Sbjct: 34   LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 873  FCSHARHSFIVYEYLEMGSLAMI--LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            F       ++V E     SL  +     A +  E  +  R   I+GV     YLHN+   
Sbjct: 94   FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN--- 145
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             +++RD+   N+ L+ + +  + DFG++  ++ D     +L GT  Y+APE+      + 
Sbjct: 146  RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 991  KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050
            + D++S G +    + GK P     + C   + +    +E   PR   P   +   LI  
Sbjct: 206  EVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINP---VASALIRR 259
Query: 1051 MEVAISCLDENPDSRPTMQKVSQLL 1075
            M      L  +P  RP+   V++LL
Sbjct: 260  M------LHADPTLRPS---VAELL 275

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-10,   Method: Composition-based stats.
 Identities = 58/210 (27%), Positives = 100/210 (47%), Gaps = 32/210 (15%)
Query: 817  GGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH 876
            G  G V++A+L + + VAVK F  PL  + + Q E   E+ S   ++H N+++F    + 
Sbjct: 26   GRFGCVWKAQLMN-DFVAVKIF--PLQDKQSWQSE--REIFSTPGMKHENLLQF--IAAE 78
Query: 877  ARHS------FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC-- 928
             R S      +++  + + GSL   L        + W +  +V + ++  LSYLH D   
Sbjct: 79   KRGSNLEVELWLITAFHDKGSLTDYLKGNI----ITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 929  ------FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAP 980
                   P I +RD  SKNVLL  +  A ++DFG++   +P     +     GT  Y+AP
Sbjct: 135  CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 981  E-----LAYTMKVTEKSDVYSFGVLALEAI 1005
            E     + +      + D+Y+ G++  E +
Sbjct: 195  EVLEGAINFQRDAFLRIDMYAMGLVLWELV 224

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA++K  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 35   IGEGAYGMVCSAYDNLNKVRVAIRKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 92
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 93   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 147  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 205  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Composition-based stats.
 Identities = 63/265 (23%), Positives = 117/265 (44%), Gaps = 26/265 (9%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    Y   ++ + E+ A K     +L +   +++   E+     + + ++V F+G
Sbjct: 50   LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 873  FCSHARHSFIVYEYLEMGSLAMI--LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            F       ++V E     SL  +     A +  E  +  R   I+GV     YLHN+   
Sbjct: 110  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN--- 161
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             +++RD+   N+ L+ + +  + DFG++  ++ D     +L GT  Y+APE+      + 
Sbjct: 162  RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 991  KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050
            + D++S G +    + GK P     + C   + +    +E   PR   P   +   LI  
Sbjct: 222  EVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINP---VASALIRR 275
Query: 1051 MEVAISCLDENPDSRPTMQKVSQLL 1075
            M      L  +P  RP+   V++LL
Sbjct: 276  M------LHADPTLRPS---VAELL 291

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.2 bits (152), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 786  FLSVLTFDRKIAYEEIVR---ATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSP 841
            +L  + F+R + ++ + R     N F +   +G GG G V   ++ ++G++ A KK    
Sbjct: 161  YLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + +   +   LNE + L ++  R +V             + Y Y    +L ++L+    
Sbjct: 221  RIKKRKGEAMALNEKQILEKVNSRFVVS------------LAYAYETKDALCLVLTLMNG 268
Query: 902  AE---------ELGWTQRMNVIKG--VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA 950
             +         + G+ +   V     +   L  LH +    IVYRD+  +N+LLD     
Sbjct: 269  GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325
Query: 951  HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             +SD G++  + P+        GT+GY+APE+    + T   D ++ G L  E I G+ P
Sbjct: 326  RISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 63.2 bits (152), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 21/267 (7%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI--- 862
             DFD    IG G    V    L   + +   +    +  E+    E ++ V++   +   
Sbjct: 52   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRV---VKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 863  --RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
               H  +V  +         F V EY+  G L   +       E            ++ A
Sbjct: 109  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---EHARFYSAEISLA 165
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS-LKPDSSNWTELAGTIGYVA 979
            L+YLH      I+YRD+   NVLLD E    ++D+G+ K  L+P  +  T   GT  Y+A
Sbjct: 166  LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIA 221
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE-ILDPRLPA 1038
            PE+          D ++ GVL  E + G+ P D + S  +   N +  L + IL+ ++  
Sbjct: 222  PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281
Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSR 1065
            P    R   +    V  S L+++P  R
Sbjct: 282  P----RSLSVKAASVLKSFLNKDPKER 304

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/240 (24%), Positives = 106/240 (44%), Gaps = 31/240 (12%)
Query: 786  FLSVLTFDRKIAYEEIVR---ATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSP 841
            +L  + F+R + ++ + R     N F +   +G GG G V   ++ ++G++ A KK    
Sbjct: 161  YLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKK 220
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + +   +   LNE + L ++  R +V             + Y Y    +L ++L+    
Sbjct: 221  RIKKRKGEAMALNEKQILEKVNSRFVVS------------LAYAYETKDALCLVLTLMNG 268
Query: 902  AE---------ELGWTQRMNVIKG--VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA 950
             +         + G+ +   V     +   L  LH +    IVYRD+  +N+LLD     
Sbjct: 269  GDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHI 325
Query: 951  HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             +SD G++  + P+        GT+GY+APE+    + T   D ++ G L  E I G+ P
Sbjct: 326  RISDLGLAVHV-PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 22   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 80   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 136
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 137  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 192
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 193  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 239
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 240  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 271

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 20   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 78   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 134
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 135  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 190
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 191  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 237
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 238  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 269

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 17   CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 75   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 131
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 132  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 187
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 188  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 234
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 235  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 266

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 14   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 72   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 128
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 129  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 184
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 185  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 231
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 232  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 263

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 17   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 75   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 131
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 132  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 187
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 188  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 234
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 235  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 266

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 19   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 77   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 133
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 134  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 189
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 190  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 236
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 237  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 268

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-10,   Method: Composition-based stats.
 Identities = 50/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 4    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 62
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   LS+ H
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLSFCH 120
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 121  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 178  CKYYSTAVDIWSLGCIFAEMV 198

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 17   CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 75   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLESKR 131
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 132  F---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 187
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 188  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 234
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 235  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 266

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 814  IGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G+G  G V   + +L+  E  A+K      ++  +     L+EV  L ++ H NI+K Y
Sbjct: 29   LGSGAYGEVLLCKDKLTGAE-RAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 872  GFCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             F    R+ ++V E    G L   +IL    S  +        ++K V    +YLH    
Sbjct: 88   EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-----IMKQVLSGTTYLHKH-- 140
Query: 930  PPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
              IV+RD+  +N+LL+ +       + DFG+S   +       E  GT  Y+APE+    
Sbjct: 141  -NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV-LRK 197
Query: 987  KVTEKSDVYSFGVLALEAIKGKHP 1010
            K  EK DV+S GV+    + G  P
Sbjct: 198  KYDEKCDVWSCGVILYILLCGYPP 221

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 120/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 45   CIGEGQFGDVHQGIYMSPENPALAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 103  KLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLA--SLILYAYQLSTALAYLESKR 159
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE     
Sbjct: 160  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINFR 215
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 216  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 262
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 263  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 294

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 18   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 75
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 76   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 132
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG +K L  +   +    G   I ++A
Sbjct: 133  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 190  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 242
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 243  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 271

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 20   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 77
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 78   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 134
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG +K L  +   +    G   I ++A
Sbjct: 135  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 191
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 192  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 244
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 245  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 273

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 19/215 (8%)
Query: 809  DEEHCIG------TGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            DE+  IG      T G+G+  + +L+    +G+ VAVK      L+  + Q+ F  EV+ 
Sbjct: 8    DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLF-REVRI 66
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
               + H NIVK +      +  ++V EY   G +   L      +E    +     + + 
Sbjct: 67   XKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKE---KEARAKFRQIV 123
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             A+ Y H      IV+RD+ ++N+LLD +    ++DFG S       +      G   Y 
Sbjct: 124  SAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT-FGNKLDAFCGAPPYA 179
Query: 979  APELAYTMKVT-EKSDVYSFGVLALEAIKGKHPRD 1012
            APEL    K    + DV+S GV+    + G  P D
Sbjct: 180  APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 814  IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            + T G+GS  + +L    ++G+ VA+K  +  +L++   Q     E+  L  +RH +I+K
Sbjct: 13   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 72
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y          +V EY        I+     +E+    +     + +  A+ Y H    
Sbjct: 73   LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH-- 126
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKV 988
              IV+RD+  +N+LLD      ++DFG+S ++  D +      G+  Y APE ++  +  
Sbjct: 127  -KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISGKLYA 184
Query: 989  TEKSDVYSFGVLALEAIKGKHPRD--FISSICSTSSNLDRTLDEILDP 1034
              + DV+S GV+    +  + P D   I  +    SN   TL + L P
Sbjct: 185  GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 232

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 23   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 80
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 81   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 137
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG +K L  +   +    G   I ++A
Sbjct: 138  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 195  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 247
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 248  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 16   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 73
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 74   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 130
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG +K L  +   +    G   I ++A
Sbjct: 131  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 188  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 240
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 241  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 814  IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            + T G+GS  + +L    ++G+ VA+K  +  +L++   Q     E+  L  +RH +I+K
Sbjct: 18   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 77
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y          +V EY        I+     +E+    +     + +  A+ Y H    
Sbjct: 78   LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH-- 131
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKV 988
              IV+RD+  +N+LLD      ++DFG+S ++  D +      G+  Y APE ++  +  
Sbjct: 132  -KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISGKLYA 189
Query: 989  TEKSDVYSFGVLALEAIKGKHPRD--FISSICSTSSNLDRTLDEILDP 1034
              + DV+S GV+    +  + P D   I  +    SN   TL + L P
Sbjct: 190  GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 237

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 15/228 (6%)
Query: 814  IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            + T G+GS  + +L    ++G+ VA+K  +  +L++   Q     E+  L  +RH +I+K
Sbjct: 9    VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 68
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y          +V EY        I+     +E+    +     + +  A+ Y H    
Sbjct: 69   LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH-- 122
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKV 988
              IV+RD+  +N+LLD      ++DFG+S ++  D +      G+  Y APE ++  +  
Sbjct: 123  -KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISGKLYA 180
Query: 989  TEKSDVYSFGVLALEAIKGKHPRD--FISSICSTSSNLDRTLDEILDP 1034
              + DV+S GV+    +  + P D   I  +    SN   TL + L P
Sbjct: 181  GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 228

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 39/277 (14%)
Query: 812  HCIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
             CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +I
Sbjct: 396  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHI 453
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            VK  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL + 
Sbjct: 454  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLESK 510
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYT 985
             F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE    
Sbjct: 511  RF---VHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 566
Query: 986  MKVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             + T  SDV+ FGV   E +       +G    D I  I +               RLP 
Sbjct: 567  RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPM 613
Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            P  N    L S+M     C   +P  RP   ++   L
Sbjct: 614  PP-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 646

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/274 (23%), Positives = 123/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   + +G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 23   EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 80
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 81   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 137
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 138  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 195  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 247
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 248  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 26/265 (9%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    Y   ++ + E+ A K     +L +   +++   E+     + + ++V F+G
Sbjct: 50   LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 873  FCSHARHSFIVYEYLEMGSLAMI--LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            F       ++V E     SL  +     A +  E  +  R   I+GV     YLHN+   
Sbjct: 110  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN--- 161
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             +++RD+   N+ L+ + +  + DFG++  ++ D      L GT  Y+APE+      + 
Sbjct: 162  RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 991  KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050
            + D++S G +    + GK P     + C   + +    +E   PR   P   +   LI  
Sbjct: 222  EVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINP---VASALIRR 275
Query: 1051 MEVAISCLDENPDSRPTMQKVSQLL 1075
            M      L  +P  RP+   V++LL
Sbjct: 276  M------LHADPTLRPS---VAELL 291

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 63/265 (23%), Positives = 116/265 (43%), Gaps = 26/265 (9%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG    Y   ++ + E+ A K     +L +   +++   E+     + + ++V F+G
Sbjct: 50   LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 873  FCSHARHSFIVYEYLEMGSLAMI--LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            F       ++V E     SL  +     A +  E  +  R   I+GV     YLHN+   
Sbjct: 110  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMR-QTIQGV----QYLHNN--- 161
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             +++RD+   N+ L+ + +  + DFG++  ++ D      L GT  Y+APE+      + 
Sbjct: 162  RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSF 221
Query: 991  KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISI 1050
            + D++S G +    + GK P     + C   + +    +E   PR   P   +   LI  
Sbjct: 222  EVDIWSLGCILYTLLVGKPP---FETSCLKETYIRIKKNEYSVPRHINP---VASALIRR 275
Query: 1051 MEVAISCLDENPDSRPTMQKVSQLL 1075
            M      L  +P  RP+   V++LL
Sbjct: 276  M------LHADPTLRPS---VAELL 291

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 13/204 (6%)
Query: 814  IGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            + T G+GS  + +L    ++G+ VA+K  +  +L++   Q     E+  L  +RH +I+K
Sbjct: 19   VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIK 78
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y          +V EY        I+     +E+    +     + +  A+ Y H    
Sbjct: 79   LYDVIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQ----EARRFFQQIISAVEYCHRH-- 132
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKV 988
              IV+RD+  +N+LLD      ++DFG+S ++  D +      G+  Y APE ++  +  
Sbjct: 133  -KIVHRDLKPENLLLDEHLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVISGKLYA 190
Query: 989  TEKSDVYSFGVLALEAIKGKHPRD 1012
              + DV+S GV+    +  + P D
Sbjct: 191  GPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 4    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 62
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 121  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 178  XKYYSTAVDIWSLGCIFAEMV 198

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 9/196 (4%)
Query: 818  GQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            G+GS  +A L      G    +K+ +   +S    ++E   EV  L  ++H NIV++   
Sbjct: 33   GEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE-REESRREVAVLANMKHPNIVQYRES 91
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
                   +IV +Y E G L   + NA         Q ++    +  AL ++H+     I+
Sbjct: 92   FEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR---KIL 147
Query: 934  YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSD 993
            +RDI S+N+ L  +    + DFGI++ L           GT  Y++PE+        KSD
Sbjct: 148  HRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSD 207
Query: 994  VYSFGVLALEAIKGKH 1009
            +++ G +  E    KH
Sbjct: 208  IWALGCVLYELCTLKH 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 26   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 83
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 84   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 140
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 141  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 198  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 250
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  +   C   + DSRP  +++
Sbjct: 251  PPICT-----IDVYMIMRKCWMIDADSRPKFREL 279

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 16   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 73
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 74   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 130
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 131  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 188  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 240
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  +   C   + DSRP  +++
Sbjct: 241  PPICT-----IDVYMIMRKCWMIDADSRPKFREL 269

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 19   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 76
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 77   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 133
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 134  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 191  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 243
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  +   C   + DSRP  +++
Sbjct: 244  PPICT-----IDVYMIMRKCWMIDADSRPKFREL 272

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 8    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 66
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 67   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 124
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 125  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 181
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 182  CKYYSTAVDIWSLGCIFAEMV 202

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 35   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 92
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 93   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +     E   T  Y APE+  
Sbjct: 147  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 205  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 36   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 93
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 94   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 147
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +     E   T  Y APE+  
Sbjct: 148  --ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 206  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 245

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 4    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 62
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 121  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 178  CKYYSTAVDIWSLGCIFAEMV 198

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 61   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+
Sbjct: 119  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 175
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 176  LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 120  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L M     + ++A +   L   +  + +  +   L+
Sbjct: 61   NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 119  FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 176  LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 120  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMV 197

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 4    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 62
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 121  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 178  CKYYSTAVDIWSLGCIFAEMV 198

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   + +G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 23   EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 80
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 81   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 137
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 138  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 195  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 247
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 248  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 276

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   + +G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 16   EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 73
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 74   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 130
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A
Sbjct: 131  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 188  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 240
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  + + C   + DSRP  +++
Sbjct: 241  PPICT-----IDVYMIMVKCWMIDADSRPKFREL 269

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L M     + ++A +   L   +  + +  +   L+
Sbjct: 63   NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 121  FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 9/164 (5%)
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            Q   + + ++  + H +IV+  G C  +    +V +YL +GSL   +     A  LG   
Sbjct: 60   QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQL 116
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-- 967
             +N    +A  + YL       +V+R+++++NVLL    +  V+DFG++  L PD     
Sbjct: 117  LLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
            ++E    I ++A E  +  K T +SDV+S+GV   E +  G  P
Sbjct: 174  YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP   +  CQ+  L E+K L   RH NI+    
Sbjct: 51   IGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFRHENIIGIND 108
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                     +   YL    +   L      + L        +  +   L Y+H+     +
Sbjct: 109  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANV 165
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAYTMKVT 989
            ++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+    K  
Sbjct: 166  LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 225
Query: 990  EKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
             KS D++S G +  E +       GKH  D ++ I
Sbjct: 226  TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 63/302 (20%), Positives = 124/302 (41%), Gaps = 60/302 (19%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF E   IG+GG G V++A+    G+   +++            ++   EVK+L ++ H 
Sbjct: 13   DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYN-------NEKAEREVKALAKLDHV 65
Query: 866  NIVKFYGFC------------------------------SHARHSFIVYEYLEMGSLAMI 895
            NIV + G C                              S  +  FI  E+ + G+L   
Sbjct: 66   NIVHYNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQW 124
Query: 896  LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF 955
            +      E+L     + + + +   + Y+H+     +++RD+   N+ L    +  + DF
Sbjct: 125  IEK-RRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDF 180
Query: 956  GISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFIS 1015
            G+  SLK D    T   GT+ Y++PE   +    ++ D+Y+ G++  E +          
Sbjct: 181  GLVTSLKNDGKR-TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH--------- 230
Query: 1016 SICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             +C T+    +   ++ D  +     +I DK    +   +  L + P+ RP   ++ + L
Sbjct: 231  -VCDTAFETSKFFTDLRDGIIS----DIFDKKEKTLLQKL--LSKKPEDRPNTSEILRTL 283
Query: 1076 KI 1077
             +
Sbjct: 284  TV 285

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L M     + ++A +   L   +  + +  +   L+
Sbjct: 62   NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 120  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 177  LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 11   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 69
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 70   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 127
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 128  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 185  XKYYSTAVDIWSLGCIFAEMV 205

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N+F+    +G G  G V    E ++G   A+K     ++         L E + L   RH
Sbjct: 148  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALS 922
              +    Y F +H R  F++ EY   G L   LS      E     R       +  AL 
Sbjct: 208  PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 262
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH++    +VYRD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+
Sbjct: 263  YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 320
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                      D +  GV+  E + G+ P
Sbjct: 321  LEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 49/201 (24%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 11   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 69
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 70   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 127
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 128  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 184
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 185  CKYYSTAVDIWSLGCIFAEMV 205

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N+F+    +G G  G V    E ++G   A+K     ++         L E + L   RH
Sbjct: 151  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 865  RNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALS 922
              +    Y F +H R  F++ EY   G L   LS      E     R       +  AL 
Sbjct: 211  PFLTALKYSFQTHDRLCFVM-EYANGGELFFHLSRERVFSE----DRARFYGAEIVSALD 265
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH++    +VYRD+  +N++LD +    ++DFG+ K    D +      GT  Y+APE+
Sbjct: 266  YLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEV 323
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                      D +  GV+  E + G+ P
Sbjct: 324  LEDNDYGRAVDWWGLGVVMYEMMCGRLP 351

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 61.6 bits (148), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A  +  ++ VA+KK  SP     T  Q  L E+K L   RH NI+    
Sbjct: 35   IGEGAYGMVCSAYDNLNKVRVAIKKI-SPF-EHQTYXQRTLREIKILLRFRHENIIGIND 92
Query: 873  FC-----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +  +IV + +E     ++ +   S + + +      +  +   L Y+H+ 
Sbjct: 93   IIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY-----FLYQILRGLKYIHS- 146
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y APE+  
Sbjct: 147  --ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 205  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 244

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 120/277 (43%), Gaps = 39/277 (14%)
Query: 812  HCIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
             CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +I
Sbjct: 396  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHI 453
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            VK  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL + 
Sbjct: 454  VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLESK 510
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYT 985
             F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE    
Sbjct: 511  RF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESINF 566
Query: 986  MKVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             + T  SDV+ FGV   E +       +G    D I  I +               RLP 
Sbjct: 567  RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPM 613
Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            P  N    L S+M     C   +P  RP   ++   L
Sbjct: 614  PP-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 646

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 9/164 (5%)
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            Q   + + ++  + H +IV+  G C  +    +V +YL +GSL   +     A  LG   
Sbjct: 78   QAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA--LGPQL 134
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-- 967
             +N    +A  + YL       +V+R+++++NVLL    +  V+DFG++  L PD     
Sbjct: 135  LLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHP 1010
            ++E    I ++A E  +  K T +SDV+S+GV   E +  G  P
Sbjct: 192  YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 119/276 (43%), Gaps = 39/276 (14%)
Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            CIG G  G V++    S E     VA+K   +   +  + +++FL E  ++ +  H +IV
Sbjct: 17   CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN--CTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            K  G  +     +I+ E   +G L   L     + +L     +     ++ AL+YL +  
Sbjct: 75   KLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLA--SLILYAYQLSTALAYLESKR 131
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
            F   V+RDI+++NVL+       + DFG+S+ ++ DS+      G   I ++APE     
Sbjct: 132  F---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWMAPESINFR 187
Query: 987  KVTEKSDVYSFGVLALEAI-------KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            + T  SDV+ FGV   E +       +G    D I  I +               RLP P
Sbjct: 188  RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------RLPMP 234
Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              N    L S+M     C   +P  RP   ++   L
Sbjct: 235  P-NCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 266

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 49/204 (24%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L M     + ++A +   L   +  + +  +   L+
Sbjct: 63   NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 121  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-09,   Method: Composition-based stats.
 Identities = 76/301 (25%), Positives = 124/301 (41%), Gaps = 51/301 (16%)
Query: 808  FDEEHC--IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H   I   G+G+    EL        ++G +VAVK+      S    Q++F  E++
Sbjct: 7    FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQ 63
Query: 858  SLTEIRHRNIVKFYGFC-SHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  +    IVK+ G      R S  +V EYL  G L   L    +   L  ++ +    
Sbjct: 64   ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSS 121
Query: 916  GVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL--- 971
             +   + YL    C    V+RD++++N+L++ E    ++DFG++K L  D   +      
Sbjct: 122  QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 177
Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               I + APE       + +SDV+SFGV+  E         +    CS S+   R +   
Sbjct: 178  QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGSE 231
Query: 1032 LD--------------PRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D               RLPA P+C        + E+   C   +P  RP+   +   L 
Sbjct: 232  RDVPALSRLLELLEEGQRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLD 286
Query: 1077 I 1077
            +
Sbjct: 287  M 287

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/214 (22%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +++ F +   +G G   +VY+    ++G  VA+K+    L SE       + E+  + E+
Sbjct: 3    SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTAIREISLMKEL 60
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR---MNVIK---- 915
            +H NIV+ Y          +V+E+++       L     +  +G T R   +N++K    
Sbjct: 61   KHENIVRLYDVIHTENKLTLVFEFMDND-----LKKYMDSRTVGNTPRGLELNLVKYFQW 115
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +   L++ H +    I++RD+  +N+L++   +  + DFG++++     + ++    T+
Sbjct: 116  QLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 976  GYVAPELAYTMKVTEKS-DVYSFGVLALEAIKGK 1008
             Y AP++    +    S D++S G +  E I GK
Sbjct: 173  WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 22/221 (9%)
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCS--HARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
            ++   E+  L ++ H N+VK        +  H ++V+E +  G +  + +    +E+   
Sbjct: 81   EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                ++IKG+     YLH   +  I++RDI   N+L+  +    ++DFG+S   K   + 
Sbjct: 141  FYFQDLIKGI----EYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 968  WTELAGTIGYVAPE-LAYTMKV--TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
             +   GT  ++APE L+ T K+   +  DV++ GV     + G+ P      +C  S   
Sbjct: 194  LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK 253
Query: 1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             + L+    P  P  + +++D LI+ M      LD+NP+SR
Sbjct: 254  SQALEF---PDQPDIAEDLKD-LITRM------LDKNPESR 284

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 6/132 (4%)
Query: 881  FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSK 940
            + V EY+  G L   +      +E    Q +     ++  L +LH      I+YRD+   
Sbjct: 96   YFVMEYVNGGDLMYHIQQVGKFKE---PQAVFYAAEISIGLFFLHKRG---IIYRDLKLD 149
Query: 941  NVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVL 1000
            NV+LD E    ++DFG+ K    D     E  GT  Y+APE+       +  D +++GVL
Sbjct: 150  NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVL 209
Query: 1001 ALEAIKGKHPRD 1012
              E + G+ P D
Sbjct: 210  LYEMLAGQPPFD 221

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 65/269 (24%), Positives = 115/269 (42%), Gaps = 30/269 (11%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ---QEFLNEVKSLTEIRHRNIVKF 870
            +G G  GSV    L   +  ++K     +  + + Q   +EFL+E   + +  H N+++ 
Sbjct: 42   LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 871  YGFCSHARHS-----FIVYEYLEMGSLAMILSNA---TSAEELGWTQRMNVIKGVADALS 922
             G C            ++  +++ G L   L  +   T  + +     +  +  +A  + 
Sbjct: 102  LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL-KPDSSNWTELAGT-IGYVAP 980
            YL N  F   ++RD++++N +L  +    V+DFG+SK +   D      +A   + ++A 
Sbjct: 162  YLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 981  ELAYTMKVTEKSDVYSFGVLALE-AIKGKHPRDFISSICSTSSNLDRTLDEILDP-RLPA 1038
            E       T KSDV++FGV   E A +G  P   + +            D +L   RL  
Sbjct: 219  ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--------HEMYDYLLHGHRLKQ 270
Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPT 1067
            P     D L  + E+  SC   +P  RPT
Sbjct: 271  P----EDCLDELYEIMYSCWRTDPLDRPT 295

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 149
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 150  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                 ++ SD+++ G +  + + G  P
Sbjct: 207  TEKSASKSSDLWALGCIIYQLVAGLPP 233

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/194 (29%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 814  IGTGGQGSVY--RAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G+G  G V   + +L+  E  A+K      ++  +     L+EV  L ++ H NI+K Y
Sbjct: 12   LGSGAYGEVLLCKDKLTGAE-RAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 70
Query: 872  GFCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             F    R+ ++V E    G L   +IL    S           ++K V    +YLH    
Sbjct: 71   EFFEDKRNYYLVMEVYRGGELFDEIILRQKFSE-----VDAAVIMKQVLSGTTYLHK--- 122
Query: 930  PPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
              IV+RD+  +N+LL+ +       + DFG+S   +       E  GT  Y+APE+    
Sbjct: 123  HNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEV-GGKMKERLGTAYYIAPEV-LRK 180
Query: 987  KVTEKSDVYSFGVL 1000
            K  EK DV+S GV+
Sbjct: 181  KYDEKCDVWSCGVI 194

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 78/153 (50%), Gaps = 11/153 (7%)
Query: 851  EFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR 910
            + L EV  L  + H NI+K Y F    R+ ++V E  + G L   + +     E+     
Sbjct: 82   KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV- 140
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD-LEYEA--HVSDFGISKSLKPDSSN 967
              +IK V   ++YLH      IV+RD+  +N+LL+  E +A   + DFG+S ++  +   
Sbjct: 141  --IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS-AVFENQKK 194
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVL 1000
              E  GT  Y+APE+    K  EK DV+S GV+
Sbjct: 195  MKERLGTAYYIAPEV-LRKKYDEKCDVWSIGVI 226

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 58/249 (23%), Positives = 108/249 (43%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +       N T     + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 45   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 99
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 100  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 159
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 160  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 214
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 215  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 244

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 11/208 (5%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 38   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 97
Query: 866  NIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              VK Y FC       +    Y + G L   +    S +E   T        +  AL YL
Sbjct: 98   FFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYL 153
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPEL 982
            H      I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL
Sbjct: 154  HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 210
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                   + SD+++ G +  + + G  P
Sbjct: 211  LTEKSACKSSDLWALGCIIYQLVAGLPP 238

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Composition-based stats.
 Identities = 50/200 (25%), Positives = 87/200 (43%), Gaps = 22/200 (11%)
Query: 830  GEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEIRHRNIVKFY----GFCSHARHSFIVY 884
            G+I+    F + +L+ E+   +E+  ++     I   N V +        S   H F V 
Sbjct: 35   GKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 885  EYLEMG---SLAMILSNATSAEELGWTQRMNVIKG---------VADALSYLHNDCFPPI 932
             Y        L   LS A + E L + +++              +  AL YLH      I
Sbjct: 95   LYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GI 151
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL       +
Sbjct: 152  IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACK 211
Query: 991  KSDVYSFGVLALEAIKGKHP 1010
             SD+++ G +  + + G  P
Sbjct: 212  SSDLWALGCIIYQLVAGLPP 231

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 79   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 133
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 134  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    + +    G    
Sbjct: 194  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAML 248
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 249  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 278

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 122/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 18   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 75
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I+ + +  G L   +      + +G    +N    +A  +
Sbjct: 76   VDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 132
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG +K L  +   +    G   I ++A
Sbjct: 133  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 190  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 242
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  +   C   + DSRP  +++
Sbjct: 243  PPICT-----IDVYMIMRKCWMIDADSRPKFREL 271

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 34   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 94   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 150
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 151  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 207
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 208  TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E++       + ++A +   L   +  + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 120  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMV 197

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 76/301 (25%), Positives = 124/301 (41%), Gaps = 51/301 (16%)
Query: 808  FDEEHC--IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H   I   G+G+    EL        ++G +VAVK+      S    Q++F  E++
Sbjct: 8    FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQ 64
Query: 858  SLTEIRHRNIVKFYGFC-SHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  +    IVK+ G      R S  +V EYL  G L   L    +   L  ++ +    
Sbjct: 65   ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSS 122
Query: 916  GVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL--- 971
             +   + YL    C    V+RD++++N+L++ E    ++DFG++K L  D   +      
Sbjct: 123  QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 178
Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               I + APE       + +SDV+SFGV+  E         +    CS S+   R +   
Sbjct: 179  QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCE 232
Query: 1032 LD--------------PRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D               RLPA P+C        + E+   C   +P  RP+   +   L 
Sbjct: 233  RDVPALCRLLELLEEGQRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLD 287
Query: 1077 I 1077
            +
Sbjct: 288  M 288

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 30   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 90   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 146
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 147  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 203
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 204  TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 76/301 (25%), Positives = 124/301 (41%), Gaps = 51/301 (16%)
Query: 808  FDEEHC--IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H   I   G+G+    EL        ++G +VAVK+      S    Q++F  E++
Sbjct: 20   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQ 76
Query: 858  SLTEIRHRNIVKFYGFC-SHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  +    IVK+ G      R S  +V EYL  G L   L    +   L  ++ +    
Sbjct: 77   ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSS 134
Query: 916  GVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL--- 971
             +   + YL    C    V+RD++++N+L++ E    ++DFG++K L  D   +      
Sbjct: 135  QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               I + APE       + +SDV+SFGV+  E         +    CS S+   R +   
Sbjct: 191  QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCE 244
Query: 1032 LD--------------PRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D               RLPA P+C        + E+   C   +P  RP+   +   L 
Sbjct: 245  RDVPALSRLLELLEEGQRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLD 299
Query: 1077 I 1077
            +
Sbjct: 300  M 300

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G VY   +LS+   +A+K+       +    Q    E+     ++H+NIV++ G
Sbjct: 16   LGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYLG 72
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
              S      I  E +  GSL+ +L +     +          K + + L YLH++    I
Sbjct: 73   SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QI 129
Query: 933  VYRDISSKNVLLDLEYEA--HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT--MKV 988
            V+RDI   NVL++  Y     +SDFG SK L   +       GT+ Y+APE+        
Sbjct: 130  VHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 989  TEKSDVYSFGVLALEAIKGKHP 1010
             + +D++S G   +E   GK P
Sbjct: 189  GKAADIWSLGCTIIEMATGKPP 210

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 149
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 150  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 207  TEKSAXKSSDLWALGCIIYQLVAGLPP 233

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 31   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 147
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 148  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 50   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 108
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 109  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 164
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 165  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 221
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 222  QTVDIWSVGCIMAELLTGR 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 149
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 150  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 15   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 74
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 75   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 131
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 132  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 188
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 189  TEKSACKSSDLWALGCIIYQLVAGLPP 215

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 11   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 70
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 71   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 127
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 128  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 184
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 185  TEKSACKSSDLWALGCIIYQLVAGLPP 211

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 8    DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 67
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 68   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 124
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 125  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 181
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 182  TEKSACKSSDLWALGCIIYQLVAGLPP 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 10   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 69
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 70   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 126
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 127  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 183
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 184  TEKSACKSSDLWALGCIIYQLVAGLPP 210

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 9    DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 69   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 125
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 126  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 182
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 183  TEKSACKSSDLWALGCIIYQLVAGLPP 209

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 31   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 147
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 148  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 204
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 149
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 150  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 149
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 150  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 31   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 91   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 147
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 148  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELL 204
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 205  TEKSACKSSDLWALGCIIYQLVAGLPP 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 30   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 89
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 90   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 146
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 147  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 203
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 204  TEKSACKSSDLWALGCIIYQLVAGLPP 230

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 71/309 (22%), Positives = 134/309 (43%), Gaps = 48/309 (15%)
Query: 794  RKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL---SSGE---IVAVKKFHSPLLSEMT 847
            ++   +EI  +   F EE  +G    G VY+  L   + GE    VA+K       +E  
Sbjct: 16   KQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGP 71
Query: 848  CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
             ++EF +E      ++H N+V   G  +  +   +++ Y   G L   L   +   ++G 
Sbjct: 72   LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGS 131
Query: 908  TQRMNVIKG-------------VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSD 954
            T     +K              +A  + YL +     +V++D++++NVL+  +    +SD
Sbjct: 132  TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISD 188
Query: 955  FGISKSLKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKH 1009
             G+ + +   ++++ +L G     I ++APE     K +  SD++S+GV+  E    G  
Sbjct: 189  LGLFREVY--AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 246
Query: 1010 PRDFISSICSTSSNLDRTLDEILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067
            P       C  S   ++ + E++  R  LP P     D    +  + I C +E P  RP 
Sbjct: 247  P------YCGYS---NQDVVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPR 293
Query: 1068 MQKVSQLLK 1076
             + +   L+
Sbjct: 294  FKDIHSRLR 302

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 34   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 93
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 94   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 150
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 151  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 207
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 208  TEKSACKSSDLWALGCIIYQLVAGLPP 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 33   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 92
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 93   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 149
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 150  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 206
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 207  TEKSACKSSDLWALGCIIYQLVAGLPP 233

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 65/274 (23%), Positives = 121/274 (44%), Gaps = 29/274 (10%)
Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIV----AVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +F +   +G+G  G+VY+   +  GE V    A+K+      +     +E L+E   +  
Sbjct: 18   EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 75
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + + ++ +  G C  +    I  + +  G L   +      + +G    +N    +A  +
Sbjct: 76   VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGM 132
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVA 979
            +YL +     +V+RD++++NVL+       ++DFG +K L  +   +    G   I ++A
Sbjct: 133  NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             E       T +SDV+S+GV   E +  G  P D I +    SS L++        RLP 
Sbjct: 190  LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEK------GERLPQ 242
Query: 1039 PS-CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P  C      I +  +   C   + DSRP  +++
Sbjct: 243  PPICT-----IDVYMIMRKCWMIDADSRPKFREL 271

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 7e-09,   Method: Composition-based stats.
 Identities = 71/304 (23%), Positives = 132/304 (43%), Gaps = 48/304 (15%)
Query: 799  EEIVRATNDFDEEHCIGTGGQGSVYRAEL---SSGE---IVAVKKFHSPLLSEMTCQQEF 852
            +EI  +   F EE  +G    G VY+  L   + GE    VA+K       +E   ++EF
Sbjct: 4    KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEF 59
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
             +E      ++H N+V   G  +  +   +++ Y   G L   L   +   ++G T    
Sbjct: 60   RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 913  VIKG-------------VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK 959
             +K              +A  + YL +     +V++D++++NVL+  +    +SD G+ +
Sbjct: 120  TVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 960  SLKPDSSNWTELAGT----IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFI 1014
             +   ++++ +L G     I ++APE     K +  SD++S+GV+  E    G  P    
Sbjct: 177  EVY--AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP---- 230
Query: 1015 SSICSTSSNLDRTLDEILDPR--LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
               C  S   ++ + E++  R  LP P     D    +  + I C +E P  RP  + + 
Sbjct: 231  --YCGYS---NQDVVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIH 281
Query: 1073 QLLK 1076
              L+
Sbjct: 282  SRLR 285

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 63   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 121  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 49   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 107
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 108  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 163
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 164  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 220
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 221  QTVDIWSVGCIMAELLTGR 239

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 9/207 (4%)
Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            DF     +G G   +V  A EL++    A+K      + +         E   ++ + H 
Sbjct: 36   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 95
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
              VK Y         +    Y + G L   +    S +E   T        +  AL YLH
Sbjct: 96   FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE---TCTRFYTAEIVSALEYLH 152
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS--SNWTELAGTIGYVAPELA 983
                  I++RD+  +N+LL+ +    ++DFG +K L P+S  +      GT  YV+PEL 
Sbjct: 153  GK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELL 209
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + SD+++ G +  + + G  P
Sbjct: 210  TEKSACKSSDLWALGCIIYQLVAGLPP 236

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 814  IGTGGQGSVYRA------ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRN 866
            +G G  G V  A      +  +   VAVK       + +T ++  ++E+K L+ +  H N
Sbjct: 31   LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMN 88
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSL---------AMILSNATSA------EELGWTQRM 911
            IV   G C+    + ++ EY   G L         + I S  + A        L     +
Sbjct: 89   IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 912  NVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            +    VA  +++L + +C    ++RD++++N+LL       + DFG+++ +K DS+   +
Sbjct: 149  SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 971  LAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027
                  + ++APE  +    T +SDV+S+G+   E    G  P   +       S   + 
Sbjct: 205  GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDSKFYKM 260
Query: 1028 LDE---ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + E   +L P   AP+     ++  IM+   +C D +P  RPT +++ QL++
Sbjct: 261  IKEGFRMLSPE-HAPA-----EMYDIMK---TCWDADPLKRPTFKQIVQLIE 303

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G VY   +LS+   +A+K+       +    Q    E+     ++H+NIV++ G
Sbjct: 30   LGKGTYGIVYAGRDLSNQVRIAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNA-----TSAEELGWTQRMNVIKGVADALSYLHND 927
              S      I  E +  GSL+ +L +       + + +G+       K + + L YLH++
Sbjct: 87   SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-----YTKQILEGLKYLHDN 141
Query: 928  CFPPIVYRDISSKNVLLDLEYEA--HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
                IV+RDI   NVL++  Y     +SDFG SK L   +       GT+ Y+APE+   
Sbjct: 142  ---QIVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 986  --MKVTEKSDVYSFGVLALEAIKGKHP 1010
                  + +D++S G   +E   GK P
Sbjct: 198  GPRGYGKAADIWSLGCTIIEMATGKPP 224

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 63   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 121  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 62   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 120  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 177  LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 60   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 118  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 175  LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 36   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 95   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 150
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 151  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 207
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 208  QTVDIWSVGCIMAELLTGR 226

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 60   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 118  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 175  LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 62   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 120  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 177  LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 167/636 (26%), Positives = 255/636 (40%), Gaps = 69/636 (10%)
Query: 109 HLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQF 168
           ++  L+L  NQ+  +  +     S+L  LD+  N+ S   P     L MLK+L L  N+ 
Sbjct: 36  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 95
Query: 169 SGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLK 228
           S          + L  LHL  N +            NL  + L +N LS +       L+
Sbjct: 96  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 155
Query: 229 SLSGLELGYNKLSGSMPLSLGNLPN--LATLDLHDNSLSGSIPLSF---GNLTNLDILNL 283
           +L  L L  NK+       L    N  L  L+L  N +    P  F   G L  L + N+
Sbjct: 156 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 215
Query: 284 PHN-SLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL--TKLTILYLSDNLL---- 336
               SL+  +  E+ N  S+  L LS ++LS +  ++   L  T LT+L LS N L    
Sbjct: 216 QLGPSLTEKLCLELAN-TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 274
Query: 337 ---FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIX 393
              F  +P     L Y F+LE   N +     HSL  L N+  L L  +    SI     
Sbjct: 275 NDSFAWLP----QLEY-FFLEY--NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI----- 322
Query: 394 XXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
                               +SF  L  +  L++  N + G     +  L+ L  L LS 
Sbjct: 323 ----------SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS- 371
Query: 454 NQLQGPIPDLRNLTR----------LARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
                    LR LT           L  + L +N ++   S++F    +L  ++L   + 
Sbjct: 372 ----NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 427
Query: 504 YGEIS-FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIPSELG 560
             E++  +W    N+  + +S N    +        P L+ L L    +  V   PS   
Sbjct: 428 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 487
Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS----NSIPGS----LGNLVK 612
            LR+L  L L+ N  +      L  L +LE LDL  N L+    ++ PG     L  L  
Sbjct: 488 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 547
Query: 613 LYYLNLSNNQFSGEIPIKLEK-FIHLSDLDLSHNFLGEEIPSQVCSMQ-SLEKLNLAHNN 670
           L+ LNL +N F  EIP+++ K    L  +DL  N L   +P+ V + Q SL+ LNL  N 
Sbjct: 548 LHILNLESNGF-DEIPVEVFKDLFELKIIDLGLNNLN-TLPASVFNNQVSLKSLNLQKNL 605
Query: 671 LSGFIPRCF-KEMHGLVYIDISYNKLHGPIPNSAAF 705
           ++    + F      L  +D+ +N       + A F
Sbjct: 606 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 641

>pdb|3ULU|A Chain A, Structure Of Quaternary Complex Of Human Tlr3ecd With Three Fabs (Form1) Length = 694

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 139/552 (25%), Positives = 210/552 (38%), Gaps = 60/552 (10%)
Query: 204 TNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS 263
           TN+ ++ L +N L     +       L+ L++G+N +S   P     LP L  L+L  N 
Sbjct: 35  TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 94
Query: 264 LSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL 323
           LS     +F   TNL  L+L  NS+     +     K+L  L LS N LS +   +   L
Sbjct: 95  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 154
Query: 324 TKLTILYLSDNLL--FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
             L  L LS+N +    S   +I     L  LEL  N++    P     +  L  L+L  
Sbjct: 155 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 214
Query: 382 NLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNL-----TNMIVLSIYSNALSGAI 436
             L  S+  ++                      S         TN+ +L +  N L+   
Sbjct: 215 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 274
Query: 437 PKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYI 496
              +  L +L    L YN +Q       +L  L  VR        N+  SF   S    I
Sbjct: 275 NDSFAWLPQLEYFFLEYNNIQHLFS--HSLHGLFNVRY------LNLKRSFTKQS----I 322
Query: 497 NLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH-----I 551
           +L+      + SF W K   L  L++  N+I GI          LK L LS++      +
Sbjct: 323 SLASLPKIDDFSFQWLKC--LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 380
Query: 552 VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS----L 607
             E    L     L  L L +N+ S         L  LE LDL  N +   + G     L
Sbjct: 381 TNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 439
Query: 608 GNLVKLY-----YLNLSNNQFS------------------GEIPIKLEKFIHLSDLDLSH 644
            N+ ++Y     YL L+ N F+                     P   +   +L+ LDLS+
Sbjct: 440 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 499
Query: 645 NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH--GLVYIDISYNKLHGPIPNS 702
           N +       +  ++ LE L+L HNNL+    R +K  +  G +Y     + LH     S
Sbjct: 500 NNIANINDDMLEGLEKLEILDLQHNNLA----RLWKHANPGGPIYFLKGLSHLHILNLES 555
Query: 703 AAFKHAPMEALQ 714
             F   P+E  +
Sbjct: 556 NGFDEIPVEVFK 567

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 61   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 119  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 176  LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 60   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 118  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 175  LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 167/636 (26%), Positives = 255/636 (40%), Gaps = 69/636 (10%)
Query: 109 HLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQF 168
           ++  L+L  NQ+  +  +     S+L  LD+  N+ S   P     L MLK+L L  N+ 
Sbjct: 31  NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNEL 90
Query: 169 SGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLK 228
           S          + L  LHL  N +            NL  + L +N LS +       L+
Sbjct: 91  SQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLE 150
Query: 229 SLSGLELGYNKLSGSMPLSLGNLPN--LATLDLHDNSLSGSIPLSF---GNLTNLDILNL 283
           +L  L L  NK+       L    N  L  L+L  N +    P  F   G L  L + N+
Sbjct: 151 NLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNV 210
Query: 284 PHN-SLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL--TKLTILYLSDNLL---- 336
               SL+  +  E+ N  S+  L LS ++LS +  ++   L  T LT+L LS N L    
Sbjct: 211 QLGPSLTEKLCLELAN-TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 269
Query: 337 ---FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIX 393
              F  +P     L Y F+LE   N +     HSL  L N+  L L  +    SI     
Sbjct: 270 NDSFAWLP----QLEY-FFLEY--NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI----- 317
Query: 394 XXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
                               +SF  L  +  L++  N + G     +  L+ L  L LS 
Sbjct: 318 ----------SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS- 366
Query: 454 NQLQGPIPDLRNLTR----------LARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
                    LR LT           L  + L +N ++   S++F    +L  ++L   + 
Sbjct: 367 ----NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEI 422
Query: 504 YGEIS-FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIPSELG 560
             E++  +W    N+  + +S N    +        P L+ L L    +  V   PS   
Sbjct: 423 GQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQ 482
Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS----NSIPGS----LGNLVK 612
            LR+L  L L+ N  +      L  L +LE LDL  N L+    ++ PG     L  L  
Sbjct: 483 PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSH 542
Query: 613 LYYLNLSNNQFSGEIPIKLEK-FIHLSDLDLSHNFLGEEIPSQVCSMQ-SLEKLNLAHNN 670
           L+ LNL +N F  EIP+++ K    L  +DL  N L   +P+ V + Q SL+ LNL  N 
Sbjct: 543 LHILNLESNGF-DEIPVEVFKDLFELKIIDLGLNNLN-TLPASVFNNQVSLKSLNLQKNL 600
Query: 671 LSGFIPRCF-KEMHGLVYIDISYNKLHGPIPNSAAF 705
           ++    + F      L  +D+ +N       + A F
Sbjct: 601 ITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 636

>pdb|2A0Z|A Chain A, The Molecular Structure Of Toll-like Receptor 3 Ligand Binding Domain Length = 705

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 139/552 (25%), Positives = 210/552 (38%), Gaps = 60/552 (10%)
Query: 204 TNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS 263
           TN+ ++ L +N L     +       L+ L++G+N +S   P     LP L  L+L  N 
Sbjct: 30  TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 89
Query: 264 LSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL 323
           LS     +F   TNL  L+L  NS+     +     K+L  L LS N LS +   +   L
Sbjct: 90  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 149
Query: 324 TKLTILYLSDNLL--FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
             L  L LS+N +    S   +I     L  LEL  N++    P     +  L  L+L  
Sbjct: 150 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 209
Query: 382 NLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNL-----TNMIVLSIYSNALSGAI 436
             L  S+  ++                      S         TN+ +L +  N L+   
Sbjct: 210 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 269
Query: 437 PKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYI 496
              +  L +L    L YN +Q       +L  L  VR        N+  SF   S    I
Sbjct: 270 NDSFAWLPQLEYFFLEYNNIQHLFS--HSLHGLFNVRY------LNLKRSFTKQS----I 317
Query: 497 NLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH-----I 551
           +L+      + SF W K   L  L++  N+I GI          LK L LS++      +
Sbjct: 318 SLASLPKIDDFSFQWLKC--LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 375
Query: 552 VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS----L 607
             E    L     L  L L +N+ S         L  LE LDL  N +   + G     L
Sbjct: 376 TNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 434
Query: 608 GNLVKLY-----YLNLSNNQFS------------------GEIPIKLEKFIHLSDLDLSH 644
            N+ ++Y     YL L+ N F+                     P   +   +L+ LDLS+
Sbjct: 435 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 494
Query: 645 NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH--GLVYIDISYNKLHGPIPNS 702
           N +       +  ++ LE L+L HNNL+    R +K  +  G +Y     + LH     S
Sbjct: 495 NNIANINDDMLEGLEKLEILDLQHNNLA----RLWKHANPGGPIYFLKGLSHLHILNLES 550
Query: 703 AAFKHAPMEALQ 714
             F   P+E  +
Sbjct: 551 NGFDEIPVEVFK 562

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 60   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 118  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 175  LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+   
Sbjct: 120  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMV 197

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 63   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 121  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+   
Sbjct: 120  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 176
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMV 197

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 9e-09,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 5    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 63
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 64   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 121
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+   
Sbjct: 122  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLG 178
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 179  CKYYSTAVDIWSLGCIFAEMV 199

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 40   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 98
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 99   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 154
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 155  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 211
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 212  QTVDIWSVGCIMAELLTGR 230

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 3    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 62
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 63   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 121  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 178  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 5    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 63
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 64   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 121
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 122  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 178
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 179  LLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+ K      +E       + E+  L E+ H 
Sbjct: 4    NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETE-GVPSTAIREISLLKELNHP 62
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 63   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 120
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 121  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 177
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 178  CKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 8/201 (3%)
Query: 807  DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+ K      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETE-GVPSTAIREISLLKELNHP 61
Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   L   +  + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLAFCH 119
Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE+   
Sbjct: 120  SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 986  MKVTEKS-DVYSFGVLALEAI 1005
             K    + D++S G +  E +
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 2    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 60
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 61   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 118
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 119  FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 175
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 176  LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 89/208 (42%), Gaps = 10/208 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIV-AVKKFHSPLLSEMTCQQEFLNEVKSLTE-IR 863
            +DF     IG G  G V  A   + E+  AVK      + +   ++  ++E   L + ++
Sbjct: 38   SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VADALS 922
            H  +V  +     A   + V +Y+  G L   L      E      R       +A AL 
Sbjct: 98   HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALG 153
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH+     IVYRD+  +N+LLD +    ++DFG+ K     +S  +   GT  Y+APE+
Sbjct: 154  YLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210
Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             +        D +  G +  E + G  P
Sbjct: 211  LHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/188 (31%), Positives = 82/188 (43%), Gaps = 4/188 (2%)
Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK 183
           IPS I  ++K   LDL SN  S         L+ L++LYL+ N+           L  L+
Sbjct: 31  IPSNIPADTK--KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88
Query: 184 ALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGS 243
            L + +N L          L NLA + L  N L    P    +L  L+ L LGYN+L  S
Sbjct: 89  TLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-S 147
Query: 244 MPLSL-GNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSL 302
           +P  +   L +L  L L++N L      +F  LT L  L L +N L         +L+ L
Sbjct: 148 LPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207
Query: 303 YGLGLSFN 310
             L L  N
Sbjct: 208 KMLQLQEN 215

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 59/178 (33%), Positives = 82/178 (46%), Gaps = 4/178 (2%)
Query: 183 KALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLS 241
           K L L  N LS     +   LT L ++YL +N L  ++P+ I   LK+L  L +  NKL 
Sbjct: 40  KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ 98
Query: 242 GSMPLSL-GNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLK 300
            ++P+ +   L NLA L L  N L    P  F +LT L  L+L +N L          L 
Sbjct: 99  -ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLT 157
Query: 301 SLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDN 358
           SL  L L  N+L      +   LT+L  L L +N L         +L  L  L+L +N
Sbjct: 158 SLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 67/162 (41%), Gaps = 5/162 (3%)
Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXI 412
           L+L  NKLS     +   LT L  LYL  N L  ++P+ I                   +
Sbjct: 42  LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQAL 100
Query: 413 PYS-FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLA 470
           P   F  L N+  L +  N L    P+ + +L KLT L L YN+LQ  P      LT L 
Sbjct: 101 PIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK 160
Query: 471 RVRLDRNHLTGNISESFGIHSNLSYINLSHK--KFYGEISFD 510
            +RL  N L      +F   + L  + L +   K   E +FD
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 8/208 (3%)
Query: 516 NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
           N  ++D S+  +T I P  I      K LDL SN +         +L  L  L LN N+ 
Sbjct: 17  NKNSVDCSSKKLTAI-PSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 576 SGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI 635
                     L  LE L ++ N+L     G    LV L  L L  NQ     P   +   
Sbjct: 74  QTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLT 133
Query: 636 HLSDLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
            L+ L L +N L + +P  V   + SL++L L +N L       F ++  L  + +  N+
Sbjct: 134 KLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
Query: 695 LHGPIPNSA--AFKHAPMEALQGNKGLC 720
           L   +P  A  + +   M  LQ N   C
Sbjct: 193 LKR-VPEGAFDSLEKLKMLQLQENPWDC 219

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 3    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 61
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 62   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 119
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 120  FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 176
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 177  LLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            + F      ++++ H+++V  YG C     + +V E+++ GSL   L    +   + W  
Sbjct: 57   ESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW-- 114
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA--------HVSDFGISKSL 961
            ++ V K +A A+ +L  +    +++ ++ +KN+LL  E +          +SD GIS ++
Sbjct: 115  KLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
             P       L   I +V PE     K +   +D +SFG    E    G  P   + S   
Sbjct: 172  LPKDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                 DR        +LPAP      K   +  +  +C+D  PD RP+ + +
Sbjct: 228  LQFYEDRH-------QLPAP------KAAELANLINNCMDYEPDHRPSFRAI 266

>pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/175 (34%), Positives = 91/175 (52%), Gaps = 14/175 (8%)
Query: 109 HLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQF 168
           +L  L+L+ NQI  + P  + N +K+  L+LS N         I  L  +K L L++ Q 
Sbjct: 70  NLIGLELKDNQITDLTP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKTLDLTSTQI 125
Query: 169 SGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLK 228
           +   P  +  LS L+ L+L  N ++   P  L  LTNL  + + NN ++   P  + NL 
Sbjct: 126 TDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNNQVNDLTP--LANLS 179
Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNL 283
            L+ L    NK+S   PL+  +LPNL  + L DN +S   PL+  NL+NL I+ L
Sbjct: 180 KLTTLRADDNKISDISPLA--SLPNLIEVHLKDNQISDVSPLA--NLSNLFIVTL 230

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 18/225 (8%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 3    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 62
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 63   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++        
Sbjct: 121  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----- 172
Query: 968  WTELAGTIG---YVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
              E+AG +    Y APE+    M   +  D++S G +  E + G+
Sbjct: 173  -DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 854  NEVKSLTEIR----HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            N  K +T ++    H NIVK +       H+F+V E L  G L          +    T+
Sbjct: 51   NTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL---FERIKKKKHFSETE 107
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSS 966
               +++ +  A+S++H+     +V+RD+  +N+L   E    E  + DFG ++   PD+ 
Sbjct: 108  ASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164
Query: 967  NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                   T+ Y APEL       E  D++S GV+    + G+ P
Sbjct: 165  PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 35   IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 94   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 149
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 150  DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 206
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 207  QTVDIWSVGCIMAELLTGR 225

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT-M 986
             I++RD+   N+ ++ + E  + DFG+++          E+AG +    Y APE+    M
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTD------DEMAGFVATRWYRAPEIMLNWM 198
Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
               +  D++S G +  E + G+
Sbjct: 199  HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG---YVAPELAYT-M 986
             I++RD+   N+ ++ + E  + DFG+++          E+AG +    Y APE+    M
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTD------DEMAGFVATRWYRAPEIMLNWM 198
Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
               +  D++S G +  E + G+
Sbjct: 199  HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 167/635 (26%), Positives = 254/635 (40%), Gaps = 69/635 (10%)
Query: 110 LAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS 169
           +  L+L  NQ+  +  +     S+L  LD+  N+ S   P     L MLK+L L  N+ S
Sbjct: 27  ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 170 GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS 229
                     + L  LHL  N +            NL  + L +N LS +       L++
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 230 LSGLELGYNKLSGSMPLSLGNLPN--LATLDLHDNSLSGSIPLSF---GNLTNLDILNLP 284
           L  L L  NK+       L    N  L  L+L  N +    P  F   G L  L + N+ 
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 285 HN-SLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL--TKLTILYLSDNLL----- 336
              SL+  +  E+ N  S+  L LS ++LS +  ++   L  T LT+L LS N L     
Sbjct: 207 LGPSLTEKLCLELAN-TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGN 265
Query: 337 --FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXX 394
             F  +P     L Y F+LE   N +     HSL  L N+  L L  +    SI      
Sbjct: 266 DSFAWLP----QLEY-FFLEY--NNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI------ 312
Query: 395 XXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYN 454
                              +SF  L  +  L++  N + G     +  L+ L  L LS  
Sbjct: 313 ---------SLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS-- 361
Query: 455 QLQGPIPDLRNLTR----------LARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
                   LR LT           L  + L +N ++   S++F    +L  ++L   +  
Sbjct: 362 ---NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIG 418
Query: 505 GEIS-FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIPSELGK 561
            E++  +W    N+  + +S N    +        P L+ L L    +  V   PS    
Sbjct: 419 QELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQP 478
Query: 562 LRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS----NSIPGS----LGNLVKL 613
           LR+L  L L+ N  +      L  L +LE LDL  N L+    ++ PG     L  L  L
Sbjct: 479 LRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHL 538
Query: 614 YYLNLSNNQFSGEIPIKLEK-FIHLSDLDLSHNFLGEEIPSQVCSMQ-SLEKLNLAHNNL 671
           + LNL +N F  EIP+++ K    L  +DL  N L   +P+ V + Q SL+ LNL  N +
Sbjct: 539 HILNLESNGF-DEIPVEVFKDLFELKIIDLGLNNLN-TLPASVFNNQVSLKSLNLQKNLI 596
Query: 672 SGFIPRCF-KEMHGLVYIDISYNKLHGPIPNSAAF 705
           +    + F      L  +D+ +N       + A F
Sbjct: 597 TSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWF 631

>pdb|1ZIW|A Chain A, Human Toll-Like Receptor 3 Extracellular Domain Structure Length = 680

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 139/552 (25%), Positives = 210/552 (38%), Gaps = 60/552 (10%)
Query: 204 TNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS 263
           TN+ ++ L +N L     +       L+ L++G+N +S   P     LP L  L+L  N 
Sbjct: 25  TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 264 LSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL 323
           LS     +F   TNL  L+L  NS+     +     K+L  L LS N LS +   +   L
Sbjct: 85  LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 324 TKLTILYLSDNLL--FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
             L  L LS+N +    S   +I     L  LEL  N++    P     +  L  L+L  
Sbjct: 145 ENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNN 204
Query: 382 NLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNL-----TNMIVLSIYSNALSGAI 436
             L  S+  ++                      S         TN+ +L +  N L+   
Sbjct: 205 VQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264
Query: 437 PKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYI 496
              +  L +L    L YN +Q       +L  L  VR        N+  SF   S    I
Sbjct: 265 NDSFAWLPQLEYFFLEYNNIQHLFS--HSLHGLFNVRY------LNLKRSFTKQS----I 312
Query: 497 NLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH-----I 551
           +L+      + SF W K   L  L++  N+I GI          LK L LS++      +
Sbjct: 313 SLASLPKIDDFSFQWLKC--LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370
Query: 552 VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS----L 607
             E    L     L  L L +N+ S         L  LE LDL  N +   + G     L
Sbjct: 371 TNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 608 GNLVKLY-----YLNLSNNQFS------------------GEIPIKLEKFIHLSDLDLSH 644
            N+ ++Y     YL L+ N F+                     P   +   +L+ LDLS+
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSN 489
Query: 645 NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH--GLVYIDISYNKLHGPIPNS 702
           N +       +  ++ LE L+L HNNL+    R +K  +  G +Y     + LH     S
Sbjct: 490 NNIANINDDMLEGLEKLEILDLQHNNLA----RLWKHANPGGPIYFLKGLSHLHILNLES 545
Query: 703 AAFKHAPMEALQ 714
             F   P+E  +
Sbjct: 546 NGFDEIPVEVFK 557

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 814  IGTGGQGSVYRA------ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRN 866
            +G G  G V  A      +  +   VAVK       + +T ++  ++E+K L+ +  H N
Sbjct: 49   LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMN 106
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSL---------AMILSNATSA------EELGWTQRM 911
            IV   G C+    + ++ EY   G L         + I S  + A        L     +
Sbjct: 107  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 166
Query: 912  NVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            +    VA  +++L + +C    ++RD++++N+LL       + DFG+++ +K DS+   +
Sbjct: 167  SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 222
Query: 971  LAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027
                  + ++APE  +    T +SDV+S+G+   E    G  P   +       S   + 
Sbjct: 223  GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDSKFYKM 278
Query: 1028 LDE---ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + E   +L P   AP+     ++  IM+   +C D +P  RPT +++ QL++
Sbjct: 279  IKEGFRMLSPE-HAPA-----EMYDIMK---TCWDADPLKRPTFKQIVQLIE 321

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 48/204 (23%), Positives = 96/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 1    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 59
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+L       + ++A +   L   +  + +  +   L+
Sbjct: 60   NHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIK--SYLFQLLQGLA 117
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 118  FCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 175  LLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/237 (24%), Positives = 101/237 (42%), Gaps = 16/237 (6%)
Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR- 863
            ++F+    +G G  G V  A +  +G++ AVK     ++ +    +  + E + L+  R 
Sbjct: 23   DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H  + + +         F V E++  G L   +  +   +E    +       +  AL +
Sbjct: 83   HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE---ARARFYAAEIISALMF 139
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH+     I+YRD+   NVLLD E    ++DFG+ K    +        GT  Y+APE+ 
Sbjct: 140  LHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
              M      D ++ GVL  E + G  P +        + N D   + IL+  +  P+
Sbjct: 197  QEMLYGPAVDWWAMGVLLYEMLCGHAPFE--------AENEDDLFEAILNDEVVYPT 245

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 814  IGTGGQGSVYRA------ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRN 866
            +G G  G V  A      +  +   VAVK       + +T ++  ++E+K L+ +  H N
Sbjct: 54   LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMN 111
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSL---------AMILSNATSA------EELGWTQRM 911
            IV   G C+    + ++ EY   G L         + I S  + A        L     +
Sbjct: 112  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 912  NVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            +    VA  +++L + +C    ++RD++++N+LL       + DFG+++ +K DS+   +
Sbjct: 172  SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 227
Query: 971  LAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027
                  + ++APE  +    T +SDV+S+G+   E    G  P   +       S   + 
Sbjct: 228  GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDSKFYKM 283
Query: 1028 LDE---ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + E   +L P   AP+     ++  IM+   +C D +P  RPT +++ QL++
Sbjct: 284  IKEGFRMLSPE-HAPA-----EMYDIMK---TCWDADPLKRPTFKQIVQLIE 326

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 131/292 (44%), Gaps = 48/292 (16%)
Query: 814  IGTGGQGSVYRA------ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRN 866
            +G G  G V  A      +  +   VAVK       + +T ++  ++E+K L+ +  H N
Sbjct: 47   LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMN 104
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSL---------AMILSNATSA------EELGWTQRM 911
            IV   G C+    + ++ EY   G L         + I S  + A        L     +
Sbjct: 105  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 164
Query: 912  NVIKGVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            +    VA  +++L   +C    ++RD++++N+LL       + DFG+++ +K DS+   +
Sbjct: 165  SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 220
Query: 971  LAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027
                  + ++APE  +    T +SDV+S+G+   E    G  P   +       S   + 
Sbjct: 221  GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDSKFYKM 276
Query: 1028 LDE---ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + E   +L P   AP+     ++  IM+   +C D +P  RPT +++ QL++
Sbjct: 277  IKEGFRMLSPE-HAPA-----EMYDIMK---TCWDADPLKRPTFKQIVQLIE 319

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 71   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 125
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 126  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNV 182
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 183  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 242
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 243  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 291
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 292  TFKQLVEDL 300

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 35   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 94   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 149
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 150  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 206
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 207  QTVDIWSVGCIMAELLTGR 225

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 98/220 (44%), Gaps = 26/220 (11%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G V  A +      VA+KK  SP   +  CQ+  L E++ L   RH N++    
Sbjct: 51   IGEGAYGMVSSAYDHVRKTRVAIKKI-SPFEHQTYCQRT-LREIQILLRFRHENVIGIRD 108
Query: 873  FCSHA-----RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                +     R  +IV + +E     ++ S   S + + +      +  +   L Y+H+ 
Sbjct: 109  ILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY-----FLYQILRGLKYIHS- 162
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAPELAY 984
                +++RD+   N+L++   +  + DFG+++   P+  +    TE   T  Y APE+  
Sbjct: 163  --ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 985  TMKVTEKS-DVYSFGVLALEAIK------GKHPRDFISSI 1017
              K   KS D++S G +  E +       GKH  D ++ I
Sbjct: 221  NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 260

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 808  FDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +D    +GTG  G V+R  E ++G   A K   +P  S+   ++    E+++++ +RH  
Sbjct: 159  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 215
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +V  +          ++YE++  G L   +  A    ++   + +  ++ V   L ++H 
Sbjct: 216  LVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 927  DCFPPIVYRDISSKNVLLDLEY--EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            + +   V+ D+  +N++   +   E  + DFG++  L P  S      GT  + APE+A 
Sbjct: 274  NNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAE 329
Query: 985  TMKVTEKSDVYSFGVLA------LEAIKGKHPRDFISSICSTSSNLD 1025
               V   +D++S GVL+      L    G++  + + ++ S   N+D
Sbjct: 330  GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 27   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 86
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 87   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 145  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 201
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 202  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 49/210 (23%), Positives = 97/210 (46%), Gaps = 11/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            T+++     IG G    V R  +L +G   A K  ++  LS     Q+   E +    ++
Sbjct: 3    TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARD-HQKLEREARICRLLK 61
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +   S     ++V++ +  G L     +  + E        + I+ + +A+ +
Sbjct: 62   HSNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLH 118
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H      +V+RD+  +N+LL  + +     ++DFG++  ++ D   W   AGT GY++P
Sbjct: 119  CHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+       +  D+++ GV+    + G  P
Sbjct: 176  EVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNAMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 76   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 130
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 131  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 187
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 188  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 247
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 248  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 296
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 297  TFKQLVEDL 305

>pdb|4FMZ|A Chain A, Crystal Structure Of An Internalin (Inlf) From Listeria Monocytogenes Str. 4b F2365 At 1.91 A Resolution Length = 347

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 134/283 (47%), Gaps = 19/283 (6%)
Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
             +L YL+L  NQI  I P  ++N  KL  L + +N  +     Q  NL+ L+ LYL+ +
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISALQ--NLTNLRELYLNED 120
Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGN 226
             S   P  + +L+   +L+L  N     + P L N T L  + +  + +    P  I N
Sbjct: 121 NISDISP--LANLTKXYSLNLGANHNLSDLSP-LSNXTGLNYLTVTESKVKDVTP--IAN 175
Query: 227 LKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHN 286
           L  L  L L YN++    PL   +L +L     + N ++   P+   N T L+ L + +N
Sbjct: 176 LTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITPV--ANXTRLNSLKIGNN 231
Query: 287 SLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGN 346
            ++   P  + NL  L  L +  N++S    +++ +LTKL  L +  N +  S    + N
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKXLNVGSNQI--SDISVLNN 285
Query: 347 LRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIP 389
           L  L  L L +N+L       +G LTNL TL+L  N ++   P
Sbjct: 286 LSQLNSLFLNNNQLGNEDXEVIGGLTNLTTLFLSQNHITDIRP 328

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 73   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 127
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 128  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 184
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 185  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 244
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 245  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 293
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 294  TFKQLVEDL 302

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 100/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 3    TFYRQELAKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 62
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N     +L  
Sbjct: 63   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCAKLTD 120
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 121  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 178  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 58.9 bits (141), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 30   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 89
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 90   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 147
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 148  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 204
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 205  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 132/292 (45%), Gaps = 48/292 (16%)
Query: 814  IGTGGQGSVYRA------ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRN 866
            +G G  G V  A      +  +   VAVK       + +T ++  ++E+K L+ +  H N
Sbjct: 54   LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMN 111
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSL---------AMILSNATSA------EELGWTQRM 911
            IV   G C+    + ++ EY   G L         + I S  + A        L     +
Sbjct: 112  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 171
Query: 912  NVIKGVADALSYLHN-DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
            +    VA  +++L + +C    ++RD++++N+LL       + DFG+++ +K DS+   +
Sbjct: 172  SFSYQVAKGMAFLASKNC----IHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVK 227
Query: 971  LAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRT 1027
                  + ++APE  +    T +SDV+S+G+   E    G  P   +       S   + 
Sbjct: 228  GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----PVDSKFYKM 283
Query: 1028 LDE---ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + E   +L P   AP+     ++  IM+   +C D +P  RPT +++ QL++
Sbjct: 284  IKEGFRMLSPE-HAPA-----EMYDIMK---TCWDADPLKRPTFKQIVQLIE 326

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 75/276 (27%), Positives = 128/276 (46%), Gaps = 40/276 (14%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIRHRNIVKFY 871
            +G G  G V +   + SG+I+AVK+  + + S+   Q+  L ++  S+  +     V FY
Sbjct: 59   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCPFTVTFY 116
Query: 872  GFCSHARHSFIVYEYLEMGSL-----AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            G        +I  E ++  SL      +I    T  E++     ++++K    AL +LH+
Sbjct: 117  GALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVK----ALEHLHS 171
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
                 +++RD+   NVL++   +  + DFGIS  L  DS   T  AG   Y+APE     
Sbjct: 172  KL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DSVAKTIDAGCKPYMAPERINPE 228
Query: 983  ----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
                 Y++    KSD++S G+  +E    + P D   S  +    L + ++E   P+LPA
Sbjct: 229  LNQKGYSV----KSDIWSLGITMIELAILRFPYD---SWGTPFQQLKQVVEEP-SPQLPA 280
Query: 1039 PSCNIRDKLIS-IMEVAISCLDENPDSRPTMQKVSQ 1073
                  DK  +  ++    CL +N   RPT  ++ Q
Sbjct: 281  ------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 73/276 (26%), Positives = 128/276 (46%), Gaps = 40/276 (14%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIRHRNIVKFY 871
            +G G  G V +   + SG+I+AVK+  + + S+   Q+  L ++  S+  +     V FY
Sbjct: 15   LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQE--QKRLLMDLDISMRTVDCPFTVTFY 72
Query: 872  GFCSHARHSFIVYEYLEMGSL-----AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            G        +I  E ++  SL      +I    T  E++     ++++K    AL +LH+
Sbjct: 73   GALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVK----ALEHLHS 127
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
                 +++RD+   NVL++   +  + DFGIS  L  D +   + AG   Y+APE     
Sbjct: 128  KL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID-AGCKPYMAPERINPE 184
Query: 983  ----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
                 Y++    KSD++S G+  +E    + P D   S  +    L + ++E   P+LPA
Sbjct: 185  LNQKGYSV----KSDIWSLGITMIELAILRFPYD---SWGTPFQQLKQVVEEP-SPQLPA 236
Query: 1039 PSCNIRDKLIS-IMEVAISCLDENPDSRPTMQKVSQ 1073
                  DK  +  ++    CL +N   RPT  ++ Q
Sbjct: 237  ------DKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 63   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 118  KGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 174
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 175  DLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 235  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 286
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 287  ---DCWHAVPSQRPTFKQLVEDL 306

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  SGE VA+KK   P  SE+  ++ +  E+  L  ++H N++    
Sbjct: 32   VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90
Query: 873  FCSHARHSFIVYE-YLEM----GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
              + A      Y+ YL M      L  I+    S E++ +     ++  +   L Y+H+ 
Sbjct: 91   VFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIHS- 144
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-M 986
                +V+RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+  + M
Sbjct: 145  --AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVV---TRWYRAPEVILSWM 199
Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
               +  D++S G +  E + GK
Sbjct: 200  HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 26   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 85
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 86   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 143
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 144  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 200
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 201  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 36   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 95   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 150
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 151  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 207
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 208  QTVDIWSVGCIMAELLTGR 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 41   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 100  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 155
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 156  DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 212
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 213  QTVDIWSVGCIMAELLTGR 231

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 35   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 94   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 149
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 150  DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 206
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 207  QTVDIWSVGCIMAELLTGR 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 56/220 (25%), Positives = 105/220 (47%), Gaps = 36/220 (16%)
Query: 814  IGTGGQGSVYRAE---LSSGEI---VAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRN 866
            +G+G  G V  A    +S   +   VAVK       ++ + ++  ++E+K +T++  H N
Sbjct: 53   LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHEN 110
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT---SAEELGWTQR--------MNVIK 915
            IV   G C+ +   ++++EY   G L   L +     S +E+ +  +        +NV+ 
Sbjct: 111  IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 916  ---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
                      VA  + +L    F   V+RD++++NVL+       + DFG+++ +  D S
Sbjct: 171  FEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD-S 226
Query: 967  NWTELAGT---IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
            N+         + ++APE  +    T KSDV+S+G+L  E
Sbjct: 227  NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 32/232 (13%)
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            + F      ++++ H+++V  YG C     + +V E+++ GSL   L    +   + W  
Sbjct: 57   ESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW-- 114
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA--------HVSDFGISKSL 961
            ++ V K +A A+ +L  +    +++ ++ +KN+LL  E +          +SD GIS ++
Sbjct: 115  KLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019
             P       L   I +V PE     K +   +D +SFG    E    G  P   + S   
Sbjct: 172  LPKDI----LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227
Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                 DR        +LPAP      K   +  +  +C+D  PD RP+ + +
Sbjct: 228  LQFYEDRH-------QLPAP------KAAELANLINNCMDYEPDHRPSFRAI 266

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 90/194 (46%), Gaps = 10/194 (5%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMT--CQQEFLNEVKSLTEIRHRNIVKF 870
            +G G   +VY+A + ++ +IVA+KK      SE      +  L E+K L E+ H NI+  
Sbjct: 18   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
                 H  +  +V++++E     +I  N+     L  +     +      L YLH     
Sbjct: 78   LDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE 990
             I++RD+   N+LLD      ++DFG++KS    +  +     T  Y APEL +  ++  
Sbjct: 133  -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYG 191
Query: 991  KS-DVYSFGVLALE 1003
               D+++ G +  E
Sbjct: 192  VGVDMWAVGCILAE 205

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 57/249 (22%), Positives = 107/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++ EY   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 47/204 (23%), Positives = 97/204 (47%), Gaps = 8/204 (3%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+
Sbjct: 4    SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKEL 62
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
             H NIVK           ++V+E+++      + ++A +   L   +  + +  +   L+
Sbjct: 63   NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIK--SYLFQLLQGLA 120
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            + H+     +++RD+  +N+L++ E    ++DFG++++       +     T+ Y APE+
Sbjct: 121  FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 177
Query: 983  AYTMKVTEKS-DVYSFGVLALEAI 1005
                K    + D++S G +  E +
Sbjct: 178  LLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/227 (22%), Positives = 106/227 (46%), Gaps = 18/227 (7%)
Query: 808  FDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            +D    +GTG  G V+R  E ++G   A K   +P  S+   ++    E+++++ +RH  
Sbjct: 53   YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPT 109
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +V  +          ++YE++  G L   +  A    ++   + +  ++ V   L ++H 
Sbjct: 110  LVNLHDAFEDDNEMVMIYEFMSGGELFEKV--ADEHNKMSEDEAVEYMRQVCKGLCHMHE 167
Query: 927  DCFPPIVYRDISSKNVLLDLEY--EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            + +   V+ D+  +N++   +   E  + DFG++  L P  S      GT  + APE+A 
Sbjct: 168  NNY---VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-TTGTAEFAAPEVAE 223
Query: 985  TMKVTEKSDVYSFGVLA------LEAIKGKHPRDFISSICSTSSNLD 1025
               V   +D++S GVL+      L    G++  + + ++ S   N+D
Sbjct: 224  GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 270

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 91   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 146
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 147  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 203
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 204  QTVDIWSVGCIMAELLTGR 222

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 91   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 146
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 147  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 203
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 204  QTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 91   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 146
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 147  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 203
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 204  QTVDIWSVGCIMAELLTGR 222

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 42   VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 101  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 156
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 157  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 213
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 214  QTVDIWSVGCIMAELLTGR 232

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 48   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 102
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 103  KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 159
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 160  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 220  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 271
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 272  ---DCWHAVPSQRPTFKQLVEDL 291

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKK---FHSPLLSEMTCQQEFLNEVKSLT 860
            ++DF  +  +G G  G V  A    +GEIVA+KK   F  PL +  T     L E+K L 
Sbjct: 10   SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-----LREIKILK 64
Query: 861  EIRHRNIVKFYGF-----CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
              +H NI+  +         +    +I+ E ++     +I +   S + + +      I 
Sbjct: 65   HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIY 119
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-------- 967
                A+  LH      +++RD+   N+L++   +  V DFG+++ +   +++        
Sbjct: 120  QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 968  --WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALE 1003
               TE   T  Y APE+  T  K +   DV+S G +  E
Sbjct: 177  SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 36   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 95   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 150
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 151  DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 207
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 208  QTVDIWSVGCIMAELLTGR 226

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 36   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 94
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 95   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 150
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 151  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 207
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 208  QTVDIWSVGCIMAELLTGR 226

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 7    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 67   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 125  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 181
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 182  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 41   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 99
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 100  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 155
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 156  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 212
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 213  QTVDIWSVGCIMAELLTGR 231

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 4    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 63
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 64   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 121
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 122  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 179  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKK---FHSPLLSEMTCQQEFLNEVKSLT 860
            ++DF  +  +G G  G V  A    +GEIVA+KK   F  PL +  T     L E+K L 
Sbjct: 10   SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-----LREIKILK 64
Query: 861  EIRHRNIVKFYGF-----CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
              +H NI+  +         +    +I+ E ++     +I +   S + + +      I 
Sbjct: 65   HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIY 119
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-------- 967
                A+  LH      +++RD+   N+L++   +  V DFG+++ +   +++        
Sbjct: 120  QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 968  --WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALE 1003
               TE   T  Y APE+  T  K +   DV+S G +  E
Sbjct: 177  SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 4    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 63
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 64   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 121
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 122  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 178
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 179  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 3    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 63   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 120
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 121  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 177
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 178  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 96   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 151
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 152  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 208
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 209  QTVDIWSVGCIMAELLTGR 227

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 42   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 101  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 156
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 157  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 213
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 214  QTVDIWSVGCIMAELLTGR 232

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 42   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 100
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 101  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 156
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 157  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 213
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 214  QTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 35   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 93
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 94   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 149
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 150  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 206
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 207  QTVDIWSVGCIMAELLTGR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 32   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 90
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 91   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 146
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 147  DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 203
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 204  QTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/222 (23%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 5    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 64
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 65   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 122
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++    + + 
Sbjct: 123  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 179
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
            +     T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 180  YV---ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 29   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 87
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 88   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 143
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 144  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 200
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 201  QTVDIWSVGCIMAELLTGR 219

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 56   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 110
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 111  KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 167
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 168  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 227
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 228  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 279
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 280  ---DCWHAVPSQRPTFKQLVEDL 299

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 96   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 151
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 152  DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV---ATRWYRAPEIMLNWMHYN 208
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 209  QTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 96   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 151
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 152  DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV---ATRWYRAPEIMLNWMHYN 208
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 209  QTVDIWSVGCIMAELLTGR 227

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 55   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 109
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 110  KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 166
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 167  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 226
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 227  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 278
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 279  ---DCWHAVPSQRPTFKQLVEDL 298

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 63   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 118  KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 174
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 175  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 235  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 286
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 287  ---DCWHAVPSQRPTFKQLVEDL 306

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  LAGT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LAGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 101/225 (44%), Gaps = 18/225 (8%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 27   TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAK 86
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 87   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 144
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++        
Sbjct: 145  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----- 196
Query: 968  WTELAGTIG---YVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
              E+ G +    Y APE+    M   +  D++S G +  E + G+
Sbjct: 197  -DEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 37   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 96   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 151
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 152  DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV---ATRWYRAPEIMLNWMHYN 208
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 209  QTVDIWSVGCIMAELLTGR 227

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 52   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 106
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 107  KGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 163
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 164  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 223
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 224  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 275
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 276  ---DCWHAVPSQRPTFKQLVEDL 295

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 63   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 118  KGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 174
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 175  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 235  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 286
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 287  ---DCWHAVPSQRPTFKQLVEDL 306

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 63/263 (23%), Positives = 112/263 (42%), Gaps = 39/263 (14%)
Query: 833  VAVKKFHSPL----LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE 888
            VAVK   S      LS++  + E +  +      +H+NI+   G C+     +++ EY  
Sbjct: 63   VAVKMLKSDATEKDLSDLISEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVEYAS 117
Query: 889  MGSLAMILS-------------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYR 935
             G+L   L              +    E+L     ++    VA  + YL +      ++R
Sbjct: 118  KGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHR 174
Query: 936  DISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSD 993
            D++++NVL+  +    ++DFG+++ +           G   + ++APE  +    T +SD
Sbjct: 175  DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 994  VYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIME 1052
            V+SFGVL  E    G  P   +         L + L E    R+  PS N  ++L  +M 
Sbjct: 235  VWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE--GHRMDKPS-NCTNELYMMMR 286
Query: 1053 VAISCLDENPDSRPTMQKVSQLL 1075
                C    P  RPT +++ + L
Sbjct: 287  ---DCWHAVPSQRPTFKQLVEDL 306

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N   +++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+ +    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 102/233 (43%), Gaps = 32/233 (13%)
Query: 801  IVRATNDFDEEHCIGTG--GQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            I+  ++ +D    IG+G  G   + R +L+  E+VAVK        +   Q+E +N    
Sbjct: 15   IMHDSDRYDFVKDIGSGNFGVARLMRDKLTK-ELVAVKYIERGAAIDENVQREIINH--- 70
Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
               +RH NIV+F        H  I+ EY   G L   + NA    E    +     + + 
Sbjct: 71   -RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE---DEARFFFQQLL 126
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLD--LEYEAHVSDFGISKS----LKPDSSNWTELA 972
              +SY H+     I +RD+  +N LLD        + DFG SKS     +P S+      
Sbjct: 127  SGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----V 178
Query: 973  GTIGYVAPELAYTMKVTEK-SDVYSFGVLALEAIKG-------KHPRDFISSI 1017
            GT  Y+APE+    +   K +DV+S GV     + G       + PRD+  +I
Sbjct: 179  GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 62   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L       E            +     YL
Sbjct: 122  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE---PHARFYAAQIVLTFEYL 178
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K   + WT L GT  Y+APE+  
Sbjct: 179  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GATWT-LCGTPEYLAPEIIL 232
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 233  SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G+G  GSV   Y A L   + VAVKK   P  S +  ++ +  E++ L  ++H N++  
Sbjct: 28   VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 84
Query: 871  YGFCSHARHSFIVYE-YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                + A       E YL    +   L+N    + L       ++  +   L Y+H+   
Sbjct: 85   LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS--- 141
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKV 988
              I++RD+   NV ++ + E  + DFG+++    + + +     T  Y APE+    M  
Sbjct: 142  AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMHY 198
Query: 989  TEKSDVYSFGVLALEAIKGK 1008
             +  D++S G +  E ++GK
Sbjct: 199  NQTVDIWSVGCIMAELLQGK 218

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 123/284 (43%), Gaps = 7/284 (2%)
Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
           I TL+   F+SFPHL  L+L  N +  + P    N   L+ L L SN            L
Sbjct: 44  IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGL 103
Query: 156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS 215
           S L  L +S N+    +      L  LK+L + +N L      +   L +L  + L   +
Sbjct: 104 SNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN 163
Query: 216 LSGSIPSE-IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDL-HDNSLSGSIPLSFG 273
           L+ SIP+E + +L  L  L L +  ++     S   L  L  L++ H   L    P    
Sbjct: 164 LT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLY 222
Query: 274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD 333
            L NL  L++ H +L+      + +L  L  L LS+N +S    S L  L +L  + L  
Sbjct: 223 GL-NLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVG 281
Query: 334 NLLFGSIPCEIGNLRYLFYLELGDNKLSG---SIPHSLGNLTNL 374
             L    P     L YL  L +  N+L+    S+ HS+GNL  L
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325

>pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 65/160 (40%), Gaps = 1/160 (0%)
Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
           PE G   + ++LDL  N I      E      L +L LN N  S   P    +L  L  L
Sbjct: 27  PE-GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTL 85
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIP 652
            L SNRL     G    L  L  L++S N+    +    +   +L  L++  N L     
Sbjct: 86  GLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISH 145
Query: 653 SQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISY 692
                + SLE+L L   NL+         +HGL+ + + +
Sbjct: 146 RAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Composition-based stats.
 Identities = 54/222 (24%), Positives = 99/222 (44%), Gaps = 12/222 (5%)
Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            TF R+   + I      +     +G+G  GSV  A +  +G  VAVKK   P  S +  +
Sbjct: 7    TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 66
Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGW 907
            + +  E++ L  ++H N++      + AR S   +   YL    +   L+N    ++L  
Sbjct: 67   RTY-RELRLLKHMKHENVIGLLDVFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTD 124
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                 +I  +   L Y+H+     I++RD+   N+ ++ + E  + DFG+++        
Sbjct: 125  DHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH---TDDE 178
Query: 968  WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
             T    T  Y APE+    M   +  D++S G +  E + G+
Sbjct: 179  MTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY  ++S      S   VAVK    P +     + +FL E   ++++ H+NI
Sbjct: 39   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSY 923
            V+  G    +   FI+ E +  G L   L       +    L     ++V + +A    Y
Sbjct: 97   VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 924  LHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            L  + F   ++RDI+++N LL        A + DFG+++ +    +++    G     + 
Sbjct: 157  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPVK 211
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALE 1003
            ++ PE       T K+D +SFGVL  E
Sbjct: 212  WMPPEAFMEGIFTSKTDTWSFGVLLWE 238

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY  ++S      S   VAVK    P +     + +FL E   ++++ H+NI
Sbjct: 53   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSY 923
            V+  G    +   FI+ E +  G L   L       +    L     ++V + +A    Y
Sbjct: 111  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 924  LHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            L  + F   ++RDI+++N LL        A + DFG+++ +    +++    G     + 
Sbjct: 171  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPVK 225
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALE 1003
            ++ PE       T K+D +SFGVL  E
Sbjct: 226  WMPPEAFMEGIFTSKTDTWSFGVLLWE 252

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 53   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 111
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 112  VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 167
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + DFG+++    +   +     T  Y APE+    M   
Sbjct: 168  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYV---ATRWYRAPEIMLNWMHYN 224
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 225  QTVDIWSVGCIMAELLTGR 243

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 65/269 (24%), Positives = 121/269 (44%), Gaps = 33/269 (12%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMT---CQQEFLNEVKSLTEIRHRNIVK 869
            +G+G  G+VY+   +  GE V +      +L E T     +E L+E   +  +    + +
Sbjct: 25   LGSGAFGTVYKGIWIPDGENVKIP-VAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSR 83
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE-ELGWTQRMNVIKGVADALSYLHNDC 928
              G C  +    +V + +  G L   L +       LG    +N    +A  +SYL +  
Sbjct: 84   LLGICLTSTVQ-LVTQLMPYGCL---LDHVRENRGRLGSQDLLNWCMQIAKGMSYLED-- 137
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
               +V+RD++++NVL+       ++DFG+++ L  D + +    G   I ++A E     
Sbjct: 138  -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRR 196
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPS-CN 1042
            + T +SDV+S+GV   E +  G  P D I +         R + ++L+   RLP P  C 
Sbjct: 197  RFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---------REIPDLLEKGERLPQPPICT 247
Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                 I +  + + C   + + RP  +++
Sbjct: 248  -----IDVYMIMVKCWMIDSECRPRFREL 271

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 122/285 (42%), Gaps = 37/285 (12%)
Query: 814  IGTGGQGSVYRAE---LSSGEIVAVKKFHSPLLSEMTCQQEF---LNEVKSLTEI-RHRN 866
            +G G  G V  AE   L   +   V K    +L     +++    ++E++ +  I +H+N
Sbjct: 77   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILS-------------NATSAEELGWTQRMNV 913
            I+   G C+     +++ EY   G+L   L              +    E+L     ++ 
Sbjct: 137  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
               VA  + YL +      ++RD++++NVL+  +    ++DFG+++ +           G
Sbjct: 197  AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 974  T--IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDE 1030
               + ++APE  +    T +SDV+SFGVL  E    G  P   +         L + L E
Sbjct: 254  RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VEELFKLLKE 308
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                R+  PS N  ++L  +M     C    P  RPT +++ + L
Sbjct: 309  --GHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 347

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 4    FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 63
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 64   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 120
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 121  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 177
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     WT L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 178  K--GRTWT-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 223

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 135
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 136  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     WT L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 193  K--GRTWT-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 26/211 (12%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN---IVK 869
            IG G  GSV +     SG+I+AVK+  S +  +   Q++ L ++  +  +R  +   IV+
Sbjct: 30   IGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVV--MRSSDCPYIVQ 85
Query: 870  FYGFCSHARHSFIVYEYLEMG------SLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            FYG        +I  E +          +  +L +    E LG      +      AL++
Sbjct: 86   FYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNH 140
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL- 982
            L  +    I++RDI   N+LLD      + DFGIS  L  DS   T  AG   Y+APE  
Sbjct: 141  LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPERI 197
Query: 983  ---AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               A       +SDV+S G+   E   G+ P
Sbjct: 198  DPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 55/226 (24%), Positives = 99/226 (43%), Gaps = 15/226 (6%)
Query: 816  TGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            T G+GS  + +L++     + VA+K     LL +         E+  L  +RH +I+K Y
Sbjct: 16   TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
               +      +V EY        I+      E+ G        + +  A+ Y H      
Sbjct: 76   DVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEG----RRFFQQIICAIEYCHRH---K 128
Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVTE 990
            IV+RD+  +N+LLD      ++DFG+S ++  D +      G+  Y APE+    +    
Sbjct: 129  IVHRDLKPENLLLDDNLNVKIADFGLS-NIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187
Query: 991  KSDVYSFGVLALEAIKGKHPRD--FISSICSTSSNLDRTLDEILDP 1034
            + DV+S G++    + G+ P D  FI ++    ++    + + L P
Sbjct: 188  EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 33/219 (15%)
Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKK---FHSPLLSEMTCQQEFLNEVKSLT 860
            ++DF  +  +G G  G V  A    +GEIVA+KK   F  PL +  T     L E+K L 
Sbjct: 10   SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT-----LREIKILK 64
Query: 861  EIRHRNIVKFYGF-----CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
              +H NI+  +         +    +I+ E ++     +I +   S + + +      I 
Sbjct: 65   HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY-----FIY 119
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-------- 967
                A+  LH      +++RD+   N+L++   +  V DFG+++ +   +++        
Sbjct: 120  QTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 968  --WTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALE 1003
                E   T  Y APE+  T  K +   DV+S G +  E
Sbjct: 177  SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAE 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 38   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 92
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 93   QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 153  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 207
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 208  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 38   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 92
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 93   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 153  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 207
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 208  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 237

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 76/296 (25%), Positives = 121/296 (40%), Gaps = 51/296 (17%)
Query: 793  DRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTC 848
            D  I +E +V  +     +  IG G  G VY  E    +   I  A+K      ++EM  
Sbjct: 13   DVLIPHERVVTHS-----DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQ 65
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARH-SFIVYEYLEMGSLAMILSNATSAEELGW 907
             + FL E   +  + H N++   G          ++  Y+  G L   + +         
Sbjct: 66   VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP-------- 117
Query: 908  TQRMNVIKG-------VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS 960
             QR   +K        VA  + YL    F   V+RD++++N +LD  +   V+DFG+++ 
Sbjct: 118  -QRNPTVKDLISFGLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARD 173
Query: 961  LKPDSSNWT-----ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFI 1014
            +  D   ++          + + A E   T + T KSDV+SFGVL  E + +G  P   I
Sbjct: 174  IL-DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232
Query: 1015 SSICSTSSNLDRTLDEILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQ 1069
                      D T       RLP P  C   D L  +M+    C + +P  RPT +
Sbjct: 233  DP-------FDLTHFLAQGRRLPQPEYCP--DSLYQVMQ---QCWEADPAVRPTFR 276

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 53   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 107
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 108  QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 168  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 222
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 223  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 252

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 30   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 84
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 85   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 144
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 145  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 199
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 200  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 229

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 65   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 119
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 120  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 179
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 180  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 234
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 235  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 264

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 39   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 93
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 94   QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 153
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 154  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 208
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 209  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 238

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  + D+G+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY  ++S      S   VAVK    P +     + +FL E   +++  H+NI
Sbjct: 55   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSY 923
            V+  G    +   FI+ E +  G L   L       +    L     ++V + +A    Y
Sbjct: 113  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 924  LHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            L  + F   ++RDI+++N LL        A + DFG+++ +    +++    G     + 
Sbjct: 173  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAMLPVK 227
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALE 1003
            ++ PE       T K+D +SFGVL  E
Sbjct: 228  WMPPEAFMEGIFTSKTDTWSFGVLLWE 254

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 6e-08,   Method: Composition-based stats.
 Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 46/296 (15%)
Query: 797  AYEEIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNE 855
            A E      +D +    +G G  G V +   + SG+I AVK+  + + S+   Q+  L +
Sbjct: 25   AXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQE--QKRLLXD 82
Query: 856  VKSLTEIRHRNI-----VKFYGFCSHARHSFIVYEY----LEMGSLAMILSNATSAEELG 906
            +    +I  R +     V FYG        +I  E     L+     +I    T  E++ 
Sbjct: 83   L----DISXRTVDCPFTVTFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDIL 138
Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
                ++++K    AL +LH+     +++RD+   NVL++   +    DFGIS  L  D +
Sbjct: 139  GKIAVSIVK----ALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA 192
Query: 967  NWTELAGTIGYVAPEL--------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
               + AG   Y APE          Y++    KSD++S G+  +E    + P D   S  
Sbjct: 193  KDID-AGCKPYXAPERINPELNQKGYSV----KSDIWSLGITXIELAILRFPYD---SWG 244
Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLIS-IMEVAISCLDENPDSRPTMQKVSQ 1073
            +    L + ++E   P+LPA      DK  +  ++    CL +N   RPT  ++ Q
Sbjct: 245  TPFQQLKQVVEEP-SPQLPA------DKFSAEFVDFTSQCLKKNSKERPTYPELXQ 293

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 47/210 (22%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++++D +  +G G    V R    ++G   A K  ++  LS    Q+    E +   +++
Sbjct: 5    SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +         ++V++ +  G L     +  + E        + I+ + ++++Y
Sbjct: 64   HPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H++    IV+R++  +N+LL  + +     ++DFG++  +  DS  W   AGT GY++P
Sbjct: 121  CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+      ++  D+++ GV+    + G  P
Sbjct: 177  EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 47/210 (22%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++++D +  +G G    V R    ++G   A K  ++  LS    Q+    E +   +++
Sbjct: 4    SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 62
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +         ++V++ +  G L     +  + E        + I+ + ++++Y
Sbjct: 63   HPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAY 119
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H++    IV+R++  +N+LL  + +     ++DFG++  +  DS  W   AGT GY++P
Sbjct: 120  CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 175
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+      ++  D+++ GV+    + G  P
Sbjct: 176  EVLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 47/210 (22%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++++D +  +G G    V R    ++G   A K  ++  LS    Q+    E +   +++
Sbjct: 5    SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 63
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +         ++V++ +  G L     +  + E        + I+ + ++++Y
Sbjct: 64   HPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAY 120
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H++    IV+R++  +N+LL  + +     ++DFG++  +  DS  W   AGT GY++P
Sbjct: 121  CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 176
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+      ++  D+++ GV+    + G  P
Sbjct: 177  EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  SGE VA+KK   P  SE+  ++ +  E+  L  ++H N++    
Sbjct: 50   VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 108
Query: 873  FCSHARHSFIVYE-YLEM----GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
              + A      Y+ YL M      L  I+    S E++ +     ++  +   L Y+H+ 
Sbjct: 109  VFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIHSA 163
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-M 986
                +V+RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+  + M
Sbjct: 164  G---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV---VTRWYRAPEVILSWM 217
Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
               +  D++S G +  E + GK
Sbjct: 218  HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 14/239 (5%)
Query: 781  GNAP--GFLSVLTFDRKIAY---EEIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVA 834
            G AP   FL  L F R + +   E      + F +   +G GG G V+  ++ ++G++ A
Sbjct: 155  GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA 214
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLA 893
             KK +   L +    Q  + E K L ++  R IV   Y F +      +V   +  G + 
Sbjct: 215  CKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIR 273
Query: 894  MILSNATSAEELGWTQRMNVI--KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH 951
              + N    +  G+ +   +     +   L +LH      I+YRD+  +NVLLD +    
Sbjct: 274  YHIYN-VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329
Query: 952  VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +SD G++  LK   +     AGT G++APEL    +     D ++ GV   E I  + P
Sbjct: 330  ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 14/239 (5%)
Query: 781  GNAP--GFLSVLTFDRKIAY---EEIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVA 834
            G AP   FL  L F R + +   E      + F +   +G GG G V+  ++ ++G++ A
Sbjct: 155  GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA 214
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLA 893
             KK +   L +    Q  + E K L ++  R IV   Y F +      +V   +  G + 
Sbjct: 215  CKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIR 273
Query: 894  MILSNATSAEELGWTQRMNVI--KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH 951
              + N    +  G+ +   +     +   L +LH      I+YRD+  +NVLLD +    
Sbjct: 274  YHIYN-VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329
Query: 952  VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +SD G++  LK   +     AGT G++APEL    +     D ++ GV   E I  + P
Sbjct: 330  ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S      S   VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 53   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVYSEQDELDFLMEALIISKFNH 107
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 108  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 167
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT--- 974
              YL  + F   ++RDI+++N LL        A + DFG+++ +    +++    G    
Sbjct: 168  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RASYYRKGGCAML 222
Query: 975  -IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             + ++ PE       T K+D +SFGVL  E
Sbjct: 223  PVKWMPPEAFMEGIFTSKTDTWSFGVLLWE 252

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 14/239 (5%)
Query: 781  GNAP--GFLSVLTFDRKIAY---EEIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVA 834
            G AP   FL  L F R + +   E      + F +   +G GG G V+  ++ ++G++ A
Sbjct: 155  GQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYA 214
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLA 893
             KK +   L +    Q  + E K L ++  R IV   Y F +      +V   +  G + 
Sbjct: 215  CKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC-LVMTIMNGGDIR 273
Query: 894  MILSNATSAEELGWTQRMNVI--KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH 951
              + N    +  G+ +   +     +   L +LH      I+YRD+  +NVLLD +    
Sbjct: 274  YHIYN-VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVR 329
Query: 952  VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +SD G++  LK   +     AGT G++APEL    +     D ++ GV   E I  + P
Sbjct: 330  ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S    E +  +E   E+     +RH NI+ F
Sbjct: 9    QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 63
Query: 871  YGFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    ++    +V +Y E GSL   L+  T   E      + +    A  L++LH 
Sbjct: 64   IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 119
Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTI 975
            +       P I +RD+ SKN+L+       ++D G+  +++ DS+  T         GT 
Sbjct: 120  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTK 177
Query: 976  GYVAPEL---AYTMKVTE---KSDVYSFGVLALE-----AIKGKHPR------DFISSIC 1018
             Y+APE+   +  MK  E   ++D+Y+ G++  E     +I G H        D + S  
Sbjct: 178  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 237
Query: 1019 STSSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            S         ++ L P +P    SC     +  IM     C   N  +R T  ++ + L
Sbjct: 238  SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 293

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S    E +  +E   E+     +RH NI+ F
Sbjct: 8    QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 62
Query: 871  YGFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    ++    +V +Y E GSL   L+  T   E      + +    A  L++LH 
Sbjct: 63   IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 118
Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTI 975
            +       P I +RD+ SKN+L+       ++D G+  +++ DS+  T         GT 
Sbjct: 119  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTK 176
Query: 976  GYVAPEL---AYTMKVTE---KSDVYSFGVLALE-----AIKGKHPR------DFISSIC 1018
             Y+APE+   +  MK  E   ++D+Y+ G++  E     +I G H        D + S  
Sbjct: 177  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 1019 STSSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            S         ++ L P +P    SC     +  IM     C   N  +R T  ++ + L
Sbjct: 237  SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 292

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S    E +  +E   E+     +RH NI+ F
Sbjct: 34   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 88
Query: 871  YGFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    ++    +V +Y E GSL   L+  T   E      + +    A  L++LH 
Sbjct: 89   IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 144
Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTI 975
            +       P I +RD+ SKN+L+       ++D G+  +++ DS+  T         GT 
Sbjct: 145  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTK 202
Query: 976  GYVAPEL---AYTMKVTE---KSDVYSFGVLALE-----AIKGKHPR------DFISSIC 1018
             Y+APE+   +  MK  E   ++D+Y+ G++  E     +I G H        D + S  
Sbjct: 203  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 262
Query: 1019 STSSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            S         ++ L P +P    SC     +  IM     C   N  +R T  ++ + L
Sbjct: 263  SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 318

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S    E +  +E   E+     +RH NI+ F
Sbjct: 14   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 68
Query: 871  YGFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    ++    +V +Y E GSL   L+  T   E      + +    A  L++LH 
Sbjct: 69   IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 124
Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTI 975
            +       P I +RD+ SKN+L+       ++D G+  +++ DS+  T         GT 
Sbjct: 125  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTK 182
Query: 976  GYVAPEL---AYTMKVTE---KSDVYSFGVLALE-----AIKGKHPR------DFISSIC 1018
             Y+APE+   +  MK  E   ++D+Y+ G++  E     +I G H        D + S  
Sbjct: 183  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 242
Query: 1019 STSSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            S         ++ L P +P    SC     +  IM     C   N  +R T  ++ + L
Sbjct: 243  SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 298

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S    E +  +E   E+     +RH NI+ F
Sbjct: 11   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 65
Query: 871  YGFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    ++    +V +Y E GSL   L+  T   E      + +    A  L++LH 
Sbjct: 66   IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 121
Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTI 975
            +       P I +RD+ SKN+L+       ++D G+  +++ DS+  T         GT 
Sbjct: 122  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTK 179
Query: 976  GYVAPEL---AYTMKVTE---KSDVYSFGVLALE-----AIKGKHPR------DFISSIC 1018
             Y+APE+   +  MK  E   ++D+Y+ G++  E     +I G H        D + S  
Sbjct: 180  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 239
Query: 1019 STSSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            S         ++ L P +P    SC     +  IM     C   N  +R T  ++ + L
Sbjct: 240  SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 295

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-08,   Method: Composition-based stats.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 48/299 (16%)
Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S    E +  +E   E+     +RH NI+ F
Sbjct: 47   QESIGKGRFGEVWRGKWR-GEEVAVKIFSSR--EERSWFRE--AEIYQTVMLRHENILGF 101
Query: 871  YGFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    ++    +V +Y E GSL   L+  T   E      + +    A  L++LH 
Sbjct: 102  IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE----GMIKLALSTASGLAHLHM 157
Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT------ELAGTI 975
            +       P I +RD+ SKN+L+       ++D G+  +++ DS+  T         GT 
Sbjct: 158  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVRHDSATDTIDIAPNHRVGTK 215
Query: 976  GYVAPEL---AYTMKVTE---KSDVYSFGVLALE-----AIKGKHPR------DFISSIC 1018
             Y+APE+   +  MK  E   ++D+Y+ G++  E     +I G H        D + S  
Sbjct: 216  RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 1019 STSSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            S         ++ L P +P    SC     +  IM     C   N  +R T  ++ + L
Sbjct: 276  SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 331

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY  ++S      S   VAVK    P +     + +FL E   +++  H+NI
Sbjct: 39   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSY 923
            V+  G    +   FI+ E +  G L   L       +    L     ++V + +A    Y
Sbjct: 97   VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 924  LHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            L  + F   ++RDI+++N LL        A + DFG+++ +    +++    G     + 
Sbjct: 157  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIY--RASYYRKGGCAMLPVK 211
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALE 1003
            ++ PE       T K+D +SFGVL  E
Sbjct: 212  WMPPEAFMEGIFTSKTDTWSFGVLLWE 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFAEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 35/217 (16%)
Query: 814  IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPL----LSEMTCQQEFLNEVKSLTE 861
            +G G  G V  AE              VAVK          LS++  + E +  +     
Sbjct: 89   LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG---- 144
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-------------NATSAEELGWT 908
             +H+NI+   G C+     +++ EY   G+L   L              N    E++ + 
Sbjct: 145  -KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
              ++    +A  + YL +      ++RD++++NVL+       ++DFG+++ +       
Sbjct: 204  DLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 260
Query: 969  TELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
                G   + ++APE  +    T +SDV+SFGVL  E
Sbjct: 261  KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 47/210 (22%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            T+++     +G G    V R  ++ +G+  A K  ++  LS     Q+   E +    ++
Sbjct: 3    TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD-HQKLEREARICRLLK 61
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +   S     ++V++ +  G L     +  + E        + I+ + +++++
Sbjct: 62   HPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H      IV+RD+  +N+LL  + +     ++DFG++  ++ D   W   AGT GY++P
Sbjct: 119  CH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+       +  D+++ GV+    + G  P
Sbjct: 176  EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 47/210 (22%), Positives = 99/210 (47%), Gaps = 11/210 (5%)
Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            T+++     +G G    V R  ++ +G+  A K  ++  LS     Q+   E +    ++
Sbjct: 3    TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARD-HQKLEREARICRLLK 61
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +   S     ++V++ +  G L     +  + E        + I+ + +++++
Sbjct: 62   HPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIQQILESVNH 118
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H      IV+RD+  +N+LL  + +     ++DFG++  ++ D   W   AGT GY++P
Sbjct: 119  CH---LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSP 175
Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            E+       +  D+++ GV+    + G  P
Sbjct: 176  EVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 56.6 bits (135), Expect = 8e-08,   Method: Composition-based stats.
 Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 24/207 (11%)
Query: 814  IGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G G  G VY  ++S      S   VAVK    P +     + +FL E   +++  H+NI
Sbjct: 56   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSLAMILSNA----TSAEELGWTQRMNVIKGVADALSY 923
            V+  G    +   FI+ E +  G L   L       +    L     ++V + +A    Y
Sbjct: 114  VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 924  LHNDCFPPIVYRDISSKNVLLDLE---YEAHVSDFGISKSLKPDSSNWTELAGT----IG 976
            L  + F   ++RDI+++N LL        A + DFG+++ +    + +    G     + 
Sbjct: 174  LEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYRKGGCAMLPVK 228
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALE 1003
            ++ PE       T K+D +SFGVL  E
Sbjct: 229  WMPPEAFMEGIFTSKTDTWSFGVLLWE 255

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++  Y   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 25/219 (11%)
Query: 799  EEIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            EE+  AT+       +G G  G V+R E   +G   AVKK    +      + E L    
Sbjct: 90   EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVF-----RAEELMACA 140
Query: 858  SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
             LT  R   IV  YG         I  E LE GSL  ++       E    + +  +   
Sbjct: 141  GLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQA 194
Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAG--- 973
             + L YLH+     I++ D+ + NVLL  +   A + DFG +  L+PD    + L G   
Sbjct: 195  LEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYI 251
Query: 974  --TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              T  ++APE+        K DV+S   + L  + G HP
Sbjct: 252  PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 42   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 102  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 158
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 159  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 212
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 213  SKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 15/230 (6%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNAT 900
             + ++   +  LNE + L  +    +VK  Y F  ++ + ++V EY+  G +    S+  
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS-NLYMVMEYVPGGEM---FSHLR 133
Query: 901  SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS 960
                            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K 
Sbjct: 134  RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 961  LKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 191  VK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 15/230 (6%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNAT 900
             + ++   +  LNE + L  +    +VK  Y F  ++ + ++V EY+  G +    S+  
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS-NLYMVMEYVPGGEM---FSHLR 133
Query: 901  SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS 960
                            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K 
Sbjct: 134  RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 961  LKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 191  VK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 15/230 (6%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKF-YGFCSHARHSFIVYEYLEMGSLAMILSNAT 900
             + ++   +  LNE + L  +    +VK  Y F  ++ + ++V EY+  G +    S+  
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNS-NLYMVMEYVPGGEM---FSHLR 133
Query: 901  SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS 960
                            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K 
Sbjct: 134  RIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190
Query: 961  LKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 191  VK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 808  FDEEHC--IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H   I   G+G+    EL        ++G +VAVK+      S    Q++F  E++
Sbjct: 4    FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQ 60
Query: 858  SLTEIRHRNIVKFYGFC-SHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  +    IVK+ G      R    +V EYL  G L   L    +   L  ++ +    
Sbjct: 61   ILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSS 118
Query: 916  GVADALSYL-HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL--- 971
             +   + YL    C    V+RD++++N+L++ E    ++DFG++K L  D          
Sbjct: 119  QICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPG 174
Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
               I + APE       + +SDV+SFGV+  E         +    CS S+   R +   
Sbjct: 175  QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGCE 228
Query: 1032 LD--------------PRLPA-PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D               RLPA P+C        + E+   C   +P  RP+   +   L 
Sbjct: 229  RDVPALCRLLELLEEGQRLPAPPACPAE-----VHELMKLCWAPSPQDRPSFSALGPQLD 283
Query: 1077 I 1077
            +
Sbjct: 284  M 284

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LXGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + F+    IGTG  G V   + + +G   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + F+    IGTG  G V   + + +G   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYMPGGDM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/208 (24%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKF----HSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            IG G  G V++     +G+IVA+KKF      P++ ++      L E++ L +++H N+V
Sbjct: 11   IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-----LREIRMLKQLKHPNLV 65
Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQR---MNVIKGVA----DAL 921
                     R   +V+EY           + T   EL   QR    +++K +      A+
Sbjct: 66   NLLEVFRRKRRLHLVFEY----------CDHTVLHELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 922  SYLH-NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
            ++ H ++C    ++RD+  +N+L+       + DFG ++ L   S  + +   T  Y +P
Sbjct: 116  NFCHKHNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSP 171
Query: 981  ELAY-TMKVTEKSDVYSFGVLALEAIKG 1007
            EL     +     DV++ G +  E + G
Sbjct: 172  ELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 28   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 88   PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 144
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 145  HS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 199  SKGYNKAVDWWALGVLIYEMAAGYPP 224

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 35/235 (14%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN--ATSAEELG 906
            +Q F  E + L  ++H NIV+FY            +E    G   ++L     TS     
Sbjct: 69   RQRFKEEAEXLKGLQHPNIVRFYD----------SWESTVKGKKCIVLVTELXTSGTLKT 118
Query: 907  WTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFG 956
            + +R  V K          +   L +LH    PPI++RD+   N+ +        + D G
Sbjct: 119  YLKRFKVXKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLG 177
Query: 957  ISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016
            ++ +LK  +S    + GT  + APE  Y  K  E  DVY+FG   LE    ++P     S
Sbjct: 178  LA-TLK-RASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYP----YS 230
Query: 1017 ICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             C  ++ + R +   +      P+   +  +  + E+   C+ +N D R +++ +
Sbjct: 231  ECQNAAQIYRRVTSGVK-----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 280

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 46/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 36   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 90
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  + E + +    ++ K   D L+
Sbjct: 91   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKTPEDLYK---DFLT 146
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 147  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 207  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 262
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 263  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 802  VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFH-SPLLSEMTCQQEFLNEVKSL 859
            +R T  F E   +G+G    V+  +   +G++ A+K    SP   + + +    NE+  L
Sbjct: 7    IRKTFIFME--VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE----NEIAVL 60
Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVA 918
             +I+H NIV          H ++V + +  G L   IL      E+        VI+ V 
Sbjct: 61   KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK----DASLVIQQVL 116
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             A+ YLH +    IV+RD+  +N+L    +   +  ++DFG+SK     +   +   GT 
Sbjct: 117  SAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM--EQNGIMSTACGTP 171
Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            GYVAPE+      ++  D +S GV+    + G  P
Sbjct: 172  GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L       E            +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 56/249 (22%), Positives = 106/249 (42%), Gaps = 35/249 (14%)
Query: 843  LSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS----- 897
            LS++  + E +  +      +H+NI+   G C+     +++  Y   G+L   L      
Sbjct: 84   LSDLVSEMEMMKMIG-----KHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPP 138
Query: 898  --------NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    N    E++ +   ++    +A  + YL +      ++RD++++NVL+     
Sbjct: 139  GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNV 195
Query: 950  AHVSDFGISKSLKPDSSNWTELAG--TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK- 1006
              ++DFG+++ +           G   + ++APE  +    T +SDV+SFGVL  E    
Sbjct: 196  MKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 255
Query: 1007 GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            G  P   I         L + L E    R+  P+ N  ++L  +M     C    P  RP
Sbjct: 256  GGSPYPGIP-----VEELFKLLKE--GHRMDKPA-NCTNELYMMMR---DCWHAVPSQRP 304
Query: 1067 TMQKVSQLL 1075
            T +++ + L
Sbjct: 305  TFKQLVEDL 313

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L       E            +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L       E            +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 36   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L       E            +     YL
Sbjct: 96   PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 152
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 153  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 206
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 207  SKGYNKAVDWWALGVLIYEMAAGYPP 232

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 45/201 (22%), Positives = 95/201 (47%), Gaps = 11/201 (5%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G    V R  ++ +G+  A K  ++  LS     Q+   E +    ++H NIV+ + 
Sbjct: 30   LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARD-HQKLEREARICRLLKHPNIVRLHD 88
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
              S   H +++++ +  G L     +  + E        + I+ + +A+ + H      +
Sbjct: 89   SISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGV 142
Query: 933  VYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
            V+RD+  +N+LL  + +     ++DFG++  ++ +   W   AGT GY++PE+       
Sbjct: 143  VHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYG 202
Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
            +  D+++ GV+    + G  P
Sbjct: 203  KPVDLWACGVILYILLVGYPP 223

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 92/203 (45%), Gaps = 9/203 (4%)
Query: 812  HCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
              +G GG G V+  ++ ++G++ A KK +   L +    Q  + E K L ++  R IV  
Sbjct: 191  RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 871  -YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI--KGVADALSYLHND 927
             Y F +      +V   +  G +   + N    +  G+ +   +     +   L +LH  
Sbjct: 251  AYAFETKTDLC-LVMTIMNGGDIRYHIYN-VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMK 987
                I+YRD+  +NVLLD +    +SD G++  LK   +     AGT G++APEL    +
Sbjct: 309  ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE 365
Query: 988  VTEKSDVYSFGVLALEAIKGKHP 1010
                 D ++ GV   E I  + P
Sbjct: 366  YDFSVDYFALGVTLYEMIAARGP 388

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 88/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + F+    IGTG  G V   + + +G   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 93/200 (46%), Gaps = 14/200 (7%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G+G  GSV   Y A L   + VAVKK   P  S +  ++ +  E++ L  ++H N++  
Sbjct: 36   VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 871  YGFCSHARHSFIVYE-YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                + A       E YL    +   L+N   ++ L       ++  +   L Y+H+   
Sbjct: 93   LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAG- 151
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKV 988
              I++RD+   NV ++ + E  + DFG+++    + + +     T  Y APE+    M  
Sbjct: 152  --IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMHY 206
Query: 989  TEKSDVYSFGVLALEAIKGK 1008
             +  D++S G +  E ++GK
Sbjct: 207  NQTVDIWSVGCIMAELLQGK 226

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            +KK  S        ++E   EV  L ++ H N++  +    +     ++ E +  G L  
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEYE-AHV 952
             L+   S  E    +  + IK + D ++YLH      I + D+  +N+ LLD      H+
Sbjct: 105  FLAQKESLSE---EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158
Query: 953  S--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               DFG++  ++ D   +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 159  KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 1011 ------RDFISSICSTSSNLD 1025
                  ++ +++I S S + D
Sbjct: 218  FLGDTKQETLANITSVSYDFD 238

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            +KK  S        ++E   EV  L ++ H N++  +    +     ++ E +  G L  
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEYE-AHV 952
             L+   S  E    +  + IK + D ++YLH      I + D+  +N+ LLD      H+
Sbjct: 105  FLAQKESLSE---EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158
Query: 953  S--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               DFG++  ++ D   +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 159  KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 1011 ------RDFISSICSTSSNLD 1025
                  ++ +++I S S + D
Sbjct: 218  FLGDTKQETLANITSVSYDFD 238

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 99/200 (49%), Gaps = 12/200 (6%)
Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++++D +  +G G    V R    ++G   A K  ++  LS    Q+    E +   +++
Sbjct: 28   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQ 86
Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV+ +         ++V++ +  G L     +  + E        + I+ + ++++Y
Sbjct: 87   HPNIVRLHDSIQEESFHYLVFDLVTGGEL---FEDIVAREFYSEADASHCIQQILESIAY 143
Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             H++    IV+R++  +N+LL  + +     ++DFG++  +  DS  W   AGT GY++P
Sbjct: 144  CHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSP 199
Query: 981  ELAYTMKVTEKSDVYSFGVL 1000
            E+      ++  D+++ GV+
Sbjct: 200  EVLKKDPYSKPVDIWACGVI 219

>pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 56/185 (30%), Positives = 84/185 (45%), Gaps = 2/185 (1%)
Query: 209 MYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNS-LSGS 267
           ++L+ N +S    +   + ++L+ L L  N L+G    +   L  L  LDL DN+ L   
Sbjct: 36  IFLHGNRISYVPAASFQSCRNLTILWLHSNALAGIDAAAFTGLTLLEQLDLSDNAQLRVV 95
Query: 268 IPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLT 327
            P +F  L +L  L+L    L    P     L +L  L L  N L     ++  +L  LT
Sbjct: 96  DPTTFRGLGHLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDLGNLT 155
Query: 328 ILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
            L+L  N +          L  L  L L  N ++   PH+  +L  L TLYLF N LS  
Sbjct: 156 HLFLHGNRIPSVPEHAFRGLHSLDRLLLHQNHVARVHPHAFRDLGRLMTLYLFANNLS-M 214
Query: 388 IPSEI 392
           +P+E+
Sbjct: 215 LPAEV 219

>pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 80/299 (26%), Positives = 125/299 (41%), Gaps = 30/299 (10%)
Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKE--YGNLVKLTLLVLSYNQLQGPI--PDLRNLTR 468
           P +F  L ++  L +Y   LS A+ K+  + NL  LT L LS NQ++     P    L  
Sbjct: 90  PDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS 149
Query: 469 LARVRLDRNHLTGNISESFG--IHSNLSYINLSHKKFYGEISFDWGKFPN------LGTL 520
           L  +    N +               LS+ +L+    Y  +S DWGK  N      L  L
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEIL 209
Query: 521 DVSAN----NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFS 576
           DVS N    +ITG     I  S    ++   ++HI+G      G     IK   ++N F+
Sbjct: 210 DVSGNGWTVDITGNFSNAISKSQAFSLI--LAHHIMGA-----GFGFHNIK-DPDQNTFA 261
Query: 577 GQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIH 636
           G   + +       HLDLS   + +        L  L  LNL+ N+ +           +
Sbjct: 262 GLARSSV------RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 637 LSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
           L  L+LS+N LGE   S    +  +  ++L  N+++    + FK +  L  +D+  N L
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL 374

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G+G  GSV   Y A L   + VAVKK   P  S +  ++ +  E++ L  ++H N++  
Sbjct: 36   VGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTY-RELRLLKHLKHENVIGL 92
Query: 871  YGFCSHARHSFIVYE-YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                + A       E YL    +   L+N    + L       ++  +   L Y+H+   
Sbjct: 93   LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS--- 149
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKV 988
              I++RD+   NV ++ + E  + DFG+++    + + +     T  Y APE+    M  
Sbjct: 150  AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYV---ATRWYRAPEIMLNWMHY 206
Query: 989  TEKSDVYSFGVLALEAIKGK 1008
             +  D++S G +  E ++GK
Sbjct: 207  NQTVDIWSVGCIMAELLQGK 226

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRR 134
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 135  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 192  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 66/285 (23%), Positives = 118/285 (41%), Gaps = 41/285 (14%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATXRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 89
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATS---------AEELGWTQRMNV 913
            H N+V   G C+       ++ E+ + G+L+  L +  +          + L     +  
Sbjct: 90   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTEL 971
               VA  + +L +      ++RD++++N+LL  +    + DFG+++ +   PD     + 
Sbjct: 150  SFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDA 206
Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDE 1030
               + ++APE  +    T +SDV+SFGVL  E    G  P   +           R L E
Sbjct: 207  RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFXRRLKE 262
Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 263  --GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 48/201 (23%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            +KK  S        ++E   EV  L ++ H N++  +    +     ++ E +  G L  
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEYE-AHV 952
             L+   S  E    +  + IK + D ++YLH      I + D+  +N+ LLD      H+
Sbjct: 105  FLAQKESLSE---EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158
Query: 953  S--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               DFG++  ++ D   +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 159  KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 1011 ------RDFISSICSTSSNLD 1025
                  ++ +++I S S + D
Sbjct: 218  FLGDTKQETLANITSVSYDFD 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 11   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 70
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 71   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 127
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 128  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 185  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 135
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 136  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 193  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 135
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 136  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 193  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 135
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 136  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 193  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 135
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 136  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 193  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 134
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 135  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 192  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 134
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 135  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 192  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +    S+   
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM---FSHLRR 134
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
                           +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 135  IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 192  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+++D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIII 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 19/215 (8%)
Query: 807  DFDEEHCIGTGGQGSVYRAELSSG----EIVAVKKFH-SPLLSEMTCQQEFLNEVKSLTE 861
            +F+    +GTG  G V+     SG    ++ A+K    + ++ +    +    E + L  
Sbjct: 55   NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 862  IRHRN--IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG-VA 918
            IR     +   Y F +  +   I+ +Y+  G L   LS      E      + +  G + 
Sbjct: 115  IRQSPFLVTLHYAFQTETKLHLIL-DYINGGELFTHLSQRERFTE----HEVQIYVGEIV 169
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGTIGY 977
             AL +LH      I+YRDI  +N+LLD      ++DFG+SK    D +    +  GTI Y
Sbjct: 170  LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 978  VAPELAYTMKVTEKS--DVYSFGVLALEAIKGKHP 1010
            +AP++            D +S GVL  E + G  P
Sbjct: 227  MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/79 (35%), Positives = 41/79 (51%)
Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            I+YRD+   NV+LD E    ++DFG+ K    D        GT  Y+APE+       + 
Sbjct: 463  IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 522
Query: 992  SDVYSFGVLALEAIKGKHP 1010
             D ++FGVL  E + G+ P
Sbjct: 523  VDWWAFGVLLYEMLAGQAP 541

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 62   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L       E            +     YL
Sbjct: 122  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE---PHARFYAAQIVLTFEYL 178
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 179  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 232
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 233  SKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  +   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYQMAAGYPP 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/199 (24%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  +G  VAVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 30   VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 88
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + AR S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 89   VFTPAR-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 144
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVT 989
             I++RD+   N+ ++ + E  +  FG+++    + + +     T  Y APE+    M   
Sbjct: 145  DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYV---ATRWYRAPEIMLNWMHYN 201
Query: 990  EKSDVYSFGVLALEAIKGK 1008
            +  D++S G +  E + G+
Sbjct: 202  QTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Composition-based stats.
 Identities = 28/79 (35%), Positives = 41/79 (51%)
Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            I+YRD+   NV+LD E    ++DFG+ K    D        GT  Y+APE+       + 
Sbjct: 142  IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKS 201
Query: 992  SDVYSFGVLALEAIKGKHP 1010
             D ++FGVL  E + G+ P
Sbjct: 202  VDWWAFGVLLYEMLAGQAP 220

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 11   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 70
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +   L     
Sbjct: 71   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR 130
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
              E            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 131  FXE---PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 184
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 185  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 230

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            ++E   EV  L EIRH NI+  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 59   REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 118
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            Q    +K + D + YLH+     I + D+  +N+ LLD         + DFGI+  ++  
Sbjct: 119  Q---FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 171
Query: 965  SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             + +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 172  GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +   L     
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR 137
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
              E            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 138  FXE---PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 192  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +   L     
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR 137
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
              E            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 138  FXE---PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 192  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            ++E   EV  L EIRH NI+  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 52   REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            Q    +K + D + YLH+     I + D+  +N+ LLD         + DFGI+  ++  
Sbjct: 112  Q---FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 164
Query: 965  SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             + +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 165  GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 57/229 (24%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +   L     
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR 138
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
              E            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 139  FXE---PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 192
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 193  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            L EV+ L ++ H NI+K +     +   +IV E    G L          +         
Sbjct: 69   LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR 125
Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPDSSNWT 969
            +IK V   ++Y+H      IV+RD+  +N+LL   + + +  + DFG+S   +  ++   
Sbjct: 126  IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMK 181
Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +  GT  Y+APE+       EK DV+S GV+    + G  P
Sbjct: 182  DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            L EV+ L ++ H NI+K +     +   +IV E    G L          +         
Sbjct: 69   LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR 125
Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPDSSNWT 969
            +IK V   ++Y+H      IV+RD+  +N+LL   + + +  + DFG+S   +  ++   
Sbjct: 126  IIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMK 181
Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +  GT  Y+APE+       EK DV+S GV+    + G  P
Sbjct: 182  DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/212 (22%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 803  RATNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            R T+D+     +G G    V R  + +  +  A K  ++  LS     Q+   E +    
Sbjct: 28   RFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARD-HQKLEREARICRL 86
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            ++H NIV+ +   S     ++V++ +  G L     +  + E        + I  + +++
Sbjct: 87   LKHPNIVRLHDSISEEGFHYLVFDLVTGGEL---FEDIVAREYYSEADASHCIHQILESV 143
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +++H      IV+RD+  +N+LL  + +     ++DFG++  ++ +   W   AGT GY+
Sbjct: 144  NHIHQH---DIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYL 200
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +PE+       +  D+++ GV+    + G  P
Sbjct: 201  SPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 54.7 bits (130), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 11/166 (6%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            ++E   EV  L EIRH NI+  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 73   REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 132
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            Q    +K + D + YLH+     I + D+  +N+ LLD         + DFGI+  ++  
Sbjct: 133  Q---FLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA- 185
Query: 965  SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             + +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 186  GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/201 (23%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            +KK  S        ++E   EV  L ++ H N++  +    +     ++ E +  G L  
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEYE-AHV 952
             L+   S  E    +  + IK + D ++YLH      I + D+  +N+ LLD      H+
Sbjct: 105  FLAQKESLSE---EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158
Query: 953  S--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               DFG++  ++ D   +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 159  KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 1011 ------RDFISSICSTSSNLD 1025
                  ++ +++I + S + D
Sbjct: 218  FLGDTKQETLANITAVSYDFD 238

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-07,   Method: Composition-based stats.
 Identities = 47/201 (23%), Positives = 92/201 (45%), Gaps = 17/201 (8%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            +KK  S        ++E   EV  L ++ H N++  +    +     ++ E +  G L  
Sbjct: 45   IKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD 104
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEYE-AHV 952
             L+   S  E    +  + IK + D ++YLH      I + D+  +N+ LLD      H+
Sbjct: 105  FLAQKESLSE---EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHI 158
Query: 953  S--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               DFG++  ++ D   +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 159  KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 1011 ------RDFISSICSTSSNLD 1025
                  ++ +++I + S + D
Sbjct: 218  FLGDTKQETLANITAVSYDFD 238

>pdb|1OZN|A Chain A, 1.5a Crystal Structure Of The Nogo Receptor Ligand Binding Domain Reveals A Convergent Recognition Scaffold Mediating Inhibition Of Myelination Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 2/184 (1%)
Query: 209 MYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSI 268
           ++L+ N +S    +     ++L+ L L  N L+     +   L  L  LDL DN+   S+
Sbjct: 37  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 269 -PLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLT 327
            P +F  L  L  L+L    L    P     L +L  L L  N L      +  +L  LT
Sbjct: 97  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 156
Query: 328 ILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
            L+L  N +          L  L  L L  N+++   PH+  +L  L TLYLF N LS +
Sbjct: 157 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 215
Query: 388 IPSE 391
           +P+E
Sbjct: 216 LPTE 219

>pdb|1P8T|A Chain A, Crystal Structure Of Nogo-66 Receptor Length = 285

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 55/184 (29%), Positives = 82/184 (44%), Gaps = 2/184 (1%)
Query: 209 MYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSI 268
           ++L+ N +S    +     ++L+ L L  N L+     +   L  L  LDL DN+   S+
Sbjct: 36  IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 95
Query: 269 -PLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLT 327
            P +F  L  L  L+L    L    P     L +L  L L  N L      +  +L  LT
Sbjct: 96  DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLT 155
Query: 328 ILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
            L+L  N +          L  L  L L  N+++   PH+  +L  L TLYLF N LS +
Sbjct: 156 HLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-A 214
Query: 388 IPSE 391
           +P+E
Sbjct: 215 LPTE 218

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 17/241 (7%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G  G V+R   +S +   + KF   +  + T Q     E+  L   RHRNI+  +  
Sbjct: 13   LGRGEFGIVHRCVETSSKKTYMAKF---VKVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIV 933
                    +++E++    L +     TSA EL   + ++ +  V +AL +LH+     I 
Sbjct: 70   FESMEELVMIFEFIS--GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIG 124
Query: 934  YRDISSKNVLLDLEYEAHVS--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            + DI  +N++      + +   +FG ++ LKP   N+  L     Y APE+     V+  
Sbjct: 125  HFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDVVSTA 183
Query: 992  SDVYSFGVLALEAIKGKHPRDFIS----SICSTSSNLDRTLDEILDPRLPAPSCNIRDKL 1047
            +D++S G L    + G +P  F++     I     N + T DE     +   + +  D+L
Sbjct: 184  TDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 1048 I 1048
            +
Sbjct: 242  L 242

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK            + + + +  +L M++  A  
Sbjct: 78   KVVKLKEIEHTLNEKRILQAVNFPFLVK------------LEFSFKDNSNLYMVMEYAPG 125
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 126  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG++K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 183  TDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 75/168 (44%), Gaps = 32/168 (19%)
Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
           QL+ LDL++ H+ G +PS +  L  L KL L+ N F         +   L HL +  N  
Sbjct: 276 QLQELDLTATHLKG-LPSGMKGLNLLKKLVLSVNHFDQLCQISAANFPSLTHLYIRGN-- 332
Query: 600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQ 659
                      VK  +L +            LEK  +L  LDLSHN +     S  CS+Q
Sbjct: 333 -----------VKKLHLGVG----------CLEKLGNLQTLDLSHNDIE---ASDCCSLQ 368
Query: 660 -----SLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNS 702
                 L+ LNL+HN   G   + FKE   L  +D+++ +LH   P S
Sbjct: 369 LKNLSHLQTLNLSHNEPLGLQSQAFKECPQLELLDLAFTRLHINAPQS 416

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 119/289 (41%), Gaps = 49/289 (16%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATXRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 89
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  +     +    ++ K   D L+
Sbjct: 90   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE----FVPYKDLYK---DFLT 142
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 143  LEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 203  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 258
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 259  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Composition-based stats.
 Identities = 66/287 (22%), Positives = 118/287 (41%), Gaps = 43/287 (14%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATXRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 91
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATS-----------AEELGWTQRM 911
            H N+V   G C+       ++ E+ + G+L+  L +  +            + L     +
Sbjct: 92   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK--PDSSNWT 969
                 VA  + +L +      ++RD++++N+LL  +    + DFG+++ +   PD     
Sbjct: 152  XYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTL 1028
            +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R L
Sbjct: 209  DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRL 264
Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 265  KE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 109/268 (40%), Gaps = 17/268 (6%)
Query: 69  ISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQI 128
           + P   F   C+    +  +  +  GL     D      P  A LDL+ N+I  I     
Sbjct: 21  MGPVCPFRCQCH----LRVVQCSDLGLEKVPKDLP----PDTALLDLQNNKITEIKDGDF 72
Query: 129 ANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLF 188
            N   L  L L +N  S   P     L  L+ LYLS NQ    +P ++     L+ L + 
Sbjct: 73  KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH 129
Query: 189 ENGLSGSIPPSLGNLTNLAIMYLYNNSL--SGSIPSEIGNLKSLSGLELGYNKLSGSMPL 246
           EN ++         L  + ++ L  N L  SG        +K LS + +    ++ ++P 
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLG 306
            L   P+L  L L  N ++     S   L NL  L L  NS+S      + N   L  L 
Sbjct: 189 GLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 307 LSFNKLSGSIPSSLGNLTKLTILYLSDN 334
           L+ NKL   +P  L +   + ++YL +N
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNN 273

>pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 10/214 (4%)
Query: 415 SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRL 474
            F NL N+  L + +N +S   P  +  LVKL  L LS NQL+  +P+    T L  +R+
Sbjct: 71  DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKT-LQELRV 128
Query: 475 DRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLD---VSANNITGIL 531
             N +T      F   + +  + L           + G F  +  L    ++  NIT I 
Sbjct: 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSS-GIENGAFQGMKKLSYIRIADTNITTI- 186
Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEH 591
            P+ G  P L  L L  N I     + L  L +L KL L+ N  S      L +   L  
Sbjct: 187 -PQ-GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244
Query: 592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
           L L++N+L   +PG L +   +  + L NN  S 
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT  Y+AP +  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEYLAPAIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 109/268 (40%), Gaps = 17/268 (6%)
Query: 69  ISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQI 128
           + P   F   C+    +  +  +  GL     D      P  A LDL+ N+I  I     
Sbjct: 21  MGPVCPFRCQCH----LRVVQCSDLGLEKVPKDLP----PDTALLDLQNNKITEIKDGDF 72
Query: 129 ANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLF 188
            N   L  L L +N  S   P     L  L+ LYLS NQ    +P ++     L+ L + 
Sbjct: 73  KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVH 129
Query: 189 ENGLSGSIPPSLGNLTNLAIMYLYNNSL--SGSIPSEIGNLKSLSGLELGYNKLSGSMPL 246
           EN ++         L  + ++ L  N L  SG        +K LS + +    ++ ++P 
Sbjct: 130 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLG 306
            L   P+L  L L  N ++     S   L NL  L L  NS+S      + N   L  L 
Sbjct: 189 GLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH 246
Query: 307 LSFNKLSGSIPSSLGNLTKLTILYLSDN 334
           L+ NKL   +P  L +   + ++YL +N
Sbjct: 247 LNNNKLV-KVPGGLADHKYIQVVYLHNN 273

>pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 10/214 (4%)
Query: 415 SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRL 474
            F NL N+  L + +N +S   P  +  LVKL  L LS NQL+  +P+    T L  +R+
Sbjct: 71  DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKT-LQELRV 128
Query: 475 DRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLD---VSANNITGIL 531
             N +T      F   + +  + L           + G F  +  L    ++  NIT I 
Sbjct: 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSS-GIENGAFQGMKKLSYIRIADTNITTI- 186
Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEH 591
            P+ G  P L  L L  N I     + L  L +L KL L+ N  S      L +   L  
Sbjct: 187 -PQ-GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRE 244
Query: 592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
           L L++N+L   +PG L +   +  + L NN  S 
Sbjct: 245 LHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA 277

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 39   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 98
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK         + ++V EY+  G +   L     
Sbjct: 99   KVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGR 158
Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
              E            +     YLH+     ++YRD+  +N+L+D +    V+DFG +K +
Sbjct: 159  FSE---PHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 212
Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 213  K--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 258

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK            + + + +  +L M++  A  
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVK------------LEFSFKDNSNLYMVMEYAPG 125
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 126  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 183  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-07,   Method: Composition-based stats.
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK            + + + +  +L M++  A  
Sbjct: 78   KVVKLKEIEHTLNEKRILQAVNFPFLVK------------LEFSFKDNSNLYMVMEYAPG 125
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 126  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG++K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 183  TDFGLAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-07,   Method: Composition-based stats.
 Identities = 54/218 (24%), Positives = 99/218 (45%), Gaps = 21/218 (9%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSP-------LLSEMTCQQEFLNE 855
            AT+ ++    IG G  G+VY+A +  SG  VA+K    P        L   T ++  L  
Sbjct: 7    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL-- 64
Query: 856  VKSLTEIRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQR 910
            ++ L    H N+V+    C+ +R        +V+E+++   L   L  A        T +
Sbjct: 65   LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE 970
             ++++     L +LH +C   IV+RD+  +N+L+       ++DFG+++      +  T 
Sbjct: 124  -DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTP 178
Query: 971  LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK 1008
            +  T+ Y APE+          D++S G +  E  + K
Sbjct: 179  VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 80
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 81   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 137
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSLK--PDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 138  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 198  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 253
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 254  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 89
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 90   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 146
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 147  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 206
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 207  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 262
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 263  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 56/238 (23%), Positives = 97/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK            + + + +  +L M++  A  
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLVK------------LEFSFKDNSNLYMVMEYAPG 126
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 127  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 184  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 89
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 90   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 146
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 147  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVR 206
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 207  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 262
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 263  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK            + + + +  +L M++  A  
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVK------------LEFSFKDNSNLYMVMEYAPG 125
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 126  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 183  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 120/289 (41%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 37   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 91
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  + E + + +    +    D L+
Sbjct: 92   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EFVPYKEAPEDL--YKDFLT 148
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 149  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 208
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 209  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 264
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 265  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Composition-based stats.
 Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 80
Query: 864  HRNIVKFYGFCSHARHSFIVY-EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+      +V  E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 81   HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 137
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSLK--PDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 138  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVR 197
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 198  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 253
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 254  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 8e-07,   Method: Composition-based stats.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 18   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 77
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    +VK            + + + +  +L M++  A  
Sbjct: 78   KVVKLKQIEHTLNEKRILQAVNFPFLVK------------LEFSFKDNSNLYMVMEYAPG 125
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 126  GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 183  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 853  LNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            L EV  L ++  H NI++           F+V++ ++ G L   L+   +  E    + M
Sbjct: 71   LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
              +  V  AL  L+      IV+RD+  +N+LLD +    ++DFG S  L P      E+
Sbjct: 131  RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 183
Query: 972  AGTIGYVAPEL----------AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             GT  Y+APE+           Y  +V    D++S GV+    + G  P
Sbjct: 184  CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 47/169 (27%), Positives = 76/169 (44%), Gaps = 22/169 (13%)
Query: 853  LNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            L EV  L ++  H NI++           F+V++ ++ G L   L+   +  E    + M
Sbjct: 58   LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 117
Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
              +  V  AL  L+      IV+RD+  +N+LLD +    ++DFG S  L P      E+
Sbjct: 118  RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLREV 170
Query: 972  AGTIGYVAPEL----------AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             GT  Y+APE+           Y  +V    D++S GV+    + G  P
Sbjct: 171  CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 215

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  + ++ SG  +AVKK   P  S +  ++ +  E++ L  ++H N++    
Sbjct: 59   VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 117
Query: 873  FCSHARHSFIVYE--YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
              + A  S   +   YL    +   L+N    ++L       +I  +   L Y+H+    
Sbjct: 118  VFTPAT-SLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---A 173
Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA-----YT 985
             I++RD+   N+ ++ + E  + DFG+++    + + +     T  Y APE+      Y 
Sbjct: 174  DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VATRWYRAPEIMLNWMHYN 230
Query: 986  MKVTEKSDVYSFGVLALEAIKGK 1008
            M V    D++S G +  E + G+
Sbjct: 231  MTV----DIWSVGCIMAELLTGR 249

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE----MTCQQEFLNEVKS 858
            AT+ ++    IG G  G+VY+A +  SG  VA+K    P   E     T ++  L  ++ 
Sbjct: 2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--LRR 59
Query: 859  LTEIRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNV 913
            L    H N+V+    C+ +R        +V+E+++   L   L  A        T + ++
Sbjct: 60   LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DL 117
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK------SLKPDSSN 967
            ++     L +LH +C   IV+RD+  +N+L+       ++DFG+++      +L P    
Sbjct: 118  MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP---- 170
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK 1008
               +  T+ Y APE+          D++S G +  E  + K
Sbjct: 171  ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE----MTCQQEFLNEVKS 858
            AT+ ++    IG G  G+VY+A +  SG  VA+K    P   E     T ++  L  ++ 
Sbjct: 2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--LRR 59
Query: 859  LTEIRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNV 913
            L    H N+V+    C+ +R        +V+E+++   L   L  A        T + ++
Sbjct: 60   LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DL 117
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK------SLKPDSSN 967
            ++     L +LH +C   IV+RD+  +N+L+       ++DFG+++      +L P    
Sbjct: 118  MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAP---- 170
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK 1008
               +  T+ Y APE+          D++S G +  E  + K
Sbjct: 171  ---VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 72   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 126
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 127  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 183
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 184  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 243
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 244  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 299
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 300  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-07,   Method: Composition-based stats.
 Identities = 67/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 89
Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+       ++ E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 90   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 146
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 147  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 207  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 262
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 263  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 51/206 (24%), Positives = 86/206 (41%), Gaps = 10/206 (4%)
Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +    S+                  +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEM---FSHLRRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +K +K     W  L GT   +APE+  
Sbjct: 158  HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--GRTWX-LCGTPEALAPEIIL 211
Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +    +  D ++ GVL  E   G  P
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPP 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 80
Query: 864  HRNIVKFYGFCSHARHSFIVY-EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+      +V  E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 81   HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 137
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 138  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 198  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 253
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 254  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 68/289 (23%), Positives = 118/289 (40%), Gaps = 45/289 (15%)
Query: 814  IGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 26   LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 80
Query: 864  HRNIVKFYGFCSHARHSFIVY-EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N+V   G C+      +V  E+ + G+L+  L +  +          ++ K   D L+
Sbjct: 81   HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK---DFLT 137
Query: 923  YLHNDCFP-------------PIVYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSN 967
              H  C+                ++RD++++N+LL  +    + DFG+++ +   PD   
Sbjct: 138  LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 197
Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDR 1026
              +    + ++APE  +    T +SDV+SFGVL  E    G  P   +           R
Sbjct: 198  KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCR 253
Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             L E    R+ AP     +    + +  + C    P  RPT  ++ + L
Sbjct: 254  RLKE--GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 38/217 (17%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            IG G  G V+  +   GE VAVK F +    E +  +E   E+     +RH NI+ F   
Sbjct: 45   IGKGRYGEVWMGKWR-GEKVAVKVFFTT--EEASWFRE--TEIYQTVLMRHENILGFIAA 99
Query: 874  CSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                  S    +++ +Y E GSL   L + T    L     + +       L +LH + F
Sbjct: 100  DIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 930  -----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW----TELAGTIGYVAP 980
                 P I +RD+ SKN+L+       ++D G++     D++          GT  Y+ P
Sbjct: 156  STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 981  EL-----------AYTMKVTEKSDVYSFGVLALEAIK 1006
            E+           +Y M     +D+YSFG++  E  +
Sbjct: 216  EVLDESLNRNHFQSYIM-----ADMYSFGLILWEVAR 247

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 53/215 (24%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 804  ATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE----MTCQQEFLNEVKS 858
            AT+ ++    IG G  G+VY+A +  SG  VA+K    P   E     T ++  L  ++ 
Sbjct: 2    ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVAL--LRR 59
Query: 859  LTEIRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNV 913
            L    H N+V+    C+ +R        +V+E+++   L   L  A        T + ++
Sbjct: 60   LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK-DL 117
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
            ++     L +LH +C   IV+RD+  +N+L+       ++DFG+++      + +  +  
Sbjct: 118  MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV- 173
Query: 974  TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK 1008
            T+ Y APE+          D++S G +  E  + K
Sbjct: 174  TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 63/219 (28%), Positives = 91/219 (41%), Gaps = 25/219 (11%)
Query: 799  EEIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            EE+  AT+       +G G  G V+R E   +G   AVKK    +      + E L    
Sbjct: 71   EEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVF-----RAEELMACA 121
Query: 858  SLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
             LT  R   IV  YG         I  E LE GSL  ++       E    + +  +   
Sbjct: 122  GLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPE---DRALYYLGQA 175
Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAG--- 973
             + L YLH+     I++ D+ + NVLL  +   A + DFG +  L+PD      L G   
Sbjct: 176  LEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYI 232
Query: 974  --TIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              T  ++APE+        K DV+S   + L  + G HP
Sbjct: 233  PGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 11/161 (6%)
Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            L EV+ L ++ H NI+K +     +   +IV E    G L          +         
Sbjct: 69   LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL---FDEIIKRKRFSEHDAAR 125
Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPDSSNWT 969
            +IK V   ++Y+H      IV+RD+  +N+LL   + + +  + DFG+S   + + +   
Sbjct: 126  IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMK 181
Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +  GT  Y+APE+       EK DV+S GV+    + G  P
Sbjct: 182  DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP 221

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 814  IGTGGQG-SVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  G +    +  S E+VAVK        +   ++E +N       +RH NIV+F  
Sbjct: 26   IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 81
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                  H  IV EY   G L   + NA   +E+        +I GV    SY H      
Sbjct: 82   VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV----SYCHA---MQ 134
Query: 932  IVYRDISSKNVLLD--LEYEAHVSDFGISKS----LKPDSSNWTELAGTIGYVAPELAYT 985
            + +RD+  +N LLD        + DFG SKS     +P S+      GT  Y+APE+   
Sbjct: 135  VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLK 189
Query: 986  MKVTEK-SDVYSFGVLALEAIKGKHP 1010
             +   K +DV+S GV     + G +P
Sbjct: 190  KEYDGKVADVWSCGVTLYVMLVGAYP 215

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 835  VKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAM 894
            +KK  S       C++E   EV  L ++ H NI+  +    +     ++ E +  G L  
Sbjct: 45   IKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD 104
Query: 895  ILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEYEA-HV 952
             L+   S  E   T   + IK + D ++YLH      I + D+  +N+ LLD      H+
Sbjct: 105  FLAQKESLSEEEAT---SFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 953  S--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
               DFG++  ++ D   +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 159  KLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
Query: 1011 ------RDFISSICSTSSNLD 1025
                  ++ +++I + S + D
Sbjct: 218  FLGDTKQETLANITAVSYDFD 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Composition-based stats.
 Identities = 64/245 (26%), Positives = 101/245 (41%), Gaps = 30/245 (12%)
Query: 806  NDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +D D    +   G G+   A L     + E+VAVK        +   ++E +N       
Sbjct: 16   HDSDRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINH----RS 71
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +RH NIV+F        H  IV EY   G L   + NA    E    +     + +   +
Sbjct: 72   LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE---DEARFFFQQLISGV 128
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAH--VSDFGISKS----LKPDSSNWTELAGTI 975
            SY H      + +RD+  +N LLD        ++DFG SK+     +P S+      GT 
Sbjct: 129  SYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA-----VGTP 180
Query: 976  GYVAPELAYTMKVTEK-SDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             Y+APE+    +   K +DV+S GV     + G +P +          N  +T+  IL+ 
Sbjct: 181  AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEE----PKNFRKTIHRILNV 236
Query: 1035 RLPAP 1039
            +   P
Sbjct: 237  QYAIP 241

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 814  IGTGGQG-SVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  G +    +  S E+VAVK            ++E +N       +RH NIV+F  
Sbjct: 27   IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKE 82
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                  H  IV EY   G L   + NA   +E+        +I GV    SY H      
Sbjct: 83   VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV----SYCHA---MQ 135
Query: 932  IVYRDISSKNVLLD--LEYEAHVSDFGISKS----LKPDSSNWTELAGTIGYVAPELAYT 985
            + +RD+  +N LLD        + DFG SKS     +P S+      GT  Y+APE+   
Sbjct: 136  VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLK 190
Query: 986  MKVTEK-SDVYSFGVLALEAIKGKHP 1010
             +   K +DV+S GV     + G +P
Sbjct: 191  KEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R  L     +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWESPAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE +    +    +VK            + + + +  +L M+L  A  
Sbjct: 79   KVVKLKQIEHTLNEKRIQQAVNFPFLVK------------LEFSFKDNSNLYMVLEYAPG 126
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+L+D +    V
Sbjct: 127  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 183
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 184  ADFGFAKRVK--GRTW-XLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 41   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 92
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 93   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 152
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 153  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 208
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 209  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 142/559 (25%), Positives = 216/559 (38%), Gaps = 89/559 (15%)
Query: 176 IGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLEL 235
           +   S+LK  H         IP  L   +N+ ++ L +N L    P+       L+ L+ 
Sbjct: 8   VADCSHLKLTH---------IPDDLP--SNITVLNLTHNQLRRLPPTNFTRYSQLAILDA 56
Query: 236 GYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSE 295
           G+N +S   P     LP L  L+L  N LS     +F   TNL  L+L  NS+     + 
Sbjct: 57  GFNSISKLEPELCQILPLLKVLNLQHNELSQISDQTFVFCTNLTELDLMSNSIHKIKSNP 116
Query: 296 MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN--LLFGSIPCEIGNLRYLFYL 353
             N K+L  L LS N LS +   +   L  L  L L+ N  L   S   E      L  L
Sbjct: 117 FKNQKNLIKLDLSHNGLSSTKLGTGVQLENLQELLLAKNKILALRSEELEFLGNSSLRKL 176
Query: 354 ELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIXXXXXXXXXXXXXXXXXXXIP 413
           +L  N L    P     +  L  L L    L+  +  ++                     
Sbjct: 177 DLSSNPLKEFSPGCFQTIGKLFALLLNNAQLNPHLTEKLC-------------------- 216
Query: 414 YSFGNLTNMIVLSIYSNALSGAIPKEYGNL--VKLTLLVLSYNQLQGP-------IPDLR 464
           +   N T++  LS+ +N L       +  L    LT L LSYN L          +P LR
Sbjct: 217 WELSN-TSIQNLSLANNQLLATSESTFSGLKWTNLTQLDLSYNNLHDVGNGSFSYLPSLR 275
Query: 465 NLTRLARVRLDRNHLTGNISESFGIHSNLSYINL------------SHKKFYGEISFDWG 512
            L+      L+ N++      SF   SNL Y++L            SH     + SF W 
Sbjct: 276 YLS------LEYNNIQRLSPRSFYGLSNLRYLSLKRAFTKQSVSLASHPNI-DDFSFQWL 328
Query: 513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH-----IVGEIPSELGKLRSLIK 567
           K+  L  L++  NNI             LK L LS        +  E    L     L+ 
Sbjct: 329 KY--LEYLNMDDNNIPSTKSNTFTGLVSLKYLSLSKTFTSLQTLTNETFVSLAH-SPLLT 385
Query: 568 LTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS----LGNLVKLY-----YLNL 618
           L L +N  S         L QL  LDL  N +   + G     L N+ ++Y     YL L
Sbjct: 386 LNLTKNHISKIANGTFSWLGQLRILDLGLNEIEQKLSGQEWRGLRNIFEIYLSYNKYLQL 445
Query: 619 SNNQFSGEIPIK--LEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP 676
           S + F+    ++  + + + L ++D+S        PS    +++L  L+L++NN++    
Sbjct: 446 STSSFALVPSLQRLMLRRVALKNVDIS--------PSPFRPLRNLTILDLSNNNIANINE 497
Query: 677 RCFKEMHGLVYIDISYNKL 695
              + +  L  +D  +N L
Sbjct: 498 DLLEGLENLEILDFQHNNL 516

>pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 111/270 (41%), Gaps = 61/270 (22%)
Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
           SN++ +NL+H +       ++ ++  L  LD   N+I+ + P      P LKVL+L  N 
Sbjct: 25  SNITVLNLTHNQLRRLPPTNFTRYSQLAILDAGFNSISKLEPELCQILPLLKVLNLQHNE 84
Query: 551 I----------------VGEIPSELGKLRS--------LIKLTLNRNQFSGQLPTELGSL 586
           +                +  + + + K++S        LIKL L+ N  S    T+LG+ 
Sbjct: 85  LSQISDQTFVFCTNLTELDLMSNSIHKIKSNPFKNQKNLIKLDLSHNGLSS---TKLGTG 141
Query: 587 I-----------------------------QLEHLDLSSNRLSNSIPGSLGNLVKLYYLN 617
           +                              L  LDLSSN L    PG    + KL+ L 
Sbjct: 142 VQLENLQELLLAKNKILALRSEELEFLGNSSLRKLDLSSNPLKEFSPGCFQTIGKLFALL 201
Query: 618 LSNNQFSGEIPIKLEKFIH---LSDLDLSHNFLGEEIPSQVCSMQ--SLEKLNLAHNNLS 672
           L+N Q +  +  KL   +    + +L L++N L     S    ++  +L +L+L++NNL 
Sbjct: 202 LNNAQLNPHLTEKLCWELSNTSIQNLSLANNQLLATSESTFSGLKWTNLTQLDLSYNNLH 261
Query: 673 GFIPRCFKEMHGLVYIDISYNKLHGPIPNS 702
                 F  +  L Y+ + YN +    P S
Sbjct: 262 DVGNGSFSYLPSLRYLSLEYNNIQRLSPRS 291

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    + K            + + + +  +L M++  A  
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLTK------------LEFSFKDNSNLYMVMEYAPG 126
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 127  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 184  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    + K            + + + +  +L M++  A  
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLTK------------LEFSFKDNSNLYMVMEYAPG 126
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 127  GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 184  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 34   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 85
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 86   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 146  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 201
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 202  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 30   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 81
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 82   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 141
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 142  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 197
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 198  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Composition-based stats.
 Identities = 54/238 (22%), Positives = 96/238 (40%), Gaps = 31/238 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA----ELSSGEIVAVKKFHSP 841
            FL+    D    +E   + T   D+   I T G GS  R      + +G   A+K     
Sbjct: 19   FLAKAKEDFLKKWENPAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQ 78
Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
             + ++   +  LNE + L  +    + K            + + + +  +L M++  A  
Sbjct: 79   KVVKLKQIEHTLNEKRILQAVNFPFLTK------------LEFSFKDNSNLYMVMEYAPG 126
Query: 902  AEELGWTQRMNVIK---------GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV 952
             E     +R+              +     YLH+     ++YRD+  +N+++D +    V
Sbjct: 127  GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 953  SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +DFG +K +K     W  L GT  Y+APE+  +    +  D ++ GVL  E   G  P
Sbjct: 184  TDFGFAKRVK--GRTWX-LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 238

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            +G GG G V+ A +    + VA+KK    +L++    +  L E+K +  + H NIVK + 
Sbjct: 19   LGCGGNGLVFSAVDNDCDKRVAIKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 872  -------------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
                         G  +     +IV EY+E   LA +L      EE        +++G  
Sbjct: 76   ILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRG-- 132
Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAG---T 974
              L Y+H+     +++RD+   N+ ++ E     + DFG+++ + P  S+   L+    T
Sbjct: 133  --LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 975  IGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGK 1008
              Y +P L  +    T+  D+++ G +  E + GK
Sbjct: 188  KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 34   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 85
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 86   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 145
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 146  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 201
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 202  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 35   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 86
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 87   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 146
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 147  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 202
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 203  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/201 (22%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPL-LSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G+G  G V+R  E ++G +   K  ++P  L + T +    NE+  + ++ H  ++  +
Sbjct: 59   LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK----NEISIMNQLHHPKLINLH 114
Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                      ++ E+L  G L   +  A    ++   + +N ++   + L ++H      
Sbjct: 115  DAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHEHS--- 169
Query: 932  IVYRDISSKNVLLDLEYEAHVS--DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
            IV+ DI  +N++ + +  + V   DFG++  L PD       A T  + APE+     V 
Sbjct: 170  IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA-TAEFAAPEIVDREPVG 228
Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
              +D+++ GVL    + G  P
Sbjct: 229  FYTDMWAIGVLGYVLLSGLSP 249

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 804  ATNDFDE-EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            A +DF E E  +G G    VYR +    +    K +   +L +   ++    E+  L  +
Sbjct: 50   ALSDFFEVESELGRGATSIVYRCKQKGTQ----KPYALKVLKKTVDKKIVRTEIGVLLRL 105
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADAL 921
             H NI+K            +V E +  G L   I+     +E        + +K + +A+
Sbjct: 106  SHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSER----DAADAVKQILEAV 161
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDL---EYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +YLH +    IV+RD+  +N+L      +    ++DFG+SK ++      T + GT GY 
Sbjct: 162  AYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT-VCGTPGYC 217
Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            APE+        + D++S G++    + G  P
Sbjct: 218  APEILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S      +VY     +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 56   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 107
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 108  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 168  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 223
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 224  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 27   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 78
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 79   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 138
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 139  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 194
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 195  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 101  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 152
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 153  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 212
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 213  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 268
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 269  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 47/200 (23%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+V++A+   + EIVA+K+       E       L E+  L E++H+NIV+ + 
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHD 68
Query: 873  FCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                 +   +V+E+ +        S N     E+  +    ++KG    L + H+     
Sbjct: 69   VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG----LGFCHSR---N 121
Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +++RD+  +N+L++   E  ++DFG++++       ++    T+ Y  P++ +  K+   
Sbjct: 122  VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 992  S-DVYSFGVLALEAIKGKHP 1010
            S D++S G +  E      P
Sbjct: 182  SIDMWSAGCIFAELANAARP 201

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 22/169 (13%)
Query: 853  LNEVKSLTEIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            L EV  L ++  H NI++           F+V++ ++ G L   L+   +  E    + M
Sbjct: 71   LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIM 130
Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
              +  V  AL  L+      IV+RD+  +N+LLD +    ++DFG S  L P       +
Sbjct: 131  RALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-GEKLRSV 183
Query: 972  AGTIGYVAPEL----------AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             GT  Y+APE+           Y  +V    D++S GV+    + G  P
Sbjct: 184  CGTPSYLAPEIIECSMNDNHPGYGKEV----DMWSTGVIMYTLLAGSPP 228

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDF     IG GG G VY   +  +G++ A+K      +     +   LNE   L+ +  
Sbjct: 188  NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 865  RN----IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT-QRMNVIKGVAD 919
             +    +   Y F +  + SFI+ + +  G L   LS      E         +I G   
Sbjct: 248  GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 303
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL---KPDSSNWTELAGTIG 976
             L ++HN     +VYRD+   N+LLD      +SD G++      KP +S      GT G
Sbjct: 304  -LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 354
Query: 977  YVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
            Y+APE L   +     +D +S G +  + ++G  P  F          +DR
Sbjct: 355  YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDR 403

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 48/134 (35%), Positives = 62/134 (46%), Gaps = 3/134 (2%)
Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSI 316
           LDL    L+     +F  LT L  LNL +N L         +L  L  LGL+ N+L+   
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 317 PSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLA 375
                +LT+L  LYL  N L  S+P  +   L  L  L L  N+L      +   LTNL 
Sbjct: 100 LGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ 158
Query: 376 TLYLFTNLLSGSIP 389
           TL L TN L  S+P
Sbjct: 159 TLSLSTNQLQ-SVP 171

>pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 40/134 (29%), Positives = 59/134 (44%), Gaps = 2/134 (1%)
Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSN 549
           + L+++NL + +     +  +     LGTL + ANN    LP  + D   QL  L L  N
Sbjct: 59  TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL-ANNQLASLPLGVFDHLTQLDKLYLGGN 117
Query: 550 HIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGN 609
            +         +L  L +L LN NQ           L  L+ L LS+N+L +   G+   
Sbjct: 118 QLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDR 177
Query: 610 LVKLYYLNLSNNQF 623
           L KL  + L  NQF
Sbjct: 178 LGKLQTITLFGNQF 191

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 48/134 (35%), Positives = 62/134 (46%), Gaps = 3/134 (2%)
Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSI 316
           LDL    L+     +F  LT L  LNL +N L         +L  L  LGL+ N+L+   
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLP 99
Query: 317 PSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLA 375
                +LT+L  LYL  N L  S+P  +   L  L  L L  N+L      +   LTNL 
Sbjct: 100 LGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQ 158
Query: 376 TLYLFTNLLSGSIP 389
           TL L TN L  S+P
Sbjct: 159 TLSLSTNQLQ-SVP 171

>pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 40/134 (29%), Positives = 59/134 (44%), Gaps = 2/134 (1%)
Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSN 549
           + L+++NL + +     +  +     LGTL + ANN    LP  + D   QL  L L  N
Sbjct: 59  TKLTWLNLDYNQLQTLSAGVFDDLTELGTLGL-ANNQLASLPLGVFDHLTQLDKLYLGGN 117
Query: 550 HIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGN 609
            +         +L  L +L LN NQ           L  L+ L LS+N+L +   G+   
Sbjct: 118 QLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDR 177
Query: 610 LVKLYYLNLSNNQF 623
           L KL  + L  NQF
Sbjct: 178 LGKLQTITLFGNQF 191

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDF     IG GG G VY   +  +G++ A+K      +     +   LNE   L+ +  
Sbjct: 189  NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 865  RN----IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT-QRMNVIKGVAD 919
             +    +   Y F +  + SFI+ + +  G L   LS      E         +I G   
Sbjct: 249  GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 304
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL---KPDSSNWTELAGTIG 976
             L ++HN     +VYRD+   N+LLD      +SD G++      KP +S      GT G
Sbjct: 305  -LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 355
Query: 977  YVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
            Y+APE L   +     +D +S G +  + ++G  P  F          +DR
Sbjct: 356  YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDR 404

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDF     IG GG G VY   +  +G++ A+K      +     +   LNE   L+ +  
Sbjct: 189  NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 865  RN----IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT-QRMNVIKGVAD 919
             +    +   Y F +  + SFI+ + +  G L   LS      E         +I G   
Sbjct: 249  GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 304
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL---KPDSSNWTELAGTIG 976
             L ++HN     +VYRD+   N+LLD      +SD G++      KP +S      GT G
Sbjct: 305  -LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 355
Query: 977  YVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
            Y+APE L   +     +D +S G +  + ++G  P  F          +DR
Sbjct: 356  YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDR 404

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 25/231 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDF     IG GG G VY   +  +G++ A+K      +     +   LNE   L+ +  
Sbjct: 189  NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 865  RN----IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT-QRMNVIKGVAD 919
             +    +   Y F +  + SFI+ + +  G L   LS      E         +I G   
Sbjct: 249  GDCPFIVCMSYAFHTPDKLSFIL-DLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG--- 304
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL---KPDSSNWTELAGTIG 976
             L ++HN     +VYRD+   N+LLD      +SD G++      KP +S      GT G
Sbjct: 305  -LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-----VGTHG 355
Query: 977  YVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
            Y+APE L   +     +D +S G +  + ++G  P  F          +DR
Sbjct: 356  YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP--FRQHKTKDKHEIDR 404

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 60   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 111
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 112  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 171
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 172  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 227
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 228  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 58   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 109
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 110  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 169
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 170  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 225
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 226  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Composition-based stats.
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 20/228 (8%)
Query: 799  EEIVRATNDFDEEHCIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLN 854
            E+++     F     +G G  GSV  A+L   +     VAVK   + +++    + EFL 
Sbjct: 16   EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIE-EFLR 74
Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHS------FIVYEYLEMGSLAMILSNATSAEE---L 905
            E   + E  H ++ K  G    +R         ++  +++ G L   L  +   E    L
Sbjct: 75   EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS 965
                 +  +  +A  + YL +  F   ++RD++++N +L  +    V+DFG+S+ +    
Sbjct: 135  PLQTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
Query: 966  SNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHP 1010
                  A    + ++A E       T  SDV++FGV   E + +G+ P
Sbjct: 192  YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L+ ++      E + +     ++      + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSYLLYQMLV-----GIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S GV+  E IKG
Sbjct: 199  GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 56   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 107
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 108  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 168  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 223
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 224  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 95/203 (46%), Gaps = 11/203 (5%)
Query: 802  VRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
             R T ++     +G G    V R  ++ +G+  A    ++  LS     Q+   E +   
Sbjct: 7    TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICR 65
Query: 861  EIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
             ++H NIV+ +   S   H +++++ +  G L     +  + E        + I+ + +A
Sbjct: 66   LLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL---FEDIVAREYYSEADASHCIQQILEA 122
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISKSLKPDSSNWTELAGTIGY 977
            + + H      +V+R++  +N+LL  + +     ++DFG++  ++ +   W   AGT GY
Sbjct: 123  VLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY 179
Query: 978  VAPELAYTMKVTEKSDVYSFGVL 1000
            ++PE+       +  D+++ GV+
Sbjct: 180  LSPEVLRKDPYGKPVDLWACGVI 202

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK    +L +    + F N E++ + ++ H 
Sbjct: 50   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK----VLQD----KRFKNRELQIMRKLDHC 101
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 102  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 161
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 162  SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 217
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 218  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 50.4 bits (119), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/203 (24%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L+ ++      E + +     ++      + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSYLLYQMLV-----GIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S GV+  E IKG
Sbjct: 199  GMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V+R  +  +G   AVKK    +          + E+ +   +    IV  YG
Sbjct: 66   VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYG 117
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                     I  E LE GSL  ++       E    + +  +    + L YLH      I
Sbjct: 118  AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---RI 171
Query: 933  VYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAG-----TIGYVAPELAYTM 986
            ++ D+ + NVLL  +   A + DFG +  L+PD    + L G     T  ++APE+    
Sbjct: 172  LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 987  KVTEKSDVYSFGVLALEAIKGKHP 1010
                K D++S   + L  + G HP
Sbjct: 232  PCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 6e-06,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V+R  +  +G   AVKK    +          + E+ +   +    IV  YG
Sbjct: 82   VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYG 133
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                     I  E LE GSL  ++       E    + +  +    + L YLH      I
Sbjct: 134  AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---RI 187
Query: 933  VYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAG-----TIGYVAPELAYTM 986
            ++ D+ + NVLL  +   A + DFG +  L+PD    + L G     T  ++APE+    
Sbjct: 188  LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 987  KVTEKSDVYSFGVLALEAIKGKHP 1010
                K D++S   + L  + G HP
Sbjct: 248  PCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGE-IVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
             DF+    IG G  G V   ++ + E I A+K   K+     +E  C   F  E   L  
Sbjct: 74   EDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC---FREERDVLVN 130
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA--EELGWTQRMNVIKGVAD 919
               + I   +       H ++V +Y   G L  +LS       E++       ++  + D
Sbjct: 131  GDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI-D 189
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYV 978
            ++  LH       V+RDI   NVLLD+     ++DFG    +  D +  + +A GT  Y+
Sbjct: 190  SIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYI 243
Query: 979  APELAYTM-----KVTEKSDVYSFGVLALEAIKGKHP 1010
            +PE+   M     K   + D +S GV   E + G+ P
Sbjct: 244  SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 121/272 (44%), Gaps = 43/272 (15%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 17   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAM--ILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             Y +    ++ ++V   +E G++ +   L    S +   W +R +  K + +A+  +H  
Sbjct: 74   LYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDP--W-ERKSYWKNMLEAVHTIHQH 127
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYT 985
                IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    GT+ Y+ PE    
Sbjct: 128  G---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 986  MKVTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD 1033
            M  + ++           DV+S G +      GK P +  I+ I          L  I+D
Sbjct: 184  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIID 235
Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            P       +I +K   + +V   CL  +P  R
Sbjct: 236  PNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 265

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 22/224 (9%)
Query: 799  EEIVRATNDFDEEHCIGTGGQGSVYRAELSSGE-IVAVK---KFHSPLLSEMTCQQEFLN 854
            +E+     DF+    IG G  G V   ++ + E I A+K   K+     +E  C   F  
Sbjct: 83   KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETAC---FRE 139
Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA--EELGWTQRMN 912
            E   L     + I   +       H ++V +Y   G L  +LS       E++       
Sbjct: 140  ERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGE 199
Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
            ++  + D++  LH       V+RDI   NVLLD+     ++DFG    +  D +  + +A
Sbjct: 200  MVLAI-DSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVA 252
Query: 973  -GTIGYVAPELAYTM-----KVTEKSDVYSFGVLALEAIKGKHP 1010
             GT  Y++PE+   M     K   + D +S GV   E + G+ P
Sbjct: 253  VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-06,   Method: Composition-based stats.
 Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 21/204 (10%)
Query: 814  IGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V+R  +  +G   AVKK    +          + E+ +   +    IV  YG
Sbjct: 80   LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYG 131
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                     I  E LE GSL  ++       E    + +  +    + L YLH      I
Sbjct: 132  AVREGPWVNIFMELLEGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTR---RI 185
Query: 933  VYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAG-----TIGYVAPELAYTM 986
            ++ D+ + NVLL  +   A + DFG +  L+PD    + L G     T  ++APE+    
Sbjct: 186  LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 987  KVTEKSDVYSFGVLALEAIKGKHP 1010
                K D++S   + L  + G HP
Sbjct: 246  PCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V  A E  + + VA+K     KF      E         E++ L ++ H  I
Sbjct: 18   LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +K   F   A   +IV E +E G L   ++ N    E    T ++   + +  A+ YLH 
Sbjct: 78   IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA---TCKLYFYQMLL-AVQYLHE 132
Query: 927  DCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +NVLL  + E     ++DFG SK L  ++S    L GT  Y+APE+ 
Sbjct: 133  N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVL 188
Query: 984  Y---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
                T       D +S GV+    + G  P
Sbjct: 189  VSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V  A E  + + VA+K     KF      E         E++ L ++ H  I
Sbjct: 18   LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +K   F   A   +IV E +E G L   ++ N    E    T ++   + +  A+ YLH 
Sbjct: 78   IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA---TCKLYFYQMLL-AVQYLHE 132
Query: 927  DCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +NVLL  + E     ++DFG SK L  ++S    L GT  Y+APE+ 
Sbjct: 133  N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVL 188
Query: 984  Y---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
                T       D +S GV+    + G  P
Sbjct: 189  VSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V  A E  + + VA+K     KF      E         E++ L ++ H  I
Sbjct: 17   LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +K   F   A   +IV E +E G L   ++ N    E    T ++   + +  A+ YLH 
Sbjct: 77   IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA---TCKLYFYQMLL-AVQYLHE 131
Query: 927  DCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +NVLL  + E     ++DFG SK L  ++S    L GT  Y+APE+ 
Sbjct: 132  N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVL 187
Query: 984  Y---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
                T       D +S GV+    + G  P
Sbjct: 188  VSVGTAGYNRAVDCWSLGVILFICLSGYPP 217

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V  A E  + + VA+K     KF      E         E++ L ++ H  I
Sbjct: 18   LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +K   F   A   +IV E +E G L   ++ N    E    T ++   + +  A+ YLH 
Sbjct: 78   IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA---TCKLYFYQMLL-AVQYLHE 132
Query: 927  DCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +NVLL  + E     ++DFG SK L  ++S    L GT  Y+APE+ 
Sbjct: 133  N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVL 188
Query: 984  Y---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
                T       D +S GV+    + G  P
Sbjct: 189  VSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.7 bits (117), Expect = 9e-06,   Method: Composition-based stats.
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 22/210 (10%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V  A E  + + VA+K     KF      E         E++ L ++ H  I
Sbjct: 24   LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +K   F   A   +IV E +E G L   ++ N    E    T ++   + +  A+ YLH 
Sbjct: 84   IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEA---TCKLYFYQMLL-AVQYLHE 138
Query: 927  DCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +NVLL  + E     ++DFG SK L  ++S    L GT  Y+APE+ 
Sbjct: 139  N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVL 194
Query: 984  Y---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
                T       D +S GV+    + G  P
Sbjct: 195  VSVGTAGYNRAVDCWSLGVILFICLSGYPP 224

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 87/202 (43%), Gaps = 17/202 (8%)
Query: 814  IGTGGQG-SVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  G +    +  S E+VAVK        +   ++E +N       +RH NIV+F  
Sbjct: 27   IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                  H  IV EY   G L   + NA   +E+        +I GV    SY H      
Sbjct: 83   VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV----SYCHA---MQ 135
Query: 932  IVYRDISSKNVLLD--LEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
            + +RD+  +N LLD        +  FG SKS     S   +  GT  Y+APE+    +  
Sbjct: 136  VCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPKDTVGTPAYIAPEVLLKKEYD 194
Query: 990  EK-SDVYSFGVLALEAIKGKHP 1010
             K +DV+S GV     + G +P
Sbjct: 195  GKVADVWSCGVTLYVMLVGAYP 216

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 98/226 (43%), Gaps = 34/226 (15%)
Query: 799 EEIVRATNDFDEEHCIGTGGQGSVYRAELSSGE--IVAVKKFHSPLLSEM---------- 846
           +E  +  ND+     I T  QG   +  L   +    A+KK+   LL +           
Sbjct: 24  KEKDKYINDY---RIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 847 ----TCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-------MI 895
               +   +F NE++ +T+I++   +   G  ++    +I+YEY+E  S+        ++
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140
Query: 896 LSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF 955
             N T    +   +   +IK V ++ SY+HN+    I +RD+   N+L+D      +SDF
Sbjct: 141 DKNYTCFIPIQVIK--CIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 956 GISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTE--KSDVYSFGV 999
           G S+ +       +   GT  ++ PE           K D++S G+
Sbjct: 197 GESEYMVDKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/211 (24%), Positives = 96/211 (45%), Gaps = 27/211 (12%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF 873
            +G G +G++    +     VAVK+      S    + + L E        H N++++  F
Sbjct: 32   LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE-----HPNVIRY--F 84
Query: 874  CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKGVADALSYLHNDCFPP 931
            C+     F   +Y+ +   A  L      ++      + + +++     L++LH+     
Sbjct: 85   CTEKDRQF---QYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LN 138
Query: 932  IVYRDISSKNVLLDL-----EYEAHVSDFGISKSL---KPDSSNWTELAGTIGYVAPE-L 982
            IV+RD+   N+L+ +     + +A +SDFG+ K L   +   S  + + GT G++APE L
Sbjct: 139  IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 983  AYTMKV--TEKSDVYSFGVLALEAI-KGKHP 1010
            +   K   T   D++S G +    I +G HP
Sbjct: 199  SEDCKENPTYTVDIFSAGCVFYYVISEGSHP 229

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.7 bits (117), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 30/187 (16%)
Query: 814 IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE-----FLNEVKSLTEIRHRNI 867
           IG G  G V++A    +G+ VA+KK        M  ++E      L E+K L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 79
Query: 868 VKFYGFC-------SHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
           V     C       +  + S ++V+++ E   LA +LSN      L   +R  V++ + +
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK--SLKPDS--SNWTELAGTI 975
            L Y+H +    I++RD+ + NVL+  +    ++DFG+++  SL  +S  + +     T+
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 976 GYVAPEL 982
            Y  PEL
Sbjct: 194 WYRPPEL 200

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 89/206 (43%), Gaps = 25/206 (12%)
Query: 814  IGTGGQG-SVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  G +    +  S E+VAVK        +   ++E +N       +RH NIV+F  
Sbjct: 27   IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKE 82
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATS-AEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                  H  IV EY   G L   + NA   +E+        +I GV    SY H      
Sbjct: 83   VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGV----SYCHA---MQ 135
Query: 932  IVYRDISSKNVLLD--LEYEAHVSDFGISKS----LKPDSSNWTELAGTIGYVAPELAYT 985
            + +RD+  +N LLD        +  FG SKS     +P S+      GT  Y+APE+   
Sbjct: 136  VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST-----VGTPAYIAPEVLLK 190
Query: 986  MKVTEK-SDVYSFGVLALEAIKGKHP 1010
             +   K +DV+S GV     + G +P
Sbjct: 191  KEYDGKVADVWSCGVTLYVMLVGAYP 216

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/84 (39%), Positives = 49/84 (58%), Gaps = 3/84 (3%)
Query: 206 LAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLS 265
           L  +YL  NSL+  +P+EI NL +L  L+L +N+L+ S+P  LG+   L      DN ++
Sbjct: 249 LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT 306
Query: 266 GSIPLSFGNLTNLDILNLPHNSLS 289
            ++P  FGNL NL  L +  N L 
Sbjct: 307 -TLPWEFGNLCNLQFLGVEGNPLE 329

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/120 (35%), Positives = 60/120 (50%), Gaps = 14/120 (11%)
Query: 254 LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG---NLKSLYGLGLSFN 310
           L  L L+ NSL+  +P    NL+NL +L+L HN L+ S+P+E+G    LK  Y     F+
Sbjct: 249 LTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFY----FFD 302
Query: 311 KLSGSIPSSLGNLTKLTILYLSDNLL---FGSIPCEIGNLRYLFYLELGDNKLSGSIPHS 367
            +  ++P   GNL  L  L +  N L   F  I  E      +FYL   DN+    +PH 
Sbjct: 303 NMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLR--DNRPEIPLPHE 360

>pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 60/145 (41%), Gaps = 28/145 (19%)
Query: 326 LTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
           LT LYL+ N L   +P EI NL  L  L+L  N+L+ S+P  LG+   L   Y F N+++
Sbjct: 249 LTRLYLNGNSL-TELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT 306
Query: 386 GSIPSEIXXXXXXXXXXXXXXXXXXXIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNL-V 444
                                     +P+ FGNL N+  L +  N L     K      V
Sbjct: 307 -------------------------TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSV 341
Query: 445 KLTLLVLSYNQLQGPIPDLRNLTRL 469
              +  L  N+ + P+P  R    +
Sbjct: 342 TGLIFYLRDNRPEIPLPHERRFIEI 366

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 11/159 (6%)
Query: 194 GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSL-GNLP 252
            S+P   G  TN  I+YL++N ++   P    +L +L  L LG N+L G++P+ +  +L 
Sbjct: 32  ASVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLT 88
Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL 312
            L  LDL  N L+      F  L +L  L +  N L+  +P  +  L  L  L L  N+L
Sbjct: 89  QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 313 SGSIP-SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYL 350
             SIP  +   L+ LT  YL  N       CE  ++ YL
Sbjct: 148 K-SIPHGAFDRLSSLTHAYLFGN----PWDCECRDIMYL 181

>pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 35/120 (29%), Positives = 53/120 (44%), Gaps = 1/120 (0%)
Query: 568 LTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEI 627
           L L+ NQ +   P    SLI L+ L L SN+L     G   +L +L  L+L  NQ +   
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLP 104
Query: 628 PIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVY 687
               ++ +HL +L +  N L  E+P  +  +  L  L L  N L       F  +  L +
Sbjct: 105 SAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 30/187 (16%)
Query: 814 IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE-----FLNEVKSLTEIRHRNI 867
           IG G  G V++A    +G+ VA+KK        M  ++E      L E+K L  ++H N+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 78
Query: 868 VKFYGFC-------SHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
           V     C       +  + S ++V+++ E   LA +LSN      L   +R  V++ + +
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 135
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK--SLKPDS--SNWTELAGTI 975
            L Y+H +    I++RD+ + NVL+  +    ++DFG+++  SL  +S  + +     T+
Sbjct: 136 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 192
Query: 976 GYVAPEL 982
            Y  PEL
Sbjct: 193 WYRPPEL 199

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 30/187 (16%)
Query: 814 IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE-----FLNEVKSLTEIRHRNI 867
           IG G  G V++A    +G+ VA+KK        M  ++E      L E+K L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 79
Query: 868 VKFYGFC-------SHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
           V     C       +  + S ++V+++ E   LA +LSN      L   +R  V++ + +
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK--SLKPDS--SNWTELAGTI 975
            L Y+H +    I++RD+ + NVL+  +    ++DFG+++  SL  +S  + +     T+
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 976 GYVAPEL 982
            Y  PEL
Sbjct: 194 WYRPPEL 200

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 89/187 (47%), Gaps = 30/187 (16%)
Query: 814 IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQE-----FLNEVKSLTEIRHRNI 867
           IG G  G V++A    +G+ VA+KK        M  ++E      L E+K L  ++H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKILQLLKHENV 79
Query: 868 VKFYGFCSHARHSF--------IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
           V     C      +        +V+++ E   LA +LSN      L   +R  V++ + +
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTLSEIKR--VMQMLLN 136
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK--SLKPDSS--NWTELAGTI 975
            L Y+H +    I++RD+ + NVL+  +    ++DFG+++  SL  +S    +     T+
Sbjct: 137 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTL 193
Query: 976 GYVAPEL 982
            Y  PEL
Sbjct: 194 WYRPPEL 200

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/272 (23%), Positives = 121/272 (44%), Gaps = 43/272 (15%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 64   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAM--ILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             Y +    ++ ++V   +E G++ +   L    S +   W +R +  K + +A+  +H  
Sbjct: 121  LYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDP--W-ERKSYWKNMLEAVHTIHQH 174
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYT 985
                IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    GT+ Y+ PE    
Sbjct: 175  G---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 986  MKVTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD 1033
            M  + ++           DV+S G +      GK P +  I+ I          L  I+D
Sbjct: 231  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIID 282
Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            P       +I +K   + +V   CL  +P  R
Sbjct: 283  PNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 24/234 (10%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLL 843
            LT D +  Y + +R  +++     +G+G  G V  A E  + + VA++     KF     
Sbjct: 135  LTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 192
Query: 844  SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSA 902
             E         E++ L ++ H  I+K   F   A   +IV E +E G L   ++ N    
Sbjct: 193  READPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLK 251
Query: 903  EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISK 959
            E    T ++   + +  A+ YLH +    I++RD+  +NVLL  + E     ++DFG SK
Sbjct: 252  EA---TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 304
Query: 960  SLKPDSSNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
             L  ++S    L GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 305  ILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 357

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 22/217 (10%)
Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGE-IVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
             DF+    IG G  G V   +L + + + A+K   K+     +E  C   F  E   L  
Sbjct: 74   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 130
Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA--EELGWTQRMNVIKGVAD 919
               + I   +       + ++V +Y   G L  +LS       EE+       ++  + D
Sbjct: 131  GDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAI-D 189
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYV 978
            ++  LH       V+RDI   N+L+D+     ++DFG    L  D +  + +A GT  Y+
Sbjct: 190  SVHQLH------YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 979  APELAYTM-----KVTEKSDVYSFGVLALEAIKGKHP 1010
            +PE+   M     +   + D +S GV   E + G+ P
Sbjct: 244  SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/240 (22%), Positives = 96/240 (40%), Gaps = 21/240 (8%)
Query: 798  YEEIVRA-------TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQ 850
            YE+IV+          D+D    IG G  G V      + + V   K  S          
Sbjct: 60   YEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDS 119
Query: 851  EFLNEVKSLTEIRHRN-IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
             F  E + +    +   +V+ +      ++ ++V EY+  G L  ++SN    E+  W +
Sbjct: 120  AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAK 177
Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
                   V  AL  +H+     +++RD+   N+LLD      ++DFG    +        
Sbjct: 178  FYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHC 232
Query: 970  ELA-GTIGYVAPELAYTMK----VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
            + A GT  Y++PE+  +         + D +S GV   E + G  P  +  S+  T S +
Sbjct: 233  DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF-YADSLVGTYSKI 291

>pdb|3T6Q|A Chain A, Crystal Structure Of Mouse Rp105MD-1 Complex Length = 606

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 90/293 (30%), Positives = 127/293 (43%), Gaps = 33/293 (11%)
Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRI 172
           ++L+ +  F I  +     S L+ LDL++   S  +P  +  LS LK L LS N+F    
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 173 P------PQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS--EI 224
                  P + HLS        E G        L NL NL  + L ++ +  S     ++
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGTG-----CLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 225 GNLKSLSGLELGYNKLSGSMPLSLGN-----LPNLATLDLHDNSLSGSIPLS-FGNLTNL 278
            NL  L  L L YN+     PLSL        P L  LDL    L      S F NL  L
Sbjct: 373 RNLSHLQSLNLSYNE-----PLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLL 427
Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL-SGSI--PSSLGNLTKLTILYLSDNL 335
            +LNL H+ L  S       L +L  L L  N    G+I   +SL  L +L IL LS   
Sbjct: 428 KVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCD 487
Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSI 388
           L         +L+ + +++L  N+L+ S   S+  L++L  +YL  NL S  I
Sbjct: 488 LSSIDQHAFTSLKMMNHVDLSHNRLTSS---SIEALSHLKGIYL--NLASNHI 535

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 63/278 (22%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 16   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 72
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAM--ILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             Y +    ++   +Y  +E G++ +   L    S +   W +R +  K + +A+  +H  
Sbjct: 73   LYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDP--W-ERKSYWKNMLEAVHTIHQH 126
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYT 985
                IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    GT+ Y+ PE    
Sbjct: 127  ---GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 986  MKVTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD 1033
            M  + ++           DV+S G +      GK P +  I+ I          L  I+D
Sbjct: 183  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIID 234
Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P       +I +K   + +V   CL  +P  R ++ ++
Sbjct: 235  PNHEIEFPDIPEK--DLQDVLKCCLKRDPKQRISIPEL 270

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 63/278 (22%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 64   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAM--ILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             Y +    ++   +Y  +E G++ +   L    S +   W +R +  K + +A+  +H  
Sbjct: 121  LYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDP--W-ERKSYWKNMLEAVHTIHQH 174
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYT 985
                IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    GT+ Y+ PE    
Sbjct: 175  ---GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 986  MKVTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD 1033
            M  + ++           DV+S G +      GK P +  I+ I          L  I+D
Sbjct: 231  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIID 282
Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P       +I +K   + +V   CL  +P  R ++ ++
Sbjct: 283  PNHEIEFPDIPEK--DLQDVLKCCLKRDPKQRISIPEL 318

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 20/227 (8%)
Query: 796  IAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQE 851
            +  +E+    +DF+    IG G    V   ++  +G++ A+K   K+      E++C   
Sbjct: 51   VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--- 107
Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            F  E   L     R I + +       + ++V EY   G L  +LS     E +      
Sbjct: 108  FREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMAR 165
Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
              +  +  A+  +H   +   V+RDI   N+LLD      ++DFG    L+ D +  + +
Sbjct: 166  FYLAEIVMAIDSVHRLGY---VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 972  A-GTIGYVAPELAYTMKVTE-------KSDVYSFGVLALEAIKGKHP 1010
            A GT  Y++PE+   +           + D ++ GV A E   G+ P
Sbjct: 223  AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 23   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 74
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 75   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 134
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 135  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 190
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 191  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 26   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 77
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 78   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 137
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 138  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 193
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 194  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQGKAFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIK----GVAD 919
            NIV+  Y F S       VY  L +  + A +   A        T  +  +K     +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.9 bits (115), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 106/234 (45%), Gaps = 24/234 (10%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLL 843
            LT D +  Y + +R  +++     +G+G  G V  A E  + + VA++     KF     
Sbjct: 121  LTVDDQSVYPKALR--DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 844  SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSA 902
             E         E++ L ++ H  I+K   F   A   +IV E +E G L   ++ N    
Sbjct: 179  READPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLK 237
Query: 903  EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA---HVSDFGISK 959
            E    T ++   + +  A+ YLH +    I++RD+  +NVLL  + E     ++DFG SK
Sbjct: 238  EA---TCKLYFYQMLL-AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290
Query: 960  SLKPDSSNWTELAGTIGYVAPELAY---TMKVTEKSDVYSFGVLALEAIKGKHP 1010
             L  ++S    L GT  Y+APE+     T       D +S GV+    + G  P
Sbjct: 291  ILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L+ ++      E + +     ++      + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSYLLYQMLV-----GIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 46/200 (23%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G  G+V++A+   + EIVA+K+       E       L E+  L E++H+NIV+ + 
Sbjct: 10   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKHKNIVRLHD 68
Query: 873  FCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                 +   +V+E+ +        S N     E+  +    ++KG    L + H+     
Sbjct: 69   VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG----LGFCHSR---N 121
Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
            +++RD+  +N+L++   E  +++FG++++       ++    T+ Y  P++ +  K+   
Sbjct: 122  VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181
Query: 992  S-DVYSFGVLALEAIKGKHP 1010
            S D++S G +  E      P
Sbjct: 182  SIDMWSAGCIFAELANAGRP 201

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL  +    + DFG+++ +   PD     +    + ++APE  +    T 
Sbjct: 215  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 274
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +SDV+SFGVL  E    G  P   +           R L E    R+ AP     +    
Sbjct: 275  QSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLKE--GTRMRAPDYTTPE---- 324
Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            + +  + C    P  RPT  ++ + L
Sbjct: 325  MYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 106/226 (46%), Gaps = 18/226 (7%)
Query: 792  FDRKI--AYEEIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTC 848
            FD +I  A +  V +     +   +G G  G V++ E  ++G  +A K   +     M  
Sbjct: 73   FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKD 129
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGW 907
            ++E  NE+  + ++ H N+++ Y          +V EY++ G L   I+  + +  EL  
Sbjct: 130  KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL-- 187
Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPD 964
               +  +K + + + ++H      I++ D+  +N+L    D + +  + DFG+++  KP 
Sbjct: 188  -DTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPR 242
Query: 965  SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                    GT  ++APE+     V+  +D++S GV+A   + G  P
Sbjct: 243  EKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 16/227 (7%)
Query: 805  TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
              D++    IG G  G V      S   V   K  S           F  E + +    +
Sbjct: 73   AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 865  RNIVK--FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
               V   FY F    R+ ++V EY+  G L  ++SN    E+  W +       V  AL 
Sbjct: 133  SPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALD 187
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAPE 981
             +H+  F   ++RD+   N+LLD      ++DFG    +  +     + A GT  Y++PE
Sbjct: 188  AIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244
Query: 982  LAYTM----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
            +  +         + D +S GV   E + G  P  +  S+  T S +
Sbjct: 245  VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKI 290

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 61/276 (22%), Positives = 123/276 (44%), Gaps = 39/276 (14%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 36   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             Y +    ++   +Y  +E G++ +  S     + +   +R +  K + +A+  +H    
Sbjct: 93   LYDYEITDQY---IYMVMECGNIDLN-SWLKKKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYTMK 987
              IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    GT+ Y+ PE    M 
Sbjct: 147  -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 988  VTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILDPR 1035
             + ++           DV+S G +      GK P +  I+ I          L  I+DP 
Sbjct: 205  SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIIDPN 256
Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                  +I +K   + +V   CL  +P  R ++ ++
Sbjct: 257  HEIEFPDIPEK--DLQDVLKCCLKRDPKQRISIPEL 290

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQDKRFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKVVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L+ ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 63/278 (22%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 20   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 76
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAM--ILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             Y +    ++   +Y  +E G++ +   L    S +   W +R +  K + +A+  +H  
Sbjct: 77   LYDYEITDQY---IYMVMECGNIDLNSWLKKKKSIDP--W-ERKSYWKNMLEAVHTIHQH 130
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYT 985
                IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    GT+ Y+ PE    
Sbjct: 131  ---GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 986  MKVTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD 1033
            M  + ++           DV+S G +      GK P +  I+ I          L  I+D
Sbjct: 187  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIID 238
Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P       +I +K   + +V   CL  +P  R ++ ++
Sbjct: 239  PNHEIEFPDIPEK--DLQDVLKCCLKRDPKQRISIPEL 274

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 103/235 (43%), Gaps = 33/235 (14%)
Query: 787  LSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEM 846
            + VL  D K   +  +  TN       IG G  G V++A+L   + VA+KK        +
Sbjct: 25   IKVLASDGKTGEQREIAYTNC----KVIGNGSFGVVFQAKLVESDEVAIKK--------V 72
Query: 847  TCQQEFLN-EVKSLTEIRHRNIVK----FYGFCSHARHSF--IVYEYLEMGSLAMILSNA 899
               + F N E++ +  ++H N+V     FY         F  +V EY+       +   +
Sbjct: 73   LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRAS 128
Query: 900  TSAEELGWTQRMNVIK----GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSD 954
                +L  T  M +IK     +  +L+Y+H+     I +RDI  +N+LLD       + D
Sbjct: 129  RHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLID 185
Query: 955  FGISKSLKPDSSNWTELAGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            FG +K L     N + +     Y APEL +     T   D++S G +  E ++G+
Sbjct: 186  FGSAKILIAGEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 16/227 (7%)
Query: 805  TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
              D++    IG G  G V      S   V   K  S           F  E + +    +
Sbjct: 68   AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 865  RNIVK--FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
               V   FY F    R+ ++V EY+  G L  ++SN    E+  W +       V  AL 
Sbjct: 128  SPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALD 182
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAPE 981
             +H+  F   ++RD+   N+LLD      ++DFG    +  +     + A GT  Y++PE
Sbjct: 183  AIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 239
Query: 982  LAYTM----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
            +  +         + D +S GV   E + G  P  +  S+  T S +
Sbjct: 240  VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKI 285

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 9/187 (4%)
Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPS----ELGKLRSLIKLT 569
            P+L TL++  N +T +         +L+ L L +N I   IPS     +  LR L    
Sbjct: 82  LPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLRRLDLGE 140
Query: 570 LNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPI 629
           L R ++  +   E   L+ L +L+L    L + IP +L  LV+L  L LS N+     P 
Sbjct: 141 LKRLEYISEAAFE--GLVNLRYLNLGMCNLKD-IP-NLTALVRLEELELSGNRLDLIRPG 196
Query: 630 KLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYID 689
             +    L  L L H  +     +    ++SLE+LNL+HNNL       F  +H L  + 
Sbjct: 197 SFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVH 256
Query: 690 ISYNKLH 696
           +++N  H
Sbjct: 257 LNHNPWH 263

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 41/90 (45%)
Query: 101 DFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKI 160
           D  F   PHL  L+L+ NQ+ GI P+     S ++ L L  N            L  LK 
Sbjct: 47  DGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKT 106
Query: 161 LYLSTNQFSGRIPPQIGHLSYLKALHLFEN 190
           L L  NQ S  +P    HL+ L +L+L  N
Sbjct: 107 LNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 43.5 bits (101), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 46/96 (47%), Gaps = 2/96 (2%)
Query: 552 VGEIPSE--LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGN 609
           +G I S+   G+L  L+KL L RNQ +G  P        ++ L L  N++          
Sbjct: 41  LGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLG 100
Query: 610 LVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
           L +L  LNL +NQ S  +P   E    L+ L+L+ N
Sbjct: 101 LHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL  +    + DFG+++ +   PD     +    + ++APE  +    T 
Sbjct: 213  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 272
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +SDV+SFGVL  E    G  P   +           R L E    R+ AP     +    
Sbjct: 273  QSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLKE--GTRMRAPDYTTPE---- 322
Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            + +  + C    P  RPT  ++ + L
Sbjct: 323  MYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTC 848
            +TFD    YE I            IG G  G V  A    +G+ VA+KK  +     +T 
Sbjct: 49   VTFDVGDEYEII----------ETIGNGAYGVVSSARRRLTGQQVAIKKIPN-AFDVVTN 97
Query: 849  QQEFLNEVKSLTEIRHRNIVKF---------YGFCSHARHSFIVYEYLEMGSLAMILSNA 899
             +  L E+K L   +H NI+           YG     +  ++V + +E   L  I+   
Sbjct: 98   AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFKSVYVVLDLME-SDLHQIIH-- 151
Query: 900  TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK 959
             S++ L        +  +   L Y+H+     +++RD+   N+L++   E  + DFG+++
Sbjct: 152  -SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 207
Query: 960  SL--KPDSSNW--TELAGTIGYVAPELAYTM-KVTEKSDVYSFGVL 1000
             L   P    +  TE   T  Y APEL  ++ + T+  D++S G +
Sbjct: 208  GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCI 253

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 33   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 89
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 90   LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 143
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 144  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 199
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 200  GMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL  +    + DFG+++ +   PD     +    + ++APE  +    T 
Sbjct: 222  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 281
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +SDV+SFGVL  E    G  P   +           R L E    R+ AP     +    
Sbjct: 282  QSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLKE--GTRMRAPDYTTPE---- 331
Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            + +  + C    P  RPT  ++ + L
Sbjct: 332  MYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 90/227 (39%), Gaps = 16/227 (7%)
Query: 805  TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
              D++    IG G  G V      S   V   K  S           F  E + +    +
Sbjct: 73   AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 132
Query: 865  RNIVK--FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
               V   FY F    R+ ++V EY+  G L  ++SN    E+  W +       V  AL 
Sbjct: 133  SPWVVQLFYAF-QDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTA--EVVLALD 187
Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA-GTIGYVAPE 981
             +H+  F   ++RD+   N+LLD      ++DFG    +  +     + A GT  Y++PE
Sbjct: 188  AIHSMGF---IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE 244
Query: 982  LAYTM----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
            +  +         + D +S GV   E + G  P  +  S+  T S +
Sbjct: 245  VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF-YADSLVGTYSKI 290

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 13/146 (8%)
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL  +    + DFG+++ +   PD     +    + ++APE  +    T 
Sbjct: 220  IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 279
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            +SDV+SFGVL  E    G  P   +           R L E    R+ AP     +    
Sbjct: 280  QSDVWSFGVLLWEIFSLGASPYPGV----KIDEEFCRRLKE--GTRMRAPDYTTPE---- 329
Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            + +  + C    P  RPT  ++ + L
Sbjct: 330  MYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISL 88
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 89   LNVFTPQK----TLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 145  ---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 201  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 231

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L+ ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 93/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L+ ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLSQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDATLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 92/203 (45%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPEVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 199  GMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISL 88
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 89   LNVFTPQK----TLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLHS 144
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 145  ---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 201  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 231

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 790  LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTC 848
            +TFD    YE I            IG G  G V  A    +G+ VA+KK  +     +T 
Sbjct: 48   VTFDVGDEYEII----------ETIGNGAYGVVSSARRRLTGQQVAIKKIPN-AFDVVTN 96
Query: 849  QQEFLNEVKSLTEIRHRNIVKF---------YGFCSHARHSFIVYEYLEMGSLAMILSNA 899
             +  L E+K L   +H NI+           YG     +  ++V + +E   L  I+   
Sbjct: 97   AKRTLRELKILKHFKHDNIIAIKDILRPTVPYG---EFKSVYVVLDLME-SDLHQIIH-- 150
Query: 900  TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK 959
             S++ L        +  +   L Y+H+     +++RD+   N+L++   E  + DFG+++
Sbjct: 151  -SSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR 206
Query: 960  SL--KPDSSNW--TELAGTIGYVAPELAYTM-KVTEKSDVYSFGVL 1000
             L   P    +  TE   T  Y APEL  ++ + T+  D++S G +
Sbjct: 207  GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCI 252

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 14/154 (9%)
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADA 920
            +H NI+         +H ++V E +  G L   ++     S  E  +     V+  +   
Sbjct: 79   QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASF-----VLHTIGKT 133
Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYE----AHVSDFGISKSLKPDSSNWTELAGTIG 976
            + YLH+     +V+RD+   N+L   E        + DFG +K L+ ++        T  
Sbjct: 134  VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTAN 190
Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +VAPE+       E  D++S G+L    + G  P
Sbjct: 191  FVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKXVNHKNIISL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHERMSY-----LLYQMLXGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 199  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 86/187 (45%), Gaps = 9/187 (4%)
Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPS----ELGKLRSLIKLT 569
            P+L TL++  N +T +         +L+ L L +N I   IPS     +  LR L    
Sbjct: 82  LPSLNTLELFDNRLTTVPTQAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSLRRLDLGE 140
Query: 570 LNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPI 629
           L R ++  +   E   L+ L +L+L    L + IP +L  LV+L  L LS N+     P 
Sbjct: 141 LKRLEYISEAAFE--GLVNLRYLNLGMCNLKD-IP-NLTALVRLEELELSGNRLDLIRPG 196
Query: 630 KLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYID 689
             +    L  L L H  +     +    ++SLE+LNL+HNNL       F  +H L  + 
Sbjct: 197 SFQGLTSLRKLWLMHAQVATIERNAFDDLKSLEELNLSHNNLMSLPHDLFTPLHRLERVH 256
Query: 690 ISYNKLH 696
           +++N  H
Sbjct: 257 LNHNPWH 263

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 39/162 (24%), Positives = 74/162 (45%), Gaps = 11/162 (6%)
Query: 855  EVKSLTEIRHRNIVKFYG--FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            E++ L  +RH+N+++     +    +  ++V EY   G   M+  ++   +     Q   
Sbjct: 56   EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEML--DSVPEKRFPVCQAHG 113
Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT--E 970
                + D L YLH+     IV++DI   N+LL       +S  G++++L P +++ T   
Sbjct: 114  YFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170
Query: 971  LAGTIGYVAPELAYTMKVTE--KSDVYSFGVLALEAIKGKHP 1010
              G+  +  PE+A  +      K D++S GV       G +P
Sbjct: 171  SQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G QG V  A +   G  VAVKK   P  ++   ++ +  E+  L  + H+NI+    
Sbjct: 30   IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAY-RELVLLKCVNHKNIISLLN 88
Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHNDC 928
              +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+  
Sbjct: 89   VFTPQK----TLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS-- 142
Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--TELAGTIGYVAPELAYTM 986
               I++RD+   N+++  +    + DFG++++    S+N+  T    T  Y APE+   M
Sbjct: 143  -AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVILGM 198
Query: 987  KVTEKSDVYSFGVLALEAIKG 1007
               E  D++S G +  E +KG
Sbjct: 199  GYKENVDIWSVGCIMGELVKG 219

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 47.8 bits (112), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 25   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 82   LNVFTPQK----TLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS 137
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 138  ---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 194  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQGKAFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Composition-based stats.
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHR 865
            + +   IG G  G VY+A+L  SGE+VA+KK        +   + F N E++ + ++ H 
Sbjct: 22   YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--------VLQGKAFKNRELQIMRKLDHC 73
Query: 866  NIVKF-YGFCSHARHSFIVY-----EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+  Y F S       VY     +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-HVSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +     Y 
Sbjct: 134  SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-YR 189
Query: 979  APELAY-TMKVTEKSDVYSFGVLALEAIKGK 1008
            APEL +     T   DV+S G +  E + G+
Sbjct: 190  APELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/153 (24%), Positives = 65/153 (42%), Gaps = 12/153 (7%)
Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADAL 921
            +H NI+         +H ++V E +  G L   IL     +E     +   V+  +   +
Sbjct: 79   QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSER----EASFVLHTIGKTV 134
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYE----AHVSDFGISKSLKPDSSNWTELAGTIGY 977
             YLH+     +V+RD+   N+L   E        + DFG +K L+ ++        T  +
Sbjct: 135  EYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANF 191
Query: 978  VAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            VAPE+       E  D++S G+L    + G  P
Sbjct: 192  VAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTP 224

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 120/272 (44%), Gaps = 43/272 (15%)
Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRN--IVK 869
            IG+GG   V++      +I A+K  +   L E   Q    + NE+  L +++  +  I++
Sbjct: 64   IGSGGSSKVFQVLNEKKQIYAIKYVN---LEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 870  FYGFCSHARHSFIVYEYLEMGSLAM--ILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
             Y +    ++ ++V   +E G++ +   L    S +   W +R +  K + +A+  +H  
Sbjct: 121  LYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDP--W-ERKSYWKNMLEAVHTIHQH 174
Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPELAYT 985
                IV+ D+   N L+ ++    + DFGI+  ++PD+++  +    G + Y+ PE    
Sbjct: 175  G---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 986  MKVTEKS-----------DVYSFGVLALEAIKGKHP-RDFISSICSTSSNLDRTLDEILD 1033
            M  + ++           DV+S G +      GK P +  I+ I          L  I+D
Sbjct: 231  MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK--------LHAIID 282
Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            P       +I +K   + +V   CL  +P  R
Sbjct: 283  PNHEIEFPDIPEK--DLQDVLKCCLKRDPKQR 312

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 65/263 (24%), Positives = 119/263 (45%), Gaps = 33/263 (12%)
Query: 814  IGTGGQGSVYRAELSS--GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G  G VY    ++  GE + V          +  +++F++E   +  + H +IVK  
Sbjct: 32   LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 872  GFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLHN-DCF 929
            G       ++I+ E    G L   L  N  S + L  T  +  ++ +  A++YL + +C 
Sbjct: 92   GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQ-ICKAMAYLESINC- 146
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD---SSNWTELAGTIGYVAPELAYTM 986
               V+RDI+ +N+L+       + DFG+S+ ++ +    ++ T L   I +++PE     
Sbjct: 147  ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 201
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPSCNI 1043
            + T  SDV+ F V   E +  GK P  ++          ++ +  +L+   RLP P    
Sbjct: 202  RFTTASDVWMFAVCMWEILSFGKQPFFWLE---------NKDVIGVLEKGDRLPKPDL-C 251
Query: 1044 RDKLISIMEVAISCLDENPDSRP 1066
               L ++M     C D +P  RP
Sbjct: 252  PPVLYTLM---TRCWDYDPSDRP 271

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 65/263 (24%), Positives = 119/263 (45%), Gaps = 33/263 (12%)
Query: 814  IGTGGQGSVYRAELSS--GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G  G VY    ++  GE + V          +  +++F++E   +  + H +IVK  
Sbjct: 16   LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 872  GFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLHN-DCF 929
            G       ++I+ E    G L   L  N  S + L  T  +  ++ +  A++YL + +C 
Sbjct: 76   GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQ-ICKAMAYLESINC- 130
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD---SSNWTELAGTIGYVAPELAYTM 986
               V+RDI+ +N+L+       + DFG+S+ ++ +    ++ T L   I +++PE     
Sbjct: 131  ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 185
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPSCNI 1043
            + T  SDV+ F V   E +  GK P  ++          ++ +  +L+   RLP P    
Sbjct: 186  RFTTASDVWMFAVCMWEILSFGKQPFFWLE---------NKDVIGVLEKGDRLPKPDL-C 235
Query: 1044 RDKLISIMEVAISCLDENPDSRP 1066
               L ++M     C D +P  RP
Sbjct: 236  PPVLYTLM---TRCWDYDPSDRP 255

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Composition-based stats.
 Identities = 65/263 (24%), Positives = 119/263 (45%), Gaps = 33/263 (12%)
Query: 814  IGTGGQGSVYRAELSS--GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G  G VY    ++  GE + V          +  +++F++E   +  + H +IVK  
Sbjct: 20   LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 872  GFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVADALSYLHN-DCF 929
            G       ++I+ E    G L   L  N  S + L  T  +  ++ +  A++YL + +C 
Sbjct: 80   GIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVL--TLVLYSLQ-ICKAMAYLESINC- 134
Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD---SSNWTELAGTIGYVAPELAYTM 986
               V+RDI+ +N+L+       + DFG+S+ ++ +    ++ T L   I +++PE     
Sbjct: 135  ---VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP--IKWMSPESINFR 189
Query: 987  KVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP--RLPAPSCNI 1043
            + T  SDV+ F V   E +  GK P  ++          ++ +  +L+   RLP P    
Sbjct: 190  RFTTASDVWMFAVCMWEILSFGKQPFFWLE---------NKDVIGVLEKGDRLPKPDL-C 239
Query: 1044 RDKLISIMEVAISCLDENPDSRP 1066
               L ++M     C D +P  RP
Sbjct: 240  PPVLYTLM---TRCWDYDPSDRP 259

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 67/146 (45%), Gaps = 13/146 (8%)
Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSL--KPDSSNWTELAGTIGYVAPELAYTMKVTE 990
            ++RD++++N+LL       + DFG+++ +   PD     +    + ++APE  +    + 
Sbjct: 221  IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYST 280
Query: 991  KSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
            KSDV+S+GVL  E    G  P   +       S L   +      R+ AP  +  +    
Sbjct: 281  KSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGM------RMRAPEYSTPE---- 330
Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLL 1075
            I ++ + C   +P  RP   ++ + L
Sbjct: 331  IYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2FT3|A Chain A, Crystal Structure Of The Biglycan Dimer Core Protein Length = 332

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 115/260 (44%), Gaps = 16/260 (6%)
Query: 108 PHLAYLDLRVNQI----FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYL 163
           P   +  LRV Q        +P +I+ ++ L  LDL +N  S         L  L  L L
Sbjct: 28  PFGCHCHLRVVQCSDLGLKAVPKEISPDTTL--LDLQNNDISELRKDDFKGLQHLYALVL 85
Query: 164 STNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
             N+ S         L  L+ L++ +N L   IPP+L   ++L  + +++N +       
Sbjct: 86  VNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGV 142
Query: 224 IGNLKSLSGLELGYNKL--SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
              L++++ +E+G N L  SG  P +   L  L  L + +  L+G IP        L+ L
Sbjct: 143 FSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLPE--TLNEL 198
Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
           +L HN +      ++     LY LGL  N++      SL  L  L  L+L +N L   +P
Sbjct: 199 HLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL-SRVP 257
Query: 342 CEIGNLRYLFYLELGDNKLS 361
             + +L+ L  + L  N ++
Sbjct: 258 AGLPDLKLLQVVYLHTNNIT 277

>pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 59/133 (44%), Gaps = 2/133 (1%)
Query: 557 SELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYL 616
           S L +L +L  L L  NQ           L  L+ L L  N+L +   G    L  L YL
Sbjct: 79  SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYL 138
Query: 617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGFI 675
           NL++NQ         +K  +L++LDLS+N L + +P  V   +  L+ L L  N L    
Sbjct: 139 NLAHNQLQSLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKSVP 197
Query: 676 PRCFKEMHGLVYI 688
              F  +  L YI
Sbjct: 198 DGVFDRLTSLQYI 210

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/203 (23%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 34   IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIIGL 90
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        +IV E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 91   LNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 144
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S        T  Y APE+  
Sbjct: 145  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMVPFVVTRYYRAPEVIL 200
Query: 985  TMKVTEKSDVYSFGVLALEAIKG 1007
             M   E  D++S G +  E IKG
Sbjct: 201  GMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHERMSY-----LLYQMLXGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 199  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 32/236 (13%)
Query: 782  NAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHS 840
              PG +SV       + +   R T        +G G  G VY+A +  + E VA+K+   
Sbjct: 17   QGPGSMSVSAAPSATSIDRYRRITK-------LGEGTYGEVYKAIDTVTNETVAIKRIRL 69
Query: 841  PLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT 900
                E       + EV  L E++HRNI++      H     +++EY E      +  N  
Sbjct: 70   EH-EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPD 128
Query: 901  SAEELGWTQRMNVIKG----VADALSYLH-NDCFPPIVYRDISSKNVLLDLEYEAH---- 951
             +        M VIK     + + +++ H   C    ++RD+  +N+LL +   +     
Sbjct: 129  VS--------MRVIKSFLYQLINGVNFCHSRRC----LHRDLKPQNLLLSVSDASETPVL 176
Query: 952  -VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKS-DVYSFGVLALEAI 1005
             + DFG++++       +T    T+ Y  PE+    +    S D++S   +  E +
Sbjct: 177  KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 26   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 82
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 83   LNVFTPQK----TLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 139  ---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 195  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 225

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 26   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 82
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 83   LNVFTPQK----TLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 138
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 139  ---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 195  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 225

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Composition-based stats.
 Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 21/211 (9%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 25   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 81
Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAE----ELGWTQRMNVIKGVADALSYLHN 926
                +  +      E  +   L M L +A   +    EL   +   ++  +   + +LH+
Sbjct: 82   LNVFTPQK----TLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS 137
Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 138  ---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 987  KVTEKSDVYSFGVLALEAIKGK--HP-RDFI 1014
               E  D++S G +  E ++ K   P RD+I
Sbjct: 194  GYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224

>pdb|3P72|A Chain A, Structure Of Platelet Glycoprotein 1b Alpha With A Bound Peptide Inhibitor Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 478 HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
           HL+ N+  +F + + + Y  L+     +    ++  D G  P LGTLD+S N +  +  P
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVD-GTLPVLGTLDLSHNQLQSL--P 93
Query: 534 EIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
            +G + P L VLD+S N +       L  L  L +L L  N+     P  L    +LE L
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
            L++N+L+    G L  L  L  L L  N
Sbjct: 154 SLANNQLTELPAGLLNGLENLDTLLLQEN 182

>pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 82/191 (42%), Gaps = 14/191 (7%)
Query: 516 NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
           N+    VS   +  +L P    SP L  LD S+N +   +    G L  L  L L  NQ 
Sbjct: 303 NIKNFTVSGTRMVHMLCPS-KISPFLH-LDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 576 S-----GQLPTELGSLIQLEHLDLSSNRLS-NSIPGSLGNLVKLYYLNLSNNQFSGEIPI 629
                  ++ T++ SL QL   D+S N +S +   G       L  LN+S+N  +  I  
Sbjct: 361 KELSKIAEMTTQMKSLQQL---DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
Query: 630 KLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYID 689
            L   I + DL   H+   + IP QV  +++L++LN+A N L       F  +  L  I 
Sbjct: 418 CLPPRIKVLDL---HSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIW 474
Query: 690 ISYNKLHGPIP 700
           +  N      P
Sbjct: 475 LHTNPWDCSCP 485

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 33   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 89
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 90   LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 143
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 144  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 199
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 200  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 40/181 (22%)
Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
           +++ LDL++ H+ G +PS +  + SL KL LN N F         S   L  L +     
Sbjct: 278 RVQELDLTAAHLNG-LPSGIEGMNSLKKLVLNANSFDQLCQINAASFPSLRDLYIK---- 332
Query: 600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-LEKFIHLSDLDLSHNFLGEEIPSQVCSM 658
                   GN+ KL            ++  + LEK  +L  LDLSH+ +     S  C++
Sbjct: 333 --------GNMRKL------------DLGTRCLEKLENLQKLDLSHSDIE---ASDCCNL 369
Query: 659 Q-----SLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEAL 713
           Q      L+ LNL++N   G   + FKE   L  +D+++  LH   P      H+P + L
Sbjct: 370 QLKNLRHLQYLNLSYNEPLGLEDQAFKECPQLELLDVAFTHLHVKAP------HSPFQNL 423
Query: 714 Q 714
Sbjct: 424 H 424

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 33   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 89
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 90   LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 143
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 144  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 199
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 200  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 234

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 29/190 (15%)
Query: 855  EVKSLTEIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNV 913
            EV+ L + + HRN+++   F       ++V+E +  GS   ILS+          +   V
Sbjct: 60   EVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS---ILSHIHKRRHFNELEASVV 116
Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS-----DFGISKSLKPDSS-- 966
            ++ VA AL +LHN     I +RD+  +N+L   E+   VS     DFG+   +K +    
Sbjct: 117  VQDVASALDFLHNK---GIAHRDLKPENIL--CEHPNQVSPVKICDFGLGSGIKLNGDCS 171
Query: 967  --NWTEL---AGTIGYVAPEL--AYTMKVT---EKSDVYSFGVLALEAIKGKHPRDFISS 1016
              +  EL    G+  Y+APE+  A++ + +   ++ D++S GV+    + G  P  F+  
Sbjct: 172  PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP--FVGR 229
Query: 1017 ICSTSSNLDR 1026
             C +    DR
Sbjct: 230  -CGSDCGWDR 238

>pdb|1U0N|D Chain D, The Ternary Von Willebrand Factor A1-Glycoprotein Ibalpha- Botrocetin Complex Length = 265

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 478 HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
           HL+ N+  +F + + + Y  L+     +    ++  D G  P LGTLD+S N +  +  P
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVD-GTLPVLGTLDLSHNQLQSL--P 93
Query: 534 EIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
            +G + P L VLD+S N +       L  L  L +L L  N+     P  L    +LE L
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
            L++N+L+    G L  L  L  L L  N
Sbjct: 154 SLANNQLTELPAGLLNGLENLDTLLLQEN 182

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/190 (24%), Positives = 89/190 (46%), Gaps = 12/190 (6%)
Query: 818  GQGSVYRAELS--SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNIVKFYGFC 874
            G+ +V R  +S  +G+  A K F         C+ E L+E+  L   +    ++  +   
Sbjct: 40   GKFAVVRQCISKSTGQEYAAK-FLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY 98
Query: 875  SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVY 934
             +     ++ EY   G +   L     AE +     + +IK + + + YLH +    IV+
Sbjct: 99   ENTSEIILILEYAAGGEI-FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVH 154
Query: 935  RDISSKNVLLDLEY---EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEK 991
             D+  +N+LL   Y   +  + DFG+S+ +   +    E+ GT  Y+APE+     +T  
Sbjct: 155  LDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILNYDPITTA 213
Query: 992  SDVYSFGVLA 1001
            +D+++ G++A
Sbjct: 214  TDMWNIGIIA 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 31   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 87
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 88   LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 141
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 142  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 197
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 198  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 232

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 199  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 32   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 88
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 89   LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 142
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 143  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 198
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 199  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 233

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 70   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 127  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 180
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 181  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 236
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 237  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|1GWB|B Chain B, Structure Of Glycoprotein 1b Length = 281

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 462 DLRNLTRLARVRLDRN----HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGK 513
           D RNLT L    L ++    HL+ N+  +F + + + Y  L+     +    ++  D G 
Sbjct: 19  DKRNLTALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVD-GT 76
Query: 514 FPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
            P LGTLD+S N +  +  P +G + P L VLD+S N +       L  L  L +L L  
Sbjct: 77  LPVLGTLDLSHNQLQSL--PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 134
Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           N+     P  L    +LE L L++N L+    G L  L  L  L L  N  
Sbjct: 135 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 185

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +  GG   VY A+ + SG   A+K+    L +E    +  + EV  + ++  H NIV+F 
Sbjct: 36   LAEGGFAFVYEAQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQF- 91
Query: 872  GFCSHA----------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
              CS A          +  F++   L  G L   L    S   L     + +      A+
Sbjct: 92   --CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK--PDSSNWTELA------- 972
             ++H    PPI++RD+  +N+LL  +    + DFG + ++   PD S W+          
Sbjct: 150  QHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS-WSAQRRALVEEE 207
Query: 973  ----GTIGYVAPE---LAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
                 T  Y  PE   L     + EK D+++ G +       +HP
Sbjct: 208  ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

>pdb|3PMH|G Chain G, Mechanism Of Sulfotyrosine-Mediated Glycoprotein Ib Interaction With Two Distinct Alpha-Thrombin Sites Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 462 DLRNLTRLARVRLDRN----HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGK 513
           D RNLT L    L ++    HL+ N+  +F + + + Y  L+     +    ++  D G 
Sbjct: 18  DKRNLTALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GT 75
Query: 514 FPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
            P LGTLD+S N +  +  P +G + P L VLD+S N +       L  L  L +L L  
Sbjct: 76  LPVLGTLDLSHNQLQSL--PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133
Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           N+     P  L    +LE L L++N L+    G L  L  L  L L  N  
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 814  IGTGGQGSV---YRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            IG+G QG V   Y A L     VA+KK   P  ++   ++ +  E+  +  + H+NI+  
Sbjct: 70   IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISL 126
Query: 871  YGFCSHAR------HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
                +  +        ++V E ++  +L  ++      E + +     ++  +   + +L
Sbjct: 127  LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQMELDHERMSY-----LLYQMLCGIKHL 180
Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+  
Sbjct: 181  HS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVIL 236
Query: 985  TMKVTEKSDVYSFGVLALEAIKGK--HP-RDFISS 1016
             M   E  D++S G +  E ++ K   P RD+I  
Sbjct: 237  GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 271

>pdb|1P9A|G Chain G, Crystal Structure Of N-terminal Domain Of Human Platelet Receptor Glycoprotein Ib-alpha At 1.7 Angstrom Resolution Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/169 (31%), Positives = 78/169 (46%), Gaps = 13/169 (7%)
Query: 462 DLRNLTRLARVRLDRN----HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGK 513
           D RNLT L    L ++    HL+ N+  +F + + + Y  L+     +    ++  D G 
Sbjct: 18  DKRNLTALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GT 75
Query: 514 FPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
            P LGTLD+S N +  +  P +G + P L VLD+S N +       L  L  L +L L  
Sbjct: 76  LPVLGTLDLSHNQLQSL--PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133
Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
           N+     P  L    +LE L L++N L+    G L  L  L  L L  N
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182

>pdb|1OOK|G Chain G, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Human Alpha-thrombin Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 462 DLRNLTRLARVRLDRN----HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGK 513
           D RNLT L    L ++    HL+ N+  +F + + + Y  L+     +    ++  D G 
Sbjct: 18  DKRNLTALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD-GT 75
Query: 514 FPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
            P LGTLD+S N +  +  P +G + P L VLD+S N +       L  L  L +L L  
Sbjct: 76  LPVLGTLDLSHNQLQSL--PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKG 133
Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           N+     P  L    +LE L L++N L+    G L  L  L  L L  N  
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184

>pdb|1M10|B Chain B, Crystal Structure Of The Complex Of Glycoprotein Ib Alpha And The Von Willebrand Factor A1 Domain Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 478 HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
           HL+ N+  +F + + + Y  L+     +    ++  D G  P LGTLD+S N +  +  P
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVD-GTLPVLGTLDLSHNQLQSL--P 93
Query: 534 EIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
            +G + P L VLD+S N +       L  L  L +L L  N+     P  L    +LE L
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
            L++N+L+    G L  L  L  L L  N
Sbjct: 154 SLANNQLTELPAGLLNGLENLDTLLLQEN 182

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 803 RATNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
           R T +F E   IG+G  GSV++  +   G I A+K+   PL   +  +Q  L EV +   
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 64
Query: 862 I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVAD 919
           + +H ++V+++   +   H  I  EY   GSLA  +S N          +  +++  V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLL 944
            L Y+H+     +V+ DI   N+ +
Sbjct: 125 GLRYIHS---MSLVHMDIKPSNIFI 146

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 803 RATNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
           R T +F E   IG+G  GSV++  +   G I A+K+   PL   +  +Q  L EV +   
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 66
Query: 862 I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVAD 919
           + +H ++V+++   +   H  I  EY   GSLA  +S N          +  +++  V  
Sbjct: 67  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLL 944
            L Y+H+     +V+ DI   N+ +
Sbjct: 127 GLRYIHS---MSLVHMDIKPSNIFI 148

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 803 RATNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
           R T +F E   IG+G  GSV++  +   G I A+K+   PL   +  +Q  L EV +   
Sbjct: 6   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 64
Query: 862 I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVAD 919
           + +H ++V+++   +   H  I  EY   GSLA  +S N          +  +++  V  
Sbjct: 65  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 124
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLL 944
            L Y+H+     +V+ DI   N+ +
Sbjct: 125 GLRYIHS---MSLVHMDIKPSNIFI 146

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Composition-based stats.
 Identities = 61/239 (25%), Positives = 102/239 (42%), Gaps = 32/239 (13%)
Query: 786  FLSVLTFDRKIAYEEIVRATNDFDEEHC-----IGTGGQGSVYRAELSSGEIVAVKKFHS 840
             LS  +F RK +   I     D   E       IG G  G VY      GE VA++    
Sbjct: 8    LLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDI 65
Query: 841  PLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT 900
               +E   +  F  EV +  + RH N+V F G C    H  I+    +  +L  ++ +A 
Sbjct: 66   ERDNEDQLKA-FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124
Query: 901  SAEELGWTQRM--NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG-- 956
               ++  T+++   ++KG    + YLH      I+++D+ SKNV  D   +  ++DFG  
Sbjct: 125  IVLDVNKTRQIAQEIVKG----MGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176
Query: 957  -ISKSLKPD--SSNWTELAGTIGYVAPELAYTMK---------VTEKSDVYSFGVLALE 1003
             IS  L+            G + ++APE+   +           ++ SDV++ G +  E
Sbjct: 177  SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235

>pdb|1M0Z|A Chain A, Crystal Structure Of The Von Willebrand Factor Binding Domain Of Glycoprotein Ib Alpha Length = 290

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 70/149 (46%), Gaps = 8/149 (5%)
Query: 478 HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
           HL+ N+  +F + + + Y  L+     +    ++  D G  P LGTLD+S N +  +  P
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVD-GTLPVLGTLDLSHNQLQSL--P 93
Query: 534 EIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
            +G + P L VLD+S N +       L  L  L +L L  N+     P  L    +LE L
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
            L++N+L+    G L  L  L  L L  N
Sbjct: 154 SLANNQLTELPAGLLNGLENLDTLLLQEN 182

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +  AL YL       +++RD+   N+LLD   +  + DFGIS  L  D +     AG  
Sbjct: 132  AIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCA 188
Query: 976  GYVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGKHP 1010
             Y+APE       T+     ++DV+S G+  +E   G+ P
Sbjct: 189  AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 7/145 (4%)
Query: 803 RATNDFDEEHCIGTGGQGSVYR-AELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
           R T +F E   IG+G  GSV++  +   G I A+K+   PL   +  +Q  L EV +   
Sbjct: 4   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD-EQNALREVYAHAV 62
Query: 862 I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILS-NATSAEELGWTQRMNVIKGVAD 919
           + +H ++V+++   +   H  I  EY   GSLA  +S N          +  +++  V  
Sbjct: 63  LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 122
Query: 920 ALSYLHNDCFPPIVYRDISSKNVLL 944
            L Y+H+     +V+ DI   N+ +
Sbjct: 123 GLRYIHS---MSLVHMDIKPSNIFI 144

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 57   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 117  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 168
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 169  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 57   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 116
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 117  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 168
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 169  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Composition-based stats.
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 13/167 (7%)
Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            +++   EV  L EI+H N++  +    +     ++ E +  G L   L+   S  E   T
Sbjct: 58   REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV-LLDLEY---EAHVSDFGISKSLKPD 964
            +    +K + + + YLH+     I + D+  +N+ LLD         + DFG++   K D
Sbjct: 118  E---FLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KID 169
Query: 965  SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
              N +  + GT  +VAPE+     +  ++D++S GV+    + G  P
Sbjct: 170  FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 87/206 (42%), Gaps = 7/206 (3%)
Query: 508 SFDWGKFPNLGTLDVSANNIT--GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
           +F     P+L  LD+S N ++  G        +  LK LDLS N ++    + LG L  L
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG-LEQL 398
Query: 566 IKLTLNRNQFSGQLPTELG-SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
             L    +         +  SL  L +LD+S      +  G    L  L  L ++ N F 
Sbjct: 399 EHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQ 458
Query: 625 GE-IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH 683
              +P    +  +L+ LDLS   L +  P+   S+ SL+ LN++HNN        +K ++
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 684 GLVYIDISYNKLHGPIPNSAAFKHAP 709
            L  +D S N  H         +H P
Sbjct: 519 SLQVLDYSLN--HIMTSKKQELQHFP 542

>pdb|1P8V|A Chain A, Crystal Structure Of The Complex Of Platelet Receptor Gpib-alpha And Alpha-thrombin At 2.6a Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 8/151 (5%)
Query: 478 HLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGKFPNLGTLDVSANNITGILPP 533
           HL+ N+  +F + + + Y  L+     +    ++  D G  P LGTLD+S N +  +  P
Sbjct: 37  HLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVD-GTLPVLGTLDLSHNQLQSL--P 93
Query: 534 EIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
            +G + P L VLD+S N +       L  L  L +L L  N+     P  L    +LE L
Sbjct: 94  LLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKL 153
Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
            L++N L+    G L  L  L  L L  N  
Sbjct: 154 SLANNNLTELPAGLLNGLENLDTLLLQENSL 184

>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 3/209 (1%)
Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
           GI +N   +NL   +        +    +L  L +S N+I  I          L  L+L 
Sbjct: 61  GISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120
Query: 548 SNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSS-NRLSNSIPGS 606
            N +          L  L +L L  N            +  L  LDL    RLS    G+
Sbjct: 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGA 180
Query: 607 LGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNL 666
              L  L YLNL+      EIP  L   I L +LDLS N L    P     +  L+KL +
Sbjct: 181 FEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWM 238
Query: 667 AHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
             + +       F  +  LV I++++N L
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNL 267

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	1077
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	0.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-131
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-93
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	5e-43
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-30
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-13
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-119
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-109
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-85
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-104
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-103
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-95
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-81
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-67
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-57
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-97
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-93
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	6e-81
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-63
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-29
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	1e-94
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	2e-77
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-73
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-94
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-94
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-93
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-85
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-54
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-90
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-87
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-84
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-65
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	5e-50
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-30
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-19
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-90
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-83
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-73
1o6v_A	466	Internalin A; bacterial infection, extracellular r	1e-69
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-69
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-61
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-69
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-67
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-65
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-66
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-64
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-52
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-43
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-26
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-25
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-11
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-65
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-65
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-52
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-35
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	5e-62
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-61
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-59
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-56
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-50
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-19
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-61
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-60
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-58
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-50
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-37
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-33
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-60
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-59
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-58
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-58
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-55
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-53
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	4e-51
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-50
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-50
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-44
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-41
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	9e-41
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-56
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-53
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-51
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-50
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-50
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-44
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	3e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	8e-30
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-53
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-51
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-51
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-47
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-39
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-37
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-26
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-24
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-50
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-50
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-50
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-46
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-45
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-42
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-39
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-37
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-49
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-48
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-47
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	9e-47
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-45
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-44
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-43
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-42
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-46
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-44
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-43
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-43
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-42
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-25
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-46
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	5e-46
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-45
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-44
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-43
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-43
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-41
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-34
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	8e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-46
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-43
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-42
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-38
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-25
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	9e-42
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-41
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-41
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-42
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-42
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-41
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-41
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-37
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-33
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-23
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-41
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-41
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-33
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-28
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-24
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-21
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	6e-40
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-07
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-38
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-37
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-37
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-37
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-30
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-29
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-25
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-23
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-17
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-36
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-36
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-36
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-36
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	7e-32
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-25
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-19
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-15
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-12
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-35
2a19_B	284	Interferon-induced, double-stranded RNA-activated	6e-35
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-34
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-34
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-34
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	4e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	9e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-24
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-23
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	1e-15
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	6e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-34
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-34
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	7e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-28
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-07
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	7e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-32
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-31
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	8e-25
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-20
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	9e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-32
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-32
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-32
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-32
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-31
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-25
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	5e-12
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	6e-32
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-32
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-31
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-30
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-28
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-27
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	6e-25
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-23
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	3e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-17
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-31
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-31
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-31
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-31
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-31
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-31
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-31
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-31
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-30
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-30
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-25
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-30
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-30
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	5e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	9e-24
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-22
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-04
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-30
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-30
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-30
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-30
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-29
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-28
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-26
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	9e-23
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-29
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-29
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	8e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-28
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-28
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-28
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-28
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	9e-28
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-27
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-27
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-27
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-27
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-27
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-26
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-25
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	7e-23
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-20
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	4e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-16
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-26
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	3e-26
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-22
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-20
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-18
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-17
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	7e-15
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-26
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	6e-26
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-23
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	4e-21
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-20
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-17
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-26
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-25
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-25
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-25
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-25
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-25
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-22
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-19
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-17
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-25
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-24
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-24
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	5e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	7e-24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-22
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-20
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-18
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-18
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-23
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-23
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	1e-21
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	4e-17
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	5e-15
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-23
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	3e-22
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	5e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-22
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-22
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-22
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-21
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-21
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-21
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-21
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-19
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	7e-15
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	4e-14
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-12
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-06
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-21
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-21
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-21
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	4e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-21
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-21
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-21
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	8e-21
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	9e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-20
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-20
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-20
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-20
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-20
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-20
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-20
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-20
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	1e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-18
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	3e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	4e-13
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	7e-12
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-19
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	3e-15
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-14
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	2e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-19
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-19
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-19
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-18
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-15
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	7e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-08
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-18
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-18
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-18
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-17
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	5e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	6e-17
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-16
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-10
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	4e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	8e-17
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-17
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-16
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	3e-15
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	4e-12
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-11
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-16
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-16
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-16
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-16
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-15
3m19_A	251	Variable lymphocyte receptor A diversity region; a	3e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	7e-14
3m19_A	251	Variable lymphocyte receptor A diversity region; a	4e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-10
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-09
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-07
3m19_A	251	Variable lymphocyte receptor A diversity region; a	8e-04
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-16
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-12
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	8e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-09
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	5e-07
3e6j_A	229	Variable lymphocyte receptor diversity region; var	2e-06
3e6j_A	229	Variable lymphocyte receptor diversity region; var	9e-05
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-16
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-14
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	9e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-08
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-07
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	6e-16
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-15
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	7e-11
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-10
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	2e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-14
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-14
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-13
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-13
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-13
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-11
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	9e-10
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-08
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-13
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-13
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	7e-13
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	9e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	9e-13
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-12
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	2e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	5e-08
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-12
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-12
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-12
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-12
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	6e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	6e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	7e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	7e-11
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	6e-09
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-06
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-11
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-11
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-11
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-11
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-11
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	5e-11
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-09
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-08
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	5e-11
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-11
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-11
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	5e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	9e-09
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	2e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-10
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	4e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	7e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	6e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-10
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-09
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	5e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	8e-06
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-10
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	7e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	9e-10
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-08
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	5e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	7e-05
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	8e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	4e-06
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	1e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	6e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-06
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-04
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	9e-04
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	8e-08
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	1e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-05
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-05
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-08
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-07
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	2e-06
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	8e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	9e-07
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	8e-06
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	2e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	3e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-06
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	1e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	2e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	6e-04
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	3e-06
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	9e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	7e-06
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	4e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	9e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	2e-04
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	7e-06
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-05
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	3e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-04
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  620 bits (1600), Expect = 0.0
 Identities = 221/774 (28%), Positives = 326/774 (42%), Gaps = 83/774 (10%)

Query: 31  SSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSI-- 88
           S +   E H L+ +K  L + N     LP W+ N     +PC + G+ C    KV SI  
Sbjct: 7   SQSLYREIHQLISFKDVLPDKN----LLPDWSSNK----NPCTFDGVTCRD-DKVTSIDL 57

Query: 89  -------------------------NLTSAGLIGTLHDF--------------------- 102
                                     L+++ + G++  F                     
Sbjct: 58  SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVT 117

Query: 103 ---SFSSFPHLAYLDLRVNQIFGIIPSQIANN-SKLKYLDLSSNSFSGTIPPQI---GNL 155
              S  S   L +L++  N +            + L+ LDLS+NS SG            
Sbjct: 118 TLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGC 177

Query: 156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS 215
             LK L +S N+ SG +   +     L+ L +  N  S  IP  LG+ + L  + +  N 
Sbjct: 178 GELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNK 234

Query: 216 LSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLS-FGN 274
           LSG     I     L  L +  N+  G +P     L +L  L L +N  +G IP    G 
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGA 292

Query: 275 LTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIP-SSLGNLTKLTILYLSD 333
              L  L+L  N   G++P   G+   L  L LS N  SG +P  +L  +  L +L LS 
Sbjct: 293 CDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF 352

Query: 334 NLLFGSIPCEIGNLRY-LFYLELGDNKLSGSIPHSLGN--LTNLATLYLFTNLLSGSIPS 390
           N   G +P  + NL   L  L+L  N  SG I  +L       L  LYL  N  +G IP 
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412

Query: 391 EIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLV 450
            + N + L  L LS N LSG+IP S G+L+ +  L ++ N L G IP+E   +  L  L+
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472

Query: 451 LSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISF 509
           L +N L G IP  L N T L  + L  N LTG I +  G   NL+ + LS+  F G I  
Sbjct: 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPA 532

Query: 510 DWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLT 569
           + G   +L  LD++ N   G +P  +          +++N I G+    +       +  
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECH 588

Query: 570 L--NRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEI 627
              N  +F G    +L  L      +++S         +  N   + +L++S N  SG I
Sbjct: 589 GAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYI 648

Query: 628 PIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVY 687
           P ++    +L  L+L HN +   IP +V  ++ L  L+L+ N L G IP+    +  L  
Sbjct: 649 PKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTE 708

Query: 688 IDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSCKASKSDKQASRK 741
           ID+S N L GPIP    F+  P      N GLCG     P C  S +D  A  +
Sbjct: 709 IDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG--YPLPRCDPSNADGYAHHQ 760

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  412 bits (1061), Expect = e-131
 Identities = 152/649 (23%), Positives = 237/649 (36%), Gaps = 39/649 (6%)

Query: 99  LHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSML 158
           L         ++  L+L  NQ+  +  +     S+L  LD+  N+ S   P     L ML
Sbjct: 16  LTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
           K+L L  N+ S          + L  LHL  N +            NL  + L +N LS 
Sbjct: 76  KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135

Query: 219 SIPSEIGNLKSLSGLELGYNKLSG--SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLT 276
           +       L++L  L L  NK+    S  L +    +L  L+L  N +    P  F  + 
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIG 195

Query: 277 NLDILNLPHNSLSGSIPSEMG---NLKSLYGLGLSFNKLSGSIPSSLGNL--TKLTILYL 331
            L  L L +  L  S+  ++       S+  L LS ++LS +  ++   L  T LT+L L
Sbjct: 196 RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDL 255

Query: 332 SDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE 391
           S N L          L  L Y  L  N +     HSL  L N+  L L  +         
Sbjct: 256 SYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK------ 309

Query: 392 IGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVL 451
                      +S   L     +SF  L  +  L++  N + G     +  L+ L  L L
Sbjct: 310 ---------QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360

Query: 452 SYNQLQGPIPDLRNL-----TRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGE 506
           S +                 + L  + L +N ++   S++F    +L  ++L   +   E
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420

Query: 507 ISFD-WGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIPSELGKLR 563
           ++   W    N+  + +S N    +        P L+ L L    +  V   PS    LR
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480

Query: 564 SLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS--------NSIPGSLGNLVKLYY 615
           +L  L L+ N  +      L  L +LE LDL  N L+              L  L  L+ 
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540

Query: 616 LNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFI 675
           LNL +N F        +    L  +DL  N L     S   +  SL+ LNL  N ++   
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600

Query: 676 PRCFKE-MHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDI 723
            + F      L  +D+ +N       + A F +   E       L    
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  310 bits (796), Expect = 8e-93
 Identities = 108/497 (21%), Positives = 187/497 (37%), Gaps = 27/497 (5%)

Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL 288
           S    +  + KL+  +P  L    N+  L+L  N L      +F   + L  L++  N++
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 289 SGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLR 348
           S   P     L  L  L L  N+LS     +    T LT L+L  N +           +
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 349 YLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLN--SLSDLGLSEN 406
            L  L+L  N LS +   +   L NL  L L  N +      E+      SL  L LS N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181

Query: 407 ELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYG---NLVKLTLLVLSYNQLQGPIPDL 463
           ++    P  F  +  +  L + +  L  ++ ++         +  L LS +QL       
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241

Query: 464 ---RNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTL 520
                 T L  + L  N+L    ++SF     L Y  L +       S       N+  L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301

Query: 521 D---------VSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLN 571
           +         +S  ++  I          L+ L++  N I G   +    L +L  L+L+
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361

Query: 572 RNQFSGQLPTELG----SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEI 627
            +  S +  T       +   L  L+L+ N++S     +   L  L  L+L  N+   E+
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421

Query: 628 PIK-LEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF--IPRCFKEMHG 684
             +      ++ ++ LS+N   +   +    + SL++L L    L      P  F+ +  
Sbjct: 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481

Query: 685 LVYIDISYNKLHGPIPN 701
           L  +D+S N +     +
Sbjct: 482 LTILDLSNNNIANINDD 498

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  167 bits (424), Expect = 5e-43
 Identities = 61/258 (23%), Positives = 90/258 (34%), Gaps = 17/258 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQ-IANNSKLKYLDLSSNSFSGTIPPQIGN 154
           I  +   +FS   HL  LDL +N+I   +  Q       +  + LS N +          
Sbjct: 393 ISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFAL 452

Query: 155 LSMLKILYLSTNQFSG--RIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLY 212
           +  L+ L L           P     L  L  L L  N ++      L  L  L I+ L 
Sbjct: 453 VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQ 512

Query: 213 NNSLS--------GSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL 264
           +N+L+        G     +  L  L  L L  N           +L  L  +DL  N+L
Sbjct: 513 HNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNL 572

Query: 265 SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG-NLKSLYGLGLSFNKLSGSIPSSLG-- 321
           +      F N  +L  LNL  N ++       G   ++L  L + FN    +  S     
Sbjct: 573 NTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFV 632

Query: 322 ---NLTKLTILYLSDNLL 336
              N T   I  LS + L
Sbjct: 633 NWINETHTNIPELSSHYL 650

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  126 bits (319), Expect = 4e-30
 Identities = 56/218 (25%), Positives = 83/218 (38%), Gaps = 16/218 (7%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGI--IPSQIANNSKLKYLDLSSNSFSGTIPPQIG 153
              L   SF+  P L  L LR   +  +   PS       L  LDLS+N+ +      + 
Sbjct: 442 YLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501

Query: 154 NLSMLKILYLSTNQFS--------GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTN 205
            L  L+IL L  N  +        G     +  LS+L  L+L  NG          +L  
Sbjct: 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFE 561

Query: 206 LAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG-NLPNLATLDLHDNSL 264
           L I+ L  N+L+    S   N  SL  L L  N ++       G    NL  LD+  N  
Sbjct: 562 LKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621

Query: 265 SGSIP-----LSFGNLTNLDILNLPHNSLSGSIPSEMG 297
             +       +++ N T+ +I  L  + L  + P   G
Sbjct: 622 DCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHG 659

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 73.5 bits (181), Expect = 2e-13
 Identities = 28/143 (19%), Positives = 44/143 (30%), Gaps = 6/143 (4%)

Query: 86  NSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFS 145
           N++             +      HL  L+L  N    I      +  +LK +DL  N+ +
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573

Query: 146 GTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGH-LSYLKALHLFENGLSGSIPPSLG--- 201
                   N   LK L L  N  +       G     L  L +  N    +         
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633

Query: 202 --NLTNLAIMYLYNNSLSGSIPS 222
             N T+  I  L ++ L  + P 
Sbjct: 634 WINETHTNIPELSSHYLCNTPPH 656

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  380 bits (979), Expect = e-119
 Identities = 104/673 (15%), Positives = 216/673 (32%), Gaps = 90/673 (13%)

Query: 24  LDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNN-ATKISPCAW---FGIHC 79
           +   L  ++   ++  AL +   +L   N       +    N         W    G+  
Sbjct: 18  VPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSL 77

Query: 80  NHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFG----IIPSQIANNSKLK 135
           N  G+V  ++L   G  G + D +      L  L L  +          P  I+ N   +
Sbjct: 78  NSNGRVTGLSLEGFGASGRVPD-AIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136

Query: 136 YLDLSSNSFSGTIPPQIGNLSMLKI--LYLSTNQFSGRIPPQIGHLSYLKALHLFENGLS 193
                   +  T            +    ++++     I            +    N ++
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT 196

Query: 194 GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPN 253
             +  ++  LT L   Y+ N+        E    ++       Y +   +  L   NL +
Sbjct: 197 -FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKD 250

Query: 254 LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL--------SGSIPSEMGNLKSLYGL 305
           L  +++++      +P     L  + ++N+  N               ++    + +  +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 306 GLSFNKL-SGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI 364
            + +N L +  + +SL  + KL +L    N L G +P   G+   L  L L  N+++   
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369

Query: 365 PHSLGNLTNLATLYLFTNLLSGSIPS--EIGNLNSLSDLGLSENELSGSIPYSFGNLTNM 422
            +  G    +  L    N L   IP+  +  +++ +S +  S NE+      +F      
Sbjct: 370 ANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP---- 424

Query: 423 IVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTG 481
                        +       + ++ + LS NQ+     +     + L+ + L  N LT 
Sbjct: 425 -------------LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE 471

Query: 482 NISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS--P 539
               S                   + + ++     L ++D+  N +T +   +   +  P
Sbjct: 472 IPKNSL-----------------KDENENFKNTYLLTSIDLRFNKLTKL-SDDFRATTLP 513

Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
            L  +DLS N    + P++     +L    +                      D   NR 
Sbjct: 514 YLVGIDLSYNSF-SKFPTQPLNSSTLKGFGIRNQ------------------RDAQGNRT 554

Query: 600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQ 659
               P  +     L  L + +N    ++  K+    ++S LD+  N       S VC   
Sbjct: 555 LREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYI 611

Query: 660 SLEKLNLAHNNLS 672
                 L ++   
Sbjct: 612 EAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  352 bits (906), Expect = e-109
 Identities = 82/592 (13%), Positives = 181/592 (30%), Gaps = 89/592 (15%)

Query: 122 GIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSG----RIPPQIG 177
                 + +N ++  L L     SG +P  IG L+ L++L L ++          P  I 
Sbjct: 71  AQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGIS 130

Query: 178 HLSYLKALHLFENGLSGSIPPSLG--NLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLEL 235
                +           +        + ++L    + ++    SI          + +  
Sbjct: 131 ANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQ 190

Query: 236 GYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSE 295
             N ++  +  ++  L  L    + ++              N +           +   +
Sbjct: 191 LSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ-----YKTEDLK 244

Query: 296 MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLEL 355
             NLK L  + +        +P+ L  L ++ ++ ++ N                  +  
Sbjct: 245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG----------------ISG 288

Query: 356 GDNKLSGSIPHSLGNLTNLATLYLFTN-LLSGSIPSEIGNLNSLSDLGLSENELSGSIPY 414
              K              +  +Y+  N L +  + + +  +  L  L    N+L G +P 
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP- 347

Query: 415 SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG--PIPDLRNLTRLARV 472
           +FG+   +  L++  N ++       G   ++  L  ++N+L+    I D ++++ ++ +
Sbjct: 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAI 407

Query: 473 RLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILP 532
               N +     ++F                   +     K  N+ ++++S N I+    
Sbjct: 408 DFSYNEIGSVDGKNFD-----------------PLDPTPFKGINVSSINLSNNQISKFPK 450

Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
                   L  ++L  N +  EIP    K                       +   L  +
Sbjct: 451 ELFSTGSPLSSINLMGNML-TEIPKNSLKD----------------ENENFKNTYLLTSI 493

Query: 593 DLSSNRLSNSIPGSL--GNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEE 650
           DL  N+L+  +        L  L  ++LS N FS   P +      L    + +      
Sbjct: 494 DLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ----- 546

Query: 651 IPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNS 702
                         +   N      P        L  + I  N +   +   
Sbjct: 547 -------------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEK 584

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  289 bits (742), Expect = 1e-85
 Identities = 74/481 (15%), Positives = 153/481 (31%), Gaps = 69/481 (14%)

Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSG----SIPSEMGNLKSL 302
           SL +   +  L L     SG +P + G LT L++L L  +          P  +    S 
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 303 YGLGLSFNKLSGSIPSSLG--NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKL 360
                       +        + + L    ++ +    SI            +    N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 361 SGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLT 420
           +  +  ++  LT L   Y+  +        E     +         +   +    + NL 
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLK 249

Query: 421 NMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLT 480
           ++  + +Y+      +P     L ++ L+ ++ N+         +   LA          
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALA---------- 299

Query: 481 GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGI-LPPEIGDSP 539
                   +   +  I + +                        NN+    +   +    
Sbjct: 300 -----DAPVGEKIQIIYIGY------------------------NNLKTFPVETSLQKMK 330

Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
           +L +L+   N + G++P   G    L  L L  NQ +       G   Q+E+L  + N+L
Sbjct: 331 KLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKL 389

Query: 600 SN-SIPGSLGNLVKLYYLNLSNNQFSG-------EIPIKLEKFIHLSDLDLSHNFLGEEI 651
                     ++  +  ++ S N+           +     K I++S ++LS+N + +  
Sbjct: 390 KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP 449

Query: 652 PSQVCSMQSLEKLNLAHNNLSGF-------IPRCFKEMHGLVYIDISYNKLHGPIPNSAA 704
                +   L  +NL  N L+             FK  + L  ID+ +NKL   + +   
Sbjct: 450 KELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFR 508

Query: 705 F 705
            
Sbjct: 509 A 509

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  338 bits (870), Expect = e-104
 Identities = 120/544 (22%), Positives = 192/544 (35%), Gaps = 28/544 (5%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
                 LDL  N +  +      +  +L+ LDLS             +LS L  L L+ N
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSL-SGSIPSEIG 225
                       LS L+ L   E  L+      +G+L  L  + + +N + S  +P    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 226 NLKSLSGLELGYNKLSGSMPLSLGNLPNL----ATLDLHDNSLSGSIPLSFGNLTNLDIL 281
           NL +L  L+L  NK+       L  L  +     +LDL  N ++   P +F  +  L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKL 205

Query: 282 NLPHNSLSGSIPSE-MGNLKSL------YGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
            L +N  S ++    +  L  L       G   +   L     S+L  L  LTI      
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 335 LL---FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE 391
            L      I      L  +    L    +      S         L L           +
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLK 323

Query: 392 IGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS--GAIPKEYGNLVKLTLL 449
           + +L  L+          G   +S  +L ++  L +  N LS  G   +       L  L
Sbjct: 324 LKSLKRLTF-----TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378

Query: 450 VLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISES-FGIHSNLSYINLSHKKFYGEIS 508
            LS+N +     +   L +L  +    ++L      S F    NL Y+++SH       +
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 509 FDWGKFPNLGTLDVSANNITGILPPEI-GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIK 567
             +    +L  L ++ N+      P+I  +   L  LDLS   +    P+    L SL  
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 568 LTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK-LYYLNLSNNQFSGE 626
           L ++ N F          L  L+ LD S N +  S    L +    L +LNL+ N F+  
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558

Query: 627 IPIK 630
              +
Sbjct: 559 CEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  335 bits (861), Expect = e-103
 Identities = 119/552 (21%), Positives = 195/552 (35%), Gaps = 32/552 (5%)

Query: 172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLS 231
           IP  +      K L L  N L      S  +   L ++ L    +         +L  LS
Sbjct: 22  IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 232 GLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL-SG 290
            L L  N +      +   L +L  L   + +L+       G+L  L  LN+ HN + S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 291 SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTI----LYLSDNLLFGSIPCEIGN 346
            +P    NL +L  L LS NK+     + L  L ++ +    L LS N +    P     
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE 199

Query: 347 LRYLFYLELGDNKLSGSIP-HSLGNLTNLATLYLFTNLLSGSI---PSEIGNLNSLSDLG 402
           +R L  L L +N  S ++    +  L  L    L              +   L  L +L 
Sbjct: 200 IR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT 258

Query: 403 LSENELS------GSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           + E  L+        I   F  LTN+   S+ S  +       +        L L   + 
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKF 316

Query: 457 QG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKK--FYGEISFDWGK 513
              P   L++L      RL      G  + S     +L +++LS     F G  S     
Sbjct: 317 GQFPTLKLKSLK-----RLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFG 371

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIP-SELGKLRSLIKLTLNR 572
             +L  LD+S N +  +         QL+ LD   +++      S    LR+LI L ++ 
Sbjct: 372 TTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSI-PGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
                        L  LE L ++ N    +  P     L  L +L+LS  Q     P   
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490

Query: 632 EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHG-LVYIDI 690
                L  L++SHN            + SL+ L+ + N++     +  +     L ++++
Sbjct: 491 NSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550

Query: 691 SYNKLHGPIPNS 702
           + N       + 
Sbjct: 551 TQNDFACTCEHQ 562

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  315 bits (808), Expect = 2e-95
 Identities = 113/548 (20%), Positives = 188/548 (34%), Gaps = 55/548 (10%)

Query: 198 PSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATL 257
           P +  + N+        +    IP  +    S   L+L +N L      S  + P L  L
Sbjct: 2   PCVEVVPNI-TYQCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVL 57

Query: 258 DLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIP 317
           DL    +      ++ +L++L  L L  N +          L SL  L      L+    
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 318 SSLGNLTKLTILYLSDNLL-FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNL-- 374
             +G+L  L  L ++ NL+    +P    NL  L +L+L  NK+       L  L  +  
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 375 --ATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIP------------------- 413
              +L L  N ++   P     +  L  L L  N  S ++                    
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 414 ---------YSFGNLTNMIVLSIYSNALS------GAIPKEYGNLVKLTLLVLSYNQLQG 458
                    +    L  +  L+I    L+        I   +  L  ++   L    ++ 
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

Query: 459 PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLG 518
            + D         + L         +       +L  +  +  K     S      P+L 
Sbjct: 297 -VKDFSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAFSE--VDLPSLE 350

Query: 519 TLDVSANNIT--GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFS 576
            LD+S N ++  G        +  LK LDLS N ++  + S    L  L  L    +   
Sbjct: 351 FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK 409

Query: 577 GQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEI-PIKLEKF 634
                    SL  L +LD+S      +  G    L  L  L ++ N F     P    + 
Sbjct: 410 QMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL 469

Query: 635 IHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
            +L+ LDLS   L +  P+   S+ SL+ LN++HNN        +K ++ L  +D S N 
Sbjct: 470 RNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNH 529

Query: 695 LHGPIPNS 702
           +       
Sbjct: 530 IMTSKKQE 537

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  276 bits (708), Expect = 2e-81
 Identities = 114/523 (21%), Positives = 186/523 (35%), Gaps = 33/523 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSF-SGTIPPQIGN 154
           I +L   +FS    L  L      +  +    I +   LK L+++ N   S  +P    N
Sbjct: 88  IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147

Query: 155 LSMLKILYLSTNQFSGRIPPQIGHLSYLKA----LHLFENGLSGSIPPSLGNLTNLAIMY 210
           L+ L+ L LS+N+        +  L  +      L L  N ++  I P       L  + 
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206

Query: 211 LYNNSLSGSIPSE-IGNLKSLSGLELGYNKLSGSMPL---SLGNLPNLATLDLHDNSLS- 265
           L NN  S ++    I  L  L    L   +      L       L  L  L + +  L+ 
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266

Query: 266 -----GSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSL 320
                  I   F  LTN+   +L   ++                L L   K        L
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGWQHLELVNCKFGQFPTLKL 324

Query: 321 GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLS--GSIPHSLGNLTNLATLY 378
            +L +LT         F  +     +L  L +L+L  N LS  G    S    T+L  L 
Sbjct: 325 KSLKRLTFTSNKGGNAFSEV-----DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379

Query: 379 LFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSIYSNALSGAIP 437
           L  N +   + S    L  L  L    + L     +S F +L N+I L I       A  
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438

Query: 438 KEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSY 495
             +  L  L +L ++ N  Q          L  L  + L +  L      +F   S+L  
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498

Query: 496 INLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSP-QLKVLDLSSNHIVGE 554
           +N+SH  F+   +F +    +L  LD S N+I      E+   P  L  L+L+ N     
Sbjct: 499 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558

Query: 555 IPSE--LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLS 595
              +  L  ++   +L +   +     P++   +  +  L+++
Sbjct: 559 CEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  238 bits (608), Expect = 1e-67
 Identities = 93/471 (19%), Positives = 151/471 (32%), Gaps = 44/471 (9%)

Query: 96  IGTLHDFSFSSFPHLAY----LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQ 151
           I +++         +      LDL +N +  I P       +L  L L +N  S  +   
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKT 219

Query: 152 -IGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMY 210
            I  L+ L++  L   +F                    E  L      +L  L NL I  
Sbjct: 220 CIQGLAGLEVHRLVLGEFRN------------------EGNLEKFDKSALEGLCNLTIEE 261

Query: 211 LYNNSLSGS---IPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGS 267
                L      I      L ++S   L    +      S         L+L +      
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQF 319

Query: 268 IPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS--GSIPSSLGNLTK 325
             L   +L  L   +       G       +L SL  L LS N LS  G    S    T 
Sbjct: 320 PTLKLKSLKRLTFTS-----NKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374

Query: 326 LTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS-LGNLTNLATLYLFTNLL 384
           L  L LS N +   +      L  L +L+   + L      S   +L NL  L +     
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433

Query: 385 SGSIPSEIGNLNSLSDLGLSENELSGSI-PYSFGNLTNMIVLSIYSNALSGAIPKEYGNL 443
             +       L+SL  L ++ N    +  P  F  L N+  L +    L    P  + +L
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 493

Query: 444 VKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFG-IHSNLSYINLSHK 501
             L +L +S+N          + L  L  +    NH+  +  +      S+L+++NL+  
Sbjct: 494 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553

Query: 502 KFYGEISFDW--GKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
            F              +   L V    +    P +    P +  L+++   
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNITCQM 603

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  208 bits (532), Expect = 2e-57
 Identities = 69/400 (17%), Positives = 133/400 (33%), Gaps = 25/400 (6%)

Query: 84  KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFG---IIPSQIANNSKLKYLDLS 140
           +++ + L +      +          L    L + +      +     +    L  L + 
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260

Query: 141 SNSFS------GTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSG 194
               +        I      L+ +    L +            +    + L L       
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQ 318

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS--GSMPLSLGNLP 252
                L +L       L   S  G       +L SL  L+L  N LS  G    S     
Sbjct: 319 FPTLKLKSLKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNK 311
           +L  LDL  N +   +  +F  L  L+ L+  H++L       +  +L++L  L +S   
Sbjct: 374 SLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 312 LSGSIPSSLGNLTKLTILYLSDNLLFGSI-PCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
              +       L+ L +L ++ N    +  P     LR L +L+L   +L    P +  +
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 371 LTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNL-TNMIVLSIYS 429
           L++L  L +  N            LNSL  L  S N +  S      +  +++  L++  
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 552

Query: 430 NALSGAIPKEY--GNLVKLTLLVLSYNQLQGPIP-DLRNL 466
           N  +     +     +     L++   +++   P D + +
Sbjct: 553 NDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM 592

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  187 bits (477), Expect = 2e-50
 Identities = 72/400 (18%), Positives = 133/400 (33%), Gaps = 44/400 (11%)

Query: 322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
            +  +T   +  N     IP  +        L+L  N L     +S  +   L  L L  
Sbjct: 6   VVPNITYQCMELNFY--KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSR 61

Query: 382 NLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYG 441
             +         +L+ LS L L+ N +      +F  L+++  L      L+       G
Sbjct: 62  CEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIG 121

Query: 442 NLVKLTLLVLSYNQLQG-PIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLS 499
           +L  L  L +++N +Q   +P+   NLT L  + L  N +         +   +  +NLS
Sbjct: 122 HLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS 181

Query: 500 HKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE- 558
                               LD+S N +  I  P      +L  L L +N     +    
Sbjct: 182 --------------------LDLSLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKTC 220

Query: 559 LGKLRSLIKLTLNRNQFSGQ---LPTELGSLIQLEHLDLSSNRLS------NSIPGSLGN 609
           +  L  L    L   +F  +      +  +L  L +L +   RL+      + I      
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280

Query: 610 LVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHN 669
           L  +   +L +                   L+L +   G+    ++ S++ L   +    
Sbjct: 281 LTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338

Query: 670 NLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAP 709
           N    +     ++  L ++D+S N L      S +     
Sbjct: 339 NAFSEV-----DLPSLEFLDLSRNGLSFKGCCSQSDFGTT 373

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 86.6 bits (215), Expect = 2e-17
 Identities = 28/174 (16%), Positives = 63/174 (36%), Gaps = 26/174 (14%)

Query: 88  INLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGT 147
           + +             F+   +L +LDL   Q+  + P+   + S L+ L++S N+F   
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL 509

Query: 148 IPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLA 207
                  L+ L++L  S N        ++ H                         ++LA
Sbjct: 510 DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF-----------------------PSSLA 546

Query: 208 IMYLYNNSLSGSIPSE--IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDL 259
            + L  N  + +   +  +  +K    L +   ++  + P     +P + +L++
Sbjct: 547 FLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMP-VLSLNI 599

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  328 bits (843), Expect = 1e-97
 Identities = 97/630 (15%), Positives = 202/630 (32%), Gaps = 96/630 (15%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRI 172
            +  ++         + NN ++  L L+     G +P  IG L+ LK+L   T+  +   
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363

Query: 173 PPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLS 231
                           ++ +        L     L +  L  ++++ +   E+  +K  S
Sbjct: 364 RLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDS 421

Query: 232 GLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGS 291
            + L   ++                     N ++  I  +   LT L I+   ++  +  
Sbjct: 422 RISLKDTQIGNL-----------------TNRIT-FISKAIQRLTKLQIIYFANSPFTYD 463

Query: 292 IPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLF 351
             +      +       + K   +   S  NL  LT + L +      +P  + +L  L 
Sbjct: 464 NIAVDWEDAN-----SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQ 518

Query: 352 YLELGDNKLSG---------SIPHSLGNLTNLATLYLFTNLLSGSIPS-EIGNLNSLSDL 401
            L +  N+             +         +   Y+  N L     S  +  +  L  L
Sbjct: 519 SLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL 578

Query: 402 GLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYG-NLVKLTLLVLSYNQLQGPI 460
               N++   +  +FG    +  L +  N +   IP+++     ++  L  S+N+L+  I
Sbjct: 579 DCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-I 634

Query: 461 PD---LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNL 517
           P+    +++  +  V    N +            +   IN S                  
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST----------------- 677

Query: 518 GTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI-------VGEIPSELGKLRSLIKLTL 570
             + +S N I             +  + LS+N +       +            L  + L
Sbjct: 678 --VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDL 735

Query: 571 NRNQFSGQLPTEL--GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIP 628
             N+ +  L  +    +L  L ++D+S N  S S P    N  +L    + +        
Sbjct: 736 RFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQ------- 786

Query: 629 IKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYI 688
                       D   N +  + P+ + +  SL +L +  N++   +         L  +
Sbjct: 787 -----------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKL--TPQLYIL 832

Query: 689 DISYNKL-HGPIPNSAAFKHAPMEALQGNK 717
           DI+ N      + +   +  A M  L  +K
Sbjct: 833 DIADNPNISIDVTSVCPYIEAGMYVLLYDK 862

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  317 bits (813), Expect = 2e-93
 Identities = 94/637 (14%), Positives = 195/637 (30%), Gaps = 80/637 (12%)

Query: 65  NATKISPCAWFGIHCNHAGKVNSINL-TSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGI 123
            A       ++    N+     + N      + G        +   +  L L      G 
Sbjct: 279 EALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGR 338

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPP-QIGHLSYL 182
           +P  I   ++LK L   ++S + +            +     ++         + +   L
Sbjct: 339 VPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398

Query: 183 KALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG------SIPSEIGNLKSLSGLELG 236
               L ++ ++ +  P +  +   + + L +  +         I   I  L  L  +   
Sbjct: 399 NLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFA 456

Query: 237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM 296
            +  +           +    +        +  LS+ NL +L  + L +      +P  +
Sbjct: 457 NSPFTY-----DNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFL 511

Query: 297 GNLKSLYGLGLSFNKLSG---------SIPSSLGNLTKLTILYLSDNLLFG-SIPCEIGN 346
            +L  L  L ++ N+             +        K+ I Y+  N L        +  
Sbjct: 512 YDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQK 571

Query: 347 LRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIG-NLNSLSDLGLSE 405
           +  L  L+   NK+      + G    L  L L  N +   IP +     + +  LG S 
Sbjct: 572 MVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSH 628

Query: 406 NELSGSIP--YSFGNLTNMIVLSIYSNALSGAIPK-----EYGNLVKLTLLVLSYNQLQG 458
           N+L   IP  ++  ++  M  +    N +           +    +  + + LSYN++Q 
Sbjct: 629 NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQK 687

Query: 459 PIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNL 517
              +     + ++ + L  N +T     S                       ++     L
Sbjct: 688 FPTELFATGSPISTIILSNNLMTSIPENSL-----------------KPKDGNYKNTYLL 730

Query: 518 GTLDVSANNITGILPPEIGDS--PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
            T+D+  N +T +   +   +  P L  +D+S N      P++      L    +     
Sbjct: 731 TTIDLRFNKLTSL-SDDFRATTLPYLSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQ-- 786

Query: 576 SGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI 635
                            D   NR+    P  +     L  L + +N    ++  KL    
Sbjct: 787 ----------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TP 827

Query: 636 HLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
            L  LD++ N       + VC         L ++   
Sbjct: 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  282 bits (722), Expect = 6e-81
 Identities = 106/646 (16%), Positives = 196/646 (30%), Gaps = 101/646 (15%)

Query: 31  SSNSTEEAHALLKWKTSLQNHNNK---GSFLPSWTLNN-ATKISPCAWF---GIHCNHAG 83
           ++   ++  AL     +L   N +   G+   +    N         W    G+  ++ G
Sbjct: 264 TAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNG 323

Query: 84  KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPS----------------- 126
           +V  ++L   G  G + D +      L  L    +                         
Sbjct: 324 RVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHR 382

Query: 127 --------QIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSG------RI 172
                    +  + +L   DL  ++ +    P++  +     + L   Q          I
Sbjct: 383 IRMHYKKMFLDYDQRLNLSDLLQDAINRN--PEMKPIKKDSRISLKDTQIGNLTNRITFI 440

Query: 173 PPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSG 232
              I  L+ L+ ++   +  +           N             +      NLK L+ 
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWSNLKDLTD 495

Query: 233 LELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG---------SIPLSFGNLTNLDILNL 283
           +EL        +P  L +LP L +L++  N              +         + I  +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555

Query: 284 PHNSLSGSIPS-EMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
            +N+L     S  +  +  L  L    NK+      + G   KLT L L  N +   IP 
Sbjct: 556 GYNNLEEFPASASLQKMVKLGLLDCVHNKVR--HLEAFGTNVKLTDLKLDYNQI-EEIPE 612

Query: 343 EIG-NLRYLFYLELGDNKLSGSIPH--SLGNLTNLATLYLFTNLLSGSIPSEIG------ 393
           +       +  L    NKL   IP+  +  ++  + ++    N +  S    I       
Sbjct: 613 DFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG-SEGRNISCSMDDY 670

Query: 394 NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS-------GAIPKEYGNLVKL 446
              + S + LS NE+       F   + +  + + +N ++             Y N   L
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730

Query: 447 TLLVLSYNQLQGPIPDLR--NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
           T + L +N+L     D R   L  L+ + +  N  +          S L    + H    
Sbjct: 731 TTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRH---- 785

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRS 564
                           D   N I    P  I   P L  L + SN I  ++  +L     
Sbjct: 786 --------------QRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKL--TPQ 828

Query: 565 LIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNL 610
           L  L +  N       T +   I+     L  ++  +        +
Sbjct: 829 LYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGI 874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  231 bits (591), Expect = 1e-63
 Identities = 84/567 (14%), Positives = 175/567 (30%), Gaps = 49/567 (8%)

Query: 153 GNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLY 212
              + LK + ++  + S               + +     +  +P     +        Y
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAY---TTY 224

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
           + S       E  +++  S   +  NKL+             A + +     +  I    
Sbjct: 225 SQSGIKRSELETQSVRGES-FTVIDNKLTKD-----------ANVPIQLKETAEYIKDYK 272

Query: 273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
                 + L+  +        +   +  +        +         L N  ++T L L+
Sbjct: 273 ALKAIWEALDGKNWRYYSGTINNTIHSLNW-NFNKELDMWGDQPGVDLDNNGRVTGLSLA 331

Query: 333 DNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
                G +P  IG L  L  L  G +  + S                  + +        
Sbjct: 332 GFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMF 391

Query: 393 G----NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI--YSNALSGAIPKEYGNLVKL 446
                 LN    L  + N      P    +  ++    I   +N ++  I K    L KL
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKL 450

Query: 447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGE 506
            ++  + +        +           D      N   S+    +L+ + L +     +
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDAN----SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQ 506

Query: 507 ISFDWGKFPNLGTLDVSANNITGI---------LPPEIGDSPQLKVLDLSSNHIVGEIPS 557
           +       P L +L+++ N              L  +    P++++  +  N++  E P+
Sbjct: 507 LPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA 565

Query: 558 E--LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYY 615
              L K+  L  L    N+         G+ ++L  L L  N++            ++  
Sbjct: 566 SASLQKMVKLGLLDCVHNKVRH--LEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEG 623

Query: 616 LNLSNNQFSGEIP--IKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQ-----SLEKLNLAH 668
           L  S+N+    IP     +    +  +D S+N +G E  +  CSM      +   + L++
Sbjct: 624 LGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSY 682

Query: 669 NNLSGFIPRCFKEMHGLVYIDISYNKL 695
           N +  F    F     +  I +S N +
Sbjct: 683 NEIQKFPTELFATGSPISTIILSNNLM 709

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  124 bits (314), Expect = 3e-29
 Identities = 37/219 (16%), Positives = 67/219 (30%), Gaps = 20/219 (9%)

Query: 97  GTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFS-------GTIP 149
                       + + + L  N+I        A  S +  + LS+N  +           
Sbjct: 662 NISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKD 721

Query: 150 PQIGNLSMLKILYLSTNQFSGRIPPQI--GHLSYLKALHLFENGLSGSIPPSLGNLTNLA 207
               N  +L  + L  N+ +  +        L YL  + +  N  S S P    N + L 
Sbjct: 722 GNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLK 779

Query: 208 IMYL------YNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
              +        N +    P+ I    SL  L++G N +     +     P L  LD+ D
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK---VDEKLTPQLYILDIAD 836

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLK 300
           N        S        +  L ++        +   ++
Sbjct: 837 NPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDALGIE 875

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  304 bits (782), Expect = 2e-95
 Identities = 88/298 (29%), Positives = 144/298 (48%), Gaps = 11/298 (3%)

Query: 124 IPSQIANNSKL----KYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGR--IPPQIG 177
           I   + N + L       D  + ++ G +         +  L LS         IP  + 
Sbjct: 14  IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73

Query: 178 HLSYLKALHLF-ENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELG 236
           +L YL  L++   N L G IPP++  LT L  +Y+ + ++SG+IP  +  +K+L  L+  
Sbjct: 74  NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133

Query: 237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLD-ILNLPHNSLSGSIPSE 295
           YN LSG++P S+ +LPNL  +    N +SG+IP S+G+ + L   + +  N L+G IP  
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT 193

Query: 296 MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLEL 355
             NL +L  + LS N L G      G+      ++L+ N L   +  ++G  + L  L+L
Sbjct: 194 FANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDL 251

Query: 356 GDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIP 413
            +N++ G++P  L  L  L +L +  N L G IP   GNL        + N+     P
Sbjct: 252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  302 bits (776), Expect = 1e-94
 Identities = 97/315 (30%), Positives = 151/315 (47%), Gaps = 16/315 (5%)

Query: 33  NSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCN---HAGKVNSIN 89
           N  ++  ALL+ K  L N       L SW     T      W G+ C+      +VN+++
Sbjct: 4   NPQDKQ-ALLQIKKDLGNPTT----LSSW--LPTTDCCNRTWLGVLCDTDTQTYRVNNLD 56

Query: 90  LTSAGLIGTLH-DFSFSSFPHLAYLDLR-VNQIFGIIPSQIANNSKLKYLDLSSNSFSGT 147
           L+   L        S ++ P+L +L +  +N + G IP  IA  ++L YL ++  + SG 
Sbjct: 57  LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116

Query: 148 IPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLA 207
           IP  +  +  L  L  S N  SG +PP I  L  L  +    N +SG+IP S G+ + L 
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176

Query: 208 -IMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG 266
             M +  N L+G IP    NL +L+ ++L  N L G   +  G+  N   + L  NSL+ 
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235

Query: 267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
            +    G   NL+ L+L +N + G++P  +  LK L+ L +SFN L G IP   GNL + 
Sbjct: 236 DLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRF 293

Query: 327 TILYLSDNLLFGSIP 341
            +   ++N      P
Sbjct: 294 DVSAYANNKCLCGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  255 bits (655), Expect = 2e-77
 Identities = 91/316 (28%), Positives = 132/316 (41%), Gaps = 36/316 (11%)

Query: 267 SIPLSFGNLTNL----DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS--IPSSL 320
            I    GN T L       +  + +  G +         +  L LS   L     IPSSL
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 321 GNLTKLTILYLSD-NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYL 379
            NL  L  LY+   N L G IP  I  L  L YL +    +SG+IP  L  +  L TL  
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDF 132

Query: 380 FTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMI-VLSIYSNALSGAIPK 438
             N LSG++P  I +L +L  +    N +SG+IP S+G+ + +   ++I  N L+G IP 
Sbjct: 133 SYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPP 192

Query: 439 EYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
            + NL  L  + LS N L+G       +     ++ L +N L  ++ +            
Sbjct: 193 TFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK------------ 239

Query: 498 LSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPS 557
                         G   NL  LD+  N I G LP  +     L  L++S N++ GEIP 
Sbjct: 240 -------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286

Query: 558 ELGKLRSLIKLTLNRN 573
             G L+         N
Sbjct: 287 G-GNLQRFDVSAYANN 301

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  244 bits (625), Expect = 3e-73
 Identities = 82/352 (23%), Positives = 135/352 (38%), Gaps = 61/352 (17%)

Query: 387 SIPSEIGNLNSLSD----LGLSENELSGSIPYSFGNLTNMIVLSIYSNALSG--AIPKEY 440
            I  ++GN  +LS              G +  +      +  L +    L     IP   
Sbjct: 13  QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72

Query: 441 GNLVKLTLLVLS-YNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINL 498
            NL  L  L +   N L GPIP  +  LT+L  + +   +++G I +            +
Sbjct: 73  ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS--------QI 124

Query: 499 SHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE 558
                             L TLD S N ++G LPP I   P L  +    N I G IP  
Sbjct: 125 K----------------TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168

Query: 559 LGKLRSLIK-LTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLN 617
            G    L   +T++RN+ +G++P    +L  L  +DLS N L        G+      ++
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIH 227

Query: 618 LSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPR 677
           L+ N  + ++                          +V   ++L  L+L +N + G +P+
Sbjct: 228 LAKNSLAFDLG-------------------------KVGLSKNLNGLDLRNNRIYGTLPQ 262

Query: 678 CFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSC 729
              ++  L  +++S+N L G IP     +   + A   NK LCG     P+C
Sbjct: 263 GLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  313 bits (804), Expect = 1e-94
 Identities = 119/536 (22%), Positives = 190/536 (35%), Gaps = 19/536 (3%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK 183
           IP  + N+   + L+ S N            L  L  L L+  Q              L 
Sbjct: 27  IPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84

Query: 184 ALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGS 243
            L L  N L      +L     L  ++     +S      + N K+L  L LG N +S  
Sbjct: 85  TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144

Query: 244 MPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDI--LNLPHNSLSGSIPSEMGNLKS 301
                     L  LD  +N++         +L       LNL  N ++  I     +   
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGAFDSAV 203

Query: 302 LYGLGLSFNKLSGSIPSSLGN--LTKLTILYLSDNLLFGSIPCEIGNLR--YLFYLELGD 357
              L     +    I   L N  +  L +    D       P     L    +  + L  
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK 263

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFG 417
           +       ++    + L  L L    LS  +PS +  L++L  L LS N+       S  
Sbjct: 264 HYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISAS 322

Query: 418 NLTNMIVLSIYSNALSGAIPKEY-GNLVKLTLLVLSYNQLQGPIPD---LRNLTRLARVR 473
           N  ++  LSI  N     +      NL  L  L LS++ ++        LRNL+ L  + 
Sbjct: 323 NFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLN 382

Query: 474 LDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFD-WGKFPNLGTLDVSANNITGILP 532
           L  N      +E+F     L  ++L+  +   + +   +     L  L++S + +     
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442

Query: 533 PEIGDSPQLKVLDLSSNHIVGEI---PSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQL 589
                 P L+ L+L  NH         + L  L  L  L L+    S        SL  +
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMM 502

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            H+DLS NRL++S   +L +L  + YLNL++N  S  +P  L        ++L  N
Sbjct: 503 NHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQN 557

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  312 bits (802), Expect = 2e-94
 Identities = 109/552 (19%), Positives = 182/552 (32%), Gaps = 18/552 (3%)

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
           K         +  IP  +   +  + L    N L      +   L NL  + L    +  
Sbjct: 15  KTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNL 278
                  +   L  L L  N L      +L     L  L      +S    +   N   L
Sbjct: 72  IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131

Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF- 337
           + L L  N +S     +    + L  L    N +       + +L + T L L+ N    
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191

Query: 338 GSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN--LTNLATLYLFTNLLSGSIPSEIGNL 395
             I     +      L  G  +    I   L N  + +L              P+    L
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251

Query: 396 --NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
              S+  + L ++        +F   + +  L + +  LS  +P     L  L  LVLS 
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSA 310

Query: 454 NQLQGPIPD-LRNLTRLARVRLDRNHLTGNI-SESFGIHSNLSYINLSHKKFY--GEISF 509
           N+ +        N   L  + +  N     + +       NL  ++LSH         + 
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 510 DWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG-EIPSELGKLRSLIKL 568
                 +L +L++S N    +      + PQL++LDL+   +   +  S    L  L  L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 569 TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI---PGSLGNLVKLYYLNLSNNQFSG 625
            L+ +            L  L+HL+L  N           SL  L +L  L LS    S 
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
                      ++ +DLSHN L       +  ++ +  LNLA N++S  +P     +   
Sbjct: 491 IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549

Query: 686 VYIDISYNKLHG 697
             I++  N L  
Sbjct: 550 RTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  309 bits (793), Expect = 3e-93
 Identities = 116/610 (19%), Positives = 206/610 (33%), Gaps = 27/610 (4%)

Query: 78  HCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYL 137
            C       + N  + GL    ++   +       L+   N +  I  +  +    L +L
Sbjct: 7   KCIEKEVNKTYNCENLGL----NEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62

Query: 138 DLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIP 197
           DL+             +   L  L L+ N         +     LK L   + G+S    
Sbjct: 63  DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122

Query: 198 PSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLA-- 255
             L N   L  +YL +N +S     +    + L  L+   N +       + +L      
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGN--LKSLYGLGLSFNKLS 313
           +L+L+ N ++  I     +      LN         I   + N  ++SL+          
Sbjct: 183 SLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDE 241

Query: 314 GSIPSSLGNLTKLTI--LYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNL 371
              P+    L ++++  + L  +  F            L  L+L    LS  +P  L  L
Sbjct: 242 DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGL 300

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI-PYSFGNLTNMIVLSIYSN 430
           + L  L L  N           N  SL+ L +  N     +      NL N+  L +  +
Sbjct: 301 STLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHD 360

Query: 431 AL--SGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISES- 486
            +  S     +  NL  L  L LSYN+      +  +   +L  + L    L    ++S 
Sbjct: 361 DIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420

Query: 487 FGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGI---LPPEIGDSPQLKV 543
           F     L  +NLSH          +   P L  L++  N+           +    +L++
Sbjct: 421 FQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI 480

Query: 544 LDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI 603
           L LS   +          L+ +  + L+ N+ +      L  L  + +L+L+SN +S  +
Sbjct: 481 LVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIIL 539

Query: 604 PGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSM-QSLE 662
           P  L  L +   +NL  N            F+       +   L  +    +C     L 
Sbjct: 540 PSLLPILSQQRTINLRQNPLDCT--CSNIYFLEW--YKENMQKLE-DTEDTLCENPPLLR 594

Query: 663 KLNLAHNNLS 672
            + L+   LS
Sbjct: 595 GVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  286 bits (733), Expect = 8e-85
 Identities = 104/506 (20%), Positives = 170/506 (33%), Gaps = 17/506 (3%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
              N  L+  IP  +    S   LE  +N L      +   L NL  LDL    +     
Sbjct: 18  NCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHE 74

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTIL 329
            +F +   LD L L  N L     + +   K+L  L      +S      L N   L  L
Sbjct: 75  DTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESL 134

Query: 330 YLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYL-FTNLLSGSI 388
           YL  N +      +      L  L+  +N +       + +L     L L         I
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGI 194

Query: 389 PSEIGNLNSLSDLGLSENELSGSIP--YSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
                +      L     +    I        + ++ + +          P  +  L ++
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254

Query: 447 TL--LVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
           ++  + L  +       +     + L  + L   HL+  +       S L  + LS  KF
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKF 313

Query: 504 YGEISFDWGKFPNLGTLDVSANNITGILPPE-IGDSPQLKVLDLSSNHI--VGEIPSELG 560
                     FP+L  L +  N     L    + +   L+ LDLS + I        +L 
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLR 373

Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS-LGNLVKLYYLNLS 619
            L  L  L L+ N+             QLE LDL+  RL      S   NL  L  LNLS
Sbjct: 374 NLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLS 433

Query: 620 NNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV---CSMQSLEKLNLAHNNLSGFIP 676
           ++          +    L  L+L  N   +    +     ++  LE L L+  +LS    
Sbjct: 434 HSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQ 493

Query: 677 RCFKEMHGLVYIDISYNKLHGPIPNS 702
             F  +  + ++D+S+N+L      +
Sbjct: 494 HAFTSLKMMNHVDLSHNRLTSSSIEA 519

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  198 bits (506), Expect = 4e-54
 Identities = 64/366 (17%), Positives = 121/366 (33%), Gaps = 13/366 (3%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI 412
               +  L+  IP +L    +   L    N+L     +    L +L+ L L+  ++    
Sbjct: 17  YNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLAR 471
             +F +   +  L + +N L             L  L      +       L N   L  
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 472 VRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLG--TLDVSANNITG 529
           + L  NH++            L  ++  +   +     D          +L+++ N+I G
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193

Query: 530 ILPPEIGDSPQLKVLDLSSNHIVGEIPSELG--KLRSLIKLTLNRNQFSGQLPTELGSL- 586
           I  P   DS   + L+      +  I   L    ++SL   T          P     L 
Sbjct: 194 I-EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252

Query: 587 -IQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            + +E ++L  +   N    +      L  L+L+    S E+P  L     L  L LS N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSAN 311

Query: 646 FLGEEIPSQVCSMQSLEKLNLAHNNLSGFI-PRCFKEMHGLVYIDISYNKLHGPIPNSAA 704
                      +  SL  L++  N     +   C + +  L  +D+S++ +      +  
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371

Query: 705 FKHAPM 710
            ++   
Sbjct: 372 LRNLSH 377

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  301 bits (774), Expect = 2e-90
 Identities = 121/570 (21%), Positives = 196/570 (34%), Gaps = 32/570 (5%)

Query: 146 GTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTN 205
           G++ P I  +  +        + S ++P  I   S  K + L  N L      S  N + 
Sbjct: 2   GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 206 LAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLS 265
           L  + L    +          L  LS L L  N +    P S   L +L  L   +  L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 266 GSIPLSFGNLTNLDILNLPHNSLSG-SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLT 324
                  G L  L  LN+ HN +    +P+   NL +L  + LS+N +     + L  L 
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 325 KLTI----LYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIP-HSLGNLTNLATLYL 379
           +       L +S N +   I  +      L  L L  N  S +I    L NL  L    L
Sbjct: 178 ENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 380 FTNLLSGSIPSEIGNLNSLS--------DLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
                      EI   + +         +  L+           F  L N+  +S+   +
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296

Query: 432 LSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIH 490
           +     ++     K   L +   QL+  P  DL  L  L    L  N  +  IS      
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGS--ISFKKVAL 349

Query: 491 SNLSYINLSHKKFY--GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSS 548
            +LSY++LS       G  S+      +L  LD+S N    I+        +L+ LD   
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQH 408

Query: 549 NHIVGEIP-SELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIP-GS 606
           + +      S    L  L+ L ++              L  L  L ++ N   ++     
Sbjct: 409 STLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468

Query: 607 LGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNL 666
             N   L +L+LS  Q         +    L  L++SHN L     S    + SL  L+ 
Sbjct: 469 FANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528

Query: 667 AHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
           + N +             L + +++ N + 
Sbjct: 529 SFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  291 bits (747), Expect = 9e-87
 Identities = 113/551 (20%), Positives = 198/551 (35%), Gaps = 30/551 (5%)

Query: 170 GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS 229
           G + P I  +  +      +  LS  +P  +   ++   + L  N L         N   
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57

Query: 230 LSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS 289
           L  L+L   ++      +   L +L+ L L  N +    P SF  LT+L+ L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 290 GSIPSEMGNLKSLYGLGLSFNKLSG-SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLR 348
                 +G L +L  L ++ N +    +P+   NLT L  + LS N +      ++  LR
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177

Query: 349 YL----FYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE-IGNLNSLSDLGL 403
                   L++  N +   I         L  L L  N  S +I    + NL  L    L
Sbjct: 178 ENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236

Query: 404 SENELSGSI------PYSFGNLTN--MIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
              E           P     L +  +    +           ++  L  ++ + L+   
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296

Query: 456 LQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFP 515
           ++  + D+    +   + + R  L    +        L  + L+  K  G ISF     P
Sbjct: 297 IKY-LEDVPKHFKWQSLSIIRCQLKQFPTLDL---PFLKSLTLTMNK--GSISFKKVALP 350

Query: 516 NLGTLDVSANNITGI--LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
           +L  LD+S N ++           +  L+ LDLS N  +  + +    L  L  L    +
Sbjct: 351 SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHS 409

Query: 574 QFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-L 631
                       SL +L +LD+S         G    L  L  L ++ N F         
Sbjct: 410 TLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVF 469

Query: 632 EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
               +L+ LDLS   L +       ++  L+ LN++HNNL       + +++ L  +D S
Sbjct: 470 ANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCS 529

Query: 692 YNKLHGPIPNS 702
           +N++       
Sbjct: 530 FNRIETSKGIL 540

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  285 bits (732), Expect = 1e-84
 Identities = 113/536 (21%), Positives = 185/536 (34%), Gaps = 26/536 (4%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
                 +DL  N +  +     +N S+L++LDLS              L  L  L L+ N
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG-SIPSEIG 225
                 P     L+ L+ L   E  L+      +G L  L  + + +N +    +P+   
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 226 NLKSLSGLELGYNKLSGSMPLSLGNLPNLA----TLDLHDNSLSGSIPLSFGNLTNLDIL 281
           NL +L  ++L YN +       L  L        +LD+  N +   I         L  L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209

Query: 282 NLPHNSLSGSIPSE-MGNLKSLYGLGLSFNKLSGSI------PSSLGNLTKLTI--LYLS 332
            L  N  S +I    + NL  L+   L   +           PS +  L  +TI    L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269

Query: 333 DNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
               F     +   L  +  + L    +       +       +L +    L    P+  
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPT-- 324

Query: 393 GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS--GAIPKEYGNLVKLTLLV 450
            +L  L  L L+ N+   SI +    L ++  L +  NALS  G           L  L 
Sbjct: 325 LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382

Query: 451 LSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISES-FGIHSNLSYINLSHKKFYGEISF 509
           LS+N       +   L  L  +    + L      S F     L Y+++S+     +   
Sbjct: 383 LSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442

Query: 510 DWGKFPNLGTLDVSANNITGILPPEI-GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL 568
            +    +L TL ++ N+        +  ++  L  LDLS   +          L  L  L
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502

Query: 569 TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
            ++ N       +    L  L  LD S NR+  S          L + NL+NN  +
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  232 bits (593), Expect = 1e-65
 Identities = 99/475 (20%), Positives = 157/475 (33%), Gaps = 28/475 (5%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSG-TIPPQIGN 154
           I +    SFS    L  L     ++  +    I     LK L+++ N      +P    N
Sbjct: 92  IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151

Query: 155 LSMLKILYLSTNQFSGRIPPQIGHLSYLKA----LHLFENGLSGSIPPSLGNLTNLAIMY 210
           L+ L  + LS N         +  L         L +  N +   I         L  + 
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELT 210

Query: 211 LYNNSLSGSIPSE-IGNLKSLSGLEL------GYNKLSGSMPLSLGNLPNLAT--LDLHD 261
           L  N  S +I    + NL  L    L          L    P  +  L ++      L  
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG 321
            +      + F  L N+  ++L   S+      ++        L +   +L    P+   
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLK-QFPTL-- 325

Query: 322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNL--TNLATLYL 379
           +L  L  L L+ N    SI  +   L  L YL+L  N LS S   S  +L   +L  L L
Sbjct: 326 DLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383

Query: 380 FTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSIYSNALSGAIPK 438
             N     + +    L  L  L    + L     +S F +L  ++ L I           
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDG 442

Query: 439 EYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYI 496
            +  L  L  L ++ N  +         N T L  + L +  L       F     L  +
Sbjct: 443 IFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLL 502

Query: 497 NLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI 551
           N+SH       S  + +  +L TLD S N I             L   +L++N +
Sbjct: 503 NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  186 bits (475), Expect = 5e-50
 Identities = 70/359 (19%), Positives = 120/359 (33%), Gaps = 20/359 (5%)

Query: 87  SINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLK--------YLD 138
            + L        +      +   L    L + +       +I   S ++           
Sbjct: 208 ELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267

Query: 139 LSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP 198
           L+  +       +   L+ +  + L+           +      ++L +    L      
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQFPTL 325

Query: 199 SLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNL--PNLAT 256
            L  L +L    L  N    SI  +   L SLS L+L  N LS S   S  +L   +L  
Sbjct: 326 DLPFLKSL---TLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRH 380

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIP-SEMGNLKSLYGLGLSFNKLSGS 315
           LDL  N     +  +F  L  L  L+  H++L      S   +L+ L  L +S+      
Sbjct: 381 LDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439

Query: 316 IPSSLGNLTKLTILYLSDN-LLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNL 374
                  LT L  L ++ N     ++     N   L +L+L   +L          L  L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499

Query: 375 ATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
             L +  N L     S    L SLS L  S N +  S         ++   ++ +N+++
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  127 bits (322), Expect = 1e-30
 Identities = 38/195 (19%), Positives = 76/195 (38%), Gaps = 6/195 (3%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
             +   +D+S N +  +      +  +L+ LDLS   I          L  L  L L  N
Sbjct: 31  PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90

Query: 574 QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG-EIPIKLE 632
                 P     L  LE+L     +L++     +G L+ L  LN+++N     ++P    
Sbjct: 91  PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150

Query: 633 KFIHLSDLDLSHNFLGEEIPSQVCSMQ----SLEKLNLAHNNLSGFIPRCFKEMHGLVYI 688
              +L  +DLS+N++     + +  ++        L+++ N +     + F+ +  L  +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIK-LHEL 209

Query: 689 DISYNKLHGPIPNSA 703
            +  N     I  + 
Sbjct: 210 TLRGNFNSSNIMKTC 224

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 92.4 bits (230), Expect = 2e-19
 Identities = 32/155 (20%), Positives = 63/155 (40%), Gaps = 5/155 (3%)

Query: 553 GEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK 612
           G +   +  + ++        + S ++P ++ S    +++DLS N L      S  N  +
Sbjct: 2   GSLNPCIEVVPNIT-YQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57

Query: 613 LYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
           L +L+LS  +             HLS+L L+ N +    P     + SLE L      L+
Sbjct: 58  LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117

Query: 673 GFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKH 707
                   ++  L  +++++N +H      A F +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHS-CKLPAYFSN 151

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  291 bits (747), Expect = 3e-90
 Identities = 94/297 (31%), Positives = 161/297 (54%), Gaps = 21/297 (7%)

Query: 794  RKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQ---Q 850
            ++ +  E+  A+++F  ++ +G GG G VY+  L+ G +VAVK+     L E   Q    
Sbjct: 18   KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR-----LKEERTQGGEL 72

Query: 851  EFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE-LGWTQ 909
            +F  EV+ ++   HRN+++  GFC       +VY Y+  GS+A  L     ++  L W +
Sbjct: 73   QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-W 968
            R  +  G A  L+YLH+ C P I++RD+ + N+LLD E+EA V DFG++K +    ++  
Sbjct: 133  RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT 192

Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL---- 1024
            T + GTIG++APE   T K +EK+DV+ +GV+ LE I G+   D           L    
Sbjct: 193  TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252

Query: 1025 -----DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 ++ L+ ++D  L        +++  +++VA+ C   +P  RP M +V ++L+
Sbjct: 253  KGLLKEKKLEALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  272 bits (699), Expect = 2e-83
 Identities = 96/325 (29%), Positives = 151/325 (46%), Gaps = 34/325 (10%)

Query: 770  RSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSS 829
               S+   S          V     ++   ++  ATN+FD +  IG G  G VY+  L  
Sbjct: 3    SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 830  GEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL 887
            G  VA+K+      +  + Q  +EF  E+++L+  RH ++V   GFC       ++Y+Y+
Sbjct: 63   GAKVALKR-----RTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 888  EMGSLAMILSNATSAEE-LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL 946
            E G+L   L  +      + W QR+ +  G A  L YLH      I++RD+ S N+LLD 
Sbjct: 118  ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDE 174

Query: 947  EYEAHVSDFGISKSLKPDSSNW---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALE 1003
             +   ++DFGISK    +       T + GT+GY+ PE     ++TEKSDVYSFGV+  E
Sbjct: 175  NFVPKITDFGISK-KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233

Query: 1004 AIKGKHPRDFISSICSTSSNL---------DRTLDEILDPRL---PAPSCNIRDKLISIM 1051
             +  +       S+     NL         +  L++I+DP L     P       L    
Sbjct: 234  VLCARSAIV--QSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES-----LRKFG 286

Query: 1052 EVAISCLDENPDSRPTMQKVSQLLK 1076
            + A+ CL  + + RP+M  V   L+
Sbjct: 287  DTAVKCLALSSEDRPSMGDVLWKLE 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  242 bits (621), Expect = 8e-73
 Identities = 92/304 (30%), Positives = 150/304 (49%), Gaps = 35/304 (11%)

Query: 794  RKIAYEEIVRATNDFDEEHC------IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMT 847
               ++ E+   TN+FDE         +G GG G VY+  ++    VAVKK  + +    T
Sbjct: 13   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDIT-T 70

Query: 848  CQ--QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL 905
             +  Q+F  E+K + + +H N+V+  GF S      +VY Y+  GSL   LS       L
Sbjct: 71   EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS 965
             W  R  + +G A+ +++LH +     ++RDI S N+LLD  + A +SDFG+++      
Sbjct: 131  SWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLAR-ASEKF 186

Query: 966  SNW---TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS 1022
            +     + + GT  Y+APE A   ++T KSD+YSFGV+ LE I G    D          
Sbjct: 187  AQTVMTSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDE----HREPQ 241

Query: 1023 NL----------DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
             L          ++T+++ +D ++          + ++  VA  CL E  + RP ++KV 
Sbjct: 242  LLLDIKEEIEDEEKTIEDYIDKKMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQ 298

Query: 1073 QLLK 1076
            QLL+
Sbjct: 299  QLLQ 302

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  239 bits (612), Expect = 1e-69
 Identities = 118/499 (23%), Positives = 204/499 (40%), Gaps = 39/499 (7%)

Query: 83  GKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSN 142
           G + S  +T    I  +  F+ ++        L    +   +     +  ++  L     
Sbjct: 1   GPLGSATITQDTPINQI--FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56

Query: 143 SFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGN 202
                    +  L+ L  +  S NQ +   P  + +L+ L  + +  N ++   P  L N
Sbjct: 57  GI--KSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LAN 110

Query: 203 LTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDN 262
           LTNL  + L+NN ++   P  + NL +L+ LEL  N +S     +L  L +L  L    N
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GN 165

Query: 263 SLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGN 322
            ++   PL   NLT L+ L++  N +S    S +  L +L  L  + N++S   P  LG 
Sbjct: 166 QVTDLKPL--ANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGI 219

Query: 323 LTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTN 382
           LT L  L L+ N L       + +L  L  L+L +N++S   P  L  LT L  L L  N
Sbjct: 220 LTNLDELSLNGNQL--KDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275

Query: 383 LLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGN 442
            +S   P  +  L +L++L L+EN+L    P    NL N+  L++Y N +S   P    +
Sbjct: 276 QISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329

Query: 443 LVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKK 502
           L KL  L    N++   +  L NLT +  +    N ++          + ++ + L+ + 
Sbjct: 330 LTKLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQA 386

Query: 503 FYGEISFDWGKFPNLGTLDVSANNITGILPP-EIGDSPQLKVLDLSSNHIVGEIPSELGK 561
           +    +       N+   +   N    ++ P  I D       D++ N            
Sbjct: 387 W---TNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP-SYTNEVSYT 442

Query: 562 LRSLIKLTLNRNQFSGQLP 580
               + +      FSG + 
Sbjct: 443 FSQPVTIGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  238 bits (609), Expect = 4e-69
 Identities = 109/483 (22%), Positives = 191/483 (39%), Gaps = 35/483 (7%)

Query: 198 PSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATL 257
            +   L       L   +++ ++     +L  ++ L+     +       +  L NL  +
Sbjct: 18  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 73

Query: 258 DLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIP 317
           +  +N L+   PL   NLT L  + + +N ++   P  + NL +L GL L  N+++   P
Sbjct: 74  NFSNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129

Query: 318 SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL 377
             L NLT L  L LS N +  S    +  L  L  L  G N+++   P  L NLT L  L
Sbjct: 130 --LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERL 182

Query: 378 YLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
            + +N +S    S +  L +L  L  + N++S   P   G LTN+  LS+  N L     
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236

Query: 438 KEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
               +L  LT L L+ NQ+   +  L  LT+L  ++L  N ++          + L+ + 
Sbjct: 237 GTLASLTNLTDLDLANNQISN-LAPLSGLTKLTELKLGANQISN--ISPLAGLTALTNLE 293

Query: 498 LSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPS 557
           L+  +             NL  L +  NNI+ I    +    +L+ L   +N +     S
Sbjct: 294 LNENQLEDISPI--SNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKV--SDVS 347

Query: 558 ELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLN 617
            L  L ++  L+   NQ S    T L +L ++  L L+    +N+      N+     + 
Sbjct: 348 SLANLTNINWLSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVK 405

Query: 618 LSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPR 677
                     P  +      ++ D++ N           +      +       SG + +
Sbjct: 406 NVTGALI--APATISDGGSYTEPDITWNLP-SYTNEVSYTFSQPVTIGKGTTTFSGTVTQ 462

Query: 678 CFK 680
             K
Sbjct: 463 PLK 465

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  215 bits (551), Expect = 3e-61
 Identities = 108/456 (23%), Positives = 177/456 (38%), Gaps = 56/456 (12%)

Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLG 306
           +   L       L   +++ ++  +  +L  +  L      +       +  L +L  + 
Sbjct: 19  TDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQIN 74

Query: 307 LSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH 366
            S N+L+   P  L NLTKL  + +++N +    P  + NL  L  L L +N+++   P 
Sbjct: 75  FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129

Query: 367 SLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLS 426
            L NLTNL  L L +N +S    S +  L SL  L    N+++   P    NLT +  L 
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLD 183

Query: 427 IYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISES 486
           I SN +S         L  L  L+ + NQ+   I  L  LT L  + L+ N L  +I   
Sbjct: 184 ISSNKVSD--ISVLAKLTNLESLIATNNQISD-ITPLGILTNLDELSLNGNQLK-DIGT- 238

Query: 487 FGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDL 546
                                        NL  LD++ N I+ +    +    +L  L L
Sbjct: 239 ------------------------LASLTNLTDLDLANNQISNL--APLSGLTKLTELKL 272

Query: 547 SSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS 606
            +N I    P  L  L +L  L LN NQ      + + +L  L +L L  N +S+  P  
Sbjct: 273 GANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP-- 326

Query: 607 LGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNL 666
           + +L KL  L   NN+ S      L    +++ L   HN + +  P  + ++  + +L L
Sbjct: 327 VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGL 382

Query: 667 AHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNS 702
                +         +     +      L  P   S
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATIS 418

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  241 bits (616), Expect = 4e-69
 Identities = 116/538 (21%), Positives = 183/538 (34%), Gaps = 41/538 (7%)

Query: 172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLS 231
           IP  +      K L L  N L      S  +   L ++ L    +         +L  LS
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLS 79

Query: 232 GLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL-SG 290
            L L  N +      +   L +L  L   + +L+       G+L  L  LN+ HN + S 
Sbjct: 80  TLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF 139

Query: 291 SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTI----LYLSDNLLFGSIPCEIGN 346
            +P    NL +L  L LS NK+     + L  L ++ +    L LS N +   I      
Sbjct: 140 KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFK 198

Query: 347 LRYLFYLELGDNKLSGSIPH-SLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSE 405
              L  L L +N  S ++    +  L  L    L        +  E  N  +L     S 
Sbjct: 199 EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRL--------VLGEFRNEGNLEKFDKS- 249

Query: 406 NELSGSIPYSFGNLTNMIVLSIYSNALSG---AIPKEYGNLVKLTLLVLSYNQLQGPIPD 462
                    +   L N+ +       L      I   +  L  ++   L    ++  + D
Sbjct: 250 ---------ALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKD 299

Query: 463 LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDV 522
                    + L         +       +L  +  +  K     S      P+L  LD+
Sbjct: 300 FSYNFGWQHLELVNCKFGQFPTLKL---KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDL 354

Query: 523 SANNIT--GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLP 580
           S N ++  G        +  LK LDLS N ++  + S    L  L  L    +       
Sbjct: 355 SRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSE 413

Query: 581 TE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-LEKFIHLS 638
                SL  L +LD+S      +  G    L  L  L ++ N F          +  +L+
Sbjct: 414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473

Query: 639 DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
            LDLS   L +  P+   S+ SL+ LN+A N L       F  +  L  I +  N   
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  235 bits (602), Expect = 4e-67
 Identities = 112/526 (21%), Positives = 185/526 (35%), Gaps = 34/526 (6%)

Query: 198 PSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATL 257
           P +  + N+        +    IP  +    S   L+L +N L      S  + P L  L
Sbjct: 2   PCVEVVPNITY-QCMELNFY-KIPDNLPF--STKNLDLSFNPLRHLGSYSFFSFPELQVL 57

Query: 258 DLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIP 317
           DL    +      ++ +L++L  L L  N +          L SL  L      L+    
Sbjct: 58  DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117

Query: 318 SSLGNLTKLTILYLSDNLL-FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNL-- 374
             +G+L  L  L ++ NL+    +P    NL  L +L+L  NK+       L  L  +  
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177

Query: 375 --ATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIP-YSFGNLTNMIVLSIYSNA 431
              +L L  N ++  I         L  L L  N  S ++       L  + V  +    
Sbjct: 178 LNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE 236

Query: 432 LSGAIPKEY------GNLVKLTLLVLSYNQLQGPIPDL----RNLTRLARVRLDRNHLTG 481
                  E         L  LT+       L   + D+      LT ++   L    +  
Sbjct: 237 FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER 296

Query: 482 NISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQL 541
               S+  +    ++ L + KF     F   K  +L  L  ++N           D P L
Sbjct: 297 VKDFSY--NFGWQHLELVNCKFG---QFPTLKLKSLKRLTFTSNKGGNA--FSEVDLPSL 349

Query: 542 KVLDLSSNHI--VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
           + LDLS N +   G          SL  L L+ N     + +    L QLEHLD   + L
Sbjct: 350 EFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL 408

Query: 600 SNSIPGS-LGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV-CS 657
                 S   +L  L YL++S+                L  L ++ N   E     +   
Sbjct: 409 KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468

Query: 658 MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
           +++L  L+L+   L    P  F  +  L  ++++ N+L   +P+  
Sbjct: 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS-VPDGI 513

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  229 bits (587), Expect = 4e-65
 Identities = 110/552 (19%), Positives = 178/552 (32%), Gaps = 63/552 (11%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
                 LDL  N +  +      +  +L+ LDLS             +LS L  L L+ N
Sbjct: 27  PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGN 226
                       LS L+ L   E  L+      +G+L  L  + + +N +          
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ--------- 137

Query: 227 LKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDI----LN 282
                         S  +P    NL NL  LDL  N +          L  + +    L+
Sbjct: 138 --------------SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLTILYLSDNLLFGSIP 341
           L  N ++  I         L+ L L  N  S ++    +  L  L +  L          
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEF----- 237

Query: 342 CEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS---IPSEIGNLNSL 398
                          +  L      +L  L NL         L      I      L ++
Sbjct: 238 -------------RNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNV 284

Query: 399 SDLGLSENELSGSIPYSF-GNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ 457
           S   L    +     +S+     ++ +++                L  L  L  + N+  
Sbjct: 285 SSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT------LKLKSLKRLTFTSNKGG 338

Query: 458 GPIPDLRNLTRLARVRLDRNHLT--GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFP 515
                  +L  L  + L RN L+  G  S+S    ++L Y++LS       +S ++    
Sbjct: 339 N-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLE 396

Query: 516 NLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
            L  LD   +N+  +    +  S   L  LD+S  H           L SL  L +  N 
Sbjct: 397 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNS 456

Query: 575 FSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
           F      +    L  L  LDLS  +L    P +  +L  L  LN+++NQ         ++
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDR 516

Query: 634 FIHLSDLDLSHN 645
              L  + L  N
Sbjct: 517 LTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  166 bits (421), Expect = 2e-43
 Identities = 87/391 (22%), Positives = 145/391 (37%), Gaps = 27/391 (6%)

Query: 96  IGTLHDFSFSSFPHLAY----LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQ 151
           I +++         +      LDL +N +  I         +L  L L +N  S  +   
Sbjct: 161 IQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFI-QPGAFKEIRLHKLTLRNNFDSLNVMKT 219

Query: 152 -IGNLSMLKILYLSTNQFSGR---IPPQIGHLSYLKALHLFENGLSG------SIPPSLG 201
            I  L+ L++  L   +F             L  L  L + E  L+        I     
Sbjct: 220 CIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279

Query: 202 NLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
            LTN++   L + ++   +     N      LEL   K           L +L  L    
Sbjct: 280 CLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKF---GQFPTLKLKSLKRLTFTS 334

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLS--GSIPSEMGNLKSLYGLGLSFNKLSGSIPSS 319
           N    +   S  +L +L+ L+L  N LS  G          SL  L LSFN +  ++ S+
Sbjct: 335 NKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSN 391

Query: 320 LGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLY 378
              L +L  L    + L       +  +LR L YL++       +       L++L  L 
Sbjct: 392 FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLK 451

Query: 379 LFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
           +  N    +   +I   L +L+ L LS+ +L    P +F +L+++ VL++ SN L     
Sbjct: 452 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD 511

Query: 438 KEYGNLVKLTLLVLSYNQLQGPIPDLRNLTR 468
             +  L  L  + L  N      P +  L+R
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  230 bits (589), Expect = 1e-66
 Identities = 110/510 (21%), Positives = 191/510 (37%), Gaps = 68/510 (13%)

Query: 172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLS 231
           I P+    ++L+      + L+  +P    N+ +    Y   +    + P   G  + ++
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 232 GLELGYNKLSGSMPLSLGN---------LPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
              L       +  L L N          P+L +L    NSL+  +P    +L +L + N
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
               +LS   P     L+ L    +S N+L   +P  L N + L I+ + +N L   +P 
Sbjct: 121 NNLKALSDLPP----LLEYLG---VSNNQLE-KLP-ELQNSSFLKIIDVDNNSL-KKLPD 170

Query: 343 EIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLG 402
              +L    ++  G+N+L   +P  L NL  L  +Y   N L   +P    +L S+    
Sbjct: 171 LPPSLE---FIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSLESIV--- 221

Query: 403 LSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD 462
              N L   +P    NL  +  +   +N L   +P    +L  L    +  N L      
Sbjct: 222 AGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLTDLPEL 275

Query: 463 LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDV 522
            ++LT L       + L+           NL Y+N S  +    +       P+L  L+V
Sbjct: 276 PQSLTFLDVSENIFSGLSELP-------PNLYYLNASSNEI-RSLCDLP---PSLEELNV 324

Query: 523 SANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTE 582
           S N +   LP       +L+ L  S NH+  E+P     L+    L +  N    + P  
Sbjct: 325 SNNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQNLKQ---LHVEYNPLR-EFPDI 375

Query: 583 LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDL 642
             S+  L      ++ L   +P    NL +   L++  N    E P   E    + DL +
Sbjct: 376 PESVEDLR----MNSHL-AEVPELPQNLKQ---LHVETNPLR-EFPDIPES---VEDLRM 423

Query: 643 SHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
           +   + +       +   LE     H++  
Sbjct: 424 NSERVVDPYEFAHETTDKLEDDVFEHHHHH 453

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  225 bits (575), Expect = 1e-64
 Identities = 108/534 (20%), Positives = 188/534 (35%), Gaps = 98/534 (18%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK 183
           I  +  +N+ L+     S++ +  +P +  N+      Y + +++    PP  G    + 
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 184 ALHLFENGLSG------------SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLS 231
              L +                 S+P    +L +L       NSL+  +P    +LKSL 
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSSLPELPPHLESL---VASCNSLT-ELPELPQSLKSLL 117

Query: 232 GLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGS 291
                   LS          P L  L + +N L   +P    N + L I+++ +NSL   
Sbjct: 118 VDNNNLKALS-------DLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-K 167

Query: 292 IPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLF 351
           +P    +L+ +       N+L   +P  L NL  LT +Y  +N L   +P    +L    
Sbjct: 168 LPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSL-KKLPDLPLSLE--- 218

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGS 411
            +  G+N L       L NL  L T+Y   NLL  ++P    +L +L+   + +N L+  
Sbjct: 219 SIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-D 271

Query: 412 IPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLAR 471
           +P    +LT + V     + LS   P        L  L  S N+++       +L  L  
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEIRSLCDLPPSLEEL-- 322

Query: 472 VRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGIL 531
             +  N L   +                                 L  L  S N++   +
Sbjct: 323 -NVSNNKLI-ELPALPP---------------------------RLERLIASFNHLAE-V 352

Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEH 591
           P        LK L +  N +  E P     +       L  N    ++P    +   L+ 
Sbjct: 353 PELPQ---NLKQLHVEYNPLR-EFPDIPESVED-----LRMNSHLAEVPELPQN---LKQ 400

Query: 592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
           L + +N L    P    ++  L    +++ +         E    L D    H+
Sbjct: 401 LHVETNPLR-EFPDIPESVEDLR---MNSERVVDPYEFAHETTDKLEDDVFEHH 450

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  188 bits (480), Expect = 6e-52
 Identities = 105/515 (20%), Positives = 182/515 (35%), Gaps = 124/515 (24%)

Query: 196 IPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLA 255
           I P   + T L     ++++L+  +P E  N+KS +     +++   + P   G    +A
Sbjct: 3   INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
              L D                   L L +  LS S+P    +L+SL     S N L+  
Sbjct: 62  VSRLRDCLD-----------RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-E 105

Query: 316 IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLA 375
           +P    +L  L +   +   L    P        L YL + +N+L   +P  L N + L 
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLK 156

Query: 376 TLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGA 435
            + +  N L   +P    +L  ++      N+L   +P    NL  +  +   +N+L   
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLEFIA---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-K 209

Query: 436 IPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSY 495
           +P      + L  +V   N L+  +P+L+NL  L  +  D N L                
Sbjct: 210 LPDL---PLSLESIVAGNNILEE-LPELQNLPFLTTIYADNNLLK--------------- 250

Query: 496 INLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEI 555
                                              LP        L+ L++  N++  ++
Sbjct: 251 ----------------------------------TLPDLPP---SLEALNVRDNYLT-DL 272

Query: 556 PSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYY 615
           P     L  L       +  S   P        L +L+ SSN +  S+     +L +L  
Sbjct: 273 PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSNEI-RSLCDLPPSLEEL-- 322

Query: 616 LNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF- 674
            N+SNN+   E+P    +   L  L  S N L  E+P      Q+L++L++ +N L  F 
Sbjct: 323 -NVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPE---LPQNLKQLHVEYNPLREFP 373

Query: 675 --------------IPRCFKEMHGLVYIDISYNKL 695
                         +    +    L  + +  N L
Sbjct: 374 DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPL 408

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  162 bits (412), Expect = 6e-43
 Identities = 88/429 (20%), Positives = 149/429 (34%), Gaps = 72/429 (16%)

Query: 28  LIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNS 87
           L+ S NS  E   L +   SL   NN    L          +       +  N       
Sbjct: 96  LVASCNSLTELPELPQSLKSLLVDNNNLKALSDL-PPLLEYLG------VSNNQ------ 142

Query: 88  INLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGT 147
                   +  L +    +   L  +D+  N +   +P    +   L+++   +N     
Sbjct: 143 --------LEKLPE--LQNSSFLKIIDVDNNSL-KKLPDLPPS---LEFIAAGNNQL--E 186

Query: 148 IPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLA 207
             P++ NL  L  +Y   N    ++P        L+++    N L     P L NL  L 
Sbjct: 187 ELPELQNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNIL--EELPELQNLPFLT 240

Query: 208 IMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGS 267
            +Y  NN L  ++P    +L++L+   +  N L+  +P    +L  L   +   + LS  
Sbjct: 241 TIYADNNLLK-TLPDLPPSLEALN---VRDNYLT-DLPELPQSLTFLDVSENIFSGLSEL 295

Query: 268 IPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLT 327
            P       NL  LN   N +  S+     +L+ L    +S NKL   +P+    L +  
Sbjct: 296 PP-------NLYYLNASSNEIR-SLCDLPPSLEELN---VSNNKLI-ELPALPPRLER-- 341

Query: 328 ILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
            L  S N L   +P    NL+    L +  N L    P    ++ +L       N     
Sbjct: 342 -LIASFNHL-AEVPELPQNLK---QLHVEYNPLR-EFPDIPESVEDLR-----MNSHLAE 390

Query: 388 IPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLT 447
           +P    NL  L    +  N L    P    ++ +   L + S  +       +    KL 
Sbjct: 391 VPELPQNLKQLH---VETNPLR-EFPDIPESVED---LRMNSERVVDPYEFAHETTDKLE 443

Query: 448 LLVLSYNQL 456
             V  ++  
Sbjct: 444 DDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  111 bits (279), Expect = 8e-26
 Identities = 55/308 (17%), Positives = 104/308 (33%), Gaps = 62/308 (20%)

Query: 389 PSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTL 448
           P  + N   L +     + L+  +P    N+ +        +      P   G   ++ +
Sbjct: 5   PRNVSNTF-LQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 449 LVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEIS 508
             L                +   + L+   L+ ++ E                       
Sbjct: 63  SRLRDC----------LDRQAHELELNNLGLS-SLPELPP-------------------- 91

Query: 509 FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL 568
                  +L +L  S N++T  LP        L V + +   +    P        L  L
Sbjct: 92  -------HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPL-------LEYL 136

Query: 569 TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIP 628
            ++ NQ   +LP EL +   L+ +D+ +N L   +P    +L    ++   NNQ   E+P
Sbjct: 137 GVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLE-ELP 189

Query: 629 IKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYI 688
            +L+    L+ +   +N L +++P       SLE +   +N L        + +  L  I
Sbjct: 190 -ELQNLPFLTAIYADNNSL-KKLPD---LPLSLESIVAGNNILE--ELPELQNLPFLTTI 242

Query: 689 DISYNKLH 696
               N L 
Sbjct: 243 YADNNLLK 250

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  110 bits (277), Expect = 1e-25
 Identities = 47/257 (18%), Positives = 84/257 (32%), Gaps = 35/257 (13%)

Query: 442 NLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHK 501
           +   L   +   + L     +  N+          +    N     G    ++   L   
Sbjct: 9   SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD- 67

Query: 502 KFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGK 561
                             L+++   ++  LP        L+ L  S N +  E+P     
Sbjct: 68  ----------CLDRQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQS 112

Query: 562 LRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
           L+SL+    N    S   P        LE+L +S+N+L   +P  L N   L  +++ NN
Sbjct: 113 LKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNN 163

Query: 622 QFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKE 681
               ++P        L  +   +N L EE+P  + ++  L  +   +N+L          
Sbjct: 164 SLK-KLPDLPP---SLEFIAAGNNQL-EELPE-LQNLPFLTAIYADNNSLKKLPD----L 213

Query: 682 MHGLVYIDISYNKLHGP 698
              L  I    N L   
Sbjct: 214 PLSLESIVAGNNILEEL 230

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.2 bits (162), Expect = 2e-11
 Identities = 20/146 (13%), Positives = 49/146 (33%), Gaps = 18/146 (12%)

Query: 556 PSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYY 615
           P  +     L +   + +  + ++P E  ++        + +    + P   G   ++  
Sbjct: 5   PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62

Query: 616 LNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFI 675
             L +                  +L+L++  L   +P        LE L  + N+L+  +
Sbjct: 63  SRLRDCLDR-----------QAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT-EL 106

Query: 676 PRCFKEMHGLVYIDISYNKLHGPIPN 701
           P   + +  L+  + +   L    P 
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPL 132

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  223 bits (569), Expect = 2e-65
 Identities = 68/309 (22%), Positives = 116/309 (37%), Gaps = 40/309 (12%)

Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
             E +   +           G  G V++A+L   E VAVK F            +   EV 
Sbjct: 16   TENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSW----QNEYEVY 70

Query: 858  SLTEIRHRNIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNV 913
            SL  ++H NI++F G            +++  + E GSL+  L        + W +  ++
Sbjct: 71   SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHI 126

Query: 914  IKGVADALSYLHNDCF-------PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
             + +A  L+YLH D         P I +RDI SKNVLL     A ++DFG++   +   S
Sbjct: 127  AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 967  NW--TELAGTIGYVAPELA-----YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS 1019
                    GT  Y+APE+      +      + D+Y+ G++  E        D       
Sbjct: 187  AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 1020 T----SSNLDRTLDEI--------LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067
                       +L+++          P L          +  + E    C D + ++R +
Sbjct: 247  LPFEEEIGQHPSLEDMQEVVVHKKKRPVLR-DYWQKHAGMAMLCETIEECWDHDAEARLS 305

Query: 1068 MQKVSQLLK 1076
               V + + 
Sbjct: 306  AGCVGERIT 314

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  235 bits (602), Expect = 4e-65
 Identities = 122/581 (20%), Positives = 209/581 (35%), Gaps = 52/581 (8%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILY 162
                    L L  N I  +  S      +L+ L+L S     TI  +   NL  L+IL 
Sbjct: 20  PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILD 79

Query: 163 LSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPS--LGNLTNLAIMYLYNNSLSG- 218
           L +++    + P     L +L  L L+  GLS ++       NL  L  + L  N +   
Sbjct: 80  LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNL--PNLATLDLHDNSLSGSIPLSFGNLT 276
            +    G L SL  ++   N++       L  L    L+   L  NSL   + + +G   
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198

Query: 277 N-LDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
           N    + L    +SG       N  ++   G   N +S S   SL     +       + 
Sbjct: 199 NPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

Query: 336 LFGSIPCEIGNLR--YLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIG 393
           +          L    + +L+L    +          L +L  L L  N ++        
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 394 NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
            L++L  L LS N L      +F  L  +  + +  N ++    + +  L KL  L L  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 454 NQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG-EISFDWG 512
           N L      +  +  +  + L  N L      +       + I+LS  +    +I +   
Sbjct: 372 NALT----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSENRLENLDILYFLL 423

Query: 513 KFPNLGTLDVSANNITGILPPEI-GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLN 571
           + P+L  L ++ N  +     +   ++P L+ L L  N +     +EL            
Sbjct: 424 RVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL------------ 471

Query: 572 RNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
                         L  L+ L L+ N L++  PG   +L  L  L+L++N+ +  +    
Sbjct: 472 -------CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLS-HN 522

Query: 632 EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
           +   +L  LD+S N L    P       SL  L++ HN   
Sbjct: 523 DLPANLEILDISRNQLLAPNPD---VFVSLSVLDITHNKFI 560

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  196 bits (501), Expect = 4e-52
 Identities = 99/506 (19%), Positives = 175/506 (34%), Gaps = 74/506 (14%)

Query: 208 IMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGS 267
           I +    +L+  +P     L +   L L +N +      S   L  L  L+L       +
Sbjct: 8   IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLT 63

Query: 268 I-PLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSI--PSSLGNLT 324
           I   +F NL NL IL+L  + +    P     L  L+ L L F  LS ++       NL 
Sbjct: 64  IDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLK 123

Query: 325 KLTILYLSDNLLFG-SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLT--NLATLYLFT 381
            LT L LS N +    +    G L  L  ++   N++     H L  L    L+   L  
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183

Query: 382 NLLSGSIPSEIGN-LNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEY 440
           N L   +  + G  +N   ++ L   ++SG       N   + +   +SNA+S +     
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSL 236

Query: 441 GNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
                +      ++ ++                 D+N   G         S++ +++LSH
Sbjct: 237 ILAHHIMGAGFGFHNIK---------------DPDQNTFAGLA------RSSVRHLDLSH 275

Query: 501 KKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELG 560
                                     +  +          LKVL+L+ N I         
Sbjct: 276 ------------------------GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
            L +L  L L+ N       +    L ++ ++DL  N ++     +   L KL  L+L +
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 621 NQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF-IPRCF 679
           N  +      +     + D+ LS N L   +P       +   ++L+ N L    I    
Sbjct: 372 NALT-----TIHFIPSIPDIFLSGNKL-VTLPKINL---TANLIHLSENRLENLDILYFL 422

Query: 680 KEMHGLVYIDISYNKLHGPIPNSAAF 705
             +  L  + ++ N+           
Sbjct: 423 LRVPHLQILILNQNRFSS-CSGDQTP 447

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  144 bits (364), Expect = 3e-35
 Identities = 86/434 (19%), Positives = 156/434 (35%), Gaps = 54/434 (12%)

Query: 100 HDFSFSSFPHLAYLDLRVNQIFGIIPSQIAN------NSKLKYLDLSSNSFS-------- 145
           H+        L++  L  N ++  +            N  L+ LD+S N ++        
Sbjct: 166 HELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFS 225

Query: 146 ----GTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHL--SYLKALHLFENGLSGSIPPS 199
                +    +     +       +            L  S ++ L L    +       
Sbjct: 226 NAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRV 285

Query: 200 LGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDL 259
              L +L ++ L  N ++         L +L  L L YN L      +   LP +A +DL
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345

Query: 260 HDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSS 319
             N ++     +F  L  L  L+L  N+L     + +  + S+  + LS NKL      +
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVTLPKIN 400

Query: 320 LGNLTKLTILYLSDNLLFG-SIPCEIGNLRYLFYLELGDNKLSG-SIPHSLGNLTNLATL 377
           L       +++LS+N L    I   +  + +L  L L  N+ S  S   +     +L  L
Sbjct: 401 L----TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL 456

Query: 378 YLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
           +L  N+L  +  +E+                       F  L+++ VL +  N L+   P
Sbjct: 457 FLGENMLQLAWETELC-------------------WDVFEGLSHLQVLYLNHNYLNSLPP 497

Query: 438 KEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
             + +L  L  L L+ N+L   +        L  + + RN L     + F    +LS ++
Sbjct: 498 GVFSHLTALRGLSLNSNRLTV-LSHNDLPANLEILDISRNQLLAPNPDVF---VSLSVLD 553

Query: 498 LSHKKFYGEISFDW 511
           ++H KF  E     
Sbjct: 554 ITHNKFICECELST 567

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  143 bits (361), Expect = 6e-35
 Identities = 79/383 (20%), Positives = 142/383 (37%), Gaps = 22/383 (5%)

Query: 50  NHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPH 109
             N+  S +                  +  +  G    I    +  I     FS     H
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHH 241

Query: 110 LAYLDLRVNQIFGIIPSQIAN--NSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTN 166
           +       + I     +  A    S +++LDLS      ++  ++   L  LK+L L+ N
Sbjct: 242 IMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYN 300

Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGN 226
           + +         L  L+ L+L  N L      +   L  +A + L  N ++         
Sbjct: 301 KINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKF 360

Query: 227 LKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHN 286
           L+ L  L+L  N L+     ++  +P++  + L  N L     ++       ++++L  N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTLPKINL----TANLIHLSEN 411

Query: 287 SLSG-SIPSEMGNLKSLYGLGLSFNKLSG-SIPSSLGNLTKLTILYLSDNLLFGSIPCEI 344
            L    I   +  +  L  L L+ N+ S  S   +      L  L+L +N+L  +   E+
Sbjct: 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471

Query: 345 -----GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLS 399
                  L +L  L L  N L+   P    +LT L  L L +N L+  +        +L 
Sbjct: 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLE 529

Query: 400 DLGLSENELSGSIPYSFGNLTNM 422
            L +S N+L    P  F +L+ +
Sbjct: 530 ILDISRNQLLAPNPDVFVSLSVL 552

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  214 bits (547), Expect = 5e-62
 Identities = 94/395 (23%), Positives = 159/395 (40%), Gaps = 50/395 (12%)

Query: 230 LSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS 289
            + L      ++   P +  +L       L   S++  +      L ++  L +    ++
Sbjct: 2   AATLATLPAPINQIFPDA--DLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57

Query: 290 GSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRY 349
                 +  L +L  L L+ N+++   P  L NL KLT LY+  N +  +    + NL  
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 350 LFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELS 409
           L  L L ++ +S   P  L NLT + +L L  N    S  S + N+  L+ L ++E+++ 
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168

Query: 410 GSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRL 469
              P    NLT++  LS+  N +    P    +L  L       NQ+   I  + N+TRL
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRL 223

Query: 470 ARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITG 529
             +++  N +T                                    L  L++  N I+ 
Sbjct: 224 NSLKIGNNKITDLSP--------------------------LANLSQLTWLEIGTNQISD 257

Query: 530 ILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQL 589
           I    + D  +LK+L++ SN I     S L  L  L  L LN NQ   +    +G L  L
Sbjct: 258 I--NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
             L LS N +++  P  L +L K+   + +N    
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  210 bits (538), Expect = 7e-61
 Identities = 88/356 (24%), Positives = 162/356 (45%), Gaps = 25/356 (7%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F  +         L+   +  ++         +  L ++    + +I   I  L+ L+ L
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYL 71

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
            L+ NQ +   P  + +L  L  L++  N +  +   +L NLTNL  +YL  +++S   P
Sbjct: 72  NLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP 127

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
             + NL  +  L LG N    S    L N+  L  L + ++ +    P    NLT+L  L
Sbjct: 128 --LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
           +L +N +    P  + +L SL+      N+++   P  + N+T+L  L + +N +    P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238

Query: 342 CEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDL 401
             + NL  L +LE+G N++S    +++ +LT L  L + +N +S    S + NL+ L+ L
Sbjct: 239 --LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSL 292

Query: 402 GLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ 457
            L+ N+L        G LTN+  L +  N ++   P    +L K+     +   ++
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  207 bits (528), Expect = 2e-59
 Identities = 94/368 (25%), Positives = 163/368 (44%), Gaps = 28/368 (7%)

Query: 134 LKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLS 193
              L       +   P    +L+      L     +  +      L  +  L +    ++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 194 GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPN 253
            SI   +  LTNL  + L  N ++   P  + NL  L+ L +G NK++     +L NL N
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD--ISALQNLTN 111

Query: 254 LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS 313
           L  L L+++++S   PL   NLT +  LNL  N    S  S + N+  L  L ++ +K+ 
Sbjct: 112 LRELYLNEDNISDISPL--ANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168

Query: 314 GSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
              P  + NLT L  L L+ N +    P  + +L  L Y     N+++   P  + N+T 
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTR 222

Query: 374 LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
           L +L +  N ++   P  + NL+ L+ L +  N++S  I  +  +LT + +L++ SN +S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQIS 278

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSN 492
                   NL +L  L L+ NQL     + +  LT L  + L +NH+T          S 
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD--IRPLASLSK 334

Query: 493 LSYINLSH 500
           +   + ++
Sbjct: 335 MDSADFAN 342

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  196 bits (501), Expect = 9e-56
 Identities = 88/421 (20%), Positives = 159/421 (37%), Gaps = 77/421 (18%)

Query: 275 LTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
              L  L  P N +         +L       L    ++  +      L  +T L ++  
Sbjct: 2   AATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGE 54

Query: 335 LLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGN 394
            +  SI   I  L  L YL L  N+++   P  L NL  L  LY+ TN ++    S + N
Sbjct: 55  KV-ASIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQN 108

Query: 395 LNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYN 454
           L +L +L L+E+ +S   P    NLT M  L++ +N           N+  L  L ++ +
Sbjct: 109 LTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTES 165

Query: 455 QLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF 514
           +++  +  + NLT                                               
Sbjct: 166 KVKD-VTPIANLT----------------------------------------------- 177

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
            +L +L ++ N I  I    +     L       N I    P  +  +  L  L +  N+
Sbjct: 178 -DLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232

Query: 575 FSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKF 634
            +    + L +L QL  L++ +N++S+    ++ +L KL  LN+ +NQ S    +     
Sbjct: 233 ITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISVL--NNL 286

Query: 635 IHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
             L+ L L++N LG E    +  + +L  L L+ N+++   P     +  +   D +   
Sbjct: 287 SQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQV 344

Query: 695 L 695
           +
Sbjct: 345 I 345

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  180 bits (460), Expect = 3e-50
 Identities = 75/375 (20%), Positives = 136/375 (36%), Gaps = 48/375 (12%)

Query: 326 LTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
              L      +    P    +L       L    ++  +      L ++  L +    ++
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 386 GSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
                 I  L +L  L L+ N+++   P    NL  +  L I +N ++        NL  
Sbjct: 58  S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
           L  L L+ + +   I  L NLT++  + L  NH   ++S                     
Sbjct: 112 LRELYLNEDNISD-ISPLANLTKMYSLNLGANHNLSDLSPL------------------- 151

Query: 506 EISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
                      L  L V+ + +  +    I +   L  L L+ N I    P  L  L SL
Sbjct: 152 ------SNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSL 201

Query: 566 IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
              T   NQ +    T + ++ +L  L + +N++++  P  L NL +L +L +  NQ S 
Sbjct: 202 HYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD 257

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
                ++    L  L++  N + +   S + ++  L  L L +N L          +  L
Sbjct: 258 INA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313

Query: 686 VYIDISYNKLHGPIP 700
             + +S N +    P
Sbjct: 314 TTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 89.1 bits (222), Expect = 4e-19
 Identities = 32/161 (19%), Positives = 63/161 (39%), Gaps = 12/161 (7%)

Query: 541 LKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS 600
              L      I  +I      L   I+  L +   +         L  +  L ++  +++
Sbjct: 2   AATLATLPAPI-NQI-FPDADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57

Query: 601 NSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQS 660
            SI G +  L  L YLNL+ NQ +   P  L   + L++L +  N +     S + ++ +
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111

Query: 661 LEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPN 701
           L +L L  +N+S   P     +  +  +++  N     +  
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  218 bits (557), Expect = 3e-61
 Identities = 103/514 (20%), Positives = 194/514 (37%), Gaps = 25/514 (4%)

Query: 190 NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
              + SIP  L     +  + L  N ++     ++    +L  L L  ++++     +  
Sbjct: 15  RSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFY 71

Query: 250 NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSG-SIPSEMGNLKSLYGLGLS 308
           +L +L  LDL DN LS      FG L++L  LNL  N      + S   NL +L  L + 
Sbjct: 72  SLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIG 131

Query: 309 FNKLSGSIP-SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS 367
             +    I       LT L  L +    L       + ++R + +L L  ++ +  +   
Sbjct: 132 NVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIF 191

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
              L+++  L L    L+    S +      S +       S     SF  L  ++   +
Sbjct: 192 ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESF 487
             + +      +   L  L     S + +   +  +  +T + R+ + + +L  ++S  +
Sbjct: 252 ELSEVE----FDDCTLNGLGDFNPSESDVVSELGKVETVT-IRRLHIPQFYLFYDLSTVY 306

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPE---IGDSPQLKVL 544
            +   +  I + + K +           +L  LD+S N +           G  P L+ L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 545 DLSSNHI--VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNS 602
            LS NH+  + +    L  L++L  L ++RN F   +P       ++  L+LSS  +   
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-V 424

Query: 603 IPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLE 662
           +         L  L++SNN       + L +   L +L +S N L + +P        L 
Sbjct: 425 VK--TCIPQTLEVLDVSNNNLD-SFSLFLPR---LQELYISRNKL-KTLPDAS-LFPVLL 476

Query: 663 KLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
            + ++ N L       F  +  L  I +  N   
Sbjct: 477 VMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  214 bits (546), Expect = 7e-60
 Identities = 104/500 (20%), Positives = 188/500 (37%), Gaps = 27/500 (5%)

Query: 211 LYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL 270
             + S + SIPS +    ++  L+L +NK++      L    NL  L L  + ++     
Sbjct: 12  GRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68

Query: 271 SFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSG-SIPSSLGNLTKLTI 328
           +F +L +L+ L+L  N LS S+ S   G L SL  L L  N      + S   NLT L  
Sbjct: 69  AFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127

Query: 329 LYLSDNLLFGSIPCE-IGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
           L + +   F  I       L  L  LE+    L      SL ++ ++  L L  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 388 IPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLT 447
           +      L+S+  L L +  L+               +   +   S    + +  L+KL 
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247

Query: 448 LLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEI 507
             +L  ++++       + T       + +               +  +++     + ++
Sbjct: 248 RYILELSEVE-----FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDL 302

Query: 508 SFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEI---PSELGKLRS 564
           S  +     +  + V  + +  +          L+ LDLS N +V E     +  G   S
Sbjct: 303 STVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362

Query: 565 LIKLTLNRNQFS--GQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
           L  L L++N      +    L +L  L  LD+S N     +P S     K+ +LNLS+  
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421

Query: 623 FSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEM 682
               +   +     L  LD+S+N L +        +  L++L ++ N L           
Sbjct: 422 IR-VVKTCI--PQTLEVLDVSNNNL-DSFSL---FLPRLQELYISRNKLKTLPDASL--F 472

Query: 683 HGLVYIDISYNKLHGPIPNS 702
             L+ + IS N+L       
Sbjct: 473 PVLLVMKISRNQLKSVPDGI 492

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  209 bits (533), Expect = 4e-58
 Identities = 103/527 (19%), Positives = 178/527 (33%), Gaps = 52/527 (9%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
              +  LDL  N+I  I    +   + L+ L L S+  + TI      +L  L+ L LS 
Sbjct: 25  TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSD 83

Query: 166 NQFSGRIPPQ-IGHLSYLKALHLFENGLSG-SIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
           N  S  +     G LS LK L+L  N      +     NLTNL  + + N      I   
Sbjct: 84  NHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142

Query: 224 -IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
               L SL+ LE+    L      SL ++ ++  L LH +  +  + +    L+++  L 
Sbjct: 143 DFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLE 202

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
           L   +L+    S +   +    +     + S     S   L KL    L  + +      
Sbjct: 203 LRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------ 256

Query: 343 EIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLG 402
           E  +       +   ++              +  L++    L   + +    L  +  + 
Sbjct: 257 EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRIT 316

Query: 403 LSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE---YGNLVKLTLLVLSYNQLQ-- 457
           +  +++         +L ++  L +  N +     K     G    L  LVLS N L+  
Sbjct: 317 VENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSM 376

Query: 458 -GPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPN 516
                 L  L  L  + + RN     + +S      + ++NLS                 
Sbjct: 377 QKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR---VVKTCIPQT 432

Query: 517 LGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFS 576
           L  LDVS NN+           P+L+ L +S N +   +P                    
Sbjct: 433 LEVLDVSNNNLDSFSL----FLPRLQELYISRNKLK-TLPDA------------------ 469

Query: 577 GQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
                       L  + +S N+L +   G    L  L  + L  N +
Sbjct: 470 -------SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  186 bits (473), Expect = 3e-50
 Identities = 95/484 (19%), Positives = 165/484 (34%), Gaps = 62/484 (12%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSG-TIPPQIGN 154
           I T+   +F S   L +LDL  N +  +  S     S LKYL+L  N +    +     N
Sbjct: 62  INTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPN 121

Query: 155 LSMLKILYLSTNQFSGRIPPQ-IGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
           L+ L+ L +   +    I       L+ L  L +    L      SL ++ ++  + L+ 
Sbjct: 122 LTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181

Query: 214 NSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFG 273
           +  +  +      L S+  LEL    L+      L      + +       S     SF 
Sbjct: 182 SESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241

Query: 274 NLT----------NLDILNLPHNSLSGSIPSEMGNLK--------SLYGLGLSFNKLSGS 315
            L            ++  +   N L    PSE   +         ++  L +    L   
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301

Query: 316 IPSSLGNLTKLTILYLSDNLLFGSIPCEIG-NLRYLFYLELGDNKLSGSIPHS---LGNL 371
           + +    L K+  + + ++ +F  +PC    +L+ L +L+L +N +      +    G  
Sbjct: 302 LSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 372 TNLATLYLFTNLLSGSIPSEIG---NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIY 428
            +L TL L  N L  S+         L +L+ L +S N     +P S      M  L++ 
Sbjct: 361 PSLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLS 418

Query: 429 SNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFG 488
           S  +   +         L +L +S N L      L  L  L    + RN L      S  
Sbjct: 419 STGIR-VVKT--CIPQTLEVLDVSNNNLDSFSLFLPRLQEL---YISRNKLKTLPDASL- 471

Query: 489 IHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSS 548
                                    FP L  + +S N +  +          L+ + L +
Sbjct: 472 -------------------------FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

Query: 549 NHIV 552
           N   
Sbjct: 507 NPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  152 bits (387), Expect = 4e-39
 Identities = 68/424 (16%), Positives = 134/424 (31%), Gaps = 30/424 (7%)

Query: 64  NNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGI 123
           N    +   + F     +   + ++ + +      +    F+    L  L+++   +   
Sbjct: 108 NPYQTLGVTSLFP----NLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK 183
               + +   + +L L  +  +  +      LS ++ L L     +      +       
Sbjct: 164 QSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSS 223

Query: 184 ALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGS 243
            +       S     S   L  L    L  + +         +       +   ++    
Sbjct: 224 PMKKLAFRGSVLTDESFNELLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVV 277

Query: 244 MPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG-NLKSL 302
             L       +  L +    L   +   +  L  +  + + ++ +   +P     +LKSL
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSL 336

Query: 303 YGLGLSFNKLSGSI---PSSLGNLTKLTILYLSDNLLFGSIPCEIG---NLRYLFYLELG 356
             L LS N +        +  G    L  L LS N L  S+         L+ L  L++ 
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHL-RSMQKTGEILLTLKNLTSLDIS 395

Query: 357 DNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSF 416
            N     +P S      +  L L +  +   + + I    +L  L +S N L  S     
Sbjct: 396 RNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSLFL 450

Query: 417 GNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLD 475
             L     L I  N L   +P +      L ++ +S NQL+         LT L ++ L 
Sbjct: 451 PRLQ---ELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505

Query: 476 RNHL 479
            N  
Sbjct: 506 TNPW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  148 bits (375), Expect = 1e-37
 Identities = 80/425 (18%), Positives = 144/425 (33%), Gaps = 67/425 (15%)

Query: 280 ILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGS 339
           + +    S + SIPS  G   ++  L LSFNK++      L     L +L L  + +  +
Sbjct: 9   VCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NT 64

Query: 340 IPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG-SIPSEIGNLNS 397
           I  +   +L  L +L+L DN LS       G L++L  L L  N      + S   NL +
Sbjct: 65  IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTN 124

Query: 398 LSDLGLSENELSGSIPY-SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           L  L +   E    I    F  LT++  L I + +L     +   ++  +  L L  ++ 
Sbjct: 125 LQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSES 184

Query: 457 QGPIPDLRN-LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFP 515
              +    + L+ +  + L   +L         +    S +                 F 
Sbjct: 185 AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA-------------FR 231

Query: 516 NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
                D S N +   L   I +  +++  D + N +    PSE   +  L K+       
Sbjct: 232 GSVLTDESFNELLK-LLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKV------- 283

Query: 576 SGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI 635
                      + +  L +    L   +      L K+  + + N++             
Sbjct: 284 ---------ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF----------- 323

Query: 636 HLSDLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGFI---PRCFKEMHGLVYIDIS 691
                          +P      ++SLE L+L+ N +         C      L  + +S
Sbjct: 324 --------------LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369

Query: 692 YNKLH 696
            N L 
Sbjct: 370 QNHLR 374

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  134 bits (340), Expect = 4e-33
 Identities = 53/361 (14%), Positives = 125/361 (34%), Gaps = 13/361 (3%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI 412
            +      + SIP  L     + +L L  N ++     ++    +L  L L  + ++   
Sbjct: 10  CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66

Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ--GPIPDLRNLTRLA 470
             +F +L ++  L +  N LS      +G L  L  L L  N  Q  G      NLT L 
Sbjct: 67  GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126

Query: 471 RVRLDRNHLTGNISE-SFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITG 529
            +R+        I    F   ++L+ + +         S       ++  L +  +    
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAF 186

Query: 530 ILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQL 589
           +L         ++ L+L   ++     S L        +     + S         L++L
Sbjct: 187 LLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE 649
               L  + +         +       + + ++      +   + + +  L +   +L  
Sbjct: 247 LRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFY 300

Query: 650 EIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL-HGPIPNSAAFKHA 708
           ++ +    ++ ++++ + ++ +        + +  L ++D+S N +    + NSA     
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAW 360

Query: 709 P 709
           P
Sbjct: 361 P 361

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  207 bits (528), Expect = 5e-60
 Identities = 67/277 (24%), Positives = 124/277 (44%), Gaps = 31/277 (11%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             + + E  +G G  G V +A+    + VA+K+  S    +      F+ E++ L+ + H 
Sbjct: 8    KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESERK-----AFIVELRQLSRVNHP 61

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK YG C +     +V EY E GSL  +L  A           M+     +  ++YLH
Sbjct: 62   NIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119

Query: 926  NDCFPPIVYRDISSKNVLLDLEYE-AHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            +     +++RD+   N+LL        + DFG +  ++   ++ T   G+  ++APE+  
Sbjct: 120  SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFE 176

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL-----DPRLPAP 1039
                +EK DV+S+G++  E I  + P             +      I+       R P  
Sbjct: 177  GSNYSEKCDVFSWGIILWEVITRRKP----------FDEIGGPAFRIMWAVHNGTRPPLI 226

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              N+   + S+M     C  ++P  RP+M+++ +++ 
Sbjct: 227  K-NLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMT 259

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  205 bits (524), Expect = 2e-59
 Identities = 89/271 (32%), Positives = 134/271 (49%), Gaps = 13/271 (4%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             D + +  IG G  G+V+RAE   G  VAVK              EFL EV  +  +RH 
Sbjct: 37   CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAER-VNEFLREVAIMKRLRHP 94

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIV F G  +   +  IV EYL  GSL  +L  + + E+L   +R+++   VA  ++YLH
Sbjct: 95   NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            N   PPIV+R++ S N+L+D +Y   V DFG+S+       +    AGT  ++APE+   
Sbjct: 155  N-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD 213

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRD 1045
                EKSDVYSFGV+  E    + P   ++     ++   +        RL  P  N+  
Sbjct: 214  EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------RLEIPR-NLNP 266

Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            ++ +I+E    C    P  RP+   +  LL+
Sbjct: 267  QVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  201 bits (513), Expect = 2e-58
 Identities = 73/280 (26%), Positives = 122/280 (43%), Gaps = 26/280 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMT-CQQEFLNEVKSLTEIRH 864
             +   E  IG GG G VYRA    G+ VAVK        +++   +    E K    ++H
Sbjct: 7    AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NI+   G C    +  +V E+   G L  +LS     + +     +N    +A  ++YL
Sbjct: 66   PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KRIPPDILVNWAVQIARGMNYL 121

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAH--------VSDFGISKSLKPDSSNWTELAGTIG 976
            H++   PI++RD+ S N+L+  + E          ++DFG+++     +      AG   
Sbjct: 122  HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK--MSAAGAYA 179

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            ++APE+      ++ SDV+S+GVL  E + G+ P   I  +          L       L
Sbjct: 180  WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL------AL 233

Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            P PS    +    +ME    C + +P SRP+   +   L 
Sbjct: 234  PIPS-TCPEPFAKLME---DCWNPDPHSRPSFTNILDQLT 269

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  203 bits (518), Expect = 2e-58
 Identities = 53/336 (15%), Positives = 106/336 (31%), Gaps = 27/336 (8%)

Query: 130 NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFE 189
           ++S  + L    ++        +           +    + R      + +  +      
Sbjct: 10  HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTG 65

Query: 190 NGLSGSIPPSLGNLT--NLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLS 247
             L  +    L + T      + L +  L    P +   L  L  + +    L   +P +
Sbjct: 66  RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122

Query: 248 LGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGL 307
           +     L TL L  N L  ++P S  +L  L  L++        +P  + +         
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST-------- 173

Query: 308 SFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS 367
                          L  L  L L    +  S+P  I NL+ L  L++ ++ LS ++  +
Sbjct: 174 -------DASGEHQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPA 224

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
           + +L  L  L L       + P   G    L  L L +     ++P     LT +  L +
Sbjct: 225 IHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDL 284

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDL 463
                   +P     L    ++++  +         
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  194 bits (496), Expect = 2e-55
 Identities = 59/311 (18%), Positives = 107/311 (34%), Gaps = 21/311 (6%)

Query: 110 LAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS 169
              L  + +         ++   +    D +    +        N +  +I   +     
Sbjct: 14  RENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALK 69

Query: 170 GRIPPQIGHLSY--LKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNL 227
                 +   +     AL L    L    P     L++L  M +    L   +P  +   
Sbjct: 70  -ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQF 126

Query: 228 KSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN---------LTNL 278
             L  L L  N L  ++P S+ +L  L  L +        +P    +         L NL
Sbjct: 127 AGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNL 185

Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG 338
             L L    +  S+P+ + NL++L  L +  + LS ++  ++ +L KL  L L       
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243

Query: 339 SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSL 398
           + P   G    L  L L D     ++P  +  LT L  L L   +    +PS I  L + 
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303

Query: 399 SDLGLSENELS 409
             + +  +  +
Sbjct: 304 CIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  189 bits (481), Expect = 2e-53
 Identities = 55/284 (19%), Positives = 104/284 (36%), Gaps = 20/284 (7%)

Query: 103 SFSSFPHLAYLDLRVNQIFGI--IPSQI--ANNSKLKYLDLSSNSFSGTIPPQIGNLSML 158
           S     +     +       +      +  A       L+L S       P Q   LS L
Sbjct: 48  SAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHL 106

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
           + + +        +P  +   + L+ L L  N L  ++P S+ +L  L  + +       
Sbjct: 107 QHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164

Query: 219 SIPSEIGN---------LKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
            +P  + +         L +L  L L +  +  S+P S+ NL NL +L + ++ LS ++ 
Sbjct: 165 ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALG 222

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLS-FNKLSGSIPSSLGNLTKLTI 328
            +  +L  L+ L+L   +   + P   G    L  L L   + L  ++P  +  LT+L  
Sbjct: 223 PAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEK 281

Query: 329 LYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLT 372
           L L   +    +P  I  L     + +  +  +    H      
Sbjct: 282 LDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARP 325

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  182 bits (464), Expect = 4e-51
 Identities = 55/318 (17%), Positives = 103/318 (32%), Gaps = 36/318 (11%)

Query: 194 GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMP-------- 245
           GS      + +    +Y   ++        +   +     +      +            
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE 61

Query: 246 -------------LSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSI 292
                        L     P    L+L    L    P     L++L  + +    L   +
Sbjct: 62  TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-EL 119

Query: 293 PSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGN------ 346
           P  M     L  L L+ N L  ++P+S+ +L +L  L +        +P  + +      
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 347 ---LRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGL 403
              L  L  L L    +  S+P S+ NL NL +L +  + LS ++   I +L  L +L L
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236

Query: 404 SENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD- 462
                  + P  FG    +  L +   +    +P +   L +L  L L        +P  
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296

Query: 463 LRNLTRLARVRLDRNHLT 480
           +  L     + +  +   
Sbjct: 297 IAQLPANCIILVPPHLQA 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  180 bits (459), Expect = 2e-50
 Identities = 56/244 (22%), Positives = 101/244 (41%), Gaps = 14/244 (5%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
              ++ P    L+LR   +    P Q    S L+++ + +      +P  +   + L+ L
Sbjct: 75  LEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETL 132

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGN---------LTNLAIMYLY 212
            L+ N     +P  I  L+ L+ L +        +P  L +         L NL  + L 
Sbjct: 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
              +  S+P+ I NL++L  L++  + LS ++  ++ +LP L  LDL   +   + P  F
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249

Query: 273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
           G    L  L L   S   ++P ++  L  L  L L        +PS +  L    I+ + 
Sbjct: 250 GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVP 309

Query: 333 DNLL 336
            +L 
Sbjct: 310 PHLQ 313

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  180 bits (458), Expect = 3e-50
 Identities = 58/365 (15%), Positives = 107/365 (29%), Gaps = 50/365 (13%)

Query: 242 GSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKS 301
           GS      +      L    ++                  +      +        N  +
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57

Query: 302 LYGLGLSFNKLSGSIPSSLGNLT--KLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNK 359
                 +   L  +    L + T      L L    L    P +   L +L ++ +    
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAG 115

Query: 360 LSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNL 419
           L   +P ++     L TL L  N L  ++P+ I +LN L +L +        +P    + 
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHL 479
                              E+  LV L  L L +  ++     + NL  L  +++  + L
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPL 218

Query: 480 TGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSP 539
           +                          +       P L  LD+         PP  G   
Sbjct: 219 S-------------------------ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253

Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
            LK L L     +  +P ++ +L  L KL L       +LP+ +  L     + +  +  
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

Query: 600 SNSIP 604
           +    
Sbjct: 314 AQLDQ 318

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  163 bits (414), Expect = 2e-44
 Identities = 54/361 (14%), Positives = 103/361 (28%), Gaps = 50/361 (13%)

Query: 314 GSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
           GS      + +    LY   +         +   +  +  +               N  N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 374 LATLYLFTNLLSGSIPSEIGNLNS--LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
                     L  +    + +        L L    L    P     L+++  ++I +  
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115

Query: 432 LSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHS 491
           L   +P        L  L L+ N L+                         +  S    +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR------------------------ALPASIASLN 150

Query: 492 NLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI 551
            L  +++                P L  L     +       E      L+ L L    I
Sbjct: 151 RLRELSIRA-------------CPELTELPEPLASTD--ASGEHQGLVNLQSLRLEWTGI 195

Query: 552 VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLV 611
              +P+ +  L++L  L +  +  S  L   +  L +LE LDL       + P   G   
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253

Query: 612 KLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNL 671
            L  L L +      +P+ + +   L  LDL        +PS +  + +   + +  +  
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313

Query: 672 S 672
           +
Sbjct: 314 A 314

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  153 bits (390), Expect = 3e-41
 Identities = 60/352 (17%), Positives = 109/352 (30%), Gaps = 46/352 (13%)

Query: 362 GSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTN 421
           GS  H   + +    LY   +         +       +   +         +   N  N
Sbjct: 2   GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNN 57

Query: 422 MIVLSIYSNALSGAIPKEYGNL--VKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNH 478
             + +    AL  A      +        L L    L    PD    L+ L  + +D   
Sbjct: 58  PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAG 115

Query: 479 LTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS 538
           L   + ++                          +F  L TL ++ N +   LP  I   
Sbjct: 116 LM-ELPDTMQ------------------------QFAGLETLTLARNPLR-ALPASIASL 149

Query: 539 PQLKVLDLSSNHIVGEIPSELGK---------LRSLIKLTLNRNQFSGQLPTELGSLIQL 589
            +L+ L + +   + E+P  L           L +L  L L        LP  + +L  L
Sbjct: 150 NRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNL 208

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE 649
           + L + ++ LS ++  ++ +L KL  L+L         P        L  L L       
Sbjct: 209 KSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL 267

Query: 650 EIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPN 701
            +P  +  +  LEKL+L        +P    ++     I +  +       +
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  152 bits (386), Expect = 9e-41
 Identities = 50/233 (21%), Positives = 90/233 (38%), Gaps = 13/233 (5%)

Query: 103 SFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILY 162
                 HL ++ +    +   +P  +   + L+ L L+ N     +P  I +L+ L+ L 
Sbjct: 99  QAFRLSHLQHMTIDAAGL-MELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELS 156

Query: 163 LSTNQFSGRIPPQIG---------HLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
           +        +P  +           L  L++L L   G+  S+P S+ NL NL  + + N
Sbjct: 157 IRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRN 215

Query: 214 NSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFG 273
           + LS ++   I +L  L  L+L       + P   G    L  L L D S   ++PL   
Sbjct: 216 SPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIH 274

Query: 274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
            LT L+ L+L        +PS +  L +   + +  +  +             
Sbjct: 275 RLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  197 bits (502), Expect = 1e-56
 Identities = 79/285 (27%), Positives = 126/285 (44%), Gaps = 32/285 (11%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLLSEMTCQ----QEFLNEVKSLT 860
            N+ + E  IG GG G V++  L     +VA+K          T      QEF  EV  ++
Sbjct: 19   NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 861  EIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
             + H NIVK YG   +     +V E++  G L   L +      + W+ ++ ++  +A  
Sbjct: 79   NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALG 134

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYE-----AHVSDFGISKSLKPDSSNWTELAGTI 975
            + Y+ N   PPIV+RD+ S N+ L    E     A V+DFG+S+     S   + L G  
Sbjct: 135  IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-QSVHSV--SGLLGNF 190

Query: 976  GYVAPEL--AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS--ICSTSSNLDRTLDEI 1031
             ++APE   A     TEK+D YSF ++    + G+ P D  S   I   +   +  L   
Sbjct: 191  QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL--- 247

Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               R   P  +   +L +++E    C   +P  RP    + + L 
Sbjct: 248  ---RPTIPE-DCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELS 285

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  192 bits (490), Expect = 6e-53
 Identities = 74/481 (15%), Positives = 148/481 (30%), Gaps = 27/481 (5%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYL 163
             +        +  + +   + S   +   +K LDLS N  S      +   + L++L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 164 STNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
           S+N         +  LS L+ L L  N +       L    ++  ++  NN++S  +   
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117

Query: 224 IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG-SIPLSFGNLTNLDILN 282
               +    + L  NK++    L  G    +  LDL  N +   +      +   L+ LN
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
           L +N +   +  ++     L  L LS NKL+  +     +   +T + L +N L   I  
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEK 231

Query: 343 EIGNLRYLFYLELGDNKLS-GSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDL 401
            +   + L + +L  N    G++         + T+      +              +  
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTVPTLG 289

Query: 402 GLSENELSGSIPYSFGNLTNMIVLSIYSNALSG----AIPKEYGNLVKLTLLVLSYNQLQ 457
                            L  +        +  G     +  E  N  +   +     Q +
Sbjct: 290 HYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYR 349

Query: 458 GPIPDL-RNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPN 516
             I  +         +   +  L   +S     H+ L            E+     +   
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSP 408

Query: 517 LGTLDVSANNIT-GILPPEIGDSPQLKVLDLSSNHI--VGEIPSELGKLRSLIKLTLNRN 573
           L  L           +  +   +  ++  D+  +    + E  + L KL     L L   
Sbjct: 409 LQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASA 468

Query: 574 Q 574
            
Sbjct: 469 N 469

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  187 bits (476), Expect = 3e-51
 Identities = 70/462 (15%), Positives = 149/462 (32%), Gaps = 27/462 (5%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
           +I     N     I  + ++SL  ++ S   +  ++  L+L  N LS      L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 255 ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG 314
             L+L  N L  ++     +L+ L  L+L +N +      E+    S+  L  + N +S 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG-SIPHSLGNLTN 373
            +  S         +YL++N +      + G    + YL+L  N++   +      +   
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 374 LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
           L  L L  N +   +  ++     L  L LS N+L+  +   F +   +  +S+ +N L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
             I K       L    L  N                   + +  +     ++    +  
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 494 SYINLSHKKFYGEISFDWGKFPNLGTLDVSAN-------NITGILPPEIGDSPQLKVLDL 546
           +  +                   L  L    +       + T  L  E  +  + + +D 
Sbjct: 287 TLGHYGAYCC---EDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDA 343

Query: 547 SSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS 606
                   I     + ++ I L   +     Q+     +  +L+     +      +  +
Sbjct: 344 LKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHA 402

Query: 607 LGNLVKLYYLNLSNNQFS-GEIPIKLEKFIHLSDLDLSHNFL 647
                 L  L     ++    +  +  +   + D D+  +  
Sbjct: 403 TEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKE 444

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  185 bits (472), Expect = 1e-50
 Identities = 68/448 (15%), Positives = 140/448 (31%), Gaps = 46/448 (10%)

Query: 267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
           +I     N     I  +  +SL  ++ S   +  ++  L LS N LS    + L   TKL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
            +L LS N+L+ ++   + +L  L  L+L +N +       L    ++ TL+   N +S 
Sbjct: 61  ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSG-AIPKEYGNLVK 445
            +           ++ L+ N+++       G  + +  L +  N +      +   +   
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
           L  L L YN +   +       +L  + L  N L   +   F   + +++I+L +     
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRN----- 223

Query: 506 EISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
                              N +  I    +  S  L+  DL  N        +    ++ 
Sbjct: 224 -------------------NKLVLI-EKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQ 262

Query: 566 IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
              T+ +                       +    +        L+ L     +     G
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322

Query: 626 ----EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFK- 680
                +  + E      ++D         I       Q+   L      L   +    + 
Sbjct: 323 SETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRA 382

Query: 681 --EMHGLVYIDISYNKLHGPIPNSAAFK 706
             E+ G +   +   +L       +  +
Sbjct: 383 HAELDGTLQQAVGQIELQHATEEQSPLQ 410

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  185 bits (471), Expect = 2e-50
 Identities = 65/463 (14%), Positives = 138/463 (29%), Gaps = 23/463 (4%)

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNL 278
           +I     N       ++  + L  ++     +  N+  LDL  N LS          T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG 338
           ++LNL  N L      ++ +L +L  L L+ N +       L     +  L+ ++N +  
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112

Query: 339 SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG-SIPSEIGNLNS 397
            +       +    + L +NK++       G  + +  L L  N +   +      + ++
Sbjct: 113 RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 398 LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ 457
           L  L L  N +   +         +  L + SN L+  +  E+ +   +T + L  N+L 
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 458 GPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNL 517
                LR    L    L  N         F    N     ++ +        +  +    
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 518 GTLDVSANNITGILPPEIG-----DSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
                 A     +  P           +  +L    +     +  E        ++   +
Sbjct: 287 TLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDALK 345

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLE 632
            Q+   +            L+     L   +        +L            E+    E
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATE 404

Query: 633 KFIHLSDLDLSHN-FLGEEIPSQVCSMQSLEKLNLAHNNLSGF 674
           +   L  L      +    +  Q     ++   ++  +  +  
Sbjct: 405 EQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQL 447

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  167 bits (425), Expect = 2e-44
 Identities = 60/393 (15%), Positives = 120/393 (30%), Gaps = 25/393 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
           +  +     + F  L  L+L  N ++  +   + + S L+ LDL++N        ++   
Sbjct: 46  LSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVG 98

Query: 156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS 215
             ++ L+ + N  S R+          K ++L  N ++       G  + +  + L  N 
Sbjct: 99  PSIETLHAANNNIS-RVSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155

Query: 216 LSG-SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
           +   +      +  +L  L L YN +   +   +     L TLDL  N L+  +   F +
Sbjct: 156 IDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQS 212

Query: 275 LTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS-GSIPSSLGNLTKLTILYLSD 333
              +  ++L +N L   I   +   ++L    L  N    G++        ++  +    
Sbjct: 213 AAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT 271

Query: 334 NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS----IP 389
                    E            G              L  L           GS    + 
Sbjct: 272 VKKLTGQNEE--ECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329

Query: 390 SEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL--- 446
            E  N     ++   + +    I          I L     AL   +        +L   
Sbjct: 330 CERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGT 389

Query: 447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHL 479
               +   +LQ    +   L  L  +      +
Sbjct: 390 LQQAVGQIELQHATEEQSPLQLLRAIVKRYEEM 422

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (362), Expect = 3e-36
 Identities = 52/284 (18%), Positives = 108/284 (38%), Gaps = 16/284 (5%)

Query: 435 AIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
           AI +   N  +  +  ++ + L+  +    ++   +  + L  N L+   +      + L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 494 SYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG 553
             +NLS    Y  +         L TLD++ N +      E+   P ++ L  ++N+I  
Sbjct: 61  ELLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-S 112

Query: 554 EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN-SIPGSLGNLVK 612
            +       +    + L  N+ +     + G   ++++LDL  N +   +      +   
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 613 LYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
           L +LNL  N    ++      F  L  LDLS N L   +  +  S   +  ++L +N L 
Sbjct: 171 LEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV 227

Query: 673 GFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGN 716
             I +  +    L + D+  N  H         K+  ++ +   
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  123 bits (311), Expect = 8e-30
 Identities = 48/320 (15%), Positives = 91/320 (28%), Gaps = 12/320 (3%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGI-IPSQIANNSKLKYLDLSSNSFSGTIPPQIGN 154
           I  L D        + YLDL++N+I  +      A++  L++L+L  N     +  Q+  
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-V 189

Query: 155 LSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN 214
            + LK L LS+N+ +  + P+    + +  + L  N L   I  +L    NL    L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 215 SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
                        K+     +    +      +                           
Sbjct: 248 GFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADR 306

Query: 275 LTNLDILNLPHNSLSGS----IPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILY 330
           L  L        S  GS    +  E  N      +     +    I            L 
Sbjct: 307 LIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLE 366

Query: 331 LSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL-YLFTNLLSGSIP 389
                L   +         L             + H+    + L  L  +        + 
Sbjct: 367 QKKKALDEQVSNGRRAHAELDGTLQQAVGQ-IELQHATEEQSPLQLLRAIVKRYEEMYVE 425

Query: 390 SEIGNLNSLSDLGLSENELS 409
            +    N++ D  + +++ +
Sbjct: 426 QQSVQNNAIRDWDMYQHKET 445

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  185 bits (473), Expect = 6e-53
 Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 24/276 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
               +    +     G +++     G  + VK       S     ++F  E   L    H 
Sbjct: 10   KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRK-SRDFNEECPRLRIFSHP 67

Query: 866  NIVKFYGFCSH--ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            N++   G C    A H  ++  ++  GSL  +L   T+   +  +Q +     +A  +++
Sbjct: 68   NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAF 126

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL- 982
            LH    P I    ++S++V++D +  A +S   +  S +              +VAPE  
Sbjct: 127  LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-----PGRMYAPAWVAPEAL 180

Query: 983  --AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
                       +D++SF VL  E +  + P   +S++          L      R   P 
Sbjct: 181  QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------RPTIPP 234

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              I   +  +M+    C++E+P  RP    +  +L+
Sbjct: 235  -GISPHVSKLMK---ICMNEDPAKRPKFDMIVPILE 266

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  184 bits (468), Expect = 1e-51
 Identities = 75/323 (23%), Positives = 117/323 (36%), Gaps = 53/323 (16%)

Query: 796  IAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNE 855
             A  E     ++      IG G  G+VY+  L     VAVK F          +Q F+NE
Sbjct: 3    AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSF------ANRQNFINE 55

Query: 856  VK--SLTEIRHRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWT 908
                 +  + H NI +F                +V EY   GSL   LS  T      W 
Sbjct: 56   KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111

Query: 909  QRMNVIKGVADALSYLHND------CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK 962
                +   V   L+YLH +        P I +RD++S+NVL+  +    +SDFG+S  L 
Sbjct: 112  SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171

Query: 963  PDSSNW--------TELAGTIGYVAPE-------LAYTMKVTEKSDVYSFGVLALEAIKG 1007
             +                GTI Y+APE       L       ++ D+Y+ G++  E    
Sbjct: 172  GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

Query: 1008 KHPRDFISSIC------STSSNLDRTLDEILD--------PRLPAPSCNIRDKLISIMEV 1053
                    S+        T      T +++          P+ P         + S+ E 
Sbjct: 232  CTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 1054 AISCLDENPDSRPTMQKVSQLLK 1076
               C D++ ++R T Q   + + 
Sbjct: 292  IEDCWDQDAEARLTAQXAEERMA 314

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  189 bits (481), Expect = 2e-51
 Identities = 85/493 (17%), Positives = 173/493 (35%), Gaps = 23/493 (4%)

Query: 137 LDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSI 196
           +D S N     +P  +       IL +S N  S      I  LS L+ L +  N +    
Sbjct: 5   VDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 197 PPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLS--LGNLPNL 254
                    L  + L +N L   I        +L  L+L +N    ++P+    GN+  L
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQL 117

Query: 255 ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG 314
             L L    L  S  L   +L    +L +   +           L+      L     + 
Sbjct: 118 KFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFNTESLHIVFPTN 175

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNL 374
                + +++  T+  L  + +   +     +       +L  N    ++  +    T  
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWN 235

Query: 375 ATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSG 434
           + + +   +   ++        S+S++ L          YS  +L  + +  + S+    
Sbjct: 236 SFIRILQLVWHTTVWY-----FSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290

Query: 435 AIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
                Y     + +   + +  +   +     ++    +    N LT  + E+ G  + L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350

Query: 494 SYINLSHKKF--YGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSP-QLKVLDLSSNH 550
             + L   +     +I+    +  +L  LD+S N+++             L  L++SSN 
Sbjct: 351 ETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNI 410

Query: 551 IVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNL 610
           +   I   L     +  L L+ N+    +P ++  L  L+ L+++SN+L +   G    L
Sbjct: 411 LTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRL 467

Query: 611 VKLYYLNLSNNQF 623
             L  + L  N +
Sbjct: 468 TSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  176 bits (447), Expect = 4e-47
 Identities = 104/518 (20%), Positives = 175/518 (33%), Gaps = 55/518 (10%)

Query: 189 ENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSL 248
           +NGL   +P  L       I+ +  N +S    S+I +L  L  L + +N++        
Sbjct: 9   KNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVF 65

Query: 249 GNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL-SGSIPSEMGNLKSLYGLGL 307
                L  LDL  N L     +S     NL  L+L  N+  +  I  E GN+  L  LGL
Sbjct: 66  KFNQELEYLDLSHNKLVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122

Query: 308 SFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS 367
           S   L  S    + +L    +L +                                    
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETY--------------------------GEKED 156

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
              L +  T  L     +      I +++  +   L  + +          +      S 
Sbjct: 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK--------CVLEDNKCSY 208

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESF 487
           + + L+        + + L  +  ++N     I  L   T +    +    L G +    
Sbjct: 209 FLSILAKLQTNPKLSNLTLNNIETTWNSFIR-ILQLVWHTTVWYFSISNVKLQGQLDFRD 267

Query: 488 GIHSN-----LSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLK 542
             +S      LS   +    F    S+ +  F N+   + + +    +            
Sbjct: 268 FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFL 327

Query: 543 VLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG---SLIQLEHLDLSSNRL 599
            LD S+N +   +    G L  L  L L  NQ   +L         +  L+ LD+S N +
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSV 386

Query: 600 SNSIP-GSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSM 658
           S     G       L  LN+S+N  +  I   L     +  LDL  N + + IP QV  +
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLHSNKI-KSIPKQVVKL 443

Query: 659 QSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
           ++L++LN+A N L       F  +  L  I +  N   
Sbjct: 444 EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  153 bits (389), Expect = 2e-39
 Identities = 90/490 (18%), Positives = 166/490 (33%), Gaps = 68/490 (13%)

Query: 211 LYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL 270
              N L   +P ++   +  + L +  N +S      + +L  L  L +  N +      
Sbjct: 7   RSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDIS 63

Query: 271 SFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL-SGSIPSSLGNLTKLTIL 329
            F     L+ L+L HN L   I        +L  L LSFN   +  I    GN+++L  L
Sbjct: 64  VFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFL 120

Query: 330 YLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIP 389
            LS   L  S    I +L     L +               L +  T  L     +    
Sbjct: 121 GLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE--DPEGLQDFNTESLHIVFPTNKEF 178

Query: 390 SEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLL 449
             I +++  +   L  + +   +  +  +    I+  + +N                 L 
Sbjct: 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNP---------------KLS 223

Query: 450 VLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISF 509
            L+ N ++        + +L                    H+ + Y ++S+ K  G++ F
Sbjct: 224 NLTLNNIETTWNSFIRILQLVW------------------HTTVWYFSISNVKLQGQLDF 265

Query: 510 DWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLT 569
                      D S  ++             L +  + S+              ++    
Sbjct: 266 R--------DFDYSGTSLK-----------ALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306

Query: 570 LNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPI 629
              +            +    HLD S+N L++++  + G+L +L  L L  NQ   E+  
Sbjct: 307 FTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSK 365

Query: 630 KLEKFIHLS---DLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
             E    +     LD+S N +  +     CS  +SL  LN++ N L+  I RC      +
Sbjct: 366 IAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRI 423

Query: 686 VYIDISYNKL 695
             +D+  NK+
Sbjct: 424 KVLDLHSNKI 433

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  146 bits (370), Expect = 4e-37
 Identities = 90/427 (21%), Positives = 156/427 (36%), Gaps = 28/427 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSF-SGTIPPQIGN 154
           I  L    F     L YLDL  N++  I      N   LK+LDLS N+F +  I  + GN
Sbjct: 57  IQYLDISVFKFNQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFDALPICKEFGN 113

Query: 155 LSMLKILYLSTNQFSGRIPPQIGHLSYLK-ALHLFENGLSGSIPPSLGNL--TNLAIMYL 211
           +S LK L LST          I HL+  K  L L E       P  L +    +L I++ 
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173

Query: 212 YNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLAT------LDLHDNSLS 265
            N      +   +  + +L    +            L  L  L T      L L++   +
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233

Query: 266 GSI---PLSFGNLTNLDILNLPHNSLSGSIPSEMG-----NLKSLYGLGLSFNKLSGSIP 317
            +     L     T +   ++ +  L G +          +LK+L    +  +       
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293

Query: 318 SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL 377
                 + + I   + +            +    +L+  +N L+ ++  + G+LT L TL
Sbjct: 294 YIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETL 353

Query: 378 YLFTNLLSGSIPSEIG---NLNSLSDLGLSENELSGSIPY-SFGNLTNMIVLSIYSNALS 433
            L  N L   +         + SL  L +S+N +S            +++ L++ SN L+
Sbjct: 354 ILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILT 412

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
             I +      ++ +L L  N+++     +  L  L  + +  N L       F   ++L
Sbjct: 413 DTIFRCL--PPRIKVLDLHSNKIKSIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSL 470

Query: 494 SYINLSH 500
             I L  
Sbjct: 471 QKIWLHT 477

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  123 bits (310), Expect = 2e-29
 Identities = 67/376 (17%), Positives = 132/376 (35%), Gaps = 27/376 (7%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPP---QIGNLSMLKI 160
           F +   L +L L    +       IA+ +  K L +   ++     P   Q  N   L I
Sbjct: 111 FGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHI 170

Query: 161 LYLSTNQFSGRIPPQIGHLSYLKALHLFEN------GLSGSIPPSLGNLTNLAIMYLYNN 214
           ++ +  +F   +   +  ++ L+  ++             SI   L     L+ + L N 
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNI 230

Query: 215 SLSGSIPSEIGNLKSLSGLE--------LGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG 266
             + +    I  L   + +         L           S  +L  L+   +  +    
Sbjct: 231 ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGF 290

Query: 267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
                +   +N++I N   +            +     L  S N L+ ++  + G+LT+L
Sbjct: 291 PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL 350

Query: 327 TILYLSDNLLFGSIPCEIG---NLRYLFYLELGDNKLSGSIPHSL-GNLTNLATLYLFTN 382
             L L  N L   +         ++ L  L++  N +S            +L +L + +N
Sbjct: 351 ETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409

Query: 383 LLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YG 441
           +L+ +I   +     +  L L  N++  SIP     L  +  L++ SN L  ++P   + 
Sbjct: 410 ILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFD 465

Query: 442 NLVKLTLLVLSYNQLQ 457
            L  L  + L  N   
Sbjct: 466 RLTSLQKIWLHTNPWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  121 bits (306), Expect = 5e-29
 Identities = 76/426 (17%), Positives = 135/426 (31%), Gaps = 43/426 (10%)

Query: 280 ILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGS 339
           +++   N L   +P      +    L +S N +S    S + +L+KL IL +S N +   
Sbjct: 4   LVDRSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI-QY 59

Query: 340 IPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLL-SGSIPSEIGNLNS 397
           +   +    + L YL+L  NKL   I        NL  L L  N   +  I  E GN++ 
Sbjct: 60  LDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQ 116

Query: 398 LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL- 456
           L  LGLS   L  S      +L    VL +          ++   L       L      
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIVFPT 174

Query: 457 QGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPN 516
                 + +++      L+ +++   + ++   +       L                  
Sbjct: 175 NKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN--------PKLSNLT 226

Query: 517 LGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFS 576
           L  ++ + N+   IL          +++  ++               S+  + L      
Sbjct: 227 LNNIETTWNSFIRIL----------QLVWHTTVWYF-----------SISNVKLQGQLDF 265

Query: 577 GQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIH 636
                   SL  L    + S+               +   N + +       +   K   
Sbjct: 266 RDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISP 325

Query: 637 LSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS--GFIPRCFKEMHGLVYIDISYNK 694
              LD S+N L + +      +  LE L L  N L     I     +M  L  +DIS N 
Sbjct: 326 FLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385

Query: 695 LHGPIP 700
           +     
Sbjct: 386 VSYDEK 391

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  112 bits (282), Expect = 5e-26
 Identities = 61/322 (18%), Positives = 113/322 (35%), Gaps = 25/322 (7%)

Query: 48  LQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSF 107
           +   N +  F+   ++     +       I C       S  L+    + T    S  + 
Sbjct: 171 VFPTNKEFHFILDVSVKTVANLE---LSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTL 227

Query: 108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLS-----MLKILY 162
            ++        +I      Q+  ++ + Y  +S+    G +  +  + S      L I  
Sbjct: 228 NNIETTWNSFIRIL-----QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS 222
           + ++ F           S +   +   +G           ++    +   NN L+ ++  
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFE 342

Query: 223 EIGNLKSLSGLELGYNKLSGSMPLSLG---NLPNLATLDLHDNSLSGSIP-LSFGNLTNL 278
             G+L  L  L L  N+L   +         + +L  LD+  NS+S            +L
Sbjct: 343 NCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401

Query: 279 DILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
             LN+  N L+ +I   +   +K L    L  NK+  SIP  +  L  L  L ++ N L 
Sbjct: 402 LSLNMSSNILTDTIFRCLPPRIKVLD---LHSNKIK-SIPKQVVKLEALQELNVASNQL- 456

Query: 338 GSIPCEI-GNLRYLFYLELGDN 358
            S+P  I   L  L  + L  N
Sbjct: 457 KSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  108 bits (270), Expect = 2e-24
 Identities = 58/367 (15%), Positives = 120/367 (32%), Gaps = 30/367 (8%)

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGS 411
            L +  N +S      + +L+ L  L +  N +     S       L  L LS N+L   
Sbjct: 25  ILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-K 83

Query: 412 IPYSFGNLTNMIVLSIYSNAL-SGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLA 470
           I        N+  L +  NA  +  I KE+GN+ +L  L LS   L+     +  +  L 
Sbjct: 84  IS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKS--SVLPIAHLN 139

Query: 471 RVRLDRNHLTGNIS-ESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITG 529
             ++           E      + +  +L       +              ++  +NI  
Sbjct: 140 ISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 530 ILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLI-- 587
           +L             + +       I ++L     L  LTLN  + +      +  L+  
Sbjct: 200 VL-------------EDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWH 246

Query: 588 -QLEHLDLSSNRL-----SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLD 641
             + +  +S+ +L           S  +L  L    + ++ F        E F +++  +
Sbjct: 247 TTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKN 306

Query: 642 LSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIP 700
            + +     +     S +     L+ ++N L+  +      +  L  + +  N+L     
Sbjct: 307 FTVSGT-RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSK 365

Query: 701 NSAAFKH 707
            +     
Sbjct: 366 IAEMTTQ 372

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  180 bits (459), Expect = 1e-50
 Identities = 71/287 (24%), Positives = 124/287 (43%), Gaps = 34/287 (11%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D      +G G  G   +     +GE++ +K+       E T Q+ FL EVK +  + H
Sbjct: 10   SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEET-QRTFLKEVKVMRCLEH 66

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             N++KF G     +    + EY++ G+L  I+ +     +  W+QR++  K +A  ++YL
Sbjct: 67   PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYL 124

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL--------------KPDSSNWTE 970
            H+     I++RD++S N L+       V+DFG+++ +              KPD      
Sbjct: 125  HS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT 181

Query: 971  LAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE 1030
            + G   ++APE+       EK DV+SFG++  E I   +              +D  L+ 
Sbjct: 182  VVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-----LPRTMDFGLNV 236

Query: 1031 ILDPRLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    P  C        I      C D +P+ RP+  K+   L+
Sbjct: 237  RGFLDRYCPPNCP--PSFFPITV---RCCDLDPEKRPSFVKLEHWLE 278

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  178 bits (454), Expect = 3e-50
 Identities = 72/276 (26%), Positives = 131/276 (47%), Gaps = 20/276 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
                    IG+G  G+VY+ +   G+ VAVK  +    +     Q F NEV  L + RH 
Sbjct: 24   GQITVGQRIGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHV 80

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI+ F G+ +  + + IV ++ E  SL   L  + +  +    + +++ +  A  + YLH
Sbjct: 81   NILLFMGYSTAPQLA-IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLH 137

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS--KSLKPDSSNWTELAGTIGYVAPEL- 982
                  I++RD+ S N+ L  +    + DFG++  KS    S  + +L+G+I ++APE+ 
Sbjct: 138  A---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 983  --AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
                +   + +SDVY+FG++  E + G+ P   I++       + R     L P L    
Sbjct: 195  RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR---GSLSPDLSKVR 251

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             N   ++  +M     CL +  D RP+  ++   ++
Sbjct: 252  SNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIE 284

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  186 bits (474), Expect = 6e-50
 Identities = 76/330 (23%), Positives = 133/330 (40%), Gaps = 47/330 (14%)

Query: 127 QIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALH 186
           +   N+    L++  +  + T+P  +     +  L +  N  +  +P     L   + L 
Sbjct: 35  RACLNNGNAVLNVGESGLT-TLPDCLPAH--ITTLVIPDNNLT-SLPALPPEL---RTLE 87

Query: 187 LFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPL 246
           +  N L+ S+P     L  L+I       L    P+    L     L +  N+L+ S+P+
Sbjct: 88  VSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSGLCK---LWIFGNQLT-SLPV 138

Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLG 306
                  L  L + DN L+ S+P     L  L   N   N L+ S+P     L+ L    
Sbjct: 139 LPP---GLQELSVSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQELS--- 187

Query: 307 LSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH 366
           +S N+L+ S+P+    L KL       N    S+P     L+    L +  N+L+ S+P 
Sbjct: 188 VSDNQLA-SLPTLPSELYKLWAY----NNRLTSLPALPSGLK---ELIVSGNRLT-SLPV 238

Query: 367 SLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLS 426
               L     L +  N L+ S+P     L SLS   +  N+L+  +P S  +L++   ++
Sbjct: 239 LPSELKE---LMVSGNRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVN 290

Query: 427 IYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           +  N LS     +     ++T        +
Sbjct: 291 LEGNPLS-ERTLQALR--EITSAPGYSGPI 317

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  177 bits (449), Expect = 1e-46
 Identities = 77/345 (22%), Positives = 131/345 (37%), Gaps = 43/345 (12%)

Query: 105 SSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS 164
               H+  L +  N +   +P+       L+ L++S N  + ++P     L  L I    
Sbjct: 58  CLPAHITTLVIPDNNL-TSLPALPPE---LRTLEVSGNQLT-SLPVLPPGLLELSIFSNP 112

Query: 165 TNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI 224
                  +P        L  L +F N L+ S+P     L  L    + +N L+ S+P+  
Sbjct: 113 LTHLP-ALPSG------LCKLWIFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPALP 160

Query: 225 GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLP 284
             L     L    N+L+ S+P+       L  L + DN L+ S+P     L  L   N  
Sbjct: 161 SELCK---LWAYNNQLT-SLPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNR 212

Query: 285 HNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI 344
             SL    P+    LK L    +S N+L+ S+P     L +   L +S N L  S+P   
Sbjct: 213 LTSL----PALPSGLKELI---VSGNRLT-SLPVLPSELKE---LMVSGNRL-TSLPMLP 260

Query: 345 GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLS 404
             L  L    +  N+L+  +P SL +L++  T+ L  N LS      +  + S       
Sbjct: 261 SGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316

Query: 405 ENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLL 449
                 +   +      + + +  ++ L  A   E     +  + 
Sbjct: 317 IIRFDMAGASAPRETRALHLAA--ADWLVPAREGEPAPADRWHMF 359

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  173 bits (441), Expect = 1e-45
 Identities = 86/422 (20%), Positives = 145/422 (34%), Gaps = 94/422 (22%)

Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL 312
             A L++ ++ L+ ++P       ++  L +P N+L+ S+P+    L++L    +S N+L
Sbjct: 41  GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTLE---VSGNQL 93

Query: 313 SGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLT 372
           + S+P     L +L+I           +P     L  L    +  N+L+ S+P     L 
Sbjct: 94  T-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQLT-SLPVLPPGLQ 144

Query: 373 NLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNAL 432
            L    +  N L+ S+P+    L  L       N+L+ S+P     L     LS+  N L
Sbjct: 145 EL---SVSDNQLA-SLPALPSELCKLW---AYNNQLT-SLPMLPSGLQE---LSVSDNQL 193

Query: 433 SGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSN 492
           + ++P     L KL       N+L                      L    S        
Sbjct: 194 A-SLPTLPSELYKLWAY---NNRL--------------------TSLPALPS-------- 221

Query: 493 LSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIV 552
                                   L  L VS N +T  LP       +LK L +S N + 
Sbjct: 222 -----------------------GLKELIVSGNRLTS-LPVLPS---ELKELMVSGNRLT 254

Query: 553 GEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK 612
             +P     L SL   ++ RNQ + +LP  L  L     ++L  N LS     +L  +  
Sbjct: 255 -SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309

Query: 613 LYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
               +    +F         +   L       ++L      +              +N  
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALHLAAA--DWLVPAREGEPAPADRWHMFG-QEDNAD 366

Query: 673 GF 674
            F
Sbjct: 367 AF 368

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  162 bits (412), Expect = 6e-42
 Identities = 78/336 (23%), Positives = 129/336 (38%), Gaps = 44/336 (13%)

Query: 105 SSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS 164
           +  P L  L++  NQ+   +P       +L             +P        L  L++ 
Sbjct: 78  ALPPELRTLEVSGNQL-TSLPVLPPGLLELSIFSNPLTH----LPALPSG---LCKLWIF 129

Query: 165 TNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI 224
            NQ +  +P     L     L + +N L+ S+P     L  L   + YNN L+ S+P   
Sbjct: 130 GNQLT-SLPVLPPGLQE---LSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLP 180

Query: 225 GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLP 284
             L+ LS   +  N+L+ S+P     L     L  ++N L+ S+P     L  L +    
Sbjct: 181 SGLQELS---VSDNQLA-SLPTLPSELYK---LWAYNNRLT-SLPALPSGLKELIVSG-- 230

Query: 285 HNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI 344
            N L+ S+P     LK L    +S N+L+ S+P     L     L +  N L   +P  +
Sbjct: 231 -NRLT-SLPVLPSELKELM---VSGNRLT-SLPMLPSGLLS---LSVYRNQL-TRLPESL 280

Query: 345 GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLY---LFTNLLSGSIPSEIGNLNSLSDL 401
            +L     + L  N LS     +L  +T+        +  ++   S P E   L+  +  
Sbjct: 281 IHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAAD 340

Query: 402 GLSENELSGSIP----YSFGNLTNMIVLSIYSNALS 433
            L         P    + FG   N    S++ + LS
Sbjct: 341 WLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  155 bits (393), Expect = 2e-39
 Identities = 80/387 (20%), Positives = 132/387 (34%), Gaps = 91/387 (23%)

Query: 299 LKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDN 358
                 L +  + L+ ++P  L     +T L + DN L  S+P     LR L   E+  N
Sbjct: 39  NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNL-TSLPALPPELRTL---EVSGN 91

Query: 359 KLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGN 418
           +L+ S+P     L  L+            +P+    L  L    +  N+L+ S+P     
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLT----HLPALPSGLCKLW---IFGNQLT-SLPVLPPG 142

Query: 419 LTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNH 478
           L     LS+  N L+ ++P     L KL       NQL   +P L               
Sbjct: 143 LQE---LSVSDNQLA-SLPALPSELCKLWA---YNNQLTS-LPML--------------- 179

Query: 479 LTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS 538
                                                 L  L VS N +   LP      
Sbjct: 180 -----------------------------------PSGLQELSVSDNQLA-SLPTLPS-- 201

Query: 539 PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
            +L  L   +N +   +P+    L+ LI   ++ N+ +  LP       +L+ L +S NR
Sbjct: 202 -ELYKLWAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPS---ELKELMVSGNR 252

Query: 599 LSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSM 658
           L+ S+P     L+ L   ++  NQ +  +P  L      + ++L  N L E     +  +
Sbjct: 253 LT-SLPMLPSGLLSL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307

Query: 659 QSLEKLNLAHNNLSGFIPRCFKEMHGL 685
            S    +              +E   L
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRAL 334

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  149 bits (378), Expect = 1e-37
 Identities = 67/321 (20%), Positives = 115/321 (35%), Gaps = 45/321 (14%)

Query: 103 SFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILY 162
                  L+     +      +P+  +    L  L +  N  + ++P        L+ L 
Sbjct: 99  LPPGLLELSIFSNPLTH----LPALPSG---LCKLWIFGNQLT-SLPVLPPG---LQELS 147

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS 222
           +S NQ +  +P     L  L A +   N L+ S+P     L  L    + +N L+ S+P+
Sbjct: 148 VSDNQLA-SLPALPSELCKLWAYN---NQLT-SLPMLPSGLQEL---SVSDNQLA-SLPT 198

Query: 223 EIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
               L     L    N+L+ S+P        L  L +  N L+ S+P+    L  L +  
Sbjct: 199 LPSELYK---LWAYNNRLT-SLPALPS---GLKELIVSGNRLT-SLPVLPSELKELMVSG 250

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
              N L+ S+P     L SL    +  N+L+  +P SL +L+  T + L  N L      
Sbjct: 251 ---NRLT-SLPMLPSGLLSLS---VYRNQLT-RLPESLIHLSSETTVNLEGNPL-SERTL 301

Query: 343 EIGNLRYLFYLELG----DNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE----IGN 394
           +            G     +    S P     L   A  +L         P++     G 
Sbjct: 302 QALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQ 361

Query: 395 LNSLSDLGLSENELSGSIPYS 415
            ++     L  + LS +  + 
Sbjct: 362 EDNADAFSLFLDRLSETENFI 382

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  176 bits (449), Expect = 3e-49
 Identities = 57/290 (19%), Positives = 107/290 (36%), Gaps = 43/290 (14%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
               +    IG G  G VY      GE VA++       +E    + F  EV +  + RH 
Sbjct: 33   EQLEIGELIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQ-LKAFKREVMAYRQTRHE 89

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            N+V F G C    H  I+    +  +L  ++ +A     L   +   + + +   + YLH
Sbjct: 90   NVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLH 147

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK-----SLKPDSSNWTELAGTIGYVAP 980
                  I+++D+ SKNV  D   +  ++DFG+                    G + ++AP
Sbjct: 148  A---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 981  EL---------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI 1031
            E+            +  ++ SDV++ G +  E    + P               +  + I
Sbjct: 204  EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK------------TQPAEAI 251

Query: 1032 L-----DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +       +       +  ++  I+     C     + RPT  K+  +L+
Sbjct: 252  IWQMGTGMKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLE 298

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  171 bits (435), Expect = 1e-47
 Identities = 70/298 (23%), Positives = 122/298 (40%), Gaps = 44/298 (14%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
              C+G G  G V+R     GE VAVK F S         +E   E+ +   +RH NI+ F
Sbjct: 13   LECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSW--FRET--ELYNTVMLRHENILGF 67

Query: 871  YGFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                  +RHS    +++  Y EMGSL   L   T    L     + ++  +A  L++LH 
Sbjct: 68   IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHI 123

Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS----NWTELAGTIGY 977
            + F     P I +RD+ SKN+L+    +  ++D G++      ++          GT  Y
Sbjct: 124  EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 978  VAPEL------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC---STSSNLDRTL 1028
            +APE+             ++ D+++FG++  E  +       +             D + 
Sbjct: 184  MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 1029 DEILD--------PRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +++          P +P    S      L  +M+    C  +NP +R T  ++ + L 
Sbjct: 244  EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK---ECWYQNPSARLTALRIKKTLT 298

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  171 bits (436), Expect = 9e-47
 Identities = 78/391 (19%), Positives = 133/391 (34%), Gaps = 47/391 (12%)

Query: 260 HDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSS 319
                   I  +         +++   +       E   L +   +    + +     + 
Sbjct: 5   PRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL 64

Query: 320 LGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLY 378
           L +  ++ +L L+D  +   I          +  L +G N +    PH   N+  L  L 
Sbjct: 65  LDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 123

Query: 379 LFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
           L  N LS S+P  I  N   L+ L +S N L      +F   T++  L + SN L+  + 
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD 181

Query: 438 KEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
                +  L    +SYN L   +     +  L       N +                  
Sbjct: 182 L--SLIPSLFHANVSYNLLST-LAIPIAVEEL---DASHNSIN----------------- 218

Query: 498 LSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPS 557
                              L  L +  NN+T      + + P L  +DLS N +  +I  
Sbjct: 219 ----------VVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMY 265

Query: 558 E-LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYL 616
               K++ L +L ++ N+    L      +  L+ LDLS N L   +  +     +L  L
Sbjct: 266 HPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENL 323

Query: 617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFL 647
            L +N       +KL     L +L LSHN  
Sbjct: 324 YLDHNSIV---TLKLSTHHTLKNLTLSHNDW 351

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  168 bits (427), Expect = 1e-45
 Identities = 68/353 (19%), Positives = 135/353 (38%), Gaps = 31/353 (8%)

Query: 86  NSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFS 145
             I++ +  +      F   +  +   +  + + +  +  + + +  +++ L+L+     
Sbjct: 26  VHIDMQTQDV---YFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82

Query: 146 GTIPPQI-GNLSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GN 202
             I          ++ LY+  N     +PP +  ++  L  L L  N LS S+P  +  N
Sbjct: 83  -EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139

Query: 203 LTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
              L  + + NN+L   I  +      SL  L+L  N+L+    + L  +P+L   ++  
Sbjct: 140 TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPSLFHANVSY 195

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG 321
           N LS     +      ++ L+  HNS++  +         L  L L  N L+    + L 
Sbjct: 196 NLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTD--TAWLL 245

Query: 322 NLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLF 380
           N   L  + LS N L   I       ++ L  L + +N+L  ++      +  L  L L 
Sbjct: 246 NYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303

Query: 381 TNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
            N L   +       + L +L L  N +  ++         +  L++  N   
Sbjct: 304 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  168 bits (427), Expect = 1e-45
 Identities = 73/364 (20%), Positives = 131/364 (35%), Gaps = 27/364 (7%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYL 182
           I S +  +     + +   +       +   L+  KI+    +    ++P  +      +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 183 KALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKL 240
           + L+L +  +   I   +      +  +Y+  N++   +P  +  N+  L+ L L  N L
Sbjct: 72  ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129

Query: 241 SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLK 300
           S        N P L TL + +N+L      +F   T+L  L L  N L+  +      + 
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIP 186

Query: 301 SLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKL 360
           SL+   +S+N L     S+L     +  L  S N +   +         L  L+L  N L
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSI-NVVR--GPVNVELTILKLQHNNL 238

Query: 361 SGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNL 419
           +      L N   L  + L  N L   I       +  L  L +S N L  ++      +
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNH 478
             + VL +  N L   + +      +L  L L +N +    +     L  L    L  N 
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL---TLSHND 350

Query: 479 LTGN 482
              N
Sbjct: 351 WDCN 354

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  167 bits (426), Expect = 2e-45
 Identities = 78/391 (19%), Positives = 143/391 (36%), Gaps = 24/391 (6%)

Query: 333 DNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
               +  I   +      + + +               L N   +    + +   +P+ +
Sbjct: 6   RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAAL 64

Query: 393 -GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVL 451
             +   +  L L++ ++     Y+F     +  L +  NA+    P  + N+  LT+LVL
Sbjct: 65  LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 124

Query: 452 SYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISF 509
             N L   +P     N  +L  + +  N+L     ++F   ++L  + LS  +       
Sbjct: 125 ERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL---THV 180

Query: 510 DWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLT 569
           D    P+L   +VS N ++      +     ++ LD S N I   +   +     L  L 
Sbjct: 181 DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILK 232

Query: 570 LNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPI 629
           L  N  +      L +   L  +DLS N L   +      + +L  L +SNN+    + +
Sbjct: 233 LQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNL 289

Query: 630 KLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYID 689
             +    L  LDLSHN L   +         LE L L HN++   +       H L  + 
Sbjct: 290 YGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLT 345

Query: 690 ISYNKLHGPIPNSAAFKHAPMEALQGNKGLC 720
           +S+N         A F++    A+      C
Sbjct: 346 LSHNDWD-CNSLRALFRNVARPAVDDADQHC 375

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  163 bits (415), Expect = 6e-44
 Identities = 84/429 (19%), Positives = 145/429 (33%), Gaps = 68/429 (15%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
            I  +L        +++   +       E   L +   +    + +       L +   +
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71

Query: 255 ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG 314
             L+L+D  +      +F     +  L +  N++   +P                     
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP--------------------- 109

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
             P    N+  LT+L L  N L  S+P  I  N   L  L + +N L      +    T+
Sbjct: 110 --PHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 166

Query: 374 LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
           L  L L +N L+  +   +  + SL    +S N LS     +      +  L    N+++
Sbjct: 167 LQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 218

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
             +       V+LT+L L +N L      L N   L  V L  N L   +   F     L
Sbjct: 219 -VVRG--PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 274

Query: 494 SYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG 553
             + +S+                        N +  +        P LKVLDLS NH++ 
Sbjct: 275 ERLYISN------------------------NRLVAL-NLYGQPIPTLKVLDLSHNHLL- 308

Query: 554 EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS-NSIPGSLGNLVK 612
            +     +   L  L L+ N     L   L +   L++L LS N    NS+     N+ +
Sbjct: 309 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 365

Query: 613 LYYLNLSNN 621
               +   +
Sbjct: 366 PAVDDADQH 374

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  162 bits (413), Expect = 1e-43
 Identities = 75/392 (19%), Positives = 143/392 (36%), Gaps = 28/392 (7%)

Query: 101 DFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLK 159
           D +         + + +         +    +  K +   +++    +P  +  +   ++
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72

Query: 160 ILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPS-LGNLTNLAIMYLYNNSLS 217
           +L L+  Q    I      +   ++ L++  N +   +PP    N+  L ++ L  N LS
Sbjct: 73  LLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS 130

Query: 218 GSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLT 276
            S+P  I  N   L+ L +  N L      +     +L  L L  N L+    +    + 
Sbjct: 131 -SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIP 186

Query: 277 NLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL 336
           +L   N+ +N L     S +    ++  L  S N ++  +   +    +LTIL L  N L
Sbjct: 187 SLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL 238

Query: 337 FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLN 396
                  + N   L  ++L  N+L   + H    +  L  LY+  N L  ++      + 
Sbjct: 239 -TDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295

Query: 397 SLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           +L  L LS N L   +  +      +  L +  N++   +         L  L LS+N  
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDW 351

Query: 457 QG--PIPDLRNLTRLARVRLDRNHLTGNISES 486
                    RN+ R A    D++       E 
Sbjct: 352 DCNSLRALFRNVARPAVDDADQHCKIDYQLEH 383

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  160 bits (407), Expect = 6e-43
 Identities = 68/359 (18%), Positives = 129/359 (35%), Gaps = 21/359 (5%)

Query: 172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSL 230
           I   + +      +H+               L N  I+   N+++   +P+ +  + + +
Sbjct: 13  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71

Query: 231 SGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSG 290
             L L   ++      +      +  L +  N++    P  F N+  L +L L  N LS 
Sbjct: 72  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130

Query: 291 SIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRY 349
           S+P  +  N   L  L +S N L      +    T L  L LS N L   +   +  +  
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPS 187

Query: 350 LFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELS 409
           LF+  +  N LS     +L     +  L    N ++  +   +     L+ L L  N L+
Sbjct: 188 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 239

Query: 410 GSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRL 469
                   N   ++ + +  N L   +   +  + +L  L +S N+L       + +  L
Sbjct: 240 -DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTL 297

Query: 470 ARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
             + L  NHL  ++  +      L  + L H      ++        L  L +S N+  
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI---VTLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  159 bits (405), Expect = 1e-42
 Identities = 75/357 (21%), Positives = 135/357 (37%), Gaps = 23/357 (6%)

Query: 147 TIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPS-LGNLTN 205
            I   +    +   +++           +   L+  K +    + +   +P + L +   
Sbjct: 12  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70

Query: 206 LAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL 264
           + ++ L +  +   I +       ++  L +G+N +    P    N+P L  L L  N L
Sbjct: 71  VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 129

Query: 265 SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNL 323
           S      F N   L  L++ +N+L   I  +      SL  L LS N+L+  +   L  +
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185

Query: 324 TKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNL 383
             L    +S NLL       +     +  L+   N ++  +   +     L  L L  N 
Sbjct: 186 PSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN 237

Query: 384 LSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNL 443
           L+      + N   L ++ LS NEL   + + F  +  +  L I +N L  A+      +
Sbjct: 238 LT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294

Query: 444 VKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
             L +L LS+N L     +     RL  + LD N +    +     H  L  + LSH
Sbjct: 295 PTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSH 348

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  169 bits (429), Expect = 1e-46
 Identities = 58/301 (19%), Positives = 110/301 (36%), Gaps = 16/301 (5%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYL 163
             +        +  + +   + S   +   +K LDLS N  S      +   + L++L L
Sbjct: 6   KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65

Query: 164 STNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
           S+N         +  LS L+ L L  N +       L    ++  ++  NN++S  +   
Sbjct: 66  SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS 117

Query: 224 IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG-SIPLSFGNLTNLDILN 282
               +    + L  NK++    L  G    +  LDL  N +   +      +   L+ LN
Sbjct: 118 R--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
           L +N +   +  ++     L  L LS NKL+  +     +   +T + L +N L   I  
Sbjct: 176 LQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-VLIEK 231

Query: 343 EIGNLRYLFYLELGDNKLS-GSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDL 401
            +   + L + +L  N    G++         + T+   T         E   + +L   
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291

Query: 402 G 402
           G
Sbjct: 292 G 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  162 bits (413), Expect = 2e-44
 Identities = 64/381 (16%), Positives = 121/381 (31%), Gaps = 67/381 (17%)

Query: 267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
           +I     N     I  +  +SL  ++ S   +  ++  L LS N LS    + L   TKL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
            +L LS N+L      ++ +L  L  L+L +N +       L    ++ TL+   N +S 
Sbjct: 61  ELLNLSSNVL-YETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSG-AIPKEYGNLVK 445
            +           ++ L+ N+++       G  + +  L +  N +      +   +   
Sbjct: 113 RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
           L  L L YN +   +       +L  + L  N L                          
Sbjct: 171 LEHLNLQYNFIYD-VKGQVVFAKLKTLDLSSNKLA------------------------- 204

Query: 506 EISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
                                    + PE   +  +  + L +N +V  I   L   ++L
Sbjct: 205 ------------------------FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 566 IKLTLNRNQFS-GQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
               L  N F  G L        +++ +   +      + G       +  L        
Sbjct: 240 EHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV---KKLTGQNEEECTVPTLGHYGAYCC 296

Query: 625 GEIPI-KLEKFIHLSDLDLSH 644
            ++P    ++ I L      H
Sbjct: 297 EDLPAPFADRLIALGHHHHHH 317

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  159 bits (404), Expect = 3e-43
 Identities = 60/336 (17%), Positives = 117/336 (34%), Gaps = 24/336 (7%)

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNL 278
           +I     N       ++  + L  ++     +  N+  LDL  N LS          T L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG 338
           ++LNL  N L      ++ +L +L  L L+ N +       L     +  L+ ++N +  
Sbjct: 61  ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNI-S 112

Query: 339 SIPCEIG-NLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG-SIPSEIGNLN 396
            + C  G   + ++   L +NK++       G  + +  L L  N +   +      + +
Sbjct: 113 RVSCSRGQGKKNIY---LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 397 SLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           +L  L L  N +   +         +  L + SN L+  +  E+ +   +T + L  N+L
Sbjct: 170 TLEHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL 226

Query: 457 QGPIPDLRNLTRLARVRLDRNHLT-GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFP 515
                 LR    L    L  N    G + + F  +  +  +     K     + +    P
Sbjct: 227 VLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 516 NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI 551
            L               P        +++ L  +H 
Sbjct: 287 TL----GHYGAYCCEDLPA---PFADRLIALGHHHH 315

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  158 bits (402), Expect = 5e-43
 Identities = 64/308 (20%), Positives = 112/308 (36%), Gaps = 18/308 (5%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
           +I     N     I  + ++SL  ++ S   +  ++  L+L  N LS      L     L
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 255 ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG 314
             L+L  N L         +L+ L  L+L +N +      E+    S+  L  + N +S 
Sbjct: 61  ELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS- 112

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG-SIPHSLGNLTN 373
            +  S         +YL++N +      + G    + YL+L  N++   +      +   
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 374 LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
           L  L L  N +   +  ++     L  L LS N+L+  +   F +   +  +S+ +N L 
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQ-GPIPDLR-NLTRLARVRLDRNH-LTGNISESFGIH 490
             I K       L    L  N    G + D      R+  V       LTG   E   + 
Sbjct: 228 -LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286

Query: 491 SNLSYINL 498
           +   Y   
Sbjct: 287 TLGHYGAY 294

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  157 bits (399), Expect = 1e-42
 Identities = 58/315 (18%), Positives = 104/315 (33%), Gaps = 21/315 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
           +         S  ++  LDL  N +  I  + +A  +KL+ L+LSSN         + +L
Sbjct: 22  LKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLDLESL 79

Query: 156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS 215
           S L+ L L+ N        ++     ++ LH   N +S  +  S         +YL NN 
Sbjct: 80  STLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKNIYLANNK 131

Query: 216 LSGSIPSEIGNLKSLSGLELGYNKLSG-SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN 274
           ++     + G    +  L+L  N++   +      +   L  L+L  N +   +      
Sbjct: 132 ITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-V 189

Query: 275 LTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
              L  L+L  N L+  +  E  +   +  + L  NKL   I  +L     L    L  N
Sbjct: 190 FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247

Query: 335 LLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGN 394
                     G LR  F        ++      L                      ++  
Sbjct: 248 GF------HCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA 301

Query: 395 LNSLSDLGLSENELS 409
             +   + L  +   
Sbjct: 302 PFADRLIALGHHHHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  147 bits (373), Expect = 3e-39
 Identities = 57/311 (18%), Positives = 106/311 (34%), Gaps = 62/311 (19%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
           +I     N N      ++++ L  ++     +  N+  L +  N LS     +     KL
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60

Query: 447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGE 506
            LL LS N L     DL +L+ L  + L+ N++                           
Sbjct: 61  ELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-------------------------- 93

Query: 507 ISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLI 566
                                      E+   P ++ L  ++N+I   +       +   
Sbjct: 94  ---------------------------ELLVGPSIETLHAANNNI-SRVSCSR--GQGKK 123

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN-SIPGSLGNLVKLYYLNLSNNQFSG 625
            + L  N+ +     + G   ++++LDL  N +   +      +   L +LNL  N    
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
           ++      F  L  LDLS N L   +  +  S   +  ++L +N L   I +  +    L
Sbjct: 183 DVK-GQVVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239

Query: 686 VYIDISYNKLH 696
            + D+  N  H
Sbjct: 240 EHFDLRGNGFH 250

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  106 bits (268), Expect = 3e-25
 Identities = 32/177 (18%), Positives = 69/177 (38%), Gaps = 11/177 (6%)

Query: 531 LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLE 590
           +     +  + K+  ++ + +   + S      ++ +L L+ N  S     +L    +LE
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61

Query: 591 HLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEE 650
            L+LSSN L       L +L  L  L+L+NN        +L     +  L  ++N +   
Sbjct: 62  LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113

Query: 651 IPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKH 707
           +       Q  + + LA+N ++            + Y+D+  N++   +  +     
Sbjct: 114 VSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT-VNFAELAAS 167

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  167 bits (426), Expect = 4e-46
 Identities = 73/340 (21%), Positives = 126/340 (37%), Gaps = 60/340 (17%)

Query: 771  SSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSG 830
               Q+Q S +G+    L   T  ++I   +             IG G  G V+  +   G
Sbjct: 14   LIEQSQSSGSGSGLPLLVQRTIAKQIQMVK------------QIGKGRYGEVWMGKWR-G 60

Query: 831  EIVAVKKFHSPLLSEMTCQQEFLNEVK--SLTEIRHRNIVKFYGFCSHARHS----FIVY 884
            E VAVK F +        +  +  E +      +RH NI+ F         S    +++ 
Sbjct: 61   EKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLIT 114

Query: 885  EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF-----PPIVYRDISS 939
            +Y E GSL   L + T    L     + +       L +LH + F     P I +RD+ S
Sbjct: 115  DYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKS 170

Query: 940  KNVLLDLEYEAHVSDFGISKSLKPDSSNW----TELAGTIGYVAPEL------AYTMKVT 989
            KN+L+       ++D G++     D++          GT  Y+ PE+          +  
Sbjct: 171  KNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSY 230

Query: 990  EKSDVYSFGVLALEAIKGKHPRDFISSIC---STSSNLDRTLDEILDP------RLPAPS 1040
              +D+YSFG++  E  +       +             D + +++ +       R   P+
Sbjct: 231  IMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290

Query: 1041 CNIRD----KLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                D    ++  +M     C   NP SR T  +V + L 
Sbjct: 291  RWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (426), Expect = 5e-46
 Identities = 72/339 (21%), Positives = 124/339 (36%), Gaps = 60/339 (17%)

Query: 772  SSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGE 831
                  S +G+    L   T  R I  +E             IG G  G V+R +   GE
Sbjct: 20   IYDMTTSGSGSGLPLLVQRTIARTIVLQE------------SIGKGRFGEVWRGKWR-GE 66

Query: 832  IVAVKKFHSPLLSEMTCQQEFLNE--VKSLTEIRHRNIVKFYGFCSHARHS----FIVYE 885
             VAVK F S         + +  E  +     +RH NI+ F    +    +    ++V +
Sbjct: 67   EVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 120

Query: 886  YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF-----PPIVYRDISSK 940
            Y E GSL   L+  T    +     + +    A  L++LH +       P I +RD+ SK
Sbjct: 121  YHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSK 176

Query: 941  NVLLDLEYEAHVSDFGISKSLKPDSS----NWTELAGTIGYVAPEL------AYTMKVTE 990
            N+L+       ++D G++      +           GT  Y+APE+          +  +
Sbjct: 177  NILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 236

Query: 991  KSDVYSFGVLALEAIKGKHPRDFISSIC---STSSNLDRTLDEILD--------PRLPA- 1038
            ++D+Y+ G++  E  +                     D +++E+          P +P  
Sbjct: 237  RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR 296

Query: 1039 -PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              SC     +  IM     C   N  +R T  ++ + L 
Sbjct: 297  WQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  164 bits (416), Expect = 2e-43
 Identities = 76/316 (24%), Positives = 130/316 (41%), Gaps = 14/316 (4%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYL 182
           +P  I   ++ + LDL  N        +  +   L+ L L+ N  S  + P    +L  L
Sbjct: 26  VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNL 82

Query: 183 KALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKL 240
           + L L  N L   IP      L+NL  + +  N +   +   +  +L +L  LE+G N L
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140

Query: 241 SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNL 299
                 +   L +L  L L   +L+     +  +L  L +L L H +++ +I       L
Sbjct: 141 VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRL 199

Query: 300 KSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCE-IGNLRYLFYLELGDN 358
             L  L +S      ++  +      LT L ++   L  ++P   + +L YL +L L  N
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVRHLVYLRFLNLSYN 258

Query: 359 KLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFG 417
            +S      L  L  L  + L    L+  +       LN L  L +S N+L+      F 
Sbjct: 259 PISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFH 317

Query: 418 NLTNMIVLSIYSNALS 433
           ++ N+  L + SN L+
Sbjct: 318 SVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  161 bits (408), Expect = 3e-42
 Identities = 83/297 (27%), Positives = 134/297 (45%), Gaps = 14/297 (4%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I TL+   F+SFPHL  L+L  N +  + P    N   L+ L L SN     IP  +   
Sbjct: 44  IKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTG 102

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLY 212
           LS L  L +S N+    +   +   L  LK+L + +N L   I   +   L +L  + L 
Sbjct: 103 LSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLE 160

Query: 213 NNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLS 271
             +L+ SIP+E   +L  L  L L +  ++     S   L  L  L++       ++  +
Sbjct: 161 KCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN 219

Query: 272 FGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILY 330
                NL  L++ H +L+ ++P     +L  L  L LS+N +S    S L  L +L  + 
Sbjct: 220 CLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQ 278

Query: 331 LSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSL-GNLTNLATLYLFTNLLS 385
           L    L   +       L YL  L +  N+L+ ++  S+  ++ NL TL L +N L+
Sbjct: 279 LVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  150 bits (380), Expect = 1e-38
 Identities = 76/348 (21%), Positives = 130/348 (37%), Gaps = 34/348 (9%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI 412
           +     +   ++P  +   T    L L  N +      E  +   L +L L+EN +S   
Sbjct: 16  VLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72

Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVKLTLLVLSYNQLQGPIPD--LRNLTRL 469
           P +F NL N+  L + SN L   IP   +  L  LT L +S N++   + D   ++L  L
Sbjct: 73  PGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNL 130

Query: 470 ARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITG 529
             + +  N L                  +SH+ F G          +L  L +   N+T 
Sbjct: 131 KSLEVGDNDLV----------------YISHRAFSG--------LNSLEQLTLEKCNLTS 166

Query: 530 ILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQL 589
           I    +     L VL L   +I         +L  L  L ++   +   +       + L
Sbjct: 167 IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE 649
             L ++   L+     ++ +LV L +LNLS N  S      L + + L ++ L    L  
Sbjct: 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-A 285

Query: 650 EIPSQVCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
            +       +  L  LN++ N L+      F  +  L  + +  N L 
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  110 bits (278), Expect = 1e-25
 Identities = 44/196 (22%), Positives = 75/196 (38%), Gaps = 12/196 (6%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNR 572
                 LD+  N I  +   E    P L+ L+L+ N +   +       L +L  L L  
Sbjct: 31  PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRS 89

Query: 573 NQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
           N+    +P      L  L  LD+S N++   +     +L  L  L + +N     I  + 
Sbjct: 90  NRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRA 147

Query: 632 EKFIHLS---DLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVY 687
             F  L+    L L    L   IP++    +  L  L L H N++      FK ++ L  
Sbjct: 148 --FSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKV 204

Query: 688 IDISYNKLHGPIPNSA 703
           ++IS+      +  + 
Sbjct: 205 LEISHWPYLDTMTPNC 220

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  163 bits (415), Expect = 2e-42
 Identities = 86/487 (17%), Positives = 167/487 (34%), Gaps = 35/487 (7%)

Query: 132 SKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENG 191
            + +Y           I   +    +   +++           +   L+  K +    + 
Sbjct: 3   GQQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNST 62

Query: 192 LSGSIPPS-LGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLG 249
           +   +P + L +   + ++ L +  +   I +       ++  L +G+N +    P    
Sbjct: 63  MR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQ 120

Query: 250 NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLS 308
           N+P L  L L  N LS      F N   L  L++ +N+L   I  +      SL  L LS
Sbjct: 121 NVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179

Query: 309 FNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSL 368
            N+L+  +   L  +  L    +S NLL       +     +  L+   N ++  +   +
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV 230

Query: 369 GNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIY 428
                L  L L  N L+      + N   L ++ LS NEL   + + F  +  +  L I 
Sbjct: 231 --NVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286

Query: 429 SNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFG 488
           +N L  A+      +  L +L LS+N L     +     RL  + LD N +    +    
Sbjct: 287 NNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLYLDHNSIV---TLKLS 342

Query: 489 IHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS---------- 538
            H  L  + LSH  +          F N+    V   +    +  ++             
Sbjct: 343 THHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPY 400

Query: 539 PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
               +  ++   +V ++    G+  +   +   ++            L   E L+   N 
Sbjct: 401 LDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNE 460

Query: 599 LSNSIPG 605
           L   +  
Sbjct: 461 LRAEVQQ 467

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  163 bits (413), Expect = 4e-42
 Identities = 78/408 (19%), Positives = 138/408 (33%), Gaps = 71/408 (17%)

Query: 243 SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKS 301
            +  +L        + +   +           L N  I+   ++++   +P+ +  + + 
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76

Query: 302 LYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLS 361
           +  L L+  ++      +      +  LY+  N +   +P                    
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAI-RYLP-------------------- 115

Query: 362 GSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLT 420
              PH   N+  L  L L  N LS S+P  I  N   L+ L +S N L      +F   T
Sbjct: 116 ---PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATT 171

Query: 421 NMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLT 480
           ++  L + SN L+  +      +  L    +SYN L   +     +  L       N + 
Sbjct: 172 SLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLST-LAIPIAVEEL---DASHNSIN 224

Query: 481 GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQ 540
                                               L  L +  NN+T      + + P 
Sbjct: 225 ---------------------------VVRGPVNVELTILKLQHNNLTDT--AWLLNYPG 255

Query: 541 LKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
           L  +DLS N +  +I      K++ L +L ++ N+    L      +  L+ LDLS N L
Sbjct: 256 LVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHL 313

Query: 600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFL 647
              +  +     +L  L L +N       +KL     L +L LSHN  
Sbjct: 314 L-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDW 357

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  162 bits (412), Expect = 5e-42
 Identities = 100/580 (17%), Positives = 200/580 (34%), Gaps = 51/580 (8%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           +  L      SF  +  L+L   QI  I     A    ++ L +  N+    +PP +  N
Sbjct: 63  MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQN 121

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPS-LGNLTNLAIMYLY 212
           + +L +L L  N  S  +P  I  +   L  L +  N L   I        T+L  + L 
Sbjct: 122 VPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLS 179

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
           +N L+  +   +  + SL    + YN LS     +L     +  LD   NS++    +  
Sbjct: 180 SNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV---VRG 228

Query: 273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
                L IL L HN+L+      + N   L  + LS+N+L   +      + +L  LY+S
Sbjct: 229 PVNVELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYIS 286

Query: 333 DNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
           +N L  ++      +  L  L+L  N L   +  +      L  LYL  N +  ++   +
Sbjct: 287 NNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--L 341

Query: 393 GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLS 452
              ++L +L LS N+   +   +     N+   ++        I                
Sbjct: 342 STHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKID------------YQL 387

Query: 453 YNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWG 512
            + L     D   L RL +  +    +   +  + G  S    IN      +        
Sbjct: 388 EHGLCCKESDKPYLDRLLQ-YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGV 446

Query: 513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
                  L+   N +   +        QL    +    ++  + +E+       +L  + 
Sbjct: 447 PLQGNEQLEAEVNELRAEV-------QQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDG 499

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLY-YLNLSNNQFSGEI-PIK 630
              S     ++ + ++         R + +         K    L   N     ++   +
Sbjct: 500 LARSSDNLNKVFTHLKERQ--AFKLRETQARRTEADAKQKETEDLEQENIALEKQLDNKR 557

Query: 631 LEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNN 670
            ++     +  L    + +++ ++        +++  H++
Sbjct: 558 AKQAELRQETSLKRQKV-KQLEAKKNRNPDTRRVSHHHHH 596

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  162 bits (410), Expect = 9e-42
 Identities = 74/362 (20%), Positives = 135/362 (37%), Gaps = 21/362 (5%)

Query: 337 FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNL 395
           +  I   +      + + +               L N   +    + +   +P+ +  + 
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSF 74

Query: 396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
             +  L L++ ++     Y+F     +  L +  NA+    P  + N+  LT+LVL  N 
Sbjct: 75  RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERND 134

Query: 456 LQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF 514
           L   P     N  +L  + +  N+L     ++F   ++L  + LS  +       D    
Sbjct: 135 LSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL---THVDLSLI 191

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
           P+L   +VS N ++      +     ++ LD S N I   +   +     L  L L  N 
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNN 243

Query: 575 FSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKF 634
            +      L +   L  +DLS N L   +      + +L  L +SNN+    + +  +  
Sbjct: 244 LT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 300

Query: 635 IHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
             L  LDLSHN L   +         LE L L HN++   +       H L  + +S+N 
Sbjct: 301 PTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHND 356

Query: 695 LH 696
             
Sbjct: 357 WD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  160 bits (406), Expect = 3e-41
 Identities = 93/548 (16%), Positives = 180/548 (32%), Gaps = 58/548 (10%)

Query: 172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSL 230
           I   + +      +H+               L N  I+   N+++   +P+ +  + + +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77

Query: 231 SGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSG 290
             L L   ++      +      +  L +  N++    P  F N+  L +L L  N LS 
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 136

Query: 291 SIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRY 349
           S+P  +  N   L  L +S N L      +    T L  L LS N L   +   +  +  
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPS 193

Query: 350 LFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELS 409
           LF+  +  N LS     +L     +  L    N ++  +   +     L+ L L  N L+
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 245

Query: 410 GSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRL 469
                   N   ++ + +  N L   +   +  + +L  L +S N+L       + +  L
Sbjct: 246 -DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTL 303

Query: 470 ARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITG 529
             + L  NHL                           +  +  +F  L  L +  N+I  
Sbjct: 304 KVLDLSHNHLL-------------------------HVERNQPQFDRLENLYLDHNSIVT 338

Query: 530 ILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQL 589
           +   ++     LK L LS N         L   R++ +  ++      ++  +L   +  
Sbjct: 339 L---KLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCC 393

Query: 590 EHLD----------LSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSD 639
           +  D          ++   +   +  + G       +N   +                  
Sbjct: 394 KESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQ 453

Query: 640 LDLSHNFLGEEIPS-QVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGP 698
           L+   N L  E+       +Q  + L   H  +   + R      GL     + NK+   
Sbjct: 454 LEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTH 513

Query: 699 IPNSAAFK 706
           +    AFK
Sbjct: 514 LKERQAFK 521

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  159 bits (404), Expect = 5e-41
 Identities = 84/429 (19%), Positives = 145/429 (33%), Gaps = 68/429 (15%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
            I  +L        +++   +       E   L +   +    + +       L +   +
Sbjct: 18  CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77

Query: 255 ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG 314
             L+L+D  +      +F     +  L +  N++   +P                     
Sbjct: 78  ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLP--------------------- 115

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
             P    N+  LT+L L  N L  S+P  I  N   L  L + +N L      +    T+
Sbjct: 116 --PHVFQNVPLLTVLVLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTS 172

Query: 374 LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
           L  L L +N L+  +   +  + SL    +S N LS     +      +  L    N+++
Sbjct: 173 LQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 224

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
             +       V+LT+L L +N L      L N   L  V L  N L   +   F     L
Sbjct: 225 -VVRG--PVNVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRL 280

Query: 494 SYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG 553
             + +S+                        N +  +        P LKVLDLS NH++ 
Sbjct: 281 ERLYISN------------------------NRLVAL-NLYGQPIPTLKVLDLSHNHLL- 314

Query: 554 EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS-NSIPGSLGNLVK 612
            +     +   L  L L+ N     L   L +   L++L LS N    NS+     N+ +
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVAR 371

Query: 613 LYYLNLSNN 621
               +   +
Sbjct: 372 PAVDDADQH 380

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  159 bits (404), Expect = 7e-42
 Identities = 85/453 (18%), Positives = 149/453 (32%), Gaps = 49/453 (10%)

Query: 182 LKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS 241
             +       +  +   S   L  L  +  +N+S++  +   I  L  L+ L    N ++
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT 77

Query: 242 GSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKS 301
               L L    NL  L    N L+    L    LT L  LN   N L+    S+   L  
Sbjct: 78  T---LDLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKLDVSQNPLLTY 131

Query: 302 LYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLS 361
           L     + N L+  I   + + T+LT L    N     +   +     L  L+   NK++
Sbjct: 132 LN---CARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT 183

Query: 362 GSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTN 421
                 +     L  L   TN ++  +   +     L+ L  S N+L+  I      LT 
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234

Query: 422 MIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLT 480
           +       N L+  +      L KLT L      L    +     L              
Sbjct: 235 LTYFDCSVNPLT-ELDV--STLSKLTTLHCIQTDLLEIDLTHNTQLI-----YFQAEGCR 286

Query: 481 GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQ 540
                    ++ L  ++            D  + P L  L ++   +T +   ++  + +
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGI---TELDLSQNPKLVYLYLNNTELTEL---DVSHNTK 340

Query: 541 LKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS 600
           LK L   + HI  +    +GK+ +L        Q    +P E  +   L  + +S + L 
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLD 396

Query: 601 NS-----IPGSLGNLVKLYYLNLSNNQFSGEIP 628
                  I    G +       ++    S + P
Sbjct: 397 QFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  159 bits (403), Expect = 8e-42
 Identities = 83/495 (16%), Positives = 152/495 (30%), Gaps = 67/495 (13%)

Query: 131 NSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFEN 190
           +        ++     T       L+ L  L    +  +      I  L+ L  L    N
Sbjct: 17  DDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSN 74

Query: 191 GLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGN 250
            ++ ++   L   TNL  +   +N L+ ++   +  L  L+ L    NKL+    L +  
Sbjct: 75  NIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQ 125

Query: 251 LPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFN 310
            P L  L+   N+L+    +   + T L  L+   N     +   +     L  L  SFN
Sbjct: 126 NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180

Query: 311 KLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
           K++      +     L  L    N +   +   +     L +L+   NKL+  I   +  
Sbjct: 181 KITE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTP 231

Query: 371 LTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
           LT L       N L+  +   +  L+ L+ L   + +L   I     + T +I       
Sbjct: 232 LTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGC 285

Query: 431 ALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIH 490
                +  +  +  +L LL      +     DL    +L  + L+   LT          
Sbjct: 286 RKIKEL--DVTHNTQLYLLDCQAAGITE--LDLSQNPKLVYLYLNNTELT---------- 331

Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
                              D      L +L     +I       +G  P L     +   
Sbjct: 332 -----------------ELDVSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQ 372

Query: 551 IVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNL 610
            +      L      I ++ +     G           +   D ++N ++     +    
Sbjct: 373 TITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGV--YDQATNTITWENLSTDNPA 430

Query: 611 VKLYYLNLSNNQFSG 625
           V  Y     N    G
Sbjct: 431 VT-YTFTSENGAIVG 444

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  157 bits (400), Expect = 2e-41
 Identities = 75/427 (17%), Positives = 145/427 (33%), Gaps = 47/427 (11%)

Query: 252 PNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNK 311
            N A+       +  +  +S   L  L  L+  ++S++  +   +  L  L  L  + N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNN 75

Query: 312 LSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNL 371
           ++ ++   L   T LT L    N L  ++   +  L  L YL    NKL+      +   
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQN 126

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
             L  L    N L+  I   + +   L++L    N+    +       T +  L    N 
Sbjct: 127 PLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNK 181

Query: 432 LSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHS 491
           ++     +      L  L    N +     DL    +L  +    N LT          +
Sbjct: 182 ITEL---DVSQNKLLNRLNCDTNNITK--LDLNQNIQLTFLDCSSNKLT---EIDVTPLT 233

Query: 492 NLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI 551
            L+Y + S          D      L TL     ++  I   ++  + QL          
Sbjct: 234 QLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRK 287

Query: 552 VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLV 611
           + E+  ++     L  L       + +L   L    +L +L L++  L+  +   + +  
Sbjct: 288 IKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNT 339

Query: 612 KLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSL------EKLN 665
           KL  L+  N     +    + K   L++   +       +P +  +  SL      + L+
Sbjct: 340 KLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT-ITMPKETLTNNSLTIAVSPDLLD 396

Query: 666 LAHNNLS 672
              N ++
Sbjct: 397 QFGNPMN 403

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  156 bits (396), Expect = 6e-41
 Identities = 79/426 (18%), Positives = 145/426 (34%), Gaps = 42/426 (9%)

Query: 103 SFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILY 162
           S      L  LD   + I  +  + I   + L  L  +SN+ + T+   +   + L  L 
Sbjct: 37  SEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLA 91

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS 222
             +N+ +  +   +  L+ L  L+   N L+  +  S      L  +    N+L+  I  
Sbjct: 92  CDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPLLTYLNCARNTLT-EID- 143

Query: 223 EIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
            + +   L+ L+   NK      L +     L TLD   N ++    L       L+ LN
Sbjct: 144 -VSHNTQLTELDCHLNKKITK--LDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLN 197

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
              N+++  +   +     L  L  S NKL+  I   +  LT+LT    S N L   +  
Sbjct: 198 CDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPL-TELD- 249

Query: 343 EIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLG 402
            +  L  L  L      L   I   L + T L             +  ++ +   L  L 
Sbjct: 250 -VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLD 303

Query: 403 LSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD 462
                ++  +         ++ L + +  L+  +     +  KL  L      +Q     
Sbjct: 304 CQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FSS 356

Query: 463 LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDV 522
           +  +  L               E+  + +N   I +S        +    +  + G  D 
Sbjct: 357 VGKIPALNNNFEAEGQTITMPKET--LTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQ 414

Query: 523 SANNIT 528
           + N IT
Sbjct: 415 ATNTIT 420

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  146 bits (370), Expect = 2e-37
 Identities = 79/429 (18%), Positives = 144/429 (33%), Gaps = 48/429 (11%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYL 163
                 L  L    N I  +    ++ N+ L YL   SN  +  +   +  L+ L  L  
Sbjct: 60  IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113

Query: 164 STNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
            TN+ +  +   +     L  L+   N L+  I   + + T L  +  + N     +   
Sbjct: 114 DTNKLTK-LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD-- 165

Query: 224 IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNL 283
           +     L+ L+  +NK++    L +     L  L+   N+++    L       L  L+ 
Sbjct: 166 VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDC 219

Query: 284 PHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCE 343
             N L+  I   +  L  L     S N L+  +  S   L+KLT L+     L   I   
Sbjct: 220 SSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDL-LEID-- 270

Query: 344 IGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGL 403
           + +   L Y +    +    +   + + T L  L      ++  +   +     L  L L
Sbjct: 271 LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYL 325

Query: 404 SENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPD 462
           +  EL+  +     + T +  LS  +  +        G +  L     +  Q    P   
Sbjct: 326 NNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKET 380

Query: 463 LRNLTRLARVRLDRNHLTGNISES--------FGIHSNLSYINLSHKKFYGEISFDWGKF 514
           L N +    V  D     GN                + +++ NLS        +F     
Sbjct: 381 LTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENG 440

Query: 515 PNLGTLDVS 523
             +GT+   
Sbjct: 441 AIVGTVTTP 449

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  132 bits (334), Expect = 8e-33
 Identities = 58/369 (15%), Positives = 127/369 (34%), Gaps = 40/369 (10%)

Query: 99  LHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSML 158
           L +   +    L YL+   N++  +  S    N  L YL+ + N+ +  I   + + + L
Sbjct: 97  LTNLDVTPLTKLTYLNCDTNKLTKLDVS---QNPLLTYLNCARNTLT-EID--VSHNTQL 150

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
             L    N+        +   + L  L    N ++      +     L  +    N+++ 
Sbjct: 151 TELDCHLNKKIT--KLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT- 204

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNL 278
            +   +     L+ L+   NKL+    + +  L  L   D   N L+    L    L+ L
Sbjct: 205 KLD--LNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT---ELDVSTLSKL 256

Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG 338
             L+     L     +    L      G    K        + + T+L +L      +  
Sbjct: 257 TTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIK-----ELDVTHNTQLYLLDCQAAGI-T 310

Query: 339 SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSL 398
            +   +     L YL L + +L+  +   + + T L +L      +       +G + +L
Sbjct: 311 ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPAL 363

Query: 399 SDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG 458
           ++   +E +   ++P       + + +++  + L      ++GN + +            
Sbjct: 364 NNNFEAEGQTI-TMPKETLTNNS-LTIAVSPDLLD-----QFGNPMNIEPGDGGVYDQAT 416

Query: 459 PIPDLRNLT 467
                 NL+
Sbjct: 417 NTITWENLS 425

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  104 bits (261), Expect = 2e-23
 Identities = 58/278 (20%), Positives = 105/278 (37%), Gaps = 30/278 (10%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
           N  + +  +    A    I +E   L  LT L    + +   +  +  LT L ++    N
Sbjct: 19  NFASEVAAAFEMQAT-DTISEE--QLATLTSLDCHNSSITD-MTGIEKLTGLTKLICTSN 74

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
           ++T   +     ++NL+Y+     K     + D      L  L+   N +T +   ++  
Sbjct: 75  NIT---TLDLSQNTNLTYLACDSNKLT---NLDVTPLTKLTYLNCDTNKLTKL---DVSQ 125

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
           +P L  L+ + N +  EI   +     L +L  + N+   +L   +    QL  LD S N
Sbjct: 126 NPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFN 180

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS 657
           +++      +     L  LN   N  +    + L + I L+ LD S N L  EI   V  
Sbjct: 181 KITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKL-TEID--VTP 231

Query: 658 MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
           +  L   + + N L+        +   L  +      L
Sbjct: 232 LTQLTYFDCSVNPLTELDVSTLSK---LTTLHCIQTDL 266

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  161 bits (408), Expect = 1e-41
 Identities = 102/497 (20%), Positives = 173/497 (34%), Gaps = 39/497 (7%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
              N +L+  +P ++        L L  N +S      +  L  L  L L  N +  S+ 
Sbjct: 37  DYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLD 92

Query: 270 LS-FGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSS--LGNLTKL 326
              F    +L+ L++ HN L  +I      + SL  L LSFN     +P     GNLTKL
Sbjct: 93  FHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKL 148

Query: 327 TILYLSDNLLFGSIPCEIGNLR-YLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
           T L LS           + +L      L+L    + G    SL    N   L+L  +  S
Sbjct: 149 TFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNS 207

Query: 386 GSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
                   ++N+L  L LS  +L+           + +        ++    +       
Sbjct: 208 LFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLS-----YINLSH 500
                     ++              + +    +T  I      +S  +       ++ +
Sbjct: 268 KLFQFFWPRPVE-------------YLNIYNLTITERIDREEFTYSETALKSLMIEHVKN 314

Query: 501 KKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELG 560
           + F       +  F  +    +S ++   I             L+ + N     +     
Sbjct: 315 QVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCS 374

Query: 561 KLRSLIKLTLNRNQFSGQLPT---ELGSLIQLEHLDLSSNRLSNSIPGSL-GNLVKLYYL 616
            L+ L  L L RN              ++  LE LD+S N L++            +  L
Sbjct: 375 TLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL 433

Query: 617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP 676
           NLS+N  +G +   L     +  LDL +N +   IP  V  +Q+L++LN+A N L     
Sbjct: 434 NLSSNMLTGSVFRCLPP--KVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPD 490

Query: 677 RCFKEMHGLVYIDISYN 693
             F  +  L YI +  N
Sbjct: 491 GVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  158 bits (401), Expect = 8e-41
 Identities = 96/513 (18%), Positives = 190/513 (37%), Gaps = 40/513 (7%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQ-IGHLSYL 182
             +  +N  +   +D S+ + +  +P  +      K L LS N  S  +    I  LS L
Sbjct: 24  SMTPFSNELE-SMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSIS-ELRMPDISFLSEL 78

Query: 183 KALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS 241
           + L L  N +  S+   +     +L  + + +N L  +I      + SL  L+L +N   
Sbjct: 79  RVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDFD 134

Query: 242 GSMPLS--LGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDI----LNLPHNSLSGSIPSE 295
             +P+    GNL  L  L L          L    + +L +    L+L    + G     
Sbjct: 135 -VLPVCKEFGNLTKLTFLGLSAAKFRQ---LDLLPVAHLHLSCILLDLVSYHIKGGETES 190

Query: 296 MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLEL 355
           +    +   L L F+  S        ++  L  L LS+  L       +           
Sbjct: 191 LQIPNTTV-LHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP 249

Query: 356 GDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYS 415
               ++          T   ++ LF       +        ++ +L ++E        YS
Sbjct: 250 TLLNVT----LQHIETTWKCSVKLFQFFWPRPVEY-----LNIYNLTITERIDREEFTYS 300

Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLARVRL 474
              L ++++  + +     +    Y    ++ + +LS +      +    + +    +  
Sbjct: 301 ETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNF 360

Query: 475 DRNHLTGNISESFGIHSNLSYINLSHKKF--YGEISFDWGKFPNLGTLDVSANNIT-GIL 531
            +N  T ++ +       L  + L       + +++       +L TLDVS N++     
Sbjct: 361 TQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAY 420

Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEH 591
                 +  + VL+LSSN + G +   L     +  L L+ N+    +P ++  L  L+ 
Sbjct: 421 DRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQE 477

Query: 592 LDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQF 623
           L+++SN+L  S+P G    L  L Y+ L +N +
Sbjct: 478 LNVASNQL-KSVPDGVFDRLTSLQYIWLHDNPW 509

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  135 bits (342), Expect = 2e-33
 Identities = 88/453 (19%), Positives = 152/453 (33%), Gaps = 51/453 (11%)

Query: 252 PNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFN 310
           P    L L  NS+S         L+ L +L L HN +  S+   +    + L  L +S N
Sbjct: 52  PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHN 110

Query: 311 KLSGSIPSSLGNLTKLTILYLSDNLLFGSIP--CEIGNLRYLFYLELGDNKLSGSIPHSL 368
           +L  +I      +  L  L LS N     +P   E GNL  L +L L   K        L
Sbjct: 111 RLQ-NISC--CPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFRQL---DL 163

Query: 369 GNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIY 428
             + +L    +  +L+S  I    G   SL     +   L       F    NM V ++ 
Sbjct: 164 LPVAHLHLSCILLDLVSYHIKG--GETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNAL- 220

Query: 429 SNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISE--- 485
                      +  L  + L   +  +L   + +L     L  V L     T   S    
Sbjct: 221 ----------GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270

Query: 486 SFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLD 545
            F     + Y+N+ +      I  +   +                          L +  
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETAL-------------------KSLMIEH 311

Query: 546 LSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPG 605
           + +   +    +       +    L+ +           S      L+ + N  ++S+  
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371

Query: 606 SLGNLVKLYYLNLSNNQFS--GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-MQSLE 662
               L +L  L L  N      ++ +  +    L  LD+S N L      + C+  +S+ 
Sbjct: 372 GCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL 431

Query: 663 KLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
            LNL+ N L+G + RC      +  +D+  N++
Sbjct: 432 VLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRI 462

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  119 bits (300), Expect = 4e-28
 Identities = 92/425 (21%), Positives = 160/425 (37%), Gaps = 28/425 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSF-SGTIPPQIGN 154
           I +L    F     L YLD+  N++  I    +A+   L++LDLS N F    +  + GN
Sbjct: 88  IRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMAS---LRHLDLSFNDFDVLPVCKEFGN 144

Query: 155 LSMLKILYLSTNQFSGRIPPQIGHLS-YLKALHLFENGLSGSIPPSL--GNLTNLAIMYL 211
           L+ L  L LS  +F       + HL      L L    + G    SL   N T L +++ 
Sbjct: 145 LTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204

Query: 212 YNNSLSGSIPSEIGNLKSL--SGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
            N+  S  +   +  L  L  S ++L        M            L++    +  +  
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264

Query: 270 -----LSFGNLTNLDILNLPHNSLSGSIPSEMGN-----LKSLYGLGLSFNKLSGSIPSS 319
                  F     ++ LN+ + +++  I  E        LKSL    +       S  + 
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324

Query: 320 LGNLTKLTILYLSDNLL-FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLY 378
                ++ I  LS +   F  + C   +     +L    N  + S+      L  L TL 
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCP-PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383

Query: 379 LFTNLLSGSIPSEIGNLNSLSDLGLSENEL----SGSIPYSFGNLTNMIVLSIYSNALSG 434
           L  N L  +         ++S L   +  L    S +   +     +++VL++ SN L+G
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442

Query: 435 AIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLS 494
           ++ +      K+ +L L  N++     D+ +L  L  + +  N L       F   ++L 
Sbjct: 443 SVFRCL--PPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500

Query: 495 YINLS 499
           YI L 
Sbjct: 501 YIWLH 505

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  107 bits (269), Expect = 3e-24
 Identities = 69/401 (17%), Positives = 128/401 (31%), Gaps = 50/401 (12%)

Query: 99  LHDFSFSSFPHLAYLDLRVNQIFGI-IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSM 157
           L + S      L +LDL  N    + +  +  N +KL +L LS+  F       + +L +
Sbjct: 112 LQNISCCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHL 171

Query: 158 LKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLS 217
             IL    +        +   +     LHL  +  S        ++  L  + L N  L+
Sbjct: 172 SCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLN 231

Query: 218 GSIPSEIGNL----------------------------------KSLSGLELGYNKLSG- 242
                 +                                     + +  L +    ++  
Sbjct: 232 DENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITER 291

Query: 243 ----SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGN 298
                   S   L +L    + +     S    +     ++I  L  +           +
Sbjct: 292 IDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPS 351

Query: 299 LKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDN 358
             S   L  + N  + S+      L +L  L L  N L  +        + +  LE  D 
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL-KNFFKVALMTKNMSSLETLDV 410

Query: 359 KL----SGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPY 414
            L    S +   +     ++  L L +N+L+GS+   +     +  L L  N +  SIP 
Sbjct: 411 SLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPK 467

Query: 415 SFGNLTNMIVLSIYSNALSGAIPKE-YGNLVKLTLLVLSYN 454
              +L  +  L++ SN L  ++P   +  L  L  + L  N
Sbjct: 468 DVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 97.6 bits (243), Expect = 5e-21
 Identities = 58/306 (18%), Positives = 112/306 (36%), Gaps = 14/306 (4%)

Query: 14  SLILLILFPALDFPLIVSSNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCA 73
           SL  + +  +++    +  ++ +      +   +  +   +G  L + TL +      C+
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCS 266

Query: 74  WFGIHCNHAGKVNSINLTSAGLIG----TLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIA 129
                      V  +N+ +  +          +S ++   L    ++         +  +
Sbjct: 267 VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326

Query: 130 NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFE 189
             +++    LS +           + S    L  + N F+  +      L  L+ L L  
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386

Query: 190 NGLSGSIPPSLGNLTNLAIMYLYNNSL----SGSIPSEIGNLKSLSGLELGYNKLSGSMP 245
           NGL  +         N++ +   + SL    S +        +S+  L L  N L+GS+ 
Sbjct: 387 NGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445

Query: 246 LSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYG 304
             L   P +  LDLH+N +  SIP    +L  L  LN+  N L  S+P  +   L SL  
Sbjct: 446 RCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501

Query: 305 LGLSFN 310
           + L  N
Sbjct: 502 IWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 65.3 bits (159), Expect = 6e-11
 Identities = 44/316 (13%), Positives = 105/316 (33%), Gaps = 24/316 (7%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVK 445
            +P ++        L LS+N +S         L+ + VL +  N +  ++    +     
Sbjct: 45  HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQD 101

Query: 446 LTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTG-NISESFGIHSNLSYINLSHKKF 503
           L  L +S+N+LQ      + +L  L    L  N      + + FG  + L+++ LS  KF
Sbjct: 102 LEYLDVSHNRLQNISCCPMASLRHL---DLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKF 158

Query: 504 YGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS---PQLKVLDLSSNHIVGEIPSELG 560
                 D     +L    +  + ++  +     +S   P   VL L  +           
Sbjct: 159 R---QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215

Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
            + +L  L L+  + + +    L + +       +   ++     +        +     
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275

Query: 621 NQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFK 680
                        ++++ +L ++     EE      +++SL   ++ +          + 
Sbjct: 276 RPVE---------YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326

Query: 681 EMHGLVYIDISYNKLH 696
               +    +S +   
Sbjct: 327 VFAEMNIKMLSISDTP 342

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  153 bits (388), Expect = 6e-40
 Identities = 83/394 (21%), Positives = 138/394 (35%), Gaps = 38/394 (9%)

Query: 252 PNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFN 310
            ++  +DL  NS++     SF  L +L  L +   +    I +     L SL  L L +N
Sbjct: 30  AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89

Query: 311 KLSGSIPSS-LGNLTKLTILYLSDNLLFGS-IPCEI-GNLRYLFYLELGDNKLSGSIPHS 367
           +    + +     L  L +L L+   L G+ +       L  L  L L DN +    P S
Sbjct: 90  QFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148

Query: 368 L-GNLTNLATLYLFTNLLSGSIPSEI-----------GNLNSLSDLGLSENELSGSIPYS 415
              N+     L L  N +  SI  E              L+S++   ++E  L      +
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207

Query: 416 FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
               T++  L +  N    ++ K + +   +    +    L        +         D
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDA--IAGTKIQSLILSNSYNMGSSFGHTNFKDPD 265

Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEIS---FDWGKFPNLGTLDVSANNITGILP 532
                G  +      S +   +LS  K    +    F    F +L  L ++ N I   + 
Sbjct: 266 NFTFKGLEA------SGVKTCDLSKSKI-FALLKSVFSH--FTDLEQLTLAQNEIN-KID 315

Query: 533 PEIGDS-PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSGQLPTEL-GSLIQL 589
                    L  L+LS N + G I S +   L  L  L L+ N     L  +    L  L
Sbjct: 316 DNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNL 373

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           + L L +N+L +   G    L  L  + L  N +
Sbjct: 374 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  136 bits (343), Expect = 5e-34
 Identities = 82/415 (19%), Positives = 138/415 (33%), Gaps = 39/415 (9%)

Query: 291 SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRY 349
            +P    ++  +    LS N ++    +S   L  L  L +        I       L  
Sbjct: 24  QVPELPAHVNYVD---LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 350 LFYLELGDNKLSGSIPHS-LGNLTNLATLYLFTNLL-SGSIPSEI-GNLNSLSDLGLSEN 406
           L  L+L  N+    +       L NL  L L    L    +       L SL  L L +N
Sbjct: 81  LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139

Query: 407 ELSGSIPYS-FGNLTNMIVLSIYSNALSGAIPKEYGNLVK--LTLLVLSYNQLQGPIPDL 463
            +    P S F N+    VL +  N +     ++  N      TLL LS   LQ      
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQ------ 193

Query: 464 RNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVS 523
                     ++   L      +   +++++ ++LS   F   ++    +F +       
Sbjct: 194 ---------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA---KRFFDAIAGTKI 241

Query: 524 ANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTEL 583
            + I                 D  +    G   S       +    L++++    L +  
Sbjct: 242 QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS------GVKTCDLSKSKIFALLKSVF 295

Query: 584 GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLSDLDL 642
                LE L L+ N ++     +   L  L  LNLS N     I  ++ E    L  LDL
Sbjct: 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDL 354

Query: 643 SHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
           S+N +   +  Q    + +L++L L  N L       F  +  L  I +  N   
Sbjct: 355 SYNHI-RALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  132 bits (335), Expect = 5e-33
 Identities = 72/426 (16%), Positives = 141/426 (33%), Gaps = 71/426 (16%)

Query: 58  LPSWT------LNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLA 111
           LP+        LN+  +++  ++  +       +  + +        + + +F     L 
Sbjct: 28  LPAHVNYVDLSLNSIAELNETSFSRLQ-----DLQFLKVEQQTPGLVIRNNTFRGLSSLI 82

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSF-SGTIPPQI-GNLSMLKILYLSTNQFS 169
            L L  NQ   +        + L+ L L+  +     +       L+ L++L L  N   
Sbjct: 83  ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN-- 140

Query: 170 GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS 229
                    +  ++    F             N+    ++ L  N +  SI  E   L +
Sbjct: 141 ---------IKKIQPASFFL------------NMRRFHVLDLTFNKVK-SICEED--LLN 176

Query: 230 LSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS 289
             G                  L ++   D+++  L      +    T++  L+L  N   
Sbjct: 177 FQGKHFTLL-----------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFK 225

Query: 290 GSIPSEMGNLKSL-------------YGLGLSFNKLSGSIPSSLGNL--TKLTILYLSDN 334
            S+     +  +               G              +   L  + +    LS +
Sbjct: 226 ESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKS 285

Query: 335 LLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI- 392
            +F ++   +  +   L  L L  N+++    ++   LT+L  L L  N L  SI S + 
Sbjct: 286 KIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMF 343

Query: 393 GNLNSLSDLGLSENELSGSIPY-SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVL 451
            NL+ L  L LS N +  ++   SF  L N+  L++ +N L       +  L  L  + L
Sbjct: 344 ENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWL 402

Query: 452 SYNQLQ 457
             N   
Sbjct: 403 HTNPWD 408

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.1 bits (125), Expect = 7e-07
 Identities = 23/119 (19%), Positives = 37/119 (31%), Gaps = 23/119 (19%)

Query: 589 LEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLG 648
           + ++DLS N ++     S   L  L +L +        I      F  LS          
Sbjct: 32  VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT--FRGLS---------- 79

Query: 649 EEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKH 707
                      SL  L L +N         F  +  L  + ++   L G + +   FK 
Sbjct: 80  -----------SLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  144 bits (365), Expect = 2e-38
 Identities = 61/275 (22%), Positives = 113/275 (41%), Gaps = 36/275 (13%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
             IG G   +VY+  +  +   VA  +     L++ + +Q F  E + L  ++H NIV+FY
Sbjct: 33   EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 872  G----FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
                      +   +V E +  G+L   L      +        +  + +   L +LH  
Sbjct: 92   DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI---KVLRSWCRQILKGLQFLH-T 147

Query: 928  CFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
              PPI++RD+   N+ +        + D G++   +   +    + GT  ++APE+ Y  
Sbjct: 148  RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPEFMAPEM-YEE 204

Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-----TSSNLDRTLDEILDPRLPAPSC 1041
            K  E  DVY+FG+  LE    ++P     +        TS     + D++  P       
Sbjct: 205  KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP------- 257

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +++ +I        C+ +N D R +   +  LL 
Sbjct: 258  EVKE-IIE------GCIRQNKDERYS---IKDLLN 282

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (363), Expect = 5e-38
 Identities = 59/300 (19%), Positives = 122/300 (40%), Gaps = 48/300 (16%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQ-QEFLNEVKSLT 860
            R   DF+   C+G GG G V+ A+        A+K+     L       ++ + EVK+L 
Sbjct: 2    RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR---LPNRELAREKVMREVKALA 58

Query: 861  EIRHRNIVKFYGFC------------SHARHSFIVYEYLEMGSLAMILSNATSAEELGWT 908
            ++ H  IV+++               S   + +I  +     +L   ++   + EE   +
Sbjct: 59   KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK------ 962
              +++   +A+A+ +LH+     +++RD+   N+   ++    V DFG+  ++       
Sbjct: 119  VCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175

Query: 963  ------PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016
                  P  +  T   GT  Y++PE  +    + K D++S G++  E +   +P      
Sbjct: 176  TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YP------ 226

Query: 1017 ICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              ST     RTL ++ + + P            +++     L  +P  RP       +++
Sbjct: 227  -FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQ---DMLSPSPMERPE---AINIIE 279

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  142 bits (361), Expect = 2e-37
 Identities = 68/276 (24%), Positives = 117/276 (42%), Gaps = 21/276 (7%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
           I  + D  F +  +L  L L  N+I  I P   A   KL+ L LS N     +P      
Sbjct: 64  ITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMP 120

Query: 156 SMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGL-SGSIPP-SLGNLTNLAIMYLY 212
             L+ L +  N+ + ++   +   L+ +  + L  N L S  I   +   +  L+ + + 
Sbjct: 121 KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
           + +++ +IP   G   SL+ L L  NK++     SL  L NLA L L  NS+S     S 
Sbjct: 180 DTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSL 236

Query: 273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSS-------LGNLTK 325
            N  +L  L+L +N L   +P  + + K +  + L  N +S +I S+             
Sbjct: 237 ANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKAS 294

Query: 326 LTILYLSDN-LLFGSIPCEI-GNLRYLFYLELGDNK 359
            + + L  N + +  I       +     ++LG+ K
Sbjct: 295 YSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  142 bits (359), Expect = 4e-37
 Identities = 72/289 (24%), Positives = 110/289 (38%), Gaps = 23/289 (7%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
            P  A LDL+ N+I  I      N   L  L L +N  S  I P     L  L+ LYLS 
Sbjct: 51  PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSK 109

Query: 166 NQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSL-SGSIPSE 223
           NQ    +P        L+ L + EN ++  +       L  + ++ L  N L S  I + 
Sbjct: 110 NQLK-ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 224 I-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
               +K LS + +    ++    +  G  P+L  L L  N ++     S   L NL  L 
Sbjct: 166 AFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 222

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL------ 336
           L  NS+S      + N   L  L L+ NKL   +P  L +   + ++YL +N +      
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281

Query: 337 -FGSIPCEIGNLRYLFYLELGDNKLSGSI--PHSLGNLTNLATLYLFTN 382
            F   P           + L  N +      P +   +   A + L   
Sbjct: 282 DFCP-PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  141 bits (358), Expect = 5e-37
 Identities = 71/308 (23%), Positives = 128/308 (41%), Gaps = 23/308 (7%)

Query: 205 NLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL 264
           +L ++   +  L   +P ++      + L+L  NK++        NL NL TL L +N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 265 SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLT 324
           S   P +F  L  L+ L L  N L   +P +M   K+L  L +  N+++    S    L 
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145

Query: 325 KLTILYLSDNLL-FGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTN 382
           ++ ++ L  N L    I       ++ L Y+ + D  ++ +IP  L    +L  L+L  N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202

Query: 383 LLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYG 441
            ++  + +     LN+L+ LGLS N +S     S  N  ++  L + +N L   +P    
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260

Query: 442 NLVKLTLLVLSYNQLQ-------GPIPDLRNLTRLARVRLDRNHLT-GNISES-FGIHSN 492
           +   + ++ L  N +         P          + V L  N +    I  S F     
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320

Query: 493 LSYINLSH 500
            + + L +
Sbjct: 321 RAAVQLGN 328

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  133 bits (337), Expect = 3e-34
 Identities = 74/309 (23%), Positives = 124/309 (40%), Gaps = 23/309 (7%)

Query: 181 YLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL 240
           +L+ +   + GL   +P  L    + A++ L NN ++     +  NLK+L  L L  NK+
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 241 SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNL 299
           S   P +   L  L  L L  N L   +P        L  L +  N ++  +   +   L
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELP--EKMPKTLQELRVHENEIT-KVRKSVFNGL 144

Query: 300 KSLYGLGLSFNKLSGSI--PSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGD 357
             +  + L  N L  S     +   + KL+ + ++D  +  +IP   G    L  L L  
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI-TTIP--QGLPPSLTELHLDG 201

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFG 417
           NK++     SL  L NLA L L  N +S      + N   L +L L+ N+L   +P    
Sbjct: 202 NKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLA 260

Query: 418 NLTNMIVLSIYSNALSG------AIPKEYGNLVKLTLLVLSYNQLQ-GPIPD--LRNLTR 468
           +   + V+ +++N +S         P         + + L  N +Q   I     R +  
Sbjct: 261 DHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 320

Query: 469 LARVRLDRN 477
            A V+L   
Sbjct: 321 RAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  121 bits (306), Expect = 3e-30
 Identities = 57/268 (21%), Positives = 99/268 (36%), Gaps = 17/268 (6%)

Query: 446 LTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
             LL L  N++      D +NL  L  + L  N ++     +F     L  + LS  +  
Sbjct: 54  TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI-VGEIPSE-LGKL 562
                       L  L V  N IT +         Q+ V++L +N +    I +     +
Sbjct: 114 ---ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGM 170

Query: 563 RSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
           + L  + +     +  +P   G    L  L L  N+++     SL  L  L  L LS N 
Sbjct: 171 KKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 227

Query: 623 FSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF------IP 676
            S      L    HL +L L++N L  ++P  +   + ++ + L +NN+S         P
Sbjct: 228 ISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286

Query: 677 RCFKEMHGLVYIDISYNKL-HGPIPNSA 703
               +      + +  N + +  I  S 
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPST 314

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  120 bits (303), Expect = 1e-29
 Identities = 70/321 (21%), Positives = 124/321 (38%), Gaps = 48/321 (14%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
            +P ++      + L L  N+++      F NL N+  L + +N +S   P  +  LVKL
Sbjct: 45  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 447 TLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
             L LS NQL+  P    + L  L   R+  N +T                 +    F G
Sbjct: 103 ERLYLSKNQLKELPEKMPKTLQEL---RVHENEIT----------------KVRKSVFNG 143

Query: 506 EISFDWGKFPNLGTLDVSANNITGI-LPPEI-GDSPQLKVLDLSSNHIVGEIPSELGKLR 563
                      +  +++  N +    +         +L  + ++  +I   IP  L    
Sbjct: 144 --------LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PP 192

Query: 564 SLIKLTLNRNQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
           SL +L L+ N+ + ++    L  L  L  L LS N +S    GSL N   L  L+L+NN+
Sbjct: 193 SLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251

Query: 623 FSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV-------CSMQSLEKLNLAHNNLSGFI 675
              ++P  L    ++  + L +N +   I S             S   ++L  N +  + 
Sbjct: 252 LV-KVPGGLADHKYIQVVYLHNNNI-SAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 676 --PRCFKEMHGLVYIDISYNK 694
             P  F+ ++    + +   K
Sbjct: 310 IQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  107 bits (269), Expect = 3e-25
 Identities = 48/211 (22%), Positives = 97/211 (45%), Gaps = 10/211 (4%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
            +  + + ++L + K       D+    NL TL +  N I+ I P       +L+ L LS
Sbjct: 49  DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108

Query: 548 SNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI--PG 605
            N +  E+P ++   ++L +L ++ N+ +    +    L Q+  ++L +N L +S    G
Sbjct: 109 KNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165

Query: 606 SLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-MQSLEKL 664
           +   + KL Y+ +++   +  IP  L     L++L L  N +  ++ +     + +L KL
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKL 221

Query: 665 NLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
            L+ N++S            L  + ++ NKL
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  101 bits (254), Expect = 2e-23
 Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 12/199 (6%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
            P+   LD+  N IT I   +  +   L  L L +N I    P     L  L +L L++N
Sbjct: 51  PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 110

Query: 574 QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
           Q   +LP ++     L+ L +  N ++         L ++  + L  N       I+   
Sbjct: 111 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLK-SSGIENGA 166

Query: 634 F---IHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDI 690
           F     LS + ++   +   IP  +    SL +L+L  N ++       K ++ L  + +
Sbjct: 167 FQGMKKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGL 223

Query: 691 SYNKLHGPIPNSAAFKHAP 709
           S+N +   + N  +  + P
Sbjct: 224 SFNSISA-VDNG-SLANTP 240

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 83.1 bits (206), Expect = 3e-17
 Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 11/167 (6%)

Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
            L+V+  S   +  ++P +L        L L  N+ +     +  +L  L  L L +N++
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV-CSM 658
           S   PG+   LVKL  L LS NQ   E+P K+     L +L +  N +  ++   V   +
Sbjct: 89  SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI-TKVRKSVFNGL 144

Query: 659 QSLEKLNLAHNNL--SGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
             +  + L  N L  SG     F+ M  L YI I+   +   IP   
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL 190

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  139 bits (353), Expect = 1e-36
 Identities = 73/317 (23%), Positives = 124/317 (39%), Gaps = 38/317 (11%)

Query: 772  SSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAE-LSSG 830
              Q+Q       P F         + Y  +     +F  E  IG G    VYRA  L  G
Sbjct: 2    DEQSQGMQGPPVPQFQPQKALRPDMGYNTL----ANFRIEKKIGRGQFSEVYRAACLLDG 57

Query: 831  EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMG 890
              VA+KK     L +   + + + E+  L ++ H N++K+Y          IV E  + G
Sbjct: 58   VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAG 117

Query: 891  SLAMILSNATSA-----EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD 945
             L+ ++ +         E   W         +  AL ++H+     +++RDI   NV + 
Sbjct: 118  DLSRMIKHFKKQKRLIPERTVW----KYFVQLCSALEHMHSRR---VMHRDIKPANVFIT 170

Query: 946  LEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI 1005
                  + D G+ +     ++    L GT  Y++PE  +      KSD++S G L  E  
Sbjct: 171  ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230

Query: 1006 KGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAP--SCNIRDKLISIMEVAISCLDE 1060
              + P  F         NL     +I     P LP+   S  +R  L++       C++ 
Sbjct: 231  ALQSP--FYGD----KMNLYSLCKKIEQCDYPPLPSDHYSEELRQ-LVN------MCINP 277

Query: 1061 NPDSRPTMQKVSQLLKI 1077
            +P+ RP    V+ +  +
Sbjct: 278  DPEKRPD---VTYVYDV 291

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  140 bits (356), Expect = 2e-36
 Identities = 71/283 (25%), Positives = 118/283 (41%), Gaps = 28/283 (9%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKS 858
             +     D      IG G  G V+   L +    VAVK     L  ++  + +FL E + 
Sbjct: 110  VLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDL--KAKFLQEARI 165

Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            L +  H NIV+  G C+  +  +IV E ++ G     L        L     + ++   A
Sbjct: 166  LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAA 223

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IG 976
              + YL + C    ++RD++++N L+  +    +SDFG+S+         +       + 
Sbjct: 224  AGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP- 1034
            + APE     + + +SDV+SFG+L  E    G  P   +       SN   T + +    
Sbjct: 281  WTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-------SNQQ-TREFVEKGG 332

Query: 1035 RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            RLP P  C   D +  +ME    C    P  RP+   + Q L+
Sbjct: 333  RLPCPELCP--DAVFRLME---QCWAYEPGQRPSFSTIYQELQ 370

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (354), Expect = 2e-36
 Identities = 63/281 (22%), Positives = 115/281 (40%), Gaps = 38/281 (13%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMT--CQQEFLNEVKSLTEI 862
              +     IG G  G     +    G    +K+ +   +S M+   ++E   EV  L  +
Sbjct: 24   EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEIN---ISRMSSKEREESRREVAVLANM 80

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA---EELGWTQRMNVIKGVAD 919
            +H NIV++          +IV +Y E G L   ++        E+       +    +  
Sbjct: 81   KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQIL----DWFVQICL 136

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVA 979
            AL ++H+     I++RDI S+N+ L  +    + DFGI++ L           GT  Y++
Sbjct: 137  ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193

Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRL 1036
            PE+        KSD+++ G +  E    KH   F       + ++   + +I+    P +
Sbjct: 194  PEICENKPYNNKSDIWALGCVLYELCTLKHA--F------EAGSMKNLVLKIISGSFPPV 245

Query: 1037 PAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                S ++R  L+S           NP  RP+   V+ +L+
Sbjct: 246  SLHYSYDLRS-LVS------QLFKRNPRDRPS---VNSILE 276

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  138 bits (350), Expect = 8e-36
 Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 27/282 (9%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
              +  LDL  N+I  I  S +     L+ L L+SN  + TI      +L  L+ L LS 
Sbjct: 51  TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109

Query: 166 NQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPS--LGNLTNLAIMYLYNNSLSGSIPS 222
           N  S  +       LS L  L+L  N    ++  +    +LT L I+ + N      I  
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQR 167

Query: 223 EI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
           +    L  L  LE+  + L    P SL ++ N++ L LH       + +     ++++ L
Sbjct: 168 KDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
            L    L                    F++LS    +SL        + ++D  LF  + 
Sbjct: 228 ELRDTDLD----------------TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVM 270

Query: 342 CEIGNLRYLFYLELGDNKLSGSIPHS-LGNLTNLATLYLFTN 382
             +  +  L  LE   N+L  S+P      LT+L  ++L TN
Sbjct: 271 KLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  127 bits (320), Expect = 7e-32
 Identities = 68/295 (23%), Positives = 116/295 (39%), Gaps = 25/295 (8%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
              + SL+ SIPS +   +++  L+L  N+++      L    NL  L L  N ++    
Sbjct: 37  KGSSGSLN-SIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSL-GNLTKLT 327
            SF +L +L+ L+L +N LS ++ S     L SL  L L  N       +SL  +LTKL 
Sbjct: 94  DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQ 152

Query: 328 ILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
           IL + +   F  I  +    L +L  LE+  + L    P SL ++ N++ L L       
Sbjct: 153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI- 211

Query: 387 SIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
            +        +S+  L L + +L                 + + + LS            
Sbjct: 212 LLLEIFVDVTSSVECLELRDTDLD----------------TFHFSELSTGETNSLIKKFT 255

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
              + ++   L   +  L  ++ L  +   RN L       F   ++L  I L  
Sbjct: 256 FRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  108 bits (271), Expect = 2e-25
 Identities = 47/289 (16%), Positives = 97/289 (33%), Gaps = 38/289 (13%)

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
             +  L + +N ++     +    V L  LVL+ N +   I +    +L  L  + L  N
Sbjct: 52  EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYN 110

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEI-G 536
           +L+ N+S S                      F      +L  L++  N    +    +  
Sbjct: 111 YLS-NLSSS---------------------WFK--PLSSLTFLNLLGNPYKTLGETSLFS 146

Query: 537 DSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLS 595
              +L++L + +     +I  +    L  L +L ++ +      P  L S+  + HL L 
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206

Query: 596 SNRLSNSIPGSLGNLVKLYYLNLSNNQFSG----EIPI----KLEKFIHLSDLDLSHNFL 647
             +    +   +     +  L L +         E+       L K     ++ ++   L
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266

Query: 648 GEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
             ++   +  +  L +L  + N L       F  +  L  I +  N   
Sbjct: 267 -FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 89.0 bits (221), Expect = 5e-19
 Identities = 44/194 (22%), Positives = 73/194 (37%), Gaps = 8/194 (4%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNR 572
              + +LD+S N IT I   ++     L+ L L+SN I   I  +    L SL  L L+ 
Sbjct: 51  TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSY 109

Query: 573 NQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIPGSL-GNLVKLYYLNLSNNQFSGEIPIK 630
           N  S  L +     L  L  L+L  N        SL  +L KL  L + N     +I  K
Sbjct: 110 NYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168

Query: 631 -LEKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYI 688
                  L +L++  + L +    +   S+Q++  L L        +         +  +
Sbjct: 169 DFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECL 227

Query: 689 DISYNKLHGPIPNS 702
           ++    L     + 
Sbjct: 228 ELRDTDLDTFHFSE 241

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 31/172 (18%), Positives = 58/172 (33%), Gaps = 14/172 (8%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQI-ANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKIL 161
           FS    L  L +     F  I  +  A  + L+ L++ ++    +  P+   ++  +  L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHL 203

Query: 162 YLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSG----SIPP----SLGNLTNLAIMYLY 212
            L   Q    +        S ++ L L +  L       +      SL        + + 
Sbjct: 204 ILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL 264
           + SL   +   +  +  L  LE   N+L          L +L  + LH N  
Sbjct: 263 DESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 68.2 bits (167), Expect = 3e-12
 Identities = 34/194 (17%), Positives = 71/194 (36%), Gaps = 31/194 (15%)

Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQ 588
                      +  +   SS  +   IPS L    ++  L L+ N+ +    ++L   + 
Sbjct: 21  ESSNQASLSCDRNGICKGSSGSL-NSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVN 77

Query: 589 LEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLSDLDLSHNFL 647
           L+ L L+SN ++     S  +L  L +L+LS N  S  +     +    L+ L+L  N  
Sbjct: 78  LQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPY 136

Query: 648 GE-------------------------EIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKE 681
                                      +I  +    +  LE+L +  ++L  + P+  K 
Sbjct: 137 KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS 196

Query: 682 MHGLVYIDISYNKL 695
           +  + ++ +   + 
Sbjct: 197 IQNVSHLILHMKQH 210

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (343), Expect = 1e-35
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 37/285 (12%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             D++  + IGTG  G   +    S G+I+  K+     ++E   +Q  ++EV  L E++H
Sbjct: 6    EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKH 64

Query: 865  RNIVKFYG--FCSHARHSFIVYEYLEMGSLAMILSNATSA-----EELGWTQRMNVIKGV 917
             NIV++Y           +IV EY E G LA +++  T       EE        V+  +
Sbjct: 65   PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQL 120

Query: 918  ADALSYLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
              AL   H  +D    +++RD+   NV LD +    + DFG+++ L  D+S      GT 
Sbjct: 121  TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTP 180

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-- 1033
             Y++PE    M   EKSD++S G L  E      P  F      T+ +      +I +  
Sbjct: 181  YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP--F------TAFSQKELAGKIREGK 232

Query: 1034 -PRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              R+P   S  + + +I+        L+     RP+   V ++L+
Sbjct: 233  FRRIPYRYSDELNE-IIT------RMLNLKDYHRPS---VEEILE 267

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  134 bits (339), Expect = 6e-35
 Identities = 59/296 (19%), Positives = 114/296 (38%), Gaps = 58/296 (19%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQ-QEFLNEVKSLT 860
            R   DF E   IG+GG G V++A+    G+   +K         +    ++   EVK+L 
Sbjct: 8    RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK--------RVKYNNEKAEREVKALA 59

Query: 861  EIRHRNIVKFYGF----------------CSHARHSFIVYEYLEMGSLAMILSNATSA-- 902
            ++ H NIV + G                  S  +  FI  E+ + G+L   +        
Sbjct: 60   KLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKL 119

Query: 903  -EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
             + L       + + +   + Y+H+     ++ RD+   N+ L    +  + DFG+  SL
Sbjct: 120  DKVLAL----ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL 172

Query: 962  KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS 1021
            K D        GT+ Y++PE   +    ++ D+Y+ G++  E +               +
Sbjct: 173  KNDGKRTR-SKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----------A 221

Query: 1022 SNLDRTLDEILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                +   ++ D  +        +  L+         L + P+ RP     S++L+
Sbjct: 222  FETSKFFTDLRDGIISDIFDKKEKT-LLQ------KLLSKKPEDRPN---TSEILR 267

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (339), Expect = 1e-34
 Identities = 64/316 (20%), Positives = 110/316 (34%), Gaps = 48/316 (15%)

Query: 769  RRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-EL 827
            RR S + + S    +PG+        +  +++       F     +G G  G V++    
Sbjct: 29   RRVSFRGEASETLQSPGYDPS---RPESFFQQ------SFQRLSRLGHGSYGEVFKVRSK 79

Query: 828  SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEY 886
              G + AVK+  SP       +   L EV S  ++ +H   V+           ++  E 
Sbjct: 80   EDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138

Query: 887  LEMGSLAMILSNATSA--EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLL 944
                SL        ++  E   W      ++    AL++LH+     +V+ D+   N+ L
Sbjct: 139  CG-PSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQ---GLVHLDVKPANIFL 190

Query: 945  DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL---AYTMKVTEKSDVYSFGVLA 1001
                   + DFG+   L    +   +  G   Y+APEL   +Y       +DV+S G+  
Sbjct: 191  GPRGRCKLGDFGLLVELGTAGAGEVQE-GDPRYMAPELLQGSY----GTAADVFSLGLTI 245

Query: 1002 LEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP-SCNIRDKLISIMEVAISCLDE 1060
            LE                      +     L P   A  S  +R  ++         L+ 
Sbjct: 246  LEVACNMELP-------HGGEGWQQLRQGYLPPEFTAGLSSELRS-VLV------MMLEP 291

Query: 1061 NPDSRPTMQKVSQLLK 1076
            +P  R T      LL 
Sbjct: 292  DPKLRAT---AEALLA 304

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  141 bits (356), Expect = 1e-34
 Identities = 66/296 (22%), Positives = 109/296 (36%), Gaps = 55/296 (18%)

Query: 781  GNAPGFLSVLTFDRKIA--YEEIVRATNDFDEEHCIGTGGQGSVYRAE---LSSGEIVAV 835
            G+   FL  L     +A  YE +           CI  GG G +Y A    ++ G  V +
Sbjct: 63   GSPYSFLPQLNPGDIVAGQYE-VKG---------CIAHGGLGWIYLALDRNVN-GRPVVL 111

Query: 836  KKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS-----FIVYEYLEMG 890
            K       +E   Q   + E + L E+ H +IV+ + F  H         +IV EY+   
Sbjct: 112  KGLVHSGDAEA--QAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQ 169

Query: 891  SLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEA 950
            SL          ++L   + +  +  +  ALSYLH+     +VY D+  +N++L  E + 
Sbjct: 170  SLKRSK-----GQKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLT-EEQL 220

Query: 951  HVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             + D G    +         L GT G+ APE+  T   T  +D+Y+ G            
Sbjct: 221  KLIDLGAVSRINSFGY----LYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPT 275

Query: 1011 RDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRP 1066
            R            +D   ++    +             S   +    +D +P  R 
Sbjct: 276  R--------NGRYVDGLPEDDPVLKTYD----------SYGRLLRRAIDPDPRQRF 313

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  133 bits (337), Expect = 3e-34
 Identities = 66/318 (20%), Positives = 111/318 (34%), Gaps = 42/318 (13%)

Query: 769  RRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-EL 827
                 +    +  N    L+         Y E V        +  +G G  G V+R  + 
Sbjct: 24   SAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH---WMTHQPRVGRGSFGEVHRMKDK 80

Query: 828  SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYL 887
             +G   AVK        ++  +   + E+ +   +    IV  YG         I  E L
Sbjct: 81   QTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132

Query: 888  EMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE 947
            E GSL  ++       E    + +  +    + L YLH      I++ D+ + NVLL  +
Sbjct: 133  EGGSLGQLIKQMGCLPE---DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSD 186

Query: 948  -YEAHVSDFGISKSLKPDSSNWTE-----LAGTIGYVAPELAYTMKVTEKSDVYSFGVLA 1001
               A + DFG +  L+PD    +      + GT  ++APE+        K D++S   + 
Sbjct: 187  GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMM 246

Query: 1002 LEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAPSCNIRDKLISIMEVAIS-CL 1058
            L  + G HP           +         +I     P P   I      +   AI   L
Sbjct: 247  LHMLNGCHPW----------TQYFRGPLCLKI--ASEPPPIREIPPSCAPLTAQAIQEGL 294

Query: 1059 DENPDSRPTMQKVSQLLK 1076
             + P  R +     +L +
Sbjct: 295  RKEPVHRAS---AMELRR 309

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  133 bits (337), Expect = 3e-34
 Identities = 67/287 (23%), Positives = 107/287 (37%), Gaps = 26/287 (9%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
            P    LDL+ N I  +          L  L L +N  S  I  +    L  L+ LY+S 
Sbjct: 53  SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISK 111

Query: 166 NQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSL-SGSIPSE 223
           N     IPP     S L  L + +N +   +P      L N+  + +  N L +      
Sbjct: 112 NHLV-EIPP--NLPSSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 224 IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP-LSFGNLTNLDILN 282
             +   L+ L +   KL+G   +       L  L L  N +  +I        + L  L 
Sbjct: 168 AFDGLKLNYLRISEAKLTG---IPKDLPETLNELHLDHNKIQ-AIELEDLLRYSKLYRLG 223

Query: 283 LPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL----- 336
           L HN +   I +     L +L  L L  NKLS  +P+ L +L  L ++YL  N +     
Sbjct: 224 LGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGV 281

Query: 337 --FGSIPCEIGNLRYLFYLELGDNKLSGSI--PHSLGNLTNLATLYL 379
             F  +   +    Y   + L +N +      P +   +T+   +  
Sbjct: 282 NDFCPVGFGV-KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQF 327

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  132 bits (335), Expect = 6e-34
 Identities = 59/275 (21%), Positives = 103/275 (37%), Gaps = 20/275 (7%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
           I  L    F    HL  L L  N+I  I     +   KL+ L +S N     IPP +   
Sbjct: 66  ISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--P 122

Query: 156 SMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGL-SGSIPPSLGNLTNLAIMYLYN 213
           S L  L +  N+   ++P  +   L  +  + +  N L +    P   +   L  + +  
Sbjct: 123 SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181

Query: 214 NSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFG 273
             L+  IP      ++L+ L L +NK+       L     L  L L  N +      S  
Sbjct: 182 AKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLS 238

Query: 274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSS-------LGNLTKL 326
            L  L  L+L +N LS  +P+ + +LK L  + L  N ++  +  +              
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYY 296

Query: 327 TILYLSDNLL-FGSIPCEI-GNLRYLFYLELGDNK 359
             + L +N + +  +       +     ++ G+ K
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  121 bits (305), Expect = 4e-30
 Identities = 65/333 (19%), Positives = 114/333 (34%), Gaps = 46/333 (13%)

Query: 181 YLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL 240
           +L+ +   + GL  ++P  +    +  ++ L NN +S     +   L+ L  L L  NK+
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 241 SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLK 300
           S     +   L  L  L +  N L                           IP  +    
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-------------------------EIPPNL--PS 123

Query: 301 SLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL-FGSIPCEIGNLRYLFYLELGDNK 359
           SL  L +  N++          L  +  + +  N L          +   L YL + + K
Sbjct: 124 SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAK 183

Query: 360 LSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGN 418
           L+  IP  L     L  L+L  N +  +I  E     + L  LGL  N++      S   
Sbjct: 184 LT-GIPKDL--PETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSF 239

Query: 419 LTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ-------GPIPDLRNLTRLAR 471
           L  +  L + +N LS  +P    +L  L ++ L  N +         P+           
Sbjct: 240 LPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNG 298

Query: 472 VRLDRNHLT-GNISES-FGIHSNLSYINLSHKK 502
           + L  N +    +  + F   ++   I   + K
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  120 bits (303), Expect = 9e-30
 Identities = 68/320 (21%), Positives = 116/320 (36%), Gaps = 47/320 (14%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
           ++P EI      + L L  N++S      F  L ++  L + +N +S    K +  L KL
Sbjct: 47  AVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKL 104

Query: 447 TLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
             L +S N L   P     +L  L   R+  N +                  +    F G
Sbjct: 105 QKLYISKNHLVEIPPNLPSSLVEL---RIHDNRIR----------------KVPKGVFSG 145

Query: 506 EISFDWGKFPNLGTLDVSANNITGI-LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRS 564
                     N+  +++  N +      P   D  +L  L +S   +   IP +L    +
Sbjct: 146 --------LRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PET 194

Query: 565 LIKLTLNRNQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           L +L L+ N+    +  E L    +L  L L  N++     GSL  L  L  L+L NN+ 
Sbjct: 195 LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253

Query: 624 SGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV-------CSMQSLEKLNLAHNNLSGFI- 675
           S  +P  L     L  + L  N +  ++                   ++L +N +  +  
Sbjct: 254 S-RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEV 311

Query: 676 -PRCFKEMHGLVYIDISYNK 694
            P  F+ +   + I     K
Sbjct: 312 QPATFRCVTDRLAIQFGNYK 331

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  103 bits (259), Expect = 6e-24
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 11/211 (5%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
            I  + + ++L +         D+    +L  L +  N I+ I         +L+ L +S
Sbjct: 51  EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110

Query: 548 SNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSI--PG 605
            NH+V EIP  L    SL++L ++ N+           L  +  +++  N L NS   PG
Sbjct: 111 KNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167

Query: 606 SLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-MQSLEKL 664
           +   L KL YL +S  + +  IP  L     L++L L HN + + I  +       L +L
Sbjct: 168 AFDGL-KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRL 222

Query: 665 NLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
            L HN +          +  L  + +  NKL
Sbjct: 223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKL 253

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  102 bits (256), Expect = 1e-23
 Identities = 45/252 (17%), Positives = 82/252 (32%), Gaps = 33/252 (13%)

Query: 446 LTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
            TLL L  N +      D + L  L  + L  N ++    ++F     L  + +S     
Sbjct: 56  TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI-VGEIPSELGKLR 563
                      +L  L +  N I  +          +  +++  N +             
Sbjct: 116 ---EIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL 172

Query: 564 SLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
            L  L ++  + +  +P +L     L  L L  N++       L    KLY L L +NQ 
Sbjct: 173 KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQI 229

Query: 624 SGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH 683
                I+      L                      +L +L+L +N LS  +P    ++ 
Sbjct: 230 RM---IENGSLSFLP---------------------TLRELHLDNNKLS-RVPAGLPDLK 264

Query: 684 GLVYIDISYNKL 695
            L  + +  N +
Sbjct: 265 LLQVVYLHTNNI 276

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 48/185 (25%), Positives = 77/185 (41%), Gaps = 16/185 (8%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
            P+L +L  + + +    P        L+V+  S   +   +P E+        L L  N
Sbjct: 13  IPDLDSLPPTYSAM---CPFGC--HCHLRVVQCSDLGLK-AVPKEISP--DTTLLDLQNN 64

Query: 574 QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
             S     +   L  L  L L +N++S     +   L KL  L +S N    EIP  L  
Sbjct: 65  DISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL-- 121

Query: 634 FIHLSDLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNL--SGFIPRCFKEMHGLVYIDI 690
              L +L +  N +  ++P  V S ++++  + +  N L  SGF P  F  +  L Y+ I
Sbjct: 122 PSSLVELRIHDNRI-RKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK-LNYLRI 179

Query: 691 SYNKL 695
           S  KL
Sbjct: 180 SEAKL 184

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  132 bits (334), Expect = 6e-34
 Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 32/287 (11%)

Query: 797  AYEEIVRATN---DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF 852
            A   +V   +     D    IG G  G V  A E  SG  VAVK      L +   ++  
Sbjct: 33   ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELL 89

Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
             NEV  + + +H N+V+ Y         +++ E+L+ G+L  I+S     EE    Q   
Sbjct: 90   FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE----QIAT 145

Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
            V + V  AL+YLH      +++RDI S ++LL L+    +SDFG    +  D      L 
Sbjct: 146  VCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 202

Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDE 1030
            GT  ++APE+        + D++S G++ +E + G+ P            +    + +  
Sbjct: 203  GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY----------FSDSPVQAMKR 252

Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
            +     P P      K+  ++   +   L  +P  R T     +LL 
Sbjct: 253  L--RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLD 294

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  131 bits (332), Expect = 6e-34
 Identities = 70/276 (25%), Positives = 132/276 (47%), Gaps = 29/276 (10%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               +     IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E +
Sbjct: 19   KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            + NIV +          ++V EYL  GSL  +++     E     Q   V +    AL +
Sbjct: 76   NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEF 131

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH++    +++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+ 
Sbjct: 132  LHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAPSC 1041
                   K D++S G++A+E I+G+ P            N +  R L  I       P  
Sbjct: 189  TRKAYGPKVDIWSLGIMAIEMIEGEPPY----------LNENPLRALYLI--ATNGTPEL 236

Query: 1042 NIRDKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
               +KL +I    ++ CL+ + + R +     +LL+
Sbjct: 237  QNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQ 269

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  131 bits (332), Expect = 8e-34
 Identities = 61/235 (25%), Positives = 93/235 (39%), Gaps = 10/235 (4%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSN--SFSGTIPPQIGNLSMLKILYLS 164
                 L+L  N++  +        ++L  L LSSN  SF G         + LK L LS
Sbjct: 27  PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86

Query: 165 TNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSE 223
            N     +      L  L+ L    + L      S+  +L NL  + + +        + 
Sbjct: 87  FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144

Query: 224 I-GNLKSLSGLELGYNK-LSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
           I   L SL  L++  N      +P     L NL  LDL    L    P +F +L++L +L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 204

Query: 282 NLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNL-TKLTILYLSDN 334
           N+ HN+   S+ +     L SL  L  S N +  S    L +  + L  L L+ N
Sbjct: 205 NMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  125 bits (315), Expect = 1e-31
 Identities = 46/226 (20%), Positives = 83/226 (36%), Gaps = 12/226 (5%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQI--FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIG 153
           + +L    F     L  L L  N +   G         + LKYLDLS N    T+     
Sbjct: 40  LQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFL 98

Query: 154 NLSMLKILYLSTNQFSGRIPPQ--IGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMY 210
            L  L+ L    +    ++        L  L  L +                L++L ++ 
Sbjct: 99  GLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLK 156

Query: 211 LYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
           +  NS   +   +I   L++L+ L+L   +L    P +  +L +L  L++  N+      
Sbjct: 157 MAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 216

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEM--GNLKSLYGLGLSFNKLS 313
             +  L +L +L+   N +  +   +       SL  L L+ N  +
Sbjct: 217 FPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  122 bits (309), Expect = 7e-31
 Identities = 57/254 (22%), Positives = 103/254 (40%), Gaps = 9/254 (3%)

Query: 185 LHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS--G 242
           +     GL+ S+P  +   ++   + L +N L          L  L+ L L  N LS  G
Sbjct: 12  IRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68

Query: 243 SMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKS 301
               S     +L  LDL  N +  ++  +F  L  L+ L+  H++L       +  +L++
Sbjct: 69  CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127

Query: 302 LYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKL 360
           L  L +S      +       L+ L +L ++ N    +   +I   LR L +L+L   +L
Sbjct: 128 LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 187

Query: 361 SGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNL- 419
               P +  +L++L  L +  N            LNSL  L  S N +  S      +  
Sbjct: 188 EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFP 247

Query: 420 TNMIVLSIYSNALS 433
           +++  L++  N  +
Sbjct: 248 SSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  114 bits (287), Expect = 6e-28
 Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 10/230 (4%)

Query: 471 RVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT-- 528
            +R +   LT   S   GI S+ + + L   K        + K   L  L +S+N ++  
Sbjct: 11  EIRCNSKGLT---SVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTEL-GSLI 587
           G        +  LK LDLS N ++  + S    L  L  L    +         +  SL 
Sbjct: 68  GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126

Query: 588 QLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-LEKFIHLSDLDLSHNF 646
            L +LD+S      +  G    L  L  L ++ N F          +  +L+ LDLS   
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186

Query: 647 LGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
           L E++      S+ SL+ LN++HNN        +K ++ L  +D S N +
Sbjct: 187 L-EQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 235

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  112 bits (282), Expect = 3e-27
 Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 15/247 (6%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS--GAIPKEYGNLV 444
           S+P+ I   +S + L L  N+L       F  LT +  LS+ SN LS  G   +      
Sbjct: 21  SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 445 KLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISES-FGIHSNLSYINLSHKKF 503
            L  L LS+N +     +   L +L  +    ++L      S F    NL Y+++SH   
Sbjct: 79  SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138

Query: 504 YGEISFDWGKF---PNLGTLDVSANNITGILPPEI-GDSPQLKVLDLSSNHIVGEIPSE- 558
                   G F    +L  L ++ N+      P+I  +   L  LDLS   +  ++    
Sbjct: 139 ---RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTA 194

Query: 559 LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK-LYYLN 617
              L SL  L ++ N F          L  L+ LD S N +  S    L +    L +LN
Sbjct: 195 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 254

Query: 618 LSNNQFS 624
           L+ N F+
Sbjct: 255 LTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 24/106 (22%), Positives = 44/106 (41%), Gaps = 5/106 (4%)

Query: 88  INLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGT 147
           + +             F+   +L +LDL   Q+  + P+   + S L+ L++S N+F  +
Sbjct: 155 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-S 213

Query: 148 IPPQI-GNLSMLKILYLSTNQFSGRIPPQI--GHLSYLKALHLFEN 190
           +       L+ L++L  S N        Q      S L  L+L +N
Sbjct: 214 LDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQN 258

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  129 bits (327), Expect = 4e-33
 Identities = 68/274 (24%), Positives = 119/274 (43%), Gaps = 30/274 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             F +   IG G  G V++  +  + ++VA+K     L       ++   E+  L++    
Sbjct: 23   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKII--DLEEAEDEIEDIQQEITVLSQCDSP 80

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
             + K+YG        +I+ EYL  GS   +L      E     Q   +++ +   L YLH
Sbjct: 81   YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET----QIATILREILKGLDYLH 136

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT 985
            ++     ++RDI + NVLL    E  ++DFG++  L           GT  ++APE+   
Sbjct: 137  SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ 193

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAPSCNI 1043
                 K+D++S G+ A+E  +G+ P           S L   + L  I  P+   P+  +
Sbjct: 194  SAYDSKADIWSLGITAIELARGEPPH----------SELHPMKVLFLI--PKNNPPT--L 239

Query: 1044 RDKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
                   ++  +  CL++ P  RPT     +LLK
Sbjct: 240  EGNYSKPLKEFVEACLNKEPSFRPT---AKELLK 270

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  127 bits (321), Expect = 9e-33
 Identities = 67/287 (23%), Positives = 126/287 (43%), Gaps = 40/287 (13%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
             I    ++      IG+G  G V+     + + VA+K     +      +++F+ E + +
Sbjct: 4    VIDP--SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKT----IREGAMSEEDFIEEAEVM 57

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             ++ H  +V+ YG C       +V E++E G L+  L              + +   V +
Sbjct: 58   MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCE 115

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IG 976
             ++YL   C    ++RD++++N L+       VSDFG+++ +  D   +T   GT   + 
Sbjct: 116  GMAYLEEACV---IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVK 170

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP- 1034
            + +PE+    + + KSDV+SFGVL  E   +GK P +            +R+  E+++  
Sbjct: 171  WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE------------NRSNSEVVEDI 218

Query: 1035 ----RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                RL  P   +    +  IM     C  E P+ RP   ++ + L 
Sbjct: 219  STGFRLYKPRLAS--THVYQIM---NHCWRERPEDRPAFSRLLRQLA 260

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  128 bits (323), Expect = 1e-32
 Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 40/277 (14%)

Query: 813  CIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
             +G G  G VY   +LS+   +A+K+       +    Q    E+     ++H+NIV++ 
Sbjct: 29   VLGKGTYGIVYAGRDLSNQVRIAIKEIP---ERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
            G  S      I  E +  GSL+ +L +     +          K + + L YLH++    
Sbjct: 86   GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 932  IVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPE--LAYTMK 987
            IV+RDI   NVL++  Y   +  SDFG SK L   +       GT+ Y+APE        
Sbjct: 143  IVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201

Query: 988  VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEI-------LDPRLPAP- 1039
              + +D++S G   +E   GK P             L      +       + P +P   
Sbjct: 202  YGKAADIWSLGCTIIEMATGKPPF----------YELGEPQAAMFKVGMFKVHPEIPESM 251

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            S   +  +       + C + +PD R      + LL 
Sbjct: 252  SAEAKAFI-------LKCFEPDPDKRAC---ANDLLV 278

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  131 bits (331), Expect = 1e-32
 Identities = 68/255 (26%), Positives = 109/255 (42%), Gaps = 12/255 (4%)

Query: 182 LKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS 241
              +      L   +P  +   TN  ++ L+ N +     +   +L+ L  L+L  N + 
Sbjct: 45  FSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101

Query: 242 GSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHNSLSGSIPSEM-GNL 299
                +   L NL TL+L DN L+ +IP  +F  L+ L  L L +N +  SIPS     +
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159

Query: 300 KSLYGLGLS-FNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDN 358
            SL  L L    +LS     +   L+ L  L L+   L   IP  +  L  L  L+L  N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNL-REIP-NLTPLIKLDELDLSGN 217

Query: 359 KLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE-IGNLNSLSDLGLSENELSGSIPYSFG 417
            LS   P S   L +L  L++  + +   I      NL SL ++ L+ N L+      F 
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276

Query: 418 NLTNMIVLSIYSNAL 432
            L ++  + ++ N  
Sbjct: 277 PLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  129 bits (327), Expect = 5e-32
 Identities = 69/257 (26%), Positives = 109/257 (42%), Gaps = 14/257 (5%)

Query: 131 NSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFEN 190
           +++   +     +    +P  I   +  ++L L  NQ          HL +L+ L L  N
Sbjct: 42  SNQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 191 GLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSL 248
            +  +I   +   L NL  + L++N L+ +IP+     L  L  L L  N +      + 
Sbjct: 99  HIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAF 156

Query: 249 GNLPNLATLDL-HDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGL 307
             +P+L  LDL     LS     +F  L+NL  LNL   +L   IP+ +  L  L  L L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDL 214

Query: 308 SFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCE-IGNLRYLFYLELGDNKLSGSIPH 366
           S N LS   P S   L  L  L++  + +   I      NL+ L  + L  N L+  +PH
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLT-LLPH 272

Query: 367 S-LGNLTNLATLYLFTN 382
                L +L  ++L  N
Sbjct: 273 DLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  129 bits (325), Expect = 7e-32
 Identities = 66/233 (28%), Positives = 92/233 (39%), Gaps = 11/233 (4%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
             +   L+L  NQI  I  +   +   L+ L LS N    TI       L+ L  L L  
Sbjct: 63  STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFD 121

Query: 166 NQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSE 223
           N+ +  IP     +LS LK L L  N +  SIP      + +L  + L        I   
Sbjct: 122 NRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179

Query: 224 I-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
               L +L  L L    L   +P +L  L  L  LDL  N LS   P SF  L +L  L 
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237

Query: 283 LPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
           +  + +   I      NL+SL  + L+ N L+         L  L  ++L  N
Sbjct: 238 MIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  129 bits (325), Expect = 9e-32
 Identities = 64/252 (25%), Positives = 98/252 (38%), Gaps = 12/252 (4%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
                +L   +P  I    +   L L  N++      S  +L +L  L L  N +     
Sbjct: 49  ICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI 105

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSL-GNLTKLT 327
            +F  L NL+ L L  N L+ +IP+     L  L  L L  N +  SIPS     +  L 
Sbjct: 106 GAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLR 163

Query: 328 ILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
            L L +      I       L  L YL L    L   IP+ L  L  L  L L  N LS 
Sbjct: 164 RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS- 220

Query: 387 SIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
           +I       L  L  L + ++++      +F NL +++ +++  N L+      +  L  
Sbjct: 221 AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280

Query: 446 LTLLVLSYNQLQ 457
           L  + L +N   
Sbjct: 281 LERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  127 bits (321), Expect = 3e-31
 Identities = 64/219 (29%), Positives = 91/219 (41%), Gaps = 9/219 (4%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I  +   SF    HL  L L  N I  I        + L  L+L  N  + TIP      
Sbjct: 76  IQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVY 134

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLY 212
           LS LK L+L  N     IP      +  L+ L L E      I   +   L+NL  + L 
Sbjct: 135 LSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLA 193

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
             +L   IP+ +  L  L  L+L  N LS   P S   L +L  L +  + +      +F
Sbjct: 194 MCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAF 251

Query: 273 GNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFN 310
            NL +L  +NL HN+L+  +P ++   L  L  + L  N
Sbjct: 252 DNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  109 bits (275), Expect = 2e-25
 Identities = 54/198 (27%), Positives = 86/198 (43%), Gaps = 11/198 (5%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I T+   +F+   +L  L+L  N++  I        SKLK L L +N    +IP      
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158

Query: 155 LSMLKILYLS-TNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLY 212
           +  L+ L L    + S  I       LS L+ L+L    L   IP +L  L  L  + L 
Sbjct: 159 IPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215

Query: 213 NNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLS 271
            N LS +I       L  L  L +  +++      +  NL +L  ++L  N+L+  +P  
Sbjct: 216 GNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273

Query: 272 -FGNLTNLDILNLPHNSL 288
            F  L +L+ ++L HN  
Sbjct: 274 LFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (270), Expect = 8e-25
 Identities = 65/297 (21%), Positives = 104/297 (35%), Gaps = 59/297 (19%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI 412
           +      L   +P  +   TN   L L  N +     +   +L  L  L LS N +    
Sbjct: 48  VICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIE 104

Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVKLTLLVLSYNQLQGPIPD--LRNLTRL 469
             +F  L N+  L ++ N L+  IP   +  L KL  L L  N ++  IP      +  L
Sbjct: 105 IGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIES-IPSYAFNRIPSL 162

Query: 470 ARVRLDR-NHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
            R+ L     L+                 +S   F G          NL  L+++  N+ 
Sbjct: 163 RRLDLGELKRLS----------------YISEGAFEG--------LSNLRYLNLAMCNLR 198

Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQ 588
            I  P +    +L  LDLS NH+                  +    F G        L+ 
Sbjct: 199 EI--PNLTPLIKLDELDLSGNHLS----------------AIRPGSFQG--------LMH 232

Query: 589 LEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
           L+ L +  +++      +  NL  L  +NL++N  +           HL  + L HN
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 95.2 bits (237), Expect = 1e-20
 Identities = 51/185 (27%), Positives = 68/185 (36%), Gaps = 8/185 (4%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRN 573
                 +     N+  + P  I  S   ++L+L  N I     +    LR L  L L+RN
Sbjct: 42  SNQFSKVICVRKNLREV-PDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98

Query: 574 QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-E 632
                       L  L  L+L  NRL+    G+   L KL  L L NN     IP     
Sbjct: 99  HIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFN 157

Query: 633 KFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
           +   L  LDL        I       + +L  LNLA  NL   IP     +  L  +D+S
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLS 215

Query: 692 YNKLH 696
            N L 
Sbjct: 216 GNHLS 220

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 67.5 bits (165), Expect = 9e-12
 Identities = 36/156 (23%), Positives = 63/156 (40%), Gaps = 13/156 (8%)

Query: 64  NNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGI 123
           N    I   A+  I       +  ++L     +  + + +F    +L YL+L +  +  I
Sbjct: 146 NPIESIPSYAFNRIP-----SLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI 200

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGRIPPQ-IGHLSY 181
               +    KL  LDLS N  S  I P     L  L+ L++  +Q    I      +L  
Sbjct: 201 --PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQS 256

Query: 182 LKALHLFENGLSGSIPPS-LGNLTNLAIMYLYNNSL 216
           L  ++L  N L+  +P      L +L  ++L++N  
Sbjct: 257 LVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  131 bits (331), Expect = 1e-32
 Identities = 70/256 (27%), Positives = 108/256 (42%), Gaps = 14/256 (5%)

Query: 182 LKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS 241
              +     GLS  +P  +   +N   + L  N++         +L  L  L+LG N + 
Sbjct: 56  FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112

Query: 242 GSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHNSLSGSIPSEM-GNL 299
                +   L +L TL+L DN L+  IP  +F  L+ L  L L +N +  SIPS     +
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170

Query: 300 KSLYGLGLS-FNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDN 358
            SL  L L    KL      +   L  L  L L    +   +P  +  L  L  LE+  N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGN 228

Query: 359 KLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE-IGNLNSLSDLGLSENELSGSIPYS-F 416
                 P S   L++L  L++  + +S  I       L SL +L L+ N LS S+P+  F
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLF 286

Query: 417 GNLTNMIVLSIYSNAL 432
             L  ++ L ++ N  
Sbjct: 287 TPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  130 bits (329), Expect = 3e-32
 Identities = 67/257 (26%), Positives = 102/257 (39%), Gaps = 14/257 (5%)

Query: 131 NSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFEN 190
           +++   +  +    S  +P  I   S  + L L  N           HL +L+ L L  N
Sbjct: 53  SNQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109

Query: 191 GLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSL 248
            +   I   +   L +L  + L++N L+  IPS     L  L  L L  N +      + 
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAF 167

Query: 249 GNLPNLATLDL-HDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGL 307
             +P+L  LDL     L      +F  L NL  LNL   ++   +P+ +  L  L  L +
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEM 225

Query: 308 SFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCE-IGNLRYLFYLELGDNKLSGSIPH 366
           S N      P S   L+ L  L++ ++ +   I       L  L  L L  N LS S+PH
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWVMNSQV-SLIERNAFDGLASLVELNLAHNNLS-SLPH 283

Query: 367 S-LGNLTNLATLYLFTN 382
                L  L  L+L  N
Sbjct: 284 DLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  130 bits (329), Expect = 3e-32
 Identities = 64/233 (27%), Positives = 90/233 (38%), Gaps = 11/233 (4%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
             +  YL+L  N I  I      +   L+ L L  NS    I       L+ L  L L  
Sbjct: 74  PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFD 132

Query: 166 NQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSE 223
           N  +  IP     +LS L+ L L  N +  SIP  +   + +L  + L        I   
Sbjct: 133 NWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEG 190

Query: 224 I-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
               L +L  L LG   +   MP +L  L  L  L++  N      P SF  L++L  L 
Sbjct: 191 AFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLW 248

Query: 283 LPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
           + ++ +S  I       L SL  L L+ N LS         L  L  L+L  N
Sbjct: 249 VMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  129 bits (326), Expect = 7e-32
 Identities = 61/219 (27%), Positives = 89/219 (40%), Gaps = 9/219 (4%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I  +   +F    HL  L L  N I  I        + L  L+L  N  +  IP      
Sbjct: 87  IQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEY 145

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLY 212
           LS L+ L+L  N     IP      +  L  L L E      I   +   L NL  + L 
Sbjct: 146 LSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
             ++   +P+ +  L  L  LE+  N      P S   L +L  L + ++ +S     +F
Sbjct: 205 MCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAF 262

Query: 273 GNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFN 310
             L +L  LNL HN+LS S+P ++   L+ L  L L  N
Sbjct: 263 DGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  128 bits (323), Expect = 2e-31
 Identities = 66/253 (26%), Positives = 101/253 (39%), Gaps = 14/253 (5%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
                 LS  +P  I    +   L L  N +      +  +L +L  L L  NS+     
Sbjct: 60  VCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEV 116

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLT 327
            +F  L +L+ L L  N L+  IPS     L  L  L L  N +  SIPS +   +  L 
Sbjct: 117 GAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLM 174

Query: 328 ILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
            L L +      I       L  L YL LG   +   +P+ L  L  L  L +  N    
Sbjct: 175 RLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP- 231

Query: 387 SIPSE-IGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLV 444
            I       L+SL  L +  +++S     +F  L +++ L++  N LS ++P + +  L 
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLR 290

Query: 445 KLTLLVLSYNQLQ 457
            L  L L +N   
Sbjct: 291 YLVELHLHHNPWN 303

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  117 bits (294), Expect = 7e-28
 Identities = 66/276 (23%), Positives = 101/276 (36%), Gaps = 37/276 (13%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSI 412
           +      LS  +P  +   +N   L L  N +         +L+ L  L L  N +    
Sbjct: 59  VVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIE 115

Query: 413 PYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVKLTLLVLSYNQLQGPIPD--LRNLTRL 469
             +F  L ++  L ++ N L+  IP   +  L KL  L L  N ++  IP      +  L
Sbjct: 116 VGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIES-IPSYAFNRVPSL 173

Query: 470 ARVRLDR-NHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
            R+ L     L                  +S   F G          NL  L++   NI 
Sbjct: 174 MRLDLGELKKLE----------------YISEGAFEG--------LFNLKYLNLGMCNIK 209

Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTELGSLI 587
            +  P +     L+ L++S NH   EI       L SL KL +  +Q S         L 
Sbjct: 210 DM--PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLA 266

Query: 588 QLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
            L  L+L+ N LS+        L  L  L+L +N +
Sbjct: 267 SLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  110 bits (278), Expect = 1e-25
 Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 10/232 (4%)

Query: 468 RLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNI 527
           + ++V   R  L+  + +  GI SN  Y+NL         +  +    +L  L +  N+I
Sbjct: 55  QFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111

Query: 528 TGILPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTELGSL 586
             I          L  L+L  N +   IPS     L  L +L L  N            +
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170

Query: 587 IQLEHLDLSS-NRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
             L  LDL    +L     G+   L  L YLNL       ++P  L   + L +L++S N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGN 228

Query: 646 FLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
               EI       + SL+KL + ++ +S      F  +  LV +++++N L 
Sbjct: 229 HF-PEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS 279

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  110 bits (277), Expect = 1e-25
 Identities = 51/197 (25%), Positives = 77/197 (39%), Gaps = 9/197 (4%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I  +   +F+    L  L+L  N +  I        SKL+ L L +N    +IP      
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
           +  L  L L   +    I       L  LK L+L    +   +P +L  L  L  + +  
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227

Query: 214 NSLSGSIPSE-IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLS- 271
           N     I       L SL  L +  +++S     +   L +L  L+L  N+LS S+P   
Sbjct: 228 NHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285

Query: 272 FGNLTNLDILNLPHNSL 288
           F  L  L  L+L HN  
Sbjct: 286 FTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  107 bits (268), Expect = 2e-24
 Identities = 68/281 (24%), Positives = 100/281 (35%), Gaps = 37/281 (13%)

Query: 396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
           N  S +  +   LS  +P      +N   L++  N +       + +L  L +L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 456 LQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGK 513
           ++  I       L  L  + L  N LT        I S           F          
Sbjct: 111 IRQ-IEVGAFNGLASLNTLELFDNWLTV-------IPSGA---------FEY-------- 145

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNR 572
              L  L +  N I  I        P L  LDL     +  I       L +L  L L  
Sbjct: 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGM 205

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-L 631
                 +P  L  L+ LE L++S N      PGS   L  L  L + N+Q S  I     
Sbjct: 206 CNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAF 262

Query: 632 EKFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNL 671
           +    L +L+L+HN L   +P  +   ++ L +L+L HN  
Sbjct: 263 DGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 68.2 bits (167), Expect = 5e-12
 Identities = 38/156 (24%), Positives = 65/156 (41%), Gaps = 13/156 (8%)

Query: 64  NNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGI 123
           N    I   A+  +       +  ++L     +  + + +F    +L YL+L +  I  +
Sbjct: 157 NPIESIPSYAFNRVP-----SLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQ-IGNLSMLKILYLSTNQFSGRIPPQ-IGHLSY 181
               +     L+ L++S N F   I P     LS LK L++  +Q S  I       L+ 
Sbjct: 212 --PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLAS 267

Query: 182 LKALHLFENGLSGSIPPS-LGNLTNLAIMYLYNNSL 216
           L  L+L  N LS S+P      L  L  ++L++N  
Sbjct: 268 LVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  126 bits (319), Expect = 6e-32
 Identities = 79/301 (26%), Positives = 131/301 (43%), Gaps = 45/301 (14%)

Query: 789  VLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLS 844
              +F R+I    I         E  IG+G  G V    L      ++ VA+K   +    
Sbjct: 39   GRSFTREIEASRIHI-------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE 91

Query: 845  EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE 904
                +++FL+E   + +  H NI++  G  +  R + IV EY+E GSL   L       +
Sbjct: 92   RQ--RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQ 147

Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
                Q + +++GV   + YL +  +   V+RD++++NVL+D      VSDFG+S+ L+ D
Sbjct: 148  FTIMQLVGMLRGVGAGMRYLSDLGY---VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204

Query: 965  SSNWTELAGT---IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICST 1020
                    G    I + APE       +  SDV+SFGV+  E +  G+ P          
Sbjct: 205  PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYW-------- 256

Query: 1021 SSNLDRTLDEILDP-----RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074
                + T  +++       RLPAP  C     L  +M   + C  ++   RP   ++  +
Sbjct: 257  ----NMTNRDVISSVEEGYRLPAPMGCP--HALHQLM---LDCWHKDRAQRPRFSQIVSV 307

Query: 1075 L 1075
            L
Sbjct: 308  L 308

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  125 bits (317), Expect = 6e-32
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG  +VY AE       VA+K    P   +    + F  EV + +++ H+NIV    
Sbjct: 19   LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
                    ++V EY+E  +L+  +    S   L     +N    + D + + H+     I
Sbjct: 79   VDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHDM---RI 132

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE---LAGTIGYVAPELAYTMKVT 989
            V+RDI  +N+L+D      + DFGI+K+L    ++ T+   + GT+ Y +PE A      
Sbjct: 133  VHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
            E +D+YS G++  E + G+ P
Sbjct: 191  ECTDIYSIGIVLYEMLVGEPP 211

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  126 bits (318), Expect = 6e-32
 Identities = 73/273 (26%), Positives = 131/273 (47%), Gaps = 29/273 (10%)

Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            FD    +G G  GSVY+A    +G+IVA+K+   P+ S++   QE + E+  + +    +
Sbjct: 31   FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDL---QEIIKEISIMQQCDSPH 85

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +VK+YG        +IV EY   GS++ I+      + L   +   +++     L YLH 
Sbjct: 86   VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR--LRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                  ++RDI + N+LL+ E  A ++DFG++  L    +    + GT  ++APE+   +
Sbjct: 144  M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 987  KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAPSCNIR 1044
                 +D++S G+ A+E  +GK P           +++   R +  I  P  P P+    
Sbjct: 201  GYNCVADIWSLGITAIEMAEGKPPY----------ADIHPMRAIFMI--PTNPPPTFRKP 248

Query: 1045 DKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
            +         +  CL ++P+ R T    +QLL+
Sbjct: 249  ELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQ 278

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  125 bits (316), Expect = 6e-32
 Identities = 60/297 (20%), Positives = 110/297 (37%), Gaps = 48/297 (16%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            R T +F E   IG+G  GSV++  +   G I A+K+   PL      +Q  L EV +   
Sbjct: 8    RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAV 66

Query: 862  I-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVAD 919
            + +H ++V+++   +   H  I  EY   GSLA  I  N          +  +++  V  
Sbjct: 67   LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS-------------------DFGISKS 960
             L Y+H+     +V+ DI   N+ +      + +                   D G    
Sbjct: 127  GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183

Query: 961  LKPDSSNWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS 1019
            +    S+     G   ++A E L        K+D+++  +  + A   +           
Sbjct: 184  I----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL--------- 230

Query: 1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                      EI   RLP     +  +   +++     +  +P+ RP+      L+K
Sbjct: 231  --PRNGDQWHEIRQGRLPRIPQVLSQEFTELLK---VMIHPDPERRPS---AMALVK 279

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  126 bits (318), Expect = 6e-32
 Identities = 55/285 (19%), Positives = 107/285 (37%), Gaps = 37/285 (12%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +     +G GG   V   E L  G   A+K+    L  E   ++E   E        H 
Sbjct: 30   HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHP 86

Query: 866  NIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQR--MNVIKGVAD 919
            NI++   +C   R +    +++  + + G+L   +      +    T+   + ++ G+  
Sbjct: 87   NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICR 145

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA------- 972
             L  +H        +RD+   N+LL  E +  + D G             +         
Sbjct: 146  GLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 973  --GTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
               TI Y APEL    ++ + + E++DV+S G +    + G+ P  +        S    
Sbjct: 203  QRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP--YDMVFQKGDSVALA 259

Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +++  P+ P  S  +   L++ M      +  +P  RP +  +
Sbjct: 260  VQNQLSIPQSPRHSSALWQ-LLNSM------MTVDPHQRPHIPLL 297

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  124 bits (314), Expect = 1e-31
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 9/209 (4%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLST 165
                 + L  N+I  +  +       L  L L SN  +  I       L++L+ L LS 
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSD 89

Query: 166 NQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSE 223
           N     + P     L  L  LHL   GL   + P     L  L  +YL +N+L  ++P +
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDD 147

Query: 224 I-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
              +L +L+ L L  N++S     +   L +L  L LH N ++   P +F +L  L  L 
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 283 LPHNSLSGSIPSE-MGNLKSLYGLGLSFN 310
           L  N+LS ++P+E +  L++L  L L+ N
Sbjct: 208 LFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  120 bits (303), Expect = 3e-30
 Identities = 57/228 (25%), Positives = 88/228 (38%), Gaps = 12/228 (5%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
                 L  ++P  I    +   + L  N++S     S     NL  L LH N L+    
Sbjct: 17  SCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDA 73

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLT 327
            +F  L  L+ L+L  N+   S+       L  L+ L L    L   +       L  L 
Sbjct: 74  AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ 132

Query: 328 ILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
            LYL DN L  ++P +   +L  L +L L  N++S     +   L +L  L L  N ++ 
Sbjct: 133 YLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA- 190

Query: 387 SIPSEI-GNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSIYSNAL 432
            +      +L  L  L L  N LS ++P      L  +  L +  N  
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  115 bits (291), Expect = 1e-28
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 9/198 (4%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I  +   SF +  +L  L L  N +  I  +     + L+ LDLS N+   ++ P     
Sbjct: 44  ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG 103

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLY 212
           L  L  L+L        + P +   L+ L+ L+L +N L  ++P  +  +L NL  ++L+
Sbjct: 104 LGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLH 161

Query: 213 NNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLS 271
            N +S S+P      L SL  L L  N+++   P +  +L  L TL L  N+LS ++P  
Sbjct: 162 GNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219

Query: 272 -FGNLTNLDILNLPHNSL 288
               L  L  L L  N  
Sbjct: 220 ALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  111 bits (280), Expect = 3e-27
 Identities = 56/227 (24%), Positives = 89/227 (39%), Gaps = 11/227 (4%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
           T       L  ++P+          + L  N +S    +     ++L  L L  N L+  
Sbjct: 15  TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71

Query: 316 IPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPH-SLGNLTN 373
             ++   L  L  L LSDN    S+       L  L  L L    L   +       L  
Sbjct: 72  DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAA 130

Query: 374 LATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNAL 432
           L  LYL  N L  ++P +   +L +L+ L L  N +S     +F  L ++  L ++ N +
Sbjct: 131 LQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV 189

Query: 433 SGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
           +   P  + +L +L  L L  N L   +P   L  L  L  +RL+ N
Sbjct: 190 AHVHPHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  105 bits (263), Expect = 6e-25
 Identities = 42/186 (22%), Positives = 71/186 (38%), Gaps = 7/186 (3%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNR 572
                 + +  N I+ +          L +L L SN +   I +     L  L +L L+ 
Sbjct: 31  PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSD 89

Query: 573 NQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK- 630
           N     +       L +L  L L    L    PG    L  L YL L +N     +P   
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 631 LEKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYID 689
                +L+ L L  N +   +P +    + SL++L L  N ++   P  F+++  L+ + 
Sbjct: 149 FRDLGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 690 ISYNKL 695
           +  N L
Sbjct: 208 LFANNL 213

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 47/212 (22%), Positives = 72/212 (33%), Gaps = 5/212 (2%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
           GI +    I L   +     +  +    NL  L + +N +  I          L+ LDLS
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 548 SNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPG 605
            N  +  +       L  L  L L+R     +L       L  L++L L  N L      
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 606 SLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-MQSLEKL 664
           +  +L  L +L L  N+ S            L  L L  N +   +       +  L  L
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRV-AHVHPHAFRDLGRLMTL 206

Query: 665 NLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
            L  NNLS         +  L Y+ ++ N   
Sbjct: 207 YLFANNLSALPTEALAPLRALQYLRLNDNPWV 238

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 50/232 (21%), Positives = 75/232 (32%), Gaps = 34/232 (14%)

Query: 446 LTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
              + L  N++   P    R    L  + L  N L                  +    F 
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA----------------RIDAAAFT 77

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEI-GDSPQLKVLDLSSNHIVGEIPSE-LGKL 562
           G           L  LD+S N     + P       +L  L L    +  E+       L
Sbjct: 78  G--------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGL 128

Query: 563 RSLIKLTLNRNQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
            +L  L L  N     LP +    L  L HL L  NR+S+    +   L  L  L L  N
Sbjct: 129 AALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187

Query: 622 QFSGEIPIK-LEKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNL 671
           + +  +          L  L L  N L   +P++    +++L+ L L  N  
Sbjct: 188 RVA-HVHPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 47/210 (22%), Positives = 88/210 (41%), Gaps = 26/210 (12%)

Query: 46  TSLQNHNNKGSFLPSWTL-------------NNATKISPCAWFGIHCNHAGKVNSINLTS 92
             +  H N+ S +P+ +              N   +I   A+ G+       +  ++L+ 
Sbjct: 35  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLA-----LLEQLDLSD 89

Query: 93  AGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI 152
              + ++   +F     L  L L    +  + P      + L+YL L  N+    +P   
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148

Query: 153 -GNLSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIM 209
             +L  L  L+L  N+ S  +P +    L  L  L L +N ++  + P +  +L  L  +
Sbjct: 149 FRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTL 206

Query: 210 YLYNNSLSGSIPSEI-GNLKSLSGLELGYN 238
           YL+ N+LS ++P+E    L++L  L L  N
Sbjct: 207 YLFANNLS-ALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 78.5 bits (194), Expect = 7e-16
 Identities = 31/152 (20%), Positives = 59/152 (38%), Gaps = 6/152 (3%)

Query: 554 EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKL 613
            +P  +    +  ++ L+ N+ S        +   L  L L SN L+     +   L  L
Sbjct: 25  AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 614 YYLNLSNNQFSGEIPIK-LEKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNL 671
             L+LS+N     +          L  L L    L +E+   +   + +L+ L L  N L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNAL 141

Query: 672 SGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
                  F+++  L ++ +  N++   +P  A
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISS-VPERA 172

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  124 bits (313), Expect = 2e-31
 Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 32/282 (11%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            EI     D      +GTG  G V   +      VA+K     +      + EF+ E K +
Sbjct: 20   EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKM----IKEGSMSEDEFIEEAKVM 73

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
              + H  +V+ YG C+  R  FI+ EY+  G L   L            Q + + K V +
Sbjct: 74   MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCE 131

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IG 976
            A+ YL +  F   ++RD++++N L++ +    VSDFG+S+ +  D   +T   G+   + 
Sbjct: 132  AMEYLESKQF---LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVR 186

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP- 1034
            +  PE+    K + KSD+++FGVL  E    GK P +         +N + T + I    
Sbjct: 187  WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-------TNSE-TAEHIAQGL 238

Query: 1035 RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            RL  P   +  +K+ +IM    SC  E  D RPT + +   +
Sbjct: 239  RLYRPHLAS--EKVYTIM---YSCWHEKADERPTFKILLSNI 275

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (314), Expect = 2e-31
 Identities = 72/308 (23%), Positives = 115/308 (37%), Gaps = 61/308 (19%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            R  +DF+E   +G G  G V +A         A+KK      +E       L+EV  L  
Sbjct: 3    RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEE-KLSTILSEVMLLAS 58

Query: 862  IRHRNIVKFYGFCSHARHS-------------FIVYEYLEMGSLA--MILSNATSAEELG 906
            + H+ +V++Y      R+              FI  EY E G+L   +   N     +  
Sbjct: 59   LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
            W     + + + +ALSY+H+     I++RD+   N+ +D      + DFG++K++     
Sbjct: 119  W----RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLD 171

Query: 967  NWTELA--------------GTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPR 1011
                 +              GT  YVA E L  T    EK D+YS G++  E I      
Sbjct: 172  ILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---- 227

Query: 1012 DFISSICSTSSNLDRTLDEILDPRLPAPS---CNIRDKLISIMEVAISCLDENPDSRPTM 1068
                   ST       L ++    +  P     N       I+      +D +P+ RP  
Sbjct: 228  ------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIR---LLIDHDPNKRPG- 277

Query: 1069 QKVSQLLK 1076
                 LL 
Sbjct: 278  --ARTLLN 283

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  123 bits (312), Expect = 2e-31
 Identities = 78/287 (27%), Positives = 133/287 (46%), Gaps = 40/287 (13%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R   +      +G+G  G V   +      VAVK     +      + EF  E +++
Sbjct: 4    ELKR--EEITLLKELGSGQFGVVKLGKWKGQYDVAVKM----IKEGSMSEDEFFQEAQTM 57

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             ++ H  +VKFYG CS     +IV EY+  G L   L +    + L  +Q + +   V +
Sbjct: 58   MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCE 115

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IG 976
             +++L +  F   ++RD++++N L+D +    VSDFG+++ +  D   +    GT   + 
Sbjct: 116  GMAFLESHQF---IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ--YVSSVGTKFPVK 170

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP- 1034
            + APE+ +  K + KSDV++FG+L  E    GK P D              T  E++   
Sbjct: 171  WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD------------LYTNSEVVLKV 218

Query: 1035 ----RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                RL  P   +  D +  IM    SC  E P+ RPT Q++   ++
Sbjct: 219  SQGHRLYRPHLAS--DTIYQIM---YSCWHELPEKRPTFQQLLSSIE 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  124 bits (313), Expect = 2e-31
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 30/276 (10%)

Query: 810  EEHCIGTGGQGSVYRAEL--SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
             +  +G G  GSV +        +I VA+K        +    +E + E + + ++ +  
Sbjct: 14   ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKAD-TEEMMREAQIMHQLDNPY 71

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+  G C       +V E    G L   L      EE+  +    ++  V+  + YL  
Sbjct: 72   IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEE 128

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELA 983
              F   V+RD++++NVLL   + A +SDFG+SK+L  D S +T  +     + + APE  
Sbjct: 129  KNF---VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-RLPAP-S 1040
               K + +SDV+S+GV   EA+  G+ P   +          +  +  I    R+  P  
Sbjct: 186  NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KGPE-VMAFIEQGKRMECPPE 237

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            C    +L ++M     C     + RP    V Q ++
Sbjct: 238  CP--PELYALM---SDCWIYKWEDRPDFLTVEQRMR 268

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  124 bits (313), Expect = 2e-31
 Identities = 73/289 (25%), Positives = 123/289 (42%), Gaps = 44/289 (15%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E+ R   D   +H +G G  G VY        + VAVK     L  +    +EFL E   
Sbjct: 9    EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAV 62

Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +   ++
Sbjct: 63   MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQIS 121

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD----SSN------W 968
             A+ YL    F   ++RD++++N L+   +   V+DFG+S+ +  D     +       W
Sbjct: 122  SAMEYLEKKNF---IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 178

Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRT 1027
            T         APE     K + KSDV++FGVL  E    G  P   I             
Sbjct: 179  T---------APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-------DLSQ-V 221

Query: 1028 LDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             + +    R+  P     +K+  +M    +C   NP  RP+  ++ Q  
Sbjct: 222  YELLEKDYRMERPE-GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 266

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  124 bits (313), Expect = 2e-31
 Identities = 66/295 (22%), Positives = 123/295 (41%), Gaps = 33/295 (11%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLN 854
               +          +G G  G V          ++GE VAVK    P         +   
Sbjct: 17   HFEK--RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-PESGGNH-IADLKK 72

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
            E++ L  + H NIVK+ G C+    +   ++ E+L  GSL   L    +  ++   Q++ 
Sbjct: 73   EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--NKNKINLKQQLK 130

Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
                +   + YL +  +   V+RD++++NVL++ E++  + DFG++K+++ D   +T   
Sbjct: 131  YAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187

Query: 973  GT---IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNL--DR 1026
                 + + APE     K    SDV+SFGV   E +         ++             
Sbjct: 188  DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQM 247

Query: 1027 TLDEILDP-----RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            T+  +++      RLP P  C   D++  +M     C +  P +R + Q + +  
Sbjct: 248  TVTRLVNTLKEGKRLPCPPNC--PDEVYQLM---RKCWEFQPSNRTSFQNLIEGF 297

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  124 bits (313), Expect = 2e-31
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 38/293 (12%)

Query: 808  FDEEH-----CIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK      S     ++F  E++
Sbjct: 7    FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIE 63

Query: 858  SLTEIRHRNIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A      ++ EYL  GSL   L      E +   + +    
Sbjct: 64   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 121

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D   +       
Sbjct: 122  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR----TL 1028
              I + APE     K +  SDV+SFGV+  E            +        D+     +
Sbjct: 179  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 238

Query: 1029 DEILDP-----RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              +++      RLP P  C   D++  IM     C + N + RP+ + ++  +
Sbjct: 239  FHLIELLKNNGRLPRPDGC--PDEIYMIMT---ECWNNNVNQRPSFRDLALRV 286

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (324), Expect = 2e-31
 Identities = 75/286 (26%), Positives = 129/286 (45%), Gaps = 38/286 (13%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E+ R   D   +H +G G  G VY        + VAVK     L  +    +EFL E   
Sbjct: 216  EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT----LKEDTMEVEEFLKEAAV 269

Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            + EI+H N+V+  G C+     +I+ E++  G+L   L    + +E+     + +   ++
Sbjct: 270  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQIS 328

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---I 975
             A+ YL    F   ++R+++++N L+   +   V+DFG+S+ +  D+  +T  AG    I
Sbjct: 329  SAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPI 383

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP 1034
             + APE     K + KSDV++FGVL  E    G  P   I             L ++ + 
Sbjct: 384  KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI------------DLSQVYEL 431

Query: 1035 -----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                 R+  P     +K+  +M    +C   NP  RP+  ++ Q  
Sbjct: 432  LEKDYRMERPE-GCPEKVYELM---RACWQWNPSDRPSFAEIHQAF 473

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  123 bits (311), Expect = 3e-31
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 27/270 (10%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             DF+    +G G  G+VY A E  S  I+A+K      L +   + +   EV+  + +RH
Sbjct: 9    EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NI++ YG+   A   +++ EY  +G++   L   +  +E    +    I  +A+ALSY 
Sbjct: 69   PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDE---QRTATYITELANALSYC 125

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     +++RDI  +N+LL    E  ++DFG S    P S     L GT+ Y+ PE+  
Sbjct: 126  HSKR---VIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTD-LCGTLDYLPPEMIE 180

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SC 1041
                 EK D++S GVL  E + GK P +        ++    T   I       P   + 
Sbjct: 181  GRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPDFVTE 232

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              RD LIS +      L  NP  RP +++V
Sbjct: 233  GARD-LISRL------LKHNPSQRPMLREV 255

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  123 bits (310), Expect = 4e-31
 Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 38/280 (13%)

Query: 810  EEHCIGTGGQGSVYRAEL--SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E+  +G+G  G+V +           VAVK       ++   + E L E   + ++ +  
Sbjct: 21   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVMQQLDNPY 79

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+  G C       +V E  E+G L   L        +     + ++  V+  + YL  
Sbjct: 80   IVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELA 983
              F   V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +         + + APE  
Sbjct: 136  SNF---VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLP 1037
               K + KSDV+SFGVL  EA   G+ P                   E+        R+ 
Sbjct: 193  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR------------GMKGSEVTAMLEKGERMG 240

Query: 1038 AP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P  C    ++  +M     C   + ++RP    V   L+
Sbjct: 241  CPAGCP--REMYDLM---NLCWTYDVENRPGFAAVELRLR 275

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  123 bits (310), Expect = 5e-31
 Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 30/273 (10%)

Query: 814  IGTGGQGSVYRAELSSGEI----VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  G V R E  +       VAVK     +LS+     +F+ EV ++  + HRN+++
Sbjct: 26   LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             YG         +V E   +GSL   L                    VA+ + YL +  F
Sbjct: 86   LYGVVL-TPPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKRF 142

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTM 986
               ++RD++++N+LL       + DFG+ ++L  +  ++           + APE   T 
Sbjct: 143  ---IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199

Query: 987  KVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP--RLPAP-SCN 1042
              +  SD + FGV   E    G+ P   +       +     L +I     RLP P  C 
Sbjct: 200  TFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQ-ILHKIDKEGERLPRPEDCP 251

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                + ++M   + C    P+ RPT   +   L
Sbjct: 252  --QDIYNVM---VQCWAHKPEDRPTFVALRDFL 279

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  126 bits (318), Expect = 5e-31
 Identities = 58/279 (20%), Positives = 110/279 (39%), Gaps = 36/279 (12%)

Query: 807  DFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHR 865
             F  +  +G G +G++    +     VAVK+          C      EV+ L E   H 
Sbjct: 25   SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP------ECFSFADREVQLLRESDEHP 78

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVADALSYL 924
            N+++++      +  +I  E     +L   +     +   L   + + +++     L++L
Sbjct: 79   NVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL---EPITLLQQTTSGLAHL 134

Query: 925  HNDCFPPIVYRDISSKNVLL-----DLEYEAHVSDFGISKSLKPDSS---NWTELAGTIG 976
            H+     IV+RD+   N+L+       + +A +SDFG+ K L          + + GT G
Sbjct: 135  HSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191

Query: 977  YVAPEL---AYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEIL 1032
            ++APE+         T   D++S G +    I +G HP        +       +LD + 
Sbjct: 192  WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251

Query: 1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +        R+ LI         +  +P  RP+ + V
Sbjct: 252  PEKHEDVIA--RE-LIE------KMIAMDPQKRPSAKHV 281

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 6e-31
 Identities = 74/275 (26%), Positives = 115/275 (41%), Gaps = 40/275 (14%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
               IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N+V+ 
Sbjct: 26   LQTIGKGEFGDVMLGDYR-GNKVAVKC-----IKNDATAQAFLAEASVMTQLRHSNLVQL 79

Query: 871  YGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             G     +   +IV EY+  GSL   L +      LG    +     V +A+ YL  + F
Sbjct: 80   LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN------WTELAGTIGYVAPELA 983
               V+RD++++NVL+  +  A VSDFG++K              WT         APE  
Sbjct: 139  ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 186

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSC 1041
               K + KSDV+SFG+L  E    G+ P   I          D  +  +    ++ AP  
Sbjct: 187  REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-------PLKD-VVPRVEKGYKMDAPD- 237

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 +  +M    +C   +   RP+  ++ + L+
Sbjct: 238  GCPPAVYEVM---KNCWHLDAAMRPSFLQLREQLE 269

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  123 bits (310), Expect = 8e-31
 Identities = 47/201 (23%), Positives = 87/201 (43%), Gaps = 12/201 (5%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G GG G VY AE      IVA+K     L S+   +     E ++   ++  ++V  + 
Sbjct: 42   VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 873  FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPI 932
            F       ++    +    LA +L        L   + + +++ +  AL   H       
Sbjct: 102  FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA---GA 155

Query: 933  VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA---GTIGYVAPELAYTMKVT 989
             +RD+  +N+L+  +  A++ DFGI+ +        T+L    GT+ Y+APE       T
Sbjct: 156  THRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAPERFSESHAT 213

Query: 990  EKSDVYSFGVLALEAIKGKHP 1010
             ++D+Y+   +  E + G  P
Sbjct: 214  YRADIYALTCVLYECLTGSPP 234

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (310), Expect = 8e-31
 Identities = 74/293 (25%), Positives = 126/293 (43%), Gaps = 38/293 (12%)

Query: 808  FDEEH-----CIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++GE+VAVKK      S     ++F  E++
Sbjct: 38   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIE 94

Query: 858  SLTEIRHRNIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  ++H NIVK+ G C  A      ++ EYL  GSL   L      E +   + +    
Sbjct: 95   ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK--HKERIDHIKLLQYTS 152

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             +   + YL    +   ++RD++++N+L++ E    + DFG++K L  D   +       
Sbjct: 153  QICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR----TL 1028
              I + APE     K +  SDV+SFGV+  E            +        D+     +
Sbjct: 210  SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269

Query: 1029 DEILDP-----RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              +++      RLP P  C   D++  IM     C + N + RP+ + ++  +
Sbjct: 270  FHLIELLKNNGRLPRPDGC--PDEIYMIMT---ECWNNNVNQRPSFRDLALRV 317

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (308), Expect = 1e-30
 Identities = 71/295 (24%), Positives = 130/295 (44%), Gaps = 35/295 (11%)

Query: 794  RKIAYEEIVRATN---DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ 849
            +   YE + R  +    ++    +G G  G VY+A    +G + A K       SE    
Sbjct: 4    KSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEE-L 60

Query: 850  QEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            ++++ E++ L    H  IVK  G   H    +I+ E+   G++  I+        L   Q
Sbjct: 61   EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQ 118

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
               V + + +AL++LH+     I++RD+ + NVL+ LE +  ++DFG+S           
Sbjct: 119  IQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD 175

Query: 970  ELAGTIGYVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
               GT  ++APE+     + +     K+D++S G+  +E  + + P             L
Sbjct: 176  SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH----------HEL 225

Query: 1025 D--RTLDEILDPRLPAPSCNIRDKLISIMEVAIS-CLDENPDSRPTMQKVSQLLK 1076
            +  R L +I   +   P+     K        +   LD+NP++RP+    +QLL+
Sbjct: 226  NPMRVLLKI--AKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLE 275

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  127 bits (320), Expect = 1e-30
 Identities = 74/394 (18%), Positives = 123/394 (31%), Gaps = 104/394 (26%)

Query: 267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
           SI L   N  +L   N  +N++S    ++                      S+     K 
Sbjct: 2   SIMLPINNNFSL-SQNSFYNTIS-GTYAD--------------------YFSAWDKWEKQ 39

Query: 327 TILYLSDNLLFGSIP-CEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
            +   + N     +  C I     L   +L    LS S+P +L     +  L +  N L 
Sbjct: 40  ALPGENRNEAVSLLKECLINQFSEL---QLNRLNLS-SLPDNLP--PQITVLEITQNALI 93

Query: 386 GSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
            S+P    +L  L      +N LS ++P    +L +   L + +N L+  +P+    L  
Sbjct: 94  -SLPELPASLEYLD---ACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPALL-- 142

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
              +    NQL   +P+L   T L  + +  N LT                         
Sbjct: 143 -EYINADNNQLTM-LPEL--PTSLEVLSVRNNQLTF------------------------ 174

Query: 506 EISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
                                    LP        L+ LD+S+N +   +P+   +    
Sbjct: 175 -------------------------LPELPE---SLEALDVSTNLLE-SLPAVPVRNHHS 205

Query: 566 ----IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
               I      N+ +  +P  + SL     + L  N LS+ I  SL         +    
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRI 264

Query: 622 QFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV 655
            FS       +  +H    D    +  E   S V
Sbjct: 265 YFSMSDGQ--QNTLHRPLADAVTAWFPENKQSDV 296

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  124 bits (312), Expect = 2e-29
 Identities = 55/314 (17%), Positives = 106/314 (33%), Gaps = 40/314 (12%)

Query: 411 SIPYSFGNLTNMIVLSIYSNALSGAIPKEY----GNLVKLTLLVLSYNQLQGPIPD--LR 464
           SI     N  ++   S Y N +S     +Y        K  L   + N+    + +  + 
Sbjct: 2   SIMLPINNNFSLSQNSFY-NTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLKECLIN 59

Query: 465 NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA 524
             + L   +L+R +L+ ++ ++      ++ + ++       +        +L  LD   
Sbjct: 60  QFSEL---QLNRLNLS-SLPDNLP--PQITVLEITQNAL-ISLP---ELPASLEYLDACD 109

Query: 525 NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
           N ++  LP        LK LD+ +N +   +P     L     +  + NQ +  LP    
Sbjct: 110 NRLS-TLPELPA---SLKHLDVDNNQLT-MLPELPALLE---YINADNNQLT-MLPELPT 160

Query: 585 SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSD----L 640
           SL   E L + +N+L   +P    +L  L   ++S N     +P    +  H  +     
Sbjct: 161 SL---EVLSVRNNQL-TFLPELPESLEAL---DVSTNLLE-SLPAVPVRNHHSEETEIFF 212

Query: 641 DLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIP 700
               N +   IP  + S+     + L  N LS  I     +                   
Sbjct: 213 RCRENRI-THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDG 271

Query: 701 NSAAFKHAPMEALQ 714
                     +A+ 
Sbjct: 272 QQNTLHRPLADAVT 285

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  110 bits (276), Expect = 4e-25
 Identities = 58/323 (17%), Positives = 101/323 (31%), Gaps = 43/323 (13%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
            P +  L++  N +   +P   A+   L+YLD   N  S T+P    +L   K L +  N
Sbjct: 79  PPQITVLEITQNAL-ISLPELPAS---LEYLDACDNRLS-TLPELPASL---KHLDVDNN 130

Query: 167 QFSGRIPPQIGHLSY-----------------LKALHLFENGLSGSIPPSLGNLTNLAIM 209
           Q +  +P     L Y                 L+ L +  N L+  +P    +L  L   
Sbjct: 131 QLT-MLPELPALLEYINADNNQLTMLPELPTSLEVLSVRNNQLT-FLPELPESLEAL--- 185

Query: 210 YLYNNSLSGSIPSEIGNLKSLS----GLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLS 265
            +  N L  S+P+                   N+++  +P ++ +L    T+ L DN LS
Sbjct: 186 DVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS 243

Query: 266 GSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTK 325
             I  S    T     + P    S S   +  N                +  S +  +  
Sbjct: 244 SRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTLHRPLADAVTAWFPENKQSDVSQIWH 301

Query: 326 LTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
                   N         +  L                +   L  L+  A L   +  ++
Sbjct: 302 AFEHEEHANTFS----AFLDRLSDTVSARNTSG-FREQVAAWLEKLSASAELRQQSFAVA 356

Query: 386 GSIPSEIGNLNSLSDLGLSENEL 408
                   +  +L+   L +  L
Sbjct: 357 ADATESCEDRVALTWNNLRKTLL 379

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  125 bits (315), Expect = 2e-30
 Identities = 75/279 (26%), Positives = 116/279 (41%), Gaps = 48/279 (17%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
               IG G  G V   +   G  VAVK      +      Q FL E   +T++RH N+V+ 
Sbjct: 198  LQTIGKGEFGDVMLGDYR-GNKVAVKC-----IKNDATAQAFLAEASVMTQLRHSNLVQL 251

Query: 871  YGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
             G     +    IV EY+  GSL   L +      LG    +     V +A+ YL  + F
Sbjct: 252  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNNF 310

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN------WTELAGTIGYVAPELA 983
               V+RD++++NVL+  +  A VSDFG++K              WT         APE  
Sbjct: 311  ---VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT---------APEAL 358

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLP 1037
               K + KSDV+SFG+L  E    G+ P   I             L +++       ++ 
Sbjct: 359  REKKFSTKSDVWSFGILLWEIYSFGRVPYPRI------------PLKDVVPRVEKGYKMD 406

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            AP       +  +M    +C   +  +RPT  ++ + L+
Sbjct: 407  APD-GCPPAVYDVM---KNCWHLDAATRPTFLQLREQLE 441

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  124 bits (314), Expect = 2e-30
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 36/274 (13%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E  +G G  G V+    +    VA+K             + FL E + + ++RH  +V+ 
Sbjct: 189  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLRHEKLVQL 244

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            Y   S     +IV EY+  GSL   L    + + L   Q +++   +A  ++Y+    + 
Sbjct: 245  YAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY- 301

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
              V+RD+ + N+L+       V+DFG+++ ++ +   +T   G    I + APE A   +
Sbjct: 302  --VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 357

Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSC 1041
             T KSDV+SFG+L  E   KG+ P                   E+LD      R+P P  
Sbjct: 358  FTIKSDVWSFGILLTELTTKGRVPYP------------GMVNREVLDQVERGYRMPCPP- 404

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               + L  +M     C  + P+ RPT + +   L
Sbjct: 405  ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 435

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  121 bits (306), Expect = 2e-30
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            +G GG   V+ A  L     VAVK   + L  + +    F  E ++   + H  IV  Y 
Sbjct: 20   LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 872  -GF--CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
             G          +IV EY++  +L  I+    +   +   + + VI     AL++ H + 
Sbjct: 80   TGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALNFSHQN- 135

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE---LAGTIGYVAPELAYT 985
               I++RD+   N+++       V DFGI++++    ++ T+   + GT  Y++PE A  
Sbjct: 136  --GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 986  MKVTEKSDVYSFGVLALEAIKGKHP 1010
              V  +SDVYS G +  E + G+ P
Sbjct: 194  DSVDARSDVYSLGCVLYEVLTGEPP 218

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  124 bits (314), Expect = 2e-30
 Identities = 63/270 (23%), Positives = 122/270 (45%), Gaps = 28/270 (10%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E  +G G  G V+ A  +    VAVK             + FL E   +  ++H  +VK 
Sbjct: 193  EKKLGAGQFGEVWMATYNKHTKVAVKTMKP----GSMSVEAFLAEANVMKTLQHDKLVKL 248

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            +   +     +I+ E++  GSL   L +     +    + ++    +A+ ++++    + 
Sbjct: 249  HAVVTK-EPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 305

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
              ++RD+ + N+L+       ++DFG+++ ++ +   +T   G    I + APE      
Sbjct: 306  --IHRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGS 361

Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-RLPAPSCNIRD 1045
             T KSDV+SFG+L +E +  G+ P           SN +  +  +    R+P P  N  +
Sbjct: 362  FTIKSDVWSFGILLMEIVTYGRIP-------YPGMSNPE-VIRALERGYRMPRPE-NCPE 412

Query: 1046 KLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            +L +IM   + C    P+ RPT + +  +L
Sbjct: 413  ELYNIM---MRCWKNRPEERPTFEYIQSVL 439

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  121 bits (305), Expect = 3e-30
 Identities = 61/284 (21%), Positives = 116/284 (40%), Gaps = 20/284 (7%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F   +  +   +    + +   +    A+   +  L       + TI   +  L+ L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
            L  NQ +  + P + +L+ +  L L  N L  ++   +  L ++  + L +  ++   P
Sbjct: 69  ELKDNQIT-DLAP-LKNLTKITELELSGNPLK-NVSA-IAGLQSIKTLDLTSTQITDVTP 124

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
             +  L +L  L L  N+++   PL+   L NL  L + +  +S   PL+  NL+ L  L
Sbjct: 125 --LAGLSNLQVLYLDLNQITNISPLA--GLTNLQYLSIGNAQVSDLTPLA--NLSKLTTL 178

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
               N +S  I S + +L +L  + L  N++S    S L N + L I+ L++  +     
Sbjct: 179 KADDNKIS-DI-SPLASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPV 234

Query: 342 CEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
               NL       +     +   P ++ +    A+  L  NL S
Sbjct: 235 FYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  103 bits (258), Expect = 4e-24
 Identities = 50/236 (21%), Positives = 97/236 (41%), Gaps = 18/236 (7%)

Query: 460 IPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGT 519
           I     L    ++   ++++T   + +      ++ ++         I        NL  
Sbjct: 12  IFPDPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGV-TTIEG-VQYLNNLIG 67

Query: 520 LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
           L++  N IT +    + +  ++  L+LS N +  +  S +  L+S+  L L   Q +   
Sbjct: 68  LELKDNQITDL--APLKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVT 123

Query: 580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSD 639
           P  L  L  L+ L L  N+++N  P  L  L  L YL++ N Q S   P  L     L+ 
Sbjct: 124 P--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTT 177

Query: 640 LDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
           L    N +  +I   + S+ +L +++L +N +S   P        L  + ++   +
Sbjct: 178 LKADDNKI-SDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTI 229

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  102 bits (257), Expect = 5e-24
 Identities = 58/277 (20%), Positives = 104/277 (37%), Gaps = 41/277 (14%)

Query: 346 NLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSE 405
            L     +  G + ++ ++     +L  + TL  F   ++ +I   +  LN+L  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72

Query: 406 NELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRN 465
           N+++  +     NLT +  L +  N L          L  +  L L+  Q+   +  L  
Sbjct: 73  NQIT-DLA-PLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD-VTPLAG 127

Query: 466 LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
           L+ L  + LD N +T NIS             L+                NL  L +   
Sbjct: 128 LSNLQVLYLDLNQIT-NIS------------PLAG-------------LTNLQYLSIGNA 161

Query: 526 NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS 585
            ++ +    + +  +L  L    N I     S L  L +LI++ L  NQ S   P  L +
Sbjct: 162 QVSDL--TPLANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSP--LAN 215

Query: 586 LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
              L  + L++  ++N       NLV    +   +  
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGA 252

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  102 bits (255), Expect = 9e-24
 Identities = 52/273 (19%), Positives = 98/273 (35%), Gaps = 41/273 (15%)

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
              L N   +    + ++        +L+ ++ L      ++ +I      L N+I L +
Sbjct: 15  DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLEL 70

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESF 487
             N ++   P    NL K+T L LS N L+  +  +  L  +  + L    +T       
Sbjct: 71  KDNQITDLAP--LKNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQIT------- 120

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
                     L+                NL  L +  N IT I    +     L+ L + 
Sbjct: 121 ------DVTPLAG-------------LSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIG 159

Query: 548 SNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSL 607
           +  +     + L  L  L  L  + N+ S    + L SL  L  + L +N++S+  P  L
Sbjct: 160 NAQV--SDLTPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--L 213

Query: 608 GNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDL 640
            N   L+ + L+N   + +        +  + +
Sbjct: 214 ANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 97.8 bits (244), Expect = 3e-22
 Identities = 55/285 (19%), Positives = 107/285 (37%), Gaps = 41/285 (14%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
            L N I ++   + ++  + +   +L  +T L      +   I  ++ L  L  + L  N
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDN 73

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
            +T           +L+ +                    +  L++S N +  +    I  
Sbjct: 74  QIT-----------DLAPL---------------KNLTKITELELSGNPLKNV--SAIAG 105

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
              +K LDL+S  I    P  L  L +L  L L+ NQ +    + L  L  L++L + + 
Sbjct: 106 LQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITN--ISPLAGLTNLQYLSIGNA 161

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS 657
           ++S+  P  L NL KL  L   +N+ S   P  L    +L ++ L +N + +  P  + +
Sbjct: 162 QVSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN 215

Query: 658 MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNS 702
             +L  + L +  ++         +     +         P   S
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPATIS 260

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 14/102 (13%), Positives = 32/102 (31%), Gaps = 8/102 (7%)

Query: 594 LSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPS 653
                ++   P     L     +    +  +  +         ++ L      +   I  
Sbjct: 4   TQPTAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV-TTIEG 58

Query: 654 QVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
            V  + +L  L L  N ++   P   K +  +  +++S N L
Sbjct: 59  -VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  121 bits (306), Expect = 3e-30
 Identities = 66/282 (23%), Positives = 119/282 (42%), Gaps = 33/282 (11%)

Query: 814  IGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            +G G  G V           +GE+VAVK            +  +  E+  L  + H +I+
Sbjct: 39   LGEGHFGKVSLYCYDPTNDGTGEMVAVKALK-ADAGPQH-RSGWKQEIDILRTLYHEHII 96

Query: 869  KFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            K+ G C  A  +   +V EY+ +GSL   L        +G  Q +   + + + ++YLH 
Sbjct: 97   KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHA 152

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELA 983
              +   ++RD++++NVLLD +    + DFG++K++      +         + + APE  
Sbjct: 153  QHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSN--LDRTLDEILDP-----R 1035
               K    SDV+SFGV   E +      +   +             T+  + +      R
Sbjct: 210  KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGER 269

Query: 1036 LPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            LP P  C    ++  +M+   +C +     RPT + +  +LK
Sbjct: 270  LPRPDKC--PAEVYHLMK---NCWETEASFRPTFENLIPILK 306

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  126 bits (318), Expect = 3e-30
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 36/295 (12%)

Query: 797  AYEEIVRATNDFDEEHC------IGTGGQGSVYRAEL--SSGEI-VAVKKFHSPLLSEMT 847
              EE+         ++       +G G  GSV +        +I VA+K           
Sbjct: 321  DPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKAD- 379

Query: 848  CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGW 907
              +E + E + + ++ +  IV+  G C       +V E    G L   L      EE+  
Sbjct: 380  -TEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVG--KREEIPV 435

Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
            +    ++  V+  + YL    F   V+R+++++NVLL   + A +SDFG+SK+L  D S 
Sbjct: 436  SNVAELLHQVSMGMKYLEEKNF---VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492

Query: 968  WTELAGT---IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSN 1023
            +T  +     + + APE     K + +SDV+S+GV   EA+  G+ P   +         
Sbjct: 493  YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-------KG 545

Query: 1024 LDRTLDEILDP-RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +  +  I    R+  P  C    +L ++M     C     + RP    V Q ++
Sbjct: 546  PE-VMAFIEQGKRMECPPECP--PELYALM---SDCWIYKWEDRPDFLTVEQRMR 594

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  121 bits (306), Expect = 4e-30
 Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 37/292 (12%)

Query: 808  FDEEH-----CIGTGGQGSVYRAEL-----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVK 857
            F+E H      +G G  GSV          ++G +VAVK+      S    Q++F  E++
Sbjct: 20   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDFQREIQ 76

Query: 858  SLTEIRHRNIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
             L  +    IVK+ G           +V EYL  G L   L        L  ++ +    
Sbjct: 77   ILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR--HRARLDASRLLLYSS 134

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
             +   + YL +      V+RD++++N+L++ E    ++DFG++K L  D   +       
Sbjct: 135  QICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNL--DRTLD 1029
              I + APE       + +SDV+SFGV+  E            +              L 
Sbjct: 192  SPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251

Query: 1030 EILDP-----RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             +L+      RLPAP  C    ++  +M+    C   +P  RP+   +   L
Sbjct: 252  RLLELLEEGQRLPAPPAC--PAEVHELMK---LCWAPSPQDRPSFSALGPQL 298

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  120 bits (303), Expect = 4e-30
 Identities = 58/305 (19%), Positives = 112/305 (36%), Gaps = 65/305 (21%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEI--------VAVKKFHSPLLSEMTCQQE 851
            +I      F+E   +G G    +++                V +K       +     + 
Sbjct: 4    KIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSES 58

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM 911
            F      ++++ H+++V  YG C     + +V E+++ GSL   L    +   +    ++
Sbjct: 59   FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKL 116

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH--------VSDFGISKSLKP 963
             V K +A A+ +L  +     ++ ++ +KN+LL  E +          +SD GIS ++ P
Sbjct: 117  EVAKQLAAAMHFLEENTL---IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173

Query: 964  DSS-----NWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISS 1016
                     W           PE +     +   +D +SFG    E    G  P      
Sbjct: 174  KDILQERIPWV---------PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS---- 220

Query: 1017 ICSTSSNLDRTLDEILDP-----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                           L       +LPAP      +L +++    +C+D  PD RP+ + +
Sbjct: 221  --------ALDSQRKLQFYEDRHQLPAP-KA--AELANLI---NNCMDYEPDHRPSFRAI 266

Query: 1072 SQLLK 1076
             + L 
Sbjct: 267  IRDLN 271

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  120 bits (304), Expect = 5e-30
 Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 45/271 (16%)

Query: 814  IGTGGQGSVYRAELS----SGEI-VAVKKFHSPLLSEMTCQQ---EFLNEVKSLTEIRHR 865
            +G+G  G+VY+          +I VA+K+     L E T  +   E L+E   +  + + 
Sbjct: 23   LGSGAFGTVYKGLWIPEGEKVKIPVAIKE-----LREATSPKANKEILDEAYVMASVDNP 77

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            ++ +  G C       ++ + +  G L   +      + +G    +N    +A  ++YL 
Sbjct: 78   HVCRLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELA 983
            +      V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A E  
Sbjct: 135  DRRL---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLP 1037
                 T +SDV+S+GV   E +  G  P D                 EI        RLP
Sbjct: 192  LHRIYTHQSDVWSYGVTVWELMTFGSKPYD------------GIPASEISSILEKGERLP 239

Query: 1038 APS-CNIRDKLISIMEVAISCLDENPDSRPT 1067
             P  C     +  IM     C   + DSRP 
Sbjct: 240  QPPIC--TIDVYMIM---RKCWMIDADSRPK 265

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  124 bits (313), Expect = 1e-29
 Identities = 65/276 (23%), Positives = 108/276 (39%), Gaps = 20/276 (7%)

Query: 110 LAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS 169
           +         I  I P      ++    +L   S +  +      L+ +  +  + +   
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 170 GRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS 229
             +   I +L  +  L L  N L+  I P L NL NL  ++L  N +   + S + +LK 
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DL-SSLKDLKK 110

Query: 230 LSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS 289
           L  L L +N +S  +   L +LP L +L L +N ++    LS   LT LD L+L  N +S
Sbjct: 111 LKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQIS 166

Query: 290 GSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRY 349
             I   +  L  L  L LS N +S  +  +L  L  L +L L              NL  
Sbjct: 167 -DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 350 LFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
              ++  D  L    P  + +  +     +  +L  
Sbjct: 223 PNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 256

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  119 bits (299), Expect = 6e-28
 Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 20/300 (6%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F   +F      +L+   +   +       + +  +  +++    ++   I  L  +  L
Sbjct: 15  FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
           +L+ N+ +  I P + +L  L  L L EN +   +   L +L  L  + L +N +S  I 
Sbjct: 71  FLNGNKLT-DIKP-LTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHNGIS-DIN 125

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
             + +L  L  L LG NK++    LS   L  L TL L DN +S  +PL+   LT L  L
Sbjct: 126 G-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVPLA--GLTKLQNL 180

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG--- 338
            L  N +S  +   +  LK+L  L L   +      +   NL     +  +D  L     
Sbjct: 181 YLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEI 238

Query: 339 -SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNS 397
            S   +       ++L    N++S      +      A  +         + +   +++ 
Sbjct: 239 ISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSYDVDG 298

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  113 bits (284), Expect = 4e-26
 Identities = 65/298 (21%), Positives = 115/298 (38%), Gaps = 18/298 (6%)

Query: 158 LKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLS 217
           +      +     +I P     +     +L +  ++ ++      L ++  +   N+ + 
Sbjct: 1   MGETITVSTPIK-QIFP-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56

Query: 218 GSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTN 277
            S+   I  L +++ L L  NKL+   PL+  NL NL  L L +N +     L   +L  
Sbjct: 57  -SV-QGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNLGWLFLDENKIKDLSSLK--DLKK 110

Query: 278 LDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
           L  L+L HN +S  I   + +L  L  L L  NK++    + L  LTKL  L L DN + 
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQI- 165

Query: 338 GSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNS 397
             I   +  L  L  L L  N +S  +  +L  L NL  L LF+        +   NL  
Sbjct: 166 SDIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVV 222

Query: 398 LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
            + +  ++  L      S         +  +    +  +   +   V +      ++ 
Sbjct: 223 PNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  103 bits (257), Expect = 9e-23
 Identities = 54/278 (19%), Positives = 105/278 (37%), Gaps = 17/278 (6%)

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
           +   +     ++  I          +  L +  +T  ++++    +++  I  ++     
Sbjct: 1   MGETITVSTPIKQ-IFPDDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDI-K 56

Query: 506 EISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
            +       PN+  L ++ N +T I P  + +   L  L L  N I  ++ S L  L+ L
Sbjct: 57  SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DL-SSLKDLKKL 111

Query: 566 IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
             L+L  N  S  +   L  L QLE L L +N++++     L  L KL  L+L +NQ S 
Sbjct: 112 KSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS- 166

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
           +I   L     L +L LS N +  ++   +  +++L+ L L               +   
Sbjct: 167 DIVP-LAGLTKLQNLYLSKNHI-SDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVP 223

Query: 686 VYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDI 723
             +  +   L  P   S    +              ++
Sbjct: 224 NTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  102 bits (255), Expect = 1e-22
 Identities = 53/274 (19%), Positives = 104/274 (37%), Gaps = 17/274 (6%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
                I  ++   +++ A+ +    L  +  ++ + + ++  +  ++ L  + ++ L+ N
Sbjct: 19  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGN 75

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
            LT +I        NL ++ L   K   ++S        L +L +  N I+ I    +  
Sbjct: 76  KLT-DIK-PLTNLKNLGWLFLDENKI-KDLSSL-KDLKKLKSLSLEHNGISDING--LVH 129

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
            PQL+ L L +N I     + L +L  L  L+L  NQ S      L  L +L++L LS N
Sbjct: 130 LPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKN 185

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS 657
            +S+     L  L  L  L L + +   +        +  + +  +   L    P  +  
Sbjct: 186 HISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISD 241

Query: 658 MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
               EK N+  +         F     +      
Sbjct: 242 DGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAK 275

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  102 bits (254), Expect = 2e-22
 Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 41/280 (14%)

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
                      L    ++ ++      LNS+  +  + +++  S+      L N+  L +
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 72

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESF 487
             N L+   P    NL  L  L L  N+++  +  L++L +L  + L+ N ++ +I+   
Sbjct: 73  NGNKLTDIKPLT--NLKNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGIS-DIN--- 125

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
                     L H              P L +L +  N IT I    +    +L  L L 
Sbjct: 126 ---------GLVH-------------LPQLESLYLGNNKITDITV--LSRLTKLDTLSLE 161

Query: 548 SNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSL 607
            N I  +I   L  L  L  L L++N  S      L  L  L+ L+L S    N      
Sbjct: 162 DNQIS-DI-VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQ 217

Query: 608 GNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFL 647
            NLV    +  ++        I           ++  +  
Sbjct: 218 SNLVVPNTVKNTDGSLVTPEII--SDDGDYEKPNVKWHLP 255

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 94.4 bits (234), Expect = 6e-20
 Identities = 60/345 (17%), Positives = 114/345 (33%), Gaps = 65/345 (18%)

Query: 254 LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS 313
           +         +    P            NL   S++ ++      L S+  +  + + + 
Sbjct: 1   MGETITVSTPIKQIFPDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 56

Query: 314 GSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
            S+   +  L  +T L+L+ N L   I   + NL+ L +L L +NK+   +  SL +L  
Sbjct: 57  -SV-QGIQYLPNVTKLFLNGNKL-TDIK-PLTNLKNLGWLFLDENKIK-DLS-SLKDLKK 110

Query: 374 LATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALS 433
           L +L L  N +S  I   + +L  L  L L  N            +T++ VLS       
Sbjct: 111 LKSLSLEHNGIS-DING-LVHLPQLESLYLGNN-----------KITDITVLS------- 150

Query: 434 GAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNL 493
                    L KL  L L  NQ+   I  L  LT+L  + L +NH++           +L
Sbjct: 151 --------RLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS-----------DL 190

Query: 494 SYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG 553
             +                   NL  L++ +            +      +  +   +V 
Sbjct: 191 RALA---------------GLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT 235

Query: 554 EIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
                         +  +  +F+ ++       + +       + 
Sbjct: 236 PEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHG 280

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (304), Expect = 1e-29
 Identities = 73/286 (25%), Positives = 131/286 (45%), Gaps = 32/286 (11%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNE 855
            E+     +   +  +G G  G V    L   S  EI VA+K        +   +++FL E
Sbjct: 41   ELDA--TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ--RRDFLGE 96

Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
               + +  H NI++  G  + ++   IV EY+E GSL   L       +    Q + +++
Sbjct: 97   ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLR 154

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT- 974
            G+A  + YL +  +   V+RD++++N+L++      VSDFG+ + L+ D        G  
Sbjct: 155  GIASGMKYLSDMGY---VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211

Query: 975  --IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEI 1031
              I + +PE     K T  SDV+S+G++  E +  G+ P           SN D  +  +
Sbjct: 212  IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYW-------EMSNQD-VIKAV 263

Query: 1032 LD-PRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
             +  RLP P  C     L  +M   + C  ++ ++RP  +++  +L
Sbjct: 264  DEGYRLPPPMDCP--AALYQLM---LDCWQKDRNNRPKFEQIVSIL 304

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  123 bits (311), Expect = 1e-29
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 36/274 (13%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            E  +G G  G V+    +    VA+K             + FL E + + ++RH  +V+ 
Sbjct: 272  EVKLGQGCFGEVWMGTWNGTTRVAIKTLKP----GTMSPEAFLQEAQVMKKLRHEKLVQL 327

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
            Y   S     +IV EY+  GSL   L    + + L   Q +++   +A  ++Y+    + 
Sbjct: 328  YAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMNY- 384

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELAYTMK 987
              V+RD+ + N+L+       V+DFG+++ ++ +   +T   G    I + APE A   +
Sbjct: 385  --VHRDLRAANILVGENLVCKVADFGLARLIEDNE--YTARQGAKFPIKWTAPEAALYGR 440

Query: 988  VTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPSC 1041
             T KSDV+SFG+L  E   KG+ P                   E+LD      R+P P  
Sbjct: 441  FTIKSDVWSFGILLTELTTKGRVPYP------------GMVNREVLDQVERGYRMPCPP- 487

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
               + L  +M     C  + P+ RPT + +   L
Sbjct: 488  ECPESLHDLM---CQCWRKEPEERPTFEYLQAFL 518

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  118 bits (298), Expect = 2e-29
 Identities = 66/281 (23%), Positives = 125/281 (44%), Gaps = 30/281 (10%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            E+ R          +G G  G V+    +    VAVK     L         FL E   +
Sbjct: 9    EVPR--ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKS----LKQGSMSPDAFLAEANLM 62

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             +++H+ +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+
Sbjct: 63   KQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAE 120

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IG 976
             ++++    +   ++RD+ + N+L+       ++DFG+++ ++ +   +T   G    I 
Sbjct: 121  GMAFIEERNY---IHRDLRAANILVSDTLSCKIADFGLARLIEDN--EYTAREGAKFPIK 175

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP- 1034
            + APE       T KSDV+SFG+L  E +  G+ P   +       +N +  +  +    
Sbjct: 176  WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPE-VIQNLERGY 227

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
            R+  P  N  ++L  +M     C  E P+ RPT   +  +L
Sbjct: 228  RMVRPD-NCPEELYQLM---RLCWKERPEDRPTFDYLRSVL 264

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  118 bits (298), Expect = 4e-29
 Identities = 81/299 (27%), Positives = 132/299 (44%), Gaps = 38/299 (12%)

Query: 789  VLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEI-VAVKKFHSPLL 843
            VL F  +I    + R       +  IG G  G VY+  L       E+ VA+K   +   
Sbjct: 34   VLKFTTEIHPSCVTR-------QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT 86

Query: 844  SEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAE 903
             +   + +FL E   + +  H NI++  G  S  +   I+ EY+E G+L   L       
Sbjct: 87   EKQ--RVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDG 142

Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
            E    Q + +++G+A  + YL N  +   V+RD++++N+L++      VSDFG+S+ L+ 
Sbjct: 143  EFSVLQLVGMLRGIAAGMKYLANMNY---VHRDLAARNILVNSNLVCKVSDFGLSRVLED 199

Query: 964  DSSNWTELAGT---IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICS 1019
            D       +G    I + APE     K T  SDV+SFG++  E +  G+ P         
Sbjct: 200  DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW------- 252

Query: 1020 TSSNLDRTLDEILD-PRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              SN +  +  I D  RLP P  C     +  +M   + C  +    RP    +  +L 
Sbjct: 253  ELSNHE-VMKAINDGFRLPTPMDCP--SAIYQLM---MQCWQQERARRPKFADIVSILD 305

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  118 bits (297), Expect = 4e-29
 Identities = 74/289 (25%), Positives = 121/289 (41%), Gaps = 42/289 (14%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI- 862
               F+    +G G  G VY+   + +G++ A+K     +  +   ++E   E+  L +  
Sbjct: 23   AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE--EEEIKQEINMLKKYS 78

Query: 863  RHRNIVKFYG------FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG 916
             HRNI  +YG              ++V E+   GS+  ++   T    L       + + 
Sbjct: 79   HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICRE 137

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIG 976
            +   LS+LH      +++RDI  +NVLL    E  + DFG+S  L           GT  
Sbjct: 138  ILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 194

Query: 977  YVAPELAYTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLD 1029
            ++APE+    +  +     KSD++S G+ A+E  +G  P            ++   R L 
Sbjct: 195  WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL----------CDMHPMRALF 244

Query: 1030 EILDPRLPAPSCNIRDKLIS--IMEVAISCLDENPDSRPTMQKVSQLLK 1076
             I  PR PAP   ++ K  S        SCL +N   RP      QL+K
Sbjct: 245  LI--PRNPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPAT---EQLMK 286

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  118 bits (298), Expect = 6e-29
 Identities = 70/282 (24%), Positives = 121/282 (42%), Gaps = 45/282 (15%)

Query: 808  FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G+VY A ++ + E+VA+KK            Q+ + EV+ L ++RH N
Sbjct: 56   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
             +++ G       +++V EY    +  ++  +    +E    +   V  G    L+YLH+
Sbjct: 116  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQE---VEIAAVTHGALQGLAYLHS 172

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 +++RD+ + N+LL       + DFG +  + P +S      GT  ++APE+   M
Sbjct: 173  H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 225

Query: 987  KVTE---KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD--RTLDEILDPRLPAP-- 1039
               +   K DV+S G+  +E  + K P            N++    L  I   +  +P  
Sbjct: 226  DEGQYDGKVDVWSLGITCIELAERKPPL----------FNMNAMSALYHI--AQNESPAL 273

Query: 1040 -----SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 S   R+  +        CL + P  RPT      LLK
Sbjct: 274  QSGHWSEYFRN-FVDS------CLQKIPQDRPT---SEVLLK 305

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (293), Expect = 7e-29
 Identities = 72/276 (26%), Positives = 121/276 (43%), Gaps = 39/276 (14%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DFD    +G G  G+VY A E  +  I+A+K      L +   + +   E++  + +RH
Sbjct: 14   DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN------VIKGVA 918
             NI++ Y +    +  +++ E+   G L   L             R +       ++ +A
Sbjct: 74   PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH---------GRFDEQRSATFMEELA 124

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
            DAL Y H      +++RDI  +N+L+  + E  ++DFG S    P     T + GT+ Y+
Sbjct: 125  DALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSV-HAPSLRRRT-MCGTLDYL 179

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
             PE+       EK D++  GVL  E + G  P D        S +   T   I++  L  
Sbjct: 180  PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD--------SPSHTETHRRIVNVDLKF 231

Query: 1039 P---SCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            P   S   +D LIS +      L  +P  R  ++ V
Sbjct: 232  PPFLSDGSKD-LISKL------LRYHPPQRLPLKGV 260

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  117 bits (294), Expect = 8e-29
 Identities = 70/297 (23%), Positives = 126/297 (42%), Gaps = 50/297 (16%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +D++ +  IG+G    V  A      E VA+K+    L    T   E L E++++++  H
Sbjct: 15   DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI--NLEKCQTSMDELLKEIQAMSQCHH 72

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN------VIKGVA 918
             NIV +Y         ++V + L  GS+  I+ +  +  E   +  ++      +++ V 
Sbjct: 73   PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-SGVLDESTIATILREVL 131

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA------ 972
            + L YLH +     ++RD+ + N+LL  +    ++DFG+S  L     + T         
Sbjct: 132  EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA-TGGDITRNKVRKTFV 187

Query: 973  GTIGYVAPEL-----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLD-- 1025
            GT  ++APE+      Y  K     D++SFG+ A+E   G  P                 
Sbjct: 188  GTPCWMAPEVMEQVRGYDFKA----DIWSFGITAIELATGAAPY----------HKYPPM 233

Query: 1026 RTLDEILD---PRLPAPSCNIRDKLI---SIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + L   L    P L     +         S  ++   CL ++P+ RPT    ++LL+
Sbjct: 234  KVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLR 287

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (292), Expect = 1e-28
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 27/272 (9%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +     +G GG    +   +  + E+ A K     LL +   +++   E+     + H+
Sbjct: 16   RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVADALSYL 924
            ++V F+GF       F+V E     SL  +        E          ++ +     YL
Sbjct: 76   HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY----YLRQIVLGCQYL 131

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H +    +++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+  
Sbjct: 132  HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 188

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SC 1041
                + + DV+S G +    + GK P +        +S L  T   I       P   + 
Sbjct: 189  KKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKKNEYSIPKHINP 240

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                 LI  M      L  +P +RPT+ ++  
Sbjct: 241  VAAS-LIQKM------LQTDPTARPTINELLN 265

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  116 bits (293), Expect = 2e-28
 Identities = 59/272 (21%), Positives = 108/272 (39%), Gaps = 27/272 (9%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +     +G GG    +   +  + E+ A K     LL +   +++   E+     + H+
Sbjct: 42   RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVADALSYL 924
            ++V F+GF       F+V E     SL  +        E          ++ +     YL
Sbjct: 102  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY----YLRQIVLGCQYL 157

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H +    +++RD+   N+ L+ + E  + DFG++  ++ D      L GT  Y+APE+  
Sbjct: 158  HRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SC 1041
                + + DV+S G +    + GK P +        +S L  T   I       P   + 
Sbjct: 215  KKGHSFEVDVWSIGCIMYTLLVGKPPFE--------TSCLKETYLRIKKNEYSIPKHINP 266

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                 LI  M      L  +P +RPT+ ++  
Sbjct: 267  VAAS-LIQKM------LQTDPTARPTINELLN 291

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  117 bits (293), Expect = 2e-28
 Identities = 29/297 (9%), Positives = 72/297 (24%), Gaps = 55/297 (18%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +  G +  V+   ++   E  A+K F     +  +  +       +   +   +  +   
Sbjct: 70   LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 873  FCSHAR--------------------------HSFIVYEYLEMGSLAMILS----NATSA 902
                                            +  ++        L ++ S         
Sbjct: 130  RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFR 188

Query: 903  EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK 962
             + G      +   +    + L +     +V+   +  N+ +  +    + D        
Sbjct: 189  GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL---W 242

Query: 963  PDSSNWTELAGTIGYVAPEL--AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST 1020
               +     +  + Y   E   A T   T   + +  G+          P  F       
Sbjct: 243  KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP--FGLVTPGI 300

Query: 1021 SSNLDRTLDEILDPR-LPAPSC-----NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +  R    +     L   SC      ++  LI         L+ +   R    + 
Sbjct: 301  KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKT-LIG------RFLNFDRRRRLLPLEA 350

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  116 bits (293), Expect = 4e-28
 Identities = 54/319 (16%), Positives = 103/319 (32%), Gaps = 56/319 (17%)

Query: 805  TNDFDEEHCIGTGGQ--GSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFL-NEVKSLT 860
               ++    IG G +   +V  A    +GE V V++    L +       FL  E+    
Sbjct: 24   GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGELHVSK 81

Query: 861  EIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
               H NIV +          ++V  ++  GS   ++      + +       +++GV  A
Sbjct: 82   LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKA 140

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL-------KPDSSNWTELAG 973
            L Y+H+      V+R + + ++L+ ++ + ++S    + S+       +           
Sbjct: 141  LDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 974  TIGYVAPELAYTMKV--TEKSDVYSFGVLALEAIKGK------HP--------------- 1010
             + +++PE+          KSD+YS G+ A E   G                        
Sbjct: 198  VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 1011 RDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAI-------------SC 1057
             D  +      +                 +   R                         C
Sbjct: 258  LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 1058 LDENPDSRPTMQKVSQLLK 1076
            L  NPD+RP+    S LL 
Sbjct: 318  LQRNPDARPS---ASTLLN 333

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  114 bits (287), Expect = 4e-28
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 28/274 (10%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             DF   + +G G    VYRA  + +G  VA+K      + +    Q   NEVK   +++H
Sbjct: 11   EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA--EELGWTQRMNVIKGVADALS 922
             +I++ Y +   + + ++V E    G +   L N      E          +  +   + 
Sbjct: 71   PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH----FMHQIITGML 126

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YLH+     I++RD++  N+LL       ++DFG++  LK        L GT  Y++PE+
Sbjct: 127  YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEI 183

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP--- 1039
            A       +SDV+S G +    + G+ P D        +  +  TL++++      P   
Sbjct: 184  ATRSAHGLESDVWSLGCMFYTLLIGRPPFD--------TDTVKNTLNKVVLADYEMPSFL 235

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            S   +D LI  +      L  NP  R ++  V  
Sbjct: 236  SIEAKD-LIHQL------LRRNPADRLSLSSVLD 262

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (293), Expect = 5e-28
 Identities = 38/297 (12%), Positives = 81/297 (27%), Gaps = 60/297 (20%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEV---KSLTEIRH----- 864
            +G     +   A    +GE   V   +          ++   EV   + L  I++     
Sbjct: 86   LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 865  --------------RNIVKFYGFCSHARHSFIVYEYLEM----GSLAM----ILSNATSA 902
                              K        R  +++  +        +L      +LS++++ 
Sbjct: 146  VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 903  EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL- 961
            + L    R+ +   V   L+ LH+     +V+  +   +++LD      ++ F       
Sbjct: 206  KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 962  KPDSSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016
                S            A  +          +T   D ++ G+          P      
Sbjct: 263  ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP--N--- 317

Query: 1017 ICSTSSNLDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
               T        + I      +P P   +R  L+         L    + R    + 
Sbjct: 318  ---TDDAALGGSEWIFRSCKNIPQP---VRA-LLE------GFLRYPKEDRLLPLQA 361

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  114 bits (288), Expect = 6e-28
 Identities = 62/291 (21%), Positives = 116/291 (39%), Gaps = 46/291 (15%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
              +     IG+GG   V++      +I A+K  +       T    + NE+  L +++  
Sbjct: 28   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQH 86

Query: 866  N--IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            +  I++ Y +    ++ ++V E      L   L    S +     +R +  K + +A+  
Sbjct: 87   SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDP---WERKSYWKNMLEAVHT 142

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--TELAGTIGYVAPE 981
            +H      IV+ D+   N L+  +    + DFGI+  ++PD+++       GT+ Y+ PE
Sbjct: 143  IHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

Query: 982  L-----------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE 1030
                            K++ KSDV+S G +      GK P  F         N    L  
Sbjct: 199  AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKLHA 251

Query: 1031 ILDPRLPAP-----SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            I+DP            +++D ++        CL  +P  R +   + +LL 
Sbjct: 252  IIDPNHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRIS---IPELLA 292

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  116 bits (293), Expect = 9e-28
 Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 47/296 (15%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RH 864
            N    E  +G G  G+V       G  VAVK+               L E+K LTE   H
Sbjct: 15   NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI------DFCDIALMEIKLLTESDDH 68

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRM---NVIKGVADA 920
             N++++Y   +  R  +I  E     +L  ++ S   S E L   +     ++++ +A  
Sbjct: 69   PNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAH-------------VSDFGISKSLKPDSSN 967
            +++LH+     I++RD+  +N+L+                    +SDFG+ K L    S+
Sbjct: 128  VAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSS 184

Query: 968  WT----ELAGTIGYVAPEL-------AYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFIS 1015
            +       +GT G+ APEL           ++T   D++S G +    + KGKHP     
Sbjct: 185  FRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244

Query: 1016 SICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            S  S       +LDE+      +      D LIS        +D +P  RPT  KV
Sbjct: 245  SRESNIIRGIFSLDEMKCLHDRSLIAEATD-LIS------QMIDHDPLKRPTAMKV 293

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  114 bits (287), Expect = 9e-28
 Identities = 63/284 (22%), Positives = 107/284 (37%), Gaps = 38/284 (13%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIR 863
            ND +    +G+G  G V++     +G ++AVK+       E    +  L ++   L    
Sbjct: 25   NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEE--NKRILMDLDVVLKSHD 82

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
               IV+ +G        FI  E +   +  +         E        +   +  AL Y
Sbjct: 83   CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPE---RILGKMTVAIVKALYY 139

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            L       +++RD+   N+LLD   +  + DFGIS  L  D       AG   Y+APE  
Sbjct: 140  LKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLV-DDKAKDRSAGCAAYMAPERI 196

Query: 984  YTMKVTE-----KSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PR 1035
                 T+     ++DV+S G+  +E   G+ P     +           L ++L    P 
Sbjct: 197  DPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-------EVLTKVLQEEPPL 249

Query: 1036 LPAP---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            LP     S + +   +        CL ++   RP      +LL+
Sbjct: 250  LPGHMGFSGDFQS-FVK------DCLTKDHRKRPKYN---KLLE 283

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  114 bits (287), Expect = 9e-28
 Identities = 61/268 (22%), Positives = 110/268 (41%), Gaps = 39/268 (14%)

Query: 814  IGTGGQGSVYRAELS----SGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
            +G+G  G+VY+          +I VA+K+      +     +E L+E   +  + + ++ 
Sbjct: 23   LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVC 80

Query: 869  KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC 928
            +  G C       ++ + +  G L   +      + +G    +N    +A  ++YL +  
Sbjct: 81   RLLGICL-TSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR 137

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAYTM 986
                V+RD++++NVL+       ++DFG++K L  +   +    G   I ++A E     
Sbjct: 138  L---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

Query: 987  KVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLPAPS 1040
              T +SDV+S+GV   E +  G  P D                 EI        RLP P 
Sbjct: 195  IYTHQSDVWSYGVTVWELMTFGSKPYD------------GIPASEISSILEKGERLPQPP 242

Query: 1041 -CNIRDKLISIMEVAISCLDENPDSRPT 1067
             C     +  IM   + C   + DSRP 
Sbjct: 243  IC--TIDVYMIM---VKCWMIDADSRPK 265

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (287), Expect = 1e-27
 Identities = 45/296 (15%), Positives = 105/296 (35%), Gaps = 32/296 (10%)

Query: 794  RKIAYEEIVRAT-NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEF 852
             K+  E    A               +    + +    EI    +     LS  +     
Sbjct: 49   EKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP 108

Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
              +++ +     +N V      S   + +I  +     +L   ++   S E+      ++
Sbjct: 109  SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168

Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS------ 966
            +   +A+A+ +LH+     +++RD+   N+   ++    V DFG+  ++  D        
Sbjct: 169  IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225

Query: 967  ------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST 1020
                    T   GT  Y++PE  +    + K D++S G++  E +   +         ST
Sbjct: 226  PMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YS-------FST 275

Query: 1021 SSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 R + ++ + + P        +   +++     L  +P  RP     + +++
Sbjct: 276  QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQ---DMLSPSPTERPE---ATDIIE 325

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (281), Expect = 2e-27
 Identities = 29/267 (10%), Positives = 70/267 (26%), Gaps = 41/267 (15%)

Query: 811  EHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
                G       ++A   +    VA+       +      QE L+    L+ I    + +
Sbjct: 36   LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 870  FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                        +V E++  GSL  +   + S         +  ++ +A A    H    
Sbjct: 96   VLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG-----AIRAMQSLAAAADAAHRA-- 148

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVT 989
              +         V + ++ +  ++                        +           
Sbjct: 149  -GVALSIDHPSRVRVSIDGDVVLAYP--------------------ATMPD-------AN 180

Query: 990  EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLIS 1049
             + D+   G      +  + P        +   +     +     +   P+   RD    
Sbjct: 181  PQDDIRGIGASLYALLVNRWPLP-----EAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ 235

Query: 1050 IMEVAISCLDENPDSRPTMQKVSQLLK 1076
            I  VA   +  +   R     ++ + +
Sbjct: 236  ISAVAARSVQGDGGIRSASTLLNLMQQ 262

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  114 bits (288), Expect = 2e-27
 Identities = 64/329 (19%), Positives = 126/329 (38%), Gaps = 46/329 (13%)

Query: 768  RRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL 827
            +  ++++ ++    +              A E I      +     IG+GG   V++   
Sbjct: 18   KETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLN 77

Query: 828  SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH--RNIVKFYGFCSHARHSFIVYE 885
               +I A+K  +       T    + NE+  L +++     I++ Y +    ++ ++V E
Sbjct: 78   EKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136

Query: 886  YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD 945
                  L   L    S +     +R +  K + +A+  +H      IV+ D+   N L+ 
Sbjct: 137  CGN-IDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV 189

Query: 946  LEYEAHVSDFGISKSLKPDSSNWTE--LAGTIGYVAPEL-----------AYTMKVTEKS 992
             +    + DFGI+  ++PD+++  +    G + Y+ PE                K++ KS
Sbjct: 190  -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248

Query: 993  DVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP-----SCNIRDKL 1047
            DV+S G +      GK P  F         N    L  I+DP            +++D +
Sbjct: 249  DVWSLGCILYYMTYGKTP--F-----QQIINQISKLHAIIDPNHEIEFPDIPEKDLQD-V 300

Query: 1048 ISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +        CL  +P  R ++    +LL 
Sbjct: 301  LK------CCLKRDPKQRISIP---ELLA 320

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  113 bits (284), Expect = 2e-27
 Identities = 68/295 (23%), Positives = 117/295 (39%), Gaps = 50/295 (16%)

Query: 789  VLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL----SSGEI-VAVK--KFHSP 841
            +    R     E+ +          +G+G  G+V++        S +I V +K  +  S 
Sbjct: 3    MKVLARIFKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS- 54

Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATS 901
                 +  Q   + + ++  + H +IV+  G C       +V +YL +GSL   +     
Sbjct: 55   --GRQS-FQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ--H 108

Query: 902  AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
               LG    +N    +A  + YL        V+R+++++NVLL    +  V+DFG++  L
Sbjct: 109  RGALGPQLLLNWGVQIAKGMYYLEEHGM---VHRNLAARNVLLKSPSQVQVADFGVADLL 165

Query: 962  KPDSSNWTELAGT--IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSIC 1018
             PD            I ++A E  +  K T +SDV+S+GV   E +  G  P        
Sbjct: 166  PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA------ 219

Query: 1019 STSSNLDRTLDEILDP-----RLPAPS-CNIRDKLISIMEVAISCLDENPDSRPT 1067
                     L E+ D      RL  P  C     +  +M   + C   + + RPT
Sbjct: 220  ------GLRLAEVPDLLEKGERLAQPQIC--TIDVYMVM---VKCWMIDENIRPT 263

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  113 bits (285), Expect = 2e-27
 Identities = 62/293 (21%), Positives = 115/293 (39%), Gaps = 50/293 (17%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH- 864
              +     IG+GG   V++      +I A+K  +       T    + NE+  L +++  
Sbjct: 9    RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDS-YRNEIAYLNKLQQH 67

Query: 865  -RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
               I++ Y +    ++ ++V E      L   L    S +     +R +  K + +A+  
Sbjct: 68   SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKSIDP---WERKSYWKNMLEAVHT 123

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNW--TELAGTIGYVA 979
            +H      IV+ D+   N L+    +  +   DFGI+  ++PD+++       GT+ Y+ 
Sbjct: 124  IHQHG---IVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 980  PEL-----------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
            PE                K++ KSDV+S G +      GK P  F         N    L
Sbjct: 178  PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--F-----QQIINQISKL 230

Query: 1029 DEILDPRLPAP-----SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              I+DP            +++D ++        CL  +P  R ++    +LL 
Sbjct: 231  HAIIDPNHEIEFPDIPEKDLQD-VLK------CCLKRDPKQRISIP---ELLA 273

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  113 bits (285), Expect = 3e-27
 Identities = 69/304 (22%), Positives = 116/304 (38%), Gaps = 45/304 (14%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            +DF++   +G G  G V++     SG ++A K  H  L  +   + + + E++ L E   
Sbjct: 33   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKPAIRNQIIRELQVLHECNS 90

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              IV FYG         I  E+++ GSL  +L  A    E        V   V   L+YL
Sbjct: 91   PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAVIKGLTYL 147

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
                   I++RD+   N+L++   E  + DFG+S  L  DS   +   GT  Y++PE   
Sbjct: 148  REKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI-DSMANS-FVGTRSYMSPERLQ 203

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP---------------RDFISSICSTSSNLDRTLD 1029
                + +SD++S G+  +E   G++P               +    +  +          
Sbjct: 204  GTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263

Query: 1030 EILDPRLPAPSCNIRDKLISIMEVAI-----------------SCLDENPDSRPTMQKVS 1072
                     P   I + L  I+                      CL +NP  R  ++   
Sbjct: 264  LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK--- 320

Query: 1073 QLLK 1076
            QL+ 
Sbjct: 321  QLMV 324

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  113 bits (284), Expect = 3e-27
 Identities = 71/287 (24%), Positives = 116/287 (40%), Gaps = 39/287 (13%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIR 863
             D  +   IG G  GSV +     SG+I+AVK+  S +  +   Q++ L ++   +    
Sbjct: 22   EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE--QKQLLMDLDVVMRSSD 79

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADAL 921
               IV+FYG        +I  E +   S         S  +    + +   +      AL
Sbjct: 80   CPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            ++L  +    I++RDI   N+LLD      + DFGIS  L  DS   T  AG   Y+APE
Sbjct: 139  NHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV-DSIAKTRDAGCRPYMAPE 195

Query: 982  ----LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---P 1034
                 A       +SDV+S G+   E   G+ P           +++   L +++    P
Sbjct: 196  RIDPSASRQGYDVRSDVWSLGITLYELATGRFPY-------PKWNSVFDQLTQVVKGDPP 248

Query: 1035 RLPAP-----SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +L        S +  +  ++       CL ++   RP      +LLK
Sbjct: 249  QLSNSEEREFSPSFIN-FVN------LCLTKDESKRPK---YKELLK 285

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  111 bits (279), Expect = 5e-27
 Identities = 64/283 (22%), Positives = 113/283 (39%), Gaps = 47/283 (16%)

Query: 811  EHCIGTGGQGSVYRAELSSGEI----VAVK--KFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
               +G G  G VY    ++ +     VAVK  K    L ++    ++F++E   +  + H
Sbjct: 17   NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK----EKFMSEAVIMKNLDH 72

Query: 865  RNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
             +IVK  G         +I+ E    G L   L    +   L     +     +  A++Y
Sbjct: 73   PHIVKLIGIIE--EEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAP 980
            L +      V+RDI+ +N+L+       + DFG+S+ +  +  ++ + + T   I +++P
Sbjct: 129  LESINC---VHRDIAVRNILVASPECVKLGDFGLSRYI--EDEDYYKASVTRLPIKWMSP 183

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP----- 1034
            E     + T  SDV+ F V   E +  GK P                   +++       
Sbjct: 184  ESINFRRFTTASDVWMFAVCMWEILSFGKQPFF------------WLENKDVIGVLEKGD 231

Query: 1035 RLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            RLP P  C     L ++M     C D +P  RP   ++   L 
Sbjct: 232  RLPKPDLCP--PVLYTLM---TRCWDYDPSDRPRFTELVCSLS 269

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  110 bits (277), Expect = 1e-26
 Identities = 64/291 (21%), Positives = 106/291 (36%), Gaps = 29/291 (9%)

Query: 401 LGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPI 460
           LG ++ EL G      G  +   +L             +    + L  L +   ++   I
Sbjct: 31  LGAADVELYG------GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRI 84

Query: 461 PD----LRNLTRLARVRLDRNHLTGNISESFGI--HSNLSYINLSHKKFYGEISFDWGKF 514
                 +  ++ L  + L+   +TG            +L+ +NL +  +    ++     
Sbjct: 85  LFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQ 144

Query: 515 ----PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE----LGKLRSLI 566
               P L  L ++  +       ++   P L  LDLS N  +GE          K  +L 
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

Query: 567 KLTLNRNQF---SGQLPTELGSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQ 622
            L L        SG       + +QL+ LDLS N L ++    S     +L  LNLS   
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 623 FSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSG 673
              ++P  L     LS LDLS+N L +  PS    +  +  L+L  N    
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRL-DRNPS-PDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =  106 bits (265), Expect = 5e-25
 Identities = 56/260 (21%), Positives = 83/260 (31%), Gaps = 24/260 (9%)

Query: 98  TLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIA---NNSKLKYLDLSSNSFSGTIPPQIGN 154
                       L  L +R  +I   I          S L+ L L +   +GT PP +  
Sbjct: 58  LGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117

Query: 155 LSMLKILYLSTNQFSGRIPP------QIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAI 208
            +   +  L+    S           Q      LK L + +          +     L+ 
Sbjct: 118 ATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALST 177

Query: 209 MYLYNNSLSGSI-------PSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
           + L +N   G         P +   L+ L+    G    SG           L  LDL  
Sbjct: 178 LDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH 237

Query: 262 NSLSGSIP-LSFGNLTNLDILNLPHNSLSGSIPSEMG-NLKSLYGLGLSFNKLSGSIPSS 319
           NSL  +    S    + L+ LNL    L   +P  +   L  L    LS+N+L    PS 
Sbjct: 238 NSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPAKLSVLD---LSYNRLD-RNPSP 292

Query: 320 LGNLTKLTILYLSDNLLFGS 339
              L ++  L L  N    S
Sbjct: 293 DE-LPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score =   99 bits (249), Expect = 6e-23
 Identities = 65/277 (23%), Positives = 96/277 (34%), Gaps = 23/277 (8%)

Query: 129 ANNSKLKYLDLSSNSFSGTIP-PQIGNLSMLKILYLSTNQFSGRIPPQIGHL---SYLKA 184
                L+YL    ++ +       I     LK L +   +   RI      +   S L+ 
Sbjct: 40  GGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQE 99

Query: 185 LHLFENGLSGSIPPSLGNLTNLAIMYLY--NNSLSG--SIPSEIGNL--KSLSGLELGYN 238
           L L    ++G+ PP L   T   +  L   N S +   +  +E+       L  L +   
Sbjct: 100 LTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQA 159

Query: 239 KLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL-------SFGNLTNLDILNLPHNSLSGS 291
                    +   P L+TLDL DN   G   L        F  L  L + N    + SG 
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219

Query: 292 IPSEMGNLKSLYGLGLSFNKLSGSIPSSL-GNLTKLTILYLSDNLLFGSIPCEIGNLRYL 350
             +       L GL LS N L  +  +      ++L  L LS   L   +P  +     L
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKL 276

Query: 351 FYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
             L+L  N+L    P S   L  +  L L  N    S
Sbjct: 277 SVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 99.6 bits (248), Expect = 7e-23
 Identities = 59/291 (20%), Positives = 100/291 (34%), Gaps = 31/291 (10%)

Query: 201 GNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMP---LSLGNLPNLATL 257
           G  +   ++   +        ++I    SL  L +   ++   +    L +  +  L  L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 258 DLHDNSLSGSIPLSFGNLT--NLDILNLPHNSLSG--SIPSEMGNL--KSLYGLGLSFNK 311
            L +  ++G+ P      T  +L+ILNL + S +   +  +E+       L  L ++   
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 312 LSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNL 371
                   +     L+ L LSDN   G                     +S   P     L
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERG-----------------LISALCPLKFPTL 203

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIP-YSFGNLTNMIVLSIYSN 430
             LA         SG   +       L  L LS N L  +    S    + +  L++   
Sbjct: 204 QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFT 263

Query: 431 ALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTG 481
            L   +PK  G   KL++L LSYN+L    P    L ++  + L  N    
Sbjct: 264 GLK-QVPK--GLPAKLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 92.3 bits (229), Expect = 2e-20
 Identities = 50/224 (22%), Positives = 78/224 (34%), Gaps = 22/224 (9%)

Query: 492 NLSYINLSHKKFYGEISFDWGKF---PNLGTLDVSANNITGILPPEIGD--SPQLKVLDL 546
           +L  + +   +    I F   +      L  L +    +TG  PP + +   P L +L+L
Sbjct: 69  SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128

Query: 547 SSNHIVGEIPSELGKL-----RSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN 601
            +        + L +L       L  L++ +         ++     L  LDLS N    
Sbjct: 129 RNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187

Query: 602 SI-------PGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQ 654
                    P     L  L   N      SG         + L  LDLSHN L +   + 
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247

Query: 655 VCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHG 697
            C     L  LNL+   L   +P+       L  +D+SYN+L  
Sbjct: 248 SCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDR 288

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.8 bits (220), Expect = 4e-19
 Identities = 60/315 (19%), Positives = 96/315 (30%), Gaps = 55/315 (17%)

Query: 321 GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS---LGNLTNLATL 377
           G  +   +L   D         +I     L  L +   ++   I      +  ++ L  L
Sbjct: 41  GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100

Query: 378 YLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGN------LTNMIVLSIYSNA 431
            L    ++G+ P  +          L+   +S +   ++           + VLSI    
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160

Query: 432 LSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHS 491
                 ++      L+ L LS N   G    +  L  L    L                 
Sbjct: 161 SLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTL----------------Q 204

Query: 492 NLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQ-LKVLDLSSNH 550
            L+  N   +   G  S        L  LD+S N++         D P  L  L+LS   
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264

Query: 551 IVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNL 610
           +                          Q+P  L +  +L  LDLS NRL    P S   L
Sbjct: 265 LK-------------------------QVPKGLPA--KLSVLDLSYNRLD-RNP-SPDEL 295

Query: 611 VKLYYLNLSNNQFSG 625
            ++  L+L  N F  
Sbjct: 296 PQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 80.7 bits (199), Expect = 2e-16
 Identities = 43/204 (21%), Positives = 60/204 (29%), Gaps = 23/204 (11%)

Query: 89  NLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTI 148
           N++ A     L +      P L  L +           Q+     L  LDLS N   G  
Sbjct: 130 NVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGER 189

Query: 149 PPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAI 208
                               S   P +   L  L   +      SG           L  
Sbjct: 190 GL-----------------ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQG 232

Query: 209 MYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGS 267
           + L +NSL  +  +        L+ L L +  L     +  G    L+ LDL  N L   
Sbjct: 233 LDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPAKLSVLDLSYNRLD-R 288

Query: 268 IPLSFGNLTNLDILNLPHNSLSGS 291
            P S   L  +  L+L  N    S
Sbjct: 289 NP-SPDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 33/166 (19%), Positives = 59/166 (35%), Gaps = 10/166 (6%)

Query: 559 LGKLRSLIKLTLNRNQFSGQLP-TELGSLIQLEHLDLSSNRLSNSIPGS---LGNLVKLY 614
            G  RSL  L    +  +     T++   + L+ L + + R+ + I      +  +  L 
Sbjct: 39  YGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQ 98

Query: 615 YLNLSNNQFSGEIPIKLEKFIH--LSDLDLSHNFLGEEIPS----QVCSMQSLEKLNLAH 668
            L L N + +G  P  L +     L+ L+L +             Q      L+ L++A 
Sbjct: 99  ELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQ 158

Query: 669 NNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQ 714
            +   F     +    L  +D+S N   G     +A        LQ
Sbjct: 159 AHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  111 bits (279), Expect = 2e-26
 Identities = 44/294 (14%), Positives = 86/294 (29%), Gaps = 33/294 (11%)

Query: 799  EEIVRATNDFDEEHCIGTGGQGSVYRAE------LSSGEIVAVKKFHSPLLSEMTCQQEF 852
             E    +      H +G G    VY A         + +   +K        E       
Sbjct: 58   TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEF---YIG 114

Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQ--R 910
               ++ L        +KFY        S +V E    G+L   ++   +  E    Q   
Sbjct: 115  TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH-----------VSDFGISK 959
            ++    +   +  +H+     I++ DI   N +L   +              + D G S 
Sbjct: 175  ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 960  SLK--PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPR-DFISS 1016
             +K  P  + +T    T G+   E+        + D +         + G + +      
Sbjct: 232  DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291

Query: 1017 ICSTSSNLDR-----TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             C       R       +E     L  P C+    L  + +       ++  ++
Sbjct: 292  ECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  108 bits (273), Expect = 2e-26
 Identities = 66/270 (24%), Positives = 113/270 (41%), Gaps = 39/270 (14%)

Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
              CIG G  G V++       +  + VA+K   +     +  +++FL E  ++ +  H +
Sbjct: 20   GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 77

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IVK  G  +     +I+ E   +G L   L        L     +     ++ AL+YL +
Sbjct: 78   IVKLIGVITENPV-WIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLES 134

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT---IGYVAPELA 983
              F   V+RDI+++NVL+       + DFG+S+ +  + S + + +     I ++APE  
Sbjct: 135  KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESI 189

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP-----RLP 1037
               + T  SDV+ FGV   E +  G  P                  ++++       RLP
Sbjct: 190  NFRRFTSASDVWMFGVCMWEILMHGVKPFQ------------GVKNNDVIGRIENGERLP 237

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPT 1067
             P  N    L S+M     C   +P  RP 
Sbjct: 238  MPP-NCPPTLYSLM---TKCWAYDPSRRPR 263

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score =  109 bits (274), Expect = 3e-26
 Identities = 65/278 (23%), Positives = 107/278 (38%), Gaps = 20/278 (7%)

Query: 108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQ 167
           P  +        I  I        ++    +L   S +  +      L+ +  +  + + 
Sbjct: 2   PLGSETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSD 57

Query: 168 FSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNL 227
               +   I +L  +  L L  N L+  I P L NL NL  ++L  N +   + S + +L
Sbjct: 58  IK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DL-SSLKDL 111

Query: 228 KSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNS 287
           K L  L L +N +S    L   +LP L +L L +N ++    LS   LT LD L+L  N 
Sbjct: 112 KKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQ 167

Query: 288 LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNL 347
           +S  I   +  L  L  L LS N +S  +  +L  L  L +L L              NL
Sbjct: 168 IS-DI-VPLAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNL 223

Query: 348 RYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
                ++  D  L    P  + +  +     +  +L  
Sbjct: 224 VVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPE 259

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 61/231 (26%), Positives = 100/231 (43%), Gaps = 16/231 (6%)

Query: 178 HLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGY 237
             +     +L +  ++ ++      L ++  +   N+ +  S+   I  L +++ L L  
Sbjct: 22  AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNG 77

Query: 238 NKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG 297
           NKL+   PL+  NL NL  L L +N +     L   +L  L  L+L HN +S  I   + 
Sbjct: 78  NKLTDIKPLA--NLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGIS-DING-LV 131

Query: 298 NLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGD 357
           +L  L  L L  NK++    + L  LTKL  L L DN +   I   +  L  L  L L  
Sbjct: 132 HLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 187

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENEL 408
           N +S  +  +L  L NL  L LF+        +   NL   + +  ++  L
Sbjct: 188 NHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 59/261 (22%), Positives = 99/261 (37%), Gaps = 21/261 (8%)

Query: 103 SFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILY 162
           + +    +  +    + I  +    I     +  L L+ N  +  I P + NL  L  L+
Sbjct: 41  TQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLF 96

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS 222
           L  N+    +   +  L  LK+L L  NG+S  I   L +L  L  +YL NN +  +  +
Sbjct: 97  LDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKI--TDIT 150

Query: 223 EIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
            +  L  L  L L  N++S  +PL+   L  L  L L  N +S    L+   L NLD+L 
Sbjct: 151 VLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISDLRALA--GLKNLDVLE 206

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
           L          +   NL     +  +   L    P  + +        +  +L     P 
Sbjct: 207 LFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHL-----PE 259

Query: 343 EIGNLRYLFYLELGDNKLSGS 363
               + ++FY  +   K    
Sbjct: 260 FTNEVSFIFYQPVTIGKAKAR 280

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 88.2 bits (219), Expect = 4e-19
 Identities = 53/243 (21%), Positives = 94/243 (38%), Gaps = 16/243 (6%)

Query: 460 IPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGT 519
           I          +  L +  +T     +    +++  I  ++      +       PN+  
Sbjct: 17  IFSDDAFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDI-KSVQG-IQYLPNVTK 72

Query: 520 LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
           L ++ N +T I P  + +   L  L L  N +  ++ S L  L+ L  L+L  N  S   
Sbjct: 73  LFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS--D 126

Query: 580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSD 639
              L  L QLE L L +N++++     L  L KL  L+L +NQ S  +P  L     L +
Sbjct: 127 INGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182

Query: 640 LDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPI 699
           L LS N +  ++   +  +++L+ L L               +     +  +   L  P 
Sbjct: 183 LYLSKNHI-SDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPE 240

Query: 700 PNS 702
             S
Sbjct: 241 IIS 243

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 51/254 (20%), Positives = 97/254 (38%), Gaps = 39/254 (15%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
                I  ++   +++ A+ +    L  +  ++ + + ++  +  ++ L  + ++ L+ N
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGN 78

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
            LT +I              L++               NLG L +  N +  +    + D
Sbjct: 79  KLT-DIK------------PLAN-------------LKNLGWLFLDENKVKDLSS--LKD 110

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
             +LK L L  N I     + L  L  L  L L  N+ +    T L  L +L+ L L  N
Sbjct: 111 LKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDN 166

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS 657
           ++S  I   L  L KL  L LS N  S ++   L    +L  L+L       +  +   +
Sbjct: 167 QIS-DIVP-LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSN 222

Query: 658 MQSLEKLNLAHNNL 671
           +     +     +L
Sbjct: 223 LVVPNTVKNTDGSL 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 83.2 bits (206), Expect = 2e-17
 Identities = 56/263 (21%), Positives = 95/263 (36%), Gaps = 39/263 (14%)

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
                      L    ++ ++      LNS+  +  + +++  S+      L N+  L +
Sbjct: 20  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFL 75

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESF 487
             N L+   P    NL  L  L L  N+++  +  L++L +L  + L+ N ++ +I+   
Sbjct: 76  NGNKLTDIKP--LANLKNLGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGIS-DIN--- 128

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
                     L H              P L +L +  N IT I    +    +L  L L 
Sbjct: 129 ---------GLVH-------------LPQLESLYLGNNKITDITV--LSRLTKLDTLSLE 164

Query: 548 SNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSL 607
            N I  +I   L  L  L  L L++N  S      L  L  L+ L+L S    N      
Sbjct: 165 DNQIS-DI-VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQ 220

Query: 608 GNLVKLYYLNLSNNQFSGEIPIK 630
            NLV    +  ++        I 
Sbjct: 221 SNLVVPNTVKNTDGSLVTPEIIS 243

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 75.5 bits (186), Expect = 7e-15
 Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 12/188 (6%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
              ++  +L +L L  N++  +    + +  KLK L L  N  S  I   + +L  L+ L
Sbjct: 84  KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS-DING-LVHLPQLESL 139

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
           YL  N+ +  I   +  L+ L  L L +N +S  I P L  LT L  +YL  N +S  + 
Sbjct: 140 YLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHIS-DL- 193

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF-GNLTNLDI 280
             +  LK+L  LEL   +          NL    T+   D SL     +S  G+    ++
Sbjct: 194 RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNV 253

Query: 281 -LNLPHNS 287
             +LP  +
Sbjct: 254 KWHLPEFT 261

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score =  105 bits (264), Expect = 6e-26
 Identities = 28/181 (15%), Positives = 62/181 (34%), Gaps = 10/181 (5%)

Query: 154 NLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
                    L  +  +         ++ L  + L    ++  +   +    N+  + + N
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINN 75

Query: 214 NSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFG 273
              +    + I  L +L  L +    ++     +L  L +L  LD+  ++   SI     
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD 333
            L  ++ ++L +N     I   +  L  L  L + F+ +       + +  KL  LY   
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFS 190

Query: 334 N 334
            
Sbjct: 191 Q 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score =  105 bits (264), Expect = 6e-26
 Identities = 34/185 (18%), Positives = 71/185 (38%), Gaps = 10/185 (5%)

Query: 202 NLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
                    L  +S +    +++ +L  ++   +    L+G     +    N+  L +++
Sbjct: 21  TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG-----IEYAHNIKDLTINN 75

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG 321
              +   P+S   L+NL+ L +    ++      +  L SL  L +S +    SI + + 
Sbjct: 76  IHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
            L K+  + LS N     I   +  L  L  L +  + +       + +   L  LY F+
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 382 NLLSG 386
             + G
Sbjct: 191 QTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 98.5 bits (246), Expect = 1e-23
 Identities = 35/178 (19%), Positives = 77/178 (43%), Gaps = 10/178 (5%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRI 172
             L  +    I  +Q+ +   L Y+ L++ + +      I     +K L ++    +   
Sbjct: 28  GLLGQSSTANITEAQMNS---LTYITLANINVTDLTG--IEYAHNIKDLTINNIHATN-Y 81

Query: 173 PPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSG 232
            P I  LS L+ L +    ++    P+L  LT+L ++ + +++   SI ++I  L  ++ 
Sbjct: 82  NP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNS 140

Query: 233 LELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSG 290
           ++L YN     +   L  LP L +L++  + +     +   +   L+ L     ++ G
Sbjct: 141 IDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 97.0 bits (242), Expect = 5e-23
 Identities = 22/183 (12%), Positives = 61/183 (33%), Gaps = 7/183 (3%)

Query: 252 PNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNK 311
                        S +  ++   + +L  + L + +++  + + +    ++  L ++   
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIH 77

Query: 312 LSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNL 371
            +    + +  L+ L  L +    +       +  L  L  L++  +    SI   +  L
Sbjct: 78  ATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
             + ++ L  N     I   +  L  L  L +  + +         +   +  L  +S  
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

Query: 432 LSG 434
           + G
Sbjct: 193 IGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 29/166 (17%), Positives = 59/166 (35%), Gaps = 7/166 (4%)

Query: 101 DFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKI 160
           + + +    L Y+ L    +  +    I     +K L +++   +   P  I  LS L+ 
Sbjct: 37  NITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92

Query: 161 LYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSI 220
           L +     +    P +  L+ L  L +  +    SI   +  L  +  + L  N     I
Sbjct: 93  LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

Query: 221 PSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG 266
              +  L  L  L + ++ +     +   + P L  L     ++ G
Sbjct: 153 -MPLKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 25/181 (13%), Positives = 65/181 (35%), Gaps = 7/181 (3%)

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
                        +            L  + L++ ++     + +    ++  LT+N   
Sbjct: 20  STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINV--TDLTGIEYAHNIKDLTINNIH 77

Query: 575 FSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKF 634
            +      +  L  LE L +    +++    +L  L  L  L++S++     I  K+   
Sbjct: 78  ATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTL 135

Query: 635 IHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
             ++ +DLS+N    +I   + ++  L+ LN+  + +  +     ++   L  +      
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQT 192

Query: 695 L 695
           +
Sbjct: 193 I 193

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.6 bits (228), Expect = 4e-21
 Identities = 31/185 (16%), Positives = 63/185 (34%), Gaps = 10/185 (5%)

Query: 274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD 333
                    L  +S +         + SL  + L+   ++  + + +     +  L +++
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75

Query: 334 NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIG 393
                  P  I  L  L  L +    ++     +L  LT+L  L +  +    SI ++I 
Sbjct: 76  IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 394 NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
            L  ++ + LS N     I      L  +  L+I  + +         +  KL  L    
Sbjct: 134 TLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190

Query: 454 NQLQG 458
             + G
Sbjct: 191 QTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 91.2 bits (227), Expect = 4e-21
 Identities = 30/162 (18%), Positives = 65/162 (40%), Gaps = 7/162 (4%)

Query: 512 GKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLN 571
            +  +L  + ++  N+T +    I  +  +K L +++ H      + +  L +L +L + 
Sbjct: 41  AQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPISGLSNLERLRIM 96

Query: 572 RNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
               +      L  L  L  LD+S +   +SI   +  L K+  ++LS N    +I   L
Sbjct: 97  GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PL 155

Query: 632 EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSG 673
           +    L  L++  + + +     +     L +L      + G
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 87.7 bits (218), Expect = 9e-20
 Identities = 28/209 (13%), Positives = 70/209 (33%), Gaps = 33/209 (15%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
                +   +  ++ +         +  LT + L+   +   +  +     +  + ++  
Sbjct: 21  TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNI 76

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
           H T           N + I                   NL  L +   ++T    P +  
Sbjct: 77  HAT-----------NYNPI---------------SGLSNLERLRIMGKDVTSDKIPNLSG 110

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
              L +LD+S +     I +++  L  +  + L+ N     +   L +L +L+ L++  +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFD 169

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
            + +     + +  KL  L   +    G+
Sbjct: 170 GVHDYRG--IEDFPKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 81.5 bits (202), Expect = 1e-17
 Identities = 33/209 (15%), Positives = 67/209 (32%), Gaps = 33/209 (15%)

Query: 322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
                    L  +    +       +  L Y+ L +  ++      +    N+  L +  
Sbjct: 21  TFKAYLNGLLGQS---STANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINN 75

Query: 382 NLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYG 441
              +    + I  L++L  L +   +++     +   LT++ +L I  +A   +I  +  
Sbjct: 76  IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133

Query: 442 NLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHK 501
            L K+  + LSYN     I  L+ L  L  + +  + +            +   I     
Sbjct: 134 TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVH-----------DYRGIE---- 178

Query: 502 KFYGEISFDWGKFPNLGTLDVSANNITGI 530
                       FP L  L   +  I G 
Sbjct: 179 -----------DFPKLNQLYAFSQTIGGK 196

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (280), Expect = 7e-26
 Identities = 69/270 (25%), Positives = 115/270 (42%), Gaps = 36/270 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V    +  +G+  AVK      + + T ++  L EV+ L ++ H NI+K Y 
Sbjct: 34   LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
            F     + ++V E    G L   I+S    +E         +I+ V   ++Y+H +    
Sbjct: 94   FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----DAARIIRQVLSGITYMHKNK--- 146

Query: 932  IVYRDISSKNVLL-DLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
            IV+RD+  +N+LL     +A++   DFG+S   +       +  GT  Y+APE+      
Sbjct: 147  IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MKDKIGTAYYIAPEV-LHGTY 204

Query: 989  TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL-------DPRLPAPSC 1041
             EK DV+S GV+    + G  P  F        +N    L ++         P+    S 
Sbjct: 205  DEKCDVWSTGVILYILLSGCPP--F------NGANEYDILKKVEKGKYTFELPQWKKVSE 256

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            + +D LI  M      L   P  R + +  
Sbjct: 257  SAKD-LIRKM------LTYVPSMRISARDA 279

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (270), Expect = 8e-26
 Identities = 69/292 (23%), Positives = 117/292 (40%), Gaps = 53/292 (18%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVK-SLTEIR 863
            +D +    +G G  G V +   + SG+I+AVK+           Q+  L ++  S+  + 
Sbjct: 7    DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR--ATVNSQEQKRLLMDLDISMRTVD 64

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSA------EELGWTQRMNVIKGV 917
                V FYG        +I  E ++  SL                + LG      +   +
Sbjct: 65   CPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILG-----KIAVSI 118

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGY 977
              AL +LH+     +++RD+   NVL++   +  + DFGIS  L  D       AG   Y
Sbjct: 119  VKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV-DDVAKDIDAGCKPY 175

Query: 978  VAPE--------LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029
            +APE          Y++    KSD++S G+  +E    + P         +     + L 
Sbjct: 176  MAPERINPELNQKGYSV----KSDIWSLGITMIELAILRFP-------YDSWGTPFQQLK 224

Query: 1030 EILD---PRLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            ++++   P+LPA   S    D   S       CL +N   RPT     +L++
Sbjct: 225  QVVEEPSPQLPADKFSAEFVD-FTS------QCLKKNSKERPT---YPELMQ 266

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  108 bits (272), Expect = 1e-25
 Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 48/300 (16%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQE-- 851
            E+ R          +G G  G VY  ++S          VAVK      L E+  +Q+  
Sbjct: 26   EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDEL 78

Query: 852  -FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL----SNATSAEELG 906
             FL E   +++  H+NIV+  G    +   FI+ E +  G L   L       +    L 
Sbjct: 79   DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA 138

Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV---SDFGISKSLKP 963
                ++V + +A    YL  + F   ++RDI+++N LL       V    DFG+++ +  
Sbjct: 139  MLDLLHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY- 194

Query: 964  DSSNWTELAGT----IGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSI 1017
              +++    G     + ++ PE        T K+D +SFGVL  E    G  P       
Sbjct: 195  -RASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP------- 245

Query: 1018 CSTSSNLDRTLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              + SN +  L+ +    R+  P  N    +  IM     C    P+ RP    + + ++
Sbjct: 246  YPSKSNQE-VLEFVTSGGRMDPPK-NCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 300

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  108 bits (272), Expect = 1e-25
 Identities = 61/293 (20%), Positives = 103/293 (35%), Gaps = 50/293 (17%)

Query: 811  EHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIV 868
               +  GG   VY A+ + SG   A+K+    L +E    +  + EV  + ++  H NIV
Sbjct: 33   RRVLAEGGFAFVYEAQDVGSGREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 869  KFYGFCSHARHS-------FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            +F    S  +         F++   L  G L   L    S   L     + +      A+
Sbjct: 90   QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA--------- 972
             ++H    PPI++RD+  +N+LL  +    + DFG + ++                    
Sbjct: 150  QHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208

Query: 973  ---GTIGYVAPELAYTMK---VTEKSDVYSFGVLALEAIKGKHPRDF----ISSICSTSS 1022
                T  Y  PE+        + EK D+++ G +       +HP  F       I +   
Sbjct: 209  TRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKLRIVNGK- 265

Query: 1023 NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                       P            LI  M      L  NP+ R ++ +V   L
Sbjct: 266  --------YSIPPHDTQYTVFHS-LIRAM------LQVNPEERLSIAEVVHQL 303

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (268), Expect = 2e-25
 Identities = 64/288 (22%), Positives = 108/288 (37%), Gaps = 30/288 (10%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNE 855
             I         +  IG G  G VY  E           A+K     +       + FL E
Sbjct: 15   LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQ-VEAFLRE 72

Query: 856  VKSLTEIRHRNIVKFYGFCSHAR-HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI 914
               +  + H N++   G          ++  Y+  G L   + +            ++  
Sbjct: 73   GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS--PQRNPTVKDLISFG 130

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT 974
              VA  + YL    F   V+RD++++N +LD  +   V+DFG+++ +        +    
Sbjct: 131  LQVARGMEYLAEQKF---VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRH 187

Query: 975  ----IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLD 1029
                + + A E   T + T KSDV+SFGVL  E + +G  P   I          D    
Sbjct: 188  ARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI-------DPFD-LTH 239

Query: 1030 EILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             +    RLP P     D L  +M+    C + +P  RPT + +   ++
Sbjct: 240  FLAQGRRLPQPE-YCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVE 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  112 bits (280), Expect = 2e-25
 Identities = 63/288 (21%), Positives = 108/288 (37%), Gaps = 40/288 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            +GTGG G V R     +GE VA+K+    L  +   ++ +  E++ + ++ H N+V    
Sbjct: 22   LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKN--RERWCLEIQIMKKLNHPNVVSARE 79

Query: 872  -----GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                    +      +  EY E G L   L+   +   L       ++  ++ AL YLH 
Sbjct: 80   VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +    I++RD+  +N++L    +     + D G +K L           GT+ Y+APEL 
Sbjct: 140  NR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE-FVGTLQYLAPELL 195

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHP-----------------RDFISSICSTSSNLDR 1026
               K T   D +SFG LA E I G  P                  +    +    +   +
Sbjct: 196  EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVK 255

Query: 1027 TLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                +  P  L        ++ +  M      L  +   R T  +   
Sbjct: 256  FSSVLPTPNHLSGILAGKLERWLQCM------LMWHQRQRGTDPQNPN 297

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  107 bits (268), Expect = 2e-25
 Identities = 55/278 (19%), Positives = 116/278 (41%), Gaps = 25/278 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G   +V+R     +G++ A+K F++            + E + L ++ H+NIVK + 
Sbjct: 17   LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74

Query: 873  F--CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
                +  RH  ++ E+   GSL  +L   ++A  L  ++ + V++ V   +++L  +   
Sbjct: 75   IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 931  PIVYRDISSKNVLLDLEYEAH----VSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
             IV+R+I   N++  +  +      ++DFG ++ L+ D   +  L GT  Y+ P++    
Sbjct: 133  -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190

Query: 983  ----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
                 +  K     D++S GV    A  G  P  F              + +I+  +   
Sbjct: 191  VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPF--EGPRRNKEVMYKIITGKPSG 246

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                ++      ++ +         SR     ++ +L 
Sbjct: 247  AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 2e-25
 Identities = 69/277 (24%), Positives = 110/277 (39%), Gaps = 39/277 (14%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
               ++  +G+G  G V    +  +    A+K      +S  +   + L EV  L  + H 
Sbjct: 40   QRVKK--LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSS-NSKLLEEVAVLKLLDHP 96

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYL 924
            NI+K Y F    R+ ++V E  + G L   I+      E         +IK V   ++YL
Sbjct: 97   NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV----DAAVIIKQVLSGVTYL 152

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            H      IV+RD+  +N+LL+ + +     + DFG+S   +       E  GT  Y+APE
Sbjct: 153  HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK-MKERLGTAYYIAPE 208

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL-------DP 1034
            +    K  EK DV+S GV+    + G  P  F              L ++         P
Sbjct: 209  V-LRKKYDEKCDVWSIGVILFILLAGYPP--F------GGQTDQEILRKVEKGKYTFDSP 259

Query: 1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                 S   +D LI  M      L  +   R + Q+ 
Sbjct: 260  EWKNVSEGAKD-LIKQM------LQFDSQRRISAQQA 289

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  108 bits (271), Expect = 3e-25
 Identities = 69/287 (24%), Positives = 114/287 (39%), Gaps = 48/287 (16%)

Query: 814  IGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G VY  ++S          VAVK      L E+  +Q+   FL E   +++  H
Sbjct: 79   LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT-----LPEVCSEQDELDFLMEALIISKFNH 133

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL----SNATSAEELGWTQRMNVIKGVADA 920
            +NIV+  G    +   FI+ E +  G L   L       +    L     ++V + +A  
Sbjct: 134  QNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV---SDFGISKSLKPDSSNWTELAGTIGY 977
              YL  + F   ++RDI+++N LL       V    DFG+++ +    + +    G    
Sbjct: 194  CQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIY--RAGYYR-KGGCAM 247

Query: 978  V-----APE-LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDE 1030
            +      PE        T K+D +SFGVL  E    G  P         + SN +  L+ 
Sbjct: 248  LPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGYMP-------YPSKSNQE-VLEF 298

Query: 1031 ILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +    R+  P  N    +  IM     C    P+ RP    + + ++
Sbjct: 299  VTSGGRMDPPK-NCPGPVYRIMT---QCWQHQPEDRPNFAIILERIE 341

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score =  105 bits (265), Expect = 3e-25
 Identities = 57/232 (24%), Positives = 83/232 (35%), Gaps = 38/232 (16%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSG 170
            LDL  N +  +      +  +L+ LDLS      TI      +LS L  L L+ N    
Sbjct: 32  NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89

Query: 171 RIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEIGNLK 228
            +       LS L+ L   E  L+ S+     G+L  L  + + +N +  S         
Sbjct: 90  SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKL------ 141

Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDI----LNL 283
                           P    NL NL  LDL  N +  SI       L  + +    L+L
Sbjct: 142 ----------------PEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDL 184

Query: 284 PHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLTILYLSDN 334
             N ++  I         L  L L  N+L  S+P      LT L  ++L  N
Sbjct: 185 SLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 57/220 (25%), Positives = 90/220 (40%), Gaps = 17/220 (7%)

Query: 291 SIPSEM-GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLR 348
            IP  +  + K+L    LSFN L      S  +  +L +L LS   +  +I      +L 
Sbjct: 21  KIPDNLPFSTKNLD---LSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLS 76

Query: 349 YLFYLELGDNKLSGSIPHSL-GNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSEN 406
           +L  L L  N +  S+       L++L  L      L+ S+ +   G+L +L +L ++ N
Sbjct: 77  HLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHN 134

Query: 407 ELSGSIPYS--FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTL----LVLSYNQLQGPI 460
            +  S      F NLTN+  L + SN +      +   L ++ L    L LS N +    
Sbjct: 135 LIQ-SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQ 193

Query: 461 PDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
           P      RL  + LD N L       F   ++L  I L  
Sbjct: 194 PGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHT 233

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 58/244 (23%), Positives = 92/244 (37%), Gaps = 39/244 (15%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVK 445
            IP  +    S  +L LS N L     YSF +   + VL +    +   I    Y +L  
Sbjct: 21  KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH 77

Query: 446 LTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
           L+ L+L+ N +Q  +       L+ L ++     +L                 +L +   
Sbjct: 78  LSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA----------------SLENFPI 120

Query: 504 YGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSE---- 558
                   G    L  L+V+ N I     PE   +   L+ LDLSSN I   I       
Sbjct: 121 --------GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171

Query: 559 LGKLRSL-IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLN 617
           L ++  L + L L+ N  +  +       I+L+ L L +N+L +   G    L  L  + 
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIW 230

Query: 618 LSNN 621
           L  N
Sbjct: 231 LHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 61/237 (25%), Positives = 91/237 (38%), Gaps = 36/237 (15%)

Query: 250 NLP-NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGL 307
           NLP +   LDL  N L      SF +   L +L+L    +  +I      +L  L  L L
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLIL 83

Query: 308 SFNKLSGSIPSSL-GNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIP 365
           + N +  S+       L+ L  L   +  L  S+     G+L+ L  L +  N +  S  
Sbjct: 84  TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFK 140

Query: 366 HS--LGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNM 422
                 NLTNL  L L +N +  SI       L+ +  L LS                  
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS------------------ 181

Query: 423 IVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
             L +  N ++  I       ++L  L L  NQL+  +PD     LT L ++ L  N
Sbjct: 182 --LDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 89.3 bits (222), Expect = 1e-19
 Identities = 56/253 (22%), Positives = 89/253 (35%), Gaps = 53/253 (20%)

Query: 446 LTLLVLSYNQLQGPIP--DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
              L LS+N L+  +      +   L  + L R  +   I +                  
Sbjct: 30  TKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDG----------------- 70

Query: 504 YGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSEL-GK 561
               ++      +L TL ++ N I   L          L+ L     ++   + +   G 
Sbjct: 71  ----AYQ--SLSHLSTLILTGNPIQS-LALGAFSGLSSLQKLVAVETNLA-SLENFPIGH 122

Query: 562 LRSLIKLTLNRNQF-SGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
           L++L +L +  N   S +LP    +L  LEHLDLSSN++ +     L  L ++  LNLS 
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLS- 181

Query: 621 NQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFK 680
                              LDLS N +   I         L++L L  N L       F 
Sbjct: 182 -------------------LDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIFD 221

Query: 681 EMHGLVYIDISYN 693
            +  L  I +  N
Sbjct: 222 RLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 48/198 (24%), Positives = 68/198 (34%), Gaps = 34/198 (17%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           +  L  +SF SFP L  LDL   +I  I      + S L  L L+ N    ++       
Sbjct: 40  LRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSG 98

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLY 212
           LS L+ L       +  +     GHL  LK L++  N +     P    NLTNL  + L 
Sbjct: 99  LSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157

Query: 213 NNSLSGSIPSEI----GNLK------------------------SLSGLELGYNKLSGSM 244
           +N +  SI          +                          L  L L  N+L    
Sbjct: 158 SNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVP 216

Query: 245 PLSLGNLPNLATLDLHDN 262
                 L +L  + LH N
Sbjct: 217 DGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 34/138 (24%), Positives = 55/138 (39%), Gaps = 9/138 (6%)

Query: 564 SLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           S   L L+ N           S  +L+ LDLS   +     G+  +L  L  L L+ N  
Sbjct: 29  STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88

Query: 624 S---GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFI-PRC 678
                     L     L  L      L   + +     +++L++LN+AHN +  F  P  
Sbjct: 89  QSLALGAFSGLSS---LQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144

Query: 679 FKEMHGLVYIDISYNKLH 696
           F  +  L ++D+S NK+ 
Sbjct: 145 FSNLTNLEHLDLSSNKIQ 162

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (269), Expect = 5e-25
 Identities = 55/278 (19%), Positives = 116/278 (41%), Gaps = 25/278 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G   +V+R     +G++ A+K F++            + E + L ++ H+NIVK + 
Sbjct: 17   LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP--VDVQMREFEVLKKLNHKNIVKLFA 74

Query: 873  F--CSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
                +  RH  ++ E+   GSL  +L   ++A  L  ++ + V++ V   +++L  +   
Sbjct: 75   IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG-- 132

Query: 931  PIVYRDISSKNVLLDLEYEAH----VSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
             IV+R+I   N++  +  +      ++DFG ++ L+ D   +  L GT  Y+ P++    
Sbjct: 133  -IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERA 190

Query: 983  ----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
                 +  K     D++S GV    A  G  P  F              + +I+  +   
Sbjct: 191  VLRKDHQKKYGATVDLWSIGVTFYHAATGSLP--FRPF--EGPRRNKEVMYKIITGKPSG 246

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                ++      ++ +         SR     ++ +L 
Sbjct: 247  AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (274), Expect = 5e-25
 Identities = 65/280 (23%), Positives = 109/280 (38%), Gaps = 46/280 (16%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK----------KFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +G+G  G V    E +     A+K          ++     +     +E  NE+  L  +
Sbjct: 44   LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADAL 921
             H NI+K +      ++ ++V E+ E G L   I++     E        N++K +   +
Sbjct: 104  DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC----DAANIMKQILSGI 159

Query: 922  SYLHNDCFPPIVYRDISSKNVLL---DLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
             YLH      IV+RDI  +N+LL   +      + DFG+S     D     +  GT  Y+
Sbjct: 160  CYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRLGTAYYI 215

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL------ 1032
            APE     K  EK DV+S GV+    + G  P  F         N    + ++       
Sbjct: 216  APE-VLKKKYNEKCDVWSCGVIMYILLCGYPP--F------GGQNDQDIIKKVEKGKYYF 266

Query: 1033 -DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                    S   ++ LI +M      L  + + R T ++ 
Sbjct: 267  DFNDWKNISDEAKE-LIKLM------LTYDYNKRCTAEEA 299

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  107 bits (268), Expect = 6e-25
 Identities = 73/336 (21%), Positives = 126/336 (37%), Gaps = 41/336 (12%)

Query: 762  GLFFMFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEE---------H 812
            G+  +    +S   +  S        + +  D      E+V+A                 
Sbjct: 36   GICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE 95

Query: 813  CIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIV 868
             IG G  G VY   L   +      AVK  +  +        +FL E   + +  H N++
Sbjct: 96   VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGE-VSQFLTEGIIMKDFSHPNVL 153

Query: 869  KFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
               G C  +  S  +V  Y++ G L   + N            +     VA  + +L + 
Sbjct: 154  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV-----APEL 982
             F   V+RD++++N +LD ++   V+DFG+++ +     +      T   +     A E 
Sbjct: 212  KF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH-NKTGAKLPVKWMALES 267

Query: 983  AYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILD-PRLPAPS 1040
              T K T KSDV+SFGVL  E + +G  P   +       +  D     +L   RL  P 
Sbjct: 268  LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFD-ITVYLLQGRRLLQPE 319

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                D L  +M   + C     + RP+  ++   + 
Sbjct: 320  -YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 351

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  104 bits (262), Expect = 1e-24
 Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 48/286 (16%)

Query: 811  EHCIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
               IG G  G VY   L   +      AVK  +  +        +FL E   + +  H N
Sbjct: 30   NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGE-VSQFLTEGIIMKDFSHPN 87

Query: 867  IVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            ++   G C  +  S  +V  Y++ G L   + N            +     VA  + YL 
Sbjct: 88   VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLA 145

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL-------KPDSSN------WTELA 972
            +  F   V+RD++++N +LD ++   V+DFG+++ +         + +       W    
Sbjct: 146  SKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM--- 199

Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEI 1031
                  A E   T K T KSDV+SFGVL  E + +G  P   +       +  D     +
Sbjct: 200  ------ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFD-ITVYL 245

Query: 1032 LD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            L   RL  P     D L  +M   + C     + RP+  ++   + 
Sbjct: 246  LQGRRLLQPE-YCPDPLYEVM---LKCWHPKAEMRPSFSELVSRIS 287

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  104 bits (262), Expect = 2e-24
 Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 58/307 (18%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQ--E 851
             I R       E  +G G  G V+ AE  +        +VAVK      L E +     +
Sbjct: 37   HIKRRDIVLKWE--LGEGAFGKVFLAECHNLLPEQDKMLVAVKA-----LKEASESARQD 89

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL------------AMILSNA 899
            F  E + LT ++H++IV+F+G C+  R   +V+EY+  G L             +     
Sbjct: 90   FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149

Query: 900  TSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK 959
             +   LG  Q + V   VA  + YL    F   V+RD++++N L+       + DFG+S+
Sbjct: 150  VAPGPLGLGQLLAVASQVAAGMVYLAGLHF---VHRDLATRNCLVGQGLVVKIGDFGMSR 206

Query: 960  SLKPDSSNWTELAGT----IGYVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFI 1014
             +   S+++  + G     I ++ PE + Y  K T +SDV+SFGV+  E          I
Sbjct: 207  DI--YSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDVWSFGVVLWE----------I 253

Query: 1015 SSICST----SSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069
             +         SN +  +D I     L  P      ++ +IM     C    P  R +++
Sbjct: 254  FTYGKQPWYQLSNTE-AIDCITQGRELERPR-ACPPEVYAIMR---GCWQREPQQRHSIK 308

Query: 1070 KVSQLLK 1076
             V   L+
Sbjct: 309  DVHARLQ 315

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 2e-24
 Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 50/290 (17%)

Query: 811  EHCIGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
               +G G  GSV    L   +     VAVK       S+    +EFL+E   + +  H N
Sbjct: 39   GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPN 97

Query: 867  IVKFYGFCS-----HARHSFIVYEYLEMGSLAMIL---SNATSAEELGWTQRMNVIKGVA 918
            +++  G C            ++  +++ G L   L      T  + +     +  +  +A
Sbjct: 98   VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-----------N 967
              + YL N  F   ++RD++++N +L  +    V+DFG+SK +                 
Sbjct: 158  LGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214

Query: 968  WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDR 1026
            W          A E       T KSDV++FGV   E   +G  P   +        N + 
Sbjct: 215  WI---------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV-------QNHE- 257

Query: 1027 TLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
              D +L   RL  P  +  D+L  IM    SC   +P  RPT   +   L
Sbjct: 258  MYDYLLHGHRLKQPE-DCLDELYEIMY---SCWRTDPLDRPTFSVLRLQL 303

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (263), Expect = 2e-24
 Identities = 39/302 (12%), Positives = 87/302 (28%), Gaps = 69/302 (22%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPL---------LSEMTCQQEFLNEVKSLTEI- 862
            +G     +   A +  +GE   V   +            + E   +   L  +K+  +  
Sbjct: 81   LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 863  ------------RHRNIVKFYGFCSHARHSFIVYEYLEM----GSLAM----ILSNATSA 902
                        +     K        R  +++  +        +L      +LS++++ 
Sbjct: 141  VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 903  EELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLK 962
            + L    R+ +   V   L+ LH+     +V+  +   +++LD      ++ F       
Sbjct: 201  KSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD- 256

Query: 963  PDSSNWTELAGTIGYVAPEL-----------AYTMKVTEKSDVYSFGVLALEAIKGKHPR 1011
                     + + G+  PEL                +T   D ++ G++         P 
Sbjct: 257  ---GARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP- 312

Query: 1012 DFISSICSTSSNLDRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069
                    T        + I      +P P   +R  L+         L    + R    
Sbjct: 313  -I------TKDAALGGSEWIFRSCKNIPQP---VRA-LLE------GFLRYPKEDRLLPL 355

Query: 1070 KV 1071
            + 
Sbjct: 356  QA 357

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  103 bits (258), Expect = 5e-24
 Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 54/303 (17%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQE-- 851
            E+ R       E  +G G  G VY               VA+K      ++E    +E  
Sbjct: 21   EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIK-----TVNEAASMRERI 73

Query: 852  -FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------SNATSAE 903
             FLNE   + E    ++V+  G  S  + + ++ E +  G L   L       +N     
Sbjct: 74   EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133

Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
                ++ + +   +AD ++YL+ + F   V+RD++++N ++  ++   + DFG+++ +  
Sbjct: 134  PPSLSKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190

Query: 964  DSSNWTELAGTIGYV-----APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
                     G  G +     +PE       T  SDV+SFGV+  E          I+++ 
Sbjct: 191  TD---YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE----------IATLA 237

Query: 1019 ST----SSNLDRTLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                   SN    L  +++   L  P  N  D L  +M     C   NP  RP+  ++  
Sbjct: 238  EQPYQGLSNEQ-VLRFVMEGGLLDKPD-NCPDMLFELMR---MCWQYNPKMRPSFLEIIS 292

Query: 1074 LLK 1076
             +K
Sbjct: 293  SIK 295

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  102 bits (256), Expect = 6e-24
 Identities = 78/305 (25%), Positives = 135/305 (44%), Gaps = 53/305 (17%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQ--QE 851
             I R       E  +G G  G V+ AE  +        +VAVK      L + T    ++
Sbjct: 11   HIKRRDIVLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKA-----LKDPTLAARKD 63

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSN 898
            F  E + LT ++H +IVKFYG C       +V+EY++ G L              +    
Sbjct: 64   FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123

Query: 899  ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS 958
              +  ELG +Q +++   +A  + YL +  F   V+RD++++N L+       + DFG+S
Sbjct: 124  RQAKGELGLSQMLHIASQIASGMVYLASQHF---VHRDLATRNCLVGANLLVKIGDFGMS 180

Query: 959  KSLKPDSSNWTELAGT----IGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRD 1012
            + +   S+++  + G     I ++ PE + Y  K T +SDV+SFGV+  E    GK P  
Sbjct: 181  RDV--YSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWEIFTYGKQPWF 237

Query: 1013 FISSICSTSSNLDRTLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             +       SN +  ++ I     L  P      ++  +M     C    P  R  ++++
Sbjct: 238  QL-------SNTE-VIECITQGRVLERPR-VCPKEVYDVML---GCWQREPQQRLNIKEI 285

Query: 1072 SQLLK 1076
             ++L 
Sbjct: 286  YKILH 290

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (265), Expect = 6e-24
 Identities = 67/270 (24%), Positives = 108/270 (40%), Gaps = 37/270 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V +  +  + +  AVK  +             L EV+ L ++ H NI+K + 
Sbjct: 30   LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFE 88

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                +   +IV E    G L   I+     +E         +IK V   ++Y+H      
Sbjct: 89   ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHN--- 141

Query: 932  IVYRDISSKNVLL-DLEYEAH--VSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
            IV+RD+  +N+LL   E +    + DFG+S   + ++    +  GT  Y+APE+      
Sbjct: 142  IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEV-LRGTY 199

Query: 989  TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL-------DPRLPAPSC 1041
             EK DV+S GV+    + G  P  F         N    L  +         P+    S 
Sbjct: 200  DEKCDVWSAGVILYILLSGTPP--F------YGKNEYDILKRVETGKYAFDLPQWRTISD 251

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            + +D LI  M      L  +P  R T  + 
Sbjct: 252  DAKD-LIRKM------LTFHPSLRITATQC 274

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  102 bits (255), Expect = 7e-24
 Identities = 59/209 (28%), Positives = 88/209 (42%), Gaps = 15/209 (7%)

Query: 226 NLKSLSGLELGYNKLSGSMPLSLGNLP-NLATLDLHDNSLSGSIPLSFGNLTNLDILNLP 284
            + S   +      L+ ++P    +LP +   L L +N L      +    T L  LNL 
Sbjct: 8   KVASHLEVNCDKRNLT-ALP---PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 285 HNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI 344
              L+  +  + G L  L  L LS N+L  S+P     L  LT+L +S N L  S+P   
Sbjct: 64  RAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRL-TSLPLGA 119

Query: 345 -GNLRYLFYLELGDNKLSGSIPHSL-GNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDL 401
              L  L  L L  N+L  ++P  L      L  L L  N L+  +P+ +   L +L  L
Sbjct: 120 LRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTL 177

Query: 402 GLSENELSGSIPYSFGNLTNMIVLSIYSN 430
            L EN L  +IP  F     +    ++ N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 52/183 (28%), Positives = 72/183 (39%), Gaps = 10/183 (5%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTN 166
                 L L  N ++    + +   ++L  L+L       T     G L +L  L LS N
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL--TKLQVDGTLPVLGTLDLSHN 87

Query: 167 QFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI- 224
           Q    +P     L  L  L +  N L+ S+P      L  L  +YL  N L  ++P  + 
Sbjct: 88  QLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLL 144

Query: 225 GNLKSLSGLELGYNKLSGSMPLSL-GNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNL 283
                L  L L  N L+  +P  L   L NL TL L +NSL  +IP  F     L    L
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202

Query: 284 PHN 286
             N
Sbjct: 203 HGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 92.5 bits (230), Expect = 1e-20
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 10/170 (5%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL 155
           + T    +   +  L  L+L   ++  +          L  LDLS N    ++P     L
Sbjct: 43  LYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTL 99

Query: 156 SMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYN 213
             L +L +S N+ +  +P      L  L+ L+L  N L  ++PP L      L  + L N
Sbjct: 100 PALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLAN 157

Query: 214 NSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDN 262
           N+L+  +P+ +   L++L  L L  N L  ++P        L    LH N
Sbjct: 158 NNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 91.3 bits (227), Expect = 3e-20
 Identities = 52/231 (22%), Positives = 79/231 (34%), Gaps = 36/231 (15%)

Query: 394 NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
            + S  ++   +  L+ ++P       +  +L +  N L            +LT L L  
Sbjct: 8   KVASHLEVNCDKRNLT-ALP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64

Query: 454 NQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGK 513
            +L   +     L  L  + L  N L  ++         L                    
Sbjct: 65  AELTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLG---QTL-------------------- 99

Query: 514 FPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLN 571
            P L  LDVS N +T  LP        +L+ L L  N +   +P  L      L KL+L 
Sbjct: 100 -PALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLA 156

Query: 572 RNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
            N  + +LP  L   L  L+ L L  N L  +IP        L +  L  N
Sbjct: 157 NNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 52/207 (25%), Positives = 80/207 (38%), Gaps = 9/207 (4%)

Query: 464 RNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVS 523
             +     V  D+ +LT   +    +  + + ++LS    Y         +  L  L++ 
Sbjct: 7   SKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 524 ANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTEL 583
              +T +     G  P L  LDLS N +   +P     L +L  L ++ N+ +      L
Sbjct: 64  RAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 584 GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLSDLDL 642
             L +L+ L L  N L    PG L    KL  L+L+NN  + E+P  L     +L  L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLL 179

Query: 643 SHNFLGEEIPSQVCSMQSLEKLNLAHN 669
             N L   IP        L    L  N
Sbjct: 180 QENSL-YTIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 11/191 (5%)

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
            +   ++    N+T + PP++       +L LS N +     + L     L +L L+R +
Sbjct: 10  ASHLEVNCDKRNLTAL-PPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE 66

Query: 575 FSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EK 633
            + +L  + G+L  L  LDLS N+L  S+P     L  L  L++S N+ +  +P+     
Sbjct: 67  LT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRG 122

Query: 634 FIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISY 692
              L +L L  N L + +P  +      LEKL+LA+NNL+         +  L  + +  
Sbjct: 123 LGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 693 NKLHGPIPNSA 703
           N L+  IP   
Sbjct: 182 NSLYT-IPKGF 191

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  106 bits (265), Expect = 1e-23
 Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 29/274 (10%)

Query: 811  EHCIGTGGQGSVYRAEL---SSGEI-VAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
              CIG G  G V++       +  + VA+K   +     +  +++FL E  ++ +  H +
Sbjct: 395  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV--REKFLQEALTMRQFDHPH 452

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IVK  G  +     +I+ E   +G L   L        L     +     ++ AL+YL +
Sbjct: 453  IVKLIGVIT-ENPVWIIMELCTLGELRSFLQ--VRKFSLDLASLILYAYQLSTALAYLES 509

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT--IGYVAPELAY 984
              F   V+RDI+++NVL+       + DFG+S+ ++ DS+ +    G   I ++APE   
Sbjct: 510  KRF---VHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPESIN 565

Query: 985  TMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILD-PRLPAPSCN 1042
              + T  SDV+ FGV   E +  G  P   +        N D  +  I +  RLP P  N
Sbjct: 566  FRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNND-VIGRIENGERLPMPP-N 616

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                L S+M     C   +P  RP   ++   L 
Sbjct: 617  CPPTLYSLM---TKCWAYDPSRRPRFTELKAQLS 647

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  101 bits (254), Expect = 2e-23
 Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 51/289 (17%)

Query: 814  IGTGGQGSVYRAELSSGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK 869
            +G G  GSV  A+L   +     VAVK   + +++     +EFL E   + E  H ++ K
Sbjct: 31   LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAK 89

Query: 870  FYGFCS------HARHSFIVYEYLEMGSLAMIL---SNATSAEELGWTQRMNVIKGVADA 920
              G               ++  +++ G L   L       +   L     +  +  +A  
Sbjct: 90   LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-----------NWT 969
            + YL +  F   ++RD++++N +L  +    V+DFG+S+ +                 W 
Sbjct: 150  MEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL 206

Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTL 1028
                     A E       T  SDV++FGV   E + +G+ P   I        N +   
Sbjct: 207  ---------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI-------ENAE-IY 249

Query: 1029 DEILD-PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + ++   RL  P     +++  +M     C   +P  RP+   +   L+
Sbjct: 250  NYLIGGNRLKQPP-ECMEEVYDLMY---QCWSADPKQRPSFTCLRMELE 294

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score =  101 bits (254), Expect = 2e-23
 Identities = 41/235 (17%), Positives = 78/235 (33%), Gaps = 14/235 (5%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLS- 164
             +   L   + ++  I     +    L+ +++S N     I   +  NL  L  + +  
Sbjct: 29  PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 165 TNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPS 222
            N     I P+   +L  L+ L +   G+   +P     +     ++ + +N    +I  
Sbjct: 89  ANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIER 146

Query: 223 EI--GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDI 280
               G       L L  N +      +             +N+L       F   +   I
Sbjct: 147 NSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206

Query: 281 LNLPHNSLSGSIPSE-MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
           L++    +  S+PS  + NLK L        K    +P +L  L  L    L+  
Sbjct: 207 LDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 97.2 bits (242), Expect = 1e-21
 Identities = 42/221 (19%), Positives = 78/221 (35%), Gaps = 12/221 (5%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQI-ANNSKLKYLDLSSNSFSGTIPPQI-G 153
           +  +   +FS F  L  +++  N +  +I + + +N  KL  + +   +    I P+   
Sbjct: 42  LRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQ 101

Query: 154 NLSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLT-NLAIMY 210
           NL  L+ L +S       +P     H      L + +N    +I   S   L+    I++
Sbjct: 102 NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160

Query: 211 LYNNSLSGSIPSEIGNLKSLSGLEL-GYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
           L  N +   I +   N   L  L L   N L                LD+    +     
Sbjct: 161 LNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 219

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFN 310
               NL  L   +  +      +P+ +  L +L    L++ 
Sbjct: 220 YGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 90.3 bits (224), Expect = 2e-19
 Identities = 58/299 (19%), Positives = 105/299 (35%), Gaps = 46/299 (15%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVK 445
            IPS++    +  +L     +L      +F    ++  + I  N +   I  + + NL K
Sbjct: 23  EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 446 LTLLVLS-YNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKK 502
           L  + +   N L   I     +NL  L  + +    +  ++ +   IHS           
Sbjct: 81  LHEIRIEKANNLLY-INPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS----------- 127

Query: 503 FYGEISFDWGKFPNLGTLDVSANNITGILPPEI--GDSPQLKVLDLSSNHIVGEIPSELG 560
                            LD+  N     +      G S +  +L L+ N I  EI +   
Sbjct: 128 ------------LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAF 174

Query: 561 KLRSLIKLTLNRNQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLS 619
               L +L L+ N    +LP +          LD+S  R+ +     L NL KL   +  
Sbjct: 175 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 234

Query: 620 NNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRC 678
           N +   ++P  LEK + L +  L++       PS  C+  +  +     + +       
Sbjct: 235 NLK---KLPT-LEKLVALMEASLTY-------PSHCCAFANWRRQISELHPICNKSILR 282

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 83.3 bits (206), Expect = 4e-17
 Identities = 40/190 (21%), Positives = 77/190 (40%), Gaps = 10/190 (5%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTL-N 571
             N   L      +  I          L+ +++S N ++  I ++    L  L ++ +  
Sbjct: 29  PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88

Query: 572 RNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
            N      P    +L  L++L +S+  + +       + ++   L++ +N     I    
Sbjct: 89  ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148

Query: 632 EKFIHLS----DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNN-LSGFIPRCFKEMHGLV 686
             F+ LS     L L+ N + +EI +   +   L++LNL+ NN L       F    G V
Sbjct: 149 --FVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPV 205

Query: 687 YIDISYNKLH 696
            +DIS  ++H
Sbjct: 206 ILDISRTRIH 215

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 52/303 (17%), Positives = 101/303 (33%), Gaps = 62/303 (20%)

Query: 277 NLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLL 336
           +  +     + ++  IPS++   ++   L     KL      +      L  + +S N +
Sbjct: 10  SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 337 FGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLF-TNLLSGSIPSEI-GN 394
              I                             NL  L  + +   N L   I  E   N
Sbjct: 67  LEVIE-----------------------ADVFSNLPKLHEIRIEKANNLL-YINPEAFQN 102

Query: 395 LNSLSDLGLSENELSGSIP-YSFGNLTNMIVLSIYSNALSGAIPKE--YGNLVKLTLLVL 451
           L +L  L +S   +   +P     +    ++L I  N     I +    G   +  +L L
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161

Query: 452 SYNQLQGPIPDLRNLTRLARVRL-DRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFD 510
           + N +Q       N T+L  + L D N+L         + +++         F+G     
Sbjct: 162 NKNGIQEIHNSAFNGTQLDELNLSDNNNLE-------ELPNDV---------FHG----- 200

Query: 511 WGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTL 570
                    LD+S   I  +    + +  +L+     +     ++P+ L KL +L++ +L
Sbjct: 201 ---ASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASL 253

Query: 571 NRN 573
              
Sbjct: 254 TYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 76.8 bits (189), Expect = 5e-15
 Identities = 39/206 (18%), Positives = 74/206 (35%), Gaps = 30/206 (14%)

Query: 84  KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNS 143
           K++ I +  A  +  ++  +F + P+L YL +    I  +      ++ +   LD+  N 
Sbjct: 80  KLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDN- 138

Query: 144 FSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNL 203
                         + I  +  N F        G       L L +NG+   I  S  N 
Sbjct: 139 --------------INIHTIERNSFV-------GLSFESVILWLNKNGIQ-EIHNSAFNG 176

Query: 204 TNL-AIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
           T L  +    NN+L   +P+++         L++   ++       L NL  L     ++
Sbjct: 177 TQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 235

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNS 287
                 +P +   L  L   +L + S
Sbjct: 236 LK---KLP-TLEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.6 bits (173), Expect = 6e-13
 Identities = 40/229 (17%), Positives = 82/229 (35%), Gaps = 11/229 (4%)

Query: 472 VRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGIL 531
                + +T  I     +  N   +     K        +  F +L  +++S N++  ++
Sbjct: 14  FLCQESKVT-EIPS--DLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70

Query: 532 PPEI-GDSPQLKVLDLS-SNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTELGSLIQ 588
             ++  + P+L  + +  +N+++  I  E    L +L  L ++               +Q
Sbjct: 71  EADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129

Query: 589 LEHLDLSSNRLSNSIP-GSLGNL-VKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNF 646
              LD+  N   ++I   S   L  +   L L+ N    EI         L +L+LS N 
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNN 188

Query: 647 LGEEIPSQVCS-MQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
             EE+P+ V         L+++   +        + +  L        K
Sbjct: 189 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  101 bits (253), Expect = 2e-23
 Identities = 71/308 (23%), Positives = 125/308 (40%), Gaps = 61/308 (19%)

Query: 798  YEEIVRATNDFDEEHCIGTGGQGSVYRAELSSGE---IVAVKKFHSPLLSEMTCQQE--- 851
            Y  +    ND   +  IG G  G V +A +         A+K+     + E   + +   
Sbjct: 19   YPVLDW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR-----MKEYASKDDHRD 71

Query: 852  FLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILS 897
            F  E++ L ++  H NI+   G C H  + ++  EY   G+L                  
Sbjct: 72   FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131

Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
              ++A  L   Q ++    VA  + YL    F   ++RD++++N+L+   Y A ++DFG+
Sbjct: 132  ANSTASTLSSQQLLHFAADVARGMDYLSQKQF---IHRDLAARNILVGENYVAKIADFGL 188

Query: 958  SKSLKPDSSNWTELAGT---IGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI-KGKHPRD 1012
            S+        + +       + ++A E L Y+   T  SDV+S+GVL  E +  G  P  
Sbjct: 189  SR----GQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYC 243

Query: 1013 FISSICSTSSNLDRTLDEILDP-----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPT 1067
             ++              E+ +      RL  P  N  D++  +M     C  E P  RP+
Sbjct: 244  GMTC------------AELYEKLPQGYRLEKPL-NCDDEVYDLM---RQCWREKPYERPS 287

Query: 1068 MQKVSQLL 1075
              ++   L
Sbjct: 288  FAQILVSL 295

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 66/194 (34%), Positives = 98/194 (50%), Gaps = 16/194 (8%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGRIPPQI-GHLSY 181
           IPS I  +   K LDL SN  S ++P +    L+ L++LYL+ N+    +P  I   L  
Sbjct: 31  IPSNIPAD--TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86

Query: 182 LKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNK 239
           L+ L + +N L  ++P  +   L NLA + L  N L  S+P  +  +L  L+ L LGYN+
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE 144

Query: 240 LSGSMPLSL-GNLPNLATLDLHDNSLSGSIPLS-FGNLTNLDILNLPHNSLSGSIPSEM- 296
           L  S+P  +   L +L  L L++N L   +P   F  LT L  L L +N L   +P    
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGAF 201

Query: 297 GNLKSLYGLGLSFN 310
            +L+ L  L L  N
Sbjct: 202 DSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 55/180 (30%), Positives = 83/180 (46%), Gaps = 10/180 (5%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSG 170
            LDL+ N++  +        +KL+ L L+ N    T+P  I   L  L+ L+++ N+   
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ- 98

Query: 171 RIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNL 227
            +P  +   L  L  L L  N L  S+PP +  +LT L  + L  N L  S+P  +   L
Sbjct: 99  ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKL 156

Query: 228 KSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
            SL  L L  N+L      +   L  L TL L +N L   +P  +F +L  L +L L  N
Sbjct: 157 TSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 13/207 (6%)

Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL 312
           N  ++D     L+ +IP       +   L+L  N LS         L  L  L L+ NKL
Sbjct: 17  NKNSVDCSSKKLT-AIPS--NIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 313 SGSIPSSL-GNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSL-G 369
             ++P+ +   L  L  L+++DN L  ++P  +   L  L  L L  N+L  S+P  +  
Sbjct: 74  Q-TLPAGIFKELKNLETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130

Query: 370 NLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSI 427
           +LT L  L L  N L  S+P  +   L SL +L L  N+L   +P   F  LT +  L +
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKL 188

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYN 454
            +N L       + +L KL +L L  N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 78.5 bits (194), Expect = 5e-16
 Identities = 58/203 (28%), Positives = 84/203 (41%), Gaps = 33/203 (16%)

Query: 424 VLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTG 481
            L + SN LS    K +  L KL LL L+ N+LQ  +P    + L  L  + +  N L  
Sbjct: 41  KLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ- 98

Query: 482 NISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQ 540
             +   G+   L                      NL  L +  N +   LPP + DS  +
Sbjct: 99  --ALPIGVFDQLV---------------------NLAELRLDRNQLKS-LPPRVFDSLTK 134

Query: 541 LKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSGQLPTEL-GSLIQLEHLDLSSNR 598
           L  L L  N +   +P  +  KL SL +L L  NQ   ++P      L +L+ L L +N+
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQ 192

Query: 599 LSNSIPGSLGNLVKLYYLNLSNN 621
           L     G+  +L KL  L L  N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 56/192 (29%), Positives = 87/192 (45%), Gaps = 12/192 (6%)

Query: 516 NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
           N  ++D S+  +T I P  I      K LDL SN +         +L  L  L LN N+ 
Sbjct: 17  NKNSVDCSSKKLTAI-PSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73

Query: 576 SGQLPTEL-GSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQFSGEIPIKL-E 632
              LP  +   L  LE L ++ N+L  ++P G    LV L  L L  NQ    +P ++ +
Sbjct: 74  Q-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFD 130

Query: 633 KFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
               L+ L L +N L + +P  V   + SL++L L +N L       F ++  L  + + 
Sbjct: 131 SLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189

Query: 692 YNKLHGPIPNSA 703
            N+L   +P  A
Sbjct: 190 NNQLKR-VPEGA 200

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 12/186 (6%)

Query: 514 FPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLN 571
             +   LD+ +N ++  LP +      +L++L L+ N +   +P+ +  +L++L  L + 
Sbjct: 36  PADTKKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVT 93

Query: 572 RNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQFSGEIPI 629
            N+    LP  +   L+ L  L L  N+L  S+P     +L KL YL+L  N+    +P 
Sbjct: 94  DNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150

Query: 630 KL-EKFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVY 687
            + +K   L +L L +N L + +P      +  L+ L L +N L       F  +  L  
Sbjct: 151 GVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKM 209

Query: 688 IDISYN 693
           + +  N
Sbjct: 210 LQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 51/204 (25%), Positives = 71/204 (34%), Gaps = 31/204 (15%)

Query: 446 LTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
              L L  N+L          LT+L  + L+ N L                  L    F 
Sbjct: 39  TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ----------------TLPAGIF- 81

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSP-QLKVLDLSSNHIVGEIPSEL-GKL 562
                   +  NL TL V+ N +   LP  + D    L  L L  N +   +P  +   L
Sbjct: 82  -------KELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSL 132

Query: 563 RSLIKLTLNRNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
             L  L+L  N+    LP  +   L  L+ L L +N+L     G+   L +L  L L NN
Sbjct: 133 TKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNN 191

Query: 622 QFSGEIPIKLEKFIHLSDLDLSHN 645
           Q         +    L  L L  N
Sbjct: 192 QLKRVPEGAFDSLEKLKMLQLQEN 215

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 98.1 bits (245), Expect = 3e-22
 Identities = 76/359 (21%), Positives = 136/359 (37%), Gaps = 81/359 (22%)

Query: 762  GLFFMFRRRSSSQTQ----QSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTG 817
            G+ + ++++   Q +    +S  GN+  F+          +E   R    F +   +G G
Sbjct: 1    GVDYKYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWE-FPRNNLQFGKT--LGAG 57

Query: 818  GQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-RHRNI 867
              G V  A         +   VAVK      L       E    ++E+K ++ + +H NI
Sbjct: 58   AFGKVVEATAFGLGKEDAVLKVAVKM-----LKSTAHADEKEALMSELKIMSHLGQHENI 112

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-----------AMILSNATSAEELGWTQRMNVIKG 916
            V   G C+H     ++ EY   G L               + A +         ++    
Sbjct: 113  VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS-----SN---- 967
            VA  +++L +      ++RD++++NVLL   + A + DFG+++ +  DS      N    
Sbjct: 173  VAQGMAFLASKNC---IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 229

Query: 968  --WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHP-------RDFISSI 1017
              W          APE  +    T +SDV+S+G+L  E    G +P         F   +
Sbjct: 230  VKWM---------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 280

Query: 1018 CSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                             ++  P+      + SIM+   +C    P  RPT Q++   L+
Sbjct: 281  --KDGY-----------QMAQPA-FAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQ 322

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 98.1 bits (245), Expect = 4e-22
 Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 28/209 (13%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLT 860
            +  E   IG G    V R     +G+  AVK     KF S   S     ++   E     
Sbjct: 27   ELCEV--IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS---SPGLSTEDLKREASICH 81

Query: 861  EIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVAD 919
             ++H +IV+     S     ++V+E+++   L   I+  A +          + ++ + +
Sbjct: 82   MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 920  ALSYLH-NDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTI 975
            AL Y H N+    I++RD+    VLL  +  +    +  FG++  L           GT 
Sbjct: 142  ALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 976  GYVAPEL----AYTMKVTEKSDVYSFGVL 1000
             ++APE+     Y   V    DV+  GV+
Sbjct: 198  HFMAPEVVKREPYGKPV----DVWGCGVI 222

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.3 bits (245), Expect = 4e-22
 Identities = 59/304 (19%), Positives = 109/304 (35%), Gaps = 48/304 (15%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVK--------------KFHSPLLSEMTCQQE 851
            ND+     +  G    +   E    +  A+K              K ++  +S  +   +
Sbjct: 31   NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89

Query: 852  FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-----AMILSNATSAEELG 906
            F NE++ +T+I++   +   G  ++    +I+YEY+E  S+        + +      + 
Sbjct: 90   FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
                  +IK V ++ SY+HN     I +RD+   N+L+D      +SDFG S+    D  
Sbjct: 150  IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKK 206

Query: 967  NWTELAGTIGYVAPELAYTMKVT--EKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
                  GT  ++ PE           K D++S G+          P  F     S   +L
Sbjct: 207  IKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP--F-----SLKISL 258

Query: 1025 DRTLDEIL--DPRLPAPSCNIRDKLISIMEVAISC-------------LDENPDSRPTMQ 1069
                + I   +   P    +    L +      +              L +NP  R T +
Sbjct: 259  VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 1070 KVSQ 1073
               +
Sbjct: 319  DALK 322

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 65/315 (20%), Positives = 120/315 (38%), Gaps = 72/315 (22%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTC---QQ 850
            EI  +   F EE  +G    G VY+  L           VA+K      L +      ++
Sbjct: 5    EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT-----LKDKAEGPLRE 57

Query: 851  EFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILS 897
            EF +E      ++H N+V   G  +  +   +++ Y   G L                  
Sbjct: 58   EFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117

Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
            + T    L     ++++  +A  + YL +      V++D++++NVL+  +    +SD G+
Sbjct: 118  DRTVKSALEPPDFVHLVAQIAAGMEYLSSHHV---VHKDLATRNVLVYDKLNVKISDLGL 174

Query: 958  SKSL------KPDSSN-----WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK 1006
             + +      K   ++     W          APE     K +  SD++S+GV+  E   
Sbjct: 175  FREVYAADYYKLLGNSLLPIRWM---------APEAIMYGKFSIDSDIWSYGVVLWE--- 222

Query: 1007 GKHPRDFISSICST----SSNLDRTLDEILD-PRLPAPSCNIRDKLISIMEVAISCLDEN 1061
                   + S         SN D  ++ I +   LP P  +    + ++M   I C +E 
Sbjct: 223  -------VFSYGLQPYCGYSNQD-VVEMIRNRQVLPCPD-DCPAWVYALM---IECWNEF 270

Query: 1062 PDSRPTMQKVSQLLK 1076
            P  RP  + +   L+
Sbjct: 271  PSRRPRFKDIHSRLR 285

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.9 bits (247), Expect = 8e-22
 Identities = 46/202 (22%), Positives = 95/202 (47%), Gaps = 23/202 (11%)

Query: 807 DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
              EE  +G G    V R  ++ +G+  A    ++  LS     Q+   E +    ++H 
Sbjct: 14  QLFEE--LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHP 70

Query: 866 NIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVADALSYL 924
           NIV+ +   S   H +++++ +  G L   I++    +E        + I+ + +A+ + 
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA----DASHCIQQILEAVLHC 126

Query: 925 HNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
           H      +V+R++  +N+LL  + +     ++DFG++  ++ +   W   AGT GY++PE
Sbjct: 127 HQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPE 183

Query: 982 L----AYTMKVTEKSDVYSFGV 999
           +     Y   V    D+++ GV
Sbjct: 184 VLRKDPYGKPV----DLWACGV 201

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 20/202 (9%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
               +   +G G  G V++  E ++G  +A K   +     M  ++E  NE+  + ++ H 
Sbjct: 90   TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQR--MNVIKGVADALS 922
            N+++ Y          +V EY++ G L   I+      E    T+   +  +K + + + 
Sbjct: 147  NLIQLYDAFESKNDIVLVMEYVDGGELFDRII-----DESYNLTELDTILFMKQICEGIR 201

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAP 980
            ++H      I++ D+  +N+L        +   DFG+++  KP         GT  ++AP
Sbjct: 202  HMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAP 257

Query: 981  E-LAYTMKVTEKSDVYSFGVLA 1001
            E + Y   V+  +D++S GV+A
Sbjct: 258  EVVNYD-FVSFPTDMWSVGVIA 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 97.1 bits (242), Expect = 2e-21
 Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 22/202 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D  EE  +G+G  G V+R  E ++G +   K  ++P   +   +    NE+  + ++ H 
Sbjct: 54   DILEE--LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHP 108

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQR--MNVIKGVADALS 922
             ++  +          ++ E+L  G L   I      AE+   ++   +N ++   + L 
Sbjct: 109  KLINLHDAFEDKYEMVLILEFLSGGELFDRIA-----AEDYKMSEAEVINYMRQACEGLK 163

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAP 980
            ++H      IV+ DI  +N++ + +  + V   DFG++  L PD         T  + AP
Sbjct: 164  HMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAP 219

Query: 981  E-LAYTMKVTEKSDVYSFGVLA 1001
            E +     V   +D+++ GVL 
Sbjct: 220  EIVDREP-VGFYTDMWAIGVLG 240

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 51/194 (26%), Positives = 86/194 (44%), Gaps = 21/194 (10%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
           +G G  G V +  +  + +  AVK  +             L EV+ L ++ H NI+K + 
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFE 88

Query: 873 FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
               +   +IV E    G L   I+     +E         +IK V   ++Y+H      
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH----DAARIIKQVFSGITYMHKHN--- 141

Query: 932 IVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPEL---AYT 985
           IV+RD+  +N+LL+ + +     + DFG+S   + ++    +  GT  Y+APE+    Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRIGTAYYIAPEVLRGTYD 200

Query: 986 MKVTEKSDVYSFGV 999
            K     DV+S GV
Sbjct: 201 EKC----DVWSAGV 210

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 53/248 (21%), Positives = 93/248 (37%), Gaps = 19/248 (7%)

Query: 176 IGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLEL 235
              L+     +L +  ++  +      L+ +      N+++  S+ + +    +L  L L
Sbjct: 15  DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKELHL 70

Query: 236 GYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSE 295
            +N++S   PL   +L  L  L ++ N L     L+      L  L L +N L       
Sbjct: 71  SHNQISDLSPLK--DLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDS 123

Query: 296 MGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLEL 355
           + +LK+L  L +  NKL  SI   LG L+KL +L L  N +  +    +  L+ + +++L
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDL 179

Query: 356 GDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELS--GSIP 413
              K           L    T+           P  I N  S  D  +          + 
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPVYTDEVS 237

Query: 414 YSFGNLTN 421
           Y F    N
Sbjct: 238 YKFSEYIN 245

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 48/262 (18%), Positives = 91/262 (34%), Gaps = 22/262 (8%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F      +    +L    +  ++       S ++  +  +++   ++   +   + LK L
Sbjct: 13  FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKEL 68

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
           +LS NQ S  + P +  L+ L+ L +  N L          L+ L   +L NN L     
Sbjct: 69  HLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKNLNGIPSACLSRL---FLDNNELRD--T 121

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
             + +LK+L  L +  NKL   + L    L  L  LDLH N ++ +  L+   L  ++ +
Sbjct: 122 DSLIHLKNLEILSIRNNKLKSIVMLG--FLSKLEVLDLHGNEITNTGGLT--RLKKVNWI 177

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
           +L               L     +     +     P  + N        +   L     P
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWEL-----P 230

Query: 342 CEIGNLRYLFYLELGDNKLSGS 363
                + Y F   +   +    
Sbjct: 231 VYTDEVSYKFSEYINVGETEAI 252

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 77.0 bits (190), Expect = 1e-15
 Identities = 37/183 (20%), Positives = 77/183 (42%), Gaps = 15/183 (8%)

Query: 513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
              N    ++   ++T ++     +   ++  +  +++I  +  + +    +L +L L+ 
Sbjct: 17  GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSH 72

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLE 632
           NQ S    + L  L +LE L ++ NRL N        L +L+   L NN+        L 
Sbjct: 73  NQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRDTDS--LI 125

Query: 633 KFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISY 692
              +L  L + +N L + I   +  +  LE L+L  N ++         +  + +ID++ 
Sbjct: 126 HLKNLEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181

Query: 693 NKL 695
            K 
Sbjct: 182 QKC 184

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 75.1 bits (185), Expect = 7e-15
 Identities = 41/182 (22%), Positives = 70/182 (38%), Gaps = 15/182 (8%)

Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
           +N    NL  +     +S    +   +   +   +NI  +    +     LK L LS N 
Sbjct: 19  ANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSHNQ 74

Query: 551 IVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNL 610
           I  ++ S L  L  L +L++NRN+              L  L L +N L +    SL +L
Sbjct: 75  IS-DL-SPLKDLTKLEELSVNRNRLKN---LNGIPSACLSRLFLDNNELRD--TDSLIHL 127

Query: 611 VKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNN 670
             L  L++ NN+    I + L     L  LDL  N +       +  ++ +  ++L    
Sbjct: 128 KNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEI-TNT-GGLTRLKKVNWIDLTGQK 183

Query: 671 LS 672
             
Sbjct: 184 CV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 45/211 (21%), Positives = 81/211 (38%), Gaps = 18/211 (8%)

Query: 460 IPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGT 519
           +     L    +  L +  +T ++  S    S +   N  +      ++     F NL  
Sbjct: 12  VFPDPGLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNI-QSLA-GMQFFTNLKE 67

Query: 520 LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
           L +S N I+ + P  + D  +L+ L ++ N +   +         L +L L+ N+     
Sbjct: 68  LHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL--NGIPSACLSRLFLDNNELRD-- 120

Query: 580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSD 639
              L  L  LE L + +N+L + I   LG L KL  L+L  N+ +      L +   ++ 
Sbjct: 121 TDSLIHLKNLEILSIRNNKLKS-IVM-LGFLSKLEVLDLHGNEITNTGG--LTRLKKVNW 176

Query: 640 LDLSHNFLGEEIPSQVCSMQSLEKLNLAHNN 670
           +DL+      E    V     L   N   + 
Sbjct: 177 IDLTGQKCVNE---PVKYQPELYITNTVKDP 204

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 72.8 bits (179), Expect = 4e-14
 Identities = 31/230 (13%), Positives = 81/230 (35%), Gaps = 16/230 (6%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
            L N +  ++   +++  + ++   L  +       + +Q  +  ++  T L  + L  N
Sbjct: 17  GLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHN 73

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
            ++ ++       + L  ++++  +     + +      L  L +  N +       +  
Sbjct: 74  QIS-DL-SPLKDLTKLEELSVNRNRL---KNLNGIPSACLSRLFLDNNELRDTDS--LIH 126

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
              L++L + +N +   I   LG L  L  L L+ N+ +      L  L ++  +DL+  
Sbjct: 127 LKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWIDLTGQ 182

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFL 647
           +  N        L     +   + ++    P  +       D  +     
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 67.0 bits (164), Expect = 3e-12
 Identities = 43/235 (18%), Positives = 83/235 (35%), Gaps = 18/235 (7%)

Query: 318 SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL 377
                L       L    +  +       L  +      ++ +  S+   +   TNL  L
Sbjct: 13  FPDPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKEL 68

Query: 378 YLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIP 437
           +L  N +S  + S + +L  L +L ++ N L          L+    L + +N L     
Sbjct: 69  HLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIPSACLSR---LFLDNNELRDTDS 123

Query: 438 KEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
               +L  L +L +  N+L+  I  L  L++L  + L  N +T N          +++I+
Sbjct: 124 LI--HLKNLEILSIRNNKLKS-IVMLGFLSKLEVLDLHGNEIT-NTG-GLTRLKKVNWID 178

Query: 498 LSHKKFYGEISFDWGKFPNLGTLD-VSANNITGILPPEIGDSPQLKVLDLSSNHI 551
           L+ +K    ++      P L   + V   +   I P  I +        +     
Sbjct: 179 LTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELP 230

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.4 bits (121), Expect = 1e-06
 Identities = 24/149 (16%), Positives = 49/149 (32%), Gaps = 8/149 (5%)

Query: 99  LHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSML 158
           L + +      L+ L L  N++       + +   L+ L + +N    +I   +G LS L
Sbjct: 97  LKNLNGIPSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKLK-SIVM-LGFLSKL 152

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
           ++L L  N+ +      +  L  +  + L               L     +   +     
Sbjct: 153 EVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWIS 210

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLS 247
             P  I N  S     + +     +  +S
Sbjct: 211 --PYYISNGGSYVDGCVLWELPVYTDEVS 237

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.1 bits (247), Expect = 2e-21
 Identities = 45/201 (22%), Positives = 90/201 (44%), Gaps = 20/201 (9%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D  EE  +GTG  G V+R  E ++G   A K   +      + ++    E+++++ +RH 
Sbjct: 160  DIHEE--LGTGAFGVVHRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHP 214

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQR--MNVIKGVADALS 922
             +V  +          ++YE++  G L   +       E    ++   +  ++ V   L 
Sbjct: 215  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA-----DEHNKMSEDEAVEYMRQVCKGLC 269

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAP 980
            ++H +     V+ D+  +N++   +    +   DFG++  L P   +     GT  + AP
Sbjct: 270  HMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTTGTAEFAAP 325

Query: 981  ELAYTMKVTEKSDVYSFGVLA 1001
            E+A    V   +D++S GVL+
Sbjct: 326  EVAEGKPVGYYTDMWSVGVLS 346

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 95.8 bits (239), Expect = 2e-21
 Identities = 65/304 (21%), Positives = 120/304 (39%), Gaps = 75/304 (24%)

Query: 814  IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI 862
            +G G  G V  AE              VAVK      L +   +++    ++E++ +  I
Sbjct: 43   LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM-----LKDDATEKDLSDLVSEMEMMKMI 97

Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSNATSAEELGWT 908
             +H+NI+   G C+     +++ EY   G+L                  N    E++ + 
Sbjct: 98   GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD---- 964
              ++    +A  + YL +      ++RD++++NVL+       ++DFG+++ +       
Sbjct: 158  DLVSCTYQLARGMEYLASQKC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYK 214

Query: 965  -SSN------WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISS 1016
             ++N      W          APE  +    T +SDV+SFGVL  E    G  P   I  
Sbjct: 215  KTTNGRLPVKWM---------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265

Query: 1017 ICSTSSNLDRTLDEILDP-----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                        +E+        R+  P+ N  ++L  +M     C    P  RPT +++
Sbjct: 266  ------------EELFKLLKEGHRMDKPA-NCTNELYMMMR---DCWHAVPSQRPTFKQL 309

Query: 1072 SQLL 1075
             + L
Sbjct: 310  VEDL 313

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.1 bits (239), Expect = 2e-21
 Identities = 68/313 (21%), Positives = 111/313 (35%), Gaps = 73/313 (23%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQ--QEFLNEVKSLTEIRHRNIVKF 870
            IG G  G V  A E  +  I A+K  +   + ++  +  +    EV+ + ++ H NI + 
Sbjct: 34   IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 871  YGFCSHARHSFIVYEYLEMGSL-----------------------------------AMI 895
            Y      ++  +V E    G L                                      
Sbjct: 94   YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 896  LSNATSAEELGWTQRM--NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV- 952
            +     + +    +++  N+++ +  AL YLHN     I +RDI  +N L        + 
Sbjct: 154  IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210

Query: 953  -SDFGISKSLKP----DSSNWTELAGTIGYVAPEL--AYTMKVTEKSDVYSFGVLALEAI 1005
              DFG+SK        +    T  AGT  +VAPE+          K D +S GVL    +
Sbjct: 211  LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270

Query: 1006 KGKHPRDFISSICSTSSNLDRTLDEIL-------DPRLPAPSCNIRDKLISIMEVAISCL 1058
             G  P  F         N   T+ ++L       +P     S   RD L+S +      L
Sbjct: 271  MGAVP--F------PGVNDADTISQVLNKKLCFENPNYNVLSPLARD-LLSNL------L 315

Query: 1059 DENPDSRPTMQKV 1071
            + N D R    + 
Sbjct: 316  NRNVDERFDAMRA 328

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 95.9 bits (239), Expect = 4e-21
 Identities = 72/345 (20%), Positives = 134/345 (38%), Gaps = 78/345 (22%)

Query: 774  QTQQSSAGNAPGFLSVLTFDRKIAYE-EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE- 831
             T+ SS  + P    V  ++     + E  R      +   +G G  G V  AE    + 
Sbjct: 50   TTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKP--LGEGCFGQVVMAEAVGIDK 107

Query: 832  -------IVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-RHRNIVKFYGFCSHARHS 880
                    VAVK      L +   +++    ++E++ +  I +H+NI+   G C+     
Sbjct: 108  DKPKEAVTVAVKM-----LKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 162

Query: 881  FIVYEYLEMGSL-------------AMILSNATSAEELGWTQRMNVIKGVADALSYLHND 927
            +++ EY   G+L                  N    E++ +   ++    +A  + YL + 
Sbjct: 163  YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ 222

Query: 928  CFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-----SSN------WTELAGTIG 976
                 ++RD++++NVL+       ++DFG+++ +        ++N      W        
Sbjct: 223  KC---IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWM------- 272

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDP- 1034
              APE  +    T +SDV+SFGVL  E    G  P   I              +E+    
Sbjct: 273  --APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV------------EELFKLL 318

Query: 1035 ----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                R+  P+ N  ++L  +M     C    P  RPT +++ + L
Sbjct: 319  KEGHRMDKPA-NCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 359

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 94.2 bits (235), Expect = 4e-21
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 17/191 (8%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
           +G+G    V+   +  +G++ A+K                 NE+  L +I+H NIV    
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLED 73

Query: 873 FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                 H ++V + +  G L   IL      E+        VI+ V  A+ YLH +    
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEK----DASLVIQQVLSAVKYLHENG--- 126

Query: 932 IVYRDISSKNVLL-DLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV 988
           IV+RD+  +N+L    E  + +  +DFG+SK  +      +   GT GYVAPE+      
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPY 184

Query: 989 TEKSDVYSFGV 999
           ++  D +S GV
Sbjct: 185 SKAVDCWSIGV 195

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 95.9 bits (239), Expect = 4e-21
 Identities = 66/305 (21%), Positives = 121/305 (39%), Gaps = 75/305 (24%)

Query: 814  IGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI 862
            +G G  G V  AE         +    VAVK      L     +++    ++E++ +  I
Sbjct: 77   LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-----LKSDATEKDLSDLISEMEMMKMI 131

Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-------------AMILSNATSAEELGWT 908
             +H+NI+   G C+     +++ EY   G+L                  +    E+L   
Sbjct: 132  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD---- 964
              ++    VA  + YL +      ++RD++++NVL+  +    ++DFG+++ +       
Sbjct: 192  DLVSCAYQVARGMEYLASKKC---IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 248

Query: 965  -SSN------WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISS 1016
             ++N      W          APE  +    T +SDV+SFGVL  E    G  P   +  
Sbjct: 249  KTTNGRLPVKWM---------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP- 298

Query: 1017 ICSTSSNLDRTLDEILDP-----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                       ++E+        R+  PS N  ++L  +M     C    P  RPT +++
Sbjct: 299  -----------VEELFKLLKEGHRMDKPS-NCTNELYMMMR---DCWHAVPSQRPTFKQL 343

Query: 1072 SQLLK 1076
             + L 
Sbjct: 344  VEDLD 348

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 94.3 bits (235), Expect = 7e-21
 Identities = 68/324 (20%), Positives = 126/324 (38%), Gaps = 82/324 (25%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQE-- 851
            E  R   ++  +  IG G  G V++A            +VAVK      L E        
Sbjct: 43   EYPRNNIEYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKM-----LKEEASADMQA 95

Query: 852  -FLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL------------------ 892
             F  E   + E  + NIVK  G C+  +   +++EY+  G L                  
Sbjct: 96   DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHS 155

Query: 893  ---AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYE 949
                    ++     L   +++ + + VA  ++YL    F   V+RD++++N L+     
Sbjct: 156  DLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF---VHRDLATRNCLVGENMV 212

Query: 950  AHVSDFGISKSL------KPDSSN-----WTELAGTIGYVAPE-LAYTMKVTEKSDVYSF 997
              ++DFG+S+++      K D ++     W           PE + Y  + T +SDV+++
Sbjct: 213  VKIADFGLSRNIYSADYYKADGNDAIPIRWM---------PPESIFYN-RYTTESDVWAY 262

Query: 998  GVLALEAIKGKHPRDFISSICST----SSNLDRTLDEILDP-RLPAPSCNIRDKLISIME 1052
            GV+  E          I S         ++ +  +  + D   L  P  N   +L ++M 
Sbjct: 263  GVVLWE----------IFSYGLQPYYGMAHEE-VIYYVRDGNILACPE-NCPLELYNLMR 310

Query: 1053 VAISCLDENPDSRPTMQKVSQLLK 1076
                C  + P  RP+   + ++L+
Sbjct: 311  ---LCWSKLPADRPSFCSIHRILQ 331

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 93.0 bits (232), Expect = 8e-21
 Identities = 47/195 (24%), Positives = 95/195 (48%), Gaps = 22/195 (11%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
           +G G    V R    ++G   A K  ++  LS     Q+   E +   +++H NIV+ + 
Sbjct: 14  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHD 72

Query: 873 FCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                   ++V++ +  G L   I++    +E        + I+ + ++++Y H++    
Sbjct: 73  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEA----DASHCIQQILESIAYCHSNG--- 125

Query: 932 IVYRDISSKNVLLDLEYE-AHV--SDFGISKSLKPDSSNWTELAGTIGYVAPEL----AY 984
           IV+R++  +N+LL  + + A V  +DFG++  +    + W   AGT GY++PE+     Y
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLSPEVLKKDPY 184

Query: 985 TMKVTEKSDVYSFGV 999
           +  V    D+++ GV
Sbjct: 185 SKPV----DIWACGV 195

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 94.3 bits (235), Expect = 8e-21
 Identities = 75/355 (21%), Positives = 130/355 (36%), Gaps = 76/355 (21%)

Query: 767  FRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYE-EIVRATNDFDEEHCIGTGGQGSVYRA 825
            FR  S  Q  Q +  +   +  V   + +   + E  R   +F +   +G+G  G V  A
Sbjct: 7    FRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKV--LGSGAFGKVMNA 64

Query: 826  EL------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-RHRNIVKFYGFCS 875
                         VAVK      L E     E    ++E+K +T++  H NIV   G C+
Sbjct: 65   TAYGISKTGVSIQVAVKM-----LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119

Query: 876  HARHSFIVYEYLEMGSL--------------------AMILSNATSAEELGWTQRMNVIK 915
             +   ++++EY   G L                       L        L +   +    
Sbjct: 120  LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-----SSN--- 967
             VA  + +L        V+RD++++NVL+       + DFG+++ +  D       N   
Sbjct: 180  QVAKGMEFLEFKSC---VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236

Query: 968  ---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSN 1023
               W          APE  +    T KSDV+S+G+L  E    G +P   I         
Sbjct: 237  PVKWM---------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV------- 280

Query: 1024 LDRTLDEILDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             D    +++    ++  P     +++  IM+   SC   +   RP+   ++  L 
Sbjct: 281  -DANFYKLIQNGFKMDQPF-YATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 330

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 93.5 bits (233), Expect = 9e-21
 Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 64/300 (21%)

Query: 814  IGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A         +   VAVK      L       E    ++E+K L+ +  
Sbjct: 31   LGAGAFGKVVEATAYGLIKSDAAMTVAVKM-----LKPSAHLTEREALMSELKVLSYLGN 85

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG------- 916
            H NIV   G C+    + ++ EY   G L   L     +     T    +          
Sbjct: 86   HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 917  --------VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD---- 964
                    VA  +++L +      ++RD++++N+LL       + DFG+++ +K D    
Sbjct: 146  DLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 965  -SSN------WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISS 1016
               N      W          APE  +    T +SDV+S+G+   E    G  P   +  
Sbjct: 203  VKGNARLPVKWM---------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM-- 251

Query: 1017 ICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 S   + + E    R+ +P  +   ++  IM+   +C D +P  RPT +++ QL++
Sbjct: 252  --PVDSKFYKMIKE--GFRMLSPE-HAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIE 303

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEI 862
            +  EE  +G+G    V +  +  +G+  A K   K           ++E   EV  L EI
Sbjct: 8    EMGEE--LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADAL 921
            RH NI+  +    +     ++ E +  G L   +    +  E+    +    +K + D +
Sbjct: 66   RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTED----EATQFLKQILDGV 121

Query: 922  SYLHNDCFPPIVYRDISSKNVLL-DLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGY 977
             YLH+     I + D+  +N++L D         + DFGI+  ++  +  +  + GT  +
Sbjct: 122  HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGTPEF 177

Query: 978  VAPE-LAYTMKVTEKSDVYSFGVLA 1001
            VAPE + Y   +  ++D++S GV+ 
Sbjct: 178  VAPEIVNYE-PLGLEADMWSIGVIT 201

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.5 bits (233), Expect = 1e-20
 Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 21/205 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEI 862
            D  EE  +G+G    V +  E S+G   A K   K  +        +++   EV  L EI
Sbjct: 14   DTGEE--LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADAL 921
            +H N++  +    +     ++ E +  G L   +    +  EE    +    +K + + +
Sbjct: 72   QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEE----EATEFLKQILNGV 127

Query: 922  SYLHNDCFPPIVYRDISSKNVLL-DLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGY 977
             YLH+     I + D+  +N++L D         + DFG++  +   +  +  + GT  +
Sbjct: 128  YYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 183

Query: 978  VAPE-LAYTMKVTEKSDVYSFGVLA 1001
            VAPE + Y   +  ++D++S GV+ 
Sbjct: 184  VAPEIVNYE-PLGLEADMWSIGVIT 207

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 52/206 (25%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEI 862
            D  EE  +G+G    V +  E S+G   A K   K  S       C++E   EV  L ++
Sbjct: 15   DIGEE--LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADA 920
             H NI+  +    +     ++ E +  G L   +    + S EE       + IK + D 
Sbjct: 73   LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILDG 127

Query: 921  LSYLHNDCFPPIVYRDISSKNVLL-DLEYEAH---VSDFGISKSLKPDSSNWTELAGTIG 976
            ++YLH      I + D+  +N++L D         + DFG++  ++     +  + GT  
Sbjct: 128  VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPE 183

Query: 977  YVAPE-LAYTMKVTEKSDVYSFGVLA 1001
            +VAPE + Y   +  ++D++S GV+ 
Sbjct: 184  FVAPEIVNYE-PLGLEADMWSIGVIT 208

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 807 DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            F  +  +G+G  G V+   E SSG    +K  +          ++   E++ L  + H 
Sbjct: 25  IFKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHP 80

Query: 866 NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYL 924
           NI+K +       + +IV E  E G L   I+S     + L       ++K + +AL+Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 925 HNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
           H+     +V++D+  +N+L           + DFG+++  K D    T  AGT  Y+APE
Sbjct: 141 HSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAAGTALYMAPE 196

Query: 982 -LAYTMKVTEKSDVYSFGV 999
                  VT K D++S GV
Sbjct: 197 VFKR--DVTFKCDIWSAGV 213

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 92.3 bits (230), Expect = 2e-20
 Identities = 45/202 (22%), Positives = 82/202 (40%), Gaps = 23/202 (11%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
               E+  +G G  G V+R  E SS +    K        +         E+  L   RHR
Sbjct: 8    MIAED--LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQR--MNVIKGVADALS 922
            NI+  +          +++E++    +   I             +R  ++ +  V +AL 
Sbjct: 62   NILHLHESFESMEELVMIFEFISGLDIFERIN-----TSAFELNEREIVSYVHQVCEALQ 116

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAP 980
            +LH+     I + DI  +N++      + +   +FG ++ LKP   N+  L     Y AP
Sbjct: 117  FLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLFTAPEYYAP 172

Query: 981  E-LAYTMKVTEKSDVYSFGVLA 1001
            E   + + V+  +D++S G L 
Sbjct: 173  EVHQHDV-VSTATDMWSLGTLV 193

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 91.9 bits (229), Expect = 2e-20
 Identities = 53/216 (24%), Positives = 91/216 (42%), Gaps = 27/216 (12%)

Query: 803 RATNDFDEE----HCIGTGGQGSVYRA-ELSSGEIVAVK---KFHSPLLSEMTCQ---QE 851
            +T+ F E       +G G    V R     + +  AVK          S    Q   + 
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69

Query: 852 FLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQ 909
            L EV  L ++  H NI++           F+V++ ++ G L   +    T +E+    +
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK----E 125

Query: 910 RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
              +++ + + +  LH      IV+RD+  +N+LLD +    ++DFG S  L P      
Sbjct: 126 TRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LR 181

Query: 970 ELAGTIGYVAPE-LAYTMKVTEKS-----DVYSFGV 999
           E+ GT  Y+APE +  +M           D++S GV
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 91.9 bits (229), Expect = 3e-20
 Identities = 64/303 (21%), Positives = 108/303 (35%), Gaps = 73/303 (24%)

Query: 814  IGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
            +G G  G V  A+       ++   VAVK      L E     E    ++E+K L  I  
Sbjct: 35   LGRGAFGQVIEADAFGIDKTATCRTVAVKM-----LKEGATHSEHRALMSELKILIHIGH 89

Query: 864  HRNIVKFYGFCSHA-RHSFIVYEYLEMGSL-------------AMILSNATSAEELGWTQ 909
            H N+V   G C+       ++ E+ + G+L               +       + L    
Sbjct: 90   HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS--- 966
             +     VA  + +L +      ++RD++++N+LL  +    + DFG+++ +  D     
Sbjct: 150  LICYSFQVAKGMEFLASRKC---IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 206

Query: 967  --------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSI 1017
                     W          APE  +    T +SDV+SFGVL  E    G  P   +   
Sbjct: 207  KGDARLPLKWM---------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 257

Query: 1018 CSTSSNLDRTLDEILDP-----RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVS 1072
                       +E         R+ AP      ++   M     C    P  RPT  ++ 
Sbjct: 258  -----------EEFCRRLKEGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPTFSELV 302

Query: 1073 QLL 1075
            + L
Sbjct: 303  EHL 305

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.8 bits (231), Expect = 3e-20
 Identities = 48/214 (22%), Positives = 101/214 (47%), Gaps = 26/214 (12%)

Query: 799 EEIVRATNDFDEE----HCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFL 853
           E ++ A+  F +       +G G    V R    ++G   A K  ++  LS     Q+  
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLE 76

Query: 854 NEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA-MILSNATSAEELGWTQRMN 912
            E +   +++H NIV+ +         ++V++ +  G L   I++    +E        +
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA----DASH 132

Query: 913 VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWT 969
            I+ + ++++Y H++    IV+R++  +N+LL  + +     ++DFG++  +    + W 
Sbjct: 133 CIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WH 188

Query: 970 ELAGTIGYVAPEL----AYTMKVTEKSDVYSFGV 999
             AGT GY++PE+     Y+  V    D+++ GV
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPV----DIWACGV 218

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 91.9 bits (229), Expect = 3e-20
 Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 23/206 (11%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEI 862
            D  EE  +G+G    V +  E S+G   A K   K  S        ++E   EV  L ++
Sbjct: 15   DIGEE--LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSL--AMILSNATSAEELGWTQRMNVIKGVADA 920
             H N++  +    +     ++ E +  G L   +    + S EE       + IK + D 
Sbjct: 73   LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA-----TSFIKQILDG 127

Query: 921  LSYLHNDCFPPIVYRDISSKNVLL-DLEYEAH---VSDFGISKSLKPDSSNWTELAGTIG 976
            ++YLH      I + D+  +N++L D         + DFG++  ++     +  + GT  
Sbjct: 128  VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGTPE 183

Query: 977  YVAPE-LAYTMKVTEKSDVYSFGVLA 1001
            +VAPE + Y   +  ++D++S GV+ 
Sbjct: 184  FVAPEIVNYE-PLGLEADMWSIGVIT 208

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 91.5 bits (228), Expect = 4e-20
 Identities = 68/310 (21%), Positives = 114/310 (36%), Gaps = 82/310 (26%)

Query: 814  IGTGGQGSVYRAELSSGE------IVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEIRH 864
            +G G  G V +A     +       VAVK      L E     E    L+E   L ++ H
Sbjct: 31   LGEGEFGKVVKATAFHLKGRAGYTTVAVKM-----LKENASPSELRDLLSEFNVLKQVNH 85

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSL---------------------AMILSNATSAE 903
             +++K YG CS      ++ EY + GSL                          +     
Sbjct: 86   PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145

Query: 904  ELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP 963
             L     ++    ++  + YL        V+RD++++N+L+    +  +SDFG+S+ +  
Sbjct: 146  ALTMGDLISFAWQISQGMQYLAEMKL---VHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 964  D-----SSN------WTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAI-KGKHP 1010
            +      S       W          A E L      T +SDV+SFGVL  E +  G +P
Sbjct: 203  EDSYVKRSQGRIPVKWM---------AIESLFDH-IYTTQSDVWSFGVLLWEIVTLGGNP 252

Query: 1011 RDFISSICSTSSNLDRTLDEILDP-----RLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
               I              + + +      R+  P  N  +++  +M     C  + PD R
Sbjct: 253  YPGIPP------------ERLFNLLKTGHRMERPD-NCSEEMYRLML---QCWKQEPDKR 296

Query: 1066 PTMQKVSQLL 1075
            P    +S+ L
Sbjct: 297  PVFADISKDL 306

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 92.5 bits (230), Expect = 4e-20
 Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 22/200 (11%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIR-HRN 866
           IG G    V R    ++G   AVK                 ++    E   L ++  H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161

Query: 867 IVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
           I+        +   F+V++ +  G L   +      +E+    +  ++++ + +A+S+LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK----ETRSIMRSLLEAVSFLH 217

Query: 926 NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAY 984
            +    IV+RD+  +N+LLD   +  +SDFG S  L+P      EL GT GY+APE L  
Sbjct: 218 ANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELCGTPGYLAPEILKC 273

Query: 985 TMKVTEKS-----DVYSFGV 999
           +M  T        D+++ GV
Sbjct: 274 SMDETHPGYGKEVDLWACGV 293

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 59/204 (28%), Positives = 83/204 (40%), Gaps = 32/204 (15%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
           +G+G  G V  A E  + + VA+K     KF      E         E++ L ++ H  I
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 868 VKFYGFCSHARHSFIVYEYLEMGSL------AMILSNATSAEELGWTQRMNVIKGVADAL 921
           +K   F   A   +IV E +E G L         L  AT                +  A+
Sbjct: 78  IKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCK---------LYFYQMLLAV 127

Query: 922 SYLHNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYV 978
            YLH +    I++RD+  +NVLL  + E     ++DFG SK L   S     L GT  Y+
Sbjct: 128 QYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYL 183

Query: 979 APE-LAYTMKV--TEKSDVYSFGV 999
           APE L            D +S GV
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGV 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 92.8 bits (231), Expect = 6e-20
 Identities = 57/200 (28%), Positives = 85/200 (42%), Gaps = 22/200 (11%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V  A E  + + VA++     KF      E         E++ L ++ H  I
Sbjct: 143  LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202

Query: 868  VKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            +K   F   A   +IV E +E G L   ++ N    E             +  A+ YLH 
Sbjct: 203  IKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATC----KLYFYQMLLAVQYLHE 257

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPE-L 982
            +    I++RD+  +NVLL  + E     ++DFG SK L   S     L GT  Y+APE L
Sbjct: 258  NG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCGTPTYLAPEVL 313

Query: 983  AYTMKV--TEKSDVYSFGVL 1000
                        D +S GV+
Sbjct: 314  VSVGTAGYNRAVDCWSLGVI 333

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 91.8 bits (228), Expect = 7e-20
 Identities = 47/165 (28%), Positives = 70/165 (42%), Gaps = 15/165 (9%)

Query: 250 NLP-NLATLDLHDNSLSGSIP--LSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGL 305
           +LP   A LDL  N+LS  +    +   LTNL  L L HN L+  I SE    + +L  L
Sbjct: 36  SLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYL 93

Query: 306 GLSFNKLSGSIPS-SLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGS 363
            LS N L  ++      +L  L +L L +N +   +      ++  L  L L  N++S  
Sbjct: 94  DLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS-R 150

Query: 364 IP----HSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLS 404
            P         L  L  L L +N L     +++  L +    GL 
Sbjct: 151 FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 87.6 bits (217), Expect = 1e-18
 Identities = 44/187 (23%), Positives = 72/187 (38%), Gaps = 18/187 (9%)

Query: 519 TLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSE--LGKLRSLIKLTLNRNQFS 576
            L  S   +  + P  +       +LDLS N++   + +E    +L +L  L L+ N  +
Sbjct: 22  ILSCSKQQLPNV-PQSL--PSYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN 77

Query: 577 GQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-LEKF 634
             + +E    +  L +LDLSSN L         +L  L  L L NN     +     E  
Sbjct: 78  -FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDM 135

Query: 635 IHLSDLDLSHNFLGEEIPSQV----CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDI 690
             L  L LS N +    P ++      +  L  L+L+ N L        +++   V   +
Sbjct: 136 AQLQKLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194

Query: 691 SYNKLHG 697
               LH 
Sbjct: 195 Y---LHN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 86.8 bits (215), Expect = 3e-18
 Identities = 43/168 (25%), Positives = 66/168 (39%), Gaps = 14/168 (8%)

Query: 107 FPHLAYLDLRVNQIFGIIPSQI-ANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLS 164
             + A LDL  N +  +         + L  L LS N  +  I  +    +  L+ L LS
Sbjct: 38  PSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96

Query: 165 TNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPS 222
           +N     +   +   L  L+ L L+ N +   +   +  ++  L  +YL  N +S   P 
Sbjct: 97  SNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPV 153

Query: 223 EI----GNLKSLSGLELGYNKLSGSMPLSLGNLPNL--ATLDLHDNSL 264
           E+      L  L  L+L  NKL       L  LP      L LH+N L
Sbjct: 154 ELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 83.7 bits (207), Expect = 3e-17
 Identities = 41/182 (22%), Positives = 72/182 (39%), Gaps = 15/182 (8%)

Query: 137 LDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI--GHLSYLKALHLFENGLSG 194
           L  S       +P  + +     +L LS N  S R+  +     L+ L +L L  N L+ 
Sbjct: 23  LSCSKQQLP-NVPQSLPSY--TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN- 77

Query: 195 SIPP-SLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLP 252
            I   +   + NL  + L +N L  ++   +  +L++L  L L  N +      +  ++ 
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMA 136

Query: 253 NLATLDLHDNSLSGSIP----LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLS 308
            L  L L  N +S   P         L  L +L+L  N L     +++  L +    GL 
Sbjct: 137 QLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195

Query: 309 FN 310
            +
Sbjct: 196 LH 197

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 71.4 bits (175), Expect = 4e-13
 Identities = 44/195 (22%), Positives = 78/195 (40%), Gaps = 35/195 (17%)

Query: 363 SIPHSLGNLTNLATLYLFTNLLSGSIPSEI--GNLNSLSDLGLSENELSGSIPY-SFGNL 419
           ++P SL   +  A L L  N LS  + +E     L +L  L LS N L+  I   +F  +
Sbjct: 32  NVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87

Query: 420 TNMIVLSIYSNALSGAIPKEY-GNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDR 476
            N+  L + SN L   + +    +L  L +L+L  N +   +      ++ +L ++ L +
Sbjct: 88  PNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQ 145

Query: 477 NHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIG 536
           N ++    E     + L                     P L  LD+S+N +  +   ++ 
Sbjct: 146 NQISRFPVELIKDGNKL---------------------PKLMLLDLSSNKLKKLPLTDLQ 184

Query: 537 DSPQLKV--LDLSSN 549
             P      L L +N
Sbjct: 185 KLPAWVKNGLYLHNN 199

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.2 bits (164), Expect = 7e-12
 Identities = 35/128 (27%), Positives = 53/128 (41%), Gaps = 9/128 (7%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           +  +   +F   P+L YLDL  N +  +     ++   L+ L L +N     +      +
Sbjct: 76  LNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFED 134

Query: 155 LSMLKILYLSTNQFSGRIPPQI----GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIM- 209
           ++ L+ LYLS NQ S R P ++      L  L  L L  N L       L  L       
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193

Query: 210 -YLYNNSL 216
            YL+NN L
Sbjct: 194 LYLHNNPL 201

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 89.6 bits (223), Expect = 1e-19
 Identities = 44/201 (21%), Positives = 75/201 (37%), Gaps = 25/201 (12%)

Query: 807 DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +    IG G  G V  A +  +    A KK        +     F  E++ +  + H 
Sbjct: 12  TLENT--IGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHP 66

Query: 866 NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYL 924
           NI++ Y         ++V E    G L   ++      E         ++K V  A++Y 
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYC 122

Query: 925 HNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
           H      + +RD+  +N L   +       + DFG++   KP         GT  YV+P+
Sbjct: 123 HKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQ 178

Query: 982 L---AYTMKVTEKSDVYSFGV 999
           +    Y  +     D +S GV
Sbjct: 179 VLEGLYGPEC----DEWSAGV 195

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 40/199 (20%), Positives = 79/199 (39%), Gaps = 12/199 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQI-ANNSKLKYLDLSSNSFSGTIPPQI-G 153
           + T+   +FS+ P+++ + + ++     + S    N SK+ ++++ +      I P    
Sbjct: 43  LRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALK 102

Query: 154 NLSMLKILYLSTNQFSGRIPPQ--IGHLSYLKALHLFENGLSGSIPP-SLGNLTN-LAIM 209
            L +LK L +         P    +        L + +N    SIP  +   L N    +
Sbjct: 103 ELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTL 161

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMP-LSLGNLPN-LATLDLHDNSLSGS 267
            LYNN  + S+     N   L  + L  NK    +   + G + +  + LD+   S++ +
Sbjct: 162 KLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-A 219

Query: 268 IP-LSFGNLTNLDILNLPH 285
           +P     +L  L   N   
Sbjct: 220 LPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 43/207 (20%), Positives = 78/207 (37%), Gaps = 12/207 (5%)

Query: 108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTN 166
           P    L L    +  I     +N   +  + +S +     +      NLS +  + +   
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 167 QFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP--SLGNLTNLAIMYLYNNSLSGSIPSE 223
           +    I P     L  LK L +F  GL    P    + +     I+ + +N    SIP  
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 224 I--GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP-LSFGNL-TNLD 279
              G       L+L  N  + S+     N   L  + L+ N     I   +FG + +   
Sbjct: 150 AFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208

Query: 280 ILNLPHNSLSGSIPSE-MGNLKSLYGL 305
           +L++   S++ ++PS+ + +LK L   
Sbjct: 209 LLDVSQTSVT-ALPSKGLEHLKELIAR 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 31/192 (16%), Positives = 71/192 (36%), Gaps = 14/192 (7%)

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRN 573
           P+  TL +   ++  I      + P +  + +S +  + ++ S     L  +  + +   
Sbjct: 31  PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90

Query: 574 QFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPG--SLGNLVKLYYLNLSNNQFSGEIPIK 630
           +    +  + L  L  L+ L + +  L    P    + +    + L +++N +   IP+ 
Sbjct: 91  RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVN 149

Query: 631 LEKFIHLS----DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPR-CFKEMH-G 684
              F  L      L L +N     +     +   L+ + L  N     I +  F  ++ G
Sbjct: 150 A--FQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSG 206

Query: 685 LVYIDISYNKLH 696
              +D+S   + 
Sbjct: 207 PSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 42/215 (19%), Positives = 87/215 (40%), Gaps = 17/215 (7%)

Query: 276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLTILYLSDN 334
              +   +    +   IPS   + ++L    L    L  +IPS +  NL  ++ +Y+S +
Sbjct: 11  HQEEDFRVTCKDIQ-RIPSLPPSTQTLK---LIETHLR-TIPSHAFSNLPNISRIYVSID 65

Query: 335 LLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHS-LGNLTNLATLYLFTNLLSGSIPSE- 391
           +    +      NL  + ++E+ + +    I    L  L  L  L +F   L    P   
Sbjct: 66  VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLT 124

Query: 392 -IGNLNSLSDLGLSENELSGSIPY-SFGNLTNM-IVLSIYSNALSGAIPKEYGNLVKLTL 448
            + + +    L +++N    SIP  +F  L N  + L +Y+N  + ++     N  KL  
Sbjct: 125 KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDA 183

Query: 449 LVLSYNQLQGPIPD--LRNL-TRLARVRLDRNHLT 480
           + L+ N+    I       + +  + + + +  +T
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 38/231 (16%), Positives = 73/231 (31%), Gaps = 31/231 (13%)

Query: 397 SLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEY-GNLVKLTLLVLSYNQ 455
           S   L L E  L     ++F NL N+  + +  +     +      NL K+T + +   +
Sbjct: 32  STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 456 LQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGK 513
               I    L+ L  L  + +    L     +   ++S                      
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYST--------------------- 129

Query: 514 FPNLGTLDVSANNITGILPPEI--GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLN 571
                 L+++ N     +P     G   +   L L +N     +         L  + LN
Sbjct: 130 -DIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLN 187

Query: 572 RNQFSGQLPTEL--GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
           +N++   +  +   G       LD+S   ++      L +L +L   N   
Sbjct: 188 KNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWT 238

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 30/180 (16%), Positives = 63/180 (35%), Gaps = 10/180 (5%)

Query: 514 FPNLGTLDVSANNITGILPPEI-GDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLN 571
            PN+  + VS +     L      +  ++  +++ +   +  I  + L +L  L  L + 
Sbjct: 54  LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIF 113

Query: 572 RNQFSGQLP--TELGSLIQLEHLDLSSNRLSNSIP-GSLGNLVK-LYYLNLSNNQFSGEI 627
                   P  T++ S      L+++ N    SIP  +   L      L L NN F+  +
Sbjct: 114 NTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SV 171

Query: 628 PIKLEKFIHLSDLDLSHNFLGEEIPSQVCS--MQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
                    L  + L+ N     I              L+++  +++    +  + +  L
Sbjct: 172 QGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKEL 231

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 16/118 (13%), Positives = 38/118 (32%), Gaps = 3/118 (2%)

Query: 589 LEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLSDLDLSHNFL 647
            + L L    L      +  NL  +  + +S +    ++          ++ +++ +   
Sbjct: 33  TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRN 92

Query: 648 GEEIPSQVCS-MQSLEKLNLAHNNLSGFIPRCF-KEMHGLVYIDISYNKLHGPIPNSA 703
              I       +  L+ L + +  L  F              ++I+ N     IP +A
Sbjct: 93  LTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 90.8 bits (226), Expect = 2e-19
 Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 50/279 (17%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + F+    IG G  G V   +   + ++ A+K  +     E    +    E++ +  + H
Sbjct: 15   DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74

Query: 865  RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRMNV 913
              +V  +Y F       F+V + L  G L   L                E          
Sbjct: 75   PFLVNLWYSFQDEED-MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICE---------- 123

Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
               +  AL YL N     I++RD+   N+LLD     H++DF I+  L  ++   T +AG
Sbjct: 124  ---LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT-MAG 176

Query: 974  TIGYVAPEL-------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
            T  Y+APE+        Y+  V    D +S GV A E ++G+ P  +      +S++   
Sbjct: 177  TKPYMAPEMFSSRKGAGYSFAV----DWWSLGVTAYELLRGRRP--YHI---RSSTSSKE 227

Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             +       +  PS     +++S+++     L+ NPD R
Sbjct: 228  IVHTFETTVVTYPS-AWSQEMVSLLK---KLLEPNPDQR 262

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 89.7 bits (223), Expect = 3e-19
 Identities = 52/239 (21%), Positives = 99/239 (41%), Gaps = 26/239 (10%)

Query: 768 RRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-E 826
             +S S    S+A      +     D      + +    + + E  +G G    VYR  +
Sbjct: 19  YFQSMSSVTASAAPGTASLVPDYWIDGS--NRDALSDFFEVESE--LGRGATSIVYRCKQ 74

Query: 827 LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY 886
             + +  A+K     +  ++        E+  L  + H NI+K            +V E 
Sbjct: 75  KGTQKPYALKVLKKTVDKKI-----VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLEL 129

Query: 887 LEMGSL-AMILSNATSAEELGWTQRM--NVIKGVADALSYLHNDCFPPIVYRDISSKNVL 943
           +  G L   I+          +++R   + +K + +A++YLH +    IV+RD+  +N+L
Sbjct: 130 VTGGELFDRIVEKGY------YSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLL 180

Query: 944 L-DLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGV 999
                 +A +  +DFG+SK ++        + GT GY APE+        + D++S G+
Sbjct: 181 YATPAPDAPLKIADFGLSKIVEHQVL-MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 46/198 (23%), Positives = 89/198 (44%), Gaps = 21/198 (10%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR-NIVKFY 871
            +G G    V +    S+G+  A K        +  C+ E L+E+  L   +    ++  +
Sbjct: 37   LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH 95

Query: 872  GFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGW-TQR--MNVIKGVADALSYLHND 927
                +     ++ EY   G + ++ L      E     ++   + +IK + + + YLH +
Sbjct: 96   EVYENTSEIILILEYAAGGEIFSLCL-----PELAEMVSENDVIRLIKQILEGVYYLHQN 150

Query: 928  CFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPE-LA 983
                IV+ D+  +N+LL   Y      + DFG+S+ +        E+ GT  Y+APE L 
Sbjct: 151  N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYLAPEILN 206

Query: 984  YTMKVTEKSDVYSFGVLA 1001
            Y   +T  +D+++ G++A
Sbjct: 207  YD-PITTATDMWNIGIIA 223

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 38/141 (26%), Positives = 64/141 (45%), Gaps = 15/141 (10%)

Query: 250 NLP-NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPS----EMGNLKSLYG 304
           NLP  +  + L  N++    P +F     L  ++L +N +S  +       + +L SL  
Sbjct: 29  NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLV- 86

Query: 305 LGLSFNKLSGSIPSSL-GNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSG 362
             L  NK++  +P SL   L  L +L L+ N +   +  +   +L  L  L L DNKL  
Sbjct: 87  --LYGNKIT-ELPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQ- 141

Query: 363 SIPH-SLGNLTNLATLYLFTN 382
           +I   +   L  + T++L  N
Sbjct: 142 TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 74.7 bits (184), Expect = 4e-15
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 10/143 (6%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGRIPPQI-GHLSY 181
           IP+ +     +  + L  N+    IPP        L+ + LS NQ S  + P     L  
Sbjct: 26  IPTNLPET--ITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81

Query: 182 LKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNK 239
           L +L L+ N ++  +P SL   L +L ++ L  N ++  +  +   +L +L+ L L  NK
Sbjct: 82  LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139

Query: 240 LSGSMPLSLGNLPNLATLDLHDN 262
           L      +   L  + T+ L  N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 35/130 (26%), Positives = 59/130 (45%), Gaps = 8/130 (6%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGR 171
           + L  N I  I P   +   KL+ +DLS+N  S  + P     L  L  L L  N+ +  
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 172 IPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSEI-GNLK 228
           +P  +   L  L+ L L  N ++  +   +  +L NL ++ LY+N L  +I       L+
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLR 152

Query: 229 SLSGLELGYN 238
           ++  + L  N
Sbjct: 153 AIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 31/122 (25%), Positives = 51/122 (41%), Gaps = 6/122 (4%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           I  +   +FS +  L  +DL  NQI  + P        L  L L  N  +  +P  +   
Sbjct: 44  IKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEG 102

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLY 212
           L  L++L L+ N+ +  +       L  L  L L++N L  +I   +   L  +  M+L 
Sbjct: 103 LFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLA 160

Query: 213 NN 214
            N
Sbjct: 161 QN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 32/152 (21%), Positives = 61/152 (40%), Gaps = 28/152 (18%)

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI 364
           + L  N +    P +     KL  + LS+N +   +                        
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELA----------------------- 72

Query: 365 PHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPY-SFGNLTNM 422
           P +   L +L +L L+ N ++  +P  +   L SL  L L+ N+++  +   +F +L N+
Sbjct: 73  PDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNL 130

Query: 423 IVLSIYSNALSGAIPKEYGNLVKLTLLVLSYN 454
            +LS+Y N L       +  L  +  + L+ N
Sbjct: 131 NLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 4/129 (3%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
           ++ L +N      P       +L  +DLS+N++S   P +   L  L  L L  N+ + E
Sbjct: 36  EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-E 94

Query: 627 IPIKL-EKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHG 684
           +P  L E    L  L L+ N +   +       + +L  L+L  N L       F  +  
Sbjct: 95  LPKSLFEGLFSLQLLLLNANKI-NCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153

Query: 685 LVYIDISYN 693
           +  + ++ N
Sbjct: 154 IQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 34/114 (29%), Positives = 49/114 (42%), Gaps = 6/114 (5%)

Query: 513 KFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTL 570
            +  L  +D+S N I+  L P+       L  L L  N I  E+P  L   L SL  L L
Sbjct: 54  PYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLL 111

Query: 571 NRNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           N N+ +  L  +    L  L  L L  N+L     G+   L  +  ++L+ N F
Sbjct: 112 NANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 5/116 (4%)

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLSDLDLSHNFLG 648
             + L  N +    PG+     KL  ++LSNNQ S E+     +    L+ L L  N + 
Sbjct: 35  TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKI- 92

Query: 649 EEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
            E+P  +   + SL+ L L  N ++      F+++H L  + +  NKL   I    
Sbjct: 93  TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT-IAKGT 147

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 30/165 (18%), Positives = 51/165 (30%), Gaps = 41/165 (24%)

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIP-----DLRNLTRLARVRL 474
             +  + +  N +    P  +    KL  + LS NQ+   +       LR+L  L    L
Sbjct: 32  ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRSLNSL---VL 87

Query: 475 DRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF---PNLGTLDVSANNITGIL 531
             N +T                                 F    +L  L ++AN I  + 
Sbjct: 88  YGNKIT---------------------------ELPKSLFEGLFSLQLLLLNANKINCL- 119

Query: 532 PPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
             +       L +L L  N +          LR++  + L +N F
Sbjct: 120 RVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 88.7 bits (220), Expect = 3e-18
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 22/237 (9%)

Query: 786  FLSVLTFDRKIAYEEIVRAT---NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSP 841
            FL  L F R + ++ +       + F +   +G GG G V+  ++ ++G++ A KK +  
Sbjct: 162  FLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKK 221

Query: 842  LLSEMTCQQEFLNEVKSLTEIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT 900
             L +    Q  + E K L ++  R IV   Y F +      +V   +  G +   + N  
Sbjct: 222  RLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNVD 280

Query: 901  SAEELGWTQRMNV-IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGI 957
                     R       +   L +LH      I+YRD+  +NVLLD   + +V  SD G+
Sbjct: 281  EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLD--DDGNVRISDLGL 335

Query: 958  SKSLKPDSSNWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            +  LK   +     AGT G++APEL     Y   V    D ++ GV   E I  + P
Sbjct: 336  AVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 88.7 bits (220), Expect = 4e-18
 Identities = 61/268 (22%), Positives = 110/268 (41%), Gaps = 47/268 (17%)

Query: 766  MFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRAT---NDFDEEHCIGTGGQGSV 822
            +F+  +    +  S      +L  + F+R + ++ + R     N F +   +G GG G V
Sbjct: 141  LFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEV 200

Query: 823  YRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVK-FYGFCSHARHS 880
               ++ ++G++ A KK     + +   +   LNE + L ++  R +V   Y + +     
Sbjct: 201  CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD-AL 259

Query: 881  FIVYEYLEMGSLAMILSNAT------------SAEELGWTQRMNVIKGVADALSYLHNDC 928
             +V   +  G L   + +              +AE             +   L  LH + 
Sbjct: 260  CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE-------------ICCGLEDLHRER 306

Query: 929  FPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
               IVYRD+  +N+LLD     H+  SD G++  +    +      GT+GY+APE+    
Sbjct: 307  ---IVYRDLKPENILLD--DHGHIRISDLGLAVHVPEGQTIKG-RVGTVGYMAPEVVKNE 360

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
             YT       D ++ G L  E I G+ P
Sbjct: 361  RYTFSP----DWWALGCLLYEMIAGQSP 384

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.8 bits (213), Expect = 4e-18
 Identities = 46/199 (23%), Positives = 81/199 (40%), Gaps = 31/199 (15%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +G G      +     S +  AVK     + +          E+ +L     H NIVK +
Sbjct: 19   LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT------QKEITALKLCEGHPNIVKLH 72

Query: 872  GFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRM--NVIKGVADALSYLHNDC 928
                   H+F+V E L  G L   I           +++     +++ +  A+S++H+  
Sbjct: 73   EVFHDQLHTFLVMELLNGGELFERIKKKKH------FSETEASYIMRKLVSAVSHMHDVG 126

Query: 929  FPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPEL--- 982
               +V+RD+  +N+L   E +     + DFG ++   PD+        T+ Y APEL   
Sbjct: 127  ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ 183

Query: 983  -AYTMKVTEKSDVYSFGVL 1000
              Y        D++S GV+
Sbjct: 184  NGYDESC----DLWSLGVI 198

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 60/280 (21%), Positives = 100/280 (35%), Gaps = 55/280 (19%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             DF     +G G   +V  A EL++    A+K      + +         E   ++ + H
Sbjct: 30   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRMNVI 914
               VK Y         +    Y + G L   +              +AE           
Sbjct: 90   PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAE----------- 138

Query: 915  KGVADALSYLH-NDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSN---W 968
              +  AL YLH       I++RD+  +N+LL+   + H+  +DFG +K L P+S      
Sbjct: 139  --IVSALEYLHGKG----IIHRDLKPENILLN--EDMHIQITDFGTAKVLSPESKQARAN 190

Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
            +   GT  YV+PEL       + SD+++ G +  + + G  P  F       + N     
Sbjct: 191  S-FVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP--F------RAGNEYLIF 241

Query: 1029 DEILDPRLPAP---SCNIRDKLISIMEVAISCLDENPDSR 1065
             +I+      P       RD L+         L  +   R
Sbjct: 242  QKIIKLEYDFPEKFFPKARD-LVE------KLLVLDATKR 274

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 65/272 (23%), Positives = 111/272 (40%), Gaps = 42/272 (15%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG G    V  A  + +G  VA+K      L+  + Q+ F  EV+ +  + H NIVK + 
Sbjct: 23   IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF-REVRIMKILNHPNIVKLFE 81

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELG---WTQRMNVIKGVADALSYLHNDC 928
                 +  +++ EY   G +   ++++    E+     + Q       +  A+ Y H   
Sbjct: 82   VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ-------IVSAVQYCHQKR 134

Query: 929  FPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AY 984
               IV+RD+ ++N+LLD +    ++DFG S              G   Y APEL     Y
Sbjct: 135  ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYAAPELFQGKKY 190

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SC 1041
                  + DV+S GV+    + G  P D          NL    + +L  +   P   S 
Sbjct: 191  DGP---EVDVWSLGVILYTLVSGSLPFD--------GQNLKELRERVLRGKYRIPFYMST 239

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +  + L+         L  NP  R T++++ +
Sbjct: 240  DCEN-LLKRF------LVLNPIKRGTLEQIMK 264

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 84.3 bits (209), Expect = 2e-17
 Identities = 47/217 (21%), Positives = 85/217 (39%), Gaps = 33/217 (15%)

Query: 799  EEIVRATNDFDEE----HCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFL 853
            +++ R +  F +       IG G      R    ++    AVK            +++  
Sbjct: 11   QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-------KSKRDPT 63

Query: 854  NEVKSL-TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRM 911
             E++ L    +H NI+         ++ ++V E ++ G L   IL     +E     +  
Sbjct: 64   EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER----EAS 119

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH----VSDFGISKSLKPDSSN 967
             V+  +   + YLH      +V+RD+   N+L   E        + DFG +K L+ ++  
Sbjct: 120  AVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176

Query: 968  WTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVL 1000
                  T  +VAPE+     Y        D++S GVL
Sbjct: 177  LMTPCYTANFVAPEVLERQGYDAAC----DIWSLGVL 209

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 86.0 bits (212), Expect = 2e-17
 Identities = 53/324 (16%), Positives = 96/324 (29%), Gaps = 21/324 (6%)

Query: 34  STEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSA 93
           S EEA   + +   L   +  G+ L        +            +H    +    +  
Sbjct: 251 SREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLN 310

Query: 94  GLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIG 153
             +         +        + +           A + +L   +LS    S  +  ++ 
Sbjct: 311 DQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVEK-STVLQSELE 369

Query: 154 NLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
           +   L+ L          I   I  +  L  L   +  L          L  +  M    
Sbjct: 370 SCKELQELEPENKWCLLTI---ILLMRALDPLLYEKETLQ-----YFSTLKAVDPMRAAY 421

Query: 214 NSLSGSI-----PSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSI 268
                S               +  L L +  L+  +   L  L  +  LDL  N L  ++
Sbjct: 422 LDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-AL 478

Query: 269 PLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG-SIPSSLGNLTKLT 327
           P +   L  L++L    N+L  ++   + NL  L  L L  N+L   +    L +  +L 
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLV 536

Query: 328 ILYLSDNLLFGSIPCEIGNLRYLF 351
           +L L  N L          L  + 
Sbjct: 537 LLNLQGNSL-CQEEGIQERLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 84.8 bits (209), Expect = 5e-17
 Identities = 44/273 (16%), Positives = 85/273 (31%), Gaps = 12/273 (4%)

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
            +L    L   L   +        +S  +  L ++               +    +    
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360

Query: 432 LSGAIPKEYGNLVKLTLLVLSYN-QLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIH 490
            +  +  E  +  +L  L       L   I  +R L  L   +    + +  +     + 
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS-TLKAVDPMR 418

Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
           +       S       +            L ++  ++T +    +     +  LDLS N 
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVR--VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNR 474

Query: 551 IVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN-SIPGSLGN 609
           +   +P  L  LR L  L  + N     +   + +L +L+ L L +NRL   +    L +
Sbjct: 475 LR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVS 531

Query: 610 LVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDL 642
             +L  LNL  N    E  I+      L  +  
Sbjct: 532 CPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 84.8 bits (209), Expect = 6e-17
 Identities = 48/225 (21%), Positives = 76/225 (33%), Gaps = 10/225 (4%)

Query: 449 LVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEIS 508
            VL  ++ +    D     +L R  L     T  +         L  +   +K     I 
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI- 388

Query: 509 FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL 568
                   L  L      +      +  D  +   LD   +  + E      +   +  L
Sbjct: 389 --ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446

Query: 569 TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIP 628
            L     +  L   L  L+ + HLDLS NRL  ++P +L  L  L  L  S+N     + 
Sbjct: 447 HLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD 502

Query: 629 IKLEKFIHLSDLDLSHNFLGE-EIPSQVCSMQSLEKLNLAHNNLS 672
             +     L +L L +N L +      + S   L  LNL  N+L 
Sbjct: 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 82.9 bits (204), Expect = 2e-16
 Identities = 43/210 (20%), Positives = 72/210 (34%), Gaps = 9/210 (4%)

Query: 437 PKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYI 496
            ++     +L    LS  +      +L +   L  +  +       I         L Y 
Sbjct: 342 CRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYE 401

Query: 497 NLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIP 556
             + + F    + D         LD   +           +   ++VL L+   +   + 
Sbjct: 402 KETLQYFSTLKAVD---PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVL 456

Query: 557 SELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYL 616
             L +L  +  L L+ N+    LP  L +L  LE L  S N L  ++ G + NL +L  L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQEL 513

Query: 617 NLSNNQFSG-EIPIKLEKFIHLSDLDLSHN 645
            L NN+         L     L  L+L  N
Sbjct: 514 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 79.4 bits (195), Expect = 2e-15
 Identities = 43/251 (17%), Positives = 82/251 (32%), Gaps = 29/251 (11%)

Query: 467 TRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANN 526
             L    L+           +    +     L   +       D      L   ++S   
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFRCELSVEK 360

Query: 527 ITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL------------------ 568
            T +L  E+    +L+ L+  +   +  I   +  L  L+                    
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRA 419

Query: 569 ---TLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
                 R++F  +          +  L L+   L+  +   L  L+ + +L+LS+N+   
Sbjct: 420 AYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR- 476

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF-IPRCFKEMHG 684
            +P  L     L  L  S N L E +   V ++  L++L L +N L      +       
Sbjct: 477 ALPPALAALRCLEVLQASDNAL-ENVDG-VANLPRLQELLLCNNRLQQSAAIQPLVSCPR 534

Query: 685 LVYIDISYNKL 695
           LV +++  N L
Sbjct: 535 LVLLNLQGNSL 545

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 63.6 bits (154), Expect = 2e-10
 Identities = 46/292 (15%), Positives = 89/292 (30%), Gaps = 35/292 (11%)

Query: 276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
            +L   +L       +         S     L  ++             +L    LS   
Sbjct: 302 CDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEK 360

Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNL 395
               +  E+ + + L  LE  +     +I   +  L  L  LY    L   S    +  +
Sbjct: 361 ST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL--LYEKETLQYFSTLKAVDPM 417

Query: 396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
              + L    ++             ++ VL +    L+  +      L+ +T L LS+N+
Sbjct: 418 R-AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNR 474

Query: 456 LQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFP 515
           L+   P L  L  L  ++   N L            N+  +                  P
Sbjct: 475 LRALPPALAALRCLEVLQASDNALE-----------NVDGV---------------ANLP 508

Query: 516 NLGTLDVSANNITGI-LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLI 566
            L  L +  N +        +   P+L +L+L  N +  +      +L  ++
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 559

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 46.7 bits (110), Expect = 4e-05
 Identities = 35/243 (14%), Positives = 81/243 (33%), Gaps = 14/243 (5%)

Query: 462 DLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLD 521
           +  ++     V  +   L+   S    + S +  + L   +    + +      N  +  
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299

Query: 522 VSANNITGILPPEIGDSPQLKVLD--------LSSNHIVGEIPSELGKLRSLIKLTLNRN 573
              +     L  ++       +          +           +      L +  L+  
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359

Query: 574 QFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
           + S  L +EL S  +L+ L+  +     +I   +  L  L Y   +   FS    +K   
Sbjct: 360 K-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFST---LKAVD 415

Query: 634 FIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYN 693
            +  + LD   +    E          +  L+LAH +L+       +++  + ++D+S+N
Sbjct: 416 PMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHN 473

Query: 694 KLH 696
           +L 
Sbjct: 474 RLR 476

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 84.0 bits (208), Expect = 4e-17
 Identities = 59/260 (22%), Positives = 99/260 (38%), Gaps = 56/260 (21%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
            +DF+    IG G    V   ++  +G++ A+K   K+      E++C   F  E   L  
Sbjct: 61   DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC---FREERDVLVN 117

Query: 862  IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNATS-----------AEELGWTQ 909
               R I +  + F     + ++V EY   G L  +LS               AE      
Sbjct: 118  GDRRWITQLHFAFQD-ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE------ 170

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSN 967
                   +  A+  +H       V+RDI   N+LLD     H+  +DFG    L+ D + 
Sbjct: 171  -------IVMAIDSVHRLG---YVHRDIKPDNILLD--RCGHIRLADFGSCLKLRADGTV 218

Query: 968  WTELA-GTIGYVAPELAYTMKVTEKSDVY-------SFGVLALEAIKGKHPRDFISSICS 1019
             + +A GT  Y++PE+   +     +  Y       + GV A E   G+ P  F      
Sbjct: 219  RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP--F------ 270

Query: 1020 TSSNLDRTLDEILDPRLPAP 1039
             + +   T  +I+  +    
Sbjct: 271  YADSTAETYGKIVHYKEHLS 290

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 84.6 bits (209), Expect = 8e-17
 Identities = 62/262 (23%), Positives = 96/262 (36%), Gaps = 33/262 (12%)

Query: 766  MFRRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRAT----NDFDEEHCIGTGGQGS 821
            +F+       Q         F+    F R   ++ +        NDF     IG GG G 
Sbjct: 145  LFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGE 204

Query: 822  VYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI---RHRNIVK-FYGFCSH 876
            VY      +G++ A+K      +     +   LNE   L+ +       IV   Y F + 
Sbjct: 205  VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264

Query: 877  ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNV-IKGVADALSYLHNDCFPPIVYR 935
                  + + +  G L   LS      E      M      +   L ++HN     +VYR
Sbjct: 265  D-KLSFILDLMNGGDLHYHLSQHGVFSE----ADMRFYAAEIILGLEHMHNRF---VVYR 316

Query: 936  DISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPEL-----AYTMKV 988
            D+   N+LLD     HV  SD G++        +     GT GY+APE+     AY    
Sbjct: 317  DLKPANILLD--EHGHVRISDLGLACDFSKKKPH--ASVGTHGYMAPEVLQKGVAYDSSA 372

Query: 989  TEKSDVYSFGVLALEAIKGKHP 1010
                D +S G +  + ++G  P
Sbjct: 373  ----DWFSLGCMLFKLLRGHSP 390

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 82.8 bits (205), Expect = 9e-17
 Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 53/256 (20%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             D++    IG G  G V      S+ ++ A+K      + + +    F  E   +     
Sbjct: 69   EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128

Query: 865  RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT---------SAEELGWTQRMNVI 914
              +V+ FY F    R+ ++V EY+  G L  ++SN           +AE           
Sbjct: 129  PWVVQLFYAFQD-DRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAE----------- 176

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELA 972
              V  AL  +H+      ++RD+   N+LLD     H+  +DFG    +  +     + A
Sbjct: 177  --VVLALDAIHSMG---FIHRDVKPDNMLLD--KSGHLKLADFGTCMKMNKEGMVRCDTA 229

Query: 973  -GTIGYVAPEL--------AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
             GT  Y++PE+         Y  +     D +S GV   E + G  P  F       + +
Sbjct: 230  VGTPDYISPEVLKSQGGDGYYGREC----DWWSVGVFLYEMLVGDTP--F------YADS 277

Query: 1024 LDRTLDEILDPRLPAP 1039
            L  T  +I++ +    
Sbjct: 278  LVGTYSKIMNHKNSLT 293

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 83.1 bits (206), Expect = 1e-16
 Identities = 89/475 (18%), Positives = 146/475 (30%), Gaps = 93/475 (19%)

Query: 253 NLATLDLHDNSLS-GSIPLSFGNLTNLDILNLPHNSLS----GSIPSEMGNLKSLYGLGL 307
           ++ +LD+    LS          L    ++ L    L+      I S +    +L  L L
Sbjct: 4   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 63

Query: 308 SFNKLSGSIPSSLGNL-----TKLTILYLSDNLL----FGSIPCEIGNLRYLFYLELGDN 358
             N+L       +         K+  L L +  L     G +   +  L  L  L L DN
Sbjct: 64  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 123

Query: 359 KLSGSIPHSLG-----NLTNLATLYLFTNLLS----GSIPSEIGNLNSLSDLGLSENELS 409
            L  +    L          L  L L    LS      + S +       +L +S N+++
Sbjct: 124 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183

Query: 410 GSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL-----QGPIPDLR 464
            +                    L   +     +  +L  L L    +     +     + 
Sbjct: 184 EAG----------------VRVLCQGLKD---SPCQLEALKLESCGVTSDNCRDLCGIVA 224

Query: 465 NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA 524
           +   L  + L  N L        G+      +     +              L TL +  
Sbjct: 225 SKASLRELALGSNKLG-----DVGMAELCPGLLHPSSR--------------LRTLWIWE 265

Query: 525 NNIT----GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKL-----RSLIKLTLNRNQF 575
             IT    G L   +     LK L L+ N +  E    L +        L  L +    F
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325

Query: 576 SGQLPTELGSLIQ----LEHLDLSSNRLSNSIPGSLG-----NLVKLYYLNLSNNQFSGE 626
           +    +   S++     L  L +S+NRL ++    L          L  L L++   S  
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDS 385

Query: 627 ----IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSM-----QSLEKLNLAHNNLS 672
               +   L     L +LDLS+N LG+    Q+          LE+L L     S
Sbjct: 386 SCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 78.9 bits (195), Expect = 3e-15
 Identities = 76/414 (18%), Positives = 133/414 (32%), Gaps = 76/414 (18%)

Query: 350 LFYLELGDNKLS-GSIPHSLGNLTNLATLYLFTNLLS----GSIPSEIGNLNSLSDLGLS 404
           +  L++   +LS       L  L     + L    L+      I S +    +L++L L 
Sbjct: 5   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64

Query: 405 ENELSGS--------IPYSFGNLTNMIVLSIYSNALS----GAIPKEYGNLVKLTLLVLS 452
            NEL           +      +     LS+ +  L+    G +      L  L  L LS
Sbjct: 65  SNELGDVGVHCVLQGLQTPSCKIQK---LSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 453 YNQLQGP------IPDLRNLTRLARVRLDRNHLT----GNISESFGIHSNLSYINLSHKK 502
            N L            L    RL +++L+   L+      ++       +   + +S+  
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 503 FYGEISFDWG--------KFPN--LGTLDVSANNIT----GILPPEIGDSPQLKVLDLSS 548
                  + G        K     L  L + +  +T      L   +     L+ L L S
Sbjct: 182 IN-----EAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236

Query: 549 NHIVGE-----IPSELGKLRSLIKLTLNRNQFSGQ----LPTELGSLIQLEHLDLSSNRL 599
           N +         P  L     L  L +     + +    L   L +   L+ L L+ N L
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNEL 296

Query: 600 SNSIPGSLGNLVK-----LYYLNLSNNQFSGE----IPIKLEKFIHLSDLDLSHNFLGEE 650
            +     L   +      L  L + +  F+          L +   L +L +S+N L + 
Sbjct: 297 GDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDA 356

Query: 651 IPSQVCSM-----QSLEKLNLAHNNLS----GFIPRCFKEMHGLVYIDISYNKL 695
              ++C         L  L LA  ++S      +       H L  +D+S N L
Sbjct: 357 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCL 410

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 71.5 bits (176), Expect = 6e-13
 Identities = 69/418 (16%), Positives = 120/418 (28%), Gaps = 69/418 (16%)

Query: 105 SSFPHLAYLDLRVNQI----FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL----- 155
                   + L    +       I S +  N  L  L+L SN         +        
Sbjct: 25  PLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPS 84

Query: 156 SMLKILYLSTNQFSGR----IPPQIGHLSYLKALHLFENGLSGSIPPSLG-----NLTNL 206
             ++ L L     +G     +   +  L  L+ LHL +N L  +    L          L
Sbjct: 85  CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144

Query: 207 AIMYLYNNSLS----GSIPSEIGNLKSLSGLELGYNKLS--GSMPLSLG---NLPNLATL 257
             + L   SLS      + S +        L +  N ++  G   L  G   +   L  L
Sbjct: 145 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEAL 204

Query: 258 DLHDNSLS----GSIPLSFGNLTNLDILNLPHNSLSGS-----IPSEMGNLKSLYGLGLS 308
            L    ++      +     +  +L  L L  N L         P  +     L  L + 
Sbjct: 205 KLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIW 264

Query: 309 FNKLS----GSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNL-----RYLFYLELGDNK 359
              ++    G +   L     L  L L+ N L       +          L  L +    
Sbjct: 265 ECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCS 324

Query: 360 LSG----SIPHSLGNLTNLATLYLFTNLLSGSIPSEIG-----NLNSLSDLGLSENELS- 409
            +          L     L  L +  N L  +   E+        + L  L L++ ++S 
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384

Query: 410 ---GSIPYSFGNLTNMIVLSIYSN--------ALSGAIPKEYGNLVKLTLLVLSYNQL 456
               S+  +     ++  L + +N         L  ++ +       L  LVL     
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ---PGCLLEQLVLYDIYW 439

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 68.8 bits (169), Expect = 4e-12
 Identities = 84/494 (17%), Positives = 154/494 (31%), Gaps = 103/494 (20%)

Query: 131 NSKLKYLDLSSNSFSGT-IPPQIGNLSMLKILYLSTNQFSGR----IPPQIGHLSYLKAL 185
           +  ++ LD+     S       +  L   +++ L     +      I   +     L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 186 HLFENGLSGSIPPSLGNL-----TNLAIMYLYNNSLS----GSIPSEIGNLKSLSGLELG 236
           +L  N L       +          +  + L N  L+    G + S +  L +L  L L 
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 237 YNKL--SGSMPLSLGNLPN---LATLDLHDNSLS----GSIPLSFGNLTNLDILNLPHNS 287
            N L  +G   L  G L     L  L L   SLS      +        +   L + +N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 288 LSGS--------IPSEMGNLKSLYGLGLSFNKLS----GSIPSSLGNLTKLTILYLSDNL 335
           ++ +        +      L++L    L    ++      +   + +   L  L L  N 
Sbjct: 182 INEAGVRVLCQGLKDSPCQLEALK---LESCGVTSDNCRDLCGIVASKASLRELALGSN- 237

Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS----GSIPSE 391
                             +LGD  ++   P  L   + L TL+++   ++    G +   
Sbjct: 238 ------------------KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV 279

Query: 392 IGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVL 451
           +    SL +L L+ NEL        G           +  L   + +      +L  L +
Sbjct: 280 LRAKESLKELSLAGNELGDE-----G-----------ARLLCETLLE---PGCQLESLWV 320

Query: 452 SYNQL-----QGPIPDLRNLTRLARVRLDRNHLTG----NISESFGI-HSNLSYINLSHK 501
                           L     L  +++  N L       + +  G   S L  + L+  
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 502 KF----YGEISFDWGKFPNLGTLDVSANNIT--GILPPEIGDS-----PQLKVLDLSSNH 550
                    ++       +L  LD+S N +   GIL  ++ +S       L+ L L   +
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL--QLVESVRQPGCLLEQLVLYDIY 438

Query: 551 IVGEIPSELGKLRS 564
              E+   L  L  
Sbjct: 439 WSEEMEDRLQALEK 452

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 67.3 bits (165), Expect = 1e-11
 Identities = 36/181 (19%), Positives = 68/181 (37%), Gaps = 23/181 (12%)

Query: 538 SPQLKVLDLSSNHIVGEIPSELGK-LRSLIKLTLNRNQFSGQLPTELGSLIQ----LEHL 592
           S  ++ LD+    +     +EL   L+    + L+    +     ++ S ++    L  L
Sbjct: 2   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61

Query: 593 DLSSNRLSNSIPGSLGNLVK-----LYYLNLSNNQFSGE----IPIKLEKFIHLSDLDLS 643
           +L SN L +     +   ++     +  L+L N   +G     +   L     L +L LS
Sbjct: 62  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLS 121

Query: 644 HNFLGEEIPSQVCSMQ-----SLEKLNLAHNNLS----GFIPRCFKEMHGLVYIDISYNK 694
            N LG+     +C         LEKL L + +LS      +    +       + +S N 
Sbjct: 122 DNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181

Query: 695 L 695
           +
Sbjct: 182 I 182

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 66.5 bits (163), Expect = 2e-11
 Identities = 62/351 (17%), Positives = 110/351 (31%), Gaps = 56/351 (15%)

Query: 86  NSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQI-----FGIIPSQIANNSKLKYLDLS 140
             +     G++ +       + P L  L L  N +       +    +    +L+ L L 
Sbjct: 95  CCLTGAGCGVLSST----LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLE 150

Query: 141 SNSFSGTIPPQIG----NLSMLKILYLSTNQFSGR----IPPQIGHLSY-LKALHLFENG 191
             S S      +          K L +S N  +      +   +      L+AL L   G
Sbjct: 151 YCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCG 210

Query: 192 LS----GSIPPSLGNLTNLAIMYLYNNSLSGS-----IPSEIGNLKSLSGLELGYNKLS- 241
           ++      +   + +  +L  + L +N L         P  +     L  L +    ++ 
Sbjct: 211 VTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITA 270

Query: 242 -GSMPLS--LGNLPNLATLDLHDNSL--SGSIPLSFG---NLTNLDILNLPHNSLSG--- 290
            G   L   L    +L  L L  N L   G+  L          L+ L +   S +    
Sbjct: 271 KGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACC 330

Query: 291 -SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG-----NLTKLTILYLSDNLLFGSIPCE- 343
               S +   + L  L +S N+L  +    L        + L +L+L+D  +     C  
Sbjct: 331 SHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV-SDSSCSS 389

Query: 344 ----IGNLRYLFYLELGDNKLSGSIPHSLG-----NLTNLATLYLFTNLLS 385
               +     L  L+L +N L  +    L          L  L L+    S
Sbjct: 390 LAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 81.7 bits (202), Expect = 1e-16
 Identities = 60/273 (21%), Positives = 106/273 (38%), Gaps = 43/273 (15%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVK-----KFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI 867
            +G+G  G V+ A      + V VK     K       E     +   E+  L+ + H NI
Sbjct: 32   LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 868  VKFYGFCSHARHSFIVYEYLEMGS--LAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            +K      +     +V E    G    A I  +    E L       + + +  A+ YL 
Sbjct: 92   IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA---S-YIFRQLVSAVGYLR 147

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL--- 982
                  I++RDI  +N+++  ++   + DFG +  L+     +T   GTI Y APE+   
Sbjct: 148  LKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT-FCGTIEYCAPEVLMG 203

Query: 983  -AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD-EILDPRLPAPS 1040
              Y      + +++S GV     +  ++P             L+ T++  I  P L +  
Sbjct: 204  NPYRGP---ELEMWSLGVTLYTLVFEENPFC----------ELEETVEAAIHPPYLVSKE 250

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                  L+S +      L   P+ R T++K+  
Sbjct: 251  LM---SLVSGL------LQPVPERRTTLEKLVT 274

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 82.5 bits (204), Expect = 2e-16
 Identities = 62/261 (23%), Positives = 102/261 (39%), Gaps = 56/261 (21%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
             DF+    IG G  G V   +L ++ ++ A+K   K+     +E  C   F  E   L  
Sbjct: 74   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC---FREERDVLVN 130

Query: 862  IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT-----------SAEELGWTQ 909
               + I    Y F     + ++V +Y   G L  +LS               AE      
Sbjct: 131  GDSKWITTLHYAFQD-DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE------ 183

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSN 967
                   +  A+  +H       V+RDI   N+L+D     H+  +DFG    L  D + 
Sbjct: 184  -------MVIAIDSVHQLH---YVHRDIKPDNILMD--MNGHIRLADFGSCLKLMEDGTV 231

Query: 968  WTELA-GTIGYVAPELAYTMKVTEKS-----DVYSFGVLALEAIKGKHPRDFISSICSTS 1021
             + +A GT  Y++PE+   M+  +       D +S GV   E + G+ P  F       +
Sbjct: 232  QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP--F------YA 283

Query: 1022 SNLDRTLDEILD--PRLPAPS 1040
             +L  T  +I++   R   P+
Sbjct: 284  ESLVETYGKIMNHKERFQFPT 304

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 80.0 bits (198), Expect = 3e-16
 Identities = 63/278 (22%), Positives = 103/278 (37%), Gaps = 51/278 (18%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEIR----HR 865
            +G GG G+V+    L+    VA+K   +      S ++       EV  L ++     H 
Sbjct: 39   LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGS--LAMILSNATSAEELGWTQRMNVIKGVADALSY 923
             +++   +        +V E           I       E      R      V  A+ +
Sbjct: 99   GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPS---R-CFFGQVVAAIQH 154

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
             H+     +V+RDI  +N+L+DL    A + DFG   +L  D   +T+  GT  Y  PE 
Sbjct: 155  CHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHD-EPYTDFDGTRVYSPPEW 209

Query: 983  ----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
                 Y       + V+S G+L  + + G  P +                 EIL+  L  
Sbjct: 210  ISRHQYHAL---PATVWSLGILLYDMVCGDIPFE------------RD--QEILEAELHF 252

Query: 1039 P---SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            P   S +    LI        CL   P SRP+++++  
Sbjct: 253  PAHVSPDCCA-LIR------RCLAPKPSSRPSLEEILL 283

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 57/155 (36%), Positives = 77/155 (49%), Gaps = 10/155 (6%)

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGS 315
           LDL    L+     +F  LT L  LNL +N L  ++ + +  +L  L  LGL+ N+L+ S
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 316 IPSSL-GNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSL-GNLT 372
           +P  +  +LT+L  LYL  N L  S+P  +   L  L  L L  N+L  SIP      LT
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 373 NLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSEN 406
           NL TL L TN L  S+P      L  L  + L  N
Sbjct: 156 NLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 61/191 (31%), Positives = 83/191 (43%), Gaps = 32/191 (16%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
           S+P   G   +   + L +  L+    +    L  L+ L L YN+L         +L  L
Sbjct: 28  SVPS--GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTEL 85

Query: 255 ATLDLHDNSLSGSIPLS-FGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS 313
            TL L +N L+ S+PL  F +LT LD L L  N L  S+PS +            F++  
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV------------FDR-- 129

Query: 314 GSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPH-SLGNL 371
                    LTKL  L L+ N L  SIP      L  L  L L  N+L  S+PH +   L
Sbjct: 130 ---------LTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRL 178

Query: 372 TNLATLYLFTN 382
             L T+ LF N
Sbjct: 179 GKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 74.7 bits (184), Expect = 7e-15
 Identities = 45/154 (29%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGR 171
           LDL+   +  +  +     +KL +L+L  N    T+   +  +L+ L  L L+ NQ +  
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 172 IPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLK 228
           +P  +  HL+ L  L+L  N L  S+P  +   LT L  + L  N L  SIP+     L 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDN 262
           +L  L L  N+L      +   L  L T+ L  N
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 54/168 (32%), Positives = 75/168 (44%), Gaps = 12/168 (7%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYL 182
           +PS I  +++   LDL S   +         L+ L  L L  NQ    +   +   L+ L
Sbjct: 29  VPSGIPADTE--KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTEL 85

Query: 183 KALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKL 240
             L L  N L+ S+P  +  +LT L  +YL  N L  S+PS +   L  L  L L  N+L
Sbjct: 86  GTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL 143

Query: 241 SGSMPLSL-GNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
             S+P      L NL TL L  N L  S+P  +F  L  L  + L  N
Sbjct: 144 Q-SIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 54/155 (34%), Positives = 77/155 (49%), Gaps = 8/155 (5%)

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGS 363
           L L    L+    ++   LTKLT L L  N L  ++   +  +L  L  L L +N+L+ S
Sbjct: 40  LDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-S 97

Query: 364 IPHSL-GNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYS-FGNLT 420
           +P  +  +LT L  LYL  N L  S+PS +   L  L +L L+ N+L  SIP   F  LT
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 421 NMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
           N+  LS+ +N L       +  L KL  + L  NQ
Sbjct: 156 NLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 45/147 (30%), Positives = 68/147 (46%), Gaps = 8/147 (5%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GN 154
           + TL D +F     L +L+L  NQ+  +      + ++L  L L++N  + ++P  +  +
Sbjct: 47  LATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDH 105

Query: 155 LSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLY 212
           L+ L  LYL  NQ    +P  +   L+ LK L L  N L  SIP      LTNL  + L 
Sbjct: 106 LTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLS 163

Query: 213 NNSLSGSIPSEI-GNLKSLSGLELGYN 238
            N L  S+P      L  L  + L  N
Sbjct: 164 TNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 14/160 (8%)

Query: 471 RVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF---PNLGTLDVSANNI 527
           ++ L    L      +F   + L+++NL + +     +   G F     LGTL ++ N +
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL---QTLSAGVFDDLTELGTLGLANNQL 95

Query: 528 TGILPPEIGDSP-QLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSGQLPTEL-G 584
              LP  + D   QL  L L  N +   +PS +  +L  L +L LN NQ    +P     
Sbjct: 96  AS-LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152

Query: 585 SLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQF 623
            L  L+ L LS+N+L  S+P G+   L KL  + L  NQF
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 48/181 (26%), Positives = 69/181 (38%), Gaps = 29/181 (16%)

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG-PIPDLRNLTRLARVRLDRNH 478
            +   L + S  L+      +  L KLT L L YNQLQ        +LT L  + L  N 
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQ 94

Query: 479 LTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS 538
           L    S   G+                   FD      L  L +  N +   LP  + D 
Sbjct: 95  LA---SLPLGV-------------------FD--HLTQLDKLYLGGNQLKS-LPSGVFDR 129

Query: 539 -PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSS 596
             +LK L L++N +   IP+    KL +L  L+L+ NQ           L +L+ + L  
Sbjct: 130 LTKLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188

Query: 597 N 597
           N
Sbjct: 189 N 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 57.4 bits (139), Expect = 5e-09
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 5/112 (4%)

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSIYSN 430
            +   L L +  L+    +    L  L+ L L  N+L  ++    F +LT +  L + +N
Sbjct: 35  ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANN 93

Query: 431 ALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLT 480
            L+      + +L +L  L L  NQL+  +P      LT+L  +RL+ N L 
Sbjct: 94  QLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ 144

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 9/141 (6%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS-- 624
           KL L     +         L +L  L+L  N+L     G   +L +L  L L+NNQ +  
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASL 98

Query: 625 -GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEM 682
              +   L +   L  L L  N L + +PS V   +  L++L L  N L       F ++
Sbjct: 99  PLGVFDHLTQ---LDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKL 154

Query: 683 HGLVYIDISYNKLHGPIPNSA 703
             L  + +S N+L   +P+ A
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGA 174

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 41.6 bits (98), Expect = 8e-04
 Identities = 31/107 (28%), Positives = 45/107 (42%), Gaps = 2/107 (1%)

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE 649
           E LDL S  L+     +   L KL +LNL  NQ         +    L  L L++N L  
Sbjct: 38  EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQL-A 96

Query: 650 EIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
            +P  V   +  L+KL L  N L       F  +  L  + ++ N+L
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQL 143

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 78.2 bits (193), Expect = 3e-16
 Identities = 44/131 (33%), Positives = 64/131 (48%), Gaps = 11/131 (8%)

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHN---SLSGSIPSEMGNLKSLYGLGLSFNKLS 313
           L LHDN ++   P  F +L NL  L L  N   +L   +   +  L  L    L  N+L+
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD---LGTNQLT 101

Query: 314 GSIPSSL-GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH-SLGNL 371
             +PS++   L  L  L++  N L   +P  I  L +L +L L  N+L  SIPH +   L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRL 158

Query: 372 TNLATLYLFTN 382
           ++L   YLF N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 50/154 (32%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
           T+D      + S+P   G  TN  IL L  N ++   P    +L +L  L L  N+L  +
Sbjct: 23  TVDCRSKRHA-SVPA--GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-A 78

Query: 316 IPSSL-GNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLGNLTN 373
           +P  +  +LT+LT+L L  N L   +P  +   L +L  L +  NKL+  +P  +  LT+
Sbjct: 79  LPVGVFDSLTQLTVLDLGTNQL-TVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH 136

Query: 374 LATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSEN 406
           L  L L  N L  SIP      L+SL+   L  N
Sbjct: 137 LTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 7/141 (4%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYL 182
           +P+ I  N++   L L  N  +   P    +L  LK LYL +NQ    +P  +   L+ L
Sbjct: 34  VPAGIPTNAQ--ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90

Query: 183 KALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS 241
             L L  N L+  +P ++   L +L  +++  N L+  +P  I  L  L+ L L  N+L 
Sbjct: 91  TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148

Query: 242 GSMPLSLGNLPNLATLDLHDN 262
                +   L +L    L  N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 44/131 (33%), Positives = 64/131 (48%), Gaps = 7/131 (5%)

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLS 217
           +ILYL  NQ +   P     L  LK L+L  N L  ++P  +  +LT L ++ L  N L+
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101

Query: 218 GSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNL 275
             +PS +   L  L  L +  NKL+  +P  +  L +L  L L  N L  SIP  +F  L
Sbjct: 102 -VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRL 158

Query: 276 TNLDILNLPHN 286
           ++L    L  N
Sbjct: 159 SSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 64.3 bits (157), Expect = 1e-11
 Identities = 40/129 (31%), Positives = 69/129 (53%), Gaps = 7/129 (5%)

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGS 363
           L L  N+++   P    +L  L  LYL  N L G++P  +  +L  L  L+LG N+L+  
Sbjct: 45  LYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 364 IPHSL-GNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPY-SFGNLTN 421
           +P ++   L +L  L++  N L+  +P  I  L  L+ L L +N+L  SIP+ +F  L++
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSS 160

Query: 422 MIVLSIYSN 430
           +    ++ N
Sbjct: 161 LTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 42/130 (32%), Positives = 60/130 (46%), Gaps = 7/130 (5%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSG 170
            L L  NQI  + P    +   LK L L SN     +P  +  +L+ L +L L TNQ + 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 171 RIPPQI-GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLK 228
            +P  +   L +LK L +  N L+  +P  +  LT+L  + L  N L  SIP      L 
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLS 159

Query: 229 SLSGLELGYN 238
           SL+   L  N
Sbjct: 160 SLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 41/130 (31%), Positives = 63/130 (48%), Gaps = 8/130 (6%)

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSG 410
            L L DN+++   P    +L NL  LYL +N L  ++P  +  +L  L+ L L  N+L+ 
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT- 101

Query: 411 SIPYS-FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLT 467
            +P + F  L ++  L +  N L+  +P+    L  LT L L  NQL+  IP      L+
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLS 159

Query: 468 RLARVRLDRN 477
            L    L  N
Sbjct: 160 SLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 4/129 (3%)

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSIYSN 430
           TN   LYL  N ++   P    +L +L +L L  N+L  ++P   F +LT + VL + +N
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98

Query: 431 ALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGI 489
            L+      +  LV L  L +  N+L   +P  +  LT L  + LD+N L      +F  
Sbjct: 99  QLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDR 157

Query: 490 HSNLSYINL 498
            S+L++  L
Sbjct: 158 LSSLTHAYL 166

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 34/106 (32%), Positives = 52/106 (49%), Gaps = 3/106 (2%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
            L L+ NQ +   P    SLI L+ L L SN+L     G   +L +L  L+L  NQ +  
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT-V 102

Query: 627 IPIKL-EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNL 671
           +P  + ++ +HL +L +  N L  E+P  +  +  L  L L  N L
Sbjct: 103 LPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQL 147

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 36/124 (29%), Positives = 57/124 (45%), Gaps = 11/124 (8%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGI---IPSQIANNSKLKYLDLSSNSFSGTIPPQI 152
           I  L    F S  +L  L L  NQ+  +   +   +     L  LDL +N  +  +P  +
Sbjct: 52  ITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLGTNQLT-VLPSAV 107

Query: 153 -GNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMY 210
              L  LK L++  N+ +  +P  I  L++L  L L +N L  SIP  +   L++L   Y
Sbjct: 108 FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAY 165

Query: 211 LYNN 214
           L+ N
Sbjct: 166 LFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 37/136 (27%), Positives = 58/136 (42%), Gaps = 3/136 (2%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDL 546
           GI +N   + L   +        +    NL  L + +N +   LP  + DS  QL VLDL
Sbjct: 37  GIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDL 95

Query: 547 SSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS 606
            +N +     +   +L  L +L +  N+ +  LP  +  L  L HL L  N+L +   G+
Sbjct: 96  GTNQLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGA 154

Query: 607 LGNLVKLYYLNLSNNQ 622
              L  L +  L  N 
Sbjct: 155 FDRLSSLTHAYLFGNP 170

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 40/179 (22%), Positives = 60/179 (33%), Gaps = 50/179 (27%)

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHL 479
           TN  +L ++ N ++   P  + +L+ L  L L  NQL                       
Sbjct: 40  TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG---------------------- 77

Query: 480 TGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS- 538
               +   G+                   FD      L  LD+  N +T  LP  + D  
Sbjct: 78  ----ALPVGV-------------------FD--SLTQLTVLDLGTNQLTV-LPSAVFDRL 111

Query: 539 PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
             LK L +  N +  E+P  + +L  L  L L++NQ           L  L H  L  N
Sbjct: 112 VHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 44.3 bits (105), Expect = 9e-05
 Identities = 32/115 (27%), Positives = 55/115 (47%), Gaps = 4/115 (3%)

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE 649
           + L L  N+++   PG   +L+ L  L L +NQ         +    L+ LDL  N L  
Sbjct: 43  QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQL-T 101

Query: 650 EIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
            +PS V   +  L++L +  N L+  +PR  + +  L ++ +  N+L   IP+ A
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGA 154

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 79.6 bits (197), Expect = 5e-16
 Identities = 57/252 (22%), Positives = 100/252 (39%), Gaps = 50/252 (19%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRMNVI 914
              +VK         + ++V EY+  G +   L              +A+           
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQ----------- 149

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELA 972
              +     YLH+     ++YRD+  +N+L+D   + ++  +DFG +K  +     WT L 
Sbjct: 150  --IVLTFEYLHSLD---LIYRDLKPENLLID--QQGYIQVTDFGFAK--RVKGRTWT-LC 199

Query: 973  GTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
            GT   +APE+     Y   V    D ++ GVL  E   G  P  F       +    +  
Sbjct: 200  GTPEALAPEIILSKGYNKAV----DWWALGVLIYEMAAGYPP--F------FADQPIQIY 247

Query: 1029 DEILDPRLPAPS 1040
            ++I+  ++  PS
Sbjct: 248  EKIVSGKVRFPS 259

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 32/167 (19%), Positives = 62/167 (37%), Gaps = 31/167 (18%)

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSL-GNLPNLATLDLHDNSLSGSIPLSFGNLTN 277
            IP  I   +  + L L  N+ +      +   LP L  ++  +N ++     +F   + 
Sbjct: 25  KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASG 82

Query: 278 LDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
           ++ + L  N L  ++  +M            F             L  L  L L  N + 
Sbjct: 83  VNEILLTSNRLE-NVQHKM------------FKG-----------LESLKTLMLRSNRI- 117

Query: 338 GSIPCEI-GNLRYLFYLELGDNKLSGSIPH-SLGNLTNLATLYLFTN 382
             +  +    L  +  L L DN+++ ++   +   L +L+TL L  N
Sbjct: 118 TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 30/133 (22%), Positives = 61/133 (45%), Gaps = 9/133 (6%)

Query: 159 KILYLSTNQFSGRIPPQIG--HLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNS 215
             L L+ N+F+  +        L  L+ ++   N ++  I   +    + +  + L +N 
Sbjct: 35  AELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNR 92

Query: 216 LSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFG 273
           L  ++  ++   L+SL  L L  N+++     S   L ++  L L+DN ++ ++   +F 
Sbjct: 93  LE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFD 150

Query: 274 NLTNLDILNLPHN 286
            L +L  LNL  N
Sbjct: 151 TLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 26/115 (22%), Positives = 51/115 (44%), Gaps = 6/115 (5%)

Query: 103 SFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKIL 161
            F   P L  ++   N+I  I        S +  + L+SN     +  ++   L  LK L
Sbjct: 52  IFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTL 110

Query: 162 YLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNN 214
            L +N+ +  +       LS ++ L L++N ++ ++ P +   L +L+ + L  N
Sbjct: 111 MLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 29/114 (25%), Positives = 49/114 (42%), Gaps = 6/114 (5%)

Query: 513 KFPNLGTLDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTL 570
           K P L  ++ S N IT  +     +    +  + L+SN +   +  ++   L SL  L L
Sbjct: 55  KLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLML 112

Query: 571 NRNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
             N+ +  +  +    L  +  L L  N+++   PG+   L  L  LNL  N F
Sbjct: 113 RSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 31/141 (21%), Positives = 50/141 (35%), Gaps = 7/141 (4%)

Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSE--LGKLRSLIKLTLNRNQFSGQLPTELGSLIQL 589
           P  I        L L++N     + +     KL  L K+  + N+ +            +
Sbjct: 27  PEHI--PQYTAELRLNNNEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL-EKFIHLSDLDLSHNFLG 648
             + L+SNRL N        L  L  L L +N+ +  +          +  L L  N + 
Sbjct: 84  NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142

Query: 649 EEIPSQVCSMQSLEKLNLAHN 669
              P    ++ SL  LNL  N
Sbjct: 143 TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 62.0 bits (151), Expect = 8e-11
 Identities = 33/148 (22%), Positives = 62/148 (41%), Gaps = 11/148 (7%)

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPH-SLGNLT 372
            IP  +   T    L L++N         I   L  L  +   +NK++  I   +    +
Sbjct: 25  KIPEHIPQYT--AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS 81

Query: 373 NLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIP-YSFGNLTNMIVLSIYSN 430
            +  + L +N L  ++  ++   L SL  L L  N ++  +   SF  L+++ +LS+Y N
Sbjct: 82  GVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139

Query: 431 ALSGAIPKE-YGNLVKLTLLVLSYNQLQ 457
            ++  +    +  L  L+ L L  N   
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLANPFN 166

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 28/130 (21%), Positives = 52/130 (40%), Gaps = 4/130 (3%)

Query: 372 TNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
              A L L  N  +    + I   L  L  +  S N+++     +F   + +  + + SN
Sbjct: 32  QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91

Query: 431 ALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFG 488
            L     K +  L  L  L+L  N++   + +     L+ +  + L  N +T     +F 
Sbjct: 92  RLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150

Query: 489 IHSNLSYINL 498
              +LS +NL
Sbjct: 151 TLHSLSTLNL 160

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 24/115 (20%), Positives = 52/115 (45%), Gaps = 6/115 (5%)

Query: 592 LDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQFSGEIPIK-LEKFIHLSDLDLSHNFLGE 649
           L L++N  +     G    L +L  +N SNN+ + +I     E    ++++ L+ N L E
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRL-E 94

Query: 650 EIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
            +  ++   ++SL+ L L  N ++      F  +  +  + +  N++   +   A
Sbjct: 95  NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 27/129 (20%), Positives = 48/129 (37%), Gaps = 9/129 (6%)

Query: 64  NNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGI 123
           N  T +     F        ++  IN ++   I  + + +F     +  + L  N++  +
Sbjct: 42  NEFTVLEATGIF----KKLPQLRKINFSNNK-ITDIEEGAFEGASGVNEILLTSNRLENV 96

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGRIPPQI-GHLSY 181
                     LK L L SN  +  +       LS +++L L  NQ +  + P     L  
Sbjct: 97  QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154

Query: 182 LKALHLFEN 190
           L  L+L  N
Sbjct: 155 LSTLNLLAN 163

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 64/232 (27%), Positives = 96/232 (41%), Gaps = 49/232 (21%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLS--GSIPSEMGNLKSLYGLGLSFNKLS 313
             +L   S++     +   L ++D +   ++ +     I      L ++  L L  NKL 
Sbjct: 23  KANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH 76

Query: 314 GSIPSSLG---NLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPHSLG 369
                 +     LT LT L L+ N L  S+P  +   L  L  L L +N+L  S+P  + 
Sbjct: 77  -----DISALKELTNLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVF 129

Query: 370 N-LTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSI 427
           + LTNL  L L  N L  S+P  +   L +L++L LS N+L  S+P              
Sbjct: 130 DKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLP-------------- 173

Query: 428 YSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
                 G   K    L +L  L L  NQL+  +PD     LT L  + L  N
Sbjct: 174 -----EGVFDK----LTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 40/228 (17%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGR 171
             +L+   +   +       + +  +  +++         I  L  ++ L L  N+    
Sbjct: 23  KANLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVRYLALGGNK---- 74

Query: 172 IPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSL 230
                     L  +   +             LTNL  + L  N L  S+P+ +   L +L
Sbjct: 75  ----------LHDISALK------------ELTNLTYLILTGNQLQ-SLPNGVFDKLTNL 111

Query: 231 SGLELGYNKLSGSMPLSLGN-LPNLATLDLHDNSLSGSIPLS-FGNLTNLDILNLPHNSL 288
             L L  N+L  S+P  + + L NL  L+L  N L  S+P   F  LTNL  L+L +N L
Sbjct: 112 KELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL 169

Query: 289 SGSIPSEM-GNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLTILYLSDN 334
             S+P  +   L  L  L L  N+L  S+P      LT L  ++L DN
Sbjct: 170 Q-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 57/182 (31%), Positives = 85/182 (46%), Gaps = 19/182 (10%)

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI 364
             L    ++    +    L  +  +  +++ +  S+   I  L  + YL LG NKL    
Sbjct: 24  ANLKKKSVT-DAVTQNE-LNSIDQIIANNSDI-KSVQ-GIQYLPNVRYLALGGNKLH--- 76

Query: 365 PHSLG---NLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSGSIPYS-FGNL 419
              +     LTNL  L L  N L  S+P+ +   L +L +L L EN+L  S+P   F  L
Sbjct: 77  --DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKL 132

Query: 420 TNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
           TN+  L++  N L       +  L  LT L LSYNQLQ  +P+     LT+L  +RL +N
Sbjct: 133 TNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQN 191

Query: 478 HL 479
            L
Sbjct: 192 QL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 50/167 (29%), Positives = 74/167 (44%), Gaps = 16/167 (9%)

Query: 103 SFSSFPHLAYLDLRVNQI--FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLK 159
                P++ YL L  N++     +       + L YL L+ N    ++P  +   L+ LK
Sbjct: 58  GIQYLPNVRYLALGGNKLHDISALKEL----TNLTYLILTGNQLQ-SLPNGVFDKLTNLK 112

Query: 160 ILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLS 217
            L L  NQ    +P  +   L+ L  L+L  N L  S+P  +   LTNL  + L  N L 
Sbjct: 113 ELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ 170

Query: 218 GSIPSEI-GNLKSLSGLELGYNKLSGSMPL-SLGNLPNLATLDLHDN 262
            S+P  +   L  L  L L  N+L  S+P      L +L  + LHDN
Sbjct: 171 -SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 61.6 bits (150), Expect = 3e-10
 Identities = 63/278 (22%), Positives = 92/278 (33%), Gaps = 91/278 (32%)

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGS 411
              L    ++     +   L ++  +    + +  S+   I  L ++  L L  N+L   
Sbjct: 23  KANLKKKSVT-DAV-TQNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-D 77

Query: 412 IPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLAR 471
           I  +   LTN+  L +  N L       +  L  L  LVL  NQLQ              
Sbjct: 78  IS-ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-------------- 122

Query: 472 VRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGIL 531
                       S   G+                   FD  K  NL  L+++ N +   L
Sbjct: 123 ------------SLPDGV-------------------FD--KLTNLTYLNLAHNQLQS-L 148

Query: 532 PPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLI-----KLTLNRNQFSGQLPTELGS 585
           P  + D    L  LDLS N           +L+SL      KLT                
Sbjct: 149 PKGVFDKLTNLTELDLSYN-----------QLQSLPEGVFDKLT---------------- 181

Query: 586 LIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQ 622
             QL+ L L  N+L  S+P G    L  L Y+ L +N 
Sbjct: 182 --QLKDLRLYQNQL-KSVPDGVFDRLTSLQYIWLHDNP 216

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 47/199 (23%), Positives = 80/199 (40%), Gaps = 25/199 (12%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
              +     NL  K     ++ +  +  ++  +  + ++I  +    I   P ++ L L 
Sbjct: 16  DAFAETIKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALG 71

Query: 548 SNHIVGEIPSELG---KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIP 604
            N +      ++    +L +L  L L  NQ           L  L+ L L  N+L +   
Sbjct: 72  GNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPD 126

Query: 605 GSLGNLVKLYYLNLSNNQFSGEIPIKLE-----KFIHLSDLDLSHNFLGEEIPSQVC-SM 658
           G    L  L YLNL++NQ        L      K  +L++LDLS+N L + +P  V   +
Sbjct: 127 GVFDKLTNLTYLNLAHNQLQ-----SLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKL 180

Query: 659 QSLEKLNLAHNNLSGFIPR 677
             L+ L L  N L   +P 
Sbjct: 181 TQLKDLRLYQNQLKS-VPD 198

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 39/184 (21%), Positives = 66/184 (35%), Gaps = 44/184 (23%)

Query: 519 TLDVSANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIPSELGKLRSLIKLTLNRNQFS 576
             ++   ++T     +   +  +  +  +++ I  V  I      L ++  L L  N+  
Sbjct: 23  KANLKKKSVTD-AVTQNELN-SIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKL- 75

Query: 577 GQLPTELG---SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK 633
                ++     L  L +L L+ N+L +   G    L  L  L L  NQ        L  
Sbjct: 76  ----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-----SLPD 126

Query: 634 --FIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
             F  L++L                       LNLAHN L       F ++  L  +D+S
Sbjct: 127 GVFDKLTNLT---------------------YLNLAHNQLQSLPKGVFDKLTNLTELDLS 165

Query: 692 YNKL 695
           YN+L
Sbjct: 166 YNQL 169

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 77.3 bits (191), Expect = 3e-15
 Identities = 47/211 (22%), Positives = 83/211 (39%), Gaps = 34/211 (16%)

Query: 811  EHCIGTGGQGSVYRA-ELSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEIR-HR 865
            E  +G G    V     L + +  AVK   K           +     EV+ L + + HR
Sbjct: 18   EDVLGEGAHARVQTCINLITSQEYAVKIIEK------QPGHIRSRVFREVEMLYQCQGHR 71

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYL 924
            N+++   F       ++V+E +  GS+ + I       E     +   V++ VA AL +L
Sbjct: 72   NVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL----EASVVVQDVASALDFL 127

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSS-------NWTELAGT 974
            HN     I +RD+  +N+L +   +     + DF +   +K +               G+
Sbjct: 128  HN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 975  IGYVAPELAYTMKVTEKS-----DVYSFGVL 1000
              Y+APE+               D++S GV+
Sbjct: 185  AEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 77.0 bits (190), Expect = 4e-15
 Identities = 43/198 (21%), Positives = 80/198 (40%), Gaps = 27/198 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFY 871
            +G G  G V       +G+  A+K  +           +   EV    +     +IV   
Sbjct: 37   LGLGVNGKVLECFHRRTGQKCALKLLYD--------SPKARQEVDHHWQASGGPHIVCIL 88

Query: 872  GFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADALSYLH 925
                +  H      I+ E +E G L    S      +  +T+R    +++ +  A+ +LH
Sbjct: 89   DVYENMHHGKRCLLIIMECMEGGEL---FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            +     I +RD+  +N+L   + +     ++DFG +K    ++        T  YVAPE+
Sbjct: 146  SHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPEV 200

Query: 983  AYTMKVTEKSDVYSFGVL 1000
                K  +  D++S GV+
Sbjct: 201  LGPEKYDKSCDMWSLGVI 218

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 75.5 bits (186), Expect = 1e-14
 Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 43/273 (15%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTEIRHR--NI 867
            +G+GG GSVY    +S    VA+K   K       E+        EV  L ++      +
Sbjct: 51   LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 868  VKFYGFCSHARHSFIVYEYLE-MGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            ++   +        ++ E  E +  L   I       EEL    R +    V +A+ + H
Sbjct: 111  IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA---R-SFFWQVLEAVRHCH 166

Query: 926  NDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-- 982
            N     +++RDI  +N+L+DL   E  + DFG   +L  D+  +T+  GT  Y  PE   
Sbjct: 167  NCG---VLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDT-VYTDFDGTRVYSPPEWIR 221

Query: 983  --AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
               Y  +    + V+S G+L  + + G  P +    I            ++   +  +  
Sbjct: 222  YHRYHGR---SAAVWSLGILLYDMVCGDIPFEHDEEIIR---------GQVFFRQRVSSE 269

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            C  +  LI        CL   P  RPT +++  
Sbjct: 270  C--QH-LIR------WCLALRPSDRPTFEEIQN 293

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.3 bits (188), Expect = 1e-14
 Identities = 67/279 (24%), Positives = 112/279 (40%), Gaps = 54/279 (19%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            N+F+    +G G  G V   +  ++G   A+K     ++         L E + L   RH
Sbjct: 148  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207

Query: 865  RNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRMNV 913
              +    Y F +H      V EY   G L   LS              AE          
Sbjct: 208  PFLTALKYSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE---------- 256

Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLKPDSSNWTE 970
               +  AL YLH++    +VYRD+  +N++LD   + H+  +DFG+ K  +K  ++  T 
Sbjct: 257  ---IVSALDYLHSEK--NVVYRDLKLENLMLD--KDGHIKITDFGLCKEGIKDGATMKT- 308

Query: 971  LAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDR 1026
              GT  Y+APE+     Y   V    D +  GV+  E + G+ P  F       + + ++
Sbjct: 309  FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP--F------YNQDHEK 356

Query: 1027 TLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
              + IL   +  P   +  +  S++      L ++P  R
Sbjct: 357  LFELILMEEIRFPR-TLGPEAKSLLS---GLLKKDPKQR 391

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 74.5 bits (184), Expect = 2e-14
 Identities = 71/256 (27%), Positives = 109/256 (42%), Gaps = 58/256 (22%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
             DF     +GTG  G V+      +G   A+K   K     L ++       +E   L+ 
Sbjct: 6    QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT---NDERLMLSI 62

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQRM 911
            + H  I++ +G    A+  F++ +Y+E G L  +L  +           +AE        
Sbjct: 63   VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE-------- 114

Query: 912  NVIKGVADALSYLH-NDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNW 968
                 V  AL YLH  D    I+YRD+  +N+LLD     H+  +DFG +K        +
Sbjct: 115  -----VCLALEYLHSKD----IIYRDLKPENILLD--KNGHIKITDFGFAK--YVPDVTY 161

Query: 969  TELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
            T L GT  Y+APE+     Y   +    D +SFG+L  E + G  P  F        SN 
Sbjct: 162  T-LCGTPDYIAPEVVSTKPYNKSI----DWWSFGILIYEMLAGYTP--F------YDSNT 208

Query: 1025 DRTLDEILDPRLPAPS 1040
             +T ++IL+  L  P 
Sbjct: 209  MKTYEKILNAELRFPP 224

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 74.6 bits (184), Expect = 3e-14
 Identities = 57/245 (23%), Positives = 90/245 (36%), Gaps = 50/245 (20%)

Query: 791  TFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQ 849
                  A E   +  + F  E   G G  G+V   +   +G  VA+KK    +       
Sbjct: 8    LNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV---IQDPRFRN 64

Query: 850  QEFLNEVKSLTEIRHRNIVK-FYGFCSHARHSF------IVYEYLEMGSLAMILSNATSA 902
            +E L  ++ L  + H NIV+    F +            +V EY+   +L     N    
Sbjct: 65   RE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR 122

Query: 903  EELGWTQRMNV--IKG----VADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDF 955
            +            IK     +  ++  LH      + +RDI   NVL++       + DF
Sbjct: 123  Q-----VAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDF 176

Query: 956  GISKSLKPDSSNWTELAGTIGYV------APEL-----AYTMKVTEKSDVYSFG-VLALE 1003
            G +K L P   N       + Y+      APEL      YT  V    D++S G + A E
Sbjct: 177  GSAKKLSPSEPN-------VAYICSRYYRAPELIFGNQHYTTAV----DIWSVGCIFA-E 224

Query: 1004 AIKGK 1008
             + G+
Sbjct: 225  MMLGE 229

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 74.8 bits (184), Expect = 3e-14
 Identities = 47/198 (23%), Positives = 82/198 (41%), Gaps = 26/198 (13%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFY 871
            +G G  G V +     + E  A+K              +   EV+      +  +IV+  
Sbjct: 70   LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 121

Query: 872  GFC----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADALSYLH 925
                   +  +   IV E L+ G L    S      +  +T+R    ++K + +A+ YLH
Sbjct: 122  DVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            +     I +RD+  +N+L   +       ++DFG +K     +S  T    T  YVAPE+
Sbjct: 179  SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPCYTPYYVAPEV 234

Query: 983  AYTMKVTEKSDVYSFGVL 1000
                K  +  D++S GV+
Sbjct: 235  LGPEKYDKSCDMWSLGVI 252

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.4 bits (181), Expect = 6e-14
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 59/282 (20%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            + F+    +G G  G V+  +      + ++ A+K      L     +     E   L E
Sbjct: 24   SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVE 82

Query: 862  IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQR 910
            + H  IVK  Y F +  +  +++ ++L  G L   LS              AE       
Sbjct: 83   VNHPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE------- 134

Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLKPDSSN 967
                  +A AL +LH+     I+YRD+  +N+LLD   E H+  +DFG+SK S+  +   
Sbjct: 135  ------LALALDHLHSLG---IIYRDLKPENILLD--EEGHIKLTDFGLSKESIDHEKKA 183

Query: 968  WTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
            ++   GT+ Y+APE+     +T       D +SFGVL  E + G  P  F         +
Sbjct: 184  YS-FCGTVEYMAPEVVNRRGHTQSA----DWWSFGVLMFEMLTGTLP--F------QGKD 230

Query: 1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
               T+  IL  +L  P   +  +  S++         NP +R
Sbjct: 231  RKETMTMILKAKLGMPQ-FLSPEAQSLLR---MLFKRNPANR 268

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 61/296 (20%), Positives = 111/296 (37%), Gaps = 60/296 (20%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVK-------------------KFHSPLLSEMTCQQEFL 853
            IG G  G V  A   +     A+K                   +   P        +  +
Sbjct: 21   IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 854  N----EVKSLTEIRHRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGW 907
                 E+  L ++ H N+VK           H ++V+E +  G +  + +    +E+   
Sbjct: 81   EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140

Query: 908  TQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN 967
                ++IKG+     YLH      I++RDI   N+L+  +    ++DFG+S   K   + 
Sbjct: 141  FYFQDLIKGI----EYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193

Query: 968  WTELAGTIGYVAPELAYTMKVT---EKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSS 1022
             +   GT  ++APE     +     +  DV++ GV         G+ P            
Sbjct: 194  LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF--GQCPFM--------DE 243

Query: 1023 NLDRTLDEILD-----PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
             +     +I       P  P  + +++D LI+ M      LD+NP+SR  + ++  
Sbjct: 244  RIMCLHSKIKSQALEFPDQPDIAEDLKD-LITRM------LDKNPESRIVVPEIKL 292

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 65/284 (22%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V  A    + E VAVK        +     +   E+     + H N+VKFYG
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMN----------VIKGVADAL 921
                    ++  EY   G L   I  +            M           ++ GV    
Sbjct: 73   HRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGV---- 118

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA---GTIGYV 978
             YLH      I +RDI  +N+LLD      +SDFG++   + ++     L    GT+ YV
Sbjct: 119  VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYV 174

Query: 979  APEL----AYTMKVTEKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032
            APEL     +     E  DV+S G++  A+ A  G+ P D         S+  +   +  
Sbjct: 175  APELLKRREFH---AEPVDVWSCGIVLTAMLA--GELPWD-------QPSDSCQEYSDWK 222

Query: 1033 D-----PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            +                  L+  +      L ENP +R T+  +
Sbjct: 223  EKKTYLNPWKKIDSAPLA-LLHKI------LVENPSARITIPDI 259

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 39/271 (14%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V   E   +G  VAVK  +   +  +    +   E+++L   RH +I+K Y 
Sbjct: 19   LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
              S     F+V EY+  G L   I  +    E     +   + + +  A+ Y H      
Sbjct: 79   VISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EARRLFQQILSAVDYCHRHM--- 131

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AYTMK 987
            +V+RD+  +NVLLD    A ++DFG+S  +       T   G+  Y APE+     Y   
Sbjct: 132  VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA-- 188

Query: 988  VTEKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SCN 1042
               + D++S GV+  AL    G  P D          ++     +I       P   + +
Sbjct: 189  -GPEVDIWSCGVILYALLC--GTLPFD--------DEHVPTLFKKIRGGVFYIPEYLNRS 237

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +   L+  M      L  +P  R T++ + +
Sbjct: 238  VAT-LLMHM------LQVDPLKRATIKDIRE 261

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 50/167 (29%), Positives = 70/167 (41%), Gaps = 32/167 (19%)

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLS-FGNLTN 277
           S+P+ I      + L+L  N L          L +L  L L  N L  S+P   F  LT+
Sbjct: 21  SVPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS 77

Query: 278 LDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
           L  LNL  N L  S+P+ +            F+K           LT+L  L L+ N L 
Sbjct: 78  LTYLNLSTNQLQ-SLPNGV------------FDK-----------LTQLKELALNTNQL- 112

Query: 338 GSIPCEI-GNLRYLFYLELGDNKLSGSIPH-SLGNLTNLATLYLFTN 382
            S+P  +   L  L  L L  N+L  S+P      LT+L  ++L  N
Sbjct: 113 QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 43/131 (32%), Positives = 59/131 (45%), Gaps = 8/131 (6%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGN-LSMLKILYLSTNQFSG 170
           YLDL  N +  +        + L  L L  N    ++P  + N L+ L  L LSTNQ   
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 171 RIPPQI-GHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNL 227
            +P  +   L+ LK L L  N L  S+P  +   LT L  + LY N L  S+P  +   L
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRL 147

Query: 228 KSLSGLELGYN 238
            SL  + L  N
Sbjct: 148 TSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 59.3 bits (144), Expect = 6e-10
 Identities = 47/131 (35%), Positives = 66/131 (50%), Gaps = 9/131 (6%)

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGN-LNSLSDLGLSENELSG 410
           YL+L  N L          LT+L  LYL  N L  S+P+ + N L SL+ L LS N+L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ- 89

Query: 411 SIPYS-FGNLTNMIVLSIYSNALSGAIPKE-YGNLVKLTLLVLSYNQLQGPIPD--LRNL 466
           S+P   F  LT +  L++ +N L  ++P   +  L +L  L L  NQL+  +PD     L
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147

Query: 467 TRLARVRLDRN 477
           T L  + L  N
Sbjct: 148 TSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 58.9 bits (143), Expect = 9e-10
 Identities = 45/143 (31%), Positives = 64/143 (44%), Gaps = 10/143 (6%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYL 182
           +P+ I   +   YLDL +NS           L+ L  LYL  N+    +P  +   L+ L
Sbjct: 22  VPTGIPAQTT--YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78

Query: 183 KALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKL 240
             L+L  N L  S+P  +   LT L  + L  N L  S+P  +   L  L  L L  N+L
Sbjct: 79  TYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136

Query: 241 SGSMPL-SLGNLPNLATLDLHDN 262
             S+P      L +L  + LHDN
Sbjct: 137 K-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 40/140 (28%), Positives = 66/140 (47%), Gaps = 8/140 (5%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSP-QLKVLDL 546
           GI +  +Y++L         +  + +  +L  L +  N +   LP  + +    L  L+L
Sbjct: 25  GIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS-LPNGVFNKLTSLTYLNL 83

Query: 547 SSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIP 604
           S+N +   +P+ +  KL  L +L LN NQ    LP  +   L QL+ L L  N+L  S+P
Sbjct: 84  STNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL-KSVP 140

Query: 605 -GSLGNLVKLYYLNLSNNQF 623
            G    L  L Y+ L +N +
Sbjct: 141 DGVFDRLTSLQYIWLHDNPW 160

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 40/129 (31%), Positives = 56/129 (43%), Gaps = 3/129 (2%)

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
                L L TN L          L SL+ L L  N+L       F  LT++  L++ +N 
Sbjct: 28  AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQ 87

Query: 432 LSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGI 489
           L       +  L +L  L L+ NQLQ  +PD     LT+L  +RL +N L       F  
Sbjct: 88  LQSLPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDR 146

Query: 490 HSNLSYINL 498
            ++L YI L
Sbjct: 147 LTSLQYIWL 155

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 38/123 (30%), Positives = 65/123 (52%), Gaps = 8/123 (6%)

Query: 96  IGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANN-SKLKYLDLSSNSFSGTIPPQI-G 153
           + +L +  F     L  L L  N++   +P+ + N  + L YL+LS+N    ++P  +  
Sbjct: 40  LKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFD 97

Query: 154 NLSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYL 211
            L+ LK L L+TNQ    +P  +   L+ LK L L++N L  S+P      LT+L  ++L
Sbjct: 98  KLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWL 155

Query: 212 YNN 214
           ++N
Sbjct: 156 HDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 34/113 (30%), Positives = 46/113 (40%), Gaps = 5/113 (4%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
            L L  N            L  L  L L  N+L +   G    L  L YLNLS NQ    
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-S 90

Query: 627 IPIKL-EKFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNNLSGFIPR 677
           +P  + +K   L +L L+ N L + +P  V   +  L+ L L  N L   +P 
Sbjct: 91  LPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKS-VPD 141

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 30/115 (26%), Positives = 49/115 (42%), Gaps = 3/115 (2%)

Query: 590 EHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE 649
            +LDL +N L +   G    L  L  L L  N+          K   L+ L+LS N L +
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-Q 89

Query: 650 EIPSQVC-SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSA 703
            +P+ V   +  L++L L  N L       F ++  L  + +  N+L   +P+  
Sbjct: 90  SLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKS-VPDGV 143

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 56/275 (20%), Positives = 108/275 (39%), Gaps = 39/275 (14%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFH-SPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY 871
            +G G  G V       +    AVK      L      +     E++ L  +RH+N+++  
Sbjct: 13   LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 872  GFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                +   +  ++V EY   G   M+  ++   +     Q       + D L YLH+   
Sbjct: 73   DVLYNEEKQKMYMVMEYCVCGMQEML--DSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG- 129

Query: 930  PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA----GTIGYVAPELAYT 985
              IV++DI   N+LL       +S  G++++L P +++  +      G+  +  PE+A  
Sbjct: 130  --IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD--DTCRTSQGSPAFQPPEIANG 185

Query: 986  MKVTE--KSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP-- 1039
            +      K D++S GV    +    G +P +          N+ +  + I       P  
Sbjct: 186  LDTFSGFKVDIWSAGVTLYNITT--GLYPFE--------GDNIYKLFENIGKGSYAIPGD 235

Query: 1040 -SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                + D L+  M      L+  P  R +++++ Q
Sbjct: 236  CGPPLSD-LLKGM------LEYEPAKRFSIRQIRQ 263

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 66/287 (22%), Positives = 106/287 (36%), Gaps = 70/287 (24%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTE-- 861
             DF     +G G  G V+ AE   + +  A+K      L +     +  ++V+  + E  
Sbjct: 17   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIK-----ALKKDVVLMD--DDVECTMVEKR 69

Query: 862  -----IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEEL 905
                   H  +   F  F +     F V EYL  G L   + +            +AE  
Sbjct: 70   VLSLAWEHPFLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAE-- 126

Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLK 962
                       +   L +LH+     IVYRD+   N+LLD   + H+  +DFG+ K ++ 
Sbjct: 127  -----------IILGLQFLHSK---GIVYRDLKLDNILLD--KDGHIKIADFGMCKENML 170

Query: 963  PDSSNWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
             D+   T   GT  Y+APE+     Y   V    D +SFGVL  E + G+ P  F     
Sbjct: 171  GDAKTNT-FCGTPDYIAPEILLGQKYNHSV----DWWSFGVLLYEMLIGQSP--F----- 218

Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
                + +     I       P   +  +   ++          P+ R
Sbjct: 219  -HGQDEEELFHSIRMDNPFYPR-WLEKEAKDLLV---KLFVREPEKR 260

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 71.4 bits (175), Expect = 6e-13
 Identities = 42/202 (20%), Positives = 84/202 (41%), Gaps = 18/202 (8%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFY- 871
            IG+G QG V  A +      VA+KK   P  ++   ++    E+  +  + H+NI+    
Sbjct: 70   IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKNIISLLN 128

Query: 872  -----GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                       +  ++V E ++     +I                 + + +   + +LH+
Sbjct: 129  VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE-----RMSYLLYQMLC-GIKHLHS 182

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 I++RD+   N+++  +    + DFG++++    S   T    T  Y APE+   M
Sbjct: 183  AG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVILGM 238

Query: 987  KVTEKSDVYSFGVLALEAIKGK 1008
               E  D++S G +  E ++ K
Sbjct: 239  GYKENVDIWSVGCIMGEMVRHK 260

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 70.9 bits (174), Expect = 6e-13
 Identities = 48/213 (22%), Positives = 89/213 (41%), Gaps = 22/213 (10%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               +     IG+G QG V  A +      VA+KK   P  ++   ++    E+  +  + 
Sbjct: 24   LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVN 82

Query: 864  HRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIK 915
            H+NI+               +  +IV E ++  +L  ++      E + +   Q +  IK
Sbjct: 83   HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIK 141

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
                   +LH+     I++RD+   N+++  +    + DFG++++        T    T 
Sbjct: 142  -------HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTR 190

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK 1008
             Y APE+   M   E  D++S G +  E IKG 
Sbjct: 191  YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 46/194 (23%), Positives = 85/194 (43%), Gaps = 23/194 (11%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEM---TCQQEFLNEVKSLTEIRHRNIVK 869
           +G G  G V +     +G IVA+KKF      +M         + E+K L ++RH N+V 
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----MREIKLLKQLRHENLVN 88

Query: 870 FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
               C   +  ++V+E+++  ++   L        L +      +  + + + + H+   
Sbjct: 89  LLEVCKKKKRWYLVFEFVDH-TILDDLEL--FPNGLDYQVVQKYLFQIINGIGFCHSHN- 144

Query: 930 PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-----AY 984
             I++RDI  +N+L+       + DFG +++L      + +   T  Y APEL      Y
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 985 TMKVTEKSDVYSFG 998
              V    DV++ G
Sbjct: 203 GKAV----DVWAIG 212

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.9 bits (172), Expect = 7e-13
 Identities = 68/257 (26%), Positives = 109/257 (42%), Gaps = 57/257 (22%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEF-LNEVKSLT 860
              F+    +G GG G V++       ++G+I A+K     ++            E   L 
Sbjct: 17   ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76

Query: 861  EIRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQ 909
            E++H  IV   Y F +  +  +++ EYL  G L M L               AE      
Sbjct: 77   EVKHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAE------ 129

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLKPDSS 966
                   ++ AL +LH      I+YRD+  +N++L+  ++ HV  +DFG+ K S+   + 
Sbjct: 130  -------ISMALGHLHQK---GIIYRDLKPENIMLN--HQGHVKLTDFGLCKESIHDGTV 177

Query: 967  NWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS 1022
              T   GTI Y+APE+     +   V    D +S G L  + + G  P  F      T  
Sbjct: 178  THT-FCGTIEYMAPEILMRSGHNRAV----DWWSLGALMYDMLTGAPP--F------TGE 224

Query: 1023 NLDRTLDEIL--DPRLP 1037
            N  +T+D+IL     LP
Sbjct: 225  NRKKTIDKILKCKLNLP 241

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 69.6 bits (171), Expect = 9e-13
 Identities = 70/279 (25%), Positives = 104/279 (37%), Gaps = 55/279 (19%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V  A    + E VAVK        +     +   E+     + H N+VKFYG
Sbjct: 15   LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK--KEICINKMLNHENVVKFYG 72

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMN----------VIKGVADAL 921
                    ++  EY   G L   I  +            M           ++ GV    
Sbjct: 73   HRREGNIQYLFLEYCSGGELFDRIEPD----------IGMPEPDAQRFFHQLMAGV---- 118

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA---GTIGYV 978
             YLH      I +RDI  +N+LLD      +SDFG++   + ++     L    GT+ YV
Sbjct: 119  VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNKMCGTLPYV 174

Query: 979  APEL----AYTMKVTEKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032
            APEL     +     E  DV+S G++  A+ A  G+ P D  S  C      D    +  
Sbjct: 175  APELLKRREFH---AEPVDVWSCGIVLTAMLA--GELPWDQPSDSCQEY--SDWKEKKTY 227

Query: 1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                          L+  +      L ENP +R T+  +
Sbjct: 228  LNPWKKIDSAPLA-LLHKI------LVENPSARITIPDI 259

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.9 bits (172), Expect = 9e-13
 Identities = 71/282 (25%), Positives = 110/282 (39%), Gaps = 61/282 (21%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
            NDFD    +G G  G V      ++G   A+K   K       E+      + E + L  
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT---VTESRVLQN 61

Query: 862  IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQR 910
             RH  +    Y F +H      V EY   G L   LS              AE       
Sbjct: 62   TRHPFLTALKYAFQTHD-RLCFVMEYANGGELFFHLSRERVFTEERARFYGAE------- 113

Query: 911  MNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLKPDSSN 967
                  +  AL YLH+     +VYRDI  +N++LD   + H+  +DFG+ K  +   ++ 
Sbjct: 114  ------IVSALEYLHSR---DVVYRDIKLENLMLD--KDGHIKITDFGLCKEGISDGATM 162

Query: 968  WTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
             T   GT  Y+APE+     Y   V    D +  GV+  E + G+ P  F       + +
Sbjct: 163  KT-FCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVMYEMMCGRLP--F------YNQD 209

Query: 1024 LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             +R  + IL   +  P   +  +  S++      L ++P  R
Sbjct: 210  HERLFELILMEEIRFPR-TLSPEAKSLLA---GLLKKDPKQR 247

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 43/275 (15%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            IG+G  G         + E+VAVK        +   Q+E    + +   +RH NIV+F  
Sbjct: 28   IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
                  H  I+ EY   G L   I +    +E+        ++ GV    SY H+     
Sbjct: 84   VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV----SYCHSMQ--- 136

Query: 932  IVYRDISSKNVLLDLEYEAH--VSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AYT 985
            I +RD+  +N LLD        + DFG SKS    S   + + GT  Y+APE+     Y 
Sbjct: 137  ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLRQEYD 195

Query: 986  MKVTEKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEILD-----PRLPA 1038
             K    +DV+S GV    +    G +P +          +  +T+  IL      P    
Sbjct: 196  GK---IADVWSCGVTLYVMLV--GAYPFE----DPEEPRDYRKTIQRILSVKYSIPDDIR 246

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
             S      LIS +         +P +R ++ ++  
Sbjct: 247  ISPECCH-LISRI------FVADPATRISIPEIKT 274

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.8 bits (173), Expect = 1e-12
 Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 70/287 (24%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTE-- 861
             DF+    +G G  G V  +E   + E+ AVK     +L +    Q+  ++V+  + E  
Sbjct: 341  TDFNFLMVLGKGSFGKVMLSERKGTDELYAVK-----ILKKDVVIQD--DDVECTMVEKR 393

Query: 862  -----IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEEL 905
                  +   + +    F +  R  + V EY+  G L   +              +AE  
Sbjct: 394  VLALPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-- 450

Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLK 962
                       +A  L +L +     I+YRD+   NV+LD   E H+  +DFG+ K ++ 
Sbjct: 451  -----------IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIW 494

Query: 963  PDSSNWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
               +  T   GT  Y+APE+     Y   V    D ++FGVL  E + G+ P  F     
Sbjct: 495  DGVTTKT-FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP--F----- 542

Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
                + D     I++  +  P  ++  + ++I +     + ++P  R
Sbjct: 543  -EGEDEDELFQSIMEHNVAYPK-SMSKEAVAICK---GLMTKHPGKR 584

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 7/118 (5%)

Query: 219 SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNL 278
            +P  I   + ++ L L  N+ +  +P  L N  +L  +DL +N +S     SF N+T L
Sbjct: 24  VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80

Query: 279 DILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIP-SSLGNLTKLTILYLSDN 334
             L L +N L   IP      LKSL  L L  N +S  +P  +  +L+ L+ L +  N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 5/106 (4%)

Query: 327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
           T LYL  N     +P E+ N ++L  ++L +N++S     S  N+T L TL L  N L  
Sbjct: 34  TELYLDGNQF-TLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91

Query: 387 SIPSEI-GNLNSLSDLGLSENELSGSIPY-SFGNLTNMIVLSIYSN 430
            IP      L SL  L L  N++S  +P  +F +L+ +  L+I +N
Sbjct: 92  CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 34/118 (28%), Positives = 56/118 (47%), Gaps = 9/118 (7%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYL 182
           +P  I  +     L L  N F+  +P ++ N   L ++ LS N+ S  +  Q   +++ L
Sbjct: 25  LPKGIPRDVT--ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQL 80

Query: 183 KALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYN 238
             L L  N L   IPP     L +L ++ L+ N +S  +P     +L +LS L +G N
Sbjct: 81  LTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 31/109 (28%), Positives = 52/109 (47%), Gaps = 6/109 (5%)

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA 431
            ++  LYL  N  +  +P E+ N   L+ + LS N +S     SF N+T ++ L +  N 
Sbjct: 31  RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR 89

Query: 432 LSGAIPKE-YGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
           L   IP   +  L  L LL L  N +   +P+    +L+ L+ + +  N
Sbjct: 90  LR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 5/104 (4%)

Query: 185 LHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGS 243
           L+L  N  +  +P  L N  +L ++ L NN +S ++ ++   N+  L  L L YN+L   
Sbjct: 36  LYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCI 93

Query: 244 MPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
            P +   L +L  L LH N +S  +P  +F +L+ L  L +  N
Sbjct: 94  PPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 33/105 (31%), Positives = 54/105 (51%), Gaps = 7/105 (6%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGR 171
           L L  NQ   ++P +++N   L  +DLS+N  S T+  Q   N++ L  L LS N+    
Sbjct: 36  LYLDGNQF-TLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 172 IPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNN 214
           IPP+    L  L+ L L  N +S  +P  +  +L+ L+ + +  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 53.5 bits (129), Expect = 5e-08
 Identities = 28/80 (35%), Positives = 41/80 (51%), Gaps = 3/80 (3%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
           +L L+ NQF+  +P EL +   L  +DLS+NR+S     S  N+ +L  L LS N+    
Sbjct: 35  ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-C 92

Query: 627 IPIKL-EKFIHLSDLDLSHN 645
           IP +  +    L  L L  N
Sbjct: 93  IPPRTFDGLKSLRLLSLHGN 112

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 68.7 bits (169), Expect = 2e-12
 Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 14/173 (8%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVK 869
           IG G  G V++     +G+IVA+KKF                 L E++ L +++H N+V 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA----LREIRMLKQLKHPNLVN 66

Query: 870 FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF 929
                   R   +V+EY +  ++   L            +  ++      A+++ H    
Sbjct: 67  LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVK--SITWQTLQAVNFCHKHN- 122

Query: 930 PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
              ++RD+  +N+L+       + DFG ++ L   S  + +   T  Y +PEL
Sbjct: 123 --CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 69.4 bits (170), Expect = 2e-12
 Identities = 65/278 (23%), Positives = 111/278 (39%), Gaps = 64/278 (23%)

Query: 768  RRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRA------------TNDFDEEHCIG 815
            R R++S  +       P     +   R     ++                  + +   IG
Sbjct: 4    RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63

Query: 816  TGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHRNIVKFYGF 873
             G  G VY+A+L  SGE+VA+KK            + F N E++ + ++ H NIV+   F
Sbjct: 64   NGSFGVVYQAKLCDSGELVAIKKVLQ--------DKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 874  CSHARHSF------IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG----VADALSY 923
               +          +V +Y+      +    + + + L     +  +K     +  +L+Y
Sbjct: 116  FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP----VIYVKLYMYQLFRSLAY 171

Query: 924  LHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAGTIGYV---- 978
            +H+     I +RDI  +N+LLD +     + DFG +K L     N       + Y+    
Sbjct: 172  IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-------VSYICSRY 221

Query: 979  --APEL-----AYTMKVTEKSDVYSFG-VLALEAIKGK 1008
              APEL      YT  +    DV+S G VLA E + G+
Sbjct: 222  YRAPELIFGATDYTSSI----DVWSAGCVLA-ELLLGQ 254

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 67.5 bits (166), Expect = 3e-12
 Identities = 50/197 (25%), Positives = 90/197 (45%), Gaps = 30/197 (15%)

Query: 814 IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVKF 870
           IG G  G VY+A+ + GE  A+KK       E    T     + E+  L E++H NIVK 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT----IREISILKELKHSNIVKL 65

Query: 871 YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA----DALSYLHN 926
           Y      +   +V+E+L+   L  +L       E          K       + ++Y H+
Sbjct: 66  YDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLE------SVTAKSFLLQLLNGIAYCHD 118

Query: 927 DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL---- 982
                +++RD+  +N+L++ E E  ++DFG++++       +T    T+ Y AP++    
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175

Query: 983 -AYTMKVTEKSDVYSFG 998
             Y+  +    D++S G
Sbjct: 176 KKYSTTI----DIWSVG 188

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.4 bits (168), Expect = 3e-12
 Identities = 74/294 (25%), Positives = 114/294 (38%), Gaps = 84/294 (28%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTEIR 863
            +DF     IG G  G V  A   +     AVK     +L +    ++   E K  ++E  
Sbjct: 38   SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVK-----VLQKKAILKK--KEEKHIMSE-- 88

Query: 864  HRNIVKFYGFCSHARHSFIV------------Y---EYLEMGSLAMILSNAT-------- 900
             RN+        + +H F+V            Y   +Y+  G L   L            
Sbjct: 89   -RNV-----LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRAR 142

Query: 901  --SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFG 956
              +AE             +A AL YLH+     IVYRD+  +N+LLD   + H+  +DFG
Sbjct: 143  FYAAE-------------IASALGYLHSL---NIVYRDLKPENILLD--SQGHIVLTDFG 184

Query: 957  ISK-SLKPDSSNWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPR 1011
            + K +++ +S+  T   GT  Y+APE+     Y   V    D +  G +  E + G  P 
Sbjct: 185  LCKENIEHNSTTST-FCGTPEYLAPEVLHKQPYDRTV----DWWCLGAVLYEMLYGLPP- 238

Query: 1012 DFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
             F       S N     D IL+  L     NI +    ++E     L ++   R
Sbjct: 239  -F------YSRNTAEMYDNILNKPLQLKP-NITNSARHLLE---GLLQKDRTKR 281

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 63/271 (23%), Positives = 106/271 (39%), Gaps = 40/271 (14%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V  A    + + VA+K     LL +         E+  L  +RH +I+K Y 
Sbjct: 17   LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
              +      +V EY   G L   I+      E+ G        + +  A+ Y H      
Sbjct: 77   VITTPTDIVMVIEYAG-GELFDYIVEKKRMTEDEG----RRFFQQIICAIEYCHRHK--- 128

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AYTMK 987
            IV+RD+  +N+LLD      ++DFG+S  +   +   T   G+  Y APE+     Y   
Sbjct: 129  IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT-SCGSPNYAAPEVINGKLYA-- 185

Query: 988  VTEKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SCN 1042
               + DV+S G++   +    G+ P D           +     ++       P   S  
Sbjct: 186  -GPEVDVWSCGIVLYVMLV--GRLPFD--------DEFIPNLFKKVNSCVYVMPDFLSPG 234

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
             +  LI  M      +  +P  R T+Q++ +
Sbjct: 235  AQS-LIRRM------IVADPMQRITIQEIRR 258

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 67.7 bits (166), Expect = 4e-12
 Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 37/203 (18%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVK 869
           +G G  G VY+A +  + E VA+K+       E    T     + EV  L E++HRNI++
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA----IREVSLLKELQHRNIIE 97

Query: 870 FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG----VADALSYLH 925
                 H     +++EY E   L   +              M VIK     + + +++ H
Sbjct: 98  LKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVS-------MRVIKSFLYQLINGVNFCH 149

Query: 926 NDCFPPIVYRDISSKNVLLDLEYEAH-----VSDFGISKSLKPDSSNWTELAGTIGYVAP 980
           +      ++RD+  +N+LL +   +      + DFG++++       +T    T+ Y  P
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPP 206

Query: 981 EL-----AYTMKVTEKSDVYSFG 998
           E+      Y+  V    D++S  
Sbjct: 207 EILLGSRHYSTSV----DIWSIA 225

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 67.3 bits (165), Expect = 6e-12
 Identities = 64/256 (25%), Positives = 100/256 (39%), Gaps = 47/256 (18%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLSEMTCQQEF-LNEVKSLT 860
             +F+    +GTG  G V+         +G++ A+K      + +     E    E + L 
Sbjct: 54   ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113

Query: 861  EIRHRN-IVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWT 908
             IR    +V   Y F +  +   ++ +Y+  G L   LS               E     
Sbjct: 114  HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGE----- 167

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSS 966
                    +  AL +LH      I+YRDI  +N+LLD     HV  +DFG+SK    D +
Sbjct: 168  --------IVLALEHLHKL---GIIYRDIKLENILLD--SNGHVVLTDFGLSKEFVADET 214

Query: 967  NWTE-LAGTIGYVAPE-LAYTMKVTEKS-DVYSFGVLALEAIKGKHPRDFISSICSTSSN 1023
                   GTI Y+AP+ +       +K+ D +S GVL  E + G  P  F        ++
Sbjct: 215  ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVD--GEKNS 270

Query: 1024 LDRTLDEIL--DPRLP 1037
                   IL  +P  P
Sbjct: 271  QAEISRRILKSEPPYP 286

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 66.8 bits (164), Expect = 6e-12
 Identities = 48/193 (24%), Positives = 90/193 (46%), Gaps = 22/193 (11%)

Query: 814 IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVKF 870
           +G G  G VY+A+ S G IVA+K+       E    T     + E+  L E+ H NIV  
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA----IREISLLKELHHPNIVSL 84

Query: 871 YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
                  R   +V+E++E   L  +L    +   L  +Q    +  +   +++ H     
Sbjct: 85  IDVIHSERCLTLVFEFMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR-- 139

Query: 931 PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-----AYT 985
            I++RD+  +N+L++ +    ++DFG++++      ++T    T+ Y AP++      Y+
Sbjct: 140 -ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198

Query: 986 MKVTEKSDVYSFG 998
             V    D++S G
Sbjct: 199 TSV----DIWSIG 207

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.9 bits (166), Expect = 7e-12
 Identities = 46/208 (22%), Positives = 90/208 (43%), Gaps = 36/208 (17%)

Query: 814 IGTGGQGSVYRA---ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
           +G G  G VY+A   +    +  A+K+     +S   C+     E+  L E++H N++  
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-----EIALLRELKHPNVISL 83

Query: 871 YG-FCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMN--VIKGVA----DALS 922
              F SHA    +++++Y E   L  I+    +++      ++   ++K +     D + 
Sbjct: 84  QKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 923 YLHNDCFPPIVYRDISSKNVLLDLEYEAH----VSDFGISKSLKPDSSNWTELAG---TI 975
           YLH +    +++RD+   N+L+  E        ++D G ++          +L     T 
Sbjct: 143 YLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199

Query: 976 GYVAPEL-----AYTMKVTEKSDVYSFG 998
            Y APEL      YT  +    D+++ G
Sbjct: 200 WYRAPELLLGARHYTKAI----DIWAIG 223

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.8 bits (164), Expect = 7e-12
 Identities = 42/199 (21%), Positives = 92/199 (46%), Gaps = 29/199 (14%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE----MTCQQEFLNEVKSLTEIRHRNIV 868
           +G G   +VY+    ++G  VA+K+    L SE     T     + E+  + E++H NIV
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVK--LDSEEGTPSTA----IREISLMKELKHENIV 66

Query: 869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA----DALSYL 924
           + Y          +V+E+++   L   + +  +         +N++K         L++ 
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 925 HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-- 982
           H +    I++RD+  +N+L++   +  + DFG++++     + ++    T+ Y AP++  
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLM 181

Query: 983 ---AYTMKVTEKSDVYSFG 998
               Y+  +    D++S G
Sbjct: 182 GSRTYSTSI----DIWSCG 196

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.3 bits (165), Expect = 7e-12
 Identities = 76/284 (26%), Positives = 115/284 (40%), Gaps = 55/284 (19%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
             DFD    IG G    V    L  +  I A+K   K       ++   Q    E     +
Sbjct: 9    QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ---TEKHVFEQ 65

Query: 862  I-RHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQ 909
               H  +V     F + +R  F V EY+  G L   +              SAE      
Sbjct: 66   ASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 118

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLKPDSS 966
                   ++ AL+YLH      I+YRD+   NVLLD   E H+  +D+G+ K  L+P  +
Sbjct: 119  -------ISLALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDT 166

Query: 967  NWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHP-RDFISSICSTS 1021
              T   GT  Y+APE+     Y   V    D ++ GVL  E + G+ P     SS     
Sbjct: 167  TST-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 221

Query: 1022 SNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            +  D     IL+ ++  P  ++  K  S+++   S L+++P  R
Sbjct: 222  NTEDYLFQVILEKQIRIP-RSLSVKAASVLK---SFLNKDPKER 261

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.4 bits (165), Expect = 1e-11
 Identities = 74/284 (26%), Positives = 114/284 (40%), Gaps = 55/284 (19%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVK---KFHSPLLSEMTCQQEFLNEVKSLTE 861
             DFD    IG G    V    L  +  I A++   K       ++        E     +
Sbjct: 52   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV---QTEKHVFEQ 108

Query: 862  I-RHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEELGWTQ 909
               H  +V     F + +R  F V EY+  G L   +              SAE      
Sbjct: 109  ASNHPFLVGLHSCFQTESRL-FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAE------ 161

Query: 910  RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLKPDSS 966
                   ++ AL+YLH      I+YRD+   NVLLD   E H+  +D+G+ K  L+P  +
Sbjct: 162  -------ISLALNYLHER---GIIYRDLKLDNVLLD--SEGHIKLTDYGMCKEGLRPGDT 209

Query: 967  NWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHP-RDFISSICSTS 1021
              T   GT  Y+APE+     Y   V    D ++ GVL  E + G+ P     SS     
Sbjct: 210  TST-FCGTPNYIAPEILRGEDYGFSV----DWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 264

Query: 1022 SNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
            +  D     IL+ ++  P  ++  K  S+++   S L+++P  R
Sbjct: 265  NTEDYLFQVILEKQIRIP-RSLSVKAASVLK---SFLNKDPKER 304

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 60/359 (16%), Positives = 117/359 (32%), Gaps = 76/359 (21%)

Query: 110 LAYLDLRVNQI----FGIIPSQIANNSKLKYLDLSSNSFSGT----IPPQIGNLSMLKIL 161
           +    L+++ I       + + +  +  +K + LS N+        +   I +   L+I 
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
             S   F+GR+  +I               L   +  +L     L  + L +N+   +  
Sbjct: 66  EFSDI-FTGRVKDEI------------PEALR-LLLQALLKCPKLHTVRLSDNAFGPTAQ 111

Query: 222 SEIGNL----KSLSGLELGYNKLS-------------GSMPLSLGNLPNLATLDLHDNSL 264
             + +       L  L L  N L               ++     N P L ++    N L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

Query: 265 S--GSIPLS--FGNLTNLDILNLPHNSL-----SGSIPSEMGNLKSLYGLGLSFNKLSG- 314
                   +  F +   L  + +  N +        +   +   + L  L L  N  +  
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231

Query: 315 ---SIPSSLGNLTKLTILYLSDNLL-------FGSIPCEIGNLRYLFYLELGDNKLSG-- 362
              ++  +L +   L  L L+D LL             ++ N+  L  L L  N++    
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIG-LQTLRLQYNEIELDA 290

Query: 363 --SIPHSLG-NLTNLATLYLFTNLLS--GSIPSEI---------GNLNSLSDLGLSENE 407
             ++   +   + +L  L L  N  S    +  EI         G L+ L D+    +E
Sbjct: 291 VRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDE 349

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 50/324 (15%), Positives = 100/324 (30%), Gaps = 60/324 (18%)

Query: 397 SLSDLGLSENELSG----SIPYSFGNLTNMIVLSIYSN--------ALSGAIPKEYGNLV 444
           S+    L  + ++     S+        ++  + +  N         LS  I     +L 
Sbjct: 5   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENI-ASKKDLE 63

Query: 445 KLTLLVLSYNQLQGPIPD--------LRNLTRLARVRLDRNHLTGN----ISESFGIHSN 492
                 +   +++  IP+        L    +L  VRL  N         + +    H+ 
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 493 LSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI- 551
           L ++ L +    G                ++       +  +  ++P L+ +    N + 
Sbjct: 124 LEHLYLHNNGL-GPQ----------AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE 172

Query: 552 ---VGEIPSELGKLRSLIKLTLNRNQFSGQ-----LPTELGSLIQLEHLDLSSNRLSN-- 601
              + E        R L  + + +N    +     L   L    +L+ LDL  N  ++  
Sbjct: 173 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG 232

Query: 602 --SIPGSLGNLVKLYYLNLSNNQFSGE------IPIKLEKFIHLSDLDLSHNFLGEE--- 650
             ++  +L +   L  L L++   S              + I L  L L +N +  +   
Sbjct: 233 SSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVR 292

Query: 651 --IPSQVCSMQSLEKLNLAHNNLS 672
                    M  L  L L  N  S
Sbjct: 293 TLKTVIDEKMPDLLFLELNGNRFS 316

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 64.3 bits (157), Expect = 7e-11
 Identities = 47/311 (15%), Positives = 96/311 (30%), Gaps = 62/311 (19%)

Query: 446 LTLLVLSYNQL-----QGPIPDLRNLTRLARVRLDRNHLTGN----ISESFGIHSNLSYI 496
           +    L  + +     +     L     +  + L  N +       +SE+     +L   
Sbjct: 6   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65

Query: 497 NLSHKKFYGEISFDWG-----------KFPNLGTLDVSANNITGI----LPPEIGDSPQL 541
             S   F G +  +             K P L T+ +S N         L   +     L
Sbjct: 66  EFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 124

Query: 542 KVLDLSSNHI-------------VGEIPSELGKLRSLIKLTLNRNQFSGQ----LPTELG 584
           + L L +N +                +  +      L  +   RN+              
Sbjct: 125 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 184

Query: 585 SLIQLEHLDLSSNRL-----SNSIPGSLGNLVKLYYLNLSNNQFSGE----IPIKLEKFI 635
           S   L  + +  N +      + +   L    +L  L+L +N F+      + I L+ + 
Sbjct: 185 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 244

Query: 636 HLSDLDLSHNFLGEE----IPS--QVCSMQSLEKLNLAHNNLSG----FIPRCFKE-MHG 684
           +L +L L+   L       +           L+ L L +N +       +     E M  
Sbjct: 245 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 304

Query: 685 LVYIDISYNKL 695
           L++++++ N+ 
Sbjct: 305 LLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 58.2 bits (141), Expect = 6e-09
 Identities = 45/276 (16%), Positives = 86/276 (31%), Gaps = 67/276 (24%)

Query: 108 PHLAYLDLRVNQI----------FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNL-- 155
             L   +                  ++   +    KL  + LS N+F  T    + +   
Sbjct: 60  KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119

Query: 156 --SMLKILYLSTNQFS-------------GRIPPQIGHLSYLKALHLFENGLSG----SI 196
             + L+ LYL  N                  +  +  +   L+++    N L        
Sbjct: 120 KHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEW 179

Query: 197 PPSLGNLTNLAIMYLYNNSL-----SGSIPSEIGNLKSLSGLELGYNKLS--GSMPLS-- 247
             +  +   L  + +  N +        +   +   + L  L+L  N  +  GS  L+  
Sbjct: 180 AKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIA 239

Query: 248 LGNLPNLATLDLHDNSLS--GSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGL 305
           L + PNL  L L+D  LS  G+  +        D  +   N               L  L
Sbjct: 240 LKSWPNLRELGLNDCLLSARGAAAVV-------DAFSKLEN-------------IGLQTL 279

Query: 306 GLSFNKLSG----SIPSSLG-NLTKLTILYLSDNLL 336
            L +N++      ++ + +   +  L  L L+ N  
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 26/168 (15%), Positives = 47/168 (27%), Gaps = 35/168 (20%)

Query: 563 RSLIKLTLNRNQFSGQ----LPTELGSLIQLEHLDLSSNRLSN----SIPGSLGNLVKLY 614
            S+   +L  +  + +    +   L     ++ + LS N +       +  ++ +   L 
Sbjct: 4   FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63

Query: 615 YLNLSNNQFSGEIPIK----------LEKFIHLSDLDLSHNFLGEEIPSQVCSM----QS 660
               S+                    L K   L  + LS N  G      +         
Sbjct: 64  IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123

Query: 661 LEKLNLAHNNLS-------------GFIPRCFKEMHGLVYIDISYNKL 695
           LE L L +N L                + +  K    L  I    N+L
Sbjct: 124 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 66.5 bits (163), Expect = 1e-11
 Identities = 51/219 (23%), Positives = 97/219 (44%), Gaps = 39/219 (17%)

Query: 803 RATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE-----MTCQQEFLNEV 856
              + +++   IG G  G V++A    +G+ VA+KK    + +E     +T     L E+
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL--MENEKEGFPITA----LREI 67

Query: 857 KSLTEIRHRNIVKFYGFCSHARHS--------FIVYEYLEMGSLAMILSNATSAEELGWT 908
           K L  ++H N+V     C              ++V+++ E   LA +LSN     +   +
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN--VLVKFTLS 124

Query: 909 QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG----ISKSLKPD 964
           +   V++ + + L Y+H +    I++RD+ + NVL+  +    ++DFG     S +    
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ 181

Query: 965 SSNWTELAGTIGYVAPEL-----AYTMKVTEKSDVYSFG 998
            + +T    T+ Y  PEL      Y   +    D++  G
Sbjct: 182 PNRYTNRVVTLWYRPPELLLGERDYGPPI----DLWGAG 216

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 65.2 bits (160), Expect = 2e-11
 Identities = 40/198 (20%), Positives = 87/198 (43%), Gaps = 31/198 (15%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVK 869
           IG G  G+V++A    + EIVA+K+       E    +     L E+  L E++H+NIV+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA----LREICLLKELKHKNIVR 65

Query: 870 FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA----DALSYLH 925
            +      +   +V+E+ +   L          +         ++K         L + H
Sbjct: 66  LHDVLHSDKKLTLVFEFCDQ-DLKKYF------DSCNGDLDPEIVKSFLFQLLKGLGFCH 118

Query: 926 NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL--- 982
           +     +++RD+  +N+L++   E  +++FG++++       ++    T+ Y  P++   
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 983 --AYTMKVTEKSDVYSFG 998
              Y+  +    D++S G
Sbjct: 176 AKLYSTSI----DMWSAG 189

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 66.7 bits (163), Expect = 2e-11
 Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 39/271 (14%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G G  G V   +   +G  VAVK  +   +  +    +   E+++L   RH +I+K Y 
Sbjct: 24   LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 873  FCSHARHSFIVYEYLEMGSL-AMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
              S     F+V EY+  G L   I  N    E+        + + +   + Y H      
Sbjct: 84   VISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES----RRLFQQILSGVDYCHRHM--- 136

Query: 932  IVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL----AYTMK 987
            +V+RD+  +NVLLD    A ++DFG+S  +       T   G+  Y APE+     Y   
Sbjct: 137  VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYAAPEVISGRLYA-- 193

Query: 988  VTEKSDVYSFGVL--ALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP---SCN 1042
               + D++S GV+  AL    G  P D          ++     +I D     P   + +
Sbjct: 194  -GPEVDIWSSGVILYALLC--GTLPFD--------DDHVPTLFKKICDGIFYTPQYLNPS 242

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
            +   L+  M      L  +P  R T++ + +
Sbjct: 243  VIS-LLKHM------LQVDPMKRATIKDIRE 266

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 66.1 bits (162), Expect = 2e-11
 Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 70/287 (24%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTE-- 861
             DF+    +G G  G V  +E   + E+ AVK     +L +    Q+  ++V+  + E  
Sbjct: 20   TDFNFLMVLGKGSFGKVMLSERKGTDELYAVK-----ILKKDVVIQD--DDVECTMVEKR 72

Query: 862  -----IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEEL 905
                  +   + +    F +  R  + V EY+  G L   +              +AE  
Sbjct: 73   VLALPGKPPFLTQLHSCFQTMDRL-YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-- 129

Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLK 962
                       +A  L +L +     I+YRD+   NV+LD   E H+  +DFG+ K ++ 
Sbjct: 130  -----------IAIGLFFLQSK---GIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIW 173

Query: 963  PDSSNWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
               +  T   GT  Y+APE+     Y   V    D ++FGVL  E + G+ P  F     
Sbjct: 174  DGVTTKT-FCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYEMLAGQAP--F----- 221

Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
                + D     I++  +  P  ++  + ++I +     + ++P  R
Sbjct: 222  -EGEDEDELFQSIMEHNVAYPK-SMSKEAVAICK---GLMTKHPGKR 263

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 65.8 bits (161), Expect = 2e-11
 Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 25/205 (12%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG 872
            +G+G  GSV  A +  SGE VA+KK   P  SE+  ++    E+  L  ++H N++    
Sbjct: 32   VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRA-YRELLLLKHMQHENVIGLLD 90

Query: 873  -FCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKGVADALSYL 924
             F   +        ++V  +++   L  I+    S E++ +   Q   ++KG    L Y+
Sbjct: 91   VFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ---MLKG----LKYI 142

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     +V+RD+   N+ ++ + E  + DFG+++    +    T    T  Y APE+  
Sbjct: 143  HS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---MTGYVVTRWYRAPEVIL 196

Query: 985  T-MKVTEKSDVYSFGVLALEAIKGK 1008
            + M   +  D++S G +  E + GK
Sbjct: 197  SWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 49/212 (23%), Positives = 97/212 (45%), Gaps = 20/212 (9%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               + +   +G+G  G+V  A +  +G  VA+KK + P  SE+  ++    E++ L  +R
Sbjct: 24   RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMR 82

Query: 864  HRNIVKFY------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
            H N++                  ++V  ++    L  ++ +    E+LG  +   ++  +
Sbjct: 83   HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKH----EKLGEDRIQFLVYQM 137

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGY 977
               L Y+H      I++RD+   N+ ++ + E  + DFG+++    +    T    T  Y
Sbjct: 138  LKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE---MTGYVVTRWY 191

Query: 978  VAPELAYT-MKVTEKSDVYSFGVLALEAIKGK 1008
             APE+    M+ T+  D++S G +  E I GK
Sbjct: 192  RAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 64.9 bits (159), Expect = 4e-11
 Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 70/287 (24%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTE-- 861
            ++F+    +G G  G V  A +  +G++ AVK     +L +    Q+  ++V+  +TE  
Sbjct: 23   DNFEFIRVLGKGSFGKVMLARVKETGDLYAVK-----VLKKDVILQD--DDVECTMTEKR 75

Query: 862  -----IRHRNIVK-FYGFCSHARHSFIVYEYLEMGSLAMILSNAT----------SAEEL 905
                   H  + + F  F +  R  F V E++  G L   +  +           +AE  
Sbjct: 76   ILSLARNHPFLTQLFCCFQTPDRL-FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAE-- 132

Query: 906  GWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK-SLK 962
                       +  AL +LH+     I+YRD+   NVLLD  +E H   +DFG+ K  + 
Sbjct: 133  -----------IISALMFLHDK---GIIYRDLKLDNVLLD--HEGHCKLADFGMCKEGIC 176

Query: 963  PDSSNWTELAGTIGYVAPEL----AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSIC 1018
               +  T   GT  Y+APE+     Y   V    D ++ GVL  E + G  P  F     
Sbjct: 177  NGVTTAT-FCGTPDYIAPEILQEMLYGPAV----DWWAMGVLLYEMLCGHAP--F----- 224

Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
              + N D   + IL+  +  P+  + +    I++   S + +NP  R
Sbjct: 225  -EAENEDDLFEAILNDEVVYPT-WLHEDATGILK---SFMTKNPTMR 266

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 64.6 bits (156), Expect = 5e-11
 Identities = 25/160 (15%), Positives = 51/160 (31%), Gaps = 21/160 (13%)

Query: 531 LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS--LIQ 588
           L P +   P L  L +   + +         L+SL    +        +  ++    L  
Sbjct: 164 LSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVVEDILGSDLPN 220

Query: 589 LEHLDL---SSNRLSNSIPGSL------GNLVKLYYLNLSNNQFSGEIPIKLEKFI---H 636
           LE L L     +   +                 L +L + + +    +     +      
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 637 LSDLDLSHNFLG----EEIPSQVCSMQSLEKLNLAHNNLS 672
           L  +D+S   L       +   V  ++ L+ +N+ +N LS
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 60.4 bits (145), Expect = 1e-09
 Identities = 28/187 (14%), Positives = 64/187 (34%), Gaps = 27/187 (14%)

Query: 481 GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-- 538
            ++S        L+ + +        +S      PNL +L++ +  +   +  +I  S  
Sbjct: 162 VDLSPVLDAMPLLNNLKIK---GTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDL 218

Query: 539 PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
           P L+ L L           ++   R L                       L+ L +    
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD---------------RFPNLKWLGIVDAE 263

Query: 599 LSNSIPGSLGN---LVKLYYLNLSNNQFSGE----IPIKLEKFIHLSDLDLSHNFLGEEI 651
             N +         L +L  +++S    + E    +   ++K  HL  +++ +N+L +E+
Sbjct: 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323

Query: 652 PSQVCSM 658
             ++   
Sbjct: 324 KKELQKS 330

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 57.3 bits (137), Expect = 1e-08
 Identities = 30/159 (18%), Positives = 51/159 (32%), Gaps = 17/159 (10%)

Query: 194 GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPN 253
             + P L  +  L  + +   +          NLKSL  +  G    S    +   +LPN
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLE-IISGGLPDSVVEDILGSDLPN 220

Query: 254 LATLDLH--------DNSLSGSIP-LSFGNLTNLDILNLPHNSLSGSIPS---EMGNLKS 301
           L  L L+        D  ++   P  S     NL  L +        +     E   L  
Sbjct: 221 LEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQ 280

Query: 302 LYGLGLSFNKLSGS----IPSSLGNLTKLTILYLSDNLL 336
           L  + +S   L+      +   +  +  L  + +  N L
Sbjct: 281 LETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.8 bits (115), Expect = 6e-06
 Identities = 27/194 (13%), Positives = 55/194 (28%), Gaps = 31/194 (15%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIG--NLSMLKIL 161
             + P L  L ++      I          LK L++ S     ++   I   +L  L+ L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKP---RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKL 224

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
            L            +     L                S     NL  + + +      + 
Sbjct: 225 VLYVGVEDYGFDGDMNVFRPL---------------FSKDRFPNLKWLGIVDAEEQNVVV 269

Query: 222 SEIGN---LKSLSGLELGYNKLS--GSMPL--SLGNLPNLATLDLHDNSLSG----SIPL 270
                   L  L  +++    L+  G+  L   +  + +L  +++  N LS      +  
Sbjct: 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQK 329

Query: 271 SFGNLTNLDILNLP 284
           S     ++      
Sbjct: 330 SLPMKIDVSDSQEY 343

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 47.6 bits (112), Expect = 1e-05
 Identities = 27/167 (16%), Positives = 54/167 (32%), Gaps = 21/167 (12%)

Query: 141 SNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSL 200
           S      + P +  + +L  L +     +  I  +      LK+L +   GL  S+   +
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTN-NLSIGKK--PRPNLKSLEIISGGLPDSVVEDI 213

Query: 201 G-----NLTNLAIMYLYNNSLSGSIPSEI------GNLKSLSGLELGYNKLSGSMPLSLG 249
                 NL  L +     +       +            +L  L +   +    +     
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273

Query: 250 N---LPNLATLDLHDNSLSGS----IPLSFGNLTNLDILNLPHNSLS 289
               LP L T+D+    L+      +      + +L  +N+ +N LS
Sbjct: 274 ESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.5 bits (109), Expect = 3e-05
 Identities = 29/236 (12%), Positives = 66/236 (27%), Gaps = 44/236 (18%)

Query: 196 IPPSLGNLTNLAIMYLYNNSLSGSIPSEIGN------LKSLSGLELGYNKLSGSMPLSLG 249
           I  +     +   ++  +        S I        L ++  L     K + ++ +   
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKK 190

Query: 250 NLPNLATLDLHDNSLSGSIPLSFG-----NLTNLDILNLPHNSLSGSIPSEM------GN 298
             PNL +L++    L  S+          NL  L +     +       +          
Sbjct: 191 PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDR 250

Query: 299 LKSLYGLGLSFNKLSGSIPSSLGN---LTKLTILYLSDNLLFGSIPCEIGNLRYLFYLEL 355
             +L  LG+   +    +         L +L  + +S                      L
Sbjct: 251 FPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAG-------------------VL 291

Query: 356 GDNKLSGSIPHSLGNLTNLATLYLFTNLLSG----SIPSEIGNLNSLSDLGLSENE 407
            D      +   +  + +L  + +  N LS      +   +     +SD    +++
Sbjct: 292 TDEGAR-LLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQEYDDD 346

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 43.4 bits (101), Expect = 3e-04
 Identities = 13/75 (17%), Positives = 30/75 (40%), Gaps = 7/75 (9%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIAN---NSKLKYLDLSSNSFSGT----IPPQIGN 154
           FS   FP+L +L +   +   ++           +L+ +D+S+   +      +   +  
Sbjct: 246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDK 305

Query: 155 LSMLKILYLSTNQFS 169
           +  LK + +  N  S
Sbjct: 306 IKHLKFINMKYNYLS 320

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 64.6 bits (158), Expect = 5e-11
 Identities = 57/301 (18%), Positives = 98/301 (32%), Gaps = 67/301 (22%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLN---------EVKSLTEIRH 864
            I +G  G+V     S G  VA+K+  +  +S+        +         E++ L    H
Sbjct: 30   ISSGSYGAVCAGVDSEGIPVAIKRVFNT-VSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 865  RNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVI----- 914
             NI+     F      +     +V E +      +I             Q +        
Sbjct: 89   PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP----QHIQYFMYHIL 144

Query: 915  KGVADALSYLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELA 972
             G    L  LH        +V+RD+   N+LL    +  + DF +++    D +N T   
Sbjct: 145  LG----LHVLHEAG-----VVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYV 194

Query: 973  GTIGYVAPELAYT-MKVTEKSDVYSFG-VLA-----------------LEAIK---GKHP 1010
                Y APEL       T+  D++S G V+A                 L  I    G   
Sbjct: 195  THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254

Query: 1011 RDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDE----NPDSRP 1066
             + +    S         D + +     P+      + +   VA+  + +    NP  R 
Sbjct: 255  IEDVVMFSS-----PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309

Query: 1067 T 1067
            +
Sbjct: 310  S 310

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 64.5 bits (158), Expect = 5e-11
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 30/199 (15%)

Query: 814 IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF----LNEVKSLTEIRHRNIV 868
           +G G   +VY+A + ++ +IVA+KK    L      +       L E+K L E+ H NI+
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK--LGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG----VADALSYL 924
                  H  +  +V++++E   L +I+ +  ++  L      + IK         L YL
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKD--NSLVLT----PSHIKAYMLMTLQGLEYL 128

Query: 925 HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL-- 982
           H      I++RD+   N+LLD      ++DFG++KS    +  +T    T  Y APEL  
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 185

Query: 983 ---AYTMKVTEKSDVYSFG 998
               Y + V    D+++ G
Sbjct: 186 GARMYGVGV----DMWAVG 200

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 49/246 (19%), Positives = 100/246 (40%), Gaps = 30/246 (12%)

Query: 773  SQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGE 831
            +      +   P F        K  +E        +     +G+G  GSV  A +  +G 
Sbjct: 2    AHHHHHHSQERPTFYRQELN--KTIWE----VPERYQNLSPVGSGAYGSVCAAFDTKTGL 55

Query: 832  IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFC--SHARHSF----IVYE 885
             VAVKK   P  S +  ++    E++ L  ++H N++        + +   F    +V  
Sbjct: 56   RVAVKKLSRPFQSIIHAKRT-YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH 114

Query: 886  YLEMGSLAMILSNATSAEELGWT--QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL 943
             +      ++     + + + +   Q   +++G    L Y+H+     I++RD+   N+ 
Sbjct: 115  LMGADLNNIVKCQKLTDDHVQFLIYQ---ILRG----LKYIHS---ADIIHRDLKPSNLA 164

Query: 944  LDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLAL 1002
            ++ + E  + DFG+++    +    T    T  Y APE+    M   +  D++S G +  
Sbjct: 165  VNEDCELKILDFGLARHTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221

Query: 1003 EAIKGK 1008
            E + G+
Sbjct: 222  ELLTGR 227

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 32/132 (24%), Positives = 53/132 (40%), Gaps = 17/132 (12%)

Query: 544 LDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFS---GQLPTELGSLIQLEHLDLSSNRLS 600
           L      I  ++ + L  L++   L L+ N            L  +  L  L L  N + 
Sbjct: 30  LHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKISS-----LSGMENLRILSLGRNLIK 83

Query: 601 NSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-LEKFIHLSDLDLSHNFLG--EEIPSQVCS 657
             I         L  L +S NQ +    +  +EK ++L  L +S+N +    EI  ++ +
Sbjct: 84  -KIENLDAVADTLEELWISYNQIAS---LSGIEKLVNLRVLYMSNNKITNWGEI-DKLAA 138

Query: 658 MQSLEKLNLAHN 669
           +  LE L LA N
Sbjct: 139 LDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 36/160 (22%), Positives = 58/160 (36%), Gaps = 30/160 (18%)

Query: 223 EIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
                + +  L      +   M  +L  L     L L  N++     LS   + NL IL+
Sbjct: 21  VATEAEKVE-LHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSLS--GMENLRILS 76

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
           L  N +   I +      +L  L +S+N+++ S+ S +  L  L +LY+S+N        
Sbjct: 77  LGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNK------- 126

Query: 343 EIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTN 382
            I N   +  L                 L  L  L L  N
Sbjct: 127 -ITNWGEIDKLA---------------ALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 56.2 bits (136), Expect = 5e-09
 Identities = 27/144 (18%), Positives = 57/144 (39%), Gaps = 7/144 (4%)

Query: 565 LIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
            ++L          +   L +L   +HL LS+N +   I   L  +  L  L+L  N   
Sbjct: 27  KVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK 83

Query: 625 GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP-RCFKEMH 683
            +I         L +L +S+N +   + S +  + +L  L +++N ++ +        + 
Sbjct: 84  -KIENLDAVADTLEELWISYNQI-ASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALD 140

Query: 684 GLVYIDISYNKLHGPIPNSAAFKH 707
            L  + ++ N L+     + A   
Sbjct: 141 KLEDLLLAGNPLYNDYKENNATSE 164

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 55.5 bits (134), Expect = 9e-09
 Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 21/159 (13%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRI 172
           L   +  I  +  + ++     K+L LS+N+    I   +  +  L+IL L  N    +I
Sbjct: 30  LHGMIPPIEKM-DATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLIK-KI 85

Query: 173 PPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSG 232
                    L+ L +  N ++ S+   +  L NL ++Y+ NN ++     EI  L +L  
Sbjct: 86  ENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAALDK 141

Query: 233 LE---LGYNKLSGSMPLS----------LGNLPNLATLD 258
           LE   L  N L      +          +  LPNL  LD
Sbjct: 142 LEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 25/133 (18%), Positives = 55/133 (41%), Gaps = 8/133 (6%)

Query: 565 LIKLTLNRNQFSGQLPTELGSLIQLEHLDL--SSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
           + K T  ++        +     + E ++L      +   +  +L  L    +L LS N 
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNN 59

Query: 623 FSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEM 682
              +I   L    +L  L L  N + ++I +      +LE+L +++N ++       +++
Sbjct: 60  IE-KI-SSLSGMENLRILSLGRNLI-KKIENLDAVADTLEELWISYNQIASL--SGIEKL 114

Query: 683 HGLVYIDISYNKL 695
             L  + +S NK+
Sbjct: 115 VNLRVLYMSNNKI 127

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 30/128 (23%), Positives = 51/128 (39%), Gaps = 9/128 (7%)

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI 364
           L      +   + ++L  L     L LS N +   I   +  +  L  L LG N +   I
Sbjct: 30  LHGMIPPIEK-MDATLSTLKACKHLALSTNNI-EKI-SSLSGMENLRILSLGRNLIK-KI 85

Query: 365 PHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELS--GSIPYSFGNLTNM 422
            +       L  L++  N ++ S+ S I  L +L  L +S N+++  G I      L  +
Sbjct: 86  ENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKITNWGEIDK-LAALDKL 142

Query: 423 IVLSIYSN 430
             L +  N
Sbjct: 143 EDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 34/134 (25%), Positives = 52/134 (38%), Gaps = 30/134 (22%)

Query: 513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
                  L +S NNI  I    +     L++L L  N I      ++  L ++       
Sbjct: 46  TLKACKHLALSTNNIEKISS--LSGMENLRILSLGRNLI-----KKIENLDAVAD----- 93

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPI-KL 631
                           LE L +S N+++ S+ G +  LV L  L +SNN+ +    I KL
Sbjct: 94  ---------------TLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKL 136

Query: 632 EKFIHLSDLDLSHN 645
                L DL L+ N
Sbjct: 137 AALDKLEDLLLAGN 150

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 5/124 (4%)

Query: 436 IPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSY 495
           +      L     L LS N ++  I  L  +  L  + L RN +   I     +   L  
Sbjct: 40  MDATLSTLKACKHLALSTNNIEK-ISSLSGMENLRILSLGRNLIK-KIENLDAVADTLEE 97

Query: 496 INLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPE-IGDSPQLKVLDLSSNHIVGE 554
           + +S+ +    +S    K  NL  L +S N IT     + +    +L+ L L+ N +  +
Sbjct: 98  LWISYNQI-ASLS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND 155

Query: 555 IPSE 558
               
Sbjct: 156 YKEN 159

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 64.7 bits (158), Expect = 6e-11
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 51/219 (23%)

Query: 814  IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHRNIVK-FY 871
            IG G  G V++A+L   + VA+KK            + F N E++ +  ++H N+V    
Sbjct: 48   IGNGSFGVVFQAKLVESDEVAIKKVLQ--------DKRFKNRELQIMRIVKHPNVVDLKA 99

Query: 872  GFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKG----VADALS 922
             F S+          +V EY+           A   + +     M +IK     +  +L+
Sbjct: 100  FFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP----MLLIKLYMYQLLRSLA 155

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAGTIGYV--- 978
            Y+H+     I +RDI  +N+LLD       + DFG +K L     N       + Y+   
Sbjct: 156  YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-------VSYICSR 205

Query: 979  ---APEL-----AYTMKVTEKSDVYSFG-VLALEAIKGK 1008
               APEL      YT  +    D++S G V+A E ++G+
Sbjct: 206  YYRAPELIFGATNYTTNI----DIWSTGCVMA-ELMQGQ 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 63.8 bits (156), Expect = 8e-11
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 38/223 (17%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               +     IG G  G V  A +  +   VA+KK  SP   +  CQ+  L E+K L   R
Sbjct: 26   GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI-SPFEHQTYCQRT-LREIKILLRFR 83

Query: 864  HRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKG 916
            H NI+       +          IV + +E     ++ +   S + + +   Q   +++G
Sbjct: 84   HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQ---ILRG 140

Query: 917  VADALSYLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTEL 971
                L Y+H  N     +++RD+   N+LL+   +  + DFG+++   PD  +    TE 
Sbjct: 141  ----LKYIHSAN-----VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191

Query: 972  AGTIGYVAPEL-----AYTMKVTEKSDVYSFG-VLALEAIKGK 1008
              T  Y APE+      YT  +    D++S G +LA E +  +
Sbjct: 192  VATRWYRAPEIMLNSKGYTKSI----DIWSVGCILA-EMLSNR 229

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 63.0 bits (154), Expect = 1e-10
 Identities = 40/203 (19%), Positives = 87/203 (42%), Gaps = 26/203 (12%)

Query: 806 NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSE----MTCQQEFLNEVKSLT 860
             + +   +G G   +VY+     +  +VA+K+    L  E     T     + EV  L 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR--LEHEEGAPCTA----IREVSLLK 55

Query: 861 EIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
           +++H NIV  +      +   +V+EYL+   L   L +      +        +  +   
Sbjct: 56  DLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDD--CGNIINMHNVKLFLFQLLRG 112

Query: 921 LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
           L+Y H      +++RD+  +N+L++   E  ++DFG++++    +  +     T+ Y  P
Sbjct: 113 LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

Query: 981 EL-----AYTMKVTEKSDVYSFG 998
           ++      Y+ ++    D++  G
Sbjct: 170 DILLGSTDYSTQI----DMWGVG 188

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 42/128 (32%), Positives = 56/128 (43%), Gaps = 28/128 (21%)

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSI 316
           L+L  N L       F  LT L  L+L  N +  S+P  +            F+K     
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGV------------FDK----- 74

Query: 317 PSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSGSIPH-SLGNLTNL 374
                 LTKLTILYL +N L  S+P  +   L  L  L L  N+L  S+P      LT+L
Sbjct: 75  ------LTKLTILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSL 126

Query: 375 ATLYLFTN 382
             ++L TN
Sbjct: 127 QKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 4e-07
 Identities = 33/106 (31%), Positives = 45/106 (42%), Gaps = 4/106 (3%)

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSG 410
            LEL  NKL          LT L  L L  N +  S+P  +   L  L+ L L EN+L  
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89

Query: 411 SIPYS-FGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
           S+P   F  LT +  L++ +N L       +  L  L  + L  N 
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 35/114 (30%), Positives = 52/114 (45%), Gaps = 5/114 (4%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
           S+P+ I +  S + L L  N+L       F  LT +  LS+  N +       +  L KL
Sbjct: 21  SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78

Query: 447 TLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINL 498
           T+L L  N+LQ  +P+     LT+L  + LD N L       F   ++L  I L
Sbjct: 79  TILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWL 131

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 31/106 (29%), Positives = 50/106 (47%), Gaps = 6/106 (5%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSG 170
            L+L  N++  +        ++L  L LS N    ++P  +   L+ L ILYL  N+   
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89

Query: 171 RIPPQI-GHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNN 214
            +P  +   L+ LK L L  N L  S+P      LT+L  ++L+ N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.4 bits (116), Expect = 2e-06
 Identities = 36/106 (33%), Positives = 48/106 (45%), Gaps = 8/106 (7%)

Query: 185 LHLFENGLSGSIPPSL-GNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSG 242
           L L  N L  S+P  +   LT L  + L  N +  S+P  +   L  L+ L L  NKL  
Sbjct: 33  LELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ- 89

Query: 243 SMPLSL-GNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
           S+P  +   L  L  L L  N L  S+P   F  LT+L  + L  N
Sbjct: 90  SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 7/110 (6%)

Query: 372 TNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYS-FGNLTNMIVLSIYSN 430
           ++   L L +N L          L  L+ L LS+N++  S+P   F  LT + +L ++ N
Sbjct: 28  SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86

Query: 431 ALSGAIPKE-YGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
            L  ++P   +  L +L  L L  NQL+  +PD     LT L ++ L  N
Sbjct: 87  KLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 31/106 (29%), Positives = 47/106 (44%), Gaps = 5/106 (4%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
           +L L  N+           L QL  L LS N++ +   G    L KL  L L  N+    
Sbjct: 32  RLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 627 IPIKL-EKFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHNN 670
           +P  + +K   L +L L  N L + +P  +   + SL+K+ L H N
Sbjct: 91  LPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWL-HTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 46.9 bits (112), Expect = 6e-06
 Identities = 34/106 (32%), Positives = 47/106 (44%), Gaps = 6/106 (5%)

Query: 520 LDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQ 578
           L++ +N +   LP  + D   QL  L LS N I         KL  L  L L+ N+    
Sbjct: 33  LELESNKLQS-LPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 579 LPTEL-GSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQ 622
           LP  +   L QL+ L L +N+L  S+P G    L  L  + L  N 
Sbjct: 91  LPNGVFDKLTQLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNP 135

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 60.4 bits (147), Expect = 2e-10
 Identities = 32/131 (24%), Positives = 46/131 (35%), Gaps = 33/131 (25%)

Query: 257 LDLHDNSLSGSIPLS--FGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLS 313
           L L+DN L   I     FG L +L  L L  N L+  I          +  L L  NK+ 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 314 GSIPSSL-GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH-SLGNL 371
             I + +   L +L  L L DN +                           +   S  +L
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQI-------------------------SCVMPGSFEHL 125

Query: 372 TNLATLYLFTN 382
            +L +L L +N
Sbjct: 126 NSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 33/107 (30%), Positives = 48/107 (44%), Gaps = 9/107 (8%)

Query: 185 LHLFENGLSGSIPPS--LGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLS 241
           L L +N L   I      G L +L  + L  N L+  I          +  L+LG NK+ 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK 91

Query: 242 GSMPLSL-GNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
             +   +   L  L TL+L+DN +S  +   SF +L +L  LNL  N
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 56.5 bits (137), Expect = 4e-09
 Identities = 28/108 (25%), Positives = 49/108 (45%), Gaps = 7/108 (6%)

Query: 520 LDVSANNITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSG 577
           L ++ N +  I    +    P L  L+L  N +   I          + +L L  N+   
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIK- 91

Query: 578 QLPTEL-GSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQF 623
           ++  ++   L QL+ L+L  N++S  +  GS  +L  L  LNL++N F
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASNPF 138

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 7/108 (6%)

Query: 159 KILYLSTNQFSGRIPPQ--IGHLSYLKALHLFENGLSGSIPPSL-GNLTNLAIMYLYNNS 215
             L L+ N+   RI      G L +L  L L  N L+  I P+     +++  + L  N 
Sbjct: 32  TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENK 89

Query: 216 LSGSIPSEI-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDN 262
           +   I +++   L  L  L L  N++S  MP S  +L +L +L+L  N
Sbjct: 90  IK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 34/107 (31%), Positives = 49/107 (45%), Gaps = 9/107 (8%)

Query: 305 LGLSFNKLSGSIPSS--LGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLS 361
           L L+ N+L   I S    G L  L  L L  N L   I         ++  L+LG+NK+ 
Sbjct: 34  LLLNDNELG-RISSDGLFGRLPHLVKLELKRNQL-TGIEPNAFEGASHIQELQLGENKIK 91

Query: 362 GSIPHSL-GNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSEN 406
             I + +   L  L TL L+ N +S  +      +LNSL+ L L+ N
Sbjct: 92  -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 30/106 (28%), Positives = 43/106 (40%), Gaps = 5/106 (4%)

Query: 567 KLTLNRNQFSGQLPTEL-GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
           +L LN N+        L G L  L  L+L  N+L+   P +      +  L L  N+   
Sbjct: 33  ELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK- 91

Query: 626 EIPIKL-EKFIHLSDLDLSHNFLGEEIPSQVC-SMQSLEKLNLAHN 669
           EI  K+      L  L+L  N +   +       + SL  LNLA N
Sbjct: 92  EISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 49.6 bits (119), Expect = 8e-07
 Identities = 29/115 (25%), Positives = 54/115 (46%), Gaps = 6/115 (5%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPY-SFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
            IP +I      ++L L++NEL        FG L +++ L +  N L+G  P  +     
Sbjct: 22  EIPRDI--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79

Query: 446 LTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINL 498
           +  L L  N+++  I +     L +L  + L  N ++  +  SF   ++L+ +NL
Sbjct: 80  IQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 46.9 bits (112), Expect = 8e-06
 Identities = 29/113 (25%), Positives = 43/113 (38%), Gaps = 28/113 (24%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILY 162
           F   PHL  L+L+ NQ+ GI P+     S ++ L L  N     I  ++   L  LK L 
Sbjct: 50  FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLN 108

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNN 214
           L  NQ              +             + P S  +L +L  + L +N
Sbjct: 109 LYDNQ--------------IS-----------CVMPGSFEHLNSLTSLNLASN 136

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 61.1 bits (149), Expect = 6e-10
 Identities = 53/248 (21%), Positives = 100/248 (40%), Gaps = 63/248 (25%)

Query: 794  RKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF 852
            ++I Y         F  +  +G G  G V  A    +GEIVA+KK   P    +   +  
Sbjct: 3    KRIVYNISSD----FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI-EPFDKPLFALRT- 56

Query: 853  LNEVKSLTEIRHRNIVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGW 907
            L E+K L   +H NI+  +      +  +F    I+ E ++   L  ++S          
Sbjct: 57   LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVIS---------- 105

Query: 908  TQRMN----------VIKGVADALSYLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDF 955
            TQ ++           ++     +  LH  N     +++RD+   N+L++   +  V DF
Sbjct: 106  TQMLSDDHIQYFIYQTLRA----VKVLHGSN-----VIHRDLKPSNLLINSNCDLKVCDF 156

Query: 956  GISKSLKPDSSNWTELAGTIG----YV------APEL-----AYTMKVTEKSDVYSFGVL 1000
            G+++ +   +++ +E  G       +V      APE+      Y+  +    DV+S G +
Sbjct: 157  GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCI 212

Query: 1001 ALEAIKGK 1008
              E    +
Sbjct: 213  LAELFLRR 220

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 60.7 bits (148), Expect = 7e-10
 Identities = 51/223 (22%), Positives = 91/223 (40%), Gaps = 47/223 (21%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKK--FHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +G GG G V+ A +    + VA+KK     P   +       L E+K +  + H NIVK 
Sbjct: 19   LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA-----LREIKIIRRLDHDNIVKV 73

Query: 871  Y----------GFCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWT--QRMNVI 914
            +               +        IV EY+E     ++       E       Q   ++
Sbjct: 74   FEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQ---LL 130

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSN---WTE 970
            +G    L Y+H+     +++RD+   N+ ++ E     + DFG+++ + P  S+    +E
Sbjct: 131  RG----LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 971  LAGTIGYVAPEL-----AYTMKVTEKSDVYSFGVLALEAIKGK 1008
               T  Y +P L      YT  +    D+++ G +  E + GK
Sbjct: 184  GLVTKWYRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGK 222

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 60.7 bits (148), Expect = 7e-10
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 29/213 (13%)

Query: 803 RATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF----LNEVK 857
            AT+ ++    IG G  G+VY+A +  SG  VA+K     + +            + EV 
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR--VPNGGGGGGGLPISTVREVA 63

Query: 858 SLTEIR---HRNIVKFYGFCSHARHS-----FIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            L  +    H N+V+    C+ +R        +V+E+++   L   L        L    
Sbjct: 64  LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDK-APPPGLPAET 121

Query: 910 RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
             ++++     L +LH +C   IV+RD+  +N+L+       ++DFG+++         T
Sbjct: 122 IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALT 177

Query: 970 ELAGTIGYVAPEL----AYTMKVTEKSDVYSFG 998
            +  T+ Y APE+     Y   V    D++S G
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPV----DMWSVG 206

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 58.1 bits (141), Expect = 9e-10
 Identities = 27/128 (21%), Positives = 54/128 (42%), Gaps = 6/128 (4%)

Query: 543 VLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNS 602
           ++ L++  I  E  ++        +L L   +    +     +L Q + +D S N +   
Sbjct: 1   MVKLTAELI--EQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-K 56

Query: 603 IPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE-EIPSQVCSMQSL 661
           + G    L +L  L ++NN+         +    L++L L++N L E      + S++SL
Sbjct: 57  LDG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115

Query: 662 EKLNLAHN 669
             L +  N
Sbjct: 116 TYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 27/128 (21%), Positives = 51/128 (39%), Gaps = 8/128 (6%)

Query: 520 LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
           + ++A  I      +  ++ + + LDL    I   I +    L     +  + N+   +L
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KL 57

Query: 580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS--GEIPIKLEKFIHL 637
                 L +L+ L +++NR+     G    L  L  L L+NN     G++   L     L
Sbjct: 58  DG-FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSL 115

Query: 638 SDLDLSHN 645
           + L +  N
Sbjct: 116 TYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 54.7 bits (132), Expect = 1e-08
 Identities = 19/115 (16%), Positives = 42/115 (36%), Gaps = 6/115 (5%)

Query: 581 TELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-LEKFIHLSD 639
            +  + ++   LDL   ++   I      L +   ++ S+N+      +        L  
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 68

Query: 640 LDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF-IPRCFKEMHGLVYIDISYN 693
           L +++N +         ++  L +L L +N+L           +  L Y+ I  N
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 53.1 bits (128), Expect = 4e-08
 Identities = 27/136 (19%), Positives = 44/136 (32%), Gaps = 26/136 (19%)

Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLG 306
              N      LDL    +   I      L   D ++   N +   +      L+ L  L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLL 70

Query: 307 LSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH 366
           ++ N++          L  LT L L++N L      E+G+L  L                
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSL-----VELGDLDPLA--------------- 110

Query: 367 SLGNLTNLATLYLFTN 382
              +L +L  L +  N
Sbjct: 111 ---SLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 52.4 bits (126), Expect = 7e-08
 Identities = 31/137 (22%), Positives = 47/137 (34%), Gaps = 29/137 (21%)

Query: 439 EYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINL 498
           +Y N V+   L L   +    IP + NL      + D    + N                
Sbjct: 14  QYTNAVRDRELDLRGYK----IPVIENLGA-TLDQFDAIDFSDNEIRKLD---------- 58

Query: 499 SHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIP 556
                       +     L TL V+ N I  I        P L  L L++N +  +G++ 
Sbjct: 59  -----------GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL- 106

Query: 557 SELGKLRSLIKLTLNRN 573
             L  L+SL  L + RN
Sbjct: 107 DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 26/138 (18%), Positives = 41/138 (29%), Gaps = 28/138 (20%)

Query: 198 PSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLS-LGNLPNLAT 256
               N      + L    +   I +    L     ++   N++     L     L  L T
Sbjct: 13  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR---KLDGFPLLRRLKT 68

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSI 316
           L +++N +          L +L  L L +NSL          L  L              
Sbjct: 69  LLVNNNRICRIGEGLDQALPDLTELILTNNSLV--------ELGDL-------------- 106

Query: 317 PSSLGNLTKLTILYLSDN 334
              L +L  LT L +  N
Sbjct: 107 -DPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 15/104 (14%), Positives = 38/104 (36%), Gaps = 5/104 (4%)

Query: 592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEI 651
           + L++  +  +      N V+   L+L   +    I            +D S N +  ++
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKL 57

Query: 652 PSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
                 ++ L+ L + +N +        + +  L  + ++ N L
Sbjct: 58  -DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL 100

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 28/150 (18%), Positives = 44/150 (29%), Gaps = 28/150 (18%)

Query: 113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRI 172
           + L    I     +Q  N  + + LDL        I      L     +  S N+   ++
Sbjct: 2   VKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL 57

Query: 173 PPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSG 232
                 L  LK L +  N +          L +L  + L NN         +  L  L  
Sbjct: 58  D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN--------SLVELGDLD- 107

Query: 233 LELGYNKLSGSMPLSLGNLPNLATLDLHDN 262
                          L +L +L  L +  N
Sbjct: 108 --------------PLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 23/115 (20%), Positives = 40/115 (34%), Gaps = 6/115 (5%)

Query: 318 SSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATL 377
           +   N  +   L L    +   I      L     ++  DN++   +      L  L TL
Sbjct: 13  AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69

Query: 378 YLFTNLLSGSIPSEIGNLNSLSDLGLSENELS--GSIPYSFGNLTNMIVLSIYSN 430
            +  N +          L  L++L L+ N L   G +     +L ++  L I  N
Sbjct: 70  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 24/113 (21%), Positives = 41/113 (36%), Gaps = 5/113 (4%)

Query: 367 SLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLS 426
              N      L L    +   I +    L+    +  S+NE+   +   F  L  +  L 
Sbjct: 14  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70

Query: 427 IYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGP--IPDLRNLTRLARVRLDRN 477
           + +N +          L  LT L+L+ N L     +  L +L  L  + + RN
Sbjct: 71  VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.6 bits (98), Expect = 4e-04
 Identities = 16/81 (19%), Positives = 29/81 (35%), Gaps = 7/81 (8%)

Query: 105 SSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS 164
           ++      +D   N+I  +         +LK L +++N            L  L  L L+
Sbjct: 39  ATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 96

Query: 165 TNQFSGRIPPQIGHLSYLKAL 185
            N        ++G L  L +L
Sbjct: 97  NNSLV-----ELGDLDPLASL 112

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.6 bits (137), Expect = 1e-09
 Identities = 37/131 (28%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 564 SLIKLTLNRNQFS-GQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
            + +L L+ ++ + G+L        +LE L   +  L+ SI   L  L KL  L LS+N+
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75

Query: 623 FSGEIPIKLEKFIHLSDLDLSHNFLGE-EIPSQVCSMQSLEKLNLAHN---NLSGFIPRC 678
            SG + +  EK  +L+ L+LS N + +      +  +++L+ L+L +    NL+ +    
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENV 135

Query: 679 FKEMHGLVYID 689
           FK +  L Y+D
Sbjct: 136 FKLLPQLTYLD 146

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 56.2 bits (136), Expect = 2e-09
 Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 4/108 (3%)

Query: 540 QLKVLDLSSNHI-VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNR 598
            +K L L ++    G++     +   L  L+      +  +   L  L +L+ L+LS NR
Sbjct: 18  DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNR 75

Query: 599 LSNSIPGSLGNLVKLYYLNLSNNQFSG-EIPIKLEKFIHLSDLDLSHN 645
           +S  +         L +LNLS N+         L+K  +L  LDL + 
Sbjct: 76  VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 30/139 (21%), Positives = 47/139 (33%), Gaps = 28/139 (20%)

Query: 246 LSLGNLPNLATLDLHDNSLS-GSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYG 304
           L      ++  L L ++  + G +         L+ L+  +  L+               
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT--------------- 55

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG-S 363
                  ++      L  L KL  L LSDN + G +         L +L L  NK+   S
Sbjct: 56  ------SIAN-----LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLS 104

Query: 364 IPHSLGNLTNLATLYLFTN 382
               L  L NL +L LF  
Sbjct: 105 TIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.9 bits (117), Expect = 8e-07
 Identities = 29/113 (25%), Positives = 44/113 (38%), Gaps = 5/113 (4%)

Query: 298 NLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGD 357
           ++K L       N+  G +        +L  L   +  L  SI   +  L  L  LEL D
Sbjct: 18  DVKELVLDNSRSNE--GKLEGLTDEFEELEFLSTINVGL-TSIAN-LPKLNKLKKLELSD 73

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSG-SIPSEIGNLNSLSDLGLSENELS 409
           N++SG +        NL  L L  N +   S    +  L +L  L L   E++
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 48.1 bits (115), Expect = 1e-06
 Identities = 31/167 (18%), Positives = 51/167 (30%), Gaps = 52/167 (31%)

Query: 171 RIPPQIGHLSY--LKALHLFENGLS-GSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNL 227
           RI  ++ + +   +K L L  +  + G +         L  +   N             L
Sbjct: 6   RIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINV-----------GL 54

Query: 228 KSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNS 287
            S++ L                 L  L  L+L DN +SG + +      NL  LNL  N 
Sbjct: 55  TSIANLP---------------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK 99

Query: 288 LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
           +         +L ++                 L  L  L  L L + 
Sbjct: 100 IK--------DLSTI---------------EPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 46.2 bits (110), Expect = 7e-06
 Identities = 20/90 (22%), Positives = 44/90 (48%), Gaps = 4/90 (4%)

Query: 606 SLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLN 665
           +  ++ +L   N  +N   G++    ++F  L  L   +  L   I + +  +  L+KL 
Sbjct: 15  TPSDVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGL-TSI-ANLPKLNKLKKLE 70

Query: 666 LAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
           L+ N +SG +    ++   L ++++S NK+
Sbjct: 71  LSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 45.8 bits (109), Expect = 8e-06
 Identities = 26/112 (23%), Positives = 43/112 (38%), Gaps = 4/112 (3%)

Query: 464 RNLTRLARVRLDRNHLT-GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDV 522
           R  + +  + LD +    G +         L +++  +      I+ +  K   L  L++
Sbjct: 14  RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGL-TSIA-NLPKLNKLKKLEL 71

Query: 523 SANNITGILPPEIGDSPQLKVLDLSSNHIVG-EIPSELGKLRSLIKLTLNRN 573
           S N ++G L       P L  L+LS N I        L KL +L  L L   
Sbjct: 72  SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 25/114 (21%), Positives = 42/114 (36%), Gaps = 5/114 (4%)

Query: 370 NLTNLATLYLFTN-LLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIY 428
             +++  L L  +    G +         L  L      L+ SI  +   L  +  L + 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72

Query: 429 SNALSGAIPKEYGNLVKLTLLVLSYNQLQGP--IPDLRNLTRLARVRLDRNHLT 480
            N +SG +         LT L LS N+++    I  L+ L  L  + L    +T
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 18/65 (27%), Positives = 25/65 (38%), Gaps = 3/65 (4%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFS--GTIPPQIGNLSMLKIL 161
                 L  L+L  N++ G +         L +L+LS N      TI P +  L  LK L
Sbjct: 60  LPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP-LKKLENLKSL 118

Query: 162 YLSTN 166
            L   
Sbjct: 119 DLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 40.4 bits (95), Expect = 7e-04
 Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 3/87 (3%)

Query: 105 SSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS 164
             F  L +L      +  I  + +   +KLK L+LS N  SG +         L  L LS
Sbjct: 39  DEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96

Query: 165 TNQFSG-RIPPQIGHLSYLKALHLFEN 190
            N+         +  L  LK+L LF  
Sbjct: 97  GNKIKDLSTIEPLKKLENLKSLDLFNC 123

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 61.4 bits (148), Expect = 1e-09
 Identities = 96/655 (14%), Positives = 183/655 (27%), Gaps = 224/655 (34%)

Query: 501  KKFYGEI---SFDW--------GKFPNLGTLD-VSANNITGILPPEIGDSPQLKVLDLSS 548
            +KF  E+   ++ +         + P++ T   +   +          D+      ++S 
Sbjct: 80   QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRD------RLYNDNQVFAKYNVSR 133

Query: 549  NHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS----LIQLEHLD-LSSNRLSNSI 603
                 ++   L +LR    + ++     G L    GS    +     LD   S ++   +
Sbjct: 134  LQPYLKLRQALLELRPAKNVLID-----GVL----GSGKTWVA----LDVCLSYKVQCKM 180

Query: 604  PGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEK 663
                    K+++LNL N      +   L+K ++  D + +                  E 
Sbjct: 181  DF------KIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234

Query: 664  LNL----AHNN-------------LSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFK 706
              L     + N              + F   C K    L+    +  K      ++A   
Sbjct: 235  RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSC-KI---LL---TTRFKQVTDFLSAATTT 287

Query: 707  HAPMEALQGN------KGLCGDIKGFPSCKASKSDKQASRKIWVVIVFPLLGSFALLISL 760
            H  ++           K L         C+     ++           P        +S+
Sbjct: 288  HISLDHHSMTLTPDEVKSLLLKYLD---CRPQDLPREVLT------TNPRR------LSI 332

Query: 761  IGLFFM--------FRRRSSSQ---TQQSSAGNAPGFLSVLTFD--RKIAYEEIVRATND 807
            I             ++  +  +     +SS       L+VL     RK+ ++ +      
Sbjct: 333  IAESIRDGLATWDNWKHVNCDKLTTIIESS-------LNVLEPAEYRKM-FDRLSV---- 380

Query: 808  FDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLL-----SEMTC-----QQEFLNEVK 857
            F     I T     ++   + S  +V V K H   L      E T        E   +++
Sbjct: 381  FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440

Query: 858  SLTEIRHRNIVKFY----GFCSHAR---------HSFIVYEYLEMGSLAMILSNATSAEE 904
            +   + HR+IV  Y     F S            +S I +           L N    E 
Sbjct: 441  NEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHH----------LKNIEHPER 489

Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
            +                       F            V LD         F + + ++ D
Sbjct: 490  M---------------------TLFR----------MVFLDF-------RF-LEQKIRHD 510

Query: 965  SSNWTELAGTIGYVAPELAYTMKVTEKSDV--YSFGVLALEAIKGKHPRDFISSICSTSS 1022
            S+ W       G +   L           +  Y               + +I        
Sbjct: 511  STAW----NASGSILNTL---------QQLKFY---------------KPYICDNDPK-- 540

Query: 1023 NLDRTLDEILDPRLPAPSCN-IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              +R ++ ILD  LP    N I  K   ++ +A+       D     +   Q+ +
Sbjct: 541  -YERLVNAILD-FLPKIEENLICSKYTDLLRIALM----AEDEAIFEEAHKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 58.3 bits (140), Expect = 1e-08
 Identities = 83/638 (13%), Positives = 161/638 (25%), Gaps = 228/638 (35%)

Query: 25  DFPLIVSSNSTEEAHALLKWKTSLQNHN---NKGSFLPS---------WTLNNA-TKISP 71
           ++  ++S   TE+    +  +  ++  +   N                  L  A  ++ P
Sbjct: 90  NYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRP 149

Query: 72  CAWFGIH----CNHAGKVNSINLTSAGLIGTLHDFSF-SSFPHLAYLDLRVNQIFGIIPS 126
                I         GK  +  +           +                 +IF     
Sbjct: 150 AKNVLIDGVLGS---GK--TW-VALD----VCLSYKVQCKMD---------FKIF----- 185

Query: 127 QIANNSKLKYLDLSSNSFSGTIPPQIGNLSM-LKILYLSTNQFSGRIPPQI----GHLSY 181
                    +L+L + +   T+   +  L   +   + S +  S  I  +I      L  
Sbjct: 186 ---------WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 182 LKALHLFENGLSGSIPPSLGNLTNLAIMYLYN---------------NSLSGSIPSEIGN 226
           L     +EN L   +   L N+ N      +N               + LS +  + I  
Sbjct: 237 LLKSKPYENCLL--V---LLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL 291

Query: 227 LKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHN 286
                 L                         L                 +    +LP  
Sbjct: 292 DHHSMTLTPDE------------------VKSL------------LLKYLDCRPQDLPRE 321

Query: 287 SLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGN 346
            L+ +                         P             LS   +        G 
Sbjct: 322 VLTTN-------------------------P-----------RRLS---IIAES-IRDGL 341

Query: 347 LRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLG-LSE 405
             +  +  +  +KL+  I  SL  L                 P+E   +     L     
Sbjct: 342 ATWDNWKHVNCDKLTTIIESSLNVLE----------------PAEYRKM--FDRLSVFPP 383

Query: 406 NELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGN-LVKLTLLVLSYNQLQGPIPDL- 463
           +     IP          +LS+    +  +      N L K +L+     +    IP + 
Sbjct: 384 SAH---IPTI--------LLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432

Query: 464 -------RNLTRLARVRLDR---------NHLTGNISESFGIHSNLSY----INLSHK-- 501
                   N   L R  +D          + L     + +  +S++ +    I    +  
Sbjct: 433 LELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQY-FYSHIGHHLKNIEHPERMT 491

Query: 502 ---KFYGEISFDW--GKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIP 556
                +  + F +   K  +  T    A N +G +   +        L     +I    P
Sbjct: 492 LFRMVF--LDFRFLEQKIRHDST----AWNASGSILNTLQQ------LKFYKPYICDNDP 539

Query: 557 SELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDL 594
                + +++        F   LP    +LI  ++ DL
Sbjct: 540 KYERLVNAILD-------F---LPKIEENLICSKYTDL 567

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 1e-07
 Identities = 53/374 (14%), Positives = 108/374 (28%), Gaps = 106/374 (28%)

Query: 763  LFFMFRRRSSSQTQQSSAGNAPGFL-SVLTFDRKIAYEEIVRATNDFDEEHCIGTGGQGS 821
            LF+    +     Q+        F+  VL  + K     I        +           
Sbjct: 67   LFWTLLSKQEEMVQK--------FVEEVLRINYKFLMSPI--------KTEQRQPSMMTR 110

Query: 822  VYRAELSS--GEIVAVKKFHSPLLSEMTCQQEFLNEVKS-LTEIRHRNIVKFYGF----- 873
            +Y  +      +     K++         + +   +++  L E+R    V   G      
Sbjct: 111  MYIEQRDRLYNDNQVFAKYNVS-------RLQPYLKLRQALLELRPAKNVLIDGVLGSGK 163

Query: 874  -------CS----HARHSFIVYEYLEMGS-------LAM-------ILSNATSAEELGWT 908
                   C       +  F ++ +L + +       L M       I  N TS  +    
Sbjct: 164  TWVALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSN 222

Query: 909  QRMNVIKGVADALSYL-----HNDCFPPIVYRDISSKNVL--LDLE-------YEAHVSD 954
             ++  I  +   L  L     + +C   +V  ++ +       +L            V+D
Sbjct: 223  IKLR-IHSIQAELRRLLKSKPYENCL--LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 955  FGISKSLKPDSSNWTELAGTIGYVAPE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDF 1013
            F  + +    S +   +         E  +  +K  +         L  E +   +PR  
Sbjct: 280  FLSAATTTHISLDHHSM----TLTPDEVKSLLLKYLDCR----PQDLPREVLTT-NPR-R 329

Query: 1014 ISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDEN------------ 1061
            +S I  +  +   T D               DKL +I+E +++ L+              
Sbjct: 330  LSIIAESIRDGLATWDNWKHVNC--------DKLTTIIESSLNVLEPAEYRKMFDRLSVF 381

Query: 1062 PDSRPTMQKVSQLL 1075
            P S      +  L+
Sbjct: 382  PPSAHIPTILLSLI 395

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 59.9 bits (145), Expect = 2e-09
 Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 20/165 (12%)

Query: 917  VADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT-- 974
            VA  + +L        ++RD++++N+LL  +    + DFG+++ +  D     +      
Sbjct: 202  VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258

Query: 975  IGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILD 1033
            + ++APE  +    T +SDV+SFGVL  E    G  P   +         +D      L 
Sbjct: 259  LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK--------IDEEFCRRLK 310

Query: 1034 P--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               R+ AP      ++   M     C    P  RPT  ++ + L 
Sbjct: 311  EGTRMRAPD-YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 351

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 32/159 (20%), Positives = 58/159 (36%), Gaps = 26/159 (16%)

Query: 814 IGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQE---FLNEVKSLTEI-R 863
           +G G  G V  A+       ++   VAVK     +L E     E    ++E+K L  I  
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVK-----MLKEGATHSEHRALMSELKILIHIGH 84

Query: 864 HRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
           H N+V   G C+       ++ E+ + G+L+  L           ++R   +        
Sbjct: 85  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGAR 134

Query: 923 YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL 961
           +     +   +  D+  +   +     +  S F   KSL
Sbjct: 135 FRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 26/118 (22%), Positives = 35/118 (29%), Gaps = 24/118 (20%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
                L    NL  +Y+ N      +                           L  L  L
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELR-----------------------DLRGLGEL 58

Query: 255 ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKL 312
             L +  + L    P +F     L  LNL  N+L  S+  +     SL  L LS N L
Sbjct: 59  RNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 2e-09
 Identities = 27/135 (20%), Positives = 47/135 (34%), Gaps = 7/135 (5%)

Query: 554 EIPSELGKLRSLIKLTLNRNQFSGQLPTE-LGSLIQLEHLDLSSNRLSNSIPGSLGNLVK 612
           +    L    +L +L +   Q    L    L  L +L +L +  + L    P +     +
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 613 LYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
           L  LNLS N     +  K  + + L +L LS N L        C+++ L++         
Sbjct: 82  LSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL-----HCSCALRWLQRWEEEGLGGV 135

Query: 673 GFIPRCFKEMHGLVY 687
                       L +
Sbjct: 136 PEQKLQCHGQGPLAH 150

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.4 bits (143), Expect = 3e-09
 Identities = 20/93 (21%), Positives = 33/93 (35%), Gaps = 2/93 (2%)

Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSE-LGKLRSLIKLTLNRNQFSGQLPTELGSLIQLE 590
              +  +  L  L + +   +  +    L  L  L  LT+ ++      P       +L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 591 HLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
            L+LS N L  S+       + L  L LS N  
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 4e-09
 Identities = 22/99 (22%), Positives = 31/99 (31%), Gaps = 4/99 (4%)

Query: 238 NKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHNSLSGSIPSEM 296
              +      L    NL  L + +      + L     L  L  L +  + L   +  + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDA 75

Query: 297 -GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDN 334
                 L  L LSFN L  S+         L  L LS N
Sbjct: 76  FHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 56.7 bits (136), Expect = 2e-08
 Identities = 23/100 (23%), Positives = 35/100 (35%), Gaps = 2/100 (2%)

Query: 310 NKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCE-IGNLRYLFYLELGDNKLSGSIPHSL 368
              +      L     LT LY+ +      +    +  L  L  L +  + L    P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 369 GNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENEL 408
                L+ L L  N L  S+  +     SL +L LS N L
Sbjct: 77  HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 21/96 (21%), Positives = 37/96 (38%), Gaps = 4/96 (4%)

Query: 147 TIPPQIGNLSMLKILYLSTNQFSGRIPPQ-IGHLSYLKALHLFENGLSGSIPP-SLGNLT 204
                +     L  LY+   Q    +  + +  L  L+ L + ++GL   + P +     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80

Query: 205 NLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL 240
            L+ + L  N+L  S+  +     SL  L L  N L
Sbjct: 81  RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.1 bits (132), Expect = 5e-08
 Identities = 19/102 (18%), Positives = 32/102 (31%), Gaps = 4/102 (3%)

Query: 165 TNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNNSLSGSIPSE 223
           T   +      +     L  L++        +    L  L  L  + +  + L   +  +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 224 I-GNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL 264
                  LS L L +N L  S+        +L  L L  N L
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 54.4 bits (130), Expect = 1e-07
 Identities = 17/102 (16%), Positives = 36/102 (35%), Gaps = 3/102 (2%)

Query: 381 TNLLSGSIPSEIGNLNSLSDLGLSENELSGSIP-YSFGNLTNMIVLSIYSNALSGAIPKE 439
           T   +      +    +L++L +   +    +       L  +  L+I  + L   +  +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74

Query: 440 -YGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLT 480
            +    +L+ L LS+N L+           L  + L  N L 
Sbjct: 75  AFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 53.6 bits (128), Expect = 2e-07
 Identities = 20/100 (20%), Positives = 31/100 (31%), Gaps = 2/100 (2%)

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSGSIPSSL 320
              +           NL  L + +      +       L  L  L +  + L    P + 
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 321 GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKL 360
               +L+ L LS N L  S+  +      L  L L  N L
Sbjct: 77  HFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 3e-07
 Identities = 23/101 (22%), Positives = 39/101 (38%), Gaps = 2/101 (1%)

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSE-IGNLNSLSDLGLSENELSGSIPYSF 416
              +    H L    NL  LY+        +    +  L  L +L + ++ L    P +F
Sbjct: 17  RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76

Query: 417 GNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ 457
                +  L++  NAL  ++  +    + L  LVLS N L 
Sbjct: 77  HFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 16/98 (16%), Positives = 35/98 (35%), Gaps = 5/98 (5%)

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQV-CSMQSLEKLNLAHNNLSGFIPRCFKEMHG 684
           +    L    +L++L + +    + +  +    +  L  L +  + L    P  F     
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81

Query: 685 LVYIDISYNKLHGPIPNSAAFKHAPME--ALQGNKGLC 720
           L  +++S+N L          +   ++   L GN   C
Sbjct: 82  LSRLNLSFNALESLSWK--TVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 4e-06
 Identities = 17/100 (17%), Positives = 31/100 (31%), Gaps = 4/100 (4%)

Query: 285 HNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS-SLGNLTKLTILYLSDNLLFGSIPCE 343
               +      +   ++L  L +   +    +    L  L +L  L +  + L   +  +
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPD 74

Query: 344 I-GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTN 382
                  L  L L  N L  S+        +L  L L  N
Sbjct: 75  AFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGN 113

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 49.4 bits (117), Expect = 4e-06
 Identities = 23/110 (20%), Positives = 38/110 (34%), Gaps = 14/110 (12%)

Query: 72  CAWF-GIHCNHAGKVNSI-------NLTSAGL-----IGTLHDFSFSSFPHLAYLDLRVN 118
                G+ C   G ++S+       NLT   +     +  L          L  L +  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 119 QIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQF 168
            +  + P       +L  L+LS N+        +  LS L+ L LS N  
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 21/126 (16%), Positives = 38/126 (30%), Gaps = 27/126 (21%)

Query: 429 SNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRNHLTGNISES 486
           +   +            LT L +   Q    +    LR L  L  + + ++ L       
Sbjct: 16  TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR------ 69

Query: 487 FGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDL 546
                      ++   F+          P L  L++S N +   L  +      L+ L L
Sbjct: 70  ----------FVAPDAFHF--------TPRLSRLNLSFNALE-SLSWKTVQGLSLQELVL 110

Query: 547 SSNHIV 552
           S N + 
Sbjct: 111 SGNPLH 116

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.5 bits (134), Expect = 6e-09
 Identities = 37/136 (27%), Positives = 63/136 (46%), Gaps = 8/136 (5%)

Query: 558 ELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLN 617
               +R L+ L   ++   G++       + LE L L +  L  S+   L  L KL  L 
Sbjct: 22  TPAAVRELV-LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLE 77

Query: 618 LSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE-EIPSQVCSMQSLEKLNLAHN---NLSG 673
           LS N+  G + +  EK  +L+ L+LS N L +      +  ++ L+ L+L +    NL+ 
Sbjct: 78  LSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLND 137

Query: 674 FIPRCFKEMHGLVYID 689
           +    FK +  L Y+D
Sbjct: 138 YRESVFKLLPQLTYLD 153

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.5 bits (134), Expect = 7e-09
 Identities = 28/110 (25%), Positives = 46/110 (41%), Gaps = 6/110 (5%)

Query: 539 PQLKVLDLSSNHI-VGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
             ++ L L +     G+I     +  +L  L+L        +   L  L +L+ L+LS N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSEN 81

Query: 598 RLSNSIPGSLGNLVKLYYLNLSNNQFS--GEIPIKLEKFIHLSDLDLSHN 645
           R+   +      L  L +LNLS N+      +   L+K   L  LDL + 
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.9 bits (122), Expect = 2e-07
 Identities = 35/139 (25%), Positives = 47/139 (33%), Gaps = 28/139 (20%)

Query: 246 LSLGNLPNLATLDLHDNSLS-GSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYG 304
           L       +  L L +   + G I        NL+ L+L +  L                
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------------- 62

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG-S 363
                  +S      L  L KL  L LS+N +FG +      L  L +L L  NKL   S
Sbjct: 63  ------SVSN-----LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS 111

Query: 364 IPHSLGNLTNLATLYLFTN 382
               L  L  L +L LF  
Sbjct: 112 TLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 48.2 bits (115), Expect = 2e-06
 Identities = 34/140 (24%), Positives = 51/140 (36%), Gaps = 8/140 (5%)

Query: 276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
           + +D+    H  L    P+    ++ L  L    +   G I         L  L L +  
Sbjct: 6   SGMDMKRRIHLELRNRTPAA---VRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLINVG 60

Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG-SIPSEIGN 394
           L  S+   +  L  L  LEL +N++ G +      L NL  L L  N L   S    +  
Sbjct: 61  L-ISVSN-LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKK 118

Query: 395 LNSLSDLGLSENELSGSIPY 414
           L  L  L L   E++    Y
Sbjct: 119 LECLKSLDLFNCEVTNLNDY 138

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.8 bits (114), Expect = 2e-06
 Identities = 36/182 (19%), Positives = 54/182 (29%), Gaps = 57/182 (31%)

Query: 153 GNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLY 212
             + M + +     +   R P  +  L     L   ++   G I        NL  + L 
Sbjct: 6   SGMDMKRRI---HLELRNRTPAAVRELV----LDNCKSND-GKIEGLTAEFVNLEFLSLI 57

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF 272
           N             L S+S L                 LP L  L+L +N + G + +  
Sbjct: 58  NV-----------GLISVSNLP---------------KLPKLKKLELSENRIFGGLDMLA 91

Query: 273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
             L NL  LNL  N L         ++ +L                 L  L  L  L L 
Sbjct: 92  EKLPNLTHLNLSGNKLK--------DISTL---------------EPLKKLECLKSLDLF 128

Query: 333 DN 334
           + 
Sbjct: 129 NC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 47.4 bits (113), Expect = 3e-06
 Identities = 29/113 (25%), Positives = 42/113 (37%), Gaps = 6/113 (5%)

Query: 464 RNLTRLARVRLDRNHLT-GNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDV 522
           R    +  + LD      G I        NL +++L +       +    K P L  L++
Sbjct: 21  RTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSNLP--KLPKLKKLEL 78

Query: 523 SANNITGILPPEIGDSPQLKVLDLSSNHI--VGEIPSELGKLRSLIKLTLNRN 573
           S N I G L       P L  L+LS N +  +  +   L KL  L  L L   
Sbjct: 79  SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.3 bits (105), Expect = 4e-05
 Identities = 22/81 (27%), Positives = 43/81 (53%), Gaps = 3/81 (3%)

Query: 616 LNLSNNQFS-GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF 674
           L L N + + G+I     +F++L  L L +  L   + S +  +  L+KL L+ N + G 
Sbjct: 29  LVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGL-ISV-SNLPKLPKLKKLELSENRIFGG 86

Query: 675 IPRCFKEMHGLVYIDISYNKL 695
           +    +++  L ++++S NKL
Sbjct: 87  LDMLAEKLPNLTHLNLSGNKL 107

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 29/134 (21%), Positives = 45/134 (33%), Gaps = 25/134 (18%)

Query: 84  KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNS 143
            V  + L +        +   + F +L +L L    +  +  S +    KLK L+LS N 
Sbjct: 25  AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENR 82

Query: 144 FSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNL 203
             G +      L  L  L LS N+        I  L  LK                   L
Sbjct: 83  IFGGLDMLAEKLPNLTHLNLSGNKLK-----DISTLEPLK------------------KL 119

Query: 204 TNLAIMYLYNNSLS 217
             L  + L+N  ++
Sbjct: 120 ECLKSLDLFNCEVT 133

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.1 bits (94), Expect = 9e-04
 Identities = 26/118 (22%), Positives = 40/118 (33%), Gaps = 5/118 (4%)

Query: 366 HSLGNLTNLATLYL-FTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIV 424
                   +  L L       G I        +L  L L    L  S+  +   L  +  
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKK 75

Query: 425 LSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGP--IPDLRNLTRLARVRLDRNHLT 480
           L +  N + G +      L  LT L LS N+L+    +  L+ L  L  + L    +T
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 56.8 bits (138), Expect = 1e-08
 Identities = 45/213 (21%), Positives = 89/213 (41%), Gaps = 31/213 (14%)

Query: 803 RATNDFDEEHCIGTGGQGSVYRA--ELSSGEIVAVKKFHSPLLSE---MTCQQEFLNEVK 857
           RA   ++    IG G  G V++A    + G  VA+K+       E   ++     + EV 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST----IREVA 63

Query: 858 SLTEIR---HRNIVK----FYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQ 909
            L  +    H N+V+         +       +V+E+++   L   L        +    
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDK-VPEPGVPTET 121

Query: 910 RMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT 969
             +++  +   L +LH+     +V+RD+  +N+L+    +  ++DFG+++         T
Sbjct: 122 IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI-YSFQMALT 177

Query: 970 ELAGTIGYVAPEL----AYTMKVTEKSDVYSFG 998
            +  T+ Y APE+    +Y   V    D++S G
Sbjct: 178 SVVVTLWYRAPEVLLQSSYATPV----DLWSVG 206

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 56.4 bits (136), Expect = 3e-08
 Identities = 45/242 (18%), Positives = 87/242 (35%), Gaps = 24/242 (9%)

Query: 768 RRRSSSQTQQSSAGNAPGFLSVLTFDRKIAYEEIVRATNDFDEE------HCIGTGGQGS 821
            ++ +S TQ + +G+                  + R  +D+         H IGTG  G 
Sbjct: 9   AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGH 68

Query: 822 VYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYG-FCSHARH 879
           V  A +     +VA+KK        + C++  L E+  L  + H ++VK           
Sbjct: 69  VCEAYDKLEKRVVAIKKILRVFEDLIDCKRI-LREIAILNRLNHDHVVKVLDIVIPKDVE 127

Query: 880 SF----IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH--NDCFPPIV 933
            F    +V E  +     +  +     E    T   N++ G    + Y+H        I+
Sbjct: 128 KFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG----VKYVHSAG-----IL 178

Query: 934 YRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSD 993
           +RD+   N L++ +    V DFG+++++    +  ++L  +       L           
Sbjct: 179 HRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKR 238

Query: 994 VY 995
             
Sbjct: 239 QL 240

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 55.5 bits (134), Expect = 4e-08
 Identities = 58/337 (17%), Positives = 111/337 (32%), Gaps = 56/337 (16%)

Query: 128 IANNSKLKYLDLSSNSFSGTIPPQIG-----NLSMLKILYLSTNQFSGRIPPQIGHL--- 179
            +    +  LDLS N+       ++        + +  L LS N    +   ++  +   
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 180 --SYLKALHLFENGLSGSIPPSLGNL-----TNLAIMYLYNNSLSGSIPSEIGNL----- 227
             + + +L+L  N LS      L          + ++ L  N  S    SE         
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 228 KSLSGLELGYNKLS--GSMPLS--LGNLP-NLATLDLHDNSLS--GSIPLSFG---NLTN 277
            S++ L L  N L    S  L   L  +P N+ +L+L  N+L+      L+        +
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197

Query: 278 LDILNLPHNSLSGSIPSE-----MGNLKSLYGLGLSFNKLSGS----IPSSLGNLTKLTI 328
           +  L+L  N L     +E           +  L L  N L G     +     +L  L  
Sbjct: 198 VTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQT 257

Query: 329 LYLSDNLL--FGSIPCE-----IGNLRYLFYLELGDNKLSGSIPHSLGNL-----TNLAT 376
           +YL  +++       C+       N++ +  ++    ++  S    + NL          
Sbjct: 258 VYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGKADV 317

Query: 377 LYLFTNLLS-----GSIPSEIGNLNSLSDLGLSENEL 408
             L    L       +   ++   + L +   +   L
Sbjct: 318 PSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPL 354

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 46/238 (19%), Positives = 87/238 (36%), Gaps = 37/238 (15%)

Query: 516 NLGTLDVSANNITGILPPEIGD-----SPQLKVLDLSSNHIVGEIPSELGKL-----RSL 565
           ++ +L++S N++      E+          +  L+LS N +  +   EL K       ++
Sbjct: 52  SVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTI 111

Query: 566 IKLTLNRNQFSGQLPTELGSLIQ-----LEHLDLSSNRLSNSIPGSLGNLVK-----LYY 615
             L L  N FS +  +E           +  L+L  N L       L  ++      +  
Sbjct: 112 TVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNS 171

Query: 616 LNLSNNQFSGEIPIKLEKFI-----HLSDLDLSHNFLGEEIPSQVCSM-----QSLEKLN 665
           LNL  N  + +   +L KF+      ++ LDLS N LG +  +++  +       +  LN
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLN 231

Query: 666 LAHNNLSG----FIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGL 719
           L  N L G     +      +  L  + + Y+ +            A   A    + +
Sbjct: 232 LCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCK---ALGAAFPNIQKI 286

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 52/343 (15%), Positives = 103/343 (30%), Gaps = 63/343 (18%)

Query: 368 LGNLTNLATLYLFTNLLSGSIPSEIG-----NLNSLSDLGLSENELSGSIPYSFG----- 417
                 + +L L  N L      E+         S++ L LS N L              
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 418 NLTNMIVLSIYSN--------ALSGAIPKEYGNLVKLTLLVLSYNQLQGP-IPDL----- 463
              N+  L++  N         L   +         +T+L L +N        +      
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAA---IPFTITVLDLGWNDFSSKSSSEFKQAFS 134

Query: 464 RNLTRLARVRLDRNHLTGN----ISESF-GIHSNLSYINLSHKKFYGEISFDWGKF---- 514
                +  + L  N L       + +    I +N++ +NL       +   +  KF    
Sbjct: 135 NLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI 194

Query: 515 -PNLGTLDVSANNITGILPPEIGD-----SPQLKVLDLSSNHI----VGEIPSELGKLRS 564
             ++ +LD+SAN +      E+          +  L+L  N +    +  +      L+ 
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254

Query: 565 LIKLTLNRNQFSGQ-------LPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK----- 612
           L  + L+ +            L     ++ ++  +D +   +  S    + NL++     
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSGK 314

Query: 613 LYYLNLSNN-----QFSGEIPIKLEKFIHLSDLDLSHNFLGEE 650
               +L N      Q        L     L +   +   L E 
Sbjct: 315 ADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQTCKPLLEH 357

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.4 bits (113), Expect = 2e-05
 Identities = 42/265 (15%), Positives = 89/265 (33%), Gaps = 55/265 (20%)

Query: 109 HLAYLDLRVNQIFGIIPSQIA-----NNSKLKYLDLSSNSFSGTIPPQIGNL-----SML 158
           ++  L+L  N +      ++          +  LDL  N FS     +         + +
Sbjct: 81  NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASI 140

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
             L L  N            L    +  L +  L+           N+  + L  N+L+ 
Sbjct: 141 TSLNLRGND-----------LGIKSSDELIQ-ILA-------AIPANVNSLNLRGNNLAS 181

Query: 219 SIPSEIGNL-----KSLSGLELGYNKL--SGSMPLS---LGNLPNLATLDLHDNSLSGS- 267
              +E+         S++ L+L  N L       L+        ++ +L+L  N L G  
Sbjct: 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241

Query: 268 ---IPLSFGNLTNLDILNLPHNSLSG-------SIPSEMGNLKSLYGLGLSFNKLSGSIP 317
              + L   +L +L  + L ++ +         ++ +   N++ +  +  +  ++  S  
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301

Query: 318 SSLGNL-----TKLTILYLSDNLLF 337
             + NL      K  +  L +  L 
Sbjct: 302 IPISNLIRELSGKADVPSLLNQCLI 326

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 47.0 bits (112), Expect = 2e-05
 Identities = 37/278 (13%), Positives = 90/278 (32%), Gaps = 47/278 (16%)

Query: 442 NLVKLTLLVLSYNQLQGP----IPDL--RNLTRLARVRLDRNHLTGN----ISESF-GIH 490
               +T L LS N L       +  +       +  + L  N L+      + ++   I 
Sbjct: 49  TPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIP 108

Query: 491 SNLSYINLSHKKFYGEISFDWGKF-----PNLGTLDVSANNITGILPPEIGDS-----PQ 540
             ++ ++L    F  + S ++ +       ++ +L++  N++      E+          
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPAN 168

Query: 541 LKVLDLSSNHI----VGEIPSELGKL-RSLIKLTLNRNQFSGQLPTELGSLIQ-----LE 590
           +  L+L  N++      E+   L  +  S+  L L+ N    +   EL  +       + 
Sbjct: 169 VNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVV 228

Query: 591 HLDLSSNRLSNS----IPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI-------HLSD 639
            L+L  N L       +     +L  L  + L  +        + +           +  
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288

Query: 640 LDLSHNFLGEEIPSQVCSM-----QSLEKLNLAHNNLS 672
           +D +   +       + ++        +  +L +  L 
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLI 326

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 45.9 bits (109), Expect = 5e-05
 Identities = 30/134 (22%), Positives = 46/134 (34%), Gaps = 20/134 (14%)

Query: 559 LGKLRSLIKLTLNRNQFSGQLPTELGSLIQ-----LEHLDLSSNRLSNSIPGSLGNLVK- 612
                 +  L L+ N        EL          +  L+LS N L       L  ++  
Sbjct: 18  TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77

Query: 613 ----LYYLNLSNNQFSGEIPIKLEKFI-----HLSDLDLSHNFLGEEIPSQVCSM----- 658
               +  LNLS N  S +   +L K +      ++ LDL  N    +  S+         
Sbjct: 78  IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137

Query: 659 QSLEKLNLAHNNLS 672
            S+  LNL  N+L 
Sbjct: 138 ASITSLNLRGNDLG 151

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.8 bits (132), Expect = 9e-08
 Identities = 47/231 (20%), Positives = 87/231 (37%), Gaps = 59/231 (25%)

Query: 808 FDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
           +  +H IG G  G VY A + ++ + VA+KK +      + C++  L E+  L  ++   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLKSDY 86

Query: 867 IVKFYG-FCSHARHSF----IVYEYLEMGSLAMILSNATSAEELGWTQRM-----NVIKG 916
           I++ Y          F    IV E  +     +  +     EE      +     N++ G
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-----HIKTILYNLLLG 141

Query: 917 VADALSYLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGT 974
                +++H        I++RD+   N LL+ +    V DFG+++++  +          
Sbjct: 142 ----ENFIHESG-----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLE 192

Query: 975 I----------------GYV------APEL-----AYTMKVTEKSDVYSFG 998
                             +V      APEL      YT  +    D++S G
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTG 239

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 54.9 bits (132), Expect = 1e-07
 Identities = 71/471 (15%), Positives = 136/471 (28%), Gaps = 54/471 (11%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG------------NLKSLY 303
           T+ L   +    +   F NL +L +   P  ++   IP   G            NL+ L 
Sbjct: 56  TMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115

Query: 304 GLGLSFNKLSGSIPSSL--GNLTKLTILYLSDNLLFG--SIPCEIGNLRYLFYLELGDNK 359
            +      +S      L       L  L L     F    +   + + R +  L + ++ 
Sbjct: 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESS 175

Query: 360 LSGSIPHSLG----NLTNLATLYL----FTNLLSGSIPSEIGNLNSLSDLGLSENELS-- 409
            S      L     + T+L  L      F  +    + +   N  SL  + + + E+   
Sbjct: 176 FSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILEL 235

Query: 410 GSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRL 469
                +  NL      S+  +              KL  L LSY              ++
Sbjct: 236 VGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQI 295

Query: 470 ARVRLDR-NHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVS---AN 525
            ++ L      T +         NL  +   +      +         L  L +      
Sbjct: 296 RKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADE 355

Query: 526 NITGILPPEIGDS---------PQLKVLDLSSNHI----VGEIPSELGKLRSLIKLTLNR 572
                    +             +L+ + +  + I    +  I + L  L     + L+R
Sbjct: 356 QGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDR 415

Query: 573 NQFSGQLPTELG------SLIQLEHLDLSSN--RLSNSIPGSLG-NLVKLYYLNLSNNQF 623
            +    LP + G         +L           L++     +G     + ++ L     
Sbjct: 416 EERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGE 475

Query: 624 SGEIPIKLEKFIH-LSDLDLSHNFLGEE-IPSQVCSMQSLEKLNLAHNNLS 672
           S E  ++  +    L  L++      E  I + V  + SL  L +     S
Sbjct: 476 SDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 50.7 bits (121), Expect = 2e-06
 Identities = 74/538 (13%), Positives = 146/538 (27%), Gaps = 97/538 (18%)

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPP-QIGNLSMLKILY 162
              FP+L  L L+      +      N      +       S  +   +  +   + +  
Sbjct: 69  SRRFPNLRSLKLKGKPRAAMFNLIPENWGGY--VTPWVTEISNNLRQLKSVHFRRMIVSD 126

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPS 222
           L  ++ +      +  L   K      +GL  SI      +  L +     +   G    
Sbjct: 127 LDLDRLAKARADDLETLKLDKCSGFTTDGLL-SIVTHCRKIKTLLMEESSFSEKDGKWLH 185

Query: 223 EIG-NLKSLSGLELGYNKLSGSMPLSL----GNLPNLATLDLHDNSLS--GSIPLSFGNL 275
           E+  +  SL  L     + +   P  L     N  +L ++ + D  +        +  NL
Sbjct: 186 ELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANL 245

Query: 276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
                 +L  +         +   + L  LGLS+   +  +P       ++  L L   L
Sbjct: 246 EEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYAL 304

Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNL 395
           L     C +                       +    NL  L     +    +       
Sbjct: 305 LETEDHCTL-----------------------IQKCPNLEVLETRNVIGDRGLEVLAQYC 341

Query: 396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
             L  L +        +    G ++   ++++                 +L  + +  + 
Sbjct: 342 KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSD 389

Query: 456 -----LQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFD 510
                L+     L+NL     V LDR     ++    G+ S L                 
Sbjct: 390 ITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI---------------- 433

Query: 511 WGKFPNLGTLDVSAN--NITGILPPEIGDS-PQLKVLDLSSNHIVGEIPSELGKLRSLIK 567
                 L           +T +    IG   P ++ + L       E          L++
Sbjct: 434 --GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDE---------GLME 482

Query: 568 LTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN-SIPGSLGNLVKLYYLNLSNNQFS 624
                                L+ L++     S  +I  ++  L  L YL +   + S
Sbjct: 483 F--------------SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 50/248 (20%), Positives = 80/248 (32%), Gaps = 76/248 (30%)

Query: 814  IGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLN-EVKSLTEIRHRNIVK-- 869
            +GTG  G V       SG+  A+KK              + N E+  +  + H NI+K  
Sbjct: 15   LGTGSFGIVCEVFDIESGKRFALKKVLQ--------DPRYKNRELDIMKVLDHVNIIKLV 66

Query: 870  --FYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN--------------- 912
              FY             +            N      +    +                 
Sbjct: 67   DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 913  VIKGVAD-------------------ALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHV 952
            V+K                       A+ ++H+     I +RDI  +N+L++ +     +
Sbjct: 127  VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKL 183

Query: 953  SDFGISKSLKPDSSNWTELAGTIGYV------APEL-----AYTMKVTEKSDVYSFG-VL 1000
             DFG +K L P   +       + Y+      APEL      YT  +    D++S G V 
Sbjct: 184  CDFGSAKKLIPSEPS-------VAYICSRFYRAPELMLGATEYTPSI----DLWSIGCVF 232

Query: 1001 ALEAIKGK 1008
              E I GK
Sbjct: 233  G-ELILGK 239

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 37/182 (20%), Positives = 71/182 (39%), Gaps = 42/182 (23%)

Query: 814 IGTGGQGSVYRAELSSGEIVAVK---------KFHSPLLSEMT-----CQQEFLNEVKSL 859
           IG GG G +Y A+++S E V              + PL +E+       + E + +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 860 TEIRHRNIVKFYGFCSH----ARHSFIVYEYLEMG-SLAMILSNATSAEELGWTQRMNVI 914
            ++++  + K++G   H      + F++ +    G  L  I              +    
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYE---------ANAKRFSR 151

Query: 915 KGVA-------DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDS 965
           K V        D L Y+H   +   V+ DI + N+LL+ +    V   D+G++    P+ 
Sbjct: 152 KTVLQLSLRILDILEYIHEHEY---VHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 966 SN 967
            +
Sbjct: 209 VH 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 39/180 (21%), Positives = 70/180 (38%), Gaps = 41/180 (22%)

Query: 814 IGTGGQGSVYRAE-LSSGEIVAVK------KFHSPLLSEM-----TCQQEFLNEVKSLTE 861
           IG+GG G +Y A   +  E  A        + + PL SE+       +++ + +     +
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 862 IRHRNIVKFYGFCSHA----RHSFIVYEYLEMG-SLAMILSNATSAEELGWTQRMNVIKG 916
           + +  I  FYG          + F+V E L  G  L  I                     
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG---------QNGTFK-KST 152

Query: 917 VA-------DALSYLHNDCFPPIVYRDISSKNVLLDLEYE--AHVSDFGISKSLKPDSSN 967
           V        D L Y+H + +   V+ DI + N+LL  +     +++D+G+S    P+ ++
Sbjct: 153 VLQLGIRMLDVLEYIHENEY---VHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 52.7 bits (127), Expect = 3e-07
 Identities = 43/214 (20%), Positives = 81/214 (37%), Gaps = 44/214 (20%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +G G    V+ A  +++ E V VK            +++   E+K L  +R   NI+   
Sbjct: 44   LGRGKYSEVFEAINITNNEKVVVKILK------PVKKKKIKREIKILENLRGGPNIITLA 97

Query: 872  GFCSHARHSFI---VYEYLEMGSLAMILSNATSAE------ELGWTQRMNVIKGVADALS 922
                    S     V+E++       +    T  +      E+        +K     L 
Sbjct: 98   D-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI--------LKA----LD 144

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            Y H+     I++RD+   NV++D E+ +  + D+G+++   P    +     +  +  PE
Sbjct: 145  YCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGPE 200

Query: 982  L-----AYTMKVTEKSDVYSFGVLALEAIKGKHP 1010
            L      Y   +    D++S G +    I  K P
Sbjct: 201  LLVDYQMYDYSL----DMWSLGCMLASMIFRKEP 230

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 51.7 bits (124), Expect = 8e-07
 Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 42/174 (24%)

Query: 814 IGTGGQGSVYRAE---------LSSGEIVAVK--KFHSPLLSEM-----TCQQEFLNEVK 857
                QG +Y A              +  ++K       L +E        +   +N+ K
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 858 SLTEIRHRNIVKFYGFCSH-ARHSFIVYEYLEMG-SLAMILSNATSAEELGWTQRMNV-I 914
            L       I    GF  H  ++ F+V   L  G SL   L           + +  +  
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALD---------VSPKHVLSE 158

Query: 915 KGVA-------DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISK 959
           + V        DAL +LH + +   V+ +++++N+ +D E ++ V  + +G + 
Sbjct: 159 RSVLQVACRLLDALEFLHENEY---VHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 51.8 bits (124), Expect = 9e-07
 Identities = 68/510 (13%), Positives = 140/510 (27%), Gaps = 88/510 (17%)

Query: 78  HCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANN-SKLKY 136
              H    N +     G +    +   SS+  L  + L+   +       IA +    K 
Sbjct: 75  GKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKV 134

Query: 137 LDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSG-- 194
           L LSS               +  I                     LK L L E+ +    
Sbjct: 135 LVLSSCE-------GFSTDGLAAIA---------------ATCRNLKELDLRESDVDDVS 172

Query: 195 -----SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
                  P +  +L +L I  L +     ++   +    +L  L+L        +   L 
Sbjct: 173 GHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQ 232

Query: 250 NLPNLATLDLH------DNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLY 303
             P L  L            +   + ++      L  L+   +++   +P+       L 
Sbjct: 233 RAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLT 292

Query: 304 GLGLSFNKLSG-SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG 362
            L LS+  +    +   L    KL  L++ D +    +       + L  L +       
Sbjct: 293 TLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP--SEP 350

Query: 363 SIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNM 422
            +      LT    + +               L S+               Y    +TN 
Sbjct: 351 FVMEPNVALTEQGLVSVSMGCP---------KLESVL--------------YFCRQMTNA 387

Query: 423 IVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGN 482
            +++I              N   +T   L   + + P         +    +  +     
Sbjct: 388 ALITIAR------------NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEH----- 430

Query: 483 ISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDS-PQL 541
                    +L  ++LS         +       +  L V+    + +    +      L
Sbjct: 431 -------CKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSL 483

Query: 542 KVLDLSSNHIVGE-IPSELGKLRSLIKLTL 570
           + L++       + + +   KL ++  L +
Sbjct: 484 RKLEIRDCPFGDKALLANASKLETMRSLWM 513

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.7 bits (116), Expect = 8e-06
 Identities = 54/329 (16%), Positives = 105/329 (31%), Gaps = 34/329 (10%)

Query: 376 TLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNA---- 431
            +     +   ++      + S+   G         +P  +G      + ++ S+     
Sbjct: 49  FIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108

Query: 432 ---LSG---------AIPKEYGNLVKLTLL---VLSYNQLQGPIPDLRNLTRLARVRLDR 476
              L            I K + N   L L      S + L       RNL  L     D 
Sbjct: 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDV 168

Query: 477 NHLTGNISESFGIH-SNLSYINLSHKKFYGEISFD-----WGKFPNLGTLDVSANNITGI 530
           + ++G+    F    ++L  +N+S      E+SF        + PNL +L ++       
Sbjct: 169 DDVSGHWLSHFPDTYTSLVSLNISC--LASEVSFSALERLVTRCPNLKSLKLNRAVPLEK 226

Query: 531 LPPEIGDSPQLKVLDLSS------NHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG 584
           L   +  +PQL+ L            +   +   L   + L  L+   +     LP    
Sbjct: 227 LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYS 286

Query: 585 SLIQLEHLDLSSNRLS-NSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLS 643
              +L  L+LS   +    +   L    KL  L + +      + +       L +L + 
Sbjct: 287 VCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVF 346

Query: 644 HNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
            +      P+   + Q L  +++    L 
Sbjct: 347 PSEPFVMEPNVALTEQGLVSVSMGCPKLE 375

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 48.0 bits (114), Expect = 2e-05
 Identities = 64/488 (13%), Positives = 146/488 (29%), Gaps = 88/488 (18%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNL------------KSLY 303
            +         ++   F  + ++++   PH +    +P   G                L 
Sbjct: 49  FIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108

Query: 304 GLGLSFNKLSGSIPSSLG-NLTKLTILYLSDNLLFG--SIPCEIGNLRYLFYLELGDNKL 360
            + L    ++      +  +     +L LS    F    +       R L  L+L ++ +
Sbjct: 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDV 168

Query: 361 SGSIPHSLG----NLTNLATLYLF------------------TNL----LSGSIPSE--- 391
                H L       T+L +L +                    NL    L+ ++P E   
Sbjct: 169 DDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLA 228

Query: 392 --IGNLNSLSDLGLS------ENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNL 443
             +     L +LG          ++   +  +      +  LS + +A+   +P  Y   
Sbjct: 229 TLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288

Query: 444 VKLTLLVLSYNQLQ--GPIPDLRNLTRLARVRLDRNHLTGNISESFGIH-SNLSYINLSH 500
            +LT L LSY  +Q    +  L    +L R+ +  +++     E       +L  + +  
Sbjct: 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWV-LDYIEDAGLEVLASTCKDLRELRVFP 347

Query: 501 KKFYGEISF----DWG------KFPNLGTLDVSANNIT--GILPPEIGDS-PQLKVLDLS 547
            + +         + G        P L ++      +T   ++   I  + P +    L 
Sbjct: 348 SEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALI--TIARNRPNMTRFRLC 405

Query: 548 S-NHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS 606
                  +  +          +  +                 L  L LS           
Sbjct: 406 IIEPKAPDYLTLEPLDIGFGAIVEH--------------CKDLRRLSLSGLLTDKVFEYI 451

Query: 607 LGNLVKLYYLNLSNNQFSGEIPIKLEKFIH-LSDLDLSH-NFLGEEIPSQVCSMQSLEKL 664
                K+  L+++    S      +      L  L++    F  + + +    ++++  L
Sbjct: 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSL 511

Query: 665 NLAHNNLS 672
            ++  ++S
Sbjct: 512 WMSSCSVS 519

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 43.7 bits (103), Expect = 3e-04
 Identities = 55/415 (13%), Positives = 112/415 (26%), Gaps = 47/415 (11%)

Query: 106 SFPHLAYLDL-RVNQIFGIIPSQIANN-SKLKYLDLSSNSFSGTIPPQIGNLSM----LK 159
           SF +   L L           + IA     LK LDL  +         + +       L 
Sbjct: 128 SFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLV 187

Query: 160 ILYLS------TNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
            L +S      +     R+  +  +L  LK           ++      L  L       
Sbjct: 188 SLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA 247

Query: 214 NSLSG---SIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG-SIP 269
                    +   +   K L  L   ++ +   +P        L TL+L   ++    + 
Sbjct: 248 EVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTIL 329
                   L  L +        +       K L  L +        +      LT+  ++
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVF--PSEPFVMEPNVALTEQGLV 365

Query: 330 YLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIP 389
            +S              L  + Y                  +TN A + +  N       
Sbjct: 366 SVSMGCP---------KLESVLY--------------FCRQMTNAALITIARN-RPNMTR 401

Query: 390 SEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYG-NLVKLTL 448
             +  +   +   L+   L         +  ++  LS+ S  L+  + +  G    K+ +
Sbjct: 402 FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL-SGLLTDKVFEYIGTYAKKMEM 460

Query: 449 LVLSYNQL--QGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHS-NLSYINLSH 500
           L +++      G    L     L ++ +           +       +  + +S 
Sbjct: 461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSS 515

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 50.7 bits (120), Expect = 1e-06
 Identities = 28/203 (13%), Positives = 52/203 (25%), Gaps = 43/203 (21%)

Query: 804 ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKK--FHSPLLSEMTCQQ---EFLNEVKS 858
            T        IG G  G V++        VA+K      P L   + Q+   E L E+  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 859 LTEI---------RHRNIVKFYGF--CSHARHSFIVYEYLEMGS---------------- 891
             E+         R    +          +    ++  +    S                
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 892 --LAMILSNATS------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVL 943
             + +              +        +++  +  +L+           +RD+   NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNVL 194

Query: 944 LDLEYEAHVSDFGISKSLKPDSS 966
           L       +      KS    S 
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSC 217

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 48.8 bits (117), Expect = 1e-06
 Identities = 30/82 (36%), Positives = 42/82 (51%), Gaps = 8/82 (9%)

Query: 257 LDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG---NLKSLYGLGLSFNKLS 313
           L L++N ++   P  F +L NL  L    N L+ +IP+  G    L  L  L L+ N L 
Sbjct: 38  LWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLTQLTQLDLNDNHLK 94

Query: 314 GSIPS-SLGNLTKLTILYLSDN 334
            SIP  +  NL  LT +YL +N
Sbjct: 95  -SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 35/129 (27%), Positives = 57/129 (44%), Gaps = 31/129 (24%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
            ++  +  L+ S+P   G  T+   L L +N ++   P    +L +L  L  + NKL+ +
Sbjct: 16  LVNCQNIRLA-SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-A 71

Query: 316 IPSSL-GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH-SLGNLTN 373
           IP+ +   LT+LT L L+DN L                          SIP  +  NL +
Sbjct: 72  IPTGVFDKLTQLTQLDLNDNHL-------------------------KSIPRGAFDNLKS 106

Query: 374 LATLYLFTN 382
           L  +YL+ N
Sbjct: 107 LTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 31/94 (32%), Positives = 45/94 (47%), Gaps = 7/94 (7%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVK 445
           S+P+ I        L L+ N+++   P  F +L N+  L   SN L+ AIP   +  L +
Sbjct: 26  SVPAGI--PTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 446 LTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
           LT L L+ N L+  IP     NL  L  + L  N
Sbjct: 83  LTQLDLNDNHLKS-IPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 34/95 (35%), Positives = 46/95 (48%), Gaps = 10/95 (10%)

Query: 531 LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG---SLI 587
           +P  I    Q   L L++N I    P     L +L +L  N N+ +  +PT  G    L 
Sbjct: 27  VPAGIPTDKQ--RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPT--GVFDKLT 81

Query: 588 QLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNN 621
           QL  LDL+ N L  SIP G+  NL  L ++ L NN
Sbjct: 82  QLTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 20/57 (35%), Positives = 32/57 (56%), Gaps = 2/57 (3%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQ 622
           +L LN NQ +   P     L+ L+ L  +SN+L+ +IP G    L +L  L+L++N 
Sbjct: 37  RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNH 92

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 27/81 (33%), Positives = 46/81 (56%), Gaps = 4/81 (4%)

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSENELSG 410
            L L +N+++   P    +L NL  LY  +N L+ +IP+ +   L  L+ L L++N L  
Sbjct: 37  RLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK- 94

Query: 411 SIPY-SFGNLTNMIVLSIYSN 430
           SIP  +F NL ++  + +Y+N
Sbjct: 95  SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.9 bits (99), Expect = 3e-04
 Identities = 30/94 (31%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGRIPPQI-GHLSY 181
           +P+ I  +   + L L++N  +  + P +  +L  L+ LY ++N+ +  IP  +   L+ 
Sbjct: 27  VPAGIPTD--KQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 182 LKALHLFENGLSGSIPP-SLGNLTNLAIMYLYNN 214
           L  L L +N L  SIP  +  NL +L  +YLYNN
Sbjct: 83  LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.1 bits (97), Expect = 6e-04
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSL-GNLPN 253
           S+P   G  T+   ++L NN ++   P    +L +L  L    NKL+ ++P  +   L  
Sbjct: 26  SVPA--GIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 254 LATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
           L  LDL+DN L  SIP  +F NL +L  + L +N
Sbjct: 83  LTQLDLNDNHLK-SIPRGAFDNLKSLTHIYLYNN 115

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 49.7 bits (119), Expect = 3e-06
 Identities = 34/178 (19%), Positives = 67/178 (37%), Gaps = 23/178 (12%)

Query: 541 LKVLDLSSNHIVGEIPSELGKL-----RSLIKLTLNRNQFSGQLPTELGS-LIQLEHLDL 594
           L+ L+L+   +     + +  +      +L ++ L   Q        L    ++   L L
Sbjct: 74  LRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGL 133

Query: 595 SSNRLSNSIPGSLG-----NLVKLYYLNLSNNQFSGE----IPIKLEKFIHLSDLDLSHN 645
             N L       L      +  ++  L LSNN  +      +   L     ++ L L H 
Sbjct: 134 QLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHT 193

Query: 646 FLGEEIPSQVCSM----QSLEKLNLAHNNLSG----FIPRCFKEMHGLVYIDISYNKL 695
            LG+E    + +     + L++LN+A+N         + R  +E   L  + + +N+L
Sbjct: 194 GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNEL 251

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372

 Score = 48.2 bits (115), Expect = 9e-06
 Identities = 56/381 (14%), Positives = 108/381 (28%), Gaps = 88/381 (23%)

Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNL 395
           +   + C I NL  L   +    KL       L     L  L+      +    +E+  L
Sbjct: 14  VLAQLGCPIKNLDALENAQAIKKKLGKLGRQVLPPSELLDHLFFHYEFQNQRFSAEV--L 71

Query: 396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
           +SL  L L+   ++                 +    ++  +         L  + L+  Q
Sbjct: 72  SSLRQLNLAGVRMT----------------PVKCTVVAAVLGS---GRHALDEVNLASCQ 112

Query: 456 L--QGPIPDLRNLTRLARVRLDRNHLTGN----ISESFGIHSNLSYINLSHKKFYGEISF 509
           L   G    L    R  ++ L  N L       + +            L H +       
Sbjct: 113 LDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDL-----------LLHDQ------- 154

Query: 510 DWGKFPNLGTLDVSANNITGI----LPPEIGDSPQLKVLDLSSNHI----VGEIPSELGK 561
                  + TL +S N +T      L   +  +  +  L L    +    +  + ++L +
Sbjct: 155 -----CQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDR 209

Query: 562 LRSLIKLTLNRNQFSGQLPTELGSLIQ----LEHLDLSSNRLSNS-------IPGSLGNL 610
            R L +L +  N         L    +    LE L L  N LS+        + G+    
Sbjct: 210 NRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGG 269

Query: 611 VKLYYLNLSNNQFSGE---------------IPIKLEKFIHLSDLDLSHNFLGEEIPSQV 655
            ++          S                    ++++ + L   DL  +      P + 
Sbjct: 270 ARVVVSLTEGTAVSEYWSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRK 329

Query: 656 CSM----QSLEKLNLAHNNLS 672
             +      +  L     +  
Sbjct: 330 AQLLRVEGEVRALLEQLGSSG 350

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 49.2 bits (118), Expect = 3e-06
 Identities = 40/201 (19%), Positives = 71/201 (35%), Gaps = 53/201 (26%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFY 871
            +G G  G V +     + E  A+K              +   EV+      +  +IV+  
Sbjct: 26   LGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIV 77

Query: 872  GFC----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRM--NVIKGVADALSYLH 925
                   +  +   IV E L+ G L    S      +  +T+R    ++K + +A+ YLH
Sbjct: 78   DVYENLYAGRKCLLIVMECLDGGEL---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            +     I +RD+  +N+L   +       ++DFG                      A E 
Sbjct: 135  SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------AKET 170

Query: 983  ---AYTMKVTEKSDVYSFGVL 1000
                Y        D++S GV+
Sbjct: 171  TGEKYDKSC----DMWSLGVI 187

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 47.6 bits (114), Expect = 3e-06
 Identities = 30/86 (34%), Positives = 44/86 (51%), Gaps = 8/86 (9%)

Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG---NLKSLYGLGLSF 309
               L L+DN ++   P  F  LT L  L+L +N L+  +P+  G    L  L  L L+ 
Sbjct: 31  TTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA--GVFDKLTQLTQLSLND 87

Query: 310 NKLSGSIPS-SLGNLTKLTILYLSDN 334
           N+L  SIP  +  NL  LT ++L +N
Sbjct: 88  NQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 46.5 bits (111), Expect = 7e-06
 Identities = 36/129 (27%), Positives = 53/129 (41%), Gaps = 31/129 (24%)

Query: 256 TLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGS 315
           T+D    SL+ S+P   G  T   +L L  N ++   P     L  L  L L  N+L+  
Sbjct: 13  TVDCSGKSLA-SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-V 68

Query: 316 IPSSL-GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH-SLGNLTN 373
           +P+ +   LT+LT L L+DN L                          SIP  +  NL +
Sbjct: 69  LPAGVFDKLTQLTQLSLNDNQL-------------------------KSIPRGAFDNLKS 103

Query: 374 LATLYLFTN 382
           L  ++L  N
Sbjct: 104 LTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 33/94 (35%), Positives = 45/94 (47%), Gaps = 6/94 (6%)

Query: 315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSL-GNLTN 373
           S+P+  G  T   +LYL DN +    P     L  L  L+L +N+L+  +P  +   LT 
Sbjct: 23  SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 374 LATLYLFTNLLSGSIPSEI-GNLNSLSDLGLSEN 406
           L  L L  N L  SIP     NL SL+ + L  N
Sbjct: 80  LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.5 bits (106), Expect = 3e-05
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 7/94 (7%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKE-YGNLVK 445
           S+P+ I    +   L L +N+++   P  F  LT +  L + +N L+  +P   +  L +
Sbjct: 23  SVPTGI--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 446 LTLLVLSYNQLQGPIPD--LRNLTRLARVRLDRN 477
           LT L L+ NQL+  IP     NL  L  + L  N
Sbjct: 80  LTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 44.1 bits (105), Expect = 4e-05
 Identities = 32/84 (38%), Positives = 42/84 (50%), Gaps = 8/84 (9%)

Query: 542 KVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELG---SLIQLEHLDLSSNR 598
           +VL L  N I    P    +L  L +L L+ NQ +  LP   G    L QL  L L+ N+
Sbjct: 33  QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPA--GVFDKLTQLTQLSLNDNQ 89

Query: 599 LSNSIP-GSLGNLVKLYYLNLSNN 621
           L  SIP G+  NL  L ++ L NN
Sbjct: 90  LK-SIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.4 bits (103), Expect = 9e-05
 Identities = 21/57 (36%), Positives = 30/57 (52%), Gaps = 2/57 (3%)

Query: 567 KLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIP-GSLGNLVKLYYLNLSNNQ 622
            L L  NQ +   P     L QL  LDL +N+L+  +P G    L +L  L+L++NQ
Sbjct: 34  VLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQ 89

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 42.2 bits (100), Expect = 2e-04
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 6/94 (6%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSL-GNLPN 253
           S+P   G  T   ++YLY+N ++   P     L  L+ L+L  N+L+  +P  +   L  
Sbjct: 23  SVPT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 254 LATLDLHDNSLSGSIPL-SFGNLTNLDILNLPHN 286
           L  L L+DN L  SIP  +F NL +L  + L +N
Sbjct: 80  LTQLSLNDNQLK-SIPRGAFDNLKSLTHIWLLNN 112

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 48.9 bits (117), Expect = 5e-06
 Identities = 35/164 (21%), Positives = 61/164 (37%), Gaps = 34/164 (20%)

Query: 811 EHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNIV 868
              IG G  G +   + L + E VA+K     L    +   +   E +   ++     I 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68

Query: 869 KFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL-GWTQRMNVIKGVA-------DA 920
           + Y F    +++ +V E L  G          S E+L     R   +K V          
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GP---------SLEDLFDLCDRTFSLKTVLMIAIQLISR 117

Query: 921 LSYLHNDCFPPIVYRDISSKNVLLDLEYEA-----HVSDFGISK 959
           + Y+H+      +YRD+  +N L+           H+ DF ++K
Sbjct: 118 MEYVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 48.5 bits (116), Expect = 7e-06
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 61/234 (26%)

Query: 814  IGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFY 871
            +G G  G V+++ +  +GE+VAVKK      +    Q+    E+  LTE+  H NIV   
Sbjct: 17   LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT-FREIMILTELSGHENIVNLL 75

Query: 872  ------GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKGVADALSY 923
                        R  ++V++Y+E    A+I +N        +   Q   +IK     + Y
Sbjct: 76   NVLRADND----RDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ---LIKV----IKY 124

Query: 924  LH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI------ 975
            LH        +++RD+   N+LL+ E    V+DFG+S+S          +  +I      
Sbjct: 125  LHSGG-----LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 976  ---------GYV------APEL-----AYTMKVTEKSDVYSFG-VLALEAIKGK 1008
                      YV      APE+      YT  +    D++S G +L  E + GK
Sbjct: 180  FDDDQPILTDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILG-EILCGK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 45.9 bits (109), Expect = 6e-05
 Identities = 46/223 (20%), Positives = 84/223 (37%), Gaps = 43/223 (19%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVK------KFHSPLLSEMTCQQEFLNEVKSLTEIRH-- 864
            +G G   +V+ A+ + +   VA+K       +      E+    + L  V      +   
Sbjct: 27   LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEI----KLLQRVNDADNTKEDS 82

Query: 865  ---RNIVKFYGFCSH----ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGV 917
                +I+K     +H      H  +V+E L    LA+I         L + +++   K +
Sbjct: 83   MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI--SKQL 140

Query: 918  ADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH------VSDFGISKSLKPDSSNW--- 968
               L Y+H  C   I++ DI  +NVL+++           ++D G        ++ W   
Sbjct: 141  LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLG--------NACWYDE 190

Query: 969  --TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKH 1009
              T    T  Y +PE+         +D++S   L  E I G  
Sbjct: 191  HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 233

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 45.0 bits (107), Expect = 7e-05
 Identities = 38/165 (23%), Positives = 59/165 (35%), Gaps = 42/165 (25%)

Query: 814 IGTGGQGSVYRAE-LSSGEIVAVK----KFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNI 867
           IG G  G ++    L + + VA+K    +  +P L          +E ++   +     I
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQL---------RDEYRTYKLLAGCTGI 68

Query: 868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL-GWTQRMNVIKGVA-------D 919
              Y F     H+ +V + L  G          S E+L     R   +K VA        
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GP---------SLEDLLDLCGRKFSVKTVAMAAKQMLA 117

Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEA-----HVSDFGISK 959
            +  +H       VYRDI   N L+           +V DFG+ K
Sbjct: 118 RVQSIHEKSL---VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.7 bits (106), Expect = 8e-05
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 40/163 (24%)

Query: 814 IGTGGQGSVYRAE-LSSGEIVAVK----KFHSPLLSEMTCQQEFLNEVKSLTEIRH-RNI 867
           IG+G  G +Y    +++GE VA+K    K   P L           E K    ++    I
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQL---------HIESKIYKMMQGGVGI 67

Query: 868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL-GWTQRMNVIKGVA-------D 919
                  +   ++ +V E L  G          S E+L  +  R   +K V         
Sbjct: 68  PTIRWCGAEGDYNVMVMELL--GP---------SLEDLFNFCSRKFSLKTVLLLADQMIS 116

Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISK 959
            + Y+H+  F   ++RD+   N L+ L  + +   + DFG++K
Sbjct: 117 RIEYIHSKNF---IHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336

 Score = 42.9 bits (101), Expect = 3e-04
 Identities = 43/292 (14%), Positives = 84/292 (28%), Gaps = 26/292 (8%)

Query: 44  WKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGT-LHDF 102
           W+T      N    +    L+       C    +    A   +   +    L  + +   
Sbjct: 49  WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 108

Query: 103 SFSSF----PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSML 158
           +          L  L L   ++   I + +A NS L  L+LS  S            ++ 
Sbjct: 109 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-------GFSEFALQ 161

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
            +L             ++  L+        E  +  ++      +T L +     N    
Sbjct: 162 TLL---------SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKS 212

Query: 219 SIPSEIGNLKSLSGLELGY-NKLSGSMPLSLGNLPNLATLDLHD-NSLSGSIPLSFGNLT 276
            + + +    +L  L+L     L          L  L  L L     +     L  G + 
Sbjct: 213 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 272

Query: 277 NLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTI 328
            L  L +      G++      L  L    ++ +  +     ++GN     I
Sbjct: 273 TLKTLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEI 321

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.7 bits (100), Expect = 5e-04
 Identities = 39/163 (23%), Positives = 65/163 (39%), Gaps = 40/163 (24%)

Query: 814 IGTGGQGSVYRAE-LSSGEIVAVK----KFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNI 867
           IG+G  G +Y    + + E VA+K    K   P L         L E K    ++    I
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL---------LYESKIYRILQGGTGI 65

Query: 868 VKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEEL-GWTQRMNVIKGVA-------D 919
                F     ++ +V + L  G          S E+L  +  R   +K V        +
Sbjct: 66  PNVRWFGVEGDYNVLVMDLL--GP---------SLEDLFNFCSRKLSLKTVLMLADQMIN 114

Query: 920 ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH---VSDFGISK 959
            + ++H+  F   ++RDI   N L+ L   A+   + DFG++K
Sbjct: 115 RVEFVHSKSF---LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Length = 267

 Score = 41.9 bits (98), Expect = 6e-04
 Identities = 25/118 (21%), Positives = 49/118 (41%), Gaps = 16/118 (13%)

Query: 469 LARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
           L  +R D + +  NI       S ++      ++            P L +L++S N + 
Sbjct: 134 LKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEE----------NIPELLSLNLSNNRLY 183

Query: 529 GI--LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRS--LIKLTLNRNQFSGQLPTE 582
            +  +   +  +P LK+L+LS N +  +   EL K++   L +L L+ N        +
Sbjct: 184 RLDDMSSIVQKAPNLKILNLSGNEL--KSERELDKIKGLKLEELWLDGNSLCDTFRDQ 239

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

No hit with probability above 80.00

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	1077
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-58
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-54
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-54
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	7e-53
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	9e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-52
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-52
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-52
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-51
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-50
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-50
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-49
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	4e-49
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-49
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-47
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-46
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-46
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-45
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-45
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	5e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-42
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	7e-40
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	8e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-36
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-30
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-28
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-18
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	7e-16
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	6e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	3e-06
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-27
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	3e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-26
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-25
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-21
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-13
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	0.003
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	5e-26
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	4e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-22
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-21
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-18
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-16
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-23
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-21
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	6e-19
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-11
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	7e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	9e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	6e-09
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-11
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-10
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	1e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	4e-09
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	7e-08
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	3e-07
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	9e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-10
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	9e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	7e-05
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.002
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	0.004
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-10
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-09
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	7e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	8e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-07
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	9e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-09
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.001
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.002
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	0.003
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	6e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	5e-07
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	8e-06
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-08
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-07
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	2e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	4e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-07
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	6e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	7e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	8e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	9e-04
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.002
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-07
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	9e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-05
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.001
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	4e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	7e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	2e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	6e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-06
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	6e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.003
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.004
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	7e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	1e-05
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	6e-04
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	0.003
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-05
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.001
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.004
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	8e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	9e-05
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.003
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	4e-04
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	0.004

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 4e-59
 Identities = 69/276 (25%), Positives = 121/276 (43%), Gaps = 20/276 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
                    IG+G  G+VY+ +      VAVK  +    +     Q F NEV  L + RH 
Sbjct: 8    GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHV 64

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI+ F G+ +      IV ++ E  SL   L       +    + +++ +  A  + YLH
Sbjct: 65   NILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLH 121

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELA 983
                  I++RD+ S N+ L  +    + DFG++      S +  + +L+G+I ++APE+ 
Sbjct: 122  ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 984  YTMK---VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
                    + +SDVY+FG++  E + G+ P   I++       + R     L P L    
Sbjct: 179  RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---GYLSPDLSKVR 235

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             N    +  +M     CL +  D RP   ++   ++
Sbjct: 236  SNCPKAMKRLMA---ECLKKKRDERPLFPQILASIE 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (511), Expect = 9e-59
 Identities = 70/271 (25%), Positives = 124/271 (45%), Gaps = 18/271 (6%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            D++  + IGTG  G   +    S G+I+  K+     ++E   +Q  ++EV  L E++H 
Sbjct: 5    DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHP 63

Query: 866  NIVKFYGFCSHARHS--FIVYEYLEMGSLAMILSNATSAEE-LGWTQRMNVIKGVADALS 922
            NIV++Y       ++  +IV EY E G LA +++  T   + L     + V+  +  AL 
Sbjct: 64   NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 923  YLH--NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
              H  +D    +++RD+   NV LD +    + DFG+++ L  D+S      GT  Y++P
Sbjct: 124  ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
            E    M   EKSD++S G L  E      P          + +      +I + +     
Sbjct: 184  EQMNRMSYNEKSDIWSLGCLLYELCALMPPFT--------AFSQKELAGKIREGKFRRIP 235

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                D+L  I+      L+     RP+++++
Sbjct: 236  YRYSDELNEIIT---RMLNLKDYHRPSVEEI 263

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 5e-58
 Identities = 62/272 (22%), Positives = 116/272 (42%), Gaps = 20/272 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
                    +G G  G V+    +    VAVK      +S       FL E   + +++H+
Sbjct: 13   ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
             +V+ Y   +     +I+ EY+E GSL   L    S  +L   + +++   +A+ ++++ 
Sbjct: 69   RLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW-TELAGTIGYVAPELAY 984
                   ++RD+ + N+L+       ++DFG+++ ++ +           I + APE   
Sbjct: 127  ERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
                T KSDV+SFG+L  E +          +      NL+R        R+  P  N  
Sbjct: 184  YGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------GYRMVRPD-NCP 236

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            ++L  +M     C  E P+ RPT   +  +L+
Sbjct: 237  EELYQLMR---LCWKERPEDRPTFDYLRSVLE 265

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 4e-56
 Identities = 73/275 (26%), Positives = 117/275 (42%), Gaps = 23/275 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             D      +GTG  G V   +      VA+K      +SE     EF+ E K +  + H 
Sbjct: 4    KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHE 59

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
             +V+ YG C+  R  FI+ EY+  G L   L            Q + + K V +A+ YL 
Sbjct: 60   KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE 117

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-WTELAGTIGYVAPELAY 984
                   ++RD++++N L++ +    VSDFG+S+ +  D           + +  PE+  
Sbjct: 118  ---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 985  TMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043
              K + KSD+++FGVL  E    GK P +              T + I            
Sbjct: 175  YSKFSSKSDIWAFGVLMWEIYSLGKMPYE--------RFTNSETAEHIAQGLRLYRPHLA 226

Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKV-SQLLKI 1077
             +K+ +IM    SC  E  D RPT + + S +L +
Sbjct: 227  SEKVYTIMY---SCWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-55
 Identities = 58/272 (21%), Positives = 115/272 (42%), Gaps = 20/272 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            ++      IG+G  G V+     + + VA+K      +SE    ++F+ E + + ++ H 
Sbjct: 5    SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
             +V+ YG C       +V+E++E G L+  L              + +   V + ++YL 
Sbjct: 61   KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLE 118

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE-LAGTIGYVAPELAY 984
                  +++RD++++N L+       VSDFG+++ +  D    +      + + +PE+  
Sbjct: 119  E---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
              + + KSDV+SFGVL  E            S      ++      +  PRL +      
Sbjct: 176  FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHV--- 231

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                   ++   C  E P+ RP   ++ + L 
Sbjct: 232  ------YQIMNHCWKERPEDRPAFSRLLRQLA 257

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-55
 Identities = 73/267 (27%), Positives = 121/267 (45%), Gaps = 21/267 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             DF+    +G G  G+VY A    S  I+A+K      L +   + +   EV+  + +RH
Sbjct: 6    EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             NI++ YG+   A   +++ EY  +G++   L   +        +    I  +A+ALSY 
Sbjct: 66   PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     +++RDI  +N+LL    E  ++DFG S      SS  T L GT+ Y+ PE+  
Sbjct: 123  HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA--PSSRRTTLCGTLDYLPPEMIE 177

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
                 EK D++S GVL  E + GK P +        ++    T   I       P   + 
Sbjct: 178  GRMHDEKVDLWSLGVLCYEFLVGKPPFE--------ANTYQETYKRISRVEFTFPD-FVT 228

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKV 1071
            +    ++      L  NP  RP +++V
Sbjct: 229  EGARDLIS---RLLKHNPSQRPMLREV 252

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (482), Expect = 2e-54
 Identities = 69/298 (23%), Positives = 125/298 (41%), Gaps = 37/298 (12%)

Query: 798  YEEIVRATNDFDEE---------HCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLS 844
            +E+   A  +F +E           IG G  G V    L         VA+K   S    
Sbjct: 9    FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68

Query: 845  EMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEE 904
            +   +++FL+E   + +  H N++   G  + +    I+ E++E GSL   L        
Sbjct: 69   KQ--RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 905  LGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD 964
                Q + +++G+A  + YL +      V+RD++++N+L++      VSDFG+S+ L+ D
Sbjct: 127  --VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 965  SSNWTELA-----GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSIC 1018
            +S+ T  +       I + APE     K T  SDV+S+G++  E +  G+ P        
Sbjct: 182  TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYW------ 235

Query: 1019 STSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                     ++ I       P  +    L  +M     C  ++ + RP   ++   L 
Sbjct: 236  --DMTNQDVINAIEQDYRLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNTLD 288

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-54
 Identities = 66/301 (21%), Positives = 117/301 (38%), Gaps = 42/301 (13%)

Query: 804  ATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
              +DF++   +G G  G V++     SG ++A K  H  +   +  + + + E++ L E 
Sbjct: 4    KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHEC 61

Query: 863  RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
                IV FYG         I  E+++ GSL  +L     A  +       V   V   L+
Sbjct: 62   NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLT 118

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            YL       I++RD+   N+L++   E  + DFG+S  L    +      GT  Y++PE 
Sbjct: 119  YLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA--NSFVGTRSYMSPER 174

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP------------------------------RD 1012
                  + +SD++S G+  +E   G++P                                
Sbjct: 175  LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 1013 FISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAI--SCLDENPDSRPTMQK 1070
               S     S     + E+LD  +  P   +   + S+        CL +NP  R  +++
Sbjct: 235  RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 294

Query: 1071 V 1071
            +
Sbjct: 295  L 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-53
 Identities = 65/278 (23%), Positives = 116/278 (41%), Gaps = 22/278 (7%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSL 859
            EI R       E  +G G  G V+    +    VA+K      +S     + FL E + +
Sbjct: 13   EIPR--ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP----EAFLQEAQVM 66

Query: 860  TEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             ++RH  +V+ Y   S     +IV EY+  GSL +      + + L   Q +++   +A 
Sbjct: 67   KKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIAS 124

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD-SSNWTELAGTIGYV 978
             ++Y+        V+RD+ + N+L+       V+DFG+++ ++ +  +        I + 
Sbjct: 125  GMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT 181

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
            APE A   + T KSDV+SFG+L  E                    ++R       P  P 
Sbjct: 182  APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 241

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                      S+ ++   C  + P+ RPT + +   L+
Sbjct: 242  ----------SLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 7e-53
 Identities = 68/272 (25%), Positives = 109/272 (40%), Gaps = 24/272 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +      IG G  G V   +   G  VAVK   +         Q FL E   +T++RH 
Sbjct: 7    KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60

Query: 866  NIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
            N+V+  G     +   +IV EY+  GSL   L +      LG    +     V +A+ YL
Sbjct: 61   NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS-RGRSVLGGDCLLKFSLDVCEAMEYL 119

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
                    V+RD++++NVL+  +  A VSDFG++K     SS        + + APE   
Sbjct: 120  EG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALR 173

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
              K + KSDV+SFG+L  E                    L   +  +             
Sbjct: 174  EKKFSTKSDVWSFGILLWEIYSFGRVPY-------PRIPLKDVVPRVEKGYKMDAPDGCP 226

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              +  +M+   +C   +   RP+  ++ + L+
Sbjct: 227  PAVYEVMK---NCWHLDAAMRPSFLQLREQLE 255

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (469), Expect = 9e-53
 Identities = 65/311 (20%), Positives = 126/311 (40%), Gaps = 46/311 (14%)

Query: 795  KIAYEEIVRATNDFDEEHCIGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTC 848
            K+   E  R  N+ +    IG G  G V++A            +VAVK       ++M  
Sbjct: 4    KLLSLEYPR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM-- 59

Query: 849  QQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN---------- 898
            Q +F  E   + E  + NIVK  G C+  +   +++EY+  G L   L +          
Sbjct: 60   QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 899  -----------ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE 947
                       +     L   +++ + + VA  ++YL        V+RD++++N L+   
Sbjct: 120  HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGEN 176

Query: 948  YEAHVSDFGISKSLKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI 1005
                ++DFG+S+++            A  I ++ PE  +  + T +SDV+++GV+  E  
Sbjct: 177  MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236

Query: 1006 KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSR 1065
                   +           +  +  + D  + A   N   +L ++M     C  + P  R
Sbjct: 237  SYGLQPYY-------GMAHEEVIYYVRDGNILACPENCPLELYNLMR---LCWSKLPADR 286

Query: 1066 PTMQKVSQLLK 1076
            P+   + ++L+
Sbjct: 287  PSFCSIHRILQ 297

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-52
 Identities = 69/286 (24%), Positives = 123/286 (43%), Gaps = 32/286 (11%)

Query: 798  YEEIVRATN---DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFL 853
            YE + R  N    ++    +G G  G VY+A+   +  + A K   +    E+   ++++
Sbjct: 1    YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYM 57

Query: 854  NEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNV 913
             E+  L    H NIVK      +  + +I+ E+   G++  ++        L  +Q   V
Sbjct: 58   VEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP--LTESQIQVV 115

Query: 914  IKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAG 973
             K   DAL+YLH+     I++RD+ + N+L  L+ +  ++DFG+S              G
Sbjct: 116  CKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIG 172

Query: 974  TIGYVAPELAYTM-----KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
            T  ++APE+             K+DV+S G+  +E  + + P            N  R L
Sbjct: 173  TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH--------ELNPMRVL 224

Query: 1029 DEILD---PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             +I     P L  PS          ++    CL++N D+R T  ++
Sbjct: 225  LKIAKSEPPTLAQPS-RWSSNFKDFLK---KCLEKNVDARWTTSQL 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 2e-52
 Identities = 65/274 (23%), Positives = 112/274 (40%), Gaps = 26/274 (9%)

Query: 810  EEHCIGTGGQGSVYRAEL---SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            E+  +G+G  G+V +         + VAVK   +        + E L E   + ++ +  
Sbjct: 11   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDP-ALKDELLAEANVMQQLDNPY 69

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
            IV+  G C       +V E  E+G L   L        +     + ++  V+  + YL  
Sbjct: 70   IVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE- 124

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW---TELAGTIGYVAPELA 983
                  V+RD++++NVLL  ++ A +SDFG+SK+L+ D + +   T     + + APE  
Sbjct: 125  --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 984  YTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042
               K + KSDV+SFGVL  EA   G+ P                    +           
Sbjct: 183  NYYKFSSKSDVWSFGVLMWEAFSYGQKPYR--------GMKGSEVTAMLEKGERMGCPAG 234

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               ++  +M     C   + ++RP    V   L+
Sbjct: 235  CPREMYDLMN---LCWTYDVENRPGFAAVELRLR 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  182 bits (463), Expect = 5e-52
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 22/279 (7%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKS 858
            E+ R   D   +H +G G  G VY          VAVK        +    +EFL E   
Sbjct: 13   EMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAV 66

Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            + EI+H N+V+  G C+     +I+ E++  G+L   L      +E+     + +   ++
Sbjct: 67   MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 125

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-WTELAGTIGY 977
             A+ YL        ++RD++++N L+   +   V+DFG+S+ +  D+          I +
Sbjct: 126  SAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182

Query: 978  VAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
             APE     K + KSDV++FGVL  E             +      L++      D R+ 
Sbjct: 183  TAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK------DYRME 236

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P     +K+  +M    +C   NP  RP+  ++ Q  +
Sbjct: 237  RPE-GCPEKVYELMR---ACWQWNPSDRPSFAEIHQAFE 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 1e-51
 Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 27/286 (9%)

Query: 799  EEIVRATNDFD-EEHCIGTGGQGSVYRAEL---SSGEIVAVKKFHSPLLSEMTCQQEFLN 854
            +++    ++    +  +G G  GSV +           VA+K          T  +E + 
Sbjct: 1    KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMMR 58

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI 914
            E + + ++ +  IV+  G C  A    +V E    G L   L      EE+  +    ++
Sbjct: 59   EAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELL 115

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE---L 971
              V+  + YL        V+RD++++NVLL   + A +SDFG+SK+L  D S +T     
Sbjct: 116  HQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAG 172

Query: 972  AGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDE 1030
               + + APE     K + +SDV+S+GV   EA+  G+ P                 +  
Sbjct: 173  KWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK--------KMKGPEVMAF 224

Query: 1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            I   +          +L ++M     C     + RP    V Q ++
Sbjct: 225  IEQGKRMECPPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMR 267

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 3e-51
 Identities = 68/271 (25%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               +     IG G  G+VY A ++++G+ VA+++ +   L +   ++  +NE+  + E +
Sbjct: 19   KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENK 75

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            + NIV +          ++V EYL  GSL  +++     E     Q   V +    AL +
Sbjct: 76   NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG----QIAAVCRECLQALEF 131

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH++    +++RDI S N+LL ++    ++DFG    + P+ S  + + GT  ++APE+ 
Sbjct: 132  LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL---DPRLPAPS 1040
                   K D++S G++A+E I+G+ P          + N  R L  I     P L  P 
Sbjct: 189  TRKAYGPKVDIWSLGIMAIEMIEGEPPYL--------NENPLRALYLIATNGTPELQNPE 240

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +       +     CLD + + R + +++
Sbjct: 241  -KLSAIFRDFLN---RCLDMDVEKRGSAKEL 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  180 bits (458), Expect = 4e-51
 Identities = 68/271 (25%), Positives = 120/271 (44%), Gaps = 26/271 (9%)

Query: 808  FDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            F +   IG G  G+VY A  + + E+VA+KK            Q+ + EV+ L ++RH N
Sbjct: 17   FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 867  IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
             +++ G       +++V EY    +  ++  +      L   +   V  G    L+YLH+
Sbjct: 77   TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 133

Query: 927  DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTM 986
                 +++RD+ + N+LL       + DFG +  + P +S      GT  ++APE+   M
Sbjct: 134  ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS----FVGTPYWMAPEVILAM 186

Query: 987  ---KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA-PSCN 1042
               +   K DV+S G+  +E  + K P          + N    L  I     PA  S +
Sbjct: 187  DEGQYDGKVDVWSLGITCIELAERKPPLF--------NMNAMSALYHIAQNESPALQSGH 238

Query: 1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
              +   + ++   SCL + P  RPT + + +
Sbjct: 239  WSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-50
 Identities = 66/298 (22%), Positives = 113/298 (37%), Gaps = 44/298 (14%)

Query: 811  EHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKF 870
            +  IG G  G V+R +   GE VAVK F S              E+     +RH NI+ F
Sbjct: 8    QESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGF 62

Query: 871  YGFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
                +    +    ++V +Y E GSL   L+       +     + +    A  L++LH 
Sbjct: 63   IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHM 118

Query: 927  DCF-----PPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW----TELAGTIGY 977
            +       P I +RD+ SKN+L+       ++D G++      +           GT  Y
Sbjct: 119  EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 978  VAPELAYTM------KVTEKSDVYSFGVLALEAIKGKHP-----------RDFISSICST 1020
            +APE+          +  +++D+Y+ G++  E  +                D + S  S 
Sbjct: 179  MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 1021 SSNLDRTLDEILDPRLPA--PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    ++ L P +P    SC     +  IM     C   N  +R T  ++ + L 
Sbjct: 239  EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 293

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 2e-50
 Identities = 62/270 (22%), Positives = 113/270 (41%), Gaps = 25/270 (9%)

Query: 808  FDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN 866
            FD E  IG G   +VY+     +   VA  +     L++ + +Q F  E + L  ++H N
Sbjct: 13   FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 69

Query: 867  IVKFYGFC----SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            IV+FY          +   +V E +  G+L   L      + +      +  + +   L 
Sbjct: 70   IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQ 126

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            +LH    PPI++RD+   N+ +        + D G++   +   +    + GT  ++APE
Sbjct: 127  FLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA--KAVIGTPEFMAPE 183

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
            + Y  K  E  DVY+FG+  LE    ++P        S   N  +    +     PA   
Sbjct: 184  M-YEEKYDESVDVYAFGMCMLEMATSEYP-------YSECQNAAQIYRRVTSGVKPASFD 235

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             +      + E+   C+ +N D R +++ +
Sbjct: 236  KVAIP--EVKEIIEGCIRQNKDERYSIKDL 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 1e-49
 Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 28/281 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
             D      +G G  G V R E  +       VAVK     +LS+     +F+ EV ++  
Sbjct: 8    KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + HRN+++ YG         +V E   +GSL   L                    VA+ +
Sbjct: 68   LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW---TELAGTIGYV 978
             YL +      ++RD++++N+LL       + DFG+ ++L  +  ++           + 
Sbjct: 125  GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEIL--DPR 1035
            APE   T   +  SD + FGV   E    G+ P            N  + L +I     R
Sbjct: 182  APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--------GLNGSQILHKIDKEGER 233

Query: 1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            LP P  +    + ++M     C    P+ RPT   +   L 
Sbjct: 234  LPRPE-DCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLL 270

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-49
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 25/279 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGE-----IVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
            +    +  IG G  G VY+  L +        VA+K   +    +   + +FL E   + 
Sbjct: 7    SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMG 64

Query: 861  EIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADA 920
            +  H NI++  G  S  +   I+ EY+E G+L   L       E    Q + +++G+A  
Sbjct: 65   QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAG 122

Query: 921  LSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW---TELAGTIGY 977
            + YL N      V+RD++++N+L++      VSDFG+S+ L+ D       +     I +
Sbjct: 123  MKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 978  VAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
             APE     K T  SDV+SFG++  E +       +         +    +  I D    
Sbjct: 180  TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-------ELSNHEVMKAINDGFRL 232

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                +    +  +M     C  +    RP    +  +L 
Sbjct: 233  PTPMDCPSAIYQLMM---QCWQQERARRPKFADIVSILD 268

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-49
 Identities = 57/278 (20%), Positives = 101/278 (36%), Gaps = 21/278 (7%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE 861
            +   DF     +G G   +V  A EL++    A+K      + +         E   ++ 
Sbjct: 5    KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            + H   VK Y         +    Y + G L   +    S      T        +  AL
Sbjct: 65   LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSAL 121

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--TELAGTIGYVA 979
             YLH      I++RD+  +N+LL+ +    ++DFG +K L P+S         GT  YV+
Sbjct: 122  EYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
            PEL       + SD+++ G +  + + G  P          + N      +I+      P
Sbjct: 179  PELLTEKSACKSSDLWALGCIIYQLVAGLPPFR--------AGNEYLIFQKIIKLEYDFP 230

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLKI 1077
                  K   ++E     L  +   R   +++     +
Sbjct: 231  E-KFFPKARDLVE---KLLVLDATKRLGCEEMEGYGPL 264

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  176 bits (447), Expect = 3e-49
 Identities = 56/272 (20%), Positives = 114/272 (41%), Gaps = 26/272 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + +D    +GTG  G V+R  E ++G   A K   +P  S+   ++    E+++++ +RH
Sbjct: 26   DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRH 82

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +V  +          ++YE++  G L   +++  +   +   + +  ++ V   L ++
Sbjct: 83   PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHM 140

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            H +     V+ D+  +N++   +    +   DFG++  L P  S      GT  + APE+
Sbjct: 141  HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEV 196

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS-- 1040
            A    V   +D++S GVL+   + G  P            N D TL  +           
Sbjct: 197  AEGKPVGYYTDMWSVGVLSYILLSGLSPFG--------GENDDETLRNVKSCDWNMDDSA 248

Query: 1041 -CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
               I +     +      L  +P++R T+ + 
Sbjct: 249  FSGISEDGKDFIR---KLLLADPNTRMTIHQA 277

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (444), Expect = 4e-49
 Identities = 69/339 (20%), Positives = 131/339 (38%), Gaps = 58/339 (17%)

Query: 774  QTQQSSAGNAPGFLSV----LTFDRKIAYEEIVRATNDFDEEHCIGTGGQGSVYRA---- 825
            Q  Q +  +   +  V      +D K    E  R   + +    +G+G  G V  A    
Sbjct: 6    QMVQVTGSSDNEYFYVDFREYEYDLK---WEFPR--ENLEFGKVLGSGAFGKVMNATAYG 60

Query: 826  --ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSFI 882
              +      VAVK       S    ++  ++E+K +T++  H NIV   G C+ +   ++
Sbjct: 61   ISKTGVSIQVAVKMLKEKADSSE--REALMSELKMMTQLGSHENIVNLLGACTLSGPIYL 118

Query: 883  VYEYLEMGSLAMILSN--------------------ATSAEELGWTQRMNVIKGVADALS 922
            ++EY   G L   L +                          L +   +     VA  + 
Sbjct: 119  IFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGME 178

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAP 980
            +L        V+RD++++NVL+       + DFG+++ +  DS+          + ++AP
Sbjct: 179  FLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAP 235

Query: 981  ELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILD--PRLP 1037
            E  +    T KSDV+S+G+L  E    G +P             +D    +++    ++ 
Sbjct: 236  ESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP--------GIPVDANFYKLIQNGFKMD 287

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
             P     +++  IM+   SC   +   RP+   ++  L 
Sbjct: 288  QPF-YATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 6e-49
 Identities = 67/270 (24%), Positives = 108/270 (40%), Gaps = 21/270 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             D+D    +G G  G V  A    + E VAVK     +   + C +    E+     + H
Sbjct: 5    EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD--MKRAVDCPENIKKEICINKMLNH 62

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
             N+VKFYG        ++  EY   G L   +        +           +   + YL
Sbjct: 63   ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYL 119

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPEL 982
            H      I +RDI  +N+LLD      +SDFG++   + ++      ++ GT+ YVAPEL
Sbjct: 120  HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 983  AYTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
                +   E  DV+S G++    + G+ P D  S  C   S+               P  
Sbjct: 177  LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW------KEKKTYLNPWK 230

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             I    ++++      L ENP +R T+  +
Sbjct: 231  KIDSAPLALLH---KILVENPSARITIPDI 257

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 3e-48
 Identities = 65/303 (21%), Positives = 124/303 (40%), Gaps = 44/303 (14%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFL 853
            E  R  N       +G G  G V  A         +   VAVK       + +T ++  +
Sbjct: 19   EFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALM 74

Query: 854  NEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-------------- 898
            +E+K L+ +  H NIV   G C+    + ++ EY   G L   L                
Sbjct: 75   SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 899  -ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
                   L     ++    VA  +++L +      ++RD++++N+LL       + DFG+
Sbjct: 135  MEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 958  SKSLKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFIS 1015
            ++ +K DS+          + ++APE  +    T +SDV+S+G+   E            
Sbjct: 192  ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-- 249

Query: 1016 SICSTSSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073
                    +D    +++    R+ +P  +   ++  IM+   +C D +P  RPT +++ Q
Sbjct: 250  -----GMPVDSKFYKMIKEGFRMLSPE-HAPAEMYDIMK---TCWDADPLKRPTFKQIVQ 300

Query: 1074 LLK 1076
            L++
Sbjct: 301  LIE 303

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 7e-48
 Identities = 61/288 (21%), Positives = 111/288 (38%), Gaps = 33/288 (11%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSG---EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI 862
            ND   +  IG G  G V +A +         A+K+       +    ++F  E++ L ++
Sbjct: 10   NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD--HRDFAGELEVLCKL 67

Query: 863  -RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSN-------------ATSAEELGWT 908
              H NI+   G C H  + ++  EY   G+L   L                ++A  L   
Sbjct: 68   GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 909  QRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
            Q ++    VA  + YL        ++RD++++N+L+   Y A ++DFG+S+  +      
Sbjct: 128  QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 969  TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTL 1028
                  + ++A E       T  SDV+S+GVL  E +                       
Sbjct: 185  M-GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP-------YCGMTCAELY 236

Query: 1029 DEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            +++          N  D++  +M     C  E P  RP+  ++   L 
Sbjct: 237  EKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLN 281

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 1e-47
 Identities = 63/278 (22%), Positives = 107/278 (38%), Gaps = 28/278 (10%)

Query: 808  FDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            F+E   IG G  G VY   L          AVK  +   ++++    +FL E   + +  
Sbjct: 31   FNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFS 86

Query: 864  HRNIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N++   G C  +  S  +V  Y++ G L   + N T    +       +         
Sbjct: 87   HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG---- 142

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS----SNWTELAGTIGYV 978
             +        V+RD++++N +LD ++   V+DFG+++ +         N T     + ++
Sbjct: 143  -MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038
            A E   T K T KSDV+SFGVL  E +    P            N       +L  R   
Sbjct: 202  ALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFDITVYLLQGRRLL 254

Query: 1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                  D L  +M     C     + RP+  ++   + 
Sbjct: 255  QPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRIS 289

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  169 bits (429), Expect = 9e-47
 Identities = 49/272 (18%), Positives = 108/272 (39%), Gaps = 26/272 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + +D    +G+G  G V+R  E ++G +   K  ++P   +   +    NE+  + ++ H
Sbjct: 29   DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHH 85

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              ++  +          ++ E+L  G L   ++      ++   + +N ++   + L ++
Sbjct: 86   PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHM 143

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            H      IV+ DI  +N++ + +  + V   DFG++  L PD         T  + APE+
Sbjct: 144  HE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-TATAEFAAPEI 199

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS-- 1040
                 V   +D+++ GVL    + G  P            +   TL  +           
Sbjct: 200  VDREPVGFYTDMWAIGVLGYVLLSGLSPFA--------GEDDLETLQNVKRCDWEFDEDA 251

Query: 1041 -CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              ++  +    ++   + L + P  R T+   
Sbjct: 252  FSSVSPEAKDFIK---NLLQKEPRKRLTVHDA 280

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-46
 Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 27/283 (9%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNE 855
            EI R     +   CIG G  G V++    S       VA+K   +     +  +++FL E
Sbjct: 3    EIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV--REKFLQE 58

Query: 856  VKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIK 915
              ++ +  H +IVK  G  +     +I+ E   +G L   L     +  L     +    
Sbjct: 59   ALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAY 115

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS-NWTELAGT 974
             ++ AL+YL +      V+RDI+++NVL+       + DFG+S+ ++  +    ++    
Sbjct: 116  QLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

Query: 975  IGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEILD 1033
            I ++APE     + T  SDV+ FGV   E +  G  P              +  +  I +
Sbjct: 173  IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ--------GVKNNDVIGRIEN 224

Query: 1034 PRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                    N    L S+M     C   +P  RP   ++   L 
Sbjct: 225  GERLPMPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLS 264

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (415), Expect = 8e-46
 Identities = 63/283 (22%), Positives = 119/283 (42%), Gaps = 24/283 (8%)

Query: 805  TNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
            ++ ++    +G GG   V+ A  L     VAVK   + L  + +    F  E ++   + 
Sbjct: 6    SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 864  HRNIVKFYGFCSHARHS----FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            H  IV  Y        +    +IV EY++  +L  I+        +   + + VI     
Sbjct: 66   HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQ 122

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTE---LAGTIG 976
            AL++ H      I++RD+   N+++       V DFGI++++    ++ T+   + GT  
Sbjct: 123  ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            Y++PE A    V  +SDVYS G +  E + G+ P            +      + +    
Sbjct: 180  YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT--------GDSPVSVAYQHVREDP 231

Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRP-TMQKVSQ-LLKI 1077
              PS         +  V +  L +NP++R  T  ++   L+++
Sbjct: 232  IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-45
 Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 22/273 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT-EIR 863
             DF     +G G  G V+ AE   + +  A+K     ++      +  + E + L+    
Sbjct: 2    EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H  +   +       + F V EYL  G L   + +     +   ++       +   L +
Sbjct: 62   HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQF 118

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH+     IVYRD+   N+LLD +    ++DFG+ K      +      GT  Y+APE+ 
Sbjct: 119  LHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEIL 175

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043
               K     D +SFGVL  E + G+ P            + +     I       P   +
Sbjct: 176  LGQKYNHSVDWWSFGVLLYEMLIGQSPFH--------GQDEEELFHSIRMDNPFYPR-WL 226

Query: 1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
              +   ++          P+ R  ++    + +
Sbjct: 227  EKEAKDLLV---KLFVREPEKRLGVR--GDIRQ 254

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (414), Expect = 3e-45
 Identities = 64/271 (23%), Positives = 108/271 (39%), Gaps = 21/271 (7%)

Query: 805  TNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
             + +D    +GTG    V  AE   + ++VA+K      L     +    NE+  L +I+
Sbjct: 8    RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIK 65

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NIV          H +++ + +  G L   +                +I  V DA+ Y
Sbjct: 66   HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKY 122

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            LH+        +  +     LD + +  +SDFG+SK   P S   T   GT GYVAPE+ 
Sbjct: 123  LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST-ACGTPGYVAPEVL 181

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS--- 1040
                 ++  D +S GV+A   + G  P            N  +  ++IL       S   
Sbjct: 182  AQKPYSKAVDCWSIGVIAYILLCGYPPFY--------DENDAKLFEQILKAEYEFDSPYW 233

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             +I D     +      ++++P+ R T ++ 
Sbjct: 234  DDISDSAKDFIR---HLMEKDPEKRFTCEQA 261

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 6e-45
 Identities = 59/292 (20%), Positives = 115/292 (39%), Gaps = 32/292 (10%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL------SSGEIVAVKKFHSPLLSEMTCQQEFL 853
            E+ R          +G G  G VY               VA+K  +    + M  + EFL
Sbjct: 16   EVAR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFL 71

Query: 854  NEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------SNATSAEELG 906
            NE   + E    ++V+  G  S  + + ++ E +  G L   L       +N        
Sbjct: 72   NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 131

Query: 907  WTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS 966
             ++ + +   +AD ++YL+       V+RD++++N ++  ++   + DFG+++ +     
Sbjct: 132  LSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 967  --NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNL 1024
                 +    + +++PE       T  SDV+SFGV+  E                   + 
Sbjct: 189  YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-------QGLSN 241

Query: 1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            ++ L  +++  L     N  D L  +M     C   NP  RP+  ++   +K
Sbjct: 242  EQVLRFVMEGGLLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIK 290

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 1e-44
 Identities = 63/285 (22%), Positives = 123/285 (43%), Gaps = 28/285 (9%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAE-LSSGE----IVAVKKFHSPLLSEMTCQQEFLN 854
             I++ T +F +   +G+G  G+VY+   +  GE     VA+K+       +    +E L+
Sbjct: 4    RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKA--NKEILD 60

Query: 855  EVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVI 914
            E   +  + + ++ +  G C  +    ++ + +  G L   +      + +G    +N  
Sbjct: 61   EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWC 117

Query: 915  KGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW--TELA 972
              +A  ++YL       +V+RD++++NVL+       ++DFG++K L  +   +      
Sbjct: 118  VQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 973  GTIGYVAPELAYTMKVTEKSDVYSFGVLALEAI-KGKHPRDFISSICSTSSNLDRTLDEI 1031
              I ++A E       T +SDV+S+GV   E +  G  P D        +S +   L++ 
Sbjct: 175  VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----GIPASEISSILEK- 228

Query: 1032 LDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
               RLP P       +  IM     C   + DSRP  +++     
Sbjct: 229  -GERLPQPP-ICTIDVYMIMV---KCWMIDADSRPKFRELIIEFS 268

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  161 bits (409), Expect = 2e-44
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 24/274 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
             DF     +GTG  G V+      +G   A+K     ++  +   +   +E   L+ + H
Sbjct: 4    QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              I++ +G    A+  F++ +Y+E G L  +L  +                  A+    L
Sbjct: 64   PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYA------AEVCLAL 117

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
                   I+YRD+  +N+LLD      ++DFG +K +         L GT  Y+APE+  
Sbjct: 118  EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVS 174

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
            T    +  D +SFG+L  E + G  P           SN  +T ++IL+  L  P     
Sbjct: 175  TKPYNKSIDWWSFGILIYEMLAGYTPFY--------DSNTMKTYEKILNAELRFPP-FFN 225

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQKVS--QLLK 1076
            + +  ++      +  +   R    +     +  
Sbjct: 226  EDVKDLLS---RLITRDLSQRLGNLQNGTEDVKN 256

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (404), Expect = 5e-44
 Identities = 61/301 (20%), Positives = 117/301 (38%), Gaps = 41/301 (13%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRAEL--------SSGEIVAVKKFHSPLLSEMTCQQE 851
            E+ R  +       +G G  G V  AE         +    VAVK   S    +     +
Sbjct: 9    ELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSD 64

Query: 852  FLNEVKSLTEI-RHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMIL-------------S 897
             ++E++ +  I +H+NI+   G C+     +++ EY   G+L   L              
Sbjct: 65   LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124

Query: 898  NATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI 957
            +    E+L     ++    VA  + YL +      ++RD++++NVL+  +    ++DFG+
Sbjct: 125  SHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGL 181

Query: 958  SKSLKPDSSNWT--ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFIS 1015
            ++ +               + ++APE  +    T +SDV+SFGVL  E            
Sbjct: 182  ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----- 236

Query: 1016 SICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLL 1075
                    ++     + +        N  ++L  +M     C    P  RPT +++ + L
Sbjct: 237  --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDL 291

Query: 1076 K 1076
             
Sbjct: 292  D 292

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-43
 Identities = 56/271 (20%), Positives = 108/271 (39%), Gaps = 27/271 (9%)

Query: 807  DFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             +     +G G  G V+R  E SS +    K        + T Q     E+  L   RHR
Sbjct: 6    KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARHR 61

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NI+  +          +++E++    +   ++  TSA EL   + ++ +  V +AL +LH
Sbjct: 62   NILHLHESFESMEELVMIFEFISGLDIFERIN--TSAFELNEREIVSYVHQVCEALQFLH 119

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHV--SDFGISKSLKPDSSNWTELAGTIGYVAPELA 983
            +     I + DI  +N++      + +   +FG ++ LKP  +    L     Y APE+ 
Sbjct: 120  S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL-LFTAPEYYAPEVH 175

Query: 984  YTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS--- 1040
                V+  +D++S G L    + G +P          +    + ++ I++          
Sbjct: 176  QHDVVSTATDMWSLGTLVYVLLSGINPFL--------AETNQQIIENIMNAEYTFDEEAF 227

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              I  + +  ++     L +   SR T  + 
Sbjct: 228  KEISIEAMDFVD---RLLVKERKSRMTASEA 255

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (392), Expect = 2e-42
 Identities = 43/287 (14%), Positives = 101/287 (35%), Gaps = 27/287 (9%)

Query: 802  VRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
            +R  N +     IG+G  G +Y    +++GE VA+K              +   E K   
Sbjct: 3    LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYK 57

Query: 861  EIRHRNIVKFYGFC-SHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             ++    +    +C +   ++ +V E L      +    +    +      + +   +  
Sbjct: 58   MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMIS 114

Query: 920  ALSYLHNDCFPPIVYRDISSKNVL---LDLEYEAHVSDFGISKSLKPDSSN-------WT 969
             + Y+H+      ++RD+   N L          ++ DFG++K  +   ++         
Sbjct: 115  RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171

Query: 970  ELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLD 1029
             L GT  Y +      ++ + + D+ S G + +    G  P   + +  +     +R  +
Sbjct: 172  NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-ATKRQKYERISE 230

Query: 1030 EILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
            + +   +         +  + +     C     D +P    + QL +
Sbjct: 231  KKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFR 274

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (397), Expect = 2e-42
 Identities = 57/278 (20%), Positives = 99/278 (35%), Gaps = 24/278 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEV---KSLTE 861
            NDF     IG GG G VY      +G++ A+K      +     +   LNE      ++ 
Sbjct: 4    NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
                 IV              + + +  G L   LS      E            +   L
Sbjct: 64   GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---ADMRFYAAEIILGL 120

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
             ++HN     +VYRD+   N+LLD      +SD G++        + +   GT GY+APE
Sbjct: 121  EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGYMAPE 175

Query: 982  -LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040
             L   +     +D +S G +  + ++G  P          + +        L   +  P 
Sbjct: 176  VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR-----QHKTKDKHEIDRMTLTMAVELPD 230

Query: 1041 CNIRDKLISIMEVAISCLDENPDSRPTMQK--VSQLLK 1076
             +   +L S++E     L  + + R         ++ +
Sbjct: 231  -SFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKE 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 5e-42
 Identities = 48/277 (17%), Positives = 96/277 (34%), Gaps = 29/277 (10%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLS---EMTCQQEFLNEVKSLTE 861
            + +D    +G+G    V +  E S+G   A K               +++   EV  L E
Sbjct: 10   DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 862  IRHRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
            I+H N++  +    +     ++ E +  G L           E          + +   L
Sbjct: 70   IQHPNVITLHEVYENKTDVILILELVAGGEL------FDFLAEKESLTEEEATEFLKQIL 123

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLE----YEAHVSDFGISKSLKPDSSNWTELAGTIGY 977
            + ++      I + D+  +N++L           + DFG++  +   +  +  + GT  +
Sbjct: 124  NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGTPEF 182

Query: 978  VAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
            VAPE+     +  ++D++S GV+    + G  P                TL  +      
Sbjct: 183  VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL--------GDTKQETLANVSAVNYE 234

Query: 1038 APS---CNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                   N        +      L ++P  R T+Q  
Sbjct: 235  FEDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDS 268

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  152 bits (386), Expect = 6e-42
 Identities = 57/282 (20%), Positives = 111/282 (39%), Gaps = 35/282 (12%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQ------QEFLNEVKSL 859
            +++ +  +G G    V R     + +  AVK          + +      +  L EV  L
Sbjct: 4    NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 860  TEIR-HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
             ++  H NI++           F+V++ ++ G L   L+   +   L   +   +++ + 
Sbjct: 64   RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALL 120

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
            + +  LH      IV+RD+  +N+LLD +    ++DFG S  L P      E+ GT  Y+
Sbjct: 121  EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL-REVCGTPSYL 176

Query: 979  APELAYTM------KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032
            APE+             ++ D++S GV+    + G  P                 L  I+
Sbjct: 177  APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW--------HRKQMLMLRMIM 228

Query: 1033 --DPRLPAPSC-NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              + +  +P   +  D +  ++      L   P  R T ++ 
Sbjct: 229  SGNYQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEA 267

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-41
 Identities = 59/274 (21%), Positives = 100/274 (36%), Gaps = 21/274 (7%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            NDFD    +G G  G V      ++G   A+K     ++         + E + L   RH
Sbjct: 5    NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +               V EY   G L   LS      E             A+ +S L
Sbjct: 65   PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE------ERARFYGAEIVSAL 118

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
                   +VYRDI  +N++LD +    ++DFG+ K    D +      GT  Y+APE+  
Sbjct: 119  EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
                    D +  GV+  E + G+ P          + + +R  + IL   +  P   + 
Sbjct: 179  DNDYGRAVDWWGLGVVMYEMMCGRLPFY--------NQDHERLFELILMEEIRFPR-TLS 229

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQK--VSQLLK 1076
             +  S++      L ++P  R         ++++
Sbjct: 230  PEAKSLLA---GLLKKDPKQRLGGGPSDAKEVME 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  149 bits (377), Expect = 1e-40
 Identities = 57/287 (19%), Positives = 114/287 (39%), Gaps = 31/287 (10%)

Query: 806  NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
              +     IG G  G VY+A+ + GE  A+KK       E       + E+  L E++H 
Sbjct: 2    EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK Y      +   +V+E+L+     ++         L      + +  + + ++Y H
Sbjct: 61   NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCH 117

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAY 984
            +     +++RD+  +N+L++ E E  ++DFG++++       +T    T+ Y AP+ L  
Sbjct: 118  D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHP------RDFISSIC--------------STSSNL 1024
            + K +   D++S G +  E + G          D +  I               +     
Sbjct: 175  SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
            D            +    + +  I ++      L  +P+ R T ++ 
Sbjct: 235  DPNFTVYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQA 278

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 7e-40
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 32/281 (11%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEM--TCQQEFLNEVKSLTEIRHRNIVKF 870
            +G G   +VY+A   ++ +IVA+KK      SE      +  L E+K L E+ H NI+  
Sbjct: 6    LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 871  YGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFP 930
                 H  +  +V++++E     +I  N+     L  +     +      L YLH     
Sbjct: 66   LDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQHW-- 120

Query: 931  PIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKV-T 989
             I++RD+   N+LLD      ++DFG++KS    +  +T    T  Y APEL +  ++  
Sbjct: 121  -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 990  EKSDVYSFGVLALEAIKGKHP-----------------RDFISSICSTSSNLDRTLDEIL 1032
               D+++ G +  E +                                  +L   +    
Sbjct: 180  VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 1033 DPRLPAPSC--NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             P +P         D L+ +++        NP +R T  + 
Sbjct: 240  FPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQA 277

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (372), Expect = 8e-40
 Identities = 62/300 (20%), Positives = 110/300 (36%), Gaps = 39/300 (13%)

Query: 800  EIVRATNDFDEEHCIGTGGQGSVYRA------ELSSGEIVAVKKFHSPLLSEMTCQQEFL 853
            E  R  +       +G G  G V  A      + ++   VAVK             +  +
Sbjct: 9    EFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE--HRALM 64

Query: 854  NEVKSLTEIRHR-NIVKFYGFCSHARHS-FIVYEYLEMGSLAMILSN------------- 898
            +E+K L  I H  N+V   G C+       ++ E+ + G+L+  L +             
Sbjct: 65   SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 899  ATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS 958
                + L     +     VA  + +L +      ++RD++++N+LL  +    + DFG++
Sbjct: 125  DLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLA 181

Query: 959  KSLKPDSSNW--TELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISS 1016
            + +  D       +    + ++APE  +    T +SDV+SFGVL  E             
Sbjct: 182  RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY---P 238

Query: 1017 ICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                     R L E    R P        ++   M     C    P  RPT  ++ + L 
Sbjct: 239  GVKIDEEFCRRLKEGTRMRAPD---YTTPEMYQTML---DCWHGEPSQRPTFSELVEHLG 292

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 6e-39
 Identities = 54/287 (18%), Positives = 114/287 (39%), Gaps = 31/287 (10%)

Query: 807  DFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
            +F +   IG G  G VY+A    +GE+VA+KK      +E       + E+  L E+ H 
Sbjct: 3    NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61

Query: 866  NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLH 925
            NIVK           ++V+E+L       + ++A +   +      + +  +   L++ H
Sbjct: 62   NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 119

Query: 926  NDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPE-LAY 984
            +     +++RD+  +N+L++ E    ++DFG++++       +T    T+ Y APE L  
Sbjct: 120  SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSI--------------------CSTSSNL 1024
                +   D++S G +  E +  +      S I                     ++  + 
Sbjct: 177  CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
              +  +            + +   S++      L  +P+ R + +  
Sbjct: 237  KPSFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAA 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (364), Expect = 8e-39
 Identities = 43/277 (15%), Positives = 92/277 (33%), Gaps = 29/277 (10%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN-IVKFY 871
            IG G  G ++    L + + VA+K          +   +  +E ++   +     I   Y
Sbjct: 13   IGEGSFGVIFEGTNLLNNQQVAIK-----FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 872  GFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP 931
             F     H+ +V + L      ++        +          K +   +  +H      
Sbjct: 68   YFGQEGLHNVLVIDLLGPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 932  IVYRDISSKNVLLDLEYEAH-----VSDFGISKSLKPDSSN-------WTELAGTIGYVA 979
            +VYRDI   N L+      +     V DFG+ K  +   +           L+GT  Y++
Sbjct: 122  LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 980  PELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039
                   + + + D+ + G + +  ++G  P   + +  +     +R  ++     L   
Sbjct: 182  INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-TNKQKYERIGEKKQSTPLREL 240

Query: 1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076
                 ++    M       +   D+ P    +  L  
Sbjct: 241  CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 58/274 (21%), Positives = 106/274 (38%), Gaps = 33/274 (12%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLS---EMTCQQEFLNEVKSLTE 861
            + +     +G+GG GSVY    +S    VA+K      +S   E+        EV  L +
Sbjct: 4    SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 862  IR--HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            +      +++   +        ++ E  E             A  L      +    V +
Sbjct: 64   VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA--LQEELARSFFWQVLE 121

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
            A+ + HN     +++RDI  +N+L+DL   E  + DFG    LK   + +T+  GT  Y 
Sbjct: 122  AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYS 176

Query: 979  APE-LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037
             PE + Y       + V+S G+L  + + G  P +                +EI+  ++ 
Sbjct: 177  PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE--------------HDEEIIRGQVF 222

Query: 1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
                 +  +   ++     CL   P  RPT +++
Sbjct: 223  FRQ-RVSSECQHLIR---WCLALRPSDRPTFEEI 252

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 1e-37
 Identities = 53/270 (19%), Positives = 102/270 (37%), Gaps = 26/270 (9%)

Query: 811  EHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIV 868
               +G G  G V +     + E  A+K              +   EV+      +  +IV
Sbjct: 17   SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 68

Query: 869  KFYGFCSHA----RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
            +      +     +   IV E L+ G L   + +    +     +   ++K + +A+ YL
Sbjct: 69   RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAIQYL 127

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYE---AHVSDFGISKSLKPDSSNWTELAGTIGYVAPE 981
            H+     I +RD+  +N+L   +       ++DFG +K     +S  T    T  YVAPE
Sbjct: 128  HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT-PCYTPYYVAPE 183

Query: 982  LAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041
            +    K  +  D++S GV+    + G  P      +  +     R      +   P  S 
Sbjct: 184  VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWS- 242

Query: 1042 NIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
             + +++  ++    + L   P  R T+ + 
Sbjct: 243  EVSEEVKMLIR---NLLKTEPTQRMTITEF 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-37
 Identities = 53/291 (18%), Positives = 104/291 (35%), Gaps = 26/291 (8%)

Query: 803  RATNDFDEEHCIGTGGQGSVYRAE--LSSGEIVAVKKFHSPLLSEMTCQQEF--LNEVKS 858
            RA   ++    IG G  G V++A    + G  VA+K+       E         +  ++ 
Sbjct: 4    RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 859  LTEIRHRNIVKFYGFCSHARHSFIVYEYLEMGSLA---MILSNATSAEELGWTQRMNVIK 915
            L    H N+V+ +  C+ +R        L    +        +      +      +++ 
Sbjct: 64   LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 916  GVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTI 975
             +   L +LH+     +V+RD+  +N+L+    +  ++DFG+++      +  + +  T+
Sbjct: 124  QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-VVVTL 179

Query: 976  GYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHP---------RDFISSICSTSSNLDR 1026
             Y APE+          D++S G +  E  + K              I  +       D 
Sbjct: 180  WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239

Query: 1027 TLDEILDPRL--PAPSCNIRDKLISIMEVAI----SCLDENPDSRPTMQKV 1071
              D  L  +      +  I   +  I E+       CL  NP  R +    
Sbjct: 240  PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-36
 Identities = 59/294 (20%), Positives = 100/294 (34%), Gaps = 35/294 (11%)

Query: 805  TNDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               +     IG G  G V  A +  +   VA+KK         T  Q  L E+K L   R
Sbjct: 7    GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFR 64

Query: 864  HRNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSY 923
            H NI+             +   YL    +   L      + L        +  +   L Y
Sbjct: 65   HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124

Query: 924  LHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN---WTELAGTIGYVAP 980
            +H+     +++RD+   N+LL+   +  + DFG+++   PD  +    TE   T  Y AP
Sbjct: 125  IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 981  ELAYT-MKVTEKSDVYSFGVLALEAIKGKHP----------------------RDFISSI 1017
            E+       T+  D++S G +  E +  +                         D    I
Sbjct: 182  EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 1018 CSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKV 1071
               + N   +L             N   K + +++     L  NP  R  +++ 
Sbjct: 242  NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQA 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 3e-36
 Identities = 52/286 (18%), Positives = 111/286 (38%), Gaps = 27/286 (9%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
              +++   IG G  G+V++A+   + EIVA+K+       E       L E+  L E++H
Sbjct: 2    QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELKH 60

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
            +NIV+ +      +   +V+E+ +        S        G      V   +   L  L
Sbjct: 61   KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGL 114

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
                   +++RD+  +N+L++   E  +++FG++++       ++    T+ Y  P++ +
Sbjct: 115  GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174

Query: 985  TMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043
              K+ +   D++S G +  E      P    + +      + R L    + + P+ +   
Sbjct: 175  GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234

Query: 1044 RDKLISIMEVAIS------------------CLDENPDSRPTMQKV 1071
              K   +     S                   L  NP  R + ++ 
Sbjct: 235  DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (348), Expect = 3e-36
 Identities = 57/274 (20%), Positives = 104/274 (37%), Gaps = 24/274 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
            + FD    +GTG  G V   +   SG   A+K      + ++   +  LNE + L  +  
Sbjct: 41   DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 865  RNIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYL 924
              +VK         + ++V EY+  G +   L                    +     YL
Sbjct: 101  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYL 157

Query: 925  HNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAY 984
            H+     ++YRD+  +N+L+D +    V+DFG +   K        L GT   +APE+  
Sbjct: 158  HSLD---LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIIL 211

Query: 985  TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044
            +    +  D ++ GVL  E   G  P          +    +  ++I+  ++  PS +  
Sbjct: 212  SKGYNKAVDWWALGVLIYEMAAGYPPFF--------ADQPIQIYEKIVSGKVRFPS-HFS 262

Query: 1045 DKLISIMEVAISCLDENPDSRPTMQK--VSQLLK 1076
              L  ++    + L  +   R    K  V+ +  
Sbjct: 263  SDLKDLLR---NLLQVDLTKRFGNLKNGVNDIKN 293

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-36
 Identities = 59/290 (20%), Positives = 111/290 (38%), Gaps = 35/290 (12%)

Query: 807  DFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHR 865
             + +   IG G  G VY+A+L  SGE+VA+KK           ++    E++ + ++ H 
Sbjct: 21   SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHC 73

Query: 866  NIVKFYGFCSHA------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
            NIV+   F   +       +  +V +Y+      +    + + + L        +  +  
Sbjct: 74   NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAH-VSDFGISKSLKPDSSNWTELAGTIGYV 978
            +L+Y+H+     I +RDI  +N+LLD +     + DFG +K L     N + +       
Sbjct: 134  SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHP------RDFISSICS-----TSSNLDRT 1027
               +      T   DV+S G +  E + G+         D +  I       T   +   
Sbjct: 191  PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 1028 LDEILDPRLPAPSCNIRDKLI--SIMEVAIS----CLDENPDSRPTMQKV 1071
                 + + P    +   K+        AI+     L+  P +R T  + 
Sbjct: 251  NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 7e-35
 Identities = 58/282 (20%), Positives = 107/282 (37%), Gaps = 25/282 (8%)

Query: 806  NDFDEEHCIGTGGQGSVYRAEL----SSGEIVAVKKFH-SPLLSEMTCQQEFLNEVKSLT 860
             +F+    +GTG  G V+         +G++ A+K    + ++ +    +    E + L 
Sbjct: 24   ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 861  EIRHR-NIVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVAD 919
             IR    +V  +          ++ +Y+  G L   LS      E      +       +
Sbjct: 84   HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV------GE 137

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWT-ELAGTIGYV 978
             +  L +     I+YRDI  +N+LLD      ++DFG+SK    D +    +  GTI Y+
Sbjct: 138  IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 979  APELAYTMK--VTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            AP++         +  D +S GVL  E + G  P  F        ++       IL    
Sbjct: 198  APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP--FTVD--GEKNSQAEISRRILKSEP 253

Query: 1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQK--VSQLLK 1076
            P P   +      +++     L ++P  R         ++ +
Sbjct: 254  PYPQ-EMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKE 291

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-34
 Identities = 60/303 (19%), Positives = 121/303 (39%), Gaps = 39/303 (12%)

Query: 798  YEEIVRATNDFDE----EHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEF 852
             +E+ +   +          +G+G  G+V  A +  +G  VA+KK + P  SE+  ++  
Sbjct: 6    RQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-A 64

Query: 853  LNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE-YLEMGSLAMILSNATSAEELGWTQRM 911
              E++ L  +RH N++      +         + YL M  +   L      E+LG  +  
Sbjct: 65   YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ 124

Query: 912  NVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTEL 971
             ++  +   L Y+H        +RD+   N+ ++ + E  + DFG+++    + + +   
Sbjct: 125  FLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-- 179

Query: 972  AGTIGYVAPELAY-TMKVTEKSDVYSFGVLALEAIKGKHP-------------------- 1010
              T  Y APE+    M+ T+  D++S G +  E I GK                      
Sbjct: 180  -VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238

Query: 1011 -RDFISSICSTSS-NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTM 1068
              +F+  + S  + N  + L E+      +   N     ++++E     L  + + R T 
Sbjct: 239  PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTA 295

Query: 1069 QKV 1071
             + 
Sbjct: 296  GEA 298

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 6e-34
 Identities = 53/304 (17%), Positives = 109/304 (35%), Gaps = 41/304 (13%)

Query: 802  VRATNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT 860
                + +++   IG G  G V++A    +G+ VA+KK       E       L E+K L 
Sbjct: 6    CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQ 64

Query: 861  EIRHRNIVKFYGFCSHA--------RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMN 912
             ++H N+V     C              ++V+++ E     ++ +       L       
Sbjct: 65   LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV------LVKFTLSE 118

Query: 913  VIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS----NW 968
            + + +   L+ L+      I++RD+ + NVL+  +    ++DFG++++     +     +
Sbjct: 119  IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 178

Query: 969  TELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIKGKHP---------RDFISSIC 1018
            T    T+ Y  PEL    +      D++  G +  E                   IS +C
Sbjct: 179  TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238

Query: 1019 STSS-----NLDRTLDEILDPRLPAPSCNIRDKLISIMEVAI------SCLDENPDSRPT 1067
             + +     N+D          +      ++D+L + +            L  +P  R  
Sbjct: 239  GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298

Query: 1068 MQKV 1071
                
Sbjct: 299  SDDA 302

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 6e-31
 Identities = 49/303 (16%), Positives = 103/303 (33%), Gaps = 48/303 (15%)

Query: 806  NDFDEEHCIGTGGQGSVYRA-ELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRH 864
              +     IG+G QG V  A +      VA+KK   P  ++   ++    E+  +  + H
Sbjct: 17   KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-AYRELVLMKCVNH 75

Query: 865  RNIVKFYGFCSHARHS------FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVA 918
            +NI+      +  +        ++V E ++     +I             +   ++  + 
Sbjct: 76   KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQML 129

Query: 919  DALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYV 978
              + +LH+      ++RD+   N+++  +    + DFG++++    S   T    T  Y 
Sbjct: 130  CGIKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVVTRYYR 185

Query: 979  APELAYTMKVTEKSDVYSFGVLALEAIKGKHP---------------------RDFISSI 1017
            APE+   M   E  D++S G +  E ++ K                        +F+  +
Sbjct: 186  APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245

Query: 1018 CSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAIS---------CLDENPDSRPTM 1068
              T  N      +      P    +      S      +          L  +P  R ++
Sbjct: 246  QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

Query: 1069 QKV 1071
               
Sbjct: 306  DDA 308

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  121 bits (305), Expect = 9e-31
 Identities = 54/298 (18%), Positives = 104/298 (34%), Gaps = 48/298 (16%)

Query: 806  NDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR- 863
            +D+     +G G    V+ A  +++ E V VK            +++   E+K L  +R 
Sbjct: 35   DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENLRG 88

Query: 864  HRNIVKFYGFCSHA--RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADAL 921
              NI+           R   +V+E++       +       + L        +  +  AL
Sbjct: 89   GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKAL 142

Query: 922  SYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSSNWTELAGTIGYVAP 980
             Y H+     I++RD+   NV++D E  +  + D+G+++   P    +     +  +  P
Sbjct: 143  DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRVASRYFKGP 198

Query: 981  ELAYTMK-VTEKSDVYSFGVLALEAIKGKHP-------RDFISSICST------------ 1020
            EL    +      D++S G +    I  K P        D +  I               
Sbjct: 199  ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258

Query: 1021 -SSNLDRTLDEILD--PRLPAPSCNIRDKLISIMEVAI----SCLDENPDSRPTMQKV 1071
             +  LD   ++IL    R         +    +   A+      L  +  SR T ++ 
Sbjct: 259  YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-30
 Identities = 57/293 (19%), Positives = 104/293 (35%), Gaps = 30/293 (10%)

Query: 805  TNDFDEEHCIGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR 863
               +     +G+G  GSV  A    +G  VAVKK   P  S +  ++    E++ L  ++
Sbjct: 17   PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMK 75

Query: 864  HRNIVKFYGFCSHARHSF-IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALS 922
            H N++      + AR        YL    +   L+N    ++L       +I  +   L 
Sbjct: 76   HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135

Query: 923  YLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNWTELAGTIGYVAPEL 982
            Y+H+       +RD+   N+ ++ + E  + DFG+++    D      +A         +
Sbjct: 136  YIHSADII---HRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAPEIM 190

Query: 983  AYTMKVTEKSDVYSFGVLALEAIKGKHP------RDFISSICSTSSNLDRTLDE------ 1030
               M   +  D++S G +  E + G+         D +  I          L +      
Sbjct: 191  LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 1031 ---ILDPRLPAPSCNIRDKLISIMEVAI----SCLDENPDSRPTMQKVSQLLK 1076
                +      P  N  +  I    +A+      L  + D R T     Q L 
Sbjct: 251  ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA---QALA 300

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  115 bits (287), Expect = 1e-28
 Identities = 85/312 (27%), Positives = 132/312 (42%), Gaps = 15/312 (4%)

Query: 36  EEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCN---HAGKVNSINLTS 92
           ++  ALL+ K  L N       L SW     T      W G+ C+      +VN+++L+ 
Sbjct: 6   QDKQALLQIKKDLGNPTT----LSSW--LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSG 59

Query: 93  AGLIGTLH-DFSFSSFPHLAYLDLRVN-QIFGIIPSQIANNSKLKYLDLSSNSFSGTIPP 150
             L        S ++ P+L +L +     + G IP  IA  ++L YL ++  + SG IP 
Sbjct: 60  LNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119

Query: 151 QIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAI-M 209
            +  +  L  L  S N  SG +PP I  L  L  +    N +SG+IP S G+ + L   M
Sbjct: 120 FLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM 179

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP 269
            +  N L+G IP    NL               +  L   +            +      
Sbjct: 180 TISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNT--QKIHLAKNSLAFDL 237

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTIL 329
              G   NL+ L+L +N + G++P  +  LK L+ L +SFN L G IP   GNL +  + 
Sbjct: 238 GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296

Query: 330 YLSDNLLFGSIP 341
             ++N      P
Sbjct: 297 AYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 85.6 bits (210), Expect = 1e-18
 Identities = 65/293 (22%), Positives = 102/293 (34%), Gaps = 31/293 (10%)

Query: 441 GNLVKLTLLVLSYNQLQGPIP---DLRNLTRLARVRLDRNH-LTGNISESFGIHSNLSYI 496
               ++  L LS   L  P P    L NL  L  + +   + L G I  +    + L Y+
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 497 NLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIP 556
            ++H    G I     +   L TLD S N ++G LPP I   P L  +    N I G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 557 SELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYL 616
              G    L                               NRL+  IP +  NL   +  
Sbjct: 167 DSYGSFSKLFTSMTISR-----------------------NRLTGKIPPTFANLNLAFVD 203

Query: 617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP 676
              N        +              ++   +     +    +    +L +N + G +P
Sbjct: 204 LSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLP 261

Query: 677 RCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSC 729
           +   ++  L  +++S+N L G IP     +   + A   NK LCG     P+C
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG--SPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 81.0 bits (198), Expect = 6e-17
 Identities = 72/265 (27%), Positives = 111/265 (41%), Gaps = 7/265 (2%)

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPL--SLGNLPNLATLDLHDN-SLSGSIPLSFGNLTNL 278
                   ++ L+L    L    P+  SL NLP L  L +    +L G IP +   LT L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 279 DILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG 338
             L + H ++SG+IP  +  +K+L  L  S+N LSG++P S+ +L  L  +    N + G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 339 SIPCEIGNLRYLFY-LELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNS 397
           +IP   G+   LF  + +  N+L+G IP +  NL                  S +   + 
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM--LEGDASVLFGSDK 221

Query: 398 LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ 457
            +                 G   N+  L + +N + G +P+    L  L  L +S+N L 
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 458 GPIPDLRNLTRLARVRLDRN-HLTG 481
           G IP   NL R        N  L G
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCG 306

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 80.2 bits (196), Expect = 1e-16
 Identities = 64/272 (23%), Positives = 98/272 (36%), Gaps = 6/272 (2%)

Query: 390 SEIGNLNSLSDLGLSENELSG--SIPYSFGNLTNMIVLSIYSNA-LSGAIPKEYGNLVKL 446
                   +++L LS   L     IP S  NL  +  L I     L G IP     L +L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 447 TLLVLSYNQLQGPIPDLRN-LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG 505
             L +++  + G IPD  + +  L  +    N L+G +  S     NL  I     +  G
Sbjct: 104 HYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISG 163

Query: 506 EISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
            I   +G F  L T    + N      P    +  L      S +++    S L      
Sbjct: 164 AIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAF-VDLSRNMLEGDASVLFGSDKN 222

Query: 566 IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSG 625
            +              ++G    L  LDL +NR+  ++P  L  L  L+ LN+S N   G
Sbjct: 223 TQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCG 282

Query: 626 EIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS 657
           EIP +            ++N      P   C+
Sbjct: 283 EIP-QGGNLQRFDVSAYANNKCLCGSPLPACT 313

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 77.5 bits (189), Expect = 7e-16
 Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 12/278 (4%)

Query: 190 NGLSGSIPPSLGNLTNLAIMYLYNNSLSG--SIPSEIGNLKSLSGLEL-GYNKLSGSMPL 246
            G+          + NL    L   +L     IPS + NL  L+ L + G N L G +P 
Sbjct: 39  LGVLCDTDTQTYRVNNL---DLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95

Query: 247 SLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLG 306
           ++  L  L  L +   ++SG+IP     +  L  L+  +N+LSG++P  + +L +L G+ 
Sbjct: 96  AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGIT 155

Query: 307 LSFNKLSGSIPSSLGNLTKLTI-LYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIP 365
              N++SG+IP S G+ +KL   + +S N L G IP    NL   F     +     +  
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASV 215

Query: 366 HSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVL 425
               +           +L        +    +  DL    N + G++P     L  +  L
Sbjct: 216 LFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSL 273

Query: 426 SIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ--GPIP 461
           ++  N L G IP + GNL +  +   + N+     P+P
Sbjct: 274 NVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 69.4 bits (168), Expect = 3e-13
 Identities = 63/260 (24%), Positives = 101/260 (38%), Gaps = 8/260 (3%)

Query: 249 GNLPNLATLDLHDNSLSG--SIPLSFGNLTNLDILNLPHN-SLSGSIPSEMGNLKSLYGL 305
                +  LDL   +L     IP S  NL  L+ L +    +L G IP  +  L  L+ L
Sbjct: 47  TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106

Query: 306 GLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIP 365
            ++   +SG+IP  L  +  L  L  S N L G++P  I +L  L  +    N++SG+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166

Query: 366 HSLGNLTNLATLYLFT-NLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIV 424
            S G+ + L T    + N L+G IP    NLN              +      +     +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226

Query: 425 LSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNI 483
               ++             +    L    N++ G +P  L  L  L  + +  N+L G I
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDL--RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284

Query: 484 SESFGIHSNLSYINLSHKKF 503
            +  G          ++ K 
Sbjct: 285 PQ-GGNLQRFDVSAYANNKC 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 62.5 bits (150), Expect = 6e-11
 Identities = 23/65 (35%), Positives = 29/65 (44%), Gaps = 2/65 (3%)

Query: 136 YLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFEN-GLSG 194
            LDL +N   GT+P  +  L  L  L +S N   G I PQ G+L          N  L G
Sbjct: 248 GLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANNKCLCG 306

Query: 195 SIPPS 199
           S  P+
Sbjct: 307 SPLPA 311

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 62.1 bits (149), Expect = 8e-11
 Identities = 19/62 (30%), Positives = 27/62 (43%), Gaps = 1/62 (1%)

Query: 186 HLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMP 245
            L  N + G++P  L  L  L  + +  N+L G IP + GNL+         NK     P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

Query: 246 LS 247
           L 
Sbjct: 309 LP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 48.2 bits (113), Expect = 3e-06
 Identities = 42/172 (24%), Positives = 66/172 (38%), Gaps = 3/172 (1%)

Query: 528 TGILPPEIGDSPQLKVLDLSSNHIVG--EIPSELGKLRSLIKLTLNRN-QFSGQLPTELG 584
            G+L      + ++  LDLS  ++     IPS L  L  L  L +       G +P  + 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98

Query: 585 SLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSH 644
            L QL +L ++   +S +IP  L  +  L  L+ S N  SG +P  +    +L  +    
Sbjct: 99  KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158

Query: 645 NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
           N +   IP    S   L        N              L ++D+S N L 
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLE 210

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  112 bits (281), Expect = 3e-27
 Identities = 86/397 (21%), Positives = 150/397 (37%), Gaps = 34/397 (8%)

Query: 202 NLTNLAIMYLYNNSLSGSIP-SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLH 260
            L       L   +++ ++  +++  + +L    LG   + G     +  L NL  ++  
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 261 DNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSL 320
           +N L+   P    NLT L  + + +N ++   P              +   L+       
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLT---------NLTGLTLFNNQIT 123

Query: 321 GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLF 380
                  +  L+   L  +   +I  L  L  L+        +    L NLT L  L + 
Sbjct: 124 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS 183

Query: 381 TNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEY 440
           +N    S  S +  L +L  L  + N++S   P      TN+  LS+  N L        
Sbjct: 184 SN--KVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTL 237

Query: 441 GNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
            +L  LT L L+ NQ+    P L  LT+L  ++L  N ++        +    +  NL  
Sbjct: 238 ASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP----LAGLTALTNLEL 292

Query: 501 KKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELG 560
            +   E         NL  L +  NNI+ I P  +    +L+ L  ++N +     S L 
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLA 348

Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
            L ++  L+   NQ S   P  L +L ++  L L+  
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  110 bits (276), Expect = 2e-26
 Identities = 79/396 (19%), Positives = 134/396 (33%), Gaps = 32/396 (8%)

Query: 226 NLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPH 285
            L       LG   ++    +S  +L  + TL      +  SI      L NL  +N  +
Sbjct: 20  ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSN 75

Query: 286 NSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIG 345
           N L+   P  + NL  L  + ++ N+++   P +         L+ +       +     
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 346 NLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSE 405
             R         N +S     S        +               + NL +L  L +S 
Sbjct: 134 LNRLELS----SNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISS 184

Query: 406 NELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRN 465
           N+   S       LTN+  L   +N +S   P        L  L L+ NQL+  I  L +
Sbjct: 185 NK--VSDISVLAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGTLAS 239

Query: 466 LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
           LT L  + L  N ++          + L+ + L   +                   +  N
Sbjct: 240 LTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTN----LELN 293

Query: 526 NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS 585
                    I +   L  L L  N+I    P  +  L  L +L    N+ S    + L +
Sbjct: 294 ENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLAN 349

Query: 586 LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
           L  +  L    N++S+  P  L NL ++  L L++ 
Sbjct: 350 LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  109 bits (273), Expect = 3e-26
 Identities = 84/362 (23%), Positives = 141/362 (38%), Gaps = 49/362 (13%)

Query: 103 SFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILY 162
           S +    +  L      I  I    +   + L  ++ S+N  +   P  + NL+ L  + 
Sbjct: 39  SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL 94

Query: 163 LSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP------------SLGNLTNLAIMY 210
           ++ NQ +   P           L   +      +              ++ +++ L+ + 
Sbjct: 95  MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 154

Query: 211 LYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSL-GNLPNLATLDLHDNSLSGSIP 269
                  G+  +++  L +L+ LE      +    +S+   L NL +L   +N +S   P
Sbjct: 155 SLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP 214

Query: 270 LSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTIL 329
              G LTNLD L+L  N L       + +L +L  L L+ N++S   P  L  LTKLT L
Sbjct: 215 --LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTEL 268

Query: 330 YLSDNLLFGSIP--------------------CEIGNLRYLFYLELGDNKLSGSIPHSLG 369
            L  N +    P                      I NL+ L YL L  N +S   P  + 
Sbjct: 269 KLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VS 326

Query: 370 NLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
           +LT L  L+   N +S    S + NL +++ L    N++S   P    NLT +  L +  
Sbjct: 327 SLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 382

Query: 430 NA 431
            A
Sbjct: 383 QA 384

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  108 bits (271), Expect = 7e-26
 Identities = 78/410 (19%), Positives = 143/410 (34%), Gaps = 60/410 (14%)

Query: 250 NLPNLATLDLHDNSLSGSIPLS-FGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLS 308
            L       L   +++ ++  +    +T L    L   S+ G     +  L +L  +  S
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 309 FNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH-- 366
            N+L+   P  L NLTKL  + +++N +    P           L          + +  
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 367 ----------SLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSF 416
                     ++ +++ L+ L     L  G+  +++  L +L+ L   +   +     S 
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 417 -GNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLD 475
              LTN+  L   +N +S   P        L  L L+ NQL+  I  L +LT L  + L 
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD-IGTLASLTNLTDLDLA 249

Query: 476 RNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEI 535
            N ++          + L+ + L   +                   +  N         I
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN----LELNENQLEDISPI 303

Query: 536 GDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLS 595
            +   L  L L  N+I    P                          + SL +L+ L  +
Sbjct: 304 SNLKNLTYLTLYFNNISDISP--------------------------VSSLTKLQRLFFA 337

Query: 596 SNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
           +N++S+    SL NL  + +L+  +NQ S   P  L     ++ L L+  
Sbjct: 338 NNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  108 bits (269), Expect = 1e-25
 Identities = 71/393 (18%), Positives = 126/393 (32%), Gaps = 50/393 (12%)

Query: 322 NLTKLTILYLSDNLLFGSIPC-EIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLF 380
            L +     L    +  ++   ++  +  L    LG   + G     +  L NL  +   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74

Query: 381 TNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEY 440
            N L+   P  + NL  L D+ ++ N+++   P +       + L          +    
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 441 GNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
                      S N +          +       ++      ++    +       N   
Sbjct: 133 NLNRLEL----SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 501 KKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELG 560
                       K  NL +L  + N I+ I P  I     L  L L+ N +       L 
Sbjct: 189 DISV------LAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLA 238

Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIP---------------- 604
            L +L  L L  NQ S   P  L  L +L  L L +N++SN  P                
Sbjct: 239 SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQ 296

Query: 605 ----GSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQS 660
                 + NL  L YL L  N  S   P+       L  L  ++N +     S + ++ +
Sbjct: 297 LEDISPISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKV--SDVSSLANLTN 352

Query: 661 LEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYN 693
           +  L+  HN +S   P     +  +  + ++  
Sbjct: 353 INWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score =  101 bits (252), Expect = 2e-23
 Identities = 68/267 (25%), Positives = 104/267 (38%), Gaps = 16/267 (5%)

Query: 44  WKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFS 103
               L+  +N  S + + +   + +                + ++               
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYL 163
            +   +L  L    NQI  I P  I  N  L  L L+ N         + +L+ L  L L
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGILTN--LDELSLNGNQLKD--IGTLASLTNLTDLDL 248

Query: 164 STNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSE 223
           + NQ S   P  +  L+ L  L L  N +S   P  L  LT L  + L  N       S 
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISP 302

Query: 224 IGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNL 283
           I NLK+L+ L L +N +S   P+   +L  L  L   +N +S     S  NLTN++ L+ 
Sbjct: 303 ISNLKNLTYLTLYFNNISDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358

Query: 284 PHNSLSGSIPSEMGNLKSLYGLGLSFN 310
            HN +S   P  + NL  +  LGL+  
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 98.5 bits (244), Expect = 2e-22
 Identities = 68/384 (17%), Positives = 135/384 (35%), Gaps = 32/384 (8%)

Query: 298 NLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGD 357
            L       L    ++ ++  +  +L ++T L      +  SI   +  L  L  +   +
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI-KSID-GVEYLNNLTQINFSN 75

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPY--- 414
           N+L+   P  L NLT L  + +  N ++   P       +   L  ++      +     
Sbjct: 76  NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133

Query: 415 ---------SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRN 465
                    +  +++ +  L+       G    +   L  LT L                
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193

Query: 466 LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
                   L   +   +     GI +NL  ++L+  +     +       NL  LD++ N
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTL--ASLTNLTDLDLANN 251

Query: 526 NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGS 585
            I+ + P  +    +L  L L +N I    P       + ++L  N+ +    +      
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISN---- 305

Query: 586 LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
           L  L +L L  N +S+  P  + +L KL  L  +NN+ S      L    +++ L   HN
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361

Query: 646 FLGEEIPSQVCSMQSLEKLNLAHN 669
            + +  P  + ++  + +L L   
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 95.8 bits (237), Expect = 1e-21
 Identities = 93/391 (23%), Positives = 153/391 (39%), Gaps = 38/391 (9%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F+ ++        L    +   +     +  ++  L         +I   +  L+ L  +
Sbjct: 16  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQI 71

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
             S NQ +   P  + +L+ L  + +  N ++   P +         ++    +    + 
Sbjct: 72  NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129

Query: 222 ---------------SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG 266
                          S+I  L  L+ L+        +    L NL  L  LD+  N    
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KV 187

Query: 267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKL 326
           S       LTNL+ L   +N +S   P  +G L +L  L L+ N+L      +L +LT L
Sbjct: 188 SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNL 243

Query: 327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG 386
           T L L++N +    P  +  L  L  L+LG N++S   P  L  LT L  L L  N    
Sbjct: 244 TDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNEN--QL 297

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
              S I NL +L+ L L  N +S   P    +LT +  L   +N +S        NL  +
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNI 353

Query: 447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
             L   +NQ+    P L NLTR+ ++ L+  
Sbjct: 354 NWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 70.8 bits (172), Expect = 2e-13
 Identities = 63/338 (18%), Positives = 110/338 (32%), Gaps = 46/338 (13%)

Query: 394 NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
            L       L +  ++ ++  +  +L  +  L      +          L  LT +  S 
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSN 75

Query: 454 NQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGK 513
           NQL    P L+NLT+L  + ++ N +      +   +     +  +       +      
Sbjct: 76  NQLTDITP-LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134

Query: 514 FP------NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIV-------GEIPSELG 560
                    +  +   +   +            LK L   +               S L 
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194

Query: 561 KLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
           KL +L  L    NQ S   P  + +   L+ L L+ N+L +   G+L +L  L  L+L+N
Sbjct: 195 KLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250

Query: 621 NQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQS-------------------- 660
           NQ S   P  L     L++L L  N +    P    +  +                    
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308

Query: 661 LEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGP 698
           L  L L  NN+S   P     +  L  +  + NK+   
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV 344

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.8 bits (89), Expect = 0.003
 Identities = 45/256 (17%), Positives = 94/256 (36%), Gaps = 28/256 (10%)

Query: 460 IPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGT 519
             D   L    +  L + ++T  +S++      ++ +                   NL  
Sbjct: 16  FTD-TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGV--EYLNNLTQ 70

Query: 520 LDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
           ++ S N +T I P  + +  +L  + +++N I    P       + + L  N+      L
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 580 P---------------TELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
                           +++ +L  L  L   S     +    L NL  L  L++S+N+  
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV- 187

Query: 625 GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHG 684
                 L K  +L  L  ++N + +  P  +  + +L++L+L  N L          +  
Sbjct: 188 -SDISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTN 242

Query: 685 LVYIDISYNKLHGPIP 700
           L  +D++ N++    P
Sbjct: 243 LTDLDLANNQISNLAP 258

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  107 bits (267), Expect = 5e-26
 Identities = 65/280 (23%), Positives = 99/280 (35%), Gaps = 13/280 (4%)

Query: 108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQ 167
           P  A LDL+ N+I  I      N   L  L L +N  S   P     L  L+ LYLS NQ
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 168 FSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNL 227
                      L  L+        +  S+   L  +  + +        SG        +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGT-NPLKSSGIENGAFQGM 149

Query: 228 KSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNS 287
           K LS + +    ++    +  G  P+L  L L  N ++     S   L NL  L L  NS
Sbjct: 150 KKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 288 LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG------SIP 341
           +S      + N   L  L L+ NKL   +P  L +   + ++YL +N +          P
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265

Query: 342 CEIGNLRYLFYLELGDNKLSGS--IPHSLGNLTNLATLYL 379
                      + L  N +      P +   +   A + L
Sbjct: 266 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.7 bits (247), Expect = 2e-23
 Identities = 57/268 (21%), Positives = 98/268 (36%), Gaps = 12/268 (4%)

Query: 363 SIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNM 422
            +P  L    + A L L  N ++     +  NL +L  L L  N++S   P +F  L  +
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 423 IVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGN 482
             L +  N L     K    L +L +      +++  + +  N   +  +  +    +G 
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 483 ISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLK 542
            + +F     LSYI ++        +   G  P+L  L +  N IT +    +     L 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 543 VLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN- 601
            L LS N I       L     L +L LN N+     P  L     ++ + L +N +S  
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADHKYIQVVYLHNNNISAI 257

Query: 602 -----SIPGSLGNLVKLYYLNLSNNQFS 624
                  PG          ++L +N   
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.0 bits (245), Expect = 4e-23
 Identities = 60/304 (19%), Positives = 109/304 (35%), Gaps = 19/304 (6%)

Query: 277 NLDILNLPHNSLSGSIPSEMG-NLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
           +L ++      L   +P ++  +   L    L  NK++        NL  L  L L +N 
Sbjct: 11  HLRVVQCSDLGLE-KVPKDLPPDTALLD---LQNNKITEIKDGDFKNLKNLHTLILINNK 66

Query: 336 LFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNL 395
           +    P     L  L  L L  N+L          L  L         +  S+ + +  +
Sbjct: 67  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQM 126

Query: 396 NSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
             + +LG +  + SG    +F  +  +  + I    ++  IP+  G    LT L L  N+
Sbjct: 127 IVV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 182

Query: 456 LQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKF 514
           +       L+ L  LA++ L  N ++   + S     +L  ++L++ K            
Sbjct: 183 ITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADH 241

Query: 515 PNLGTLDVSANNITGI------LPPEIGDSPQLKVLDLSSNHI-VGEI-PSELGKLRSLI 566
             +  + +  NNI+ I       P           + L SN +   EI PS    +    
Sbjct: 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRA 301

Query: 567 KLTL 570
            + L
Sbjct: 302 AVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 95.5 bits (236), Expect = 6e-22
 Identities = 55/288 (19%), Positives = 109/288 (37%), Gaps = 14/288 (4%)

Query: 339 SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSL 398
            +P ++        L+L +NK++        NL NL TL L  N +S   P     L  L
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 399 SDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQG 458
             L LS+N+L          L  + V       +  ++      ++ + L          
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141

Query: 459 PIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLG 518
                + + +L+ +R+   ++T   +   G+  +L+ ++L   K     +       NL 
Sbjct: 142 ENGAFQGMKKLSYIRIADTNIT---TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLA 198

Query: 519 TLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSG- 577
            L +S N+I+ +    + ++P L+ L L++N +V ++P  L   + +  + L+ N  S  
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257

Query: 578 -----QLPTELGSLIQLEHLDLSSNRLSNS--IPGSLGNLVKLYYLNL 618
                  P           + L SN +      P +   +     + L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.4 bits (228), Expect = 8e-21
 Identities = 69/308 (22%), Positives = 115/308 (37%), Gaps = 30/308 (9%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
            +P ++      + L L  N+++      F NL N+  L + +N +S   P  +  LVKL
Sbjct: 24  KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY-- 504
             L LS NQL+     +    +   +R+  N +T      F   + +  + L        
Sbjct: 82  ERLYLSKNQLKELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRS 564
           G  +  +     L  + ++  NIT I     G  P L  L L  N I     + L  L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 565 LIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFS 624
           L KL L+ N  S      L +   L  L L++N+L   +PG L +   +  + L NN  S
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS 255

Query: 625 GEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGF--IPRCFKEM 682
               I    F                 P       S   ++L  N +  +   P  F+ +
Sbjct: 256 A---IGSNDF---------------CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297

Query: 683 HGLVYIDI 690
           +    + +
Sbjct: 298 YVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.7 bits (208), Expect = 3e-18
 Identities = 45/215 (20%), Positives = 80/215 (37%), Gaps = 4/215 (1%)

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
           P+   LD+  N IT I   +  +   L  L L +N I    P     L  L +L L++NQ
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 575 FSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKF 634
                     +L +L   +    ++  S+   L  ++ +  L  +  + SG      +  
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGM 149

Query: 635 IHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNK 694
             LS + ++   +   IP  +    SL +L+L  N ++       K ++ L  + +S+N 
Sbjct: 150 KKLSYIRIADTNI-TTIPQGLPP--SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 695 LHGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSC 729
           +      S A      E    N  L     G    
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH 241

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 77.4 bits (189), Expect = 8e-16
 Identities = 38/214 (17%), Positives = 72/214 (33%), Gaps = 7/214 (3%)

Query: 516 NLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQF 575
           +L  +  S   +  + P ++   P   +LDL +N I      +   L++L  L L  N+ 
Sbjct: 11  HLRVVQCSDLGLEKV-PKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67

Query: 576 SGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI 635
           S   P     L++LE L LS N+L          L +L        +    +   L + I
Sbjct: 68  SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 127

Query: 636 HLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
            + +L  +              M+ L  + +A  N++            L  + +  NK+
Sbjct: 128 VV-ELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGNKI 183

Query: 696 HGPIPNSAAFKHAPMEALQGNKGLCGDIKGFPSC 729
                 S    +   +       +     G  + 
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (243), Expect = 4e-23
 Identities = 67/282 (23%), Positives = 99/282 (35%), Gaps = 8/282 (2%)

Query: 130 NNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFE 189
            N                +P  I      + ++L  N+ S            L  L L  
Sbjct: 9   YNEPKVTTSCPQQGLQ-AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHS 65

Query: 190 NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSI-PSEIGNLKSLSGLELGYNKLSGSMPLSL 248
           N L+     +   L  L  + L +N+   S+ P+    L  L  L L    L    P   
Sbjct: 66  NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125

Query: 249 GNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLS 308
             L  L  L L DN+L      +F +L NL  L L  N +S         L SL  L L 
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185

Query: 309 FNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSL 368
            N+++   P +  +L +L  LYL  N L       +  LR L YL L DN        + 
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDC-RAR 244

Query: 369 GNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSG 410
                L      ++ +  S+P  +   +      L+ N+L G
Sbjct: 245 PLWAWLQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (243), Expect = 5e-23
 Identities = 64/255 (25%), Positives = 99/255 (38%), Gaps = 4/255 (1%)

Query: 252 PNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNK 311
                + LH N +S     SF    NL IL L  N L+    +    L  L  L LS N 
Sbjct: 32  AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91

Query: 312 LSGSI-PSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
              S+ P++   L +L  L+L    L    P     L  L YL L DN L      +  +
Sbjct: 92  QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151

Query: 371 LTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
           L NL  L+L  N +S         L+SL  L L +N ++   P++F +L  ++ L +++N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211

Query: 431 ALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIH 490
            LS    +    L  L  L L+ N              L + R   + +  ++ +     
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRL--- 268

Query: 491 SNLSYINLSHKKFYG 505
           +      L+     G
Sbjct: 269 AGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (226), Expect = 8e-21
 Identities = 71/293 (24%), Positives = 106/293 (36%), Gaps = 11/293 (3%)

Query: 71  PCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIAN 130
           PC      C +  KV + +    GL                 + L  N+I  +  +    
Sbjct: 1   PCP-GACVCYNEPKV-TTSCPQQGL----QAVPVGIPAASQRIFLHGNRISHVPAASFRA 54

Query: 131 NSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRI-PPQIGHLSYLKALHLFE 189
              L  L L SN  +         L++L+ L LS N     + P     L  L  LHL  
Sbjct: 55  CRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDR 114

Query: 190 NGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLG 249
            GL    P     L  L  +YL +N+L         +L +L+ L L  N++S     +  
Sbjct: 115 CGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174

Query: 250 NLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSF 309
            L +L  L LH N ++   P +F +L  L  L L  N+LS      +  L++L  L L+ 
Sbjct: 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLND 234

Query: 310 NKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG 362
           N        +      L     S + +  S+P     L       L  N L G
Sbjct: 235 NPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (212), Expect = 6e-19
 Identities = 52/265 (19%), Positives = 88/265 (33%), Gaps = 8/265 (3%)

Query: 411 SIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLA 470
           ++P           + ++ N +S      +     LT+L L  N L            L 
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 471 RVRLDRNH--LTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNIT 528
                 ++  L      +F     L  ++L            +     L  L +  N + 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 529 GILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQ 588
            +      D   L  L L  N I          L SL +L L++N+ +   P     L +
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202

Query: 589 LEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLG 648
           L  L L +N LS     +L  L  L YL L++N +  +       +  L     S + + 
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVP 261

Query: 649 EEIPSQVCSMQSLEKLNLAHNNLSG 673
             +P     +   +   LA N+L G
Sbjct: 262 CSLPQ---RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.2 bits (209), Expect = 1e-18
 Identities = 48/269 (17%), Positives = 76/269 (28%), Gaps = 20/269 (7%)

Query: 46  TSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFS 105
             +  H N+ S +P+ +      ++                                   
Sbjct: 35  QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR----------------IDAAAFTG 78

Query: 106 SFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLST 165
                        Q+  + P+      +L  L L         P     L+ L+ LYL  
Sbjct: 79  LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138

Query: 166 NQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIG 225
           N            L  L  L L  N +S     +   L +L  + L+ N ++   P    
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198

Query: 226 NLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPH 285
           +L  L  L L  N LS     +L  L  L  L L+DN               L       
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSS 257

Query: 286 NSLSGSIPSEMGNLKSLYGLGLSFNKLSG 314
           + +  S+P  +          L+ N L G
Sbjct: 258 SEVPCSLPQRLAGRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.7 bits (205), Expect = 4e-18
 Identities = 50/254 (19%), Positives = 89/254 (35%), Gaps = 6/254 (2%)

Query: 446 LTLLVLSYNQLQGPIPD-LRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
              + L  N++        R    L  + L  N L    + +F   + L  ++LS     
Sbjct: 34  SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93

Query: 505 GEI-SFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLR 563
             +    +     L TL +    +  + P        L+ L L  N +          L 
Sbjct: 94  RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153

Query: 564 SLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           +L  L L+ N+ S         L  L+ L L  NR+++  P +  +L +L  L L  N  
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213

Query: 624 SGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH 683
           S      L     L  L L+ N    +  ++      L+K   + + +   +P   + + 
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLP---QRLA 269

Query: 684 GLVYIDISYNKLHG 697
           G     ++ N L G
Sbjct: 270 GRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.4 bits (155), Expect = 1e-11
 Identities = 50/234 (21%), Positives = 77/234 (32%), Gaps = 1/234 (0%)

Query: 488 GIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLS 547
           GI +    I L   +     +  +    NL  L + +N +  I          L+ LDLS
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS 88

Query: 548 SNHIVGEI-PSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGS 606
            N  +  + P+    L  L  L L+R       P     L  L++L L  N L      +
Sbjct: 89  DNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDT 148

Query: 607 LGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNL 666
             +L  L +L L  N+ S            L  L L  N +    P     +  L  L L
Sbjct: 149 FRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208

Query: 667 AHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLC 720
             NNLS         +  L Y+ ++ N           +          ++  C
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 96.6 bits (239), Expect = 6e-22
 Identities = 45/249 (18%), Positives = 92/249 (36%), Gaps = 25/249 (10%)

Query: 814  IGTGGQGSVYRAE-LSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN------ 866
            +G G   +V+ A+ + +   VA+K        +    +   +E+K L  +   +      
Sbjct: 21   LGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 867  -----IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWT--QRMNVIKGVAD 919
                 I+K     +H   + +    +       +L+     E  G        + K +  
Sbjct: 77   MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 920  ALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFGISKSLKPDSS--NWTELAGTIG 976
             L Y+H  C   I++ DI  +NVL+++     ++    I+          ++T    T  
Sbjct: 137  GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 977  YVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036
            Y +PE+         +D++S   L  E I G     F      + +  D  + +I++   
Sbjct: 195  YRSPEVLLGAPWGCGADIWSTACLIFELITGDFL--FEPDEGHSYTKDDDHIAQIIELLG 252

Query: 1037 PAPSCNIRD 1045
              PS  +R+
Sbjct: 253  ELPSYLLRN 261

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 2e-19
 Identities = 26/162 (16%), Positives = 53/162 (32%), Gaps = 17/162 (10%)

Query: 814 IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQ-------EFLNEVKSLTEIRHRN 866
           +G G + +V+           VK       S    ++        F            R 
Sbjct: 8   MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67

Query: 867 IVKFYGFCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHN 926
           + K  G      +++      E  ++ M L +A     +       V+  + + ++  ++
Sbjct: 68  LQKLQGLAVPKVYAW------EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121

Query: 927 DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSNW 968
                IV+ D+S  NVL+  E    + DF  S  +  +    
Sbjct: 122 RG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWRE 159

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (154), Expect = 2e-11
 Identities = 50/211 (23%), Positives = 68/211 (32%), Gaps = 8/211 (3%)

Query: 78  HCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYL 137
             +       +N     L                 L L  N ++    + +   ++L  L
Sbjct: 5   EVSKVASHLEVNCDKRNL----TALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60

Query: 138 DLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIP 197
           +L       T     G L +L  L LS NQ              L  L +  N L+    
Sbjct: 61  NLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTL-PALTVLDVSFNRLTSLPL 117

Query: 198 PSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATL 257
            +L  L  L  +YL  N L    P  +     L  L L  N L+      L  L NL TL
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 258 DLHDNSLSGSIPLSFGNLTNLDILNLPHNSL 288
            L +NSL  +IP  F     L    L  N  
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.0 bits (141), Expect = 7e-10
 Identities = 47/210 (22%), Positives = 69/210 (32%), Gaps = 7/210 (3%)

Query: 223 EIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN 282
           E+  + S   +      L+ ++P  L    +   L L +N L      +    T L  LN
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPC 342
           L       +     G L  L  L LS N+L               +    + L       
Sbjct: 62  LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLG 118

Query: 343 EIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLG 402
            +  L  L  L L  N+L    P  L     L  L L  N L+      +  L +L  L 
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178

Query: 403 LSENELSGSIPYSFGNLTNMIVLSIYSNAL 432
           L EN L  +IP  F     +    ++ N  
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.6 bits (140), Expect = 9e-10
 Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 6/209 (2%)

Query: 512 GKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLN 571
            K  +   ++    N+T + PP++       +L LS N +     + L     L +L L+
Sbjct: 7   SKVASHLEVNCDKRNLTAL-PPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63

Query: 572 RNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKL 631
           R + +          + +      S+    S+P     L  L  L++S N+ +      L
Sbjct: 64  RAELTKLQVDG---TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120

Query: 632 EKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
                L +L L  N L    P  +     LEKL+LA+NNL+         +  L  + + 
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180

Query: 692 YNKLHGPIPNSAAFKHAPMEALQGNKGLC 720
            N L+            P   L GN  LC
Sbjct: 181 ENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.3 bits (134), Expect = 6e-09
 Identities = 44/207 (21%), Positives = 66/207 (31%), Gaps = 26/207 (12%)

Query: 439 EYGNLVKLTLLVLSYNQLQGPIPDL-RNLTRLARVRLDRNHLTGNISESFGIHSNLSYIN 497
           E   +     +      L    PDL ++ T L    L  N L      +   ++ L+ +N
Sbjct: 5   EVSKVASHLEVNCDKRNLTALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLN 61

Query: 498 LSHKKFYGEISFDW---------------------GKFPNLGTLDVSANNITGILPPEIG 536
           L   +                                 P L  LDVS N +T +    + 
Sbjct: 62  LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121

Query: 537 DSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSS 596
              +L+ L L  N +    P  L     L KL+L  N  +      L  L  L+ L L  
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181

Query: 597 NRLSNSIPGSLGNLVKLYYLNLSNNQF 623
           N L  +IP        L +  L  N +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.9 bits (107), Expect = 1e-05
 Identities = 23/128 (17%), Positives = 39/128 (30%), Gaps = 1/128 (0%)

Query: 63  LNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFG 122
           L                       ++   S   + +L   +      L  L L+ N++  
Sbjct: 79  LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT 138

Query: 123 IIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYL 182
           + P  +    KL+ L L++N+ +      +  L  L  L L  N     IP        L
Sbjct: 139 LPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLL 197

Query: 183 KALHLFEN 190
               L  N
Sbjct: 198 PFAFLHGN 205

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.8 bits (151), Expect = 4e-11
 Identities = 43/270 (15%), Positives = 80/270 (29%), Gaps = 19/270 (7%)

Query: 353 LELGDNKLSGSIPHSLGNLTNLATLYL-FTNLLSGSIPSEIGNLNSLSDLGLSENELSG- 410
           L+L    L    P   G L +   +             +E  +   +  + LS + +   
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61

Query: 411 SIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLL------VLSYNQLQGPIPDLR 464
           ++       + +  LS+    LS  I         L  L        S   LQ  +    
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 465 NLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH----KKFYGEISFDWGKFPNLGTL 520
            L  L                   +   ++ +NLS      +     +        +   
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 521 DVSANNITGILPPEIGDSPQLKVLDLSS-NHIVGEIPSELGKLRSLIKLTLNRNQFSGQL 579
              +  +      E      L+ L LS    I+ E   ELG++ +L  L +      G L
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 580 PTELGSLIQLEHLDLSSNRLSNSIPGSLGN 609
                +L    HL ++ +  +     ++GN
Sbjct: 242 QLLKEAL---PHLQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.1 bits (144), Expect = 3e-10
 Identities = 41/278 (14%), Positives = 89/278 (32%), Gaps = 16/278 (5%)

Query: 137 LDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSG-S 195
           LDL+  +    +  ++ +   +       +     +         ++ + L  + +   +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62

Query: 196 IPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELG--YNKLSGSMPLSLGNLPN 253
           +   L   + L  + L    LS  I + +    +L  L L         ++   L +   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 254 LATLDLHDNSLSG------SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGL 307
           L  L+L             ++      +T L++     N     + + +    +L  L L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 308 SFN-KLSGSIPSSLGNLTKLTILYLSD-NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIP 365
           S +  L          L  L  L LS    +      E+G +  L  L++      G++ 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 366 HSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGL 403
                L +L    +  +  +      IGN  +    G+
Sbjct: 243 LLKEALPHLQ---INCSHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 46/269 (17%), Positives = 91/269 (33%), Gaps = 16/269 (5%)

Query: 161 LYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG-S 219
           L L+       +  ++     + A     + +   +     +   +  M L N+ +   +
Sbjct: 5   LDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVST 62

Query: 220 IPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD--NSLSGSIPLSFGNLTN 277
           +   +     L  L L   +LS  +  +L    NL  L+L         ++     + + 
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 278 LDILNLPHNSLSG------SIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYL 331
           LD LNL             ++      +  L   G   N     + + +     L  L L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182

Query: 332 SDNLLF-GSIPCEIGNLRYLFYLELGD-NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIP 389
           SD+++       E   L YL +L L     +       LG +  L TL +F  +  G++ 
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242

Query: 390 SEIGNLNSLSDLGLSENELSGSIPYSFGN 418
                  +L  L ++ +  +     + GN
Sbjct: 243 LLK---EALPHLQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 4e-09
 Identities = 34/143 (23%), Positives = 62/143 (43%), Gaps = 5/143 (3%)

Query: 544 LDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLS-NS 602
           LDL+  ++  ++   L   + +I     R+     L  E  S  +++H+DLS++ +  ++
Sbjct: 5   LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVST 62

Query: 603 IPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLS--HNFLGEEIPSQVCSMQS 660
           + G L    KL  L+L   + S  I   L K  +L  L+LS    F    + + + S   
Sbjct: 63  LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122

Query: 661 LEKLNLAHNNLSGFIPRCFKEMH 683
           L++LNL+               H
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAH 145

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.8 bits (125), Expect = 7e-08
 Identities = 43/234 (18%), Positives = 78/234 (33%), Gaps = 13/234 (5%)

Query: 84  KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNS 143
           +V  ++L+++ +  +      S    L  L L   ++   I + +A NS L  L+LS  S
Sbjct: 47  RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS 106

Query: 144 FSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSG--------- 194
                  Q    S  ++  L+ +         +       +  + +  LSG         
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGY-NKLSGSMPLSLGNLPN 253
                      + +    +  L      E   L  L  L L     +     L LG +P 
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226

Query: 254 LATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGL 307
           L TL +      G++ L    L +L I     +  +      +GN K+    G+
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQINC---SHFTTIARPTIGNKKNQEIWGI 277

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.3 bits (121), Expect = 3e-07
 Identities = 41/276 (14%), Positives = 79/276 (28%), Gaps = 21/276 (7%)

Query: 98  TLHDFSFSSFPHLAYLDLRVNQIFGIIPS-QIANNSKLKYLDLSSNSFSGTIPPQI-GNL 155
            LH            +  R  + F   P  +  +  +++++DLS++    +    I    
Sbjct: 11  NLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQC 70

Query: 156 SMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNS 215
           S L+ L L   + S  I   +   S L  L+L                +   +  L  + 
Sbjct: 71  SKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSW 130

Query: 216 LSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNL 275
                   +    +     +    LSG                  +   S    L     
Sbjct: 131 CFDFTEKHVQVAVAHVSETITQLNLSGYR---------------KNLQKSDLSTLVRRCP 175

Query: 276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSF-NKLSGSIPSSLGNLTKLTILYLSDN 334
             + +       L      E   L  L  L LS    +       LG +  L  L +   
Sbjct: 176 NLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235

Query: 335 LLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGN 370
           +  G++      L    +L++  +  +     ++GN
Sbjct: 236 VPDGTLQLLKEALP---HLQINCSHFTTIARPTIGN 268

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (114), Expect = 2e-06
 Identities = 31/271 (11%), Positives = 81/271 (29%), Gaps = 15/271 (5%)

Query: 447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGE 506
             L L+   L   +        +   R  R+ +   ++E F     + +++LS+      
Sbjct: 3   QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61

Query: 507 -ISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSL 565
            +     +   L  L +    ++  +   +  +  L  L+LS      E   +       
Sbjct: 62  TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121

Query: 566 IKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLV---------KLYYL 616
               LN +         +   +      ++   LS        + +          ++  
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181

Query: 617 NLSNNQFSGEIPIKLEKFIHLSDLDLSH-NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFI 675
              +     +   +  +  +L  L LS    +  E   ++  + +L+ L +      G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241

Query: 676 PRCFKEMHGLVYIDISYNKLHGPIPNSAAFK 706
               +    L ++ I+ +        +   K
Sbjct: 242 QLLKE---ALPHLQINCSHFTTIARPTIGNK 269

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.2 bits (113), Expect = 2e-06
 Identities = 19/120 (15%), Positives = 37/120 (30%), Gaps = 7/120 (5%)

Query: 591 HLDLSSNRLSNSIPGSLGNLVK--LYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLG 648
            LDL+   L    P   G L+   +       +     +         +  +DLS++ + 
Sbjct: 4   TLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIE 59

Query: 649 EE-IPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKH 707
              +   +     L+ L+L    LS  I     +   LV +++S                
Sbjct: 60  VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 9e-05
 Identities = 44/251 (17%), Positives = 89/251 (35%), Gaps = 18/251 (7%)

Query: 401 LGLSENELSGSIPYSFGNLT--NMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL-- 456
           L L+   L   +    G L    +I      + +   +  E+ +  ++  + LS + +  
Sbjct: 5   LDLTGKNLHPDVT---GRLLSQGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEV 60

Query: 457 QGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISF--DWGKF 514
                 L   ++L  + L+   L+  I  +   +SNL  +NLS    + E +        
Sbjct: 61  STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120

Query: 515 PNLGTLDV------SANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL 568
             L  L++      +  ++   +        QL +     N    ++ + + +  +L+ L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180

Query: 569 TLNRN-QFSGQLPTELGSLIQLEHLDLSS-NRLSNSIPGSLGNLVKLYYLNLSNNQFSGE 626
            L+ +         E   L  L+HL LS    +       LG +  L  L +      G 
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240

Query: 627 IPIKLEKFIHL 637
           + +  E   HL
Sbjct: 241 LQLLKEALPHL 251

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 61.8 bits (148), Expect = 2e-10
 Identities = 21/92 (22%), Positives = 35/92 (38%), Gaps = 9/92 (9%)

Query: 237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM 296
            N  S  +       P+L  L++ +N L   +P     L  L       N L+  +P   
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELP 323

Query: 297 GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTI 328
            NLK L+   + +N L    P    ++  L +
Sbjct: 324 QNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 59.1 bits (141), Expect = 1e-09
 Identities = 26/92 (28%), Positives = 42/92 (45%), Gaps = 10/92 (10%)

Query: 259 LHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPS 318
            + N+ S  I        +L+ LN+ +N L   +P+    L+ L     SFN L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPE 321

Query: 319 SLGNLTKLTILYLSDNLL--FGSIPCEIGNLR 348
              NL +   L++  N L  F  IP  + +LR
Sbjct: 322 LPQNLKQ---LHVEYNPLREFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.1 bits (136), Expect = 5e-09
 Identities = 25/93 (26%), Positives = 36/93 (38%), Gaps = 9/93 (9%)

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
               N+ S  I S      SL  L +S NKL   +P+    L +L     S N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHL-AEVP 320

Query: 342 CEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNL 374
               NL+    L +  N L    P    ++ +L
Sbjct: 321 ELPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 55.2 bits (131), Expect = 2e-08
 Identities = 22/93 (23%), Positives = 32/93 (34%), Gaps = 9/93 (9%)

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
               N  S  I         L+ L++  N L   +P     L  L       N L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVP 320

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL 254
               NLK L    + YN L    P    ++ +L
Sbjct: 321 ELPQNLKQLH---VEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.3 bits (126), Expect = 7e-08
 Identities = 25/136 (18%), Positives = 46/136 (33%), Gaps = 9/136 (6%)

Query: 71  PCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIAN 130
           P +   ++       +   L  +     + +  FS    L      +N     I S    
Sbjct: 223 PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL 282

Query: 131 NSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFEN 190
              L+ L++S+N     +P        L+ L  S N  +  +P    +L     LH+  N
Sbjct: 283 PPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLA-EVPELPQNLKQ---LHVEYN 334

Query: 191 GLSGSIPPSLGNLTNL 206
            L    P    ++ +L
Sbjct: 335 PLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.9 bits (125), Expect = 9e-08
 Identities = 28/111 (25%), Positives = 42/111 (37%), Gaps = 12/111 (10%)

Query: 486 SFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLD 545
            F   S L            EI       P+L  L+VS N +  + P      P+L+ L 
Sbjct: 255 IFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIEL-PALP---PRLERLI 310

Query: 546 LSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSS 596
            S NH+  E+P     L+    L +  N    + P    S   +E L ++S
Sbjct: 311 ASFNHL-AEVPELPQNLKQ---LHVEYNPLR-EFPDIPES---VEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 51.7 bits (122), Expect = 3e-07
 Identities = 26/95 (27%), Positives = 38/95 (40%), Gaps = 9/95 (9%)

Query: 591 HLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEE 650
                 N  SN I         L  LN+SNN+   E+P        L  L  S N L  E
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHL-AE 318

Query: 651 IPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGL 685
           +P      Q+L++L++ +N L    P   + +  L
Sbjct: 319 VPE---LPQNLKQLHVEYNPLRE-FPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 50.2 bits (118), Expect = 8e-07
 Identities = 25/92 (27%), Positives = 34/92 (36%), Gaps = 9/92 (9%)

Query: 546 LSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPG 605
              N    EI S      SL +L ++ N+   +LP     L   E L  S N L+  +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPE 321

Query: 606 SLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHL 637
              NL     L++  N    E P   E    L
Sbjct: 322 LPQNLK---QLHVEYNPLR-EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.4 bits (103), Expect = 5e-05
 Identities = 21/79 (26%), Positives = 36/79 (45%), Gaps = 8/79 (10%)

Query: 617 NLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP 676
               N  S EI    +    L +L++S+N L  E+P+       LE+L  + N+L+  +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPA---LPPRLERLIASFNHLAE-VP 320

Query: 677 RCFKEMHGLVYIDISYNKL 695
              +    L  + + YN L
Sbjct: 321 ---ELPQNLKQLHVEYNPL 336

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 44.0 bits (102), Expect = 7e-05
 Identities = 21/91 (23%), Positives = 31/91 (34%), Gaps = 9/91 (9%)

Query: 358 NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFG 417
           N  S  I        +L  L +  N L   +P+    L  L     S N L+  +P    
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVPELPQ 324

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTL 448
           NL     L +  N L    P    ++  L +
Sbjct: 325 NLK---QLHVEYNPLRE-FPDIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 17/67 (25%), Positives = 26/67 (38%), Gaps = 5/67 (7%)

Query: 276 TNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNL 335
                L L +  LS S+P    +L+SL     S N L+  +P    +L  L +   +   
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 336 LFGSIPC 342
           L    P 
Sbjct: 93  LSDLPPL 99

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.4 bits (90), Expect = 0.002
 Identities = 18/60 (30%), Positives = 27/60 (45%), Gaps = 8/60 (13%)

Query: 588 QLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFL 647
           Q   L+L++  LS S+P    +L     L  S N  + E+P   E    L  L + +N L
Sbjct: 39  QAHELELNNLGLS-SLPELPPHLE---SLVASCNSLT-ELP---ELPQSLKSLLVDNNNL 90

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 39.0 bits (89), Expect = 0.002
 Identities = 21/65 (32%), Positives = 27/65 (41%), Gaps = 5/65 (7%)

Query: 182 LKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLS 241
              L L   GLS S+P    +L +L       NSL+  +P    +LKSL         LS
Sbjct: 40  AHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94

Query: 242 GSMPL 246
              PL
Sbjct: 95  DLPPL 99

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 38.3 bits (87), Expect = 0.004
 Identities = 16/65 (24%), Positives = 28/65 (43%), Gaps = 5/65 (7%)

Query: 540 QLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRL 599
           Q   L+L++  +   +P     L SL+    + N  + +LP    SL  L   + +   L
Sbjct: 39  QAHELELNNLGL-SSLPELPPHLESLV---ASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93

Query: 600 SNSIP 604
           S+  P
Sbjct: 94  SDLPP 98

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 58.5 bits (140), Expect = 5e-10
 Identities = 37/217 (17%), Positives = 70/217 (32%), Gaps = 21/217 (9%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
            L N I ++   + ++  + +   +L  +T L      +   I  ++ L  L  + L  N
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDN 73

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSA------------- 524
            +T               ++ +  K    I+          T                  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 525 -NNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTEL 583
                  +      +    +  LS  +      + L  L  L  L  + N+ S   P  L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 584 GSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSN 620
            SL  L  + L +N++S+  P  L N   L+ + L+N
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 55.0 bits (131), Expect = 7e-09
 Identities = 46/229 (20%), Positives = 77/229 (33%), Gaps = 18/229 (7%)

Query: 346 NLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSE 405
            L     +  G + ++ ++  +  +L  + TL  F   ++      +  LN+L  L L +
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72

Query: 406 NELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRN 465
           N+++        NLT +  L +  N L           +K   L  +      P+  L N
Sbjct: 73  NQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130

Query: 466 LTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSAN 525
           L  L             I+    +    +   LS                 L TL    N
Sbjct: 131 LQVL-------YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183

Query: 526 NITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
            I+ I    +   P L  + L +N I    P  L    +L  +TL  NQ
Sbjct: 184 KISDI--SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.6 bits (117), Expect = 5e-07
 Identities = 39/232 (16%), Positives = 71/232 (30%), Gaps = 18/232 (7%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F   +  +   +    + +   +    A+   +  L       + TI   +  L+ L  L
Sbjct: 13  FPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGL 68

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
            L  NQ +   P +         L         +I       T         +    +  
Sbjct: 69  ELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGL 128

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
           S +  L          + L+G                L   +   S      NL+ L  L
Sbjct: 129 SNLQVLYLDLNQITNISPLAGLTN----------LQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD 333
               N +S   P  + +L +L  + L  N++S   P  L N + L I+ L++
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 7e-07
 Identities = 39/215 (18%), Positives = 77/215 (35%), Gaps = 22/215 (10%)

Query: 179 LSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYN 238
           L+    +   ++ ++ ++  +  +L  +  +  +   ++      +  L +L GLEL  N
Sbjct: 18  LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73

Query: 239 KLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGN 298
           +++   PL          L  +      +I       T         +    +  S +  
Sbjct: 74  QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133

Query: 299 LKSLYGLGLSFNKL--------------SGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI 344
           L        + + L                S  + L NL+KLT L   DN +    P  +
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191

Query: 345 GNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYL 379
            +L  L  + L +N++S   P  L N +NL  + L
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 49.3 bits (116), Expect = 8e-07
 Identities = 42/228 (18%), Positives = 78/228 (34%), Gaps = 19/228 (8%)

Query: 274 NLTNLDILNLPHNSLSGSIP-SEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
            L N   +    ++++ ++  +++  + +L   G     + G     +  L  L  L L 
Sbjct: 17  ALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEG-----VQYLNNLIGLELK 71

Query: 333 DNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
           DN +    P +         L     K   +I       T   T    T++   +  S +
Sbjct: 72  DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131

Query: 393 GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLS 452
             L    +   + + L+G     + ++ N  V                 NL KLT L   
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVS----------DLTPLANLSKLTTLKAD 181

Query: 453 YNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSH 500
            N++   I  L +L  L  V L  N ++          SNL  + L++
Sbjct: 182 DNKISD-ISPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.9 bits (115), Expect = 9e-07
 Identities = 41/230 (17%), Positives = 81/230 (35%), Gaps = 19/230 (8%)

Query: 226 NLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPH 285
            L +   +  G + ++    ++  +L  + TL      ++ +I      L NL  L L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72

Query: 286 NSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIG 345
           N ++   P +     +   L  +  K   +I       T         ++   +    + 
Sbjct: 73  NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132

Query: 346 NLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSE 405
            L          + L+G               YL       S  + + NL+ L+ L   +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQ----------YLSIGNAQVSDLTPLANLSKLTTLKADD 182

Query: 406 NELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQ 455
           N++S   P    +L N+I + + +N +S   P    N   L ++ L+ NQ
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 9e-06
 Identities = 26/124 (20%), Positives = 43/124 (34%), Gaps = 5/124 (4%)

Query: 44  WKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFS 103
            KT            P   L+N   +        + +    + ++   S G         
Sbjct: 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP 168

Query: 104 FSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYL 163
            ++   L  L    N+I  I P  +A+   L  + L +N  S   P  + N S L I+ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 164 STNQ 167
           + NQ
Sbjct: 225 T-NQ 227

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 4e-05
 Identities = 30/215 (13%), Positives = 62/215 (28%), Gaps = 22/215 (10%)

Query: 491 SNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNH 550
           +N   I          ++        + TL      +T I    +     L  L+L  N 
Sbjct: 19  ANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQ 74

Query: 551 IVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNL 610
           I    P +     + ++L+ N  +    +                ++    +   +L  L
Sbjct: 75  ITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVL 134

Query: 611 --------------VKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVC 656
                                LS           L     L+ L    N + +  P  + 
Sbjct: 135 YLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LA 192

Query: 657 SMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDIS 691
           S+ +L +++L +N +S   P        L  + ++
Sbjct: 193 SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.9 bits (102), Expect = 4e-05
 Identities = 48/241 (19%), Positives = 82/241 (34%), Gaps = 23/241 (9%)

Query: 117 VNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI 176
           +N IF          +    +    ++ + T+     +L  +  L       +      +
Sbjct: 9   INVIF-----PDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGV 59

Query: 177 GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELG 236
            +L+ L  L L +N ++      L NLT +  + L  N L                  L 
Sbjct: 60  QYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIK----TLD 113

Query: 237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM 296
                 +    L  L NL  L L  N ++   PL+           L   +   S  + +
Sbjct: 114 LTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQ----YLSIGNAQVSDLTPL 169

Query: 297 GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELG 356
            NL  L  L    NK+S   P  L +L  L  ++L +N +    P  + N   LF + L 
Sbjct: 170 ANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

Query: 357 D 357
           +
Sbjct: 226 N 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 2e-04
 Identities = 29/172 (16%), Positives = 51/172 (29%), Gaps = 4/172 (2%)

Query: 42  LKWKTSLQNHNNKGSFLPSWTLNNATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHD 101
           +++  +L     K + +                   +        +   +   L  T   
Sbjct: 59  VQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQ 118

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
            +  +          +      I +            LS  +   +    + NLS L  L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYN 213
               N+ S   P  +  L  L  +HL  N +S   P  L N +NL I+ L N
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.6 bits (142), Expect = 1e-09
 Identities = 17/102 (16%), Positives = 33/102 (32%), Gaps = 5/102 (4%)

Query: 587 IQLEHLDLSSNRLSNS-IPGSLGNLVKLYYLNLSNNQFSGE----IPIKLEKFIHLSDLD 641
           + ++ LD+    LS++     L  L +   + L +   +      I   L     L++L+
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 642 LSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH 683
           L  N LG+     V          +   +L            
Sbjct: 62  LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGV 103

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.5 bits (134), Expect = 9e-09
 Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 10/96 (10%)

Query: 538 SPQLKVLDLSSNHIVGEIPSEL-GKLRSLIKLTLNRNQFSGQ----LPTELGSLIQLEHL 592
           S  ++ LD+    +     +EL   L+    + L+    +      + + L     L  L
Sbjct: 1   SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60

Query: 593 DLSSNRLSNSIPGSLG-----NLVKLYYLNLSNNQF 623
           +L SN L +     +         K+  L+L N   
Sbjct: 61  NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 7e-08
 Identities = 21/94 (22%), Positives = 35/94 (37%), Gaps = 15/94 (15%)

Query: 588 QLEHLDLSSNRLSN----SIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFI-----HLS 638
            L  L L+   +S+    S+  +L     L  L+LSNN       ++L + +      L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 639 DLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLS 672
            L L   +  EE+         L+ L     +L 
Sbjct: 430 QLVLYDIYWSEEME------DRLQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 51.9 bits (122), Expect = 3e-07
 Identities = 21/79 (26%), Positives = 31/79 (39%), Gaps = 9/79 (11%)

Query: 564 SLIKLTLNRNQFSGQ----LPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVK-----LY 614
            L  L L     S      L   L +   L  LDLS+N L ++    L   V+     L 
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429

Query: 615 YLNLSNNQFSGEIPIKLEK 633
            L L +  +S E+  +L+ 
Sbjct: 430 QLVLYDIYWSEEMEDRLQA 448

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.0 bits (117), Expect = 1e-06
 Identities = 16/89 (17%), Positives = 29/89 (32%), Gaps = 9/89 (10%)

Query: 100 HDFSFSSFPHLAYLDLRVNQI----FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIG-- 153
                     L  L L    +       + + +  N  L+ LDLS+N        Q+   
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 154 ---NLSMLKILYLSTNQFSGRIPPQIGHL 179
                 +L+ L L    +S  +  ++  L
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.4 bits (113), Expect = 4e-06
 Identities = 20/88 (22%), Positives = 31/88 (35%), Gaps = 9/88 (10%)

Query: 604 PGSLGNLVKLYYLNLSNNQFSGE----IPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-- 657
            G       L  L L++   S      +   L     L +LDLS+N LG+    Q+    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 658 ---MQSLEKLNLAHNNLSGFIPRCFKEM 682
                 LE+L L     S  +    + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.7 bits (111), Expect = 7e-06
 Identities = 16/84 (19%), Positives = 34/84 (40%), Gaps = 9/84 (10%)

Query: 514 FPNLGTLDVSANNITGI----LPPEIGDSPQLKVLDLSSNHIVGEIPSELGK-----LRS 564
              L  L ++  +++      L   +  +  L+ LDLS+N +      +L +        
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 565 LIKLTLNRNQFSGQLPTELGSLIQ 588
           L +L L    +S ++   L +L +
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEK 451

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 1e-05
 Identities = 16/91 (17%), Positives = 30/91 (32%), Gaps = 5/91 (5%)

Query: 205 NLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSG----SMPLSLGNLPNLATLDL 259
           ++  + +    LS +  +E+   L+    + L    L+      +  +L   P LA L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 260 HDNSLSGSIPLSFGNLTNLDILNLPHNSLSG 290
             N L                  +   SL  
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 16/95 (16%), Positives = 30/95 (31%), Gaps = 5/95 (5%)

Query: 277 NLDILNLPHNSLSGSIPSEM-GNLKSLYGLGLSFNKLSG----SIPSSLGNLTKLTILYL 331
           ++  L++    LS +  +E+   L+    + L    L+      I S+L     L  L L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 332 SDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPH 366
             N L       +         ++    L      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 10/66 (15%), Positives = 26/66 (39%), Gaps = 5/66 (7%)

Query: 635 IHLSDLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSG----FIPRCFKEMHGLVYID 689
           + +  LD+    L +   +++   +Q  + + L    L+      I    +    L  ++
Sbjct: 2   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61

Query: 690 ISYNKL 695
           +  N+L
Sbjct: 62  LRSNEL 67

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.4 bits (105), Expect = 3e-05
 Identities = 18/84 (21%), Positives = 28/84 (33%), Gaps = 9/84 (10%)

Query: 226 NLKSLSGLELGYNKLSG----SMPLSLGNLPNLATLDLHDNSLSGSIPLSFG-----NLT 276
               L  L L    +S     S+  +L    +L  LDL +N L  +  L           
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 277 NLDILNLPHNSLSGSIPSEMGNLK 300
            L+ L L     S  +   +  L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 4e-05
 Identities = 15/93 (16%), Positives = 30/93 (32%), Gaps = 5/93 (5%)

Query: 158 LKILYLSTNQFS-GRIPPQIGHLSYLKALHLFENGLSG----SIPPSLGNLTNLAIMYLY 212
           ++ L +   + S  R    +  L   + + L + GL+      I  +L     LA + L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 213 NNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMP 245
           +N L       +         ++    L     
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 19/98 (19%), Positives = 29/98 (29%), Gaps = 9/98 (9%)

Query: 260 HDNSLSGSIPLSFGNLTNLDILNLPHNSLSG----SIPSEMGNLKSLYGLGLSFNKLSGS 315
            D  +           + L +L L    +S     S+ + +    SL  L LS N L  +
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412

Query: 316 IPSSLG-----NLTKLTILYLSDNLLFGSIPCEIGNLR 348
               L          L  L L D      +   +  L 
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.6 bits (103), Expect = 5e-05
 Identities = 19/99 (19%), Positives = 31/99 (31%), Gaps = 13/99 (13%)

Query: 244 MPLSLGNLPNLATLDLHDNSLSG----SIPLSFGNLTNLDILNLPHNSLSGSIPSEMG-- 297
                     L  L L D  +S     S+  +     +L  L+L +N L  +   ++   
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 298 ---NLKSLYGLGLSFNKLSGSIPSSLGNLTK----LTIL 329
                  L  L L     S  +   L  L K    L ++
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 7e-05
 Identities = 7/92 (7%), Positives = 27/92 (29%), Gaps = 5/92 (5%)

Query: 492 NLSYINLSHKKFYGE-ISFDWGKFPNLGTLDVSANNITGI----LPPEIGDSPQLKVLDL 546
           ++  +++  ++      +           + +    +T      +   +  +P L  L+L
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 547 SSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQ 578
            SN +       + +        + +      
Sbjct: 63  RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.9 bits (96), Expect = 4e-04
 Identities = 16/84 (19%), Positives = 30/84 (35%), Gaps = 9/84 (10%)

Query: 154 NLSMLKILYLSTNQFSGR----IPPQIGHLSYLKALHLFENGLSGSIPPSLG-----NLT 204
             S+L++L+L+    S      +   +     L+ L L  N L  +    L         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 205 NLAIMYLYNNSLSGSIPSEIGNLK 228
            L  + LY+   S  +   +  L+
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.5 bits (95), Expect = 5e-04
 Identities = 19/88 (21%), Positives = 29/88 (32%), Gaps = 9/88 (10%)

Query: 293 PSEMGNLKSLYGLGLSFNKLSG----SIPSSLGNLTKLTILYLSDNLLFGSIPCEIG--- 345
                    L  L L+   +S     S+ ++L     L  L LS+N L  +   ++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 346 --NLRYLFYLELGDNKLSGSIPHSLGNL 371
                 L  L L D   S  +   L  L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQAL 449

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 15/83 (18%), Positives = 29/83 (34%), Gaps = 9/83 (10%)

Query: 490 HSNLSYINLSHKKFYGE----ISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQ----- 540
            S L  + L+           ++       +L  LD+S N +      ++ +S +     
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427

Query: 541 LKVLDLSSNHIVGEIPSELGKLR 563
           L+ L L   +   E+   L  L 
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 6e-04
 Identities = 9/90 (10%), Positives = 28/90 (31%), Gaps = 5/90 (5%)

Query: 110 LAYLDLRVNQIFGIIPSQIANN-SKLKYLDLSSNSFSG----TIPPQIGNLSMLKILYLS 164
           +  LD++  ++     +++     + + + L     +      I   +     L  L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 165 TNQFSGRIPPQIGHLSYLKALHLFENGLSG 194
           +N+        +       +  + +  L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 11/74 (14%), Positives = 18/74 (24%), Gaps = 9/74 (12%)

Query: 104 FSSFPHLAYLDLRVNQI----FGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIG-----N 154
                    + L    +       I S +  N  L  L+L SN         +       
Sbjct: 23  LPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82

Query: 155 LSMLKILYLSTNQF 168
              ++ L L     
Sbjct: 83  SCKIQKLSLQNCCL 96

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 21/91 (23%), Positives = 33/91 (36%), Gaps = 13/91 (14%)

Query: 180 SYLKALHLFENGLSG----SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIG-----NLKSL 230
           S L+ L L +  +S     S+  +L    +L  + L NN L  +   ++          L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 231 SGLELGYNKLSGSMPLSLGNL----PNLATL 257
             L L     S  M   L  L    P+L  +
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 0.001
 Identities = 18/118 (15%), Positives = 34/118 (28%), Gaps = 24/118 (20%)

Query: 298 NLKSLYGLGLSFNKLSGS-IPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELG 356
           +++SL    +   +LS +     L  L +  ++ L D                     L 
Sbjct: 3   DIQSLD---IQCEELSDARWAELLPLLQQCQVVRLDDC-------------------GLT 40

Query: 357 DNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPY 414
           + +    I  +L     LA L L +N L       +          + +  L      
Sbjct: 41  EARCK-DISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.0 bits (91), Expect = 0.002
 Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 5/90 (5%)

Query: 350 LFYLELGDNKLSGS-IPHSLGNLTNLATLYLFTNLLSG----SIPSEIGNLNSLSDLGLS 404
           +  L++   +LS +     L  L     + L    L+      I S +    +L++L L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 405 ENELSGSIPYSFGNLTNMIVLSIYSNALSG 434
            NEL     +            I   +L  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.2 bits (89), Expect = 0.003
 Identities = 16/77 (20%), Positives = 25/77 (32%), Gaps = 9/77 (11%)

Query: 346 NLRYLFYLELGDNKLSG----SIPHSLGNLTNLATLYLFTNLLSGSIPSEIG-----NLN 396
               L  L L D  +S     S+  +L    +L  L L  N L  +   ++         
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 397 SLSDLGLSENELSGSIP 413
            L  L L +   S  + 
Sbjct: 427 LLEQLVLYDIYWSEEME 443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 54.7 bits (131), Expect = 1e-09
 Identities = 29/123 (23%), Positives = 51/123 (41%), Gaps = 6/123 (4%)

Query: 519 TLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQ 578
            L ++  ++T +    +     +  LDLS N +    P+ L  LR L    L  +  + +
Sbjct: 2   VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLE--VLQASDNALE 56

Query: 579 LPTELGSLIQLEHLDLSSNRLSN-SIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHL 637
               + +L +L+ L L +NRL   +    L +  +L  LNL  N    E  I+      L
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116

Query: 638 SDL 640
             +
Sbjct: 117 PSV 119

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 2e-08
 Identities = 28/127 (22%), Positives = 50/127 (39%), Gaps = 9/127 (7%)

Query: 135 KYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSG 194
           + L L+      T+   +  L ++  L LS N+     PP +  L  L+ L   +N  + 
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDN--AL 55

Query: 195 SIPPSLGNLTNLAIMYLYNNSL-SGSIPSEIGNLKSLSGLELGYNKLSGSMPLS---LGN 250
                + NL  L  + L NN L   +    + +   L  L L  N L     +       
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 251 LPNLATL 257
           LP+++++
Sbjct: 116 LPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.1 bits (119), Expect = 6e-08
 Identities = 20/119 (16%), Positives = 38/119 (31%), Gaps = 6/119 (5%)

Query: 449 LVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEIS 508
           L L++  L   +  L  L  +  + L  N L      +      L  +  S         
Sbjct: 3   LHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLRALP-PALAALRCLEVLQASDNALENVDG 60

Query: 509 FDWGKFPNLGTLDVSANNITGI-LPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLI 566
                 P L  L +  N +        +   P+L +L+L  N +  +      +L  ++
Sbjct: 61  VAN--LPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 50.1 bits (119), Expect = 7e-08
 Identities = 31/107 (28%), Positives = 42/107 (39%), Gaps = 6/107 (5%)

Query: 568 LTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEI 627
           L L     +      L  L+ + HLDLS NRL    P +L  L  L  L  S+N      
Sbjct: 3   LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 628 PIKLEKFIHLSDLDLSHNFLGE-EIPSQVCSMQSLEKLNLAHNNLSG 673
            +       L +L L +N L +      + S   L  LNL  N+L  
Sbjct: 60  GVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.7 bits (118), Expect = 1e-07
 Identities = 28/109 (25%), Positives = 47/109 (43%), Gaps = 6/109 (5%)

Query: 159 KILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG 218
           ++L+L+    +  +   +  L  +  L L  N L   +PP+L  L  L ++   +N+   
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNA--L 55

Query: 219 SIPSEIGNLKSLSGLELGYNKL-SGSMPLSLGNLPNLATLDLHDNSLSG 266
                + NL  L  L L  N+L   +    L + P L  L+L  NSL  
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 1e-07
 Identities = 26/107 (24%), Positives = 44/107 (41%), Gaps = 6/107 (5%)

Query: 592 LDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEI 651
           L L+   L+  +   L  L+ + +L+LS+N+     P  L     L  L  S N    E 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNA--LEN 57

Query: 652 PSQVCSMQSLEKLNLAHNNLSGF-IPRCFKEMHGLVYIDISYNKLHG 697
              V ++  L++L L +N L      +       LV +++  N L  
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 48.9 bits (116), Expect = 2e-07
 Identities = 29/121 (23%), Positives = 47/121 (38%), Gaps = 7/121 (5%)

Query: 183 KALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSG 242
           + LHL    L+  +   L  L  +  + L +N L    P+ +  L+ L  L+   +  + 
Sbjct: 1   RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQ--ASDNAL 55

Query: 243 SMPLSLGNLPNLATLDLHDNSL-SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKS 301
                + NLP L  L L +N L   +      +   L +LNL  NSL          L  
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAE 114

Query: 302 L 302
           +
Sbjct: 115 M 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.8 bits (113), Expect = 4e-07
 Identities = 31/120 (25%), Positives = 45/120 (37%), Gaps = 7/120 (5%)

Query: 280 ILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGS 339
           +L+L H  L+  +   +  L  +  L LS N+L    P +L  L  L +L  SDN L   
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58

Query: 340 IPCEIGNLRYLFYLELGDNKL-SGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSL 398
                     L  L L +N+L   +    L +   L  L L  N L          L  +
Sbjct: 59  DGVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 47.4 bits (112), Expect = 5e-07
 Identities = 31/127 (24%), Positives = 48/127 (37%), Gaps = 9/127 (7%)

Query: 542 KVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSN 601
           +VL L+   +   +   L +L  +  L L+ N+     P  L +L  LE L  S N    
Sbjct: 1   RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55

Query: 602 SIPGSLGNLVKLYYLNLSNNQF-SGEIPIKLEKFIHLSDLDLSHNFLGEE---IPSQVCS 657
                + NL +L  L L NN+         L     L  L+L  N L +E          
Sbjct: 56  ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115

Query: 658 MQSLEKL 664
           + S+  +
Sbjct: 116 LPSVSSI 122

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 25/120 (20%), Positives = 44/120 (36%), Gaps = 7/120 (5%)

Query: 112 YLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGR 171
            L L    +   +   +     + +LDLS N     +PP +  L  L++L    +  +  
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQ--ASDNALE 56

Query: 172 IPPQIGHLSYLKALHLFENGL-SGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSL 230
               + +L  L+ L L  N L   +    L +   L ++ L  NSL          L  +
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 45.1 bits (106), Expect = 4e-06
 Identities = 28/111 (25%), Positives = 38/111 (34%), Gaps = 6/111 (5%)

Query: 305 LGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSI 364
           L L+   L+  +   L  L  +T L LS N L    P  +  LR L  L+  DN L    
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59

Query: 365 PHSLGNLTNLATLYLFTNLL-SGSIPSEIGNLNSLSDLGLSENELSGSIPY 414
             +         L L  N L   +    + +   L  L L  N L      
Sbjct: 60  GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 108

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.9 bits (103), Expect = 8e-06
 Identities = 26/120 (21%), Positives = 50/120 (41%), Gaps = 7/120 (5%)

Query: 328 ILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGS 387
           +L+L+   L  ++ C +  L  + +L+L  N+L    P +L  L  L  L    N  +  
Sbjct: 2   VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALE 56

Query: 388 IPSEIGNLNSLSDLGLSENEL-SGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKL 446
               + NL  L +L L  N L   +      +   +++L++  N+L          L ++
Sbjct: 57  NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 43.2 bits (101), Expect = 2e-05
 Identities = 21/108 (19%), Positives = 40/108 (37%), Gaps = 5/108 (4%)

Query: 424 VLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNI 483
           VL +    L+  +      L+ +T L LS+N+L+   P L  L  L  ++   N      
Sbjct: 2   VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNA--LEN 57

Query: 484 SESFGIHSNLSYINLSHKKFYGEISFDW-GKFPNLGTLDVSANNITGI 530
            +       L  + L + +     +       P L  L++  N++   
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 53.5 bits (127), Expect = 2e-08
 Identities = 32/216 (14%), Positives = 69/216 (31%), Gaps = 21/216 (9%)

Query: 339 SIPCEIG------NLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
           ++P  I                L    ++ ++  +   L ++  +    + +       I
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--I 64

Query: 393 GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLS 452
             L +++ L L+ N+L+        NL N+          +          +K    +  
Sbjct: 65  QYLPNVTKLFLNGNKLTD--IKPLANLKNLG---WLFLDENKVKDLSSLKDLKKLKSLSL 119

Query: 453 YNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWG 512
            +     I  L +L +L  + L  N +T     S     +   +     +    +     
Sbjct: 120 EHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE--DNQISDIVPL--A 175

Query: 513 KFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSS 548
               L  L +S N+I+ +    +     L VL+L S
Sbjct: 176 GLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 51.2 bits (121), Expect = 1e-07
 Identities = 30/203 (14%), Positives = 71/203 (34%), Gaps = 15/203 (7%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
                I  ++   +++ A+ +    L  +  ++ + + ++  +  ++ L  + ++ L+ N
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGN 78

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
            LT     +   +    +++ +  K    +               S  +        +  
Sbjct: 79  KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSL------SLEHNGISDINGLVH 132

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
            PQL+ L L +N I              +    +           L  L +L++L LS N
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTL----SLEDNQISDIVPLAGLTKLQNLYLSKN 188

Query: 598 RLSNSIPGSLGNLVKLYYLNLSN 620
            +S  +  +L  L  L  L L +
Sbjct: 189 HIS-DLR-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.5 bits (114), Expect = 1e-06
 Identities = 38/224 (16%), Positives = 79/224 (35%), Gaps = 20/224 (8%)

Query: 210 YLYNNSLSGSIPSEIGNLKSLSGLE----LGYNKLSGSMPLSLGNLPNLATLDLHDNSLS 265
            L + +++  +P+ I  + S             K S +  ++   L ++  +  +++ + 
Sbjct: 2   PLGSETIT--VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIK 59

Query: 266 GSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTK 325
               +    L N+  L L  N L+   P  + NLK       +   L           + 
Sbjct: 60  SVQGIQ--YLPNVTKLFLNGNKLTDIKP--LANLK-------NLGWLFLDENKVKDLSSL 108

Query: 326 LTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLS 385
             +  L    L  +   +I  L +L  LE      +     ++ +           +   
Sbjct: 109 KDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQI 168

Query: 386 GSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
             I   +  L  L +L LS+N +S  +  +   L N+ VL ++S
Sbjct: 169 SDIV-PLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 45/203 (22%), Positives = 71/203 (34%), Gaps = 16/203 (7%)

Query: 202 NLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHD 261
                    L   S++ ++      L S+  +    + +     +    LPN+  L L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77

Query: 262 NSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG 321
           N L+   PL+     NL  L       +                    +     I   L 
Sbjct: 78  NKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN-GLV 131

Query: 322 NLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFT 381
           +L +L  LYL +N    +    +  L  L  L L DN++S  +P  L  LT L  LYL  
Sbjct: 132 HLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 382 NLLSGSIPSEIGNLNSLSDLGLS 404
           N +S      +  L +L  L L 
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.2 bits (103), Expect = 2e-05
 Identities = 37/201 (18%), Positives = 66/201 (32%), Gaps = 15/201 (7%)

Query: 274 NLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD 333
                   NL   S++ ++      L S+  +  + + +       +  L  +T L+L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77

Query: 334 NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIG 393
           N L       + NL+ L +L L +NK+               +L          +     
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQ 135

Query: 394 NLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSY 453
             +              +       LT +  LS+  N +S  +P     L KL  L LS 
Sbjct: 136 LESL------YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187

Query: 454 NQLQGPIPDLRNLTRLARVRL 474
           N +   +  L  L  L  + L
Sbjct: 188 NHISD-LRALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 43.8 bits (102), Expect = 4e-05
 Identities = 27/197 (13%), Positives = 57/197 (28%), Gaps = 22/197 (11%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           FS  +F      +L+   +   +       + +  +  +++         I  L  +  L
Sbjct: 18  FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73

Query: 162 YLSTNQFSG---------------RIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNL 206
           +L+ N+ +                         S      L    L  +    +  L +L
Sbjct: 74  FLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHL 133

Query: 207 AIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG 266
             +       +      + +  +        +     +   L  L  L  L L  N +S 
Sbjct: 134 PQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHIS- 191

Query: 267 SIPLSFGNLTNLDILNL 283
            +  +   L NLD+L L
Sbjct: 192 DLR-ALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 1e-04
 Identities = 44/216 (20%), Positives = 73/216 (33%), Gaps = 21/216 (9%)

Query: 117 VNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI 176
           + QIF          ++    +L   S +  +      L+ +  +  + +         I
Sbjct: 14  IKQIF-----SDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--I 64

Query: 177 GHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELG 236
            +L  +  L L  N L+         L NL  +       +                   
Sbjct: 65  QYLPNVTKLFLNGNKLTDIK-----PLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSL 119

Query: 237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEM 296
            +    S    L +LP L +L L +N ++         LT LD L+L  N +S  +P  +
Sbjct: 120 EHN-GISDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDIVP--L 174

Query: 297 GNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
             L  L  L LS N +S     +L  L  L +L L 
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.5 bits (96), Expect = 2e-04
 Identities = 40/205 (19%), Positives = 71/205 (34%), Gaps = 16/205 (7%)

Query: 370 NLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYS 429
                    L    ++ ++      LNS+  +  + +++          L N+  L +  
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNG 77

Query: 430 NALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGI 489
           N L+    K   NL  L  L L  N+++             +     +     IS+  G+
Sbjct: 78  NKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDL-----KKLKSLSLEHNGISDINGL 130

Query: 490 HSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSN 549
                  +L              +   L TL +  N I+ I+P  +    +L+ L LS N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188

Query: 550 HIVGEIPSELGKLRSLIKLTLNRNQ 574
           HI       L  L++L  L L  +Q
Sbjct: 189 HISD--LRALAGLKNLDVLEL-FSQ 210

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 9/69 (13%), Positives = 26/69 (37%), Gaps = 4/69 (5%)

Query: 562 LRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNN 621
               IK  L +   +  +      L  ++ +  +++ + +     +  L  +  L L+ N
Sbjct: 23  FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 622 QFSGEIPIK 630
           + +   P+ 
Sbjct: 79  KLTDIKPLA 87

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 53.0 bits (125), Expect = 1e-07
 Identities = 44/331 (13%), Positives = 91/331 (27%), Gaps = 19/331 (5%)

Query: 277 NLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG----SIPSSLGNLTKLTILYLS 332
           +L +  +       S+ + +    S+  + LS N +       +  ++ +   L I   S
Sbjct: 9   SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67

Query: 333 DN---LLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIP 389
           D     +   IP  +  L          + +  S              +L  +     + 
Sbjct: 68  DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127

Query: 390 SEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLL 449
                L   +   ++      ++     N   +  +    N L     KE+    +   L
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187

Query: 450 VLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEISF 509
           + +   +Q  I        L         L     +        S       K +  +  
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247

Query: 510 DWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSEL-----GKLRS 564
                  L     +      +      ++  L+ L L  N I  +    L      K+  
Sbjct: 248 LGLNDCLLS----ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 565 LIKLTLNRNQFS--GQLPTELGSLIQLEHLD 593
           L+ L LN N+FS    +  E+  +       
Sbjct: 304 LLFLELNGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 42.9 bits (99), Expect = 1e-04
 Identities = 17/89 (19%), Positives = 30/89 (33%), Gaps = 7/89 (7%)

Query: 74  WFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIA---- 129
                      +N   L++ G    +  FS      L  L L+ N+I       +     
Sbjct: 239 LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVID 298

Query: 130 -NNSKLKYLDLSSNSFS--GTIPPQIGNL 155
                L +L+L+ N FS    +  +I  +
Sbjct: 299 EKMPDLLFLELNGNRFSEEDDVVDEIREV 327

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 6e-04
 Identities = 18/85 (21%), Positives = 25/85 (29%), Gaps = 13/85 (15%)

Query: 235 LGYNKLSG------SMPLSLGNLPNLATLDLHDNSLSGSIPLS-----FGNLTNLDILNL 283
           L    LS           S      L TL L  N +      +        + +L  L L
Sbjct: 250 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 309

Query: 284 PHNSLS--GSIPSEMGNLKSLYGLG 306
             N  S    +  E+  + S  G G
Sbjct: 310 NGNRFSEEDDVVDEIREVFSTRGRG 334

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 41.0 bits (94), Expect = 6e-04
 Identities = 51/340 (15%), Positives = 98/340 (28%), Gaps = 36/340 (10%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSG----TIPPQIGNLSM 157
           FS      L    +        + + +  +  +K + LS N+        +   I +   
Sbjct: 3   FSIEGK-SLKLDAITTEDE-KSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60

Query: 158 LKILYLSTNQ---FSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN 214
           L+I   S          IP  +  L          + +  S            I +L  +
Sbjct: 61  LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120

Query: 215 SLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLS-GSIPLSFG 273
           +    +      L   +G ++       ++     N P L ++    N L  GS+     
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 180

Query: 274 NLTNLDILNLPHNSLS------------GSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLG 321
              +  +L+      +              +                 +  S ++  +L 
Sbjct: 181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 240

Query: 322 NLTKLTILYLSDNLLFGSIPCEIGN------LRYLFYLELGDNKLSGSIPHSL-----GN 370
           +   L  L L+D LL       + +         L  L L  N++      +L       
Sbjct: 241 SWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEK 300

Query: 371 LTNLATLYLFTNLLS--GSIPSEIGNLNSLSDLG-LSENE 407
           + +L  L L  N  S    +  EI  + S    G L E +
Sbjct: 301 MPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELD 340

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 7e-04
 Identities = 39/315 (12%), Positives = 79/315 (25%), Gaps = 33/315 (10%)

Query: 350 LFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSG----SIPSEIGNLNSLSDLGLSE 405
           L    +       S+   L    ++  + L  N +       +   I +   L     S+
Sbjct: 10  LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68

Query: 406 N----------ELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK-------LTL 448
                      E    +  +      +  + +  NA      +   + +        L L
Sbjct: 69  IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128

Query: 449 LVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEIS 508
                    G              +        +I        N S    +       + 
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188

Query: 509 FDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKL 568
                  N    +   + +   L             +  ++     +   L    +L +L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248

Query: 569 TLNRNQFSGQLPTELG------SLIQLEHLDLSSNRLSNSIPGSL-----GNLVKLYYLN 617
            LN    S +    +         I L+ L L  N +      +L       +  L +L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 618 LSNNQFSGEIPIKLE 632
           L+ N+FS E  +  E
Sbjct: 309 LNGNRFSEEDDVVDE 323

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.6 bits (93), Expect = 8e-04
 Identities = 41/362 (11%), Positives = 93/362 (25%), Gaps = 57/362 (15%)

Query: 229 SLSGLELGYNKLSG----SMPLSLGNLPNLATLDLHDNSLSG----SIPLSFGNLTNLDI 280
           S+ G  L  + ++     S+   L    ++  + L  N++       +  +  +  +L+I
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 281 LNLPHNS---LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF 337
                     +   IP  +  L          + +  S  +      +  I +LS +   
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 338 GSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNS 397
             +      L      ++       ++     N   L ++    N L      E      
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 398 LSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQ 457
              L  +   +   I         +  L+         +                +    
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT----------HLGSS 233

Query: 458 GPIPDLRNLTRLARVRLDRNHLTGNISE------SFGIHSNLSYINLSHKKFYGEISFDW 511
                L++   L  + L+   L+   +       S   +  L  + L +           
Sbjct: 234 ALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQY----------- 282

Query: 512 GKFPNLGTLDVSANNITGILPPEIGDS-----PQLKVLDLSSNHIVGEIPSELGKLRSLI 566
                        N I       +        P L  L+L+ N    E    + ++R + 
Sbjct: 283 -------------NEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVF 328

Query: 567 KL 568
             
Sbjct: 329 ST 330

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 9e-04
 Identities = 15/103 (14%), Positives = 29/103 (28%), Gaps = 8/103 (7%)

Query: 589 LEHLDLSSNRLSN----SIPGSLGNLVKLYYLNLSNNQFSGE----IPIKLEKFIHLSDL 640
           +E   L  + ++     S+   L     +  + LS N    E    +   +     L   
Sbjct: 5   IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64

Query: 641 DLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMH 683
           + S  F G        +++ L +  L    L            
Sbjct: 65  EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 40.2 bits (92), Expect = 0.001
 Identities = 38/318 (11%), Positives = 88/318 (27%), Gaps = 34/318 (10%)

Query: 387 SIPSEIGNLNSLSDLGLSENELSG----SIPYSFGNLTNMIVLSIYSN---ALSGAIPKE 439
           S+ + +   +S+ ++ LS N +       +  +  +  ++ +          +   IP+ 
Sbjct: 22  SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81

Query: 440 YGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYI-NL 498
              L++  L     + ++          +   +     H                    +
Sbjct: 82  LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141

Query: 499 SHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD-------------SPQLKVLD 545
           +       ++      P L ++    N +      E                       +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201

Query: 546 LSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPG 605
              + ++  +          ++     +  S  L   L S   L  L L+   LS     
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261

Query: 606 SLGN------LVKLYYLNLSNNQFSGEIPIKL-----EKFIHLSDLDLSHNFLGEEIPSQ 654
           ++ +       + L  L L  N+   +    L     EK   L  L+L+ N   EE    
Sbjct: 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE-DDV 320

Query: 655 VCSMQSLEKLNLAHNNLS 672
           V  ++ +         L 
Sbjct: 321 VDEIREVFSTR-GRGELD 337

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 39.1 bits (89), Expect = 0.002
 Identities = 36/312 (11%), Positives = 85/312 (27%), Gaps = 36/312 (11%)

Query: 397 SLSDLGLSENELSG----SIPYSFGNLTNMIVLSIYSNALSG----AIPKEYGNLVKLTL 448
           S+    L  + ++     S+        ++  + +  N +       + +   +   L +
Sbjct: 4   SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 63

Query: 449 LVLSYNQLQGPIPDL----RNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFY 504
              S         ++    R L +        + +  + +             LS     
Sbjct: 64  AEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123

Query: 505 GEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRS 564
             +              ++       +  +  ++P L+ +    N +      E  K   
Sbjct: 124 EHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQ 183

Query: 565 LIKLTLNRNQFSGQLPTELGSLIQLEHLD-------------LSSNRLSNSIPGSLGNLV 611
             +L          +  E    + LE L                ++  S+++  +L +  
Sbjct: 184 SHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP 243

Query: 612 KLYYLNLSNNQFSGEIPIKLEKFI------HLSDLDLSHNFLGEEIPSQVCS-----MQS 660
            L  L L++   S      +           L  L L +N +  +    + +     M  
Sbjct: 244 NLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPD 303

Query: 661 LEKLNLAHNNLS 672
           L  L L  N  S
Sbjct: 304 LLFLELNGNRFS 315

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.2 bits (116), Expect = 3e-07
 Identities = 30/137 (21%), Positives = 46/137 (33%), Gaps = 7/137 (5%)

Query: 126 SQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKAL 185
           +Q  N  + + LDL        I      L     +  S N+   R       L  LK L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68

Query: 186 HLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG-SIPSEIGNLKSLSGLELG---YNKLS 241
            +  N +          L +L  + L NNSL        + +LKSL+ L +         
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 242 GSMPLSLGNLPNLATLD 258
                 +  +P +  LD
Sbjct: 129 HYRLYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 9e-06
 Identities = 21/137 (15%), Positives = 41/137 (29%), Gaps = 6/137 (4%)

Query: 415 SFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRL 474
            + N      L +    +   I      L +   +  S N+++  +     L RL  + +
Sbjct: 13  QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLV 70

Query: 475 DRNHLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPE 534
           + N +            +L+ + L++         D        T      N        
Sbjct: 71  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130

Query: 535 ----IGDSPQLKVLDLS 547
               I   PQ++VLD  
Sbjct: 131 RLYVIYKVPQVRVLDFQ 147

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 9e-06
 Identities = 24/136 (17%), Positives = 45/136 (33%), Gaps = 7/136 (5%)

Query: 246 LSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGL 305
               N      LDL    +   I      L   D ++   N +          L+ L  L
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68

Query: 306 GLSFNKLSGSIPSSLGNLTKLTILYLS-DNLLFGSIPCEIGNLRYLFYLELGDNK---LS 361
            ++ N++          L  LT L L+ ++L+       + +L+ L YL +  N      
Sbjct: 69  LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128

Query: 362 GSIPHSLGNLTNLATL 377
               + +  +  +  L
Sbjct: 129 HYRLYVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 9e-06
 Identities = 15/129 (11%), Positives = 39/129 (30%), Gaps = 3/129 (2%)

Query: 586 LIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN 645
            ++   LDL   ++   I      L +   ++ S+N+              L  L +++N
Sbjct: 17  AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTLLVNNN 73

Query: 646 FLGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAF 705
            +         ++  L +L L +N+L              +              +   +
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLY 133

Query: 706 KHAPMEALQ 714
               +  ++
Sbjct: 134 VIYKVPQVR 142

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (101), Expect = 3e-05
 Identities = 19/129 (14%), Positives = 42/129 (32%), Gaps = 7/129 (5%)

Query: 594 LSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPS 653
           L++  +  +      N V+   L+L   +    I            +D S N +      
Sbjct: 3   LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57

Query: 654 QVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH--GPIPNSAAFKHAPME 711
               ++ L+ L + +N +        + +  L  + ++ N L   G +   A+ K     
Sbjct: 58  GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117

Query: 712 ALQGNKGLC 720
            +  N    
Sbjct: 118 CILRNPVTN 126

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 4e-04
 Identities = 26/132 (19%), Positives = 44/132 (33%), Gaps = 7/132 (5%)

Query: 298 NLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGD 357
           N      L L   K+   I +    L +   +  SDN +          LR L  L + +
Sbjct: 16  NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNN 72

Query: 358 NKLSGSIPHSLGNLTNLATLYL-FTNLLSGSIPSEIGNLNSLSDLGLSE---NELSGSIP 413
           N++          L +L  L L   +L+       + +L SL+ L +             
Sbjct: 73  NRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132

Query: 414 YSFGNLTNMIVL 425
           Y    +  + VL
Sbjct: 133 YVIYKVPQVRVL 144

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.8 bits (89), Expect = 0.001
 Identities = 25/161 (15%), Positives = 53/161 (32%), Gaps = 31/161 (19%)

Query: 533 PEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHL 592
            +  ++ + + LDL    I                           +     +L Q + +
Sbjct: 12  AQYTNAVRDRELDLRGYKIP-------------------------VIENLGATLDQFDAI 46

Query: 593 DLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGE--- 649
           D S N +          L +L  L ++NN+         +    L++L L++N L E   
Sbjct: 47  DFSDNEIRKLDGFP--LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 104

Query: 650 -EIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYID 689
            +  + + S+  L  L     N   +      ++  +  +D
Sbjct: 105 LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.5 bits (112), Expect = 1e-06
 Identities = 30/152 (19%), Positives = 50/152 (32%), Gaps = 8/152 (5%)

Query: 234 ELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIP 293
           EL   ++   + L +    + +   L    L               +LN   +  + ++ 
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLR 58

Query: 294 SEMGNLKSLYGLGLSFNKLSG--SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLF 351
               N+  L  L LS N+L     + S +     L IL LS N L      +      L 
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 352 YLELGDNKLSGSIPHSLGNLTNLATLYLFTNL 383
            L L  N LS +       ++ +     F  L
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAI--RERFPKL 148

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.0 bits (108), Expect = 4e-06
 Identities = 28/138 (20%), Positives = 48/138 (34%), Gaps = 5/138 (3%)

Query: 578 QLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHL 637
           QL   +          L    L +     L        LN  ++  +  + I  E    L
Sbjct: 11  QLKLIMSKRYDGSQQALDLKGLRS--DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67

Query: 638 SDLDLSHNFL--GEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKL 695
             L+LS+N L   +++ S V    +L+ LNL+ N L         +   L  + +  N L
Sbjct: 68  LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127

Query: 696 HGPIPNSAAFKHAPMEAL 713
                + + +  A  E  
Sbjct: 128 SDTFRDQSTYISAIRERF 145

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 2e-05
 Identities = 24/110 (21%), Positives = 42/110 (38%), Gaps = 3/110 (2%)

Query: 195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLS--LGNLP 252
              P L       ++   ++  + ++     N+  L  L L  N+L     +S  +   P
Sbjct: 33  RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAP 91

Query: 253 NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSL 302
           NL  L+L  N L     L       L+ L L  NSLS +   +   + ++
Sbjct: 92  NLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.1 bits (98), Expect = 7e-05
 Identities = 22/135 (16%), Positives = 44/135 (32%), Gaps = 4/135 (2%)

Query: 436 IPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSY 495
           +          +   L    L+   PDL        +   R+ +   +         L  
Sbjct: 12  LKLIMSKRYDGSQQALDLKGLRS-DPDLVAQNIDVVLNR-RSSMAATLRIIEENIPELLS 69

Query: 496 INLSHKKFYGEISFDW--GKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVG 553
           +NLS+ + Y          K PNL  L++S N +      +     +L+ L L  N +  
Sbjct: 70  LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129

Query: 554 EIPSELGKLRSLIKL 568
               +   + ++ + 
Sbjct: 130 TFRDQSTYISAIRER 144

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (95), Expect = 2e-04
 Identities = 24/144 (16%), Positives = 42/144 (29%), Gaps = 6/144 (4%)

Query: 282 NLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIP 341
            L    +   +   M          L    L       L       +L    ++   ++ 
Sbjct: 3   ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMA-ATLR 58

Query: 342 CEIGNLRYLFYLELGDNKLSG--SIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLS 399
               N+  L  L L +N+L     +   +    NL  L L  N L      +      L 
Sbjct: 59  IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118

Query: 400 DLGLSENELSGSIPYSFGNLTNMI 423
           +L L  N LS +       ++ + 
Sbjct: 119 ELWLDGNSLSDTFRDQSTYISAIR 142

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (91), Expect = 6e-04
 Identities = 30/150 (20%), Positives = 52/150 (34%), Gaps = 20/150 (13%)

Query: 515 PNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQ 574
            +   LD+          P++       VL+  S+     +      +  L+ L L+ N+
Sbjct: 22  GSQQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNR 76

Query: 575 FSGQ--LPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIK-- 630
                 + + +     L+ L+LS N L +         +KL  L L  N  S     +  
Sbjct: 77  LYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQST 136

Query: 631 -----LEKFIHLSDLDLSHNFLGEEIPSQV 655
                 E+F  L  LD      G E+P  +
Sbjct: 137 YISAIRERFPKLLRLD------GHELPPPI 160

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.6 bits (111), Expect = 3e-06
 Identities = 34/224 (15%), Positives = 61/224 (27%), Gaps = 8/224 (3%)

Query: 404 SENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDL 463
            E++++  IP       N I L      L       +     L  + +S N +   I   
Sbjct: 16  QESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72

Query: 464 RNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYG-----EISFDWGKFPNLG 518
                     +        +  +     NL  +        G     ++         L 
Sbjct: 73  VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132

Query: 519 TLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQ 578
            +  + N  T      +G S +  +L L+ N I           +       + N     
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192

Query: 579 LPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQ 622
                        LD+S  R+ +     L NL KL   +  N +
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 29/251 (11%), Positives = 64/251 (25%), Gaps = 22/251 (8%)

Query: 72  CAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANN 131
           C+     C  +                + +       +   L   + ++  I     +  
Sbjct: 8   CSNRVFLCQESK---------------VTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGF 52

Query: 132 SKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENG 191
             L+ +++S N     I   + +              +          +     +L  + 
Sbjct: 53  GDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISN 112

Query: 192 LSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSG----LELGYNKLSGSMPLS 247
                 P +  + +L  + L           E  +   LS     L L  N +      +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172

Query: 248 LGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGL 307
                        +N+L       F   +   IL++    +       + NLK L     
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

Query: 308 SFNKLSGSIPS 318
              K    +P+
Sbjct: 233 YNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.4 bits (100), Expect = 6e-05
 Identities = 29/213 (13%), Positives = 53/213 (24%), Gaps = 6/213 (2%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLK 183
           IPS +  N     L                    L+ + +S N     I   +       
Sbjct: 23  IPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKL 80

Query: 184 ALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLS----GSIPSEIGNLKSLSGLELGYNK 239
                E   +              + YL  ++        +       K L  ++   N 
Sbjct: 81  HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 140

Query: 240 LSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNL 299
            +      +G       L L+ N +      +F      ++    +N+L           
Sbjct: 141 HTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGA 200

Query: 300 KSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
                L +S  ++       L NL KL      
Sbjct: 201 SGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.4 bits (95), Expect = 3e-04
 Identities = 32/230 (13%), Positives = 71/230 (30%), Gaps = 11/230 (4%)

Query: 357 DNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSF 416
           ++K++  IP  L    N   L      L             L  + +S+N++   I    
Sbjct: 17  ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADV 73

Query: 417 GNLTNMIVLSIYSNALSGAI--PKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRL 474
            +    +       A +     P+ + NL  L  L++S   ++      +  +    +  
Sbjct: 74  FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133

Query: 475 DRNHLTGNISESFGIHSNLSY---INLSHKKFYGEISFDWGKFPNLGTLDVSANNITGIL 531
            ++++  +  E             + L+        +  +             NN+  + 
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELP 193

Query: 532 PPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPT 581
                 +    +LD+S   I       L  L+ L   +    +   +LPT
Sbjct: 194 NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.0 bits (94), Expect = 3e-04
 Identities = 31/227 (13%), Positives = 64/227 (28%), Gaps = 7/227 (3%)

Query: 208 IMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGS 267
           +     + ++  IPS++   ++   L     KL      +     +L  +++  N +   
Sbjct: 12  VFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68

Query: 268 IPLSFGNLTNLDILNLPHNSLSGSI--PSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTK 325
           I     +            + +     P    NL +L  L +S   +         +  +
Sbjct: 69  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128

Query: 326 LTILYLSD--NLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNL 383
             +L + D  N+        +G       L L  N +      +              N 
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188

Query: 384 LSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSN 430
           L           +    L +S   +     Y   NL  +   S Y+ 
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 5e-04
 Identities = 11/80 (13%), Positives = 26/80 (32%), Gaps = 3/80 (3%)

Query: 71  PCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIAN 130
                     +  +++ +NL+    +  L +  F        LD+   +I  +    + N
Sbjct: 164 GIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223

Query: 131 NSKLKYLDLSSNSFSGTIPP 150
             KL+     +      +P 
Sbjct: 224 LKKLRARSTYNLK---KLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.4 bits (87), Expect = 0.003
 Identities = 9/81 (11%), Positives = 17/81 (20%)

Query: 614 YYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSG 673
             L L+ N                      +N L E              L+++   +  
Sbjct: 156 VILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHS 215

Query: 674 FIPRCFKEMHGLVYIDISYNK 694
                 + +  L        K
Sbjct: 216 LPSYGLENLKKLRARSTYNLK 236

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.6 bits (85), Expect = 0.004
 Identities = 39/245 (15%), Positives = 65/245 (26%), Gaps = 19/245 (7%)

Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSL 288
           S        +K++  +P  L    N   L      L      +F    +L+ + +  N +
Sbjct: 9   SNRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 65

Query: 289 SGSI--PSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGN 346
              I         K         N L    P +  NL  L  L +S+  +         +
Sbjct: 66  LEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH 125

Query: 347 LRYLFYLELGD--NKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLS 404
                 L++ D  N  +      +G       L+L  N +                    
Sbjct: 126 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSD 185

Query: 405 ENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLR 464
            N L       F   +  ++L I    +         NL KL                  
Sbjct: 186 NNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR------------STY 233

Query: 465 NLTRL 469
           NL +L
Sbjct: 234 NLKKL 238

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.0 bits (107), Expect = 7e-06
 Identities = 41/178 (23%), Positives = 70/178 (39%), Gaps = 10/178 (5%)

Query: 281 LNLPHNSLSGSIPSEMG-NLKSLYGLGLSFNKLSGSIPSSL-GNLTKLTILYLSDNLLFG 338
           ++     L   IP ++  +   L    L+ N+L       L G L  L  L L  N L G
Sbjct: 13  VDCTGRGLK-EIPRDIPLHTTELL---LNDNELGRISSDGLFGRLPHLVKLELKRNQLTG 68

Query: 339 SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSL 398
             P       ++  L+LG+NK+          L  L TL L+ N +S  +P    +LNSL
Sbjct: 69  IEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSL 128

Query: 399 SDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQL 456
           + L L+ N  + +          +   S+   A     P +   +  + +  L +++ 
Sbjct: 129 TSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.2 bits (105), Expect = 1e-05
 Identities = 42/187 (22%), Positives = 70/187 (37%), Gaps = 10/187 (5%)

Query: 185 LHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSGLELGYNKLSGS 243
           +     GL   IP  +    +   + L +N L       + G L  L  LEL  N+L+G 
Sbjct: 13  VDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69

Query: 244 MPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLY 303
            P +     ++  L L +N +       F  L  L  LNL  N +S  +P    +L SL 
Sbjct: 70  EPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLT 129

Query: 304 GLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI-GNLRYLFYLELGDNKLSG 362
                   L+ +  +   +L          +L  G+  C     +R +   +L  ++   
Sbjct: 130 -----SLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKC 184

Query: 363 SIPHSLG 369
           S  +S G
Sbjct: 185 SSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 40.2 bits (92), Expect = 5e-04
 Identities = 41/179 (22%), Positives = 65/179 (36%), Gaps = 14/179 (7%)

Query: 72  CAWFGIHCNHAG----------KVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIF 121
           C    + C   G              + L    L     D  F   PHL  L+L+ NQ+ 
Sbjct: 8   CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 122 GIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSY 181
           GI P+     S ++ L L  N            L  LK L L  NQ S  +P    HL+ 
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 182 LKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKL 240
           L +L+L  N  + +   +      L    L   +     PS+   ++ +   +L +++ 
Sbjct: 128 LTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 6e-04
 Identities = 36/159 (22%), Positives = 63/159 (39%), Gaps = 5/159 (3%)

Query: 514 FPNLGTLDVSANNITG-ILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNR 572
             +   L ++ N +         G  P L  L+L  N + G  P+       + +L L  
Sbjct: 28  PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87

Query: 573 NQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLE 632
           N+           L QL+ L+L  N++S  +PGS  +L  L  LNL++N F+    +   
Sbjct: 88  NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-W 146

Query: 633 KFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNL 671
               L    L+        PS    ++ ++  +L H+  
Sbjct: 147 FAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 37.9 bits (86), Expect = 0.003
 Identities = 42/178 (23%), Positives = 69/178 (38%), Gaps = 7/178 (3%)

Query: 327 TILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSL-GNLTNLATLYLFTNLLS 385
           T +  +   L   IP +I    +   L L DN+L       L G L +L  L L  N L+
Sbjct: 11  TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67

Query: 386 GSIPSEIGNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVK 445
           G  P+     + + +L L EN++       F  L  +  L++Y N +S  +P  + +L  
Sbjct: 68  GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127

Query: 446 LTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKF 503
           LT L L+ N              L +  L+                ++   +L H +F
Sbjct: 128 LTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEF 182

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (103), Expect = 1e-05
 Identities = 22/133 (16%), Positives = 39/133 (29%), Gaps = 3/133 (2%)

Query: 124 IPSQIANNSKLKYLDLSSNSFSGTIPPQI-GNLSMLKILYLSTNQFSGRIPPQIGHLSYL 182
               +     L  L + +      +  +    L  L+ L +  +      P        L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 183 KALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSI-PSEIGNLKSLSGLELGYNKLS 241
             L+L  N L  S+        +L  + L  N L  S     +   +      +   KL 
Sbjct: 83  SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141

Query: 242 GSMPLSLGNLPNL 254
                 L ++PN 
Sbjct: 142 CHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (100), Expect = 3e-05
 Identities = 27/149 (18%), Positives = 47/149 (31%), Gaps = 4/149 (2%)

Query: 132 SKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQI-GHLSYLKALHLFEN 190
                L  + +         +     L  LY+   Q    +  +    L  L+ L + ++
Sbjct: 8   HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 191 GLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLS-LG 249
           GL    P +      L+ + L  N+L  S+  +     SL  L L  N L  S  L  L 
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQ 125

Query: 250 NLPNLATLDLHDNSLSGSIPLSFGNLTNL 278
                    + +  L         ++ N 
Sbjct: 126 RWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 3e-04
 Identities = 25/147 (17%), Positives = 42/147 (28%), Gaps = 2/147 (1%)

Query: 229 SLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIP-LSFGNLTNLDILNLPHNS 287
             SGL    +         L    NL  L + +      +       L  L  L +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 288 LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNL 347
           L    P        L  L LSFN L      ++  L+   ++   + L        +   
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRW 127

Query: 348 RYLFYLELGDNKLSGSIPHSLGNLTNL 374
                  + + KL       L ++ N 
Sbjct: 128 EEEGLGGVPEQKLQCHGQGPLAHMPNA 154

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (92), Expect = 3e-04
 Identities = 30/152 (19%), Positives = 47/152 (30%), Gaps = 4/152 (2%)

Query: 174 PQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEI-GNLKSLSG 232
           P          L    +G        L    NL  +Y+ N      +       L  L  
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 233 LELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSI 292
           L +  + L    P +    P L+ L+L  N+L  S+        +L  L L  N L  S 
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 293 -PSEMGNLKSLYGLGLSFNKLSGSIPSSLGNL 323
               +   +     G+   KL       L ++
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (89), Expect = 0.001
 Identities = 20/110 (18%), Positives = 37/110 (33%), Gaps = 3/110 (2%)

Query: 588 QLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEK-FIHLSDLDLSHNF 646
               L  + +         L     L  L + N Q    + ++  +    L +L +  + 
Sbjct: 9   GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 647 LGEEIPSQVCSMQSLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLH 696
           L    P        L +LNL+ N L     +  + +     + +S N LH
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSL-QELVLSGNPLH 116

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (87), Expect = 0.002
 Identities = 17/106 (16%), Positives = 36/106 (33%), Gaps = 2/106 (1%)

Query: 616 LNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCS-MQSLEKLNLAHNNLSGF 674
           L  + +    +    L    +L++L + +    + +  +    +  L  L +  + L   
Sbjct: 13  LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71

Query: 675 IPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGLC 720
            P  F     L  +++S+N L      +          L GN   C
Sbjct: 72  APDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.1 bits (84), Expect = 0.004
 Identities = 25/153 (16%), Positives = 42/153 (27%), Gaps = 4/153 (2%)

Query: 150 PQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPP-SLGNLTNLAI 208
           P          L  + +         +     L  L++        +    L  L  L  
Sbjct: 2   PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60

Query: 209 MYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSI 268
           + +  + L    P        LS L L +N L  S+        +L  L L  N L  S 
Sbjct: 61  LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSC 119

Query: 269 PLS-FGNLTNLDILNLPHNSLSGSIPSEMGNLK 300
            L          +  +P   L       + ++ 
Sbjct: 120 ALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 36/197 (18%), Positives = 66/197 (33%), Gaps = 14/197 (7%)

Query: 418 NLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRN 477
            L   +   +    ++  + +   +L ++T L      ++  I  +  L  L ++    N
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNN 72

Query: 478 HLTGNISESFGIHSNLSYINLSHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGD 537
            LT               +N +       ++                      +      
Sbjct: 73  QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGL--------TLFNNQITDIDPL 124

Query: 538 SPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSN 597
                +  L  +       S L  L SL +L  + NQ +   P  L +L  LE LD+SSN
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSN 182

Query: 598 RLSN-SIPGSLGNLVKL 613
           ++S+ S+   L NL  L
Sbjct: 183 KVSDISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.7 bits (99), Expect = 8e-05
 Identities = 30/201 (14%), Positives = 63/201 (31%), Gaps = 18/201 (8%)

Query: 202 NLTNLAIMYLYNNSLSGSIP-SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLH 260
            L       L   +++ ++  +++  + +L    LG   + G     +  L NL  ++  
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70

Query: 261 DNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSL 320
           +N L+   PL         ++N    +    + +               +       ++L
Sbjct: 71  NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130

Query: 321 GNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLF 380
             L               +I             +L  +    +    L NLT L  L + 
Sbjct: 131 NRLELS----------SNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDIS 180

Query: 381 TNLLSGSIPSEIGNLNSLSDL 401
           +N +S    S +  L +L  L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 42.3 bits (98), Expect = 9e-05
 Identities = 41/197 (20%), Positives = 75/197 (38%), Gaps = 17/197 (8%)

Query: 274 NLTNLDILNLPHNSLSGSIP-SEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLS 332
            L       L   +++ ++  +++  + +L    L    + G     +  L  LT +  S
Sbjct: 16  ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 70

Query: 333 DNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEI 392
           +N L       + NL  L  + + +N+++   P +        TL+        +    +
Sbjct: 71  NNQLTD--ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQI----TDIDPL 124

Query: 393 GNLNSLSDLGLSENELSGSIPYSFGNLTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLS 452
            NL +L+ L LS N +S     S       +     SN ++   P    NL  L  L +S
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLN--FSSNQVTDLKP--LANLTTLERLDIS 180

Query: 453 YNQLQGPIPDLRNLTRL 469
            N++   I  L  LT L
Sbjct: 181 SNKVSD-ISVLAKLTNL 196

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.5 bits (88), Expect = 0.002
 Identities = 37/216 (17%), Positives = 68/216 (31%), Gaps = 21/216 (9%)

Query: 114 DLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIP 173
           D  +NQIF          ++     L   + + T+     +L  +  L            
Sbjct: 5   DTPINQIF-----TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--I 55

Query: 174 PQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGL 233
             + +L+ L  ++   N L+   P          +M     +    + +           
Sbjct: 56  DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFN 115

Query: 234 ELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIP 293
               +        +L  L   +      ++LSG   L   N ++  + +L          
Sbjct: 116 NQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP-------- 167

Query: 294 SEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTIL 329
             + NL +L  L +S NK+S    S L  LT L  L
Sbjct: 168 --LANLTTLERLDISSNKVSD--ISVLAKLTNLESL 199

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 34/202 (16%), Positives = 68/202 (33%), Gaps = 15/202 (7%)

Query: 102 FSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKIL 161
           F+ ++        L    +   +     +  ++  L         +I   +  L+ L  +
Sbjct: 12  FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQI 67

Query: 162 YLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIP 221
             S NQ +            LK L    + L  +   +                 +  I 
Sbjct: 68  NFSNNQLTDIT--------PLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT 119

Query: 222 SEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDIL 281
                    +   L  +  + S   +L  L +L  L+   N ++   P    NLT L+ L
Sbjct: 120 DIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERL 177

Query: 282 NLPHNSLSG-SIPSEMGNLKSL 302
           ++  N +S  S+ +++ NL+SL
Sbjct: 178 DISSNKVSDISVLAKLTNLESL 199

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 40.4 bits (93), Expect = 4e-04
 Identities = 22/180 (12%), Positives = 56/180 (31%), Gaps = 10/180 (5%)

Query: 546 LSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQLP------TELGSLIQLEHLDLSSNRL 599
           ++    + +      + +S++     + +  G +P        L +L   +HL LS+N +
Sbjct: 1   MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI 60

Query: 600 SNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQ 659
              I  SL  +  L  L+    +   +    L+      +           +      + 
Sbjct: 61  E-KIS-SLSGMENLRILS--LGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVN 116

Query: 660 SLEKLNLAHNNLSGFIPRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPMEALQGNKGL 719
                   +   +         +  L  + ++ N L+     + A     +E ++    L
Sbjct: 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNL 176

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 37.4 bits (85), Expect = 0.004
 Identities = 19/77 (24%), Positives = 28/77 (36%), Gaps = 11/77 (14%)

Query: 219 SIPSEIGNLKSLSG---LELGYNKLSGSMPL------SLGNLPNLATLDLHDNSLSGSIP 269
           +I   I   +        E    +L G +P       +L  L     L L  N++   I 
Sbjct: 6   TIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS 64

Query: 270 LSFGNLTNLDILNLPHN 286
            S   + NL IL+L  N
Sbjct: 65  -SLSGMENLRILSLGRN 80

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	1077
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	100.0
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.97
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.96
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.95
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.93
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.93
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.93
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.92
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.9
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.9
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.88
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.87
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.8
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.79
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.79
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.71
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.66
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.63
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.6
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.55
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	99.12
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	99.0
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.99
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.75
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.51
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	98.43
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.38
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	98.09
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	98.08
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	98.06
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.7
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.41

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=366.91  Aligned_cols=246  Identities=26%  Similarity=0.427  Sum_probs=208.5

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||+||+|+.. +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             053887898128582999999989998999999843017---27999999999998679998805857798899989999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.+.    .+++.++..++.|++.|++|||++   ||+||||||+|||++.++.+||+|||+|+.+...
T Consensus        97 Ey~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          97 EYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             ECCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EECCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf             703798089886415----999999999999999999999987---9722677688868878996864251564132136


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCCCC
Q ss_conf             998324333444248312245898972017889999999993999987332111357642110122119---99999998
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILD---PRLPAPSC 1041 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 1041 (1077)
                      ........||+.|+|||++.+..++.++||||+||++|||+||+.||.....        ......+..   +....   
T Consensus       170 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--------~~~~~~~~~~~~~~~~~---  238 (293)
T d1yhwa1         170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGTPELQN---  238 (293)
T ss_dssp             TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCSCCCSS---
T ss_pred             CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHCCCCCCCC---
T ss_conf             6644444447773682664479988012031372999998048899899799--------99999998579998888---


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             82889999999998636889999999888986
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                       .......+.+++.+||++||++|||++|+++
T Consensus       239 -~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 -PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             -GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -5537999999999986699668909999964

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.16  Aligned_cols=248  Identities=29%  Similarity=0.463  Sum_probs=212.1

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||+||+|+.+ +++.||+|.+.+....+....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             37699889851778589999998999499999981688567689999999999998568888885999999899989998


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf             5047985898875048---999999999999999999999988---9465220234414668998711555633544888


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCH
Q ss_conf             99832433344424831224589897201788999999999399998733211135764211012211999999998828
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                        ......||+.|+|||++.+..++.++||||+||++|||++|+.||...        ........+.......+...  
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~p~~~--  227 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN--------TYQETYKRISRVEFTFPDFV--  227 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHTTCCCCCTTS--
T ss_pred             --CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC--
T ss_conf             --523557887634999975899893144046759999983299998889--------99999999971899998668--


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             89999999998636889999999888986
Q 001440         1045 DKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                        +..+.+++.+||++||++|||++|+++
T Consensus       228 --s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         228 --TEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             --CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             --999999999976479768909999971

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=366.01  Aligned_cols=252  Identities=27%  Similarity=0.465  Sum_probs=206.4

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CC---CEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEE
Q ss_conf             59774633224688229999956-99---899999746885202457999999999930789996021798986099569
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SG---EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|.+.+.||+|+||+||+|+++ ++   ..||||++.....  ....+.|.+|+.+++.++||||++++|++...+..+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf             042785698027882999999957997889999999784459--899999999999998579988861899996288779


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             99960489999899824899878898889999999999999988379999584168889756589996699124453347
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++|+|.+++....  ..+++.++..++.|+|.||+|||+.   +|+||||||+|||++.++.+||+|||+|+.+
T Consensus       104 iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEEECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf             9997227985300210456--7999999999999999988988527---9835761504489889991998884431575


Q ss_pred             CCCCCC-----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCC-
Q ss_conf             899998-----324333444248312245898972017889999999993-9999873321113576421101221199-
Q 001440          962 KPDSSN-----WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP- 1034 (1077)
Q Consensus       962 ~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~- 1034 (1077)
                      ......     .....|++.|+|||++.+..++.++|||||||++|||+| |+.||.....        ......+... 
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~--------~~~~~~i~~~~  250 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN--------QDVINAIEQDY  250 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHTTC
T ss_pred             CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCC
T ss_conf             6777765365025666883003878883699786121445357899998679999999999--------99999997378


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             999999882889999999998636889999999888986602
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      +.+.+..    .+..+.+++.+||+.||++|||++|+++.|+
T Consensus       251 ~~~~~~~----~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~  288 (299)
T d1jpaa_         251 RLPPPMD----CPSALHQLMLDCWQKDRNHRPKFGQIVNTLD  288 (299)
T ss_dssp             CCCCCTT----CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCCCC----CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             8999742----2699999999975879768929999999999

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=368.57  Aligned_cols=256  Identities=25%  Similarity=0.402  Sum_probs=209.3

Q ss_pred             HHHHCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEE
Q ss_conf             997059774633224688229999956-9989999974688520245799999999993078999602179898609956
Q 001440          802 VRATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       802 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      +...++|.+.+.||+|+||+||+|++. +++.||||++.....    ..++|.+|+.+++.++||||++++|++.+.+..
T Consensus        13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC----HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEE
T ss_conf             7457993986598208880899999999996999999777610----399999999999867999882677527457854


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99996048999989982489987889888999999999999998837999958416888975658999669912445334
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++|++.+++..... ..+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEEEECCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEE
T ss_conf             787631467606777530355-4157999999999999978889878---930576045768998999289832445465


Q ss_pred             CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCC
Q ss_conf             7899998-3243334442483122458989720178899999999939999873321113576421101221199-9999
Q 001440          961 LKPDSSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP-RLPA 1038 (1077)
Q Consensus       961 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 1038 (1077)
                      ....... .....|++.|+|||++.+..|+.++||||||+++|||++|+.|+.....       .....+.+... +.+.
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~~~i~~~~~~~~  237 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVYELLEKDYRMER  237 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHHHHHHTTCCCCC
T ss_pred             CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHHCCCCCCC
T ss_conf             378872210355665466692787279998104302178999999867998877425-------9999999855888888


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             99882889999999998636889999999888986602
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      +..    .+..+.+++.+||+.||++|||++|+++.|+
T Consensus       238 ~~~----~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~  271 (287)
T d1opja_         238 PEG----CPEKVYELMRACWQWNPSDRPSFAEIHQAFE  271 (287)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC----CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             743----3099999999975779768939999999999

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.73  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=207.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             05977463322468822999995699899999746885202457999999999930789996021798986099569999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|.+.+.||+|+||+||+|++.+++.||||++......    .++|.+|+..++.++||||++++|++..++..++||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEE
T ss_conf             6995888898208882999999889999999998788676----899999999999668997565352431599337999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....  ..+++..++.++.|+|.|++|+|+.   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        80 E~~~~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             ECCTTCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCC
T ss_conf             8369991899752013--4788999999999999987765316---4310443153266668877686553210023688


Q ss_pred             CCC-CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCC
Q ss_conf             998-32433344424831224589897201788999999999399998733211135764211012211999-9999988
Q 001440          965 SSN-WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCN 1042 (1077)
Q Consensus       965 ~~~-~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1042 (1077)
                      ... .....|++.|+|||++.+..++.++||||||+++|||+|++.|+....       ........+..+. ...+...
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~~~~p~~~  227 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDISTGFRLYKPRLA  227 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHHHHTCCCCCCTTS
T ss_pred             CCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHHCCCCCCCCCC
T ss_conf             7335043001766678578607999840332105999999987898887789-------999999999806888995436


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             2889999999998636889999999888986602
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                          ...+.+++.+||+.||++|||++|+++.|+
T Consensus       228 ----~~~l~~li~~cl~~~p~~Rps~~~il~~L~  257 (263)
T d1sm2a_         228 ----STHVYQIMNHCWKERPEDRPAFSRLLRQLA  257 (263)
T ss_dssp             ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ----799999999976579768919999999999

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=367.47  Aligned_cols=256  Identities=26%  Similarity=0.374  Sum_probs=210.6

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE--CCEEEE
Q ss_conf             59774633224688229999956-998999997468852024579999999999307899960217989860--995699
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH--ARHSFI  882 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l  882 (1077)
                      ++|++.+.||+|+||+||+|+.+ +|+.||+|.+......+ ...+.+.+|+.+++.++||||+++++++.+  .+..|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             33799679830889199999999999799999987465797-99999999999999778999824899999178998999


Q ss_pred             EEEECCCCCHHHHHHCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             996048999989982489-98788988899999999999999883799--995841688897565899966991244533
Q 001440          883 VYEYLEMGSLAMILSNAT-SAEELGWTQRMNVIKGVADALSYLHNDCF--PPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       883 V~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~--~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                      ||||+++|+|.+++.... ....+++.+++.++.|++.|++|||++..  .+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf             99568999389999851545789999999999999999999999716778878858676542574788857980010003


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf             47899998324333444248312245898972017889999999993999987332111357642110122119999999
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      .+...........||+.|+|||++.+..++.++||||+||++|||+||+.||....        ..+....+.....+..
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i~~~~~~~~  234 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKIREGKFRRI  234 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCCC
T ss_pred             ECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCC--------HHHHHHHHHCCCCCCC
T ss_conf             22457775566778823279999839999938988752789999801889989989--------9999999971899889


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9882889999999998636889999999888986
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ...   .+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~---~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         235 PYR---YSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC---CCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             743---5999999999976799557918999972

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=0  Score=363.24  Aligned_cols=253  Identities=21%  Similarity=0.325  Sum_probs=211.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             059774633224688229999956-9989999974688520245799999999993078999602179898609956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.....   ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             6575898898407681999999889998999999845243---1699999999999867997999299999989999999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEECCCCCCCC
Q ss_conf             960489999899824899878898889999999999999988379999584168889756589--996699124453347
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL--EYEAHVSDFGISKSL  961 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~--~~~~kl~Dfgla~~~  961 (1077)
                      |||+++|+|.+++....  ..+++.++..++.||+.||+|||++   +|+||||||+||+++.  ++.+||+|||+|+.+
T Consensus       102 mE~~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         102 YEFMSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             ECCCCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEEC
T ss_conf             98579988999997623--7899999999999999999999756---976000154673641688986999545210442


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf             89999832433344424831224589897201788999999999399998733211135764211012211999999998
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...        ...+.+..+.......+..
T Consensus       177 ~~~-~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~--------~~~~~~~~i~~~~~~~~~~  247 (350)
T d1koaa2         177 DPK-QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE--------NDDETLRNVKSCDWNMDDS  247 (350)
T ss_dssp             CTT-SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHTCCCSCCG
T ss_pred             CCC-CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHCCCCCCCC
T ss_conf             565-4320006862421889975899872676554659999998598998997--------9999999998478898942


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             828899999999986368899999998889866
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 1074 (1077)
                      .....+..+.+++.+||++||++|||++|+++.
T Consensus       248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             235899999999999756896679089998629

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.88  Aligned_cols=258  Identities=26%  Similarity=0.400  Sum_probs=204.6

Q ss_pred             HHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             70597746332246882299999569989999974688520245799999999993078999602179898609956999
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       804 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..++|.+.+.||+|+||+||+|+++  ..||||++...... ....+.|.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv   81 (276)
T d1uwha_           6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV   81 (276)
T ss_dssp             CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEE
T ss_conf             5451899889830788589999999--98999999734699-8999999999999984799878645679715-589999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++....  ..+++.+++.++.|+|.||+|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        82 ~Ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EECCCEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf             96589988899985235--7899999999999999998887509---995161478997981899788750022133355


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf             99--98324333444248312245---89897201788999999999399998733211135764211012211999999
Q 001440          964 DS--SNWTELAGTIGYVAPELAYT---MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPA 1038 (1077)
Q Consensus       964 ~~--~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1038 (1077)
                      ..  .......||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.........   ..........+....
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~---~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI---IFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH---HHHHHHTSCCCCGGG
T ss_pred             CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHCCCCCCCCHH
T ss_conf             67763125665574317999995056899995315163599999999788998998969999---999965888986000


Q ss_pred             CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             99882889999999998636889999999888986602
Q 001440         1039 PSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1039 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                         .....+..+.+++.+||+.||++|||++|+++.|+
T Consensus       234 ---~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le  268 (276)
T d1uwha_         234 ---VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE  268 (276)
T ss_dssp             ---SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ---36555499999999975889768929999999999

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=363.43  Aligned_cols=253  Identities=27%  Similarity=0.333  Sum_probs=210.6

Q ss_pred             HHCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEE
Q ss_conf             7059774633224688229999956-998999997468852024579999999999307899960217989860995699
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       804 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  882 (1077)
                      ..+.|.+.+.||+|+||+||+|+.+ +++.||+|.+.......  ....+.+|+.+++.++||||+++++++.+++..|+
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l   84 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYL   84 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf             7666699889940658399999999999899999981577312--89999999999986799899919899998998889


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEECCCCCC
Q ss_conf             996048999989982489987889888999999999999998837999958416888975658---99966991244533
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD---LEYEAHVSDFGISK  959 (1077)
Q Consensus       883 V~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~---~~~~~kl~Dfgla~  959 (1077)
                      ||||+++|+|.+++...   ..+++.++..++.|++.|++|||+.   +|+||||||+||++.   .++.+||+|||+|+
T Consensus        85 vmE~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~  158 (307)
T d1a06a_          85 IMQLVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK  158 (307)
T ss_dssp             EECCCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred             EEECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEE
T ss_conf             88526898488865303---6788789999999999998752413---05568704630011046888249983154358


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf             47899998324333444248312245898972017889999999993999987332111357642110122119999999
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      ..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||...        ........+.......+
T Consensus       159 ~~~~~-~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~~~~~  229 (307)
T d1a06a_         159 MEDPG-SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE--------NDAKLFEQILKAEYEFD  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS--------SHHHHHHHHHTTCCCCC
T ss_pred             ECCCC-CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHCCCCCCC
T ss_conf             72589-7044003284225918873799980787345159999998597999998--------99999999861687778


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9882889999999998636889999999888986
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      .......+..+.+++.+||++||++|||++|+++
T Consensus       230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             7666678999999999976089757918999862

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=0  Score=360.84  Aligned_cols=251  Identities=19%  Similarity=0.280  Sum_probs=209.4

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|++.+.||+|+||.||+|+.. +|+.||+|.+.....   .....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf             035998999317782999999989997999999887264---67999999999998679979891999999899999999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEECCCCCCCCC
Q ss_conf             6048999989982489987889888999999999999998837999958416888975658--99966991244533478
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLD--LEYEAHVSDFGISKSLK  962 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~--~~~~~kl~Dfgla~~~~  962 (1077)
                      ||+++|+|.+++....  ..+++.++..++.|++.|++|||+.   ||+||||||+|||++  .++.+||+|||+|+.+.
T Consensus       106 E~~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         106 EFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             ECCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             ECCCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC
T ss_conf             8289980888898638--9989999999999999999999977---9265131445531134678848995256303437


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
Q ss_conf             99998324333444248312245898972017889999999993999987332111357642110122119999999988
Q 001440          963 PDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       963 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      ... ......|++.|+|||++.+..++.++||||+||++|||+||+.||....        ....+..+.......+...
T Consensus       181 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~~~  251 (352)
T d1koba_         181 PDE-IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDWEFDEDA  251 (352)
T ss_dssp             TTS-CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCCCCCSST
T ss_pred             CCC-CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHHCCCCCCCCC
T ss_conf             887-2010047645348999747998976333898999999996889989979--------9999999984788989300


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2889999999998636889999999888986
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ....+..+.+++.+||++||++|||++|+++
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             2479999999999975699668918999960

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.81  Aligned_cols=250  Identities=21%  Similarity=0.291  Sum_probs=211.1

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|+.+ +++.||||.+...........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             87789889850879099999998999799999986577557778999999999998768888617999999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf             7048987777653159---999999999999999999762165---0884767741236688853886032102422567


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
Q ss_conf             99--8324333444248312245898972017889999999993999987332111357642110122119999999988
Q 001440          965 SS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCN 1042 (1077)
Q Consensus       965 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1042 (1077)
                      ..  ......||+.|+|||++.+..++.++||||+||++|||++|+.||...        +.......+.......+...
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~~~~p~~~  233 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG--------NEYLIFQKIIKLEYDFPEKF  233 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHTTCCCCCTTC
T ss_pred             CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC
T ss_conf             7643335556775525844002689896662304569999980388998995--------99999999971899998547


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2889999999998636889999999888986
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                          ...+.+++.+||+.||++|||++|+.+
T Consensus       234 ----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         234 ----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ----CHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf             ----999999999985579768919789737

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.76  Aligned_cols=253  Identities=21%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             HHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             70597746332246882299999569989999974688520245799999999993078999602179898609956999
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       804 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ..++|.+.+.||+|+||+||+|.+++++.||||++......    .+.|.+|+.+++.++||||++++|++.+ +..++|
T Consensus        11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_          11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             CHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEE
T ss_conf             88993886798107982899999999999999998647688----8999999999986799988578731045-976999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++.... ...+++.+++.++.||+.|++|||+.   +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        86 ~Ey~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEECCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCC
T ss_conf             99578982888875147-89887889999999999999999748---954675642251562024404234101477358


Q ss_pred             CCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCC
Q ss_conf             999-832433344424831224589897201788999999999399998733211135764211012211999-999998
Q 001440          964 DSS-NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041 (1077)
Q Consensus       964 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1041 (1077)
                      ... ......|++.|+|||++.++.++.++||||||+++|||+||+.|+....       ........+..+. .+.+..
T Consensus       162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~-------~~~~~~~~i~~~~~~~~p~~  234 (272)
T d1qpca_         162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-------TNPEVIQNLERGYRMVRPDN  234 (272)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCTT
T ss_pred             CCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHHCCCCCCCCC
T ss_conf             86442035677444458289837999824564525799999996898888888-------99999999970688889655


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             82889999999998636889999999888986602
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                          .+..+.+++.+||+.||++||||+++++.|+
T Consensus       235 ----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         235 ----CPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ----7199999999975889768939999999861

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=364.19  Aligned_cols=256  Identities=24%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             HHCCCCCCCEECCCCCCEEEEEEECC-C-----CEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEE
Q ss_conf             70597746332246882299999569-9-----89999974688520245799999999993078-99960217989860
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELSS-G-----EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ..++|.+.+.||+|+||+||+|++.. +     ..||+|.+....  .......+.+|+..+..+ +||||+++++++.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~  112 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  112 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf             789939701983078819999998578855420499999966335--878999999999999971589968687788862


Q ss_pred             CCEEEEEEEECCCCCHHHHHHCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf             9956999960489999899824899--------------------87889888999999999999998837999958416
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS--------------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRD  936 (1077)
Q Consensus       877 ~~~~~lV~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D  936 (1077)
                      .+..++||||+++|+|.++++....                    ...+++.+++.++.|++.|++|||++   +|+|||
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD  189 (325)
T d1rjba_         113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD  189 (325)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECC
T ss_conf             99589999727999599999862577751022100001222001257789999999999999999999739---905052


Q ss_pred             CCCCCEEECCCCCEEEECCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCC
Q ss_conf             8889756589996699124453347899998--324333444248312245898972017889999999993-9999873
Q 001440          937 ISSKNVLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDF 1013 (1077)
Q Consensus       937 lk~~Nill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~ 1013 (1077)
                      |||+||+++.++.+||+|||+|+........  .....||+.|+|||++.+..++.++|||||||++|||+| |+.||..
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCC
T ss_conf             70321443459828985142222045778615623435787657838872799996330300039999998389999999


Q ss_pred             CCCCCCCCCCCCCCHHHHCCC--CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             321113576421101221199--999999882889999999998636889999999888986602
Q 001440         1014 ISSICSTSSNLDRTLDEILDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1014 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ...        ...+..++..  +++.+...    +..+.+++.+||+.||++|||++|+++.|.
T Consensus       270 ~~~--------~~~~~~~~~~~~~~~~p~~~----~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         270 IPV--------DANFYKLIQNGFKMDQPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCC--------SHHHHHHHHTTCCCCCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCH--------HHHHHHHHHCCCCCCCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             898--------99999998569989988767----899999999975889668939999999974

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=357.60  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=213.9

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             059774633224688229999956-9989999974688520245799999999993078999602179898609956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|.+.+.||+|+||.||+|+.+ +|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             47428988983176849999999899989999998156544979999999999999867999887787640356421110


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++....   .+++..+..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             00357986055553256---775999999999996521134315---962246477784765899888820565200356


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf             99983243334442483122458989720178899999999939999873321113576421101221199999999882
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........||+.|+|||++.+..|+.++||||+||++|||++|+.||...        +.......+.......+... 
T Consensus       158 ~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~--------~~~~~~~~i~~~~~~~p~~~-  228 (337)
T d1o6la_         158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ--------DHERLFELILMEEIRFPRTL-  228 (337)
T ss_dssp             TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCTTS-
T ss_pred             CCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC-
T ss_conf             786205510088996666504898883331022306788998789999996--------99999999852899898668-


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             889999999998636889999999-----888986
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPt-----~~ei~~ 1073 (1077)
                         +..+.+++.+||++||++||+     ++|+++
T Consensus       229 ---s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         229 ---SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf             ---99999999866638934422565234999972

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.32  Aligned_cols=251  Identities=24%  Similarity=0.356  Sum_probs=205.4

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|++.+.||+|+||+||+|++. +++.||+|++.....   ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS---GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf             375984799307781999999999993999999872899---99999999999998679999884988980099589999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|+|.+++.+..  ..+++.++..++.|++.|+.|||++   +|+||||||+||+++.++.+||+|||+|+.....
T Consensus        89 Ey~~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          89 EFCAGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             ECCTTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             ECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC
T ss_conf             6279981889998628--9999999999999999999999988---9887140700314878999899716123035778


Q ss_pred             CCCCCCCCCCCCCCCCCCCC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf             99832433344424831224-----5898972017889999999993999987332111357642110122119999999
Q 001440          965 SSNWTELAGTIGYVAPELAY-----TMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      ........|++.|+|||++.     ...|+.++||||+||++|||+||+.||.....        .+.+..+.....+..
T Consensus       164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~~~~~  235 (288)
T d2jfla1         164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSEPPTL  235 (288)
T ss_dssp             HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSCCCCC
T ss_pred             CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHCCCCCCC
T ss_conf             641001025626479999832025788888066578789999998208899999899--------999999970799877


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9882889999999998636889999999888986
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                       ......+..+.+++.+||+.||++|||++|+++
T Consensus       236 -~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 -AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -765669999999999976699668919999962

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=360.03  Aligned_cols=248  Identities=26%  Similarity=0.376  Sum_probs=204.2

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      +.|+..+.||+|+||+||+|+.. +++.||||++...........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf             85676279701888099999998999399999984444358899999999999999778999823899999899889999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|++..++....   .+++.++..++.|++.|+.|||++   +|+||||||+|||++.++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC
T ss_conf             8069994578997379---999999999999999999999868---9766678842179879997898443653346778


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf             998324333444248312245---89897201788999999999399998733211135764211012211999999998
Q 001440          965 SSNWTELAGTIGYVAPELAYT---MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                          ....||+.|+|||++.+   +.|+.++||||+||++|||++|+.||.....        ...+..+.....+....
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~~~  236 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNESPALQS  236 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHSCCCCCSC
T ss_pred             ----CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHCCCCCCCC
T ss_conf             ----731347663688998346788867214545589999999878899999799--------99999998289998887


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             82889999999998636889999999888986
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                        ...+..+.+++.+||+.||++|||++|+++
T Consensus       237 --~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         237 --GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             --TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             --888999999999977379657918999971

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=363.42  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=205.1

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             059774633224688229999956-9989999974688520245799999999993078999602179898609956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||+||+|+.. +|+.||+|+++...  .......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf             568889789712778099999998999699999987540--978999999999999867999999499999989999999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++.+..   .+++..+..++.|++.|+.|||+++  +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus        83 mEy~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             EECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf             97679986899874249---9999999999999999999999859--997144577994687899899954877625678


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC-------CCCC-------------
Q ss_conf             99983243334442483122458989720178899999999939999873321113-------5764-------------
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS-------TSSN------------- 1023 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~-------~~~~------------- 1023 (1077)
                      .  .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........       ....             
T Consensus       158 ~--~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         158 S--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             H--TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             C--CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf             8--62111377141194687589989488899899999999988899899887899999988751775457742123332


Q ss_pred             --------------CCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --------------21101221199999999882889999999998636889999999888986
Q 001440         1024 --------------LDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1024 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                                    .............+.  ......+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHHCCCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf             21111222354134778876650268766--764448999999999986899467908999960

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=361.67  Aligned_cols=252  Identities=25%  Similarity=0.359  Sum_probs=205.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             059774633224688229999956-9989999974688520245799999999993078999602179898609956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||+||+|+++ +|+.||+|.+......  ...+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
T ss_conf             74608998972174809999999999979999998456641--2799999999999857998884696540467436798


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++...   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+|+.+..
T Consensus        82 mEy~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          82 LEYCSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             EECCTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EECCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECC
T ss_conf             8645898089997537---9999999999999999999999975---983575468997887899879832314224046


Q ss_pred             CC--CCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf             99--98324333444248312245898-9720178899999999939999873321113576421101221199999999
Q 001440          964 DS--SNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPS 1040 (1077)
Q Consensus       964 ~~--~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1040 (1077)
                      ..  .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||......       ..............+ 
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~-------~~~~~~~~~~~~~~~-  227 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-------CQEYSDWKEKKTYLN-  227 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT-------SHHHHHHHTTCTTST-
T ss_pred             CCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHHCCCCCCC-
T ss_conf             886531113255747428728618999997101617379999998299788889859-------999999863888788-


Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             882889999999998636889999999888986
Q 001440         1041 CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1041 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                       ........+.+++.+||+.||++|||++|+++
T Consensus       228 -~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 -PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             -64469999999999976799668909999961

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=358.13  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=203.5

Q ss_pred             CCCCCCC-EECCCCCCEEEEEEEC---CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEE
Q ss_conf             5977463-3224688229999956---99899999746885202457999999999930789996021798986099569
Q 001440          806 NDFDEEH-CIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|.+.+ .||+|+||+||+|.++   ++..||||.+....  .....++|.+|+.+++.++||||++++|++.. +..+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEE
T ss_conf             47188784873060809999999608976899999988203--97899999999999986799888068656036-8079


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             99960489999899824899878898889999999999999988379999584168889756589996699124453347
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  961 (1077)
                      +||||+++|+|.+++....  ..+++.++..++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+|+.+
T Consensus        85 lvmE~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf             9998078996899752125--6999999999999999987899868---8105767646604546885420331342115


Q ss_pred             CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-
Q ss_conf             899998---324333444248312245898972017889999999993-999987332111357642110122119999-
Q 001440          962 KPDSSN---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRL- 1036 (1077)
Q Consensus       962 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 1036 (1077)
                      ......   .....|++.|+|||++....++.++||||||+++|||+| |+.||.....        .+....+..+.. 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~i~~~~~~  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFIEQGKRM  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHHHTTCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCC
T ss_conf             54343211356211374335868872799995412322017899999389999999799--------9999999818999


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             9999882889999999998636889999999888986602
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      +.+..    .+..+.+++.+||+.||++|||+.++++.|+
T Consensus       232 ~~p~~----~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         232 ECPPE----CPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             CCCTT----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             99976----7899999999975779768909999999999

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.33  Aligned_cols=250  Identities=28%  Similarity=0.439  Sum_probs=210.4

Q ss_pred             CCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             59774633224688229999956998999997468852024579999999999307899960217989860995699996
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  885 (1077)
                      ++|++.+.||+|+||+||+|++++++.||||+++.....    .++|.+|+.+++.++||||++++|++.+++..++|||
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E   79 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   79 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf             997996898207883999999889989999998747577----8999999999996689860158899850781699997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             04899998998248998788988899999999999999883799995841688897565899966991244533478999
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|++.+++....  ..+++..+.+++.|+++|++|||+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus        80 y~~~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          80 YMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             CCTTEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCC
T ss_conf             048993888641024--6776899999999999999987546---84346654135887699847988614420235787


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCC
Q ss_conf             9-8324333444248312245898972017889999999993-99998733211135764211012211999-9999988
Q 001440          966 S-NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCN 1042 (1077)
Q Consensus       966 ~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1042 (1077)
                      . ......+++.|+|||.+....++.++||||||+++|||+| |+.||....        ..+....+..+. .+.+. .
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~~~~~~~~p~-~  225 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIAQGLRLYRPH-L  225 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHHTTCCCCCCT-T
T ss_pred             CEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC--------HHHHHHHHHHCCCCCCCC-C
T ss_conf             2252465788775780786379988521033643246739755999988999--------999999998079789965-4


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             2889999999998636889999999888986602
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                         .+..+.+++.+||+.||++|||++++++.|.
T Consensus       226 ---~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         226 ---ASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             ---CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ---6599999999976689768939999998741

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=355.03  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=206.5

Q ss_pred             CCCCCCCEECCCCCCEEEEEEECCC-----CEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEE
Q ss_conf             5977463322468822999995699-----89999974688520245799999999993078999602179898609956
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSG-----EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .+|...+.||+|+||+||+|.++..     ..||||++.....  .....+|.+|+.+++.++||||++++|++.+....
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf             9968615981177909999999689987879999999884459--68999999999999856898783236778338803


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99996048999989982489987889888999999999999998837999958416888975658999669912445334
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  960 (1077)
                      ++|+||+.+|++.+++....  ..+++.+++.++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf             89997213574022210234--5420899999999999854121212---342576564427888998499845510300


Q ss_pred             CCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf             7899998---3243334442483122458989720178899999999939999873321113576421101221199999
Q 001440          961 LKPDSSN---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       961 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      +......   .....|++.|+|||++.++.++.++||||||+++|||++++.|+....       ...+....+.++..+
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~~~~~  232 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-------SNHEVMKAINDGFRL  232 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-------CHHHHHHHHHTTCCC
T ss_pred             CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHCCCCC
T ss_conf             3578765267426777734348888704999973556344898999996798865568-------999999998635789


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             999882889999999998636889999999888986602
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ....   ..+..+.+++.+||+.||++||||.|+++.|+
T Consensus       233 ~~~~---~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~  268 (283)
T d1mqba_         233 PTPM---DCPSAIYQLMMQCWQQERARRPKFADIVSILD  268 (283)
T ss_dssp             CCCT---TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCH---HHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             9850---45799999999977679768939999999999

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=356.05  Aligned_cols=254  Identities=20%  Similarity=0.276  Sum_probs=209.9

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEE
Q ss_conf             059774633224688229999956-99899999746885202---45799999999993078999602179898609956
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSE---MTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .++|++.+.||+|+||+||+|+.+ +|+.||||.+.+.....   ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf             56779827981178959999999999989999998756632134068999999999999867998999388999979989


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEECCC
Q ss_conf             99996048999989982489987889888999999999999998837999958416888975658999----66991244
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY----EAHVSDFG  956 (1077)
Q Consensus       881 ~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~----~~kl~Dfg  956 (1077)
                      ++||||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.++    .+|++|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf             99998677864310010356---421557899999999998766625---422113330127982589866646964334


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf             53347899998324333444248312245898972017889999999993999987332111357642110122119999
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1077)
                      +|...... .......|++.|+|||++.+..++.++||||+||++|||++|+.||...        ...+....+.....
T Consensus       163 ~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------~~~~~~~~i~~~~~  233 (293)
T d1jksa_         163 LAHKIDFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD--------TKQETLANVSAVNY  233 (293)
T ss_dssp             TCEECTTS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHTTCC
T ss_pred             HHHHCCCC-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC--------CHHHHHHHHHHCCC
T ss_conf             42105777-6312247777430999981899997665221409999997088998899--------99999999981688


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9999882889999999998636889999999888986
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ..+.......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             8870104788999999999986389668919999961

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=354.01  Aligned_cols=245  Identities=26%  Similarity=0.410  Sum_probs=200.4

Q ss_pred             CEECCCCCCEEEEEEEC---CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEECC
Q ss_conf             33224688229999956---998999997468852024579999999999307899960217989860995699996048
Q 001440          812 HCIGTGGQGSVYRAELS---SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEYLE  888 (1077)
Q Consensus       812 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  888 (1077)
                      +.||+|+||+||+|.++   .++.||||++.... .+....+++.+|+.++++++||||++++|++..+ ..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCC-CEEEEEECCC
T ss_conf             7834587829999998169738599999988010-8989999999999999867998985277775059-7799997478


Q ss_pred             CCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCCC-
Q ss_conf             9999899824899878898889999999999999988379999584168889756589996699124453347899998-
Q 001440          889 MGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSSN-  967 (1077)
Q Consensus       889 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~~-  967 (1077)
                      +|+|.+++....   .+++.+++.++.||+.|++|||+.   +|+||||||+||+++.++.+|++|||+|+.+...... 
T Consensus        91 ~g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          91 LGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             TEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf             896899975225---789999999999999997668747---95567776113102356751234134533134323443


Q ss_pred             --CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCCC
Q ss_conf             --324333444248312245898972017889999999993-99998733211135764211012211999-99999882
Q 001440          968 --WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCNI 1043 (1077)
Q Consensus       968 --~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 1043 (1077)
                        .....||+.|+|||++.+..++.++||||||+++|||+| |+.||.....        .+....+..+. .+.+... 
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--------~~~~~~i~~~~~~~~p~~~-  235 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTAMLEKGERMGCPAGC-  235 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHHHTTCCCCCCTTC-
T ss_pred             CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCCCCCCCC-
T ss_conf             2244567784203916653799984344303403132896589999999899--------9999999828999998656-


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             889999999998636889999999888986602
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                         +..+.+++.+||+.||++|||++++++.|+
T Consensus       236 ---~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         236 ---PREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             ---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ---799999999975889768909899999852

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=0  Score=350.00  Aligned_cols=252  Identities=20%  Similarity=0.259  Sum_probs=201.0

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHH---HHHHHHHCCCCCCCEEEEEEEEEECCEE
Q ss_conf             059774633224688229999956-998999997468852024579999---9999993078999602179898609956
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEF---LNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .++|.+.+.||+|+||.||+|+.. +|+.||+|.+.+...........+   ..++.+++.++||||+++++++.+.+..
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf             77685101884288909999999999979999998458754266799999999999998508998588999999989988


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99996048999989982489987889888999999999999998837999958416888975658999669912445334
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  960 (1077)
                      |+||||+++|+|.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+|||++.++.+||+|||+|+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf             99999148983899987325---532789999999999999999977---962204442216785889679822010233


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf             7899998324333444248312245-898972017889999999993999987332111357642110122119999999
Q 001440          961 LKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       961 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      +....  .....||+.|+|||++.. ..|+.++||||+||++|||+||+.||.....     .................+
T Consensus       157 ~~~~~--~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~~~~~  229 (364)
T d1omwa3         157 FSKKK--PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-----KDKHEIDRMTLTMAVELP  229 (364)
T ss_dssp             CSSSC--CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-----SCHHHHHHHSSSCCCCCC
T ss_pred             CCCCC--CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHCCCCCCCCC
T ss_conf             37886--43311345542168760389998441046778999999859998888998-----999999986046888788


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             9882889999999998636889999999-----888986
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ei~~ 1073 (1077)
                      ..    .+..+.+++.+||++||++|||     ++|+++
T Consensus       230 ~~----~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         230 DS----FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SS----SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CC----CCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf             77----899999999998566988808874357999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=351.39  Aligned_cols=248  Identities=26%  Similarity=0.385  Sum_probs=209.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             059774633224688229999956-9989999974688520245799999999993078999602179898609956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|++.+.||+|+||+||+|+.+ +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             HHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEE
T ss_conf             54708888972076808999999899979999998457754889999999999999863696753303568528800567


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|++..++.....   +++..+..++.|++.|++|||++   +|+||||||+|||++.++.+||+|||+|+....
T Consensus        83 mE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EEECCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf             650378632234322221---11007999999998765541247---677055681050386899889831752167124


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf             99983243334442483122458989720178899999999939999873321113576421101221199999999882
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .   .....||+.|+|||++.+..|+.++||||+||++|||+||+.||...        ........+.......+... 
T Consensus       157 ~---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~~~~p~~~-  224 (316)
T d1fota_         157 V---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS--------NTMKTYEKILNAELRFPPFF-  224 (316)
T ss_dssp             C---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHCCCCCCTTS-
T ss_pred             C---CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC-
T ss_conf             5---64345763435999983899980430465333689997598999996--------99999999970898899778-


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             88999999999863688999999-----9888986
Q 001440         1044 RDKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~ 1073 (1077)
                         ...+.+++.+||.+||++|+     |++++++
T Consensus       225 ---s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         225 ---NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf             ---99999999999544997666431021999981

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=0  Score=351.39  Aligned_cols=247  Identities=22%  Similarity=0.300  Sum_probs=210.0

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||.||+|+++ +|+.||||.+.+.........+.+.+|+.+++.++||||+++++++.+....++|+
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf             37089889611768089999998999899999982677458899999999999999748772740344443222223222


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+.+|++.+++....   .+++.++..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf             2334662266675158---989999999999999989999859---9861767999936077897886101033322566


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCH
Q ss_conf             99832433344424831224589897201788999999999399998733211135764211012211999999998828
Q 001440          965 SSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIR 1044 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1044 (1077)
                         .....|++.|+|||++.+..++.++||||+||++|||+||+.||...        ........+.......+...  
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~--------~~~~~~~~i~~~~~~~p~~~--  261 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--------QPIQIYEKIVSGKVRFPSHF--  261 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCTTC--
T ss_pred             ---CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC--
T ss_conf             ---64336763567889971799885331145007899997588998995--------99999999861798897668--


Q ss_pred             HHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf             8999999999863688999999-----9888986
Q 001440         1045 DKLISIMEVAISCLDENPDSRP-----TMQKVSQ 1073 (1077)
Q Consensus      1045 ~~~~~l~~li~~cl~~dP~~RP-----t~~ei~~ 1073 (1077)
                        ...+.+++.+||++||++|+     |++++++
T Consensus       262 --s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         262 --SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --CHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf             --99999999998340998606553454999971

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=350.77  Aligned_cols=247  Identities=22%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             CCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE----CCEEEE
Q ss_conf             774633224688229999956-998999997468852024579999999999307899960217989860----995699
Q 001440          808 FDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH----ARHSFI  882 (1077)
Q Consensus       808 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~l  882 (1077)
                      |...+.||+|+||+||+|.+. +++.||+|++...... ....+.+.+|+++++.++||||+++++++.+    ....++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf             88516970082849999999999959999998512279-89999999999999857999850699998403345888999


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCEEEECCCCCC
Q ss_conf             9960489999899824899878898889999999999999988379999--58416888975658-99966991244533
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPP--IVYRDISSKNVLLD-LEYEAHVSDFGISK  959 (1077)
Q Consensus       883 V~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~--ivH~Dlk~~Nill~-~~~~~kl~Dfgla~  959 (1077)
                      ||||+++|+|.+++....   .+++.++..++.|++.|++|||++   +  |+||||||+||+++ .++.+||+|||+|+
T Consensus        90 vmE~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCE
T ss_conf             995789894899975135---546999999999999999999978---99799687674351166799988980057654


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf             47899998324333444248312245898972017889999999993999987332111357642110122119999999
Q 001440          960 SLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAP 1039 (1077)
Q Consensus       960 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1039 (1077)
                      ....  .......||+.|+|||++.+ .++.++||||+||++|||++|+.||.....       .......+.....+..
T Consensus       164 ~~~~--~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~i~~~~~~~~  233 (270)
T d1t4ha_         164 LKRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVTSGVKPAS  233 (270)
T ss_dssp             GCCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHTTTCCCGG
T ss_pred             ECCC--CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHCCCCCCC
T ss_conf             2368--76677553813008988478-999867110079999999878899987655-------9999999973899865


Q ss_pred             CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             9882889999999998636889999999888986
Q 001440         1040 SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1040 ~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                        ........+.+++.+||++||++|||++|+++
T Consensus       234 --~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         234 --FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             --67557899999999976379758929999967

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=352.84  Aligned_cols=252  Identities=26%  Similarity=0.410  Sum_probs=206.9

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             05977463322468822999995699899999746885202457999999999930789996021798986099569999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      .++|++.+.||+|+||.||+|++++++.||||++......    .+.|.+|+.+++.++||||++++|++.+ +..++||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEE
T ss_conf             7997984699307980999999999999999998804488----8999999999986666788689999823-9759999


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+++|++.+++..... ..++|.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+||+|||+|+.+...
T Consensus        91 Ey~~~g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCC
T ss_conf             94479943542000035-5305999999999999999987541---1433531230799989992998442555425688


Q ss_pred             C-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCCC
Q ss_conf             9-9832433344424831224589897201788999999999399998733211135764211012211999-9999988
Q 001440          965 S-SNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSCN 1042 (1077)
Q Consensus       965 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 1042 (1077)
                      . .......|++.|+|||++..+.++.++||||||+++|||+||+.|+....       ...+....+.... .+.+.. 
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-------~~~~~~~~i~~~~~~~~~~~-  238 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-------VNREVLDQVERGYRMPCPPE-  238 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-------CHHHHHHHHHTTCCCCCCTT-
T ss_pred             CCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHHCCCCCCCCC-
T ss_conf             7335245455665458089837998917741323589999986899999888-------89999999982689999832-


Q ss_pred             CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             2889999999998636889999999888986602
Q 001440         1043 IRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1043 ~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                         .+..+.+++.+||+.||++||++++|+++|+
T Consensus       239 ---~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~  269 (285)
T d1fmka3         239 ---CPESLHDLMCQCWRKEPEERPTFEYLQAFLE  269 (285)
T ss_dssp             ---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ---3799999999975669758919999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=352.85  Aligned_cols=261  Identities=23%  Similarity=0.398  Sum_probs=212.5

Q ss_pred             HHHHHHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEE
Q ss_conf             99997059774633224688229999956------998999997468852024579999999999307899960217989
Q 001440          800 EIVRATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGF  873 (1077)
Q Consensus       800 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~  873 (1077)
                      +++...++|++.+.||+|+||+||+|+++      +++.||||++.....  ....++|.+|+.+++.++|||+++++++
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             HCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCC--HHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf             11389889388679820788399999988876577882999999882108--5799999999999996689976552466


Q ss_pred             EEECCEEEEEEEECCCCCHHHHHHCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCE
Q ss_conf             8609956999960489999899824899---------------------8788988899999999999999883799995
Q 001440          874 CSHARHSFIVYEYLEMGSLAMILSNATS---------------------AEELGWTQRMNVIKGVADALSYLHNDCFPPI  932 (1077)
Q Consensus       874 ~~~~~~~~lV~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  932 (1077)
                      +......++|+||+++|+|.+++.....                     ...+++.+++.++.|++.|++|||+.   ++
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred             ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CE
T ss_conf             605980389998158992999998527554210000111001210346788989999999999999985541357---86


Q ss_pred             EECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-C
Q ss_conf             8416888975658999669912445334789999--832433344424831224589897201788999999999399-9
Q 001440          933 VYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK-H 1009 (1077)
Q Consensus       933 vH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~-~ 1009 (1077)
                      +||||||+||+++.++.+||+|||+|+.+.....  ......+++.|+|||++.+..++.++||||||+++|||++|. .
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf             85488401168989992898331442113677641115777767676798997268898056302523629999806899


Q ss_pred             CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             9873321113576421101221199999999882889999999998636889999999888986602
Q 001440         1010 PRDFISSICSTSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1010 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ||....        ..+....+.++..+....   ..+..+.+++.+||+.+|++||||.||+++|+
T Consensus       242 p~~~~~--------~~e~~~~v~~~~~~~~p~---~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~  297 (301)
T d1lufa_         242 PYYGMA--------HEEVIYYVRDGNILACPE---NCPLELYNLMRLCWSKLPADRPSFCSIHRILQ  297 (301)
T ss_dssp             TTTTSC--------HHHHHHHHHTTCCCCCCT---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC--------HHHHHHHHHCCCCCCCCC---CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             999989--------999999997399788873---25299999999974889657939999999999

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=351.42  Aligned_cols=250  Identities=23%  Similarity=0.353  Sum_probs=207.2

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHC-CCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930-78999602179898609956999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLT-EIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      ++|.+.+.||+|+||+||+|+.+ +++.||||.+.+.........+.+..|...+. .++||||+++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf             97188658940878289999999999899999980555338489999999999999847999687898897049831677


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++....   .+++.++..++.||+.|++|||++   +|+||||||+|||++.++.+|++|||+|+....
T Consensus        82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf             75037980899864047---899999999999999999999868---934034765404444899630155530232356


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf             99983243334442483122458989720178899999999939999873321113576421101221199999999882
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSCNI 1043 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1043 (1077)
                      .........|++.|+|||++.+..++.++||||+||++|||+||+.||...        ........+.......+... 
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~--------~~~~~~~~i~~~~~~~p~~~-  226 (320)
T d1xjda_         156 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ--------DEEELFHSIRMDNPFYPRWL-  226 (320)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHHCCCCCCTTS-
T ss_pred             CCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHCCCCCCCCCC-
T ss_conf             653345457877768999982799883232011227898987388999998--------99999999971899897567-


Q ss_pred             HHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf             88999999999863688999999988-8986
Q 001440         1044 RDKLISIMEVAISCLDENPDSRPTMQ-KVSQ 1073 (1077)
Q Consensus      1044 ~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~ 1073 (1077)
                         +..+.+++.+||++||++||+++ ++++
T Consensus       227 ---s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         227 ---EKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             ---CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf             ---9999999999654489878388999980

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=348.61  Aligned_cols=251  Identities=21%  Similarity=0.270  Sum_probs=208.9

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf             059774633224688229999956-9989999974688520245799999999993078999602179898609956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  883 (1077)
                      .++|.+.+.||+|+||+||+|.++ +++.||+|.+.....    ....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEE
T ss_conf             0105887898317783999999989996999999757866----599999999999857997989098999889988999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCEEEECCCCCCCC
Q ss_conf             9604899998998248998788988899999999999999883799995841688897565899--96699124453347
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE--YEAHVSDFGISKSL  961 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~--~~~kl~Dfgla~~~  961 (1077)
                      |||+++|+|.+++....  ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.+  ..+|++|||+++..
T Consensus        80 mE~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          80 FEFISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             ECCCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             EECCCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCC
T ss_conf             95389980889987538--9999999999999999999999876---997513554443443788518997644111003


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf             89999832433344424831224589897201788999999999399998733211135764211012211999999998
Q 001440          962 KPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       962 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ... .......+++.|+|||...+..++.++||||+||++|||++|+.||...        .....+..+.......+..
T Consensus       155 ~~~-~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~--------~~~~~~~~i~~~~~~~~~~  225 (321)
T d1tkia_         155 KPG-DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE--------TNQQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTT-CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS--------SHHHHHHHHHHTCCCCCHH
T ss_pred             CCC-CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHHCCCCCCHH
T ss_conf             467-7532122332223402104877784011302799999998289999998--------9999999998389998802


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             82889999999998636889999999888986
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      .....+..+.+++.+||.+||++|||++|+++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             23678999999999986699668909999963

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=0  Score=348.37  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=209.4

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----E
Q ss_conf             05977463322468822999995-699899999746885202457999999999930789996021798986099----5
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR----H  879 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  879 (1077)
                      .++|.+.+.||+|+||+||+|+. .+|+.||+|.+......+....+.+.+|+.+++.++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf             62069868996089929999999999989999998556646989999999999999856999887311435432688766


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             69999604899998998248998788988899999999999999883799995841688897565899966991244533
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                      .|+||||+++|+|.+++....   .+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++..+++|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf             999997788987101120358---999999999999999999999857---95276346755665754320100344432


Q ss_pred             CCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf             4789999---8324333444248312245898972017889999999993999987332111357642110122119999
Q 001440          960 SLKPDSS---NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036 (1077)
Q Consensus       960 ~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1077)
                      .......   ......|++.|+|||++.+..++.++||||+||++|||+||+.||.....        .+....+.....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~~~~~~~  231 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDP  231 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCC
T ss_pred             HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHCCC
T ss_conf             212354433334642576243699998399999663202652899999769799899699--------999999984699


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHC
Q ss_conf             999988288999999999863688999999-9888986602
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRP-TMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-t~~ei~~~L~ 1076 (1077)
                      ..+.......+..+.+++.+||++||++|| |++++.+.|.
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHH
T ss_conf             99710034789999999999866797677739999999999

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.12  Aligned_cols=251  Identities=24%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCC----EEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEE
Q ss_conf             59774633224688229999956-998----9999974688520245799999999993078999602179898609956
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE----IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .+|++.+.||+|+||+||+|.+. +|+    +||+|++....  .....+++.+|+.+++.++||||++++|++.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CE
T ss_conf             999783198208992999999958998898999999965134--979999999999999867998881589999619-83


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99996048999989982489987889888999999999999998837999958416888975658999669912445334
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  960 (1077)
                      ++++|++.+|+|.+++....  ..+++..++.++.|+|.||+|||++   +|+||||||+||+++.++.+||+|||+|+.
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEEEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEE
T ss_conf             69998426874010111334--5799999999999999999999876---950476212031167998758602552223


Q ss_pred             CCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCC-CC
Q ss_conf             7899998--324333444248312245898972017889999999993-9999873321113576421101221199-99
Q 001440          961 LKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDP-RL 1036 (1077)
Q Consensus       961 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~ 1036 (1077)
                      .......  .....|++.|+|||++.++.++.++||||||+++|||+| |+.||.....        .+....+..+ +.
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~--------~~~~~~i~~~~~~  232 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--------SEISSILEKGERL  232 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG--------GGHHHHHHHTCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCC
T ss_conf             35444532236510586446708874699983565440799999999779999999998--------9999999759989


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             9999882889999999998636889999999888986602
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      +.+...    +..+.+++.+||+.||++|||+.|+++.|+
T Consensus       233 ~~p~~~----~~~~~~li~~cl~~dP~~RPs~~eil~~l~  268 (317)
T d1xkka_         233 PQPPIC----TIDVYMIMVKCWMIDADSRPKFRELIIEFS  268 (317)
T ss_dssp             CCCTTB----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             998556----899999999847899346919999999999

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=345.34  Aligned_cols=252  Identities=21%  Similarity=0.256  Sum_probs=199.8

Q ss_pred             HCCCCCCC-EECCCCCCEEEEEEE-CCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCC-CCCCCEEEEEEEEEE----C
Q ss_conf             05977463-322468822999995-6998999997468852024579999999999307-899960217989860----9
Q 001440          805 TNDFDEEH-CIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE-IRHRNIVKFYGFCSH----A  877 (1077)
Q Consensus       805 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~  877 (1077)
                      .++|.+.. .||+|+||+||+|+. .+++.||||++..        ...+.+|+.++.+ .+||||+++++++.+    .
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC--------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCC
T ss_conf             14879810796545486999999889998999999897--------4779999999998669999782989995034689


Q ss_pred             CEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEC
Q ss_conf             956999960489999899824899878898889999999999999988379999584168889756589---99669912
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL---EYEAHVSD  954 (1077)
Q Consensus       878 ~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~D  954 (1077)
                      ...|+||||+++|+|.+++..... ..+++.++..++.|++.|++|||+.   +|+||||||+||+++.   ++.+|++|
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             CEEEEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             789999977899849999986278-7757999999999999999999976---986444100220113555566311354


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCC
Q ss_conf             44533478999983243334442483122458989720178899999999939999873321113576421101221199
Q 001440          955 FGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDP 1034 (1077)
Q Consensus       955 fgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 1034 (1077)
                      ||+|+...... ......|++.|+|||++.+..|+.++||||+||++|||+||+.||.......    ........+...
T Consensus       158 FG~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~----~~~~~~~~i~~~  232 (335)
T d2ozaa1         158 FGFAKETTSHN-SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMG  232 (335)
T ss_dssp             CTTCEECCCCC-CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSC
T ss_pred             CCEEEECCCCC-CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHH----HHHHHHHHHHCC
T ss_conf             55123336888-6432267756379277748988888888764516778865889988988778----899999998538


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             999999882889999999998636889999999888986
Q 001440         1035 RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1035 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ....+.......+..+.+++.+||++||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             888898543469999999999975699657909999970

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=0  Score=342.14  Aligned_cols=255  Identities=22%  Similarity=0.311  Sum_probs=209.6

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCH------HHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEE
Q ss_conf             059774633224688229999956-99899999746885202------457999999999930789-9960217989860
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSE------MTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSH  876 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~  876 (1077)
                      .++|++.+.||+|+||+||+|+.. +++.||||++.......      ....+.+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf             66388852884176849999999999989999999624464114788899999999999999985079974799762146


Q ss_pred             CCEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             99569999604899998998248998788988899999999999999883799995841688897565899966991244
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       877 ~~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  956 (1077)
                      .+..|+||||+++|+|.+++....   .+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG  155 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG  155 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCH
T ss_conf             760599997689866899998659---999999999999999999999875---99432346254898689983871240


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf             53347899998324333444248312245------898972017889999999993999987332111357642110122
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYT------MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE 1030 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1030 (1077)
                      +++...... ......|+..|+|||++.+      ..++.++||||+||++|||++|+.||....        .......
T Consensus       156 ~a~~~~~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--------~~~~~~~  226 (277)
T d1phka_         156 FSCQLDPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLRM  226 (277)
T ss_dssp             TCEECCTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred             HEEECCCCC-CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCC--------HHHHHHH
T ss_conf             316726887-2134524678889888605344567889923318565602310322888988999--------9999999


Q ss_pred             HCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             11999999998828899999999986368899999998889866
Q 001440         1031 ILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1031 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 1074 (1077)
                      +.......+.......+..+.+++.+||++||++|||++|+++.
T Consensus       227 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         227 IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             98189888985434689999999999765896689199999739

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=339.69  Aligned_cols=249  Identities=24%  Similarity=0.365  Sum_probs=200.5

Q ss_pred             CCEECCCCCCEEEEEEECCC----CEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE-CCEEEEEEE
Q ss_conf             63322468822999995699----8999997468852024579999999999307899960217989860-995699996
Q 001440          811 EHCIGTGGQGSVYRAELSSG----EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-ARHSFIVYE  885 (1077)
Q Consensus       811 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e  885 (1077)
                      .++||+|+||+||+|++.++    ..||||++...  ......++|.+|++++++++||||++++|++.. ++..++|||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E  109 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP  109 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred             CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf             66981368809999999779987999999998843--6978999999999999867899986786789806994389998


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             04899998998248998788988899999999999999883799995841688897565899966991244533478999
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      |+++|++.+++....  ...++..+++++.|++.|+.|+|+.   +|+||||||+||+++.++.+||+|||+++......
T Consensus       110 ~~~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         110 YMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             CCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             EEECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf             740674144210134--5404899999999988765200336---76257766875767799988991065232255665


Q ss_pred             CC----CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf             98----32433344424831224589897201788999999999399998733211135764211012211999999998
Q 001440          966 SN----WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRLPAPSC 1041 (1077)
Q Consensus       966 ~~----~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1041 (1077)
                      ..    .....|+..|+|||.+....++.++||||||+++|||+||+.||.....       ..+....+..+..+....
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~-------~~~~~~~i~~g~~~~~p~  257 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-------TFDITVYLLQGRRLLQPE  257 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCCCCCT
T ss_pred             CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHCCCCCCCCC
T ss_conf             5531002565556455676887437999745746619999999978999988899-------999999998089889964


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             82889999999998636889999999888986602
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ..   ...+.+++.+||+.||++||++.||++.|+
T Consensus       258 ~~---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~  289 (311)
T d1r0pa_         258 YC---PDPLYEVMLKCWHPKAEMRPSFSELVSRIS  289 (311)
T ss_dssp             TC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CC---CHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             47---599999999976889768939999999999

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.27  Aligned_cols=252  Identities=24%  Similarity=0.386  Sum_probs=205.7

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEECC----CCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEE
Q ss_conf             0597746332246882299999569----989999974688520245799999999993078999602179898609956
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSS----GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHS  880 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~  880 (1077)
                      .++|.+.+.||+|+||.||+|++..    +..||+|.+....  .....+.+.+|+.+++.++||||++++|++. .+..
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEE
T ss_conf             899698779930788299999993699644999999936566--8799999999999998689999856988995-3747


Q ss_pred             EEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             99996048999989982489987889888999999999999998837999958416888975658999669912445334
Q 001440          881 FIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       881 ~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  960 (1077)
                      ++||||+++|++.+++....  ..+++.+++.++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+|+.
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEE
T ss_conf             99998406980776542247--8999999999999998775230226---744141026553206789678765034213


Q ss_pred             CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-C
Q ss_conf             789999-8324333444248312245898972017889999999993-999987332111357642110122119999-9
Q 001440          961 LKPDSS-NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRL-P 1037 (1077)
Q Consensus       961 ~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~ 1037 (1077)
                      ...... ......|++.|+|||++....++.++||||||+++|||+| |..||.....        ......+..... +
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--------~~~~~~i~~~~~~~  229 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENGERLP  229 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--------GGHHHHHHTTCCCC
T ss_pred             CCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH--------HHHHHHHHCCCCCC
T ss_conf             3677623305400583103266751699887452444247899998269999888999--------99999998189998


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             999882889999999998636889999999888986602
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      .+..    .+..+.+++.+||+.||++|||++|+++.|+
T Consensus       230 ~~~~----~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         230 MPPN----CPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             9877----7999999999976879768929999999999

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.19  Aligned_cols=260  Identities=22%  Similarity=0.349  Sum_probs=211.9

Q ss_pred             HHHHHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf             9997059774633224688229999956------9989999974688520245799999999993078999602179898
Q 001440          801 IVRATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFC  874 (1077)
Q Consensus       801 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  874 (1077)
                      ++...++|.+.+.||+|+||+||+|.+.      +++.||||+++...  .......|.+|+.+++.++||||++++|++
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             EEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEE
T ss_conf             042689918835982078818999998786447789689999987012--868999999999999976999884125478


Q ss_pred             EECCEEEEEEEECCCCCHHHHHHCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf             60995699996048999989982489-------98788988899999999999999883799995841688897565899
Q 001440          875 SHARHSFIVYEYLEMGSLAMILSNAT-------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE  947 (1077)
Q Consensus       875 ~~~~~~~lV~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~  947 (1077)
                      ......++||||+++|+|.+++....       ....+++..+.+++.|+|.||.|||++   +|+||||||+||+++.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred             ECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCC
T ss_conf             428810677760489988999875033211344468879999999999999999987647---96543286775403599


Q ss_pred             CCEEEECCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCCC
Q ss_conf             96699124453347899998--32433344424831224589897201788999999999399-9987332111357642
Q 001440          948 YEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK-HPRDFISSICSTSSNL 1024 (1077)
Q Consensus       948 ~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~-~pf~~~~~~~~~~~~~ 1024 (1077)
                      +.+||+|||+|+.+......  .....+++.|+|||.+.+..++.++||||||+++|||+||+ .||..        ...
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~--------~~~  241 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG--------LSN  241 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT--------SCH
T ss_pred             CEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC--------CCH
T ss_conf             649994245420235776303134023163237888873699883334443789999999689999999--------899


Q ss_pred             CCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             1101221199999999882889999999998636889999999888986602
Q 001440         1025 DRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1025 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      .+....+.++..+......   +..+.+++.+||+.+|++|||++++++.|+
T Consensus       242 ~~~~~~i~~~~~~~~p~~~---~~~l~~li~~cl~~~P~~RPs~~~il~~L~  290 (308)
T d1p4oa_         242 EQVLRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISSIK  290 (308)
T ss_dssp             HHHHHHHHTTCCCCCCTTC---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred             HHHHHHHHHCCCCCCCCCC---HHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             9999999808888886335---399999999975779658939999999978

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=342.43  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=205.0

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCC--EEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCEEE
Q ss_conf             59774633224688229999956-998--9999974688520245799999999993078-9996021798986099569
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGE--IVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|++.+.||+|+||+||+|.++ ++.  .||||++....  .....+++.+|+.+++.+ +||||++++|++.+.+..+
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   87 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY   87 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
T ss_conf             9968877982078828999999899969999999978233--85799999999999986228998836788884187369


Q ss_pred             EEEEECCCCCHHHHHHCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC
Q ss_conf             9996048999989982489-------------987889888999999999999998837999958416888975658999
Q 001440          882 IVYEYLEMGSLAMILSNAT-------------SAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY  948 (1077)
Q Consensus       882 lV~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~  948 (1077)
                      +||||+++|+|.++++...             ....+++.++.+++.|+|.|+.|+|+.   +|+||||||+||+++.++
T Consensus        88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCC
T ss_conf             99980289869999864035555512310123457899999999999999998766308---954555052048986887


Q ss_pred             CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf             6699124453347899998324333444248312245898972017889999999993999-987332111357642110
Q 001440          949 EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKH-PRDFISSICSTSSNLDRT 1027 (1077)
Q Consensus       949 ~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~-pf~~~~~~~~~~~~~~~~ 1027 (1077)
                      .+||+|||+|+....... .....|+..|+|||.+....++.++||||||+++|||++|.. ||...        ...+.
T Consensus       165 ~~kl~DfG~a~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~  235 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYVK-KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAEL  235 (309)
T ss_dssp             CEEECCTTCEESSCEECC-C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHH
T ss_pred             CEEECCCCCCCCCCCCCC-CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCC--------CHHHH
T ss_conf             638743443224442234-553013775555387526999962215313889999983689999999--------99999


Q ss_pred             HHHHCCCC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             12211999-99999882889999999998636889999999888986602
Q 001440         1028 LDEILDPR-LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1028 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ...+.... .+.+. .   .+..+.+++.+||+.||++||||+|+++.|+
T Consensus       236 ~~~i~~~~~~~~~~-~---~~~~~~~li~~cl~~dP~~RPs~~eil~~L~  281 (309)
T d1fvra_         236 YEKLPQGYRLEKPL-N---CDDEVYDLMRQCWREKPYERPSFAQILVSLN  281 (309)
T ss_dssp             HHHGGGTCCCCCCT-T---BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHCCCCCCCC-C---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             99998268888876-6---7899999999976789668949999999999

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=344.37  Aligned_cols=247  Identities=29%  Similarity=0.436  Sum_probs=203.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE-CCEEEEE
Q ss_conf             059774633224688229999956998999997468852024579999999999307899960217989860-9956999
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-ARHSFIV  883 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV  883 (1077)
                      .++|.+.+.||+|+||.||+|+++ |+.||||+++.+.     ..+.+.+|+.+++.++||||++++|++.+ .+..++|
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv   79 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV   79 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred             HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf             899488579820798089999999-9099999988577-----7999999999998678989854987887238928999


Q ss_pred             EEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCC
Q ss_conf             96048999989982489987889888999999999999998837999958416888975658999669912445334789
Q 001440          884 YEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKP  963 (1077)
Q Consensus       884 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~  963 (1077)
                      |||+++|+|.+++.... ...+++..+++++.|++.|++|||+.   +|+||||||+||+++.++.+|++|||+++....
T Consensus        80 ~ey~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             ECCCTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EECCCCCCHHHHHHHCC-CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCC
T ss_conf             96369998999987457-88889999999999998523211337---655366656760146899776324560034478


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCC
Q ss_conf             9998324333444248312245898972017889999999993-99998733211135764211012211999-999998
Q 001440          964 DSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPR-LPAPSC 1041 (1077)
Q Consensus       964 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 1041 (1077)
                      .   .....++..|+|||++.+..++.++||||||+++|||+| |+.||....        ..+....+.... .+.+..
T Consensus       156 ~---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--------~~~~~~~i~~~~~~~~~~~  224 (262)
T d1byga_         156 T---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRVEKGYKMDAPDG  224 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--------GGGHHHHHTTTCCCCCCTT
T ss_pred             C---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHCCCCCCCCCC
T ss_conf             7---7655666467781787279888588777579999999978999999999--------9999999980899999765


Q ss_pred             CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             82889999999998636889999999888986602
Q 001440         1042 NIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1042 ~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                          ....+.+++.+||+.||++||||++++++|+
T Consensus       225 ----~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~  255 (262)
T d1byga_         225 ----CPPAVYEVMKNCWHLDAAMRPSFLQLREQLE  255 (262)
T ss_dssp             ----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ----7999999999975669768939999999999

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=346.22  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=206.9

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC--CC--CEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEE
Q ss_conf             59774633224688229999956--99--899999746885202457999999999930789996021798986099569
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS--SG--EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  881 (1077)
                      ++|++.+.||+|+||.||+|++.  ++  ..||||++...........++|.+|+.+++.++||||++++|++.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHH
T ss_conf             8919978980388839999999889990799999999835557989999999999999868999987898777401-001


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCC
Q ss_conf             99960489999899824899878898889999999999999988379999584168889756589996699124453347
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSL  961 (1077)
Q Consensus       882 lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~  961 (1077)
                      +|+||+++|++.+++....  ..+++..++.++.|+|.|+.|||++   +|+||||||+||+++.++.+|++|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEECCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf             1465423861254442126--8999999999999999999875217---8752056688815655654332561155530


Q ss_pred             CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf             899998---324333444248312245898972017889999999993-9999873321113576421101221199999
Q 001440          962 KPDSSN---WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICSTSSNLDRTLDEILDPRLP 1037 (1077)
Q Consensus       962 ~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 1037 (1077)
                      ......   .....|+..|+|||++.+..++.++||||||+++|||+| |+.||....        ..+....+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~~~~~i~~~~~~  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEGER  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSCCC
T ss_pred             CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC--------HHHHHHHHHHCCCC
T ss_conf             3588752654763257310799998379999421566148999999968999999969--------99999999847999


Q ss_pred             CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             999882889999999998636889999999888986602
Q 001440         1038 APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1038 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      .+.  ....+..+.+++.+||+.||++||||+++.+.|+
T Consensus       234 ~~~--~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         234 LPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCC--CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             998--5445399999999976889667929999999999

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.63  Aligned_cols=256  Identities=23%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEECC--------CCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEEE
Q ss_conf             0597746332246882299999569--------989999974688520245799999999993078-9996021798986
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELSS--------GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCS  875 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~  875 (1077)
                      .++|.+.+.||+|+||.||+|+...        +..||||+++....  .....++.+|...+.++ +||||+++++++.
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCC--HHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf             89969700985167828999998578755566754999999881128--6889999999999998139996973465220


Q ss_pred             ECCEEEEEEEECCCCCHHHHHHCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCE
Q ss_conf             09956999960489999899824899-------------87889888999999999999998837999958416888975
Q 001440          876 HARHSFIVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNV  942 (1077)
Q Consensus       876 ~~~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Ni  942 (1077)
                      +++..++||||+++|++.+++.....             ...+++.+++.++.|++.|++|||+.   +|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCE
T ss_conf             18868999973699909999986067764322233457434679999999999999999876637---978630221022


Q ss_pred             EECCCCCEEEECCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf             658999669912445334789999--8324333444248312245898972017889999999993-9999873321113
Q 001440          943 LLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIK-GKHPRDFISSICS 1019 (1077)
Q Consensus       943 ll~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ellt-g~~pf~~~~~~~~ 1019 (1077)
                      +++.++.+||+|||+++.......  ......+++.|+|||++.++.|+.++||||||+++|||++ |+.||....    
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~----  242 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----  242 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             EECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC----
T ss_conf             4547897676221110113555554314667888466326675179888255547758888874017989899999----


Q ss_pred             CCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             576421101221199999999882889999999998636889999999888986602
Q 001440         1020 TSSNLDRTLDEILDPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1020 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                          .......+.++..+.....   .+..+.+++.+||++||++|||+.||++.|+
T Consensus       243 ----~~~~~~~i~~~~~~~~p~~---~~~~l~~li~~cl~~dP~~Rps~~eil~~L~  292 (299)
T d1fgka_         243 ----VEELFKLLKEGHRMDKPSN---CTNELYMMMRDCWHAVPSQRPTFKQLVEDLD  292 (299)
T ss_dssp             ----HHHHHHHHHTTCCCCCCSS---CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ----HHHHHHHHHCCCCCCCCCC---CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ----9999999972888898743---5299999999976679767939999999998

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=340.02  Aligned_cols=262  Identities=22%  Similarity=0.298  Sum_probs=198.7

Q ss_pred             CCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----EEE
Q ss_conf             5977463322468822999995699899999746885202457999999999930789996021798986099----569
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR----HSF  881 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~  881 (1077)
                      ++|...+.||+|+||.||+|++ +|+.||||++....    ........|+..+..++||||+++++++.+..    ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCC----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf             6899988982078819999999-99899999987200----467999999999962799868326889983798604899


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCEEECCCCCCCEEECCCCCEEEECCC
Q ss_conf             99960489999899824899878898889999999999999988379-----9995841688897565899966991244
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDC-----FPPIVYRDISSKNVLLDLEYEAHVSDFG  956 (1077)
Q Consensus       882 lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dlk~~Nill~~~~~~kl~Dfg  956 (1077)
                      +||||+++|+|.+++++.    .++|.++++++.|+|.|++|+|+..     .++|+||||||+||+++.++.+||+|||
T Consensus        78 lv~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EEEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf             999646698989998658----9998999999999999999988766520468986615317313578688776887638


Q ss_pred             CCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC------
Q ss_conf             5334789999----832433344424831224589------897201788999999999399998733211135------
Q 001440          957 ISKSLKPDSS----NWTELAGTIGYVAPELAYTMK------VTEKSDVYSFGVLALEAIKGKHPRDFISSICST------ 1020 (1077)
Q Consensus       957 la~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~------~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~------ 1020 (1077)
                      +++.......    ......|++.|+|||++....      ++.++||||||+++|||+||..||.........      
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf             66234677762001355250354767822105654546777675012201599999996289988766311241012255


Q ss_pred             -CCCCCCCHHHHCCCCCCCC--C-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             -7642110122119999999--9-882889999999998636889999999888986602
Q 001440         1021 -SSNLDRTLDEILDPRLPAP--S-CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1021 -~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                       .................+.  . ....+....+.+++.+||+.||++|||+.|+++.|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~  293 (303)
T d1vjya_         234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  293 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             643099999987502468887765577689999999999976069858959999999999

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.01  Aligned_cols=262  Identities=22%  Similarity=0.373  Sum_probs=203.7

Q ss_pred             HHHHHHHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCCCEEEEE
Q ss_conf             999997059774633224688229999956------9989999974688520245799999999993078-999602179
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFY  871 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~  871 (1077)
                      .+++...++|.+.+.||+|+||.||+|++.      +++.||||++......  ...+.+.+|...+.++ +|+||+.++
T Consensus         6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf             2526167997984498416783999999867775557839999998600171--78999999999988614998499741


Q ss_pred             EEEEEC-CEEEEEEEECCCCCHHHHHHCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf             898609-956999960489999899824899-------------878898889999999999999988379999584168
Q 001440          872 GFCSHA-RHSFIVYEYLEMGSLAMILSNATS-------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDI  937 (1077)
Q Consensus       872 ~~~~~~-~~~~lV~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dl  937 (1077)
                      +++... ...++||||+++|+|.++++....             ...+++.++..++.|++.|++|||++   +|+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCC
T ss_conf             1540479757999984589929999985366666532220233214689999999999999999988737---9717867


Q ss_pred             CCCCEEECCCCCEEEECCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCC
Q ss_conf             88975658999669912445334789999--832433344424831224589897201788999999999399-998733
Q 001440          938 SSKNVLLDLEYEAHVSDFGISKSLKPDSS--NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGK-HPRDFI 1014 (1077)
Q Consensus       938 k~~Nill~~~~~~kl~Dfgla~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~-~pf~~~ 1014 (1077)
                      ||+||+++.++.+||+|||+|+.......  ......||+.|+|||++.+..++.++|||||||++|||+||. .||...
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCC
T ss_conf             73106577998289845752001135665222475166721020368646889966322136789999986889999899


Q ss_pred             CCCCCCCCCCCCCHHHHCCC-CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             21113576421101221199-999999882889999999998636889999999888986602
Q 001440         1015 SSICSTSSNLDRTLDEILDP-RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1015 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ...       +.....+..+ +.+.+..    .+..+.+++.+||+.||++|||++|+++.|+
T Consensus       241 ~~~-------~~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~  292 (299)
T d1ywna1         241 KID-------EEFCRRLKEGTRMRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG  292 (299)
T ss_dssp             CCS-------HHHHHHHHHTCCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHH-------HHHHHHHHCCCCCCCCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             989-------999999963898888865----7899999999976779667919999999997

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=341.20  Aligned_cols=257  Identities=24%  Similarity=0.409  Sum_probs=206.4

Q ss_pred             HHCCCCCCCEECCCCCCEEEEEEEC------CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEE
Q ss_conf             7059774633224688229999956------9989999974688520245799999999993078-99960217989860
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS------SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEI-RHRNIVKFYGFCSH  876 (1077)
Q Consensus       804 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  876 (1077)
                      ..++|.+.+.||+|+||.||+|++.      +++.||||+++...  ......++.+|+.+++.+ +||||++++|++.+
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf             789969854982068829999998066447788699999987424--877999999999998762699988789989831


Q ss_pred             CCEEEEEEEECCCCCHHHHHHCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCC
Q ss_conf             9956999960489999899824899---------------8788988899999999999999883799995841688897
Q 001440          877 ARHSFIVYEYLEMGSLAMILSNATS---------------AEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKN  941 (1077)
Q Consensus       877 ~~~~~lV~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~N  941 (1077)
                      ....++||||+++|+|.++++....               ...+++.++..++.||+.|++|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCC
T ss_conf             997899997379987999998535665444445332223345889999999999999999988757---92666241021


Q ss_pred             EEECCCCCEEEECCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf             56589996699124453347899998--3243334442483122458989720178899999999939999873321113
Q 001440          942 VLLDLEYEAHVSDFGISKSLKPDSSN--WTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS 1019 (1077)
Q Consensus       942 ill~~~~~~kl~Dfgla~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~ 1019 (1077)
                      |+++.++.++++|||.++........  .....|++.|+|||++....++.++||||||+++|||+|++.|+....    
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~----  251 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM----  251 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC----
T ss_pred             CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC----
T ss_conf             0000257521023401023367886158620135968767788617999974001025899999985899887789----


Q ss_pred             CCCCCCCCHHHHCCC--CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             576421101221199--999999882889999999998636889999999888986602
Q 001440         1020 TSSNLDRTLDEILDP--RLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1020 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                         .....+..++..  +...+. .   .+..+.+++.+||+.||++||||++++++|+
T Consensus       252 ---~~~~~~~~~i~~~~~~~~~~-~---~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         252 ---PVDSKFYKMIKEGFRMLSPE-H---APAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             ---CSSHHHHHHHHHTCCCCCCT-T---SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHCCCCCCCCC-C---CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             ---98999999986689889854-3---6599999999975779657929999999998

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.34  Aligned_cols=258  Identities=23%  Similarity=0.265  Sum_probs=197.8

Q ss_pred             CCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHH--HHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEEE
Q ss_conf             4633224688229999956-9989999974688520245--799999999993078999602179898609956999960
Q 001440          810 EEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMT--CQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYEY  886 (1077)
Q Consensus       810 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  886 (1077)
                      ..+.||+|+||+||+|+.+ +|+.||||++.........  ..+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf             56385127282999999999996999999842021245679999999999999867999986898542258740220455


Q ss_pred             CCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf             48999989982489987889888999999999999998837999958416888975658999669912445334789999
Q 001440          887 LEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDSS  966 (1077)
Q Consensus       887 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~~  966 (1077)
                      ++++++..+....   ..+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             HCCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf             3450776554126---6778999999999999999886316---355035776258853778411465761000578755


Q ss_pred             CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC-----------CCCCCCCH---HHH
Q ss_conf             8324333444248312245-89897201788999999999399998733211135-----------76421101---221
Q 001440          967 NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-----------SSNLDRTL---DEI 1031 (1077)
Q Consensus       967 ~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~-----------~~~~~~~~---~~~ 1031 (1077)
                      ......|++.|+|||++.. ..++.++||||+||++|||+||+.||.........           ........   ...
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHCCCHHH
T ss_conf             43302047333639997267788805643630428999985969999999999999999851899725452100021344


Q ss_pred             CCCCCCCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             1999999998--82889999999998636889999999888986
Q 001440         1032 LDPRLPAPSC--NIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1032 ~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      .....+....  ........+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             30347898867856568999999999976389456908999967

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=0  Score=341.48  Aligned_cols=297  Identities=34%  Similarity=0.567  Sum_probs=189.1

Q ss_pred             CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCEEECCC---CCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             99988899999999862369999988899999999998888--5673241479---983211467887533337864689
Q 001440           32 SNSTEEAHALLKWKTSLQNHNNKGSFLPSWTLNNATKISPC--AWFGIHCNHA---GKVNSINLTSAGLIGTLHDFSFSS  106 (1077)
Q Consensus        32 ~~~~~~~~all~~k~~~~~~~~~~~~~~sW~~~~~~~~~~C--~w~gv~C~~~---~~v~~l~l~~~~~~~~l~~~~~~~  106 (1077)
                      -|.|+|++||++||+++.++.    .++||..    ++|||  +|+||+|+..   +||++|++.+.++.|..       
T Consensus         2 ~c~~~e~~aLl~~k~~~~~~~----~l~sW~~----~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~-------   66 (313)
T d1ogqa_           2 LCNPQDKQALLQIKKDLGNPT----TLSSWLP----TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPY-------   66 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCG----GGTTCCT----TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCE-------
T ss_pred             CCCHHHHHHHHHHHHHCCCCC----CCCCCCC----CCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCC-------
T ss_conf             989899999999999779998----6778899----9999889488969748999479889989899888888-------


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             99876897647732333783657999998883789-98889899988986766341454534578889977775754455
Q 001440          107 FPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSS-NSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKAL  185 (1077)
Q Consensus       107 l~~l~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~-n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L  185 (1077)
                                      .+|+.++++++|++|+|++ |.++|.+|..|+++++|++|+|++|++.+..+..+..+.+|+.+
T Consensus        67 ----------------~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l  130 (313)
T d1ogqa_          67 ----------------PIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL  130 (313)
T ss_dssp             ----------------ECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred             ----------------CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf             ----------------7984784675335202026543330024311454200110203564344332222201110011


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             312346878989987887767579834776788778755676656-5688202334687786678888777687125888
Q 001440          186 HLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSL-SGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSL  264 (1077)
Q Consensus       186 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L-~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l  264 (1077)
                      +++.|.+.+.+|..+.+++.|+.+++++|.+.+.+|..+..+..+ +.+.+++|++++..|..+..+.. ..++++.+..
T Consensus       131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~  209 (313)
T d1ogqa_         131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNML  209 (313)
T ss_dssp             ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEE
T ss_pred             CCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCC
T ss_conf             112245555685122067400000023553356203121443112323102246435332433222222-2333333433


Q ss_pred             CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             88878988877754035078988989986423788785568767888888768876887886289833862330168233
Q 001440          265 SGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEI  344 (1077)
Q Consensus       265 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l  344 (1077)
                      .+.+|..+..+.+++.+++++|.+.+.+| .+..+++|+.|+|++|+++|.+|..++++++|+.|+|++|+++|.+|. +
T Consensus       210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~  287 (313)
T d1ogqa_         210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-G  287 (313)
T ss_dssp             EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-S
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-C
T ss_conf             22222222222221112222222222222-222455444444765706660876884799999897958835166898-6


Q ss_pred             CCCCCCCEEECCCCC-CCC
Q ss_conf             454535488679985-744
Q 001440          345 GNLRYLFYLELGDNK-LSG  362 (1077)
Q Consensus       345 ~~l~~L~~L~l~~n~-l~~  362 (1077)
                      +++++|+.+++++|+ ++|
T Consensus       288 ~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         288 GNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             TTGGGSCGGGTCSSSEEES
T ss_pred             CCCCCCCHHHHCCCCCCCC
T ss_conf             6679989788688950019

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=334.81  Aligned_cols=263  Identities=20%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             CCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             5977463322468822999995-699899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|.+.+.||+|+||+||+|.+ .+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf             9977651772376809999999999979999998022257-589999999999998679983887445332243203788


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      ||+.++.+. ++.... ...+++.++..++.|++.|++|||++   +|+||||||+||+++.++.+|++|||.|+.....
T Consensus        81 e~~~~~~~~-~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          81 EFLHQDLKK-FMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             ECCSEEHHH-HHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             EECCCCHHH-HHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf             623774455-544202-56888899999999999999986528---8992135711401134676210357861343688


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC----------CCCCCCCCHHHHC-
Q ss_conf             99832433344424831224589-89720178899999999939999873321113----------5764211012211-
Q 001440          965 SSNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIKGKHPRDFISSICS----------TSSNLDRTLDEIL- 1032 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~----------~~~~~~~~~~~~~- 1032 (1077)
                      ........|++.|+|||...... ++.++||||+|+++|||++|+.||........          ..+.......... 
T Consensus       156 ~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         156 VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCCCCCCC
T ss_conf             64100103652154112213665777422103333134279668799898899999999998328983331444222421


Q ss_pred             -CCCCCCCCCC-C----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -9999999988-2----8899999999986368899999998889866
Q 001440         1033 -DPRLPAPSCN-I----RDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1033 -~~~~~~~~~~-~----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 1074 (1077)
                       ....+..... .    ......+.+++.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             243454322220444166789999999999763995579189999678

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=0  Score=332.40  Aligned_cols=261  Identities=22%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             CCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf             59774633224688229999956998999997468852024579999999999307899960217989860995699996
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVYE  885 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  885 (1077)
                      ++|++.+.||+|+||+||+|++++|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf             996343187227781899999689999999998123268-5899999999999986799868766012046773158997


Q ss_pred             ECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCCC
Q ss_conf             04899998998248998788988899999999999999883799995841688897565899966991244533478999
Q 001440          886 YLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPDS  965 (1077)
Q Consensus       886 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~~  965 (1077)
                      ++.++.+..+....   ..+++.++..++.|++.||+|||+.   +|+||||||+||+++.++.+|++|||.|.......
T Consensus        81 ~~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          81 HLDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CCSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             EEHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf             40045678998604---7751445689999999999986057---48826787750568689978732366430114676


Q ss_pred             CCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC--------------CCCCCCCCH--
Q ss_conf             983243334442483122458-989720178899999999939999873321113--------------576421101--
Q 001440          966 SNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICS--------------TSSNLDRTL-- 1028 (1077)
Q Consensus       966 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~--------------~~~~~~~~~-- 1028 (1077)
                      .......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||........              .........  
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             CCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf             54101024311013788717888884100211175899997797998988989999999986389971104212333221


Q ss_pred             HHHCCCCCCCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             22119999999-9882889999999998636889999999888986
Q 001440         1029 DEILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1029 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ........+.+ ..........+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4333335676466651258999999999986689668909999856

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=330.16  Aligned_cols=243  Identities=22%  Similarity=0.322  Sum_probs=196.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHH---HHHHHHHHHHHHHCCCC--CCCEEEEEEEEEECC
Q ss_conf             059774633224688229999956-998999997468852024---57999999999930789--996021798986099
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEM---TCQQEFLNEVKSLTEIR--HRNIVKFYGFCSHAR  878 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~  878 (1077)
                      .++|++.+.||+|+||+||+|+.. +|+.||||.+......+.   .....+.+|+.+++.++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf             88379967984087839999999999979999998568844334556799999999999974358988127999983099


Q ss_pred             EEEEEEEECCC-CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEECCC
Q ss_conf             56999960489-9998998248998788988899999999999999883799995841688897565899-966991244
Q 001440          879 HSFIVYEYLEM-GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLE-YEAHVSDFG  956 (1077)
Q Consensus       879 ~~~lV~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~-~~~kl~Dfg  956 (1077)
                      ..++||||+.+ +++.+++....   .+++.++..++.|++.|++|||+.   +|+||||||+||+++.+ +.+|++|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             EEEEEEEECCCCCHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf             68999983368622899986158---999999999999999999999877---975566761114774478848977546


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCC
Q ss_conf             53347899998324333444248312245898-97201788999999999399998733211135764211012211999
Q 001440          957 ISKSLKPDSSNWTELAGTIGYVAPELAYTMKV-TEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPR 1035 (1077)
Q Consensus       957 la~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 1035 (1077)
                      +|+....  .......||+.|+|||++.+..+ +.++||||+||++|||+||+.||.....              +....
T Consensus       157 ~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------------i~~~~  220 (273)
T d1xwsa_         157 SGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------IIRGQ  220 (273)
T ss_dssp             TCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------------HHHCC
T ss_pred             CCEECCC--CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH--------------HHHCC
T ss_conf             5353244--4556656587747999984899788653325540345367568899887367--------------76154


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             99999882889999999998636889999999888986
Q 001440         1036 LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1036 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ...+...    +..+.+++.+||+.||++|||++|+++
T Consensus       221 ~~~~~~~----s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 VFFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCC----CHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             4778779----999999999976089758939999853

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=326.99  Aligned_cols=263  Identities=19%  Similarity=0.268  Sum_probs=192.6

Q ss_pred             HHCCCCCCCEECCCCCCEEEEEEEC-C-CCEEEEEECCCCCCCHHHHHHHHHHHHHHHCC---CCCCCEEEEEEEEEE--
Q ss_conf             7059774633224688229999956-9-98999997468852024579999999999307---899960217989860--
Q 001440          804 ATNDFDEEHCIGTGGQGSVYRAELS-S-GEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTE---IRHRNIVKFYGFCSH--  876 (1077)
Q Consensus       804 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~---l~h~niv~l~~~~~~--  876 (1077)
                      ..++|++.+.||+|+||+||+|++. + ++.||||++........ ....+.+|+.+++.   .+||||+++++++..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTS-CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCH-HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf             758979888992155869999999888998999999802324516-7999999999999874258988023663221466


Q ss_pred             ---CCEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf             ---99569999604899998998248998788988899999999999999883799995841688897565899966991
Q 001440          877 ---ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVS  953 (1077)
Q Consensus       877 ---~~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~  953 (1077)
                         ....++++||++++.+.......  ...+++..+..++.|++.|++|||++   +|+||||||+|||++.++.+|++
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCCCEEEEEEEECCCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEEC
T ss_conf             66674699999740587144444303--78999899999999999999999758---89835798627898589975421


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC-------------
Q ss_conf             2445334789999832433344424831224589897201788999999999399998733211135-------------
Q 001440          954 DFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST------------- 1020 (1077)
Q Consensus       954 Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~------------- 1020 (1077)
                      |||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||.........             
T Consensus       159 dfg~~~~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         159 DFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             SCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             CHHHHHHHCCC-CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHH
T ss_conf             00010110023-45777654851148310017988811100032899999987879989989899999999840799611


Q ss_pred             -CCCCCCCHHHHCCCCCCCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             -7642110122119999999-9882889999999998636889999999888986
Q 001440         1021 -SSNLDRTLDEILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1021 -~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                       ..................+ ..........+.+++.+||++||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             0532111103330223456454404458999999999987489667918999966

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=324.54  Aligned_cols=256  Identities=23%  Similarity=0.271  Sum_probs=191.4

Q ss_pred             CCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC------CE
Q ss_conf             9774633224688229999956-9989999974688520245799999999993078999602179898609------95
Q 001440          807 DFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA------RH  879 (1077)
Q Consensus       807 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~  879 (1077)
                      +|+..++||+|+||+||+|++. +|+.||||++.....       ...+|+.+++.++||||+++++++...      .+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~   93 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY   93 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred             CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf             76751698217683999999999997999999881606-------89999999986689898738789974476577318


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCC
Q ss_conf             699996048999989982489987889888999999999999998837999958416888975658999-6699124453
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGIS  958 (1077)
Q Consensus       880 ~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla  958 (1077)
                      .++||||++++..............+++.++..++.|++.||+|||++   ||+||||||+|||++.++ .+||+|||++
T Consensus        94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf             999984168860788886310368999999999999999999999866---87645788603787358971167336605


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC-------CCCCCCCHHH
Q ss_conf             347899998324333444248312245-89897201788999999999399998733211135-------7642110122
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST-------SSNLDRTLDE 1030 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~-------~~~~~~~~~~ 1030 (1077)
                      +...... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.........       .......+..
T Consensus       171 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         171 KQLVRGE-PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             EECCTTS-CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             HHCCCCC-CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf             4404776-532002555556827764046888210002465277855028799898799999999999748981776543


Q ss_pred             ----HCCCCCCCCC------CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ----1199999999------882889999999998636889999999888986
Q 001440         1031 ----ILDPRLPAPS------CNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1031 ----~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                          ......+...      .........+.+++.+||++||++|||++|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             06210110355445674444315689999999999976589557929999966

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=320.82  Aligned_cols=256  Identities=20%  Similarity=0.309  Sum_probs=198.2

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC-----
Q ss_conf             059774633224688229999956-99899999746885202457999999999930789996021798986099-----
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR-----  878 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----  878 (1077)
                      .++|.+.+.||+|+||+||+|.+. +|+.||||++...... ....+.+.+|+.+++.++||||+++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf             77189988980177819999999999989999998522259-69999999999999866898754799986357655554


Q ss_pred             -EEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCC
Q ss_conf             -5699996048999989982489987889888999999999999998837999958416888975658999669912445
Q 001440          879 -HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGI  957 (1077)
Q Consensus       879 -~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgl  957 (1077)
                       ..++||||+ ++++..+.+..    .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+|++|||+
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~  167 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL  167 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CEEEEEEECC-CCCHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf             1599998405-52189998740----226999999999999999998737---876456685111121001221134310


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCC---------------
Q ss_conf             33478999983243334442483122458-98972017889999999993999987332111357---------------
Q 001440          958 SKSLKPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS--------------- 1021 (1077)
Q Consensus       958 a~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~--------------- 1021 (1077)
                      |+.....   .....|++.|+|||++.+. .++.++||||+||++|||++|+.||..........               
T Consensus       168 a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         168 ARQADSE---MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CEECCSS---CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             EECCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf             2206876---3102455333588998178789965010300389999997869988897689999998503788488886


Q ss_pred             ---CCCCCCHHHHCCCCCCCC--CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             ---642110122119999999--9882889999999998636889999999888986
Q 001440         1022 ---SNLDRTLDEILDPRLPAP--SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1022 ---~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                         .......... .+.....  ..........+.+++.+||..||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         245 RLQSDEAKNYMKG-LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             TCSCHHHHHHHHH-SCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHCCHHHHHHHCC-CCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             5300034433115-7866655667755689999999999977299557929999963

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=320.37  Aligned_cols=261  Identities=21%  Similarity=0.249  Sum_probs=196.1

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----E
Q ss_conf             05977463322468822999995-699899999746885202457999999999930789996021798986099----5
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHAR----H  879 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~  879 (1077)
                      .++|.+.+.||+|+||+||+|.. .+|+.||||++....  .....+.+.+|+.+++.++|||++++++++....    .
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~   84 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK   84 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCC
T ss_conf             898599789940648099999999999499999980310--958999999999999976898988588899505645541


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             69999604899998998248998788988899999999999999883799995841688897565899966991244533
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                      .+++++++.+|+|.+++...    .+++..+..++.|++.|++|||++   ||+||||||+||+++.++.+||+|||+|+
T Consensus        85 ~~~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          85 DVYLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             CEEEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf             49999962598656644058----999999999999999999999978---98677787643788799977875457056


Q ss_pred             CCCCCCC---CCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC--------CCCC---
Q ss_conf             4789999---8324333444248312245-89897201788999999999399998733211135--------7642---
Q 001440          960 SLKPDSS---NWTELAGTIGYVAPELAYT-MKVTEKSDVYSFGVLALEAIKGKHPRDFISSICST--------SSNL--- 1024 (1077)
Q Consensus       960 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~--------~~~~--- 1024 (1077)
                      .......   ......|++.|+|||++.. ..++.++||||+|+++|||++|+.||.........        ....   
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf             50477764101011026520003878604788874101004670133776697997888889999987652069975664


Q ss_pred             -----CCCHHHH-CCCCCCCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             -----1101221-1999999998--828899999999986368899999998889866
Q 001440         1025 -----DRTLDEI-LDPRLPAPSC--NIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1025 -----~~~~~~~-~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 1074 (1077)
                           ....... ..+.......  ........+.+++.+||+.||++|||++|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             2343322220244677557787778378999999999999764895679089998619

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=319.12  Aligned_cols=263  Identities=19%  Similarity=0.282  Sum_probs=196.9

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE-------
Q ss_conf             05977463322468822999995-6998999997468852024579999999999307899960217989860-------
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH-------  876 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------  876 (1077)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++......+ ...+.+.+|+.+++.++|||++++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTT-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCH-HHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCC
T ss_conf             279889999722748299999998999799999984222463-7899999999999983599966067654024654444


Q ss_pred             -CCEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECC
Q ss_conf             -9956999960489999899824899878898889999999999999988379999584168889756589996699124
Q 001440          877 -ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDF  955 (1077)
Q Consensus       877 -~~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Df  955 (1077)
                       .+..++||||++++.+..+...   ...++..++..++.|++.|+.|||+.   +|+||||||+||+++.++.+|++||
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~---~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CCCEEEEEEECCCCCCCCHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEEC
T ss_conf             57638999853578741012220---34433089999999999999885229---9885676722203668996876313


Q ss_pred             CCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC-------C
Q ss_conf             45334789999----83243334442483122458-989720178899999999939999873321113576-------4
Q 001440          956 GISKSLKPDSS----NWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS-------N 1023 (1077)
Q Consensus       956 gla~~~~~~~~----~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~-------~ 1023 (1077)
                      |+++.......    ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...........       .
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~  241 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  241 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf             50022355444321135660249787428997079998917870067864661744879989989999999999841899


Q ss_pred             CCCCHHHH----CC---CCCCCCCCCCHHH------HHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             21101221----19---9999999882889------9999999986368899999998889866
Q 001440         1024 LDRTLDEI----LD---PRLPAPSCNIRDK------LISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1024 ~~~~~~~~----~~---~~~~~~~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~ei~~~ 1074 (1077)
                      ........    ..   .............      ...+.+++.+||++||++|||++|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             8255344320344433201334455503340444599899999999873896589099999749

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=314.51  Aligned_cols=261  Identities=18%  Similarity=0.256  Sum_probs=204.9

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789996021798986099569999
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHARHSFIVY  884 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  884 (1077)
                      ++|++.+.||+|+||+||+|++. +++.||||+++.... .......+.+|+.+++.++||||+++++++.+....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf             997862697128681999999999996999999803217-8689999999999998567578882135444443115886


Q ss_pred             EECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCCCCCCC
Q ss_conf             60489999899824899878898889999999999999988379999584168889756589996699124453347899
Q 001440          885 EYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKSLKPD  964 (1077)
Q Consensus       885 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~~~~~  964 (1077)
                      |++.++++..++....   .+++..+..++.|++.||+|||++   +|+||||||+||+++.++.+|++|||.|+.....
T Consensus        81 ~~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          81 EFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             ECCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             EECCCCCCCCCCCCCC---CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf             3023322211212356---540367899999999998774339---9860014676121133782665204601104688


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCC---------------CCCCCCCH
Q ss_conf             99832433344424831224589-897201788999999999399998733211135---------------76421101
Q 001440          965 SSNWTELAGTIGYVAPELAYTMK-VTEKSDVYSFGVLALEAIKGKHPRDFISSICST---------------SSNLDRTL 1028 (1077)
Q Consensus       965 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~---------------~~~~~~~~ 1028 (1077)
                      ........++..|+|||.+.... ++.++||||+||++|||++|+.||.........               ........
T Consensus       155 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             CCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHCC
T ss_conf             75100103443101466750698888044402654188998518999988999999999998611899735513443222


Q ss_pred             HHHC---CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             2211---99999999882889999999998636889999999888986
Q 001440         1029 DEIL---DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1029 ~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      +...   .+...............+.+++.+|+++||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             113344454431043306568999999999986499668909999964

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=313.01  Aligned_cols=258  Identities=21%  Similarity=0.285  Sum_probs=200.3

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE------CC
Q ss_conf             59774633224688229999956-998999997468852024579999999999307899960217989860------99
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSH------AR  878 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~  878 (1077)
                      ++|.+.+.||+|+||+||+|++. +|+.||||++...... ......+.+|+.+++.++||||+++++++..      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf             7759988962175859999999999989999998823369-799999999999998648987648998970256434576


Q ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             56999960489999899824899878898889999999999999988379999584168889756589996699124453
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  958 (1077)
                      ..|+||||+.++.+.. +.     ..+++.++..++.|++.|++|||+.   ||+||||||+||+++.++.++++|||++
T Consensus        96 ~~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~  166 (355)
T d2b1pa1          96 DVYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_dssp             EEEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             EEEEEEECCCHHHHHH-HH-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf             2699984144677876-50-----3899999999999999999886522---1124567763211365443132010232


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCC--------------CCCCC
Q ss_conf             3478999983243334442483122458989720178899999999939999873321113--------------57642
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICS--------------TSSNL 1024 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~--------------~~~~~ 1024 (1077)
                      +..... .......+|+.|+|||++.+..++.++||||+||++|||++|+.||........              .....
T Consensus       167 ~~~~~~-~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (355)
T d2b1pa1         167 RTAGTS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred             HCCCCC-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf             114666-5533221465555813314777787743335662578986598998889778899999972058987999876


Q ss_pred             CCCHHHHCCCC----------------CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf             11012211999----------------999998828899999999986368899999998889866
Q 001440         1025 DRTLDEILDPR----------------LPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQL 1074 (1077)
Q Consensus      1025 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 1074 (1077)
                      ...........                .+............+.+++.+|++.||++|||++|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf             566777764175435666421264333543210133379999999999876994579089999669

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=0  Score=314.08  Aligned_cols=257  Identities=18%  Similarity=0.241  Sum_probs=192.7

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCC-EEEEEEEEEECCEEEE
Q ss_conf             059774633224688229999956-99899999746885202457999999999930789996-0217989860995699
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRN-IVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~l  882 (1077)
                      .++|.+.+.||+|+||+||+|++. +|+.||||.+.....     ..++..|+++++.++|++ |+.+.++..+.+..++
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEE
T ss_conf             8889996898507880999999988998999999721005-----88899999999970389960179999951987789


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEECCCCCC
Q ss_conf             9960489999899824899878898889999999999999988379999584168889756589---9966991244533
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL---EYEAHVSDFGISK  959 (1077)
Q Consensus       883 V~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~---~~~~kl~Dfgla~  959 (1077)
                      ||||+++ ++.+.+....  ..+++..+..++.|++.|++|||++   +|+||||||+||+++.   +..++++|||+|+
T Consensus        81 vme~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~  154 (299)
T d1ckia_          81 VMELLGP-SLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  154 (299)
T ss_dssp             EEECCCC-BHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred             EEEECCC-CHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCE
T ss_conf             9987387-1333244306--8876899999999999999999979---94426678766064335777615650467513


Q ss_pred             CCCCCCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHC
Q ss_conf             4789999-------832433344424831224589897201788999999999399998733211135764211012211
Q 001440          960 SLKPDSS-------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEIL 1032 (1077)
Q Consensus       960 ~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 1032 (1077)
                      .+.....       ......||+.|+|||++.+..++.++||||||+++|||+||+.||............. .......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~-~~~~~~~  233 (299)
T d1ckia_         155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE-RISEKKM  233 (299)
T ss_dssp             ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HH-HHHHHHH
T ss_pred             ECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHH-HHHCCCC
T ss_conf             425544554100013577678735329999918998983218861778999984987665530577999999-8523567


Q ss_pred             CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             99999999882889999999998636889999999888986602
Q 001440         1033 DPRLPAPSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1033 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      ....+.   .....+..+.+++.+||+.+|++||+++++.+.|+
T Consensus       234 ~~~~~~---~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         234 STPIEV---LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             HSCHHH---HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             CCCHHH---HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf             898357---53478899999999984399557919999999999

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=320.77  Aligned_cols=254  Identities=23%  Similarity=0.338  Sum_probs=202.7

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC----CCCEEEEEECCCCCCC-HHHHHHHHHHHHHHHCCCCC-CCEEEEEEEEEECCE
Q ss_conf             59774633224688229999956----9989999974688520-24579999999999307899-960217989860995
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS----SGEIVAVKKFHSPLLS-EMTCQQEFLNEVKSLTEIRH-RNIVKFYGFCSHARH  879 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~  879 (1077)
                      ++|++.+.||+|+||+||+|+..    +|+.||+|.+...... +....+.+.+|+.++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf             02599989832878399999987658879489999983677210168999999999999864679839996200024873


Q ss_pred             EEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             69999604899998998248998788988899999999999999883799995841688897565899966991244533
Q 001440          880 SFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       880 ~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                      .++|+||+.+|+|.+++.....   ++......++.|++.|++|+|+.   +|+||||||+||+++.++.+||+|||+|+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             EEEEEECCCCCHHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf             0012312341179999873045---43788888899999999885149---98965477320124699988874132022


Q ss_pred             CCCCCC-CCCCCCCCCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC
Q ss_conf             478999-983243334442483122458--98972017889999999993999987332111357642110122119999
Q 001440          960 SLKPDS-SNWTELAGTIGYVAPELAYTM--KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDEILDPRL 1036 (1077)
Q Consensus       960 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~--~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 1036 (1077)
                      .+.... .......|++.|+|||.+...  .++.++||||+||++|||++|+.||......    ............+..
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~----~~~~~i~~~~~~~~~  253 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKSEP  253 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHCCC
T ss_pred             HHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHCCCCCC
T ss_conf             2034444322122233333106876057768871325177779999997689998888777----799999983356899


Q ss_pred             CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf             9999882889999999998636889999999-----888986
Q 001440         1037 PAPSCNIRDKLISIMEVAISCLDENPDSRPT-----MQKVSQ 1073 (1077)
Q Consensus      1037 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt-----~~ei~~ 1073 (1077)
                      +.+..    ....+.+++.+||++||++|||     ++|+++
T Consensus       254 ~~~~~----~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         254 PYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             CCCCC----CCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf             88654----799999999997445898819997450999974

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=0  Score=310.85  Aligned_cols=252  Identities=21%  Similarity=0.260  Sum_probs=194.2

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEEC--CEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789-99602179898609--9569
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHA--RHSF  881 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~  881 (1077)
                      ++|.+.+.||+|+||+||+|+.. +++.||+|++....      .+.+.+|+.+++.++ ||||+++++++...  ...+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEE
T ss_conf             67189789831748199999988999799999988899------999999999998515799876799999816877126


Q ss_pred             EEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEECCCCCCC
Q ss_conf             9996048999989982489987889888999999999999998837999958416888975658999-669912445334
Q 001440          882 IVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY-EAHVSDFGISKS  960 (1077)
Q Consensus       882 lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~-~~kl~Dfgla~~  960 (1077)
                      +||||+++++|..+.      ..++..++..++.|++.||+|||++   ||+||||||+|||++.++ .+|++|||+|+.
T Consensus       109 ~v~e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EEEECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EEEEECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf             888631798589974------6899999999999999999887643---3443456441237748998366415654266


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCC------------------
Q ss_conf             78999983243334442483122458-98972017889999999993999987332111357------------------
Q 001440          961 LKPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTS------------------ 1021 (1077)
Q Consensus       961 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~------------------ 1021 (1077)
                      ..... ......++..|+|||.+.+. .++.++||||+|+++||+++|+.||..........                  
T Consensus       180 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CCTTC-CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf             46887-44432248642476102688888845232335455587604889998876018999999998788415555542


Q ss_pred             --CCCCCCHHHHCCCCCC------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             --6421101221199999------999882889999999998636889999999888986
Q 001440         1022 --SNLDRTLDEILDPRLP------APSCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1022 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                        ................      ............+.+++.+||+.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             254447430000033343311211552112448999999999986699568908999964

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=0  Score=307.55  Aligned_cols=258  Identities=21%  Similarity=0.275  Sum_probs=196.5

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEE-CCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC-----C
Q ss_conf             05977463322468822999995-69989999974688520245799999999993078999602179898609-----9
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAEL-SSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNIVKFYGFCSHA-----R  878 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  878 (1077)
                      .++|.+.+.||+|+||+||+|+. .+|+.||||++...... ....+.+.+|+.+++.++|||++++++++...     .
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf             98718888983178839999999999979999998820028-68999999999999866898742599999634645668


Q ss_pred             EEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEECCCCC
Q ss_conf             56999960489999899824899878898889999999999999988379999584168889756589996699124453
Q 001440          879 HSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHVSDFGIS  958 (1077)
Q Consensus       879 ~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla  958 (1077)
                      ..+++++++.+|+|.+++...    .+++.++..++.|++.||+|||++   ||+||||||+||+++.++.+|++|||.+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a  168 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA  168 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred             CEEEEEEEECCCCHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf             649999962588623200224----530999999999999999999738---8765166776334554322001321000


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC---------------
Q ss_conf             3478999983243334442483122458-989720178899999999939999873321113576---------------
Q 001440          959 KSLKPDSSNWTELAGTIGYVAPELAYTM-KVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS--------------- 1022 (1077)
Q Consensus       959 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~--------------- 1022 (1077)
                      .....   ......|+..|+|||...+. .++.++||||+||++|+|++|+.||...........               
T Consensus       169 ~~~~~---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         169 RHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             -CCTG---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             CCCCC---CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf             12575---444434543555835533775678551243205899999768899788988999999997307997577320


Q ss_pred             CCCCCHHHHCCCCCCCCCCCC----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf             421101221199999999882----889999999998636889999999888986
Q 001440         1023 NLDRTLDEILDPRLPAPSCNI----RDKLISIMEVAISCLDENPDSRPTMQKVSQ 1073 (1077)
Q Consensus      1023 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 1073 (1077)
                      ................+....    ......+.+++.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf             0102445444303557875556626789999999999977588345938999855

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=0  Score=305.75  Aligned_cols=256  Identities=17%  Similarity=0.227  Sum_probs=196.7

Q ss_pred             HCCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEECCEEEE
Q ss_conf             059774633224688229999956-99899999746885202457999999999930789-9960217989860995699
Q 001440          805 TNDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       805 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  882 (1077)
                      .++|.+.+.||+|+||+||+|++. +|+.||||.+.....     ...+.+|++.++.++ |++++.+++++......++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
T ss_conf             9806997998417882999999988997999999750258-----29999999999996489998779999601881179


Q ss_pred             EEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEECCCC
Q ss_conf             9960489999899824899878898889999999999999988379999584168889756589-----99669912445
Q 001440          883 VYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDL-----EYEAHVSDFGI  957 (1077)
Q Consensus       883 V~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~-----~~~~kl~Dfgl  957 (1077)
                      ||||+ +++|.+++....  ..+++.++..++.|++.|++|||+.   ||+||||||+||+++.     ++.+|++|||+
T Consensus        79 vme~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             EEECC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEEEC-CCCHHHHHHHHC--CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCE
T ss_conf             99964-888799997520--3110689999999999999999977---96626677131523475434479568723660


Q ss_pred             CCCCCCCCC-------CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHH
Q ss_conf             334789999-------8324333444248312245898972017889999999993999987332111357642110122
Q 001440          958 SKSLKPDSS-------NWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSSNLDRTLDE 1030 (1077)
Q Consensus       958 a~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~ 1030 (1077)
                      |+.+.....       ......||+.|+|||++.+..++.++||||+|+++|||+||+.||.......     .......
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~~~~  227 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYER  227 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHH
T ss_pred             EEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-----HHHHHHH
T ss_conf             57714676654111024676277510267989648888869998983199999986987678853021-----9999999


Q ss_pred             HCCCCCCCC-CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHC
Q ss_conf             119999999-9882889999999998636889999999888986602
Q 001440         1031 ILDPRLPAP-SCNIRDKLISIMEVAISCLDENPDSRPTMQKVSQLLK 1076 (1077)
Q Consensus      1031 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 1076 (1077)
                      +...+...+ .......+..+.+++..|++.+|++||+++.+.+.|+
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~  274 (293)
T d1csna_         228 IGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS  274 (293)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             HHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf             97056799958965799899999999984399300859999999999

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=0  Score=282.63  Aligned_cols=260  Identities=18%  Similarity=0.223  Sum_probs=188.6

Q ss_pred             CCCCCCCEECCCCCCEEEEEEEC-CCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC-----------CCCEEEEEEE
Q ss_conf             59774633224688229999956-99899999746885202457999999999930789-----------9960217989
Q 001440          806 NDFDEEHCIGTGGQGSVYRAELS-SGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-----------HRNIVKFYGF  873 (1077)
Q Consensus       806 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~  873 (1077)
                      .+|.+.+.||+|+||+||+|+.. +|+.||||++.....    ..+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf             857998997507781899999999997999999834313----3689999999999840145555542276764789987


Q ss_pred             EEE--CCEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC---
Q ss_conf             860--995699996048999989982489987889888999999999999998837999958416888975658999---
Q 001440          874 CSH--ARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEY---  948 (1077)
Q Consensus       874 ~~~--~~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~---  948 (1077)
                      +..  ....+++++++..+..............+++..+..++.|++.|++|||+..  ||+||||||+|||++.++   
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred             EEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHEEEECCCCCC
T ss_conf             631256520234320003542000001223467868999999999999988876405--864656770570563057656


Q ss_pred             ---CEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCCCC---
Q ss_conf             ---66991244533478999983243334442483122458989720178899999999939999873321113576---
Q 001440          949 ---EAHVSDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLALEAIKGKHPRDFISSICSTSS--- 1022 (1077)
Q Consensus       949 ---~~kl~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~elltg~~pf~~~~~~~~~~~--- 1022 (1077)
                         .++++|||.|......   .....|++.|+|||++....++.++||||+|++++||++|+.||...........   
T Consensus       167 ~~~~~kl~dfg~s~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             TEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             CCCEEEEEECCCCCCCCCC---CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf             4430567531442123445---4223665210571321466777643201237899999878899898755432102689


Q ss_pred             ----------CCCCCH------HHHCC-----CCCCC------------CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf             ----------421101------22119-----99999------------9988288999999999863688999999988
Q 001440         1023 ----------NLDRTL------DEILD-----PRLPA------------PSCNIRDKLISIMEVAISCLDENPDSRPTMQ 1069 (1077)
Q Consensus      1023 ----------~~~~~~------~~~~~-----~~~~~------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 1069 (1077)
                                ......      ....+     .....            ...........+.+++.+|++.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf             99999983799878862453220001320122024323577644421000156743589999999998779945790899


Q ss_pred             HHHHH
Q ss_conf             89866
Q 001440         1070 KVSQL 1074 (1077)
Q Consensus      1070 ei~~~ 1074 (1077)
                      |+++.
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHHCC
T ss_conf             99669

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=3.8e-44  Score=256.30  Aligned_cols=252  Identities=32%  Similarity=0.542  Sum_probs=209.2

Q ss_pred             CCCCEEECCCCCCCC--CCCCCCCCCCCCCEECCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf             999888378998889--8999889867663414545-3457888997777575445531234687898998788776757
Q 001440          132 SKLKYLDLSSNSFSG--TIPPQIGNLSMLKILYLST-NQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAI  208 (1077)
Q Consensus       132 ~~L~~L~L~~n~~~~--~~p~~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~  208 (1077)
                      .+++.|+|++|.++|  .+|..+++|++|++|+|++ |.+.|.+|..|+.+++|++|+|++|++.+..+..+..+..|+.
T Consensus        50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCC
T ss_conf             79889989899888888798478467533520202654333002431145420011020356434433222220111001


Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCEECCCCCC
Q ss_conf             9834776788778755676656568820233468778667888877-768712588888878988877754035078988
Q 001440          209 MYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNL-ATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNS  287 (1077)
Q Consensus       209 L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~  287 (1077)
                      ++++.|.+.+.+|..+.+++.++.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+.. ..+++.++.
T Consensus       130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~  208 (313)
T d1ogqa_         130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNM  208 (313)
T ss_dssp             EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSE
T ss_pred             CCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
T ss_conf             1112245555685122067400000023553356203121443112323102246435332433222222-233333343


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf             98998642378878556876788888876887688788628983386233016823345453548867998574458988
Q 001440          288 LSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHS  367 (1077)
Q Consensus       288 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~  367 (1077)
                      ..+.+|..+..+++++.+++++|.+.+.++ .+..+++|+.|++++|.++|.+|..++++++|++|++++|+++|.+|. 
T Consensus       209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-  286 (313)
T d1ogqa_         209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-  286 (313)
T ss_dssp             EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-
T ss_conf             322222222222221112222222222222-222455444444765706660876884799999897958835166898-


Q ss_pred             CCCCCCCCEEECCCCC-CCC
Q ss_conf             7887655568756877-789
Q 001440          368 LGNLTNLATLYLFTNL-LSG  386 (1077)
Q Consensus       368 l~~l~~L~~L~l~~n~-l~~  386 (1077)
                      ++++++|+.+++.+|+ ++|
T Consensus       287 ~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         287 GGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             STTGGGSCGGGTCSSSEEES
T ss_pred             CCCCCCCCHHHHCCCCCCCC
T ss_conf             66679989788688950019

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=100.00  E-value=4.4e-38  Score=222.90  Aligned_cols=355  Identities=27%  Similarity=0.363  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             12588888878988877754035078988989986423788785568767888888768876887886289833862330
Q 001440          259 LHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG  338 (1077)
Q Consensus       259 L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~  338 (1077)
                      +..+.+++.+..  ..+.+|+.|+++++.+...  +.+..+++|+.|++++|++++..+  ++++++|++|++++|.+.+
T Consensus        29 l~~~~~~~~~~~--~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~  102 (384)
T d2omza2          29 LGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD  102 (384)
T ss_dssp             TTCSSTTSEECH--HHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf             677777886398--8957878998999898776--242458999989681881798863--3477110103013433322


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             16823345453548867998574458988788765556875687778999621347878884646888767885610103
Q 001440          339 SIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGNLNSLSDLGLSENELSGSIPYSFGN  418 (1077)
Q Consensus       339 ~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~  418 (1077)
                      ..+  ++.+++|+.++++++.+++..+  ......+.......|.+.......................+.     .+..
T Consensus       103 i~~--l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~  173 (384)
T d2omza2         103 ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK-----PLAN  173 (384)
T ss_dssp             CGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG-----GGTT
T ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHH-----HHCC
T ss_conf             221--1123343334433222222222--222222211213466313100232222112222212322011-----1124


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEECC
Q ss_conf             46445023236668688898667845576785636757899643001122224750588667877753344555414023
Q 001440          419 LTNMIVLSIYSNALSGAIPKEYGNLVKLTLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINL  498 (1077)
Q Consensus       419 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L  498 (1077)
                      ...........|..  .....+..++++..+++++|.+.+..+ ....+.|+.+.+.+|.++...  .+..+++++.+++
T Consensus       174 ~~~~~~~~~~~~~~--~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l  248 (384)
T d2omza2         174 LTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDIG--TLASLTNLTDLDL  248 (384)
T ss_dssp             CTTCCEEECCSSCC--CCCGGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEEC
T ss_pred             CCCCCCCCCCCCCC--CCCCCCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCC--HHHCCCCCCHHCC
T ss_conf             54211011222433--321100223532333035774478786-444577878888777778961--3432565341004


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCC
Q ss_conf             56522477776779989975798126623588998889999977997348846888822111788784898259614577
Q 001440          499 SHKKFYGEISFDWGKFPNLGTLDVSANNITGILPPEIGDSPQLKVLDLSSNHIVGEIPSELGKLRSLIKLTLNRNQFSGQ  578 (1077)
Q Consensus       499 ~~n~i~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~~~~L~~L~L~~N~l~~~  578 (1077)
                      ++|.+.+...  +..+++|++|+++.|.+....+  +..++.++.+.+..|.+.+  ...+..+++++.|++++|++++.
T Consensus       249 ~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l  322 (384)
T d2omza2         249 ANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDI  322 (384)
T ss_dssp             CSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCC
T ss_pred             CCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCC
T ss_conf             4674478775--3554668775456744578773--2356522223323233333--22100002467677778877898


Q ss_pred             CCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCHHCCCCCCCCCEECCCC
Q ss_conf             4321000123562321577456888885444334506641032235876110134533461101466
Q 001440          579 LPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHN  645 (1077)
Q Consensus       579 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N  645 (1077)
                      .+  +..+++|+.|++++|.+++..  .+..+++|++|++++|++++..+  +..+++|+.|+|++|
T Consensus       323 ~~--l~~l~~L~~L~L~~n~l~~l~--~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N  383 (384)
T d2omza2         323 SP--VSSLTKLQRLFFANNKVSDVS--SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ  383 (384)
T ss_dssp             GG--GGGCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred             CC--CCCCCCCCEEECCCCCCCCCH--HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf             45--366898898989899899974--67089999989897995899800--003999999639789

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.5e-35  Score=208.95  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=131.7

Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             99988885673241479983211467887533337864689998768976477323337836579999988837899888
Q 001440           66 ATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFS  145 (1077)
Q Consensus        66 ~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~~~~~~l~~l~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~  145 (1077)
                      |....-|.|.+|.|+.. ..+           ++|+. +  .+.+++|+|++|+++...+..|.++++|++|++++|.+.
T Consensus         4 ~p~~c~c~~~~~~C~~~-~L~-----------~lP~~-l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~   68 (305)
T d1xkua_           4 CPFRCQCHLRVVQCSDL-GLE-----------KVPKD-L--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS   68 (305)
T ss_dssp             CCTTCEEETTEEECTTS-CCC-----------SCCCS-C--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCEECCCEEEECCC-CCC-----------CCCCC-C--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf             99988955999985599-988-----------51988-8--999798978499189869657604656523112344344


Q ss_pred             CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf             98999889867663414545345788899777757544553123468789899878877675798347767887787556
Q 001440          146 GTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIG  225 (1077)
Q Consensus       146 ~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  225 (1077)
                      ...|..|.++++|++|++++|+++. +|..+  ...++.|++..|.+                        .+..+..+.
T Consensus        69 ~i~~~~f~~l~~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l------------------------~~l~~~~~~  121 (305)
T d1xkua_          69 KISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEI------------------------TKVRKSVFN  121 (305)
T ss_dssp             CBCTTTTTTCTTCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCC------------------------CBBCHHHHT
T ss_pred             CCCHHHHHCCCCCCEECCCCCCCCC-CCCCH--HHHHHHHHCCCCCH------------------------HHHHHHHHH
T ss_conf             5235665279855783156875676-76400--11132321024610------------------------234444540


Q ss_pred             CCCCCCEEEEECCCC--CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             766565688202334--687786678888777687125888888789888777540350789889899864237887855
Q 001440          226 NLKSLSGLELGYNKL--SGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLY  303 (1077)
Q Consensus       226 ~l~~L~~L~l~~n~l--~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~  303 (1077)
                      ....+..+....|..  ....+..+..+++|+.+++++|.++ .+|..+  .++|+.|++++|...+..+..+..++.++
T Consensus       122 ~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~  198 (305)
T d1xkua_         122 GLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA  198 (305)
T ss_dssp             TCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCC
T ss_conf             133110000123333346777642234565671203467745-167101--77667898978867788826764134133


Q ss_pred             EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             68767888888768876887886289833862330168233454535488679985744
Q 001440          304 GLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSG  362 (1077)
Q Consensus       304 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~  362 (1077)
                      .|++++|.+.+..+..+.++++|++|+|++|.++ .+|..+..+++|++|++++|+++.
T Consensus       199 ~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~  256 (305)
T d1xkua_         199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISA  256 (305)
T ss_dssp             EEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCC
T ss_conf             0154455332223454334433224302554002-463110334678989898986576

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=7.2e-34  Score=199.66  Aligned_cols=222  Identities=24%  Similarity=0.309  Sum_probs=86.2

Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf             66341454534578889977775754455312346878989987887767579834776788778755676656568820
Q 001440          157 MLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELG  236 (1077)
Q Consensus       157 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~  236 (1077)
                      ++++|+|++|+++...+.+|.++++|++|++++|.+....|..|.++++|+.|++++|+++ .+|..+  ...+..|.+.
T Consensus        32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~  108 (305)
T d1xkua_          32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVH  108 (305)
T ss_dssp             TCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECC
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCC-CCCCCH--HHHHHHHHCC
T ss_conf             9798978499189869657604656523112344344523566527985578315687567-676400--1113232102


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEECCCCCCCC--CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             233468778667888877768712588888--878988877754035078988989986423788785568767888888
Q 001440          237 YNKLSGSMPLSLGNLPNLATLDLHDNSLSG--SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSG  314 (1077)
Q Consensus       237 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  314 (1077)
                      .|.+....+..+.....+..++...|....  ..+..+..+++|+.+++++|.+..                        
T Consensus       109 ~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~------------------------  164 (305)
T d1xkua_         109 ENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT------------------------  164 (305)
T ss_dssp             SSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS------------------------
T ss_pred             CCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------------------------
T ss_conf             46102344445401331100001233333467776422345656712034677451------------------------


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             76887688788628983386233016823345453548867998574458988788765556875687778999621347
Q 001440          315 SIPSSLGNLTKLTILYLSDNLLFGSIPCEIGNLRYLFYLELGDNKLSGSIPHSLGNLTNLATLYLFTNLLSGSIPSEIGN  394 (1077)
Q Consensus       315 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~p~~l~~  394 (1077)
                       +|..+  +++|+.|++++|...+..+..+..++.++.|++++|.+.+..+..+.++++|++|++.+|.++ .+|.++..
T Consensus       165 -l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~  240 (305)
T d1xkua_         165 -IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD  240 (305)
T ss_dssp             -CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTT
T ss_pred             -CCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCC
T ss_conf             -67101--776678989788677888267641341330154455332223454334433224302554002-46311033


Q ss_pred             CCCCCEEECCCCCCC
Q ss_conf             878884646888767
Q 001440          395 LNSLSDLGLSENELS  409 (1077)
Q Consensus       395 l~~L~~L~L~~n~l~  409 (1077)
                      +++|+.|++++|+|+
T Consensus       241 l~~L~~L~Ls~N~i~  255 (305)
T d1xkua_         241 HKYIQVVYLHNNNIS  255 (305)
T ss_dssp             CSSCCEEECCSSCCC
T ss_pred             CCCCCEEECCCCCCC
T ss_conf             467898989898657

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-35  Score=205.26  Aligned_cols=206  Identities=27%  Similarity=0.268  Sum_probs=112.3

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCC-CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             987689764773233378365799999888378998889899988986766341454-5345788899777757544553
Q 001440          108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLS-TNQFSGRIPPQIGHLSYLKALH  186 (1077)
Q Consensus       108 ~~l~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~-~n~~~~~~p~~~~~l~~L~~L~  186 (1077)
                      +.+++|+|++|++++..+..|.+++.|++|++++|.+....+..+..+..++.++.. .|.+....+..|.++++|++|+
T Consensus        32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~  111 (284)
T d1ozna_          32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH  111 (284)
T ss_dssp             TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCEEE
T ss_conf             99888977488179879778641421300001344543321112122222222222210223544620101010277875


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             12346878989987887767579834776788778755676656568820233468778667888877768712588888
Q 001440          187 LFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSG  266 (1077)
Q Consensus       187 L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~  266 (1077)
                      +++|.+....+..+....+|+.+++++|++++..+..|..+++|+.|++++|.++...+..|.++++|+.+++++|++++
T Consensus       112 l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~  191 (284)
T d1ozna_         112 LDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH  191 (284)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE
T ss_pred             CCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHHCCCCC
T ss_conf             68854432013533200012110200143144580574043405022314176566256665465634131421143466


Q ss_pred             CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             87898887775403507898898998642378878556876788888
Q 001440          267 SIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLS  313 (1077)
Q Consensus       267 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~  313 (1077)
                      ..|..|.++++|+.|++++|++.+..+..+..+++|+.|++++|++.
T Consensus       192 i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             ECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf             28167665320002333335221000002355465688981199887

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-34  Score=203.74  Aligned_cols=213  Identities=27%  Similarity=0.264  Sum_probs=150.9

Q ss_pred             CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECC-CCCCCCCCCCCCCC
Q ss_conf             78365799999888378998889899988986766341454534578889977775754455312-34687898998788
Q 001440          124 IPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLF-ENGLSGSIPPSLGN  202 (1077)
Q Consensus       124 ~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~-~n~l~~~~p~~~~~  202 (1077)
                      +|..+.  +.+++|+|++|.++...+..|.++++|++|++++|.+....+..+..+..++.+... .+.+....+..|.+
T Consensus        26 iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~  103 (284)
T d1ozna_          26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG  103 (284)
T ss_dssp             CCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTT
T ss_pred             CCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCC
T ss_conf             497889--998889774881798797786414213000013445433211121222222222222102235446201010


Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEC
Q ss_conf             77675798347767887787556766565688202334687786678888777687125888888789888777540350
Q 001440          203 LTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILN  282 (1077)
Q Consensus       203 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~  282 (1077)
                      +++|+.|++++|.+....+..+....+|+.+++++|.+++..+..|..+++|+.|++++|++++..+..|.++++|+.++
T Consensus       104 l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~  183 (284)
T d1ozna_         104 LGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (284)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             CCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHH
T ss_conf             10277875688544320135332000121102001431445805740434050223141765662566654656341314


Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             78988989986423788785568767888888768876887886289833862330
Q 001440          283 LPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLFG  338 (1077)
Q Consensus       283 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~  338 (1077)
                      +++|++.+..|..|..+++|+.|++++|++.+..+..+.++++|+.|++++|.+.+
T Consensus       184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C  239 (284)
T d1ozna_         184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC  239 (284)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred             HHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
T ss_conf             21143466281676653200023333352210000023554656889811998878

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-30  Score=182.13  Aligned_cols=83  Identities=24%  Similarity=0.301  Sum_probs=36.1

Q ss_pred             CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             98768976477323337836579999988837899888989998898676634145453457888997777575445531
Q 001440          108 PHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHL  187 (1077)
Q Consensus       108 ~~l~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L  187 (1077)
                      +.+++|+|++|.+.+..+..|.++++|++|+|++|.++. +| .++.+++|++|+|++|++.. .+..+..+++|+.|++
T Consensus        31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l  107 (266)
T d1p9ag_          31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDV  107 (266)
T ss_dssp             TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEEC
T ss_pred             CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCC
T ss_conf             688989884992898597786345655221356654444-31-11112232111112222211-1112122222222222


Q ss_pred             CCCCCC
Q ss_conf             234687
Q 001440          188 FENGLS  193 (1077)
Q Consensus       188 ~~n~l~  193 (1077)
                      ++|.+.
T Consensus       108 ~~~~~~  113 (266)
T d1p9ag_         108 SFNRLT  113 (266)
T ss_dssp             CSSCCC
T ss_pred             CCCCCC
T ss_conf             223110

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-30  Score=181.53  Aligned_cols=194  Identities=24%  Similarity=0.267  Sum_probs=91.8

Q ss_pred             EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf             97647732333783657999998883789988898999889867663414545345788899777757544553123468
Q 001440          113 LDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGL  192 (1077)
Q Consensus       113 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l  192 (1077)
                      .+.++++++. +|..+.  +.+++|+|++|.+++..+..|.++++|++|+|++|+++.. | .++.+++|+.|+      
T Consensus        15 v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~------   83 (266)
T d1p9ag_          15 VNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLD------   83 (266)
T ss_dssp             EECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEE------
T ss_pred             EECCCCCCCE-ECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCC------
T ss_conf             9806999886-196757--6889898849928985977863456552213566544443-1-111122321111------


Q ss_pred             CCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf             78989987887767579834776788778755676656568820233468778667888877768712588888878988
Q 001440          193 SGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSF  272 (1077)
Q Consensus       193 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  272 (1077)
                                        +++|+++ .++..+..+++|+.|++++|.+....+..+..+.++++|++++|.++...+..+
T Consensus        84 ------------------Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~  144 (266)
T d1p9ag_          84 ------------------LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL  144 (266)
T ss_dssp             ------------------CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT
T ss_pred             ------------------CCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCC
T ss_conf             ------------------1222221-111121222222222222231101100112222111122124342102212333


Q ss_pred             CCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             87775403507898898998642378878556876788888876887688788628983386233
Q 001440          273 GNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSDNLLF  337 (1077)
Q Consensus       273 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~n~l~  337 (1077)
                      ..+++++.+++++|++++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+.
T Consensus       145 ~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~  208 (266)
T d1p9ag_         145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL  208 (266)
T ss_dssp             TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred             CCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCC
T ss_conf             22111000000015652237200134212423430139785-56866777888999983699987

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.96  E-value=4.7e-25  Score=151.11  Aligned_cols=53  Identities=25%  Similarity=0.310  Sum_probs=23.1

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             8768976477323337836579999988837899888989998898676634145453457
Q 001440          109 HLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS  169 (1077)
Q Consensus       109 ~l~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~  169 (1077)
                      ++++|||+++.++. +|+.   +++|++|+|++|+++ .+|..+   .+|+.|++++|+++
T Consensus        39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~   91 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK   91 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS
T ss_pred             CCCEEEECCCCCCC-CCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC
T ss_conf             99899937999887-8898---789888989999796-336203---32033266551432

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.95  E-value=1.3e-24  Score=148.73  Aligned_cols=33  Identities=24%  Similarity=0.337  Sum_probs=16.6

Q ss_pred             CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             9988837899888989998898676634145453457
Q 001440          133 KLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS  169 (1077)
Q Consensus       133 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~  169 (1077)
                      ++++|+|+++.++ .+|+.   +++|++|++++|+++
T Consensus        39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~   71 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT   71 (353)
T ss_dssp             TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS
T ss_pred             CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC
T ss_conf             9989993799988-78898---789888989999796

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.3e-31  Score=185.84  Aligned_cols=110  Identities=26%  Similarity=0.173  Sum_probs=40.6

Q ss_pred             CCCEEECCCCCCCCCCCHHH----HCCCCCCEEECCCCCCCCCCC----CCC-CCCCCCEEEEECCCCCCCCCC----HH
Q ss_conf             78489825961457743210----001235623215774568888----854-443345066410322358761----10
Q 001440          564 SLIKLTLNRNQFSGQLPTEL----GSLIQLEHLDLSSNRLSNSIP----GSL-GNLVKLYYLNLSNNQFSGEIP----IK  630 (1077)
Q Consensus       564 ~L~~L~L~~N~l~~~~~~~l----~~l~~L~~L~Ls~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~~~~----~~  630 (1077)
                      .|+.+++++|.++......+    ...++|++|+|++|.+++...    +.+ ...+.|++|++++|.|++...    ..
T Consensus       313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~  392 (460)
T d1z7xw1         313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  392 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHH
T ss_conf             43333233341023344321332211011113201210135766400111220456777889897997975999999999


Q ss_pred             CCCCCCCCCEECCCCCCCCCCCCCCC-----CCCCCCHHCCCCCCCCC
Q ss_conf             13453346110146658997740010-----22321120245663456
Q 001440          631 LEKFIHLSDLDLSHNFLGEEIPSQVC-----SMQSLEKLNLAHNNLSG  673 (1077)
Q Consensus       631 ~~~~~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~~  673 (1077)
                      +..+++|++|++++|+|+......+.     ....|+.|++.+|.+..
T Consensus       393 l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         393 LLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             HHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             HHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCH
T ss_conf             962998898989999698799999999997478866789898987898

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=4.2e-27  Score=162.39  Aligned_cols=174  Identities=17%  Similarity=0.165  Sum_probs=122.2

Q ss_pred             CCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCC---------------HHHHHHHHHHHHHHHCCCCCCCEEEEEE
Q ss_conf             7746332246882299999569989999974688520---------------2457999999999930789996021798
Q 001440          808 FDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLS---------------EMTCQQEFLNEVKSLTEIRHRNIVKFYG  872 (1077)
Q Consensus       808 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------~~~~~~~~~~e~~~l~~l~h~niv~l~~  872 (1077)
                      +.+.++||+|+||+||+|...+|+.||||.++.....               ..........|...+..+.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf             02277802485659999997999999999986044346665565630008889999997789999999816999144998


Q ss_pred             EEEECCEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf             98609956999960489999899824899878898889999999999999988379999584168889756589996699
Q 001440          873 FCSHARHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCFPPIVYRDISSKNVLLDLEYEAHV  952 (1077)
Q Consensus       873 ~~~~~~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dlk~~Nill~~~~~~kl  952 (1077)
                      +..    .+++|||++++...          .++......++.|++.+++|||+.   ||+|+||||+||+++.+ .+++
T Consensus        82 ~~~----~~lvme~~~~~~~~----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          82 WEG----NAVLMELIDAKELY----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             EET----TEEEEECCCCEEGG----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred             ECC----CEEEEEEECCCCCC----------CHHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEE
T ss_conf             628----88999950456542----------001578999999999999998268---88983689036114289-8999


Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf             12445334789999832433344424831224589897201788999999
Q 001440          953 SDFGISKSLKPDSSNWTELAGTIGYVAPELAYTMKVTEKSDVYSFGVLAL 1002 (1077)
Q Consensus       953 ~Dfgla~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 1002 (1077)
                      +|||.|+....+... .....+... -.+. ..+.|+.++|+||..--+.
T Consensus       144 iDFG~a~~~~~~~~~-~~l~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         144 IDFPQSVEVGEEGWR-EILERDVRN-IITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCCTTCEETTSTTHH-HHHHHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EECCCCCCCCCCCCH-HHHHHHHHH-HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf             877884308998709-999877999-9999-7578998446899999874

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.8e-25  Score=153.40  Aligned_cols=222  Identities=15%  Similarity=0.098  Sum_probs=109.0

Q ss_pred             CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CC
Q ss_conf             85673241479983211467887533337864689998768976477323337836579999988837899888989-99
Q 001440           72 CAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTI-PP  150 (1077)
Q Consensus        72 C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~~~~~~l~~l~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~-p~  150 (1077)
                      |++..|.|...           ++. .+++. +  .+.+++|+|++|.+....+..|.++++|++|+|++|.+...+ +.
T Consensus         8 C~~~~i~c~~~-----------~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~   72 (242)
T d1xwdc1           8 CSNRVFLCQES-----------KVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD   72 (242)
T ss_dssp             ECSSEEEEESC-----------SCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS
T ss_pred             CCCCEEEEECC-----------CCC-CCCCC-C--CCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECC
T ss_conf             73999998189-----------988-76888-8--998899987699189649668614643232110221124201001


Q ss_pred             CCCCCCCCCEECCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf             889867663414545-3457888997777575445531234687898998788776757983477678877875567665
Q 001440          151 QIGNLSMLKILYLST-NQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKS  229 (1077)
Q Consensus       151 ~~~~l~~L~~L~l~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~  229 (1077)
                      .|.+++.++++++.. |.+....+..|.++++|+.+++.+|.+....+..                       .+..+..
T Consensus        73 ~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~-----------------------~~~~l~~  129 (242)
T d1xwdc1          73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH-----------------------KIHSLQK  129 (242)
T ss_dssp             SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT-----------------------TTCBSSC
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC-----------------------CCCCCCC
T ss_conf             12222222221111123432222221222222222234211112554333-----------------------2221111


Q ss_pred             CCEEEEECCCCCCCCCCCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf             65688202334687786678888-77768712588888878988877754035078988989986423788785568767
Q 001440          230 LSGLELGYNKLSGSMPLSLGNLP-NLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMGNLKSLYGLGLS  308 (1077)
Q Consensus       230 L~~L~l~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls  308 (1077)
                      +..+..+++.+....+..+.+++ .++.|++++|+++...+..|......+.+++++|+++...+..|..+++|+.|+++
T Consensus       130 l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls  209 (242)
T d1xwdc1         130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS  209 (242)
T ss_dssp             EEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECT
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECC
T ss_conf             22222221211122222222223310012200123333222222201110121235432464247886689999989897


Q ss_pred             CCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             88888876887688788628983
Q 001440          309 FNKLSGSIPSSLGNLTKLTILYL  331 (1077)
Q Consensus       309 ~N~l~~~~p~~~~~l~~L~~L~L  331 (1077)
                      +|+++...+..+.++++|+.+++
T Consensus       210 ~N~l~~l~~~~~~~l~~L~~l~~  232 (242)
T d1xwdc1         210 RTRIHSLPSYGLENLKKLRARST  232 (242)
T ss_dssp             TSCCCCCCSSSCTTCCEEESSSE
T ss_pred             CCCCCCCCHHHHCCCCCCCCCCC
T ss_conf             99289459779737713414767

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5e-30  Score=178.49  Aligned_cols=86  Identities=23%  Similarity=0.206  Sum_probs=30.2

Q ss_pred             CCCEEECCCCCCCCCCCCCC----CCCCCCEEEEECCCCCCCCCCHHC-----CCCCCCCCEECCCCCCCCC----CCCC
Q ss_conf             35623215774568888854----443345066410322358761101-----3453346110146658997----7400
Q 001440          588 QLEHLDLSSNRLSNSIPGSL----GNLVKLYYLNLSNNQFSGEIPIKL-----EKFIHLSDLDLSHNFLGEE----IPSQ  654 (1077)
Q Consensus       588 ~L~~L~Ls~N~l~~~~~~~~----~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~L~~L~Ls~N~l~~~----~~~~  654 (1077)
                      .|+.+++++|.++......+    ...++|++|+|++|++++.....+     .....|+.|+|++|.|+..    +...
T Consensus       313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~  392 (460)
T d1z7xw1         313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT  392 (460)
T ss_dssp             CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred             CCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHH
T ss_conf             43333233341023344321332211011113201210135766400111220456777889897997975999999999


Q ss_pred             CCCCCCCCHHCCCCCCCCC
Q ss_conf             1022321120245663456
Q 001440          655 VCSMQSLEKLNLAHNNLSG  673 (1077)
Q Consensus       655 ~~~l~~L~~L~l~~N~l~~  673 (1077)
                      +...++|++|++++|++++
T Consensus       393 l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         393 LLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHHCCCCCEEECCSSSCCH
T ss_pred             HHCCCCCCEEECCCCCCCH
T ss_conf             9629988989899996987

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=5.6e-25  Score=150.67  Aligned_cols=180  Identities=17%  Similarity=0.059  Sum_probs=68.6

Q ss_pred             CCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEE
Q ss_conf             6634145453457888997777575445531234687898-9987887767579834-7767887787556766565688
Q 001440          157 MLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSI-PPSLGNLTNLAIMYLY-NNSLSGSIPSEIGNLKSLSGLE  234 (1077)
Q Consensus       157 ~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~-~n~l~~~~p~~~~~l~~L~~L~  234 (1077)
                      ++++||+++|.+....+..|.++++|++|++++|.+...+ +..|.+++.++.+.+. .|.+....+..|.++++|+.++
T Consensus        30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~  109 (242)
T d1xwdc1          30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL  109 (242)
T ss_dssp             CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEE
T ss_pred             CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf             88999876991896496686146432321102211242010011222222222111112343222222122222222223


Q ss_pred             EECCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCEECCCCCCCCCCCCCCCCCCCCCCEE-ECCCCC
Q ss_conf             20233468778-6678888777687125888888789888777-54035078988989986423788785568-767888
Q 001440          235 LGYNKLSGSMP-LSLGNLPNLATLDLHDNSLSGSIPLSFGNLT-NLDILNLPHNSLSGSIPSEMGNLKSLYGL-GLSFNK  311 (1077)
Q Consensus       235 l~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~n~l~~~~p~~~~~l~~L~~L-~Ls~N~  311 (1077)
                      +.+|.+....+ ..+..+..+..+...++.+....+..|.++. .++.|++++|+++... .......++..+ .+++|+
T Consensus       110 l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~-~~~~~~~~l~~~~~l~~n~  188 (242)
T d1xwdc1         110 ISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIH-NCAFNGTQLDELNLSDNNN  188 (242)
T ss_dssp             EESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEEC-TTTTTTCCEEEEECTTCTT
T ss_pred             CCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-CCCCCCHHHHCCCCCCCCC
T ss_conf             421111255433322211112222222121112222222222331001220012333322-2222201110121235432


Q ss_pred             CCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             88876887688788628983386233
Q 001440          312 LSGSIPSSLGNLTKLTILYLSDNLLF  337 (1077)
Q Consensus       312 l~~~~p~~~~~l~~L~~L~L~~n~l~  337 (1077)
                      ++...+..|.++++|+.|++++|.+.
T Consensus       189 l~~l~~~~f~~l~~L~~L~Ls~N~l~  214 (242)
T d1xwdc1         189 LEELPNDVFHGASGPVILDISRTRIH  214 (242)
T ss_dssp             CCCCCTTTTTTSCCCSEEECTTSCCC
T ss_pred             CCCCCHHHHCCCCCCCEEECCCCCCC
T ss_conf             46424788668999998989799289

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.92  E-value=2.4e-24  Score=147.23  Aligned_cols=17  Identities=35%  Similarity=0.270  Sum_probs=6.0

Q ss_pred             CCCCCCCCEECCCCCCC
Q ss_conf             89867663414545345
Q 001440          152 IGNLSMLKILYLSTNQF  168 (1077)
Q Consensus       152 ~~~l~~L~~L~l~~n~~  168 (1077)
                      +..+++|++|++++|.+
T Consensus        59 l~~l~~L~~L~ls~n~i   75 (227)
T d1h6ua2          59 VQYLNNLIGLELKDNQI   75 (227)
T ss_dssp             GGGCTTCCEEECCSSCC
T ss_pred             HHCCCCCCEEECCCCEE
T ss_conf             74488883763578532

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.90  E-value=5e-24  Score=145.42  Aligned_cols=138  Identities=23%  Similarity=0.288  Sum_probs=84.9

Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCC
Q ss_conf             99988885673241479983211467887533337864689998768976477323337-83657999998883789988
Q 001440           66 ATKISPCAWFGIHCNHAGKVNSINLTSAGLIGTLHDFSFSSFPHLAYLDLRVNQIFGII-PSQIANNSKLKYLDLSSNSF  144 (1077)
Q Consensus        66 ~~~~~~C~w~gv~C~~~~~v~~l~l~~~~~~~~l~~~~~~~l~~l~~L~L~~n~~~~~~-p~~~~~l~~L~~L~L~~n~~  144 (1077)
                      |+...-|+|..|.|+..           +++ ++|+. +  .+++++|+|++|.|++.+ +..|.++++|++|+|++|.+
T Consensus         2 CP~~C~C~~~~v~Cs~~-----------~L~-~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i   66 (192)
T d1w8aa_           2 CPAMCHCEGTTVDCTGR-----------GLK-EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQL   66 (192)
T ss_dssp             CCTTSEEETTEEECTTS-----------CCS-SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCC
T ss_pred             CCCCCEECCCEEEEECC-----------CCC-CCCCC-C--CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCC
T ss_conf             39998976999997089-----------967-02989-8--978788984898775530200257876272130136322


Q ss_pred             CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             89899988986766341454534578889977775754455312346878989987887767579834776788
Q 001440          145 SGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLSG  218 (1077)
Q Consensus       145 ~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~  218 (1077)
                      ....+..|..+++|++|+|++|++....+..|.++++|+.|+|++|++++..+..|..+++|++++|++|.+..
T Consensus        67 ~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~  140 (192)
T d1w8aa_          67 TGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC  140 (192)
T ss_dssp             CCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred             CCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             12121222112222101003553443497998079746552457745353597785687533420003644343

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.90  E-value=1.3e-23  Score=143.12  Aligned_cols=104  Identities=28%  Similarity=0.337  Sum_probs=35.6

Q ss_pred             CCCEEECCCCCCCCCC-CCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf             9988837899888989-998898676634145453457888997777575445531234687898998788776757983
Q 001440          133 KLKYLDLSSNSFSGTI-PPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYL  211 (1077)
Q Consensus       133 ~L~~L~L~~n~~~~~~-p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L  211 (1077)
                      .+++|+|++|.+++.+ +..|.++++|++|+|++|.+....+..+..+++|++|+|++|++++..+..|.++++|+.|+|
T Consensus        30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L  109 (192)
T d1w8aa_          30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL  109 (192)
T ss_dssp             TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred             CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHHCCCCCCCCCC
T ss_conf             87889848987755302002578762721301363221212122211222210100355344349799807974655245


Q ss_pred             CCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf             4776788778755676656568820
Q 001440          212 YNNSLSGSIPSEIGNLKSLSGLELG  236 (1077)
Q Consensus       212 ~~n~l~~~~p~~~~~l~~L~~L~l~  236 (1077)
                      ++|++++..+++|..+++|++|+|+
T Consensus       110 ~~N~l~~i~~~~f~~l~~L~~l~L~  134 (192)
T d1w8aa_         110 YDNQISCVMPGSFEHLNSLTSLNLA  134 (192)
T ss_dssp             CSSCCCEECTTSSTTCTTCCEEECT
T ss_pred             CCCCCCCCCHHHHCCCCCCCCCCCC
T ss_conf             7745353597785687533420003

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.88  E-value=2.6e-22  Score=136.00  Aligned_cols=180  Identities=29%  Similarity=0.416  Sum_probs=0.0

Q ss_pred             ECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf             37899888989998898676634145453457888997777575445531234687898998788776757983477678
Q 001440          138 DLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNNSLS  217 (1077)
Q Consensus       138 ~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~  217 (1077)
                      .+..+.+++.++.  ..+.+|++|++++|.+....+  +..+++|++|++++|++++..+  ++.+++|+.|++++|+++
T Consensus        30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~  103 (210)
T d1h6ta2          30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK  103 (210)
T ss_dssp             HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred             HHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
T ss_conf             8575765775188--795484589782798887444--7648998987698960258601--135862120143333321


Q ss_pred             CCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCC
Q ss_conf             87787556766565688202334687786678888777687125888888789888777540350789889899864237
Q 001440          218 GSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGNLTNLDILNLPHNSLSGSIPSEMG  297 (1077)
Q Consensus       218 ~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~  297 (1077)
                       .+| .+..+++|+.|++++|.+....+  +..++.++.+++++|.+++  +..+..+++|+.+++++|++++..+  +.
T Consensus       104 -~l~-~l~~l~~L~~L~l~~~~~~~~~~--l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~--l~  175 (210)
T d1h6ta2         104 -DLS-SLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVP--LA  175 (210)
T ss_dssp             -CGG-GGTTCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred             -CCC-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf             -222-12122211122345653221122--0111112221122233345--4310001332100134643025645--36


Q ss_pred             CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf             887855687678888887688768878862898338
Q 001440          298 NLKSLYGLGLSFNKLSGSIPSSLGNLTKLTILYLSD  333 (1077)
Q Consensus       298 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~  333 (1077)
                      ++++|+.|++++|+++ .++ .+.++++|++|++++
T Consensus       176 ~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~  209 (210)
T d1h6ta2         176 GLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS  209 (210)
T ss_dssp             TCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred             CCCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf             7898999989799899-872-116999989997118

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.87  E-value=9.5e-22  Score=132.88  Aligned_cols=175  Identities=26%  Similarity=0.396  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf             64773233378365799999888378998889899988986766341454534578889977775754455312346878
Q 001440          115 LRVNQIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSG  194 (1077)
Q Consensus       115 L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~  194 (1077)
                      ++.+.+++.++..  .+.++++|++++|.++..  +.+..+++|++|++++|++++..|  +.++++|++|++++|.+..
T Consensus        25 l~~~~~~~~~~~~--~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~   98 (199)
T d2omxa2          25 LGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD   98 (199)
T ss_dssp             TTCSSTTSEECHH--HHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred             HCCCCCCCCCCHH--HHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf             6778778855987--946878998999999775--202137886757545655667640--1677522311112222222


Q ss_pred             CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf             98998788776757983477678877875567665656882023346877866788887776871258888887898887
Q 001440          195 SIPPSLGNLTNLAIMYLYNNSLSGSIPSEIGNLKSLSGLELGYNKLSGSMPLSLGNLPNLATLDLHDNSLSGSIPLSFGN  274 (1077)
Q Consensus       195 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~  274 (1077)
                      ..+  +.+++.|+.|++++|......+  +..+++|+.|++++|++....+  +..+++|+.|++++|++++..+  +++
T Consensus        99 ~~~--l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--l~~~~~L~~L~l~~n~l~~l~~--l~~  170 (199)
T d2omxa2          99 ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLNFSSNQVTDLKP--LAN  170 (199)
T ss_dssp             CGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTT
T ss_pred             CCC--CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCC
T ss_conf             211--1112232221112222223210--0012236776431111002343--3321111112234555567701--167


Q ss_pred             CCCCCEECCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf             7754035078988989986423788785568
Q 001440          275 LTNLDILNLPHNSLSGSIPSEMGNLKSLYGL  305 (1077)
Q Consensus       275 l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L  305 (1077)
                      +++|+.|++++|++++..+  +..+++|+.|
T Consensus       171 l~~L~~L~ls~N~i~~i~~--l~~L~~L~~L  199 (199)
T d2omxa2         171 LTTLERLDISSNKVSDISV--LAKLTNLESL  199 (199)
T ss_dssp             CTTCCEEECCSSCCCCCGG--GGGCTTCSEE
T ss_pred             CCCCCEEECCCCCCCCCCC--CCCCCCCCCC
T ss_conf             9989999787997998810--1278998949

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.80  E-value=6.2e-22  Score=133.90  Aligned_cols=13  Identities=31%  Similarity=0.337  Sum_probs=5.0

Q ss_pred             CCEEEEECCCCCC
Q ss_conf             4506641032235
Q 001440          612 KLYYLNLSNNQFS  624 (1077)
Q Consensus       612 ~L~~L~L~~N~l~  624 (1077)
                      .|++|++++|.|+
T Consensus       274 ~L~~L~ls~N~i~  286 (344)
T d2ca6a1         274 GLQTLRLQYNEIE  286 (344)
T ss_dssp             CCCEEECCSSCCB
T ss_pred             CCCEEECCCCCCC
T ss_conf             8898989898698

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.79  E-value=5e-22  Score=134.43  Aligned_cols=41  Identities=22%  Similarity=0.147  Sum_probs=15.7

Q ss_pred             CCCCCCEEEEECCCCCCCCCCHHCC------CCCCCCCEECCCCCCC
Q ss_conf             4433450664103223587611013------4533461101466589
Q 001440          608 GNLVKLYYLNLSNNQFSGEIPIKLE------KFIHLSDLDLSHNFLG  648 (1077)
Q Consensus       608 ~~l~~L~~L~L~~N~l~~~~~~~~~------~~~~L~~L~Ls~N~l~  648 (1077)
                      ...++|++|++++|.|++.....+.      ....|+.|++++|+|+
T Consensus       240 ~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~  286 (344)
T d2ca6a1         240 KSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE  286 (344)
T ss_dssp             GGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCB
T ss_pred             CCCCCCHHHHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCC
T ss_conf             23221111030047567156678887763156888898989898698

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=2.7e-20  Score=124.90  Aligned_cols=261  Identities=15%  Similarity=0.103  Sum_probs=0.0

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCC-CCCCCCCCCCCEEECCCC
Q ss_conf             6785636757899643001122224750588667877753344555414023565224777-767799899757981266
Q 001440          447 TLLVLSYNQLQGPIPDLRNLTRLARVRLDRNHLTGNISESFGIHSNLSYINLSHKKFYGEI-SFDWGKFPNLGTLDVSAN  525 (1077)
Q Consensus       447 ~~L~Ls~N~l~~~~~~l~~l~~L~~L~L~~n~l~~~~~~~~~~~~~L~~L~L~~n~i~~~~-~~~~~~~~~L~~L~L~~n  525 (1077)
                      +++|++++.+......----.....+++....+.......+... .+++|+++++.+.... ...+..+++|++|++++|
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~~~~~~lrl~~~~~~~~~~~~~~~~-~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~   81 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGL   81 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHHTTCSEEECTTCEECSCCCSCCCCB-CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTC
T ss_pred             CEEECCCCCCCCHHHHHHHHCCCEEEECCCCCCCCCHHHHCCCC-CCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf             77978999788147999874554274652333455224425678-78878898984577799999974877651452346


Q ss_pred             CCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCHHHC-CCCCCCEEECCC-CCCCCCCCHHHHC--CCCCCEEECCCC--C
Q ss_conf             23588998889999977997348-846888822111-788784898259-6145774321000--123562321577--4
Q 001440          526 NITGILPPEIGDSPQLKVLDLSS-NHIVGEIPSELG-KLRSLIKLTLNR-NQFSGQLPTELGS--LIQLEHLDLSSN--R  598 (1077)
Q Consensus       526 ~l~~~~~~~~~~l~~L~~L~L~~-n~l~~~~~~~l~-~~~~L~~L~L~~-N~l~~~~~~~l~~--l~~L~~L~Ls~N--~  598 (1077)
                      .+.+.....+..+++|+.|++++ +.+++.....+. .+++|++|++++ +.+++........  .+.|+.|+++++  .
T Consensus        82 ~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~  161 (284)
T d2astb2          82 RLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKN  161 (284)
T ss_dssp             BCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGG
T ss_pred             CCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCC
T ss_conf             79867899985189975715100134123554036578874356522453323332200010001111101221355424


Q ss_pred             CCCCCCCCC-CCCCCCEEEEECCCC-CCCCCCHHCCCCCCCCCEECCC-CCCCCCCCCCCCCCCCCCHHCCCCCCCCCCC
Q ss_conf             568888854-443345066410322-3587611013453346110146-6589977400102232112024566345653
Q 001440          599 LSNSIPGSL-GNLVKLYYLNLSNNQ-FSGEIPIKLEKFIHLSDLDLSH-NFLGEEIPSQVCSMQSLEKLNLAHNNLSGFI  675 (1077)
Q Consensus       599 l~~~~~~~~-~~l~~L~~L~L~~N~-l~~~~~~~~~~~~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~  675 (1077)
                      +++.....+ ..+++|++|++++|. +++.....+..+++|++|++++ +.++......+..+++|++|++.++--....
T Consensus       162 i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~l  241 (284)
T d2astb2         162 LQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL  241 (284)
T ss_dssp             SCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTCH
T ss_pred             CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECCCCHHHH
T ss_conf             44443434232322212355322347783033332135768779899999787378999726999898964488898999


Q ss_pred             CHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf             101211566408831477146989997423568722
Q 001440          676 PRCFKEMHGLVYIDISYNKLHGPIPNSAAFKHAPME  711 (1077)
Q Consensus       676 ~~~l~~l~~L~~l~l~~N~l~~~~~~~~~~~~~~~~  711 (1077)
                      ......+|+|..   +.++++...+...........
T Consensus       242 ~~l~~~lp~L~i---~~~~ls~~~~~~~~~~~~~~i  274 (284)
T d2astb2         242 QLLKEALPHLQI---NCSHFTTIARPTIGNKKNQEI  274 (284)
T ss_dssp             HHHHHHSTTSEE---SCCCSCCTTCSSCSSTTCCCB
T ss_pred             HHHHHHCCCCCC---CCCCCCCCCCCCCCCCCCCHH
T ss_conf             999976843661---686587777885476664001

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.71  E-value=2.4e-18  Score=114.15  Aligned_cols=131  Identities=23%  Similarity=0.195  Sum_probs=0.0

Q ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf             83657999998883789988898999889867663414545345788899777757544553123468789899878877
Q 001440          125 PSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLT  204 (1077)
Q Consensus       125 p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~  204 (1077)
                      ...+.+..++++|+|++|+++ .+|..+..+++|++|||++|.++..  +.+..+++|++|++++|+++...+..+..++
T Consensus        11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~   87 (162)
T d1a9na_          11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP   87 (162)
T ss_dssp             SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred             HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf             175168574848978899788-6576200414599898979978764--7744576130643102134577763223345


Q ss_pred             CCCEEECCCCCCCCCCC-CCCCCCCCCCEEEEECCCCCCCC---CCCCCCCCCCCEEE
Q ss_conf             67579834776788778-75567665656882023346877---86678888777687
Q 001440          205 NLAIMYLYNNSLSGSIP-SEIGNLKSLSGLELGYNKLSGSM---PLSLGNLPNLATLD  258 (1077)
Q Consensus       205 ~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~---p~~l~~l~~L~~L~  258 (1077)
                      +|+.|++++|+++.... ..+..+++|+.|++++|.++...   +..+..+++|++||
T Consensus        88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf             3443420300016654211001365320664079963456106999998789958337

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.66  E-value=5.8e-18  Score=112.03  Aligned_cols=130  Identities=25%  Similarity=0.267  Sum_probs=69.4

Q ss_pred             CCHHHCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCHHCCCC
Q ss_conf             82211178878489825961457743210001235623215774568888854443345066410322358761101345
Q 001440          555 IPSELGKLRSLIKLTLNRNQFSGQLPTELGSLIQLEHLDLSSNRLSNSIPGSLGNLVKLYYLNLSNNQFSGEIPIKLEKF  634 (1077)
Q Consensus       555 ~~~~l~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~  634 (1077)
                      .+..+..+++|++|+|++|+|+. ++ .+..+++|+.|++++|.++ .++..+..+++|++|++++|+|++.  ..+..+
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l  114 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKL  114 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHH
T ss_pred             HHHHHHCCCCCCEEECCCCCCCC-CC-CCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCC
T ss_conf             24677626046151994468998-64-4247825357341353432-1000033221233333333222222--222222


Q ss_pred             CCCCCEECCCCCCCCCCC-CCCCCCCCCCHHCCCCCCCCCCCCH----------HHHCCCCCCEEE
Q ss_conf             334611014665899774-0010223211202456634565310----------121156640883
Q 001440          635 IHLSDLDLSHNFLGEEIP-SQVCSMQSLEKLNLAHNNLSGFIPR----------CFKEMHGLVYID  689 (1077)
Q Consensus       635 ~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~~~----------~l~~l~~L~~l~  689 (1077)
                      ++|+.|++++|+|+.... ..+..+++|+.|++++|++....+.          .+..+|+|+.||
T Consensus       115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD  180 (198)
T d1m9la_         115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD  180 (198)
T ss_dssp             HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred             CCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCEEC
T ss_conf             234111234102125542212367776302342798434676322220558999998788958769

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.63  E-value=4.2e-16  Score=101.75  Aligned_cols=118  Identities=25%  Similarity=0.345  Sum_probs=0.0

Q ss_pred             CEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf             88837899888989998898676634145453457888997777575445531234687898998788776757983477
Q 001440          135 KYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNLTNLAIMYLYNN  214 (1077)
Q Consensus       135 ~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n  214 (1077)
                      |+|+|++|.++ .++. +.++++|++|++++|++. .+|..++.+++|+.|++++|.+++.  +.+.++++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCC--GGGTTCSSCCEEECCSS
T ss_pred             CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCC--CCCCCCCCCCEEECCCC
T ss_conf             98986899898-8710-105898898979787168-6521565543135453243211235--74123355576888898


Q ss_pred             CCCCCCC-CCCCCCCCCCEEEEECCCCCCCC---CCCCCCCCCCCEE
Q ss_conf             6788778-75567665656882023346877---8667888877768
Q 001440          215 SLSGSIP-SEIGNLKSLSGLELGYNKLSGSM---PLSLGNLPNLATL  257 (1077)
Q Consensus       215 ~l~~~~p-~~~~~l~~L~~L~l~~n~l~~~~---p~~l~~l~~L~~L  257 (1077)
                      +++.... ..+..+++|+.|++++|.++...   ......+|+|+.|
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf             65888882565379999999897996886826799999989673138

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=2e-15  Score=98.04  Aligned_cols=66  Identities=15%  Similarity=0.147  Sum_probs=30.7

Q ss_pred             CCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf             689998768976477-323337836579999988837899888989998898676634145453457
Q 001440          104 FSSFPHLAYLDLRVN-QIFGIIPSQIANNSKLKYLDLSSNSFSGTIPPQIGNLSMLKILYLSTNQFS  169 (1077)
Q Consensus       104 ~~~l~~l~~L~L~~n-~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~l~~n~~~  169 (1077)
                      +..++.+++|++++| .+..+.+..|.++++|+.|+|++|+++.+.|..|..+++|++|+|++|+++
T Consensus        27 l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~   93 (156)
T d2ifga3          27 LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE   93 (156)
T ss_dssp             SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred             CCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf             2576565743168986644369212256666672162021247742011124554333322678785

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.55  E-value=6.9e-15  Score=95.07  Aligned_cols=92  Identities=17%  Similarity=0.148  Sum_probs=45.5

Q ss_pred             CCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf             836579999988837899-8889899988986766341454534578889977775754455312346878989987887
Q 001440          125 PSQIANNSKLKYLDLSSN-SFSGTIPPQIGNLSMLKILYLSTNQFSGRIPPQIGHLSYLKALHLFENGLSGSIPPSLGNL  203 (1077)
Q Consensus       125 p~~~~~l~~L~~L~L~~n-~~~~~~p~~~~~l~~L~~L~l~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l  203 (1077)
                      |..+..+++|++|++++| .++.+.++.|.++++|+.|++++|+++.+.+..|.++++|++|+|++|+++...+..|..+
T Consensus        24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~~  103 (156)
T d2ifga3          24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGL  103 (156)
T ss_dssp             TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCSC
T ss_pred             CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCCC
T ss_conf             60025765657431689866443692122566666721620212477420111245543333226787851574563353


Q ss_pred             CCCCEEECCCCCCC
Q ss_conf             76757983477678
Q 001440          204 TNLAIMYLYNNSLS  217 (1077)
Q Consensus       204 ~~L~~L~L~~n~l~  217 (1077)
                       +|+.|+|++|.+.
T Consensus       104 -~l~~L~L~~Np~~  116 (156)
T d2ifga3         104 -SLQELVLSGNPLH  116 (156)
T ss_dssp             -CCCEEECCSSCCC
T ss_pred             -CCCCCCCCCCCCC
T ss_conf             -2124335798633

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=99.12  E-value=5.2e-10  Score=68.23  Aligned_cols=149  Identities=13%  Similarity=0.074  Sum_probs=98.7

Q ss_pred             HHHHHHHCCCCCCCEECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEEC
Q ss_conf             99999705977463322468822999995699899999746885202457999999999930789-99602179898609
Q 001440          799 EEIVRATNDFDEEHCIGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHA  877 (1077)
Q Consensus       799 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~  877 (1077)
                      .++......|...+..+.+....||+... +++.+++|+........   ...+.+|...+..+. +--+.+++++...+
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~   82 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCC---HHHHHHHHHHHHHHHCCCCCCCEEEEEECC
T ss_conf             99997513527997678998771899990-89869999848876532---556999999999876069987289997508


Q ss_pred             CEEEEEEEECCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC----------------------------
Q ss_conf             9569999604899998998248998788988899999999999999883799----------------------------
Q 001440          878 RHSFIVYEYLEMGSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF----------------------------  929 (1077)
Q Consensus       878 ~~~~lV~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----------------------------  929 (1077)
                      +..++||+++++.++.+.....        .....++.+++..++.||+...                            
T Consensus        83 ~~~~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          83 GWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             CCEEEEEEECCCCCCCCCCCCC--------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf             9649999860433435433440--------26999999899999998556842143576446565557789987765555


Q ss_pred             ----------------------------CCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             ----------------------------995841688897565899966991244533
Q 001440          930 ----------------------------PPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       930 ----------------------------~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                                                  +.++|+|+.+.||+++.+..+.+.||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf             4303323200579999999984498678178986004764236499659996023144

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.00  E-value=1.7e-11  Score=76.35  Aligned_cols=64  Identities=31%  Similarity=0.302  Sum_probs=23.7

Q ss_pred             HCCCCCCEEECCCCCCCCCC--CCCCCCCCCCEEEEECCCCCCCCCCHHCCCCCCCCCEECCCCCC
Q ss_conf             00123562321577456888--88544433450664103223587611013453346110146658
Q 001440          584 GSLIQLEHLDLSSNRLSNSI--PGSLGNLVKLYYLNLSNNQFSGEIPIKLEKFIHLSDLDLSHNFL  647 (1077)
Q Consensus       584 ~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l  647 (1077)
                      ..+++|+.|++++|+|+...  +..+..+++|+.|++++|.|++.....+.....|+.|++++|++
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl  127 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL  127 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTT
T ss_pred             HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCC
T ss_conf             748787886377766667731588986588561000435721342344222033104266489976

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.99  E-value=2.4e-11  Score=75.59  Aligned_cols=82  Identities=30%  Similarity=0.231  Sum_probs=37.4

Q ss_pred             CCCCCCEEEEECCCCCCCCC--CHHCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCC-------HH
Q ss_conf             44334506641032235876--1101345334611014665899774001022321120245663456531-------01
Q 001440          608 GNLVKLYYLNLSNNQFSGEI--PIKLEKFIHLSDLDLSHNFLGEEIPSQVCSMQSLEKLNLAHNNLSGFIP-------RC  678 (1077)
Q Consensus       608 ~~l~~L~~L~L~~N~l~~~~--~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~-------~~  678 (1077)
                      ..+++|++|++++|+|++..  +..+..+++|+.|++++|.|.....-.+....+|+.+++++|++.....       ..
T Consensus        62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i  141 (162)
T d1koha1          62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI  141 (162)
T ss_dssp             HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHH
T ss_pred             HHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHH
T ss_conf             74878788637776666773158898658856100043572134234422203310426648997676766615699999


Q ss_pred             HHCCCCCCEEE
Q ss_conf             21156640883
Q 001440          679 FKEMHGLVYID  689 (1077)
Q Consensus       679 l~~l~~L~~l~  689 (1077)
                      +..+|+|+.||
T Consensus       142 ~~~~P~L~~LD  152 (162)
T d1koha1         142 RERFPKLLRLD  152 (162)
T ss_dssp             HTTSTTCCEET
T ss_pred             HHHCCCCCEEC
T ss_conf             99889978799

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.75  E-value=7.1e-09  Score=61.96  Aligned_cols=130  Identities=17%  Similarity=0.126  Sum_probs=82.5

Q ss_pred             EECCCCC-CEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC--CCCEEEEEEEEEECCEEEEEEEECCC
Q ss_conf             3224688-22999995699899999746885202457999999999930789--99602179898609956999960489
Q 001440          813 CIGTGGQ-GSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR--HRNIVKFYGFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       813 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~  889 (1077)
                      .+..|.. ..||+....++..+++|........      .+..|...++.+.  .-.+.+++++..+++..++||+++++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH------HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEEC
T ss_conf             767865477589999389878999958966776------89999999999986599988613222456615999874413


Q ss_pred             CCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC----------------------------------------
Q ss_conf             9998998248998788988899999999999999883799----------------------------------------
Q 001440          890 GSLAMILSNATSAEELGWTQRMNVIKGVADALSYLHNDCF----------------------------------------  929 (1077)
Q Consensus       890 g~L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----------------------------------------  929 (1077)
                      .++.+.        ...   ....+.+++..++.||+...                                        
T Consensus        91 ~~~~~~--------~~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (255)
T d1nd4a_          91 QDLLSS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA  159 (255)
T ss_dssp             EETTTS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred             CCCCCC--------CCC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHH
T ss_conf             554322--------126---899999999999987368854488755412468899999987541101134011213799


Q ss_pred             ---------------CCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             ---------------995841688897565899966991244533
Q 001440          930 ---------------PPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       930 ---------------~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                                     +.++|+|+.+.||+++.+..+.+.||+.+.
T Consensus       160 ~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         160 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf             999999871876579567867888763577379658999853326

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.51  E-value=2.9e-08  Score=58.58  Aligned_cols=14  Identities=21%  Similarity=0.401  Sum_probs=4.9

Q ss_pred             CCCCEEECCCCCCC
Q ss_conf             87848982596145
Q 001440          563 RSLIKLTLNRNQFS  576 (1077)
Q Consensus       563 ~~L~~L~L~~N~l~  576 (1077)
                      +.|+.|++++|.++
T Consensus        44 ~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          44 KHIEKFSLANTAIS   57 (167)
T ss_dssp             SCCCEEECTTSCCB
T ss_pred             CCCCEEECCCCCCC
T ss_conf             76454012015621

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=98.43  E-value=2.4e-08  Score=59.06  Aligned_cols=16  Identities=19%  Similarity=0.382  Sum_probs=6.3

Q ss_pred             CCCCCCEEECCCCCCC
Q ss_conf             0123562321577456
Q 001440          585 SLIQLEHLDLSSNRLS  600 (1077)
Q Consensus       585 ~l~~L~~L~Ls~N~l~  600 (1077)
                      ..+.|+.|++++|.+.
T Consensus        42 ~n~~L~~L~Ls~n~l~   57 (167)
T d1pgva_          42 NSKHIEKFSLANTAIS   57 (167)
T ss_dssp             TCSCCCEEECTTSCCB
T ss_pred             HCCCCCEEECCCCCCC
T ss_conf             3776454012015621

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.38  E-value=1.3e-06  Score=49.52  Aligned_cols=79  Identities=13%  Similarity=0.015  Sum_probs=45.9

Q ss_pred             CCEECCCCCCEEEEEEECC-CCEEEEEECCCCCC---CH-HHHHHHHHHHHHHHCCC-C--CCCEEEEEEEEEECCEEEE
Q ss_conf             6332246882299999569-98999997468852---02-45799999999993078-9--9960217989860995699
Q 001440          811 EHCIGTGGQGSVYRAELSS-GEIVAVKKFHSPLL---SE-MTCQQEFLNEVKSLTEI-R--HRNIVKFYGFCSHARHSFI  882 (1077)
Q Consensus       811 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~-~~~~~~~~~e~~~l~~l-~--h~niv~l~~~~~~~~~~~l  882 (1077)
                      .+.+|.|....||+++..+ ++.+++|.......   .. .........|.+.++.+ .  ...+++++.+.  +...++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf             998079852768999957998489996177130346777888778999999999986505798855289985--988779


Q ss_pred             EEEECCCCC
Q ss_conf             996048999
Q 001440          883 VYEYLEMGS  891 (1077)
Q Consensus       883 V~e~~~~g~  891 (1077)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEECCCCCC
T ss_conf             871357765

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.09  E-value=1.4e-07  Score=54.82  Aligned_cols=15  Identities=7%  Similarity=0.025  Sum_probs=5.4

Q ss_pred             CCCCCEEECCCCCCC
Q ss_conf             887848982596145
Q 001440          562 LRSLIKLTLNRNQFS  576 (1077)
Q Consensus       562 ~~~L~~L~L~~N~l~  576 (1077)
                      .++|++|++++|.++
T Consensus        45 n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          45 NTYVKKFSIVGTRSN   59 (166)
T ss_dssp             CCSCCEEECTTSCCC
T ss_pred             CCCCCEEECCCCCCC
T ss_conf             982574301589611

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=98.08  E-value=4.3e-07  Score=52.15  Aligned_cols=15  Identities=7%  Similarity=0.158  Sum_probs=5.6

Q ss_pred             CCCCCEEECCCCCCC
Q ss_conf             123562321577456
Q 001440          586 LIQLEHLDLSSNRLS  600 (1077)
Q Consensus       586 l~~L~~L~Ls~N~l~  600 (1077)
                      .+.|+.|++++|.++
T Consensus        45 n~~L~~L~Ls~n~l~   59 (166)
T d1io0a_          45 NTYVKKFSIVGTRSN   59 (166)
T ss_dssp             CCSCCEEECTTSCCC
T ss_pred             CCCCCEEECCCCCCC
T ss_conf             982574301589611

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=98.06  E-value=2.1e-05  Score=42.86  Aligned_cols=138  Identities=12%  Similarity=0.091  Sum_probs=72.7

Q ss_pred             CCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCCCCCE--EEEE-----EEEEECCEEEEEEEECCC
Q ss_conf             688229999956998999997468852024579999999999307899960--2179-----898609956999960489
Q 001440          817 GGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIRHRNI--VKFY-----GFCSHARHSFIVYEYLEM  889 (1077)
Q Consensus       817 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~-----~~~~~~~~~~lV~e~~~~  889 (1077)
                      +..-.||+++..+|+.|++|.......+    .+++..|...+..+...++  +..+     ......+..+.++++++|
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             CCCCEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf             6120269998389997999984787788----999999999999998559987875206898056653479999865277


Q ss_pred             CCH------------------HHHHHCCCC--CCCCCH-------------------H---HHHHHHHHHHHHHHHHH-H
Q ss_conf             999------------------899824899--878898-------------------8---89999999999999988-3
Q 001440          890 GSL------------------AMILSNATS--AEELGW-------------------T---QRMNVIKGVADALSYLH-N  926 (1077)
Q Consensus       890 g~L------------------~~~l~~~~~--~~~l~~-------------------~---~~~~i~~~ia~~l~~LH-~  926 (1077)
                      ..+                  +........  ....++                   .   .....+..+...+.-.- .
T Consensus       109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~  188 (325)
T d1zyla1         109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE  188 (325)
T ss_dssp             EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf             68899999999998999999886303578655677897887665689998747699889899999999999999984545


Q ss_pred             CCCCCEEECCCCCCCEEECCCCCEEEECCCCCCC
Q ss_conf             7999958416888975658999669912445334
Q 001440          927 DCFPPIVYRDISSKNVLLDLEYEAHVSDFGISKS  960 (1077)
Q Consensus       927 ~~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~~  960 (1077)
                      ....+++|+|+.+.||+++. + ..+.||+-+..
T Consensus       189 ~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         189 DFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             CCCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf             68712024788804287838-9-35886520146

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.70  E-value=0.00012  Score=38.70  Aligned_cols=73  Identities=21%  Similarity=0.242  Sum_probs=44.2

Q ss_pred             CCEECCCCCCEEEEEEECCC--------CEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEECCEEE
Q ss_conf             63322468822999995699--------899999746885202457999999999930789-996021798986099569
Q 001440          811 EHCIGTGGQGSVYRAELSSG--------EIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-HRNIVKFYGFCSHARHSF  881 (1077)
Q Consensus       811 ~~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~  881 (1077)
                      .+.++.|-.-.+|++..+++        +.|.++..-.. ..    .-...+|..+++.+. +.-..++++++..    +
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~----~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET----ESHLVAESVIFTLLSERHLGPKLYGIFSG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred             EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-CH----HHHHHHHHHHHHHHHHCCCCCEEEEECCC----C
T ss_conf             999178533434899968877544578981799965996-11----65899999999999757999808998189----5


Q ss_pred             EEEEECCCCCH
Q ss_conf             99960489999
Q 001440          882 IVYEYLEMGSL  892 (1077)
Q Consensus       882 lV~e~~~~g~L  892 (1077)
                      +|+||+++.++
T Consensus       118 ~I~efi~g~~l  128 (395)
T d1nw1a_         118 RLEEYIPSRPL  128 (395)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEECCCCC
T ss_conf             69997345548

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.41  E-value=0.0016  Score=32.49  Aligned_cols=159  Identities=11%  Similarity=0.052  Sum_probs=80.5

Q ss_pred             CCCHHHHHHHHCCCCCCCE-----ECCCCCCEEEEEEECCCCEEEEEECCCCCCCHHHHHHHHHHHHHHHCCCC-----C
Q ss_conf             6779999997059774633-----22468822999995699899999746885202457999999999930789-----9
Q 001440          795 KIAYEEIVRATNDFDEEHC-----IGTGGQGSVYRAELSSGEIVAVKKFHSPLLSEMTCQQEFLNEVKSLTEIR-----H  864 (1077)
Q Consensus       795 ~~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----h  864 (1077)
                      ..+.+++.....+|.+++.     +..|..-+.|+.+..+|+ +++|.+.....     ..++..|...+..+.     .
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~-----~~~l~~~~~~l~~L~~~g~pv   75 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE-----KNDLPFFLGLMQHLAAKGLSC   75 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC--------CCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCCC-----HHHHHHHHHHHHHHHHCCCCC
T ss_conf             889999999998679998568523788852673899978972-89998078999-----889999999987543025554


Q ss_pred             CCEEEEE-E--EEEECCEEEEEEEECCCCCHH--------------HHHHC----CCCC--C------------------
Q ss_conf             9602179-8--986099569999604899998--------------99824----8998--7------------------
Q 001440          865 RNIVKFY-G--FCSHARHSFIVYEYLEMGSLA--------------MILSN----ATSA--E------------------  903 (1077)
Q Consensus       865 ~niv~l~-~--~~~~~~~~~lV~e~~~~g~L~--------------~~l~~----~~~~--~------------------  903 (1077)
                      |..+... |  +....+....++.+..+....              ..++.    ....  .                  
T Consensus        76 p~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (316)
T d2ppqa1          76 PLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERA  155 (316)
T ss_dssp             CCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGG
T ss_pred             CCCCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHH
T ss_conf             55641048976213412550245311465533320467888889987645444320245310111012002456777765


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEECCCCCC
Q ss_conf             889888999999999999998837-99995841688897565899966991244533
Q 001440          904 ELGWTQRMNVIKGVADALSYLHND-CFPPIVYRDISSKNVLLDLEYEAHVSDFGISK  959 (1077)
Q Consensus       904 ~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dlk~~Nill~~~~~~kl~Dfgla~  959 (1077)
                      ..........+......+...... ...|++|+|+.+.||+++.+...-+.||+.+.
T Consensus       156 ~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         156 DEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCC
T ss_conf             311412799999998764204855454503337863656402045412674222123